Citrus Sinensis ID: 036342

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590------
Protein Sequence
EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRQRGKKPSNDANMPLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP
Secondary Structure (PSIPRED)
cccHHccccccccccccccccccccccHHHHccccccEEEccccccEEEccHHHHcccccccEEEccccEEcccccHHHHHcccccEEEccccEEEEcccccccccccccEEEccccccccccccccccccccccccccEEEccccccccccccccccccccccccEEccccEEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccccHHccccccccccccccccccHHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHHccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEccHHHHHHHHHHccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccEEEEcccccccccccccccccEEEccccEEEccc
Secondary Structure Prediction (SSPRO)
cccHHHccccccEEEEcccccccccccHHHccccccEEEEcccccccccccHHHHHHHccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEcccccccccccccccHHHccccccEEEEEccccccccccHHHHcccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEccEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccccccHHHccHHHcccccEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHcccHccEEEcccccEEEEcHHHHHHHHHHHHHHHHHHHHHHHHEcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEEcccccEEEcccccHHHHHHcHHHHEcccccccccEHHccccccccc
Coil and Loop (DISEMBL)
eipleignlqnleeLQLGQNKLIGTVPAAIFNVSTLKFLglqnnslsgslssianvrlpnleklylwgnnfsgtiprfifnasklsklslgmnsfsgfipstfgnlrnleqlgldenyltsstpelsflsslsncksltlidlsnnpldgilpktsiSNLSRSLEEFYMYNcnisggipeeisnltnlveidlggnklngsipitlGKLRKLQRlnlednilegsipdDICRLAELYRLElgsnklygsipacfgNLASLRILSlgsnkltsipltFWNLKDILQlnfssnfltgpllleiGNLKVLIGIDfsmnnfsgvipreigEKLSYLEDLNLSFNKlkgeiprggsfgnfsaesfegnellcgspnlqvppcktsihhtswKNSLLLGIVLPLSTTLLIVVIWLILRYRqrgkkpsndanmplvATWRTFSYLELCratdefsennligrgGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEymphgslekylyssnCILDIFQRLNIMIDVASALEYLHFGYSALVIHcdlkpsnvllddnmvahlsdfsiaklltgedqsmtqtqtlgtigymap
Flexible Loop (DISEMBL)
EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDlsnnpldgilPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDnilegsipddICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRqrgkkpsndanmplVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKlltgedqsmtqtqtlgtigymap
Low Complexity Region (SEG)
EIPleignlqnleelqlgqnklIGTVPAAIFNVSTLKFlglqnnslsgslssIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLGIVLPlsttllivviwlilRYRQRGKKPSNDANMPLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP
Disordered region (IsUnstruct)
********LQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRQR*******ANMPLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT********************
Disordered Region (DISOPRED)
EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSP*********************LGIVLPLSTTLLIVVIWLILR*********************TFSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED***TQTQTLGTIGYMAP
Disordered Region (DISEMBL)
EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRQRGKKPSNDANMPLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP
Disordered Region (DISPRO)
EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRQR**********PLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL*****M**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRQRGKKPSNDANMPLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	596	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.983	0.580	0.362	5e-96
C0LGT6	1031	LRR receptor-like serine/	no	no	0.996	0.576	0.355	2e-92
Q9SD62	1025	Putative receptor-like pr	no	no	0.998	0.580	0.367	1e-89
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.978	0.594	0.323	4e-81
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.983	0.560	0.322	3e-76
Q9LP24	1120	Probable leucine-rich rep	no	no	0.971	0.516	0.318	1e-74
C0LGW6	966	LRR receptor-like serine/	no	no	0.983	0.606	0.322	4e-72
Q42371	976	LRR receptor-like serine/	no	no	0.984	0.601	0.315	1e-70
Q6XAT2	967	LRR receptor-like serine/	no	no	0.974	0.600	0.324	2e-70
Q9FL28	1173	LRR receptor-like serine/	no	no	0.978	0.497	0.316	2e-69

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  352 bits (903), Expect = 5e-96,   Method: Compositional matrix adjust.
 Identities = 254/700 (36%), Positives = 358/700 (51%), Gaps = 114/700 (16%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           EIP ++  L  +  LQL  N   G  P A++N+S+LK LG+  N  SG L     + LPN
Sbjct: 201 EIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPN 260

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L    + GN F+G+IP  + N S L +L +  N+ +G IP TFGN+ NL+ L L  N L 
Sbjct: 261 LLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLG 319

Query: 121 S-STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSR----------------- 162
           S S+ +L FL+SL+NC  L  + +  N L G LP  SI+NLS                  
Sbjct: 320 SDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLP-ISIANLSAKLVTLDLGGTLISGSIP 378

Query: 163 -------------------------------SLEEFYMYNCNISGGIPEEISNLTNLVEI 191
                                          +L    +++  +SGGIP  I N+T L  +
Sbjct: 379 YDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETL 438

Query: 192 DLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIP 251
           DL  N   G +P +LG    L  L + DN L G+IP +I ++ +L RL++  N L GS+P
Sbjct: 439 DLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLP 498

Query: 252 ACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLL-EIGNLKVLIG 309
              G L +L  LSLG NKL+  +P T  N      L   S FL G L   +I +LK L+G
Sbjct: 499 QDIGALQNLGTLSLGDNKLSGKLPQTLGNC-----LTMESLFLEGNLFYGDIPDLKGLVG 553

Query: 310 ---IDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELL 366
              +D S N+ SG IP E     S LE LNLSFN L+G++P  G F N +  S  GN  L
Sbjct: 554 VKEVDLSNNDLSGSIP-EYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDL 612

Query: 367 CGS-PNLQVPPCKTSI-----HHTSWKNSLLLGIVLPLSTTLL-----IVVIWLILRYRQ 415
           CG     Q+ PC +        H+S    +++G+ + ++  LL     + +IW  LR R+
Sbjct: 613 CGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIW--LRKRK 670

Query: 416 RGKKPSNDANMPLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAF---------- 465
           + K+ +N     L       SY +L  AT+ FS +N++G G F    +A           
Sbjct: 671 KNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAV 730

Query: 466 -----------KSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLE 509
                      KSF  ECE +K IRHRNL+K++++CS+      EF+AL+ E+MP+GSL+
Sbjct: 731 KVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLD 790

Query: 510 KYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN 561
            +L+             L + +RLNI IDVAS L+YLH      + HCDLKPSNVLLDD+
Sbjct: 791 MWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDD 850

Query: 562 MVAHLSDFSIAKLLTGEDQ-----SMTQTQTLGTIGYMAP 596
           + AH+SDF +A+LL   D+      ++     GTIGY AP
Sbjct: 851 LTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP 890

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  340 bits (872), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 247/695 (35%), Positives = 351/695 (50%), Gaps = 101/695 (14%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           EIP E+  L  +   Q+  N   G  P A++N+S+L+ L L +NS SG+L +     LPN
Sbjct: 208 EIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPN 267

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD-ENYL 119
           L +L L  N F+G IP+ + N S L +  +  N  SG IP +FG LRNL  LG+   +  
Sbjct: 268 LRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLG 327

Query: 120 TSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
            +S+  L F+ +++NC  L  +D+  N L G LP  SI+NLS +L   ++    ISG IP
Sbjct: 328 NNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELP-ASIANLSTTLTSLFLGQNLISGTIP 386

Query: 180 EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
            +I NL +L E+ L  N L+G +P++ GKL  LQ ++L  N + G IP     +  L +L
Sbjct: 387 HDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKL 446

Query: 240 ELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLL 298
            L SN  +G IP   G    L  L + +N+L  +IP     +  +  ++ S+NFLTG   
Sbjct: 447 HLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFP 506

Query: 299 LEIGNLKVLIG-----------------------------------------------ID 311
            E+G L++L+G                                               +D
Sbjct: 507 EEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKNVD 566

Query: 312 FSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGS-P 370
           FS NN SG IPR +   L  L +LNLS NK +G +P  G F N +A S  GN  +CG   
Sbjct: 567 FSNNNLSGRIPRYLAS-LPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVR 625

Query: 371 NLQVPPCKTSIHHT-----SWKNSLLLGIVLPLSTTLLIVVIWLILRYRQRGKK-PSNDA 424
            +Q+ PC            S +  ++ GI + +++ LLI+++  +  + +R KK  ++D 
Sbjct: 626 EMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDG 685

Query: 425 NMPLVATWRTF----SYLELCRATDEFSENNLIGRGGFALFIR----------------- 463
           N     T   F    SY EL  AT  FS  NLIG G F    +                 
Sbjct: 686 NPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNL 745

Query: 464 ----AFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLY- 513
               A KSF  ECE  K IRHRNL+K+I+ CS+      +F+ALV E+MP GSL+ +L  
Sbjct: 746 LKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQL 805

Query: 514 -------SSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHL 566
                    +  L   ++LNI IDVASALEYLH      V HCD+KPSN+LLDD++ AH+
Sbjct: 806 EDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHV 865

Query: 567 SDFSIAKLLTGEDQ-----SMTQTQTLGTIGYMAP 596
           SDF +A+LL   D+       +     GTIGY AP
Sbjct: 866 SDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAP 900

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  331 bits (849), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 255/693 (36%), Positives = 355/693 (51%), Gaps = 98/693 (14%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           EIP +I  L+ +   ++  NK  G  P  I+N+S+L FL +  NS SG+L       LPN
Sbjct: 216 EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPN 275

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L+ LY+  N+F+GTIP  + N S L +L +  N  +G IP +FG L+NL  LGL+ N L 
Sbjct: 276 LQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLG 335

Query: 121 S-STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
           + S+ +L FL +L+NC  L  +++  N L G LP   I+NLS  L E  +    ISG IP
Sbjct: 336 NYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLP-VFIANLSTQLTELSLGGNLISGSIP 394

Query: 180 EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
             I NL +L  +DLG N L G +P +LG+L +L+++ L  N L G IP  +  ++ L  L
Sbjct: 395 HGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYL 454

Query: 240 ELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLL 298
            L +N   GSIP+  G+ + L  L+LG+NKL  SIP     L  ++ LN S N L GPL 
Sbjct: 455 YLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLR 514

Query: 299 LEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSY----------------------LEDLN 336
            +IG LK L+ +D S N  SG IP+ +   LS                       L  L+
Sbjct: 515 QDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRGLTGLRFLD 574

Query: 337 LSFNKLKGEIPR------------------------GGSFGNFSAESFEGNELLCGS-PN 371
           LS N L G IP                          G F N SA S  GN  LCG  P+
Sbjct: 575 LSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPS 634

Query: 372 LQVPPCKTSI--HHTSWKNSLLLGI-----VLPLSTTLLIVVIWLILRYRQ-RGKKPSND 423
           LQ+ PC   +   H+S +  + + +      L L    ++ + W  LR +  R     ND
Sbjct: 635 LQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEND 694

Query: 424 ANM-PLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAF----------------- 465
            +  P+ + +   SY EL + T  FS +NLIG G F    + F                 
Sbjct: 695 RSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCK 754

Query: 466 ----KSFDVECEMMKSIRHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSSN 516
               KSF  ECE +  IRHRNL+K+++ CS+      +F+ALV E+MP+G+L+ +L+   
Sbjct: 755 RGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDE 814

Query: 517 C--------ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD 568
                     L +F RLNI IDVASAL YLH      + HCD+KPSN+LLD ++ AH+SD
Sbjct: 815 IEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSD 874

Query: 569 FSIAKLLTGEDQSMTQTQ-----TLGTIGYMAP 596
           F +A+LL   D+     Q       GTIGY AP
Sbjct: 875 FGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAP 907

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  302 bits (774), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 235/726 (32%), Positives = 358/726 (49%), Gaps = 143/726 (19%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIF---NVSTLKFLGLQNNSLSGSLSSIANVRL 58
           IP E+G L  L  L LG N+L G++P  +F   + S+L+++ L NNSL+G +    +  L
Sbjct: 131 IPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHL 190

Query: 59  PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPS-TFGNLRNLEQLGLDEN 117
             L  L LW N  +GT+P  + N++ L  + L  N  SG +PS     +  L+ L L  N
Sbjct: 191 KELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYN 250

Query: 118 YLTS---STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNI 174
           +  S   +T    F +SL+N   L  ++L+ N L G +  +S+ +LS +L + ++    I
Sbjct: 251 HFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEI-TSSVRHLSVNLVQIHLDQNRI 309

Query: 175 SGGIPEEIS------------------------NLTNLVEIDLGGNKLNGSIPITLGKLR 210
            G IP EIS                         L+ L  + L  N L G IP+ LG + 
Sbjct: 310 HGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIP 369

Query: 211 KLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKL 270
           +L  L++  N L GSIPD    L++L RL L  N L G++P   G   +L IL L  N L
Sbjct: 370 RLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNL 429

Query: 271 T-SIPL-TFWNLKDI-LQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGE 327
           T +IP+    NL+++ L LN SSN L+GP+ LE+  + +++ +D S N  SG IP ++G 
Sbjct: 430 TGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGS 489

Query: 328 -----------------------KLSYLEDLNLSFNKLKGEIPRG--------------- 349
                                  +L YL++L++SFN+L G IP                 
Sbjct: 490 CIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFN 549

Query: 350 ---------GSFGNFSAESFEGNELLCGS-PNLQVPPCKTSIHHTSWKNSLLLGIVLPLS 399
                    GSF   + ESF G+ LLCGS   +Q   CK       + + LL  ++  ++
Sbjct: 550 LLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQA--CKKK---HKYPSVLLPVLLSLIA 604

Query: 400 TTLLIVVIWLILRYRQRG---------------KKPSNDANMPLVATWRTFSYLELCRAT 444
           T +L V  + +++  + G               K+  ND   P +      SY +L  AT
Sbjct: 605 TPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRI------SYQQLIAAT 658

Query: 445 DEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNL 483
             F+ ++LIG G F    +                        SF  EC+++K  RHRNL
Sbjct: 659 GGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNL 718

Query: 484 IKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF 540
           I++I++CS   F ALVL  MP+GSLE++LY    S+  LD+ Q +NI  DVA  + YLH 
Sbjct: 719 IRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH 778

Query: 541 GYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL----------GT 590
                V+HCDLKPSN+LLDD M A ++DF I++L+ G +++++   ++          G+
Sbjct: 779 YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGS 838

Query: 591 IGYMAP 596
           +GY+AP
Sbjct: 839 VGYIAP 844

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  286 bits (732), Expect = 3e-76,   Method: Compositional matrix adjust.
 Identities = 220/683 (32%), Positives = 329/683 (48%), Gaps = 97/683 (14%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGS-------LSSI 53
           EIP EIGN+  L+ L L  NKL G +P+ + N+ TL  L L  N L+GS       + S+
Sbjct: 277 EIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESM 336

Query: 54  ANV----------------RLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSG 97
            ++                +L  LE L+L  N  SG IP  I N+++L+ L L  N+F+G
Sbjct: 337 IDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTG 396

Query: 98  FIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL------------------- 138
           F+P T      LE L LD+N+     P+     SL +CKSL                   
Sbjct: 397 FLPDTICRGGKLENLTLDDNHFEGPVPK-----SLRDCKSLIRVRFKGNSFSGDISEAFG 451

Query: 139 -----TLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL 193
                  IDLSNN   G L  ++    S+ L  F + N +I+G IP EI N+T L ++DL
Sbjct: 452 VYPTLNFIDLSNNNFHGQL--SANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDL 509

Query: 194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPAC 253
             N++ G +P ++  + ++ +L L  N L G IP  I  L  L  L+L SN+    IP  
Sbjct: 510 SSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPT 569

Query: 254 FGNLASLRILSLGSNKL-TSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDF 312
             NL  L  ++L  N L  +IP     L  +  L+ S N L G +  +  +L+ L  +D 
Sbjct: 570 LNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDL 629

Query: 313 SMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNL 372
           S NN SG IP    + L+ L  +++S N L+G IP   +F N   ++FEGN+ LCGS N 
Sbjct: 630 SHNNLSGQIPPSFKDMLA-LTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNT 688

Query: 373 Q--VPPCKTSIHHTSWKN-SLLLGIVLPLSTTLLI--VVIWLILRYRQRGKK-------P 420
              + PC  +    S K+ +L++ I++P+   ++I  V   + + +R+R K+        
Sbjct: 689 TQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSE 748

Query: 421 SNDANMPLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRA---------------- 464
           S    + + +      Y E+ +AT EF    LIG GG     +A                
Sbjct: 749 SGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNAIMAVKKLNETT 808

Query: 465 ---------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 515
                     + F  E   +  IRHRN++K+   CS+     LV EYM  GSL K L + 
Sbjct: 809 DSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLEND 868

Query: 516 NCI--LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           +    LD  +R+N++  VA AL Y+H   S  ++H D+   N+LL ++  A +SDF  AK
Sbjct: 869 DEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAK 928

Query: 574 LLTGEDQSMTQTQTLGTIGYMAP 596
           LL  +  S   +   GT GY+AP
Sbjct: 929 LL--KPDSSNWSAVAGTYGYVAP 949

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  281 bits (719), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 218/684 (31%), Positives = 327/684 (47%), Gaps = 105/684 (15%)

Query: 2    IPLEIGNLQNLEELQLGQNKLIGTVPAA------------------------IFNVSTLK 37
            IP E+GN++++ +LQL  NKL G++P++                        + N+ ++ 
Sbjct: 358  IPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMI 417

Query: 38   FLGLQNNSLSGSL-SSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFS 96
             L L  N L+GS+  S  N     LE LYL  N+ SG IP  + N+S L+ L L  N+F+
Sbjct: 418  NLDLSQNKLTGSVPDSFGN--FTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFT 475

Query: 97   GFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL------------------ 138
            GF P T    R L+ + LD N+L    P+     SL +CKSL                  
Sbjct: 476  GFFPETVCKGRKLQNISLDYNHLEGPIPK-----SLRDCKSLIRARFLGNKFTGDIFEAF 530

Query: 139  ------TLIDLSNNPLDGILPKTSISNLSRS--LEEFYMYNCNISGGIPEEISNLTNLVE 190
                    ID S+N   G +     SN  +S  L    M N NI+G IP EI N+T LVE
Sbjct: 531  GIYPDLNFIDFSHNKFHGEIS----SNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVE 586

Query: 191  IDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSI 250
            +DL  N L G +P  +G L  L RL L  N L G +P  +  L  L  L+L SN     I
Sbjct: 587  LDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEI 646

Query: 251  PACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIG 309
            P  F +   L  ++L  NK   SIP     L  + QL+ S N L G +  ++ +L+ L  
Sbjct: 647  PQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDK 705

Query: 310  IDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGS 369
            +D S NN SG+IP    E +  L ++++S NKL+G +P   +F   +A++ E N  LC +
Sbjct: 706  LDLSHNNLSGLIPTTF-EGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSN 764

Query: 370  -PNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIW-----LILRYRQ----RGKK 419
             P  ++ PC+  +       +L++ I++P+   L+I+ I        +R R+    R   
Sbjct: 765  IPKQRLKPCR-ELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTD 823

Query: 420  PSNDANMPLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRA--------------- 464
            P    NM + +    F Y ++  +T+EF   +LIG GG++   RA               
Sbjct: 824  PETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQDTIIAVKRLHDT 883

Query: 465  ----------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 514
                       + F  E + +  IRHRN++K+   CS+     L+ EYM  GSL K L +
Sbjct: 884  IDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLAN 943

Query: 515  SNCI--LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA 572
                  L   +R+N++  VA AL Y+H      ++H D+   N+LLD++  A +SDF  A
Sbjct: 944  DEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTA 1003

Query: 573  KLLTGEDQSMTQTQTLGTIGYMAP 596
            KLL  +  S   +   GT GY+AP
Sbjct: 1004 KLL--KTDSSNWSAVAGTYGYVAP 1025

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1

 Score =  273 bits (697), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 224/695 (32%), Positives = 322/695 (46%), Gaps = 109/695 (15%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLK----------------------- 37
           +IP  I  L+ LE L L  N+L G VPA +  +  LK                       
Sbjct: 134 DIPFSISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVL 193

Query: 38  -FLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFS 96
            +LGL+ N L+G+LSS    +L  L    + GNN +GTIP  I N +    L +  N  +
Sbjct: 194 QYLGLRGNMLTGTLSSDM-CQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQIT 252

Query: 97  GFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTS 156
           G IP   G L+ +  L L  N LT   PE+  L      ++L ++DLS+N L G +P   
Sbjct: 253 GEIPYNIGFLQ-VATLSLQGNRLTGRIPEVIGL-----MQALAVLDLSDNELVGPIPPI- 305

Query: 157 ISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLN 216
           + NLS +  + Y++   ++G IP E+ N++ L  + L  NKL G+IP  LGKL +L  LN
Sbjct: 306 LGNLSFT-GKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELN 364

Query: 217 LEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT----- 271
           L +N L G IP +I   A L +  +  N L GSIP  F NL SL  L+L SN        
Sbjct: 365 LANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPV 424

Query: 272 --------------------SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGID 311
                               SIPLT  +L+ +L LN S N L+G L  E GNL+ +  ID
Sbjct: 425 ELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMID 484

Query: 312 FSMNNFSGVIPREIGEKLSY-----------------------LEDLNLSFNKLKGEIPR 348
            S N  SGVIP E+G+  +                        L +LN+SFN L G +P 
Sbjct: 485 VSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPP 544

Query: 349 GGSFGNFSAESFEGNELLCGS--PNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVV 406
             +F  F+  SF GN  LCG+   ++  P  K+ +        ++LG++  L    L V 
Sbjct: 545 MKNFSRFAPASFVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLCMIFLAVY 604

Query: 407 IWLILRYRQRGKKPSNDANMPLV---ATWRTFSYLELCRATDEFSENNLIGRGG------ 457
             +  +   +G     +    LV         ++ ++ R T+  +E  +IG G       
Sbjct: 605 KSMQQKKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYK 664

Query: 458 --------------FALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 503
                         +  +    + F+ E E + SIRHRN++ +     +     L  +YM
Sbjct: 665 CALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYM 724

Query: 504 PHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN 561
            +GSL   L+ S     LD   RL I +  A  L YLH   +  +IH D+K SN+LLD+N
Sbjct: 725 ENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDEN 784

Query: 562 MVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             AHLSDF IAK +    ++   T  LGTIGY+ P
Sbjct: 785 FEAHLSDFGIAKSIPAS-KTHASTYVLGTIGYIDP 818

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1

 Score =  268 bits (684), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 220/697 (31%), Positives = 325/697 (46%), Gaps = 110/697 (15%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           +IP  I  L+ LE+L L  N+LIG +P+ +  +  LK L L  N LSG +  +       
Sbjct: 131 DIPFSISKLKQLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWN-EV 189

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L+ L L GNN  G I   +   + L    +  NS +G IP T GN    + L L  N LT
Sbjct: 190 LQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLT 249

Query: 121 SSTP-ELSFL-----------------SSLSNCKSLTLIDLSNNPLDGILPKTSISNLSR 162
              P ++ FL                 S +   ++L ++DLS N L G +P   + NL+ 
Sbjct: 250 GEIPFDIGFLQVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPI-LGNLTF 308

Query: 163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNIL 222
           + E+ Y+++  ++G IP E+ N++ L  ++L  N L G IP  LGKL  L  LN+ +N L
Sbjct: 309 T-EKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDL 367

Query: 223 EGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS---------- 272
           EG IPD +     L  L +  NK  G+IP  F  L S+  L+L SN +            
Sbjct: 368 EGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIG 427

Query: 273 ---------------IPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNF 317
                          IP +  +L+ +L++N S N +TG +  + GNL+ ++ ID S N+ 
Sbjct: 428 NLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDI 487

Query: 318 SGVIPREIGE----KLSYLED------------------LNLSFNKLKGEIPRGGSFGNF 355
           SG IP E+ +     L  LE+                  LN+S N L G+IP+  +F  F
Sbjct: 488 SGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSRF 547

Query: 356 SAESFEGNELLCGSPNLQVPPCKTSIH--HTSWKNSLLLGIVLPLSTTLLIVVIWLILRY 413
           S +SF GN  LCGS      PC  S      S   + +LGI +     L+I+++ LI   
Sbjct: 548 SPDSFIGNPGLCGS--WLNSPCHDSRRTVRVSISRAAILGIAI---GGLVILLMVLIAAC 602

Query: 414 RQRGKKPSNDANMPLVATWRT------------FSYLELCRATDEFSENNLIGRGGFALF 461
           R     P  D ++    T+ T              Y ++ R T+  SE  +IG G  +  
Sbjct: 603 RPHNPPPFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTV 662

Query: 462 IR--------------------AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 501
            +                    + K F+ E EM+ SI+HRNL+ + +   +     L  +
Sbjct: 663 YKCVLKNCKPVAIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYD 722

Query: 502 YMPHGSLEKYLY--SSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD 559
           Y+ +GSL   L+  +    LD   RL I    A  L YLH   S  +IH D+K SN+LLD
Sbjct: 723 YLENGSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLD 782

Query: 560 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            ++ A L+DF IAK L    +S T T  +GTIGY+ P
Sbjct: 783 KDLEARLTDFGIAKSLC-VSKSHTSTYVMGTIGYIDP 818

Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1

 Score =  267 bits (683), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 219/675 (32%), Positives = 321/675 (47%), Gaps = 94/675 (13%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
           IP  +  + NL+ L L +N+L G +P  ++    L++LGL+ N L+G+LS     +L  L
Sbjct: 161 IPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPDM-CQLTGL 219

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
               + GNN +GTIP  I N +    L +  N  +G IP   G L+ +  L L  N LT 
Sbjct: 220 WYFDVRGNNLTGTIPESIGNCTSFEILDVSYNQITGVIPYNIGFLQ-VATLSLQGNKLTG 278

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
             PE+  L      ++L ++DLS+N L G +P   + NLS +  + Y++   ++G IP E
Sbjct: 279 RIPEVIGL-----MQALAVLDLSDNELTGPIPPI-LGNLSFT-GKLYLHGNKLTGQIPPE 331

Query: 182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLEL 241
           + N++ L  + L  N+L G IP  LGKL +L  LNL +N L G IP +I   A L +  +
Sbjct: 332 LGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCAALNQFNV 391

Query: 242 GSNKLYGSIPACFGNLASLRILSLGSNKLT-------------------------SIPLT 276
             N L G++P  F NL SL  L+L SN                            SIPLT
Sbjct: 392 HGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLT 451

Query: 277 FWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGE--------- 327
             +L+ +L LN S N L G L  E GNL+ +  ID S N  +GVIP E+G+         
Sbjct: 452 LGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLIL 511

Query: 328 -----------KLS---YLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQ 373
                      +L+    L +LN+SFN L G IP   +F  FS  SF GN  LCG  N  
Sbjct: 512 NNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCG--NWV 569

Query: 374 VPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRQRGKKP--SNDANMPLVAT 431
              C  S+  +     + + I + L    LI +I++ + Y+ + +KP     +  P  +T
Sbjct: 570 GSICGPSLPKSQVFTRVAV-ICMVLGFITLICMIFIAV-YKSKQQKPVLKGSSKQPEGST 627

Query: 432 WRTFSYLELC--------RATDEFSENNLIGRGGFALFIRA------------------- 464
                ++++         R T+   E  +IG G  +   +                    
Sbjct: 628 KLVILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPS 687

Query: 465 -FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY--SSNCILDI 521
            F+ F+ E E + SIRHRN++ +     +     L  +YM +GSL   L+       LD 
Sbjct: 688 NFREFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDW 747

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 581
             RL I +  A  L YLH   +  +IH D+K SN+LLD N  A LSDF IAK +    ++
Sbjct: 748 ETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPAT-KT 806

Query: 582 MTQTQTLGTIGYMAP 596
              T  LGTIGY+ P
Sbjct: 807 YASTYVLGTIGYIDP 821

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  263 bits (673), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 217/685 (31%), Positives = 346/685 (50%), Gaps = 102/685 (14%)

Query: 1    EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
            E+P ++G L NL  L    N L G +P++I N + LK L L +N ++G +         N
Sbjct: 375  ELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPR--GFGRMN 432

Query: 61   LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
            L  + +  N+F+G IP  IFN S L  LS+  N+ +G +    G L+ L  L +  N LT
Sbjct: 433  LTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLT 492

Query: 121  SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPE 180
               P       + N K L ++ L +N   G +P+  +SNL+  L+   MY+ ++ G IPE
Sbjct: 493  GPIPR-----EIGNLKDLNILYLHSNGFTGRIPR-EMSNLTL-LQGLRMYSNDLEGPIPE 545

Query: 181  EI------------------------SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLN 216
            E+                        S L +L  + L GNK NGSIP +L  L  L   +
Sbjct: 546  EMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFD 605

Query: 217  LEDNILEGSIPDDICRLAELYRLEL----GSNKLYGSIPACFGNLASLRILSLGSNKLT- 271
            + DN+L G+IP ++  LA L  ++L     +N L G+IP   G L  ++ + L +N  + 
Sbjct: 606  ISDNLLTGTIPGEL--LASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSG 663

Query: 272  SIPLTFWNLKDILQLNFSSNFLTGPLLLEI-------------------------GNLKV 306
            SIP +    K++  L+FS N L+G +  E+                         GN+  
Sbjct: 664  SIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTH 723

Query: 307  LIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELL 366
            L+ +D S NN +G IP  +   LS L+ L L+ N LKG +P  G F N +A    GN  L
Sbjct: 724  LVSLDLSSNNLTGEIPESLA-NLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDL 782

Query: 367  CGSPNLQVPPC--KTSIHHTSWKNS---LLLGIVLPLSTTLLIVVIWLILRYRQRGKKPS 421
            CGS    + PC  K    H S +     ++LG    L   LL+V+I    + +++  + S
Sbjct: 783  CGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENS 841

Query: 422  NDANMPLVAT---WRTFSYLELCRATDEFSENNLIGRGGFA-----------------LF 461
            +++++P + +    + F   EL +ATD F+  N+IG    +                 L 
Sbjct: 842  SESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLN 901

Query: 462  IRAF-----KSFDVECEMMKSIRHRNLIKVIS-SCSNEEFKALVLEYMPHGSLEKYLYSS 515
            ++ F     K F  E + +  ++HRNL+K++  +  + + KALVL +M +G+LE  ++ S
Sbjct: 902  LKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGS 961

Query: 516  NC-ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
               I  + +++++ + +AS ++YLH GY   ++HCDLKP+N+LLD + VAH+SDF  A++
Sbjct: 962  AAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARI 1021

Query: 575  LT-GEDQSMTQTQTL--GTIGYMAP 596
            L   ED S T + +   GTIGY+AP
Sbjct: 1022 LGFREDGSTTASTSAFEGTIGYLAP 1046

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	596
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.991	0.481	0.493	1e-156
359483675	1250	PREDICTED: LRR receptor-like serine/thre	0.994	0.474	0.488	1e-156
255585401	843	serine-threonine protein kinase, plant-t	0.988	0.698	0.491	1e-156
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.993	0.491	0.497	1e-155
147852480	1229	hypothetical protein VITISV_039533 [Viti	0.991	0.480	0.490	1e-154
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.991	0.480	0.488	1e-154
147769371	1241	hypothetical protein VITISV_010511 [Viti	0.994	0.477	0.484	1e-154
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.991	0.406	0.482	1e-153
224116832	1061	predicted protein [Populus trichocarpa]	0.994	0.558	0.476	1e-153
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.991	0.518	0.485	1e-152

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  560 bits (1442), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 330/669 (49%), Positives = 413/669 (61%), Gaps = 78/669 (11%)

Query: 2    IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
            IP   GNL+ L+ LQLG N L GT+P  IFN+S L+ L L  N LSG L S     LP+L
Sbjct: 452  IPTSFGNLKALKFLQLGSNNLTGTIPEDIFNISKLQTLALAQNHLSGGLPSSIGTWLPDL 511

Query: 62   EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
            E L++ GN FSGTIP  I N SKL +L +  N F+G +P    NLR LE L L  N LT 
Sbjct: 512  EGLFIGGNEFSGTIPVSISNMSKLIRLHISDNYFTGNVPKDLSNLRKLEVLNLAGNQLTD 571

Query: 122  S--TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
               T E+ FL+SL+NCK L  + +  NPL G LP  S+ NLS +LE F    C+  G IP
Sbjct: 572  EHLTSEVGFLTSLTNCKFLRTLWIDYNPLKGTLPN-SLGNLSVALESFTASACHFRGTIP 630

Query: 180  EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
              I NLTNL+ +DLG N L GSIP TLG L+KLQRL +  N ++GSIP+D+C L  L  L
Sbjct: 631  TGIGNLTNLIWLDLGANDLTGSIPTTLGHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYL 690

Query: 240  ELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLL 298
             L SNKL GSIP+CFG+L +LR LSL SN L  +IP++FW+L+D++ L+ SSNFLTG L 
Sbjct: 691  HLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLP 750

Query: 299  LEIGNLKVLIGIDFSMNNFSGVIPREIGE------------------------------- 327
             E+GN+K +  +D S N  SG IPR +GE                               
Sbjct: 751  PEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESM 810

Query: 328  ----------------KLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN 371
                             L YL+ LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+
Sbjct: 811  DLSQNNLFGTIPKSLEALIYLKHLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPH 870

Query: 372  LQVPPCKTSIHHTSWKNS--LLLGIVLPL-STTLLIVVIWLILRYRQRGKKPSN-DANMP 427
             QV  C  +    SWK    +L  I+LP+ S   L+  I L +R R   + P+  D+ +P
Sbjct: 871  FQVIACDKNNRTQSWKTKSFILKYILLPVGSAVTLVAFIVLWIRRRDNTEIPAPIDSWLP 930

Query: 428  LVATWRTFSYLELCRATDEFSENNLIGRGGFAL--------------------FIRAFKS 467
                    S  +L  AT+ F E+NLIG+G   +                    F  A +S
Sbjct: 931  --GAHEKISQQQLLYATNGFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRS 988

Query: 468  FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
            FD ECE+M+ I HRNLI++I+ CSN +FKALVLEYMP GSL+K+LYS N  LD+FQRLNI
Sbjct: 989  FDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNI 1048

Query: 528  MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            MIDVASALEYLH   S+LV+HCDLKPSNVLLD+NMVAH++DF IA+LLT E +SM QT+T
Sbjct: 1049 MIDVASALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIARLLT-ETESMQQTKT 1107

Query: 588  LGTIGYMAP 596
            LGTIGYMAP
Sbjct: 1108 LGTIGYMAP 1116

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  558 bits (1439), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 326/667 (48%), Positives = 411/667 (61%), Gaps = 74/667 (11%)

Query: 2    IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
            IP   GNL+ L+ LQLG N LIGT+P  IFN+S L+ L L  N LSG L S  +  LP+L
Sbjct: 452  IPTSFGNLKALKFLQLGSNNLIGTIPEDIFNISKLQTLALAQNHLSGGLPSSISTWLPDL 511

Query: 62   EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
            E L++ GN FSGTIP  I N SKL +L +  N F G +P    NLR LE L L  N LT 
Sbjct: 512  EGLFIGGNEFSGTIPVSISNMSKLIRLHISDNYFIGNVPKDLSNLRKLEVLNLAGNQLTD 571

Query: 122  S--TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
               T E+ FL+SL+NCK L  + +  NPL G LP  S+ NLS +LE F    C+  G IP
Sbjct: 572  EHLTSEVGFLTSLTNCKFLRTLWIDYNPLKGTLPN-SLGNLSVALESFTASACHFRGTIP 630

Query: 180  EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
              I NLTNL+ +DLG N L GSIP TLG+L+KLQRL +  N ++GSIP+D+  L  L  L
Sbjct: 631  TGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQRLYIAGNRIQGSIPNDLFHLKNLGYL 690

Query: 240  ELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLL 298
             L SNKL GSIP+CFG+L +LR LSL SN L  +IP++FW+L+D+L L+ SSNFLTG L 
Sbjct: 691  HLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLSLSSNFLTGNLP 750

Query: 299  LEIGNLKVLIGIDFSMNNFSGVIPREIGE------------------------------- 327
             E+GN+K +  +D S N  SG IPR +GE                               
Sbjct: 751  PEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESM 810

Query: 328  ----------------KLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN 371
                             L YL+ LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+
Sbjct: 811  DLSQNNLSGTIPKSLEALIYLKHLNVSFNKLQGEIPDGGPFVNFTAESFIFNEALCGAPH 870

Query: 372  LQVPPCKTSIHHTSWKNS--LLLGIVLPLSTTLLIVVIWLILRYRQRGKKPSNDANMPLV 429
             QV  C  + H  SWK    +L  I+LP+ + + +V   ++   RQ   +     +  L 
Sbjct: 871  FQVIACDKNNHTQSWKTKSFILKYILLPVGSIVTLVAFIVLWIRRQDNTEIPAPIDSWLP 930

Query: 430  ATWRTFSYLELCRATDEFSENNLIGRGGFAL--------------------FIRAFKSFD 469
                  S  +L  AT++F E+NLIG+G   +                    F  A +SFD
Sbjct: 931  GAHEKISQQQLLYATNDFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFD 990

Query: 470  VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
             ECE+M+ I HRNLI++I+ CSN +FKALVLEYMP GSL+K+LYS N  LD+FQRLNIMI
Sbjct: 991  SECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMI 1050

Query: 530  DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            DVA ALEYLH   S+LV+HCDLKPSNVLLD+NMVAH++DF IA+LLT E +SM QT+TLG
Sbjct: 1051 DVALALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIARLLT-ETESMQQTKTLG 1109

Query: 590  TIGYMAP 596
            TIGYMAP
Sbjct: 1110 TIGYMAP 1116

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  557 bits (1436), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 326/663 (49%), Positives = 414/663 (62%), Gaps = 74/663 (11%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
           IP EIG L NL  L L  N L G++P+ + N+S +K + +  N LSG L S     LPNL
Sbjct: 67  IPTEIGKLSNLVHLLLRYNFLTGSIPSTLLNISAIKTISINVNQLSGHLPSTLGYGLPNL 126

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           E+LY+  N F GT+P  I NASKL+ L    NS SG IP T  NL+NL++L L +N   S
Sbjct: 127 EELYITRNQFIGTLPPSISNASKLTILESSSNSLSGPIPDTLCNLKNLKRLNLADN---S 183

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
            T EL FL+SL+ CK L  + L  NPL+  LP TSI NLS S+E F + +CNI G IP E
Sbjct: 184 FTDELGFLASLARCKELRRLVLIGNPLNSTLP-TSIGNLS-SIEYFNVQSCNIKGNIPSE 241

Query: 182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLEL 241
           I  L+NL+ + L  N+L GSIP+T+G L+KLQRL L  N+L GSIP DIC L+ L  L L
Sbjct: 242 IGVLSNLITLHLQNNELVGSIPVTIGGLQKLQRLYLHGNLLYGSIPTDICHLSNLGELFL 301

Query: 242 GSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLLE 300
            +N L+G +PACFG+L SLRIL L SN  TS IP + W+LKD+L+LN SSN L+G + L 
Sbjct: 302 SNNSLFGPLPACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLSSNSLSGHIPLS 361

Query: 301 IGNLKVLIGIDFSMNNFSGVIPREIG---------------------------------- 326
           IGNLKVL  +DFS N+ SG+IP  IG                                  
Sbjct: 362 IGNLKVLTQVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPFGELISLESLDL 421

Query: 327 -------------EKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQ 373
                        E+L YL+ LN+SFN L GE+P  G+F NFSA SF GN  LCGS  L 
Sbjct: 422 SSNNLSGKIPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGNLALCGSRLLP 481

Query: 374 VPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRQRGKKPSNDANMPLVATWR 433
           + PCK + H  S  ++ LL I +  ++ L I  I + LR ++   +  N  ++  V TWR
Sbjct: 482 LMPCKNNTHGGSKTSTKLLLIYVLPASILTIAFILVFLRCQKVKLELENVMDIITVGTWR 541

Query: 434 TFSYLELCRATDEFSENNLIGRGGFALFIR--------------------AFKSFDVECE 473
             S+ EL +ATD F  +NL+G GG+    +                    AFK FD ECE
Sbjct: 542 RISFQELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEGAFKIFDTECE 601

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           +M SIRHRNL+K+IS CSN++FKA+VLEYMP+GSLEK+LYS N  L+I QRL +MIDVAS
Sbjct: 602 VMSSIRHRNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNIQQRLEVMIDVAS 661

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
           ALEYLH G+SA ++HCDLKPSNVLLD +MV H++DF +AKLL GE   +TQT+TL TIGY
Sbjct: 662 ALEYLHHGFSAPIVHCDLKPSNVLLDQDMVGHVADFGMAKLL-GEGDLITQTKTLATIGY 720

Query: 594 MAP 596
           MAP
Sbjct: 721 MAP 723

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  555 bits (1431), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 332/668 (49%), Positives = 413/668 (61%), Gaps = 76/668 (11%)

Query: 2    IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
            IP   GNL+ L+ L LG N L GTVP AIFN+S L+ L L  N LSGSL S     LP+L
Sbjct: 429  IPTSFGNLKALKFLNLGINFLTGTVPEAIFNISELQNLALVQNHLSGSLPSSIGTWLPDL 488

Query: 62   EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
            E LY+  N FSGTIP  I N SKL+ LSL  NSF+G +P    NL  L+ L L  N LT 
Sbjct: 489  EGLYIGANEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLKFLNLAHNQLTD 548

Query: 122  S--TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
                  + FL+SL+NCK L  + +  NPL G LP  S+ NL  +LE F  Y C   G IP
Sbjct: 549  EHLASGVGFLTSLTNCKFLRYLWIGYNPLKGTLPN-SLGNLPIALESFTAYACQFRGTIP 607

Query: 180  EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
              I NLTNL+ +DLG N L GSIP TLG+L+KLQRL++  N + GSIP+D+C L  L  L
Sbjct: 608  TGIGNLTNLIWLDLGANDLTGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYL 667

Query: 240  ELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLL 298
             L SNKL GS P+CFG+L +LR L L SN L  +IP + W+L+D+L LN SSNFLTG L 
Sbjct: 668  GLSSNKLSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLP 727

Query: 299  LEIGNLKVLIGIDFSMNNFSGVIPREIG-------------------------------- 326
             E+GN+K +  +D S N  SG IP  +G                                
Sbjct: 728  PEVGNMKSITTLDLSKNLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLVSLESL 787

Query: 327  ---------------EKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN 371
                           E L YL+ LN+SFNKL+GEIP GG F  F+AESF  NE LCG+P+
Sbjct: 788  DLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPH 847

Query: 372  LQVPPCKTSIHHTSWKNS--LLLGIVLPL-STTLLIVVIWLILRYRQRGKKPSNDANMPL 428
             QV  C  +    SWK    +L  I+LP+ ST  L+V I L +R R   + P+   +  L
Sbjct: 848  FQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPT-PIDSWL 906

Query: 429  VATWRTFSYLELCRATDEFSENNLIGRG------------GFALFIRAF--------KSF 468
            + T    S+ +L  AT++F E+NLIG+G            G  + I+ F        +SF
Sbjct: 907  LGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSF 966

Query: 469  DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
            D ECE+M+ IRHRNL+++I+ CSN +FKALVLEYMP+GSLEK+LYS N  LD+ QRLNIM
Sbjct: 967  DSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIM 1026

Query: 529  IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
            IDVASALEYLH   S+LV+HCDLKPSNVLLDD+MVAH++DF IAKLLT E +SM QT+TL
Sbjct: 1027 IDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLT-ETESMQQTKTL 1085

Query: 589  GTIGYMAP 596
            GTIGYMAP
Sbjct: 1086 GTIGYMAP 1093

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147852480|emb|CAN78527.1| hypothetical protein VITISV_039533 [Vitis vinifera]

 Score =  552 bits (1422), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 328/669 (49%), Positives = 415/669 (62%), Gaps = 78/669 (11%)

Query: 2    IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
            IP   GNL  L+ L LG N L GTVP AIFN+S L+ L +  N LSGSL S     LP+L
Sbjct: 453  IPTSFGNLMALKFLNLGINNLTGTVPEAIFNISKLQSLAMAINHLSGSLPSSIGTWLPDL 512

Query: 62   EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
            E L++ GN FSG IP  I N SKL++L +  NSF G +P   GNL  LE L L  N  T+
Sbjct: 513  EGLFIGGNEFSGIIPVSISNMSKLTQLDVSRNSFIGNVPKDLGNLTKLEVLNLAGNQFTN 572

Query: 122  S--TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
                 E+SFL+SL+NCK L  + + NNP  G LP  S+ NL  +LE F    C   G IP
Sbjct: 573  EHLASEVSFLTSLTNCKFLKNLWIGNNPFKGTLPN-SLGNLPIALESFIASACQFRGTIP 631

Query: 180  EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
              I NLTNL+ +DLG N L GSIP  LG+L+KLQRL++  N L GSIP+D+C L  L  L
Sbjct: 632  TGIGNLTNLIWLDLGANDLTGSIPTILGRLKKLQRLHIAGNRLRGSIPNDLCHLKNLGYL 691

Query: 240  ELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLL 298
             L SNKL GSIP+CFG+L +L+ L L SN L  +IP + W+L+D+L LN SSNFLTG L 
Sbjct: 692  HLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLP 751

Query: 299  LEIGNLKVLIGIDFSMNNFSGVIPREIGEK------------------------------ 328
             E+GN+K +  +D S N  SG IPR +GE+                              
Sbjct: 752  PEVGNMKSITTLDLSKNLVSGYIPRRMGEQQNLAKLSLSQNRLQGPIPVEFGDLVSLESL 811

Query: 329  -----------------LSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN 371
                             L YL+ LN+S NKL+GEIP GG F NF+AESF  NE LCG+P+
Sbjct: 812  DLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGPFVNFTAESFMFNEALCGAPH 871

Query: 372  LQVPPCKTSIHHTSWKNS--LLLGIVLPLSTTL-LIVVIWLILRYRQRGKKPSN-DANMP 427
             QV  C  +    SWK    +L  I+LP+ +T+ L+V I L +R R   + P+  D+ +P
Sbjct: 872  FQVMACDKNNRTQSWKTKSFILKYILLPVGSTITLVVFIVLWIRRRDNMEIPTPIDSWLP 931

Query: 428  LVATWRTFSYLELCRATDEFSENNLIGRG------------GFALFIRAF--------KS 467
               T    S+  L  AT++F E+NLIG+G            G  + I+ F        +S
Sbjct: 932  --GTHEKISHQRLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRS 989

Query: 468  FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
            FD ECE+M+ IRHRNL+++I+ CSN +FKALVL+YMP+GSLEK+LYS N  LD+ QRLNI
Sbjct: 990  FDSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNI 1049

Query: 528  MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            MIDVASALEYLH   S+LV+HCDLKPSNVLLDD+MVAH++DF I KLLT + +SM QT+T
Sbjct: 1050 MIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGITKLLT-KTESMQQTKT 1108

Query: 588  LGTIGYMAP 596
            LGTIGYMAP
Sbjct: 1109 LGTIGYMAP 1117

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  551 bits (1421), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 327/669 (48%), Positives = 415/669 (62%), Gaps = 78/669 (11%)

Query: 2    IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
            IP   GNL+ L+ L LG N L GTVP AIFN+S L+ L +  N LSGSL S     L +L
Sbjct: 453  IPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLSDL 512

Query: 62   EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
            E L++ GN FSG IP  I N SKL+ L L  NSF+G +P   GNL  L+ L L  N LT 
Sbjct: 513  EGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTD 572

Query: 122  S--TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
                 E+ FL+SL+NCK L  + + NNP  G LP  S+ NL  +LE F    C   G IP
Sbjct: 573  EHVASEVGFLTSLTNCKFLKNLWIGNNPFKGTLPN-SLGNLPIALESFIASACQFRGTIP 631

Query: 180  EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
              I NLTNL+ +DLG N L GSIP TLG+L+KLQ+L++  N L GSIP+D+C L  L  L
Sbjct: 632  TRIGNLTNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYL 691

Query: 240  ELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLL 298
             L SNKL GSIP+CFG+L +L+ L L SN L  +IP + W+L+D+L LN SSNFLTG L 
Sbjct: 692  HLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLP 751

Query: 299  LEIGNLKVLIGIDFSMNNFSGVIPREIGEK------------------------------ 328
             E+GN+K +  +D S N  SG IPR++GE+                              
Sbjct: 752  PEVGNMKSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESL 811

Query: 329  -----------------LSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN 371
                             L YL+ LN+S NKL+GEIP GG F NF+AESF  NE LCG+P+
Sbjct: 812  DLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPH 871

Query: 372  LQVPPCKTSIHHTSWKNS--LLLGIVLPL-STTLLIVVIWLILRYRQRGKKPSN-DANMP 427
             QV  C  +    SWK    +L  I+LP+ S   L+V I L +R R   + P+  D+ +P
Sbjct: 872  FQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP 931

Query: 428  LVATWRTFSYLELCRATDEFSENNLIGRG------------GFALFIRAF--------KS 467
               T    S+ +L  AT++F E+NLIG+G            G  + I+ F        +S
Sbjct: 932  --GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRS 989

Query: 468  FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
            FD ECE+M+ IRHRNL+++I+ CSN +FKALVLEYMP+GSLEK+LYS N  LD+ QRLNI
Sbjct: 990  FDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNI 1049

Query: 528  MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            MIDVASALEYLH   S+LV+HCDLKP+NVLLDD+MVAH++DF I KLLT + +SM QT+T
Sbjct: 1050 MIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLT-KTESMQQTKT 1108

Query: 588  LGTIGYMAP 596
            LGTIGYMAP
Sbjct: 1109 LGTIGYMAP 1117

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera]

 Score =  551 bits (1419), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 323/667 (48%), Positives = 411/667 (61%), Gaps = 74/667 (11%)

Query: 2    IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
            IP   GNL  L+ L LG N L GTVP AIFN+S L+ L L  N LSGSL       LP+L
Sbjct: 465  IPTSFGNLMALKYLDLGMNFLTGTVPEAIFNISELQILVLVQNHLSGSLPPSIGTWLPDL 524

Query: 62   EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
            E LY+  N FSGTIP  I N SKL +L +  NSF+G +P   GNL  LE L L  N LT+
Sbjct: 525  EGLYIGSNKFSGTIPMSISNMSKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLAANQLTN 584

Query: 122  S--TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
                  + FL+SL+NCK L  + + +NP  G LP  S+ NL  +LE F    C   G IP
Sbjct: 585  EHLASGVGFLTSLTNCKFLRHLWIDDNPFKGTLPN-SLGNLPIALESFTASACQFRGTIP 643

Query: 180  EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
              I NLTNL+E+DLG N L  SIP TLG+L+KLQRL++  N + GSIP+D+C L  L  L
Sbjct: 644  TGIGNLTNLIELDLGANDLTRSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYL 703

Query: 240  ELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLL 298
             L SNKL GSIP+CFG+L +L+ L L SN L  +IP + W+L+D+L LN SSNFLTG L 
Sbjct: 704  HLXSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLP 763

Query: 299  LEIGNLKVLIGIDFSMNNFSGVIPREIGEK------------------------------ 328
             E+GN+K +  +D S N  SG IPR +GE+                              
Sbjct: 764  PEVGNMKSITTLDLSKNLVSGYIPRRMGEQQNLAKLSLSQNRLQGPIPXEFGDLVSLESL 823

Query: 329  -----------------LSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN 371
                             L YL+ LN+S NKL+GEIP GG F NF+AESF  NE LCG+P+
Sbjct: 824  DLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGPFXNFTAESFMFNEALCGAPH 883

Query: 372  LQVPPCKTSIHHTSWKNS--LLLGIVLPLSTTLLIVVIWLILRYRQRGKKPSNDANMPLV 429
             QV  C  +    SWK    +L  I+LP+ +T+ +VV  ++   R+   +     +  L 
Sbjct: 884  FQVMACDKNNRTQSWKTKSFILKYILLPVGSTITLVVFIVLWIRRRDNMEIXTPIDSWLP 943

Query: 430  ATWRTFSYLELCRATDEFSENNLIGRG------------GFALFIRAF--------KSFD 469
             T    S+ +L  AT++F E+NLIG+G            G  + I+ F        +SFD
Sbjct: 944  GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFD 1003

Query: 470  VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
             ECE+M+ IRHRNL+++I+ CSN +FKALVL+YMP+GSLEK+LYS N  LD+ QRLNIMI
Sbjct: 1004 SECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMI 1063

Query: 530  DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            DVASALEYLH   S+LV+HCDLKPSNVLLDDBMVAH++DF IAKLLT + +SM QT+TLG
Sbjct: 1064 DVASALEYLHHDCSSLVVHCDLKPSNVLLDDBMVAHVTDFGIAKLLT-KTESMQQTKTLG 1122

Query: 590  TIGYMAP 596
            TIGYMAP
Sbjct: 1123 TIGYMAP 1129

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  548 bits (1412), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 323/669 (48%), Positives = 414/669 (61%), Gaps = 78/669 (11%)

Query: 2    IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
            IP E+GNL NL+ L+L +N L G +P AIFN+S L+ L L  N  SGSL S    +LP+L
Sbjct: 678  IPNELGNLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSLPSSLGTQLPDL 737

Query: 62   EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
            E L +  N FSG IP  I N S+L++L +  N F+G +P   GNLR LE L L  N LT 
Sbjct: 738  EGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTD 797

Query: 122  --STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
              S  E+ FL+SL+NC  L  + + +NPL GILP  S+ NLS SLE F    C   G IP
Sbjct: 798  EHSASEVGFLTSLTNCNFLRTLWIEDNPLKGILPN-SLGNLSISLESFDASACQFRGTIP 856

Query: 180  EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
              I NLT+L+ ++LG N L G IP TLG+L+KLQ L +  N L GSIP+D+CRL  L  L
Sbjct: 857  TGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYL 916

Query: 240  ELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLL 298
             L SN+L GSIP+C G L  LR L L SN L S IP + W L+ +L LN SSNFLTG L 
Sbjct: 917  FLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLP 976

Query: 299  LEIGNLKVLIGIDFSMNNFSGVIPREIGE------------------------------- 327
             E+GN+K +  +D S N  SG IPR +GE                               
Sbjct: 977  PEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFL 1036

Query: 328  ----------------KLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN 371
                             L+YL+ LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+
Sbjct: 1037 DLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPH 1096

Query: 372  LQVPPCKTSIHHTSWKNSL-LLGIVLPLSTTLLIVVIWLILRYRQRG--KKPSN-DANMP 427
             QV  C  S    SW+  L +L  +LP   +++ +V++L+L  R+R   + P+  D+ +P
Sbjct: 1097 FQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRKNLEVPTPIDSWLP 1156

Query: 428  LVATWRTFSYLELCRATDEFSENNLIGRGGFAL--------------------FIRAFKS 467
               +    S+ +L  AT+ F E+NLIG+G  ++                    F  AF+S
Sbjct: 1157 --GSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRS 1214

Query: 468  FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
            FD ECE+M+SIRHRNL+K+I+ CSN +FKALVLEYMP GSL+K+LYS N  LD+ QRLNI
Sbjct: 1215 FDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNI 1274

Query: 528  MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            MIDVASALEYLH    +LV+HCDLKP+N+LLDD+MVAH+ DF IA+LLT E +SM QT+T
Sbjct: 1275 MIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLLT-ETESMQQTKT 1333

Query: 588  LGTIGYMAP 596
            LGTIGYMAP
Sbjct: 1334 LGTIGYMAP 1342

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  547 bits (1409), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 318/667 (47%), Positives = 406/667 (60%), Gaps = 74/667 (11%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
           IP E+GNL  L+EL LG N + G++P+  FN S L+ + +  N LSG L S   + LPNL
Sbjct: 275 IPNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNL 334

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           E+LYL  N  SG IP  I NASKL  L L  NSFSG IP   GNLRNL++L L EN LTS
Sbjct: 335 EELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTS 394

Query: 122 STPELSFLSSLS--NCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
            +         S  NC+SL  +  + NPL G LP  SI NLS SLEE Y ++C I G IP
Sbjct: 395 KSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLP-VSIGNLSASLEELYAFDCRIIGNIP 453

Query: 180 EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
             I NL+NL+ + L  N+L G+IP  +G+L+ LQ  +L  N L+G IP++IC L  L  L
Sbjct: 454 RGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYL 513

Query: 240 ELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLL 299
            L  N   GS+PAC  N+ SLR L LGSN+ TSIP TFW+LKD+LQ+N S N LTG L L
Sbjct: 514 YLLENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPL 573

Query: 300 EIGNLKVLIGIDFSMNNFSGVIPREIG--------------------------------- 326
           EIGNLKV+  IDFS N  SG IP  I                                  
Sbjct: 574 EIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLD 633

Query: 327 --------------EKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNL 372
                         EKL +L+  N+SFN+L+GEI  GG F NFS  SF  NE LCG   +
Sbjct: 634 LSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRM 693

Query: 373 QVPPCKT-SIHHTSWK-NSLLLGIVLPLSTTLLIVVIWLILRYRQRGKKPSNDANMPLV- 429
           QVPPCK+ S H  S +    ++  ++P    +++V+   ++ +R+  K+  +    PL  
Sbjct: 694 QVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPP 753

Query: 430 ATWRTFSYLELCRATDEFSENNLIGRG------------GFALFIRAFK--------SFD 469
           ATWR  SY EL RAT+ F+E NL+G G            G  + ++ F          FD
Sbjct: 754 ATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFD 813

Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            ECE+++ +RHRNL+K+ISSC N +FKAL+LE++PHGSLEK+LYS N  LDI QRLNIMI
Sbjct: 814 SECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMI 873

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           DVASALEYLH G +  V+HCDLKPSNVL++++MVAH+SDF I++LL GE  ++TQT TL 
Sbjct: 874 DVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL-GEGDAVTQTLTLA 932

Query: 590 TIGYMAP 596
           TIGYMAP
Sbjct: 933 TIGYMAP 939

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  545 bits (1404), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 325/669 (48%), Positives = 412/669 (61%), Gaps = 78/669 (11%)

Query: 2    IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
            IP   GNL+ L+ L LG N L GTVP AIFN+S L+ L +  N LSGSL S     LP+L
Sbjct: 364  IPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLPDL 423

Query: 62   EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
            E L++ GN FSG IP  I N SKL+ L L  NSF+G +P   GNL  L+ L L  N LT 
Sbjct: 424  EGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTD 483

Query: 122  S--TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
                 E+ FL+SL+NCK L  + + N P  G LP  S+ NL  +LE F    C   G IP
Sbjct: 484  EHVASEVGFLTSLTNCKFLKNLWIGNIPFKGTLPN-SLGNLPIALESFIASACQFRGTIP 542

Query: 180  EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
              I NLTNL+ +DLG N L GSIP TLG+L+KLQ L +  N + GSIP+D+C L +L  L
Sbjct: 543  TGIGNLTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYL 602

Query: 240  ELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLL 298
             L SNKL GSIP+CFG+L +L+ L L SN L  +IP + W+L+D+L LN SSNFLTG L 
Sbjct: 603  FLSSNKLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLP 662

Query: 299  LEIGNLKVLIGIDFSMNNFSGVIPREIG-------------------------------- 326
             E+GN+K +  +D S N  SG IP ++G                                
Sbjct: 663  PEVGNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESL 722

Query: 327  ---------------EKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN 371
                           E L YL+ LN+S NKL+GEIP GG F NF+AESF  NE LCG+P+
Sbjct: 723  DLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPH 782

Query: 372  LQVPPCKTSIHHTSWKNS--LLLGIVLPL-STTLLIVVIWLILRYRQRGKKPSN-DANMP 427
             QV  C  +    SWK    +L  I+LP+ S   L+V I L +R R   + P+  D+ +P
Sbjct: 783  FQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP 842

Query: 428  LVATWRTFSYLELCRATDEFSENNLIGRG------------GFALFIRAF--------KS 467
               T    S+ +L  AT++F E+NLIG+G            G  + I+ F        +S
Sbjct: 843  --GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRS 900

Query: 468  FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
            FD ECE+M+ IRHRNL+++I+ CSN +FKALVLEYMP+GSLEK+LYS N  LD+ QRLNI
Sbjct: 901  FDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNI 960

Query: 528  MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            MIDVASALEYLH   S+LV+HCDLKP+NVLLDD+MVAH++DF I KLLT + +SM QT+T
Sbjct: 961  MIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLT-KTESMQQTKT 1019

Query: 588  LGTIGYMAP 596
            LGTIGYMAP
Sbjct: 1020 LGTIGYMAP 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	596
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.540	0.314	0.404	4.3e-79
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.761	0.449	0.316	8.1e-79
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.570	0.329	0.354	5.7e-78
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.701	0.407	0.344	2e-77
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.538	0.318	0.360	6.1e-73
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.538	0.317	0.351	1.9e-72
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.793	0.403	0.303	2.3e-68
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.540	0.328	0.338	5.5e-68
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.484	0.258	0.426	1.1e-66
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.602	0.325	0.333	7e-65

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 529 (191.3 bits), Expect = 4.3e-79, Sum P(2) = 4.3e-79
 Identities = 132/326 (40%), Positives = 181/326 (55%)

Query:    24 GTVPAAIFNVSTLKFXXXXXXXXXXXXXXIANVRLPNLEKLYLWGNNFSGTIPRFIFNAS 83
             G  P  I+N+S+L F                   LPNL+ LY+  N+F+GTIP  + N S
Sbjct:   239 GVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNIS 298

Query:    84 KLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS-STPELSFLSSLSNCKSLTLID 142
              L +L +  N  +G IP +FG L+NL  LGL+ N L + S+ +L FL +L+NC  L  ++
Sbjct:   299 SLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLN 358

Query:   143 LSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSI 202
             +  N L G LP   I+NLS  L E  +    ISG IP  I NL +L  +DLG N L G +
Sbjct:   359 VGFNKLGGQLP-VFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKL 417

Query:   203 PITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRI 262
             P +LG+L +L+++ L  N L G IP  +  ++ L  L L +N   GSIP+  G+ + L  
Sbjct:   418 PPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLD 477

Query:   263 LSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVI 321
             L+LG+NKL  SIP     L  ++ LN S N L GPL  +IG LK L+ +D S N  SG I
Sbjct:   478 LNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQI 537

Query:   322 PREIGEKLSYLEDLNLSFNKLKGEIP 347
             P+ +   LS LE L L  N   G IP
Sbjct:   538 PQTLANCLS-LEFLLLQGNSFVGPIP 562

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 499 (180.7 bits), Expect = 8.1e-79, Sum P(2) = 8.1e-79
 Identities = 156/493 (31%), Positives = 235/493 (47%)

Query:    24 GTVPAAIFNVSTLKFXXXXXXXXXXXXXXIANVRLPNLEKLYLWGNNFSGTIPR---FIF 80
             G++P  + N+STL+                 NV  PNL+ L+L  N+      R   F+ 
Sbjct:   273 GSIPTTLSNISTLERLGMNENNLTGSIPTFGNV--PNLKLLFLHTNSLGSDSSRDLEFLT 330

Query:    81 ---NASKLSKLSLGMNSFSGFIPSTFGNLR-NLEQLGLDENYLTSSTPELSFLSSLSNCK 136
                N ++L  L +G N   G +P +  NL   L  L L    ++ S P       + N  
Sbjct:   331 SLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPY-----DIGNLI 385

Query:   137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN 196
             +L  + L  N L G LP TS+  L  +L    +++  +SGGIP  I N+T L  +DL  N
Sbjct:   386 NLQKLILDQNMLSGPLP-TSLGKLL-NLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNN 443

Query:   197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGN 256
                G +P +LG    L  L + DN L G+IP +I ++ +L RL++  N L GS+P   G 
Sbjct:   444 GFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGA 503

Query:   257 LASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLL-EIGNLKVLIGI---D 311
             L +L  LSLG NKL+  +P T  N      L   S FL G L   +I +LK L+G+   D
Sbjct:   504 LQNLGTLSLGDNKLSGKLPQTLGNC-----LTMESLFLEGNLFYGDIPDLKGLVGVKEVD 558

Query:   312 FSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGS-P 370
              S N+ SG IP E     S LE LNLSFN L+G++P  G F N +  S  GN  LCG   
Sbjct:   559 LSNNDLSGSIP-EYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIM 617

Query:   371 NLQVPPCKT---SI--HHTSWKNSLLLGIVLPXXXXXXXXXXXXXX---RYRQRGKKPSN 422
               Q+ PC +   S+   H+S    +++G+ +                  R R++ K+ +N
Sbjct:   618 GFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNN 677

Query:   423 DANMPLVATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMK--SIRH 480
                  L       SY +L  AT+ FS +N++G G F    +A    + +   +K  +++ 
Sbjct:   678 PTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQR 737

Query:   481 RNLIK-VISSCSN 492
             R  +K  ++ C +
Sbjct:   738 RGAMKSFMAECES 750

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 513 (185.6 bits), Expect = 5.7e-78, Sum P(2) = 5.7e-78
 Identities = 122/344 (35%), Positives = 179/344 (52%)

Query:    24 GTVPAAIFNVSTLKFXXXXXXXXXXXXXXIANVRLPNLEKLYLWGNNFSGTIPRFIFNAS 83
             G  P A++N+S+L+                    LPNL +L L  N F+G IP+ + N S
Sbjct:   231 GGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANIS 290

Query:    84 KLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL-TSSTPELSFLSSLSNCKSLTLID 142
              L +  +  N  SG IP +FG LRNL  LG+  N L  +S+  L F+ +++NC  L  +D
Sbjct:   291 SLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLD 350

Query:   143 LSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSI 202
             +  N L G LP  SI+NLS +L   ++    ISG IP +I NL +L E+ L  N L+G +
Sbjct:   351 VGYNRLGGELP-ASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGEL 409

Query:   203 PITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRI 262
             P++ GKL  LQ ++L  N + G IP     +  L +L L SN  +G IP   G    L  
Sbjct:   410 PVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLD 469

Query:   263 LSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVI 321
             L + +N+L  +IP     +  +  ++ S+NFLTG    E+G L++L+G+  S N  SG +
Sbjct:   470 LWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKM 529

Query:   322 PREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNEL 365
             P+ IG  LS +E L +  N   G IP      +     F  N L
Sbjct:   530 PQAIGGCLS-MEFLFMQGNSFDGAIPDISRLVSLKNVDFSNNNL 572

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 504 (182.5 bits), Expect = 2.0e-77, Sum P(2) = 2.0e-77
 Identities = 155/450 (34%), Positives = 215/450 (47%)

Query:    24 GTVPAAIFNVSTLKFXXXXXXXXXXXXXXIANVRLPNLEKLYLWGNNFS-------GTIP 76
             G +PA++ N S L                    RL NL +LYLW N F        G I 
Sbjct:   287 GKIPASVANASHLTVIQIYGNLFSGIITSGFG-RLRNLTELYLWRNLFQTREQDDWGFIS 345

Query:    77 RFIFNASKLSKLSLGMNSFSGFIPSTFGNLR-NLEQLGLDENYLTSSTPELSFLSSLSNC 135
               + N SKL  L+LG N+  G +P++F NL  +L  L L+ N +T S P+      + N 
Sbjct:   346 D-LTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPK-----DIGNL 399

Query:   136 KSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG 195
               L  + L NN   G LP +S+  L ++L     Y  N+SG IP  I NLT L  + LG 
Sbjct:   400 IGLQHLYLCNNNFRGSLP-SSLGRL-KNLGILLAYENNLSGSIPLAIGNLTELNILLLGT 457

Query:   196 NKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAEL-YRLELGSNKLYGSIPACF 254
             NK +G IP TL  L  L  L L  N L G IP ++  +  L   + +  N L GSIP   
Sbjct:   458 NKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEI 517

Query:   255 GNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFS 313
             G+L +L      SN+L+  IP T  + + +  L   +N L+G +   +G LK L  +D S
Sbjct:   518 GHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLS 577

Query:   314 MNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGS-PNL 372
              NN SG IP  + + ++ L  LNLSFN   GE+P  G+F   S  S +GN  LCG  P+L
Sbjct:   578 SNNLSGQIPTSLAD-ITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDL 636

Query:   373 QVPPCKTSIHHTSWKNSLLLGIVLPXXXXXXXXXXXXXXRYRQRGKK--PSNDA--NMPL 428
              +P C   + +      L + + L                + +R KK  PS  +    PL
Sbjct:   637 HLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLIT-WHKRTKKGAPSRTSMKGHPL 695

Query:   429 VATWRTFSYLELCRATDEFSENNLIGRGGF 458
             V      SY +L +ATD F+  NL+G G F
Sbjct:   696 V------SYSQLVKATDGFAPTNLLGSGSF 719

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 440 (159.9 bits), Expect = 6.1e-73, Sum P(2) = 6.1e-73
 Identities = 118/327 (36%), Positives = 164/327 (50%)

Query:    24 GTVPAAIFNVSTLK-FXXXXXXXXXXXXXXIANVRLPNLEKLYLWGNNFSGTIPRFIFNA 82
             G  P A +N+S+L+                  N+ LPN+ +L L GN  +G IP  + N 
Sbjct:   224 GVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNL-LPNIHELSLHGNFLTGAIPTTLANI 282

Query:    83 SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS-STPELSFLSSLSNCKSLTLI 141
             S L    +G N  +G I   FG L NL  L L  N L S S  +L+FL +L+NC  L  +
Sbjct:   283 STLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGL 342

Query:   142 DLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGS 201
              +S N L G LP TSI N+S  L    +    I G IP +I NL  L  + L  N L G 
Sbjct:   343 SVSYNRLGGALP-TSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGP 401

Query:   202 IPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLR 261
             +P +LG L  L  L L  N   G IP  I  L +L +L L +N   G +P   G+ + + 
Sbjct:   402 LPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHML 461

Query:   262 ILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGV 320
              L +G NKL  +IP     +  ++ LN  SN L+G L  +IG L+ L+ +    NN SG 
Sbjct:   462 DLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGH 521

Query:   321 IPREIGEKLSYLEDLNLSFNKLKGEIP 347
             +P+ +G+ LS +E + L  N   G IP
Sbjct:   522 LPQTLGKCLS-MEVIYLQENHFDGTIP 547

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 453 (164.5 bits), Expect = 1.9e-72, Sum P(2) = 1.9e-72
 Identities = 115/327 (35%), Positives = 167/327 (51%)

Query:    24 GTVPAAIFNVSTLK-FXXXXXXXXXXXXXXIANVRLPNLEKLYLWGNNFSGTIPRFIFNA 82
             G  P AI+N+S L+                  N+ LPN+ +L L  N+  G IP  + N 
Sbjct:   224 GVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNL-LPNIRELNLGENDLVGAIPTTLSNI 282

Query:    83 SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST-PELSFLSSLSNCKSLTLI 141
             S L K  +  N  +G I   FG + +L+ L L EN L S T  +L F+ SL+NC  L L+
Sbjct:   283 STLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLL 342

Query:   142 DLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGS 201
              +    L G LP TSI+N+S  L    +   +  G IP++I NL  L  + LG N L G 
Sbjct:   343 SVGYTRLGGALP-TSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGP 401

Query:   202 IPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLR 261
             +P +LGKL +L  L+L  N + G IP  I  L +L  L L +N   G +P   G  + + 
Sbjct:   402 LPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHML 461

Query:   262 ILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGV 320
              L +G NKL  +IP     +  ++ L+   N L+G L  +IG+L+ L+ +    N FSG 
Sbjct:   462 DLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGH 521

Query:   321 IPREIGEKLSYLEDLNLSFNKLKGEIP 347
             +P+ +G  L+ +E L L  N   G IP
Sbjct:   522 LPQTLGNCLA-MEQLFLQGNSFDGAIP 547

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 459 (166.6 bits), Expect = 2.3e-68, Sum P(2) = 2.3e-68
 Identities = 153/504 (30%), Positives = 235/504 (46%)

Query:    24 GTVPAAIFNVSTLKFXXXXXXXXXXXXXXIANVRLPNLEKLYLWGNNFSGTIPRFIFNAS 83
             G +P  IFN S L+               +   +L  L  L +  N+ +G IPR I N  
Sbjct:   445 GEIPDDIFNCSNLETLSVADNNLTGTLKPLIG-KLQKLRILQVSYNSLTGPIPREIGNLK 503

Query:    84 KLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDL 143
              L+ L L  N F+G IP    NL  L+ L +  N L    PE  F     + K L+++DL
Sbjct:   504 DLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMF-----DMKLLSVLDL 558

Query:   144 SNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIP 203
             SNN   G +P    S L  SL    +     +G IP  + +L+ L   D+  N L G+IP
Sbjct:   559 SNNKFSGQIPAL-FSKLE-SLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIP 616

Query:   204 -ITLGKLRKLQR-LNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLR 261
                L  L+ +Q  LN  +N+L G+IP ++ +L  +  ++L +N   GSIP       ++ 
Sbjct:   617 GELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVF 676

Query:   262 ILSLGSNKLTS-IP-LTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSG 319
              L    N L+  IP   F  +  I+ LN S N  +G +    GN+  L+ +D S NN +G
Sbjct:   677 TLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTG 736

Query:   320 VIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC-- 377
              IP  +   LS L+ L L+ N LKG +P  G F N +A    GN  LCGS    + PC  
Sbjct:   737 EIPESLAN-LSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTI 794

Query:   378 KTSIHHTSWKNSLLLGIVLPXXXXXXXXXXXXXXRY--RQRGKKPSN--DANMPLVAT-- 431
             K    H S +  ++L I+L                   +++ KK  N  ++++P + +  
Sbjct:   795 KQKSSHFSKRTRVIL-IILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSAL 853

Query:   432 -WRTFSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSC 490
               + F   EL +ATD F+  N+IG    +     +K   +E   + +++  NL K  S+ 
Sbjct:   854 KLKRFEPKELEQATDSFNSANIIGSSSLST---VYKG-QLEDGTVIAVKVLNL-KEFSAE 908

Query:   491 SNEEF--KALVLEYMPHGSLEKYL 512
             S++ F  +A  L  + H +L K L
Sbjct:   909 SDKWFYTEAKTLSQLKHRNLVKIL 932

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 418 (152.2 bits), Expect = 5.5e-68, Sum P(2) = 5.5e-68
 Identities = 113/334 (33%), Positives = 179/334 (53%)

Query:    24 GTVPAAIF---NVSTLKFXXXXXXXXXXXXXXIANVRLPNLEKLYLWGNNFSGTIPRFIF 80
             G++P  +F   + S+L++                +  L  L  L LW N  +GT+P  + 
Sbjct:   153 GSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLS 212

Query:    81 NASKLSKLSLGMNSFSGFIPS-TFGNLRNLEQLGLDENYLTSSTPELS---FLSSLSNCK 136
             N++ L  + L  N  SG +PS     +  L+ L L  N+  S     +   F +SL+N  
Sbjct:   213 NSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSS 272

Query:   137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN 196
              L  ++L+ N L G +  +S+ +LS +L + ++    I G IP EISNL NL  ++L  N
Sbjct:   273 DLQELELAGNSLGGEIT-SSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSN 331

Query:   197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGN 256
              L+G IP  L KL KL+R+ L +N L G IP ++  +  L  L++  N L GSIP  FGN
Sbjct:   332 LLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGN 391

Query:   257 LASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLLEI-GNLKVL-IGIDFS 313
             L+ LR L L  N L+ ++P +     ++  L+ S N LTG + +E+  NL+ L + ++ S
Sbjct:   392 LSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLS 451

Query:   314 MNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
              N+ SG IP E+  K+  +  ++LS N+L G+IP
Sbjct:   452 SNHLSGPIPLELS-KMDMVLSVDLSSNELSGKIP 484

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 502 (181.8 bits), Expect = 1.1e-66, Sum P(2) = 1.1e-66
 Identities = 128/300 (42%), Positives = 171/300 (57%)

Query:    56 VRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD 115
             + L NL  + L  N  SGTIP    N SKL    L  N  +G I  + GNL+NL  L L 
Sbjct:    99 ISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLH 158

Query:   116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS 175
             +NYLTS  P     S L N +S+T + LS N L G +P +S+ NL ++L   Y+Y   ++
Sbjct:   159 QNYLTSVIP-----SELGNMESMTDLALSQNKLTGSIP-SSLGNL-KNLMVLYLYENYLT 211

Query:   176 GGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAE 235
             G IP E+ N+ ++ ++ L  NKL GSIP TLG L+ L  L L +N L G IP +I  +  
Sbjct:   212 GVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMES 271

Query:   236 LYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLT 294
             +  L L  NKL GSIP+  GNL +L +LSL  N LT  IP    N++ ++ L  S+N LT
Sbjct:   272 MTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLT 331

Query:   295 GPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGN 354
             G +   +GNLK L  +    N  +GVIP E+G   S + DL L+ NKL G IP   SFGN
Sbjct:   332 GSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMI-DLQLNNNKLTGSIP--SSFGN 388

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 424 (154.3 bits), Expect = 7.0e-65, Sum P(3) = 7.0e-65
 Identities = 123/369 (33%), Positives = 184/369 (49%)

Query:    24 GTVPAAIFNVSTLKFXXXXXXXXXXXXXXIANVRLPNLEKLYLWGNNFSGTIPRFIFNAS 83
             G +P  I N S+L+               +   +L +LE L ++ N  SG++P  I N  
Sbjct:   111 GKIPKEIGNCSSLEILKLNNNQFDGEIP-VEIGKLVSLENLIIYNNRISGSLPVEIGNLL 169

Query:    84 KLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDL 143
              LS+L    N+ SG +P + GNL+ L      +N ++ S P     S +  C+SL ++ L
Sbjct:   170 SLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLP-----SEIGGCESLVMLGL 224

Query:   144 SNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIP 203
             + N L G LPK  I  L + L +  ++    SG IP EISN T+L  + L  N+L G IP
Sbjct:   225 AQNQLSGELPK-EIGMLKK-LSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIP 282

Query:   204 ITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRIL 263
               LG L+ L+ L L  N L G+IP +I  L+    ++   N L G IP   GN+  L +L
Sbjct:   283 KELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELL 342

Query:   264 SLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIP 322
              L  N+LT +IP+    LK++ +L+ S N LTGP+ L    L+ L  +    N+ SG IP
Sbjct:   343 YLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIP 402

Query:   323 REIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIH 382
              ++G   S L  L++S N L G IP      +       G   L G+    +  CKT + 
Sbjct:   403 PKLGW-YSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQ 461

Query:   383 HTSWKNSLL 391
                 +N+L+
Sbjct:   462 LRLARNNLV 470

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	596
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-62
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-52
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-43
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-31
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-28
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-22
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-22
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-21
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-19
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-16
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-14
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-14
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-14
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-11
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-11
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-11
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-10
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-09
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-09
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-09
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-08
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-08
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-08
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-08
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-08
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	7e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-08
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-07
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-07
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-07
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-07
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-06
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-06
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-06
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-06
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-06
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-05
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-05
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-05
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-05
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-05
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-05
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-05
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-05
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-04
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-04
PLN03210	1153	PLN03210, PLN03210, Resistant to P	3e-04
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-04
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-04
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-04
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	0.001
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.001
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	0.001
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	0.001
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	0.001
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	0.002
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.002
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	0.002
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.002
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.003
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	0.003
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.003
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.003
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.003
cd12094	44	cd12094, TM_ErbB2, Transmembrane domain of ErbB2,	0.004
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	0.004
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	0.004
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  220 bits (563), Expect = 5e-62
 Identities = 180/597 (30%), Positives = 275/597 (46%), Gaps = 54/597 (9%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
            IP  +GNL+NL+ L L QNKL G +P +IF++  L  L L +NSLSG +  +  ++L N
Sbjct: 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV-IQLQN 309

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           LE L+L+ NNF+G IP  + +  +L  L L  N FSG IP   G   NL  L L  N LT
Sbjct: 310 LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPE 180
              PE      L +  +L  + L +N L+G +PK S+    RSL    + + + SG +P 
Sbjct: 370 GEIPE-----GLCSSGNLFKLILFSNSLEGEIPK-SLGA-CRSLRRVRLQDNSFSGELPS 422

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE 240
           E + L  +  +D+  N L G I      +  LQ L+L  N   G +PD       L  L+
Sbjct: 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLD 481

Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLL 299
           L  N+  G++P   G+L+ L  L L  NKL+  IP    + K ++ L+ S N L+G +  
Sbjct: 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA 541

Query: 300 EIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAES 359
               + VL  +D S N  SG IP+ +G  +  L  +N+S N L G +P  G+F   +A +
Sbjct: 542 SFSEMPVLSQLDLSQNQLSGEIPKNLG-NVESLVQVNISHNHLHGSLPSTGAFLAINASA 600

Query: 360 FEGNELLCGSPNLQ-VPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRQRG- 417
             GN  LCG      +PPCK      SW     +   L     L +V    +    +   
Sbjct: 601 VAGNIDLCGGDTTSGLPPCKRVRKTPSW--WFYITCTLGAFLVLALVAFGFVFIRGRNNL 658

Query: 418 --KKPSNDANMPLVATWRTFSYLELCRATDEFS---------ENNLIGRG---------- 456
             K+  N+       TW    +    + +   +         E N+I RG          
Sbjct: 659 ELKRVENED-----GTWELQFFDS--KVSKSITINDILSSLKEENVISRGKKGASYKGKS 711

Query: 457 ---GFALFIRAFKSFDVECEM----MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 509
              G    ++     +         M  ++H N++K+I  C +E+   L+ EY+   +L 
Sbjct: 712 IKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771

Query: 510 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHL 566
           + L +    L   +R  I I +A AL +LH   S  V+  +L P  +++D     HL
Sbjct: 772 EVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  191 bits (487), Expect = 8e-52
 Identities = 134/372 (36%), Positives = 200/372 (53%), Gaps = 33/372 (8%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           EIP +IG+  +L+ L LG N L+G +P ++ N+++L+FL L +N L G +      ++ +
Sbjct: 155 EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG-QMKS 213

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L+ +YL  NN SG IP  I   + L+ L L  N+ +G IPS+ GNL+NL+ L L +N L+
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPE 180
              P      S+ + + L  +DLS+N L G +P+  I    ++LE  ++++ N +G IP 
Sbjct: 274 GPIPP-----SIFSLQKLISLDLSDNSLSGEIPELVIQ--LQNLEILHLFSNNFTGKIPV 326

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE 240
            +++L  L  + L  NK +G IP  LGK   L  L+L  N L G IP+ +C    L++L 
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI 386

Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPL-- 297
           L SN L G IP   G   SLR + L  N  +  +P  F  L  +  L+ S+N L G +  
Sbjct: 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446

Query: 298 ------LLEIGNL---------------KVLIGIDFSMNNFSGVIPREIGEKLSYLEDLN 336
                  L++ +L               K L  +D S N FSG +PR++G  LS L  L 
Sbjct: 447 RKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLG-SLSELMQLK 505

Query: 337 LSFNKLKGEIPR 348
           LS NKL GEIP 
Sbjct: 506 LSENKLSGEIPD 517

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  166 bits (423), Expect = 1e-43
 Identities = 136/374 (36%), Positives = 185/374 (49%), Gaps = 25/374 (6%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVS-TLKFLGLQNNSLSGSLSSIANVRLP 59
           +I   I  L  ++ + L  N+L G +P  IF  S +L++L L NN+ +G   SI    +P
Sbjct: 84  KISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG---SIPRGSIP 140

Query: 60  NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
           NLE L L  N  SG IP  I + S L  L LG N   G IP++  NL +LE L L  N L
Sbjct: 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL 200

Query: 120 TSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
               P       L   KSL  I L  N L G +P   I  L+ SL    +   N++G IP
Sbjct: 201 VGQIP-----RELGQMKSLKWIYLGYNNLSGEIPY-EIGGLT-SLNHLDLVYNNLTGPIP 253

Query: 180 EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
             + NL NL  + L  NKL+G IP ++  L+KL  L+L DN L G IP+ + +L  L  L
Sbjct: 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313

Query: 240 ELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPL- 297
            L SN   G IP    +L  L++L L SNK +  IP       ++  L+ S+N LTG + 
Sbjct: 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373

Query: 298 --LLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGS---- 351
             L   GNL  L  I FS N+  G IP+ +G   S L  + L  N   GE+P   +    
Sbjct: 374 EGLCSSGNLFKL--ILFS-NSLEGEIPKSLGACRS-LRRVRLQDNSFSGELPSEFTKLPL 429

Query: 352 --FGNFSAESFEGN 363
             F + S  + +G 
Sbjct: 430 VYFLDISNNNLQGR 443

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  120 bits (302), Expect = 5e-31
 Identities = 49/135 (36%), Positives = 71/135 (52%), Gaps = 6/135 (4%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
              +    E E++K + H N++K+     +E    LV+EY   GSL+  L  +   L   
Sbjct: 33  SLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSED 92

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQS 581
           + L I++ +   LEYLH   S  +IH DLKP N+LLD DN    L+DF ++KLLT +   
Sbjct: 93  EILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL 149

Query: 582 MTQTQTLGTIGYMAP 596
           +      GT  YMAP
Sbjct: 150 LKTIV--GTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  113 bits (285), Expect = 3e-28
 Identities = 47/126 (37%), Positives = 70/126 (55%), Gaps = 6/126 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++ + H N++++I +  +++   LV+EY   G L  YL S    L   +   I + 
Sbjct: 48  EIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQ 106

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   LEYLH   S  +IH DLKP N+LLD+N V  ++DF +AK L     S+T T   GT
Sbjct: 107 ILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GT 161

Query: 591 IGYMAP 596
             YMAP
Sbjct: 162 PWYMAP 167

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  112 bits (283), Expect = 5e-28
 Identities = 42/131 (32%), Positives = 69/131 (52%), Gaps = 7/131 (5%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           +    E +++K ++H N++++     +E+   LV+EY   G L   L      L   +  
Sbjct: 42  ERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEAR 100

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
             +  + SALEYLH   S  ++H DLKP N+LLD++    L+DF +A+ L   ++  T  
Sbjct: 101 FYLRQILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF- 156

Query: 586 QTLGTIGYMAP 596
             +GT  YMAP
Sbjct: 157 --VGTPEYMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =   99 bits (250), Expect = 1e-23
 Identities = 41/131 (31%), Positives = 68/131 (51%), Gaps = 4/131 (3%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M+ + H N++K++  C+ EE   +V+EYM  G L  YL  +   L +   L
Sbjct: 46  EEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLL 105

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           +  + +A  +EYL    S   IH DL   N L+ +N+V  +SDF +++ L  +D    + 
Sbjct: 106 SFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKR 161

Query: 586 QTLGTIGYMAP 596
                I +MAP
Sbjct: 162 GGKLPIRWMAP 172

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 37/126 (29%), Positives = 64/126 (50%), Gaps = 3/126 (2%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK + H N+++++  C+  E   +V EYMP G L  +L      L +   L + + 
Sbjct: 51  EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ 110

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A  +EYL    S   +H DL   N L+ +N+V  +SDF +++ +  +D    +      
Sbjct: 111 IAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167

Query: 591 IGYMAP 596
           I +MAP
Sbjct: 168 IKWMAP 173

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 42/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQR 524
           + F  E  +M+ + H N++K++  C+ EE   +V+EYMP G L  YL  +    L +   
Sbjct: 46  EEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDL 105

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L+  + +A  +EYL    S   IH DL   N L+ +N+V  +SDF +++ L  +D     
Sbjct: 106 LSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKV 161

Query: 585 TQTLGTIGYMAP 596
                 I +MAP
Sbjct: 162 KGGKLPIRWMAP 173

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 94.9 bits (237), Expect = 9e-22
 Identities = 51/182 (28%), Positives = 78/182 (42%), Gaps = 41/182 (22%)

Query: 446 EFSENNLIGRGGF-----AL-----FIRAFKSFDV-------------ECEMMKSIRHRN 482
           E++   L+GRG F     AL      + A KS ++             E  ++ S++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 483 LIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNI------MIDVASA 534
           +++   S  +EE   L   LEY+  GSL   L         F +L           +   
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEG 113

Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           L YLH   S  ++H D+K +N+L+D + V  L+DF  AK L   +         GT  +M
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 595 AP 596
           AP
Sbjct: 171 AP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 99.2 bits (247), Expect = 2e-21
 Identities = 71/198 (35%), Positives = 97/198 (48%), Gaps = 27/198 (13%)

Query: 183 SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAE------- 235
           +N + +V IDL G  ++G I   + +L  +Q +NL +N L G IPDDI   +        
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 236 ----------------LYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFW 278
                           L  L+L +N L G IP   G+ +SL++L LG N L   IP +  
Sbjct: 126 SNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185

Query: 279 NLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLS 338
           NL  +  L  +SN L G +  E+G +K L  I    NN SG IP EIG  L+ L  L+L 
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG-LTSLNHLDLV 244

Query: 339 FNKLKGEIPRGGSFGNFS 356
           +N L G IP   S GN  
Sbjct: 245 YNNLTGPIP--SSLGNLK 260

Length = 968

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 11/134 (8%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC--------ILDIF 522
           E  +MK + H N+++++  C+ EE   LVLEYM  G L  YL  S           L + 
Sbjct: 46  EARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             L+  I +A  +EYL    S   +H DL   N L+ +++V  +SDF +++ +  +D   
Sbjct: 106 DLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYR 162

Query: 583 TQTQTLGTIGYMAP 596
            +T     I +MAP
Sbjct: 163 KKTGGKLPIRWMAP 176

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 86.8 bits (216), Expect = 4e-19
 Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 8/129 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNI 527
           E +++K + H N+IK   S   +    +V+EY   G L + +         F   Q L+ 
Sbjct: 49  EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            + +  AL+YLH   S  ++H D+KP N+ L  N +  L DF I+K+L+     + +T  
Sbjct: 109 FVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV- 163

Query: 588 LGTIGYMAP 596
           +GT  Y++P
Sbjct: 164 VGTPYYLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 44/126 (34%), Positives = 68/126 (53%), Gaps = 7/126 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++ + H  L+ +  S  +EE   LV++ +  G L +Y  S        Q    + +
Sbjct: 50  ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICE 108

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +  ALEYLH   S  +IH D+KP N+LLD+    H++DF+IA  +T +  +   T T GT
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGT 162

Query: 591 IGYMAP 596
            GYMAP
Sbjct: 163 PGYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 45/124 (36%), Positives = 64/124 (51%), Gaps = 8/124 (6%)

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           ++  I H  ++K+  +   EE   LVLEY P G L  +L       +   R     ++  
Sbjct: 46  ILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVL 104

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIG 592
           ALEYLH   S  +I+ DLKP N+LLD +    L+DF +AK L+ E     +T T  GT  
Sbjct: 105 ALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPE 158

Query: 593 YMAP 596
           Y+AP
Sbjct: 159 YLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 75.9 bits (185), Expect = 1e-14
 Identities = 56/174 (32%), Positives = 76/174 (43%), Gaps = 32/174 (18%)

Query: 452 LIGRGGFALFIRAFKSFDV---------------------ECEMMKSIRH-RNLIKVISS 489
            +G G F     A     V                     E +++ S+ H  N++K+   
Sbjct: 7   KLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66

Query: 490 CSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSALVI 547
             +E    LV+EY+  GSLE  L        L   + L I+  + SALEYLH   S  +I
Sbjct: 67  FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGII 123

Query: 548 HCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTL----GTIGYMAP 596
           H D+KP N+LLD D  V  L DF +AKLL     + +         GT GYMAP
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 6/126 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E +++K  +H N++K   S   ++   +V+E+   GSL+  L S+N  L   Q   +  +
Sbjct: 47  EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKE 106

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   LEYLH   S  +IH D+K +N+LL  +    L DF ++  L+      T    +GT
Sbjct: 107 LLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGT 160

Query: 591 IGYMAP 596
             +MAP
Sbjct: 161 PYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 36/119 (30%), Positives = 66/119 (55%), Gaps = 10/119 (8%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIF 522
             + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N   ++  
Sbjct: 45  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV 104

Query: 523 QRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 578
             L +   ++SA+EYL   +F      IH DL   N L+ +N +  ++DF +++L+TG+
Sbjct: 105 VLLYMATQISSAMEYLEKKNF------IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 38/111 (34%), Positives = 61/111 (54%), Gaps = 4/111 (3%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIF 522
           A ++F  E  +M ++RH NL++++          +V EYM  GSL  YL S    ++ + 
Sbjct: 43  AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA 102

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           Q+L   +DV   +EYL        +H DL   NVL+ +++VA +SDF +AK
Sbjct: 103 QQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 72.2 bits (178), Expect = 5e-14
 Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 7/101 (6%)

Query: 497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV 556
           ++VLEYM  GSL   L     I +      I   +   L+YLH      +IH D+KPSN+
Sbjct: 75  SIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH--TKRHIIHRDIKPSNL 131

Query: 557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LGTIGYMAP 596
           L++      ++DF I+K+L   + ++ Q  T +GT+ YM+P
Sbjct: 132 LINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 39/114 (34%), Positives = 63/114 (55%), Gaps = 10/114 (8%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           ++F  E ++MK +RH  L+++ + CS EE   +V EYM  GSL  +L S         RL
Sbjct: 46  EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRL 102

Query: 526 NIMID----VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
             ++D    +A  + YL    S   IH DL   N+L+ +N+V  ++DF +A+L+
Sbjct: 103 PQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI 153

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 71.1 bits (175), Expect = 8e-14
 Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 41/175 (23%)

Query: 451 NLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVI 487
           +LIGRG F +  +                         KS   E +++K+++H N++K I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 488 SSCSNEEFKALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFG 541
            S    +   ++LEY  +GSL + +            + ++Q       V   L YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------VLQGLAYLH-- 116

Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
               VIH D+K +N+L   + V  L+DF +A  L    +       +GT  +MAP
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 22/149 (14%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS--------- 514
           A K F+ E E++ + +H N++K    C+  +   +V EYM HG L K+L S         
Sbjct: 51  ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLK 110

Query: 515 ---SNCI-LDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
              S    L + Q L I + +AS + YL   HF      +H DL   N L+  ++V  + 
Sbjct: 111 SPDSPMGELTLSQLLQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIG 164

Query: 568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           DF +++ +   D       T+  I +M P
Sbjct: 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.9 bits (179), Expect = 2e-13
 Identities = 35/87 (40%), Positives = 49/87 (56%), Gaps = 2/87 (2%)

Query: 141 IDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNG 200
           + L N  L G +P   IS L R L+   +   +I G IP  + ++T+L  +DL  N  NG
Sbjct: 423 LGLDNQGLRGFIPND-ISKL-RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 201 SIPITLGKLRKLQRLNLEDNILEGSIP 227
           SIP +LG+L  L+ LNL  N L G +P
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 15/136 (11%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRL--- 525
           E  +++ ++H N+++      +   + L  V+EY   G L + +    C  +  + +   
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKE-RKYIEEE 105

Query: 526 ---NIMIDVASALEYLHFGYSA--LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
               I+  +  AL   H        V+H DLKP+N+ LD N    L DF +AK+L G D 
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDS 164

Query: 581 SMTQTQTLGTIGYMAP 596
           S  +T  +GT  YM+P
Sbjct: 165 SFAKT-YVGTPYYMSP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.5 bits (178), Expect = 3e-13
 Identities = 34/81 (41%), Positives = 44/81 (54%)

Query: 191 IDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSI 250
           + L    L G IP  + KLR LQ +NL  N + G+IP  +  +  L  L+L  N   GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 251 PACFGNLASLRILSLGSNKLT 271
           P   G L SLRIL+L  N L+
Sbjct: 483 PESLGQLTSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 69.1 bits (170), Expect = 6e-13
 Identities = 41/116 (35%), Positives = 60/116 (51%), Gaps = 9/116 (7%)

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDV 531
           + +   H  +IK+  +  +EE    VLEY P+G L +Y+  Y S   LD         ++
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEI 111

Query: 532 ASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
             ALEYLH   S  +IH DLKP N+LLD +M   ++DF  AK+L   + S    + 
Sbjct: 112 LLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKG 163

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.0 bits (174), Expect = 8e-13
 Identities = 35/85 (41%), Positives = 49/85 (57%)

Query: 171 NCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI 230
           N  + G IP +IS L +L  I+L GN + G+IP +LG +  L+ L+L  N   GSIP+ +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 231 CRLAELYRLELGSNKLYGSIPACFG 255
            +L  L  L L  N L G +PA  G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 41/128 (32%), Positives = 76/128 (59%), Gaps = 8/128 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 529
           EC+++K + H N+I+   +   ++   +V+EY P G+L +Y+    N +LD    L+  +
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLTGEDQSMTQTQTL 588
            +  AL ++H   + L++H DLK  N+LLD + MV  + DF I+K+L+ + ++ T    +
Sbjct: 109 QILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VV 162

Query: 589 GTIGYMAP 596
           GT  Y++P
Sbjct: 163 GTPCYISP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 18/144 (12%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------- 516
           F  E E+M  ++H N++ ++  C+ E+   ++ EY+ HG L ++L  ++           
Sbjct: 55  FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114

Query: 517 ----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA 572
                 LD    L+I I +A+ +EYL    S   +H DL   N L+ + +   +SDF ++
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 573 KLLTGEDQSMTQTQTLGTIGYMAP 596
           + +   D    Q+++L  + +M P
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 11/118 (9%)

Query: 471 ECEMMKSIRHRNLIK----VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 526
           E ++++ +RH N+++    V S      +  +V EYM H  L   L S        Q   
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKC 104

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMT 583
            M  +   L+YLH   S  ++H D+K SN+L++++ V  L+DF +A+  T       T
Sbjct: 105 YMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 5/132 (3%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 524
           K F  E ++MK +RH  LI++ + C+ EE   +V E M +GSL +YL       L + Q 
Sbjct: 46  KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL 105

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   VAS + YL    +   IH DL   NVL+ +N +  ++DF +A+++  ED    +
Sbjct: 106 IDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAR 161

Query: 585 TQTLGTIGYMAP 596
                 I + AP
Sbjct: 162 EGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 66.7 bits (164), Expect = 3e-12
 Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 5/115 (4%)

Query: 475 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 534
           +K ++H N++K++     E    LV EY     L+KYL      L      +IM  +   
Sbjct: 52  LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRG 110

Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT-QTL 588
           L Y H   S  ++H DLKP N+L++ + V  L+DF +A+      ++ T    TL
Sbjct: 111 LAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 5e-12
 Identities = 55/204 (26%), Positives = 83/204 (40%), Gaps = 57/204 (27%)

Query: 215 LNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP 274
           L L++  L G IP+DI +L  L  + L  N + G+IP   G++ SL +L           
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL----------- 471

Query: 275 LTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLED 334
                                               D S N+F+G IP  +G+ L+ L  
Sbjct: 472 ------------------------------------DLSYNSFNGSIPESLGQ-LTSLRI 494

Query: 335 LNLSFNKLKGEIPR--GGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLL 392
           LNL+ N L G +P   GG   + ++ +F  N  LCG P L    C     H S      +
Sbjct: 495 LNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACGP---HLS--VGAKI 547

Query: 393 GIVLPLSTTLLIVVIWLILRYRQR 416
           GI   +S   L +VI  +  +++R
Sbjct: 548 GIAFGVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 78/281 (27%), Positives = 124/281 (44%), Gaps = 12/281 (4%)

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
           L  N  S T+     + S+L  L L   S      S+     NL  L    +   +    
Sbjct: 50  LALNLSSNTLLLLPSSLSRLLSLDLLSPS----GISSLDGSENLLNLLPLPSLDLNLNRL 105

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNL 185
            S +S L    +LT +DL NN +  I     I  L  +L+E  + + N    +P  + NL
Sbjct: 106 RSNISELLELTNLTSLDLDNNNITDI--PPLIGLLKSNLKELDLSD-NKIESLPSPLRNL 162

Query: 186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNK 245
            NL  +DL  N L+  +P  L  L  L  L+L  N +   +P +I  L+ L  L+L +N 
Sbjct: 163 PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220

Query: 246 LYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLK 305
           +   + +   NL +L  L L +NKL  +P +  NL ++  L+ S+N ++   +  +G+L 
Sbjct: 221 II-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISS--ISSLGSLT 277

Query: 306 VLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEI 346
            L  +D S N+ S  +P      L     LNL       E+
Sbjct: 278 NLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALEL 318

Length = 394

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 65.7 bits (160), Expect = 9e-12
 Identities = 37/105 (35%), Positives = 56/105 (53%), Gaps = 7/105 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
           E  ++K++ H N++K    CS +  K   L++EY+P GSL  YL      L++ Q L   
Sbjct: 56  EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFA 113

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
             +   + YLH   S   IH DL   NVLLD++ +  + DF +AK
Sbjct: 114 QQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 32/114 (28%), Positives = 60/114 (52%), Gaps = 5/114 (4%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           F+ E E+++++ H N++K    C     ++  L++EY+P GSL  YL      +++ + L
Sbjct: 53  FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL 112

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
                +   ++YL    S   IH DL   N+L++   +  +SDF +AK+L  + 
Sbjct: 113 LFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 41/126 (32%), Positives = 64/126 (50%), Gaps = 5/126 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK  +H N++    S    +   +V+EYM  GSL   +  +   ++  Q   +  +
Sbjct: 65  EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCRE 124

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           V   LEYLH   S  VIH D+K  N+LL  +    L+DF  A  LT +++S   +  +GT
Sbjct: 125 VLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSV-VGT 179

Query: 591 IGYMAP 596
             +MAP
Sbjct: 180 PYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLN 526
           F  E + +K +RH++LI + + CS  E   ++ E M  GSL  +L S    +L +   ++
Sbjct: 49  FQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID 108

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
           +   VA  + YL        IH DL   N+L+ +++V  ++DF +A+L+
Sbjct: 109 MACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 3/103 (2%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H NL+++   C+ +    +V EYM +G L  YL      L     L++  D
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           V  A+EYL    S   IH DL   N L+ ++ V  +SDF +A+
Sbjct: 109 VCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 39/131 (29%), Positives = 61/131 (46%), Gaps = 9/131 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNI 527
           E + M    H N++K  +S    +   LV+ Y+  GSL    K  Y     LD      +
Sbjct: 49  EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATV 107

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL--TGEDQSMTQT 585
           + +V   LEYLH   S   IH D+K  N+LL ++    ++DF ++  L   G+     + 
Sbjct: 108 LKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164

Query: 586 QTLGTIGYMAP 596
             +GT  +MAP
Sbjct: 165 TFVGTPCWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 64.5 bits (158), Expect = 3e-11
 Identities = 36/122 (29%), Positives = 63/122 (51%), Gaps = 13/122 (10%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRL 525
           E ++++ +RH N+I    ++   S E+F  +  V E M    L K + S   + D   + 
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY 107

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS---M 582
             +  +   L+YLH   SA VIH DLKPSN+L++ N    + DF +A+ +  ++     +
Sbjct: 108 -FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 583 TQ 584
           T+
Sbjct: 164 TE 165

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 40/134 (29%), Positives = 61/134 (45%), Gaps = 20/134 (14%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEF-----KALVLEYMPHGSLEKYLYSSNCILDIFQR- 524
           E  ++ S+ H N+I        E F       +V+EY P G L K +        +    
Sbjct: 49  EIRILASVNHPNII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ 103

Query: 525 --LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
               I I +   L+ LH      ++H DLK +N+LL  N +  + D  I+K+L    ++M
Sbjct: 104 EIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNM 157

Query: 583 TQTQTLGTIGYMAP 596
            +TQ  GT  YMAP
Sbjct: 158 AKTQI-GTPHYMAP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 6/126 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E +++       ++    +  N    ++ +EYM  GSL+K L      +       I + 
Sbjct: 49  ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           V   L YLH  +   +IH D+KPSN+L++      L DF ++  L     S+ +T   GT
Sbjct: 109 VLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GT 162

Query: 591 IGYMAP 596
             YMAP
Sbjct: 163 SSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 3/103 (2%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E++K   H N++K+I  C  ++   +V+E +P GSL  +L      L + + L + +D
Sbjct: 42  EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD 101

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            A+ +EYL    S   IH DL   N L+ +N V  +SDF +++
Sbjct: 102 AAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 24/153 (15%)

Query: 462 IRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------- 514
           + A K F  E E++ +++H +++K    C + +   +V EYM HG L K+L +       
Sbjct: 48  LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 107

Query: 515 --------SNCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMV 563
                   +   L + Q L+I   +AS + YL   HF      +H DL   N L+  N++
Sbjct: 108 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLL 161

Query: 564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             + DF +++ +   D       T+  I +M P
Sbjct: 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 194

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 39/123 (31%), Positives = 69/123 (56%), Gaps = 9/123 (7%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S EE   +V EYM  GSL  +L       L + Q 
Sbjct: 46  EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL 104

Query: 525 LNIMIDVASALEYLH-FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           +++   +AS + Y+    Y    +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T
Sbjct: 105 VDMAAQIASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYT 158

Query: 584 QTQ 586
             Q
Sbjct: 159 ARQ 161

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 43/133 (32%), Positives = 66/133 (49%), Gaps = 10/133 (7%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQ 523
           ++F  E  +M  +RH NL++++     E+    +V EYM  GSL  YL S    +L    
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 103

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L   +DV  A+EYL    +   +H DL   NVL+ ++ VA +SDF + K     + S T
Sbjct: 104 LLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 155

Query: 584 QTQTLGTIGYMAP 596
           Q      + + AP
Sbjct: 156 QDTGKLPVKWTAP 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 36/128 (28%), Positives = 59/128 (46%), Gaps = 14/128 (10%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSC----SNEEFKA--LVLEYMPHGSLEKYLYSSN 516
              + F  E   MK   H N++K+I  C    S ++     ++L +M HG L  +L  S 
Sbjct: 43  SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR 102

Query: 517 C-----ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI 571
                  L +   L  M+D+A  +EYL    +   IH DL   N +L ++M   ++DF +
Sbjct: 103 LGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGL 159

Query: 572 AKLLTGED 579
           +K +   D
Sbjct: 160 SKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 45/127 (35%), Positives = 65/127 (51%), Gaps = 11/127 (8%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++SIRH  L+ +  S  ++    LV+EY+P G L  +L  S               
Sbjct: 51  EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQ 109

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           V  ALEYLH   S  +++ DLKP N+LLD +    ++DF  AK + G      +T TL G
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCG 160

Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 161 TPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 44/138 (31%), Positives = 69/138 (50%), Gaps = 10/138 (7%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-- 520
           +  K    E ++++ ++H NL+K      + E   + +EY   G+LE+ L     ILD  
Sbjct: 41  KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEH 99

Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
           + +   + +     L YLH   S  ++H D+KP+N+ LD N V  L DF  A  L     
Sbjct: 100 VIRVYTLQL--LEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154

Query: 581 SM-TQTQTL-GTIGYMAP 596
           +M  + Q+L GT  YMAP
Sbjct: 155 TMGEEVQSLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 4/129 (3%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E ++M  + H  L+++   C+      LV E+M HG L  YL +          L +
Sbjct: 46  FIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGM 105

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            +DV   + YL    S+ VIH DL   N L+ +N V  +SDF + + +  +DQ  + T T
Sbjct: 106 CLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGT 161

Query: 588 LGTIGYMAP 596
              + + +P
Sbjct: 162 KFPVKWSSP 170

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 10/138 (7%)

Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 524
                 E +++   +   ++K+  S   ++   LV+EY+P G L   L +    LD    
Sbjct: 37  VDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVA 95

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL------LTGE 578
              + ++  ALEYLH   S  +IH DLKP N+L+D N    L+DF ++K+      +   
Sbjct: 96  RIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152

Query: 579 DQSMTQTQTLGTIGYMAP 596
           D      + +GT  Y+AP
Sbjct: 153 DDEKEDKRIVGTPDYIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 60.7 bits (148), Expect = 5e-10
 Identities = 37/126 (29%), Positives = 67/126 (53%), Gaps = 6/126 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++++ ++H N+I ++    ++    LV E+M    LEK +   + +L      + M+ 
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLM 110

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
               LEYLH  +   ++H DLKP+N+L+  + V  L+DF +A+     ++ MT  Q + T
Sbjct: 111 TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQVV-T 165

Query: 591 IGYMAP 596
             Y AP
Sbjct: 166 RWYRAP 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 3/106 (2%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E ++M  + H  L+++   C+ +    +V EYM +G L  YL          Q L +
Sbjct: 46  FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM 105

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
             DV   + YL    S   IH DL   N L+DD     +SDF +++
Sbjct: 106 CKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 34/129 (26%), Positives = 60/129 (46%), Gaps = 5/129 (3%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F VE +++   +H N++ +  +   E    +++E+   G+L+  +      L   Q   +
Sbjct: 49  FMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV 108

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
              +  AL +LH   S  VIH DLK  N+LL  +    L+DF ++       Q   +   
Sbjct: 109 CRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTF 163

Query: 588 LGTIGYMAP 596
           +GT  +MAP
Sbjct: 164 IGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 23/150 (15%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC---ILD 520
           A + F  E E++  ++H+++++    C+      +V EYM HG L ++L S      IL 
Sbjct: 50  ARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILA 109

Query: 521 -----------IFQRLNIMIDVASALEY---LHFGYSALVIHCDLKPSNVLLDDNMVAHL 566
                      + Q L I   +AS + Y   LHF      +H DL   N L+   +V  +
Sbjct: 110 GGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKI 163

Query: 567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            DF +++ +   D      +T+  I +M P
Sbjct: 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 34/125 (27%), Positives = 66/125 (52%), Gaps = 6/125 (4%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E  +M    H N+I++    +  +   ++ EYM +G+L+KYL   +     +Q + +
Sbjct: 53  FLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGM 112

Query: 528 MIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           +  +A+ ++YL    Y    +H DL   N+L++ N+   +SDF ++++L  +D   T T 
Sbjct: 113 LRGIAAGMKYLSDMNY----VHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTT 167

Query: 587 TLGTI 591
           + G I
Sbjct: 168 SGGKI 172

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 34/132 (25%), Positives = 69/132 (52%), Gaps = 5/132 (3%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
            + + E +++K+++H  +++      ++E  ++ +EYMP GS++  L +   + +   R 
Sbjct: 49  NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR- 107

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
                +   +EYLH   S +++H D+K +N+L D      L DF  +K L     S T  
Sbjct: 108 KYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM 164

Query: 586 QTL-GTIGYMAP 596
           +++ GT  +M+P
Sbjct: 165 KSVTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 42/127 (33%), Positives = 66/127 (51%), Gaps = 11/127 (8%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H  +I++  +  ++ F  +++EY+P G L  YL +S    +         +
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASE 109

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           +  ALEYLH   S  +++ DLKP N+LLD      L+DF  AK L        +T TL G
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCG 160

Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 161 TPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 6/127 (4%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I +    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 50  RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV 109

Query: 526 NIMIDVASALEYLH-FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  +D     
Sbjct: 110 GMLRGIASGMKYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAAY 164

Query: 585 TQTLGTI 591
           T   G I
Sbjct: 165 TTRGGKI 171

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 46/185 (24%), Positives = 79/185 (42%), Gaps = 46/185 (24%)

Query: 451 NLIGRGGFALFIRAF------------------------KSFDVECEMM-KSIRHRNLIK 485
           ++IG G F   IRA                         + F  E E++ K   H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 486 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 530
           ++ +C N  +  + +EY P+G+L  +L  S  +               L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           VA+ ++YL        IH DL   NVL+ +N+ + ++DF +++   GE+  + +T     
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 591 IGYMA 595
           + +MA
Sbjct: 182 VRWMA 186

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 75/271 (27%), Positives = 120/271 (44%), Gaps = 16/271 (5%)

Query: 32  NVSTLKFLGLQNNSLSGSLSSIANV-RLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSL 90
           ++S L  L L + S   SL    N+  L  L  L L  N     I   +   + L+ L L
Sbjct: 65  SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDL 123

Query: 91  GMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDG 150
             N+ +   P       NL++L L +N + S        S L N  +L  +DLS N L  
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKIES------LPSPLRNLPNLKNLDLSFNDLSD 177

Query: 151 ILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLR 210
           +     + +   +L    +    IS  +P EI  L+ L E+DL  N +   +  +L  L+
Sbjct: 178 LPK---LLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLK 232

Query: 211 KLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKL 270
            L  L L +N LE  +P+ I  L+ L  L+L +N++  S  +  G+L +LR L L  N L
Sbjct: 233 NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSL 289

Query: 271 TSIPLTFWNLKDILQLNFSSNFLTGPLLLEI 301
           ++       L  +L+L  +       L L++
Sbjct: 290 SNALPLIALLLLLLELLLNLLLTLKALELKL 320

Length = 394

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 6/126 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E +++K + H N+IK++    ++    LV E+M    L K +      L      + +  
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L + H   S  ++H DLKP N+L++   V  L+DF +A+           T  + T
Sbjct: 107 LLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVT 161

Query: 591 IGYMAP 596
             Y AP
Sbjct: 162 RWYRAP 167

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 9/127 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+++   H  ++K+  +  ++++  +++EY   G L   L     + D +     +  
Sbjct: 43  EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIAC 101

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           V  A EYLH   +  +I+ DLKP N+LLD N    L DF  AK L    +S  +T T  G
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCG 154

Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 155 TPEYVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 31/70 (44%), Positives = 39/70 (55%), Gaps = 5/70 (7%)

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           I + +  ALEYLH   S  VIH D+KPSNVL++ N    L DF I+  L     S+ +T 
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162

Query: 587 TLGTIGYMAP 596
             G   YMAP
Sbjct: 163 DAGCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 42/123 (34%), Positives = 63/123 (51%), Gaps = 6/123 (4%)

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           ++K+++H  L+ +  S    E    VL+Y+  G L  +L    C L+   R     +VAS
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVAS 107

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
           A+ YLH   S  +I+ DLKP N+LLD      L+DF + K   G +   T +   GT  Y
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEY 162

Query: 594 MAP 596
           +AP
Sbjct: 163 LAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 4/133 (3%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           A K    E  +M S+ H ++++++  C + +   L+ + MP G L  Y+ +    +    
Sbjct: 52  ANKEILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQY 110

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  +++   
Sbjct: 111 LLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH 167

Query: 584 QTQTLGTIGYMAP 596
                  I +MA 
Sbjct: 168 AEGGKVPIKWMAL 180

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 8/130 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K ++H N+++ + S  + +   + LEY+P GS+   L +     +   R N +  
Sbjct: 56  EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQ 114

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT--- 587
           +   L YLH   +  +IH D+K +N+L+D+     +SDF I+K L     S         
Sbjct: 115 ILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171

Query: 588 -LGTIGYMAP 596
             G++ +MAP
Sbjct: 172 LQGSVFWMAP 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 9/123 (7%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 524
           +SF  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L       L +   
Sbjct: 46  ESFLEEAQIMKKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNL 104

Query: 525 LNIMIDVASALEYLH-FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           +++   VA+ + Y+    Y    IH DL+ +N+L+ D +V  ++DF +A+L+  ED   T
Sbjct: 105 VDMAAQVAAGMAYIERMNY----IHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYT 158

Query: 584 QTQ 586
             Q
Sbjct: 159 ARQ 161

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 36/119 (30%), Positives = 58/119 (48%), Gaps = 19/119 (15%)

Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILD 520
           E EMMK I +H+N+I ++  C+ E    +V+EY  HG+L  +L          S +    
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124

Query: 521 IFQRL------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
             + L      +    VA  +E+L    S   IH DL   NVL+ ++ V  ++DF +A+
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 39/129 (30%), Positives = 60/129 (46%), Gaps = 12/129 (9%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH---GSLEKYLYSSNCILDIFQRLNI 527
           E  M+K +RH NL+ +I     ++   LV E++ H     LEKY       LD  +    
Sbjct: 50  EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKY 105

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
           +  +   +E+ H   S  +IH D+KP N+L+  + V  L DF  A+ L    +    T  
Sbjct: 106 LFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDY 160

Query: 588 LGTIGYMAP 596
           + T  Y AP
Sbjct: 161 VATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 39/123 (31%), Positives = 68/123 (55%), Gaps = 9/123 (7%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 524
           ++F  E ++MK +RH  L+ + +  S EE   +V E+M  GSL  +L   +   L + Q 
Sbjct: 46  EAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL 104

Query: 525 LNIMIDVASALEYLH-FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           +++   +A  + Y+    Y    IH DL+ +N+L+ DN+V  ++DF +A+L+  ED   T
Sbjct: 105 VDMAAQIADGMAYIERMNY----IHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYT 158

Query: 584 QTQ 586
             Q
Sbjct: 159 ARQ 161

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 27/70 (38%), Positives = 38/70 (54%), Gaps = 5/70 (7%)

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           + + +  AL YL   +   VIH D+KPSN+LLD +    L DF I+  L     S  +T+
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173

Query: 587 TLGTIGYMAP 596
           + G   YMAP
Sbjct: 174 SAGCAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 42/131 (32%), Positives = 67/131 (51%), Gaps = 12/131 (9%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI- 529
           E  +   ++HRN+++ + S S   F  + +E +P GSL   L S    L   +    +I 
Sbjct: 55  EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIF 112

Query: 530 ---DVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQT 585
               +   L+YLH      ++H D+K  NVL++  + V  +SDF  +K L G +   T+T
Sbjct: 113 YTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTET 168

Query: 586 QTLGTIGYMAP 596
            T GT+ YMAP
Sbjct: 169 FT-GTLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 39/148 (26%), Positives = 67/148 (45%), Gaps = 21/148 (14%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------- 516
           A K F  E E++ +++H +++K    C   +   +V EYM HG L K+L +         
Sbjct: 50  ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 109

Query: 517 -----CILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSD 568
                  L   Q L+I   +A+ + YL   HF      +H DL   N L+ +N++  + D
Sbjct: 110 EGNRPAELTQSQMLHIAQQIAAGMVYLASQHF------VHRDLATRNCLVGENLLVKIGD 163

Query: 569 FSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           F +++ +   D       T+  I +M P
Sbjct: 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPP 191

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 18/138 (13%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDI 521
           K+   E E +K + H N+++ +   + EE+ ++ LEY+P GS    L  Y      ++  
Sbjct: 53  KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF 112

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL---LTGE 578
           F        V   L YLH   S  ++H DLK  N+L+D + +  +SDF I+K    +   
Sbjct: 113 FTE-----QVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN 164

Query: 579 DQSMTQTQTLGTIGYMAP 596
           DQ+M+     G++ +MAP
Sbjct: 165 DQNMSMQ---GSVFWMAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 13/129 (10%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++  ++H N+++ + +   E+   + LE +P GSL K L                  
Sbjct: 52  EIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQ 110

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-- 588
           +   LEYLH       +H D+K +N+L+D N V  L+DF +AK      Q +  +     
Sbjct: 111 ILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSF 161

Query: 589 -GTIGYMAP 596
            G+  +MAP
Sbjct: 162 KGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 39/171 (22%), Positives = 73/171 (42%), Gaps = 32/171 (18%)

Query: 453 IGRGGFALFIRA-------------FKSFDV-----------ECEMMKSIRHRNLIKVIS 488
           IG+G F++  +A              + F++           E +++K + H N+IK ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 489 SCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL 545
           S        +VLE    G L    K+      ++         + + SALE++H   S  
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKR 126

Query: 546 VIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           ++H D+KP+NV +    V  L D  + +  +   ++      +GT  YM+P
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 56.5 bits (136), Expect = 9e-09
 Identities = 32/109 (29%), Positives = 61/109 (55%), Gaps = 5/109 (4%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQR 524
           ++F  E  +M  + H+NL++++    +     +V+E M  G+L  +L +    ++ + Q 
Sbjct: 44  QAFLEETAVMTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQL 102

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           L   +DVA  +EYL    S  ++H DL   N+L+ ++ VA +SDF +A+
Sbjct: 103 LQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 34/135 (25%), Positives = 68/135 (50%), Gaps = 8/135 (5%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I +    +      ++ E+M +G+L+ +L  ++    + Q +
Sbjct: 50  RDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV 109

Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +A+ ++YL    Y    +H DL   N+L++ N+V  +SDF +++ L  +    T 
Sbjct: 110 GMLRGIAAGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165

Query: 585 TQTLG---TIGYMAP 596
           T +LG    I + AP
Sbjct: 166 TSSLGGKIPIRWTAP 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 56.5 bits (136), Expect = 9e-09
 Identities = 36/139 (25%), Positives = 70/139 (50%), Gaps = 10/139 (7%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI- 521
           + ++    E +++KS++H N+++ + +C ++   ++ +E++P GS+   L     + +  
Sbjct: 44  KEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPV 103

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 581
           F +    I     + YLH   +  V+H D+K +NV+L  N +  L DF  A+ L      
Sbjct: 104 FCKYTKQI--LDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158

Query: 582 MTQTQTL----GTIGYMAP 596
            T +  L    GT  +MAP
Sbjct: 159 GTHSNMLKSMHGTPYWMAP 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 19/142 (13%)

Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y    +
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            D    F+ L +    VA  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 186

Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAP 208

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 31/121 (25%), Positives = 59/121 (48%), Gaps = 4/121 (3%)

Query: 475 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 534
           M S+ H  +++++  C     + LV +  P GSL  ++      LD  + LN  + +A  
Sbjct: 63  MGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121

Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           + YL       ++H +L   N+LL  + +  ++DF +A LL  +D+    ++    I +M
Sbjct: 122 MYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 595 A 595
           A
Sbjct: 179 A 179

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 40/123 (32%), Positives = 62/123 (50%), Gaps = 6/123 (4%)

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           ++K+++H  L+ +  S    +    VL+Y+  G L  +L       +   R     ++AS
Sbjct: 49  LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIAS 107

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
           AL YLH   S  +I+ DLKP N+LLD      L+DF + K   G + S T +   GT  Y
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEY 162

Query: 594 MAP 596
           +AP
Sbjct: 163 LAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 22/132 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSC-----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           E E+++ + H N++K    C      N E + L LE+M  GSLE        I D     
Sbjct: 122 EIEILRDVNHPNVVK----CHDMFDHNGEIQVL-LEFMDGGSLE-----GTHIADEQFLA 171

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ- 584
           ++   + S + YLH      ++H D+KPSN+L++      ++DF ++++L    Q+M   
Sbjct: 172 DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA---QTMDPC 225

Query: 585 TQTLGTIGYMAP 596
             ++GTI YM+P
Sbjct: 226 NSSVGTIAYMSP 237

Length = 353

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 40/131 (30%), Positives = 57/131 (43%), Gaps = 12/131 (9%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLE---KYLYSSNCILDIFQRL 525
           E E+ KS +   ++K   +  +E      + +EY   GSL+   K +      +      
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            I   V   L YLH   S  +IH D+KPSN+LL       L DF ++  L     + T T
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFT 164

Query: 586 QTLGTIGYMAP 596
              GT  YMAP
Sbjct: 165 ---GTSFYMAP 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 19/142 (13%)

Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y+   +
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132

Query: 519 ----LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
               L     ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189

Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAP 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 5/126 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++++ +RH N++ +  +   +    LV EY+    LE  L +S   L      + +  
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQ 108

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +  A+ Y H   S  +IH D+KP N+L+ ++ V  L DF  A+ L     S   T  + T
Sbjct: 109 LLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVAT 164

Query: 591 IGYMAP 596
             Y AP
Sbjct: 165 RWYRAP 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 14/125 (11%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSC----SNEEFKA--LVLEYMPHGSLEKYLYSSNC-- 517
           + F  E   MK   H N++++I  C     +E + +  ++L +M HG L  +L  S    
Sbjct: 45  EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104

Query: 518 ---ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
               L     +  M D+AS +EYL    S   IH DL   N +L++NM   ++DF ++K 
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161

Query: 575 LTGED 579
           +   D
Sbjct: 162 IYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 20/149 (13%)

Query: 462 IRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC---- 517
            +  K F  E  +M +  H N++K++  C   E + +++E M  G L  YL  +      
Sbjct: 40  DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFG 99

Query: 518 --ILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLL-----DDNMVAHLS 567
             +L + + L+I +DVA    YL   HF      IH DL   N L+     D + V  + 
Sbjct: 100 PPLLTLKELLDICLDVAKGCVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIG 153

Query: 568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           DF +A+ +   D    + + L  + +MAP
Sbjct: 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAP 182

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 34/132 (25%), Positives = 64/132 (48%), Gaps = 17/132 (12%)

Query: 471 ECEMMKSIRHRNLIKVI------SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 524
           E + +++ +H  ++K++      S         LV+EYMP   L + L      L   Q 
Sbjct: 49  EIKALQACQHPYVVKLLDVFPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQV 101

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            + M  +   + Y+H   +  ++H DLKP+N+L+  + V  ++DF +A+L + E+     
Sbjct: 102 KSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLY 157

Query: 585 TQTLGTIGYMAP 596
           +  + T  Y AP
Sbjct: 158 SHQVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 35/183 (19%)

Query: 441 CRATDEFSENNLIGRGGFALFIRA--FKSFDV---------------------ECEMMKS 477
           CR+  EF + N IG G + +  RA    S ++                     E  ++ +
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62

Query: 478 IRHRNLIK----VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           +RH N+++    V+    +  F  LV+EY     L   L +        Q   +M+ +  
Sbjct: 63  LRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLR 119

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
            L+YLH      +IH DLK SN+LL D     ++DF +A+      + MT      T+ Y
Sbjct: 120 GLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWY 174

Query: 594 MAP 596
            AP
Sbjct: 175 RAP 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 36/131 (27%), Positives = 63/131 (48%), Gaps = 21/131 (16%)

Query: 480 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQR 524
           H N+I ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DF +++   G++  + +
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180

Query: 585 TQTLGTIGYMA 595
           T     + +MA
Sbjct: 181 TMGRLPVRWMA 191

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 6/127 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRLNIMI 529
           E  ++  ++H N+I   +   ++    + +EY   G+L +K +     + +    L  + 
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            + SA+ Y+H    A ++H D+K  N+ L    +  L DF I+K+L G + SM +T  +G
Sbjct: 109 QIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVG 163

Query: 590 TIGYMAP 596
           T  YM+P
Sbjct: 164 TPYYMSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 37/125 (29%), Positives = 65/125 (52%), Gaps = 7/125 (5%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E  +M    H N+I++    +      ++ EYM +GSL+K+L  ++    + Q + +
Sbjct: 52  FLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM 111

Query: 528 MIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           +  +AS ++YL    Y    +H DL   N+L++ N+V  +SDF +++ L  ED   T T 
Sbjct: 112 LRGIASGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRL--EDSEATYTT 165

Query: 587 TLGTI 591
             G I
Sbjct: 166 KGGKI 170

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 29/115 (25%), Positives = 61/115 (53%), Gaps = 5/115 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
           E E+++++ H N++K    C+ +      L++E++P GSL++YL  +   +++ Q+L   
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           + +   ++YL    S   +H DL   NVL++      + DF + K +  + +  T
Sbjct: 116 VQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.0 bits (135), Expect = 4e-08
 Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 1/86 (1%)

Query: 39  LGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGF 98
           LGL N  L G + +  + +L +L+ + L GN+  G IP  + + + L  L L  NSF+G 
Sbjct: 423 LGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 99  IPSTFGNLRNLEQLGLDENYLTSSTP 124
           IP + G L +L  L L+ N L+   P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 27/143 (18%)

Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 524
           F+    E  M+K  RH N++    S    +   +V+EY   GSL+          DI+Q 
Sbjct: 44  FEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ----------DIYQV 93

Query: 525 LN----------IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
                       +  +    L YLH       IH D+K +N+LL ++    L+DF ++  
Sbjct: 94  TRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQ 150

Query: 575 LTGEDQSMTQTQTL-GTIGYMAP 596
           LT    ++ + ++  GT  +MAP
Sbjct: 151 LT---ATIAKRKSFIGTPYWMAP 170

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 3/106 (2%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E  ++K   H N++K+I  C+  +   +V+E +P G    +L      L   Q +  
Sbjct: 39  FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF 98

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            +D A+ + YL    S   IH DL   N L+ +N V  +SDF +++
Sbjct: 99  ALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 37/124 (29%), Positives = 55/124 (44%), Gaps = 16/124 (12%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIM 528
           E  +M  + H  ++++I  C  E    LV+E  P G L KYL       + D+     + 
Sbjct: 46  EASVMAQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELA 101

Query: 529 IDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
             VA  + YL   HF      +H DL   NVLL +   A +SDF +++ L G      + 
Sbjct: 102 HQVAMGMAYLESKHF------VHRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDYYRA 154

Query: 586 QTLG 589
            T G
Sbjct: 155 TTAG 158

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 19/135 (14%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDIFQRLN 526
           E  +M  + H ++I+++ +   +    L +E+M  GS    L KY      ++     +N
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----IN 107

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDF-SIAKL---LTGEDQS 581
               +   L YLH      +IH D+K +N+L+D       ++DF + A+L    TG  + 
Sbjct: 108 YTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE- 163

Query: 582 MTQTQTLGTIGYMAP 596
             Q Q LGTI +MAP
Sbjct: 164 -FQGQLLGTIAFMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 47/204 (23%), Positives = 74/204 (36%), Gaps = 57/204 (27%)

Query: 445 DEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIK------------VISSCSN 492
           D+F    +IGRG F            +   MK +R  ++IK            +++   +
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 493 ------------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                       EE   LV+EYMP G L   L   +   +   R  I  ++  AL+ +H 
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHK 119

Query: 540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK------------LLTGEDQSMTQTQ- 586
            G+    IH D+KP N+L+D +    L+DF + K              +           
Sbjct: 120 LGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 587 --------------TLGTIGYMAP 596
                         T+GT  Y+AP
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAP 199

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 36/132 (27%), Positives = 67/132 (50%), Gaps = 11/132 (8%)

Query: 471 ECEMMKSIRHRNL--IKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLN 526
           E ++++  +H N+  I+ I      +FK   +V++ M    L   ++S   + +   R  
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY- 111

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG--EDQSMTQ 584
            +  +   L+Y+H   SA VIH DLKPSN+L++++    + DF +A+ L+    +     
Sbjct: 112 FLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168

Query: 585 TQTLGTIGYMAP 596
           T+ + T  Y AP
Sbjct: 169 TEYVATRWYRAP 180

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 45/185 (24%), Positives = 79/185 (42%), Gaps = 46/185 (24%)

Query: 451 NLIGRGGFALFIRAF------------------------KSFDVECEMM-KSIRHRNLIK 485
           ++IG G F   ++A                         + F  E E++ K   H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 486 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 530
           ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           VA  ++YL        IH DL   N+L+ +N VA ++DF +++   G++  + +T     
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 591 IGYMA 595
           + +MA
Sbjct: 175 VRWMA 179

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 11/135 (8%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDI 521
           F  E +  +S++H NL++ +  C+      LV+E+ P G L+ YL S             
Sbjct: 42  FLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT 101

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 581
            QR+    ++A  L +LH       IH DL   N LL  ++   + D+ ++     ED  
Sbjct: 102 LQRM--ACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156

Query: 582 MTQTQTLGTIGYMAP 596
           +T  Q    + ++AP
Sbjct: 157 VTPDQLWVPLRWIAP 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 54.3 bits (131), Expect = 7e-08
 Identities = 63/267 (23%), Positives = 99/267 (37%), Gaps = 47/267 (17%)

Query: 30  IFNVSTLKFLGLQNNSLS-GSLSSIANVRLPNLEKLYL-WGNNFSGTIPRFIFNASKLSK 87
           +  +  L+ L L+ N+L   +  ++A+   P      L    N +G IPR +        
Sbjct: 19  LPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGL-------- 70

Query: 88  LSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNP 147
            SL                  L++L L +N L         L SL    SL  + L+NN 
Sbjct: 71  QSLLQG---------LTKGCGLQELDLSDNALGPDGCG--VLESLLRSSSLQELKLNNNG 119

Query: 148 L-DGILPK--TSISNLSRSLEEFYMYNCNISGGIPEEISNL----TNLVEIDLGGNKLNG 200
           L D  L      + +L  +LE+  +    + G   E ++       +L E++L  N +  
Sbjct: 120 LGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179

Query: 201 SIPITLGK----LRKLQRLNLEDNIL--EGSIPDDIC----RLAELYRLELGSNKLYGSI 250
           +    L +       L+ L+L +N L  EG+    +      L  L  L LG N L    
Sbjct: 180 AGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--ALAETLASLKSLEVLNLGDNNL-TDA 236

Query: 251 PAC------FGNLASLRILSLGSNKLT 271
            A            SL  LSL  N +T
Sbjct: 237 GAAALASALLSPNISLLTLSLSCNDIT 263

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 83/292 (28%), Positives = 122/292 (41%), Gaps = 44/292 (15%)

Query: 1   EIPLEIGNL-QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLP 59
           +IP  IG L  NL+EL L  NK I ++P+ + N+  LK L L  N LS     ++N  L 
Sbjct: 130 DIPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSN--LS 186

Query: 60  NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
           NL  L L GN  S  +P  I   S L +L L  NS    + S+  NL+NL  L L  N  
Sbjct: 187 NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNN-- 242

Query: 120 TSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
                      S+ N  +L  +DLSNN +      +SIS+                    
Sbjct: 243 ----KLEDLPESIGNLSNLETLDLSNNQI------SSISS-------------------- 272

Query: 180 EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
             + +LTNL E+DL GN L+ ++P+    L  L  L L   +   ++   +  +     +
Sbjct: 273 --LGSLTNLRELDLSGNSLSNALPLIA-LLLLLLELLLNLLLTLKALELKLNSILLNNNI 329

Query: 240 ELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSN 291
               +    S P     L SL  L    N L    L  + +K+   +    +
Sbjct: 330 L---SNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGSLLD 378

Length = 394

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 53.4 bits (129), Expect = 8e-08
 Identities = 39/137 (28%), Positives = 59/137 (43%), Gaps = 27/137 (19%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN---- 526
           E  ++K      ++K   S        +V+EY   GS          + DI +  N    
Sbjct: 48  EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLT 97

Query: 527 ------IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
                 I+      LEYLH   S   IH D+K  N+LL++   A L+DF ++  LT    
Sbjct: 98  EEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--- 151

Query: 581 SMTQTQTL-GTIGYMAP 596
           +M +  T+ GT  +MAP
Sbjct: 152 TMAKRNTVIGTPFWMAP 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 19/142 (13%)

Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YS-SNCIL 519
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL         YS   C L
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 520 D----IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
                 F+ L +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 36/145 (24%), Positives = 67/145 (46%), Gaps = 19/145 (13%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----------SSN- 516
           F  E  +M  + H N++ ++   + E+   ++ EY+  G L ++L           SS+ 
Sbjct: 54  FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113

Query: 517 -----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI 571
                  LD    L+I I +A+ +EYL    S   +H DL   N+L+ + +   +SD  +
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 572 AKLLTGEDQSMTQTQTLGTIGYMAP 596
           ++ +   D    Q ++L  I +M P
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 9e-08
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 22/137 (16%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD----- 520
           E ++++  +H N+I    +I   S E F    +V E M    L K + + +   D     
Sbjct: 53  EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYF 111

Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GED 579
           ++Q L         L+Y+H   SA V+H DLKPSN+LL+ N    + DF +A++     D
Sbjct: 112 LYQILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161

Query: 580 QSMTQTQTLGTIGYMAP 596
            +   T+ + T  Y AP
Sbjct: 162 HTGFLTEYVATRWYRAP 178

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 39/134 (29%), Positives = 55/134 (41%), Gaps = 22/134 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKA-----LVLEYMPH---GSLEKYLYSSNCILDIF 522
           E  M+K ++H NL+ +I     E F+      LV EY  H     LEK        +   
Sbjct: 50  EIRMLKQLKHPNLVNLI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEH 100

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
               I+     A+ + H       IH D+KP N+L+       L DF  A++LTG     
Sbjct: 101 LIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157

Query: 583 TQTQTLGTIGYMAP 596
             T  + T  Y AP
Sbjct: 158 --TDYVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 37/126 (29%), Positives = 62/126 (49%), Gaps = 7/126 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+  +H N++  + S    +   +V+EY+  GSL   +  +   +D  Q   +  +
Sbjct: 66  EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRE 123

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
              ALE+LH   S  VIH D+K  N+LL  +    L+DF     +T E     ++  +GT
Sbjct: 124 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGT 178

Query: 591 IGYMAP 596
             +MAP
Sbjct: 179 PYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 32/119 (26%), Positives = 65/119 (54%), Gaps = 6/119 (5%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           ++F  E  +MK+++H  L+++ +  + EE   ++ EYM  GSL  +L S      +  +L
Sbjct: 46  QAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL 105

Query: 526 -NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            +    +A  + Y+        IH DL+ +NVL+ ++++  ++DF +A+++  ED   T
Sbjct: 106 IDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI--EDNEYT 159

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 36/155 (23%), Positives = 62/155 (40%), Gaps = 30/155 (19%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN--------- 516
             F  E  +M    H N++K++  C+  +   L+ EYM +G L ++L   +         
Sbjct: 53  ADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112

Query: 517 ------------CILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDN 561
                         L   ++L I   VA+ + YL    F      +H DL   N L+ +N
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGEN 166

Query: 562 MVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           MV  ++DF +++ +   D           I +M P
Sbjct: 167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP 201

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 37/114 (32%), Positives = 54/114 (47%), Gaps = 14/114 (12%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNC-----IL 519
           E   MK   H N+IK+I        K       ++L +M HG L  +L  S        L
Sbjct: 51  EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL 110

Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            +   +  MID+AS +EYL    S   IH DL   N +L++NM   ++DF ++K
Sbjct: 111 PLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 26/103 (25%), Positives = 52/103 (50%), Gaps = 5/103 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  I+H N++ ++      +F  LV++ M    L+K +      L   Q   I++ 
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQ 127

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           + + L  LH  Y    +H DL P+N+ ++   +  ++DF +A+
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 36/113 (31%), Positives = 58/113 (51%), Gaps = 7/113 (6%)

Query: 466 KSFDVECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           + F+ E E++KS++H N++K   V  S      + LV+EY+P+GSL  YL      LD  
Sbjct: 50  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHR 108

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
           + L     +   +EYL    S   +H DL   N+L++      + DF + K+L
Sbjct: 109 KLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 7/100 (7%)

Query: 498 LVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV 556
           LV+  M  G L+ ++Y+     L++ + ++    +   + +LH   S  +++ D+KP NV
Sbjct: 70  LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126

Query: 557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           LLDD     LSD  +A  L       T TQ  GT GYMAP
Sbjct: 127 LLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 36/133 (27%), Positives = 64/133 (48%), Gaps = 4/133 (3%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A   F  E  +M S+ H +L++++  C +   + LV + MPHG L  Y++     +   
Sbjct: 51  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQ 109

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +A+LL G+++  
Sbjct: 110 LLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166

Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 167 NADGGKMPIKWMA 179

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 40/107 (37%), Positives = 51/107 (47%), Gaps = 22/107 (20%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS--------ALEYLHFGYSALVIHC 549
           L+LEY+  G L  +L        IF     M D A         ALE+LH      +I+ 
Sbjct: 77  LILEYLSGGELFMHLEREG----IF-----MEDTACFYLSEISLALEHLH---QQGIIYR 124

Query: 550 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           DLKP N+LLD      L+DF + K    E  ++T T   GTI YMAP
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FCGTIEYMAP 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 39/123 (31%), Positives = 63/123 (51%), Gaps = 6/123 (4%)

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           ++K+++H  L+ +  S    +    VL+Y+  G L  +L    C L+   R     ++AS
Sbjct: 49  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIAS 107

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
           AL YLH   S  +++ DLKP N+LLD      L+DF + K     + + T +   GT  Y
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEY 162

Query: 594 MAP 596
           +AP
Sbjct: 163 LAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 28/110 (25%), Positives = 61/110 (55%), Gaps = 5/110 (4%)

Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H  L+++ +  + E    ++ EYM +GSL  +L +   I L I + +
Sbjct: 47  AFLAEANLMKQLQHPRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLI 105

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
           ++   +A  + ++        IH DL+ +N+L+ + +   ++DF +A+L+
Sbjct: 106 DMAAQIAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 53.3 bits (128), Expect = 4e-07
 Identities = 38/143 (26%), Positives = 62/143 (43%), Gaps = 13/143 (9%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNCILDI 521
                F  E  +   + H N++ ++ S          V EY+P  +L + L +++  L  
Sbjct: 20  HQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL-AADGALPA 78

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTG- 577
            +   +M+ V  AL   H   +  ++H DLKP N+++        A + DF I  LL G 
Sbjct: 79  GETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGV 135

Query: 578 EDQSMTQ----TQTLGTIGYMAP 596
            D  +      T+ LGT  Y AP
Sbjct: 136 RDADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 27/106 (25%), Positives = 55/106 (51%), Gaps = 3/106 (2%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E  ++K   H N++++I  C+ ++   +V+E +  G    +L +    L + + + +
Sbjct: 40  FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM 99

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           + + A+ +EYL    S   IH DL   N L+ +  V  +SDF +++
Sbjct: 100 VENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 41/123 (33%), Positives = 62/123 (50%), Gaps = 6/123 (4%)

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           ++K+++H  L+ +  S    E    VL+++  G L  +L       +   R     ++AS
Sbjct: 49  LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIAS 107

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
           AL YLH   S  +++ DLKP N+LLD      L+DF + K   G  QS T T   GT  Y
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEY 162

Query: 594 MAP 596
           +AP
Sbjct: 163 LAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           L+L+Y+  G L  +LY      +   R+ I  ++  AL++LH      +I+ D+K  N+L
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137

Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           LD      L+DF ++K    E++    +   GTI YMAP
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 32/133 (24%), Positives = 57/133 (42%), Gaps = 18/133 (13%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-------SNCILDIFQ 523
           E  ++  +    +I+   S  ++    +V+EY  +G L K L          + +   F 
Sbjct: 49  EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF- 107

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
                I +   L +LH   S  ++H D+K  N+ LD      + D  +AKLL+  D +  
Sbjct: 108 -----IQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNF 157

Query: 584 QTQTLGTIGYMAP 596
               +GT  Y++P
Sbjct: 158 ANTIVGTPYYLSP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 51.4 bits (124), Expect = 5e-07
 Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 27/130 (20%)

Query: 480 HRNLIKVISSCSNEEFKA-------LVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMI 529
           H N++K+++       KA       LV EYM    H  +       N + D+ +R  IM 
Sbjct: 66  HPNIVKLLNV-----IKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY-IMY 114

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT---GEDQSMTQTQ 586
            +  AL+Y+H   S  VIH DLKPSN+LL+ +    L+DF +A+ L+      ++   T 
Sbjct: 115 QLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 587 TLGTIGYMAP 596
            + T  Y AP
Sbjct: 172 YVATRWYRAP 181

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 7/100 (7%)

Query: 498 LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV 556
           LV+  M  G L+ ++Y+         + +     +   LE+LH      +++ DLKP NV
Sbjct: 70  LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENV 126

Query: 557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           LLDD+    +SD  +A  L G           GT GYMAP
Sbjct: 127 LLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 35/175 (20%)

Query: 447 FSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNL-------------IKVISSCSNE 493
           F++   IG+G F      FK  D   + + +I+  +L             I V+S C + 
Sbjct: 6   FTKLERIGKGSFG---EVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 494 EFKA------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 541
                           +++EY+  GS    L +     D FQ   ++ ++   L+YLH  
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH-- 118

Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            S   IH D+K +NVLL +     L+DF +A  LT  D  + +   +GT  +MAP
Sbjct: 119 -SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 6e-07
 Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 37/178 (20%)

Query: 445 DEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNL-------------IKVISSCS 491
           + F+    IG+G F      +K+ D     + +I+  +L             I+ +S C 
Sbjct: 1   ELFTLLECIGKGSFGE---VYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR 57

Query: 492 N-----------EEFK-ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 539
           +           +  K  +++EY   GS    L      LD      I+ +V   LEYLH
Sbjct: 58  SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLH 115

Query: 540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LGTIGYMAP 596
                  IH D+K +N+LL +     L+DF ++  LT    +M++  T +GT  +MAP
Sbjct: 116 ---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT---STMSKRNTFVGTPFWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 36/132 (27%), Positives = 66/132 (50%), Gaps = 9/132 (6%)

Query: 470 VECE--MMKSIRHRNLIKVISSCSNEEFKALV--LEYMPHGSLEKYLYSSNCILDIFQRL 525
           +ECE  ++K+++H  +++      +   K L   +EYMP GS++  L +   + +   R 
Sbjct: 51  LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR- 109

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
                +   + YLH   S +++H D+K +N+L D      L DF  +K L     S T  
Sbjct: 110 KYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166

Query: 586 QTL-GTIGYMAP 596
           +++ GT  +M+P
Sbjct: 167 RSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 31/149 (20%), Positives = 66/149 (44%), Gaps = 26/149 (17%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI------------ 518
           E  ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S  +            
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 519 -----------LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
                      L +   ++    ++  ++YL       ++H DL   NVL+ +     +S
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKIS 169

Query: 568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           DF +++ +  ED  + +++    + +MA 
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAI 198

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 9/132 (6%)

Query: 470 VECE--MMKSIRHRNLIKVISSCSNEEFKALVL--EYMPHGSLEKYLYSSNCILDIFQRL 525
           +ECE  ++K++RH  +++      + E K L +  EYMP GS++  L +   + +   R 
Sbjct: 51  LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR- 109

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
                +   + YLH   S +++H D+K +N+L D      L DF  +K +     S T  
Sbjct: 110 RYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166

Query: 586 QTL-GTIGYMAP 596
           +++ GT  +M+P
Sbjct: 167 KSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 5/119 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+M  + +  ++++I  C  E    LV+E    G L K+L      + +   + +M  
Sbjct: 45  EAEIMHQLDNPYIVRMIGVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQ 103

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           V+  ++YL        +H DL   NVLL +   A +SDF ++K L G D S  + ++ G
Sbjct: 104 VSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAG 158

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 19/142 (13%)

Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-----NCILDI--- 521
           E E+MK I +H+N+I ++  C+ E    +++EY   G+L ++L +      +   DI   
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 522 ------FQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
                 F+ L +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     +     + +MAP
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 36/143 (25%), Positives = 72/143 (50%), Gaps = 14/143 (9%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----YS---- 514
           A   F  E ++M  +++ N+I+++  C +++   ++ EYM +G L ++L      S    
Sbjct: 60  ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 515 SNCI--LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA 572
           +N I  + I   L + + +AS ++YL    S   +H DL   N L+ ++    ++DF ++
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 573 KLLTGEDQSMTQTQTLGTIGYMA 595
           + L   D    Q + +  I +MA
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMA 199

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 3/106 (2%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E ++M  + H  L+++   C+ ++   +V E+M +G L  YL      L     L++
Sbjct: 46  FIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSM 105

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
             DV   +EYL        IH DL   N L+    V  +SDF + +
Sbjct: 106 CQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 31/136 (22%), Positives = 65/136 (47%), Gaps = 14/136 (10%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNE-----EFKA---LVLEYMPHGSLEKYLYSSNCILDIF 522
           E ++++ ++H N++ +I  C  +      +K    LV E+  H  L   L + N    + 
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS 119

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK--LLTGEDQ 580
           +   +M  + + L Y+H      ++H D+K +N+L+  + +  L+DF +A+   L+   +
Sbjct: 120 EIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176

Query: 581 SMTQTQTLGTIGYMAP 596
               T  + T+ Y  P
Sbjct: 177 PNRYTNRVVTLWYRPP 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 7/127 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+   H +++K+I   + E    +V+E  P G L  YL  +   LD+   +     
Sbjct: 57  EAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ 115

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQTQTLG 589
           +++AL YL    S   +H D+   NVL+       L DF +++ L  ED+S    ++   
Sbjct: 116 LSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKL 170

Query: 590 TIGYMAP 596
            I +MAP
Sbjct: 171 PIKWMAP 177

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 32/148 (21%), Positives = 63/148 (42%), Gaps = 25/148 (16%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------- 513
           A + F  E +++  +   N+ +++  C+ +    +++EYM +G L ++L           
Sbjct: 62  AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121

Query: 514 ------SSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
                 S + +      L +   +AS + YL    S   +H DL   N L+  N    ++
Sbjct: 122 CNSKSLSFSTL------LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIA 172

Query: 568 DFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
           DF +++ L   D    Q +    I +MA
Sbjct: 173 DFGMSRNLYSSDYYRVQGRAPLPIRWMA 200

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 34/127 (26%), Positives = 65/127 (51%), Gaps = 7/127 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 529
           E ++++ +  R ++ +  +   ++   LVL  M  G L+ ++Y       +  + +    
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++   LE LH      +++ DLKP N+LLDD+    +SD  +A +   E Q++     +G
Sbjct: 110 EICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRVG 163

Query: 590 TIGYMAP 596
           T+GYMAP
Sbjct: 164 TVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 26/76 (34%), Positives = 47/76 (61%), Gaps = 3/76 (3%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSL-SSIANVRLPN 60
           IP +I  L++L+ + L  N + G +P ++ ++++L+ L L  NS +GS+  S+   +L +
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG--QLTS 491

Query: 61  LEKLYLWGNNFSGTIP 76
           L  L L GN+ SG +P
Sbjct: 492 LRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)

Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 524
           F     E  M+K  +H N++    S  + E   + +EY   GSL+  +Y     L   Q 
Sbjct: 50  FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQI 108

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
             +  +    L YLH   S   +H D+K +N+LL DN    L+DF +A  +T    ++ +
Sbjct: 109 AYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA---TIAK 162

Query: 585 TQT-LGTIGYMAP 596
            ++ +GT  +MAP
Sbjct: 163 RKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 32/177 (18%)

Query: 447 FSENNLIGRGGFALFIRA-------------FKSFDV-----------ECEMMKSIRHRN 482
           F     IGRG F+   RA              + FD+           E +++K + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLH 539
           +IK  +S   +    +VLE    G L    K+      ++         + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              S  V+H D+KP+NV +    V  L D  + +  +   ++      +GT  YM+P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 34/129 (26%), Positives = 60/129 (46%), Gaps = 8/129 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNI 527
           E +++K + H N+IK + S   +    +VLE    G L    KY      ++        
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            + + SA+E++H   S  V+H D+KP+NV +    V  L D  + +  + +  +      
Sbjct: 112 FVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSL 166

Query: 588 LGTIGYMAP 596
           +GT  YM+P
Sbjct: 167 VGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 11/135 (8%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL------DI 521
           F  E +  + + H N+++ +  C       LVLE+ P G L+ YL S+  ++      D+
Sbjct: 42  FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 581
            QR+    +VAS L +LH    A  IH DL   N  L  ++   + D+ +A     ED  
Sbjct: 102 LQRM--ACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156

Query: 582 MTQTQTLGTIGYMAP 596
           +T+      + ++AP
Sbjct: 157 ITKDCHAVPLRWLAP 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 3/103 (2%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++ +S  +  I   L I   
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASP-LSGIPLPL-IKSY 105

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+
Sbjct: 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 4/103 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K ++H+N++++     +++   LV EY     L+KY  S N  +D     + M  
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQ 107

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           +   L + H   S  V+H DLKP N+L++ N    L+DF +A+
Sbjct: 108 LLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 37/139 (26%), Positives = 60/139 (43%), Gaps = 42/139 (30%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVIS----SCSNEEFKA--LVLEYMP------------ 504
           RA++       +MK + H+N+I +++      S EEF+   LV+E M             
Sbjct: 61  RAYREL----VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD 116

Query: 505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVA 564
           H  +   LY   C                 +++LH   SA +IH DLKPSN+++  +   
Sbjct: 117 HERMSYLLYQMLC----------------GIKHLH---SAGIIHRDLKPSNIVVKSDCTL 157

Query: 565 HLSDFSIAKLLTGEDQSMT 583
            + DF +A+   G    MT
Sbjct: 158 KILDFGLAR-TAGTSFMMT 175

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.1 bits (115), Expect = 6e-06
 Identities = 36/125 (28%), Positives = 61/125 (48%), Gaps = 22/125 (17%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD----- 520
           E ++++ + H N+I    ++     E F    +V E M    L + + SS  + D     
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQY 112

Query: 521 -IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
            ++Q L         L+Y+H   SA V+H DLKPSN+LL+ N    + DF +A+  + + 
Sbjct: 113 FLYQLLR-------GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162

Query: 580 QSMTQ 584
             MT+
Sbjct: 163 DFMTE 167

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 48.2 bits (114), Expect = 6e-06
 Identities = 39/133 (29%), Positives = 62/133 (46%), Gaps = 20/133 (15%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY-------LYSSNCILDIFQ 523
           E  ++K ++H N++ +      +E   LV EY+ H  L +Y       L+  N  L +FQ
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ 111

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L         L Y+H  Y   ++H DLKP N+L+ D     L+DF +A+       S T
Sbjct: 112 LLR-------GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHT 159

Query: 584 QTQTLGTIGYMAP 596
            +  + T+ Y  P
Sbjct: 160 YSNEVVTLWYRPP 172

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 34/171 (19%)

Query: 452 LIGRGGFALFIR----------AFK-------SFDV-----ECEMMKSIRH---RNLIKV 486
           LIGRG +    R          A K         DV     E  ++  +R     N+ K 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 487 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALV 546
             S        +++EY   GS+ + L  +  I + +  + I+ +V  AL+Y+H      V
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH---KVGV 122

Query: 547 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIGYMAP 596
           IH D+K +N+L+ +     L DF +A LL    Q+ ++  T  GT  +MAP
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 48.1 bits (115), Expect = 7e-06
 Identities = 30/131 (22%), Positives = 58/131 (44%), Gaps = 12/131 (9%)

Query: 471 ECEMMKSIRHRNLIK----VISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIF 522
           E +++K ++H N++      +      + K     +V  YM H  L   L + +  L   
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTES 115

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           Q    M+ +   + YLH      ++H D+K +N+L+D+  +  ++DF +A+   G   + 
Sbjct: 116 QIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 583 TQTQTLGTIGY 593
                 GT  Y
Sbjct: 173 KGGGGGGTRKY 183

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 28/70 (40%), Positives = 36/70 (51%), Gaps = 5/70 (7%)

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           I +    AL YL       +IH D+KPSN+LLD N    L DF I+  L     S+ +T+
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTR 166

Query: 587 TLGTIGYMAP 596
             G   YMAP
Sbjct: 167 DAGCRPYMAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 21/135 (15%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK-------YLYSSNCILDIFQ 523
           E  ++  ++H N++   +S        +V+EY   G L K        L+S + IL  F 
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF- 107

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLTGEDQSM 582
                + ++  L+++H      ++H D+K  N+ L  N MVA L DF IA+ L   + SM
Sbjct: 108 -----VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSM 156

Query: 583 TQTQT-LGTIGYMAP 596
               T +GT  Y++P
Sbjct: 157 ELAYTCVGTPYYLSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 35/175 (20%)

Query: 447 FSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNL-------------IKVISSCSNE 493
           F++   IG+G F      FK  D   + + +I+  +L             I V+S C + 
Sbjct: 6   FTKLEKIGKGSFG---EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 494 EFKA------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 541
                           +++EY+  GS    L      LD  Q   I+ ++   L+YLH  
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH-- 118

Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            S   IH D+K +NVLL ++    L+DF +A  LT  D  + +   +GT  +MAP
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 6/105 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIM 528
           E  +MK ++H N++++      E    LV EYM    L+KY+  +     LD     +  
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFT 106

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
             +   + + H      V+H DLKP N+L++      L+DF +A+
Sbjct: 107 YQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 22/132 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDI----FQRL 525
           E   ++ +RH N I+    C   E  A LV+EY         L S++ IL++     Q +
Sbjct: 65  EVRFLQQLRHPNTIE-YKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEV 115

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            I      AL+ L + +S   IH D+K  N+LL +     L+DF  A L       ++  
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL-------VSPA 168

Query: 586 QT-LGTIGYMAP 596
            + +GT  +MAP
Sbjct: 169 NSFVGTPYWMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 11/135 (8%)

Query: 466 KSFDV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           + F V   E  MMK  +H N++    S    +   + +E+   GSL+  +Y     L   
Sbjct: 48  EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSES 106

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           Q   +  +    L YLH   S   +H D+K +N+LL DN    L+DF ++  +T    ++
Sbjct: 107 QIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA---TI 160

Query: 583 TQTQT-LGTIGYMAP 596
            + ++ +GT  +MAP
Sbjct: 161 AKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 36/128 (28%), Positives = 65/128 (50%), Gaps = 9/128 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 529
           E ++++ +  + ++ +  +   ++   LVL  M  G L+ ++Y+  N   +  + L    
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTL 588
           ++   LE LH       ++ DLKP N+LLDD     +SD  +A K+  GE    +    +
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRV 162

Query: 589 GTIGYMAP 596
           GT+GYMAP
Sbjct: 163 GTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 34/127 (26%), Positives = 66/127 (51%), Gaps = 9/127 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+  +H N++++ SS    +   +V+E++  G+L   +  +   ++  Q   + + 
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           V  AL +LH   +  VIH D+K  ++LL  +    LSDF     ++ E   + + ++L G
Sbjct: 124 VLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVG 177

Query: 590 TIGYMAP 596
           T  +MAP
Sbjct: 178 TPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 11/127 (8%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E +++ + +   L+K++ +  ++E+  L +EY+P G     L +   + +   R   M +
Sbjct: 51  ERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAE 109

Query: 531 VASALEYLH-FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           +  A++ LH  GY    IH DLKP N L+D +    L+DF ++K +     S+     +G
Sbjct: 110 MFEAVDALHELGY----IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VG 160

Query: 590 TIGYMAP 596
           +  YMAP
Sbjct: 161 SPDYMAP 167

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 31/110 (28%), Positives = 52/110 (47%), Gaps = 16/110 (14%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K ++H N++ +      E    L+ E++    L+KYL S              +D
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMD 99

Query: 531 VASALEYLH-------FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
                 YL+       F +S  V+H DLKP N+L+D+  V  L+DF +A+
Sbjct: 100 AELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 17/89 (19%)

Query: 520 DIFQRLN--IMI----------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           D+F RL+  +M           ++A AL++LH   S  +I+ DLKP N+LLD+     L+
Sbjct: 84  DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 140

Query: 568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           DF ++K     D         GT+ YMAP
Sbjct: 141 DFGLSK--ESIDHEKKAYSFCGTVEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 37/136 (27%), Positives = 66/136 (48%), Gaps = 7/136 (5%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNC-ILD 520
           R  K+ + E +++  ++H N++    S   E+    +V+ +   G L   L      +L 
Sbjct: 41  RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLP 100

Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
             Q +   + +A AL+YLH  +   ++H DLK  NV L    +  + D  IA++L  E+Q
Sbjct: 101 ENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQ 155

Query: 581 SMTQTQTLGTIGYMAP 596
               +  +GT  YM+P
Sbjct: 156 CDMASTLIGTPYYMSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 13/103 (12%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEYLH-FGYSALVIHCDLKP 553
           L+L+Y+  G +  +LY      D F    +     ++  ALE+LH  G    +++ D+K 
Sbjct: 82  LILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKLG----IVYRDIKL 133

Query: 554 SNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            N+LLD      L+DF ++K    E++  T +   GTI YMAP
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 31/146 (21%), Positives = 64/146 (43%), Gaps = 18/146 (12%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY------------ 513
           + F  E  M   ++H N++ ++   + E+  +++  Y  H  L ++L             
Sbjct: 53  EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112

Query: 514 ---SSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS 570
              +    L+    ++I+  +A+ +E+L    S  V+H DL   NVL+ D +   +SD  
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLG 169

Query: 571 IAKLLTGEDQSMTQTQTLGTIGYMAP 596
           + + +   D       +L  I +M+P
Sbjct: 170 LFREVYAADYYKLMGNSLLPIRWMSP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 29/81 (35%), Positives = 40/81 (49%), Gaps = 5/81 (6%)

Query: 73  GTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSL 132
           G IP  I     L  ++L  NS  G IP + G++ +LE L L  N    S PE     SL
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE-----SL 486

Query: 133 SNCKSLTLIDLSNNPLDGILP 153
               SL +++L+ N L G +P
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 9/101 (8%)

Query: 498 LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV 556
           LVL  M  G L+ ++Y+  N   D  + +    ++   LE LH      +++ DLKP N+
Sbjct: 77  LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENI 133

Query: 557 LLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTLGTIGYMAP 596
           LLDD     +SD  +A ++  GE    T    +GT+GYMAP
Sbjct: 134 LLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 14/114 (12%)

Query: 466 KSFDVECE--MMKSIRHRNLI--KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 521
           K  D E E  +++ +  + L   KV++S  ++ +  L++E++   +L++        +  
Sbjct: 34  KGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE--------VSE 85

Query: 522 FQRLNIMIDVASALEYLHFGYSALV-IHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            ++ +I   +A  L  LH     LV  H DL P N+L+DD  +  + D+  A  
Sbjct: 86  EEKEDIAEQLAELLAKLH-QLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 35/114 (30%), Positives = 60/114 (52%), Gaps = 10/114 (8%)

Query: 471 ECEMMKSIRHRNLIKVISS-CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
           E +++K +RH N+I +     S  E    V E +  G+    L +S  +   F +   + 
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQY-FLY 115

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            +   L+Y+H   SA V+H DLKPSN+L+++N    + DF +A++   +D  MT
Sbjct: 116 QILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMT 163

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 29/138 (21%)

Query: 471 ECEMMKSIRHRNLIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQR 524
           E  ++K + H N+I ++     + S E+F+   LV   M    L   +          Q+
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QK 114

Query: 525 LN------IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 578
           L+      ++  +   L+Y+H   SA +IH DLKPSN+ ++++    + DF +A+     
Sbjct: 115 LSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--- 168

Query: 579 DQSMTQTQTLGTIGYMAP 596
           D  M  T  + T  Y AP
Sbjct: 169 DDEM--TGYVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 4/101 (3%)

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 532
           +MK   H N++ ++  C   E   LV L YM HG L  ++ S      +   +   + VA
Sbjct: 49  IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA 108

Query: 533 SALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
             +EYL    S   +H DL   N +LD++    ++DF +A+
Sbjct: 109 KGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 46.3 bits (109), Expect = 2e-05
 Identities = 43/128 (33%), Positives = 67/128 (52%), Gaps = 11/128 (8%)

Query: 471 ECEMMKSIRHRNLIKVISS--CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
           E  +MK +++ N++  + S    +E F  +V+EY+  GSL   + +  C +D  Q   + 
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELF--VVMEYLAGGSLTDVV-TETC-MDEAQIAAVC 121

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
            +   ALE+LH   +  VIH D+K  NVLL  +    L+DF     +T E QS   T  +
Sbjct: 122 RECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM-V 176

Query: 589 GTIGYMAP 596
           GT  +MAP
Sbjct: 177 GTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 8/102 (7%)

Query: 498 LVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPS 554
           LV+  M  G L  ++Y+    N      +       + S LE+LH      +I+ DLKP 
Sbjct: 70  LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPE 126

Query: 555 NVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           NVLLD++    +SD  +A  L  + QS T+    GT G+MAP
Sbjct: 127 NVLLDNDGNVRISDLGLAVELK-DGQSKTKGYA-GTPGFMAP 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 6/126 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K+ RH  L  +  S   ++    V+EY+  G L  +L       +   R     +
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAE 103

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SAL+YLH   S  +++ DLK  N++LD +    ++DF + K   G   + T     GT
Sbjct: 104 IVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158

Query: 591 IGYMAP 596
             Y+AP
Sbjct: 159 PEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 36/128 (28%), Positives = 64/128 (50%), Gaps = 9/128 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 529
           E  +++ +  R ++ +  +   ++   LVL  M  G L+ ++Y+  N   D  + +    
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTL 588
           ++   LE L       +++ DLKP N+LLDD     +SD  +A ++  GE    T    +
Sbjct: 110 ELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRV 162

Query: 589 GTIGYMAP 596
           GT+GYMAP
Sbjct: 163 GTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 34/132 (25%), Positives = 52/132 (39%), Gaps = 6/132 (4%)

Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRL 525
            F  E  +M S+ H NLI++           +V E  P GSL   L         I    
Sbjct: 42  DFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLC 100

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK-LLTGEDQSMTQ 584
           +  + +A+ + YL    S   IH DL   N+LL  +    + DF + + L   ED  + +
Sbjct: 101 DYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157

Query: 585 TQTLGTIGYMAP 596
                   + AP
Sbjct: 158 EHLKVPFAWCAP 169

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 19/131 (14%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS----NCILDIFQRLN 526
           E  ++  + H  ++ ++ S  +E     +LE++  G L  +L  +    N +   +    
Sbjct: 68  EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH--- 124

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
              ++  A EYLH   S  +I+ DLKP N+LLD+     ++DF  AK +        +T 
Sbjct: 125 --AELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP------DRTF 173

Query: 587 TL-GTIGYMAP 596
           TL GT  Y+AP
Sbjct: 174 TLCGTPEYLAP 184

Length = 329

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 19/141 (13%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVIS-------SCSNEEFKALVLEYMPHGSLEKYLYSS 515
           R F+    E +M+   +H N++  +            E +   V+  +    L K + S 
Sbjct: 45  RVFR----ELKMLCFFKHDNVLSALDILQPPHIDPFEEIY---VVTELMQSDLHKIIVSP 97

Query: 516 NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
             +     ++  +  +   L+YLH   SA ++H D+KP N+L++ N V  + DF +A+ +
Sbjct: 98  QPLSSDHVKV-FLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-V 152

Query: 576 TGEDQSMTQTQTLGTIGYMAP 596
              D+S   TQ + T  Y AP
Sbjct: 153 EEPDESKHMTQEVVTQYYRAP 173

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 30/125 (24%), Positives = 57/125 (45%), Gaps = 9/125 (7%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E   +    H N++++    +      +V EYM +G+L+ +L      L   Q +
Sbjct: 51  RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM 110

Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H  L    VL++ ++V  +S F   +    ED+S   
Sbjct: 111 GMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAI 162

Query: 585 TQTLG 589
             T+ 
Sbjct: 163 YTTMS 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 45.3 bits (108), Expect = 4e-05
 Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 17/130 (13%)

Query: 475 MKSIRHRNLIKVISSC----SNEEFK-ALVLEYMPHGSLEKYLYSSNCI---LDIFQRLN 526
           ++S  H N+++++  C    ++ E K  LV E++    L  YL  S C    L      +
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLPPETIKD 111

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           +M  +   +++LH   S  ++H DLKP N+L+  +    ++DF +A++ + E   M  T 
Sbjct: 112 LMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTS 165

Query: 587 TLGTIGYMAP 596
            + T+ Y AP
Sbjct: 166 VVVTLWYRAP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 29/123 (23%), Positives = 58/123 (47%), Gaps = 10/123 (8%)

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           MM       + K+  S  ++++  LV+EY+  G     + +   + + + +   + +V  
Sbjct: 50  MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVL 108

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
            +E LH      +IH D+KP N+L+D      L+DF +++        +   + +GT  Y
Sbjct: 109 GVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDY 159

Query: 594 MAP 596
           +AP
Sbjct: 160 LAP 162

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 45.3 bits (108), Expect = 4e-05
 Identities = 32/128 (25%), Positives = 63/128 (49%), Gaps = 8/128 (6%)

Query: 471 ECEMMKSIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
           E  ++  ++H N++ V  +   SN +   +V+EY+ H  L+  + +        +   +M
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
           + + S + +LH      ++H DLK SN+LL++  +  + DF +A+      +  TQ    
Sbjct: 113 LQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168

Query: 589 GTIGYMAP 596
            T+ Y AP
Sbjct: 169 -TLWYRAP 175

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 15  LQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLS-SIANVRLPNLEKLYLWGNNFSG 73
           L L    L G +P  I  +  L+ + L  NS+ G++  S+ ++   +LE L L  N+F+G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI--TSLEVLDLSYNSFNG 480

Query: 74  TIPRFIFNASKLSKLSLGMNSFSGFIPSTFG 104
           +IP  +   + L  L+L  NS SG +P+  G
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 24/125 (19%)

Query: 471 ECEMMKSIRHRNLIK----VISSCSNEEFKA------LVLEYMPH---GSLEKYL--YSS 515
           E ++++ + HRN++     V       +FK       LV EYM H   G LE  L  +S 
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115

Query: 516 NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
           + I    ++L         LE L++ +    +H D+K SN+LL++     L+DF +A+L 
Sbjct: 116 DHIKSFMKQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166

Query: 576 TGEDQ 580
             E+ 
Sbjct: 167 NSEES 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 24/96 (25%), Positives = 49/96 (51%), Gaps = 4/96 (4%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           R   +F     +M  + H++L+K+   C  +E   +V EY+  G L+ +L+     + + 
Sbjct: 43  RDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLH 101

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL 558
            +L++   +ASAL YL       ++H ++   N+L+
Sbjct: 102 WKLDVAKQLASALHYLE---DKKLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 39/134 (29%), Positives = 58/134 (43%), Gaps = 12/134 (8%)

Query: 469 DVECEMMK------SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           DV+C M +      + +H  L  +      ++    V+EY+  G L   +  S    +  
Sbjct: 38  DVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPR 97

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
            R     +V  AL +LH      VI+ DLK  N+LLD      L+DF + K   G    +
Sbjct: 98  SRF-YAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGV 151

Query: 583 TQTQTLGTIGYMAP 596
           T T   GT  Y+AP
Sbjct: 152 TTTTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 29/138 (21%), Positives = 59/138 (42%), Gaps = 12/138 (8%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCILDI 521
           F  E  +MK     ++++++   S  +   +V+E M  G L+ YL S      +N  L  
Sbjct: 56  FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115

Query: 522 FQRLNIM---IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 578
                 +    ++A  + YL    +   +H DL   N ++ +++   + DF + + +   
Sbjct: 116 PTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172

Query: 579 DQSMTQTQTLGTIGYMAP 596
           D      + L  + +MAP
Sbjct: 173 DYYRKGGKGLLPVRWMAP 190

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 20/58 (34%), Positives = 34/58 (58%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRL 58
            IP  +G++ +LE L L  N   G++P ++  +++L+ L L  NSLSG + +    RL
Sbjct: 457 NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 45.1 bits (106), Expect = 6e-05
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 7/126 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+  ++ N++  + S    +   +V+EY+  GSL   + +  C +D  Q   +  +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRE 124

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
              ALE+LH   S  VIH D+K  N+LL  +    L+DF     +T E     ++  +GT
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGT 179

Query: 591 IGYMAP 596
             +MAP
Sbjct: 180 PYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 34/133 (25%), Positives = 69/133 (51%), Gaps = 11/133 (8%)

Query: 470 VECE--MMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILD-IFQR 524
           +ECE  ++K++ H  +++      +  E   ++ +E+MP GS++  L S   + + + ++
Sbjct: 51  LECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK 110

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
               I     LE + + +S +++H D+K +N+L D      L DF  +K L     S T 
Sbjct: 111 YTRQI-----LEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165

Query: 585 TQTL-GTIGYMAP 596
            +++ GT  +M+P
Sbjct: 166 MKSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 15/132 (11%)

Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI-FQRLNIM 528
           VE E++ +  H  ++K++ +   +    +++E+ P G+++  +      LD       I 
Sbjct: 58  VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQ 113

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA----KLLTGEDQSMTQ 584
           +     LE L + +S  +IH DLK  NVLL  +    L+DF ++    K L   D     
Sbjct: 114 VICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD----- 168

Query: 585 TQTLGTIGYMAP 596
              +GT  +MAP
Sbjct: 169 -SFIGTPYWMAP 179

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 27/103 (26%), Positives = 55/103 (53%), Gaps = 4/103 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K ++H N++ +      E+   LV EY+    L++YL      +++    N+ + 
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLF 109

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           +   L  L++ +   V+H DLKP N+L+++     L+DF +A+
Sbjct: 110 LFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 4/99 (4%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           LV+EY P G L   L   N   D F        +A  +  +H  +    +H D+KP NVL
Sbjct: 78  LVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134

Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +D      L+DF  A  LT  ++ +     +GT  Y+AP
Sbjct: 135 IDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 34/121 (28%), Positives = 66/121 (54%), Gaps = 7/121 (5%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + ++F  E  +MK+++H  L+K+ +  + E    ++ E+M  GSL  +L S        Q
Sbjct: 44  SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQ 99

Query: 524 RLNIMIDVASAL-EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
            L  +ID ++ + E + F      IH DL+ +N+L+  ++V  ++DF +A+++  ED   
Sbjct: 100 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEY 157

Query: 583 T 583
           T
Sbjct: 158 T 158

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 27/103 (26%), Positives = 52/103 (50%), Gaps = 4/103 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K+++H N++ +      E    LV EY+    L++YL +   ++ +      M  
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           +   L Y H      ++H DLKP N+L+++     L+DF +A+
Sbjct: 112 LLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 18/110 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY-------LYSSNCILDIFQ 523
           E  ++K ++H N++ +      +E    V EYM H  L +Y       L+  N  L +FQ
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ 111

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            L         L Y+H  +   ++H DLKP N+L+       L+DF +A+
Sbjct: 112 LLR-------GLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 27/110 (24%), Positives = 52/110 (47%), Gaps = 4/110 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + 
Sbjct: 59  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 117

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
           +A  + YL       ++H DL   NVL+       ++DF +AKLL  +++
Sbjct: 118 IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 22/109 (20%)

Query: 498 LVLEYMPHGS---LEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGYSALVIH 548
           LV+E    GS   L K L          +RL       I+ +    L YLH      VIH
Sbjct: 86  LVMELCGGGSVTDLVKGLRKKG------KRLKEEWIAYILRETLRGLAYLH---ENKVIH 136

Query: 549 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LGTIGYMAP 596
            D+K  N+LL  N    L DF ++  L   D ++ +  T +GT  +MAP
Sbjct: 137 RDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNTFIGTPYWMAP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 8/106 (7%)

Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNI 527
           +E  +++++ H ++I++  +  +     +VL   PH S + Y Y +     L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
              +   L YLH   +  +IH D+K  N+ ++D     + D   A+
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 43/172 (25%), Positives = 74/172 (43%), Gaps = 35/172 (20%)

Query: 452 LIGRGGFALF----------IRAFKSFDVECEMMK-----SIRHRNLIKVISS------- 489
           +IGRGGF             + A K  D +   MK     ++  R ++ ++S+       
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 490 CSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 544
           C    F        +L+ M  G L  +L       +   R     ++   LE++H   + 
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH---NR 116

Query: 545 LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            V++ DLKP+N+LLD++    +SD  +A   + +        ++GT GYMAP
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 8/103 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---NI 527
           E    + ++H N++  ++S   +    +V   M +GS E  L +     +    L    I
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFI 106

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS 570
           + DV +AL+Y+H   S   IH  +K S++LL  +    LS   
Sbjct: 107 LKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLR 146

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 12/96 (12%)

Query: 501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD 560
           E+M  GSL+ Y      +L       I + V   L YL   +S  ++H D+KPSN+L++ 
Sbjct: 79  EFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNT 130

Query: 561 NMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
                L DF ++  L     S+ +T  +GT  YMAP
Sbjct: 131 RGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.8 bits (94), Expect = 1e-04
 Identities = 20/57 (35%), Positives = 28/57 (49%), Gaps = 1/57 (1%)

Query: 236 LYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSN 291
           L  L+L +N+L       F  L +L++L L  N LTSI    F  L  +  L+ S N
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 23/71 (32%), Positives = 38/71 (53%), Gaps = 5/71 (7%)

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           NI + +  AL YLH      ++H DL P+N++L ++    ++DF +AK     +  +  T
Sbjct: 117 NIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL--T 171

Query: 586 QTLGTIGYMAP 596
             +GTI Y  P
Sbjct: 172 SVVGTILYSCP 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 27/103 (26%), Positives = 54/103 (52%), Gaps = 4/103 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K ++H N++ +      ++   LV EY+    L++Y+     I+ +    N+ I 
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH---NVKIF 109

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           +   L  L + +   V+H DLKP N+L+++     L+DF +A+
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 30/128 (23%), Positives = 57/128 (44%), Gaps = 5/128 (3%)

Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIM 528
           E ++M  +  H N++ ++ +C+      ++ EY  +G L  +L       L +   L+  
Sbjct: 88  ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
             VA  + +L    S   IH DL   NVLL    +  + DF +A+ +  +   + +    
Sbjct: 148 YQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204

Query: 589 GTIGYMAP 596
             + +MAP
Sbjct: 205 LPVKWMAP 212

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 37/173 (21%)

Query: 452 LIGRGGFALF----------IRAFKSFDVECEMMK-----SIRHRNLIKVISS------- 489
           +IGRGGF             + A K  D +   MK     ++  R ++ ++S+       
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 490 CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 544
           C +  F      + +L+ M  G L  +L S + +    +      ++   LE++H   + 
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMH---NR 116

Query: 545 LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLGTIGYMAP 596
            V++ DLKP+N+LLD++    +SD  +A      D S  +   ++GT GYMAP
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.4 bits (93), Expect = 2e-04
 Identities = 17/60 (28%), Positives = 22/60 (36%)

Query: 60  NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
           NL+ L L  N  +            L  L L  N+ +   P  F  L +L  L L  N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 19/123 (15%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-------SSNCI 518
           K+   E +++K+I HR +I +I +      K+ V   MP    + + Y            
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQA 187

Query: 519 LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 578
           + I +RL        AL YLH      +IH D+K  N+ LD+   A L DF  A  L   
Sbjct: 188 ITIQRRL------LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 579 DQS 581
             +
Sbjct: 239 PDT 241

Length = 392

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 36/150 (24%), Positives = 73/150 (48%), Gaps = 21/150 (14%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS--------- 514
           A   F  E +++  ++  N+I+++  C +E+   ++ EYM +G L ++L S         
Sbjct: 62  ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 515 -------SNCILDIFQR--LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH 565
                  ++C+  I     L++ + +AS ++YL    S   +H DL   N L+ +N+   
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIK 178

Query: 566 LSDFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
           ++DF +++ L   D    Q + +  I +MA
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMA 208

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 32/177 (18%)

Query: 445 DEFSENNLIGRGGFA--LFIRAFKSFDV-------ECEMMKS------------IRHRN- 482
           ++F    +IGRG F     +R   S  V       + EM+K             + H N 
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102

Query: 483 --LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
             ++++  +  ++++  +V+EYMP G L   L S+  I + + R     +V  AL+ +H 
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVLALDAIHS 160

Query: 540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            G+    IH D+KP N+LLD +    L+DF     +         T  +GT  Y++P
Sbjct: 161 MGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISP 212

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 11/106 (10%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLE-YMPHGSLEKYLYSSNCI-------LDIF 522
           E  ++  + H+N++ ++  C  +     VL  YM  G+L+ +L             L   
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD 568
           Q +++ I +A  + YLH      VIH D+   N ++D+ +   ++D
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 7/100 (7%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI-DVASALEYLHFGYSALVIHCDLKPSNV 556
           L+L+Y+  G L  +L       +  Q + I   ++  ALE+LH      +I+ D+K  N+
Sbjct: 82  LILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH---KLGIIYRDIKLENI 136

Query: 557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           LLD N    L+DF ++K    ED+        GTI YMAP
Sbjct: 137 LLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 3e-04
 Identities = 24/65 (36%), Positives = 29/65 (44%), Gaps = 5/65 (7%)

Query: 84  KLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDL 143
            L  L L  N  +      F  L NL+ L L  N LTS +PE     + S   SL  +DL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE-----AFSGLPSLRSLDL 55

Query: 144 SNNPL 148
           S N L
Sbjct: 56  SGNNL 60

Length = 60

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 42.9 bits (102), Expect = 3e-04
 Identities = 34/123 (27%), Positives = 57/123 (46%), Gaps = 21/123 (17%)

Query: 463 RAFKSFDVECEMM---KSIR----HRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYL 512
           + F S++ EC  +   KS+R    H N++K   V     N+E    V EYM  G+L + +
Sbjct: 34  KKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELY-FVFEYM-EGNLYQLM 88

Query: 513 YSSNCI-LDIFQRLNIMIDVASALEYLH-FGYSALVIHCDLKPSNVLLDDNMVAHLSDFS 570
                         +I+  +   L ++H  G+     H DLKP N+L+    V  ++DF 
Sbjct: 89  KDRKGKPFSESVIRSIIYQILQGLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFG 144

Query: 571 IAK 573
           +A+
Sbjct: 145 LAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 30/104 (28%), Positives = 53/104 (50%), Gaps = 5/104 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 529
           E  ++K + H N+++++    +E    LV E++    L+KY+ S     LD     + + 
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            +   + Y H   S  V+H DLKP N+L+D      L+DF +A+
Sbjct: 107 QLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 66/251 (26%), Positives = 99/251 (39%), Gaps = 52/251 (20%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSI------- 53
           E+P  I  L  LE+L + + + +  +P  I N+ +L  L L   S   S   I       
Sbjct: 672 ELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWL 730

Query: 54  -----------ANVRLPNLEKLYL--------WGNNFSGTIPRFIFNASKLSKLSLGMNS 94
                      +N+RL NL++L L        W      T P     +  L++L L    
Sbjct: 731 DLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLT-PLMTMLSPSLTRLFLSDIP 789

Query: 95  FSGFIPSTFGNLRNLEQLGLDE--NYLTSSTP-ELSFLSSL--SNCKSL-TLIDLSNNPL 148
               +PS+  NL  LE L ++   N  T  T   L  L SL  S C  L T  D+S N  
Sbjct: 790 SLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDISTNIS 849

Query: 149 DGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGK 208
           D  L +T I       EE           +P  I   +NL  +D+ G      + + + K
Sbjct: 850 DLNLSRTGI-------EE-----------VPWWIEKFSNLSFLDMNGCNNLQRVSLNISK 891

Query: 209 LRKLQRLNLED 219
           L+ L+ ++  D
Sbjct: 892 LKHLETVDFSD 902

syringae 6; Provisional. Length = 1153

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 7/97 (7%)

Query: 500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD 559
           +E+M  GSL++ L  +  I +      I I V   L YL   +   ++H D+KPSN+L++
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRDVKPSNILVN 134

Query: 560 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
                 L DF ++  L     SM  +  +GT  YM+P
Sbjct: 135 SRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 26/75 (34%), Positives = 42/75 (56%), Gaps = 17/75 (22%)

Query: 508 LEKYLYSSNCILDIFQRL---------NIMIDVASALEYLH-FGYSALVIHCDLKPSNVL 557
           LEK + ++    +IF+R+         NIM D+ + LEY+H  G S    H D+KP N++
Sbjct: 106 LEKLVENTK---EIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGIS----HGDIKPENIM 158

Query: 558 LDDNMVAHLSDFSIA 572
           +D N   ++ D+ IA
Sbjct: 159 VDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 42.4 bits (99), Expect = 4e-04
 Identities = 39/126 (30%), Positives = 64/126 (50%), Gaps = 7/126 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+  ++ N++  + S    +   +V+EY+  GSL   + +  C +D  Q   +  +
Sbjct: 66  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRE 123

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
              AL++LH   S  VIH D+K  N+LL  +    L+DF     +T E QS   T  +GT
Sbjct: 124 CLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGT 178

Query: 591 IGYMAP 596
             +MAP
Sbjct: 179 PYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 29/110 (26%), Positives = 50/110 (45%), Gaps = 18/110 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-------IFQ 523
           E  ++K ++H N++ +      ++   LV EY+    L++Y+      L        +FQ
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            L         L Y H      V+H DLKP N+L+ +     L+DF +A+
Sbjct: 112 LLR-------GLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 33/142 (23%), Positives = 66/142 (46%), Gaps = 13/142 (9%)

Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YS 514
           A   F  E ++M  ++  N+I++++ C   +   ++ EYM +G L ++L           
Sbjct: 62  ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121

Query: 515 SNCILDIFQRLNIM-IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           ++ +   +  L  M   +AS ++YL    S   +H DL   N L+  N    ++DF +++
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 574 LLTGEDQSMTQTQTLGTIGYMA 595
            L   D    Q + +  I +M+
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMS 200

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 31/108 (28%), Positives = 56/108 (51%), Gaps = 12/108 (11%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI--- 527
           E  ++K ++H N++++     +E+   LV EY+    L+K++ SS    D  +   +   
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKT 106

Query: 528 -MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVA-HLSDFSIAK 573
            +  +   + Y H   S  V+H DLKP N+L+D    A  L+DF +A+
Sbjct: 107 YLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 39/125 (31%), Positives = 62/125 (49%), Gaps = 16/125 (12%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKA--------LVLEYMPHGSLEKYL--YS-SNCIL 519
           E  +MK++ H N+I +      E FK         +V+E++P  ++ KY+  Y+ +N  L
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167

Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGE 578
            +F        +  AL Y+H   S  + H DLKP N+L+D N     L DF  AK L   
Sbjct: 168 PLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224

Query: 579 DQSMT 583
            +S++
Sbjct: 225 QRSVS 229

Length = 440

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 26/70 (37%), Positives = 39/70 (55%), Gaps = 5/70 (7%)

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           I+ ++   L+YLH   S   IH D+K +NVLL +     L+DF +A  LT  D  + +  
Sbjct: 106 ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNT 160

Query: 587 TLGTIGYMAP 596
            +GT  +MAP
Sbjct: 161 FVGTPFWMAP 170

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 37/144 (25%), Positives = 61/144 (42%), Gaps = 24/144 (16%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------SSNCI 518
           F +E  +M    H+N++++I        + ++LE M  G L+ +L          SS  +
Sbjct: 56  FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM 115

Query: 519 LDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIA 572
            D+   L    DVA   +YL   HF      IH D+   N LL       VA ++DF +A
Sbjct: 116 KDL---LFCARDVAKGCKYLEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMA 166

Query: 573 KLLTGEDQSMTQTQTLGTIGYMAP 596
           + +          + +  I +M P
Sbjct: 167 RDIYRASYYRKGGRAMLPIKWMPP 190

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 32/119 (26%), Positives = 59/119 (49%), Gaps = 6/119 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+ + +  ++++I  C  E +  LV+E    G L K+L  +  + +      ++  
Sbjct: 46  EANVMQQLDNPYIVRMIGICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQ 103

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           V+  ++YL        +H DL   NVLL     A +SDF ++K L G D++  + +T G
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHG 158

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 25/134 (18%)

Query: 475 MKSIRHRNLIKVISSC----SNEEFK-ALVLEYMPHGSLEKYL-------YSSNCILDIF 522
           +++  H N+++++  C    ++ E K  LV E++    L  YL         +  I D+ 
Sbjct: 56  LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           ++          L++LH   +  ++H DLKP N+L+       L+DF +A++ + +   M
Sbjct: 115 RQF------LRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---M 162

Query: 583 TQTQTLGTIGYMAP 596
             T  + T+ Y AP
Sbjct: 163 ALTPVVVTLWYRAP 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 14/135 (10%)

Query: 469 DVECEMMK------SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           DVEC M++      +  H  L  +  +   +E    V+EY+  G L  ++ SS    D  
Sbjct: 38  DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEA 96

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LTGEDQS 581
           +      ++   L++LH      +I+ DLK  NVLLD +    ++DF + K  + GE ++
Sbjct: 97  RARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153

Query: 582 MTQTQTLGTIGYMAP 596
            T     GT  Y+AP
Sbjct: 154 ST---FCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 36/118 (30%), Positives = 59/118 (50%), Gaps = 8/118 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIM 528
           E E++ ++ H  L  + +S   E +  LV++Y P G L + L      C+ +   R    
Sbjct: 51  EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110

Query: 529 IDVASALEYLH-FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            +V  ALEYLH  G     ++ DLKP N+LL ++    LSDF ++K    E   +++ 
Sbjct: 111 -EVLLALEYLHLLGI----VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 6/126 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++++ RH  L  +  +    +    V+EY   G L  +L       +   R     +
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAE 103

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH   S  V++ D+K  N++LD +    ++DF + K   G     T     GT
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 591 IGYMAP 596
             Y+AP
Sbjct: 159 PEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 17/130 (13%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---LDIFQRLNI 527
           E +++  I H   + +  S  +E +  LVLE++  G    +L  +      +  F    I
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
           ++      EYL    S  +++ DLKP N+LLD +    ++DF  AK++       T+T T
Sbjct: 141 VL----IFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYT 187

Query: 588 L-GTIGYMAP 596
           L GT  Y+AP
Sbjct: 188 LCGTPEYIAP 197

Length = 340

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 33/117 (28%), Positives = 64/117 (54%), Gaps = 17/117 (14%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLYSSN 516
           RA++    E  ++K + H+N+I +++      S EEF+   LV+E M   +L + ++   
Sbjct: 66  RAYR----ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME- 119

Query: 517 CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
             LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DF +A+
Sbjct: 120 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 41.5 bits (97), Expect = 9e-04
 Identities = 32/115 (27%), Positives = 63/115 (54%), Gaps = 8/115 (6%)

Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           ++++  +  ++++  +V+EYMP G L   L S+  + + + +     +V  AL+ +H   
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH--- 159

Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LGTIGYMAP 596
           S  +IH D+KP N+LLD +    L+DF     +  ++  M +  T +GT  Y++P
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 41.3 bits (97), Expect = 9e-04
 Identities = 32/106 (30%), Positives = 53/106 (50%), Gaps = 9/106 (8%)

Query: 492 NEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSALVIHCD 550
           NE    + +E+M  GSL++       I ++I  +  I + V   L YL+      ++H D
Sbjct: 74  NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHRD 129

Query: 551 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +KPSN+L++      L DF ++  L     S+  T  +GT  YM+P
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 41.3 bits (97), Expect = 9e-04
 Identities = 21/64 (32%), Positives = 38/64 (59%), Gaps = 5/64 (7%)

Query: 535 LEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGE-DQSMTQTQTLGTIG 592
           L+Y+H   SA V+H DLKP+NV ++ +++V  + DF +A+++          ++ L T  
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183

Query: 593 YMAP 596
           Y +P
Sbjct: 184 YRSP 187

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 36/134 (26%), Positives = 64/134 (47%), Gaps = 25/134 (18%)

Query: 475 MKSIRHRNLIKVISSCS----NEEFK-ALVLEYMPHGSLEKYL-------YSSNCILDIF 522
           +++  H N++++   C+    + E K  LV E++    L  YL         +  I D+ 
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM- 115

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
                M  +   L++LH   S  V+H DLKP N+L+  +    L+DF +A++ + +   M
Sbjct: 116 -----MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---M 164

Query: 583 TQTQTLGTIGYMAP 596
             T  + T+ Y AP
Sbjct: 165 ALTSVVVTLWYRAP 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 33/114 (28%), Positives = 58/114 (50%), Gaps = 6/114 (5%)

Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           ++++  +  ++ +  +V+EYMP G L   L S+  + + + R     +V  AL+ +H   
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH--- 159

Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           S   IH D+KP N+LLD +    L+DF     +  E      T  +GT  Y++P
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 9/127 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+  +H+N++++  S    E   +++E++  G+L   +  S   L+  Q   +   
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCES 125

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           V  AL YLH   S  VIH D+K  ++LL  +    LSDF     ++   + + + ++L G
Sbjct: 126 VLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKSLVG 179

Query: 590 TIGYMAP 596
           T  +MAP
Sbjct: 180 TPYWMAP 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 26/114 (22%), Positives = 55/114 (48%), Gaps = 11/114 (9%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--------L 519
           F  E +M + + H+N+++++  C   E   ++LEY   G L+++L ++           L
Sbjct: 55  FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114

Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
              Q++ +   +A  +++L    +A  +H DL   N L+       +S  S++K
Sbjct: 115 STKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 38/135 (28%), Positives = 60/135 (44%), Gaps = 14/135 (10%)

Query: 469 DVECEMM-KSI-----RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           DVEC M  K +     +H  L ++ S    ++    V+EY+  G L  ++  S    D  
Sbjct: 38  DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEP 96

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           +      ++   L++LH      +I+ DLK  NVLLD      ++DF + K       + 
Sbjct: 97  RARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT- 152

Query: 583 TQTQTL-GTIGYMAP 596
             T T  GT  Y+AP
Sbjct: 153 --TSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 26/149 (17%)

Query: 458 FALFIRAFKSFDVECEMMKSIRHRNLIKVIS----SCSNEEFKALVLEYMPHGSLEKYLY 513
           F   I A +++  E  ++K ++H N+I ++     + S E F  + L     G+      
Sbjct: 52  FQSLIHARRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA------ 104

Query: 514 SSNCILDIFQRLN------IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
             N I+   Q+L+      ++  +   L+Y+H   SA +IH DLKPSNV ++++    + 
Sbjct: 105 DLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRIL 160

Query: 568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           DF +A+     D  M  T  + T  Y AP
Sbjct: 161 DFGLAR---QADDEM--TGYVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.002
 Identities = 22/62 (35%), Positives = 32/62 (51%), Gaps = 2/62 (3%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN 196
           +L  +DLSNN L  I P  +   L  +L+   +   N++   PE  S L +L  +DL GN
Sbjct: 1   NLKSLDLSNNRLTVI-PDGAFKGLP-NLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Query: 197 KL 198
            L
Sbjct: 59  NL 60

Length = 60

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 33/126 (26%), Positives = 61/126 (48%), Gaps = 7/126 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+   H N++ + +S    +   +V+E++  G+L   +  +   ++  Q   + + 
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLS 126

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           V  AL YLH   +  VIH D+K  ++LL  +    LSDF     ++ E     +   +GT
Sbjct: 127 VLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGT 181

Query: 591 IGYMAP 596
             +MAP
Sbjct: 182 PYWMAP 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 8/100 (8%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           LVL ++  G L  +L       D+ +      ++  ALE LH      VI+ DLKP N+L
Sbjct: 70  LVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENIL 125

Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIGYMAP 596
           LD      L DF + KL   +D    +T T  GT  Y+AP
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 40/144 (27%), Positives = 69/144 (47%), Gaps = 16/144 (11%)

Query: 458 FALFIRAFKSFDVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYL 512
           F   I A +++  E  ++K ++H N+I ++     + S EEF  + L  ++    L   +
Sbjct: 54  FQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 112

Query: 513 YSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA 572
                  D  Q L  +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DF +A
Sbjct: 113 KCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 167

Query: 573 KLLTGEDQSMTQTQTLGTIGYMAP 596
           +     D  M  T  + T  Y AP
Sbjct: 168 R---HTDDEM--TGYVATRWYRAP 186

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 37/129 (28%), Positives = 58/129 (44%), Gaps = 12/129 (9%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM-I 529
           E  ++++ RH  L  +  S    +    V+EY   G L  + + S   +    R      
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL- 588
           ++ SAL YLH   S  V++ DLK  N++LD +    ++DF + K    E  S   T    
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTF 155

Query: 589 -GTIGYMAP 596
            GT  Y+AP
Sbjct: 156 CGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 10/100 (10%)

Query: 500 LEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV 556
           +EYM  GSL+K LY    +   +       I   V   L++L   ++  +IH D+KP+NV
Sbjct: 78  MEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNV 134

Query: 557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           L++ N    L DF ++  L     S+ +T  +G   YMAP
Sbjct: 135 LVNGNGQVKLCDFGVSGNLV---ASLAKTN-IGCQSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.0 bits (84), Expect = 0.003
 Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 1/61 (1%)

Query: 11 NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNN 70
          NL+ L L  N+L      A   +  LK L L  N+L+ S+S  A   LP+L  L L GNN
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59

Query: 71 F 71
           
Sbjct: 60 L 60

Length = 60

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 3/93 (3%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           +SF     MM  + H++L+     C   +   +V EY+  GSL+ YL  +  +++I  +L
Sbjct: 44  ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL 103

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL 558
            +   +A AL +L       + H ++   NVLL
Sbjct: 104 EVAKQLAWALHFLE---DKGLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 35/130 (26%), Positives = 59/130 (45%), Gaps = 18/130 (13%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI----FQRLN 526
           E   ++ +RH N I+       E    LV+EY         L S++ +L++     Q + 
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVE 116

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           I      AL+ L + +S  +IH D+K  N+LL +  +  L DF  A ++   +       
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------X 170

Query: 587 TLGTIGYMAP 596
            +GT  +MAP
Sbjct: 171 FVGTPYWMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 21/65 (32%), Positives = 36/65 (55%), Gaps = 5/65 (7%)

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG--EDQSMTQTQTLGTI 591
            L+Y+H   SA V+H DLKP N+L++ +    + DF +A+  +    + +   T+ + T 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 592 GYMAP 596
            Y AP
Sbjct: 174 WYRAP 178

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 39.7 bits (92), Expect = 0.003
 Identities = 39/140 (27%), Positives = 70/140 (50%), Gaps = 20/140 (14%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLYSSN 516
           RA++    E  +MK + H+N+I +++  +     EEF+   LV+E M   +L + +    
Sbjct: 62  RAYR----ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME- 115

Query: 517 CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
             LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DF +A+   
Sbjct: 116 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-- 168

Query: 577 GEDQSMTQTQTLGTIGYMAP 596
               S   T  + T  Y AP
Sbjct: 169 -AGTSFMMTPYVVTRYYRAP 187

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 31/101 (30%), Positives = 54/101 (53%), Gaps = 9/101 (8%)

Query: 497 ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSN 555
           ++ +E+M  GSL++ L  +  I  +I  +++I   V   L YL   +   ++H D+KPSN
Sbjct: 79  SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSN 134

Query: 556 VLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +L++      L DF ++  L     SM  +  +GT  YM+P
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|213055 cd12094, TM_ErbB2, Transmembrane domain of ErbB2, a Protein Tyrosine Kinase

 Score = 35.3 bits (81), Expect = 0.004
 Identities = 18/52 (34%), Positives = 24/52 (46%), Gaps = 8/52 (15%)

Query: 368 GSPNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRQRGKK 419
           G P  Q     TSI   +    +LL +VL      L+V   LI R RQ+ +K
Sbjct: 1   GCPAEQRASPLTSI--IAGVVGILLVVVL------LVVFGILIKRRRQKIRK 44

PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. ErbB2 (HER2, HER2/neu) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor PTKs (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane (TM) helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. It is activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. ErbB2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner of other ligand-bound EGFR proteins and functions as a signal amplifier, with the ErbB2-ErbB3 heterodimer being the most potent pair in mitogenic signaling. The TM domain not only serves as a membrane anchor, but also plays an important role in receptor dimerization and optimal activation. Mutations in the TM domain of ErbB2 have been associated with increased breast cancer risk. ErbB2 plays an important role in cell development, proliferation, survival and motility. Overexpression of ErbB2 results in its activation and downstream signaling, even in the absence of ligand. ErbB2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. ErbB2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. ErbB2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 44

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 18/130 (13%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E + ++ I+H N I+       E    LV+EY         L S++ +L++ ++    ++
Sbjct: 75  EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVE 126

Query: 531 VAS----ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           +A+    AL+ L + +S  +IH D+K  N+LL +     L+DF  A + +  +       
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------S 180

Query: 587 TLGTIGYMAP 596
            +GT  +MAP
Sbjct: 181 FVGTPYWMAP 190

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 33/132 (25%), Positives = 61/132 (46%), Gaps = 5/132 (3%)

Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 524
            + + VE +++ S  H N++K++ +   E    +++E+   G+++  +      L   Q 
Sbjct: 46  LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQI 105

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
             +      AL YLH      +IH DLK  N+L   +    L+DF ++   T   Q   +
Sbjct: 106 RVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--R 160

Query: 585 TQTLGTIGYMAP 596
              +GT  +MAP
Sbjct: 161 DSFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 33/117 (28%), Positives = 63/117 (53%), Gaps = 17/117 (14%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLYSSN 516
           RA++    E  +MK + H+N+I +++      S EEF+ +  V+E M   +L + +    
Sbjct: 69  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME- 122

Query: 517 CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
             LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DF +A+
Sbjct: 123 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	596
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.98
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.98
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.97
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.97
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.96
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.96
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.96
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.96
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.96
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.95
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.95
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.95
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.95
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.94
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.94
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.94
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.94
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.94
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.94
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.94
KOG3653	534	consensus Transforming growth factor beta/activin	99.93
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.93
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.93
KOG0198	313	consensus MEKK and related serine/threonine protei	99.93
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.93
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.93
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.93
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.92
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.92
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.92
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.92
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.92
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.91
KOG0578	550	consensus p21-activated serine/threonine protein k	99.91
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.91
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.91
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.91
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.9
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.9
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.9
KOG0589	426	consensus Serine/threonine protein kinase [General	99.9
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.9
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.9
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.9
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.9
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.9
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.9
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.9
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.9
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.9
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.9
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.9
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.9
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.9
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.9
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.9
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.9
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.9
KOG0605	550	consensus NDR and related serine/threonine kinases	99.9
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.9
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.89
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.89
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.89
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.89
PTZ00267	478	NIMA-related protein kinase; Provisional	99.89
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.89
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.89
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.89
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.89
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.89
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.89
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.89
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.89
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.89
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.89
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.89
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.89
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.89
KOG0584	632	consensus Serine/threonine protein kinase [General	99.89
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.89
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.89
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.89
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.89
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.88
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.88
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.88
PHA03211	461	serine/threonine kinase US3; Provisional	99.88
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.88
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.88
PHA03212	391	serine/threonine kinase US3; Provisional	99.88
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.88
KOG0610	459	consensus Putative serine/threonine protein kinase	99.88
KOG0586	596	consensus Serine/threonine protein kinase [General	99.88
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.88
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.88
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.88
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.88
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.88
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.88
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.88
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.88
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.88
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.88
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.87
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.87
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.87
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.87
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.87
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.87
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.87
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.87
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.87
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.87
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.87
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.87
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.87
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.87
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.87
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.87
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.87
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.87
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.87
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.87
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.87
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.87
PTZ00283	496	serine/threonine protein kinase; Provisional	99.87
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.87
PHA03207	392	serine/threonine kinase US3; Provisional	99.87
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.87
PHA03209	357	serine/threonine kinase US3; Provisional	99.87
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.87
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.87
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.86
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.86
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.86
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.86
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.86
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.86
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.86
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.86
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.86
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.86
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.86
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.86
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.86
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.86
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.86
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.86
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.86
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.86
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.86
PTZ00036	440	glycogen synthase kinase; Provisional	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.86
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.86
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.86
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.86
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.86
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.86
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.86
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.86
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.86
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.86
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.86
PHA02988	283	hypothetical protein; Provisional	99.85
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.85
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.85
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.85
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.85
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.85
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.85
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.85
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.85
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.85
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.85
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.85
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.85
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.85
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.85
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.85
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.85
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.85
PHA03210	501	serine/threonine kinase US3; Provisional	99.85
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.85
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.85
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.85
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.85
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.85
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.85
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.85
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.85
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.85
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.85
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.85
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.85
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.85
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.85
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.85
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.85
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.85
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.85
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.85
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.85
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.85
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.85
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.85
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.85
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.84
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.84
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.84
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.84
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.84
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.84
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.84
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.84
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.84
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.84
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.84
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.84
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.84
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.84
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.84
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.84
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.84
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.84
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.84
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.84
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.84
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.84
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.84
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.84
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.84
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.84
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.83
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.83
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.83
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.83
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.83
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.83
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.83
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.83
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.83
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.83
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.83
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.83
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.83
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.83
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.83
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.83
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.83
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.83
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.83
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.83
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.83
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.83
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.83
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.83
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.83
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.83
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.83
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.83
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.83
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.83
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.83
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.83
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.83
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.82
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.82
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.82
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.82
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.82
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.82
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.82
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.82
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.82
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.82
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.82
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.82
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.82
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.82
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.82
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.82
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.82
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.82
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.82
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.82
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.82
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.82
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.81
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.81
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.81
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.81
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.81
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.81
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.81
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.81
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.81
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.81
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.81
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.81
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.81
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.81
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.81
PTZ00284	467	protein kinase; Provisional	99.81
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.81
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.81
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.81
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.81
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.81
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.81
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.81
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.81
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.81
PRK09188	365	serine/threonine protein kinase; Provisional	99.81
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.81
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.81
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.81
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.81
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.81
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.8
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.8
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.8
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.8
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.8
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.8
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.8
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.8
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.8
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.8
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.8
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.8
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.8
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.8
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.8
KOG1152	772	consensus Signal transduction serine/threonine kin	99.8
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.79
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.79
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.79
PLN00009	294	cyclin-dependent kinase A; Provisional	99.79
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.79
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.79
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.79
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.79
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.79
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.79
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.79
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.79
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.79
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.79
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.79
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.79
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.79
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.79
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.79
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.79
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.78
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.78
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.78
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.78
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.78
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.78
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.78
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.78
PHA02882	294	putative serine/threonine kinase; Provisional	99.78
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.78
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.78
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.78
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.78
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.77
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.77
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.77
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.77
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.77
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.77
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.77
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.76
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.76
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.76
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.76
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.76
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.76
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.76
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.75
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.75
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.75
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.75
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.75
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.75
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.74
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.74
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.74
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.73
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.73
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.73
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.72
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.72
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.7
PRK10345	210	hypothetical protein; Provisional	99.69
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.67
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.67
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.66
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.66
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.66
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.66
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.65
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.64
PRK12274	218	serine/threonine protein kinase; Provisional	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.63
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.61
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.6
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.58
PRK14879	211	serine/threonine protein kinase; Provisional	99.57
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.56
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.54
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.53
smart00090	237	RIO RIO-like kinase.	99.52
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.52
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.5
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.5
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.48
PLN03150	623	hypothetical protein; Provisional	99.47
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.47
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.46
PLN00181	793	protein SPA1-RELATED; Provisional	99.45
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.41
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.38
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.38
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.35
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.32
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.31
PLN03150	623	hypothetical protein; Provisional	99.29
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.29
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.28
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.27
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.26
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.25
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.22
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.21
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.19
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.19
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.18
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.17
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.14
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.13
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.02
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.0
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.93
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.91
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	98.87
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.83
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.83
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.82
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.82
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.76
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.74
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.71
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	98.65
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.63
KOG3087	229	consensus Serine/threonine protein kinase [General	98.63
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.61
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.6
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.58
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.57
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.48
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.42
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.37
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.35
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.33
PRK15386	426	type III secretion protein GogB; Provisional	98.27
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	98.25
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.2
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	98.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.13
KOG1243	690	consensus Protein kinase [General function predict	98.12
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.08
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.07
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.05

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-69  Score=631.14  Aligned_cols=569  Identities=31%  Similarity=0.465  Sum_probs=421.1

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      ++|.+++.+++|++|++++|++++..|..|..+++|++|+|++|++++.+|.. +..+++|+.|+|++|.+.+.+|..+.
T Consensus       227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~Ls~n~l~~~~p~~~~  305 (968)
T PLN00113        227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS-IFSLQKLISLDLSDNSLSGEIPELVI  305 (968)
T ss_pred             cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchh-HhhccCcCEEECcCCeeccCCChhHc
Confidence            36778888888888888888888888888888888888888888887666542 22477888888888888878888888


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCch-----
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKT-----  155 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~-----  155 (596)
                      ++++|++|++++|.+++..|..+.++++|+.|++++|.+++..+.     .+..+++|+.|++++|++++.+|..     
T Consensus       306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-----~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~  380 (968)
T PLN00113        306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK-----NLGKHNNLTVLDLSTNNLTGEIPEGLCSSG  380 (968)
T ss_pred             CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCCh-----HHhCCCCCcEEECCCCeeEeeCChhHhCcC
Confidence            888888888888888877788888888888888888877653332     3555566666666666655544431     


Q ss_pred             ------------------hhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          156 ------------------SISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       156 ------------------~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                                        .+..+ ++|+.|++++|++++..|..|..+++|+.|++++|.+++.+|..+..+++|+.|++
T Consensus       381 ~L~~L~l~~n~l~~~~p~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  459 (968)
T PLN00113        381 NLFKLILFSNSLEGEIPKSLGAC-RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL  459 (968)
T ss_pred             CCCEEECcCCEecccCCHHHhCC-CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEEC
Confidence                              33344 45667777777777666777777777777777777777767666667777777777


Q ss_pred             cCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC-CCcccccccccceEEcccCCCCCc
Q 036342          218 EDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGP  296 (596)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ls~N~l~~~  296 (596)
                      ++|.+.+.+|..+ ..++|+.|++++|++++..|..+..+++|+.|+|++|++++ +|..+..+++|++|++++|.+++.
T Consensus       460 ~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  538 (968)
T PLN00113        460 ARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ  538 (968)
T ss_pred             cCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccccc
Confidence            7777776666544 45778888889999988889999999999999999999986 888899999999999999999999


Q ss_pred             hhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCCCC-CCC
Q 036342          297 LLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNL-QVP  375 (596)
Q Consensus       297 ~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~~~-~~~  375 (596)
                      .|..+..+++|+.||+++|++++.+|. .+..++.|+.|++++|++++.+|..+.+..+....+.+|+..|+.++. ..+
T Consensus       539 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~  617 (968)
T PLN00113        539 IPASFSEMPVLSQLDLSQNQLSGEIPK-NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLP  617 (968)
T ss_pred             CChhHhCcccCCEEECCCCcccccCCh-hHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCC
Confidence            999999999999999999999999998 456789999999999999999998888888888889999999986543 345


Q ss_pred             CCCcccccccccccceeeee--hhhhhhHHHHHHHhhhhhhccCC--CCCC-CCCCCc---cc--cccccCHHHHHHhcc
Q 036342          376 PCKTSIHHTSWKNSLLLGIV--LPLSTTLLIVVIWLILRYRQRGK--KPSN-DANMPL---VA--TWRTFSYLELCRATD  445 (596)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~i~--~~~~~~~l~~~i~~~~~~rr~~k--~~~~-~~~~~~---~~--~~~~~~~~~~~~~~~  445 (596)
                      +|....    ....+.+.++  ++++++++++++.+++++++++.  ++.. ......   ..  ..+.++++++.   .
T Consensus       618 ~c~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  690 (968)
T PLN00113        618 PCKRVR----KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL---S  690 (968)
T ss_pred             CCcccc----ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHH---h
Confidence            664321    1111112221  12111111222222222222211  1111 111000   00  11223334433   4


Q ss_pred             cccccccccCCCceeehhhHH-----------------hHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          446 EFSENNLIGRGGFALFIRAFK-----------------SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~~-----------------~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      .|...+.||+|+||+||+|..                 ....|++++++++|||||+++++|.+++..|+||||+++|+|
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L  770 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL  770 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence            567788999999999998731                 234679999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccccc
Q 036342          509 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  588 (596)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~  588 (596)
                      .++++.    ++|.++.+++.|+|+|++|+|+.++++|+|||+||+||+++.++.+++. ||.+.....      .....
T Consensus       771 ~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~  839 (968)
T PLN00113        771 SEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCF  839 (968)
T ss_pred             HHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCcc
Confidence            999953    6899999999999999999997778899999999999999999888876 666543321      12236


Q ss_pred             ccccccCC
Q 036342          589 GTIGYMAP  596 (596)
Q Consensus       589 gt~~y~aP  596 (596)
                      ||++||||
T Consensus       840 ~t~~y~aP  847 (968)
T PLN00113        840 ISSAYVAP  847 (968)
T ss_pred             ccccccCc
Confidence            88999998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.9e-44  Score=416.66  Aligned_cols=367  Identities=33%  Similarity=0.510  Sum_probs=242.3

Q ss_pred             CCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccC
Q 036342            2 IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFN   81 (596)
Q Consensus         2 ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (596)
                      +|..++++++|++|+|++|++.+..|..+..+++|++|+|++|++++.+|.. +..+++|++|+|++|++++.+|..+.+
T Consensus       180 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~  258 (968)
T PLN00113        180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE-IGGLTSLNHLDLVYNNLTGPIPSSLGN  258 (968)
T ss_pred             CChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChh-HhcCCCCCEEECcCceeccccChhHhC
Confidence            4666666777777777777766666666666666666666666666544431 123566666666666666666666666


Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCc-------------------cccccCCCCCCCCEEE
Q 036342           82 ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL-------------------SFLSSLSNCKSLTLID  142 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-------------------~~~~~~~~l~~L~~L~  142 (596)
                      +++|++|+|++|++++..|..+.++++|++|++++|.+++..+..                   ..+..+..+++|+.|+
T Consensus       259 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~  338 (968)
T PLN00113        259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ  338 (968)
T ss_pred             CCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEE
Confidence            666666666666666666666666666666666666555432210                   0112345556666666


Q ss_pred             CcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcc
Q 036342          143 LSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNIL  222 (596)
Q Consensus       143 ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  222 (596)
                      +++|.+++.+|. .+..+ ++|+.|++++|++++..|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+
T Consensus       339 L~~n~l~~~~p~-~l~~~-~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l  416 (968)
T PLN00113        339 LWSNKFSGEIPK-NLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF  416 (968)
T ss_pred             CcCCCCcCcCCh-HHhCC-CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEe
Confidence            666666655554 44444 4566666666666666666665555566666666666556666666666677777777777


Q ss_pred             cccCccchhcCCCCcEEEccCCcCcccchhhhccCCCC-----------------------cEEEeCCCcccC-CCcccc
Q 036342          223 EGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASL-----------------------RILSLGSNKLTS-IPLTFW  278 (596)
Q Consensus       223 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-----------------------~~L~Ls~N~l~~-ip~~~~  278 (596)
                      ++.+|..+..+++|+.|++++|++++.+|..+..+++|                       +.|+|++|++++ +|..+.
T Consensus       417 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~  496 (968)
T PLN00113        417 SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLG  496 (968)
T ss_pred             eeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhh
Confidence            66666666666666666666666666555555444444                       444555555543 455666


Q ss_pred             cccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCC-CCCCCCCc
Q 036342          279 NLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG-GSFGNFSA  357 (596)
Q Consensus       279 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~  357 (596)
                      .+++|+.|++++|++++..|..+..+++|+.|++++|.+++.+|. .+..+++|+.|+|++|++++.+|.. ..+..++.
T Consensus       497 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  575 (968)
T PLN00113        497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA-SFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ  575 (968)
T ss_pred             hhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCCh-hHhCcccCCEEECCCCcccccCChhHhcCcccCE
Confidence            777888888888888888888888888888888888888888887 5567888999999999998888876 55778889


Q ss_pred             ccccccccccCCCCC
Q 036342          358 ESFEGNELLCGSPNL  372 (596)
Q Consensus       358 l~~~~N~~~c~~~~~  372 (596)
                      +++++|++.+..|..
T Consensus       576 l~ls~N~l~~~~p~~  590 (968)
T PLN00113        576 VNISHNHLHGSLPST  590 (968)
T ss_pred             EeccCCcceeeCCCc
Confidence            999999988766643

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=343.73  Aligned_cols=346  Identities=24%  Similarity=0.269  Sum_probs=219.0

Q ss_pred             CCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEc
Q 036342           11 NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSL   90 (596)
Q Consensus        11 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L   90 (596)
                      .-+.||+++|+|..+.+..|.++++|+++++.+|.++ .+|.++. ...+|+.|+|.+|.|+.+..+++..++.|++|||
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~-~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL  156 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGH-ESGHLEKLDLRHNLISSVTSEELSALPALRSLDL  156 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccc-cccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence            3456888888888888888888888888888888886 5666442 2556777777777777666667777777777777


Q ss_pred             cCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEcc
Q 036342           91 GMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMY  170 (596)
Q Consensus        91 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~  170 (596)
                      |.|.|+.+...+|..-.++++|+|++|+|+.+..+     .|.++.+|.+|.|+.|+|+.. |...|.++ +.|+.|+|.
T Consensus       157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~-----~F~~lnsL~tlkLsrNrittL-p~r~Fk~L-~~L~~LdLn  229 (873)
T KOG4194|consen  157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETG-----HFDSLNSLLTLKLSRNRITTL-PQRSFKRL-PKLESLDLN  229 (873)
T ss_pred             hhchhhcccCCCCCCCCCceEEeeccccccccccc-----cccccchheeeecccCccccc-CHHHhhhc-chhhhhhcc
Confidence            77777766666666666677777777777766554     466666677777777776643 33356656 456666666


Q ss_pred             ccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccc
Q 036342          171 NCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSI  250 (596)
Q Consensus       171 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  250 (596)
                      .|.|.-..-.+|.++++|+.|.|..|.|...-..+|.++.++++|+|+.|+++..-...+.+++.|+.|+||+|.|..+.
T Consensus       230 rN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih  309 (873)
T KOG4194|consen  230 RNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIH  309 (873)
T ss_pred             ccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheee
Confidence            66666444556666666666666666666555556666666666666666666555555566666666666666666566


Q ss_pred             hhhhccCCCCcEEEeCCCcccCCCc-ccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChh--hhc
Q 036342          251 PACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPRE--IGE  327 (596)
Q Consensus       251 p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~--~~~  327 (596)
                      ++.|.-.++|+.|+|++|+|+.++. .|..+.+|++|+|++|+++...-..|..+++|++|||++|.++..|.+.  ++.
T Consensus       310 ~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~  389 (873)
T KOG4194|consen  310 IDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFN  389 (873)
T ss_pred             cchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhc
Confidence            6666666666666666666666544 3445566666666666666555555566666666666666665544332  344


Q ss_pred             cCCCCCeEECCCCcccccCCCC--CCCCCCCcccccccccc
Q 036342          328 KLSYLEDLNLSFNKLKGEIPRG--GSFGNFSAESFEGNELL  366 (596)
Q Consensus       328 ~l~~L~~L~l~~N~l~~~~p~~--~~~~~l~~l~~~~N~~~  366 (596)
                      .+++|+.|++.||++.. +|..  ..+.+++.+++.+|++.
T Consensus       390 gl~~LrkL~l~gNqlk~-I~krAfsgl~~LE~LdL~~Naia  429 (873)
T KOG4194|consen  390 GLPSLRKLRLTGNQLKS-IPKRAFSGLEALEHLDLGDNAIA  429 (873)
T ss_pred             cchhhhheeecCceeee-cchhhhccCcccceecCCCCcce
Confidence            45556666666665552 3322  23555555555555543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=346.51  Aligned_cols=360  Identities=24%  Similarity=0.261  Sum_probs=322.4

Q ss_pred             cccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCC
Q 036342            4 LEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNAS   83 (596)
Q Consensus         4 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~   83 (596)
                      ..|.++++|+++++..|.++ .+|.--....+|+.|+|.+|.|+ .+..-....++.|+.||||.|.|+.+...+|-.-.
T Consensus        96 ~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~  173 (873)
T KOG4194|consen   96 EFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKV  173 (873)
T ss_pred             HHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCC
Confidence            46789999999999999997 77876667788999999999998 45553333489999999999999966666777778


Q ss_pred             CCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhccccc
Q 036342           84 KLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRS  163 (596)
Q Consensus        84 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~  163 (596)
                      ++++|+|++|.|+.+..+.|.++.+|..|.|+.|+++.++..     .|.++++|+.|+|..|+|.-. ....|..+ ++
T Consensus       174 ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r-----~Fk~L~~L~~LdLnrN~iriv-e~ltFqgL-~S  246 (873)
T KOG4194|consen  174 NIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQR-----SFKRLPKLESLDLNRNRIRIV-EGLTFQGL-PS  246 (873)
T ss_pred             CceEEeeccccccccccccccccchheeeecccCcccccCHH-----Hhhhcchhhhhhccccceeee-hhhhhcCc-hh
Confidence            999999999999999999999999999999999999998765     699999999999999999744 34478888 78


Q ss_pred             ccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccC
Q 036342          164 LEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGS  243 (596)
Q Consensus       164 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  243 (596)
                      |+.|.|..|.|+..-..+|..+.++++|+|+.|+++..-..++-++++|+.|+||+|.|+.+.++.+...++|+.|+||+
T Consensus       247 l~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~  326 (873)
T KOG4194|consen  247 LQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSS  326 (873)
T ss_pred             hhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccc
Confidence            99999999999999999999999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CcCcccchhhhccCCCCcEEEeCCCcccCCCc-ccccccccceEEcccCCCCCch---hhhhccccccceEecCCCcCcc
Q 036342          244 NKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPL---LLEIGNLKVLIGIDFSMNNFSG  319 (596)
Q Consensus       244 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~~~~---~~~~~~l~~L~~L~ls~N~~~~  319 (596)
                      |+|+...+..|..+..|+.|+|++|++..+.+ .|..+++|+.|||++|.+++.+   ...|.++++|+.|++.+|++. 
T Consensus       327 N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-  405 (873)
T KOG4194|consen  327 NRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-  405 (873)
T ss_pred             cccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-
Confidence            99999999999999999999999999999876 4778999999999999998754   446788999999999999998 


Q ss_pred             cCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCCCCC
Q 036342          320 VIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQ  373 (596)
Q Consensus       320 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~~~~  373 (596)
                      .||..++..++.|+.|||.+|.|...-|....--.++++-+..-.++|++...|
T Consensus       406 ~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~W  459 (873)
T KOG4194|consen  406 SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKW  459 (873)
T ss_pred             ecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHH
Confidence            789889999999999999999998776666433378888888999999998654

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=3.2e-36  Score=304.04  Aligned_cols=348  Identities=25%  Similarity=0.385  Sum_probs=201.3

Q ss_pred             CcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccc-cccCccccC
Q 036342            3 PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFS-GTIPRFIFN   81 (596)
Q Consensus         3 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~   81 (596)
                      |.+...+++++-|.|..-++. .+|+.++.+++|++|.++||++......+..  ++.|+.+++.+|++. .-+|..++.
T Consensus        25 P~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~--Lp~LRsv~~R~N~LKnsGiP~diF~  101 (1255)
T KOG0444|consen   25 PHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSD--LPRLRSVIVRDNNLKNSGIPTDIFR  101 (1255)
T ss_pred             chhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhcc--chhhHHHhhhccccccCCCCchhcc
Confidence            445555666666666666664 5566666666666666666666533333333  566666666666654 224555666


Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhccc
Q 036342           82 ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS  161 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~  161 (596)
                      +..|++||||+|+++ ..|..+..-+++-.|+|++|+|..++..+     |.+++.|-.||||+|++... |. .+..+ 
T Consensus       102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~l-----finLtDLLfLDLS~NrLe~L-PP-Q~RRL-  172 (1255)
T KOG0444|consen  102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSL-----FINLTDLLFLDLSNNRLEML-PP-QIRRL-  172 (1255)
T ss_pred             cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchH-----HHhhHhHhhhccccchhhhc-CH-HHHHH-
Confidence            666666666666665 34555556666666666666666655442     55666666666666666533 33 34444 


Q ss_pred             ccccEEEccccccccccChhccCCCCCCEEEccCCccc-CCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEE
Q 036342          162 RSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLN-GSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE  240 (596)
Q Consensus       162 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (596)
                      ..|++|.|++|.+.-.--..+-.+++|++|.+|+.+=+ ..+|.++.++.+|..+|+|.|.+. .+|+.+..+++|+.|+
T Consensus       173 ~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLN  251 (1255)
T KOG0444|consen  173 SMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLN  251 (1255)
T ss_pred             hhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheec
Confidence            45666666666554322223334455566666654322 235556666666666666666666 5666666666666666


Q ss_pred             ccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCC-chhhhhccccccceEecCCCcCcc
Q 036342          241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTG-PLLLEIGNLKVLIGIDFSMNNFSG  319 (596)
Q Consensus       241 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~ls~N~~~~  319 (596)
                      ||+|+|+ .+..+.+...+|++|+||.|+++.+|.+++.+++|+.|.+.+|+++. -+|+.++.+..|+.+..++|.+. 
T Consensus       252 LS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-  329 (1255)
T KOG0444|consen  252 LSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-  329 (1255)
T ss_pred             cCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-
Confidence            6666665 34444455556666666666666666666666666666666666543 24556666666666666666665 


Q ss_pred             cCChhhhccCCCCCeEECCCCcccccCCCC-CCCCCCCccccccccccc
Q 036342          320 VIPREIGEKLSYLEDLNLSFNKLKGEIPRG-GSFGNFSAESFEGNELLC  367 (596)
Q Consensus       320 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~l~~~~N~~~c  367 (596)
                      ..|. -++++..|+.|.|+.|.+-. .|+. -.++.+..+++..||-+.
T Consensus       330 lVPE-glcRC~kL~kL~L~~NrLiT-LPeaIHlL~~l~vLDlreNpnLV  376 (1255)
T KOG0444|consen  330 LVPE-GLCRCVKLQKLKLDHNRLIT-LPEAIHLLPDLKVLDLRENPNLV  376 (1255)
T ss_pred             cCch-hhhhhHHHHHhcccccceee-chhhhhhcCCcceeeccCCcCcc
Confidence            4454 34556666666666666653 3333 345566666666666443

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=286.26  Aligned_cols=164  Identities=45%  Similarity=0.711  Sum_probs=147.1

Q ss_pred             cccccCHHHHHHhcccccccccccCCCceeehhh--------------------HHhHHHHHHHHhhcCCCccceeeeee
Q 036342          431 TWRTFSYLELCRATDEFSENNLIGRGGFALFIRA--------------------FKSFDVECEMMKSIRHRNLIKVISSC  490 (596)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~--------------------~~~~~~e~~~l~~l~H~niv~l~~~~  490 (596)
                      ..+.|++.++..+|++|...+.||+|+||.||||                    .++|..|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            5678999999999999999999999999999984                    24699999999999999999999999


Q ss_pred             ccCC-eeEEEEecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEec
Q 036342          491 SNEE-FKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD  568 (596)
Q Consensus       491 ~~~~-~~~lV~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~d  568 (596)
                      .+.+ ..+||||||++|+|.++++.... .++|.+|++||.++|+||+|||+.+.++|+||||||+|||+|+++.+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 49999999999999999998776 889999999999999999999999889999999999999999999999999


Q ss_pred             cccccccCCCCCccccccc-cccccccCC
Q 036342          569 FSIAKLLTGEDQSMTQTQT-LGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~~~~~~-~gt~~y~aP  596 (596)
                      ||+|+..... ... .... .||.+|+||
T Consensus       221 FGLa~~~~~~-~~~-~~~~~~gt~gY~~P  247 (361)
T KOG1187|consen  221 FGLAKLGPEG-DTS-VSTTVMGTFGYLAP  247 (361)
T ss_pred             ccCcccCCcc-ccc-eeeecCCCCccCCh
Confidence            9999765321 111 1112 799999998

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.98  E-value=6.1e-36  Score=288.42  Aligned_cols=346  Identities=27%  Similarity=0.406  Sum_probs=214.1

Q ss_pred             CCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccC
Q 036342            2 IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFN   81 (596)
Q Consensus         2 ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (596)
                      +|.+++.+.+|+.|++++|.+. ..|+.++.+..|+.|+..+|+++..+++..+  +.+|..|++.+|+++ ..|+..-+
T Consensus       106 lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~slp~~~~~--~~~l~~l~~~~n~l~-~l~~~~i~  181 (565)
T KOG0472|consen  106 LPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISSLPEDMVN--LSKLSKLDLEGNKLK-ALPENHIA  181 (565)
T ss_pred             ccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccccCchHHHH--HHHHHHhhccccchh-hCCHHHHH
Confidence            3444444444444444444443 2333344444444444444444433333333  344444444444444 22222223


Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhccc
Q 036342           82 ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS  161 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~  161 (596)
                      ++.|++||...|-++ .+|+.+++|.+|+.|+|..|++..++       .|.+|..|++|+++.|.|. .+|......+ 
T Consensus       182 m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-------ef~gcs~L~Elh~g~N~i~-~lpae~~~~L-  251 (565)
T KOG0472|consen  182 MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP-------EFPGCSLLKELHVGENQIE-MLPAEHLKHL-  251 (565)
T ss_pred             HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC-------CCCccHHHHHHHhcccHHH-hhHHHHhccc-
Confidence            445555555555444 34445555555555555555555433       3666666666666666664 3344344455 


Q ss_pred             ccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccc-----------------
Q 036342          162 RSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEG-----------------  224 (596)
Q Consensus       162 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------  224 (596)
                      +++..|||++|+++ ..|+.++-+.+|++||+|+|.|+ ..|..++++ .|+.|-+.+|.+..                 
T Consensus       252 ~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyL  328 (565)
T KOG0472|consen  252 NSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYL  328 (565)
T ss_pred             ccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHH
Confidence            56777777777776 45677777777777777777777 455666666 66666666666541                 


Q ss_pred             -----------------------------------------------cCccchhcCCC---CcEEEccCCcC--------
Q 036342          225 -----------------------------------------------SIPDDICRLAE---LYRLELGSNKL--------  246 (596)
Q Consensus       225 -----------------------------------------------~~~~~~~~l~~---L~~L~Ls~N~l--------  246 (596)
                                                                     .+|+.......   .+..+++.|++        
T Consensus       329 rs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~  408 (565)
T KOG0472|consen  329 RSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLV  408 (565)
T ss_pred             HHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhH
Confidence                                                           12222221111   22333333322        


Q ss_pred             ---------------cccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEe
Q 036342          247 ---------------YGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGID  311 (596)
Q Consensus       247 ---------------~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~  311 (596)
                                     .+-+|..++.+++|..|+|++|-+-.+|.+++.+..|+.||+|.|+|. ..|..+..+..++.+-
T Consensus       409 ~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtll  487 (565)
T KOG0472|consen  409 ELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLL  487 (565)
T ss_pred             HHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHH
Confidence                           235666777788888999999999889998888888999999999887 4666666677777777


Q ss_pred             cCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccc
Q 036342          312 FSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELL  366 (596)
Q Consensus       312 ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~  366 (596)
                      .++|++.. ++..-...+.+|.+|||.+|.+...+|..+.+.++.++.+.|||+.
T Consensus       488 as~nqi~~-vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  488 ASNNQIGS-VDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hccccccc-cChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            88888874 4544566899999999999999987777799999999999999985

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.98  E-value=4.4e-35  Score=295.85  Aligned_cols=330  Identities=28%  Similarity=0.366  Sum_probs=291.0

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCc--cccCccCccCCCCccEEEccCCccccccCcc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLS--GSLSSIANVRLPNLEKLYLWGNNFSGTIPRF   78 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~   78 (596)
                      +||++++++++|++|.+++|+++ .+-..+..++.|+.+++..|++.  |.++++..  +..|..||||+|+++ +.|..
T Consensus        46 ~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~--l~dLt~lDLShNqL~-EvP~~  121 (1255)
T KOG0444|consen   46 QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFR--LKDLTILDLSHNQLR-EVPTN  121 (1255)
T ss_pred             hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcc--cccceeeecchhhhh-hcchh
Confidence            58999999999999999999997 56677888999999999999996  44444543  899999999999999 89999


Q ss_pred             ccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhh
Q 036342           79 IFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSIS  158 (596)
Q Consensus        79 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  158 (596)
                      +...+++-.|+||+|+|..++...|.+|+.|-.|+|++|++..++|.      ...+..|++|+||+|.+....-. .+.
T Consensus       122 LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ------~RRL~~LqtL~Ls~NPL~hfQLr-QLP  194 (1255)
T KOG0444|consen  122 LEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQ------IRRLSMLQTLKLSNNPLNHFQLR-QLP  194 (1255)
T ss_pred             hhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHH------HHHHhhhhhhhcCCChhhHHHHh-cCc
Confidence            99999999999999999988888899999999999999999998876      67888999999999998644211 333


Q ss_pred             cccccccEEEccccccc-cccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCc
Q 036342          159 NLSRSLEEFYMYNCNIS-GGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELY  237 (596)
Q Consensus       159 ~l~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  237 (596)
                      .+ ++|+.|.+++.+=+ .-+|..+..+.+|..+|+|.|.+. ..|..+..+++|+.|+||+|.|+ .+......+.+|+
T Consensus       195 sm-tsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lE  271 (1255)
T KOG0444|consen  195 SM-TSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLE  271 (1255)
T ss_pred             cc-hhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhh
Confidence            44 67899999988755 457889999999999999999998 88999999999999999999999 5667777889999


Q ss_pred             EEEccCCcCcccchhhhccCCCCcEEEeCCCccc--CCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCC
Q 036342          238 RLELGSNKLYGSIPACFGNLASLRILSLGSNKLT--SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMN  315 (596)
Q Consensus       238 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N  315 (596)
                      +|+||.|+++ .+|++++.++.|+.|.+.+|++.  +||..++.+.+|+.+..++|.+. ..|..+..+..|+.|.|+.|
T Consensus       272 tLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~N  349 (1255)
T KOG0444|consen  272 TLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHN  349 (1255)
T ss_pred             hhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccc
Confidence            9999999998 89999999999999999999986  59999999999999999999987 78999999999999999999


Q ss_pred             cCcccCChhhhccCCCCCeEECCCCcccccCCC
Q 036342          316 NFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR  348 (596)
Q Consensus       316 ~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  348 (596)
                      ++- ++|. ++.-++.|+.||+..|+=--.+|.
T Consensus       350 rLi-TLPe-aIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  350 RLI-TLPE-AIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             cee-echh-hhhhcCCcceeeccCCcCccCCCC
Confidence            998 6888 566799999999999975433443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=265.33  Aligned_cols=147  Identities=30%  Similarity=0.531  Sum_probs=131.6

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ...+|...+.||+|+||+||+|+                       +....|+.+++.++|||||++++++..++.+|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            34688889999999999999963                       2356899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC------CcEEEecccccc
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN------MVAHLSDFSIAK  573 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~------~~~kl~dfGla~  573 (596)
                      ||||.||||.+|++.++ .+++..+..++.|+|.|+++||   +++|||||+||.|||++..      -.+||+|||+||
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999875 6899999999999999999999   9999999999999999764      568999999999


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+..   .....+.||+|.||||
T Consensus       164 ~L~~---~~~a~tlcGSplYMAP  183 (429)
T KOG0595|consen  164 FLQP---GSMAETLCGSPLYMAP  183 (429)
T ss_pred             hCCc---hhHHHHhhCCccccCH
Confidence            8753   2234568999999998

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.97  E-value=6.8e-35  Score=281.20  Aligned_cols=329  Identities=28%  Similarity=0.415  Sum_probs=262.6

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      ++|++++.+..|..|+..+|+++ ..|+++..+.+|..|++.+|+++..++....  +..|+.||..+|-++ .+|+.++
T Consensus       128 el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~--m~~L~~ld~~~N~L~-tlP~~lg  203 (565)
T KOG0472|consen  128 ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA--MKRLKHLDCNSNLLE-TLPPELG  203 (565)
T ss_pred             ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH--HHHHHhcccchhhhh-cCChhhc
Confidence            57889999999999999999987 7888888888999999999999865555433  778999999998887 7888899


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      ++.+|+.|+|..|.|. ..| .|.++..|++|+++.|+|..++.+     ...++.++..|||..|+++.. |+ .+..+
T Consensus       204 ~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae-----~~~~L~~l~vLDLRdNklke~-Pd-e~clL  274 (565)
T KOG0472|consen  204 GLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAE-----HLKHLNSLLVLDLRDNKLKEV-PD-EICLL  274 (565)
T ss_pred             chhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHH-----HhcccccceeeeccccccccC-ch-HHHHh
Confidence            9999999999999987 445 788888888888888888887654     356788888888888888754 44 44455


Q ss_pred             cccccEEEccccccccccChhccCCCCCCEEEccCCcccCC---------------------------------------
Q 036342          161 SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGS---------------------------------------  201 (596)
Q Consensus       161 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---------------------------------------  201 (596)
                       ++|++||+++|.|++ +|..++++ .|+.|.+.+|.+..+                                       
T Consensus       275 -rsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~  351 (565)
T KOG0472|consen  275 -RSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLP  351 (565)
T ss_pred             -hhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCC
Confidence             678888888888884 56778887 788888877766420                                       


Q ss_pred             -------------------------CCc-cccCCC--CCCeEEccCCccc-----------------------ccCccch
Q 036342          202 -------------------------IPI-TLGKLR--KLQRLNLEDNILE-----------------------GSIPDDI  230 (596)
Q Consensus       202 -------------------------~p~-~~~~l~--~L~~L~L~~N~l~-----------------------~~~~~~~  230 (596)
                                               +|+ .|..-.  -....+++.|++.                       +.+|..+
T Consensus       352 ~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l  431 (565)
T KOG0472|consen  352 SESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLEL  431 (565)
T ss_pred             CCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHH
Confidence                                     000 000000  0223444444443                       2677788


Q ss_pred             hcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceE
Q 036342          231 CRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGI  310 (596)
Q Consensus       231 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L  310 (596)
                      +.+++|..|+|++|.+. .+|..++.+..||.||+|.|++..+|..+..+..++.+-.+.|++..+.+..+.++..|++|
T Consensus       432 ~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tL  510 (565)
T KOG0472|consen  432 SQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTL  510 (565)
T ss_pred             Hhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhccee
Confidence            89999999999999887 78899999999999999999999999988888888989889999999999889999999999


Q ss_pred             ecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCC
Q 036342          311 DFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG  349 (596)
Q Consensus       311 ~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  349 (596)
                      ||.+|.+. .+|. .++++.+|+.|++.||+++ .++..
T Consensus       511 DL~nNdlq-~IPp-~LgnmtnL~hLeL~gNpfr-~Pr~~  546 (565)
T KOG0472|consen  511 DLQNNDLQ-QIPP-ILGNMTNLRHLELDGNPFR-QPRHQ  546 (565)
T ss_pred             ccCCCchh-hCCh-hhccccceeEEEecCCccC-CCHHH
Confidence            99999998 6787 5779999999999999998 44443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.96  E-value=4e-30  Score=248.07  Aligned_cols=148  Identities=31%  Similarity=0.438  Sum_probs=132.0

Q ss_pred             hcccccccccccCCCceeehhh------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRA------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..++|+..+.||+|+||+||.+                        .+....|..++.+++||+||+++..|++++.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3568999999999999999863                        1345689999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      |+||+.||+|+.++.+.+ .+++..+..++++|+.||.|||   +.+|||||+||+|||+|.+|+++++|||+++.....
T Consensus       103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            999999999999998764 6888889999999999999999   999999999999999999999999999999964322


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                        .....++|||+.||||
T Consensus       179 --~~~t~tfcGT~eYmAP  194 (357)
T KOG0598|consen  179 --GDATRTFCGTPEYMAP  194 (357)
T ss_pred             --CCccccccCCccccCh
Confidence              2345568999999999

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.8e-30  Score=249.19  Aligned_cols=146  Identities=27%  Similarity=0.464  Sum_probs=128.8

Q ss_pred             cccccccccccCCCceeehhhH----------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      -+.|...+.+|+|+||.|-.|+                            ....+|+++|++++|||||+++++|+..+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3567888999999999997542                            124589999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC---CcEEEeccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFSIA  572 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~---~~~kl~dfGla  572 (596)
                      .|+||||++||+|++++-... .+.+.....+..|++.|+.|||   +++|+||||||+|||+..+   ..+||+|||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            999999999999999998765 4677788889999999999999   9999999999999999755   88999999999


Q ss_pred             cccCCCCCccccccccccccccCC
Q 036342          573 KLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +...   ......++||||.|.||
T Consensus       327 K~~g---~~sfm~TlCGTpsYvAP  347 (475)
T KOG0615|consen  327 KVSG---EGSFMKTLCGTPSYVAP  347 (475)
T ss_pred             hccc---cceehhhhcCCccccCh
Confidence            9864   23356789999999999

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-29  Score=243.09  Aligned_cols=144  Identities=24%  Similarity=0.373  Sum_probs=129.0

Q ss_pred             cccccccccCCCceeehhh----------------------HHhHHHHHHHHhhcCCCccceeeeeeccCC-eeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRA----------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~----------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lV~e~  502 (596)
                      +.+..+.||+|..|+|||+                      .+++.+|++++++.+||+||++||+|..++ .++++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4556688999999999985                      257889999999999999999999999988 59999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      |.+|+|++.++..+ .+++...-.++.+|++||.|||+  .++||||||||+|||++..|.+||||||+++.+...    
T Consensus       160 MDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            99999999998764 57899999999999999999993  278999999999999999999999999999987543    


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ...+++||..||||
T Consensus       233 ~a~tfvGT~~YMsP  246 (364)
T KOG0581|consen  233 IANTFVGTSAYMSP  246 (364)
T ss_pred             hcccccccccccCh
Confidence            34568999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.6e-30  Score=238.04  Aligned_cols=150  Identities=23%  Similarity=0.392  Sum_probs=128.3

Q ss_pred             cccccccccccCCCceeehhh-----------------------HHhHHHHHHHHhhcCCCccceeee-eeccCCe-eEE
Q 036342          444 TDEFSENNLIGRGGFALFIRA-----------------------FKSFDVECEMMKSIRHRNLIKVIS-SCSNEEF-KAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~-----------------------~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~l  498 (596)
                      ..+|++.+.||+|+||.|||+                       .++...|+.++++++|||||++++ .+.++.. +++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            347889999999999999984                       256778999999999999999999 5555544 899


Q ss_pred             EEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          499 VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAL--VIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      |||||.+|||.+.++.   ....+++..++++..|+++|+..+|... +.  |+||||||.||+++.+|.+|++|||+++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999988865   3356899999999999999999999421 44  9999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+...  .......+|||+||+|
T Consensus       177 ~l~s~--~tfA~S~VGTPyYMSP  197 (375)
T KOG0591|consen  177 FLSSK--TTFAHSLVGTPYYMSP  197 (375)
T ss_pred             Hhcch--hHHHHhhcCCCcccCH
Confidence            87543  2344568999999998

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.96  E-value=2.1e-29  Score=235.24  Aligned_cols=146  Identities=25%  Similarity=0.392  Sum_probs=129.3

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      +.|+....+|+|+||+|||+.                       +-..+|+.++++++|+|+|.|+++|..+..+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            578889999999999999953                       346799999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ||+. ++.+-+......++...+..+++|+++|+.|+|   ..+++||||||+|||+...|.+|+||||+|+.+.++.+ 
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence            9987 555555665567889999999999999999999   99999999999999999999999999999999875433 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ..+.++.|.||+||
T Consensus       157 -~YTDYVATRWYRaP  170 (396)
T KOG0593|consen  157 -NYTDYVATRWYRAP  170 (396)
T ss_pred             -hhhhhhhhhhccCh
Confidence             34567899999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=250.11  Aligned_cols=146  Identities=32%  Similarity=0.550  Sum_probs=127.9

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC-eeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lV~e~  502 (596)
                      +....+.+|+|+||+||+|.                      +.|.+|+.+|++++|||||+++|+|.+.. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            34445669999999999852                      27999999999999999999999999887 78999999


Q ss_pred             CCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCc-eEeCCCCCCCeeeCCCC-cEEEeccccccccCCCC
Q 036342          503 MPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAL-VIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGED  579 (596)
Q Consensus       503 ~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~-i~Hrdlk~~NILl~~~~-~~kl~dfGla~~~~~~~  579 (596)
                      +++|+|.++++. ....+++..++.++.+||+|+.|||   ... |||||+||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999988 3668999999999999999999999   777 99999999999999997 99999999998764321


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                        ...+...||+.||||
T Consensus       199 --~~~~~~~GT~~wMAP  213 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAP  213 (362)
T ss_pred             --ccccCCCCCccccCh
Confidence              233446899999999

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=7.1e-29  Score=246.88  Aligned_cols=149  Identities=31%  Similarity=0.418  Sum_probs=133.2

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC--CeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~  497 (596)
                      ..+.|+..+.||+|.||.||||.                       ....+|+.+|++++|||||+|.+...++  +.+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            34678889999999999999973                       2457999999999999999999998876  6899


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|+|||++ ||.-++......+++.++..++.|++.|++|||   .++|+|||||.+|||||.+|.+||+|||+|+++..
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            99999988 998888887778999999999999999999999   99999999999999999999999999999998765


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .. ....+..+.|.||+||
T Consensus       271 ~~-~~~~T~rVvTLWYRpP  288 (560)
T KOG0600|consen  271 SG-SAPYTSRVVTLWYRPP  288 (560)
T ss_pred             CC-CcccccceEEeeccCh
Confidence            43 3345667899999998

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.7e-28  Score=247.07  Aligned_cols=146  Identities=29%  Similarity=0.448  Sum_probs=133.1

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ..|...+.||+|||+.||++.                        +...+|+++-+.++|||||+++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            468999999999999999842                        45778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |+|+.|+|..+++.+ ..+++.++..++.||+.|+.|||   +.+|+|||+|..|++++++..+||+|||+|..+..+.+
T Consensus        98 ELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            999999999999844 57899999999999999999999   99999999999999999999999999999998864422


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ...+.||||-|.||
T Consensus       174 --rk~TlCGTPNYIAP  187 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAP  187 (592)
T ss_pred             --ccceecCCCcccCh
Confidence              34668999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.95  E-value=9e-28  Score=224.01  Aligned_cols=144  Identities=31%  Similarity=0.460  Sum_probs=129.5

Q ss_pred             cccccccccccCCCceeehhh------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRA------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.+|.|+||.|...                        ++....|..+++.+.||++|++++.|.+.+.+|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            468899999999999999531                        12345689999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||++||.|+.++++.+ .+++..+..+++||+.|++|||   ...|++||+||+|||+|.+|.+||.|||+|+.+.+. 
T Consensus       123 meyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999999876 5889999999999999999999   999999999999999999999999999999987432 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                          ..+.||||.|+||
T Consensus       198 ----T~TlCGTPeYLAP  210 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAP  210 (355)
T ss_pred             ----EEEecCCccccCh
Confidence                3457999999999

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.94  E-value=1.3e-27  Score=219.68  Aligned_cols=146  Identities=27%  Similarity=0.472  Sum_probs=131.9

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|...+.+|+|.||+||+|.                       ....+|++.++.++|+||+.++++|...+.+-+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468888999999999999963                       246799999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ||+. ||+..+++....+...+...++.++.+|++|||   .+.|+|||+||.|+|++++|.+||+|||+|+.+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9977 999999998888999999999999999999999   999999999999999999999999999999988655432


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .  +..+.|.||+||
T Consensus       158 ~--~~~V~TRWYRAP  170 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAP  170 (318)
T ss_pred             c--ccceeeeeccCh
Confidence            2  233789999998

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.94  E-value=1e-27  Score=227.01  Aligned_cols=150  Identities=26%  Similarity=0.390  Sum_probs=132.7

Q ss_pred             HHhcccccccccccCCCceeehhhHH-----------------------hHHHHHHHHhhcCCCccceeeeeeccC--Ce
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAFK-----------------------SFDVECEMMKSIRHRNLIKVISSCSNE--EF  495 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~~-----------------------~~~~e~~~l~~l~H~niv~l~~~~~~~--~~  495 (596)
                      +...+.|+.++.|++|+||+||||..                       ...+|+.++.+++|||||.+.++....  +.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            45567899999999999999999741                       246899999999999999999988654  57


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      +|+|||||+. ||...+..-...+...++.-++.|+++|++|||   ..-|+|||+|++|+|+..+|.+||+|||+||.+
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999999988 999999887778889999999999999999999   999999999999999999999999999999998


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +.+.  ...+..+.|.||+||
T Consensus       228 gsp~--k~~T~lVVTLWYRaP  246 (419)
T KOG0663|consen  228 GSPL--KPYTPLVVTLWYRAP  246 (419)
T ss_pred             cCCc--ccCcceEEEeeecCH
Confidence            7553  234567899999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=240.46  Aligned_cols=150  Identities=33%  Similarity=0.557  Sum_probs=130.0

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ....+...+.||+|-||+|+.|.                   ++|.+|+++|++++|+|||+++|+|..++.+|||||||
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            33445667899999999998752                   57889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +.|+|.++++. .+..+...+.+.++.|||+|++||+   ++++||||+.++|||++++..+||+|||+||.. .++++.
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~  359 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYT  359 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCcee
Confidence            99999999997 4457888899999999999999999   999999999999999999999999999999954 334444


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......-+..|.||
T Consensus       360 ~~~~~kfPIkWtAP  373 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAP  373 (468)
T ss_pred             ecCCCCCCceecCH
Confidence            44444556778887

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.94  E-value=7.2e-27  Score=234.49  Aligned_cols=151  Identities=30%  Similarity=0.498  Sum_probs=132.8

Q ss_pred             HhcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCee
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  496 (596)
                      +...+|...+.||+|+|++||+|.                        +-..+|-.+|.++ .||.||+|+.-|+++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            345689999999999999999863                        2345788899999 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+|+||+++|+|.+++++.+ .+++..+..++++|+.|++|||   +.+||||||||+|||+|++|++||+|||-|+.+.
T Consensus       150 YFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            99999999999999998874 7899999999999999999999   9999999999999999999999999999999886


Q ss_pred             CCCCc---------ccc--ccccccccccCC
Q 036342          577 GEDQS---------MTQ--TQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~---------~~~--~~~~gt~~y~aP  596 (596)
                      +....         ...  ..++||..|.+|
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP  256 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSP  256 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCH
Confidence            43221         112  458999999988

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-27  Score=234.17  Aligned_cols=146  Identities=26%  Similarity=0.383  Sum_probs=131.5

Q ss_pred             cccccccccccCCCceeehhhH----------Hh------------HHHHHHHHhhcC-CCccceeeeeeccCC-eeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------KS------------FDVECEMMKSIR-HRNLIKVISSCSNEE-FKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------~~------------~~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~lV  499 (596)
                      .++|...+.||.|.||.||+|.          +.            -.+|++.+++++ |||||++.+++.+.+ .+|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            4688999999999999999863          11            247999999999 999999999999888 89999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||||+. +|.+.+++++..+++.++..|+.||.+||+|+|   .+++.|||+||+|||+.....+||+|||+||..... 
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-  163 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-  163 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC-
Confidence            999954 999999999889999999999999999999999   999999999999999998899999999999987533 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                        .+.+.++.|.||+||
T Consensus       164 --pPYTeYVSTRWYRAP  178 (538)
T KOG0661|consen  164 --PPYTEYVSTRWYRAP  178 (538)
T ss_pred             --CCcchhhhcccccch
Confidence              245678999999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=6.8e-27  Score=225.95  Aligned_cols=145  Identities=26%  Similarity=0.435  Sum_probs=132.1

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .+|++.+.+|+|.||.|-+|.                        -.+++|+++|+.++||||+++|++|+..+.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            468889999999999998753                        23678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||.++|+|.||+.+++ .+++..+..+..||..|+.|+|   ..+++|||+|.+|||+|.++.+||+|||++..+..   
T Consensus       133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---  205 (668)
T KOG0611|consen  133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---  205 (668)
T ss_pred             EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc---
Confidence            9999999999998875 6899999999999999999999   99999999999999999999999999999987743   


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                      .....++||+|-|.+|
T Consensus       206 ~kfLqTFCGSPLYASP  221 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASP  221 (668)
T ss_pred             ccHHHHhcCCcccCCc
Confidence            2346679999999987

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.94  E-value=3.4e-28  Score=257.24  Aligned_cols=338  Identities=30%  Similarity=0.392  Sum_probs=223.0

Q ss_pred             CCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCC-------------------cc
Q 036342            2 IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN-------------------LE   62 (596)
Q Consensus         2 ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~-------------------L~   62 (596)
                      +|.+.+++.+|++|.|.+|++. ..|..+..+++|+.||+|.|++. .+|..-+ .+..                   .+
T Consensus        83 vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~-~lt~~~~~~~s~N~~~~~lg~~~ik  159 (1081)
T KOG0618|consen   83 VPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIE-VLTAEEELAASNNEKIQRLGQTSIK  159 (1081)
T ss_pred             Cchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHH-hhhHHHHHhhhcchhhhhhccccch
Confidence            5666677777777777777764 66667777777777777777764 3333111 1222                   33


Q ss_pred             EEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEE
Q 036342           63 KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLID  142 (596)
Q Consensus        63 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~  142 (596)
                      .++|..|.+.+.++..+..++.  .|||.+|.+..   -.+.++.+|+.|..+.|+++.+.         -.-++|+.|+
T Consensus       160 ~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l~---------~~g~~l~~L~  225 (1081)
T KOG0618|consen  160 KLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLSNLANLEVLHCERNQLSELE---------ISGPSLTALY  225 (1081)
T ss_pred             hhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhhhccchhhhhhhhcccceEE---------ecCcchheee
Confidence            3444444444444444444433  46666666551   12344455555555555554421         1123555555


Q ss_pred             CcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccC----------------------
Q 036342          143 LSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNG----------------------  200 (596)
Q Consensus       143 ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----------------------  200 (596)
                      .++|.++...+.    ..+.+|+++++++|++++. |++++.+.+|+.++..+|++..                      
T Consensus       226 a~~n~l~~~~~~----p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~  300 (1081)
T KOG0618|consen  226 ADHNPLTTLDVH----PVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELE  300 (1081)
T ss_pred             eccCcceeeccc----cccccceeeecchhhhhcc-hHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhh
Confidence            666655532211    1234566666666666643 3666666666666666655532                      


Q ss_pred             CCCccccCCCCCCeEEccCCcccccCccchhc--------------------------CCCCcEEEccCCcCcccchhhh
Q 036342          201 SIPITLGKLRKLQRLNLEDNILEGSIPDDICR--------------------------LAELYRLELGSNKLYGSIPACF  254 (596)
Q Consensus       201 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--------------------------l~~L~~L~Ls~N~l~~~~p~~~  254 (596)
                      -+|....++++|++|+|..|+|. ..|+.+..                          .+.|+.|++.+|.++...-..+
T Consensus       301 yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l  379 (1081)
T KOG0618|consen  301 YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVL  379 (1081)
T ss_pred             hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhh
Confidence            34556677888889999988887 44443221                          2346777788888877666677


Q ss_pred             ccCCCCcEEEeCCCcccCCCcc-cccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCC
Q 036342          255 GNLASLRILSLGSNKLTSIPLT-FWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLE  333 (596)
Q Consensus       255 ~~l~~L~~L~Ls~N~l~~ip~~-~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~  333 (596)
                      .++++|+.|+|++|+|.++|.. +.++..|+.|+||+|+++. +|..+..+..|++|...+|++. ..|.  +..++.|+
T Consensus       380 ~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fPe--~~~l~qL~  455 (1081)
T KOG0618|consen  380 VNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFPE--LAQLPQLK  455 (1081)
T ss_pred             ccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-echh--hhhcCcce
Confidence            8889999999999999999985 6689999999999999994 6689999999999999999998 6784  44789999


Q ss_pred             eEECCCCccccc-CCCCCCCCCCCcccccccccc
Q 036342          334 DLNLSFNKLKGE-IPRGGSFGNFSAESFEGNELL  366 (596)
Q Consensus       334 ~L~l~~N~l~~~-~p~~~~~~~l~~l~~~~N~~~  366 (596)
                      .+|+|.|.|+.. +|....+++|+.++++||.+.
T Consensus       456 ~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  456 VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             EEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            999999999853 455555689999999999963

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=4.6e-26  Score=225.11  Aligned_cols=151  Identities=30%  Similarity=0.418  Sum_probs=127.5

Q ss_pred             cccccccccccCCCceeehhhH----------------HhHHHHHHHHh--hcCCCccceeeeeeccCC----eeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------KSFDVECEMMK--SIRHRNLIKVISSCSNEE----FKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------~~~~~e~~~l~--~l~H~niv~l~~~~~~~~----~~~lV~e  501 (596)
                      .+..+..+.||+|+||.||||.                +.|..|-.+.+  .++|+||++++++-....    ..+||+|
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            3445667889999999999973                45666666665  679999999999876554    6889999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc------cCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------GYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~------~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      |.+.|+|.++++..  .++|....+|+.-+++|++|||.      .+.++|+|||+|+.|||+..|+++.|+|||+|..+
T Consensus       289 fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  289 FHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             eccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            99999999999876  58999999999999999999995      34678999999999999999999999999999988


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ............+||.+||||
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAP  387 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAP  387 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCH
Confidence            644333334457999999998

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.93  E-value=9.2e-27  Score=233.83  Aligned_cols=145  Identities=30%  Similarity=0.472  Sum_probs=130.9

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|...+.||+|+||.||||.                       +...+|++++++++|||||.++++|+....+++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            468888999999999999973                       347899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ||.| +|+.++.... .+++.++..++.+++.|+.|||   +.+|.|||+||.|||++..|.+|+||||+|+.+...  .
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--T  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC--c
Confidence            9977 9999997654 6899999999999999999999   999999999999999999999999999999987543  3


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      ...+...|||.||||
T Consensus       155 ~vltsikGtPlYmAP  169 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAP  169 (808)
T ss_pred             eeeeeccCcccccCH
Confidence            344557899999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.7e-26  Score=233.08  Aligned_cols=148  Identities=27%  Similarity=0.427  Sum_probs=131.9

Q ss_pred             hcccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEF  495 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~  495 (596)
                      ....|...+.||+|+||.||.|.                          +.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            45689999999999999999752                          13347999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC-CcEEEeccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDFSIAKL  574 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~-~~~kl~dfGla~~  574 (596)
                      .|+|||||.||+|++++.. ...+.+..+..+..|++.|++|+|   +++|+||||||+|||++.+ +.+||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999998 457888999999999999999999   9999999999999999999 9999999999997


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...  ........|||+.|+||
T Consensus       171 ~~~--~~~~l~t~cGsp~Y~aP  190 (370)
T KOG0583|consen  171 SPG--EDGLLKTFCGSPAYAAP  190 (370)
T ss_pred             cCC--CCCcccCCCCCcccCCH
Confidence            631  22245678999999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=9.2e-26  Score=221.84  Aligned_cols=150  Identities=33%  Similarity=0.518  Sum_probs=128.9

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCC--eeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE--FKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lV~  500 (596)
                      ..+|...+.||+|+||.||.+.                     +.+.+|+.+|++++|||||+.+|.....+  ..++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3467788999999999999742                     23689999999999999999999865554  688999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEeccccccccCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfGla~~~~~~~  579 (596)
                      ||+++|+|.+++...+..+++..+..+..||++|++|||   +++++||||||+|||++. ++.+||+|||+++......
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            999999999999987657899999999999999999999   999999999999999999 7999999999998765311


Q ss_pred             -CccccccccccccccCC
Q 036342          580 -QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 -~~~~~~~~~gt~~y~aP  596 (596)
                       .........||+.||||
T Consensus       173 ~~~~~~~~~~Gtp~~maP  190 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAP  190 (313)
T ss_pred             ccccccccccCCccccCc
Confidence             11223347899999999

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.93  E-value=1e-25  Score=238.70  Aligned_cols=151  Identities=28%  Similarity=0.518  Sum_probs=132.3

Q ss_pred             hcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      ...+....+.||+|+||+||+|.                           ++|++|++++..++|||||+|+|+|.+++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            34456677899999999999852                           579999999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC---------C----CCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC
Q 036342          496 KALVLEYMPHGSLEKYLYSSN---------C----ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM  562 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~---------~----~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~  562 (596)
                      .|+|+|||..|||.+||....         .    .++..+.+.||.|||.|++||-   ++++||||+-++|+|+.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccce
Confidence            999999999999999997542         1    2778899999999999999999   88999999999999999999


Q ss_pred             cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          563 VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 ~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+||+|||++|.....+++.......-..+||||
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMpp  674 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP  674 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCH
Confidence            9999999999987666555444344567899998

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-28  Score=233.19  Aligned_cols=330  Identities=25%  Similarity=0.259  Sum_probs=236.5

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccC-CccccccCccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWG-NNFSGTIPRFI   79 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~   79 (596)
                      +||+++.  ....+++|..|+|+.+.|.+|+.+++|++||||+|.|+ .|.+.+|.++.+|..|-+-+ |+|+....++|
T Consensus        60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F  136 (498)
T KOG4237|consen   60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPKGAF  136 (498)
T ss_pred             cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhhhHh
Confidence            4566553  45678999999999888899999999999999999997 78888888888888777765 89997777789


Q ss_pred             cCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCcc--CC----
Q 036342           80 FNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGI--LP----  153 (596)
Q Consensus        80 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~--~~----  153 (596)
                      .+|..|+.|.+.-|++..+..++|..|++|..|.+.+|.+..+..+     +|..+..++.+.+.-|.+...  .|    
T Consensus       137 ~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~-----tf~~l~~i~tlhlA~np~icdCnL~wla~  211 (498)
T KOG4237|consen  137 GGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKG-----TFQGLAAIKTLHLAQNPFICDCNLPWLAD  211 (498)
T ss_pred             hhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccc-----cccchhccchHhhhcCccccccccchhhh
Confidence            9999999999999999999999999999999999999988887654     577888888887777772110  00    


Q ss_pred             -----chhhhcc---------------------cccccEE---EccccccccccC-hhccCCCCCCEEEccCCcccCCCC
Q 036342          154 -----KTSISNL---------------------SRSLEEF---YMYNCNISGGIP-EEISNLTNLVEIDLGGNKLNGSIP  203 (596)
Q Consensus       154 -----~~~~~~l---------------------~~~L~~L---~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p  203 (596)
                           ...++..                     ..+++.+   ..+.+...++-| ..|..+++|+.|+|++|+|+++.+
T Consensus       212 ~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~  291 (498)
T KOG4237|consen  212 DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIED  291 (498)
T ss_pred             HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhh
Confidence                 0001100                     0011111   112222222223 467888899999999999998888


Q ss_pred             ccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC-----------
Q 036342          204 ITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-----------  272 (596)
Q Consensus       204 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-----------  272 (596)
                      .+|.++..+++|.|.+|+|..+-...|.++..|++|+|.+|+|+...|.+|..+.+|..|+|-.|.+-.           
T Consensus       292 ~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wl  371 (498)
T KOG4237|consen  292 GAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWL  371 (498)
T ss_pred             hhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHH
Confidence            899999999999999999886666778888889999999999988888899988899999888886522           


Q ss_pred             -------CCcccccccccceEEcccCCCCCc---hhhhhc-----------------------cc--------cccceEe
Q 036342          273 -------IPLTFWNLKDILQLNFSSNFLTGP---LLLEIG-----------------------NL--------KVLIGID  311 (596)
Q Consensus       273 -------ip~~~~~l~~L~~L~ls~N~l~~~---~~~~~~-----------------------~l--------~~L~~L~  311 (596)
                             .|. ......++.+.++.+.+...   .|.+..                       .+        ..-+.|+
T Consensus       372 r~~~~~~~~~-Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP~d~tely  450 (498)
T KOG4237|consen  372 RKKSVVGNPR-CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIPVDVTELY  450 (498)
T ss_pred             hhCCCCCCCC-CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCCchhHHHh
Confidence                   111 11223455555555543221   011000                       01        1125788


Q ss_pred             cCCCcCcccCChhhhccCCCCCeEECCCCcccc
Q 036342          312 FSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG  344 (596)
Q Consensus       312 ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~  344 (596)
                      +.+|.++ .+|.+   .+.+| .+|+++|+|+.
T Consensus       451 l~gn~~~-~vp~~---~~~~l-~~dls~n~i~~  478 (498)
T KOG4237|consen  451 LDGNAIT-SVPDE---LLRSL-LLDLSNNRISS  478 (498)
T ss_pred             cccchhc-ccCHH---HHhhh-hcccccCceeh
Confidence            9999998 67875   45667 89999999874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=226.61  Aligned_cols=155  Identities=27%  Similarity=0.389  Sum_probs=126.7

Q ss_pred             HHHHHhcccccccccccCCCceeehhhH-----------------------------------HhHHHHHHHHhhcCCCc
Q 036342          438 LELCRATDEFSENNLIGRGGFALFIRAF-----------------------------------KSFDVECEMMKSIRHRN  482 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~-----------------------------------~~~~~e~~~l~~l~H~n  482 (596)
                      .+-.+..+.|+..+.||+|.||+|..|+                                   ++..+|+.+|++++|||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            3445567889999999999999996531                                   36789999999999999


Q ss_pred             cceeeeeeccC--CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC
Q 036342          483 LIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD  560 (596)
Q Consensus       483 iv~l~~~~~~~--~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~  560 (596)
                      ||+|+++..+.  +.+|||+|||+.|.+...= .....+.+.++++|..++..||+|||   .++|+||||||+|+|+++
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcC
Confidence            99999999765  4799999999988874322 11223788999999999999999999   999999999999999999


Q ss_pred             CCcEEEeccccccccCCCC---CccccccccccccccCC
Q 036342          561 NMVAHLSDFSIAKLLTGED---QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       561 ~~~~kl~dfGla~~~~~~~---~~~~~~~~~gt~~y~aP  596 (596)
                      +|++||+|||++.......   ........+|||.||||
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP  284 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP  284 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccch
Confidence            9999999999988652111   11122346899999998

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.93  E-value=4.7e-25  Score=240.89  Aligned_cols=263  Identities=26%  Similarity=0.374  Sum_probs=182.9

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEE
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLS   89 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (596)
                      .+-..|+|+.|+|+ .+|..+.  ++|+.|++++|+|+ .+|..    +++|++|+|++|+|+ .+|..   .++|+.|+
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l----p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~  268 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLT-SLPVL---PPGLLELS  268 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC----CCCCcEEEecCCccC-cccCc---ccccceee
Confidence            34667899999887 5677664  47889999999887 45542    578899999999888 45542   46788888


Q ss_pred             ccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEc
Q 036342           90 LGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM  169 (596)
Q Consensus        90 L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l  169 (596)
                      |++|.|+.+ |..   ..+|+.|++++|+++.++.         .+++|+.|++++|+|+++ |.     ++.+|..|++
T Consensus       269 Ls~N~L~~L-p~l---p~~L~~L~Ls~N~Lt~LP~---------~p~~L~~LdLS~N~L~~L-p~-----lp~~L~~L~L  329 (788)
T PRK15387        269 IFSNPLTHL-PAL---PSGLCKLWIFGNQLTSLPV---------LPPGLQELSVSDNQLASL-PA-----LPSELCKLWA  329 (788)
T ss_pred             ccCCchhhh-hhc---hhhcCEEECcCCccccccc---------cccccceeECCCCccccC-CC-----Cccccccccc
Confidence            888888753 332   3567788888888887543         135788888888888754 32     3356788888


Q ss_pred             cccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCccc
Q 036342          170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS  249 (596)
Q Consensus       170 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  249 (596)
                      ++|+|++ +|..   ..+|+.|+|++|+|++ +|..   .++|+.|++++|.|+ .+|..   ..+|+.|++++|+|++ 
T Consensus       330 s~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-  396 (788)
T PRK15387        330 YNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-  396 (788)
T ss_pred             ccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCcccC-
Confidence            8888875 3431   2467888888888875 3432   356777888888887 45543   2467788888888774 


Q ss_pred             chhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCCh
Q 036342          250 IPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPR  323 (596)
Q Consensus       250 ~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~  323 (596)
                      +|..   .++|+.|++++|+|+++|..   ..+|+.|++++|+|+ .+|..+..++.|+.|+|++|++++..+.
T Consensus       397 LP~l---~s~L~~LdLS~N~LssIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        397 LPVL---PSELKELMVSGNRLTSLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             CCCc---ccCCCEEEccCCcCCCCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            4432   25677788888888777753   235666777777776 4566677777777777777777766554

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.93  E-value=3.1e-26  Score=207.98  Aligned_cols=146  Identities=25%  Similarity=0.478  Sum_probs=128.8

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++.|+..+.||+|.|++|||+.                       +++.+|+.+.+.++|||||+|.+.+.+++..|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            5678889999999999999853                       56789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~dfGla~~~~~  577 (596)
                      |+|.||+|..-+-.+ ..+++..+..++.||++|+.|+|   .++|||||+||+|+++.+   ...+|++|||+|..+. 
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence            999999997666544 35678889999999999999999   999999999999999964   3579999999999886 


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                        +.....+++|||+||||
T Consensus       165 --~g~~~~G~~GtP~fmaP  181 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSP  181 (355)
T ss_pred             --CccccccccCCCcccCH
Confidence              23456778999999998

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-26  Score=232.31  Aligned_cols=155  Identities=26%  Similarity=0.458  Sum_probs=137.4

Q ss_pred             HHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          438 LELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ++|++....+.....||+|+||+||||.                    +.|+.|+.++++-+|.||+=+.|+|..++. .
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            6677777778888999999999999973                    689999999999999999999999999887 9


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|+.+|+|-+|+.+++.....++..+.+.|+.|||+|+.|||   .++|||||+|+.||++++++++||+|||++.....
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            999999999999999988888999999999999999999999   99999999999999999999999999999875433


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...........|..-||||
T Consensus       541 w~g~~q~~qp~gsilwmAP  559 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAP  559 (678)
T ss_pred             eccccccCCCccchhhhcH
Confidence            2222233445688899998

>PLN03210 Resistant to P

Probab=99.92  E-value=5.8e-24  Score=249.36  Aligned_cols=338  Identities=22%  Similarity=0.236  Sum_probs=253.1

Q ss_pred             cccCCCCCCCEEECCCCC------CccccchhhhCC-CCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccC
Q 036342            4 LEIGNLQNLEELQLGQNK------LIGTVPAAIFNV-STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIP   76 (596)
Q Consensus         4 ~~~~~l~~L~~L~Ls~n~------l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~   76 (596)
                      ..|..+.+|+.|.+..+.      +....|+.|..+ .+|+.|++.+|.++ .+|....  +.+|+.|+|++|++. .++
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~--~~~L~~L~L~~s~l~-~L~  627 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFR--PENLVKLQMQGSKLE-KLW  627 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcCC--ccCCcEEECcCcccc-ccc
Confidence            357889999999997654      333567777665 46999999999987 4555332  689999999999988 678


Q ss_pred             ccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchh
Q 036342           77 RFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTS  156 (596)
Q Consensus        77 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  156 (596)
                      ..+..+++|+.|+|++|.....+|+ +..+++|+.|+|++|.....     ++..+.++++|+.|++++|...+.+|. .
T Consensus       628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~-----lp~si~~L~~L~~L~L~~c~~L~~Lp~-~  700 (1153)
T PLN03210        628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVE-----LPSSIQYLNKLEDLDMSRCENLEILPT-G  700 (1153)
T ss_pred             cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccc-----cchhhhccCCCCEEeCCCCCCcCccCC-c
Confidence            8888999999999998765445554 78899999999998754321     334688899999999999765555564 2


Q ss_pred             hhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCccc-------ccCccc
Q 036342          157 ISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE-------GSIPDD  229 (596)
Q Consensus       157 ~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------~~~~~~  229 (596)
                      + ++ ++|+.|++++|.....+|..   ..+|+.|++++|.+. .+|..+ .+++|+.|++.++...       ...+..
T Consensus       701 i-~l-~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~  773 (1153)
T PLN03210        701 I-NL-KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLM  773 (1153)
T ss_pred             C-CC-CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhh
Confidence            2 44 68999999999766666643   467899999999987 455544 5788888888874322       112222


Q ss_pred             hhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCC-cccCCCcccccccccceEEcccCCCCCchhhhhccccccc
Q 036342          230 ICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSN-KLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLI  308 (596)
Q Consensus       230 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  308 (596)
                      +...++|+.|+|++|...+.+|..++++++|+.|++++| .+..+|... .+++|+.|++++|......|..   ..+|+
T Consensus       774 ~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~  849 (1153)
T PLN03210        774 TMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNIS  849 (1153)
T ss_pred             hhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccC
Confidence            334578999999999877788999999999999999986 567788766 7889999999998655444433   35788


Q ss_pred             eEecCCCcCcccCChhhhccCCCCCeEECCC-CcccccCCCCCCCCCCCccccccccc
Q 036342          309 GIDFSMNNFSGVIPREIGEKLSYLEDLNLSF-NKLKGEIPRGGSFGNFSAESFEGNEL  365 (596)
Q Consensus       309 ~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~~~l~~l~~~~N~~  365 (596)
                      .|+|++|.++ .+|. .+..+++|+.|++++ |++.+.++....++.++.+++++++-
T Consensus       850 ~L~Ls~n~i~-~iP~-si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~  905 (1153)
T PLN03210        850 DLNLSRTGIE-EVPW-WIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGA  905 (1153)
T ss_pred             EeECCCCCCc-cChH-HHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCcc
Confidence            8999999998 6787 456899999999988 56766544445677777777776553

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=1.1e-24  Score=237.93  Aligned_cols=254  Identities=26%  Similarity=0.360  Sum_probs=204.9

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +||+.+.  ++|+.|++++|+|+. +|..   +++|++|+|++|+|+ .+|..    .++|+.|+|++|.++ .+|..  
T Consensus       215 sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l----p~sL~~L~Ls~N~L~-~Lp~l--  280 (788)
T PRK15387        215 TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL----PPGLLELSIFSNPLT-HLPAL--  280 (788)
T ss_pred             cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc----ccccceeeccCCchh-hhhhc--
Confidence            4788776  489999999999985 5542   589999999999998 45542    568999999999998 45553  


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                       ..+|+.|+|++|+|+.+ |.   .+++|+.|++++|+++.++..         ..+|+.|++++|.|+++ |.     +
T Consensus       281 -p~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~Lp~l---------p~~L~~L~Ls~N~L~~L-P~-----l  340 (788)
T PRK15387        281 -PSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASLPAL---------PSELCKLWAYNNQLTSL-PT-----L  340 (788)
T ss_pred             -hhhcCEEECcCCccccc-cc---cccccceeECCCCccccCCCC---------cccccccccccCccccc-cc-----c
Confidence             35789999999999865 43   357899999999999986531         23578899999999853 32     4


Q ss_pred             cccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEE
Q 036342          161 SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE  240 (596)
Q Consensus       161 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (596)
                      +.+|++|+|++|+|++ +|..   ..+|+.|++++|+++. +|..   .++|+.|++++|.|+ .+|..   .++|+.|+
T Consensus       341 p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~Ld  408 (788)
T PRK15387        341 PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELM  408 (788)
T ss_pred             ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCccc-CCCCc---ccCCCEEE
Confidence            4689999999999996 4543   3578899999999995 5543   367999999999999 46643   36799999


Q ss_pred             ccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccc
Q 036342          241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNL  304 (596)
Q Consensus       241 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l  304 (596)
                      +++|+++. +|..+   .+|+.|+|++|+|+.+|..+..+++|+.|+|++|+|++..+..+..+
T Consensus       409 LS~N~Lss-IP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        409 VSGNRLTS-LPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             ccCCcCCC-CCcch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            99999985 56533   47889999999999999999999999999999999999887776443

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-27  Score=252.15  Aligned_cols=343  Identities=29%  Similarity=0.365  Sum_probs=248.6

Q ss_pred             CCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEc
Q 036342           11 NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSL   90 (596)
Q Consensus        11 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L   90 (596)
                      .|+.|||++|++. ..|..+..+.+|+.|+++.|-|...+....  .+.+|++|.|..|.+. ..|..+..+++|++|++
T Consensus        46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~--~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ldl  121 (1081)
T KOG0618|consen   46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCS--NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDL  121 (1081)
T ss_pred             eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhh--hhhcchhheeccchhh-cCchhHHhhhccccccc
Confidence            3999999999985 889999999999999999999984443343  4889999999999998 89999999999999999


Q ss_pred             cCCcccccCCccccCCCCCCEEecCCC-cCcCCCCC-------------ccccccCCCCCCCCEEECcCCCCCccCCchh
Q 036342           91 GMNSFSGFIPSTFGNLRNLEQLGLDEN-YLTSSTPE-------------LSFLSSLSNCKSLTLIDLSNNPLDGILPKTS  156 (596)
Q Consensus        91 ~~N~i~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~-------------~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  156 (596)
                      |+|++. .+|..+..++.++++..++| ++..+...             -.++-....++.  .|||..|.+. ......
T Consensus       122 S~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~dls~  197 (1081)
T KOG0618|consen  122 SFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VLDLSN  197 (1081)
T ss_pred             chhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-hhhhhh
Confidence            999997 56777777777777777777 21111100             011112222322  4677777665 211101


Q ss_pred             ----------------hhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCC
Q 036342          157 ----------------ISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN  220 (596)
Q Consensus       157 ----------------~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  220 (596)
                                      +.-..++++.|+.++|.++...+ .+. -.+|+++|++.|++++ .|.++..+.+|+.++...|
T Consensus       198 ~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~-~p~-p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N  274 (1081)
T KOG0618|consen  198 LANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDV-HPV-PLNLQYLDISHNNLSN-LPEWIGACANLEALNANHN  274 (1081)
T ss_pred             ccchhhhhhhhcccceEEecCcchheeeeccCcceeecc-ccc-cccceeeecchhhhhc-chHHHHhcccceEecccch
Confidence                            11111467777777777773322 222 2578999999999995 5599999999999999999


Q ss_pred             cccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccc----------------------
Q 036342          221 ILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFW----------------------  278 (596)
Q Consensus       221 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~----------------------  278 (596)
                      +|+ .+|..+...++|+.|....|.+. -+|....++++|++|||..|+|..+|..+.                      
T Consensus       275 ~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~  352 (1081)
T KOG0618|consen  275 RLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPS  352 (1081)
T ss_pred             hHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccc
Confidence            997 78888888889999999999998 456667778999999999999888775222                      


Q ss_pred             ----cccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCCCCCCC
Q 036342          279 ----NLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGN  354 (596)
Q Consensus       279 ----~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~  354 (596)
                          ..+.|+.|.+.+|.++......+.+.+.|+.|+|++|++. .+|...+.+++.|++|+||||+|+..+-....++.
T Consensus       353 ~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~  431 (1081)
T KOG0618|consen  353 YEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGR  431 (1081)
T ss_pred             ccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhh
Confidence                1234567777888888777777788888999999999887 67888888888899999999988743211123344


Q ss_pred             CCccccccccccc
Q 036342          355 FSAESFEGNELLC  367 (596)
Q Consensus       355 l~~l~~~~N~~~c  367 (596)
                      ++.+...+|.+.|
T Consensus       432 L~tL~ahsN~l~~  444 (1081)
T KOG0618|consen  432 LHTLRAHSNQLLS  444 (1081)
T ss_pred             hHHHhhcCCceee
Confidence            4444444444433

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.92  E-value=2.6e-25  Score=214.73  Aligned_cols=147  Identities=26%  Similarity=0.381  Sum_probs=127.3

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCc-cceeeeeeccCC-----
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRN-LIKVISSCSNEE-----  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~-----  494 (596)
                      ...|+..+.||+|+||+||+|.                       ....+|+.++++++|+| ||+|++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            4567888899999999999973                       23578999999999999 999999998776     


Q ss_pred             -eeEEEEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccc
Q 036342          495 -FKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS  570 (596)
Q Consensus       495 -~~~lV~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfG  570 (596)
                       ..++||||++. ||.+++....   ..++...+..++.|+++|++|||   +++|+|||+||.|||++++|.+|++|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             78999999965 9999998865   35777889999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCC
Q 036342          571 IAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|+...-+..  ..+.-++|.||+||
T Consensus       166 lAra~~ip~~--~yt~evvTlWYRaP  189 (323)
T KOG0594|consen  166 LARAFSIPMR--TYTPEVVTLWYRAP  189 (323)
T ss_pred             hHHHhcCCcc--cccccEEEeeccCH
Confidence            9997653322  23456789999998

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=6.2e-26  Score=205.79  Aligned_cols=147  Identities=29%  Similarity=0.428  Sum_probs=130.6

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      +.++|++.+.+|+|.||.||.|.                        +++.+|+++-+.++||||.++|++|.++..+|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            35689999999999999999753                        457789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          499 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      ++||.++|++...+++.. ..+++.....++.|+|.|+.|+|   .++++||||||+|+|++.++..|++|||-+.... 
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999998654 45888899999999999999999   9999999999999999999999999999887532 


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                         .....+.|||.-|.||
T Consensus       176 ---~~kR~tlcgt~dyl~p  191 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPP  191 (281)
T ss_pred             ---CCCceeeecccccCCH
Confidence               1124567999999998

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.92  E-value=2e-25  Score=205.61  Aligned_cols=148  Identities=32%  Similarity=0.514  Sum_probs=130.2

Q ss_pred             HhcccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhc-CCCccceeeeeec
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSI-RHRNLIKVISSCS  491 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~  491 (596)
                      ...++|+..+.+|.|..++|.|+.                             +.-.+|+.+++++ .||+|+++.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            345678888899998888887642                             3456899999987 6999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                      .+..+++|+|.|+.|.|+|++...- .+++.....|+.|+.+|++|||   ...|||||+||+|||+|++..+||+|||+
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccce
Confidence            9999999999999999999998764 6789999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+.+...   ......||||+|+||
T Consensus       170 a~~l~~G---ekLrelCGTPgYLAP  191 (411)
T KOG0599|consen  170 ACQLEPG---EKLRELCGTPGYLAP  191 (411)
T ss_pred             eeccCCc---hhHHHhcCCCcccCh
Confidence            9987532   235568999999998

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.6e-25  Score=228.44  Aligned_cols=156  Identities=27%  Similarity=0.411  Sum_probs=132.6

Q ss_pred             CHHHHHHhcccccccccccCCCceeehhh----------------------------HHhHHHHHHHHhhcCCCccceee
Q 036342          436 SYLELCRATDEFSENNLIGRGGFALFIRA----------------------------FKSFDVECEMMKSIRHRNLIKVI  487 (596)
Q Consensus       436 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~----------------------------~~~~~~e~~~l~~l~H~niv~l~  487 (596)
                      ....|+-..++....+.||+|+||.||+|                            .+++.+|+++|++++|||||++|
T Consensus       148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y  227 (474)
T KOG0194|consen  148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY  227 (474)
T ss_pred             cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            33445555667677799999999999975                            24678999999999999999999


Q ss_pred             eeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEe
Q 036342          488 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS  567 (596)
Q Consensus       488 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~  567 (596)
                      |++..+..+|+|||+|+||+|.++++.....++..+...++.++|+|++|||   +++++||||-++|+|+..++.+||+
T Consensus       228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeC
Confidence            9999999999999999999999999998767999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccccccCC
Q 036342          568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       568 dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||+++.-.  ..........-..+|+||
T Consensus       305 DFGLs~~~~--~~~~~~~~~klPirWLAP  331 (474)
T KOG0194|consen  305 DFGLSRAGS--QYVMKKFLKKLPIRWLAP  331 (474)
T ss_pred             ccccccCCc--ceeeccccccCcceecCh
Confidence            999988532  111111122356789988

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.91  E-value=4e-25  Score=222.90  Aligned_cols=150  Identities=24%  Similarity=0.421  Sum_probs=129.3

Q ss_pred             cccccccccccCCCceeehh---------------------hHHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIR---------------------AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~---------------------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .+....++.||+|.||+|..                     +.++|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            44456779999999999864                     246899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |++|||.+|+.+.... .+.....+|+.|||.|++||.   +.++||||+.+.|+|+|.++++||+|||++|.+...+.+
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999999887533 355677889999999999999   899999999999999999999999999999977554444


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      ......+-+.+||||
T Consensus       694 ~vqgr~vlpiRwmaw  708 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAW  708 (807)
T ss_pred             eeecceeeeeeehhH
Confidence            444445667889986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.7e-25  Score=224.13  Aligned_cols=146  Identities=25%  Similarity=0.376  Sum_probs=130.8

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ...|.....||+|+.|.||-|.                     +-+..|+.+|+..+|+|||++++.|..++.+|.||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4467888999999999999753                     3467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      |+||+|.|.+...  .+++.+...|+.+++.||+|||   .++|+|||||.+|||++.+|.+||+|||++..+.....  
T Consensus       352 m~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--  424 (550)
T ss_pred             cCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence            9999999998765  4889999999999999999999   99999999999999999999999999999998765432  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ...+.+|||+||||
T Consensus       425 KR~TmVGTPYWMAP  438 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAP  438 (550)
T ss_pred             ccccccCCCCccch
Confidence            34557899999998

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.9e-25  Score=228.38  Aligned_cols=147  Identities=27%  Similarity=0.397  Sum_probs=126.1

Q ss_pred             hcccccccccccCCCceeehhh------------------------HHhHHHHHHHHhhc-CCCccceeeeeeccCCeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRA------------------------FKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~------------------------~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  497 (596)
                      ..++|...++||+|+||+|+.+                        ++..+.|..++... +||.+++++.+|++++++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4578999999999999999864                        23455676666655 5999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+.|||+..+.+.  ..+++..+..|++.|+.||+|||   +++|||||+|.+|||+|.+|.+||+|||+++.-..
T Consensus       446 fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999995544433  36899999999999999999999   99999999999999999999999999999997432


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                        .....+++||||.||||
T Consensus       521 --~g~~TsTfCGTpey~aP  537 (694)
T KOG0694|consen  521 --QGDRTSTFCGTPEFLAP  537 (694)
T ss_pred             --CCCccccccCChhhcCh
Confidence              22346779999999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.3e-24  Score=213.44  Aligned_cols=150  Identities=27%  Similarity=0.375  Sum_probs=132.9

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .++|+..+.||.|..++||+|.                      ..+.+|++.|+.++|||||+.+..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4689999999999999999862                      567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||.+|++.+.++..- ..+++..+.-|.+++++||.|||   .++.||||+|+.|||++++|.+||+|||++..+.....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999998753 46889999999999999999999   99999999999999999999999999998776654432


Q ss_pred             cc-cc-ccccccccccCC
Q 036342          581 SM-TQ-TQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~-~~-~~~~gt~~y~aP  596 (596)
                      .. .. ..++||++||||
T Consensus       182 R~~~rf~tfvgtp~wmAP  199 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAP  199 (516)
T ss_pred             eeeEeeccccCcccccCh
Confidence            21 11 567999999998

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.91  E-value=2.4e-25  Score=231.42  Aligned_cols=161  Identities=25%  Similarity=0.454  Sum_probs=136.7

Q ss_pred             cccCHHHHHHhccc---------ccccccccCCCceeehhh-------------------------HHhHHHHHHHHhhc
Q 036342          433 RTFSYLELCRATDE---------FSENNLIGRGGFALFIRA-------------------------FKSFDVECEMMKSI  478 (596)
Q Consensus       433 ~~~~~~~~~~~~~~---------~~~~~~ig~G~~g~v~~~-------------------------~~~~~~e~~~l~~l  478 (596)
                      +.++|+|.-++...         ..+.++||.|.||+||+|                         ..+|..|+.+|.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            44566655544333         456799999999999985                         25799999999999


Q ss_pred             CCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee
Q 036342          479 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL  558 (596)
Q Consensus       479 ~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl  558 (596)
                      +||||++|.|+......+++|+|||++|+|+.||+...+.+.+.+...+.++||.|++||-   +.+.||||+.++|||+
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILV  764 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILV  764 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheee
Confidence            9999999999999999999999999999999999998888999999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCCC-ccccccccccccccCC
Q 036342          559 DDNMVAHLSDFSIAKLLTGEDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       559 ~~~~~~kl~dfGla~~~~~~~~-~~~~~~~~gt~~y~aP  596 (596)
                      +.+..+||+|||++|.+.++.+ .....+..-..+|.||
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAP  803 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAP  803 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecCh
Confidence            9999999999999998754432 2222223345688887

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.91  E-value=2.9e-25  Score=214.11  Aligned_cols=146  Identities=28%  Similarity=0.443  Sum_probs=120.9

Q ss_pred             cccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeeccC---Ce--eEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCSNE---EF--KALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~~~---~~--~~lV~e  501 (596)
                      +-.|...+.+|+|+||.||+|.                 +--.+|.++|++++|||||+|.-+|...   +.  ..+|||
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            4468889999999999999973                 1234799999999999999999988643   22  348999


Q ss_pred             cCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC-CcEEEeccccccccCC
Q 036342          502 YMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLTG  577 (596)
Q Consensus       502 ~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~-~~~kl~dfGla~~~~~  577 (596)
                      |||. +|.+.++..   +..++...+.-+++|+.+|+.|||   ..+|+||||||.|+|+|.+ |.+||||||-|+.+..
T Consensus       103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            9987 999988742   345667778889999999999999   8999999999999999965 9999999999998754


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   ....+..|..|+||
T Consensus       179 ~e---pniSYicSRyYRaP  194 (364)
T KOG0658|consen  179 GE---PNISYICSRYYRAP  194 (364)
T ss_pred             CC---CceeEEEeccccCH
Confidence            32   23446789999998

>PLN03210 Resistant to P

Probab=99.91  E-value=9.1e-23  Score=239.36  Aligned_cols=315  Identities=25%  Similarity=0.239  Sum_probs=244.9

Q ss_pred             CCcccCCCC-CCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            2 IPLEIGNLQ-NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         2 ip~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +|.++..++ +|+.|++.+|.+. .+|..| .+.+|++|+|++|++.......  ..+++|+.|+|++|.....+|. +.
T Consensus       580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~--~~l~~Lk~L~Ls~~~~l~~ip~-ls  654 (1153)
T PLN03210        580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGV--HSLTGLRNIDLRGSKNLKEIPD-LS  654 (1153)
T ss_pred             cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccccccccc--ccCCCCCEEECCCCCCcCcCCc-cc
Confidence            577777774 6999999999986 678777 5789999999999997433333  3489999999998765446664 88


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCC-cCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhc
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN-YLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISN  159 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~  159 (596)
                      .+++|++|+|++|.....+|..+.++++|+.|++++| .+..++..       .++++|+.|++++|...+.+|.     
T Consensus       655 ~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~-------i~l~sL~~L~Lsgc~~L~~~p~-----  722 (1153)
T PLN03210        655 MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG-------INLKSLYRLNLSGCSRLKSFPD-----  722 (1153)
T ss_pred             cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc-------CCCCCCCEEeCCCCCCcccccc-----
Confidence            8999999999998776788999999999999999986 45554432       2789999999999976555443     


Q ss_pred             ccccccEEEccccccccccChhccCCCCCCEEEccCCcc-------cCCCCccccCCCCCCeEEccCCcccccCccchhc
Q 036342          160 LSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKL-------NGSIPITLGKLRKLQRLNLEDNILEGSIPDDICR  232 (596)
Q Consensus       160 l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l-------~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  232 (596)
                      .+.+|++|++++|.++. +|..+ .+++|+.|++.++..       ....+..+...++|+.|++++|...+.+|..+.+
T Consensus       723 ~~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~  800 (1153)
T PLN03210        723 ISTNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQN  800 (1153)
T ss_pred             ccCCcCeeecCCCcccc-ccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhC
Confidence            34689999999999874 56554 578888888877432       2222333445678999999999877789999999


Q ss_pred             CCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCc-ccCCCcccccccccceEEcccCCCCCchhhhhccccccceEe
Q 036342          233 LAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNK-LTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGID  311 (596)
Q Consensus       233 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~  311 (596)
                      +++|+.|++++|...+.+|... .+++|+.|+|++|. +..+|..   ..+|+.|+|++|.++. +|..+..+++|+.|+
T Consensus       801 L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~-iP~si~~l~~L~~L~  875 (1153)
T PLN03210        801 LHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEE-VPWWIEKFSNLSFLD  875 (1153)
T ss_pred             CCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCcc-ChHHHhcCCCCCEEE
Confidence            9999999999986545677655 78999999999864 4446543   3678999999999984 677889999999999


Q ss_pred             cCCCcCcccCChhhhccCCCCCeEECCCCc
Q 036342          312 FSMNNFSGVIPREIGEKLSYLEDLNLSFNK  341 (596)
Q Consensus       312 ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~  341 (596)
                      +++|+-...+|. ....++.|+.++++++.
T Consensus       876 L~~C~~L~~l~~-~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        876 MNGCNNLQRVSL-NISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCCCcCccCc-ccccccCCCeeecCCCc
Confidence            988443335666 34578899999998874

syringae 6; Provisional

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.90  E-value=5.2e-24  Score=219.20  Aligned_cols=152  Identities=24%  Similarity=0.432  Sum_probs=125.0

Q ss_pred             HhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeeccC
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNE  493 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~  493 (596)
                      ...++|+..+.||+|+||.||+|.                           +.+..|+.+++++ +|||||+++++|...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            345789999999999999998751                           2466799999999 899999999988764


Q ss_pred             -CeeEEEEecCCCCCHHHHHhhCC--------------------------------------------------------
Q 036342          494 -EFKALVLEYMPHGSLEKYLYSSN--------------------------------------------------------  516 (596)
Q Consensus       494 -~~~~lV~e~~~~g~L~~~l~~~~--------------------------------------------------------  516 (596)
                       +..++||||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             46899999999999999987531                                                        


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccc
Q 036342          517 -----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTI  591 (596)
Q Consensus       517 -----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~  591 (596)
                           ..+++..+..++.|+++|+.|||   .++|+||||||+||++++++.+||+|||+++...............+++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 23677788899999999999999   8999999999999999999999999999998654332222222345678


Q ss_pred             cccCC
Q 036342          592 GYMAP  596 (596)
Q Consensus       592 ~y~aP  596 (596)
                      .||||
T Consensus       241 ~y~aP  245 (338)
T cd05102         241 KWMAP  245 (338)
T ss_pred             cccCc
Confidence            89998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.90  E-value=3.9e-24  Score=222.25  Aligned_cols=149  Identities=24%  Similarity=0.370  Sum_probs=128.8

Q ss_pred             HhcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ...++|+..+.||+|+||.||++.                        +.+..|+.+++.++||||+++++++..++..|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            345689999999999999999642                        23567999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++...  .+++..+..++.|++.|++|||   ..+|+||||||+|||+++++.+||+|||+|+....
T Consensus       120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999999999764  4788889999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ... ......+||+.||||
T Consensus       195 ~~~-~~~~~~~gt~~Y~aP  212 (370)
T cd05621         195 TGM-VRCDTAVGTPDYISP  212 (370)
T ss_pred             CCc-eecccCCCCcccCCH
Confidence            221 122346799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.1e-25  Score=222.75  Aligned_cols=142  Identities=30%  Similarity=0.407  Sum_probs=126.3

Q ss_pred             ccccccccccCCCceeehhh------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRA------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .-|+.++.||+|+||.||-|                        ++++..|+..+.+++|||+|.+.|||..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            35778899999999999964                        367889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |||- |+-.|.+.-...++.+..+..|+.+++.|+.|||   +.+.||||||+.|||+.+.|.+|++|||.|..+..   
T Consensus       106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            9994 5777777666567888888889999999999999   99999999999999999999999999999887542   


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                         ...++|||+||||
T Consensus       179 ---AnsFvGTPywMAP  191 (948)
T KOG0577|consen  179 ---ANSFVGTPYWMAP  191 (948)
T ss_pred             ---hhcccCCccccch
Confidence               3458999999999

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=2.4e-24  Score=217.18  Aligned_cols=148  Identities=27%  Similarity=0.459  Sum_probs=132.5

Q ss_pred             cccccccccccCCCceeehhh-----------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCe-eEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRA-----------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEF-KALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~-----------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lV  499 (596)
                      .++|...+++|+|+||.++-.                       .+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            468999999999999998642                       2356789999999999999999999999987 9999


Q ss_pred             EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          500 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+||++.+.+.+.. ..+++.+...+..|++.|+.|||   ..+|+|||+|+.||++..+..+|++|||+|+.+...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999998876 56899999999999999999999   999999999999999999999999999999998654


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      .+  ...+.+||+.||+|
T Consensus       160 ~~--~a~tvvGTp~YmcP  175 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCP  175 (426)
T ss_pred             hh--hhheecCCCcccCH
Confidence            32  34457899999998

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.90  E-value=7e-24  Score=220.31  Aligned_cols=127  Identities=24%  Similarity=0.384  Sum_probs=116.1

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        ..+..|+.++++++|++|+++++++.+++..|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            478899999999999999742                        24567999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            9999999999997654 5789999999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.90  E-value=5.1e-24  Score=218.87  Aligned_cols=144  Identities=26%  Similarity=0.384  Sum_probs=127.4

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|+..+.||+|+||.||+|.                         +.+..|+.+++.++|||||++++++.+++..|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4578999999999999999752                         235579999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++.... .+++..+..++.|++.|+.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999997654 5788999999999999999999   999999999999999999999999999999865321


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                           ....+||+.||||
T Consensus       185 -----~~~~~gt~~y~aP  197 (340)
T PTZ00426        185 -----TYTLCGTPEYIAP  197 (340)
T ss_pred             -----cceecCChhhcCH
Confidence                 2345799999998

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.90  E-value=6.8e-25  Score=204.58  Aligned_cols=146  Identities=26%  Similarity=0.388  Sum_probs=131.5

Q ss_pred             cccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          446 EFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      -|+++..+|+|+||.||||.                   +.+..|+.+|++++.|.+|++||.|.....+++|||||-.|
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            47788999999999999974                   56788999999999999999999999988999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccc
Q 036342          507 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  586 (596)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~  586 (596)
                      +..+.++.++..+.+.....+....++|++|||   ...-+|||||+.|||++.+|.+|++|||+|-.+.+.  -....+
T Consensus       114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNT  188 (502)
T KOG0574|consen  114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNT  188 (502)
T ss_pred             cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCc
Confidence            999999998888999999999999999999999   777899999999999999999999999999877532  222455


Q ss_pred             ccccccccCC
Q 036342          587 TLGTIGYMAP  596 (596)
Q Consensus       587 ~~gt~~y~aP  596 (596)
                      ..|||.||||
T Consensus       189 VIGTPFWMAP  198 (502)
T KOG0574|consen  189 VIGTPFWMAP  198 (502)
T ss_pred             cccCcccccH
Confidence            7899999998

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.5e-24  Score=206.24  Aligned_cols=149  Identities=29%  Similarity=0.371  Sum_probs=127.0

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-----C
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-----E  494 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~  494 (596)
                      ....|...+.||+|+||+|.+|.                       ++..+|+.+++.++|+|||.+.+.+..+     .
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            34566667999999999998742                       4556899999999999999999999762     3


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      .+|+|+|+| +-||.+.++..+ .++...+..++.|+++|++|+|   +.+|+|||+||+|++++.++..||+|||+|+.
T Consensus       100 DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence            589999999 459999998764 4788888889999999999999   99999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..........+..+.|.||+||
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAP  196 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAP  196 (359)
T ss_pred             ccccCcccchhcceeeeeecCH
Confidence            7543223345778999999998

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1e-23  Score=207.05  Aligned_cols=150  Identities=28%  Similarity=0.456  Sum_probs=127.3

Q ss_pred             ccccccccccCCCceeehhhH----------------HhHHHHHHHHhh--cCCCccceeeeeeccCC----eeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------KSFDVECEMMKS--IRHRNLIKVISSCSNEE----FKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~lV~e~  502 (596)
                      .+....+.||+|.||+|+||.                +.+.+|.++.+.  ++|+||..++++-..+.    .++||+||
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY  290 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY  290 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence            456778999999999999863                457788888885  59999999999875443    58999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-----cCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF-----GYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~-----~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      .+.|+|+||+...  .++....++++.-+|.||++||.     .-.+.|.|||||+.|||+.+++.+.|+|+|+|.....
T Consensus       291 He~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~  368 (513)
T KOG2052|consen  291 HEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  368 (513)
T ss_pred             ccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence            9999999999874  58889999999999999999994     2357899999999999999999999999999987654


Q ss_pred             CCC--ccccccccccccccCC
Q 036342          578 EDQ--SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~--~~~~~~~~gt~~y~aP  596 (596)
                      ..+  ....+..+||.+||||
T Consensus       369 ~t~~idi~~N~rVGTKRYMAP  389 (513)
T KOG2052|consen  369 DTDTIDIPPNPRVGTKRYMAP  389 (513)
T ss_pred             cCCcccCCCCCccceeeccCh
Confidence            322  2345678999999999

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.4e-24  Score=208.58  Aligned_cols=148  Identities=25%  Similarity=0.382  Sum_probs=131.2

Q ss_pred             hcccccccccccCCCceeehhh------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRA------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..+.|..-++||+||||.||-+                        ..-...|-+++++++.+.||.+--+|+.++.+++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            3456889999999999999842                        1234578899999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          499 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      |+..|.||||.-++...+ +.+++..+..++++|+.||++||   ...||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999988754 57899999999999999999999   99999999999999999999999999999998754


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .   ......+||.+||||
T Consensus       340 g---~~~~~rvGT~GYMAP  355 (591)
T KOG0986|consen  340 G---KPIRGRVGTVGYMAP  355 (591)
T ss_pred             C---CccccccCcccccCH
Confidence            3   234556999999999

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=7.8e-24  Score=217.14  Aligned_cols=145  Identities=28%  Similarity=0.410  Sum_probs=129.0

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .-|+..+.||+|+.|.|..|+                        ..+.+|+.+|+-+.|||++++|++|++...+|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            357788999999999998753                        24779999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|.|++++-.++ .+++.++.++..||..|+.|+|   ..+|+|||+||+|+|+|.++.+||+|||+|..-.+   
T Consensus        92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP---  164 (786)
T ss_pred             EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence            9999999999998875 6788999999999999999999   89999999999999999999999999999985322   


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                      ..-..+.||+|.|.||
T Consensus       165 gklLeTSCGSPHYA~P  180 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAP  180 (786)
T ss_pred             CccccccCCCcccCCc
Confidence            2234557999999998

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.90  E-value=2.6e-24  Score=186.60  Aligned_cols=146  Identities=27%  Similarity=0.404  Sum_probs=128.7

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|...+.||+|.||+|+||.                       ....+|+-+++.++|.|||++++....+....+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            467778999999999999974                       346799999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ||. .+|..+.....+.++...+..++.|+.+|+.|+|   ++++.|||+||.|.|++.+|+.|++|||+++..+-+.. 
T Consensus        82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr-  156 (292)
T KOG0662|consen   82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-  156 (292)
T ss_pred             Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence            994 5999999888888999999999999999999999   99999999999999999999999999999997653321 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ..+..+.|.||++|
T Consensus       157 -cysaevvtlwyrpp  170 (292)
T KOG0662|consen  157 -CYSAEVVTLWYRPP  170 (292)
T ss_pred             -eeeceeeeeeccCc
Confidence             23345678999987

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2e-24  Score=219.18  Aligned_cols=148  Identities=26%  Similarity=0.374  Sum_probs=131.5

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .+-|.+...+|.|+||.||||+                     .++..|++++..++||+||+|++.|..++.+++..||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            3457788889999999999974                     4688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      |.||-.+-.+-.-+..+.+.++..+++|++.||.|||   +..|||||+|+.|||+.-+|.++++|||++......  ..
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ  185 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence            9999998888777778999999999999999999999   999999999999999999999999999997654322  22


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ....+.|||+||||
T Consensus       186 kRDsFIGTPYWMAP  199 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAP  199 (1187)
T ss_pred             hhccccCCcccccc
Confidence            34458899999999

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.2e-23  Score=219.69  Aligned_cols=126  Identities=23%  Similarity=0.373  Sum_probs=114.7

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|...+.||+|+||.||++.                        +.+..|++++++++|||||++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            368889999999999999741                        24567999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+++.
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999997653 5788888899999999999999   99999999999999999999999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.90  E-value=1.2e-23  Score=219.83  Aligned_cols=125  Identities=22%  Similarity=0.356  Sum_probs=114.1

Q ss_pred             cccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          446 EFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .|+..+.||+|+||.||+|.                        +.+..|+.++++++|||||++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            58889999999999999752                        235679999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      |+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            999999999987654 5788888999999999999999   89999999999999999999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.90  E-value=1.5e-23  Score=212.36  Aligned_cols=149  Identities=24%  Similarity=0.432  Sum_probs=125.1

Q ss_pred             ccccccccccCCCceeehhhH--------------------------------------HhHHHHHHHHhhcCCCcccee
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------------------KSFDVECEMMKSIRHRNLIKV  486 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------------------~~~~~e~~~l~~l~H~niv~l  486 (596)
                      ++|...+.||+|+||.||++.                                      +.+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578888999999999998641                                      247789999999999999999


Q ss_pred             eeeeccCCeeEEEEecCCCCCHHHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEe
Q 036342          487 ISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------------CILDIFQRLNIMIDVASALEYLHFGYSALVIH  548 (596)
Q Consensus       487 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H  548 (596)
                      ++++...+..++||||+++|+|.+++....                  ..+++..+..++.|++.|+.|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999986532                  23577888999999999999999   889999


Q ss_pred             CCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          549 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       549 rdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||||+||++++++.+||+|||+++.+.............++..||||
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW  209 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence            999999999999999999999999865432211112234567889987

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.90  E-value=1.4e-23  Score=215.17  Aligned_cols=148  Identities=24%  Similarity=0.343  Sum_probs=128.5

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|...+.||+|+||.||++.                        ..+..|..++..++|++|+++++++..++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            478899999999999999742                        23567889999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++......+++..+..++.|++.|++|+|   .++|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875556889999999999999999999   99999999999999999999999999999987643221


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                       ......+||+.||||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (331)
T cd05624         158 -VQSSVAVGTPDYISP  172 (331)
T ss_pred             -eeeccccCCcccCCH
Confidence             122345799999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.90  E-value=9.5e-24  Score=216.23  Aligned_cols=144  Identities=26%  Similarity=0.367  Sum_probs=127.4

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||.||+|.                        +.+.+|+.++++++||||+++++++..++..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            3578999999999999999752                        2466899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++..... 
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            99999999999997654 5788888899999999999999   899999999999999999999999999999875322 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                          ....+||+.|+||
T Consensus       172 ----~~~~~gt~~y~aP  184 (329)
T PTZ00263        172 ----TFTLCGTPEYLAP  184 (329)
T ss_pred             ----cceecCChhhcCH
Confidence                1235799999998

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.5e-23  Score=214.99  Aligned_cols=148  Identities=26%  Similarity=0.347  Sum_probs=128.3

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        +.+..|..+++.++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            478899999999999999742                        23667899999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++......+++..+..++.|++.|++|||   .++|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999775556889999999999999999999   99999999999999999999999999999876543221


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                       ......+||+.||||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (331)
T cd05597         158 -VQSNVAVGTPDYISP  172 (331)
T ss_pred             -ccccceeccccccCH
Confidence             122335699999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.1e-23  Score=219.12  Aligned_cols=127  Identities=26%  Similarity=0.423  Sum_probs=116.1

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        +.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            478899999999999999742                        23567999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+++.+
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999997654 5789999999999999999999   899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=7.6e-24  Score=213.14  Aligned_cols=143  Identities=31%  Similarity=0.471  Sum_probs=126.4

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        +.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            468889999999999999752                        23567999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999997654 5788899999999999999999   999999999999999999999999999999865321  


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                         ....+||+.|+||
T Consensus       155 ---~~~~~gt~~y~aP  167 (291)
T cd05612         155 ---TWTLCGTPEYLAP  167 (291)
T ss_pred             ---cccccCChhhcCH
Confidence               1235789999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.90  E-value=1.5e-23  Score=211.00  Aligned_cols=128  Identities=26%  Similarity=0.405  Sum_probs=118.3

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..++|+.+.+||+|+||.||.|.                        +..+.|-.+|...++|.||+|+..|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            57899999999999999999752                        345678889999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ||||++|||+...|...+ .+++..+..++++.+.|+..+|   ..++|||||||+|+|||..|++|++|||++.-
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccch
Confidence            999999999999998875 6888899999999999999999   99999999999999999999999999999864

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.90  E-value=1.6e-23  Score=217.91  Aligned_cols=153  Identities=25%  Similarity=0.362  Sum_probs=130.9

Q ss_pred             HHHHHhcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccC
Q 036342          438 LELCRATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE  493 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~  493 (596)
                      .++....++|+..+.||+|+||.||++.                        +.+..|+.+++.++||||+++++++..+
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            3444556899999999999999999742                        2355789999999999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      +..|+||||+++|+|.+++...  .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999999998764  4778888899999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+.... .......+||+.||||
T Consensus       191 ~~~~~~-~~~~~~~~gt~~y~aP  212 (371)
T cd05622         191 KMNKEG-MVRCDTAVGTPDYISP  212 (371)
T ss_pred             EcCcCC-cccccCcccCccccCH
Confidence            764321 1122346799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.89  E-value=1.9e-23  Score=218.18  Aligned_cols=125  Identities=22%  Similarity=0.372  Sum_probs=114.2

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        +.+.+|+.++++++|+||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            368899999999999999742                        23567999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|.
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            9999999999997654 5788888889999999999999   8999999999999999999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.89  E-value=3.1e-23  Score=211.95  Aligned_cols=140  Identities=28%  Similarity=0.348  Sum_probs=121.2

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      +.||+|+||.||++.                        ..+..|+.++++++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            468999999999742                        23567899999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccc
Q 036342          507 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  586 (596)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~  586 (596)
                      +|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccc
Confidence            9999987654 6789999999999999999999   899999999999999999999999999998854222  112334


Q ss_pred             ccccccccCC
Q 036342          587 TLGTIGYMAP  596 (596)
Q Consensus       587 ~~gt~~y~aP  596 (596)
                      .+||+.|+||
T Consensus       155 ~~gt~~y~aP  164 (323)
T cd05571         155 FCGTPEYLAP  164 (323)
T ss_pred             eecCccccCh
Confidence            6799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.89  E-value=2.2e-23  Score=218.23  Aligned_cols=125  Identities=22%  Similarity=0.350  Sum_probs=113.9

Q ss_pred             cccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          446 EFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .|+..+.||+|+||.||+|.                        +.+..|+.++++++|||||++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            58889999999999999852                        245679999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ||++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999987653 5788888999999999999999   89999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.89  E-value=1.4e-23  Score=218.30  Aligned_cols=148  Identities=25%  Similarity=0.382  Sum_probs=127.8

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..++|+..+.||+|+||.||++.                        +.+..|+.+++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            45689999999999999999742                        235679999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++...  .+++..+..++.|++.|+.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999998764  4678888889999999999999   899999999999999999999999999999865432


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      .. ......+||+.||||
T Consensus       196 ~~-~~~~~~~gt~~y~aP  212 (370)
T cd05596         196 GM-VRCDTAVGTPDYISP  212 (370)
T ss_pred             Cc-ccCCCCCCCcCeECH
Confidence            11 122346799999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.89  E-value=2.5e-23  Score=223.47  Aligned_cols=148  Identities=22%  Similarity=0.297  Sum_probs=127.8

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      .|...+.||+|+||.||+|.                      ..+..|+.++++++|||||++++++..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            48889999999999999752                      24567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          504 PHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       504 ~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ++|+|.++++..   ...+++..+..++.|++.|+.|+|   .++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988642   235788899999999999999999   89999999999999999999999999999987643322


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                      .......+||++|+||
T Consensus       225 ~~~~~~~~gt~~y~aP  240 (478)
T PTZ00267        225 LDVASSFCGTPYYLAP  240 (478)
T ss_pred             cccccccCCCccccCH
Confidence            2223446799999998

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.89  E-value=2.5e-23  Score=213.38  Aligned_cols=148  Identities=26%  Similarity=0.367  Sum_probs=129.1

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        +.+..|+.+++.++|+||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            468899999999999999742                        24667899999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++......+++..+..++.|++.|+.|+|   ..+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999876557899999999999999999999   99999999999999999999999999999987643221


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                       .......||+.|+||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (330)
T cd05601         158 -VNSKLPVGTPDYIAP  172 (330)
T ss_pred             -eeeecccCCccccCH
Confidence             122335789999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-25  Score=215.97  Aligned_cols=280  Identities=23%  Similarity=0.222  Sum_probs=179.1

Q ss_pred             CCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCC-CcCcCCCCCccccccCCCCCC
Q 036342           59 PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE-NYLTSSTPELSFLSSLSNCKS  137 (596)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~~~~~~l~~  137 (596)
                      +.-..++|..|+|+.+.|.+|..+++|+.||||+|+|+-+.|++|.+|.+|.+|-+-+ |+|+.++.+     .|.++.+
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~-----~F~gL~s  141 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKG-----AFGGLSS  141 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhh-----HhhhHHH
Confidence            3556666666666666666666666666666666666666666666666665555444 666666554     4666666


Q ss_pred             CCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcc------------cCCCCcc
Q 036342          138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKL------------NGSIPIT  205 (596)
Q Consensus       138 L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l------------~~~~p~~  205 (596)
                      |+.|.+.-|++.-+. ...+..+ +++..|.+.+|.+..+--.+|..+.+++.+.+..|.+            ....|..
T Consensus       142 lqrLllNan~i~Cir-~~al~dL-~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ie  219 (498)
T KOG4237|consen  142 LQRLLLNANHINCIR-QDALRDL-PSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIE  219 (498)
T ss_pred             HHHHhcChhhhcchh-HHHHHHh-hhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhh
Confidence            666666666665432 2355555 4566666666666655455677777777777766662            2234555


Q ss_pred             ccCCCCCCeEEccCCcccccCccchhc-CCCCcE-EEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCc-ccccccc
Q 036342          206 LGKLRKLQRLNLEDNILEGSIPDDICR-LAELYR-LELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKD  282 (596)
Q Consensus       206 ~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~  282 (596)
                      +++........|.++++...-+..|.. +.++.. +....+........+|..+++|+.|+|++|.++.|.+ +|..+.+
T Consensus       220 tsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~  299 (498)
T KOG4237|consen  220 TSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAE  299 (498)
T ss_pred             cccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhh
Confidence            666666666666666665333333322 222221 2222223333334577888888888888888888644 5667788


Q ss_pred             cceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccC
Q 036342          283 ILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEI  346 (596)
Q Consensus       283 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~  346 (596)
                      +++|.|..|+|..+....|.++..|++|+|.+|+|+.+.|. +|+.+.+|.+|+|-.|++.+.+
T Consensus       300 l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~-aF~~~~~l~~l~l~~Np~~CnC  362 (498)
T KOG4237|consen  300 LQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG-AFQTLFSLSTLNLLSNPFNCNC  362 (498)
T ss_pred             hhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc-cccccceeeeeehccCcccCcc
Confidence            88888888888777777888888888888888888865555 6777778888888888776543

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.89  E-value=2.9e-23  Score=212.99  Aligned_cols=148  Identities=23%  Similarity=0.334  Sum_probs=128.1

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        +.+..|+.++..++|++|+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            468889999999999999742                        23667888999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++......+++..+..++.|++.|+.|+|   ..+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence            999999999999875556889899999999999999999   8999999999999999999999999999987653222 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                      .......+||+.||||
T Consensus       157 ~~~~~~~~gt~~y~aP  172 (332)
T cd05623         157 TVQSSVAVGTPDYISP  172 (332)
T ss_pred             cceecccccCccccCH
Confidence            1122345799999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=2.4e-23  Score=213.71  Aligned_cols=143  Identities=27%  Similarity=0.456  Sum_probs=126.6

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||+|.                        +.+..|++++++++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            368899999999999999752                        23567999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999997654 5788899999999999999999   89999999999999999999999999999986532   


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        .....+||+.|+||
T Consensus       154 --~~~~~~gt~~y~aP  167 (333)
T cd05600         154 --YANSVVGSPDYMAP  167 (333)
T ss_pred             --ccCCcccCccccCh
Confidence              22345799999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-23  Score=216.46  Aligned_cols=145  Identities=30%  Similarity=0.479  Sum_probs=123.6

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC------eeE
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE------FKA  497 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~  497 (596)
                      .|...+.||+|+||.||++.                      ....+|++++++++|+|||++++.-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            35667899999999999963                      24557999999999999999999876544      467


Q ss_pred             EEEecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC--C--CCcEEEecccc
Q 036342          498 LVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD--D--NMVAHLSDFSI  571 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~--~--~~~~kl~dfGl  571 (596)
                      +|||||++|||+..+....  .++++.+.+.+..+++.|+.|||   ..+|+||||||.||++.  .  ....||+|||+
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999998643  67999999999999999999999   99999999999999994  2  33689999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+.+.+..   ......||+.|.+|
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhP  192 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHP  192 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcCh
Confidence            99875432   34567899999998

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.89  E-value=2.7e-23  Score=212.58  Aligned_cols=145  Identities=26%  Similarity=0.415  Sum_probs=129.5

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l  498 (596)
                      ...|+..+.||+|.||+||++.                        ....+|+++|+++. |||||+++++|+.....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            4578888999999999999742                        36789999999999 9999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC----CcEEEeccccccc
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN----MVAHLSDFSIAKL  574 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~----~~~kl~dfGla~~  574 (596)
                      |||+|.||+|++.+...  .+++..+..++.|++.|++|||   ..+|+|||+||+|+|+...    +.+|++|||++..
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            99999999999999877  3889999999999999999999   8999999999999999643    5899999999998


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...   .......+||++|+||
T Consensus       189 ~~~---~~~~~~~~Gtp~y~AP  207 (382)
T KOG0032|consen  189 IKP---GERLHTIVGTPEYVAP  207 (382)
T ss_pred             ccC---CceEeeecCCccccCc
Confidence            754   2235668999999998

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.89  E-value=3.3e-23  Score=208.24  Aligned_cols=146  Identities=23%  Similarity=0.443  Sum_probs=126.4

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|+||.||+|.                      ..+.+|+.++++++||||+++++++..++..|+||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            578999999999999999852                      2456899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++ +|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.......  
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence            974 999998776656788899999999999999999   89999999999999999999999999999876432211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......||+.|+||
T Consensus       159 ~~~~~~~~~~y~aP  172 (288)
T cd07871         159 TYSNEVVTLWYRPP  172 (288)
T ss_pred             cccCceecccccCh
Confidence            22335689999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=230.45  Aligned_cols=150  Identities=27%  Similarity=0.470  Sum_probs=130.7

Q ss_pred             cccccccccccCCCceeehhh---------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRA---------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~---------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      ..+.+..+.||+|.||.||+|                           +.+|.+|+.+|++++|||||+++|+|.+.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            345567799999999999985                           25789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccc
Q 036342          497 ALVLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS  570 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfG  570 (596)
                      ++++|||++|||..|+++.      ...+...+.+.++.+||+|+.||+   ++++|||||.++|+|++....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999987      456888999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCC
Q 036342          571 IAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|+.+...+.+.......-..+||||
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~P  873 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPP  873 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCH
Confidence            99966544443332223445789998

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.89  E-value=4.7e-23  Score=206.74  Aligned_cols=144  Identities=26%  Similarity=0.413  Sum_probs=124.8

Q ss_pred             ccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          447 FSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      |+..+.||+|+||.||++.                        ..+.+|+.++++++|++|+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            6778999999999999742                        1356799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++|+|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            99999998876533 35789999999999999999999   9999999999999999999999999999998653221  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......||+.||||
T Consensus       157 -~~~~~~g~~~y~aP  170 (285)
T cd05631         157 -TVRGRVGTVGYMAP  170 (285)
T ss_pred             -eecCCCCCCCccCH
Confidence             22345789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.89  E-value=2.6e-23  Score=216.71  Aligned_cols=153  Identities=22%  Similarity=0.390  Sum_probs=126.5

Q ss_pred             HHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeecc
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCSN  492 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~  492 (596)
                      ....++|+..+.||+|+||.||+|.                           +.+.+|+.+++.+ +|||||+++++|..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            3345678999999999999998641                           2466899999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC--------------------------------------------------------
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSN--------------------------------------------------------  516 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~--------------------------------------------------------  516 (596)
                      ++..++|||||++|+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999999986431                                                        


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          517 ------------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       517 ------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                                        ..+++..+..++.|+++|+.|||   ..+|+||||||+||++++++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                              13678889999999999999999   899999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      ..........++..|+||
T Consensus       268 ~~~~~~~~~~~~~~y~aP  285 (375)
T cd05104         268 SNYVVKGNARLPVKWMAP  285 (375)
T ss_pred             ccccccCCCCCCcceeCh
Confidence            221112223456779998

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=5.3e-23  Score=209.14  Aligned_cols=138  Identities=29%  Similarity=0.355  Sum_probs=120.1

Q ss_pred             ccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          453 IGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       453 ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      ||+|+||.||++.                        ..+..|+.++++++|||||++++++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            6999999999742                        2356799999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccccc
Q 036342          509 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  588 (596)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~  588 (596)
                      .+++.... .+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+++......  ......+
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99997654 5789999999999999999999   8999999999999999999999999999988643221  1233467


Q ss_pred             ccccccCC
Q 036342          589 GTIGYMAP  596 (596)
Q Consensus       589 gt~~y~aP  596 (596)
                      ||+.|+||
T Consensus       155 gt~~y~aP  162 (312)
T cd05585         155 GTPEYLAP  162 (312)
T ss_pred             CCcccCCH
Confidence            99999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.89  E-value=5.1e-23  Score=213.62  Aligned_cols=127  Identities=25%  Similarity=0.394  Sum_probs=115.5

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        ..+..|+.++.+++||+|+++++++.+++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            468889999999999999741                        24567899999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9999999999987654 5788899999999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.89  E-value=6.1e-23  Score=210.12  Aligned_cols=140  Identities=28%  Similarity=0.369  Sum_probs=121.0

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      +.||+|+||.||++.                        ..+.+|+.++++++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            468999999999741                        24567899999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccc
Q 036342          507 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  586 (596)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~  586 (596)
                      +|.+++.... .+++.++..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            9999887653 5789999999999999999999   8999999999999999999999999999987542211  12234


Q ss_pred             ccccccccCC
Q 036342          587 TLGTIGYMAP  596 (596)
Q Consensus       587 ~~gt~~y~aP  596 (596)
                      .+||+.|+||
T Consensus       155 ~~gt~~y~aP  164 (328)
T cd05593         155 FCGTPEYLAP  164 (328)
T ss_pred             ccCCcCccCh
Confidence            5799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=3.2e-23  Score=212.21  Aligned_cols=143  Identities=26%  Similarity=0.451  Sum_probs=123.9

Q ss_pred             cccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe--eEEEE
Q 036342          448 SENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF--KALVL  500 (596)
Q Consensus       448 ~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lV~  500 (596)
                      .....||+|+|-+||||+                         ++|..|+.+|+.++|||||++|.+|.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            345789999999999963                         467889999999999999999999987664  67899


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEeccccccccCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfGla~~~~~~~  579 (596)
                      |.+..|+|.+|.++.+ ..+......+++||++||.||| .+.++|+|||||.+||+++. .|.+||+|+|+|..+....
T Consensus       123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLH-s~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLH-SQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhh-cCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999998875 5678889999999999999999 45789999999999999975 6899999999999874321


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                          .....|||.||||
T Consensus       201 ----aksvIGTPEFMAP  213 (632)
T KOG0584|consen  201 ----AKSVIGTPEFMAP  213 (632)
T ss_pred             ----cceeccCccccCh
Confidence                2336899999999

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.89  E-value=6.4e-23  Score=209.55  Aligned_cols=140  Identities=27%  Similarity=0.353  Sum_probs=120.6

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      +.||+|+||.||++.                        ..+..|+.++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            468999999999742                        23457999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccc
Q 036342          507 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  586 (596)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~  586 (596)
                      +|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9998887654 5789999999999999999999   8999999999999999999999999999987532211  12234


Q ss_pred             ccccccccCC
Q 036342          587 TLGTIGYMAP  596 (596)
Q Consensus       587 ~~gt~~y~aP  596 (596)
                      ..||+.|+||
T Consensus       155 ~~gt~~y~aP  164 (323)
T cd05595         155 FCGTPEYLAP  164 (323)
T ss_pred             ccCCcCcCCc
Confidence            5799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.89  E-value=6.5e-23  Score=207.66  Aligned_cols=147  Identities=24%  Similarity=0.386  Sum_probs=127.0

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .++|+..+.||+|+||.||+|.                      ..+.+|+.++++++||||+++++++..++..|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4689999999999999999852                      235689999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |++ +++.+++......+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            995 6898888776566888899999999999999999   9999999999999999999999999999987543221  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......||+.|+||
T Consensus       158 ~~~~~~~~~~~y~aP  172 (303)
T cd07869         158 HTYSNEVVTLWYRPP  172 (303)
T ss_pred             ccCCCCcccCCCCCh
Confidence            122345689999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=5.8e-23  Score=226.00  Aligned_cols=247  Identities=23%  Similarity=0.397  Sum_probs=156.7

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEE
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLS   89 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (596)
                      .+.++|++++++++ .+|..+  ..+|+.|+|++|+|+ .+|...   .++|+.|++++|+++ .+|..+.  .+|+.|+
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~I--p~~L~~L~Ls~N~Lt-sLP~~l---~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~  247 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACI--PEQITTLILDNNELK-SLPENL---QGNIKTLYANSNQLT-SIPATLP--DTIQEME  247 (754)
T ss_pred             cCceEEEeCCCCcC-cCCccc--ccCCcEEEecCCCCC-cCChhh---ccCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence            45677888888877 456544  347888888888887 344422   247888888888887 4565543  3688888


Q ss_pred             ccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEc
Q 036342           90 LGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM  169 (596)
Q Consensus        90 L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l  169 (596)
                      |++|+|.. +|..+.  .+|+.|++++|+++.++..      +.  ++|+.|++++|+|+++ |.    .++++|+.|++
T Consensus       248 Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~~LP~~------l~--~sL~~L~Ls~N~Lt~L-P~----~lp~sL~~L~L  311 (754)
T PRK15370        248 LSINRITE-LPERLP--SALQSLDLFHNKISCLPEN------LP--EELRYLSVYDNSIRTL-PA----HLPSGITHLNV  311 (754)
T ss_pred             CcCCccCc-CChhHh--CCCCEEECcCCccCccccc------cC--CCCcEEECCCCccccC-cc----cchhhHHHHHh
Confidence            88888874 444443  4678888888877765432      21  4677888888877753 32    12346777777


Q ss_pred             cccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCccc
Q 036342          170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS  249 (596)
Q Consensus       170 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  249 (596)
                      ++|.++.. |..+.  ++|+.|++++|.+++ +|..+  .++|+.|++++|+|+ .+|..+.  ++|+.|++++|+|+. 
T Consensus       312 s~N~Lt~L-P~~l~--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-  381 (754)
T PRK15370        312 QSNSLTAL-PETLP--PGLKTLEAGENALTS-LPASL--PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-  381 (754)
T ss_pred             cCCccccC-Ccccc--ccceeccccCCcccc-CChhh--cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-
Confidence            77777743 43322  567777777777764 44433  256777777777776 4555442  467777777777763 


Q ss_pred             chhhhccCCCCcEEEeCCCcccCCCccccc----ccccceEEcccCCCC
Q 036342          250 IPACFGNLASLRILSLGSNKLTSIPLTFWN----LKDILQLNFSSNFLT  294 (596)
Q Consensus       250 ~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~----l~~L~~L~ls~N~l~  294 (596)
                      +|..+.  .+|+.|++++|+|+.+|..+..    ++++..|++.+|+++
T Consensus       382 LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        382 LPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            344333  2567777777777766654332    355666666666665

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.89  E-value=3.8e-23  Score=215.27  Aligned_cols=153  Identities=24%  Similarity=0.428  Sum_probs=126.2

Q ss_pred             HHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeecc
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCSN  492 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~  492 (596)
                      ....++|+..+.||+|+||.||++.                           ..+.+|+.+++++ +|+|||+++++|..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            3455689999999999999998531                           2466899999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC--------------------------------------------------------
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSN--------------------------------------------------------  516 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~--------------------------------------------------------  516 (596)
                      .+..|+|||||++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999986421                                                        


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          517 -------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       517 -------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                                   ..+++.++..++.|+++|+.|||   .++|+||||||+||++++++.+||+|||+++.+........
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                         13677888999999999999999   89999999999999999999999999999986543221111


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....+++.||||
T Consensus       271 ~~~~~~~~~y~aP  283 (374)
T cd05106         271 KGNARLPVKWMAP  283 (374)
T ss_pred             ccCCCCccceeCH
Confidence            1223456789998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.89  E-value=1.1e-22  Score=208.00  Aligned_cols=140  Identities=28%  Similarity=0.345  Sum_probs=119.7

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      +.||+|+||.||++.                        ..+..|++++++++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            468999999999641                        23457889999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          507 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      +|.+++.... .+++..+..++.|++.|+.|||   + .+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence            9999887654 5789999999999999999999   7 689999999999999999999999999987542221  1223


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05594         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCCcccCCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.89  E-value=6.4e-23  Score=210.54  Aligned_cols=146  Identities=24%  Similarity=0.338  Sum_probs=124.9

Q ss_pred             cccccccccCCCceeehhhH----------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCee
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  496 (596)
                      +|+..+.||+|+||.||++.                            +.+..|+.+++++ +|++|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            47888999999999999531                            2356789999999 599999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ++||||+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999987654 5788999999999999999999   8999999999999999999999999999998653


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .... ......+||+.||||
T Consensus       157 ~~~~-~~~~~~~gt~~y~aP  175 (332)
T cd05614         157 SEEK-ERTYSFCGTIEYMAP  175 (332)
T ss_pred             ccCC-CccccccCCccccCH
Confidence            2221 122345799999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.88  E-value=1.7e-23  Score=210.30  Aligned_cols=151  Identities=25%  Similarity=0.407  Sum_probs=129.2

Q ss_pred             HHHHhcccccccccccCCCceeehhhH--------Hh----HHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAF--------KS----FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~--------~~----~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      .|+..-+...+++.+|+|+.|.||+|.        +.    -..+++-|++++|||||.+.|+|......|||||||+.|
T Consensus       118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  118 LWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            334444455667899999999999852        22    246889999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccc
Q 036342          507 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  586 (596)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~  586 (596)
                      -|...++..+ .+.....+.+..+||.|+.|||   ...|||||+|+-||||..+-.+||+|||-++...+.   .....
T Consensus       198 qL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS  270 (904)
T KOG4721|consen  198 QLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS  270 (904)
T ss_pred             cHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence            9999999876 4566777889999999999999   899999999999999999999999999999976432   23456


Q ss_pred             ccccccccCC
Q 036342          587 TLGTIGYMAP  596 (596)
Q Consensus       587 ~~gt~~y~aP  596 (596)
                      ++||..||||
T Consensus       271 FaGTVaWMAP  280 (904)
T KOG4721|consen  271 FAGTVAWMAP  280 (904)
T ss_pred             hhhhHhhhCH
Confidence            8999999998

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.88  E-value=8.7e-23  Score=208.60  Aligned_cols=140  Identities=29%  Similarity=0.418  Sum_probs=120.3

Q ss_pred             ccccCCCceeehhhH----------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          451 NLIGRGGFALFIRAF----------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +.||+|+||.||++.                            ..+..|+.++++++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            679999999999631                            1345799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++|+|.+++.... .+.+..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence            99999999987654 5678888889999999999999   8999999999999999999999999999987543221  1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      .....+||+.|+||
T Consensus       156 ~~~~~~gt~~y~aP  169 (323)
T cd05584         156 VTHTFCGTIEYMAP  169 (323)
T ss_pred             cccccCCCccccCh
Confidence            22345799999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.88  E-value=8.5e-23  Score=202.74  Aligned_cols=149  Identities=21%  Similarity=0.356  Sum_probs=126.2

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..+|+..+.||+|+||.||+|.                         ..+..|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            3578899999999999998751                         246789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++......+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999876557889999999999999999999   899999999999999999999999999987653221


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      . ........++..|+||
T Consensus       161 ~-~~~~~~~~~~~~y~aP  177 (266)
T cd05064         161 A-IYTTMSGKSPVLWAAP  177 (266)
T ss_pred             c-hhcccCCCCceeecCH
Confidence            1 1111123456788887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=8.4e-23  Score=216.28  Aligned_cols=149  Identities=22%  Similarity=0.265  Sum_probs=129.0

Q ss_pred             cccccccccccCCCceeehhhH---------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      ...|.+.+.||+|+||.||++.               ..+.+|++++++++|+|||++++++..++..++||||+. |+|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L  246 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL  246 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence            3478999999999999999863               245689999999999999999999999999999999994 799


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccccc
Q 036342          509 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  588 (596)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~  588 (596)
                      .+++......+++.++..++.|+++||.|||   ..+|+||||||+|||++.++.+||+|||+++...............
T Consensus       247 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  323 (461)
T PHA03211        247 YTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA  323 (461)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence            9998776557899999999999999999999   8999999999999999999999999999998754332222223457


Q ss_pred             ccccccCC
Q 036342          589 GTIGYMAP  596 (596)
Q Consensus       589 gt~~y~aP  596 (596)
                      ||+.||||
T Consensus       324 GT~~Y~AP  331 (461)
T PHA03211        324 GTVDTNAP  331 (461)
T ss_pred             CCcCCcCH
Confidence            99999998

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.88  E-value=3.2e-23  Score=194.59  Aligned_cols=151  Identities=25%  Similarity=0.386  Sum_probs=127.4

Q ss_pred             HhcccccccccccCCCceeehhhH--------------H-------------hHHHHHHHHhhcCCCccceeeeeecc-C
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF--------------K-------------SFDVECEMMKSIRHRNLIKVISSCSN-E  493 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~--------------~-------------~~~~e~~~l~~l~H~niv~l~~~~~~-~  493 (596)
                      +....|+....||+|.||.||||+              +             ..-+|+.+++.++|||+|.|..++.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            345578899999999999999973              1             23478999999999999999999987 7


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC----CcEE
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN----MVAH  565 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~----~~~k  565 (596)
                      ..+++++||++. ||.+.++-..    ..++...+..|++||..|+.|||   +.=|+|||+||.|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence            789999999988 9988886532    35777888999999999999999   8889999999999999877    9999


Q ss_pred             EeccccccccCCCCCcc-ccccccccccccCC
Q 036342          566 LSDFSIAKLLTGEDQSM-TQTQTLGTIGYMAP  596 (596)
Q Consensus       566 l~dfGla~~~~~~~~~~-~~~~~~gt~~y~aP  596 (596)
                      |+|||++|.+..+-... .....+.|.||+||
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAP  208 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAP  208 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecCh
Confidence            99999999876543322 23456789999998

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.88  E-value=1.1e-22  Score=212.89  Aligned_cols=152  Identities=24%  Similarity=0.430  Sum_probs=126.6

Q ss_pred             HhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcC-CCccceeeeeeccC
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIR-HRNLIKVISSCSNE  493 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~  493 (596)
                      ...++|...+.||+|+||.||+|.                           +.+.+|+++++++. |||||+++++|...
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            345688899999999999998641                           34678999999996 99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------------------------------------------------
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSN---------------------------------------------------------  516 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~---------------------------------------------------------  516 (596)
                      +..|+|||||++|+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999999886421                                                         


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee
Q 036342          517 --------------------------------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL  558 (596)
Q Consensus       517 --------------------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl  558 (596)
                                                            ..+++.++..++.|+++|+.|||   ..+|+||||||+||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEE
Confidence                                                  13677788899999999999999   8999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          559 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       559 ~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++++.+|++|||+++...............+++.||||
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  308 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP  308 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence            99999999999999865432222222234567889998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=1.1e-22  Score=212.75  Aligned_cols=147  Identities=24%  Similarity=0.326  Sum_probs=126.4

Q ss_pred             cccccccccccCCCceeehhhH---------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      ..+|+..+.||+|+||.||++.               +.+.+|++++++++|||||++++++..++..++|+||+. ++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L  169 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL  169 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence            3579999999999999999853               346789999999999999999999999999999999995 699


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccccc
Q 036342          509 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  588 (596)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~  588 (596)
                      .+++.... .+++..+..++.|++.||.|+|   ..+|+||||||+||+++.++.+||+|||+|+....... ......+
T Consensus       170 ~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~  244 (391)
T PHA03212        170 YCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWA  244 (391)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccccccc
Confidence            98887653 5789999999999999999999   88999999999999999999999999999975432211 1223457


Q ss_pred             ccccccCC
Q 036342          589 GTIGYMAP  596 (596)
Q Consensus       589 gt~~y~aP  596 (596)
                      ||+.|+||
T Consensus       245 gt~~y~aP  252 (391)
T PHA03212        245 GTIATNAP  252 (391)
T ss_pred             CccCCCCh
Confidence            99999998

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.88  E-value=1.2e-22  Score=207.01  Aligned_cols=148  Identities=24%  Similarity=0.419  Sum_probs=125.4

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .+|+..+.||+|+||.||+|.                          +.+..|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            478999999999999999752                          3466789999999999999999999775 4689


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      |+||+++|+|.+++......+++...+.++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999886666889999999999999999999   899999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      ..........++..|+||
T Consensus       163 ~~~~~~~~~~~~~~y~ap  180 (316)
T cd05108         163 EKEYHAEGGKVPIKWMAL  180 (316)
T ss_pred             CcceeccCCccceeecCh
Confidence            222112223456789887

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.88  E-value=1e-22  Score=198.62  Aligned_cols=129  Identities=26%  Similarity=0.338  Sum_probs=116.9

Q ss_pred             cccccccccccCCCceeehhh------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRA------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .+.|+..+.||.|..|.||.+                        ..+...|.+||+.++||.++.||+.|+.++..|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            457888899999999999963                        13566799999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          500 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ||||+||+|+...+++. ..+++..+..++++|+-||+|||   ..+||+||+||+|||+.++|++.++||.++...
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999999988765 46888889999999999999999   999999999999999999999999999886643

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.88  E-value=7.1e-23  Score=209.51  Aligned_cols=147  Identities=31%  Similarity=0.453  Sum_probs=130.9

Q ss_pred             hcccccccccccCCCceeehhh-----------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRA-----------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~-----------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ....|.+...||+|.|++|..|                       .+.+.+|+++|+.++|||||+++.+.+.+..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4567899999999999999764                       24578999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+.+|.+++++.+.+... +..+..+..|+.+|++|||   ++.|+|||+|++|||++.++.+||+|||++..+..  
T Consensus       134 ~eya~~ge~~~yl~~~gr~~-e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMK-EKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--  207 (596)
T ss_pred             EEeccCchhHHHHHhcccch-hhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc--
Confidence            99999999999999876443 4778889999999999999   99999999999999999999999999999998752  


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                       .......||++.|.||
T Consensus       208 -~~~lqt~cgsppyAaP  223 (596)
T KOG0586|consen  208 -GLMLQTFCGSPPYAAP  223 (596)
T ss_pred             -cccccccCCCCCccCh
Confidence             2234568999999998

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=8.4e-23  Score=211.26  Aligned_cols=128  Identities=28%  Similarity=0.427  Sum_probs=117.1

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|...+.||+|+||.||+|.                        +.+..|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            368899999999999999752                        24667999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ||+++|+|.+++... ..+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            999999999999876 46889999999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.88  E-value=2.1e-22  Score=206.50  Aligned_cols=145  Identities=22%  Similarity=0.347  Sum_probs=127.2

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .++|+..+.||+|+||.||++.                      +.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            4689999999999999999742                      357889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~-~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |+++|+|.+++.... .+++..+..++.|++.|+.|||   +. +|+||||||+||+++.++.+||+|||+++.....  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999997654 5788899999999999999999   64 5999999999999999999999999998865322  


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......||+.|+||
T Consensus       158 --~~~~~~g~~~y~aP  171 (331)
T cd06649         158 --MANSFVGTRSYMSP  171 (331)
T ss_pred             --ccccCCCCcCcCCH
Confidence              12335789999998

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.88  E-value=2e-22  Score=200.32  Aligned_cols=143  Identities=27%  Similarity=0.384  Sum_probs=118.1

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      +.||+|+||+||+|.                        ..+.+|+.+++.++|+||+++++++...+..|+||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999751                        24678999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          507 SLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       507 ~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +|.+++....    ...++.....++.|++.|++|||   +.+|+||||||+||++++++.+|++|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999997643    22457778899999999999999   8999999999999999999999999999987543221111


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......+++.|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (269)
T cd05042         158 TKDCHAVPLRWLAP  171 (269)
T ss_pred             ccCCCCCcccccCH
Confidence            12234566778887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.88  E-value=1.8e-22  Score=205.79  Aligned_cols=140  Identities=26%  Similarity=0.388  Sum_probs=120.9

Q ss_pred             ccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          451 NLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      +.||+|+||.||++.                          ..+..|++++++++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            579999999999531                          234579999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +|+|.+++.... .+++..+..++.|+++|+.|||   ..+|+||||||+||++++++.+||+|||+++......  ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            999999987653 5789999999999999999999   8999999999999999999999999999988653221  122


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....||+.|+||
T Consensus       156 ~~~~g~~~y~aP  167 (318)
T cd05582         156 YSFCGTVEYMAP  167 (318)
T ss_pred             ecccCChhhcCH
Confidence            345799999998

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=8.5e-24  Score=207.72  Aligned_cols=146  Identities=32%  Similarity=0.450  Sum_probs=129.6

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ..|...+.||+|+||.||||.                      .++.+|+.++..++++||.+.|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            357778999999999999973                      4577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      |.||++.+.++... .+++....-+++++..|+.|+|   ..+.+|||||+.||++..+|.+|++|||++..+.....  
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            99999999998765 3477777778999999999999   99999999999999999999999999999988754332  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ...+++|||.||||
T Consensus       167 rr~tfvGTPfwMAP  180 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAP  180 (467)
T ss_pred             ccccccccccccch
Confidence            23678999999999

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.88  E-value=2.5e-22  Score=205.70  Aligned_cols=140  Identities=26%  Similarity=0.321  Sum_probs=119.9

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||++.                        +.+..|..+++++ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            468999999999742                        2355788888888 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            99999887653 6889999999999999999999   9999999999999999999999999999987532211  1233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (329)
T cd05588         155 TFCGTPNYIAP  165 (329)
T ss_pred             cccCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.88  E-value=2.9e-22  Score=198.82  Aligned_cols=150  Identities=26%  Similarity=0.443  Sum_probs=128.1

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|+..+.||+|+||+||+|.                         +.+..|+.++++++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578899999999999999741                         346779999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++......+++.++..++.|++.|+.|||   +.+|+|+|+||+||++++++.+|++|||+++.....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999876567899999999999999999999   899999999999999999999999999999876422


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      ..........+++.|+||
T Consensus       160 ~~~~~~~~~~~~~~y~~P  177 (266)
T cd05033         160 EATYTTKGGKIPIRWTAP  177 (266)
T ss_pred             ccceeccCCCCCccccCh
Confidence            221112223456778887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.88  E-value=3e-22  Score=205.46  Aligned_cols=145  Identities=22%  Similarity=0.354  Sum_probs=126.7

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .++|+..+.||+|+||.||++.                      ..+.+|++++++++|||||+++++|..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            4689999999999999999741                      357789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~-~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |+++|+|.+++.... .+++..+..++.+++.|+.|||   .. +++||||||+||++++++.+||+|||++..+...  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999997654 5788888999999999999999   54 6999999999999999999999999998765321  


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......||..|+||
T Consensus       158 --~~~~~~~~~~y~aP  171 (333)
T cd06650         158 --MANSFVGTRSYMSP  171 (333)
T ss_pred             --ccccCCCCccccCH
Confidence              12335789999998

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.88  E-value=2.1e-22  Score=206.15  Aligned_cols=140  Identities=28%  Similarity=0.329  Sum_probs=119.1

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||++.                        +.+..|+.++.++ +|||||++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            469999999999752                        2345677787766 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence            99998887653 5789999999999999999999   8999999999999999999999999999987532221  1223


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (329)
T cd05618         155 TFCGTPNYIAP  165 (329)
T ss_pred             cccCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.4e-23  Score=195.30  Aligned_cols=148  Identities=26%  Similarity=0.336  Sum_probs=128.5

Q ss_pred             hcccccccccccCCCceeehhh----------H--------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRA----------F--------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~----------~--------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..++|+.++.+|+|.||+|..+          .              ..-..|-.+++..+||.+..|--.|+..+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3568999999999999998642          1              123457789999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+.||.|+-++.+.. .+++.....+.++|+.|+.|||   +++||+||+|.+|.|+|.+|++||+|||+++.-  -
T Consensus       246 VMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--I  319 (516)
T ss_pred             EEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc--c
Confidence            999999999999987764 5778888889999999999999   899999999999999999999999999999863  2


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      .......++||||.|+||
T Consensus       320 ~~g~t~kTFCGTPEYLAP  337 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAP  337 (516)
T ss_pred             cccceeccccCChhhcCc
Confidence            234456779999999998

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.87  E-value=3.4e-22  Score=199.87  Aligned_cols=148  Identities=24%  Similarity=0.400  Sum_probs=123.9

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ++|...+.||+|+||+||+|.                          +++..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            478888999999999999752                          235567778899999999999999864 45789


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      |+||+++|+|.+++......+++..+..++.|++.|+.|+|   ..+++||||||+||+++.++.+|++|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876667899999999999999999999   899999999999999999999999999999875433


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      ..........++..|+||
T Consensus       163 ~~~~~~~~~~~~~~y~~p  180 (279)
T cd05111         163 DKKYFYSEHKTPIKWMAL  180 (279)
T ss_pred             CcccccCCCCCcccccCH
Confidence            222222334577789887

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.87  E-value=3.4e-22  Score=204.38  Aligned_cols=145  Identities=25%  Similarity=0.272  Sum_probs=122.6

Q ss_pred             cccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCC-ccceeeeeeccCCeeEEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHR-NLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lV~  500 (596)
                      +|+..+.||+|+||.||+|.                        +.+..|..+++.++|+ +|+++++++..++..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            47888999999999999752                        2355788888888765 5888999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            9999999999987654 5788999999999999999999   8999999999999999999999999999987532111 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                       ......+||+.|+||
T Consensus       156 -~~~~~~~gt~~y~aP  170 (324)
T cd05587         156 -KTTRTFCGTPDYIAP  170 (324)
T ss_pred             -CceeeecCCccccCh
Confidence             122345799999998

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.87  E-value=2.8e-22  Score=204.83  Aligned_cols=145  Identities=25%  Similarity=0.299  Sum_probs=122.4

Q ss_pred             cccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      +|...+.||+|+||.||++.                        +.+..|..++..+ +|++|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            57888999999999999752                        1244567777766 5899999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++.... .+++.++..++.|++.|++|||   ..+|+||||||+|||+++++.+||+|||+++.....  
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence            9999999999987654 5788999999999999999999   899999999999999999999999999998754221  


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                      .......+||+.|+||
T Consensus       155 ~~~~~~~~gt~~y~aP  170 (323)
T cd05616         155 GVTTKTFCGTPDYIAP  170 (323)
T ss_pred             CCccccCCCChhhcCH
Confidence            1123346799999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.87  E-value=3.7e-22  Score=196.90  Aligned_cols=148  Identities=24%  Similarity=0.395  Sum_probs=126.3

Q ss_pred             ccccccccccCCCceeehhh-------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          445 DEFSENNLIGRGGFALFIRA-------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~-------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      ++|+..+.||+|+||.||++                   ...+..|+.++++++||||+++++++..++..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            46888899999999999974                   13677899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++......+++..+..++.|++.|+.|+|   ..+++|||+||+||++++++.+|++|||.++...... .....
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~~  159 (256)
T cd05114          84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSS  159 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eeccC
Confidence            9999999765556889999999999999999999   8999999999999999999999999999988653221 11122


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...++..|+||
T Consensus       160 ~~~~~~~y~aP  170 (256)
T cd05114         160 GAKFPVKWSPP  170 (256)
T ss_pred             CCCCchhhCCh
Confidence            23456678887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.87  E-value=3.2e-22  Score=203.69  Aligned_cols=140  Identities=26%  Similarity=0.361  Sum_probs=117.1

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhh-cCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKS-IRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||+||+|.                        +.+..|..++.. .+||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999752                        123345556654 4899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++.++..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999987654 5788899999999999999999   8999999999999999999999999999998643221  1233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05592         155 TFCGTPDYIAP  165 (316)
T ss_pred             cccCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.87  E-value=2.8e-22  Score=204.53  Aligned_cols=140  Identities=26%  Similarity=0.325  Sum_probs=118.9

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||++.                        +.+..|..+++.. +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            468999999999752                        2345677777766 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccc
Confidence            99999887654 5789999999999999999999   899999999999999999999999999998754222  11233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (320)
T cd05590         155 TFCGTPDYIAP  165 (320)
T ss_pred             ccccCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.87  E-value=2.5e-22  Score=200.59  Aligned_cols=151  Identities=19%  Similarity=0.405  Sum_probs=125.9

Q ss_pred             hcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      ..++|+..+.||+|+||.||+|.                           ..+.+|+.++++++||||+++++++..++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46789999999999999999531                           236689999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEE
Q 036342          496 KALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHL  566 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl  566 (596)
                      .++||||+++|+|.+++....         ..+++..+..++.|++.|+.|||   ..+++|||+||+||++++++.+|+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999987532         23567888999999999999999   889999999999999999999999


Q ss_pred             eccccccccCCCCCccccccccccccccCC
Q 036342          567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       567 ~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|||+++...............+++.||||
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSP  190 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcCh
Confidence            999998865432221112223457789998

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.87  E-value=3.4e-22  Score=204.33  Aligned_cols=143  Identities=27%  Similarity=0.379  Sum_probs=119.8

Q ss_pred             ccccccccCCCceeehhhH------------------------HhHHHHHHH---HhhcCCCccceeeeeeccCCeeEEE
Q 036342          447 FSENNLIGRGGFALFIRAF------------------------KSFDVECEM---MKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~---l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      |...+.||+|+||.||++.                        +.+..|+.+   +++++||||+++++++..++..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            5678899999999999752                        223445444   4567899999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|..++...  .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999888653  5889999999999999999999   8999999999999999999999999999987532221


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                        ......+||+.||||
T Consensus       156 --~~~~~~~g~~~y~aP  170 (324)
T cd05589         156 --DRTSTFCGTPEFLAP  170 (324)
T ss_pred             --CcccccccCccccCH
Confidence              122346799999998

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.87  E-value=3.7e-22  Score=203.82  Aligned_cols=140  Identities=31%  Similarity=0.387  Sum_probs=116.5

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHH-HHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVEC-EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||+|.                        +.+..|. .+++.++|||||++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999752                        1223343 367889999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++..+..++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            99998887653 5778888889999999999999   8999999999999999999999999999987532221  1223


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (321)
T cd05603         155 TFCGTPEYLAP  165 (321)
T ss_pred             cccCCcccCCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.87  E-value=4.3e-22  Score=203.36  Aligned_cols=140  Identities=28%  Similarity=0.326  Sum_probs=118.8

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||+|.                        +.+..|..+++.+ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            468999999999752                        2345678888765 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence            99999887654 5788899999999999999999   8999999999999999999999999999987543221  1233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (321)
T cd05591         155 TFCGTPDYIAP  165 (321)
T ss_pred             ccccCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.87  E-value=4.3e-22  Score=203.49  Aligned_cols=140  Identities=31%  Similarity=0.403  Sum_probs=116.9

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHH-HHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||+||+|.                        +.+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            468999999999752                        12223333 56789999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            99999987654 5788899999999999999999   8999999999999999999999999999987542221  1233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (323)
T cd05575         155 TFCGTPEYLAP  165 (323)
T ss_pred             cccCChhhcCh
Confidence            45799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.87  E-value=4.2e-22  Score=203.78  Aligned_cols=140  Identities=32%  Similarity=0.406  Sum_probs=117.1

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHH-HHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||++.                        +.+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            468999999999752                        12233443 56789999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++.++..++.|++.|+.|||   +.+|+||||||+||++++++.+||+|||+++.....  .....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcc
Confidence            99998887653 5789999999999999999999   899999999999999999999999999998753221  11233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05604         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCChhhCCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.87  E-value=3.1e-22  Score=200.99  Aligned_cols=147  Identities=21%  Similarity=0.364  Sum_probs=124.5

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||.||++.                       +.+.+|++++++++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            368899999999999999752                       346789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |++++.+..+. .....+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++...... .
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  155 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N  155 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence            99987666544 33346788899999999999999999   8999999999999999999999999999998753221 1


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......||+.|+||
T Consensus       156 ~~~~~~~~~~~y~aP  170 (287)
T cd07848         156 ANYTEYVATRWYRSP  170 (287)
T ss_pred             ccccccccccccCCc
Confidence            122345789999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.87  E-value=4.5e-22  Score=203.54  Aligned_cols=140  Identities=31%  Similarity=0.389  Sum_probs=116.1

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHH-HHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVEC-EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||+||++.                        ..+..|. .+++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999752                        1122233 356789999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+.+..+..++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence            99999987654 4677888889999999999999   8999999999999999999999999999987543221  1233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05602         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=5.6e-22  Score=198.93  Aligned_cols=145  Identities=27%  Similarity=0.416  Sum_probs=125.0

Q ss_pred             cccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          446 EFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .|+..+.||+|+||.||++.                        ..+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            47788999999999999742                        134579999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |+++|+|.+++.... ..+++..+..++.|++.|+.|||   +.+++||||||+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998886543 45889999999999999999999   8899999999999999999999999999988653221 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......|++.|+||
T Consensus       157 --~~~~~~~~~~y~aP  170 (285)
T cd05605         157 --TIRGRVGTVGYMAP  170 (285)
T ss_pred             --ccccccCCCCccCc
Confidence              12335789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.87  E-value=7.5e-22  Score=197.50  Aligned_cols=139  Identities=28%  Similarity=0.384  Sum_probs=118.9

Q ss_pred             ccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          453 IGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       453 ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      ||+|+||+||++.                        +.+..|+.++++++|+||+++.+++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999741                        2345799999999999999999999999999999999999999


Q ss_pred             HHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          509 EKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       509 ~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      .+++..   ....+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+++.+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988754   2346889999999999999999999   89999999999999999999999999999986543221  123


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...||+.|+||
T Consensus       156 ~~~g~~~y~aP  166 (280)
T cd05608         156 GYAGTPGFMAP  166 (280)
T ss_pred             ccCCCcCccCH
Confidence            45789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.87  E-value=2.7e-22  Score=207.59  Aligned_cols=142  Identities=27%  Similarity=0.479  Sum_probs=120.9

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|+||.||++.                      +.+.+|++++++++|+||+++++++..++..|+||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            456677899999999999752                      3467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++|+|.+..     ..++.....++.|++.||.|||   ..+|+||||||+|||+++++.+||+|||+++.......  
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            9999986532     3456778889999999999999   89999999999999999999999999999987542211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......||..|+||
T Consensus       224 ~~~~~~gt~~y~aP  237 (353)
T PLN00034        224 PCNSSVGTIAYMSP  237 (353)
T ss_pred             cccccccCccccCc
Confidence            12345789999998

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.87  E-value=5.7e-22  Score=202.90  Aligned_cols=140  Identities=27%  Similarity=0.327  Sum_probs=119.7

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||++.                        +.+..|+.+++++ +||+|+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999742                        2356788888888 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            99999887653 5889999999999999999999   8999999999999999999999999999987532211  1233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (327)
T cd05617         155 TFCGTPNYIAP  165 (327)
T ss_pred             cccCCcccCCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.87  E-value=6.7e-22  Score=196.62  Aligned_cols=143  Identities=28%  Similarity=0.408  Sum_probs=118.9

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      +.||+|+||.||+|.                        ..+..|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999751                        24667999999999999999999999988999999999999


Q ss_pred             CHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          507 SLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       507 ~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +|.+++....    ...++..+..++.|+++|++|+|   ..+++|||+||+||+++.++.+|++|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999987532    23567778889999999999999   8999999999999999999999999999987643322222


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (269)
T cd05087         158 TPDQLWVPLRWIAP  171 (269)
T ss_pred             cCCCcCCcccccCH
Confidence            22334577889988

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.87  E-value=5.6e-22  Score=198.74  Aligned_cols=149  Identities=24%  Similarity=0.457  Sum_probs=125.1

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ++|+..+.||+|+||.||+|.                          ..+.+|+.++++++||||+++++++..++..|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            568888999999999999752                          346789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC
Q 036342          499 VLEYMPHGSLEKYLYSSN----------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM  562 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~  562 (596)
                      ||||+++|+|.+++....                ..+++.+...++.|++.|+.|+|   +.+++|||+||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321                24678889999999999999999   88999999999999999999


Q ss_pred             cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          563 VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 ~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+|++|||+++...............++..|+||
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP  195 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecCh
Confidence            9999999999865432221222334456778887

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.87  E-value=4.9e-22  Score=219.93  Aligned_cols=149  Identities=28%  Similarity=0.406  Sum_probs=125.1

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||+|.                        +++.+|++++++++|||||++++++.+++..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            578999999999999999852                        34778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccc
Q 036342          501 EYMPHGSLEKYLYSS----------NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS  570 (596)
Q Consensus       501 e~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfG  570 (596)
                      ||++||+|.+++...          ....++..++.++.|+++|++|+|   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          123456778899999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCC----------------ccccccccccccccCC
Q 036342          571 IAKLLTGEDQ----------------SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~----------------~~~~~~~~gt~~y~aP  596 (596)
                      +++.......                .......+||+.||||
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP  200 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP  200 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence            9986521110                0011224699999998

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.87  E-value=6.6e-22  Score=200.89  Aligned_cols=146  Identities=23%  Similarity=0.430  Sum_probs=125.9

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|...+.||+|+||.||+|.                      ..+.+|++++++++||||+++++++..++..|+||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            578899999999999999852                      2466899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++ ++.+++......+++..+..++.|+++|+.|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            975 899988776656788999999999999999999   89999999999999999999999999999876432211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......+|+.|+||
T Consensus       160 ~~~~~~~~~~y~aP  173 (309)
T cd07872         160 TYSNEVVTLWYRPP  173 (309)
T ss_pred             ccccccccccccCC
Confidence            12234678899998

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=3.3e-22  Score=215.02  Aligned_cols=153  Identities=24%  Similarity=0.319  Sum_probs=127.8

Q ss_pred             HHhcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC---
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE---  494 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~---  494 (596)
                      ....++|...+.||+|+||+||++.                       ..+.+|+..+..++|+|++++++.+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3445799999999999999999752                       24667899999999999999988775432   


Q ss_pred             -----eeEEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEE
Q 036342          495 -----FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHL  566 (596)
Q Consensus       495 -----~~~lV~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl  566 (596)
                           ..++||||+++|+|.++++..   ...+++..+..++.|++.|+.|+|   .++|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence                 368999999999999998753   245788899999999999999999   999999999999999999999999


Q ss_pred             eccccccccCCCCCccccccccccccccCC
Q 036342          567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       567 ~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|||+++.+............+||+.|+||
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP  214 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAP  214 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCH
Confidence            999999876433222223446799999998

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.87  E-value=5.3e-22  Score=199.44  Aligned_cols=152  Identities=20%  Similarity=0.387  Sum_probs=125.6

Q ss_pred             HhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCC
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE  494 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~  494 (596)
                      ...++|++.+.||+|+||.||+|.                           ..+..|+.++++++||||+++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            456789999999999999999641                           23567889999999999999999999989


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEE
Q 036342          495 FKALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH  565 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~k  565 (596)
                      ..|+||||+++|+|.+++....         ...++.....++.|++.|+.|||   +++++|||+||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999997532         23456778889999999999999   99999999999999999999999


Q ss_pred             EeccccccccCCCCCccccccccccccccCC
Q 036342          566 LSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       566 l~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++|||+++...............++..|+||
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p  190 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCH
Confidence            9999999865432221112223456778887

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=3.8e-22  Score=209.32  Aligned_cols=148  Identities=25%  Similarity=0.291  Sum_probs=127.1

Q ss_pred             cccccccccccCCCceeehhhH------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      ..+|...+.||+|+||.||++.                  +...+|++++++++|||||++++++..++..|+||||+. 
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  169 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-  169 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence            3479999999999999999752                  234689999999999999999999999999999999995 


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      ++|.+++... ..+++.+++.++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++............
T Consensus       170 ~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~  245 (392)
T PHA03207        170 CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY  245 (392)
T ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccc
Confidence            6899988543 46889999999999999999999   8999999999999999999999999999998764332222223


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...||+.|+||
T Consensus       246 ~~~gt~~y~aP  256 (392)
T PHA03207        246 GWSGTLETNSP  256 (392)
T ss_pred             ccccccCccCH
Confidence            46799999998

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.87  E-value=9.3e-22  Score=197.06  Aligned_cols=149  Identities=27%  Similarity=0.530  Sum_probs=126.6

Q ss_pred             ccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ++|+..+.||+|+||.||+|.                           ..+.+|+.++++++||||+++++++...+..|
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            478889999999999999641                           34678999999999999999999999988999


Q ss_pred             EEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC
Q 036342          498 LVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM  562 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~  562 (596)
                      ++|||+++|+|.+++....               ..+++.....++.|++.|+.|||   ..+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999997542               34778889999999999999999   89999999999999999999


Q ss_pred             cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          563 VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 ~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+||+|||+++...............+++.|+||
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP  195 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCH
Confidence            9999999998865332222222334568889998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=4.1e-22  Score=206.42  Aligned_cols=147  Identities=22%  Similarity=0.282  Sum_probs=127.7

Q ss_pred             hcccccccccccCCCceeehhhH---------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS  507 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~  507 (596)
                      ...+|...+.||+|+||.||+|.               .....|+.++++++|||||++++++..++..++|+||+. |+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~  142 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD  142 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence            34579999999999999999863               234579999999999999999999999999999999994 69


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccc
Q 036342          508 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT  587 (596)
Q Consensus       508 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~  587 (596)
                      |.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.....   ......
T Consensus       143 l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~  216 (357)
T PHA03209        143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGL  216 (357)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---cccccc
Confidence            99998876667899999999999999999999   889999999999999999999999999998753221   122345


Q ss_pred             cccccccCC
Q 036342          588 LGTIGYMAP  596 (596)
Q Consensus       588 ~gt~~y~aP  596 (596)
                      .||+.|+||
T Consensus       217 ~gt~~y~aP  225 (357)
T PHA03209        217 AGTVETNAP  225 (357)
T ss_pred             cccccccCC
Confidence            799999998

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.87  E-value=8.4e-22  Score=195.81  Aligned_cols=142  Identities=21%  Similarity=0.362  Sum_probs=117.7

Q ss_pred             cccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCC
Q 036342          452 LIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS  507 (596)
Q Consensus       452 ~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~  507 (596)
                      .||+|+||.||++.                        +.+.+|+.++++++||||++++++|......|+||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            58999999999741                        357788899999999999999999999999999999999999


Q ss_pred             HHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          508 LEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       508 L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      |.+++....   ...++.....++.|+++|++|+|   +.+++||||||+||+++.++.+|++|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997642   23566677889999999999999   889999999999999999999999999998643221111112


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....++..|+||
T Consensus       159 ~~~~~~~~y~aP  170 (268)
T cd05086         159 DDKCVPLRWLAP  170 (268)
T ss_pred             cCCcCcccccCc
Confidence            345678889888

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.87  E-value=6.5e-22  Score=203.19  Aligned_cols=151  Identities=27%  Similarity=0.470  Sum_probs=124.4

Q ss_pred             hcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeeccC-
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNE-  493 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~-  493 (596)
                      +.++|+..+.||+|+||.||+|.                           +.+..|+++++++ +|+||++++++|... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            45689999999999999999752                           2355799999999 899999999988654 


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------------------------------------------------
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSN---------------------------------------------------------  516 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~---------------------------------------------------------  516 (596)
                      ...++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            56889999999999999886421                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccc
Q 036342          517 ---CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY  593 (596)
Q Consensus       517 ---~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y  593 (596)
                         ..+++..+..++.|+++|+.|+|   ..+|+||||||+||++++++.+||+|||+++.+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               25788999999999999999999   899999999999999999999999999999876433222222334567789


Q ss_pred             cCC
Q 036342          594 MAP  596 (596)
Q Consensus       594 ~aP  596 (596)
                      |||
T Consensus       242 ~aP  244 (337)
T cd05054         242 MAP  244 (337)
T ss_pred             cCc
Confidence            998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.86  E-value=7.6e-22  Score=200.89  Aligned_cols=140  Identities=26%  Similarity=0.355  Sum_probs=117.9

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhh-cCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKS-IRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||+||+|.                        +.+..|..+++. .+||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            468999999999752                        124457777775 5999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++.++..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence            99999997653 5788899999999999999999   8999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05619         155 TFCGTPDYIAP  165 (316)
T ss_pred             eecCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4e-22  Score=195.04  Aligned_cols=151  Identities=30%  Similarity=0.487  Sum_probs=128.1

Q ss_pred             cccccccccccCCCceeehhhH----------------------------HhHHHHHHHHhhcCCCccceeeeeecc-CC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------------KSFDVECEMMKSIRHRNLIKVISSCSN-EE  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~-~~  494 (596)
                      .++|-.+..+|+|||+.||||+                            +...+|-.+-+.++||.||++|++|.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4568888999999999999974                            335678889999999999999999975 45


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEecccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSI  571 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~dfGl  571 (596)
                      ..|-|.|||+|.||+-+++... ..++..+..|+.||+.||.||.+. .++|+|-|+||.|||+.+   .|.+||.|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7899999999999999998764 578899999999999999999844 689999999999999953   58999999999


Q ss_pred             ccccCCCCCc----c-ccccccccccccCC
Q 036342          572 AKLLTGEDQS----M-TQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~----~-~~~~~~gt~~y~aP  596 (596)
                      ++.+.++.+.    + -.+..+||.||++|
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPP  649 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPP  649 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCc
Confidence            9998654322    1 13567899999998

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.86  E-value=7.2e-22  Score=201.15  Aligned_cols=140  Identities=24%  Similarity=0.360  Sum_probs=117.6

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhh-cCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKS-IRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||++.                        +....|..+++. .+||||+++++++..++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999742                        124456677765 4899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++.++..++.|+++|++|||   ..+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            99999987653 5788899999999999999999   8999999999999999999999999999987532111  1233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05620         155 TFCGTPDYIAP  165 (316)
T ss_pred             ccCCCcCccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.86  E-value=7.9e-22  Score=201.50  Aligned_cols=145  Identities=24%  Similarity=0.291  Sum_probs=122.0

Q ss_pred             cccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~  500 (596)
                      +|+..+.||+|+||.||++.                        +.+..|..+++.+. |++|+++++++..++..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            46778999999999999742                        23556788888775 567888999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++.... .+++.++..++.|++.|+.|||   +.+|+||||||+||++++++.+||+|||+++...... 
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            9999999999987654 5889999999999999999999   8999999999999999999999999999987542221 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                       ......+||+.|+||
T Consensus       156 -~~~~~~~gt~~y~aP  170 (323)
T cd05615         156 -VTTRTFCGTPDYIAP  170 (323)
T ss_pred             -ccccCccCCccccCH
Confidence             122345799999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.86  E-value=1.1e-21  Score=195.54  Aligned_cols=121  Identities=23%  Similarity=0.353  Sum_probs=103.4

Q ss_pred             hHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCce
Q 036342          467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALV  546 (596)
Q Consensus       467 ~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i  546 (596)
                      .+..|+.++++++||||+++++++..+...++||||+++|+|.+++......+++..+..++.|+++|++|||   +++|
T Consensus        62 ~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i  138 (274)
T cd05076          62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNL  138 (274)
T ss_pred             HHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCc
Confidence            4567888999999999999999999999999999999999999999775557889999999999999999999   8999


Q ss_pred             EeCCCCCCCeeeCCCC-------cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          547 IHCDLKPSNVLLDDNM-------VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       547 ~Hrdlk~~NILl~~~~-------~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +||||||+||++++.+       .+|++|||++......      ....++..|+||
T Consensus       139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aP  189 (274)
T cd05076         139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAP  189 (274)
T ss_pred             cCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCc
Confidence            9999999999997643       4899999987653221      123467778887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.86  E-value=6.8e-22  Score=186.30  Aligned_cols=152  Identities=24%  Similarity=0.397  Sum_probs=126.0

Q ss_pred             CHHHHHHhcccccccccccCCCceeehhh---------------------HHhHHHHHHHHhhcC-CCccceeeeeeccC
Q 036342          436 SYLELCRATDEFSENNLIGRGGFALFIRA---------------------FKSFDVECEMMKSIR-HRNLIKVISSCSNE  493 (596)
Q Consensus       436 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~---------------------~~~~~~e~~~l~~l~-H~niv~l~~~~~~~  493 (596)
                      .+++..+.|+     +.+|+|+|+.|.-+                     ..+..+|++++.+.+ |+||++|+++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3567777765     78999999998542                     246778999999885 99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC---CcEEEeccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFS  570 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~---~~~kl~dfG  570 (596)
                      ...|+|||-|.||+|.+++.++. .+.+.++.++..+|+.||.|||   .++|.|||+||+|||..+-   ..+||+||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            99999999999999999998775 6889999999999999999999   9999999999999999643   468999998


Q ss_pred             cccccCCCCC-----ccccccccccccccCC
Q 036342          571 IAKLLTGEDQ-----SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~-----~~~~~~~~gt~~y~aP  596 (596)
                      ++.-+....+     .....+.+|+..||||
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAP  255 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAP  255 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcch
Confidence            7654322211     1123457899999998

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.86  E-value=8.1e-22  Score=198.29  Aligned_cols=148  Identities=24%  Similarity=0.430  Sum_probs=123.9

Q ss_pred             cccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          446 EFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      +|...+.||+|+||.||+|.                           +.+.+|++++++++||||+++++++..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47788999999999999742                           246689999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCC
Q 036342          499 VLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSN  555 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~N  555 (596)
                      |+||+++|+|.+++....                       ..+++..++.++.|++.|++|||   ..+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999986421                       24678899999999999999999   8999999999999


Q ss_pred             eeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          556 VLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       556 ILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |++++++.+||+|||+++...............++..|+||
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap  198 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI  198 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence            99999999999999999865332222222233456788887

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.86  E-value=6.1e-22  Score=207.12  Aligned_cols=154  Identities=23%  Similarity=0.419  Sum_probs=127.0

Q ss_pred             HHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcC-CCccceeeeeec
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIR-HRNLIKVISSCS  491 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~-H~niv~l~~~~~  491 (596)
                      +....++|...+.||+|+||.||+|.                           +.+..|+.++.++. |||||+++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            34455678888999999999999652                           24668999999997 999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCC-------------------------------------------------------
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSSN-------------------------------------------------------  516 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~~-------------------------------------------------------  516 (596)
                      .++..++||||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999986431                                                       


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCC
Q 036342          517 ------------------------------------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPS  554 (596)
Q Consensus       517 ------------------------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~  554 (596)
                                                                ..+++.+...++.|++.|++|||   ..+++|||+||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence                                                      13567788889999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          555 NVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       555 NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||++++++.+|++|||+++...............+++.||||
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  310 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP  310 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence            999999999999999999865322211112234567889987

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.9e-22  Score=217.88  Aligned_cols=152  Identities=27%  Similarity=0.401  Sum_probs=132.7

Q ss_pred             HHHhcccccccccccCCCceeehhh----------H--------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRA----------F--------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~----------~--------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      +.-..++|++++.||+|+||.|...          +              ..|+.|-.+|.--+.+=||+++-+|+++.+
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            3334678999999999999998531          1              246778888888889999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      +|+|||||+||||...+.+.. .+++..+..++++++-|+.-+|   ..++|||||||+|||+|..|++|++|||-+-.+
T Consensus       150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhc
Confidence            999999999999999998876 7889999999999999999999   999999999999999999999999999988777


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..+. .......+|||-|.+|
T Consensus       226 ~~dG-~V~s~~aVGTPDYISP  245 (1317)
T KOG0612|consen  226 DADG-TVRSSVAVGTPDYISP  245 (1317)
T ss_pred             CCCC-cEEeccccCCCCccCH
Confidence            5443 2335567999999998

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.86  E-value=1.5e-21  Score=192.10  Aligned_cols=143  Identities=24%  Similarity=0.411  Sum_probs=119.5

Q ss_pred             ccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          451 NLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      +.||+|+||.||+|.                      ..+.+|++++++++||||+++++++..++..|+||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            468999999999741                      3477899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccccc
Q 036342          509 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  588 (596)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~  588 (596)
                      .+++......+++.++..++.|++.|+.|+|   ..+++|||+||+||+++.++.+|++|||+++...............
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999776556889999999999999999999   8999999999999999999999999999988643221111111122


Q ss_pred             ccccccCC
Q 036342          589 GTIGYMAP  596 (596)
Q Consensus       589 gt~~y~aP  596 (596)
                      ++..|+||
T Consensus       158 ~~~~y~aP  165 (252)
T cd05084         158 IPVKWTAP  165 (252)
T ss_pred             CceeecCc
Confidence            34568887

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.86  E-value=6.1e-22  Score=203.77  Aligned_cols=146  Identities=23%  Similarity=0.395  Sum_probs=121.6

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-----CeeE
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-----EFKA  497 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~  497 (596)
                      +|+..+.||+|+||.||+|.                       ..+.+|+.++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            47888999999999999752                       2366899999999999999999988543     2479


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|||||+ ++|.+++.... .+++..+..++.|+++|+.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 69999887654 5789999999999999999999   89999999999999999999999999999986432


Q ss_pred             CCC-ccccccccccccccCC
Q 036342          578 EDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~-~~~~~~~~gt~~y~aP  596 (596)
                      ... ........||+.|+||
T Consensus       156 ~~~~~~~~~~~~~t~~y~aP  175 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAP  175 (338)
T ss_pred             ccCccccccCCCCCCCcCCH
Confidence            211 1112345799999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.86  E-value=1.3e-21  Score=196.62  Aligned_cols=150  Identities=27%  Similarity=0.484  Sum_probs=126.9

Q ss_pred             cccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      .++|...+.||+|+||.||++.                          +.+..|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            3578889999999999998642                          34678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEE
Q 036342          498 LVLEYMPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH  565 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~k  565 (596)
                      +||||+++|+|.+++....            ..+++.++..++.|++.|++|+|   ..+++|||+||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999987532            24789999999999999999999   89999999999999999999999


Q ss_pred             EeccccccccCCCCCccccccccccccccCC
Q 036342          566 LSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       566 l~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++|||+++...............+++.|+||
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  191 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  191 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCH
Confidence            9999999865432221122234457789998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=1.5e-21  Score=196.83  Aligned_cols=150  Identities=23%  Similarity=0.420  Sum_probs=124.8

Q ss_pred             cccccccccccCCCceeehhhH------------------------------------HhHHHHHHHHhhcCCCccceee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------------------KSFDVECEMMKSIRHRNLIKVI  487 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------------------~~~~~e~~~l~~l~H~niv~l~  487 (596)
                      .++|+..+.||+|+||.||++.                                    ..+..|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578999999999999998531                                    2466799999999999999999


Q ss_pred             eeeccCCeeEEEEecCCCCCHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCe
Q 036342          488 SSCSNEEFKALVLEYMPHGSLEKYLYSSN-----------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV  556 (596)
Q Consensus       488 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NI  556 (596)
                      +++..++..++||||+++++|.+++....           ..+++.++..++.|++.|++|||   +.+++|||+||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            99999999999999999999999986532           23678889999999999999999   89999999999999


Q ss_pred             eeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       557 Ll~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++++++.+|++|||+++...............++..|+||
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  200 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW  200 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecCh
Confidence            9999999999999998865322211112223456788887

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.86  E-value=1.4e-21  Score=194.02  Aligned_cols=149  Identities=26%  Similarity=0.450  Sum_probs=125.9

Q ss_pred             ccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ++|...+.||+|+||.||+|.                         +.+..|+.++++++||||+++++++..++..|+|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            478889999999999998641                         3567899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++......+++.++..++.|++.|+.|+|   +.+++|||+||+||+++.++.+|++|||+++.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876656889999999999999999999   8999999999999999999999999999998764322


Q ss_pred             Ccc-ccccccccccccCC
Q 036342          580 QSM-TQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~-~~~~~~gt~~y~aP  596 (596)
                      ... ......++..|+||
T Consensus       161 ~~~~~~~~~~~~~~y~~p  178 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAP  178 (267)
T ss_pred             ceeeecCCCccceeecCH
Confidence            111 11112335678887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=1.2e-21  Score=200.76  Aligned_cols=138  Identities=26%  Similarity=0.295  Sum_probs=115.4

Q ss_pred             ccCCCceeehhhH------------------------HhHHHHHHHHhhc---CCCccceeeeeeccCCeeEEEEecCCC
Q 036342          453 IGRGGFALFIRAF------------------------KSFDVECEMMKSI---RHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       453 ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      ||+|+||.||+|.                        .....|..++.+.   +||+|+++++++..++..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999752                        1123455666655   699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++..+..++.|+++|++|||   ..+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence            99999987653 5789999999999999999999   8999999999999999999999999999987542221  1233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (330)
T cd05586         155 TFCGTTEYLAP  165 (330)
T ss_pred             CccCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.86  E-value=1.5e-21  Score=192.54  Aligned_cols=148  Identities=24%  Similarity=0.416  Sum_probs=125.7

Q ss_pred             ccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      ++|...+.||+|+||.||++.                   ..+.+|+.++++++||||+++++++...+..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            467888999999999998752                   3577899999999999999999999988889999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++......+++.+++.++.|++.|+.|||   ..+++|+|+||+||++++++.+|++|||.++....... ....
T Consensus        84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~  159 (256)
T cd05113          84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSV  159 (256)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecC
Confidence            9999999775556899999999999999999999   89999999999999999999999999999886533211 1112


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...++..|+||
T Consensus       160 ~~~~~~~y~~p  170 (256)
T cd05113         160 GSKFPVRWSPP  170 (256)
T ss_pred             CCccChhhCCH
Confidence            23455678877

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.86  E-value=1.5e-21  Score=197.80  Aligned_cols=151  Identities=29%  Similarity=0.479  Sum_probs=126.3

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhc-CCCccceeeeeecc
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSI-RHRNLIKVISSCSN  492 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~  492 (596)
                      ..++|...+.||+|+||.||++.                             +.+..|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            45678899999999999999541                             2466799999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCee
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL  557 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NIL  557 (596)
                      .+..|+||||+++|+|.+++....               ..+++.++..++.|+++|+.|||   +.+++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence            999999999999999999997642               24678889999999999999999   899999999999999


Q ss_pred             eCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       558 l~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +++++.+|++|||+++...............+++.|+||
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP  208 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP  208 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence            999999999999999876432222122233466789988

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=2e-21  Score=194.30  Aligned_cols=148  Identities=24%  Similarity=0.414  Sum_probs=124.9

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ++|+..+.||+|+||.||+|.                          ..+.+|+.++++++||||+++++++.. +..++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            578888999999999999742                          246679999999999999999999987 67899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   ..+++||||||+||++++++.+|++|||+++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999876656899999999999999999999   899999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      ..........++..|+||
T Consensus       163 ~~~~~~~~~~~~~~y~~P  180 (279)
T cd05057         163 EKEYHAEGGKVPIKWMAL  180 (279)
T ss_pred             ccceecCCCcccccccCH
Confidence            221111222345678887

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.86  E-value=1.7e-21  Score=192.25  Aligned_cols=148  Identities=28%  Similarity=0.428  Sum_probs=125.0

Q ss_pred             ccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      .+|+..+.||+|+||.||++.                   ..+.+|++++++++||||+++++++...+..|+||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            357888999999999999742                   3567899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      ++|.+++......+++..+..++.|++.|++|||   +.+++|||+||+||++++++.+|++|||+++...... .....
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~  159 (256)
T cd05059          84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQ  159 (256)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccccC
Confidence            9999999876556889999999999999999999   8999999999999999999999999999988653221 11111


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...++..|+||
T Consensus       160 ~~~~~~~y~~P  170 (256)
T cd05059         160 GTKFPVKWAPP  170 (256)
T ss_pred             CCCCCccccCH
Confidence            22344578887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.86  E-value=1.2e-21  Score=208.04  Aligned_cols=147  Identities=31%  Similarity=0.487  Sum_probs=119.7

Q ss_pred             hcccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeeccC--------CeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCSNE--------EFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~  497 (596)
                      ...+|...+.||+|+||.||+|.                 ....+|+.++++++|||||++++++...        ...+
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            34579999999999999999863                 2345799999999999999999876432        2467


Q ss_pred             EEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC-CcEEEecccccc
Q 036342          498 LVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDFSIAK  573 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~-~~~kl~dfGla~  573 (596)
                      +||||+++ ++.+++..   ....+++..+..++.|++.||+|||   ..+|+||||||+|||++.+ +.+||+|||+|+
T Consensus       144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            99999975 77777653   2346889999999999999999999   8999999999999999865 479999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+....   ......||+.||||
T Consensus       220 ~~~~~~---~~~~~~~t~~y~aP  239 (440)
T PTZ00036        220 NLLAGQ---RSVSYICSRFYRAP  239 (440)
T ss_pred             hccCCC---CcccCCCCcCccCH
Confidence            764322   12345789999998

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=2.2e-21  Score=213.58  Aligned_cols=248  Identities=23%  Similarity=0.338  Sum_probs=150.9

Q ss_pred             CCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEe
Q 036342           34 STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLG  113 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  113 (596)
                      .+.+.|+++++.++. +|...   .++|+.|+|++|+|+ .+|..+.  ++|++|++++|+|+.+ |..+.  .+|+.|+
T Consensus       178 ~~~~~L~L~~~~Lts-LP~~I---p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsL-P~~l~--~~L~~L~  247 (754)
T PRK15370        178 NNKTELRLKILGLTT-IPACI---PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSI-PATLP--DTIQEME  247 (754)
T ss_pred             cCceEEEeCCCCcCc-CCccc---ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccC-Chhhh--ccccEEE
Confidence            456778888877773 44311   246778888888877 4555543  4778888888877743 44332  3677777


Q ss_pred             cCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEc
Q 036342          114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL  193 (596)
Q Consensus       114 l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  193 (596)
                      |++|.++.++..      +.  ++|+.|++++|+|+. +|.    .++++|+.|++++|+|+.. |..+.  ++|+.|++
T Consensus       248 Ls~N~L~~LP~~------l~--s~L~~L~Ls~N~L~~-LP~----~l~~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~L  311 (754)
T PRK15370        248 LSINRITELPER------LP--SALQSLDLFHNKISC-LPE----NLPEELRYLSVYDNSIRTL-PAHLP--SGITHLNV  311 (754)
T ss_pred             CcCCccCcCChh------Hh--CCCCEEECcCCccCc-ccc----ccCCCCcEEECCCCccccC-cccch--hhHHHHHh
Confidence            777777765432      21  367777777777764 343    1234677777777777643 33332  35677777


Q ss_pred             cCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCC
Q 036342          194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI  273 (596)
Q Consensus       194 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i  273 (596)
                      ++|.++. +|..+  .++|+.|++++|.+++ +|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|+|++|.|+.+
T Consensus       312 s~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~L  382 (754)
T PRK15370        312 QSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNL  382 (754)
T ss_pred             cCCcccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCC
Confidence            7777764 33322  2567777777777763 555443  56777777777776 3454442  4677777777777776


Q ss_pred             CcccccccccceEEcccCCCCCc---hhhhhccccccceEecCCCcCc
Q 036342          274 PLTFWNLKDILQLNFSSNFLTGP---LLLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       274 p~~~~~l~~L~~L~ls~N~l~~~---~~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      |..+.  ..|+.|++++|+++..   ++..+..++.+..|++.+|.++
T Consensus       383 P~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        383 PENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            66543  3566667777766632   1222233455666666666665

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.86  E-value=2.2e-21  Score=195.33  Aligned_cols=149  Identities=28%  Similarity=0.498  Sum_probs=126.3

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .+|...+.||+|+||.||++.                          +.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            467788999999999998641                          357789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc
Q 036342          499 VLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV  563 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~  563 (596)
                      ||||+++++|.+++....               ..+++..++.++.|++.|++|||   ..+++||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999997532               24788999999999999999999   999999999999999999999


Q ss_pred             EEEeccccccccCCCCCccccccccccccccCC
Q 036342          564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       564 ~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|++|||+++...............++..|+||
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  194 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  194 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence            999999999865432211122334567889988

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.86  E-value=1.5e-21  Score=199.06  Aligned_cols=140  Identities=26%  Similarity=0.326  Sum_probs=119.0

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||++.                        ..+..|..+++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999742                        2345677888877 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++.++..++.|++.|+.|||   +.+|+||||||+||++++++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence            99999887654 5889999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ..+||+.|+||
T Consensus       155 ~~~g~~~y~aP  165 (318)
T cd05570         155 TFCGTPDYIAP  165 (318)
T ss_pred             ceecCccccCH
Confidence            45789999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.86  E-value=2e-21  Score=194.22  Aligned_cols=149  Identities=23%  Similarity=0.380  Sum_probs=124.4

Q ss_pred             cccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      .++|+..+.||+|+||+||+|.                          +.+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            3578889999999999999852                          2456789999999999999999999764 478


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +++||+++|+|.+++......+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++.+..
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999876556889999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...........+++.|+||
T Consensus       162 ~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05109         162 DETEYHADGGKVPIKWMAL  180 (279)
T ss_pred             ccceeecCCCccchhhCCH
Confidence            2221112223456778887

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.86  E-value=2.6e-21  Score=195.18  Aligned_cols=150  Identities=23%  Similarity=0.370  Sum_probs=127.5

Q ss_pred             cccccccccccCCCceeehhh--------------------------------------HHhHHHHHHHHhhcCCCccce
Q 036342          444 TDEFSENNLIGRGGFALFIRA--------------------------------------FKSFDVECEMMKSIRHRNLIK  485 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~--------------------------------------~~~~~~e~~~l~~l~H~niv~  485 (596)
                      .++|+..+.||+|+||.||++                                      .+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            457899999999999999952                                      135667999999999999999


Q ss_pred             eeeeeccCCeeEEEEecCCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCC
Q 036342          486 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSN  555 (596)
Q Consensus       486 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~N  555 (596)
                      +++++..++..++||||+++++|.+++....          ..+++..+..++.|++.|++|||   ..+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987643          25789999999999999999999   8899999999999


Q ss_pred             eeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          556 VLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       556 ILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |++++++.++++|||+++...............+++.||||
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW  201 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence            99999999999999998865433222222334567789988

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.86  E-value=1.9e-21  Score=195.64  Aligned_cols=145  Identities=27%  Similarity=0.431  Sum_probs=119.9

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc---CCCccceeeeeec-----c
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI---RHRNLIKVISSCS-----N  492 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l---~H~niv~l~~~~~-----~  492 (596)
                      ++|+..+.||+|+||.||+|.                        ..+.+|+.+++++   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368889999999999999852                        1345677777665   6999999999885     2


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+|++|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            346899999996 69999987643 45789999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++.....   .......||+.|+||
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aP  178 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAP  178 (290)
T ss_pred             eEeccCC---cccccccccccccCh
Confidence            9865422   123345789999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.86  E-value=1.4e-21  Score=197.80  Aligned_cols=147  Identities=29%  Similarity=0.516  Sum_probs=123.2

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|+..+.||+|+||.||+|.                        +.+.+|+.++.++ +|+||+++++++..++..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            4688899999999999999862                        2466799999999 89999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc
Q 036342          499 VLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV  563 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~  563 (596)
                      ||||+++|+|.++++...               ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999997542               24688899999999999999999   899999999999999999999


Q ss_pred             EEEeccccccccCCCCCccccccccccccccCC
Q 036342          564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       564 ~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +||+|||+++....   ........++..|+||
T Consensus       163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aP  192 (303)
T cd05088         163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAI  192 (303)
T ss_pred             EEeCccccCcccch---hhhcccCCCcccccCH
Confidence            99999999864321   1111122345668877

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.86  E-value=2.8e-21  Score=193.04  Aligned_cols=138  Identities=30%  Similarity=0.434  Sum_probs=118.2

Q ss_pred             ccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          453 IGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       453 ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      ||+|+||.||++.                        +.+..|++++++++||||+++++++..+...|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6999999999741                        1234689999999999999999999999999999999999999


Q ss_pred             HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccc
Q 036342          509 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT  587 (596)
Q Consensus       509 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~  587 (596)
                      .+++.... ..+++..+..++.|++.|++|||   ..+++||||||+||++++++.+||+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            98886543 35788899999999999999999   8999999999999999999999999999988654321   12335


Q ss_pred             cccccccCC
Q 036342          588 LGTIGYMAP  596 (596)
Q Consensus       588 ~gt~~y~aP  596 (596)
                      .|++.|+||
T Consensus       155 ~~~~~y~aP  163 (277)
T cd05607         155 AGTNGYMAP  163 (277)
T ss_pred             CCCCCccCH
Confidence            689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.86  E-value=1.6e-21  Score=196.41  Aligned_cols=153  Identities=29%  Similarity=0.468  Sum_probs=127.2

Q ss_pred             HHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeecc
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCSN  492 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~  492 (596)
                      ....++|+..+.||+|+||.||++.                           ..+.+|+++++++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3445678899999999999998642                           2366799999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCee
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL  557 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NIL  557 (596)
                      ++..++||||+++|+|.+++...               ...+++..++.++.|++.|+.|||   ..+|+|||+||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence            99999999999999999998642               235788999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       558 l~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +++++.+|++|||+++.+.............++..|+||
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  203 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP  203 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCH
Confidence            999999999999999876433221112223456778887

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4.2e-22  Score=202.02  Aligned_cols=155  Identities=26%  Similarity=0.445  Sum_probs=131.2

Q ss_pred             HHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          438 LELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ++|+-...+..+.+.||-|.||.||.|+                    ++|..|+.+|+.++|||+|+|+|+|..+...|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            4444444567788999999999999752                    57899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          498 LVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ||+|||..|+|.+|++++.. .++....+.++.||+.|+.||.   .+++||||+.++|+|+.++..+||+|||+++.+.
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            99999999999999998763 4556667889999999999999   9999999999999999999999999999999987


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++... ...+..-...|.||
T Consensus       417 gDTYT-AHAGAKFPIKWTAP  435 (1157)
T KOG4278|consen  417 GDTYT-AHAGAKFPIKWTAP  435 (1157)
T ss_pred             CCcee-cccCccCcccccCc
Confidence            65432 22333345667776

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.86  E-value=2.4e-21  Score=196.58  Aligned_cols=144  Identities=23%  Similarity=0.360  Sum_probs=125.6

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|+||.||++.                      ..+.+|++++++++||||+++++++..++..|+||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            468899999999999999741                      3467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++|+|.++++... .+++..+..++.|+++|+.|||   + .+++|||+||+||+++.++.+|++|||++..+...   
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            99999999997653 5788899999999999999999   6 58999999999999999999999999998765321   


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......|++.|+||
T Consensus       154 -~~~~~~~~~~~~aP  167 (308)
T cd06615         154 -MANSFVGTRSYMSP  167 (308)
T ss_pred             -ccccCCCCcCccCh
Confidence             12345788899987

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=2e-21  Score=193.92  Aligned_cols=150  Identities=20%  Similarity=0.400  Sum_probs=126.6

Q ss_pred             cccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .++|...+.||+|+||.||++.                           ..+..|++++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4688899999999999998631                           2467899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEe
Q 036342          497 ALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS  567 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~  567 (596)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.|+.|+|   ..+++||||||+||++++++.+|++
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999987532         23678889999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccccccCC
Q 036342          568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       568 dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||+++...............++..|+||
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCH
Confidence            99998865433222222334567889988

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PHA02988 hypothetical protein; Provisional

Probab=99.85  E-value=2.9e-21  Score=193.45  Aligned_cols=152  Identities=16%  Similarity=0.208  Sum_probs=124.7

Q ss_pred             cccccCHHHHHHhcccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeee
Q 036342          431 TWRTFSYLELCRATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVIS  488 (596)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~  488 (596)
                      ..+.++.+++..     .....||+|++|.||+|.                      +.+.+|+.++++++|||||++++
T Consensus        11 ~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988         11 DIKCIESDDIDK-----YTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             cceecCHHHcCC-----CCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            344555555522     223679999999999852                      45669999999999999999999


Q ss_pred             eecc----CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCc
Q 036342          489 SCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMV  563 (596)
Q Consensus       489 ~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~  563 (596)
                      ++.+    ....++||||+++|+|.+++.... .+++.....++.+++.|+.|+|   . .+++||||||+||++++++.
T Consensus        86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~  161 (283)
T PHA02988         86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYK  161 (283)
T ss_pred             eEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCc
Confidence            9876    346889999999999999997754 6789999999999999999999   5 37889999999999999999


Q ss_pred             EEEeccccccccCCCCCccccccccccccccCC
Q 036342          564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       564 ~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|++|||+++.+....     ....|+..|+||
T Consensus       162 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aP  189 (283)
T PHA02988        162 LKIICHGLEKILSSPP-----FKNVNFMVYFSY  189 (283)
T ss_pred             EEEcccchHhhhcccc-----ccccCcccccCH
Confidence            9999999998654321     234688899998

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.85  E-value=1.9e-21  Score=200.36  Aligned_cols=151  Identities=26%  Similarity=0.464  Sum_probs=122.2

Q ss_pred             hcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeeccC-
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNE-  493 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~-  493 (596)
                      ..++|...+.||+|+||+||+|.                           ..+.+|+.++.++ +|||||++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            34689999999999999999752                           2356799999999 689999999988654 


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------------------------------------------------
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSN---------------------------------------------------------  516 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~---------------------------------------------------------  516 (596)
                      ...++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            46889999999999999986421                                                         


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccc
Q 036342          517 ---------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT  587 (596)
Q Consensus       517 ---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~  587 (596)
                               ..+++.++..++.|+++|+.|+|   +.+|+||||||+||++++++.+|++|||+++..............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                     13577888899999999999999   899999999999999999999999999998865332221112223


Q ss_pred             cccccccCC
Q 036342          588 LGTIGYMAP  596 (596)
Q Consensus       588 ~gt~~y~aP  596 (596)
                      .+++.|+||
T Consensus       242 ~~~~~y~aP  250 (343)
T cd05103         242 RLPLKWMAP  250 (343)
T ss_pred             CCCcceECc
Confidence            456778887

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.85  E-value=3.7e-21  Score=194.09  Aligned_cols=150  Identities=22%  Similarity=0.394  Sum_probs=123.9

Q ss_pred             cccccccccccCCCceeehhh--------------------------------------HHhHHHHHHHHhhcCCCccce
Q 036342          444 TDEFSENNLIGRGGFALFIRA--------------------------------------FKSFDVECEMMKSIRHRNLIK  485 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~--------------------------------------~~~~~~e~~~l~~l~H~niv~  485 (596)
                      .++|+..+.||+|+||.||++                                      .+.+.+|+.++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357899999999999999964                                      134678999999999999999


Q ss_pred             eeeeeccCCeeEEEEecCCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCC
Q 036342          486 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSN  555 (596)
Q Consensus       486 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~N  555 (596)
                      +++++..++..++||||+++|+|.+++....          ..+++.+...++.|++.|++|||   +.+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            9999999999999999999999999987642          23667889999999999999999   8899999999999


Q ss_pred             eeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          556 VLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       556 ILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |++++++.++++|||+++.+.............+++.|+||
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  201 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW  201 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence            99999999999999998865332211111122345677776

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.85  E-value=2.4e-21  Score=196.03  Aligned_cols=151  Identities=23%  Similarity=0.422  Sum_probs=127.2

Q ss_pred             hcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEE  494 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  494 (596)
                      ..++|...+.||+|+||.||++.                           +.+..|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            34679999999999999998541                           2467899999999 7999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ..|+||||+++|+|.+++.... ..+++.+...++.+++.|++|+|   +.+|+|+|+||+||++++++.+|++|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997643 34799999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...............++..|+||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aP  212 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAP  212 (302)
T ss_pred             cccCCCceeecCCCCcccccCCH
Confidence            65432221112223467789987

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=2.2e-21  Score=191.99  Aligned_cols=150  Identities=29%  Similarity=0.446  Sum_probs=126.6

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..++|+..+.||+|+||.||+|.                   +.+.+|+.++++++||||+++++++..++..|+||||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            34578889999999999999752                   45778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++++|.+++.... ..+++..+..++.|++.|+.|+|   ..+++||||||+||++++++.+||+|||+++....... .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999997643 45789999999999999999999   89999999999999999999999999999987642211 1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      .......+..|+||
T Consensus       160 ~~~~~~~~~~y~aP  173 (261)
T cd05068         160 AREGAKFPIKWTAP  173 (261)
T ss_pred             ccCCCcCceeccCc
Confidence            11112234578887

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.85  E-value=1.8e-21  Score=192.59  Aligned_cols=150  Identities=23%  Similarity=0.446  Sum_probs=127.2

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..++|+..+.||+|+||.||+|.                   +.+..|+.++++++|+||+++++++..++..++||||+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            34689999999999999999852                   35678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++|+|.++++.. ...+++.++..++.|+++|++|||   ..+++|||+||+||++++++.+|++|||+++....... .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999999764 345788899999999999999999   88999999999999999999999999999987543211 1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       160 ~~~~~~~~~~y~aP  173 (261)
T cd05072         160 AREGAKFPIKWTAP  173 (261)
T ss_pred             ccCCCccceecCCH
Confidence            11223456778887

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.85  E-value=2.4e-22  Score=219.76  Aligned_cols=152  Identities=30%  Similarity=0.422  Sum_probs=131.5

Q ss_pred             HHhcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ...+.+|.....||.|.||.||-|+                       +....|..++..++|||+|+.+|+-.+++.++
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            3457788999999999999999742                       45678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      |.||||++|+|.+.+.... ..++.-...+..|++.|+.|||   ..+||||||||+||+++..|.+|.+|||.|..+..
T Consensus      1311 IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999999999987764 4556666668899999999999   99999999999999999999999999999998765


Q ss_pred             CCCccc--cccccccccccCC
Q 036342          578 EDQSMT--QTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~--~~~~~gt~~y~aP  596 (596)
                      +.+...  .....||+.||||
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAP 1407 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCc
Confidence            533222  2356899999999

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.85  E-value=1.8e-21  Score=192.45  Aligned_cols=145  Identities=38%  Similarity=0.590  Sum_probs=119.9

Q ss_pred             ccccccCCCceeehhh--------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          449 ENNLIGRGGFALFIRA--------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       449 ~~~~ig~G~~g~v~~~--------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ..+.||+|+||.||+|                          .+.+..|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999984                          24688899999999999999999999988889999999


Q ss_pred             CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++|+|.+++... ...+++.++..++.|+++|+.|||   ..+++|++++++||++++++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999987 567899999999999999999999   889999999999999999999999999999876322222


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......+...|+||
T Consensus       160 ~~~~~~~~~~~~~aP  174 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAP  174 (259)
T ss_dssp             EESTTSESGGGGS-H
T ss_pred             ccccccccccccccc
Confidence            222334567788887

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.85  E-value=3.3e-21  Score=193.36  Aligned_cols=144  Identities=26%  Similarity=0.402  Sum_probs=123.9

Q ss_pred             ccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          447 FSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      |+..+.||+|+||.||++.                        ..+..|++++++++|++|+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            6667889999999998741                        1256799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++|+|.+++.... ..+++..+..++.|++.|+.|+|   ..+|+|||+||+||++++++.+|++|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999998886543 36899999999999999999999   8999999999999999999999999999987653221  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......|++.|+||
T Consensus       157 -~~~~~~g~~~~~aP  170 (285)
T cd05632         157 -SIRGRVGTVGYMAP  170 (285)
T ss_pred             -cccCCCCCcCccCh
Confidence             12234689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.85  E-value=2.7e-21  Score=192.00  Aligned_cols=147  Identities=27%  Similarity=0.364  Sum_probs=127.2

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|+..+.||+|+||.||+|.                     ..+.+|+.++++++||||+++++++..++..|+||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            4579999999999999999852                     2466899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++|+|.+++.... .+++.++..++.|++.|+.|||   ..+|+|||+||+||++++++.+|++|||+++.......  
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--  161 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--  161 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence            99999999987553 5788999999999999999999   88999999999999999999999999999886532211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......|++.|+||
T Consensus       162 ~~~~~~~~~~y~~P  175 (267)
T cd06646         162 KRKSFIGTPYWMAP  175 (267)
T ss_pred             ccCccccCccccCH
Confidence            12335688889987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.85  E-value=3.2e-21  Score=193.14  Aligned_cols=146  Identities=25%  Similarity=0.346  Sum_probs=126.2

Q ss_pred             cccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          446 EFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .|+..+.||+|+||.||++.                     +.+..|++++++++||||+++++++..++..|+|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            36778899999999999852                     356789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +|+|..++......+++..+..++.|++.|+.|||   +.+++|||+||+||+++.++.+|++|||+++......  ...
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~  160 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR  160 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence            99999988765556889999999999999999999   8999999999999999999999999999987653221  122


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....+++.|+||
T Consensus       161 ~~~~~~~~y~aP  172 (282)
T cd06643         161 DSFIGTPYWMAP  172 (282)
T ss_pred             ccccccccccCH
Confidence            335688899998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.85  E-value=2.4e-21  Score=196.53  Aligned_cols=150  Identities=29%  Similarity=0.466  Sum_probs=124.7

Q ss_pred             cccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhc-CCCccceeeeeeccC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNE  493 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~  493 (596)
                      .++|...+.||+|+||.||++.                             ..+..|+.+++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4679999999999999999541                             2356789999999 799999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL  558 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl  558 (596)
                      +..|+||||+++|+|.+++....               ..+++.++..++.|++.|++|+|   +.+++|||+||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999997642               24788899999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          559 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       559 ~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++++.+|++|||.++...............+++.||||
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  211 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  211 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence            99999999999998765322111111222345679988

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.85  E-value=4.2e-21  Score=190.15  Aligned_cols=137  Identities=22%  Similarity=0.399  Sum_probs=117.2

Q ss_pred             ccccCCCceeehhhH---------------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          451 NLIGRGGFALFIRAF---------------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~---------------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      +.||+|+||.||+|.                                 +.+..|+.++++++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999763                                 24566788999999999999999999988899


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc-------EEEeccc
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV-------AHLSDFS  570 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~-------~kl~dfG  570 (596)
                      +||||+++|+|..++......+++..+..++.|+++|++|+|   +++|+|||+||+||+++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998776566899999999999999999999   999999999999999986654       8999999


Q ss_pred             cccccCCCCCccccccccccccccCC
Q 036342          571 IAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++......      ....++..|+||
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aP  177 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAP  177 (262)
T ss_pred             CCccccCc------ccccccccccCh
Confidence            98754321      224577889988

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.85  E-value=3.3e-21  Score=192.72  Aligned_cols=150  Identities=29%  Similarity=0.506  Sum_probs=126.8

Q ss_pred             cccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .++|...+.||+|+||.||+|.                           +.+.+|++++++++|+||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568889999999999999741                           3577899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc
Q 036342          497 ALVLEYMPHGSLEKYLYSSN-------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV  563 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~  563 (596)
                      ++||||+++|+|.+++....             ..+++.++..++.|++.|+.|+|   ..+++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999997542             34678889999999999999999   899999999999999999999


Q ss_pred             EEEeccccccccCCCCCccccccccccccccCC
Q 036342          564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       564 ~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|++|||+++...............+++.|+||
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP  193 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecCh
Confidence            999999999865332221122234567889998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=2e-21  Score=194.37  Aligned_cols=149  Identities=26%  Similarity=0.349  Sum_probs=129.7

Q ss_pred             hcccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ..++|+..+.||+|+||.||++.                     +.+..|++++++++||||+++++++..++..|+|||
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            34679999999999999999852                     357789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+++|+|.+++......+++..+..++.|++.|+.|+|   ..+|+|+|+||+||+++.++.++++|||++.......  
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--  157 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--  157 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence            99999999999876667899999999999999999999   8999999999999999999999999999887543221  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......|++.|+||
T Consensus       158 ~~~~~~~~~~~y~~P  172 (280)
T cd06611         158 QKRDTFIGTPYWMAP  172 (280)
T ss_pred             cccceeecchhhcCH
Confidence            122335688889887

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.85  E-value=4.1e-21  Score=192.13  Aligned_cols=149  Identities=27%  Similarity=0.471  Sum_probs=125.3

Q ss_pred             ccccccccccCCCceeehhh--------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRA--------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~--------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .+|...+.||+|+||.||++                          .+.+..|++++++++|+||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999964                          1357889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcE
Q 036342          499 VLEYMPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVA  564 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~  564 (596)
                      ||||+++|+|.+++....              ..+++..+..++.|++.|++|||   ..+++|||+||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999987643              24788999999999999999999   8999999999999999999999


Q ss_pred             EEeccccccccCCCCCccccccccccccccCC
Q 036342          565 HLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       565 kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |++|||+++...............+++.|+||
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  193 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCH
Confidence            99999998765332211112223456789887

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.85  E-value=3.5e-21  Score=191.29  Aligned_cols=152  Identities=29%  Similarity=0.449  Sum_probs=128.2

Q ss_pred             HHHhcccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ++.+++++.....||+|+||.||+|.                     +.+.+|+.++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            45567788788899999999999852                     357789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEecccccccc
Q 036342          499 VLEYMPHGSLEKYLYSSNCIL--DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLL  575 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l--~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfGla~~~  575 (596)
                      |+||+++++|.+++......+  ++..+..++.|++.|+.|||   ..+|+|||+||+||+++. ++.+||+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999999998654344  77888889999999999999   899999999999999976 679999999998765


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .....  ......|++.|+||
T Consensus       160 ~~~~~--~~~~~~~~~~~~aP  178 (268)
T cd06624         160 AGINP--CTETFTGTLQYMAP  178 (268)
T ss_pred             ccCCC--ccccCCCCccccCh
Confidence            32211  12234578889887

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.85  E-value=3.9e-21  Score=192.84  Aligned_cols=144  Identities=26%  Similarity=0.424  Sum_probs=123.7

Q ss_pred             ccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          447 FSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      |+..+.||+|+||.||++.                        +.+..|+.++++++|++++++++.+..++..|+||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            6777899999999998731                        2355799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++|+|.+++.... ..+++.++..++.|++.|+.|+|   ..+|+||||||+||++++++.++++|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999886543 35888999999999999999999   8999999999999999999999999999987643221  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......||+.|+||
T Consensus       157 -~~~~~~g~~~y~aP  170 (285)
T cd05630         157 -TIKGRVGTVGYMAP  170 (285)
T ss_pred             -cccCCCCCccccCh
Confidence             12234789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.85  E-value=3.2e-21  Score=207.96  Aligned_cols=149  Identities=21%  Similarity=0.262  Sum_probs=122.9

Q ss_pred             hcccccccccccCCCceeehhh---------------------------------------HHhHHHHHHHHhhcCCCcc
Q 036342          443 ATDEFSENNLIGRGGFALFIRA---------------------------------------FKSFDVECEMMKSIRHRNL  483 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~---------------------------------------~~~~~~e~~~l~~l~H~ni  483 (596)
                      ..++|...+.||+|+||.||++                                       ...+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3568999999999999999952                                       1235689999999999999


Q ss_pred             ceeeeeeccCCeeEEEEecCCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC
Q 036342          484 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD  559 (596)
Q Consensus       484 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~  559 (596)
                      |++++++..++..|+|+|++. +++.+++....    ......++..++.|++.||.|||   ..+|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            999999999999999999994 58888775432    12234567789999999999999   89999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          560 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       560 ~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .++.+||+|||+++.+..... ......+||+.|+||
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aP  337 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSP  337 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCc
Confidence            999999999999987643221 122346799999998

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.85  E-value=1.9e-21  Score=192.40  Aligned_cols=150  Identities=27%  Similarity=0.494  Sum_probs=128.1

Q ss_pred             HhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++..+|+..+.||+|+||.||+|.                    ..+..|++++++++|+||+++++++...+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            455689999999999999999752                    356789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |+++|+|.+++.... ..+++.++..++.|++.|+.|||   ..+++|||+||+||++++++.+|++|||.+........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            999999999997643 45789999999999999999999   89999999999999999999999999999986543211


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......++..|+||
T Consensus       160 --~~~~~~~~~~~~~P  173 (261)
T cd05148         160 --LSSDKKIPYKWTAP  173 (261)
T ss_pred             --cccCCCCceEecCH
Confidence              11233456678887

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.85  E-value=1.7e-21  Score=207.73  Aligned_cols=153  Identities=27%  Similarity=0.369  Sum_probs=122.8

Q ss_pred             hcccccccccccCCCceeehhh---------------------HHhHHHHHHHHhhcC-CCccceeeeee-ccC------
Q 036342          443 ATDEFSENNLIGRGGFALFIRA---------------------FKSFDVECEMMKSIR-HRNLIKVISSC-SNE------  493 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~---------------------~~~~~~e~~~l~~l~-H~niv~l~~~~-~~~------  493 (596)
                      ...++++.+.|.+|||+.||.|                     .+...+|+++|++++ |+|||.+++.. ..+      
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            3456788899999999999974                     356789999999998 99999999943 221      


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla  572 (596)
                      -+++|.||||+||.|-|++..+. ..+.+.++++|+.++++|+.+|| .+.++|||||||.+||||..++..|+||||-|
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            25789999999999999998643 35899999999999999999999 44678999999999999999999999999987


Q ss_pred             cccCCCC-Cccc------cccccccccccCC
Q 036342          573 KLLTGED-QSMT------QTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~-~~~~------~~~~~gt~~y~aP  596 (596)
                      ....... ....      .-..-.|+-|+||
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsP  224 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSP  224 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccCh
Confidence            6532211 1100      0123468899998

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.85  E-value=2.2e-21  Score=194.39  Aligned_cols=149  Identities=22%  Similarity=0.388  Sum_probs=124.5

Q ss_pred             ccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      .+|...+.||+|+||.||+|.                           ..+..|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            457788999999999999752                           24678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC
Q 036342          498 LVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM  562 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~  562 (596)
                      +++||+++++|.+++...               ...+++..+..++.|++.|+.|+|   ..+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            999999999999998532               124778888999999999999999   89999999999999999999


Q ss_pred             cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          563 VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 ~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+|++|||+++...............+++.|+||
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP  195 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCH
Confidence            9999999998865433221112233467789998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.85  E-value=2.4e-21  Score=202.03  Aligned_cols=145  Identities=28%  Similarity=0.388  Sum_probs=122.6

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC-----eeE
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE-----FKA  497 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~  497 (596)
                      +|+..+.||+|+||.||++.                       +.+.+|+.+++.++|+||+++++++..++     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            47888999999999999742                       34678999999999999999999998776     789


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|+||+. ++|.+.+.... .+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 58888876543 5889999999999999999999   89999999999999999999999999999986532


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .. ........+|+.|+||
T Consensus       156 ~~-~~~~~~~~~~~~y~aP  173 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAP  173 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCH
Confidence            21 1222335688999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.85  E-value=3.8e-21  Score=194.11  Aligned_cols=146  Identities=29%  Similarity=0.521  Sum_probs=121.6

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ++|+..+.||+|+||+||+|.                        +.+.+|+++++++ +||||+++++++...+..|+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999741                        2467799999999 799999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcE
Q 036342          500 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVA  564 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~  564 (596)
                      +||+++|+|.+++....               ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999997532               24778899999999999999999   8999999999999999999999


Q ss_pred             EEeccccccccCCCCCccccccccccccccCC
Q 036342          565 HLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       565 kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||+|||++......   ........+..|+||
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aP  187 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAI  187 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCc
Confidence            99999998643211   111112234568887

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.85  E-value=2.6e-21  Score=193.03  Aligned_cols=140  Identities=26%  Similarity=0.455  Sum_probs=120.0

Q ss_pred             cccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          450 NNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       450 ~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      .+.+|+|.||+||-|+                       ...+.|+.+++.++||.||.+...|+..+.++.|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            3899999999999753                       35778999999999999999999999999999999999 55


Q ss_pred             CHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEeccccccccCCCCCcc
Q 036342          507 SLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       507 ~L~~~l~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      |..+++- ...+.+++.....++.||+.|+.|||   .++|+|+|+||+|||+.+   .-.+|+||||+||.+++.   .
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---s  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---S  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh---h
Confidence            7666554 34457888888889999999999999   899999999999999964   357999999999998643   2


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      .....+|||.|+||
T Consensus       722 FRrsVVGTPAYLaP  735 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAP  735 (888)
T ss_pred             hhhhhcCCccccCH
Confidence            34557899999998

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.85  E-value=4.1e-21  Score=190.75  Aligned_cols=150  Identities=25%  Similarity=0.491  Sum_probs=126.1

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|+..+.||+|+||.||+|.                         +.+..|++++++++|||++++++++...+..|+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4578889999999999999642                         346779999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++++|.+++......+++.++..++.|++.|++|+|   ..+++|||+||+||++++++.+|++|||+++.....
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999876667889999999999999999999   889999999999999999999999999998865432


Q ss_pred             CCcc-ccccccccccccCC
Q 036342          579 DQSM-TQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~-~~~~~~gt~~y~aP  596 (596)
                      .... .......++.|+||
T Consensus       161 ~~~~~~~~~~~~~~~y~~P  179 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAP  179 (268)
T ss_pred             cccceeccCCCcCceecCH
Confidence            2111 11112234568887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.85  E-value=3.7e-21  Score=195.87  Aligned_cols=152  Identities=28%  Similarity=0.453  Sum_probs=125.2

Q ss_pred             HhcccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhc-CCCccceeeeeec
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSI-RHRNLIKVISSCS  491 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~  491 (596)
                      ...++|...+.||+|+||.||++.                             ..+..|+.+++++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            345688899999999999999641                             2466799999999 6999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCe
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV  556 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NI  556 (596)
                      .++..|+||||+++|+|.+++....               ..+++.++..++.|++.|+.|+|   ..+++|||+||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeE
Confidence            9889999999999999999997532               24788899999999999999999   89999999999999


Q ss_pred             eeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       557 Ll~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++++++.+|++|||+++...............++..||||
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP  205 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCH
Confidence            9999999999999999865432211111222345678887

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.85  E-value=3.9e-21  Score=194.46  Aligned_cols=146  Identities=23%  Similarity=0.418  Sum_probs=125.9

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|...+.||+|+||.||+|.                      ..+..|+.++++++||||+++++++..++..|+||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            578999999999999999852                      2456799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++ ++|.+++......+++..+..++.|+++|+.|||   +.+++|+||||+||+++.++.+|++|||+++.......  
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            97 5999998876666889999999999999999999   89999999999999999999999999999876432211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......+++.|+||
T Consensus       160 ~~~~~~~~~~y~~P  173 (301)
T cd07873         160 TYSNEVVTLWYRPP  173 (301)
T ss_pred             cccccceeecccCc
Confidence            12234578889988

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.85  E-value=3.6e-21  Score=197.70  Aligned_cols=150  Identities=29%  Similarity=0.462  Sum_probs=124.7

Q ss_pred             cccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhc-CCCccceeeeeeccC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNE  493 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~  493 (596)
                      ..+|.+.+.||+|+||.||++.                             +.+..|+++++++ +||||++++++|..+
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3578899999999999998541                             3467899999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL  558 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl  558 (596)
                      +..++|+||+++|+|.+++....               ..+++.++..++.|++.|+.|||   ..+++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence            99999999999999999987532               24778889999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          559 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       559 ~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++++.+||+|||+++...............++..||||
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP  205 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence            99999999999999865432211112223445679987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.85  E-value=5e-21  Score=191.89  Aligned_cols=149  Identities=28%  Similarity=0.452  Sum_probs=122.5

Q ss_pred             ccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeecc--CCeeE
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSN--EEFKA  497 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~  497 (596)
                      ++|+..+.||+|+||.||++.                         +.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            478889999999999998741                         356789999999999999999998754  34689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++......+++..+..++.|++.|+.|||   ..+++||||||+||++++++.+||+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999776556889999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCcc-ccccccccccccCC
Q 036342          578 EDQSM-TQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~-~~~~~~gt~~y~aP  596 (596)
                      ..... ......++..|+||
T Consensus       161 ~~~~~~~~~~~~~~~~y~aP  180 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAP  180 (284)
T ss_pred             CCcceeecCCCCCceEeeCH
Confidence            22211 11112234457777

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.85  E-value=5.1e-21  Score=190.23  Aligned_cols=129  Identities=24%  Similarity=0.485  Sum_probs=117.3

Q ss_pred             ccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .+|...+.||+|+||.||+|.                         +.+..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357788999999999999641                         3577899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |||+++|+|.+++......+++.++..++.|++.|+.|||   ..+++|||+||+||+++.++.+|++|||+++...
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999876666889999999999999999999   8999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=6e-21  Score=188.89  Aligned_cols=148  Identities=25%  Similarity=0.449  Sum_probs=126.3

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ++|+..+.||+|++|.||++.                          +.+.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            478899999999999999752                          246779999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      |+||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+++|||++|+||++++++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999987654 5788889999999999999999   899999999999999999999999999998865322


Q ss_pred             CCcc-ccccccccccccCC
Q 036342          579 DQSM-TQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~-~~~~~~gt~~y~aP  596 (596)
                      .... ......|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~y~aP  176 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSP  176 (263)
T ss_pred             ccccccccCCCcCccccCc
Confidence            1111 11235678889998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.85  E-value=5.2e-21  Score=191.82  Aligned_cols=148  Identities=22%  Similarity=0.452  Sum_probs=124.0

Q ss_pred             cccccccccCCCceeehhh--------------------------HHhHHHHHHHHhhcCCCccceeeeeeccC--CeeE
Q 036342          446 EFSENNLIGRGGFALFIRA--------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKA  497 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~--------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~  497 (596)
                      .|+..+.||+|+||.||.+                          ...+.+|++++++++|||++++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            4688899999999999853                          13577899999999999999999998775  5689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++++|.+++......+++..+..++.|++.|++|+|   +++++|||+||+||+++.++.+|++|||+++.+..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999999765556789999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCCc-cccccccccccccCC
Q 036342          578 EDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~-~~~~~~~gt~~y~aP  596 (596)
                      .... .......++..|+||
T Consensus       162 ~~~~~~~~~~~~~~~~y~ap  181 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAP  181 (284)
T ss_pred             CccceeecCCCCCCccccCH
Confidence            2211 111234566778887

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.85  E-value=6.3e-21  Score=192.04  Aligned_cols=148  Identities=26%  Similarity=0.356  Sum_probs=127.6

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .+.|+..+.||+|+||.||++.                     +.+..|++++++++|+||+++++++..++..|+||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            3678899999999999999752                     4567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++++++.+++......+++..+..++.|++.|++|||   ..+++|||+||+||+++.++.+||+|||++.......  .
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~  165 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q  165 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence            9999999888765556899999999999999999999   8999999999999999999999999999987543221  1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......+++.|+||
T Consensus       166 ~~~~~~~~~~y~aP  179 (292)
T cd06644         166 RRDSFIGTPYWMAP  179 (292)
T ss_pred             ccceecCCccccCc
Confidence            12334678889887

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.85  E-value=2.6e-21  Score=194.19  Aligned_cols=157  Identities=24%  Similarity=0.345  Sum_probs=130.1

Q ss_pred             cCHHHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhc-CCCccceeeeeec--
Q 036342          435 FSYLELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSI-RHRNLIKVISSCS--  491 (596)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l-~H~niv~l~~~~~--  491 (596)
                      +.++.+..++++|+..+.||+|+||.||++.                    ..+..|+.+++++ +||||+++++++.  
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            4455667788999999999999999999752                    3466789999999 6999999999874  


Q ss_pred             ---cCCeeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEE
Q 036342          492 ---NEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH  565 (596)
Q Consensus       492 ---~~~~~~lV~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~k  565 (596)
                         .++..++||||+++|+|.+++..   ....+++..+..++.|+++|+.|||   ..+++|||+||+||++++++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence               34568999999999999988753   2245788889999999999999999   89999999999999999999999


Q ss_pred             EeccccccccCCCCCccccccccccccccCC
Q 036342          566 LSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       566 l~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++|||+++.+.....  ......|++.|+||
T Consensus       165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  193 (286)
T cd06638         165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAP  193 (286)
T ss_pred             EccCCceeecccCCC--ccccccCCCcccCh
Confidence            999999886543211  22334688999998

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.85  E-value=1.7e-21  Score=197.99  Aligned_cols=144  Identities=26%  Similarity=0.451  Sum_probs=127.0

Q ss_pred             cccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          448 SENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       448 ~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ...+.||+|.||.||+|+                          +.|.+|+.+|+.++|||||+|+|+|.+. ..++|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence            445889999999999862                          5689999999999999999999999775 5799999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      .++-|.|..|++.....++......++.|++.|+.|||   +..+|||||.++|||+.+...+|++|||++|-+.+...+
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            99999999999998888999999999999999999999   999999999999999999999999999999987654433


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      . .+...-+..||||
T Consensus       548 k-aS~~kLPIKWmaP  561 (974)
T KOG4257|consen  548 K-ASRGKLPIKWMAP  561 (974)
T ss_pred             h-ccccccceeecCc
Confidence            3 3334456789998

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.85  E-value=4.1e-21  Score=194.45  Aligned_cols=149  Identities=26%  Similarity=0.454  Sum_probs=124.3

Q ss_pred             cccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      .++|+..+.||+|+||.||++.                          ..+.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            3567888999999999999752                          2466899999999999999999998764 467


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|+||+++|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||++++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999999876656889999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...........++..|+||
T Consensus       162 ~~~~~~~~~~~~~~~y~~P  180 (303)
T cd05110         162 DEKEYNADGGKMPIKWMAL  180 (303)
T ss_pred             cccccccCCCccccccCCH
Confidence            2221112233456788887

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.85  E-value=1.7e-21  Score=192.39  Aligned_cols=144  Identities=32%  Similarity=0.540  Sum_probs=124.3

Q ss_pred             ccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          447 FSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      |+..+.||+|+||.||++.                       ....+|+.++++++||||+++++++..++..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678999999999999852                       12345899999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      ++++|.+++... ..+++..+..++.|+++|+.|||   +.+++|+||||+||+++.++.++++|||.+......  ...
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NEN  154 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSE
T ss_pred             cccccccccccc-ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc--ccc
Confidence            999999999833 35789999999999999999999   889999999999999999999999999998764211  223


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~y~aP  167 (260)
T PF00069_consen  155 FNPFVGTPEYMAP  167 (260)
T ss_dssp             BSSSSSSGGGSCH
T ss_pred             ccccccccccccc
Confidence            3456789999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.85  E-value=6.7e-21  Score=188.07  Aligned_cols=141  Identities=26%  Similarity=0.450  Sum_probs=116.8

Q ss_pred             cccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCC
Q 036342          452 LIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS  507 (596)
Q Consensus       452 ~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~  507 (596)
                      .||+|+||.||+|.                        +.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            38999999998641                        347789999999999999999999864 46799999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc-cccc
Q 036342          508 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQTQ  586 (596)
Q Consensus       508 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~-~~~~  586 (596)
                      |.+++......+++.++..++.|++.|+.|+|   ..+++||||||+||+++.++.+|++|||+++......... ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999866567899999999999999999999   8899999999999999999999999999998654322111 1122


Q ss_pred             ccccccccCC
Q 036342          587 TLGTIGYMAP  596 (596)
Q Consensus       587 ~~gt~~y~aP  596 (596)
                      ..+++.|+||
T Consensus       158 ~~~~~~y~aP  167 (257)
T cd05115         158 GKWPLKWYAP  167 (257)
T ss_pred             CCCCcccCCH
Confidence            2345678887

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.85  E-value=5.9e-21  Score=190.00  Aligned_cols=146  Identities=27%  Similarity=0.441  Sum_probs=116.9

Q ss_pred             cccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccC------Cee
Q 036342          448 SENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE------EFK  496 (596)
Q Consensus       448 ~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~  496 (596)
                      ...+.||+|+||.||+|.                         +.+..|++++++++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999752                         3466789999999999999999987432      246


Q ss_pred             EEEEecCCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          497 ALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                      ++||||+++|+|.+++...     ...+++.....++.|++.|++|||   .++|+|||+||+||++++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999887432     235789999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++.+.............+++.|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~p  183 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAI  183 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCH
Confidence            9876432211112223456678776

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.85  E-value=5.6e-21  Score=188.26  Aligned_cols=146  Identities=26%  Similarity=0.395  Sum_probs=126.8

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|++|.||++.                       +.+.+|++++++++||||+++++++..++..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            47778999999999999852                       3567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++++|.+++... ...+++.++..++.+++.|+.|||   ..+++|+|+||+||++++++.+|++|||+++.+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999775 346889999999999999999999   89999999999999999999999999999886643221 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......|++.|+||
T Consensus       157 -~~~~~~~~~~y~aP  170 (256)
T cd08529         157 -FANTIVGTPYYLSP  170 (256)
T ss_pred             -hhhccccCccccCH
Confidence             22335688899988

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.85  E-value=4.6e-21  Score=189.35  Aligned_cols=137  Identities=26%  Similarity=0.414  Sum_probs=117.8

Q ss_pred             ccccCCCceeehhhH----------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          451 NLIGRGGFALFIRAF----------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +.||+|+||.||+|.                            +.+..|+.++++++|||||++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999852                            2356788899999999999999999998899999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc--------EEEeccccccc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV--------AHLSDFSIAKL  574 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~--------~kl~dfGla~~  574 (596)
                      +++|+|.+++......+++..+..++.|++.|+.|||   +.+|+|||+||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876667889999999999999999999   999999999999999987664        69999998875


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...      .....+++.|+||
T Consensus       158 ~~~------~~~~~~~~~y~aP  173 (258)
T cd05078         158 VLP------KEILLERIPWVPP  173 (258)
T ss_pred             cCC------chhccccCCccCc
Confidence            432      1234678889888

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.85  E-value=5.8e-21  Score=192.09  Aligned_cols=143  Identities=33%  Similarity=0.441  Sum_probs=126.1

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        +.+.+|++++++++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            368889999999999999742                        23667999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+++|+||+|+||++++++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999987763 6788999999999999999999   899999999999999999999999999998875432  


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                         .....|++.|+||
T Consensus       155 ---~~~~~~~~~y~aP  167 (290)
T cd05580         155 ---TYTLCGTPEYLAP  167 (290)
T ss_pred             ---CCCCCCCccccCh
Confidence               2234688899988

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.84  E-value=6.1e-21  Score=189.01  Aligned_cols=148  Identities=27%  Similarity=0.489  Sum_probs=125.4

Q ss_pred             ccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .+|...+.||+|+||.||+|.                    +.+.+|++++++++|+||+++++++..++..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            457888999999999999852                    357789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          505 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       505 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      +|+|.+++.... ..+++..+..++.|+++|++|+|   ..+++|||+||+||++++++.+|++|||+++....... ..
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~  161 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TA  161 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-ec
Confidence            999999997643 45789999999999999999999   89999999999999999999999999999987643211 11


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....++..|+||
T Consensus       162 ~~~~~~~~~y~aP  174 (263)
T cd05052         162 HAGAKFPIKWTAP  174 (263)
T ss_pred             cCCCCCccccCCH
Confidence            1122345678887

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.84  E-value=3.9e-21  Score=190.84  Aligned_cols=147  Identities=27%  Similarity=0.365  Sum_probs=127.6

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|...+.||+|+||.||+|.                     ..+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            3578889999999999999752                     2456799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++++|.+++.... .+++.++..++.|++.|+.|+|   ..+++|+|+||+||+++.++.+|++|||++......  ..
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~  161 (267)
T cd06645          88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA  161 (267)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence            99999999987654 5789999999999999999999   889999999999999999999999999998765322  11


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......|++.|+||
T Consensus       162 ~~~~~~~~~~y~aP  175 (267)
T cd06645         162 KRKSFIGTPYWMAP  175 (267)
T ss_pred             ccccccCcccccCh
Confidence            22345789999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.84  E-value=3.4e-21  Score=214.19  Aligned_cols=155  Identities=23%  Similarity=0.382  Sum_probs=126.0

Q ss_pred             HHHHhcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc--C
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN--E  493 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~--~  493 (596)
                      +.....++|.+.+.||+|+||.||++.                       ..+..|+.++++++|||||+++++|..  .
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            344556789999999999999999742                       357789999999999999999998854  3


Q ss_pred             CeeEEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccC----CCceEeCCCCCCCeeeCC------
Q 036342          494 EFKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGY----SALVIHCDLKPSNVLLDD------  560 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~----~~~i~Hrdlk~~NILl~~------  560 (596)
                      +..|+||||+++|+|.+++...   ...+++..++.|+.||+.||.|||...    ..+|+||||||+|||++.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            5689999999999999998753   246899999999999999999999321    156999999999999964      


Q ss_pred             -----------CCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          561 -----------NMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       561 -----------~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                                 .+.+||+|||+++.+....   ......||+.|+||
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAP  210 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSP  210 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc---cccccCCCccccCH
Confidence                       2358999999998653221   12335799999998

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.84  E-value=7.6e-21  Score=189.24  Aligned_cols=147  Identities=27%  Similarity=0.456  Sum_probs=119.9

Q ss_pred             ccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe-----
Q 036342          447 FSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF-----  495 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----  495 (596)
                      |...+.||+|+||.||+|.                          ..+..|++.+++++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999642                          246789999999999999999998866543     


Q ss_pred             -eEEEEecCCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          496 -KALVLEYMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       496 -~~lV~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                       .++|+||+++|+|.+++....     ..+++..+..++.|++.|+.|+|   ..+++|||+||+||++++++.+|++||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             789999999999998885432     35788999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCC
Q 036342          570 SIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       570 Gla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+++...............++..|+||
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             cceeeccccccccccccccCCccccCH
Confidence            999876433221112223455678776

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.84  E-value=7.1e-21  Score=194.04  Aligned_cols=143  Identities=22%  Similarity=0.331  Sum_probs=116.3

Q ss_pred             cccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeecc--CCeeEEEEecCCCC
Q 036342          450 NNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHG  506 (596)
Q Consensus       450 ~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~~g  506 (596)
                      .+.||+|+||+||+|.                     ..+.+|+.++++++||||+++++++..  +...|+||||+. +
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence            4689999999999863                     246789999999999999999998854  456899999995 5


Q ss_pred             CHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee----CCCCcEEEeccccccc
Q 036342          507 SLEKYLYSSN--------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL----DDNMVAHLSDFSIAKL  574 (596)
Q Consensus       507 ~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl----~~~~~~kl~dfGla~~  574 (596)
                      ++.+++....        ..+++..+..++.|++.|+.|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            8888875321        24788889999999999999999   8999999999999999    4567999999999987


Q ss_pred             cCCCCC-ccccccccccccccCC
Q 036342          575 LTGEDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~-~~~~~~~~gt~~y~aP  596 (596)
                      ...... ........||+.||||
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             cCCCCccccccCCccccccccCC
Confidence            643221 1122346789999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=5.3e-21  Score=190.44  Aligned_cols=145  Identities=26%  Similarity=0.369  Sum_probs=129.0

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      -|+..+.||+|-|++|..|.                       ..+.+|+..|+-++|||||+||++......+|+|.|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            46777899999999987653                       3467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC-CCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~-~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      =.+|||++|+-+....+.+..+.++..||+.|+.|+|   +.++||||+||+|+.+- +-|.+|+.|||++-.+..   .
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---G  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---G  172 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC---c
Confidence            9999999999988888999999999999999999999   88899999999999875 568999999999887643   2


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      ....+.||+..|-||
T Consensus       173 ~kL~TsCGSLAYSAP  187 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAP  187 (864)
T ss_pred             chhhcccchhhccCc
Confidence            345678999999998

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.84  E-value=8.6e-21  Score=190.60  Aligned_cols=151  Identities=26%  Similarity=0.464  Sum_probs=125.2

Q ss_pred             hcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      ..++|+..+.||+|+||.||++.                           +.+.+|+.++++++||||+++++++..++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            35689999999999999999741                           347789999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCC
Q 036342          496 KALVLEYMPHGSLEKYLYSSN---------------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPS  554 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~  554 (596)
                      .++||||+++|+|.+++....                     ..+++.+++.++.|++.|++|+|   ..+++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence            999999999999999997431                     24678888999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          555 NVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       555 NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||++++++.+|++|||+++.+.............++..|+||
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP  201 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence            999999999999999998765332211112223345678887

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.84  E-value=8.7e-21  Score=189.16  Aligned_cols=148  Identities=24%  Similarity=0.428  Sum_probs=125.6

Q ss_pred             ccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ++|+..+.||+|+||.||+|.                           +.+.+|++++++++|+||+++++++.+.+..|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            578889999999999999742                           34778999999999999999999999989999


Q ss_pred             EEEecCCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          498 LVLEYMPHGSLEKYLYSSN--------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                      +||||+++|+|.+++....        ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997643        15789999999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCC
Q 036342          570 SIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       570 Gla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+++...... ........++..|+||
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~P  187 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAP  187 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecCh
Confidence            9987543221 1122334567778887

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.84  E-value=9.7e-21  Score=186.92  Aligned_cols=136  Identities=24%  Similarity=0.438  Sum_probs=115.6

Q ss_pred             ccccCCCceeehhhH------------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          451 NLIGRGGFALFIRAF------------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      +.||+|+||.||+|.                              ..+.+|+.++++++||||+++++++.. +..++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            368999999888531                              346678999999999999999999988 7789999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-------cEEEecccccc
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-------VAHLSDFSIAK  573 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-------~~kl~dfGla~  573 (596)
                      ||+++|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++       .+|++|||+++
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            999999999999876556889999999999999999999   89999999999999999887       79999999988


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....      .....++..|+||
T Consensus       157 ~~~~------~~~~~~~~~y~aP  173 (259)
T cd05037         157 TVLS------REERVERIPWIAP  173 (259)
T ss_pred             cccc------ccccccCCCccCh
Confidence            6532      1123456678877

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.84  E-value=7.3e-21  Score=190.01  Aligned_cols=151  Identities=25%  Similarity=0.380  Sum_probs=123.7

Q ss_pred             hcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      .+++|...+.||+|+||.||+|.                           ..+..|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45679999999999999998641                           246789999999999999999999998888


Q ss_pred             eEEEEecCCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC---cEEE
Q 036342          496 KALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM---VAHL  566 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~---~~kl  566 (596)
                      .++||||+++|+|.+++....      ..+++.++..++.|++.|+.|||   ..+++|||+||+||+++.++   .+|+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999987643      24789999999999999999999   88999999999999998654   6999


Q ss_pred             eccccccccCCCCCccccccccccccccCC
Q 036342          567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       567 ~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|||+++................+..|+||
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPP  190 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCH
Confidence            999999875322111111122335678887

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.84  E-value=6.9e-21  Score=196.35  Aligned_cols=144  Identities=25%  Similarity=0.389  Sum_probs=122.7

Q ss_pred             HhcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-----
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-----  493 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-----  493 (596)
                      +..++|...+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            345789999999999999999852                       2355799999999999999999988643     


Q ss_pred             -CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccc
Q 036342          494 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       494 -~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla  572 (596)
                       ...|+++|++ +++|.++++..  .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence             3478999998 78998887643  4789999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCC
Q 036342          573 KLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +.....     .....||+.|+||
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aP  184 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAP  184 (343)
T ss_pred             eecCCC-----cCCccccccccCc
Confidence            865321     2345789999998

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.84  E-value=1.7e-20  Score=185.23  Aligned_cols=143  Identities=33%  Similarity=0.541  Sum_probs=123.8

Q ss_pred             ccccCCCceeehhh-------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRA-------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~-------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||++                         .+.+.+|+.++++++|+|++++++++..++..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            46899999999874                         23566899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          506 GSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       506 g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      |+|.+++...        ...+++.+++.++.|+++|+.|||   ..+++||||||+||++++++.+|++|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        356899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...........+++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~y~aP  176 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAP  176 (262)
T ss_pred             ccccccccCCCcCccccCH
Confidence            3222223345678889988

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.7e-21  Score=189.10  Aligned_cols=155  Identities=25%  Similarity=0.269  Sum_probs=125.4

Q ss_pred             cCHHHHHHhcccccccccccCCCceeehhhHHhHHH------------------------HHHHHhhc-CCCccceeeee
Q 036342          435 FSYLELCRATDEFSENNLIGRGGFALFIRAFKSFDV------------------------ECEMMKSI-RHRNLIKVISS  489 (596)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~------------------------e~~~l~~l-~H~niv~l~~~  489 (596)
                      .+-.+..+++ +|..+.+||+|+||.|..|.+.-..                        |-.++.-- +-|.+|+++.+
T Consensus       340 ~~~~d~i~~t-DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  340 SSKRDRIKAT-DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             CCcccceeec-ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence            3334444444 6888999999999999875432222                        22222222 57899999999


Q ss_pred             eccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          490 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       490 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                      |+.-+.+|+||||+.||||.-+++.-+ .+.+..+..++++||-||-|||   .++|++||+|.+|||+|.+|++||+||
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DF  494 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADF  494 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeec
Confidence            999999999999999999998887654 5778888999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCC
Q 036342          570 SIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       570 Gla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+++.-.-  ......++||||-|+||
T Consensus       495 GmcKEni~--~~~TTkTFCGTPdYiAP  519 (683)
T KOG0696|consen  495 GMCKENIF--DGVTTKTFCGTPDYIAP  519 (683)
T ss_pred             cccccccc--CCcceeeecCCCccccc
Confidence            99986432  23345679999999998

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.84  E-value=2.4e-21  Score=181.31  Aligned_cols=148  Identities=26%  Similarity=0.337  Sum_probs=119.1

Q ss_pred             hccccccc-ccccCCCceeehhhH----------------HhHHHHHHHH-hhcCCCccceeeeeecc----CCeeEEEE
Q 036342          443 ATDEFSEN-NLIGRGGFALFIRAF----------------KSFDVECEMM-KSIRHRNLIKVISSCSN----EEFKALVL  500 (596)
Q Consensus       443 ~~~~~~~~-~~ig~G~~g~v~~~~----------------~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~~lV~  500 (596)
                      .+++|.+. ++||-|-.|.|..++                ...++|+++- ..-.|||||+++++|+.    ...+.+||
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm  138 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM  138 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence            35566543 679999999987643                2345565542 23369999999999864    34677999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC---CCCcEEEeccccccccC
Q 036342          501 EYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~---~~~~~kl~dfGla~~~~  576 (596)
                      |+|+||+|++.+..++ ..+++.++.+|+.||+.|++|||   +.+|.|||+||+|+|..   .+..+|++|||+|+.-.
T Consensus       139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            9999999999998765 46899999999999999999999   99999999999999996   45689999999999753


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .   .....+.|-||+|.||
T Consensus       216 ~---~~~L~TPc~TPyYvaP  232 (400)
T KOG0604|consen  216 E---PGDLMTPCFTPYYVAP  232 (400)
T ss_pred             C---CccccCCcccccccCH
Confidence            2   2234567899999998

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.84  E-value=9e-21  Score=188.15  Aligned_cols=147  Identities=27%  Similarity=0.452  Sum_probs=125.8

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||+|.                        ..+..|+.++++++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            578999999999999999752                        24678999999999999999999999989999999


Q ss_pred             ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      ||+++|+|.+++..   ....+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   2345788889999999999999999   89999999999999999999999999999886542


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..  .......|++.|+||
T Consensus       159 ~~--~~~~~~~~~~~~~aP  175 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSP  175 (267)
T ss_pred             hh--HHHhcCCCCccccCh
Confidence            21  112234688889988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=1.3e-20  Score=186.33  Aligned_cols=148  Identities=27%  Similarity=0.386  Sum_probs=128.8

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|+..+.||+|+||.||++.                     +.+.+|++++++++||||+++++++..++..|+||||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            4678999999999999999752                     4578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++++|.+++......+++.++..++.|++.|+.|||   ..+++|+|++|+||++++++.+|++|||.+........  
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence            9999999998876457889999999999999999999   89999999999999999999999999999876532211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       157 ~~~~~~~~~~y~~P  170 (262)
T cd06613         157 KRKSFIGTPYWMAP  170 (262)
T ss_pred             ccccccCCccccCc
Confidence            12234678889887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.84  E-value=9.3e-21  Score=210.77  Aligned_cols=147  Identities=25%  Similarity=0.369  Sum_probs=126.8

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|.+.+.||+|+||.||+|.                        +.+..|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            3578999999999999999752                        3567789999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++.... .+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~  158 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE  158 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCc
Confidence            99999999999997654 5788889999999999999999   8899999999999999999999999999998754321


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                        .......+|+.|+||
T Consensus       159 --~~~~~~~~t~~~~~p  173 (669)
T cd05610         159 --LNMMDILTTPSMAKP  173 (669)
T ss_pred             --ccccccccCccccCc
Confidence              122345678888776

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.84  E-value=1.9e-20  Score=183.94  Aligned_cols=142  Identities=27%  Similarity=0.439  Sum_probs=119.5

Q ss_pred             ccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHH
Q 036342          451 NLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE  509 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~  509 (596)
                      +.||+|+||.||+|.                     ..+..|++++++++||||+++++++...+..++||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            368999999999752                     24678999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccc
Q 036342          510 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG  589 (596)
Q Consensus       510 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~g  589 (596)
                      +++......+++..+..++.+++.|+.|+|   ..+++|||+||+||++++++.+|++|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            998776556789999999999999999999   89999999999999999999999999999875432211 11112234


Q ss_pred             cccccCC
Q 036342          590 TIGYMAP  596 (596)
Q Consensus       590 t~~y~aP  596 (596)
                      +..|+||
T Consensus       157 ~~~y~aP  163 (250)
T cd05085         157 PIKWTAP  163 (250)
T ss_pred             cccccCH
Confidence            5678887

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.84  E-value=1.7e-20  Score=184.97  Aligned_cols=146  Identities=23%  Similarity=0.374  Sum_probs=126.3

Q ss_pred             cccccccccCCCceeehhh-----------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRA-----------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~-----------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|+||.||.+                       .+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788899999999977642                       24577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++|+|.+++... ...+++.++..++.|++.|+.|+|   +.+++|+|++|+||++++++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999765 345789999999999999999999   88999999999999999999999999999887643321 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......|++.|+||
T Consensus       157 -~~~~~~~~~~y~ap  170 (256)
T cd08221         157 -MAETVVGTPYYMSP  170 (256)
T ss_pred             -cccccCCCccccCH
Confidence             22345688899887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.84  E-value=1.2e-20  Score=189.75  Aligned_cols=148  Identities=24%  Similarity=0.396  Sum_probs=125.0

Q ss_pred             hcccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++.+|...+.||+|+||.||+|.                      ..+.+|++++++++|+||+++++++..++..|+||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            45789999999999999999852                      14568999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+. +++.+++......+++.++..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 6888877665556778888889999999999999   88999999999999999999999999999876432211


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......+++.|+||
T Consensus       159 --~~~~~~~~~~y~aP  172 (291)
T cd07870         159 --TYSSEVVTLWYRPP  172 (291)
T ss_pred             --CCCCccccccccCC
Confidence              12234578889988

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.84  E-value=1.7e-20  Score=184.92  Aligned_cols=146  Identities=22%  Similarity=0.371  Sum_probs=125.3

Q ss_pred             cccccccccCCCceeehhh----------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          446 EFSENNLIGRGGFALFIRA----------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~----------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      +|+..+.||+|+||.||++                      .+.+..|+.++++++|+||+++++++..++..|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999864                      245678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++|++.+++... ...+++.....++.|++.|+.|+|   +.+++|+|+||+||++++++.++++|||.++.......  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999988653 345788899999999999999999   89999999999999999999999999999886543211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......|++.|+||
T Consensus       156 ~~~~~~~~~~~~aP  169 (255)
T cd08219         156 YACTYVGTPYYVPP  169 (255)
T ss_pred             ccccccCCccccCH
Confidence            12335688889987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.84  E-value=8.7e-21  Score=196.85  Aligned_cols=144  Identities=26%  Similarity=0.375  Sum_probs=120.1

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC-----
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE-----  494 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----  494 (596)
                      ..++|+..+.||+|+||.||++.                       +.+.+|+.++++++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            35789999999999999999852                       34568999999999999999999986543     


Q ss_pred             -eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          495 -FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       495 -~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                       ..|+||||+++ ++.+.+..   .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             47999999965 67666543   3678888899999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .....   .......||+.|+||
T Consensus       172 ~~~~~---~~~~~~~~t~~y~aP  191 (359)
T cd07876         172 TACTN---FMMTPYVVTRYYRAP  191 (359)
T ss_pred             ccccC---ccCCCCcccCCCCCc
Confidence            64321   122345789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=9.3e-22  Score=179.63  Aligned_cols=150  Identities=22%  Similarity=0.415  Sum_probs=125.2

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC------
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE------  493 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~------  493 (596)
                      ....|+....||+|.||+|++|.                       ....+|+.+++.++|+|++.+++.|...      
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            34567888999999999999973                       1345899999999999999999998542      


Q ss_pred             --CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          494 --EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       494 --~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                        ...|+||++|+. ||.-.+......+......+++.++..|+.|+|   ...|+|||+||+|+||+.+|.+|++|||+
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence              348999999987 898888877667888899999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCC--ccccccccccccccCC
Q 036342          572 AKLLTGEDQ--SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~--~~~~~~~~gt~~y~aP  596 (596)
                      ++.......  ....+..+.|.+|++|
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCH
Confidence            986543222  1112445679999887

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.84  E-value=6e-21  Score=189.97  Aligned_cols=150  Identities=26%  Similarity=0.356  Sum_probs=126.5

Q ss_pred             HhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhc-CCCccceeeeeeccC------C
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSI-RHRNLIKVISSCSNE------E  494 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~------~  494 (596)
                      .+++.|+..+.||+|+||.||+|.                    ..+..|+.+++++ +|+||+++++++...      .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            356778899999999999999852                    3577899999998 799999999998653      4


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ..|+||||+++|+|.+++.... ..+++..+..++.|++.|++|||   ..+|+|||+||+||++++++.+|++|||+++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            5899999999999999988643 45789999999999999999999   8899999999999999999999999999988


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ......  .......|++.|+||
T Consensus       160 ~~~~~~--~~~~~~~g~~~y~aP  180 (272)
T cd06637         160 QLDRTV--GRRNTFIGTPYWMAP  180 (272)
T ss_pred             eccccc--ccCCcccccccccCH
Confidence            653221  122345688899988

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.84  E-value=1.5e-20  Score=185.43  Aligned_cols=145  Identities=30%  Similarity=0.444  Sum_probs=122.6

Q ss_pred             cccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeec-cCCeeEEEEecCCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCS-NEEFKALVLEYMPH  505 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lV~e~~~~  505 (596)
                      .++|...+.||+|+||.||++.                 +.+..|+.++++++|+|++++++++. .++..|+||||+++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            3578889999999999999752                 35778999999999999999999764 45678999999999


Q ss_pred             CCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          506 GSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       506 g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      |+|.+++..... .+++..+..++.|++.|++|+|   ..+++||||||+||++++++.+|++|||+++......     
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----  156 (256)
T cd05082          85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----  156 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence            999999976543 4788999999999999999999   8999999999999999999999999999988643221     


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....++..|+||
T Consensus       157 ~~~~~~~~y~aP  168 (256)
T cd05082         157 DTGKLPVKWTAP  168 (256)
T ss_pred             CCCccceeecCH
Confidence            122345678887

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.84  E-value=9.9e-21  Score=187.43  Aligned_cols=148  Identities=26%  Similarity=0.457  Sum_probs=123.8

Q ss_pred             cccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .++|...+.||+|+||.||+|.                   +.+.+|++++++++||||+++++++.. +..|+||||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            4578999999999999999752                   357889999999999999999998754 55799999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          505 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       505 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      +|+|.+++.... ..+++..+..++.|++.|++|+|   +.+++|||+||+||++++++.+||+|||.++.+..... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~  159 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA  159 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence            999999997643 35788999999999999999999   89999999999999999999999999999986543221 11


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....++..|+||
T Consensus       160 ~~~~~~~~~y~~P  172 (262)
T cd05071         160 RQGAKFPIKWTAP  172 (262)
T ss_pred             ccCCcccceecCH
Confidence            1223466779887

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.83  E-value=1e-20  Score=190.80  Aligned_cols=146  Identities=27%  Similarity=0.393  Sum_probs=126.2

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ..+|+..+.||+|+||.||++.                     +.+.+|+.++++++|+||+++++.+..++..|+||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            3478889999999999999852                     3567899999999999999999999998999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++|+|.+++...  .+++.++..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--  171 (296)
T cd06654          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (296)
T ss_pred             cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence            9999999998654  4688999999999999999999   89999999999999999999999999999876532211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......|++.|+||
T Consensus       172 ~~~~~~~~~~y~aP  185 (296)
T cd06654         172 KRSTMVGTPYWMAP  185 (296)
T ss_pred             ccCcccCCccccCH
Confidence            12234688899988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.83  E-value=7.6e-21  Score=197.01  Aligned_cols=144  Identities=26%  Similarity=0.371  Sum_probs=120.7

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC------
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE------  493 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~------  493 (596)
                      ..++|+..+.||+|+||.||++.                       +.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            45789999999999999999752                       3456799999999999999999988643      


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ...|+||||+++ ++.+.+..   .+++..+..++.|+++|+.|||   ..+|+||||||+||++++++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            247999999965 67776643   3678888999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .....   .......||+.|+||
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aP  187 (355)
T cd07874         168 TAGTS---FMMTPYVVTRYYRAP  187 (355)
T ss_pred             cCCCc---cccCCccccCCccCH
Confidence            65322   122345789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.83  E-value=1.6e-20  Score=186.74  Aligned_cols=147  Identities=26%  Similarity=0.433  Sum_probs=123.2

Q ss_pred             ccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ++|...+.||+|+||.||+|.                         +.+..|+.++++++||||+++++++.. +..|+|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999742                         246789999999999999999999875 457899


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++......+++..+..++.+++.|+.|+|   ..+++|||+||+||+++..+.+|++|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999876556899999999999999999999   8999999999999999999999999999988654322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                      . .......++..|+||
T Consensus       162 ~-~~~~~~~~~~~y~aP  177 (270)
T cd05056         162 Y-YKASKGKLPIKWMAP  177 (270)
T ss_pred             c-eecCCCCccccccCh
Confidence            1 111223445678887

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.83  E-value=2.2e-20  Score=185.95  Aligned_cols=147  Identities=29%  Similarity=0.463  Sum_probs=124.7

Q ss_pred             cccccccccCCCceeehhhH-------------------------------HhHHHHHHHHhhcCCCccceeeeeeccCC
Q 036342          446 EFSENNLIGRGGFALFIRAF-------------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE  494 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-------------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~  494 (596)
                      +|...+.||+|+||.||+|.                               +.+..|++++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            46778899999999999852                               13567999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.|+.|+|   +.+++|||++|+||++++++.++++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999997763 6788899999999999999999   88999999999999999999999999999886


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..............|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~P  179 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAP  179 (272)
T ss_pred             ccccccccccccccCCccccCH
Confidence            5322111112334678889887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.83  E-value=1.1e-20  Score=186.75  Aligned_cols=149  Identities=27%  Similarity=0.464  Sum_probs=124.1

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..++|+..+.||+|+||.||++.                   +.+.+|+.++++++|++++++++++.. +..|+||||+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            34578899999999999999752                   457789999999999999999998854 5689999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++++|.+++.... ..+++.++..++.+++.|++|||   +.+++|||+||+||++++++.+|++|||++..+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-c
Confidence            9999999987643 45789999999999999999999   88999999999999999999999999999986543211 1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       159 ~~~~~~~~~~y~aP  172 (260)
T cd05070         159 ARQGAKFPIKWTAP  172 (260)
T ss_pred             cccCCCCCccccCh
Confidence            11223356678887

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=5.9e-21  Score=196.07  Aligned_cols=142  Identities=29%  Similarity=0.462  Sum_probs=123.5

Q ss_pred             cccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          450 NNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       450 ~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      .-++|+|.||+||-|.                     +....|+.+-++++|.|||+.+|++.+++..-+.||-++||+|
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            3579999999999763                     3456799999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEeccccccccCCCCCccccc
Q 036342          509 EKYLYSSNCIL--DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       509 ~~~l~~~~~~l--~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      .+.++..=+++  .+...-.+..||++|+.|||   ...|||||||-+|+|++. .|.+||+|||-++.+.+-.  ....
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE  734 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE  734 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence            99998764455  56677789999999999999   999999999999999975 6999999999999876432  2345


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ++.||..||||
T Consensus       735 TFTGTLQYMAP  745 (1226)
T KOG4279|consen  735 TFTGTLQYMAP  745 (1226)
T ss_pred             ccccchhhhCh
Confidence            68899999998

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.83  E-value=1.9e-20  Score=185.19  Aligned_cols=143  Identities=27%  Similarity=0.453  Sum_probs=116.5

Q ss_pred             ccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeec-cCCeeEEEEecCC
Q 036342          451 NLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCS-NEEFKALVLEYMP  504 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lV~e~~~  504 (596)
                      +.||+|+||.||+|.                         +.+.+|+.++++++||||+++++++. .++..++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999998641                         34667999999999999999999775 4556899999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc--c
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS--M  582 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~--~  582 (596)
                      +|+|.+++.......++..+..++.|+++|+.|+|   ..+++|||+||+||++++++.+|++|||+++........  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999876555678888899999999999999   889999999999999999999999999998865322110  1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (262)
T cd05058         158 NHTGAKLPVKWMAL  171 (262)
T ss_pred             ccccCcCCccccCh
Confidence            11223456788887

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.83  E-value=1.2e-20  Score=189.30  Aligned_cols=145  Identities=24%  Similarity=0.374  Sum_probs=124.8

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|+||.||++.                      ..+.+|++++++++|+||+++++++..++..|+||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            468889999999999998742                      3567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          503 MPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       503 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      +++++|.+++...  ...+++..+..++.+++.|+.|||   . .+++||||||+||+++.++.+|++|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999988764  236789999999999999999999   5 489999999999999999999999999987653221


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                          .....+++.|+||
T Consensus       158 ----~~~~~~~~~y~aP  170 (286)
T cd06622         158 ----AKTNIGCQSYMAP  170 (286)
T ss_pred             ----cccCCCccCccCc
Confidence                2234578889887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.83  E-value=1.8e-20  Score=186.40  Aligned_cols=140  Identities=31%  Similarity=0.543  Sum_probs=115.6

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||+|.                        +.+..|+++++++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999998752                        2466799999999 899999999999999999999999999


Q ss_pred             CCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccc
Q 036342          506 GSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS  570 (596)
Q Consensus       506 g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfG  570 (596)
                      |+|.+++....               ..+++.++..++.|++.|++|+|   +.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999987532               24678899999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCC
Q 036342          571 IAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +++....   .........+..|+||
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~ap  180 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAI  180 (270)
T ss_pred             Cccccch---hhhccCCCCccccCCh
Confidence            9863211   1111112345668887

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.83  E-value=1.2e-20  Score=187.35  Aligned_cols=147  Identities=28%  Similarity=0.451  Sum_probs=126.0

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|...+.||+|+||.||++.                        +.+..|+.++++++|+||+++++++..++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            478888999999999999742                        24667999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      ||+++++|.+++..   ....+++.+++.++.|++.|+.|||   ..+++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998864   2245789999999999999999999   99999999999999999999999999999886543


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...  ......|+..|+||
T Consensus       159 ~~~--~~~~~~~~~~~~ap  175 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSP  175 (267)
T ss_pred             CCc--ccccccCCcCccCH
Confidence            221  12234688889987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.83  E-value=1.6e-20  Score=188.16  Aligned_cols=145  Identities=26%  Similarity=0.401  Sum_probs=123.2

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|...+.||+|++|.||+|.                       +.+..|+.++++++||||+++++++..++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            47788999999999999852                       2467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          503 MPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       503 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ++ +++.+++....  ..+++.++..++.|++.|+.|||   ..+++|||+||+||++++++.+||+|||+++.......
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 68988886532  46789999999999999999999   89999999999999999999999999999875432211


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......+++.|+||
T Consensus       157 --~~~~~~~~~~y~aP  170 (285)
T cd07861         157 --VYTHEVVTLWYRAP  170 (285)
T ss_pred             --cccCCcccccccCh
Confidence              12234578889988

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.83  E-value=1.7e-20  Score=187.60  Aligned_cols=139  Identities=27%  Similarity=0.404  Sum_probs=121.2

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      +|+..+.||+|+||.||+|.                      +.+..|++++++++||||+++++++..++..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            67788999999999999852                      34678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      ++|++..+.     .+++..+..++.|++.|+.|+|   +.+|+|+|+||+||+++.++.+||+|||++......    .
T Consensus        82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~  149 (279)
T cd06619          82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----I  149 (279)
T ss_pred             CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----c
Confidence            999997652     3578888899999999999999   999999999999999999999999999998865322    1


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....||..|+||
T Consensus       150 ~~~~~~~~~y~aP  162 (279)
T cd06619         150 AKTYVGTNAYMAP  162 (279)
T ss_pred             ccCCCCChhhcCc
Confidence            2335789999998

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.83  E-value=1.7e-20  Score=188.75  Aligned_cols=146  Identities=23%  Similarity=0.410  Sum_probs=124.2

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|++|.||+|.                      ..+..|++++++++|+||+++++++.+++..|+||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            578899999999999999852                      2346799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++ ++|.+++......+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+|++|||+++.......  
T Consensus        85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            97 4999998876667889999999999999999999   89999999999999999999999999999875422111  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       159 ~~~~~~~~~~~~aP  172 (291)
T cd07844         159 TYSNEVVTLWYRPP  172 (291)
T ss_pred             cccccccccccCCc
Confidence            11223467788887

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.83  E-value=1.6e-20  Score=189.53  Aligned_cols=146  Identities=27%  Similarity=0.389  Sum_probs=126.3

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ..+|+..+.||+|+||.||++.                     +.+..|+.++++++|+||+++++++..++..|+||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            3578899999999999999852                     3467799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++++|.+++...  .+++.++..++.|++.|+.|||   +.+++|||+||+||+++.++.+|++|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--  170 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence            9999999998654  4688899999999999999999   89999999999999999999999999999876543221  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......+++.|+||
T Consensus       171 ~~~~~~~~~~y~aP  184 (297)
T cd06656         171 KRSTMVGTPYWMAP  184 (297)
T ss_pred             CcCcccCCccccCH
Confidence            12234678889887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.83  E-value=1.4e-20  Score=186.01  Aligned_cols=150  Identities=29%  Similarity=0.501  Sum_probs=126.8

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..++|...+.||+|+||.||+|.                   +.+..|+.++++++|+||+++++++..+...++||||+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            45689999999999999999752                   45788999999999999999999999888999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++++|.+++.... ..+++.++..++.+++.|+.|+|   ..+++|+|+||+||++++++.+|++|||+++...... ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence            9999999997643 46889999999999999999999   8899999999999999999999999999988654211 11


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       160 ~~~~~~~~~~y~~P  173 (261)
T cd05034         160 AREGAKFPIKWTAP  173 (261)
T ss_pred             hhhccCCCccccCH
Confidence            11122345678776

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.83  E-value=2.1e-20  Score=190.45  Aligned_cols=143  Identities=22%  Similarity=0.348  Sum_probs=115.8

Q ss_pred             cccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeecc--CCeeEEEEecCCCC
Q 036342          450 NNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHG  506 (596)
Q Consensus       450 ~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~~g  506 (596)
                      ...||+|+||.||+|.                     ..+.+|++++++++||||+++++++..  +...++||||+++ 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            3679999999999863                     246789999999999999999998853  4578999999964 


Q ss_pred             CHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee----CCCCcEEEeccccccc
Q 036342          507 SLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL----DDNMVAHLSDFSIAKL  574 (596)
Q Consensus       507 ~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl----~~~~~~kl~dfGla~~  574 (596)
                      ++.+++...        ...+++..+..++.|++.|+.|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            887776532        124788889999999999999999   8999999999999999    5667999999999987


Q ss_pred             cCCCCC-ccccccccccccccCC
Q 036342          575 LTGEDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~-~~~~~~~~gt~~y~aP  596 (596)
                      ...... ........||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             cCCCcccccccCcceecccccCc
Confidence            543221 1122345789999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.83  E-value=2.7e-20  Score=186.51  Aligned_cols=145  Identities=28%  Similarity=0.468  Sum_probs=119.0

Q ss_pred             ccccccccCCCceeehhh--------------------------HHhHHHHHHHHhhcCCCccceeeeeeccC--CeeEE
Q 036342          447 FSENNLIGRGGFALFIRA--------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKAL  498 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~--------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l  498 (596)
                      |+..+.||+|+||+||.+                          ...+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            378899999999999531                          13466899999999999999999988653  35899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++...  .+++.++..++.|++.|+.|||   +.+++||||||+||++++++.+|++|||+++.+...
T Consensus        86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            99999999999999764  4889999999999999999999   899999999999999999999999999999876432


Q ss_pred             CCcc-ccccccccccccCC
Q 036342          579 DQSM-TQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~-~~~~~~gt~~y~aP  596 (596)
                      .... ......++..|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~P  179 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAV  179 (283)
T ss_pred             chhhccCCCCCCCceeeCH
Confidence            2111 11223456668877

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.83  E-value=1.2e-20  Score=189.18  Aligned_cols=145  Identities=27%  Similarity=0.414  Sum_probs=124.2

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|+||.||+|.                       ..+..|++++++++||||+++++++.+.+..|+|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            47788999999999999852                       2356799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++ +++.+++......+++..+..++.|+++|+.|||   ..+++|||+||+||+++.++.+||+|||+++.......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            96 5898888765556899999999999999999999   89999999999999999999999999999886532211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......+++.|+||
T Consensus       155 ~~~~~~~~~~y~aP  168 (284)
T cd07839         155 CYSAEVVTLWYRPP  168 (284)
T ss_pred             CcCCCccccCCcCh
Confidence            12234678889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.83  E-value=2.7e-20  Score=184.59  Aligned_cols=148  Identities=24%  Similarity=0.390  Sum_probs=123.3

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccC--Cee
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFK  496 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  496 (596)
                      .+|+..+.||+|+||.||++.                          +.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            478889999999999999742                          2456799999999999999999998764  468


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ++||||+++|+|.+++.... .+++.....++.|++.|+.|+|   +.+++|+||||+||+++.++.+||+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987653 4678888999999999999999   8899999999999999999999999999988653


Q ss_pred             CCCCc-cccccccccccccCC
Q 036342          577 GEDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aP  596 (596)
                      ..... .......|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSP  178 (265)
T ss_pred             cccccccccccCCCCccccCh
Confidence            21111 112234688899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.83  E-value=2.3e-20  Score=187.15  Aligned_cols=146  Identities=25%  Similarity=0.380  Sum_probs=127.1

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++..++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            47888999999999999852                       3567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      + +++|.+++......+++.++..++.|+++|+.|||   +.+++|+|+||+||++++++.++++|||++........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999999776667899999999999999999999   89999999999999999999999999999887643221 1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......|+.+|+||
T Consensus       156 ~~~~~~~~~~y~aP  169 (286)
T cd07832         156 LYSHQVATRWYRAP  169 (286)
T ss_pred             ccccccCcccccCc
Confidence            12335688899998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.83  E-value=1.6e-20  Score=188.94  Aligned_cols=157  Identities=25%  Similarity=0.347  Sum_probs=129.8

Q ss_pred             cCHHHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhc-CCCccceeeeeeccC
Q 036342          435 FSYLELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSI-RHRNLIKVISSCSNE  493 (596)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~  493 (596)
                      +.+.++..++++|+..+.||+|+||.||++.                    ..+.+|+.+++++ +|||++++++++...
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            3445666778999999999999999999842                    3456789999998 899999999998653


Q ss_pred             -----CeeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEE
Q 036342          494 -----EFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH  565 (596)
Q Consensus       494 -----~~~~lV~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~k  565 (596)
                           +..|+||||+++|+|.++++.   ....+++..+..++.|++.|+.|||   ..+++||||||+||++++++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence                 358999999999999998863   2346789999999999999999999   88999999999999999999999


Q ss_pred             EeccccccccCCCCCccccccccccccccCC
Q 036342          566 LSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       566 l~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++|||+++.......  ......|+..|+||
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  197 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAP  197 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccCh
Confidence            999999886543211  12234678889987

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.83  E-value=2.9e-20  Score=183.34  Aligned_cols=145  Identities=30%  Similarity=0.513  Sum_probs=124.8

Q ss_pred             cccccccccccCCCceeehhh------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          444 TDEFSENNLIGRGGFALFIRA------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      .++|+..+.||+|+||.||++                  .+++..|+.++++++|+||+++++++..++..++||||+++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            457888999999999999974                  24677899999999999999999999988899999999999


Q ss_pred             CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          506 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       506 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      ++|.+++.... ..+++..+..++.|++.|+.|+|   ..+++||||||+||+++.++.+|++|||.++......     
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----  156 (256)
T cd05039          85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----  156 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc-----
Confidence            99999997654 25789999999999999999999   9999999999999999999999999999988653211     


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....++..|+||
T Consensus       157 ~~~~~~~~~~ap  168 (256)
T cd05039         157 DSGKLPVKWTAP  168 (256)
T ss_pred             ccCCCcccccCc
Confidence            122345567776

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.83  E-value=2.7e-20  Score=183.45  Aligned_cols=148  Identities=28%  Similarity=0.498  Sum_probs=126.1

Q ss_pred             ccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      .+|+..+.||+|+||.||++.                   ..+..|++++++++|||++++++++...+..++||||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            467888999999999999752                   3578899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++......+++..+..++.+++.|++|||   +.+++|||+||+||+++.++.+|++|||+++...... .....
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~  159 (256)
T cd05112          84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSST  159 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccccC
Confidence            9999999876556789999999999999999999   8899999999999999999999999999988653221 11112


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...++.+|+||
T Consensus       160 ~~~~~~~~~aP  170 (256)
T cd05112         160 GTKFPVKWSSP  170 (256)
T ss_pred             CCccchhhcCH
Confidence            23355678887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.83  E-value=2.8e-20  Score=188.52  Aligned_cols=126  Identities=24%  Similarity=0.388  Sum_probs=114.2

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        +.+..|+++++.++||||+++++.+..++..|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368889999999999999641                        24557899999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ||+++|+|.+++.... .+++..+..++.+++.|+.|+|   +.+++|||+||+||+++.++.+|++|||+++.
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            9999999999997654 5788889999999999999999   89999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.83  E-value=1.7e-20  Score=195.02  Aligned_cols=144  Identities=26%  Similarity=0.366  Sum_probs=120.8

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC------
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE------  493 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~------  493 (596)
                      ..++|...+.||+|+||.||++.                       +.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            45789999999999999998752                       3456799999999999999999988643      


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ...|+||||+++ ++.+.+..   .+++..+..++.|+++|++|||   .++|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            247999999965 77777753   3678889999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .....   .......||+.|+||
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aP  194 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAP  194 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCH
Confidence            65322   122345789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2e-20  Score=190.50  Aligned_cols=124  Identities=22%  Similarity=0.368  Sum_probs=112.0

Q ss_pred             ccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          447 FSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      |-..+.||-|+||+|..+.                        ...+.|-.||...+.+=||+||-.|++++.+|+||||
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            7778999999999996531                        2345688899999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ++|||+...|...+ .+++..+..+++++..|+++.|   ..++|||||||+|||||.+|++|+.|||++.-
T Consensus       711 IPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             cCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecccccc
Confidence            99999999988765 6888889999999999999999   99999999999999999999999999999863

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.83  E-value=2.6e-20  Score=186.26  Aligned_cols=151  Identities=21%  Similarity=0.375  Sum_probs=125.0

Q ss_pred             hcccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeecc-CCe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSN-EEF  495 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~  495 (596)
                      ..++|...+.||+|+||.||+|.                          +.+.+|+.++++++|+||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34678899999999999999752                          236689999999999999999998776 467


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEec
Q 036342          496 KALVLEYMPHGSLEKYLYSSN-------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD  568 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~d  568 (596)
                      .++++||+++|+|.+++....       ..+++.++..++.|++.|++|||   +.+++|||+||+||++++++.+|++|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999987642       34789999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccCC
Q 036342          569 FSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||+++.+.............++..|+||
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~ap  188 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMAL  188 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCH
Confidence            9999866433221112223456678887

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.83  E-value=3.5e-20  Score=183.80  Aligned_cols=147  Identities=26%  Similarity=0.460  Sum_probs=126.3

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||+|.                        +.+.+|++++++++|+|++++++++..++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            578999999999999999752                        35678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      ||+++|+|.+++...   ...+++.++..++.+++.|+.|||   ..+++|||++|+||+++.++.++++|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988642   245788999999999999999999   89999999999999999999999999999876532


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...  ......+++.|+||
T Consensus       159 ~~~--~~~~~~~~~~y~ap  175 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSP  175 (267)
T ss_pred             CCc--ccceecCCccccCH
Confidence            211  12234678889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.83  E-value=2.5e-20  Score=184.32  Aligned_cols=147  Identities=27%  Similarity=0.467  Sum_probs=122.4

Q ss_pred             ccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      ++|...+.||+|+||.||++.                   +.+.+|+.++++++|+|++++++++.. +..++||||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence            568888999999999999752                   357789999999999999999998854 567999999999


Q ss_pred             CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          506 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       506 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      |+|.+++.... ..+++..+..++.|++.|+.|||   +.+++|||+||+||++++++.+|++|||+++...... ....
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~  160 (260)
T cd05069          85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTAR  160 (260)
T ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-cccc
Confidence            99999997643 34789999999999999999999   8899999999999999999999999999998653221 1111


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....++..|+||
T Consensus       161 ~~~~~~~~y~~P  172 (260)
T cd05069         161 QGAKFPIKWTAP  172 (260)
T ss_pred             CCCccchhhCCH
Confidence            223456778887

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.83  E-value=3.5e-20  Score=183.74  Aligned_cols=147  Identities=25%  Similarity=0.454  Sum_probs=124.4

Q ss_pred             cccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      +|...+.||+|+||.||+|.                          +.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47778999999999999741                          2466799999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      +||+++|+|.+++.... .+++..+..++.|++.|++|+|   ..+++|+|++|+||++++++.+|++|||+++......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997654 5788899999999999999999   8899999999999999999999999999987642211


Q ss_pred             ----CccccccccccccccCC
Q 036342          580 ----QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ----~~~~~~~~~gt~~y~aP  596 (596)
                          .........|+..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~p  177 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAP  177 (265)
T ss_pred             ccccccccccccCCCccccCh
Confidence                01112234688889987

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.83  E-value=2.9e-20  Score=184.46  Aligned_cols=147  Identities=27%  Similarity=0.488  Sum_probs=124.1

Q ss_pred             cccccccccCCCceeehhhH------------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          446 EFSENNLIGRGGFALFIRAF------------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~------------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      +|...+.||+|+||.||+|.                              +.+.+|++++++++||||+++++++..++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            36677899999999999752                              236679999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .++||||+++++|.+++.... .+++..+..++.|++.|++|+|   ..+++||||+|+||++++++.+||+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997653 5788889999999999999999   889999999999999999999999999998876


Q ss_pred             CCCCCcc----ccccccccccccCC
Q 036342          576 TGEDQSM----TQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~----~~~~~~gt~~y~aP  596 (596)
                      .......    ......|+..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~p  181 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAP  181 (267)
T ss_pred             ccccccCCccccccccCCCcCccCh
Confidence            4221110    11224578889887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.83  E-value=3.5e-20  Score=182.55  Aligned_cols=148  Identities=27%  Similarity=0.379  Sum_probs=129.8

Q ss_pred             cccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .++|+..+.||+|+||.||++.                   +.+.+|++++++++|+||+++++++..++..|+|+||++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            4688999999999999999752                   457889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +++|.+++......+++..+..++.|++.|+.|||   ..+++|+|++|+||++++++.+|++|||++........  ..
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~  156 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KR  156 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--cc
Confidence            99999999876667899999999999999999999   88999999999999999999999999999887643221  12


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....|+..|+||
T Consensus       157 ~~~~~~~~y~~P  168 (256)
T cd06612         157 NTVIGTPFWMAP  168 (256)
T ss_pred             ccccCCccccCH
Confidence            234578889887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.83  E-value=4.2e-20  Score=182.33  Aligned_cols=140  Identities=24%  Similarity=0.418  Sum_probs=116.2

Q ss_pred             cccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          452 LIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       452 ~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      .||+|+||.||+|.                         +.+..|+.++++++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            58999999999751                         346788999999999999999999864 4578999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc-ccc
Q 036342          507 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQT  585 (596)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~-~~~  585 (596)
                      +|.+++.... .+++..+..++.|++.|++|+|   .++++|||+||+||++++++.+|++|||+++.+....... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999997653 5789999999999999999999   8999999999999999999999999999998764332211 112


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...+++.|+||
T Consensus       157 ~~~~~~~y~aP  167 (257)
T cd05116         157 HGKWPVKWYAP  167 (257)
T ss_pred             CCCCCccccCH
Confidence            23345788887

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.82  E-value=4.5e-20  Score=181.74  Aligned_cols=143  Identities=27%  Similarity=0.509  Sum_probs=120.8

Q ss_pred             ccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCC
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS  507 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~  507 (596)
                      ++|+..+.||+|+||.||++.                 +.+..|+.++++++|||++++++++..++ .++||||+++|+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~   84 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGN   84 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCC
Confidence            568899999999999999852                 35778999999999999999999987654 799999999999


Q ss_pred             HHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccc
Q 036342          508 LEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  586 (596)
Q Consensus       508 L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~  586 (596)
                      |.+++.... ..+++..+..++.|++.|+.|+|   ..+++|||+||+||+++.++.+|++|||+++.....     ...
T Consensus        85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~  156 (254)
T cd05083          85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDN  156 (254)
T ss_pred             HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCC
Confidence            999997654 35788999999999999999999   899999999999999999999999999998754221     111


Q ss_pred             ccccccccCC
Q 036342          587 TLGTIGYMAP  596 (596)
Q Consensus       587 ~~gt~~y~aP  596 (596)
                      ...+..|+||
T Consensus       157 ~~~~~~y~~p  166 (254)
T cd05083         157 SKLPVKWTAP  166 (254)
T ss_pred             CCCCceecCH
Confidence            2334567776

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.82  E-value=4.5e-20  Score=183.36  Aligned_cols=143  Identities=29%  Similarity=0.487  Sum_probs=117.6

Q ss_pred             ccccCCCceeehhhH----------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          451 NLIGRGGFALFIRAF----------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +.||+|+||.||++.                            ..+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999998531                            2456789999999999999999999998999999999


Q ss_pred             CCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-----cEEEecccc
Q 036342          503 MPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-----VAHLSDFSI  571 (596)
Q Consensus       503 ~~~g~L~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-----~~kl~dfGl  571 (596)
                      +++|+|.+++...      ...+++.++..++.|++.|++|+|   ..+++|+|+||+||+++.++     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999753      134788899999999999999999   88999999999999999877     899999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++...............++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aP  182 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAP  182 (269)
T ss_pred             ccccccccccccCcccCCCccccCH
Confidence            8865332221122233456788887

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.82  E-value=5.7e-20  Score=182.38  Aligned_cols=148  Identities=24%  Similarity=0.424  Sum_probs=123.2

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeecc--CCee
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSN--EEFK  496 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~  496 (596)
                      .+|+..+.||+|+||.||++.                          +.+.+|++++++++||||+++++++..  ++..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            368889999999999999752                          236679999999999999999998865  3568


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ++|+||+++++|.+++.... .+++.....++.|++.|+.|||   ..+++|||+||+||+++.++.+||+|||+++.+.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999997654 4788899999999999999999   8999999999999999999999999999987653


Q ss_pred             CCCC-ccccccccccccccCC
Q 036342          577 GEDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~-~~~~~~~~gt~~y~aP  596 (596)
                      .... ........++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSP  178 (266)
T ss_pred             cccccCCccccCCccccccCH
Confidence            2111 1111234578889988

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.82  E-value=3.5e-20  Score=185.80  Aligned_cols=146  Identities=27%  Similarity=0.405  Sum_probs=124.1

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||.||+|.                       +.+..|++++++++|+|++++++++..++..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            468889999999999999852                       235679999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |++++.+..+.... ..+++.++..++.|++.|+.|||   ..+++|||+||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            99998888776543 35889999999999999999999   89999999999999999999999999999987643221 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......++..|+||
T Consensus       156 -~~~~~~~~~~~~aP  169 (286)
T cd07847         156 -DYTDYVATRWYRAP  169 (286)
T ss_pred             -cccCcccccccCCH
Confidence             12234567788887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.82  E-value=4.2e-20  Score=182.23  Aligned_cols=142  Identities=25%  Similarity=0.390  Sum_probs=120.2

Q ss_pred             ccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|++|.||+|.                         +.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999998752                         356789999999999999999999988 889999999999


Q ss_pred             CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc-cc
Q 036342          506 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-MT  583 (596)
Q Consensus       506 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~-~~  583 (596)
                      |+|.+++.... ..+++...+.++.|++.|++|+|   ..+++|||+||+||+++.++.+|++|||+++.+...... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999998755 46789999999999999999999   899999999999999999999999999999876432211 11


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....++..|+||
T Consensus       157 ~~~~~~~~~y~~p  169 (257)
T cd05040         157 EEHLKVPFAWCAP  169 (257)
T ss_pred             ccCCCCCceecCH
Confidence            1234567788887

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.82  E-value=3.7e-20  Score=183.04  Aligned_cols=149  Identities=22%  Similarity=0.462  Sum_probs=124.1

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..++|+..+.||+|+||.||+|.                   ..+..|+.++++++|+||+++++++. ++..++||||+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            35678999999999999999852                   46788999999999999999999874 45689999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++|+|.+++.... ..+++.++..++.|++.|++|||   ..+++|||+||+||++++++.++++|||++....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YT  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-cc
Confidence            9999999986543 46788999999999999999999   8999999999999999999999999999987654221 11


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       159 ~~~~~~~~~~y~~p  172 (260)
T cd05067         159 AREGAKFPIKWTAP  172 (260)
T ss_pred             cccCCcccccccCH
Confidence            11223456678887

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.82  E-value=2.8e-20  Score=196.77  Aligned_cols=157  Identities=25%  Similarity=0.349  Sum_probs=133.8

Q ss_pred             cCHHHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhc-CCCccceeeeeecc-
Q 036342          435 FSYLELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSI-RHRNLIKVISSCSN-  492 (596)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~-  492 (596)
                      ..++.+...++.|++.+.||+|.+|.|||+.                    ..+..|..+++.. .|||++.++|++.. 
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            4455666678899999999999999999853                    3466777888876 69999999999853 


Q ss_pred             ----CCeeEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEe
Q 036342          493 ----EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS  567 (596)
Q Consensus       493 ----~~~~~lV~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~  567 (596)
                          ++.+|||||||.+|+..|.++.- +..+.|.....|++++++|+.+||   ...++|||+|=.|||++.++.+|++
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEe
Confidence                46899999999999999998864 346788899999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccccccCC
Q 036342          568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       568 dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||++..++...  ....+..|||.||||
T Consensus       166 DFGvSaQldsT~--grRnT~iGtP~WMAP  192 (953)
T KOG0587|consen  166 DFGVSAQLDSTV--GRRNTFIGTPYWMAP  192 (953)
T ss_pred             eeeeeeeeeccc--ccccCcCCCcccccc
Confidence            999998875432  234567899999998

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.82  E-value=3.3e-20  Score=187.31  Aligned_cols=145  Identities=28%  Similarity=0.462  Sum_probs=123.6

Q ss_pred             cccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      +|+..+.||+|+||.||+|.                          ..+..|++++++++|+||+++++++.+++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            47778899999999999852                          1245799999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+ +|+|.+++......+++..+..++.|+++|+.|||   ..+++|+||||+||+++.++.+||+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 99999999776546899999999999999999999   8999999999999999999999999999998764322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                      .  ......+++.|+||
T Consensus       157 ~--~~~~~~~~~~y~aP  171 (298)
T cd07841         157 R--KMTHQVVTRWYRAP  171 (298)
T ss_pred             c--cccccccceeeeCH
Confidence            1  12223467778887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.82  E-value=3.6e-20  Score=186.84  Aligned_cols=146  Identities=28%  Similarity=0.423  Sum_probs=126.7

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ..+|+..+.||.|+||.||++.                     +.+..|+.++++++||||+++++++..++..|+|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            3468999999999999999752                     3567799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++++|.+++...  .+++.++..++.+++.|+.|||   +.+++|||+||+||+++.++.+||+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  170 (296)
T cd06655          98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--  170 (296)
T ss_pred             cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence            9999999998654  4789999999999999999999   89999999999999999999999999999886543221  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......|++.|+||
T Consensus       171 ~~~~~~~~~~y~aP  184 (296)
T cd06655         171 KRSTMVGTPYWMAP  184 (296)
T ss_pred             cCCCcCCCccccCc
Confidence            12234688899998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.82  E-value=3.8e-20  Score=185.84  Aligned_cols=144  Identities=26%  Similarity=0.426  Sum_probs=118.6

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhc---CCCccceeeeeecc-----CC
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSI---RHRNLIKVISSCSN-----EE  494 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~  494 (596)
                      +|+..+.||+|+||+||+|.                       ..+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47888999999999999862                       1345677777765   69999999998864     24


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ..++||||++ +++.+++.... ..+++..+..++.|++.|+.|+|   +.+++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5899999997 48988887643 35789999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ......   ......||+.|+||
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aP  176 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAP  176 (288)
T ss_pred             cccCcc---cCCCccccccccCc
Confidence            654221   12335688999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.82  E-value=4.1e-20  Score=182.27  Aligned_cols=144  Identities=27%  Similarity=0.423  Sum_probs=124.5

Q ss_pred             cccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      +|...+.||+|+||+||+|.                          +.+..|++++++++|+||+++++++..++..|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            36778899999999999752                          3467899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      +||+++++|.+++.... .+++..+..++.|++.|++|+|   ..+++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999997653 5788999999999999999999   8999999999999999999999999999988653221


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         ......|+..|+||
T Consensus       157 ---~~~~~~~~~~y~~p  170 (258)
T cd06632         157 ---FAKSFKGSPYWMAP  170 (258)
T ss_pred             ---cccccCCCcceeCH
Confidence               12335678888887

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.82  E-value=5e-20  Score=185.26  Aligned_cols=146  Identities=25%  Similarity=0.325  Sum_probs=123.4

Q ss_pred             cccccccccCCCceeehhhH----------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCee
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  496 (596)
                      +|+..+.||+|+||.||++.                            +.+..|+.+++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            47788999999999998531                            2356799999999 599999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+||||+++++|.+++.... .+++..+..++.|+++|+.|||   ..+++||||+|+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999997654 5788888889999999999999   8999999999999999999999999999988653


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ... ........|+..|+||
T Consensus       157 ~~~-~~~~~~~~~~~~y~aP  175 (290)
T cd05613         157 EDE-VERAYSFCGTIEYMAP  175 (290)
T ss_pred             ccc-ccccccccCCcccCCh
Confidence            321 1122235688899988

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.82  E-value=5.6e-20  Score=181.81  Aligned_cols=149  Identities=22%  Similarity=0.427  Sum_probs=124.3

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..++|...+.||+|+||.||++.                   +.+.+|++++++++|+||+++++++.. ...|+||||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            34678999999999999999741                   357789999999999999999999887 6789999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++|+|.+++... ....++..+..++.|++.|+.|+|   ..+++||||||+||+++.++.+|++|||.++....... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            999999999764 345788899999999999999999   88999999999999999999999999999876532211 1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       159 ~~~~~~~~~~y~~P  172 (260)
T cd05073         159 AREGAKFPIKWTAP  172 (260)
T ss_pred             cccCCcccccccCH
Confidence            11223456678887

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.82  E-value=3.1e-20  Score=186.19  Aligned_cols=144  Identities=24%  Similarity=0.370  Sum_probs=124.8

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|+||.||++.                      +.+.+|+++++.++||||+++++++...+..|+||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            578889999999999999742                      3577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++|+|.+++.... .+++..+..++.+++.|+.|||   . .+++|||+||+||++++++.++++|||++......   
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            99999999887653 5789999999999999999999   5 47999999999999999999999999998754221   


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......|+..|+||
T Consensus       158 -~~~~~~~~~~~~aP  171 (284)
T cd06620         158 -IADTFVGTSTYMSP  171 (284)
T ss_pred             -ccCccccCcccCCH
Confidence             11235688899887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.82  E-value=8.7e-20  Score=179.92  Aligned_cols=146  Identities=25%  Similarity=0.423  Sum_probs=123.8

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-CeeEEEEe
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-EFKALVLE  501 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e  501 (596)
                      +|+..+.||+|++|.||++.                       +.+..|++++++++|+|++++++.+... ...|+|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            47888999999999999641                       3467799999999999999999988644 46899999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |+++++|.+++.... ..+++.++..++.+++.|+.|+|   +.+++||||||+||+++.++.++++|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            999999999997643 45789999999999999999999   8999999999999999999999999999988663221 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                       .......|++.|+||
T Consensus       157 -~~~~~~~~~~~y~aP  171 (257)
T cd08223         157 -DMASTLIGTPYYMSP  171 (257)
T ss_pred             -CccccccCCcCccCh
Confidence             122345688999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.82  E-value=7.8e-20  Score=183.07  Aligned_cols=149  Identities=26%  Similarity=0.458  Sum_probs=123.7

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeecc--CCee
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSN--EEFK  496 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~  496 (596)
                      ..|+..+.||+|+||.||++.                          +.+..|++++++++|+||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            357778999999999999752                          357789999999999999999999877  5578


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ++||||+++|+|.+++......+++.++..++.|++.|++|||   ..+++|+|+||+||+++.++.+|++|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999876656899999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCCcc-ccccccccccccCC
Q 036342          577 GEDQSM-TQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~-~~~~~~gt~~y~aP  596 (596)
                      ...... ......++..|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~P  181 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAP  181 (284)
T ss_pred             cCCcceeccCCCCCcccccCc
Confidence            222111 11122344557776

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.82  E-value=4.4e-20  Score=185.95  Aligned_cols=147  Identities=24%  Similarity=0.353  Sum_probs=125.3

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC--CeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l  498 (596)
                      .++|+..+.||+|+||.||+|.                       ..+.+|++++++++||||+++++++...  +..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            3578899999999999999852                       1346799999999999999999998877  78999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||++ ++|.+.+......+++..+..++.|++.|++|||   ..+++|+||||+||+++.++.+|++|||+++.....
T Consensus        84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999997 5999988776556899999999999999999999   889999999999999999999999999998876433


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      ..  ......+++.|+||
T Consensus       160 ~~--~~~~~~~~~~~~aP  175 (293)
T cd07843         160 LK--PYTQLVVTLWYRAP  175 (293)
T ss_pred             cc--ccccccccccccCc
Confidence            21  12234578889988

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.82  E-value=6.9e-20  Score=181.60  Aligned_cols=149  Identities=30%  Similarity=0.410  Sum_probs=128.5

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|+||.||++.                      +.+.+|+++++.++|+||+++++.+..++..|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            478899999999999999752                      3567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          503 MPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       503 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      +++++|.+++....  ..+++..+..++.|++.|+.|||   ..+++|||++|+||++++++.+|++|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999997642  35789999999999999999999   89999999999999999999999999999887654322


Q ss_pred             cc--ccccccccccccCC
Q 036342          581 SM--TQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~--~~~~~~gt~~y~aP  596 (596)
                      ..  ......|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~y~~P  175 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAP  175 (267)
T ss_pred             ccccccccccCChhhcCh
Confidence            21  12334688899987

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.82  E-value=3e-20  Score=185.53  Aligned_cols=144  Identities=26%  Similarity=0.394  Sum_probs=124.2

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      .|+..+.||+|+||.||+|.                      +.+..|+.++++++||||+++++++..+...|+||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            46677889999999999852                      34678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      ++++|.+++...  .+++..+..++.|+++|+.|+|   ..+++|+|++|+||++++++.++++|||+++.+....  ..
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            999999998653  5788899999999999999999   8999999999999999999999999999988654321  12


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....|+..|+||
T Consensus       158 ~~~~~~~~~y~aP  170 (277)
T cd06642         158 RNTFVGTPFWMAP  170 (277)
T ss_pred             hhcccCcccccCH
Confidence            2334678889887

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.82  E-value=9e-20  Score=179.96  Aligned_cols=141  Identities=28%  Similarity=0.459  Sum_probs=116.2

Q ss_pred             ccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||+|.                         +.+..|++++++++|+|||++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            468999999998752                         346789999999999999999998764 457999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc-cc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQ  584 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~-~~  584 (596)
                      |+|.+++.... .+++..+..++.|++.|++|||   ..+++|+||||+||+++.++.+|++|||+++......... ..
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998764 6789999999999999999999   8899999999999999999999999999988654322111 11


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....++..|+||
T Consensus       156 ~~~~~~~~y~aP  167 (257)
T cd05060         156 TAGRWPLKWYAP  167 (257)
T ss_pred             cCccccccccCH
Confidence            112234678887

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.82  E-value=8.3e-20  Score=179.44  Aligned_cols=143  Identities=30%  Similarity=0.493  Sum_probs=119.0

Q ss_pred             ccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHH
Q 036342          451 NLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE  509 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~  509 (596)
                      +.||+|+||.||++.                     +.+..|++++++++|+||+++++++...+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999998642                     35778999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccc
Q 036342          510 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG  589 (596)
Q Consensus       510 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~g  589 (596)
                      +++......+++..+..++.+++.|+.|+|   ..+++|||+||+||+++.++.+|++|||+++...............+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999776556788999999999999999999   89999999999999999999999999999886532111111112233


Q ss_pred             cccccCC
Q 036342          590 TIGYMAP  596 (596)
Q Consensus       590 t~~y~aP  596 (596)
                      +..|+||
T Consensus       158 ~~~y~~P  164 (251)
T cd05041         158 PIKWTAP  164 (251)
T ss_pred             eeccCCh
Confidence            5567777

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.82  E-value=3.2e-20  Score=183.27  Aligned_cols=144  Identities=33%  Similarity=0.466  Sum_probs=125.4

Q ss_pred             cccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          446 EFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      +|+..+.||.|+||.||++.                        +.+..|++++++++||||+++++++..++..|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            47888999999999999752                        356789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+++++|.+++... ..+++..+..++.|+++|+.|+|   ..+++|+|++|+||++++++.++++|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999776 46789999999999999999999   8899999999999999999999999999988654321  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......|+..|+||
T Consensus       155 -~~~~~~~~~~y~~P  168 (258)
T cd05578         155 -LTTSTSGTPGYMAP  168 (258)
T ss_pred             -cccccCCChhhcCH
Confidence             12334577888887

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.81  E-value=3.3e-20  Score=186.06  Aligned_cols=146  Identities=27%  Similarity=0.444  Sum_probs=124.7

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||.||+|.                       +.+..|++++++++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            368889999999999999852                       235689999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |++++++.++.... ..+++.++..++.|++.|+.|||   +.+++|+|++|+||++++++.+|++|||++.......  
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--  154 (286)
T cd07846          81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  154 (286)
T ss_pred             cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence            99999888876544 34789999999999999999999   8899999999999999999999999999988653322  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......++..|+||
T Consensus       155 ~~~~~~~~~~~y~aP  169 (286)
T cd07846         155 EVYTDYVATRWYRAP  169 (286)
T ss_pred             cccCcccceeeccCc
Confidence            122334578889887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=5.8e-20  Score=183.15  Aligned_cols=145  Identities=28%  Similarity=0.367  Sum_probs=127.1

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||.|+||.||+|.                      ..+.+|++++++++|+||+++++++.++...|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            468888999999999999852                      3467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++++|.+++...  .+++..+..++.|++.|+.|+|   ..+++|+|++|+||++++++.++++|||+++......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999999765  5789999999999999999999   8999999999999999999999999999998764321  1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......|++.|+||
T Consensus       154 ~~~~~~~~~~y~~P  167 (274)
T cd06609         154 KRNTFVGTPFWMAP  167 (274)
T ss_pred             ccccccCCccccCh
Confidence            22345688889988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.81  E-value=1e-19  Score=179.34  Aligned_cols=146  Identities=30%  Similarity=0.530  Sum_probs=123.6

Q ss_pred             ccccccccCCCceeehhh--------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          447 FSENNLIGRGGFALFIRA--------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~--------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      |+..+.||.|+||.||++                          .+.+..|+.++++++|+||+++++++...+..|+||
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            345688999999999864                          135678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||+++++|.+++...... +++.++..++.|++.|+.|||   +.+++|+|+||+||++++++.++++|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999775533 899999999999999999999   8899999999999999999999999999998764332


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                      ... .....+++.|+||
T Consensus       158 ~~~-~~~~~~~~~y~~P  173 (258)
T smart00219      158 YYK-KKGGKLPIRWMAP  173 (258)
T ss_pred             ccc-cccCCCcccccCh
Confidence            211 1123367889887

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.81  E-value=5.4e-20  Score=184.19  Aligned_cols=156  Identities=25%  Similarity=0.352  Sum_probs=129.1

Q ss_pred             CHHHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhc-CCCccceeeeeecc--
Q 036342          436 SYLELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSI-RHRNLIKVISSCSN--  492 (596)
Q Consensus       436 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~--  492 (596)
                      ++.++..+...|+..+.||+|+||.||+|.                    ..+..|+.+++++ +|+||+++++++..  
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            455666677899999999999999999742                    3566788899988 69999999999853  


Q ss_pred             ----CCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEe
Q 036342          493 ----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS  567 (596)
Q Consensus       493 ----~~~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~  567 (596)
                          .+..|+||||+++|+|.+++.... ..+++..+..++.|++.|+.|||   ..+++|+|++|+||++++++.++|+
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEe
Confidence                457899999999999999987643 35788888999999999999999   8899999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccccccCC
Q 036342          568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       568 dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||++........  ......|++.|+||
T Consensus       164 dfg~~~~~~~~~~--~~~~~~~~~~y~aP  190 (282)
T cd06636         164 DFGVSAQLDRTVG--RRNTFIGTPYWMAP  190 (282)
T ss_pred             eCcchhhhhcccc--CCCcccccccccCH
Confidence            9999876432211  12335688899987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.81  E-value=3e-20  Score=187.09  Aligned_cols=144  Identities=26%  Similarity=0.350  Sum_probs=122.6

Q ss_pred             cccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          446 EFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .|.....||+|+||.||++.                     +.+..|+.++++++|+||+++++.+..++..|+||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            34445679999999999742                     356789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +++|.+++...  .+++..+..++.|++.|+.|+|   +.+|+||||||+||++++++.+|++|||++........  ..
T Consensus       103 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  175 (292)
T cd06658         103 GGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR  175 (292)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence            99999988654  4788999999999999999999   88999999999999999999999999999876532211  12


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....|+..|+||
T Consensus       176 ~~~~~~~~y~aP  187 (292)
T cd06658         176 KSLVGTPYWMAP  187 (292)
T ss_pred             ceeecCccccCH
Confidence            335688999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=8.3e-20  Score=186.07  Aligned_cols=128  Identities=30%  Similarity=0.394  Sum_probs=115.8

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                        +.+..|++++++++|+||+++++.+...+..|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368889999999999999752                        24667999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          501 EYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ||+++++|.+++.... ..+++..+..++.|++.|++|||   ..+++|+||||+||+++.++.++++|||++...
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            9999999999987643 46889999999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.81  E-value=7.7e-20  Score=181.51  Aligned_cols=147  Identities=27%  Similarity=0.454  Sum_probs=124.3

Q ss_pred             cccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          446 EFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      +|+..+.||+|+||.||++.                           +.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            47788999999999999641                           356789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-cEEEeccccccccCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTG  577 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-~~kl~dfGla~~~~~  577 (596)
                      |+||+++++|.+++.... .+++..+..++.|++.|+.|||   ..+++|+||+|+||+++.++ .+|++|||.+..+..
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999997654 5788999999999999999999   89999999999999998775 699999999887643


Q ss_pred             CCC--ccccccccccccccCC
Q 036342          578 EDQ--SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~--~~~~~~~~gt~~y~aP  596 (596)
                      ...  ........|+..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~P  177 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAP  177 (268)
T ss_pred             ccccCCccccccccccceeCH
Confidence            211  1112234678889987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.81  E-value=6.6e-20  Score=184.70  Aligned_cols=146  Identities=28%  Similarity=0.402  Sum_probs=126.3

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|...+.||+|+||.||++.                     +.+..|+.++++++||||+++++++...+..|+|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            4688999999999999999852                     3467799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++|+|.+++...  .+++.++..++.+++.|+.|||   +.+++|||+||+||+++.++.+||+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            9999999998764  4678899999999999999999   99999999999999999999999999998876543221  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......|++.|+||
T Consensus       171 ~~~~~~~~~~y~~P  184 (293)
T cd06647         171 KRSTMVGTPYWMAP  184 (293)
T ss_pred             ccccccCChhhcCc
Confidence            12234688889988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.81  E-value=1.1e-19  Score=181.38  Aligned_cols=144  Identities=28%  Similarity=0.422  Sum_probs=123.9

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      -|+..+.||+|+||.||+|.                      +.+.+|+.++++++||||+++++++..++..|+||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            46678899999999999752                      34678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      ++|+|.+++...  .+++..+..++.+++.|+.|||   ..+++|+|++|+||+++.++.++++|||++.......  ..
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            999999998654  4789999999999999999999   8999999999999999999999999999987653321  11


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....++.+|+||
T Consensus       158 ~~~~~~~~~y~~P  170 (277)
T cd06641         158 RNTFVGTPFWMAP  170 (277)
T ss_pred             hccccCCccccCh
Confidence            2234678888887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.81  E-value=1.2e-20  Score=197.46  Aligned_cols=144  Identities=26%  Similarity=0.429  Sum_probs=123.6

Q ss_pred             cccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          448 SENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       448 ~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ...++||+|+||.||||.                          +++..|+-+|.+++|||+++|+|+|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            345899999999999962                          56789999999999999999999998876 789999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ||+.|.|.+|++..+..+.-...+.++.|||+|+.|||   .+.+|||||-++|||+.+-..+||.|||+|+.+..+...
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999988777888888999999999999999   999999999999999999999999999999987654433


Q ss_pred             cccccccccccccC
Q 036342          582 MTQTQTLGTIGYMA  595 (596)
Q Consensus       582 ~~~~~~~gt~~y~a  595 (596)
                      .......-.+.|||
T Consensus       855 y~~~~gK~pikwma  868 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMA  868 (1177)
T ss_pred             ccccccccCcHHHH
Confidence            32333334555654

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=5.2e-20  Score=183.25  Aligned_cols=150  Identities=25%  Similarity=0.330  Sum_probs=126.7

Q ss_pred             HhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhc-CCCccceeeeeeccCC------
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEE------  494 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~------  494 (596)
                      .++++|+..+.||+|+||.||+|.                    +.+..|+.+++++ +|+||+++++++....      
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            457899999999999999999852                    4577899999999 7999999999996543      


Q ss_pred             eeEEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                      ..|+||||+++++|.+++...   ...+++..+..++.|++.|+.|||   +.+++|+|++|+||++++++.+|++|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999988653   346789999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +.......  .......|+..|+||
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aP  182 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAP  182 (275)
T ss_pred             ceecccch--hhhcCccccccccCH
Confidence            87653221  112335688889887

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.81  E-value=1e-19  Score=179.43  Aligned_cols=146  Identities=23%  Similarity=0.406  Sum_probs=125.0

Q ss_pred             cccccccccCCCceeehhh-----------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRA-----------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~-----------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|+||.||++                       .+.+.+|+.++++++||||+++++++..++..|+||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999863                       13577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++++|.+++.... ..+++.++..++.|++.|+.|+|   +.+++|+|++|+||+++.++.++++|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999987643 35788999999999999999999   89999999999999999999999999999886543211 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......|++.|+||
T Consensus       157 -~~~~~~~~~~~~~p  170 (256)
T cd08218         157 -LARTCIGTPYYLSP  170 (256)
T ss_pred             -hhhhccCCccccCH
Confidence             12234578888887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=1.2e-19  Score=179.82  Aligned_cols=148  Identities=24%  Similarity=0.416  Sum_probs=123.5

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccC--Cee
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFK  496 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  496 (596)
                      .+|...+.||+|+||.||++.                          +.+.+|++++++++|+||+++++++...  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            368889999999999999852                          2466799999999999999999998654  468


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ++|+||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+++|+|+||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987654 4788899999999999999999   8999999999999999999999999999998653


Q ss_pred             CCCC-ccccccccccccccCC
Q 036342          577 GEDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~-~~~~~~~~gt~~y~aP  596 (596)
                      .... ........|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSP  178 (264)
T ss_pred             cccccCccccccCCcccccCH
Confidence            2110 1112235688899988

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.81  E-value=1.1e-19  Score=186.03  Aligned_cols=145  Identities=19%  Similarity=0.233  Sum_probs=117.6

Q ss_pred             ccccccCC--CceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          449 ENNLIGRG--GFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       449 ~~~~ig~G--~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..+.||+|  +||+||++.                       +.+..|+.+++.++|||||+++++|..++..|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  678888742                       23567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++|+|.+++.... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.++++|||.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999987542 35889999999999999999999   8999999999999999999999999998654432111100


Q ss_pred             -----ccccccccccccCC
Q 036342          583 -----TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 -----~~~~~~gt~~y~aP  596 (596)
                           ......++..|+||
T Consensus       159 ~~~~~~~~~~~~~~~y~aP  177 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSP  177 (327)
T ss_pred             cccccccccccceecccCh
Confidence                 01123567778887

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.81  E-value=3.7e-21  Score=196.26  Aligned_cols=106  Identities=24%  Similarity=0.233  Sum_probs=61.0

Q ss_pred             EEECCCCCCcc-ccchhhhCCCCCCEEEccCCcCccc----cCccCccCCCCccEEEccCCcccc------ccCccccCC
Q 036342           14 ELQLGQNKLIG-TVPAAIFNVSTLKFLGLQNNSLSGS----LSSIANVRLPNLEKLYLWGNNFSG------TIPRFIFNA   82 (596)
Q Consensus        14 ~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l   82 (596)
                      .|+|+.+.+++ .....|..+.+|++|++++|.++..    ++.. ....++|++|+++++.+.+      .++..+..+
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~-l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~   80 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASA-LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG   80 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHH-HhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence            46777777763 3344556677788888888887421    2221 1125567777777776652      223345555


Q ss_pred             CCCCEEEccCCcccccCCccccCCCC---CCEEecCCCcCc
Q 036342           83 SKLSKLSLGMNSFSGFIPSTFGNLRN---LEQLGLDENYLT  120 (596)
Q Consensus        83 ~~L~~L~L~~N~i~~~~~~~~~~l~~---L~~L~l~~N~l~  120 (596)
                      ++|+.|++++|.+.+..+..|..+.+   |++|++++|+++
T Consensus        81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~  121 (319)
T cd00116          81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG  121 (319)
T ss_pred             CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccc
Confidence            66666666666665444444444433   555555555544

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PTZ00284 protein kinase; Provisional

Probab=99.81  E-value=5.5e-20  Score=197.43  Aligned_cols=149  Identities=22%  Similarity=0.382  Sum_probs=120.7

Q ss_pred             HHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCC------ccceeeeeec
Q 036342          438 LELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHR------NLIKVISSCS  491 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~------niv~l~~~~~  491 (596)
                      +++....++|...+.||+|+||.||+|.                    +.+..|++++++++|.      +++++++++.
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3444567899999999999999999862                    2345688888887654      5889999887


Q ss_pred             cC-CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCC-------
Q 036342          492 NE-EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNM-------  562 (596)
Q Consensus       492 ~~-~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~-------  562 (596)
                      .+ +..|+|||++ +++|.+++.... .+++..+..++.|++.||.|||   . .+|+||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccc
Confidence            64 4788999998 779999887653 5889999999999999999999   6 5899999999999998765       


Q ss_pred             ---------cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          563 ---------VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 ---------~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                               .+||+|||.+....     ......+||++||||
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~AP  314 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSP  314 (467)
T ss_pred             ccccCCCCceEEECCCCccccCc-----cccccccCCccccCc
Confidence                     49999999876432     122346899999998

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=9e-20  Score=182.05  Aligned_cols=144  Identities=27%  Similarity=0.414  Sum_probs=124.7

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcC---CCccceeeeeeccCCeeEEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIR---HRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .|+..+.||+|+||.||+|.                      +.+.+|+.++++++   |||++++++++..+...|+||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            47788999999999999752                      34677899999997   999999999999989999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++++|.+++...  .+++..+..++.|++.|+.|+|   ..+++|+|++|+||++++++.++++|||++........
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999998654  5789999999999999999999   89999999999999999999999999999887643321


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......|+..|+||
T Consensus       157 --~~~~~~~~~~y~aP  170 (277)
T cd06917         157 --KRSTFVGTPYWMAP  170 (277)
T ss_pred             --ccccccCCcceeCH
Confidence              12334688889887

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.81  E-value=8.6e-20  Score=182.75  Aligned_cols=145  Identities=30%  Similarity=0.422  Sum_probs=118.7

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHH-HhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEM-MKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||.||++.                      ..+..|... ++..+||||+++++++..++..|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            478899999999999999852                      123445554 666799999999999999999999999


Q ss_pred             cCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          502 YMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSA-LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       502 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~-~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      |++ |+|.+++..   ....+++..+..++.|++.|+.|||   +. +++|||+||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 688877754   2246889999999999999999999   76 899999999999999999999999999886532


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .   .......|+..|+||
T Consensus       157 ~---~~~~~~~~~~~y~aP  172 (283)
T cd06617         157 S---VAKTIDAGCKPYMAP  172 (283)
T ss_pred             c---cccccccCCccccCh
Confidence            1   112234678888887

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.81  E-value=1.2e-19  Score=181.35  Aligned_cols=144  Identities=28%  Similarity=0.418  Sum_probs=124.5

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      .|+..+.||+|+||.||+|.                      +.+..|++++++++||||+++++++..+...|+||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            57778899999999999852                      34678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      ++|+|.+++...  .+++.+...++.|++.|++|+|   +.+++|+|++|+||++++++.++++|||++........  .
T Consensus        85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06640          85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence            999999998754  4788899999999999999999   89999999999999999999999999999876543221  1


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....++..|+||
T Consensus       158 ~~~~~~~~~y~ap  170 (277)
T cd06640         158 RNTFVGTPFWMAP  170 (277)
T ss_pred             cccccCcccccCH
Confidence            2234678888887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.81  E-value=4.9e-20  Score=182.59  Aligned_cols=145  Identities=26%  Similarity=0.384  Sum_probs=125.9

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|+||.||++.                      +.+.+|++++++++||||+++++++..++..++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            367888999999999999852                      3577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++++|.+++......+++.....++.|++.|+.|+|   . .+++|+|+||+||++++++.+|++|||.+.......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--  155 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--  155 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--
Confidence            9999999999876456888999999999999999999   7 899999999999999999999999999987653211  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                        .....++..|+||
T Consensus       156 --~~~~~~~~~y~~P  168 (265)
T cd06605         156 --AKTFVGTSSYMAP  168 (265)
T ss_pred             --hhcccCChhccCH
Confidence              1115678888887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.81  E-value=1.2e-19  Score=178.66  Aligned_cols=145  Identities=30%  Similarity=0.578  Sum_probs=124.4

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|+||.||++.                       +.+..|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            47888999999999999742                       3577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC-CcEEEeccccccccCCCCC
Q 036342          503 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~-~~~kl~dfGla~~~~~~~~  580 (596)
                      +++++|.+++.... ..+++..+..++.+++.|+.|+|   +.+++|+|++|+||+++++ +.+|++|||+++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997653 35789999999999999999999   8999999999999999854 568999999998764321 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......|+..|+||
T Consensus       157 --~~~~~~~~~~y~aP  170 (256)
T cd08220         157 --KAYTVVGTPCYISP  170 (256)
T ss_pred             --cccccccCCcccCc
Confidence              12234688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.81  E-value=1.4e-19  Score=179.01  Aligned_cols=149  Identities=25%  Similarity=0.411  Sum_probs=124.6

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc--CCeeEEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVL  500 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~  500 (596)
                      +|+..+.||+|+||.||++.                       +.+..|++++++++|+||+++++++..  +...|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            47788999999999999752                       346679999999999999999998754  44689999


Q ss_pred             ecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccC--CCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          501 EYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGY--SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       501 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~--~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ||+++++|.+++...   ...+++..++.++.|++.|+.|+|...  ..+++|+|++|+||++++++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998763   346889999999999999999999554  678999999999999999999999999998876


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .....  ......|++.|+||
T Consensus       161 ~~~~~--~~~~~~~~~~~~~p  179 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSP  179 (265)
T ss_pred             cCCcc--cccccccCCCccCh
Confidence            43221  12335688899988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.81  E-value=1.3e-19  Score=183.79  Aligned_cols=143  Identities=30%  Similarity=0.380  Sum_probs=123.2

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ...|...+.||+|+||.||++.                        +.+.+|++++++++||||++++++|..++..|+|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            4568888999999999999752                        3467899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||++ |++.+.+......+++..+..++.|++.|+.|||   ..+++|||++|+||++++++.+|++|||++...... 
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99996 5787777655456889999999999999999999   889999999999999999999999999998764321 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                           ....+++.|+||
T Consensus       169 -----~~~~~~~~y~aP  180 (307)
T cd06607         169 -----NSFVGTPYWMAP  180 (307)
T ss_pred             -----CCccCCccccCc
Confidence                 234577888887

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.81  E-value=9.6e-20  Score=182.54  Aligned_cols=145  Identities=26%  Similarity=0.424  Sum_probs=123.2

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|++|.||+|.                       +.+..|++++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            47888999999999999852                       2467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ++ ++|.+++.... ..+++.++..++.|+++|++|||   ..+++|||++|+||++++++.+|++|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 68988886543 46789999999999999999999   88999999999999999999999999999876532211 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......+++.|+||
T Consensus       156 -~~~~~~~~~~y~aP  169 (284)
T cd07860         156 -TYTHEVVTLWYRAP  169 (284)
T ss_pred             -ccccccccccccCC
Confidence             12223567888887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.81  E-value=1.1e-19  Score=182.55  Aligned_cols=147  Identities=25%  Similarity=0.382  Sum_probs=124.5

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||.||+|.                       +.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            368889999999999999852                       346789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |++++.+..+... ...+++.++..++.+++.|+.|||   ..+++|+|++|+||++++++.+|++|||++........ 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            9998777665544 345789999999999999999999   88999999999999999999999999999887643321 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......++.+|+||
T Consensus       156 ~~~~~~~~~~~~~~P  170 (288)
T cd07833         156 SPLTDYVATRWYRAP  170 (288)
T ss_pred             ccccCcccccCCcCC
Confidence            122335678889998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=8.9e-20  Score=185.14  Aligned_cols=140  Identities=21%  Similarity=0.256  Sum_probs=109.2

Q ss_pred             HhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccce-eeeeeccC
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIK-VISSCSNE  493 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~-l~~~~~~~  493 (596)
                      ...++|...+.||+|+||+||+|.                           +.+.+|++++++++|+|+|. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            345689999999999999999852                           12679999999999999985 5442    


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCC-CCCCeeeCCCCcEEEeccccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDL-KPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdl-k~~NILl~~~~~~kl~dfGla  572 (596)
                      +..|+||||++|++|... ...    .   ...++.++++|+.|+|   +.+|+|||| ||+|||++.++.+||+|||+|
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            457999999999999632 111    1   1457889999999999   899999999 999999999999999999999


Q ss_pred             cccCCCCCc------cccccccccccccCC
Q 036342          573 KLLTGEDQS------MTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~------~~~~~~~gt~~y~aP  596 (596)
                      +.+......      .......+++.|+||
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~p  189 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAP  189 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCc
Confidence            976432211      111345677778877

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.81  E-value=6.5e-20  Score=185.07  Aligned_cols=143  Identities=27%  Similarity=0.339  Sum_probs=122.2

Q ss_pred             ccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          447 FSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      |+....||+|+||.||++.                     +.+.+|+.+++.++||||+++++++..++..|+|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            4445679999999999752                     3567899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      ++|.+++...  .+++.++..++.|++.|+.|+|   +.+++|||+||+||+++.++.+||+|||++.......  ....
T Consensus       103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  175 (297)
T cd06659         103 GALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  175 (297)
T ss_pred             CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence            9999987653  4789999999999999999999   8999999999999999999999999999987553221  1223


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...|++.|+||
T Consensus       176 ~~~~~~~y~aP  186 (297)
T cd06659         176 SLVGTPYWMAP  186 (297)
T ss_pred             ceecCccccCH
Confidence            35688999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=3.6e-20  Score=202.00  Aligned_cols=98  Identities=26%  Similarity=0.402  Sum_probs=78.2

Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      +||-||||+.-.+.++++.....-.....+++.++|++|+.|+|   +++|||||+||.||++|++..+||+|||+|+..
T Consensus       671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~  747 (1351)
T KOG1035|consen  671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDL  747 (1351)
T ss_pred             EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhh
Confidence            47889999887777776665422135678999999999999999   999999999999999999999999999999972


Q ss_pred             C----C------------CCCccccccccccccccCC
Q 036342          576 T----G------------EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~----~------------~~~~~~~~~~~gt~~y~aP  596 (596)
                      .    .            .......+..+||.-|+||
T Consensus       748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             hhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            1    0            0011234567899999998

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.81  E-value=6.2e-20  Score=189.98  Aligned_cols=142  Identities=23%  Similarity=0.417  Sum_probs=122.3

Q ss_pred             cccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcC-C-----CccceeeeeeccCCeeEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIR-H-----RNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~-H-----~niv~l~~~~~~~~~~~lV  499 (596)
                      +|++.+.||+|+||.|.||.                    .+...|+.+|+.++ |     -|+|+++++|..++..|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            88999999999999999863                    34567899999997 3     4999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC--CCcEEEeccccccccC
Q 036342          500 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLT  576 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~--~~~~kl~dfGla~~~~  576 (596)
                      +|.++. +|.++++... .+++...+..++.||+.||.+||   ..+|||+||||+|||+.+  ...+||+|||.|....
T Consensus       267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence            999954 9999999865 46888999999999999999999   999999999999999974  3489999999998753


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..     .....-+..|+||
T Consensus       343 q~-----vytYiQSRfYRAP  357 (586)
T KOG0667|consen  343 QR-----VYTYIQSRFYRAP  357 (586)
T ss_pred             Cc-----ceeeeeccccccc
Confidence            22     1245678889998

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.81  E-value=1.2e-19  Score=181.72  Aligned_cols=145  Identities=26%  Similarity=0.417  Sum_probs=123.0

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      +|+..+.||+|++|.||+|.                      ..+..|++++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            57889999999999999852                      24567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          504 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       504 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ++ ++.+++....  ..+++.++..++.|+++|+.|+|   ..+++|||+||+||++++++.+|++|||+++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8988886543  45789999999999999999999   88999999999999999999999999999876432211 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......+++.|+||
T Consensus       156 -~~~~~~~~~~y~~P  169 (284)
T cd07836         156 -TFSNEVVTLWYRAP  169 (284)
T ss_pred             -ccccccccccccCh
Confidence             12234567888887

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.81  E-value=1.2e-19  Score=184.09  Aligned_cols=150  Identities=23%  Similarity=0.396  Sum_probs=123.9

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC-----
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE-----  494 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----  494 (596)
                      ..++|+..+.||+|+||.||+|.                       ..+.+|++++++++||||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            34579999999999999999852                       13457999999999999999999986543     


Q ss_pred             ---eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          495 ---FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       495 ---~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                         ..++||||++ +++.+.+......+++.++..++.|++.|+.|||   ..+++|+|+||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence               3599999996 5898888776556899999999999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccccccccCC
Q 036342          572 AKLLTGEDQS--MTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~--~~~~~~~gt~~y~aP  596 (596)
                      +.........  .......++..|+||
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aP  192 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPP  192 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCc
Confidence            9865432211  112234678889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.80  E-value=1.3e-19  Score=181.10  Aligned_cols=137  Identities=26%  Similarity=0.359  Sum_probs=112.6

Q ss_pred             cccCCCceeehhhH------------------------HhHHHHHHH---HhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          452 LIGRGGFALFIRAF------------------------KSFDVECEM---MKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       452 ~ig~G~~g~v~~~~------------------------~~~~~e~~~---l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .||+|+||.||++.                        ..+..|..+   +...+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999742                        112233333   333479999999999999899999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +|+|.+++.... .+++..+..++.|++.|+.|+|   ..+++||||||+||++++++.+|++|||++......    ..
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence            999999987654 5889999999999999999999   899999999999999999999999999998754321    12


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....||+.|+||
T Consensus       153 ~~~~~~~~y~aP  164 (279)
T cd05633         153 HASVGTHGYMAP  164 (279)
T ss_pred             cCcCCCcCccCH
Confidence            234689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.80  E-value=1.2e-19  Score=183.60  Aligned_cols=150  Identities=27%  Similarity=0.404  Sum_probs=124.7

Q ss_pred             HhcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC----
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE----  494 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~----  494 (596)
                      ...++|+..+.||+|+||.||+|.                       ..+.+|++++++++||||+++++++.+.+    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            456789999999999999999853                       23567999999999999999999987654    


Q ss_pred             ------eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEec
Q 036342          495 ------FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD  568 (596)
Q Consensus       495 ------~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~d  568 (596)
                            ..|+|+||+++ ++.+.+......+++.++..++.|++.|++|||   ..+|+|||+||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 787877765556899999999999999999999   88999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccCC
Q 036342          569 FSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||++........ .......++..|+||
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~P  186 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPP  186 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccCh
Confidence            999886543221 112223457778887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=1.3e-19  Score=182.55  Aligned_cols=147  Identities=24%  Similarity=0.384  Sum_probs=127.9

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ..|++.+.||+||.+.||++.                      .-|..|+..|.+++ |.+||+|++|-..++.+|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            468999999999999999842                      34789999999995 8999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |= .-||.++++.+....+...+..+..|++.|+.++|   ..+|||.|+||.|+|+-+ |.+||+|||.|..+..+...
T Consensus       441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence            76 45999999887655553477779999999999999   999999999999999875 68999999999988766555


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      ......+||+-||||
T Consensus       516 I~kdsQvGT~NYMsP  530 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSP  530 (677)
T ss_pred             eeeccccCcccccCH
Confidence            556667999999998

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.80  E-value=2.1e-19  Score=178.90  Aligned_cols=147  Identities=30%  Similarity=0.484  Sum_probs=116.7

Q ss_pred             ccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCC------
Q 036342          447 FSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE------  494 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~------  494 (596)
                      |...+.||+|+||.||+|.                          +++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5667899999999999752                          24668999999999999999999886532      


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                      ..++++||+++|+|.+++....     ..+++.....++.|++.|++|+|   +.+|+|||+||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999998875321     24688889999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCC
Q 036342          570 SIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       570 Gla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+++...............+++.|+||
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLAL  184 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCH
Confidence            998865432211112223445667766

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.80  E-value=2e-19  Score=178.08  Aligned_cols=147  Identities=33%  Similarity=0.482  Sum_probs=125.6

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|+||.||++.                       +.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            47788999999999999852                       3567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++++|.+++.... .+++..+..++.+++.|+.|||   +.+++|+|++|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999997653 4688889999999999999999   8999999999999999999999999999988764332211


Q ss_pred             c--cccccccccccCC
Q 036342          583 T--QTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~--~~~~~gt~~y~aP  596 (596)
                      .  .....+++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~P  172 (264)
T cd06626         157 GEEVQSLAGTPAYMAP  172 (264)
T ss_pred             cccccCCcCCcCccCh
Confidence            1  1134678889887

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.80  E-value=1.4e-19  Score=183.69  Aligned_cols=148  Identities=29%  Similarity=0.409  Sum_probs=124.2

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC--CeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~  497 (596)
                      ..++|+..+.||+|+||.||+|.                       ..+.+|+.++++++|+||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            45789999999999999999862                       1245799999999999999999998755  4689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||++ ++|.+++......+++.++..++.|++.|++|||   ..+++||||||+||+++.++.+||+|||+++....
T Consensus        85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999996 4898888765556899999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...  ......+++.|+||
T Consensus       161 ~~~--~~~~~~~~~~y~aP  177 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAP  177 (309)
T ss_pred             ccC--CCCcccccccccCh
Confidence            221  12223457789887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.80  E-value=1.8e-19  Score=181.62  Aligned_cols=146  Identities=23%  Similarity=0.342  Sum_probs=120.2

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCe-----
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEF-----  495 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~-----  495 (596)
                      ++|+..+.||+|+||.||+|.                       +.+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468899999999999999852                       24668999999995 6999999999877655     


Q ss_pred             eEEEEecCCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEeccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFS  570 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfG  570 (596)
                      .|+||||+++ ++.+++....    ..+++..+..++.||+.|+.|||   ..+++|||+||+||+++. ++.+|++|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 8988876532    34789999999999999999999   899999999999999998 8999999999


Q ss_pred             cccccCCCCCccccccccccccccCC
Q 036342          571 IAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +++.......  ......+++.|+||
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aP  180 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAP  180 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCCh
Confidence            9886532211  11223567788887

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.80  E-value=1.3e-19  Score=186.49  Aligned_cols=148  Identities=30%  Similarity=0.476  Sum_probs=123.7

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhc-CCCccceeeeeeccC--Cee
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSI-RHRNLIKVISSCSNE--EFK  496 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~  496 (596)
                      ..++|+..+.||+|+||.||+|.                       ..+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            35688999999999999999852                       2355799999999 999999999998654  368


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+||||++ ++|.+++...  .+++..+..++.|++.|++|||   +.+|+|||+||+||+++.++.+|++|||+++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999997 5999988765  5788899999999999999999   8999999999999999999999999999988664


Q ss_pred             CCCCc---cccccccccccccCC
Q 036342          577 GEDQS---MTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~---~~~~~~~gt~~y~aP  596 (596)
                      .....   .......||+.|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aP  181 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAP  181 (337)
T ss_pred             cccccccCcchhcccccccccCc
Confidence            33211   122345688999998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.80  E-value=1.6e-20  Score=191.67  Aligned_cols=257  Identities=25%  Similarity=0.311  Sum_probs=115.7

Q ss_pred             EEEccCCcCccccCccCccCCCCccEEEccCCcccc----ccCccccCCCCCCEEEccCCcccc------cCCccccCCC
Q 036342           38 FLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSG----TIPRFIFNASKLSKLSLGMNSFSG------FIPSTFGNLR  107 (596)
Q Consensus        38 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~------~~~~~~~~l~  107 (596)
                      .|+|.++.+++.--...+..+.+|++|+++++.++.    .++..+...++|++|+++++.+.+      .++..|..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            456666666522111222235567777777776632    133344455556666666665542      1223344444


Q ss_pred             CCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCC-C
Q 036342          108 NLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNL-T  186 (596)
Q Consensus       108 ~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l-~  186 (596)
                      +|+.|++++|.+....+.. +...... ++|+.|++++|++++..    .                  ..+...+..+ +
T Consensus        82 ~L~~L~l~~~~~~~~~~~~-~~~l~~~-~~L~~L~ls~~~~~~~~----~------------------~~l~~~l~~~~~  137 (319)
T cd00116          82 GLQELDLSDNALGPDGCGV-LESLLRS-SSLQELKLNNNGLGDRG----L------------------RLLAKGLKDLPP  137 (319)
T ss_pred             ceeEEEccCCCCChhHHHH-HHHHhcc-CcccEEEeeCCccchHH----H------------------HHHHHHHHhCCC
Confidence            5555555555444211110 0000111 22444444444443210    0                  1112223333 5


Q ss_pred             CCCEEEccCCcccCC----CCccccCCCCCCeEEccCCccccc----CccchhcCCCCcEEEccCCcCcccc----hhhh
Q 036342          187 NLVEIDLGGNKLNGS----IPITLGKLRKLQRLNLEDNILEGS----IPDDICRLAELYRLELGSNKLYGSI----PACF  254 (596)
Q Consensus       187 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~  254 (596)
                      +|+.|++++|.+++.    .+..+..+++|++|++++|.+++.    ++..+...++|+.|++++|.+.+..    +..+
T Consensus       138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~  217 (319)
T cd00116         138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETL  217 (319)
T ss_pred             CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHh
Confidence            556666666555532    122344445555566655555421    2222333445666666666554322    2233


Q ss_pred             ccCCCCcEEEeCCCcccCC-Ccccc-----cccccceEEcccCCCCC----chhhhhccccccceEecCCCcCc
Q 036342          255 GNLASLRILSLGSNKLTSI-PLTFW-----NLKDILQLNFSSNFLTG----PLLLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       255 ~~l~~L~~L~Ls~N~l~~i-p~~~~-----~l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      ..+++|++|++++|.++.. ...+.     ..+.|+.|++++|.++.    .....+..++.|+.+|+++|.++
T Consensus       218 ~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~  291 (319)
T cd00116         218 ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG  291 (319)
T ss_pred             cccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence            3445566666666555531 11111     12455666666665542    12233344455566666666655

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.80  E-value=3.8e-19  Score=176.63  Aligned_cols=149  Identities=23%  Similarity=0.300  Sum_probs=120.8

Q ss_pred             HHHHHhcccccccccc--cCCCceeehhhHH---------------h-HHHHHHHHhhc-CCCccceeeeeeccCCeeEE
Q 036342          438 LELCRATDEFSENNLI--GRGGFALFIRAFK---------------S-FDVECEMMKSI-RHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~i--g~G~~g~v~~~~~---------------~-~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  498 (596)
                      .+.....++|+..+.+  |+|+||.||++..               . ...|+.....+ +||||+++++++..++..|+
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            3444455677777777  9999999998531               1 11233333322 79999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-cEEEeccccccccCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTG  577 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-~~kl~dfGla~~~~~  577 (596)
                      ||||+++|+|.+++.... .+++.++..++.|+++|+.|+|   ..+++||||||+||+++.++ .++++|||+++....
T Consensus        87 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            999999999999998764 6899999999999999999999   88999999999999999988 999999999886532


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .      ....|+..|+||
T Consensus       163 ~------~~~~~~~~y~aP  175 (267)
T PHA03390        163 P------SCYDGTLDYFSP  175 (267)
T ss_pred             C------ccCCCCCcccCh
Confidence            1      224678889988

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.80  E-value=3.2e-19  Score=181.79  Aligned_cols=140  Identities=30%  Similarity=0.387  Sum_probs=121.4

Q ss_pred             ccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          447 FSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      |...+.||+|+||.||++.                        +.+..|++++++++|||++++++++..++..|+||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            6778899999999999752                        2467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++ |++.+.+......+++.++..++.+++.|+.|||   ..+++|||++|+||+++.++.+|++|||++.....     
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----  177 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----  177 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence            96 5888887665556899999999999999999999   89999999999999999999999999999875432     


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                       .....|++.|+||
T Consensus       178 -~~~~~~~~~y~aP  190 (317)
T cd06635         178 -ANSFVGTPYWMAP  190 (317)
T ss_pred             -cccccCCccccCh
Confidence             1234678888887

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.80  E-value=2.3e-19  Score=179.16  Aligned_cols=138  Identities=28%  Similarity=0.402  Sum_probs=117.6

Q ss_pred             ccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          453 IGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       453 ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      ||+|+||.||++.                        +.+..|++++++++||||+++++++..++..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6899999998742                        2345799999999999999999999999999999999999999


Q ss_pred             HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccc
Q 036342          509 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT  587 (596)
Q Consensus       509 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~  587 (596)
                      .+++.... ..+++.++..++.|++.|+.|+|   ..+++||||+|+||++++++.+|++|||.+.......   .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            99987654 35789999999999999999999   8999999999999999999999999999987653211   12234


Q ss_pred             cccccccCC
Q 036342          588 LGTIGYMAP  596 (596)
Q Consensus       588 ~gt~~y~aP  596 (596)
                      .++..|+||
T Consensus       155 ~~~~~y~~P  163 (277)
T cd05577         155 AGTPGYMAP  163 (277)
T ss_pred             cCCCCcCCH
Confidence            577788887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.80  E-value=3e-19  Score=178.44  Aligned_cols=137  Identities=25%  Similarity=0.364  Sum_probs=113.3

Q ss_pred             cccCCCceeehhhH------------------------HhHHHHH---HHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          452 LIGRGGFALFIRAF------------------------KSFDVEC---EMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       452 ~ig~G~~g~v~~~~------------------------~~~~~e~---~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .||+|+||.||++.                        ..+..|.   ..++...||+|+++++++..++..|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999642                        0122233   34445689999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +|+|.+++.... .+++..+..++.|+++|+.|+|   +.+++|||+||+||+++.++.+|++|||+++......    .
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            999999887643 6889999999999999999999   8999999999999999999999999999987653221    2


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....|+..|+||
T Consensus       153 ~~~~~~~~y~aP  164 (278)
T cd05606         153 HASVGTHGYMAP  164 (278)
T ss_pred             cCcCCCcCCcCc
Confidence            234789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.80  E-value=3e-19  Score=176.74  Aligned_cols=146  Identities=27%  Similarity=0.423  Sum_probs=126.7

Q ss_pred             ccccccccccCCCceeehhh----------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRA----------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~----------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|++|.||++                      .+.+..|+.++++++|+|++++++++..++..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999875                      24577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +++++|.+++... ..+++..+..++.|+++|+.|+|   . .+++|||++|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-  155 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-  155 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence            9999999999765 46789999999999999999999   8 9999999999999999999999999999887643222 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......++..|+||
T Consensus       156 -~~~~~~~~~~y~~p  169 (264)
T cd06623         156 -QCNTFVGTVTYMSP  169 (264)
T ss_pred             -cccceeecccccCH
Confidence             11234577888887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.80  E-value=7e-20  Score=167.36  Aligned_cols=153  Identities=25%  Similarity=0.323  Sum_probs=124.8

Q ss_pred             hcccccccccccCCCceeehhh---------------------HHhHHHHHHHHhhcCCCccceeeeeeccCC-----ee
Q 036342          443 ATDEFSENNLIGRGGFALFIRA---------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEE-----FK  496 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~---------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~  496 (596)
                      ...+|.+.+.+|+|||..||.+                     .+...+|++..++++|||++++++++..+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            3468999999999999999863                     245778999999999999999999885433     59


Q ss_pred             EEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          497 ALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      |+++.|...|+|.+.+...   +..+++.+.+.|+.+|++|+++||.. .++.+||||||.|||+.+.+.+++.|||-++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999998753   34789999999999999999999932 3459999999999999999999999999877


Q ss_pred             ccCCC----CC---ccccccccccccccCC
Q 036342          574 LLTGE----DQ---SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~----~~---~~~~~~~~gt~~y~aP  596 (596)
                      ...-.    .+   -+.+.....|..|+||
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAP  207 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAP  207 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCc
Confidence            64211    11   1122334678889998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.80  E-value=6.6e-20  Score=185.35  Aligned_cols=145  Identities=22%  Similarity=0.349  Sum_probs=125.1

Q ss_pred             cccccccccccCCCceeehhhH---------------H--------------hHHHHHHHHhhcC---CCccceeeeeec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------K--------------SFDVECEMMKSIR---HRNLIKVISSCS  491 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------~--------------~~~~e~~~l~~l~---H~niv~l~~~~~  491 (596)
                      ..+|...+.+|+|+||.|..|.               +              ..-.|+++|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3468889999999999987542               0              1225999999998   999999999999


Q ss_pred             cCCeeEEEEecC-CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccc
Q 036342          492 NEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS  570 (596)
Q Consensus       492 ~~~~~~lV~e~~-~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfG  570 (596)
                      ++++.|++||-. ++-||++++..+. .+++..+..|..||+-|+++||   +++|||||||-+|+.++.+|-+|++|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            999999999975 5679999997764 6789999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCC
Q 036342          571 IAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      -|....    +.+...++||..|.||
T Consensus       716 saa~~k----sgpfd~f~gtv~~aap  737 (772)
T KOG1152|consen  716 SAAYTK----SGPFDVFVGTVDYAAP  737 (772)
T ss_pred             chhhhc----CCCcceeeeeccccch
Confidence            876432    2234568999999998

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.79  E-value=3.4e-19  Score=178.86  Aligned_cols=150  Identities=30%  Similarity=0.387  Sum_probs=129.3

Q ss_pred             HhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ..++.|+..+.||+|+||.||++.                    +.+..|++++++++|+|++++++++..++..|+|+|
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            356778899999999999999842                    356789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+++++|.+++......+++..+..++.+++.|+.|+|   ..+++|+|++|+||+++.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            99999999999876546899999999999999999999   89999999999999999999999999998876533211 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......++..|+||
T Consensus       172 -~~~~~~~~~~y~~P  185 (286)
T cd06614         172 -KRNSVVGTPYWMAP  185 (286)
T ss_pred             -hhccccCCcccCCH
Confidence             12234577888887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.79  E-value=3.2e-19  Score=181.62  Aligned_cols=147  Identities=23%  Similarity=0.391  Sum_probs=120.8

Q ss_pred             cccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccC--CeeE
Q 036342          446 EFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFKA  497 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~  497 (596)
                      +|+..+.||+|+||.||+|.                          +.+.+|+.++++++||||+++++++...  +..|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788899999999999853                          1345699999999999999999999887  7899


Q ss_pred             EEEecCCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC----CCcEEEecc
Q 036342          498 LVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD----NMVAHLSDF  569 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~----~~~~kl~df  569 (596)
                      +||||+++ ++.+.+....    ..+++..+..++.|++.|+.|||   ..+++||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 7777664321    25788899999999999999999   899999999999999999    999999999


Q ss_pred             ccccccCCCCC-ccccccccccccccCC
Q 036342          570 SIAKLLTGEDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       570 Gla~~~~~~~~-~~~~~~~~gt~~y~aP  596 (596)
                      |+++....... ........++++|+||
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aP  184 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAP  184 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCH
Confidence            99886543221 1122345678899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.79  E-value=3.4e-19  Score=176.36  Aligned_cols=137  Identities=30%  Similarity=0.430  Sum_probs=118.3

Q ss_pred             ccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          453 IGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       453 ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      ||.|+||.||++.                        +.+..|+.++++++||||+++++++.++...|+|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6888898888742                        3467899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccccc
Q 036342          509 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  588 (596)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~  588 (596)
                      .+++.... .+++..+..++.|++.|+.|+|   +.+++|+|++|+||+++.++.+|++|||+++......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99997654 4788899999999999999999   8999999999999999999999999999998764321   122346


Q ss_pred             ccccccCC
Q 036342          589 GTIGYMAP  596 (596)
Q Consensus       589 gt~~y~aP  596 (596)
                      |++.|+||
T Consensus       154 ~~~~~~~P  161 (262)
T cd05572         154 GTPEYVAP  161 (262)
T ss_pred             CCcCccCh
Confidence            78889987

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.79  E-value=4.6e-19  Score=178.63  Aligned_cols=146  Identities=27%  Similarity=0.402  Sum_probs=120.5

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|++|.||+|.                       +.+..|++++++++||||+++++++..++..|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            578899999999999999852                       235679999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEeccccccccCCCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfGla~~~~~~~  579 (596)
                      |++ +++.+++.... ...++..+..++.|++.|++|||   .++++|||++|+||+++. ++.+|++|||+++......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 58888876543 23578888899999999999999   889999999999999985 5679999999997643221


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                      .  ......+++.|+||
T Consensus       158 ~--~~~~~~~~~~y~~P  172 (294)
T PLN00009        158 R--TFTHEVVTLWYRAP  172 (294)
T ss_pred             c--ccccCceeecccCH
Confidence            1  11234567888887

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.79  E-value=4e-19  Score=178.22  Aligned_cols=144  Identities=26%  Similarity=0.348  Sum_probs=123.2

Q ss_pred             cccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          446 EFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .|...+.||+|++|.||++.                     +.+.+|+.++++++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            45556899999999999752                     246789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +++|.+++...  .+++..+..++.|++.|++|+|   +.+++||||+|+||++++++.++++|||.+.......  ...
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~  172 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR  172 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence            99999998773  5788899999999999999999   8999999999999999999999999999887543221  112


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....|++.|+||
T Consensus       173 ~~~~~~~~y~aP  184 (285)
T cd06648         173 KSLVGTPYWMAP  184 (285)
T ss_pred             ccccCCccccCH
Confidence            234688899987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.79  E-value=3.3e-19  Score=179.00  Aligned_cols=145  Identities=28%  Similarity=0.337  Sum_probs=121.3

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccC--CeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~  500 (596)
                      ++|+..+.||.|++|.||++.                      ..+.+|++++++++||||++++++|...  +..|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            468888999999999999742                      3577899999999999999999988643  4689999


Q ss_pred             ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      ||+++++|.+++..   ....+++.....++.|++.|+.|+|   ..+++|+|++|+||++++++.++++|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988653   2345788889999999999999999   89999999999999999999999999999875432


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..    .....++..|+||
T Consensus       158 ~~----~~~~~~~~~y~~p  172 (287)
T cd06621         158 SL----AGTFTGTSFYMAP  172 (287)
T ss_pred             cc----cccccCCccccCH
Confidence            21    1234567788887

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.79  E-value=2.6e-19  Score=179.87  Aligned_cols=146  Identities=25%  Similarity=0.372  Sum_probs=122.8

Q ss_pred             cccccccccCCCceeehhhH----------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCee
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  496 (596)
                      +|+..+.||+|+||.||++.                            +.+..|+++++++ +||||+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            47778999999999999631                            2355789999999 599999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+||||+++|+|.+++.... .+++..+..++.|+++|+.|||   ..+++|||++|+||+++.++.++++|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999987653 5788899999999999999999   8999999999999999999999999999988654


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..... ......|+..|+||
T Consensus       157 ~~~~~-~~~~~~~~~~y~aP  175 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAP  175 (288)
T ss_pred             ccccc-ccccccCCccccCH
Confidence            32211 12234678889887

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.79  E-value=2.6e-19  Score=176.47  Aligned_cols=146  Identities=25%  Similarity=0.410  Sum_probs=123.9

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|+||.||++.                       +.+.+|++++++++|+||+++++.+...+..|+|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            47788999999999999742                       3566899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-cEEEeccccccccCCCCC
Q 036342          503 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-~~kl~dfGla~~~~~~~~  580 (596)
                      +++++|.+++.... ..+++..+..++.|++.|+.|+|   ..+++|+|+||+||++++++ .+|++|||.+.......+
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987643 35789999999999999999999   88999999999999999875 569999999886543221


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......|++.|+||
T Consensus       158 --~~~~~~~~~~~~ap  171 (257)
T cd08225         158 --LAYTCVGTPYYLSP  171 (257)
T ss_pred             --cccccCCCccccCH
Confidence              12234578889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.79  E-value=4.1e-19  Score=177.72  Aligned_cols=142  Identities=24%  Similarity=0.337  Sum_probs=119.3

Q ss_pred             ccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcC-CCccceeeeeeccC--CeeEEEEe
Q 036342          447 FSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIR-HRNLIKVISSCSNE--EFKALVLE  501 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~e  501 (596)
                      |...+.||+|+||.||++.                      .....|+.+++++. |+|++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            5677899999999999852                      12246888888885 99999999999887  78999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |++ |++.+++......+++.++..++.|++.|++|||   ..+++|||++|+||++++ +.+||+|||+++....... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            996 5888888775556899999999999999999999   889999999999999999 9999999999987643221 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                        .....+++.|+||
T Consensus       155 --~~~~~~~~~y~aP  167 (282)
T cd07831         155 --YTEYISTRWYRAP  167 (282)
T ss_pred             --cCCCCCCcccCCh
Confidence              1234578889988

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=3e-20  Score=185.05  Aligned_cols=146  Identities=26%  Similarity=0.349  Sum_probs=127.7

Q ss_pred             cccccccccccCCCceeehh----------hH--------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIR----------AF--------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~----------~~--------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ..+++....+|-|+||.|-.          |.              +....|-.+|...+.|.||++|.-|.+..++|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            34566778899999999832          11              2345688899999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||-|-||.+...+++++ .++...+..++..+.+|++|||   +++||+||+||+|.++|.+|.+|+.|||+|+.+... 
T Consensus       499 mEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-  573 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-  573 (732)
T ss_pred             HHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence            99999999999998876 6888888889999999999999   999999999999999999999999999999988543 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                        ....++||||.|.||
T Consensus       574 --~KTwTFcGTpEYVAP  588 (732)
T KOG0614|consen  574 --RKTWTFCGTPEYVAP  588 (732)
T ss_pred             --CceeeecCCcccccc
Confidence              234569999999998

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.79  E-value=7e-19  Score=174.79  Aligned_cols=145  Identities=25%  Similarity=0.430  Sum_probs=121.1

Q ss_pred             cccccccccCCCceeehhhH--------------------------------HhHHHHHHHHhh-cCCCccceeeeeecc
Q 036342          446 EFSENNLIGRGGFALFIRAF--------------------------------KSFDVECEMMKS-IRHRNLIKVISSCSN  492 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~--------------------------------~~~~~e~~~l~~-l~H~niv~l~~~~~~  492 (596)
                      +|+..+.||+|+||.||++.                                .++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999998742                                124567777764 799999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEec
Q 036342          493 EEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSD  568 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~d  568 (596)
                      ++..++||||+++++|.+++..   ....+++..++.++.|++.|+.|+|   . .+++|+|++|+||+++.++.+|++|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3346788999999999999999999   5 5799999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccCC
Q 036342          569 FSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||++.......   ......|+..|+||
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~P  182 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCP  182 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcCh
Confidence            99998654321   22345688889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.79  E-value=3.7e-19  Score=183.38  Aligned_cols=143  Identities=25%  Similarity=0.389  Sum_probs=121.5

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC-----
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE-----  494 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----  494 (596)
                      ..++|+..+.||+|+||.||++.                       +.+..|+.++++++||||+++++++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            46689999999999999999852                       23667999999999999999999987653     


Q ss_pred             -eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          495 -FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       495 -~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                       ..++||||+ +++|.+++...  .+++..+..++.|+++|++|+|   ..+|+|||+||+||+++.++.+|++|||++.
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence             358999999 77999888653  5789999999999999999999   8999999999999999999999999999988


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .....     .....+++.|+||
T Consensus       167 ~~~~~-----~~~~~~~~~y~aP  184 (343)
T cd07880         167 QTDSE-----MTGYVVTRWYRAP  184 (343)
T ss_pred             ccccC-----ccccccCCcccCH
Confidence            65321     1234678888887

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.79  E-value=3.3e-19  Score=188.77  Aligned_cols=150  Identities=21%  Similarity=0.304  Sum_probs=115.0

Q ss_pred             hcccccccccccCCCceeehhhHH-------------------------------------hH--------------HHH
Q 036342          443 ATDEFSENNLIGRGGFALFIRAFK-------------------------------------SF--------------DVE  471 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~~-------------------------------------~~--------------~~e  471 (596)
                      ..++|++.+.||+|+||+||+|..                                     +|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999997520                                     11              235


Q ss_pred             HHHHhhcCCCcc-----ceeeeeecc--------CCeeEEEEecCCCCCHHHHHhhCC----------------------
Q 036342          472 CEMMKSIRHRNL-----IKVISSCSN--------EEFKALVLEYMPHGSLEKYLYSSN----------------------  516 (596)
Q Consensus       472 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~e~~~~g~L~~~l~~~~----------------------  516 (596)
                      +.++.+++|.++     ++++++|..        ++..++||||+++|+|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666777776654     677777753        346899999999999999987431                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccC
Q 036342          517 -CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMA  595 (596)
Q Consensus       517 -~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~a  595 (596)
                       ..+++..+..++.|+++|+.|+|   ..+|+|||+||+||+++.++.+||+|||+++.+..... .......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence             12456778889999999999999   88999999999999999999999999999976532211 11122345789999


Q ss_pred             C
Q 036342          596 P  596 (596)
Q Consensus       596 P  596 (596)
                      |
T Consensus       379 P  379 (507)
T PLN03224        379 P  379 (507)
T ss_pred             h
Confidence            8

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.79  E-value=2.6e-19  Score=178.81  Aligned_cols=128  Identities=38%  Similarity=0.574  Sum_probs=116.5

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV  499 (596)
                      ++|...+.||+|+||.||++.                        +.+..|.+++++++ |+||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            368889999999999999752                        24667889999999 99999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |||+++++|.+++.... .+++..+..++.|++.|+.|||   ..+++|+|++|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999998764 6899999999999999999999   8999999999999999999999999999988654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.79  E-value=2e-19  Score=184.67  Aligned_cols=148  Identities=26%  Similarity=0.374  Sum_probs=122.8

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc----CCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN----EEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~  496 (596)
                      .++|+..+.||+|+||.||++.                       +.+..|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            3689999999999999999752                       345679999999999999999998763    3468


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+||||+. |+|.+++.... .+++..+..++.|++.|+.|||   ..+|+|||+||+||++++++.+||+|||+++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 69999987654 4889999999999999999999   8899999999999999999999999999988654


Q ss_pred             CCCCc--cccccccccccccCC
Q 036342          577 GEDQS--MTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~--~~~~~~~gt~~y~aP  596 (596)
                      .....  .......|+.+|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~P  180 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAP  180 (334)
T ss_pred             ccCcCCCcccccccccccccCh
Confidence            32211  112234788889988

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.79  E-value=7.8e-19  Score=172.61  Aligned_cols=145  Identities=30%  Similarity=0.489  Sum_probs=125.9

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|++|.||++.                       +.+.+|++++++++|+|++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47788999999999999752                       3467899999999999999999999998999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++++|.+++... ..+++..+..++.|++.|+.|+|   ..+++|||++|+||+++.++.++|+|||.+........  
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--  154 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence            9999999998765 46889999999999999999999   89999999999999999999999999999987643221  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       155 ~~~~~~~~~~y~~p  168 (254)
T cd06627         155 DDASVVGTPYWMAP  168 (254)
T ss_pred             cccccccchhhcCH
Confidence            12334678888887

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.79  E-value=4e-19  Score=178.16  Aligned_cols=145  Identities=27%  Similarity=0.411  Sum_probs=123.4

Q ss_pred             ccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC--CeeEEEEe
Q 036342          447 FSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLE  501 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e  501 (596)
                      |+..+.||+|+||.||+|.                       +.+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            5678899999999999862                       2467799999999999999999999887  78999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+++ +|.+++......+++.++..++.|+++|++|||   ..+++|+|++|+||++++++.+|++|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 899988776557889999999999999999999   88999999999999999999999999999887643321 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......++..|+||
T Consensus       156 ~~~~~~~~~~~y~~P  170 (287)
T cd07840         156 ADYTNRVITLWYRPP  170 (287)
T ss_pred             ccccccccccccCCc
Confidence            112334567889888

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.79  E-value=8.9e-20  Score=187.89  Aligned_cols=145  Identities=26%  Similarity=0.419  Sum_probs=122.3

Q ss_pred             cccccccCCCceeehhh-------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          448 SENNLIGRGGFALFIRA-------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       448 ~~~~~ig~G~~g~v~~~-------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ...+.||+|+||+|++|                         ..+|.+|+.+|.+++|+|+|+|||+..+ ....+|||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            44578999999999985                         2579999999999999999999999987 567899999


Q ss_pred             CCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ++.|+|.+.+++ ....+.......++.|||.|+.||.   .+++||||+.++|+|+...-.+||+|||+.+-+....+.
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            999999999988 4456777888899999999999999   999999999999999999999999999999988765543


Q ss_pred             cccc-cccccccccCC
Q 036342          582 MTQT-QTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~-~~~gt~~y~aP  596 (596)
                      .... .......|.||
T Consensus       269 Yvm~p~rkvPfAWCaP  284 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAP  284 (1039)
T ss_pred             eEecCCCcCcccccCH
Confidence            3222 22334456555

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.79  E-value=2.8e-19  Score=183.76  Aligned_cols=147  Identities=27%  Similarity=0.384  Sum_probs=121.8

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC-----ee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE-----FK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~  496 (596)
                      .++|+..+.||+|+||.||+|.                      ..+..|+.++++++|+||+++++++...+     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            4689999999999999999852                      23567999999999999999999876543     57


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+|+||++ +++.+.+...  .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+|++|||+++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 4888887553  5789999999999999999999   8999999999999999999999999999988653


Q ss_pred             CCCCc-cccccccccccccCC
Q 036342          577 GEDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aP  596 (596)
                      ..... .......||+.|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAP  178 (336)
T ss_pred             ccccccCCcCCcCcCCCccCh
Confidence            32111 112335788999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.79  E-value=3.5e-19  Score=176.22  Aligned_cols=140  Identities=31%  Similarity=0.448  Sum_probs=117.8

Q ss_pred             ccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          453 IGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       453 ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      ||+|+||.||++.                        +.+..|++++++++||||+++++.+..++..|+|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            5788888888742                        3567789999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC------cc
Q 036342          509 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ------SM  582 (596)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~------~~  582 (596)
                      .+++.... .+++..+..++.|+++|++|+|   ..+++|+||+|+||++++++.+|++|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99998754 6789999999999999999999   89999999999999999999999999999876432211      01


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......++..|+||
T Consensus       157 ~~~~~~~~~~~~~P  170 (265)
T cd05579         157 EDKRIVGTPDYIAP  170 (265)
T ss_pred             cccCcccCccccCH
Confidence            12334577888887

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.78  E-value=8.4e-19  Score=171.89  Aligned_cols=145  Identities=31%  Similarity=0.447  Sum_probs=126.6

Q ss_pred             cccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          446 EFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      +|+..+.||+|++|.||++.                     +.+.+|++++++++|++++++++++..++..++|+||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            47788999999999999852                     357789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +++|.+++......+++..+..++.+++.|+.|+|   ..+++|+|++|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999876556899999999999999999999   89999999999999999999999999999887643221   2


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....++..|+||
T Consensus       155 ~~~~~~~~~~~P  166 (253)
T cd05122         155 NTMVGTPYWMAP  166 (253)
T ss_pred             cceecCCcccCH
Confidence            335678888887

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.78  E-value=5.2e-19  Score=183.13  Aligned_cols=144  Identities=26%  Similarity=0.360  Sum_probs=120.6

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC------
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE------  493 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~------  493 (596)
                      ..++|+..+.||+|+||.||++.                       +.+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            35689999999999999998752                       2355799999999999999999998643      


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ...|+||||+. ++|.+.+...   +++..+..++.|++.|++|||   ..+++||||||+||+++.++.+|++|||+++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            24799999995 5888887643   788889999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ......   ......+++.|+||
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aP  186 (353)
T cd07850         167 TAGTSF---MMTPYVVTRYYRAP  186 (353)
T ss_pred             eCCCCC---CCCCCcccccccCH
Confidence            753321   12334678899998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.78  E-value=6.6e-19  Score=173.36  Aligned_cols=146  Identities=28%  Similarity=0.441  Sum_probs=126.4

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|...+.||+|+||.||++.                       +.+..|++++++++|+|++++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            47788999999999999742                       3467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          503 MPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       503 ~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      +++++|.+++....   ..+++.....++.+++.|+.|||   ..+++|+|++|+||++++++.++++|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999998752   57899999999999999999999   8899999999999999999999999999988654322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                        .......|++.|+||
T Consensus       158 --~~~~~~~~~~~y~~p  172 (258)
T cd08215         158 --DLAKTVVGTPYYLSP  172 (258)
T ss_pred             --ceecceeeeecccCh
Confidence              122334688889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=2e-20  Score=172.77  Aligned_cols=145  Identities=26%  Similarity=0.414  Sum_probs=120.6

Q ss_pred             cccccccccCCCceeehhh-----------------------HHhHHHHHHHHhhcCCCccceeeeeeccCC-----eeE
Q 036342          446 EFSENNLIGRGGFALFIRA-----------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEE-----FKA  497 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~-----------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~  497 (596)
                      +.+..+.||-|+||+||..                       .+.+.+|+.++.-++|.|+...++..+...     ++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4456689999999999931                       256788999999999999999999887653     578


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      .|+|.|.. ||++.+-..+ .++...+..+.+||.+|++|||   +.+|.||||||.|.|++++...||||||+|+... 
T Consensus       134 V~TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-  207 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD-  207 (449)
T ss_pred             HHHHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc-
Confidence            99999954 8888776543 5666777778999999999999   9999999999999999999999999999999753 


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .++....+..+.|.+|+||
T Consensus       208 ~d~~~hMTqEVVTQYYRAP  226 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAP  226 (449)
T ss_pred             hhhhhhhHHHHHHHHhccH
Confidence            3344456667788899887

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.78  E-value=3.4e-19  Score=176.07  Aligned_cols=145  Identities=23%  Similarity=0.383  Sum_probs=121.3

Q ss_pred             cccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      +|...+.||+|+||.||++.                          ..+..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999641                          1345688999999999999999999998899999


Q ss_pred             EecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          500 LEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |||+++++|.+++..   ....+++.++..++.|++.|+.|+|   ..+++|+|++|+||++++ +.+|++|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988864   2346889999999999999999999   899999999999999975 569999999988764


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....  ......|++.|+||
T Consensus       157 ~~~~--~~~~~~~~~~~~~p  174 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSP  174 (260)
T ss_pred             CCcc--cccCCCCCcCccCH
Confidence            3221  12234578888887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=9e-20  Score=172.86  Aligned_cols=148  Identities=27%  Similarity=0.339  Sum_probs=125.3

Q ss_pred             hcccccccccccCCCceeehhh----------HHhH--------------HHHHHHHhh-cCCCccceeeeeeccCCeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRA----------FKSF--------------DVECEMMKS-IRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~----------~~~~--------------~~e~~~l~~-l~H~niv~l~~~~~~~~~~~  497 (596)
                      ..++|...++||+|+|++|..+          ++..              +.|-.+..+ -+||.+|.++.+|+.+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            4678999999999999998753          1222              234444444 37999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|.||++||+|.-++.... .+++..+..+..+|.-|+.|||   .++|++||+|.+|+|+|..|.+|+.|+|+++.--.
T Consensus       328 fvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            9999999999998887654 6889999999999999999999   99999999999999999999999999999986433


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      +  ....+++||||-|.||
T Consensus       404 ~--gd~tstfcgtpnyiap  420 (593)
T KOG0695|consen  404 P--GDTTSTFCGTPNYIAP  420 (593)
T ss_pred             C--CcccccccCCCcccch
Confidence            3  3345679999999998

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.78  E-value=5.3e-19  Score=182.35  Aligned_cols=149  Identities=24%  Similarity=0.363  Sum_probs=124.4

Q ss_pred             HHHHHHhcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC
Q 036342          437 YLELCRATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE  493 (596)
Q Consensus       437 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~  493 (596)
                      ..++...+++|+..+.||+|+||.||++.                       +.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            34556678999999999999999999752                       2355799999999999999999988543


Q ss_pred             ------CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEe
Q 036342          494 ------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS  567 (596)
Q Consensus       494 ------~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~  567 (596)
                            ...|+|+|++ +++|.+++...  .+++..+..++.|+++|++|||   ..+++|||+||+||++++++.+|++
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEe
Confidence                  3468888887 78998887654  4789999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccccccCC
Q 036342          568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       568 dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||+++....     ......+++.|+||
T Consensus       163 dfg~~~~~~~-----~~~~~~~~~~y~aP  186 (345)
T cd07877         163 DFGLARHTDD-----EMTGYVATRWYRAP  186 (345)
T ss_pred             cccccccccc-----cccccccCCCccCH
Confidence            9999886432     12334678889987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.78  E-value=5.9e-19  Score=176.72  Aligned_cols=144  Identities=28%  Similarity=0.429  Sum_probs=122.3

Q ss_pred             ccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          447 FSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      |+..+.||+|++|.||+|.                       +.+..|++++++++|||++++++++..++..|+||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            5677899999999999852                       24668999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      + ++|.+++.... ..+++..+..++.|+++|++|+|   +.+++|||++|+||++++++.++++|||+++.......  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 69999987654 35789999999999999999999   88999999999999999999999999999876532211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......+++.|+||
T Consensus       155 ~~~~~~~~~~~~aP  168 (283)
T cd07835         155 TYTHEVVTLWYRAP  168 (283)
T ss_pred             ccCccccccCCCCC
Confidence            11223567889988

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.78  E-value=6.9e-19  Score=177.35  Aligned_cols=148  Identities=23%  Similarity=0.324  Sum_probs=111.5

Q ss_pred             cccccccccccCCCceeehhhHH--------------------hHH---------------HHHHHHhhcCCCccceeee
Q 036342          444 TDEFSENNLIGRGGFALFIRAFK--------------------SFD---------------VECEMMKSIRHRNLIKVIS  488 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~~--------------------~~~---------------~e~~~l~~l~H~niv~l~~  488 (596)
                      ..+|...+.||+|+||.||+|..                    .+.               .+...++.++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            35799999999999999998530                    011               1223445678999999999


Q ss_pred             eeccCC----eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcE
Q 036342          489 SCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVA  564 (596)
Q Consensus       489 ~~~~~~----~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~  564 (596)
                      ++....    ..++++|++.. ++.+.+.... ..++..+..++.|+++|+.|+|   +.+|+||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            876543    45788888743 6666665432 3567888899999999999999   8999999999999999999999


Q ss_pred             EEeccccccccCCCCCc-----cccccccccccccCC
Q 036342          565 HLSDFSIAKLLTGEDQS-----MTQTQTLGTIGYMAP  596 (596)
Q Consensus       565 kl~dfGla~~~~~~~~~-----~~~~~~~gt~~y~aP  596 (596)
                      ||+|||+|+.+......     .......||+.|+||
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap  202 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL  202 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence            99999999876422111     112335799999997

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.78  E-value=4.7e-20  Score=189.38  Aligned_cols=148  Identities=26%  Similarity=0.382  Sum_probs=129.6

Q ss_pred             hcccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ..++|+....+|+|.||.||||.                     +...+|+-+++..+|||||.++|.+..++..+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            45789999999999999999974                     235678889999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ||.+|+|.+.-+.. ..+.+.+...++++..+|++|+|   ..+-+|||||=.||++.+.|.+|++|||.+..+....  
T Consensus        93 ycgggslQdiy~~T-gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--  166 (829)
T ss_pred             ecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh--
Confidence            99999998876554 46889999999999999999999   9999999999999999999999999999988765321  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .....+.||++||||
T Consensus       167 ~KrksfiGtpywmap  181 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAP  181 (829)
T ss_pred             hhhhcccCCccccch
Confidence            123457899999998

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.78  E-value=1.1e-18  Score=177.50  Aligned_cols=140  Identities=29%  Similarity=0.365  Sum_probs=120.8

Q ss_pred             ccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          447 FSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      |...+.||+|+||+||+|.                        +.+..|++++++++|||++++++++.+++..|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            5566789999999999852                        3466899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +. |++.+++......+++.++..++.|++.|+.|||   ..+++|+|++|+||++++++.+|++|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 5888888765556889999999999999999999   88999999999999999999999999998864321     


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                       .....|+..|+||
T Consensus       174 -~~~~~~~~~y~aP  186 (313)
T cd06633         174 -ANSFVGTPYWMAP  186 (313)
T ss_pred             -CCCccccccccCh
Confidence             2235678889887

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.78  E-value=9.1e-19  Score=172.40  Aligned_cols=147  Identities=30%  Similarity=0.450  Sum_probs=126.3

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC--CeeEEEE
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVL  500 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~  500 (596)
                      +|...+.||+|++|.||+|.                       +.+..|++++++++|+||+++++.+...  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            46778999999999999852                       3477899999999999999999999888  8899999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++++|.+++.... .+++..+..++.+++.|+.|||   +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999998765 6889999999999999999999   89999999999999999999999999999887654321


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                      ........++..|+||
T Consensus       157 ~~~~~~~~~~~~y~~p  172 (260)
T cd06606         157 GEGTGSVRGTPYWMAP  172 (260)
T ss_pred             cccccCCCCCccccCH
Confidence            1112335677888887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.78  E-value=6.4e-19  Score=177.36  Aligned_cols=140  Identities=26%  Similarity=0.336  Sum_probs=119.8

Q ss_pred             cccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          450 NNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       450 ~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      ...||+|+||.||++.                     ..+..|+.++++++|+|++++++++..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            4679999999999752                     2466799999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccccc
Q 036342          509 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  588 (596)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~  588 (596)
                      .+++...  .+++.....++.|++.|++|+|   ..+++|+|++|+||++++++.++++|||++.......  .......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            9987543  4788899999999999999999   8899999999999999999999999999987653221  1123356


Q ss_pred             ccccccCC
Q 036342          589 GTIGYMAP  596 (596)
Q Consensus       589 gt~~y~aP  596 (596)
                      |++.|+||
T Consensus       178 ~~~~y~~p  185 (292)
T cd06657         178 GTPYWMAP  185 (292)
T ss_pred             cCccccCH
Confidence            88889987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.77  E-value=8.4e-19  Score=177.97  Aligned_cols=143  Identities=29%  Similarity=0.388  Sum_probs=122.3

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ...|+..+.||+|+||.||+|.                        +++..|++++++++|+|++++++++..++..++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            3457778899999999999642                        2456799999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+. |++.+.+......+++.++..++.|++.|+.|||   ..+++||||+|+||+++.++.+|++|||++...... 
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            99996 6888877655556889999999999999999999   889999999999999999999999999998765321 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                           ....|++.|+||
T Consensus       169 -----~~~~~~~~y~aP  180 (308)
T cd06634         169 -----NXFVGTPYWMAP  180 (308)
T ss_pred             -----ccccCCccccCH
Confidence                 234678888887

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.77  E-value=8e-19  Score=178.21  Aligned_cols=149  Identities=23%  Similarity=0.374  Sum_probs=122.4

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-------  493 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-------  493 (596)
                      .++|+..+.||+|+||.||+|.                       ..+.+|++++++++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            5789999999999999999852                       2357899999999999999999987543       


Q ss_pred             -CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccc
Q 036342          494 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       494 -~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla  572 (596)
                       ...|+|+||+.+ ++.+.+......+++.++..++.|+++|+.|+|   ..+++|+|+||+||++++++.+|++|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             347999999965 787777665557899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCcc---------ccccccccccccCC
Q 036342          573 KLLTGEDQSM---------TQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~---------~~~~~~gt~~y~aP  596 (596)
                      +.........         ......+++.|+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP  195 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCCh
Confidence            8654321110         11223567889988

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.77  E-value=1e-18  Score=175.02  Aligned_cols=143  Identities=23%  Similarity=0.327  Sum_probs=121.8

Q ss_pred             ccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEecC
Q 036342          447 FSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      |...+.||+|+||.||+|.                      ....+|+..+++++ |+|++++++++..++..|+||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5677899999999999863                      12346888999999 999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                       +|++.+++.... ..+++.++..++.|++.|+.|||   ..+++|+|++|+||++++++.++++|||.++.......  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             889999887754 46789999999999999999999   88999999999999999999999999999886543211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                       .....++..|+||
T Consensus       155 -~~~~~~~~~~~aP  167 (283)
T cd07830         155 -YTDYVSTRWYRAP  167 (283)
T ss_pred             -cCCCCCcccccCc
Confidence             1234578888887

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.77  E-value=7.8e-19  Score=180.55  Aligned_cols=146  Identities=28%  Similarity=0.375  Sum_probs=122.3

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-----Ce
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-----EF  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  495 (596)
                      .++|...+.||+|+||+||++.                       +.+.+|+.++++++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            4578999999999999999752                       2355799999999999999999988654     24


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+|+||+. ++|.+++.... .+++..+..++.|++.|+.|||   ..+++|||+||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 68998887653 6889999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....  .......++..|+||
T Consensus       159 ~~~~--~~~~~~~~~~~y~aP  177 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAP  177 (337)
T ss_pred             CCCc--ccccccccccCccCh
Confidence            4321  122334678889988

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.77  E-value=1.8e-18  Score=170.98  Aligned_cols=136  Identities=25%  Similarity=0.346  Sum_probs=112.7

Q ss_pred             ccccCCCceeehhhH------------------------HhHHHHHHH-HhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF------------------------KSFDVECEM-MKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~------------------------~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||+|.                        ..+..|..+ ....+|+|++++++++..++..|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            568999999999852                        112234333 3455899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++.... .+++..+..++.|++.|+.|+|   +.+++|+|++|+||++++++.+|++|||+++....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999997654 5788899999999999999999   89999999999999999999999999999875432      12


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...|++.|+||
T Consensus       152 ~~~~~~~y~~p  162 (260)
T cd05611         152 KFVGTPDYLAP  162 (260)
T ss_pred             cCCCCcCccCh
Confidence            34577888887

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.77  E-value=1.1e-18  Score=178.71  Aligned_cols=146  Identities=29%  Similarity=0.411  Sum_probs=122.4

Q ss_pred             HHHhcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc-CCe
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN-EEF  495 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~  495 (596)
                      +...+++|+..+.||+|+||.||++.                       +.+..|++++++++||||+++++++.. .+.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            34567899999999999999999752                       346689999999999999999999865 557


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+|+||+ +++|.++++..  .+++.....++.|+++|+.|||   ..+++|||++|+||++++++.+|++|||.++..
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            89999999 56898888653  4677888889999999999999   899999999999999999999999999998754


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...     .....++..|+||
T Consensus       159 ~~~-----~~~~~~~~~y~aP  174 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAP  174 (328)
T ss_pred             CCC-----cCCCcccccccCc
Confidence            321     1234567788887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.77  E-value=1.1e-18  Score=171.69  Aligned_cols=144  Identities=26%  Similarity=0.445  Sum_probs=123.5

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|+..+.||+|+||.||++.                       ..+.+|++++++++|+||+++++++..+...|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            47788999999999999741                       2456789999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          503 MPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       503 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      +++++|.+++...   ...+++..++.++.++++|+.|+|   +.+++|+|++|+||++++++.+|++|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998762   245788899999999999999999   999999999999999999999999999999876432 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         ......+++.|+||
T Consensus       157 ---~~~~~~~~~~~~~P  170 (256)
T cd08530         157 ---MAKTQIGTPHYMAP  170 (256)
T ss_pred             ---CcccccCCccccCH
Confidence               11224577888877

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.76  E-value=1.3e-18  Score=174.03  Aligned_cols=144  Identities=26%  Similarity=0.363  Sum_probs=123.1

Q ss_pred             ccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          447 FSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      |+..+.||+|++|.||++.                       ..+.+|++++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            5667889999999999852                       24668999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      ++ ++.+++......+++.++..++.|++.|+.|||   ..+++|+|+||+||++++++.+|++|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 999888876567889999999999999999999   8999999999999999999999999999988764332  11


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~~P  167 (283)
T cd05118         155 YTHYVVTRWYRAP  167 (283)
T ss_pred             ccCccCcccccCc
Confidence            2224577788887

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.76  E-value=1.6e-18  Score=173.28  Aligned_cols=144  Identities=29%  Similarity=0.429  Sum_probs=122.5

Q ss_pred             ccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          447 FSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      |+..+.||+|+||.||+|.                       +.+..|+.++++++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            5567889999999999853                       23567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      + ++|.+++......+++..+..++.+++.|+.|||   ..+++|||++|+||++++++.+||+|||+++.......  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5999999876456889999999999999999999   88999999999999999999999999999886543221  1


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~aP  167 (282)
T cd07829         155 YTHEVVTLWYRAP  167 (282)
T ss_pred             cCccccCcCcCCh
Confidence            2233457778887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.76  E-value=1.2e-18  Score=174.87  Aligned_cols=145  Identities=28%  Similarity=0.413  Sum_probs=117.1

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||.||++.                      ..+..|+.++.++. |+||+++++++..++..++|||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            356677899999999999742                      34667999999996 9999999999998889999999


Q ss_pred             cCCCCCHHHHH---hh-CCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          502 YMPHGSLEKYL---YS-SNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       502 ~~~~g~L~~~l---~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+.. ++.++.   .. ....+++..+..++.+++.|++|+|   . .+++||||||+||+++.++.+|++|||+++...
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9864 554433   22 2246889999999999999999999   5 489999999999999999999999999987653


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...   ......|++.|+||
T Consensus       160 ~~~---~~~~~~~~~~y~aP  176 (288)
T cd06616         160 DSI---AKTRDAGCRPYMAP  176 (288)
T ss_pred             cCC---ccccccCccCccCH
Confidence            221   11234578889887

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.76  E-value=1.6e-18  Score=178.63  Aligned_cols=141  Identities=26%  Similarity=0.393  Sum_probs=117.9

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE------  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~------  494 (596)
                      .++|...+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            3689999999999999999852                       23567999999999999999999987543      


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ..|+|+||+.. ++.++..   ..+++..+..++.|+++|++|||   ..+++|||+||+||+++.++.+|++|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999964 7776652   24788899999999999999999   88999999999999999999999999999886


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....     .....+++.|+||
T Consensus       167 ~~~~-----~~~~~~~~~y~aP  183 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAP  183 (342)
T ss_pred             CCCC-----CCCceeeecccCh
Confidence            4321     2234678889988

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.76  E-value=2.3e-18  Score=176.69  Aligned_cols=146  Identities=23%  Similarity=0.303  Sum_probs=118.4

Q ss_pred             cccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhc-CCCccceeeeeeccC----Ce
Q 036342          446 EFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNE----EF  495 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~~  495 (596)
                      +|...+.||+|+||.||++.                         +.+.+|+.+++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            47778999999999998742                         2356799999999 599999999975432    45


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+++||+. ++|.+++... ..+++..+..++.|++.|+.|||   ..+++||||||+||++++++.+||+|||+++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999985 6999988654 36789999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCCc--cccccccccccccCC
Q 036342          576 TGEDQS--MTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~--~~~~~~~gt~~y~aP  596 (596)
                      ......  .......||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aP  178 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAP  178 (332)
T ss_pred             ccccccccccccCcccCccccCc
Confidence            422111  112335789999998

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.76  E-value=2.8e-18  Score=176.35  Aligned_cols=127  Identities=22%  Similarity=0.441  Sum_probs=111.8

Q ss_pred             ccccc-cccccCCCceeehhhH-------------------H----------------hHHHHHHHHhhcCCCccceeee
Q 036342          445 DEFSE-NNLIGRGGFALFIRAF-------------------K----------------SFDVECEMMKSIRHRNLIKVIS  488 (596)
Q Consensus       445 ~~~~~-~~~ig~G~~g~v~~~~-------------------~----------------~~~~e~~~l~~l~H~niv~l~~  488 (596)
                      ++|.. .+.||+|+||+||+|.                   .                .+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45653 4779999999999862                   0                2567999999999999999999


Q ss_pred             eeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEec
Q 036342          489 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD  568 (596)
Q Consensus       489 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~d  568 (596)
                      ++..++..++||||++ |+|.+++.... .+++.....++.|++.|+.|||   ..+++|+||+|+||+++.++.+|++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence            9999999999999996 69999987643 5788899999999999999999   89999999999999999999999999


Q ss_pred             cccccccC
Q 036342          569 FSIAKLLT  576 (596)
Q Consensus       569 fGla~~~~  576 (596)
                      ||+++...
T Consensus       163 fg~~~~~~  170 (335)
T PTZ00024        163 FGLARRYG  170 (335)
T ss_pred             ccceeecc
Confidence            99987654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.76  E-value=1.4e-18  Score=188.66  Aligned_cols=150  Identities=23%  Similarity=0.262  Sum_probs=107.7

Q ss_pred             hcccccccccccCCCceeehhhHHh------------------HHHHHHHHhhcC---CCccceeeee------eccCCe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAFKS------------------FDVECEMMKSIR---HRNLIKVISS------CSNEEF  495 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~~~------------------~~~e~~~l~~l~---H~niv~l~~~------~~~~~~  495 (596)
                      ..++|+..+.||+|+||.||+|...                  ...|..+..+++   +.+++.+...      +..++.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            5678999999999999999997421                  112333333332   2333333222      234567


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCC-------------------CCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCe
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCI-------------------LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV  556 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~-------------------l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NI  556 (596)
                      .++||||+++++|.+++......                   .....+..++.|++.||.|+|   .++|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHE
Confidence            89999999999999998754311                   112235578999999999999   89999999999999


Q ss_pred             eeCC-CCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          557 LLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       557 Ll~~-~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+++ ++.+||+|||+|+.+..... .......+|++||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~AP  326 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAP  326 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccCh
Confidence            9985 68999999999986543222 223456889999998

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.75  E-value=2.7e-18  Score=173.20  Aligned_cols=147  Identities=24%  Similarity=0.330  Sum_probs=120.0

Q ss_pred             hcccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV  499 (596)
                      ..++|+..+.||+|+||.||++.                      +.+..|+.++.+.. ||||+++++++..+...|+|
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            34678899999999999999852                      23445676666665 99999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      |||++ +++.+.+......+++..+..++.|+++|+.|||   + .+|+|||++|+||++++++.+||+|||++..+...
T Consensus        93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99985 5787777665557889999999999999999999   6 58999999999999999999999999998765322


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   .....++..|+||
T Consensus       169 ~~---~~~~~~~~~y~aP  183 (296)
T cd06618         169 KA---KTRSAGCAAYMAP  183 (296)
T ss_pred             Cc---ccCCCCCccccCH
Confidence            11   1223577788887

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.75  E-value=3.8e-18  Score=173.66  Aligned_cols=128  Identities=23%  Similarity=0.276  Sum_probs=108.2

Q ss_pred             HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 036342          466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSA  544 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~  544 (596)
                      +.+..|++++++++|+||+++++++..++..|++|||+++|++.+++... ...+++.....++.|+++|+.|||   ..
T Consensus        44 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~  120 (314)
T cd08216          44 KLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SK  120 (314)
T ss_pred             HHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence            46788999999999999999999999999999999999999999999764 345788889999999999999999   89


Q ss_pred             ceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc-----cccccccccccccCC
Q 036342          545 LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-----MTQTQTLGTIGYMAP  596 (596)
Q Consensus       545 ~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~-----~~~~~~~gt~~y~aP  596 (596)
                      +|+|||+||+||+++.++.+|++|||.+..+......     .......++..|+||
T Consensus       121 ~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  177 (314)
T cd08216         121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP  177 (314)
T ss_pred             CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCH
Confidence            9999999999999999999999999988765322110     111234567788887

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.75  E-value=2e-18  Score=177.08  Aligned_cols=146  Identities=29%  Similarity=0.390  Sum_probs=123.4

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC-----eeE
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE-----FKA  497 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~  497 (596)
                      +|+..+.||+|+||.||++.                       +.+..|+.++++++|+||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            47888999999999999752                       35678999999999999999999998765     789


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||++ ++|.+++.... .+++..+..++.+++.|+.|||   ..+++||||||+||+++.++.++++|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 58999887654 6889999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCC-ccccccccccccccCC
Q 036342          578 EDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~-~~~~~~~~gt~~y~aP  596 (596)
                      ... ........+++.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~y~aP  175 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAP  175 (330)
T ss_pred             cccccccccccccccCcCCc
Confidence            221 0112334678889988

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.75  E-value=2.3e-18  Score=188.77  Aligned_cols=154  Identities=25%  Similarity=0.457  Sum_probs=128.1

Q ss_pred             HHHHhcccccccccccCCCceeehhh-----------------------------HHhHHHHHHHHhhc-CCCccceeee
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRA-----------------------------FKSFDVECEMMKSI-RHRNLIKVIS  488 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~-----------------------------~~~~~~e~~~l~~l-~H~niv~l~~  488 (596)
                      .++...++....+.+|+|.||.|++|                             .+.+..|+++|+.+ +|+|||.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34445555566679999999999875                             24678899999988 5999999999


Q ss_pred             eeccCCeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCC
Q 036342          489 SCSNEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKP  553 (596)
Q Consensus       489 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~  553 (596)
                      +|..++..++|+||++.|+|.++++...               ..+...+.+.++.|||.|++||+   +.++||||+-+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence            9999999999999999999999998876               34788899999999999999999   99999999999


Q ss_pred             CCeeeCCCCcEEEeccccccccCCCCCcccccccc--ccccccCC
Q 036342          554 SNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL--GTIGYMAP  596 (596)
Q Consensus       554 ~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~--gt~~y~aP  596 (596)
                      +|||+.++..+||+|||+|+.......+.. ....  -...||||
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmAp  490 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAP  490 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCH
Confidence            999999999999999999996543332221 1112  34569998

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.75  E-value=4.3e-18  Score=167.03  Aligned_cols=138  Identities=33%  Similarity=0.440  Sum_probs=118.3

Q ss_pred             ccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCH
Q 036342          453 IGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL  508 (596)
Q Consensus       453 ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L  508 (596)
                      ||+|+||.||++.                        ..+..|++++++++|+||+++++.+..++..|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6888888888641                        2567899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccccccc
Q 036342          509 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  588 (596)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~  588 (596)
                      .+++.... .+++.....++.|+++|+.|+|   ..+++|+|++|+||+++.++.++++|||++.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99997664 5789999999999999999999   8999999999999999999999999999988654321  1123356


Q ss_pred             ccccccCC
Q 036342          589 GTIGYMAP  596 (596)
Q Consensus       589 gt~~y~aP  596 (596)
                      ++..|+||
T Consensus       155 ~~~~~~~P  162 (250)
T cd05123         155 GTPEYLAP  162 (250)
T ss_pred             CCccccCh
Confidence            78888887

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.75  E-value=2e-18  Score=177.94  Aligned_cols=143  Identities=27%  Similarity=0.393  Sum_probs=122.0

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe----
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF----  495 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----  495 (596)
                      ..++|+..+.||+|+||.||+|.                       +.+.+|+.++++++|||++++++++..++.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            35689999999999999999752                       234579999999999999999998876654    


Q ss_pred             --eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          496 --KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       496 --~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                        .|+|+||+ +++|.+++...  .+++..+..++.|+++|+.|+|   ..+++|||+||+||++++++.+||+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999999 67999988753  5889999999999999999999   8999999999999999999999999999988


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .....     .....++..|+||
T Consensus       167 ~~~~~-----~~~~~~~~~y~aP  184 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAP  184 (343)
T ss_pred             ccccc-----ccCCcccccccCH
Confidence            65322     2334678888887

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.75  E-value=2.2e-18  Score=153.37  Aligned_cols=151  Identities=26%  Similarity=0.373  Sum_probs=118.7

Q ss_pred             HHHhcccccccccccCCCceeehh----------h------------HHhHHHHHHHHhh-cCCCccceeeeeeccCCee
Q 036342          440 LCRATDEFSENNLIGRGGFALFIR----------A------------FKSFDVECEMMKS-IRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~----------~------------~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~  496 (596)
                      ++...++......||+|+||+|-+          |            .++...|+.+..+ ...|.+|++||.+..++.+
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            444556666778899999998754          1            1344556665443 4799999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          497 ALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ++.||.|.. +|..+-++   .+...++.-.=+|+..|..|+.|||.  ...++|||+||+|||++.+|.+|+||||.+-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999954 77666443   34567888888899999999999994  4589999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+.+   +...+..+|...||||
T Consensus       198 ~L~d---SiAkt~daGCkpYmaP  217 (282)
T KOG0984|consen  198 YLVD---SIAKTMDAGCKPYMAP  217 (282)
T ss_pred             eehh---hhHHHHhcCCCccCCh
Confidence            6643   3333445788899998

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=3.3e-20  Score=160.08  Aligned_cols=175  Identities=29%  Similarity=0.473  Sum_probs=96.5

Q ss_pred             CCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEe
Q 036342          186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSL  265 (596)
Q Consensus       186 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  265 (596)
                      ..++.|.||+|+++ .+|..+..+.+|+.|++++|+|+ .+|..++.++.|+.|+++-|++. ..|..|+.++.|+.|||
T Consensus        33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence            44455555555555 34444555555555555555555 45555555555555555555554 45555555555555555


Q ss_pred             CCCcccC--CCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCccc
Q 036342          266 GSNKLTS--IPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK  343 (596)
Q Consensus       266 s~N~l~~--ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~  343 (596)
                      ++|++.+  +|..|+.+.-|+.|.|+.|.+. ..|..++.+++|+.|.+..|.+. .+|.+ .+.+..|++|.+.+|+++
T Consensus       110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpke-ig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKE-IGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHH-HHHHHHHHHHhcccceee
Confidence            5555554  5555555555555555555554 34555555566666666666555 45553 235556666666666666


Q ss_pred             ccCCCCCC---CCCCCcccccccccc
Q 036342          344 GEIPRGGS---FGNFSAESFEGNELL  366 (596)
Q Consensus       344 ~~~p~~~~---~~~l~~l~~~~N~~~  366 (596)
                      -.+|+.+.   ..+-+.+..+.|||.
T Consensus       187 vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  187 VLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            55444322   223345667788874

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.74  E-value=7.5e-18  Score=168.94  Aligned_cols=143  Identities=27%  Similarity=0.424  Sum_probs=117.7

Q ss_pred             ccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhc---CCCccceeeeeeccCCe-----
Q 036342          447 FSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSI---RHRNLIKVISSCSNEEF-----  495 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~-----  495 (596)
                      |+..+.||+|+||.||++.                       ..+..|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999852                       1345677777665   69999999999987776     


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      .++||||+. +++.+++.... ..+++.++..++.|+++|+.|||   +.+++|+|++|+||++++++.+|++|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999997 48998887643 35899999999999999999999   88999999999999999999999999999887


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +....   ......++..|+||
T Consensus       157 ~~~~~---~~~~~~~~~~~~~P  175 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAP  175 (287)
T ss_pred             ccCCc---ccccccccccccCh
Confidence            64321   11223577888887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.74  E-value=7e-18  Score=172.83  Aligned_cols=120  Identities=23%  Similarity=0.277  Sum_probs=105.8

Q ss_pred             ccccCC--CceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRG--GFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G--~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      ..||+|  +||+||++.                       +.+..|+.+++.++||||++++++|..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  888998742                       4567889999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          506 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       506 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      |++.+++.... ..+++..+..++.|++.|+.|+|   +.+++|||+||+||+++.++.+|++|||.+.
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            99999987643 35788899999999999999999   8999999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.74  E-value=4.6e-19  Score=163.46  Aligned_cols=145  Identities=29%  Similarity=0.356  Sum_probs=111.4

Q ss_pred             cccccccccCCCceeehhh----------------------HHhHHHHHHHHh-hcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRA----------------------FKSFDVECEMMK-SIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~----------------------~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +.+....||.|+||+|+|-                      .+++..|.++.. .-+.||||++||++..++..|+.||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            4455678999999999982                      245556665444 44789999999999999999999999


Q ss_pred             CCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          503 MPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       503 ~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      |. -++..+-+.    ....+++.-.-.|..-.+.||.||..  ...|+|||+||+|||++..|.+|+||||.+-.+.+ 
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-  220 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-  220 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence            94 466554332    12346666555666777899999974  45799999999999999999999999999877643 


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                        +...+.-+|-..||||
T Consensus       221 --SiAkT~daGCrpYmAP  236 (361)
T KOG1006|consen  221 --SIAKTVDAGCRPYMAP  236 (361)
T ss_pred             --HHHhhhccCCccccCh
Confidence              3344556789999998

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.73  E-value=5.3e-18  Score=174.76  Aligned_cols=146  Identities=27%  Similarity=0.403  Sum_probs=118.4

Q ss_pred             ccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccC----------
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNE----------  493 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~----------  493 (596)
                      .+|...+.||+|+||.||+|.                     +.+..|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            689999999999999999852                     3467899999999999999999877654          


Q ss_pred             ----CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC-CCCcEEEec
Q 036342          494 ----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSD  568 (596)
Q Consensus       494 ----~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~-~~~~~kl~d  568 (596)
                          ...|+||||++ ++|.+++...  .+++..+..++.|+++|+.|||   ..+++||||||+||+++ +++.+|++|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence                35789999997 5998888643  4788999999999999999999   88999999999999997 456889999


Q ss_pred             cccccccCCCCCcc-ccccccccccccCC
Q 036342          569 FSIAKLLTGEDQSM-TQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~-~~~~~~gt~~y~aP  596 (596)
                      ||.++......... ......++..|+||
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aP  187 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSP  187 (342)
T ss_pred             cccceecCCccccccccccccccccccCH
Confidence            99987653221111 11223578889887

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.73  E-value=8.5e-20  Score=157.58  Aligned_cols=157  Identities=34%  Similarity=0.521  Sum_probs=105.7

Q ss_pred             CCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCC
Q 036342          132 LSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRK  211 (596)
Q Consensus       132 ~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  211 (596)
                      +.+++..+.|.||+|+++.+-|  .+..+ .+|+.|++.+|+|. .+|..++.++.|+.|+++-|++. +.|..|++++.
T Consensus        29 Lf~~s~ITrLtLSHNKl~~vpp--nia~l-~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~  103 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLTVVPP--NIAEL-KNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPA  103 (264)
T ss_pred             ccchhhhhhhhcccCceeecCC--cHHHh-hhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCch
Confidence            3344555556666666654433  24444 45666666666665 45666777777777777777776 67777777777


Q ss_pred             CCeEEccCCccc-ccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEccc
Q 036342          212 LQRLNLEDNILE-GSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSS  290 (596)
Q Consensus       212 L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~  290 (596)
                      |+.|||.+|++. ..+|..|..+..|+.|+|+.|.+. .+|...+.+++|+.|.+..|.+-++|.+++.+.+|++|.+.+
T Consensus       104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqg  182 (264)
T KOG0617|consen  104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQG  182 (264)
T ss_pred             hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhccc
Confidence            777777777773 356777777777777777777776 566667777777777777777777777777777777777777


Q ss_pred             CCCC
Q 036342          291 NFLT  294 (596)
Q Consensus       291 N~l~  294 (596)
                      |+++
T Consensus       183 nrl~  186 (264)
T KOG0617|consen  183 NRLT  186 (264)
T ss_pred             ceee
Confidence            7666

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.73  E-value=1.8e-18  Score=160.19  Aligned_cols=145  Identities=23%  Similarity=0.299  Sum_probs=116.5

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +.+....||+|+.|.|+++.                      +++...+.++.+-+ .|.||+.+|+|..+..+++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            44556779999999998741                      34555666666554 89999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      |.. .++..++.-...+++.-.-++..-+.+||.||.+  .++|+|||+||+|||+|+.|.+|+||||.+-++.+.   .
T Consensus       173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---k  246 (391)
T KOG0983|consen  173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---K  246 (391)
T ss_pred             HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc---c
Confidence            954 5666666655668887777788889999999974  458999999999999999999999999998877543   2


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ..+..+|-+.||||
T Consensus       247 AhtrsAGC~~YMaP  260 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAP  260 (391)
T ss_pred             ccccccCCccccCc
Confidence            33445789999998

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.72  E-value=1.2e-17  Score=162.62  Aligned_cols=120  Identities=22%  Similarity=0.148  Sum_probs=102.3

Q ss_pred             HHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceE
Q 036342          468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVI  547 (596)
Q Consensus       468 ~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~  547 (596)
                      +..|...+....||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|+++|+.|+|   +++++
T Consensus        32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~  107 (237)
T cd05576          32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALH---REGIV  107 (237)
T ss_pred             hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            4556666667789999999999999999999999999999999987654 5889999999999999999999   89999


Q ss_pred             eCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          548 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       548 Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||+||+||+++.++.++++|||.+......     .....++..|+||
T Consensus       108 H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aP  151 (237)
T cd05576         108 CRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAP  151 (237)
T ss_pred             ccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCC
Confidence            9999999999999999999999987755321     1223456778887

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.72  E-value=2.9e-18  Score=154.86  Aligned_cols=130  Identities=23%  Similarity=0.444  Sum_probs=112.2

Q ss_pred             hcccccccccccCCCceeehhhH------------------HhHHHHHHHHhhcC-CCccceeeeeeccCC--eeEEEEe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEE--FKALVLE  501 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~lV~e  501 (596)
                      ..++|++.+.+|+|.|++|+.|.                  +.+.+|+.+++.+. |||||+|++...+..  ...+|+|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE  115 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE  115 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence            35689999999999999999863                  67899999999998 999999999998765  4679999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEeccccccccCCCC
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfGla~~~~~~~  579 (596)
                      |+.+.|..+..    +.+...+...++.+++.|+.|+|   +++|+|||+||.|+++|. .-+.+++|.|+|.++....
T Consensus       116 ~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  116 YVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            99998776554    24566778889999999999999   999999999999999995 4689999999999885443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.70  E-value=2.8e-17  Score=173.49  Aligned_cols=147  Identities=29%  Similarity=0.464  Sum_probs=116.8

Q ss_pred             cccccccccCCCcee-ehhh--------H--------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCCCCC
Q 036342          446 EFSENNLIGRGGFAL-FIRA--------F--------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS  507 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~-v~~~--------~--------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g~  507 (596)
                      -|...+++|.|+-|. ||+|        +        ....+|++.++.- +|||||++++.-.++...|++.|.|. .+
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s  588 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS  588 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence            355668889998875 5664        2        2356788888877 59999999999999999999999994 59


Q ss_pred             HHHHHhhCCCCC---CHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---C--CcEEEeccccccccCCCC
Q 036342          508 LEKYLYSSNCIL---DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---N--MVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       508 L~~~l~~~~~~l---~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~--~~~kl~dfGla~~~~~~~  579 (596)
                      |.++++......   .....+....|+++|+++||   +.+|||||+||.||||+.   +  .+++|+|||+++.+....
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            999998741111   11345778999999999999   899999999999999975   3  589999999999987655


Q ss_pred             Cccc-cccccccccccCC
Q 036342          580 QSMT-QTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~-~~~~~gt~~y~aP  596 (596)
                      ++.. ..+..||-+|+||
T Consensus       666 sS~~r~s~~sGt~GW~AP  683 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAP  683 (903)
T ss_pred             chhhcccCCCCcccccCH
Confidence            4332 3456899999998

>PRK10345 hypothetical protein; Provisional

Probab=99.69  E-value=1.3e-16  Score=150.21  Aligned_cols=121  Identities=14%  Similarity=0.264  Sum_probs=96.7

Q ss_pred             ccccccccCCCceeehhh------------------HHhHHHHHHHHhhc-----CCCccceeeeeeccCC---eeE-EE
Q 036342          447 FSENNLIGRGGFALFIRA------------------FKSFDVECEMMKSI-----RHRNLIKVISSCSNEE---FKA-LV  499 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~------------------~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~~~-lV  499 (596)
                      ....+.||+|+||.||+.                  .+.+.+|+.+++.+     .||||++++|+++++.   .++ +|
T Consensus         4 L~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cCCcceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            345688999999999862                  24578999999999     6799999999998763   434 78


Q ss_pred             Eec--CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHhccCCCceEeCCCCCCCeeeCC----CCcEEEec-ccc
Q 036342          500 LEY--MPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGYSALVIHCDLKPSNVLLDD----NMVAHLSD-FSI  571 (596)
Q Consensus       500 ~e~--~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l-~~lh~~~~~~i~Hrdlk~~NILl~~----~~~~kl~d-fGl  571 (596)
                      +||  +++|+|.++++..  .+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    .+.++|+| ||.
T Consensus        84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  6689999999764  35544  34577888777 9999   999999999999999974    34899999 555


Q ss_pred             ccc
Q 036342          572 AKL  574 (596)
Q Consensus       572 a~~  574 (596)
                      +..
T Consensus       157 ~~~  159 (210)
T PRK10345        157 STF  159 (210)
T ss_pred             cce
Confidence            443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.67  E-value=4.8e-17  Score=154.21  Aligned_cols=121  Identities=29%  Similarity=0.393  Sum_probs=104.9

Q ss_pred             HhHHHHHHHHhhcCCCccceeeeeeccCC------eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh
Q 036342          466 KSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  539 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh  539 (596)
                      ++..+|..++..++|+||++++.+|....      ..|+||||| .++|.+.+..   .++......+..|.+.|++|+|
T Consensus        60 kra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh  135 (369)
T KOG0665|consen   60 KRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLH  135 (369)
T ss_pred             hhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999997654      479999999 4588888763   4678889999999999999999


Q ss_pred             ccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       540 ~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                         +.+|+|||+||+||++..++.+||.|||+|+....   ....+..+.|..|.||
T Consensus       136 ---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~---~~~mtpyVvtRyyrap  186 (369)
T KOG0665|consen  136 ---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT---DFMMTPYVVTRYYRAP  186 (369)
T ss_pred             ---hcceeecccCcccceecchhheeeccchhhcccCc---ccccCchhheeeccCc
Confidence               99999999999999999999999999999986432   2345667899999998

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.67  E-value=1.7e-16  Score=154.02  Aligned_cols=151  Identities=21%  Similarity=0.309  Sum_probs=123.1

Q ss_pred             HHHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCC------ccceeeeee
Q 036342          437 YLELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHR------NLIKVISSC  490 (596)
Q Consensus       437 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~------niv~l~~~~  490 (596)
                      |......+.+|.++..+|+|.||.|.+++                    ++.+-|+++++++.+.      -+|++.++|
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            33333447899999999999999987531                    3456799999999432      478899999


Q ss_pred             ccCCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---------
Q 036342          491 SNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---------  560 (596)
Q Consensus       491 ~~~~~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---------  560 (596)
                      .-.+..++|+|.+ |-++.++++... ..++...+..|++|++++++|||   +..++|-|+||+|||+.+         
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEecc
Confidence            9999999999999 679999998855 46788999999999999999999   999999999999999831         


Q ss_pred             -----------CCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          561 -----------NMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       561 -----------~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                                 ...+||+|||-|+.-...     .+..+.|..|+||
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAP  278 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAP  278 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCc
Confidence                       235899999999864222     2446789999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.66  E-value=3.5e-16  Score=150.49  Aligned_cols=146  Identities=30%  Similarity=0.446  Sum_probs=122.8

Q ss_pred             ccccccccCCCceeehhh----------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          447 FSENNLIGRGGFALFIRA----------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~----------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      |...+.||+|++|.||++                      .+.+.+|++.+++++|+|++++++++...+..++|+||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            456788999999999874                      2356779999999999999999999999899999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +++|.+++......+++.....++.+++.++.|+|   ..+++|+|++|+||+++.++.++++|||.+........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            99999999876433788999999999999999999   88999999999999999999999999999887643320 012


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....++..|++|
T Consensus       157 ~~~~~~~~~~~p  168 (225)
T smart00221      157 KTVKGTPFYLAP  168 (225)
T ss_pred             cceeccCCcCCH
Confidence            234567778876

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.66  E-value=2.1e-16  Score=148.03  Aligned_cols=100  Identities=19%  Similarity=0.165  Sum_probs=80.5

Q ss_pred             HHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-Cce
Q 036342          469 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALV  546 (596)
Q Consensus       469 ~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i  546 (596)
                      ..|...+.++.|+++.....+...+  .|+||||++++++... +..  ..++..+...++.+++.++.|+|   . .+|
T Consensus        67 ~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~gi  139 (190)
T cd05145          67 EKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGL  139 (190)
T ss_pred             HHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCE
Confidence            4678899999999875444433332  4899999998865433 332  24677788899999999999999   7 899


Q ss_pred             EeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          547 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       547 ~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      +|||+||+||+++ ++.++++|||+++...
T Consensus       140 vHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         140 VHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             ecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            9999999999999 7899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.66  E-value=6.7e-17  Score=149.67  Aligned_cols=128  Identities=23%  Similarity=0.389  Sum_probs=104.9

Q ss_pred             cccccccccccCCCceeehhh--------------------HHhHHHHHHHHhhc-CCCccceeeee-eccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRA--------------------FKSFDVECEMMKSI-RHRNLIKVISS-CSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~--------------------~~~~~~e~~~l~~l-~H~niv~l~~~-~~~~~~~~lV~e  501 (596)
                      .+.|.+.+.+|+|.||.+-.+                    .++|.+|...=-.+ .|.||+.-|++ |+..+...+++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            357888999999999987543                    24566665443333 48999998874 567777889999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC--CCCcEEEeccccccccC
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~--~~~~~kl~dfGla~~~~  576 (596)
                      |++-|||.+-+...  ++.+....+++.|+++|+.|||   ++.+||||||.+|||+-  +..++|+||||+.+..+
T Consensus       103 ~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999888664  4778889999999999999999   99999999999999993  45699999999988653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.66  E-value=1.4e-16  Score=148.81  Aligned_cols=98  Identities=15%  Similarity=0.145  Sum_probs=78.1

Q ss_pred             HHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCceEeC
Q 036342          471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSALVIHC  549 (596)
Q Consensus       471 e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~l-h~~~~~~i~Hr  549 (596)
                      |++.++++.|+++.....+...  ..++||||++++++....... ..+++.+...++.|++.++.|+ |   ..+|+||
T Consensus        69 E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHr  142 (190)
T cd05147          69 EMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHA  142 (190)
T ss_pred             HHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence            8899999988776443332222  238999999988776543222 3578889999999999999999 6   7799999


Q ss_pred             CCCCCCeeeCCCCcEEEecccccccc
Q 036342          550 DLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       550 dlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      |+||+||+++ ++.++++|||+|...
T Consensus       143 DlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         143 DLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCCHHHEEEE-CCcEEEEEccccccC
Confidence            9999999998 478999999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.65  E-value=1.6e-16  Score=164.03  Aligned_cols=143  Identities=24%  Similarity=0.304  Sum_probs=115.6

Q ss_pred             cccccccccccCCCceeehhhH-----------------HhHHHHHHHHh-hcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMK-SIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      ++.|+....+|.|+|++|-++.                 .+-..|+.++. .-+||||+++.+.+.+....|+|||++.+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG  400 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence            5678888889999999997642                 11334554444 44799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee-CCCCcEEEeccccccccCCCCCcccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL-DDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl-~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      |-+.+.+......  ...+..|+++++.|+.|||   .+++||||+||+|||+ ++.+.++|+|||.++.....     .
T Consensus       401 ~ell~ri~~~~~~--~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~  470 (612)
T KOG0603|consen  401 GELLRRIRSKPEF--CSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----C  470 (612)
T ss_pred             cHHHHHHHhcchh--HHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----h
Confidence            9888887665422  2677789999999999999   8999999999999999 58999999999999976432     2


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      .+.|-|..|.||
T Consensus       471 ~tp~~t~~y~AP  482 (612)
T KOG0603|consen  471 DTPALTLQYVAP  482 (612)
T ss_pred             cccchhhcccCh
Confidence            234567778887

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.64  E-value=1.2e-15  Score=144.74  Aligned_cols=139  Identities=38%  Similarity=0.593  Sum_probs=116.5

Q ss_pred             ccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHH
Q 036342          453 IGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK  510 (596)
Q Consensus       453 ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~  510 (596)
                      ||+|++|.||++.                      +.+.+|++.+++++|++++++++++...+..++|+||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            5788888887641                      358899999999999999999999999899999999999999999


Q ss_pred             HHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEeccccccccCCCCCccccccccc
Q 036342          511 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQTLG  589 (596)
Q Consensus       511 ~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfGla~~~~~~~~~~~~~~~~g  589 (596)
                      ++......+++..+..++.++++++.|||   ..+++|+|++|.||+++. ++.++++|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            99876445789999999999999999999   889999999999999999 89999999999886543210  1122345


Q ss_pred             cccccCC
Q 036342          590 TIGYMAP  596 (596)
Q Consensus       590 t~~y~aP  596 (596)
                      ...|++|
T Consensus       156 ~~~~~~p  162 (215)
T cd00180         156 TPAYMAP  162 (215)
T ss_pred             CCCccCh
Confidence            6667665

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.64  E-value=1.1e-15  Score=141.11  Aligned_cols=114  Identities=17%  Similarity=0.158  Sum_probs=93.8

Q ss_pred             ccccccccCCCceeehhh-----------------------HHhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEec
Q 036342          447 FSENNLIGRGGFALFIRA-----------------------FKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~-----------------------~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +.....+++|+||+||.+                       ...+.+|+++|++++ |+++++++++    +..|+||||
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            345688999999999852                       124789999999995 4789999886    346999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCC-CCCCeeeCCCCcEEEecccccccc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDL-KPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdl-k~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ++|.+|.+....        ....+..|+++++.++|   ..+|+|||+ ||+|||++.++.++|+|||+|...
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            999998754321        12346789999999999   999999999 799999999999999999999854

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=1e-15  Score=166.59  Aligned_cols=122  Identities=22%  Similarity=0.282  Sum_probs=104.5

Q ss_pred             HHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccC
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE  493 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~  493 (596)
                      ......|...+.||+|+||.||++.                           +.+.+|++++++++|++++....++..+
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            3344556678999999999999831                           2366899999999999999888887777


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      +..++||||+++++|.+++.         ....++.++++++.|+|   ..+++|||+||+||++ +++.++++|||+++
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            77899999999999998874         34668999999999999   8999999999999999 67899999999998


Q ss_pred             cc
Q 036342          574 LL  575 (596)
Q Consensus       574 ~~  575 (596)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            64

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.63  E-value=6.1e-16  Score=141.05  Aligned_cols=149  Identities=20%  Similarity=0.275  Sum_probs=123.5

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCC-CccceeeeeeccCCeeEEEEec
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRH-RNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ...+|...+.||+|+||.+|.|.                   .....|..+.+.++| ..|..+..+..+++.-.+|||.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            34589999999999999999863                   245678889988876 5788888888899889999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEeccccccccCCCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~dfGla~~~~~~~  579 (596)
                      . |.+|++.+.-+...++..+++-.+-|+..-++|+|   .++.+||||||+|+|..-   ...+.++|||+|+.+.+..
T Consensus        93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            8 88999999887778899999999999999999999   899999999999999963   3578999999999875432


Q ss_pred             C-----ccccccccccccccC
Q 036342          580 Q-----SMTQTQTLGTIGYMA  595 (596)
Q Consensus       580 ~-----~~~~~~~~gt~~y~a  595 (596)
                      .     .......+||.+|.+
T Consensus       169 t~~HIpyre~r~ltGTaRYAS  189 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYAS  189 (341)
T ss_pred             ccccCccccCCccceeeeehh
Confidence            2     111234578888864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.61  E-value=2.3e-15  Score=143.42  Aligned_cols=146  Identities=22%  Similarity=0.324  Sum_probs=122.9

Q ss_pred             cccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEecCCC
Q 036342          446 EFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      .|.+.+.||+|+||+++.|.                   .+...|-...+.+. -+.|...+-+-.++-.-.||+|.. |
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            78999999999999999874                   24556777777664 689999888888887788999999 8


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-----CCcEEEeccccccccCCCCC
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-----NMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-----~~~~kl~dfGla~~~~~~~~  580 (596)
                      .+|+|.+.-++..++..++..+|.|+..-++|+|   .+..|.|||||+|+||..     ...+.++|||+|+.+.++..
T Consensus       108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            8999999888888999999999999999999999   999999999999999963     35789999999999866543


Q ss_pred             -----ccccccccccccccC
Q 036342          581 -----SMTQTQTLGTIGYMA  595 (596)
Q Consensus       581 -----~~~~~~~~gt~~y~a  595 (596)
                           +.......||.+||+
T Consensus       185 kqHIPYrE~KSLsGTARYMS  204 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMS  204 (449)
T ss_pred             cccCccccccccccceeeeE
Confidence                 112334679999996

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.60  E-value=2.3e-15  Score=146.39  Aligned_cols=125  Identities=34%  Similarity=0.471  Sum_probs=109.7

Q ss_pred             HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 036342          465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA  544 (596)
Q Consensus       465 ~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~  544 (596)
                      .+.+.+|++.+++++|+|++++++++......++|+||+++++|.+++..... +++..+..++.++++++.|||   ..
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh---~~  106 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR-LSEDEARFYARQILSALEYLH---SN  106 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---Hc
Confidence            46788999999999999999999999998999999999999999999876543 788999999999999999999   88


Q ss_pred             ceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          545 LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       545 ~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +++|+|++|+||++++++.++++|||.+.......   ......++..|+||
T Consensus       107 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p  155 (244)
T smart00220      107 GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP  155 (244)
T ss_pred             CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence            99999999999999999999999999988764321   12334577788887

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.58  E-value=5.3e-15  Score=150.62  Aligned_cols=147  Identities=26%  Similarity=0.380  Sum_probs=120.4

Q ss_pred             cccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCC----Cccceeeeee-ccCCeeEE
Q 036342          446 EFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRH----RNLIKVISSC-SNEEFKAL  498 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~~l  498 (596)
                      +|.+.+.||+|+||.||.+.                      ..+..|+.++..+..    +++.++++.. ..++..|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            79999999999999999742                      146789999999873    6899999999 57788999


Q ss_pred             EEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC-----CcEEEeccccc
Q 036342          499 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-----MVAHLSDFSIA  572 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~-----~~~kl~dfGla  572 (596)
                      ||+.+ |.+|.+...... ..++..++..++.|+..+|+++|   +.+++||||||+|+++...     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 889999886554 67889999999999999999999   9999999999999999754     46999999999


Q ss_pred             c--ccCCCCC-----ccc-cccccccccccCC
Q 036342          573 K--LLTGEDQ-----SMT-QTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~--~~~~~~~-----~~~-~~~~~gt~~y~aP  596 (596)
                      +  .+.....     ... ...+.||.+|.++
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~  206 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI  206 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccH
Confidence            9  4322211     101 2346699999874

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.57  E-value=6.7e-15  Score=140.62  Aligned_cols=116  Identities=26%  Similarity=0.320  Sum_probs=100.2

Q ss_pred             ccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          451 NLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      +.||+|++|.||+|.                           ..+.+|+.++..++|++++....++...+..++||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            578999999999862                           13567899999999999887777777777789999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      +|++|.+.+....    + .+..++.+++.++.++|   ..+++|+|++|+||+++ ++.++++|||.++..
T Consensus        82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            9999999986542    2 77889999999999999   89999999999999999 789999999998853

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.56  E-value=2.6e-14  Score=138.94  Aligned_cols=156  Identities=21%  Similarity=0.263  Sum_probs=125.6

Q ss_pred             HHHHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeee
Q 036342          438 LELCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSC  490 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~  490 (596)
                      .++....+++.....+-+|.||.||+|.                           ..+.+|.-.+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            3555556678888889999999999972                           1245677777788999999999998


Q ss_pred             ccC-CeeEEEEecCCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC
Q 036342          491 SNE-EFKALVLEYMPHGSLEKYLYSSN-------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM  562 (596)
Q Consensus       491 ~~~-~~~~lV~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~  562 (596)
                      .++ +..+..|.++.-|+|..|+.-++       ..+...+...++.|++.|++|+|   ..++||.||.++|.+||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            765 46788999999999999998322       34566778889999999999999   99999999999999999999


Q ss_pred             cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          563 VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 ~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+|++|-.++|.+...+...-....-.+..||+|
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl  467 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSL  467 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCH
Confidence            9999999999988766544333333456678875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.54  E-value=1.1e-14  Score=137.68  Aligned_cols=112  Identities=21%  Similarity=0.329  Sum_probs=92.8

Q ss_pred             cccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          452 LIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       452 ~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .||+|+||.||++.                           ..+.+|++++++++|+++.....++...+..++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            37999999999853                           234579999999998876555555555666799999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      |++|.+.+.....        .++.+++.++.++|   ..+++|+|++|+||+++ ++.+++.|||+++..
T Consensus        81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999988754321        68999999999999   99999999999999999 789999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.53  E-value=2.1e-14  Score=135.71  Aligned_cols=119  Identities=13%  Similarity=0.107  Sum_probs=99.5

Q ss_pred             cccccccccccCCCceeehhhH----------------------Hh------HHHHHHHHhhcCCCccceeeeeeccC--
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KS------FDVECEMMKSIRHRNLIKVISSCSNE--  493 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~------~~~e~~~l~~l~H~niv~l~~~~~~~--  493 (596)
                      ..+|...+.+|.|+||.||.+.                      ..      +.+|++.+.+++|++|+....++...  
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            5689999999999999998621                      11      57899999999999999999886533  


Q ss_pred             ------CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEe
Q 036342          494 ------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS  567 (596)
Q Consensus       494 ------~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~  567 (596)
                            +..++||||++|.+|.++..     ++.    ....+++.++..+|   ..+++|||++|+||++++++ ++++
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEE
Confidence                  35789999999999987731     222    24568999999999   99999999999999999988 9999


Q ss_pred             cccccccc
Q 036342          568 DFSIAKLL  575 (596)
Q Consensus       568 dfGla~~~  575 (596)
                      |||..+..
T Consensus       177 Dfg~~~~~  184 (232)
T PRK10359        177 DLSGKRCT  184 (232)
T ss_pred             ECCCcccc
Confidence            99988765

>smart00090 RIO RIO-like kinase

Probab=99.52  E-value=2.1e-14  Score=138.66  Aligned_cols=123  Identities=17%  Similarity=0.126  Sum_probs=95.9

Q ss_pred             cccccccccCCCceeehhhH-H---------------------------------------------hHHHHHHHHhhcC
Q 036342          446 EFSENNLIGRGGFALFIRAF-K---------------------------------------------SFDVECEMMKSIR  479 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-~---------------------------------------------~~~~e~~~l~~l~  479 (596)
                      -|++.+.||+|+||.||+|. .                                             .+..|+..++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46778899999999999874 0                                             0246888888887


Q ss_pred             CC--ccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc-eEeCCCCCCCe
Q 036342          480 HR--NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL-VIHCDLKPSNV  556 (596)
Q Consensus       480 H~--niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~-i~Hrdlk~~NI  556 (596)
                      +.  .+++.+++    ...++||||++++++....... ...+......++.|++.++.|+|   ..+ ++|||+||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            63  34444543    2358999999998887654322 23455667789999999999999   889 99999999999


Q ss_pred             eeCCCCcEEEeccccccccCC
Q 036342          557 LLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       557 Ll~~~~~~kl~dfGla~~~~~  577 (596)
                      +++ ++.++++|||.+.....
T Consensus       181 li~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEE-CCCEEEEEChhhhccCC
Confidence            999 88999999999886543

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.52  E-value=3.8e-16  Score=158.39  Aligned_cols=213  Identities=30%  Similarity=0.429  Sum_probs=145.1

Q ss_pred             EEEccCCcCccccCcc-CccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCC
Q 036342           38 FLGLQNNSLSGSLSSI-ANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE  116 (596)
Q Consensus        38 ~L~Ls~N~l~~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~  116 (596)
                      +|.|++-+++ .+|.. +...+.--...||+.|++. ++|..++.+..|+.+.|+.|.|. .+|.++++|..|++|||+.
T Consensus        54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~  130 (722)
T KOG0532|consen   54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS  130 (722)
T ss_pred             ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence            3455555554 33332 1122334455666666666 56666666666666666666665 4555666666666666666


Q ss_pred             CcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCC
Q 036342          117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN  196 (596)
Q Consensus       117 N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N  196 (596)
                      |+++.++..                               +..+  .|+.|.+++|+++ .+|..++.+..|..||.+.|
T Consensus       131 NqlS~lp~~-------------------------------lC~l--pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~n  176 (722)
T KOG0532|consen  131 NQLSHLPDG-------------------------------LCDL--PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKN  176 (722)
T ss_pred             chhhcCChh-------------------------------hhcC--cceeEEEecCccc-cCCcccccchhHHHhhhhhh
Confidence            666554433                               2223  2666677777776 45667777788888999999


Q ss_pred             cccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcc
Q 036342          197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLT  276 (596)
Q Consensus       197 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~  276 (596)
                      .+. .+|..+.++.+|+.|.+..|++. .+|..++.|+ |..||+|.|++. .+|.+|..|+.|++|-|.+|.|.+-|..
T Consensus       177 ei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAq  252 (722)
T KOG0532|consen  177 EIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQ  252 (722)
T ss_pred             hhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence            988 67777888889999999999988 7888888665 889999999997 7888999999999999999999887776


Q ss_pred             ccc---ccccceEEcccC
Q 036342          277 FWN---LKDILQLNFSSN  291 (596)
Q Consensus       277 ~~~---l~~L~~L~ls~N  291 (596)
                      ++.   ..=.++|+..-+
T Consensus       253 IC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  253 ICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             HHhccceeeeeeecchhc
Confidence            543   223455665554

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.50  E-value=4.5e-14  Score=133.38  Aligned_cols=117  Identities=21%  Similarity=0.167  Sum_probs=93.3

Q ss_pred             cccccccccCCCceeehhhHH------------------------------------------hHHHHHHHHhhcCCC--
Q 036342          446 EFSENNLIGRGGFALFIRAFK------------------------------------------SFDVECEMMKSIRHR--  481 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~~------------------------------------------~~~~e~~~l~~l~H~--  481 (596)
                      .|...+.||+|+||.||++..                                          ....|..++.++.|+  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            477789999999999997521                                          145678888888887  


Q ss_pred             ccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC
Q 036342          482 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN  561 (596)
Q Consensus       482 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~  561 (596)
                      .+++.++.    ...++||||++++++.+....       .....++.+++.++.++|   ..+++|||+||+||+++++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence            44444442    345899999999998765321       234568889999999999   8999999999999999999


Q ss_pred             CcEEEeccccccccC
Q 036342          562 MVAHLSDFSIAKLLT  576 (596)
Q Consensus       562 ~~~kl~dfGla~~~~  576 (596)
                      +.++++|||++....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.50  E-value=5.4e-14  Score=138.63  Aligned_cols=126  Identities=28%  Similarity=0.391  Sum_probs=110.4

Q ss_pred             HhcccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEE
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l  498 (596)
                      .-...|...+.||+|.|++||++.                      .....|++++..+. +.||+++.+++..++.+.+
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i  112 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI  112 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence            345578889999999999999974                      24567999999884 8999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEeccccccc
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKL  574 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfGla~~  574 (596)
                      |+||+++-+..++...    ++..+...+++.+..|++++|   ..+|||||+||+|+|.+. .++..+.|||+|..
T Consensus       113 vlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             EecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999888888754    457778889999999999999   999999999999999985 57889999999983

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.48  E-value=2.1e-13  Score=138.79  Aligned_cols=147  Identities=37%  Similarity=0.540  Sum_probs=123.4

Q ss_pred             ccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCC-ccceeeeeeccCCeeEEEEecCC
Q 036342          447 FSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      |...+.||.|+||.||++.                     ..+.+|+.+++.+.|+ +++++.+.+...+..++++||+.
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            5667889999999998742                     3577899999999999 79999999977777899999999


Q ss_pred             CCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-cEEEeccccccccCCCCCc
Q 036342          505 HGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       505 ~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-~~kl~dfGla~~~~~~~~~  581 (596)
                      ++++.+++....  ..+.......++.|++.++.|+|   ..+++|||+||+||+++... .++++|||.++........
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999997776653  25788899999999999999999   88899999999999999988 7999999999865433221


Q ss_pred             c----ccccccccccccCC
Q 036342          582 M----TQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~----~~~~~~gt~~y~aP  596 (596)
                      .    ......||..|+||
T Consensus       159 ~~~~~~~~~~~~t~~~~~p  177 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAP  177 (384)
T ss_pred             ccccccccccccccccCCH
Confidence            1    23557899999998

>PLN03150 hypothetical protein; Provisional

Probab=99.47  E-value=1.2e-13  Score=151.86  Aligned_cols=134  Identities=28%  Similarity=0.445  Sum_probs=102.8

Q ss_pred             CcEEEeCCCcccC-CCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECC
Q 036342          260 LRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLS  338 (596)
Q Consensus       260 L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~  338 (596)
                      ++.|+|++|.+++ +|..+..+++|+.|+|++|.++|.+|..+..++.|+.|||++|+++|.+|. .+..+++|+.|+|+
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~-~l~~L~~L~~L~Ls  498 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE-SLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCch-HHhcCCCCCEEECc
Confidence            6788888888886 788888888999999999999888888888899999999999999888887 55688889999999


Q ss_pred             CCcccccCCCCC--CCCCCCcccccccccccCCCCCCCCCCCcccccccccccceeeeehhhhhh
Q 036342          339 FNKLKGEIPRGG--SFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTT  401 (596)
Q Consensus       339 ~N~l~~~~p~~~--~~~~l~~l~~~~N~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  401 (596)
                      +|+++|.+|...  ...++..+++.+|+..|+.|.  .++|...     .....+++++++++++
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~~~-----~~~~~~i~~~~~~~~~  556 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACGPH-----LSVGAKIGIAFGVSVA  556 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCccc-----CCCceEEEEEhHHHHH
Confidence            999988888752  234556788999999998764  2456422     1223455555554443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.47  E-value=1.6e-15  Score=153.94  Aligned_cols=175  Identities=30%  Similarity=0.486  Sum_probs=107.7

Q ss_pred             CCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCC
Q 036342          134 NCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQ  213 (596)
Q Consensus       134 ~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  213 (596)
                      .+..-...||+.|++..+ |. .+..+ -.|+.+.|..|.|. .+|..++++..|++|||+.|+++ ..|..+..++ |+
T Consensus        73 ~ltdt~~aDlsrNR~~el-p~-~~~~f-~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lk  146 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFSEL-PE-EACAF-VSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LK  146 (722)
T ss_pred             cccchhhhhccccccccC-ch-HHHHH-HHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ce
Confidence            344445667777776543 32 23333 34666666666665 45666666666666666666666 4455555554 66


Q ss_pred             eEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCC
Q 036342          214 RLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFL  293 (596)
Q Consensus       214 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l  293 (596)
                      .|.+++|+++ .+|..+..+..|..||.+.|++. .+|..++++.+|+.|.+..|++..+|.+++ .-.|..||+|.|++
T Consensus       147 vli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNki  223 (722)
T KOG0532|consen  147 VLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKI  223 (722)
T ss_pred             eEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCce
Confidence            6666666666 56666666666666666666665 455566666666666666666666666655 33456666666666


Q ss_pred             CCchhhhhccccccceEecCCCcCc
Q 036342          294 TGPLLLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       294 ~~~~~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      + .+|..|..++.|++|-|.+|.+.
T Consensus       224 s-~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  224 S-YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             e-ecchhhhhhhhheeeeeccCCCC
Confidence            6 45666666666666666666665

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.46  E-value=4.6e-14  Score=141.71  Aligned_cols=154  Identities=23%  Similarity=0.295  Sum_probs=126.1

Q ss_pred             cCHHHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcC------CCccceeee
Q 036342          435 FSYLELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIR------HRNLIKVIS  488 (596)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~------H~niv~l~~  488 (596)
                      |.+.-.+.....|.+....|+|-|+.|.+|.                    +.-..|+++|++++      -.++++++.
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            4444445556789999999999999999873                    34568999999995      458999999


Q ss_pred             eeccCCeeEEEEecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEE
Q 036342          489 SCSNEEFKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAH  565 (596)
Q Consensus       489 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~k  565 (596)
                      .|.....+|||||-... +|.+.++..+  ..+....+..++.|+.-||..|.   ..+|+|.||||.|||+++ ...+|
T Consensus       502 ~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceee
Confidence            99999999999998854 8999998754  35677788889999999999999   889999999999999986 56899


Q ss_pred             EeccccccccCCCCCccccccccccccccCC
Q 036342          566 LSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       566 l~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||||-|.......    .+.+..+..|.||
T Consensus       578 LCDfGSA~~~~ene----itPYLVSRFYRaP  604 (752)
T KOG0670|consen  578 LCDFGSASFASENE----ITPYLVSRFYRAP  604 (752)
T ss_pred             eccCcccccccccc----ccHHHHHHhccCc
Confidence            99999988764332    2334566778887

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.45  E-value=5.2e-14  Score=160.76  Aligned_cols=118  Identities=16%  Similarity=0.265  Sum_probs=88.1

Q ss_pred             HhhcCC-Cccceeeeeec-------cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCce
Q 036342          475 MKSIRH-RNLIKVISSCS-------NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALV  546 (596)
Q Consensus       475 l~~l~H-~niv~l~~~~~-------~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i  546 (596)
                      .+.++| +||++++++|.       +.+.++.++||+ +++|.+++......+++.++..++.||++||.|||   .++|
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gI  101 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGI  101 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            345667 68889999882       223567888988 66999999865556899999999999999999999   9999


Q ss_pred             EeCCCCCCCeeeCC-------------------CCcEEEeccccccccCCCCC--------------ccccccccccccc
Q 036342          547 IHCDLKPSNVLLDD-------------------NMVAHLSDFSIAKLLTGEDQ--------------SMTQTQTLGTIGY  593 (596)
Q Consensus       547 ~Hrdlk~~NILl~~-------------------~~~~kl~dfGla~~~~~~~~--------------~~~~~~~~gt~~y  593 (596)
                      +||||||+|||++.                   ++.+|++|||+++.......              .......+||++|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   45566777777654211000              0001124689999


Q ss_pred             cCC
Q 036342          594 MAP  596 (596)
Q Consensus       594 ~aP  596 (596)
                      |||
T Consensus       182 ~AP  184 (793)
T PLN00181        182 TSP  184 (793)
T ss_pred             ECh
Confidence            999

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.43  E-value=2.5e-13  Score=142.74  Aligned_cols=196  Identities=32%  Similarity=0.463  Sum_probs=113.2

Q ss_pred             EEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCC-CCCEEecCCCcCcCCCCCccccccCCCCCCCCEE
Q 036342           63 KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLR-NLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLI  141 (596)
Q Consensus        63 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L  141 (596)
                      .|+++.|.+. .....+..++.++.|++.+|.++.+ +.....+. +|+.|++++|.+..++.      .+..++.|+.|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i-~~~~~~~~~nL~~L~l~~N~i~~l~~------~~~~l~~L~~L  168 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDI-PPLIGLLKSNLKELDLSDNKIESLPS------PLRNLPNLKNL  168 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccccC-ccccccchhhcccccccccchhhhhh------hhhcccccccc
Confidence            5677777664 2344455556777777777777743 33444453 77777777777776532      35677777777


Q ss_pred             ECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCc
Q 036342          142 DLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNI  221 (596)
Q Consensus       142 ~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  221 (596)
                      ++++|+++.+.+.  .... +.|+.|++++|+++. +|........|++|++++|.+. ..+..+..+.++..+.+.+|+
T Consensus       169 ~l~~N~l~~l~~~--~~~~-~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~  243 (394)
T COG4886         169 DLSFNDLSDLPKL--LSNL-SNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK  243 (394)
T ss_pred             ccCCchhhhhhhh--hhhh-hhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCce
Confidence            7777777654221  1122 456666666666663 3333333444666666666433 334455556666666666666


Q ss_pred             ccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCC
Q 036342          222 LEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP  274 (596)
Q Consensus       222 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip  274 (596)
                      +. ..+..+..++++++|++++|.++...+  ++.+.+++.|++++|.++.++
T Consensus       244 ~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~  293 (394)
T COG4886         244 LE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNAL  293 (394)
T ss_pred             ee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccc
Confidence            55 334455555556666666666653322  555566666666666665543

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.41  E-value=3.7e-13  Score=141.49  Aligned_cols=202  Identities=35%  Similarity=0.480  Sum_probs=151.3

Q ss_pred             EEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCC-CCCEEEccCCcccccCCccccCCCCCCEEecCC
Q 036342           38 FLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNAS-KLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE  116 (596)
Q Consensus        38 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~  116 (596)
                      .|+++.|.+...+.....  ++.++.|++.+|.++ .+|.....++ +|+.|++++|++.. +|..+..+++|+.|++++
T Consensus        97 ~l~~~~~~~~~~~~~~~~--~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLRSNISELLE--LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             eeeccccccccCchhhhc--ccceeEEecCCcccc-cCccccccchhhcccccccccchhh-hhhhhhccccccccccCC
Confidence            688888887545555443  577888888888888 6677777774 88888888888874 345678888888888888


Q ss_pred             CcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCC
Q 036342          117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN  196 (596)
Q Consensus       117 N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N  196 (596)
                      |+++.+++.      ....+.|+.|++++|++..+-+.  . +.+..|+++++++|.+. ..+..+.++.++..+.+.+|
T Consensus       173 N~l~~l~~~------~~~~~~L~~L~ls~N~i~~l~~~--~-~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n  242 (394)
T COG4886         173 NDLSDLPKL------LSNLSNLNNLDLSGNKISDLPPE--I-ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN  242 (394)
T ss_pred             chhhhhhhh------hhhhhhhhheeccCCccccCchh--h-hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCc
Confidence            888886543      33778888888998888765321  1 23245888999998543 44666788888888888888


Q ss_pred             cccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhcc
Q 036342          197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGN  256 (596)
Q Consensus       197 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  256 (596)
                      ++. ..+..++.++++++|++++|.++ .++. +..+.+++.|++++|.+....|.....
T Consensus       243 ~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         243 KLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             eee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhhcc
Confidence            887 34667788888999999999998 4554 788889999999999888766655543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.38  E-value=6.3e-14  Score=131.81  Aligned_cols=205  Identities=23%  Similarity=0.299  Sum_probs=145.6

Q ss_pred             CCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccC-CcccCCCCccccCCC
Q 036342          132 LSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG-NKLNGSIPITLGKLR  210 (596)
Q Consensus       132 ~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~  210 (596)
                      +..+++|+.+.+|.+.-..+.   .+..+.+.|+++...+..++..  +.+...+.+....-+. .-..|..-....-+.
T Consensus       210 l~~f~~l~~~~~s~~~~~~i~---~~~~~kptl~t~~v~~s~~~~~--~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq  284 (490)
T KOG1259|consen  210 LNAFRNLKTLKFSALSTENIV---DIELLKPTLQTICVHNTTIQDV--PSLLPETILADPSGSEPSTSNGSALVSADTWQ  284 (490)
T ss_pred             hHHhhhhheeeeeccchhhee---ceeecCchhheeeeeccccccc--ccccchhhhcCccCCCCCccCCceEEecchHh
Confidence            444556666666666533221   1222236788888887776532  1222222232221111 122233323333456


Q ss_pred             CCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEccc
Q 036342          211 KLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSS  290 (596)
Q Consensus       211 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~  290 (596)
                      .|+++|||+|.|+ .+.....-+|.++.|++|+|.|..+  +.+..+++|+.||||+|.++++..+-..+.+.+.|.|++
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~  361 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQ  361 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhh
Confidence            7899999999999 6777888889999999999999743  348899999999999999999988888899999999999


Q ss_pred             CCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccC
Q 036342          291 NFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEI  346 (596)
Q Consensus       291 N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~  346 (596)
                      |.+..  ...+..+-+|..||+++|+|........++.+|.|+.+.|.+|++++.+
T Consensus       362 N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  362 NKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            98863  3466778899999999999985555556778999999999999998643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.38  E-value=1.1e-12  Score=117.77  Aligned_cols=119  Identities=20%  Similarity=0.247  Sum_probs=100.1

Q ss_pred             ccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCC--CccceeeeeeccCCeeEEEEecCCCCCHH
Q 036342          449 ENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHGSLE  509 (596)
Q Consensus       449 ~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~g~L~  509 (596)
                      +.+.||+|.++.||++.                 ..+..|+.+++.++|  ..++++++++..++..+++|||++++.+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            35678999999988642                 257899999999987  49999999998888899999999987775


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          510 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       510 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .+        +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++..
T Consensus        82 ~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          82 EV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            43        45566778999999999999544468999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.35  E-value=3.4e-12  Score=123.58  Aligned_cols=101  Identities=22%  Similarity=0.224  Sum_probs=81.4

Q ss_pred             hHHHHHHHHhhcCCCcc--ceeeeeeccCC----eeEEEEecCCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh
Q 036342          467 SFDVECEMMKSIRHRNL--IKVISSCSNEE----FKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  539 (596)
Q Consensus       467 ~~~~e~~~l~~l~H~ni--v~l~~~~~~~~----~~~lV~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh  539 (596)
                      .+.+|+.++++++|++|  ++.+++...+.    ..++||||++| .+|.+++...  .++..    .+.+++.++.++|
T Consensus        86 r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH  159 (239)
T PRK01723         86 RAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH  159 (239)
T ss_pred             HHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH
Confidence            45679999999999885  77777654332    23599999997 6999887653  24432    3568999999999


Q ss_pred             ccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       540 ~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                         ..+|+|||+||+|||++.++.++++|||.++...
T Consensus       160 ---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        160 ---DAGVYHADLNAHNILLDPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             ---HCCCCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence               9999999999999999998999999999988643

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.32  E-value=1.6e-13  Score=135.64  Aligned_cols=209  Identities=21%  Similarity=0.253  Sum_probs=121.5

Q ss_pred             CCCCCEEEccCCcccccCC-ccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           82 ASKLSKLSLGMNSFSGFIP-STFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      +++|+...|.+..+..... +-...+++++.|||+.|-+....+-.   .-...+++|+.|+||.|++.-......-..+
T Consensus       120 ~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~---~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  120 LKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVL---KIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             HHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHH---HHHHhcccchhcccccccccCCccccchhhh
Confidence            3455555555555442211 23445566666666666555432221   1234556666666666666533322111222


Q ss_pred             cccccEEEccccccccc-cChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCc--cchhcCCCCc
Q 036342          161 SRSLEEFYMYNCNISGG-IPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP--DDICRLAELY  237 (596)
Q Consensus       161 ~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~  237 (596)
                       ++|+.|.|+.|+++.. +......+++|+.|+|+.|...++......-+..|+.|||++|++- ..+  .....++.|+
T Consensus       197 -~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~  274 (505)
T KOG3207|consen  197 -SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLN  274 (505)
T ss_pred             -hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchh
Confidence             5677777777777632 2233455678888888888644444455556677888888888775 333  3455677777


Q ss_pred             EEEccCCcCccc-chhh-----hccCCCCcEEEeCCCcccCCCc--ccccccccceEEcccCCCCC
Q 036342          238 RLELGSNKLYGS-IPAC-----FGNLASLRILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLTG  295 (596)
Q Consensus       238 ~L~Ls~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~ip~--~~~~l~~L~~L~ls~N~l~~  295 (596)
                      .|+++.+.+..+ .|++     ...+++|++|+++.|++...+.  .+..+++|+.|.+..|.++-
T Consensus       275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            777777776532 2332     3346778888888888876553  35556677777777777653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=3e-12  Score=128.15  Aligned_cols=115  Identities=25%  Similarity=0.378  Sum_probs=97.6

Q ss_pred             cccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcC--------CCccceeeeeeccC--
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIR--------HRNLIKVISSCSNE--  493 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~--------H~niv~l~~~~~~~--  493 (596)
                      ..+|-..+.||=|-|++||.|+                    +....|+.++++++        -..||+|++.|...  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            3578899999999999998753                    34667999999884        34799999999754  


Q ss_pred             --CeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC
Q 036342          494 --EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN  561 (596)
Q Consensus       494 --~~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~  561 (596)
                        ..+++|+|+. |-+|..+++... ..++...+.+|+.||+.||.|||..  .+|||.||||+|||+...
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeecc
Confidence              3799999999 779999998765 5788999999999999999999964  489999999999999643

>PLN03150 hypothetical protein; Provisional

Probab=99.29  E-value=9.7e-12  Score=136.97  Aligned_cols=113  Identities=26%  Similarity=0.379  Sum_probs=101.8

Q ss_pred             CCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC-CCcccccccccceEEcccCCCCCchhhhhccccccceEecC
Q 036342          235 ELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFS  313 (596)
Q Consensus       235 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls  313 (596)
                      .++.|+|++|.+.+.+|..++.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|++++.+|..++.+++|+.|||+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999985 89899999999999999999999999999999999999999


Q ss_pred             CCcCcccCChhhhccCCCCCeEECCCCcccccCC
Q 036342          314 MNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP  347 (596)
Q Consensus       314 ~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  347 (596)
                      +|+++|.+|..+......+..+++++|+..|..|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            9999999998655445567899999998766444

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.29  E-value=9.5e-13  Score=123.98  Aligned_cols=127  Identities=26%  Similarity=0.291  Sum_probs=80.6

Q ss_pred             ccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEc
Q 036342          162 RSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLEL  241 (596)
Q Consensus       162 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (596)
                      +.|+++||++|.|+ .+.....-++.++.|++|+|.|..+.  .++.+++|+.||||+|.++ .+...-..+.++++|.|
T Consensus       284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL  359 (490)
T ss_pred             hhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence            45777777777776 44556666777888888888877433  2667778888888888777 44444455677788888


Q ss_pred             cCCcCcccchhhhccCCCCcEEEeCCCcccCCCc--ccccccccceEEcccCCCC
Q 036342          242 GSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       242 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~--~~~~l~~L~~L~ls~N~l~  294 (596)
                      ++|.|...  ..+..+.+|.+||+++|+|..+..  .+++++-|+.+.|.+|++.
T Consensus       360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence            88877522  235566677777777777765432  3334444444444444333

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.28  E-value=3.1e-13  Score=142.38  Aligned_cols=217  Identities=27%  Similarity=0.296  Sum_probs=111.1

Q ss_pred             CCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCC
Q 036342           59 PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL  138 (596)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L  138 (596)
                      +.++.++..++.+....-. ...+..++.+++..|.|.. +...+..+++|+.|++.+|.|..+...      +..+++|
T Consensus        49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~------l~~~~~L  120 (414)
T KOG0531|consen   49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENL------LSSLVNL  120 (414)
T ss_pred             chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccc------hhhhhcc
Confidence            3455555555544311111 1334455555566666653 233355666666666666666654321      4556666


Q ss_pred             CEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCC-ccccCCCCCCeEEc
Q 036342          139 TLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIP-ITLGKLRKLQRLNL  217 (596)
Q Consensus       139 ~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L  217 (596)
                      +.|++++|.|+.+.+   +..+ +.|+.|++++|.|+..  ..+..+++|+.+++++|.+..+.+ . ...+.+++.+++
T Consensus       121 ~~L~ls~N~I~~i~~---l~~l-~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l  193 (414)
T KOG0531|consen  121 QVLDLSFNKITKLEG---LSTL-TLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDL  193 (414)
T ss_pred             hheeccccccccccc---hhhc-cchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhc
Confidence            666666666665532   2233 3366666666666543  334446666777777777665444 2 345666666666


Q ss_pred             cCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCC--CCcEEEeCCCcccCCCcccccccccceEEcccCCCC
Q 036342          218 EDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLA--SLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~  294 (596)
                      ++|.+..  ...+..+..+..+++..|.+...-+  +..+.  .|+.+++++|++..++..+..+..+..|+++.|++.
T Consensus       194 ~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~  268 (414)
T KOG0531|consen  194 GGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRIS  268 (414)
T ss_pred             cCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccccccccccccccccccchhhcccc
Confidence            6666652  2233334444444666666542211  11122  255555555555555433444444444444444443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.27  E-value=1.7e-12  Score=117.73  Aligned_cols=129  Identities=27%  Similarity=0.300  Sum_probs=43.2

Q ss_pred             CCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCE
Q 036342           32 NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQ  111 (596)
Q Consensus        32 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  111 (596)
                      +...+++|+|++|.|+ .+...+. .+.+|+.|||++|.|+. ++ .+..++.|++|++++|+|+.+.+.....+++|++
T Consensus        17 n~~~~~~L~L~~n~I~-~Ie~L~~-~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~   92 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIS-TIENLGA-TLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE   92 (175)
T ss_dssp             --------------------S--T-T-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred             cccccccccccccccc-cccchhh-hhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence            3446677777777776 4555431 36677777777777773 32 3666777777777777777553332245777777


Q ss_pred             EecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCC--chhhhcccccccEEEc
Q 036342          112 LGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILP--KTSISNLSRSLEEFYM  169 (596)
Q Consensus       112 L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~--~~~~~~l~~~L~~L~l  169 (596)
                      |++++|+|..+..    ...++.+++|+.|+|.+|+++....  ...+..+ ++|+.||-
T Consensus        93 L~L~~N~I~~l~~----l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~l-P~Lk~LD~  147 (175)
T PF14580_consen   93 LYLSNNKISDLNE----LEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKL-PSLKVLDG  147 (175)
T ss_dssp             EE-TTS---SCCC----CGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH--TT-SEETT
T ss_pred             EECcCCcCCChHH----hHHHHcCCCcceeeccCCcccchhhHHHHHHHHc-ChhheeCC
Confidence            7777777776532    2346677778888888887764311  0122333 56776654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.26  E-value=1.2e-11  Score=115.71  Aligned_cols=76  Identities=20%  Similarity=0.223  Sum_probs=59.3

Q ss_pred             eeEEEEecCCCCCHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEeccccc
Q 036342          495 FKALVLEYMPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~dfGla  572 (596)
                      ..++||||++++.+... +....  . ..+...++.+++.++.++|   . .+|+|||+||+||+++ ++.++++|||.+
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a  161 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVYIIDVPQA  161 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEECccc
Confidence            35899999999544211 11111  1 1456778999999999999   7 8999999999999999 899999999999


Q ss_pred             cccCC
Q 036342          573 KLLTG  577 (596)
Q Consensus       573 ~~~~~  577 (596)
                      .....
T Consensus       162 ~~~~~  166 (187)
T cd05119         162 VEIDH  166 (187)
T ss_pred             ccccC
Confidence            86543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.25  E-value=5.6e-13  Score=140.45  Aligned_cols=129  Identities=30%  Similarity=0.420  Sum_probs=57.4

Q ss_pred             CCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEE
Q 036342           33 VSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQL  112 (596)
Q Consensus        33 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  112 (596)
                      +..++.+++..|.+........  .+.+|+.|++..|+|.. +...+..+.+|++|+|++|+|+.+.+  +..++.|+.|
T Consensus        71 l~~l~~l~l~~n~i~~~~~~l~--~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L  145 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAKILNHLS--KLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL  145 (414)
T ss_pred             hHhHHhhccchhhhhhhhcccc--cccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence            3444445555555542111122  24455555555555552 22224445555555555555544322  3444445555


Q ss_pred             ecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccc
Q 036342          113 GLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS  175 (596)
Q Consensus       113 ~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~  175 (596)
                      ++++|.|+.+.       .+..++.|+.+++++|+++.+.+.. ...+ .+++.+++.+|.+.
T Consensus       146 ~l~~N~i~~~~-------~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~-~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  146 NLSGNLISDIS-------GLESLKSLKLLDLSYNRIVDIENDE-LSEL-ISLEELDLGGNSIR  199 (414)
T ss_pred             eeccCcchhcc-------CCccchhhhcccCCcchhhhhhhhh-hhhc-cchHHHhccCCchh
Confidence            55555554432       1333455555555555554432210 1222 34444555555443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.22  E-value=4.1e-12  Score=131.78  Aligned_cols=119  Identities=25%  Similarity=0.271  Sum_probs=103.9

Q ss_pred             HHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCce
Q 036342          468 FDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALV  546 (596)
Q Consensus       468 ~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i  546 (596)
                      ...|..++..++ ||.+|++..+++.+...+++.+|..+|++...+.... .+++.....+...++-+++++|   +.+|
T Consensus        43 t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~i  118 (612)
T KOG0603|consen   43 TKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGI  118 (612)
T ss_pred             cccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHH
Confidence            345777888887 9999999999999999999999999999999887765 4566777778889999999999   9999


Q ss_pred             EeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          547 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       547 ~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|||+|++||+++.+|.+|+.|||+++.....      ...|||..||||
T Consensus       119 iyrd~k~enilld~~Ghi~~tdfglske~v~~------~~~cgt~eymAp  162 (612)
T KOG0603|consen  119 AYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------KIACGTYEYRAP  162 (612)
T ss_pred             HHhcccccceeecccCccccCCchhhhHhHhh------hhcccchhhhhh
Confidence            99999999999999999999999999975432      223999999998

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.21  E-value=1.3e-11  Score=111.82  Aligned_cols=104  Identities=27%  Similarity=0.391  Sum_probs=23.2

Q ss_pred             CCCEEEccCCcccCCCCcccc-CCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEe
Q 036342          187 NLVEIDLGGNKLNGSIPITLG-KLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSL  265 (596)
Q Consensus       187 ~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  265 (596)
                      ++++|+|++|.|+.+.  .++ .+.+|+.|+|++|.|+ .++ .+..++.|+.|++++|.|+...+.....+++|+.|+|
T Consensus        20 ~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L   95 (175)
T PF14580_consen   20 KLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYL   95 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-
T ss_pred             cccccccccccccccc--chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEEC
Confidence            4444555555544221  222 2444555555555554 222 3444455555555555554322222234555555555


Q ss_pred             CCCcccCCCc--ccccccccceEEcccCCCC
Q 036342          266 GSNKLTSIPL--TFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       266 s~N~l~~ip~--~~~~l~~L~~L~ls~N~l~  294 (596)
                      ++|+|..+..  .+..+++|+.|+|.+|+++
T Consensus        96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             cCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            5555544322  2333444444444444443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=1.2e-11  Score=137.21  Aligned_cols=134  Identities=25%  Similarity=0.367  Sum_probs=105.8

Q ss_pred             HHHHhcccccccccccCCCceeehhhHHh-----------------HHHHHHHHhhcC---CCccceeeeeeccCCeeEE
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAFKS-----------------FDVECEMMKSIR---HRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-----------------~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~l  498 (596)
                      +.+..-..|.+.+.||+|+||.||+|...                 |---.+++.|++   -+-|..+..++...+.-++
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            34445668999999999999999997521                 222245666666   2344555555566677889


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC-------CCCcEEEecccc
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-------DNMVAHLSDFSI  571 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~-------~~~~~kl~dfGl  571 (596)
                      |+||.+-|+|.+.+... ...+|.-++.+..|+++-++.+|   ..+|||+||||+|.||.       +...++|+|||.
T Consensus       772 v~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            99999999999999843 46889999999999999999999   99999999999999994       234689999999


Q ss_pred             ccccC
Q 036342          572 AKLLT  576 (596)
Q Consensus       572 a~~~~  576 (596)
                      +..+.
T Consensus       848 siDm~  852 (974)
T KOG1166|consen  848 SIDMK  852 (974)
T ss_pred             ceeee
Confidence            88653

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.19  E-value=4.4e-12  Score=122.36  Aligned_cols=250  Identities=22%  Similarity=0.300  Sum_probs=122.5

Q ss_pred             CCCCCCEEEccCCccccc----CCccccCCCCCCEEecCCCcCcCCCCC----c-cccccCCCCCCCCEEECcCCCCCcc
Q 036342           81 NASKLSKLSLGMNSFSGF----IPSTFGNLRNLEQLGLDENYLTSSTPE----L-SFLSSLSNCKSLTLIDLSNNPLDGI  151 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~----~-~~~~~~~~l~~L~~L~ls~N~l~~~  151 (596)
                      .+..++.|+||+|.|...    +...+.+.++|+..++++--...+...    + .+.+++..+++|++||||.|.+...
T Consensus        28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~  107 (382)
T KOG1909|consen   28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK  107 (382)
T ss_pred             ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence            344455555555555422    222233444555555544321111111    0 1223466677888888888877533


Q ss_pred             CCchhhhcc---cccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCccccc---
Q 036342          152 LPKTSISNL---SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGS---  225 (596)
Q Consensus       152 ~~~~~~~~l---~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---  225 (596)
                      .+. .+..+   ..+|++|+|.+|.+.-.-...++.  .|..|.  .|+..       ..-+.|++++.++|++...   
T Consensus       108 g~~-~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk~-------~~~~~Lrv~i~~rNrlen~ga~  175 (382)
T KOG1909|consen  108 GIR-GLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKKA-------ASKPKLRVFICGRNRLENGGAT  175 (382)
T ss_pred             chH-HHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhcc-------CCCcceEEEEeeccccccccHH
Confidence            222 22211   256777888888776332222221  121111  22211       1234566666666665411   


Q ss_pred             -CccchhcCCCCcEEEccCCcCcc----cchhhhccCCCCcEEEeCCCcccC-----CCcccccccccceEEcccCCCCC
Q 036342          226 -IPDDICRLAELYRLELGSNKLYG----SIPACFGNLASLRILSLGSNKLTS-----IPLTFWNLKDILQLNFSSNFLTG  295 (596)
Q Consensus       226 -~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~-----ip~~~~~l~~L~~L~ls~N~l~~  295 (596)
                       +...|...+.|+.+.+++|.|..    ..-..|..+++|+.|||..|.++.     +...+..+++|+.|+++.+.+..
T Consensus       176 ~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~  255 (382)
T KOG1909|consen  176 ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLEN  255 (382)
T ss_pred             HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccc
Confidence             11234445566666666666531    122345566777777777777664     23345566677777777777654


Q ss_pred             chhhhh-----ccccccceEecCCCcCcccC---ChhhhccCCCCCeEECCCCcc
Q 036342          296 PLLLEI-----GNLKVLIGIDFSMNNFSGVI---PREIGEKLSYLEDLNLSFNKL  342 (596)
Q Consensus       296 ~~~~~~-----~~l~~L~~L~ls~N~~~~~~---~~~~~~~l~~L~~L~l~~N~l  342 (596)
                      .....|     ...++|+.|.+.+|.|+..-   -.......+.|..|+|++|.+
T Consensus       256 ~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  256 EGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            333222     12455666666666664110   001122345566666666655

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=3.9e-11  Score=117.45  Aligned_cols=89  Identities=25%  Similarity=0.397  Sum_probs=73.2

Q ss_pred             CCCccceeeeeecc---------------------------CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHH
Q 036342          479 RHRNLIKVISSCSN---------------------------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV  531 (596)
Q Consensus       479 ~H~niv~l~~~~~~---------------------------~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i  531 (596)
                      +|||||++.++|.+                           ...+|+||.-.+. +|++++....  .+...+.-+..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999998854                           1246899988754 8999998765  4566777799999


Q ss_pred             HHHHHHHhccCCCceEeCCCCCCCeeeC--CCC--cEEEecccccc
Q 036342          532 ASALEYLHFGYSALVIHCDLKPSNVLLD--DNM--VAHLSDFSIAK  573 (596)
Q Consensus       532 ~~~l~~lh~~~~~~i~Hrdlk~~NILl~--~~~--~~kl~dfGla~  573 (596)
                      .+|+.|||   .++|.|||+|++|||+.  +|+  ...|+|||++-
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence            99999999   99999999999999993  444  57899999864

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.17  E-value=5.4e-12  Score=124.96  Aligned_cols=37  Identities=24%  Similarity=0.204  Sum_probs=21.4

Q ss_pred             cCCCCCeEECCCCcccccCCCC---CCCCCCCccccccccc
Q 036342          328 KLSYLEDLNLSFNKLKGEIPRG---GSFGNFSAESFEGNEL  365 (596)
Q Consensus       328 ~l~~L~~L~l~~N~l~~~~p~~---~~~~~l~~l~~~~N~~  365 (596)
                      .+++|+.|+++.|++.. +++.   ...+++..+.+.+|.+
T Consensus       299 ~f~kL~~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~l  338 (505)
T KOG3207|consen  299 TFPKLEYLNISENNIRD-WRSLNHLRTLENLKHLRITLNYL  338 (505)
T ss_pred             ccccceeeecccCcccc-ccccchhhccchhhhhhcccccc
Confidence            46677777777777752 2222   2344555566655554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.14  E-value=2.4e-11  Score=131.99  Aligned_cols=121  Identities=24%  Similarity=0.330  Sum_probs=99.3

Q ss_pred             HHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCC
Q 036342          471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCD  550 (596)
Q Consensus       471 e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrd  550 (596)
                      |..+=..++|+|++.....+.+....+-+||||++ ||...+.... .+...++..+..|+..|++|+|   ..+|.|||
T Consensus       371 E~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~Giahrd  445 (601)
T KOG0590|consen  371 EFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRD  445 (601)
T ss_pred             heeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceecc
Confidence            44444567999999888888777666666999999 9999987752 4667778889999999999999   99999999


Q ss_pred             CCCCCeeeCCCCcEEEeccccccccCCCCCc--cccccccccccccCC
Q 036342          551 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS--MTQTQTLGTIGYMAP  596 (596)
Q Consensus       551 lk~~NILl~~~~~~kl~dfGla~~~~~~~~~--~~~~~~~gt~~y~aP  596 (596)
                      +|++|+++..+|.+||+|||.+....-+.+.  ......+|+..|+||
T Consensus       446 lK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~ap  493 (601)
T KOG0590|consen  446 LKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAP  493 (601)
T ss_pred             CccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCc
Confidence            9999999999999999999987754322222  345678899999998

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.13  E-value=5.8e-12  Score=121.56  Aligned_cols=66  Identities=23%  Similarity=0.309  Sum_probs=33.8

Q ss_pred             hCCCCCCEEEccCCcCccc----cCccCccCCCCccEEEccCCc---cccccCcc-------ccCCCCCCEEEccCCccc
Q 036342           31 FNVSTLKFLGLQNNSLSGS----LSSIANVRLPNLEKLYLWGNN---FSGTIPRF-------IFNASKLSKLSLGMNSFS   96 (596)
Q Consensus        31 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~~l~~L~~L~L~~N~---l~~~~~~~-------~~~l~~L~~L~L~~N~i~   96 (596)
                      ..+.+++.|+||+|.+...    +.. ...+.++|+..+++.--   +...+|++       +.+.++|++||||.|-|.
T Consensus        27 ~~~~s~~~l~lsgnt~G~EAa~~i~~-~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G  105 (382)
T KOG1909|consen   27 EPMDSLTKLDLSGNTFGTEAARAIAK-VLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG  105 (382)
T ss_pred             cccCceEEEeccCCchhHHHHHHHHH-HHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence            3567888888888877421    111 11224567777776531   11223322       223345666666666554


Q ss_pred             c
Q 036342           97 G   97 (596)
Q Consensus        97 ~   97 (596)
                      .
T Consensus       106 ~  106 (382)
T KOG1909|consen  106 P  106 (382)
T ss_pred             c
Confidence            3

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.02  E-value=2.5e-10  Score=85.16  Aligned_cols=61  Identities=38%  Similarity=0.522  Sum_probs=41.2

Q ss_pred             CCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcC
Q 036342           59 PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL  119 (596)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l  119 (596)
                      ++|++|++++|+++...+..|.++++|++|++++|+|+.+.+++|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566777777777655556666677777777777777766666677777777777766654

...

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.00  E-value=6.4e-10  Score=117.22  Aligned_cols=77  Identities=22%  Similarity=0.259  Sum_probs=60.2

Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~-~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla  572 (596)
                      +..++||||++|+++.+.........+   +..++..++. .+..+|   ..+++|+|++|.||++++++.+++.|||++
T Consensus       231 ~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~  304 (437)
T TIGR01982       231 SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIV  304 (437)
T ss_pred             CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCe
Confidence            346899999999999887654322222   3345665555 467778   889999999999999999999999999999


Q ss_pred             cccC
Q 036342          573 KLLT  576 (596)
Q Consensus       573 ~~~~  576 (596)
                      ..+.
T Consensus       305 ~~l~  308 (437)
T TIGR01982       305 GRLS  308 (437)
T ss_pred             eECC
Confidence            8764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.93  E-value=1.4e-09  Score=113.04  Aligned_cols=99  Identities=33%  Similarity=0.530  Sum_probs=91.2

Q ss_pred             HhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCce-EeCCCCC
Q 036342          475 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALV-IHCDLKP  553 (596)
Q Consensus       475 l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i-~Hrdlk~  553 (596)
                      |+.+.|.|+.+++|.+..+...+.|.+||+.|+|.|.+......++|.....++.+++.|+.|+|   .-+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            46789999999999999999999999999999999999987778999999999999999999999   4444 9999999


Q ss_pred             CCeeeCCCCcEEEeccccccccC
Q 036342          554 SNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       554 ~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      .|.++|....+|++|||+.....
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             ccceeeeeEEEEechhhhccccc
Confidence            99999999999999999987763

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.91  E-value=3.1e-11  Score=126.21  Aligned_cols=131  Identities=31%  Similarity=0.237  Sum_probs=104.4

Q ss_pred             CCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcc
Q 036342          210 RKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFS  289 (596)
Q Consensus       210 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls  289 (596)
                      ..|...+.+.|++. .+...+.-++.|+.|+|++|++...  +.+..++.|++|||++|.++.+|.--..--.|..|+++
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lr  240 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLR  240 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhhheeeeec
Confidence            46788888999988 6777888888999999999998744  37888999999999999999988643222349999999


Q ss_pred             cCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCccccc
Q 036342          290 SNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE  345 (596)
Q Consensus       290 ~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~  345 (596)
                      +|.++.  ...+.+|++|..||+++|-+++.-.-..+..+..|..|+|.||++.+-
T Consensus       241 nN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  241 NNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             ccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            998874  345778899999999999988654444455677889999999998763

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.91  E-value=1e-09  Score=81.87  Aligned_cols=60  Identities=33%  Similarity=0.476  Sum_probs=34.6

Q ss_pred             cccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcc
Q 036342          163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNIL  222 (596)
Q Consensus       163 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  222 (596)
                      +|++|++++|+|+.+.+.+|.++++|++|++++|.++.+.|.+|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            355555555555555555555566666666666666555555555555555555555543

...

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=98.87  E-value=1.1e-09  Score=102.13  Aligned_cols=101  Identities=24%  Similarity=0.505  Sum_probs=87.7

Q ss_pred             HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhccCCC
Q 036342          466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSA  544 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~~~  544 (596)
                      ++|..|.-.++-+.||||..++|+|.......++..||+-|+|+..+++... ..+..++++++.++|+|+.|||.. .+
T Consensus       232 rdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep  310 (448)
T KOG0195|consen  232 RDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EP  310 (448)
T ss_pred             chhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-ch
Confidence            4678888899999999999999999999999999999999999999988653 467889999999999999999943 34


Q ss_pred             ceEeCCCCCCCeeeCCCCcEEEe
Q 036342          545 LVIHCDLKPSNVLLDDNMVAHLS  567 (596)
Q Consensus       545 ~i~Hrdlk~~NILl~~~~~~kl~  567 (596)
                      -|..-.+.+..+++|++.+++|+
T Consensus       311 ~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  311 MIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             hhhhhhcccceEEecchhhhhee
Confidence            45556788999999999888775

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.83  E-value=5e-09  Score=96.13  Aligned_cols=93  Identities=26%  Similarity=0.276  Sum_probs=69.8

Q ss_pred             hHHHHHHHHhhcCCCcc-ceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc
Q 036342          467 SFDVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL  545 (596)
Q Consensus       467 ~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~  545 (596)
                      .+..|+.+++.+.+.++ ++++.+...  ..++||||++|.++.+.    .     .....+..+++++++.||   ..+
T Consensus        38 ~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G~~l~~~----~-----~~~~~~~~~l~~~l~~LH---~~~  103 (170)
T cd05151          38 NRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEGSELLTE----D-----FSDPENLEKIAKLLKKLH---SSP  103 (170)
T ss_pred             CHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCCCccccc----c-----ccCHHHHHHHHHHHHHHh---CCC
Confidence            46789999999876554 455555432  35799999999877543    0     111235678999999999   555


Q ss_pred             -----eEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          546 -----VIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       546 -----i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                           ++|+|++|.||+++ ++.+++.|||.+..
T Consensus       104 ~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151         104 LPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence                 59999999999999 66899999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.83  E-value=1.3e-10  Score=121.68  Aligned_cols=180  Identities=26%  Similarity=0.325  Sum_probs=132.8

Q ss_pred             ChhccCCCCCCEEEccCCcccCCCCccccCC-CCCCeEEccCCcccccCc-------cchhc---CCCCcEEEccCCcCc
Q 036342          179 PEEISNLTNLVEIDLGGNKLNGSIPITLGKL-RKLQRLNLEDNILEGSIP-------DDICR---LAELYRLELGSNKLY  247 (596)
Q Consensus       179 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~-------~~~~~---l~~L~~L~Ls~N~l~  247 (596)
                      |-.+..+.+|++|.|.++.+..  ...+..+ .+|++|...+ .++ .+.       ..+++   +..|.+.+.+.|.+.
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~-Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLD-ALRHVFASCGGDISNSPVWNKLATASFSYNRLV  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHH-HHHHHHHHhccccccchhhhhHhhhhcchhhHH
Confidence            4455667888888888888764  2222222 2556665543 222 111       11221   346888899999997


Q ss_pred             ccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhc
Q 036342          248 GSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGE  327 (596)
Q Consensus       248 ~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~  327 (596)
                       .....+.-++.|+.|||++|+++.+. .+.++++|+.|||++|.++.+......+++ |..|.+++|.++ .+..  ..
T Consensus       178 -~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~-tL~g--ie  251 (1096)
T KOG1859|consen  178 -LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALT-TLRG--IE  251 (1096)
T ss_pred             -hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeecccHHH-hhhh--HH
Confidence             67778888999999999999999987 788999999999999999976665666666 999999999998 4443  35


Q ss_pred             cCCCCCeEECCCCcccccCCC--CCCCCCCCcccccccccccC
Q 036342          328 KLSYLEDLNLSFNKLKGEIPR--GGSFGNFSAESFEGNELLCG  368 (596)
Q Consensus       328 ~l~~L~~L~l~~N~l~~~~p~--~~~~~~l~~l~~~~N~~~c~  368 (596)
                      ++.+|+.||+++|-|++.-.-  .+.+..+..++++|||+-|.
T Consensus       252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            789999999999999864322  24566788899999998774

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.82  E-value=3e-09  Score=120.05  Aligned_cols=272  Identities=26%  Similarity=0.281  Sum_probs=138.6

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCc--CccccCccCccCCCCccEEEccCCccccccCccccCCCCCCE
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNS--LSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSK   87 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~   87 (596)
                      ...+...+-+|++. .++....+ +.|++|-+..|.  +. .++...|..++.|+.|||++|.=-+.+|..+++|-+|++
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry  599 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY  599 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence            45566666666664 34444333 267777777775  33 455544555777777888777555577777777777778


Q ss_pred             EEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCC--ccCCchhhhccccccc
Q 036342           88 LSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLD--GILPKTSISNLSRSLE  165 (596)
Q Consensus        88 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~--~~~~~~~~~~l~~~L~  165 (596)
                      |+|++..|+ ..|..+.+|..|.+||+..+.-....++     ....|++|++|.+..-...  ...-. .+..+ .+|+
T Consensus       600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~-----i~~~L~~Lr~L~l~~s~~~~~~~~l~-el~~L-e~L~  671 (889)
T KOG4658|consen  600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPG-----ILLELQSLRVLRLPRSALSNDKLLLK-ELENL-EHLE  671 (889)
T ss_pred             ccccCCCcc-ccchHHHHHHhhheeccccccccccccc-----hhhhcccccEEEeeccccccchhhHH-hhhcc-cchh
Confidence            888777777 5677777777777777777653332222     2455777777776543311  11000 12222 3344


Q ss_pred             EEEccccccccccChhccCCCCCC----EEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcC------CC
Q 036342          166 EFYMYNCNISGGIPEEISNLTNLV----EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRL------AE  235 (596)
Q Consensus       166 ~L~l~~n~l~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~  235 (596)
                      .+.......  ..-..+..+++|.    .+.+.++... ..+..+..+.+|+.|.+.++.+...........      ++
T Consensus       672 ~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~  748 (889)
T KOG4658|consen  672 NLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPN  748 (889)
T ss_pred             hheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHH
Confidence            443332222  0011122223332    2222222222 345566777888888888877753322221111      11


Q ss_pred             CcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC-CCcccccccccceEEcccCCCCCc
Q 036342          236 LYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGP  296 (596)
Q Consensus       236 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ls~N~l~~~  296 (596)
                      +..+...++..- ..+....-.++|+.|.+.+....+ +......+..+..+-+..+.+.+.
T Consensus       749 l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l  809 (889)
T KOG4658|consen  749 LSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL  809 (889)
T ss_pred             HHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence            211111111110 111111234677777777766554 333333344444444444444443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.82  E-value=9.1e-09  Score=95.00  Aligned_cols=73  Identities=26%  Similarity=0.187  Sum_probs=62.6

Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.++++..+..+++.++..++.|+++|++|+|   ..+      ||+||+++.++.+|+  ||+++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            7899999876667999999999999999999999   554      999999999999999  9998865321       


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...||+.||||
T Consensus        63 ~~~g~~~y~aP   73 (176)
T smart00750       63 QSRVDPYFMAP   73 (176)
T ss_pred             cCCCcccccCh
Confidence            12688999998

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.76  E-value=1.1e-09  Score=103.60  Aligned_cols=206  Identities=22%  Similarity=0.246  Sum_probs=100.3

Q ss_pred             CCCCCCEEECCCCCCccccch-hhh-CCCCCCEEEccCCcCccc--cCccCccCCCCccEEEccCCccccccCccccCCC
Q 036342            8 NLQNLEELQLGQNKLIGTVPA-AIF-NVSTLKFLGLQNNSLSGS--LSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNAS   83 (596)
Q Consensus         8 ~l~~L~~L~Ls~n~l~~~~~~-~~~-~l~~L~~L~Ls~N~l~~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~   83 (596)
                      .+..++.|.+.++.|-.+... .|+ ..+.+++|||.+|+|+..  +..+. ..+|.|+.|+|+.|.+...+...=..++
T Consensus        43 s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~il-e~lP~l~~LNls~N~L~s~I~~lp~p~~  121 (418)
T KOG2982|consen   43 SLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAIL-EQLPALTTLNLSCNSLSSDIKSLPLPLK  121 (418)
T ss_pred             cccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHH-hcCccceEeeccCCcCCCccccCccccc
Confidence            334444566666555432211 122 256777888888887632  11121 2477888888888877633322214566


Q ss_pred             CCCEEEccCCccccc-CCccccCCCCCCEEecCCCcCcCCCCCc------c-ccccCCCCCCCCEEECcCCCCCccCCch
Q 036342           84 KLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENYLTSSTPEL------S-FLSSLSNCKSLTLIDLSNNPLDGILPKT  155 (596)
Q Consensus        84 ~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~------~-~~~~~~~l~~L~~L~ls~N~l~~~~~~~  155 (596)
                      +|++|-|.+..+.-. ....+..++.+++|+++.|.+.-....-      + -...+.-.+++..++++-|++..+    
T Consensus       122 nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~----  197 (418)
T KOG2982|consen  122 NLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI----  197 (418)
T ss_pred             ceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh----
Confidence            788887777766432 2333556777777777777443221110      0 000111112222222222222211    


Q ss_pred             hhhcccccccEEEccccccccccC-hhccCCCCCCEEEccCCcccCCC-CccccCCCCCCeEEccCCccc
Q 036342          156 SISNLSRSLEEFYMYNCNISGGIP-EEISNLTNLVEIDLGGNKLNGSI-PITLGKLRKLQRLNLEDNILE  223 (596)
Q Consensus       156 ~~~~l~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~  223 (596)
                           .+++..+.+..|.|..... ..+..++.+..|+|+.|+|.... -+++.++++|..|.+++|.+.
T Consensus       198 -----Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~  262 (418)
T KOG2982|consen  198 -----FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS  262 (418)
T ss_pred             -----cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence                 1345555555554432211 23344455555666666655322 134455555555555555554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.75  E-value=1.1e-08  Score=109.08  Aligned_cols=76  Identities=16%  Similarity=0.115  Sum_probs=51.3

Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHhccCCCceEeCCCCCCCeeeCCCC----cEEEecc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-ALEYLHFGYSALVIHCDLKPSNVLLDDNM----VAHLSDF  569 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~-~l~~lh~~~~~~i~Hrdlk~~NILl~~~~----~~kl~df  569 (596)
                      ..++||||++|+++.+.-.-.....+...   ++...+. -+..++   ..+++|+|++|.||+++.++    .+++.||
T Consensus       235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDF  308 (537)
T PRK04750        235 ETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDF  308 (537)
T ss_pred             CceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEec
Confidence            35799999999999775321111222221   2222221 122233   67899999999999999888    9999999


Q ss_pred             ccccccC
Q 036342          570 SIAKLLT  576 (596)
Q Consensus       570 Gla~~~~  576 (596)
                      |++..+.
T Consensus       309 Givg~l~  315 (537)
T PRK04750        309 GIVGSLN  315 (537)
T ss_pred             ceEEECC
Confidence            9988764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.74  E-value=2.5e-09  Score=116.47  Aligned_cols=151  Identities=26%  Similarity=0.366  Sum_probs=119.0

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l  498 (596)
                      ...|...+.||+|+|+.|-...                        .....|..+=+.+. |+|++++++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3467777889999999886532                        22334666666666 9999999999999999999


Q ss_pred             EEecCCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-cEEEeccccccccC
Q 036342          499 VLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLT  576 (596)
Q Consensus       499 V~e~~~~g~L~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-~~kl~dfGla~~~~  576 (596)
                      ++||..+|++.+.+ .......+...+-.+..|+..++.|+|.  ..++.|||+||+|.+++..+ ..|++|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999988 4332244556677789999999999994  45799999999999999999 99999999998775


Q ss_pred             C-CCCccccccccc-cccccCC
Q 036342          577 G-EDQSMTQTQTLG-TIGYMAP  596 (596)
Q Consensus       577 ~-~~~~~~~~~~~g-t~~y~aP  596 (596)
                      . ..........+| ++.|+||
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~  198 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAP  198 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCc
Confidence            4 222233445678 9999997

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.71  E-value=6.6e-08  Score=86.50  Aligned_cols=97  Identities=22%  Similarity=0.331  Sum_probs=77.7

Q ss_pred             HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc
Q 036342          466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL  545 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~  545 (596)
                      ....+|+.++.+++--.|..-.=+..+.+...+||||++|-.|.+.+...        ...++..|.+-+.-||   ..+
T Consensus        44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~g  112 (204)
T COG3642          44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAG  112 (204)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcC
Confidence            45678999999887665554444555666678999999998888888654        2446777788888899   999


Q ss_pred             eEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          546 VIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       546 i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      |+|+|+.++||++..+. +.++|||++..
T Consensus       113 ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         113 IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999999998765 88999999985

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=98.65  E-value=5.2e-09  Score=114.80  Aligned_cols=122  Identities=24%  Similarity=0.276  Sum_probs=99.0

Q ss_pred             cccccccccCCCceeehhhH--------------------HhHHH---HHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF--------------------KSFDV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~--------------------~~~~~---e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      +|...+.+|++.|=+|.||.                    +.+.+   |++ ..-++|||++.+.-+-..+...|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            56667889999998877753                    23333   444 5566999999998887777788999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ..+ +|+|.+..+. .+...+..-|+.|+..|+..+|   ..+|.|+|||.+|||+..-..+.++||.--+
T Consensus       103 vkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             Hhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccC
Confidence            976 8999887664 4555666669999999999999   9999999999999999999999999997544

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.63  E-value=4.9e-09  Score=88.13  Aligned_cols=113  Identities=19%  Similarity=0.132  Sum_probs=63.6

Q ss_pred             CCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecC
Q 036342          234 AELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFS  313 (596)
Q Consensus       234 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls  313 (596)
                      ..|+..+|++|.+....+..-...+.++.|+|++|.|+.+|.++..++.|+.|+++.|.+. ..|..+..+.++..||..
T Consensus        53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~  131 (177)
T KOG4579|consen   53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP  131 (177)
T ss_pred             ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence            3444555566655533333333334566666666666666666666666666666666665 345555567777777777


Q ss_pred             CCcCcccCChhhhccCCCCCeEECCCCcccccCCCC
Q 036342          314 MNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG  349 (596)
Q Consensus       314 ~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  349 (596)
                      +|.+. .+|...+ .-+.....++.++++.+..+..
T Consensus       132 ~na~~-eid~dl~-~s~~~al~~lgnepl~~~~~~k  165 (177)
T KOG4579|consen  132 ENARA-EIDVDLF-YSSLPALIKLGNEPLGDETKKK  165 (177)
T ss_pred             CCccc-cCcHHHh-ccccHHHHHhcCCcccccCccc
Confidence            77776 5565433 1222233344566666555543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.63  E-value=1.6e-07  Score=83.65  Aligned_cols=107  Identities=17%  Similarity=0.198  Sum_probs=78.8

Q ss_pred             HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC-CCHHHHHhhCCCCCCHHH-HHHHHHHHHHHHHHHhccC
Q 036342          465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH-GSLEKYLYSSNCILDIFQ-RLNIMIDVASALEYLHFGY  542 (596)
Q Consensus       465 ~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~-g~L~~~l~~~~~~l~~~~-~~~i~~~i~~~l~~lh~~~  542 (596)
                      .++.++|+.++.+++--.|.--.=++.+...-.++|||++| .++.+++......-.... ....+..|.+.+.-||   
T Consensus        54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---  130 (229)
T KOG3087|consen   54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---  130 (229)
T ss_pred             HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---
Confidence            35678899999988755554444444455556799999977 467788766432222222 2678889999999999   


Q ss_pred             CCceEeCCCCCCCeeeCCCC---cEEEeccccccc
Q 036342          543 SALVIHCDLKPSNVLLDDNM---VAHLSDFSIAKL  574 (596)
Q Consensus       543 ~~~i~Hrdlk~~NILl~~~~---~~kl~dfGla~~  574 (596)
                      ..+|+|+|+.++||++.+++   .+.+.|||++..
T Consensus       131 ~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  131 DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99999999999999997654   458999999764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.62  E-value=1.3e-07  Score=87.65  Aligned_cols=100  Identities=20%  Similarity=0.184  Sum_probs=74.6

Q ss_pred             hHHHHHHHHhhcCC--CccceeeeeeccCCeeEEEEecCCCCCHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHH-hccC
Q 036342          467 SFDVECEMMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHGSLE-KYLYSSNCILDIFQRLNIMIDVASALEYL-HFGY  542 (596)
Q Consensus       467 ~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~g~L~-~~l~~~~~~l~~~~~~~i~~~i~~~l~~l-h~~~  542 (596)
                      -.++|...|+++..  -++++.+++    ..-++||||+.+..+. ..++.  ..++..+...+..+++.++.++ |   
T Consensus        72 wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---  142 (197)
T cd05146          72 WAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---  142 (197)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---
Confidence            34589999998864  466777765    3468999999765432 12222  1244455667788999999998 7   


Q ss_pred             CCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       543 ~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ..+++|+|+++.||++++ +.+.++|||.+....
T Consensus       143 ~~glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         143 ECNLVHADLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             hCCeecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            789999999999999974 679999999988653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.61  E-value=1.9e-08  Score=110.27  Aligned_cols=133  Identities=27%  Similarity=0.330  Sum_probs=88.8

Q ss_pred             cccccccccccCCCceeehhhHHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHH
Q 036342          444 TDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ  523 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~  523 (596)
                      .++|...+.|..|+||.||.......+.--++ +++..|+|- .+.-...+..+.|      ||....++.-+ .++. +
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lil-Rnilt~a~npfvv------gDc~tllk~~g-~lPv-d  151 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLIL-RNILTFAGNPFVV------GDCATLLKNIG-PLPV-D  151 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccccchhh-hccccccCCccee------chhhhhcccCC-CCcc-h
Confidence            45788999999999999998754433333333 666665552 1111122223344      66666665533 2221 1


Q ss_pred             HHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC---------C----cccccccccc
Q 036342          524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED---------Q----SMTQTQTLGT  590 (596)
Q Consensus       524 ~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~---------~----~~~~~~~~gt  590 (596)
                      .       +.+++|+|   ..+|+|||+||+|.+|..-|++|+.|||+.+......         .    .....+.|||
T Consensus       152 m-------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgT  221 (1205)
T KOG0606|consen  152 M-------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGT  221 (1205)
T ss_pred             h-------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCC
Confidence            1       67899999   9999999999999999999999999999987531110         0    0012346999


Q ss_pred             ccccCC
Q 036342          591 IGYMAP  596 (596)
Q Consensus       591 ~~y~aP  596 (596)
                      |.|.||
T Consensus       222 PeyiaP  227 (1205)
T KOG0606|consen  222 PEYIAP  227 (1205)
T ss_pred             ccccCh
Confidence            999998

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.60  E-value=3.4e-08  Score=111.62  Aligned_cols=129  Identities=23%  Similarity=0.303  Sum_probs=86.9

Q ss_pred             CCCCEEEccCCcCccccCccCccCCCCccEEEccCCc--cccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCE
Q 036342           34 STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNN--FSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQ  111 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  111 (596)
                      ...+...+-+|.+. .++....  .++|+.|-+..|.  +.....+.|..++.|+.|||++|.=-+..|..+++|.+|++
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~--~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry  599 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSE--NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY  599 (889)
T ss_pred             hheeEEEEeccchh-hccCCCC--CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence            56677777777765 2333221  4578888888885  55344445667888888888887766678888888888888


Q ss_pred             EecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccc
Q 036342          112 LGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCN  173 (596)
Q Consensus       112 L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~  173 (596)
                      |++++..++.+|.      .+.+++.|.+|++..+.-...++. ....+ .+|++|.+..-.
T Consensus       600 L~L~~t~I~~LP~------~l~~Lk~L~~Lnl~~~~~l~~~~~-i~~~L-~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  600 LDLSDTGISHLPS------GLGNLKKLIYLNLEVTGRLESIPG-ILLEL-QSLRVLRLPRSA  653 (889)
T ss_pred             ccccCCCccccch------HHHHHHhhheeccccccccccccc-hhhhc-ccccEEEeeccc
Confidence            8888888876554      377778888888877765444433 23334 567777665543

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.58  E-value=3.1e-09  Score=89.30  Aligned_cols=111  Identities=22%  Similarity=0.249  Sum_probs=67.0

Q ss_pred             ccEEEccccccccc--cChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEc
Q 036342          164 LEEFYMYNCNISGG--IPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLEL  241 (596)
Q Consensus       164 L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (596)
                      +..++|++|+|..+  .+..+.....|+..+|++|.+...++..-...+.+++|+|++|.|+ .+|..+..++.|+.|++
T Consensus        29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl  107 (177)
T KOG4579|consen   29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL  107 (177)
T ss_pred             hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence            44556666665421  1223344455666677777777433333334456677777777776 56666777777777777


Q ss_pred             cCCcCcccchhhhccCCCCcEEEeCCCcccCCCcc
Q 036342          242 GSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLT  276 (596)
Q Consensus       242 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~  276 (596)
                      +.|.+. ..|..+..+.++-+||..+|.+..||..
T Consensus       108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~d  141 (177)
T KOG4579|consen  108 RFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVD  141 (177)
T ss_pred             ccCccc-cchHHHHHHHhHHHhcCCCCccccCcHH
Confidence            777765 4555555566666666666666666654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.57  E-value=1.2e-08  Score=104.33  Aligned_cols=96  Identities=28%  Similarity=0.481  Sum_probs=80.0

Q ss_pred             eeEEEEecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla  572 (596)
                      ..|+.|++|.-.+|.+|+..+.  ...++.....+..|++.|++|      ++.+|||+||.||....+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            5789999999999999997543  456788899999999999998      57899999999999999999999999998


Q ss_pred             cccCCCC----CccccccccccccccCC
Q 036342          573 KLLTGED----QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~----~~~~~~~~~gt~~y~aP  596 (596)
                      .......    .....+..+||.+||+|
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsP  431 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSP  431 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCH
Confidence            7654322    12234567899999998

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.48  E-value=5.5e-07  Score=86.41  Aligned_cols=107  Identities=21%  Similarity=0.263  Sum_probs=82.2

Q ss_pred             HhHHHHHHHHhhcCCC--ccceeeeeeccCC---eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 036342          466 KSFDVECEMMKSIRHR--NLIKVISSCSNEE---FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  540 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H~--niv~l~~~~~~~~---~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~  540 (596)
                      ..+..|.++++.+++.  .+++++.+....+   ..++||||++|+++.+.+..  ..++..+...++.++++++.++|.
T Consensus        40 ~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~  117 (223)
T cd05154          40 HDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHS  117 (223)
T ss_pred             ccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            4578899999999764  4677888876643   56899999999888765431  235666777788888888888883


Q ss_pred             c-----------------------------------------------------CCCceEeCCCCCCCeeeCC--CCcEE
Q 036342          541 G-----------------------------------------------------YSALVIHCDLKPSNVLLDD--NMVAH  565 (596)
Q Consensus       541 ~-----------------------------------------------------~~~~i~Hrdlk~~NILl~~--~~~~k  565 (596)
                      .                                                     ....++|+|+.+.||+++.  ++.+.
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~  197 (223)
T cd05154         118 VDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVA  197 (223)
T ss_pred             CChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEE
Confidence            1                                                     1245799999999999998  67789


Q ss_pred             Eeccccccc
Q 036342          566 LSDFSIAKL  574 (596)
Q Consensus       566 l~dfGla~~  574 (596)
                      +.||+.+..
T Consensus       198 iID~e~~~~  206 (223)
T cd05154         198 VLDWELATL  206 (223)
T ss_pred             EEecccccc
Confidence            999998874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.42  E-value=1e-06  Score=86.42  Aligned_cols=105  Identities=17%  Similarity=0.162  Sum_probs=79.8

Q ss_pred             hHHHHHHHHhhcCCCcc--ceeeeeecc-----CCeeEEEEecCCCC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHH
Q 036342          467 SFDVECEMMKSIRHRNL--IKVISSCSN-----EEFKALVLEYMPHG-SLEKYLYSS-NCILDIFQRLNIMIDVASALEY  537 (596)
Q Consensus       467 ~~~~e~~~l~~l~H~ni--v~l~~~~~~-----~~~~~lV~e~~~~g-~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~  537 (596)
                      .+.+|...+.++...+|  ++.+++.+.     ...-++|+|++++. +|.+++... ....+...+..++.+++..+.-
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            36788888888754333  444555532     23478999999886 798887542 1234455677899999999999


Q ss_pred             HhccCCCceEeCCCCCCCeeeCC-------CCcEEEeccccccc
Q 036342          538 LHFGYSALVIHCDLKPSNVLLDD-------NMVAHLSDFSIAKL  574 (596)
Q Consensus       538 lh~~~~~~i~Hrdlk~~NILl~~-------~~~~kl~dfGla~~  574 (596)
                      ||   ..+|+|+|++++|||++.       +..+.++||+.++.
T Consensus       154 LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99   999999999999999975       46899999998754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.37  E-value=1.1e-06  Score=86.15  Aligned_cols=75  Identities=28%  Similarity=0.394  Sum_probs=52.1

Q ss_pred             EEEEecCCCCCHHHHHhh---CCCC---CCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccc
Q 036342          497 ALVLEYMPHGSLEKYLYS---SNCI---LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS  570 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~---~~~~---l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfG  570 (596)
                      +++|+-+ .+||.+.+..   ....   +....+..+..|+.+.++++|   ..+++|+||+|+|++++.+|.++++||+
T Consensus       115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F~  190 (288)
T PF14531_consen  115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGDFS  190 (288)
T ss_dssp             EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--GG
T ss_pred             hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcChH
Confidence            5677766 5688877542   2211   223345666789999999999   9999999999999999999999999999


Q ss_pred             ccccc
Q 036342          571 IAKLL  575 (596)
Q Consensus       571 la~~~  575 (596)
                      .....
T Consensus       191 ~~~r~  195 (288)
T PF14531_consen  191 SLVRA  195 (288)
T ss_dssp             GEEET
T ss_pred             HHeec
Confidence            77654

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.35  E-value=1.8e-07  Score=88.83  Aligned_cols=204  Identities=17%  Similarity=0.110  Sum_probs=101.6

Q ss_pred             EEECcCCCCCccCCchhhhcccccccEEEcccccccc--ccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          140 LIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG--GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       140 ~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                      .|.+.++.|........++...+.++++||..|.|+.  .+...+.+++.|++|+++.|.+...+-..-..+.+|++|.|
T Consensus        49 llvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVL  128 (418)
T KOG2982|consen   49 LLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVL  128 (418)
T ss_pred             hheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEE
Confidence            4444444444333333444444667777777777763  33455677888888888888877544322235567788888


Q ss_pred             cCCcccccCc-cchhcCCCCcEEEccCCcCccc--chhhhccC-CCCcEEEeCCCcccC---CCcccccccccceEEccc
Q 036342          218 EDNILEGSIP-DDICRLAELYRLELGSNKLYGS--IPACFGNL-ASLRILSLGSNKLTS---IPLTFWNLKDILQLNFSS  290 (596)
Q Consensus       218 ~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l-~~L~~L~Ls~N~l~~---ip~~~~~l~~L~~L~ls~  290 (596)
                      .+..+...-. ..+..+|.++.|.+|.|++...  -..+.... +.++.|.+..|....   +-.--.-.+++..+-+..
T Consensus       129 NgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e  208 (418)
T KOG2982|consen  129 NGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCE  208 (418)
T ss_pred             cCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeec
Confidence            7777653222 2344566777777777743211  11111111 122222222221110   000001124445555555


Q ss_pred             CCCCCch-hhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCccc
Q 036342          291 NFLTGPL-LLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK  343 (596)
Q Consensus       291 N~l~~~~-~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~  343 (596)
                      |++.... -..+..++.+..|+|+.|+|..--.-..+..++.|..|.+++|++.
T Consensus       209 ~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~  262 (418)
T KOG2982|consen  209 GPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS  262 (418)
T ss_pred             CcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence            5553321 1233344445555666666653322234445666666666666654

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.33  E-value=8.6e-08  Score=89.82  Aligned_cols=45  Identities=27%  Similarity=0.511  Sum_probs=27.7

Q ss_pred             ccCCCCCCCCEEECcCCCCCccCCchhhhcc---cccccEEEccccccc
Q 036342          130 SSLSNCKSLTLIDLSNNPLDGILPKTSISNL---SRSLEEFYMYNCNIS  175 (596)
Q Consensus       130 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l---~~~L~~L~l~~n~l~  175 (596)
                      .++.+|+.|+..+||.|.+....|. .+..+   ...|.+|.|++|.+.
T Consensus        86 ~aLlkcp~l~~v~LSDNAfg~~~~e-~L~d~is~~t~l~HL~l~NnGlG  133 (388)
T COG5238          86 KALLKCPRLQKVDLSDNAFGSEFPE-ELGDLISSSTDLVHLKLNNNGLG  133 (388)
T ss_pred             HHHhcCCcceeeeccccccCcccch-HHHHHHhcCCCceeEEeecCCCC
Confidence            4567778888888888887654443 12111   245677777777664

>PRK15386 type III secretion protein GogB; Provisional

Probab=98.27  E-value=3.2e-06  Score=86.23  Aligned_cols=32  Identities=25%  Similarity=0.300  Sum_probs=14.8

Q ss_pred             CCCCEEEccCCcccCCCCccccCCCCCCeEEccCC
Q 036342          186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN  220 (596)
Q Consensus       186 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  220 (596)
                      ++|++|++++|... ..|..+.  .+|+.|+++.|
T Consensus       156 sSLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls~n  187 (426)
T PRK15386        156 PSLKTLSLTGCSNI-ILPEKLP--ESLQSITLHIE  187 (426)
T ss_pred             CcccEEEecCCCcc-cCccccc--ccCcEEEeccc
Confidence            34555555555533 2222221  35555555554

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=98.25  E-value=1.6e-08  Score=95.79  Aligned_cols=110  Identities=24%  Similarity=0.229  Sum_probs=68.1

Q ss_pred             CCccEEEccCCcccc-ccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCc-CcCCCCCccccccCCCCC
Q 036342           59 PNLEKLYLWGNNFSG-TIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENY-LTSSTPELSFLSSLSNCK  136 (596)
Q Consensus        59 ~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~~~~~l~  136 (596)
                      +.|+.|||+.-.|+. .+-..+...++|+.|.|.++++...+-..++.-.+|+.|+|+.+. ++.....    --+.+|+
T Consensus       185 sRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~----ll~~scs  260 (419)
T KOG2120|consen  185 SRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQ----LLLSSCS  260 (419)
T ss_pred             hhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHH----HHHHhhh
Confidence            458888888777752 222234456678888888888887777777777888888887753 3321111    1256777


Q ss_pred             CCCEEECcCCCCCccCCchhhhcccccccEEEcccc
Q 036342          137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNC  172 (596)
Q Consensus       137 ~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n  172 (596)
                      .|..|+|+++.+....-.......+.+|..|+++++
T Consensus       261 ~L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~  296 (419)
T KOG2120|consen  261 RLDELNLSWCFLFTEKVTVAVAHISETLTQLNLSGY  296 (419)
T ss_pred             hHhhcCchHhhccchhhhHHHhhhchhhhhhhhhhh
Confidence            888888888876644322223334445566666554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.23  E-value=6.6e-06  Score=77.94  Aligned_cols=106  Identities=24%  Similarity=0.278  Sum_probs=82.6

Q ss_pred             HhHHHHHHHHhhcCCC--ccceeeeeeccCC----eeEEEEecCCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 036342          466 KSFDVECEMMKSIRHR--NLIKVISSCSNEE----FKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYL  538 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H~--niv~l~~~~~~~~----~~~lV~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~l  538 (596)
                      ....+|...+.+++..  .+++.+++...+.    ..++|+|++++. +|.+++..... .+......++.++++.+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            4567788877777533  3456666655432    458999999884 79998876332 45566778999999999999


Q ss_pred             hccCCCceEeCCCCCCCeeeCCCC---cEEEecccccccc
Q 036342          539 HFGYSALVIHCDLKPSNVLLDDNM---VAHLSDFSIAKLL  575 (596)
Q Consensus       539 h~~~~~~i~Hrdlk~~NILl~~~~---~~kl~dfGla~~~  575 (596)
                      |   ..+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9   99999999999999999876   8999999987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.20  E-value=4.3e-06  Score=77.30  Aligned_cols=103  Identities=21%  Similarity=0.229  Sum_probs=67.1

Q ss_pred             hhHHhHHHHHHHHhhcCCC--ccceeeeeeccCCeeEEEEecCC--CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-
Q 036342          463 RAFKSFDVECEMMKSIRHR--NLIKVISSCSNEEFKALVLEYMP--HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY-  537 (596)
Q Consensus       463 ~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~~~~~~lV~e~~~--~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~-  537 (596)
                      .......+|...|+++...  ++++.+++.    .-++||||++  |..+.. +....  ++......+..++...+.. 
T Consensus        50 ~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~-l~~~~--~~~~~~~~~~~~il~~~~~~  122 (188)
T PF01163_consen   50 LIREWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPR-LKDVD--LSPEEPKELLEEILEEIIKM  122 (188)
T ss_dssp             HHHHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGC-HHHCG--GGGSTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhh-HHhcc--ccchhHHHHHHHHHHHHHHH
Confidence            3456678899999999876  567776553    3479999998  544433 33221  1122344566777775544 


Q ss_pred             HhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          538 LHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       538 lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      +|   ..+++|+|+.+.||+++++ .+.++|||.+....
T Consensus       123 ~~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  123 LH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HH---CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             HH---hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            57   8899999999999999988 99999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=98.13  E-value=3.8e-06  Score=75.81  Aligned_cols=65  Identities=20%  Similarity=0.181  Sum_probs=29.3

Q ss_pred             hhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCc--ccccccccceEEcccCCCC
Q 036342          230 ICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       230 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~--~~~~l~~L~~L~ls~N~l~  294 (596)
                      |..++.|.+|.|++|.|+.+-|.--.-+++|+.|.|.+|+|..+.+  .+..+++|++|.+-+|+.+
T Consensus        60 lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltll~Npv~  126 (233)
T KOG1644|consen   60 LPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTLLGNPVE  126 (233)
T ss_pred             CCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeeecCCchh
Confidence            3344444444444444443333333333444444444444444321  2334555566666566554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.13  E-value=2.3e-06  Score=89.46  Aligned_cols=147  Identities=22%  Similarity=0.236  Sum_probs=111.7

Q ss_pred             cccccccccC--CCceeehhhHH-------------------------hHHHHHHHHhhc-CCCccceeeeeeccCCeeE
Q 036342          446 EFSENNLIGR--GGFALFIRAFK-------------------------SFDVECEMMKSI-RHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       446 ~~~~~~~ig~--G~~g~v~~~~~-------------------------~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  497 (596)
                      .|.....+|+  |.+|.||.+.-                         .-.+|+..-+++ .|++.|+.+..++.++..|
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3456678899  99999987421                         112445444455 3999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHhccCCCceEeCCCCCCCeeeCCC-CcEEEeccccc
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS----ALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDFSIA  572 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~----~l~~lh~~~~~~i~Hrdlk~~NILl~~~-~~~kl~dfGla  572 (596)
                      +-+|+| +.++.++.+.....++....+.+..+..+    |+.++|   ..+++|-|+||.||...++ ..++..|||+.
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence            999999 47888888776656777888888888888    999999   9999999999999999998 89999999998


Q ss_pred             cccCCCCCcc---ccccccccccccCC
Q 036342          573 KLLTGEDQSM---TQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~---~~~~~~gt~~y~aP  596 (596)
                      ..+....-..   ......|-..|++|
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~k  297 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAK  297 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeCh
Confidence            8775432111   11112456667765

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.12  E-value=8.3e-06  Score=86.40  Aligned_cols=102  Identities=17%  Similarity=0.216  Sum_probs=85.8

Q ss_pred             HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc
Q 036342          466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL  545 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~  545 (596)
                      ....+-++.++.+|||+|+++++.++.++..|+|+|-+.  .|..++++..    .....-.+.||+.||.|||+  +.+
T Consensus        54 ~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~Gl~qIl~AL~FL~~--d~~  125 (690)
T KOG1243|consen   54 ELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCLGLFQILAALSFLND--DCN  125 (690)
T ss_pred             HHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHHHHHHHHHHHHHHhc--cCC
Confidence            345677889999999999999999999999999999884  5666666543    44455578899999999984  568


Q ss_pred             eEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          546 VIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       546 i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ++|+++.-+.|+++..|.-||++|-++...
T Consensus       126 lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  126 LVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             eeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence            999999999999999999999999877543

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.08  E-value=3e-06  Score=57.95  Aligned_cols=36  Identities=36%  Similarity=0.465  Sum_probs=16.0

Q ss_pred             CccEEEccCCccccccCccccCCCCCCEEEccCCccc
Q 036342           60 NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFS   96 (596)
Q Consensus        60 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~   96 (596)
                      +|++|++++|+|+ .+|+.+.++++|++|++++|+|+
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            3444555555444 33334444444444444444444

...

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.07  E-value=4.7e-06  Score=56.97  Aligned_cols=37  Identities=30%  Similarity=0.563  Sum_probs=16.3

Q ss_pred             CCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC
Q 036342          235 ELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS  272 (596)
Q Consensus       235 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  272 (596)
                      +|++|++++|+|+ .+|..++.|++|+.|++++|+++.
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~   38 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD   38 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence            3445555555554 233334444444444444444443

...

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.05  E-value=3e-06  Score=81.89  Aligned_cols=92  Identities=24%  Similarity=0.375  Sum_probs=76.5

Q ss_pred             HhhcCCCccceeeeeeccCC-----eeEEEEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCce
Q 036342          475 MKSIRHRNLIKVISSCSNEE-----FKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSALV  546 (596)
Q Consensus       475 l~~l~H~niv~l~~~~~~~~-----~~~lV~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i  546 (596)
                      +-++.|.|||+++.||.+..     +..+++|||+.|++.+++++..   ..+....-.+++.||..|+-||| .++++|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCcc
Confidence            34557999999999997543     5789999999999999998642   23445555679999999999999 568999


Q ss_pred             EeCCCCCCCeeeCCCCcEEEe
Q 036342          547 IHCDLKPSNVLLDDNMVAHLS  567 (596)
Q Consensus       547 ~Hrdlk~~NILl~~~~~~kl~  567 (596)
                      +|+++..+-|.+..+|-+|+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             ccCCcchhheeecCCceEEec
Confidence            999999999999999988885

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	596
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		7e-29
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-28
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-24
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-18
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-17
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-15
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-15
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-14
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-14
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-07
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-06
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-06
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-06
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-05
2ft3_A	332	Crystal Structure Of The Biglycan Dimer Core Protei		1e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-05
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-05
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-05
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-05
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-05
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-05
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-05
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-05
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-05
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-05
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		3e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-05
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		4e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-05
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		5e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-05
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-04
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-04
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		1e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		1e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-04
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		1e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-04
2o6s_A	208	Structural Diversity Of The Hagfish Variable Lympho		2e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-04
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		2e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-04
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		2e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		2e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-04
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-04
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-04
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-04
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-04
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-04
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-04
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-04
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-04
3soa_A	444	Full-Length Human Camkii Length = 444		6e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-04
3g3a_A	178	Structure Of A Lamprey Variable Lymphocyte Receptor		6e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-04
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		7e-04
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		9e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-04
3g39_A	170	Structure Of A Lamprey Variable Lymphocyte Receptor		8e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-04
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 111/348 (31%), Positives = 149/348 (42%), Gaps = 71/348 (20%)
Query: 57  RLPNLEKLYLWGNNFSGTIP-----------------------RFIFNASKLSKLSLGMN 93
           R  NLE L +  NNFS  IP                       R I   ++L  L++  N
Sbjct: 195 RCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 254
Query: 94  SFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNN------- 146
            F G IP     L++L+ L L EN  T   P+  FLS    C +LT +DLS N       
Sbjct: 255 QFVGPIPPL--PLKSLQYLSLAENKFTGEIPD--FLSGA--CDTLTGLDLSGNHFYGAVP 308
Query: 147 -----------------------PLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEIS 183
                                  P+D +L    +  L  S  EF       SG +PE ++
Sbjct: 309 PFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF-------SGELPESLT 361
Query: 184 NLT-NLVEIDLGGNKLNGSIPITLGKLRK--LQRLNLEDNILEGSIPDDICRLAELYRLE 240
           NL+ +L+ +DL  N  +G I   L +  K  LQ L L++N   G IP  +   +EL  L 
Sbjct: 362 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 421
Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLL 299
           L  N L G+IP+  G+L+ LR L L  N L   IP     +K +  L    N LTG +  
Sbjct: 422 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 481
Query: 300 EIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
            + N   L  I  S N  +G IP+ IG +L  L  L LS N   G IP
Sbjct: 482 GLSNCTNLNWISLSNNRLTGEIPKWIG-RLENLAILKLSNNSFSGNIP 528

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 111/348 (31%), Positives = 149/348 (42%), Gaps = 71/348 (20%)
Query: 57  RLPNLEKLYLWGNNFSGTIP-----------------------RFIFNASKLSKLSLGMN 93
           R  NLE L +  NNFS  IP                       R I   ++L  L++  N
Sbjct: 198 RCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257
Query: 94  SFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNN------- 146
            F G IP     L++L+ L L EN  T   P+  FLS    C +LT +DLS N       
Sbjct: 258 QFVGPIPPL--PLKSLQYLSLAENKFTGEIPD--FLSGA--CDTLTGLDLSGNHFYGAVP 311
Query: 147 -----------------------PLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEIS 183
                                  P+D +L    +  L  S  EF       SG +PE ++
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF-------SGELPESLT 364
Query: 184 NLT-NLVEIDLGGNKLNGSIPITLGKLRK--LQRLNLEDNILEGSIPDDICRLAELYRLE 240
           NL+ +L+ +DL  N  +G I   L +  K  LQ L L++N   G IP  +   +EL  L 
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLL 299
           L  N L G+IP+  G+L+ LR L L  N L   IP     +K +  L    N LTG +  
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
Query: 300 EIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
            + N   L  I  S N  +G IP+ IG +L  L  L LS N   G IP
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIG-RLENLAILKLSNNSFSGNIP 531

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 82/251 (32%), Positives = 136/251 (54%), Gaps = 11/251 (4%)
Query: 130 SSLSNCKSLTLIDLSN-NPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNL 188
           SSL+N   L  + +   N L G +P  +I+ L++ L   Y+ + N+SG IP+ +S +  L
Sbjct: 70  SSLANLPYLNFLYIGGINNLVGPIPP-AIAKLTQ-LHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 189 VEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELY-RLELGSNKLY 247
           V +D   N L+G++P ++  L  L  +  + N + G+IPD     ++L+  + +  N+L 
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 248 GSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKV 306
           G IP  F NL +L  + L  N L     + F + K+  +++ + N L    L ++G  K 
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD-LGKVGLSKN 245
Query: 307 LIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELL 366
           L G+D   N   G +P+ +  +L +L  LN+SFN L GEIP+GG+   F   ++  N+ L
Sbjct: 246 LNGLDLRNNRIYGTLPQGL-TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
Query: 367 CGSPNLQVPPC 377
           CGSP   +P C
Sbjct: 305 CGSP---LPAC 312

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 90/188 (47%), Gaps = 25/188 (13%)
Query: 433 RTFSYLELCRATDEFSENNLIGRGGFA------------LFIRAFK---------SFDVE 471
           + FS  EL  A+D FS  N++GRGGF             + ++  K          F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 472 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIM 528
            EM+    HRNL+++   C     + LV  YM +GS+   L     S   LD  +R  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
           +  A  L YLH      +IH D+K +N+LLD+   A + DF +AKL+  +D  +      
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 204
Query: 589 GTIGYMAP 596
           GTIG++AP
Sbjct: 205 GTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 88/188 (46%), Gaps = 25/188 (13%)
Query: 433 RTFSYLELCRATDEFSENNLIGRGGFA------------LFIRAFK---------SFDVE 471
           + FS  EL  A+D F   N++GRGGF             + ++  K          F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 472 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIM 528
            EM+    HRNL+++   C     + LV  YM +GS+   L     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
           +  A  L YLH      +IH D+K +N+LLD+   A + DF +AKL+  +D  +      
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 196
Query: 589 GTIGYMAP 596
           G IG++AP
Sbjct: 197 GXIGHIAP 204

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 45/121 (37%), Positives = 68/121 (56%), Gaps = 6/121 (4%)
Query: 479 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASAL 535
           RH +L+ +I  C       L+ +YM +G+L+++LY S+     +   QRL I I  A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 536 EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
            YLH   +  +IH D+K  N+LLD+N V  ++DF I+K  T  DQ+       GT+GY+ 
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 596 P 596
           P
Sbjct: 210 P 210

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 40/199 (20%)
Query: 432 WRTFSYLELCRATDEFSEN------NLIGRGGFALFIRAF-------------------- 465
           + +FS+ EL   T+ F E       N +G GGF +  + +                    
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 466 ---KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---- 518
              + FD E ++M   +H NL++++   S+ +   LV  YMP+GSL   L   +C+    
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGTP 128
Query: 519 -LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 577
            L    R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDF +A+    
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 578 EDQSMTQTQTLGTIGYMAP 596
             Q++  ++ +GT  YMAP
Sbjct: 186 FAQTVMXSRIVGTTAYMAP 204

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 40/199 (20%)
Query: 432 WRTFSYLELCRATDEFSEN------NLIGRGGFALFIRAF-------------------- 465
           + +FS+ EL   T+ F E       N +G GGF +  + +                    
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 466 ---KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---- 518
              + FD E ++M   +H NL++++   S+ +   LV  YMP+GSL   L   +C+    
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGTP 128
Query: 519 -LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 577
            L    R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDF +A+    
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 578 EDQSMTQTQTLGTIGYMAP 596
             Q++   + +GT  YMAP
Sbjct: 186 FAQTVMXXRIVGTTAYMAP 204

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 40/199 (20%)
Query: 432 WRTFSYLELCRATDEFSEN------NLIGRGGFALFIRAF-------------------- 465
           + +FS+ EL   T+ F E       N +G GGF +  + +                    
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 65
Query: 466 ---KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---- 518
              + FD E ++M   +H NL++++   S+ +   LV  YMP+GSL   L   +C+    
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGTP 122
Query: 519 -LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 577
            L    R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDF +A+    
Sbjct: 123 PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 179
Query: 578 EDQSMTQTQTLGTIGYMAP 596
             Q +   + +GT  YMAP
Sbjct: 180 FAQXVMXXRIVGTTAYMAP 198

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 26/182 (14%)
Query: 438 LELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSI------------------- 478
           ++L  AT+ F    LIG G F    +       +  + +                     
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 479 -RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASA 534
            RH +L+ +I  C       L+ +YM +G+L+++LY S+     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           L YLH   +  +IH D+K  N+LLD+N V  ++DF I+K  T   Q+       GT+GY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 595 AP 596
            P
Sbjct: 209 DP 210

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 40/199 (20%)
Query: 432 WRTFSYLELCRATDEFSEN------NLIGRGGFALFIRAF-------------------- 465
           + +FS+ EL   T+ F E       N  G GGF +  + +                    
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 62
Query: 466 ---KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---- 518
              + FD E ++    +H NL++++   S+ +   LV  Y P+GSL   L   +C+    
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL---SCLDGTP 119
Query: 519 -LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 577
            L    R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDF +A+    
Sbjct: 120 PLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 176
Query: 578 EDQSMTQTQTLGTIGYMAP 596
             Q +  ++ +GT  Y AP
Sbjct: 177 FAQXVXXSRIVGTTAYXAP 195

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 69/136 (50%), Gaps = 6/136 (4%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           R  + F  E  +M    H N+I++    +      +V EYM +GSL+ +L + +    I 
Sbjct: 92  RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM 151
Query: 523 QRLNIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQ 580
           Q + ++  V + + YL   GY    +H DL   NVL+D N+V  +SDF ++++L  + D 
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 581 SMTQTQTLGTIGYMAP 596
           + T T     I + AP
Sbjct: 208 AXTTTGGKIPIRWTAP 223

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 69/136 (50%), Gaps = 6/136 (4%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           R  + F  E  +M    H N+I++    +      +V EYM +GSL+ +L + +    I 
Sbjct: 92  RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM 151
Query: 523 QRLNIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQ 580
           Q + ++  V + + YL   GY    +H DL   NVL+D N+V  +SDF ++++L  + D 
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 581 SMTQTQTLGTIGYMAP 596
           + T T     I + AP
Sbjct: 208 AYTTTGGKIPIRWTAP 223

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 140
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 591 IGYMAP 596
             Y++P
Sbjct: 198 AQYVSP 203

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 143
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 144 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 591 IGYMAP 596
             Y++P
Sbjct: 201 AQYVSP 206

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 140
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 591 IGYMAP 596
             Y++P
Sbjct: 198 AQYVSP 203

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 141
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 142 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 591 IGYMAP 596
             Y++P
Sbjct: 199 AQYVSP 204

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 118
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 119 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 591 IGYMAP 596
             Y++P
Sbjct: 176 AQYVSP 181

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 141
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 142 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 591 IGYMAP 596
             Y++P
Sbjct: 199 AQYVSP 204

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 140
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 591 IGYMAP 596
             Y++P
Sbjct: 198 AQYVSP 203

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 117
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 118 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 591 IGYMAP 596
             Y++P
Sbjct: 175 AQYVSP 180

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 116
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 117 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 591 IGYMAP 596
             Y++P
Sbjct: 174 AQYVSP 179

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 115
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 116 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 591 IGYMAP 596
             Y++P
Sbjct: 173 AQYVSP 178

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 63/131 (48%), Gaps = 4/131 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E E+M  + H  L+++   C  +    LV E+M HG L  YL +   +      L
Sbjct: 50  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL 109
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            + +DV   + YL     A VIH DL   N L+ +N V  +SDF + + +  +DQ  + T
Sbjct: 110 GMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSST 165
Query: 586 QTLGTIGYMAP 596
            T   + + +P
Sbjct: 166 GTKFPVKWASP 176

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 140
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 591 IGYMAP 596
             Y++P
Sbjct: 198 AQYVSP 203

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 138
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 591 IGYMAP 596
             Y++P
Sbjct: 196 AQYVSP 201

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 138
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 591 IGYMAP 596
             Y++P
Sbjct: 196 AQYVSP 201

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 140
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 591 IGYMAP 596
             Y++P
Sbjct: 198 AQYVSP 203

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 138
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 591 IGYMAP 596
             Y++P
Sbjct: 196 AQYVSP 201

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 66/128 (51%), Gaps = 5/128 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIM 528
           E  +MK +RH N++  + + +     ++V EY+  GSL + L+ S     LD  +RL++ 
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
            DVA  + YLH   +  ++H DLK  N+L+D      + DF +++L       +      
Sbjct: 144 YDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAA 200
Query: 589 GTIGYMAP 596
           GT  +MAP
Sbjct: 201 GTPEWMAP 208

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 138
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 591 IGYMAP 596
             Y++P
Sbjct: 196 AQYVSP 201

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAE 140
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 591 IGYMAP 596
             Y++P
Sbjct: 198 AQYVSP 203

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 63/131 (48%), Gaps = 4/131 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E E+M  + H  L+++   C  +    LV E+M HG L  YL +   +      L
Sbjct: 47  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL 106
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            + +DV   + YL     A VIH DL   N L+ +N V  +SDF + + +  +DQ  + T
Sbjct: 107 GMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSST 162
Query: 586 QTLGTIGYMAP 596
            T   + + +P
Sbjct: 163 GTKFPVKWASP 173

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 137
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 138 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 591 IGYMAP 596
             Y++P
Sbjct: 195 AQYVSP 200

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 122
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 123 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 591 IGYMAP 596
             Y++P
Sbjct: 180 AQYVSP 185

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 137
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 138 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 591 IGYMAP 596
             Y++P
Sbjct: 195 AQYVSP 200

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 63/131 (48%), Gaps = 4/131 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E E+M  + H  L+++   C  +    LV E+M HG L  YL +   +      L
Sbjct: 45  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL 104
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            + +DV   + YL     A VIH DL   N L+ +N V  +SDF + + +  +DQ  + T
Sbjct: 105 GMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSST 160
Query: 586 QTLGTIGYMAP 596
            T   + + +P
Sbjct: 161 GTKFPVKWASP 171

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 62/129 (48%), Gaps = 4/129 (3%)
Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E E+M  + H  L+++   C  +    LV E+M HG L  YL +   +      L +
Sbjct: 69  FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGM 128
Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            +DV   + YL     A VIH DL   N L+ +N V  +SDF + + +  +DQ  + T T
Sbjct: 129 CLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGT 184
Query: 588 LGTIGYMAP 596
              + + +P
Sbjct: 185 KFPVKWASP 193

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 64/114 (56%), Gaps = 4/114 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    +V EYMP+G+L  YL   N   +     
Sbjct: 73  EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVL 132
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 578
           L +   ++SA+EYL        IH DL   N L+ +N V  ++DF +++L+TG+
Sbjct: 133 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGD 183

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 63/131 (48%), Gaps = 4/131 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E E+M  + H  L+++   C  +    LV E+M HG L  YL +   +      L
Sbjct: 48  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL 107
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            + +DV   + YL     A VIH DL   N L+ +N V  +SDF + + +  +DQ  + T
Sbjct: 108 GMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSST 163
Query: 586 QTLGTIGYMAP 596
            T   + + +P
Sbjct: 164 GTKFPVKWASP 174

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 63/131 (48%), Gaps = 4/131 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E E+M  + H  L+++   C  +    LV E+M HG L  YL +   +      L
Sbjct: 47  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL 106
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            + +DV   + YL     A VIH DL   N L+ +N V  +SDF + + +  +DQ  + T
Sbjct: 107 GMCLDVCEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSST 162
Query: 586 QTLGTIGYMAP 596
            T   + + +P
Sbjct: 163 GTKFPVKWASP 173

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 64/126 (50%), Gaps = 4/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+     ++E     L Y  +G L KY+       +   R     +
Sbjct: 87  ERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAE 145
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT
Sbjct: 146 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 591 IGYMAP 596
             Y++P
Sbjct: 203 AQYVSP 208

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 68/132 (51%), Gaps = 4/132 (3%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 524
           F++F  E  +++  RH N++  +   + +   A+V ++    SL K+L+       +FQ 
Sbjct: 76  FQAFRNEVAVLRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQL 134
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           ++I    A  ++YLH   +  +IH D+K +N+ L + +   + DF +A + +    S   
Sbjct: 135 IDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191
Query: 585 TQTLGTIGYMAP 596
            Q  G++ +MAP
Sbjct: 192 EQPTGSVLWMAP 203

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 67/128 (52%), Gaps = 5/128 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIM 528
           E  +MK +RH N++  + + +     ++V EY+  GSL + L+ S     LD  +RL++ 
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
            DVA  + YLH   +  ++H +LK  N+L+D      + DF +++L       ++     
Sbjct: 144 YDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAA 200
Query: 589 GTIGYMAP 596
           GT  +MAP
Sbjct: 201 GTPEWMAP 208

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 459 ALFI------RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL 512
           A+FI         K F+ E      + H+N++ +I     ++   LV+EY+   +L +Y+
Sbjct: 43  AIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI 102
Query: 513 YSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA 572
             S+  L +   +N    +   +++ H      ++H D+KP N+L+D N    + DF IA
Sbjct: 103 -ESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158
Query: 573 KLLTGEDQSMTQT-QTLGTIGYMAP 596
           K L+  + S+TQT   LGT+ Y +P
Sbjct: 159 KALS--ETSLTQTNHVLGTVQYFSP 181

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 66/122 (54%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF +A++L  + ++   
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT 206
Query: 585 TQ 586
           T+
Sbjct: 207 TR 208

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIF 522
            + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+  
Sbjct: 133 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEX 188
Query: 583 TQTQTLGT--IGYMAP 596
            + +  G   I + AP
Sbjct: 189 XKVKEPGESPIFWYAP 204

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIF 522
            + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  
Sbjct: 55  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+  
Sbjct: 115 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEX 170
Query: 583 TQTQTLGT--IGYMAP 596
            + +  G   I + AP
Sbjct: 171 XKVKEPGESPIFWYAP 186

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIF 522
            + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  
Sbjct: 62  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 121
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+  
Sbjct: 122 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEX 177
Query: 583 TQTQTLGT--IGYMAP 596
            + +  G   I + AP
Sbjct: 178 XKVKEPGESPIFWYAP 193

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIF 522
            + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  
Sbjct: 58  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 117
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+  
Sbjct: 118 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEX 173
Query: 583 TQTQTLGT--IGYMAP 596
            + +  G   I + AP
Sbjct: 174 XKVKEPGESPIFWYAP 189

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIF 522
            + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  
Sbjct: 61  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 120
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+  
Sbjct: 121 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEX 176
Query: 583 TQTQTLGT--IGYMAP 596
            + +  G   I + AP
Sbjct: 177 XKVKEPGESPIFWYAP 192

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIF 522
            + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+  
Sbjct: 133 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEX 188
Query: 583 TQTQTLGT--IGYMAP 596
            + +  G   I + AP
Sbjct: 189 XKVKEPGESPIFWYAP 204

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  +
Sbjct: 61  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 120
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+   
Sbjct: 121 LLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 176
Query: 584 QTQTLGT--IGYMAP 596
           + +  G   I + AP
Sbjct: 177 KVKEPGESPIFWYAP 191

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  +
Sbjct: 87  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 146
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+   
Sbjct: 147 LLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 202
Query: 584 QTQTLGT--IGYMAP 596
           + +  G   I + AP
Sbjct: 203 KVKEPGESPIFWYAP 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIF 522
            + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  
Sbjct: 53  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 112
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+  
Sbjct: 113 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEX 168
Query: 583 TQTQTLGT--IGYMAP 596
            + +  G   I + AP
Sbjct: 169 XKVKEPGESPIFWYAP 184

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIF 522
            + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  
Sbjct: 54  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 113
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+  
Sbjct: 114 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEX 169
Query: 583 TQTQTLGT--IGYMAP 596
            + +  G   I + AP
Sbjct: 170 XKVKEPGESPIFWYAP 185

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L   +   L + Q 
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQL 365
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 366 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 420
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 421 RQGAKFPIKWTAP 433

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIF 522
            + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  
Sbjct: 59  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 118
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+  
Sbjct: 119 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEX 174
Query: 583 TQTQTLGT--IGYMAP 596
            + +  G   I + AP
Sbjct: 175 XKVKEPGESPIFWYAP 190

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIF 522
            + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  
Sbjct: 55  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+  
Sbjct: 115 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEX 170
Query: 583 TQTQTLGT--IGYMAP 596
            + +  G   I + AP
Sbjct: 171 XKVKEPGESPIFWYAP 186

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 70/135 (51%), Gaps = 8/135 (5%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL +    +D  +
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIK 118
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+   
Sbjct: 119 LLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 174
Query: 584 QTQTLGT--IGYMAP 596
           + +  G   I + AP
Sbjct: 175 KVKEPGESPIFWYAP 189

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  +
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 115
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+   
Sbjct: 116 LLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEFF 171
Query: 584 QTQTLGT--IGYMAP 596
           + +  G   I + AP
Sbjct: 172 KVKEPGESPIFWYAP 186

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L   +   L + Q 
Sbjct: 48  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQL 106
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 107 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEXTA 161
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 162 RQGAKFPIKWTAP 174

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 70/137 (51%), Gaps = 15/137 (10%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    +++E+M +G+L  YL   N      Q +
Sbjct: 55  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-----RQEV 109
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG D
Sbjct: 110 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-D 165
Query: 580 QSMTQTQTLGTIGYMAP 596
                      I + AP
Sbjct: 166 TXTAHAGAKFPIKWTAP 182

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 66/122 (54%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 79  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 138
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 139 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 585 TQ 586
           T+
Sbjct: 195 TR 196

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 71/133 (53%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK IRH  L+++ +  S E    +V EYM  GSL  +L       L + Q 
Sbjct: 58  EAFLQEAQVMKKIRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQL 116
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 171
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 172 RQGAKFPIKWTAP 184

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V+EYM  GSL  +L       L + Q 
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQL 116
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEXTA 171
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 172 RQGAKFPIKWTAP 184

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 455 RGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 514
           +GG+    R  + F  E  +M    H N+I++    +N     ++ E+M +G+L+ +L  
Sbjct: 53  KGGYTE--RQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL 110
Query: 515 SNCILDIFQRLNIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           ++    + Q + ++  +AS + YL    Y    +H DL   N+L++ N+V  +SDF +++
Sbjct: 111 NDGQFTVIQLVGMLRGIASGMRYLAEMSY----VHRDLAARNILVNSNLVCKVSDFGLSR 166
Query: 574 LLTGEDQSMTQTQTLG---TIGYMAP 596
            L       T+T +LG    I + AP
Sbjct: 167 FLEENSSDPTETSSLGGKIPIRWTAP 192

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V+EYM  GSL  +L       L + Q 
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQL 116
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 171
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 172 RQGAKFPIKWTAP 184

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 66/122 (54%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 585 TQ 586
           T+
Sbjct: 207 TR 208

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 66/122 (54%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 121
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 122 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 585 TQ 586
           T+
Sbjct: 178 TR 179

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L   +   L + Q 
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 283 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 337
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 338 RQGAKFPIKWTAP 350

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L   +   L + Q 
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 283 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 337
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 338 RQGAKFPIKWTAP 350

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF + ++L  + ++   
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 585 TQ 586
           T+
Sbjct: 207 TR 208

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 66/122 (54%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 585 TQ 586
           T+
Sbjct: 207 TR 208

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 66/122 (54%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 585 TQ 586
           T+
Sbjct: 207 TR 208

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 66/122 (54%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 585 TQ 586
           T+
Sbjct: 207 TR 208

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 70/135 (51%), Gaps = 8/135 (5%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F+ E E++KS++H N++K    C +   +   L++E++P+GSL +YL      +D  +
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIK 118
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+   
Sbjct: 119 LLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 174
Query: 584 QTQTLGT--IGYMAP 596
           + +  G   I + AP
Sbjct: 175 KVKEPGESPIFWYAP 189

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L   +   L + Q 
Sbjct: 51  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQL 109
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 110 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 164
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 165 RQGAKFPIKWTAP 177

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 66/122 (54%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 89  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 148
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 149 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 204
Query: 585 TQ 586
           T+
Sbjct: 205 TR 206

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 73/140 (52%), Gaps = 21/140 (15%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    +++E+M +G+L  YL   N      Q +
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-----RQEV 113
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+ 
Sbjct: 114 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 169
Query: 580 QSMTQTQTLGT---IGYMAP 596
              T T   G    I + AP
Sbjct: 170 ---TYTAHAGAKFPIKWTAP 186

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    +++E+M +G+L  YL   N   +     
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL 111
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L +   ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG D     
Sbjct: 112 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAH 167
Query: 585 TQTLGTIGYMAP 596
                 I + AP
Sbjct: 168 AGAKFPIKWTAP 179

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 71/135 (52%), Gaps = 11/135 (8%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    +++E+M +G+L  YL   N   +     
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L +   ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+    T 
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TY 166
Query: 585 TQTLGT---IGYMAP 596
           T   G    I + AP
Sbjct: 167 TAHAGAKFPIKWTAP 181

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L   +   L + Q 
Sbjct: 55  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQL 113
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 114 VDMSAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEWTA 168
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 169 RQGAKFPIKWTAP 181

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 15/137 (10%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 113
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG D
Sbjct: 114 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-D 169
Query: 580 QSMTQTQTLGTIGYMAP 596
                      I + AP
Sbjct: 170 TXTAHAGAKFPIKWTAP 186

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 71/133 (53%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L       L + Q 
Sbjct: 47  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQL 105
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 106 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 160
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 161 RQGAKFPIKWTAP 173

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 71/135 (52%), Gaps = 11/135 (8%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    +++E+M +G+L  YL   N   +     
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L +   ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+    T 
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TY 166
Query: 585 TQTLGT---IGYMAP 596
           T   G    I + AP
Sbjct: 167 TAHAGAKFPIKWTAP 181

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 71/133 (53%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L       L + Q 
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQL 116
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 171
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 172 RQGAKFPIKWTAP 184

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 21/140 (15%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 55  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 109
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+ 
Sbjct: 110 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 165
Query: 580 QSMTQTQTLGT---IGYMAP 596
              T T   G    I + AP
Sbjct: 166 ---TYTAPAGAKFPIKWTAP 182

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L   +   L + Q 
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 283 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 337
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 338 RQGAKFPIKWTAP 350

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 71/133 (53%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L       L + Q 
Sbjct: 49  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQL 107
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 108 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 162
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 163 RQGAKFPIKWTAP 175

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L   +   L + Q 
Sbjct: 55  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQL 113
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 114 VDMSAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 168
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 169 RQGAKFPIKWTAP 181

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 69/126 (54%), Gaps = 7/126 (5%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M+ + H  L+ +  S  +EE   +V++ +  G L  +L  +    +   +L I  +
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI-CE 123
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +  AL+YL    +  +IH D+KP N+LLD++   H++DF+IA +L  E Q  T     GT
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GT 177
Query: 591 IGYMAP 596
             YMAP
Sbjct: 178 KPYMAP 183

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 71/133 (53%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L       L + Q 
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQL 116
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 171
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 172 RQGAKFPIKWTAP 184

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 21/140 (15%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 110
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+ 
Sbjct: 111 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 166
Query: 580 QSMTQTQTLGT---IGYMAP 596
              T T   G    I + AP
Sbjct: 167 ---TYTAPAGAKFPIKWTAP 183

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 15/137 (10%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 108
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG D
Sbjct: 109 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-D 164
Query: 580 QSMTQTQTLGTIGYMAP 596
                      I + AP
Sbjct: 165 TYTAHAGAKFPIKWTAP 181

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 21/140 (15%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 108
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+ 
Sbjct: 109 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 164
Query: 580 QSMTQTQTLGT---IGYMAP 596
              T T   G    I + AP
Sbjct: 165 ---TYTAHAGAKFPIKWTAP 181

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 21/140 (15%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 110
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+ 
Sbjct: 111 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 166
Query: 580 QSMTQTQTLGT---IGYMAP 596
              T T   G    I + AP
Sbjct: 167 ---TYTAHAGAKFPIKWTAP 183

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 21/140 (15%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 112
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+ 
Sbjct: 113 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 168
Query: 580 QSMTQTQTLGT---IGYMAP 596
              T T   G    I + AP
Sbjct: 169 ---TYTAHAGAKFPIKWTAP 185

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 21/140 (15%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 67  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 121
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+ 
Sbjct: 122 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 177
Query: 580 QSMTQTQTLGT---IGYMAP 596
              T T   G    I + AP
Sbjct: 178 ---TYTAHAGAKFPIKWTAP 194

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 21/140 (15%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 113
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+ 
Sbjct: 114 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 169
Query: 580 QSMTQTQTLGT---IGYMAP 596
              T T   G    I + AP
Sbjct: 170 ---TYTAHAGAKFPIKWTAP 186

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 21/140 (15%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 113
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+ 
Sbjct: 114 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 169
Query: 580 QSMTQTQTLGT---IGYMAP 596
              T T   G    I + AP
Sbjct: 170 ---TYTAHAGAKFPIKWTAP 186

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 455 RGGFALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 514
           +GG+    R  + F  E  +M    H N+I++    +N     ++ E+M +G+L+ +L  
Sbjct: 51  KGGYTE--RQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL 108
Query: 515 SNCILDIFQRLNIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           ++    + Q + ++  +AS + YL    Y    +H DL   N+L++ N+V  +SDF +++
Sbjct: 109 NDGQFTVIQLVGMLRGIASGMRYLAEMSY----VHRDLAARNILVNSNLVCKVSDFGLSR 164
Query: 574 LLTGEDQSMTQTQTLG---TIGYMAP 596
            L       T T +LG    I + AP
Sbjct: 165 FLEENSSDPTYTSSLGGKIPIRWTAP 190

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 21/140 (15%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N      Q +
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEV 110
Query: 526 NIMI------DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           N ++       ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+ 
Sbjct: 111 NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 166
Query: 580 QSMTQTQTLGT---IGYMAP 596
              T T   G    I + AP
Sbjct: 167 ---TYTAHAGAKFPIKWTAP 183

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 5/132 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N   +     
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 111
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L +   ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG D     
Sbjct: 112 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAH 167
Query: 585 TQTLGTIGYMAP 596
                 I + AP
Sbjct: 168 AGAKFPIKWTAP 179

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  +
Sbjct: 57  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 116
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L     +   +EYL    +   IH +L   N+L+++     + DF + K+L  +D+   
Sbjct: 117 LLQYTSQICKGMEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVLP-QDKEYY 172
Query: 584 QTQTLGT--IGYMAP 596
           + +  G   I + AP
Sbjct: 173 KVKEPGESPIFWYAP 187

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 66/122 (54%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   G+    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 151 GMLRGIASGMKYLSDMGF----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 585 TQ 586
           T+
Sbjct: 207 TR 208

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 18/148 (12%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS--------- 514
           A K F  E E++ +++H +++K    C + +   +V EYM HG L K+L +         
Sbjct: 60  ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 515 ------SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD 568
                 +   L + Q L+I   +AS + YL    S   +H DL   N L+  N++  + D
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGD 176
Query: 569 FSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           F +++ +   D       T+  I +M P
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPP 204

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 67/122 (54%), Gaps = 6/122 (4%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M    H N+I++    S  +   ++ EYM +G+L+K+L   +    + Q + ++  
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 531 VASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           +A+ ++YL +  Y    +H DL   N+L++ N+V  +SDF ++++L  +D   T T + G
Sbjct: 156 IAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGG 210
Query: 590 TI 591
            I
Sbjct: 211 KI 212

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V+EYM  G L  +L       L + Q 
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQL 116
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 171
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 172 RQGAKFPIKWTAP 184

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 11/135 (8%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N   +     
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L +   ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+    T 
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TY 166
Query: 585 TQTLGT---IGYMAP 596
           T   G    I + AP
Sbjct: 167 TAHAGAKFPIKWTAP 181

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/118 (36%), Positives = 61/118 (51%), Gaps = 9/118 (7%)
Query: 480 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 539
           H ++I +I S  +  F  LV + M  G L  YL +    L   +  +IM  +  A+ +LH
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTLGTIGYMAP 596
              +  ++H DLKP N+LLDDNM   LSDF  +  L  GE       +  GT GY+AP
Sbjct: 218 ---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLAP 268

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 11/135 (8%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N   +     
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L +   ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+    T 
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TY 166
Query: 585 TQTLGT---IGYMAP 596
           T   G    I + AP
Sbjct: 167 TAHAGAKFPIKWTAP 181

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 63/114 (55%), Gaps = 4/114 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N   +     
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 111
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 578
           L +   ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+
Sbjct: 112 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 11/135 (8%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N   +     
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 118
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L +   ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+TG+    T 
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TY 171
Query: 585 TQTLGT---IGYMAP 596
           T   G    I + AP
Sbjct: 172 TAHAGAKFPIKWTAP 186

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L       L + Q 
Sbjct: 225 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQL 283
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF + +L+  ED   T 
Sbjct: 284 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLI--EDNEYTA 338
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 339 RQGAKFPIKWTAP 351

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L       L + Q 
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQL 116
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL  +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLI--EDNEYTA 171
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 172 RQGAKFPIKWTAP 184

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N   ++    
Sbjct: 300 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 359
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L +   ++SA+EYL        IH +L   N L+ +N +  ++DF +++L+TG D     
Sbjct: 360 LYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH 415
Query: 585 TQTLGTIGYMAP 596
                 I + AP
Sbjct: 416 AGAKFPIKWTAP 427

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 455 RGGFALFIRAFKS-------FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 507
           RG + + I+  K        F  E ++M ++ H  L+++   C+ +    ++ EYM +G 
Sbjct: 46  RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105
Query: 508 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           L  YL          Q L +  DV  A+EYL    S   +H DL   N L++D  V  +S
Sbjct: 106 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVS 162
Query: 568 DFSIAKLLTGEDQS 581
           DF +++ +  ++++
Sbjct: 163 DFGLSRYVLDDEET 176

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQR 524
           ++F  E ++MK +RH  L+++ +  S E    +V EYM  G L  +L       L + Q 
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQL 116
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+  ED   T 
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 171
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 172 RQGAKFPIKWTAP 184

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 67/132 (50%), Gaps = 5/132 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQR 524
           + F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N   +     
Sbjct: 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 320
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L +   ++SA+EYL        IH +L   N L+ +N +  ++DF +++L+TG D     
Sbjct: 321 LYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH 376
Query: 585 TQTLGTIGYMAP 596
                 I + AP
Sbjct: 377 AGAKFPIKWTAP 388

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 73/140 (52%), Gaps = 13/140 (9%)
Query: 463 RAFKSFDV------ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN 516
           +  +S DV      E + +K  RH ++IK+    S      +V+EY+  G L  Y+    
Sbjct: 47  QKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG 106
Query: 517 CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
            + ++  R  +   + SA++Y H     +V+H DLKP NVLLD +M A ++DF ++ +++
Sbjct: 107 RVEEMEAR-RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162
Query: 577 GEDQSMTQTQTLGTIGYMAP 596
             D    +T + G+  Y AP
Sbjct: 163 --DGEFLRT-SCGSPNYAAP 179

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V E M +GSL+ +L   +    + Q +
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 121
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 122 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 585 TQ 586
           T+
Sbjct: 178 TR 179

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V E M +GSL+ +L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 150
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 585 TQ 586
           T+
Sbjct: 207 TR 208

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 66/145 (45%), Gaps = 15/145 (10%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------- 516
           A K F  E E++ +++H +++K    C   +   +V EYM HG L K+L +         
Sbjct: 58  ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 117
Query: 517 -----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI 571
                  L   Q L+I   +A+ + YL    S   +H DL   N L+ +N++  + DF +
Sbjct: 118 EGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGM 174
Query: 572 AKLLTGEDQSMTQTQTLGTIGYMAP 596
           ++ +   D       T+  I +M P
Sbjct: 175 SRDVYSTDYYRVGGHTMLPIRWMPP 199

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 470 VECEMMKSIRHRNLIKV------ISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDI 521
           +E ++MK + H N++        +   +  +   L +EY   G L KYL  + + C L  
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGE 578
                ++ D++SAL YLH      +IH DLKP N++L      ++  + D   AK L   
Sbjct: 121 GPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--- 174
Query: 579 DQSMTQTQTLGTIGYMAP 596
           DQ    T+ +GT+ Y+AP
Sbjct: 175 DQGELCTEFVGTLQYLAP 192

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 470 VECEMMKSIRHRNLIKV------ISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDI 521
           +E ++MK + H N++        +   +  +   L +EY   G L KYL  + + C L  
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 121
Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGE 578
                ++ D++SAL YLH      +IH DLKP N++L      ++  + D   AK L   
Sbjct: 122 GPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--- 175
Query: 579 DQSMTQTQTLGTIGYMAP 596
           DQ    T+ +GT+ Y+AP
Sbjct: 176 DQGELCTEFVGTLQYLAP 193

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 73/182 (40%), Gaps = 37/182 (20%)
Query: 446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRN 482
           E +   +IG GGF    RAF                       ++   E ++   ++H N
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           +I +   C  E    LV+E+   G L + L       DI   +N  + +A  + YLH   
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEA 125
Query: 543 SALVIHCDLKPSNVLLDD--------NMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
              +IH DLK SN+L+          N +  ++DF +A+    E    T+    G   +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWM 181
Query: 595 AP 596
           AP
Sbjct: 182 AP 183

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 66/126 (52%), Gaps = 6/126 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           ++F  E ++M+ + H N++K I     ++    + EY+  G+L   + S +      QR+
Sbjct: 52  RTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRV 111
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           +   D+AS + YLH   S  +IH DL   N L+ +N    ++DF +A+L+  E    TQ 
Sbjct: 112 SFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK---TQP 165
Query: 586 QTLGTI 591
           + L ++
Sbjct: 166 EGLRSL 171

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 455 RGGFALFIRAFKS-------FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 507
           RG + + I+  K        F  E ++M ++ H  L+++   C+ +    ++ EYM +G 
Sbjct: 46  RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105
Query: 508 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           L  YL          Q L +  DV  A+EYL    S   +H DL   N L++D  V  +S
Sbjct: 106 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVS 162
Query: 568 DFSIAKLLTGED 579
           DF +++ +  ++
Sbjct: 163 DFGLSRYVLDDE 174

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 435 FSYLELCRATDEFSENNLIGRGGFALFIRAFK---------SFDVECEMMKSIRHRNLIK 485
           F  +ELCR   E          G  + +++ K             E E+++++ H N++K
Sbjct: 34  FGKVELCRYDPEGDNT------GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 486 VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 543
               C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL    S
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---S 144
Query: 544 ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
              +H DL   NVL++      + DF + K +  + +  T
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 184

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 455 RGGFALFIRAFKS-------FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 507
           RG + + I+  K        F  E ++M ++ H  L+++   C+ +    ++ EYM +G 
Sbjct: 37  RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 96
Query: 508 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           L  YL          Q L +  DV  A+EYL    S   +H DL   N L++D  V  +S
Sbjct: 97  LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVS 153
Query: 568 DFSIAKLLTGED 579
           DF +++ +  ++
Sbjct: 154 DFGLSRYVLDDE 165

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 455 RGGFALFIRAFKS-------FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 507
           RG + + I+  K        F  E ++M ++ H  L+++   C+ +    ++ EYM +G 
Sbjct: 31  RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 90
Query: 508 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           L  YL          Q L +  DV  A+EYL    S   +H DL   N L++D  V  +S
Sbjct: 91  LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVS 147
Query: 568 DFSIAKLLTGED 579
           DF +++ +  ++
Sbjct: 148 DFGLSRYVLDDE 159

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 455 RGGFALFIRAFKS-------FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 507
           RG + + I+  K        F  E ++M ++ H  L+++   C+ +    ++ EYM +G 
Sbjct: 31  RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 90
Query: 508 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           L  YL          Q L +  DV  A+EYL    S   +H DL   N L++D  V  +S
Sbjct: 91  LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVS 147
Query: 568 DFSIAKLLTGED 579
           DF +++ +  ++
Sbjct: 148 DFGLSRYVLDDE 159

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 25/170 (14%)
Query: 446 EFSENNLIGRGGFALFIRA-----------------FKSFDVECEMMKSIRHRNLIKVIS 488
           E     ++GRG F +  +A                  K+F VE   +  + H N++K+  
Sbjct: 10  EIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG 69
Query: 489 SCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGYSALV 546
           +C N     LV+EY   GSL   L+ +  +        ++  +  +  + YLH      +
Sbjct: 70  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 547 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           IH DLKP N+LL    VA  +   I    T  D     T   G+  +MAP
Sbjct: 128 IHRDLKPPNLLL----VAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAP 173

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 66/122 (54%), Gaps = 5/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I +    +  +   +V EYM +GSL+ +L  ++    + Q +
Sbjct: 68  RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLV 127
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +++ ++YL   GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   
Sbjct: 128 GMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 183
Query: 585 TQ 586
           T+
Sbjct: 184 TR 185

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 25/170 (14%)
Query: 446 EFSENNLIGRGGFALFIRA-----------------FKSFDVECEMMKSIRHRNLIKVIS 488
           E     ++GRG F +  +A                  K+F VE   +  + H N++K+  
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 489 SCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGYSALV 546
           +C N     LV+EY   GSL   L+ +  +        ++  +  +  + YLH      +
Sbjct: 69  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 547 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           IH DLKP N+LL    VA  +   I    T  D     T   G+  +MAP
Sbjct: 127 IHRDLKPPNLLL----VAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAP 172

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 69/134 (51%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L++S    ++ 
Sbjct: 50  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMK 108
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L ++    + DF +A + +    S 
Sbjct: 109 KLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSH 165
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 166 QFEQLSGSILWMAP 179

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 435 FSYLELCRATDEFSENNLIGRGGFALFIRAFK---------SFDVECEMMKSIRHRNLIK 485
           F  +ELCR   E          G  + +++ K             E E+++++ H N++K
Sbjct: 22  FGKVELCRYDPEGDNT------GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 486 VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 543
               C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL    S
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---S 132
Query: 544 ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
              +H DL   NVL++      + DF + K +  + +  T
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 172

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFK-ALVLEYMPHGSLEKYLYS-SNCILDIFQ 523
           ++F  E  +M  +RH NL++++     E+    +V EYM  GSL  YL S    +L    
Sbjct: 50  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 109
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L   +DV  A+EYL        +H DL   NVL+ ++ VA +SDF + K     + S T
Sbjct: 110 LLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 161
Query: 584 QTQTLGTIGYMAP 596
           Q      + + AP
Sbjct: 162 QDTGKLPVKWTAP 174

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 72/140 (51%), Gaps = 13/140 (9%)
Query: 463 RAFKSFDV------ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN 516
           +  +S DV      E + +K  RH ++IK+    S      +V+EY+  G L  Y+    
Sbjct: 47  QKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG 106
Query: 517 CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
            + ++  R  +   + SA++Y H     +V+H DLKP NVLLD +M A ++DF ++ +++
Sbjct: 107 RVEEMEAR-RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162
Query: 577 GEDQSMTQTQTLGTIGYMAP 596
             D    +  + G+  Y AP
Sbjct: 163 --DGEFLR-DSCGSPNYAAP 179

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 455 RGGFALFIRAFKS-------FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 507
           RG + + I+  K        F  E ++M ++ H  L+++   C+ +    ++ EYM +G 
Sbjct: 30  RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 89
Query: 508 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           L  YL          Q L +  DV  A+EYL    S   +H DL   N L++D  V  +S
Sbjct: 90  LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVS 146
Query: 568 DFSIAKLLTGED 579
           DF +++ +  ++
Sbjct: 147 DFGLSRYVLDDE 158

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 66/134 (49%), Gaps = 6/134 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I +    +      ++ E+M +GSL+ +L  ++    + Q +
Sbjct: 79  RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV 138
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            ++  +A+ ++YL        +H DL   N+L++ N+V  +SDF +++ L  +    T T
Sbjct: 139 GMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 195
Query: 586 QTLG---TIGYMAP 596
             LG    I + AP
Sbjct: 196 SALGGKIPIRWTAP 209

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 455 RGGFALFIRAFKS-------FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 507
           RG + + I+  K        F  E ++M ++ H  L+++   C+ +    ++ EYM +G 
Sbjct: 26  RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85
Query: 508 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           L  YL          Q L +  DV  A+EYL    S   +H DL   N L++D  V  +S
Sbjct: 86  LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVS 142
Query: 568 DFSIAKLLTGED 579
           DF +++ +  ++
Sbjct: 143 DFGLSRYVLDDE 154

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFK-ALVLEYMPHGSLEKYLYS-SNCILDIFQ 523
           ++F  E  +M  +RH NL++++     E+    +V EYM  GSL  YL S    +L    
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L   +DV  A+EYL        +H DL   NVL+ ++ VA +SDF + K     + S T
Sbjct: 119 LLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 170
Query: 584 QTQTLGTIGYMAP 596
           Q      + + AP
Sbjct: 171 QDTGKLPVKWTAP 183

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 62  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 120
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 121 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 175
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 176 EGAKFPIKWTAP 187

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/121 (24%), Positives = 63/121 (52%), Gaps = 3/121 (2%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V E M +GSL+ +L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 150
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            ++  +AS ++YL        +H DL   N+L++ N+V  +SDF ++++L  + ++   T
Sbjct: 151 GMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 586 Q 586
           +
Sbjct: 208 R 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 63  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 121
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 122 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 176
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 177 EGAKFPIKWTAP 188

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 118
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 119 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 173
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 174 EGAKFPIKWTAP 185

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 112
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 113 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 167
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 168 EGAKFPIKWTAP 179

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 56  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 114
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 115 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 169
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 170 EGAKFPIKWTAP 181

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 112
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 113 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 167
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 168 EGAKFPIKWTAP 179

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 13/140 (9%)
Query: 463 RAFKSFDV------ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN 516
           +  +S DV      E + +K  RH ++IK+    S      +V+EY+  G L  Y+   N
Sbjct: 52  QKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKN 110
Query: 517 CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
             LD  +   +   + S ++Y H     +V+H DLKP NVLLD +M A ++DF ++ +++
Sbjct: 111 GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167
Query: 577 GEDQSMTQTQTLGTIGYMAP 596
             D    +  + G+  Y AP
Sbjct: 168 --DGEFLRX-SCGSPNYAAP 184

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 55  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 113
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 114 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 168
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 169 EGAKFPIKWTAP 180

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 112
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 113 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDAEXTAR 167
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 168 EGAKFPIKWTAP 179

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFK-ALVLEYMPHGSLEKYLYS-SNCILDIFQ 523
           ++F  E  +M  +RH NL++++     E+    +V EYM  GSL  YL S    +L    
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 103
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L   +DV  A+EYL        +H DL   NVL+ ++ VA +SDF + K     + S T
Sbjct: 104 LLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 155
Query: 584 QTQTLGTIGYMAP 596
           Q      + + AP
Sbjct: 156 QDTGKLPVKWTAP 168

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 112
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 113 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAR 167
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 168 EGAKFPIKWTAP 179

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 118
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 119 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAR 173
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 174 EGAKFPIKWTAP 185

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 59  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 117
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 118 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAR 172
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 173 EGAKFPIKWTAP 184

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 64  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 122
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 123 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAR 177
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 178 EGAKFPIKWTAP 189

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 68/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L+      ++ 
Sbjct: 51  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI 109
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L +++   + DF +A + +    S 
Sbjct: 110 KLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 166
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 167 QFEQLSGSILWMAP 180

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFK-ALVLEYMPHGSLEKYLYS-SNCILDIFQ 523
           ++F  E  +M  +RH NL++++     E+    +V EYM  GSL  YL S    +L    
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 290
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L   +DV  A+EYL        +H DL   NVL+ ++ VA +SDF + K     + S T
Sbjct: 291 LLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 342
Query: 584 QTQTLGTIGYMAP 596
           Q      + + AP
Sbjct: 343 QDTGKLPVKWTAP 355

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 4/129 (3%)
Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E + M  + H  L+K    CS E    +V EY+ +G L  YL S    L+  Q L +
Sbjct: 50  FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109
Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
             DV   + +L    S   IH DL   N L+D ++   +SDF + + +  +DQ ++   T
Sbjct: 110 CYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGT 165
Query: 588 LGTIGYMAP 596
              + + AP
Sbjct: 166 KFPVKWSAP 174

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 60/110 (54%), Gaps = 7/110 (6%)
Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           +  E E+++++ H +++K    C ++  K+  LV+EY+P GSL  YL   +C+  + Q L
Sbjct: 57  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLL 114
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
                +   + YLH   +   IH  L   NVLLD++ +  + DF +AK +
Sbjct: 115 LFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAV 161

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 68/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L+      ++ 
Sbjct: 46  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L +++   + DF +A + +    S 
Sbjct: 105 KLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 162 QFEQLSGSILWMAP 175

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 60/110 (54%), Gaps = 7/110 (6%)
Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           +  E E+++++ H +++K    C ++  K+  LV+EY+P GSL  YL   +C+  + Q L
Sbjct: 58  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLL 115
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
                +   + YLH   +   IH  L   NVLLD++ +  + DF +AK +
Sbjct: 116 LFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAV 162

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 68/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L+      ++ 
Sbjct: 74  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI 132
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L +++   + DF +A + +    S 
Sbjct: 133 KLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 189
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 190 QFEQLSGSILWMAP 203

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 66/127 (51%), Gaps = 6/127 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N++ +    +  +   +V+E+M +G+L+ +L   +    + Q +
Sbjct: 89  RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLV 148
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +A+ + YL   GY    +H DL   N+L++ N+V  +SDF +++++  +D     
Sbjct: 149 GMLRGIAAGMRYLADMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVY 203
Query: 585 TQTLGTI 591
           T T G I
Sbjct: 204 TTTGGKI 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 49  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 107
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 108 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAR 162
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 163 EGAKFPIKWTAP 174

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 68/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L++S    ++ 
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMK 120
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L ++    + DF +A   +    S 
Sbjct: 121 KLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 178 QFEQLSGSILWMAP 191

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 23/150 (15%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------- 516
           A + F  E E++  ++H+++++    C+      +V EYM HG L ++L S         
Sbjct: 86  ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA 145
Query: 517 -------CILDIFQRLNIMIDVASALEY---LHFGYSALVIHCDLKPSNVLLDDNMVAHL 566
                    L + Q L +   VA+ + Y   LHF      +H DL   N L+   +V  +
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKI 199
Query: 567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            DF +++ +   D      +T+  I +M P
Sbjct: 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 229

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 68/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L+      ++ 
Sbjct: 51  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI 109
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L +++   + DF +A + +    S 
Sbjct: 110 KLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 166
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 167 QFEQLSGSILWMAP 180

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 68/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L+      ++ 
Sbjct: 48  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI 106
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L +++   + DF +A + +    S 
Sbjct: 107 KLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 163
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 164 QFEQLSGSILWMAP 177

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILD 520
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL         YS N   +
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 521 IFQRL------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
             ++L      +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAP 262

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 68/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L+      ++ 
Sbjct: 73  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI 131
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L +++   + DF +A + +    S 
Sbjct: 132 KLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 188
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 189 QFEQLSGSILWMAP 202

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 22/146 (15%)
Query: 466 KSFDVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI------ 518
           + F  E E++  + H  N+I ++ +C +  +  L +EY PHG+L  +L  S  +      
Sbjct: 70  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 129
Query: 519 ---------LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF 569
                    L   Q L+   DVA  ++YL        IH DL   N+L+ +N VA ++DF
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF 186
Query: 570 SIAKLLTGEDQSMTQTQTLGTIGYMA 595
            +++   G++  + +T     + +MA
Sbjct: 187 GLSR---GQEVYVKKTMGRLPVRWMA 209

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 22/146 (15%)
Query: 466 KSFDVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI------ 518
           + F  E E++  + H  N+I ++ +C +  +  L +EY PHG+L  +L  S  +      
Sbjct: 60  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 119
Query: 519 ---------LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF 569
                    L   Q L+   DVA  ++YL        IH DL   N+L+ +N VA ++DF
Sbjct: 120 AIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF 176
Query: 570 SIAKLLTGEDQSMTQTQTLGTIGYMA 595
            +++   G++  + +T     + +MA
Sbjct: 177 GLSR---GQEVYVKKTMGRLPVRWMA 199

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 36/165 (21%)
Query: 442 RATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRH--------------------- 480
           R   +F E  ++G+G F   ++A  + D     +K IRH                     
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 481 ------------RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
                       RN +K +++   +    + +EY  +G+L   ++S N      +   + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
             +  AL Y+H   S  +IH DLKP N+ +D++    + DF +AK
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 68/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L+      ++ 
Sbjct: 46  QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L +++   + DF +A + +    S 
Sbjct: 105 KLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 162 QFEQLSGSILWMAP 175

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRV 149
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 207 INNIDXXKKTTNGRLPVKWMAP 228

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 207 INNIDXXKKTTNGRLPVKWMAP 228

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 23/150 (15%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------- 516
           A + F  E E++  ++H+++++    C+      +V EYM HG L ++L S         
Sbjct: 57  ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA 116
Query: 517 -------CILDIFQRLNIMIDVASALEY---LHFGYSALVIHCDLKPSNVLLDDNMVAHL 566
                    L + Q L +   VA+ + Y   LHF      +H DL   N L+   +V  +
Sbjct: 117 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKI 170
Query: 567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            DF +++ +   D      +T+  I +M P
Sbjct: 171 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 200

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILD 520
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL         YS N   +
Sbjct: 75  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 134
Query: 521 IFQRL------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
             ++L      +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 191
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 192 IHHIDYYKKTTNGRLPVKWMAP 213

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 59/107 (55%), Gaps = 7/107 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
           E ++++++ H ++IK    C ++  K+L  V+EY+P GSL  YL   +  + + Q L   
Sbjct: 66  EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFA 123
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
             +   + YLH   S   IH +L   NVLLD++ +  + DF +AK +
Sbjct: 124 QQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARD 206
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAP 228

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILD 520
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL         YS N   +
Sbjct: 72  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 131
Query: 521 IFQRL------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
             ++L      +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 188
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 189 IHHIDYYKKTTNGRLPVKWMAP 210

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 68/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L++S    ++ 
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMK 120
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L ++    + DF +A   +    S 
Sbjct: 121 KLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 178 QFEQLSGSILWMAP 191

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 23/150 (15%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS--------- 514
           A + F  E E++  ++H+++++    C+      +V EYM HG L ++L S         
Sbjct: 63  ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA 122
Query: 515 -----SNCILDIFQRLNIMIDVASALEY---LHFGYSALVIHCDLKPSNVLLDDNMVAHL 566
                +   L + Q L +   VA+ + Y   LHF      +H DL   N L+   +V  +
Sbjct: 123 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKI 176
Query: 567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            DF +++ +   D      +T+  I +M P
Sbjct: 177 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 206

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILD 520
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL         YS N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 142
Query: 521 IFQRL------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
             ++L      +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAP 221

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILD 520
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL         YS N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHN 142
Query: 521 IFQRL------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
             ++L      +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAP 221

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 79  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 138
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 139 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 195
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 196 INNIDYYKKTTNGRLPVKWMAP 217

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 69/133 (51%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 524
           +SF  E ++MK ++H  L+++ +  S E    +V EYM  GSL  +L       L +   
Sbjct: 49  ESFLEEAQIMKKLKHDKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNL 107
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +++   VA+ + Y+        IH DL+ +N+L+ + ++  ++DF +A+L+  ED   T 
Sbjct: 108 VDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARLI--EDNEXTA 162
Query: 585 TQTLG-TIGYMAP 596
            Q     I + AP
Sbjct: 163 RQGAKFPIKWTAP 175

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILD 520
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL         YS N   +
Sbjct: 76  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 135
Query: 521 IFQRL------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
             ++L      +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 192
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 193 IHHIDYYKKTTNGRLPVKWMAP 214

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 63/121 (52%), Gaps = 3/121 (2%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I +    +  +   ++ EYM +GSL+ +L  ++    + Q +
Sbjct: 75  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV 134
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            ++  + S ++YL        +H DL   N+L++ N+V  +SDF ++++L  + ++   T
Sbjct: 135 GMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT 191
Query: 586 Q 586
           +
Sbjct: 192 R 192

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 63/123 (51%), Gaps = 6/123 (4%)
Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           ++K+++H  L+ +  S    +    VL+Y+  G L  +L    C L+   R     ++AS
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIAS 150
Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
           AL YLH   S  +++ DLKP N+LLD      L+DF + K     + + T +   GT  Y
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEY 205
Query: 594 MAP 596
           +AP
Sbjct: 206 LAP 208

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 207 INNIDYYKNTTNGRLPVKWMAP 228

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 90  EMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAP 228

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 90  EMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAP 228

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 82  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 141
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 142 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 198
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 199 INNIDYYKKTTNGRLPVKWMAP 220

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAP 228

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK + H N++K+      E+   LV+EY   G +  YL +   + +   R      
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-Q 122
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
           + SA++Y H  Y   ++H DLK  N+LLD +M   ++DF  +   T
Sbjct: 123 IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFT 165

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAP 274

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 67/126 (53%), Gaps = 6/126 (4%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++++ + H N+I ++ +  ++   +LV ++M    LE  +  ++ +L        M+ 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
               LEYLH  +   ++H DLKP+N+LLD+N V  L+DF +AK     +++      + T
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVT 175
Query: 591 IGYMAP 596
             Y AP
Sbjct: 176 RWYRAP 181

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 67/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L+      ++ 
Sbjct: 46  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L +++   + DF +A   +    S 
Sbjct: 105 KLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH 161
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 162 QFEQLSGSILWMAP 175

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL           Y  N +
Sbjct: 77  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 136
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 137 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARD 193
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 194 INNIDYYKKTTNGRLPVKWMAP 215

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   + H N++++ +   +     L+LEY P G L K L  S C  D  +   IM +
Sbjct: 73  EIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEE 131
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A AL Y H      VIH D+KP N+LL       ++DF      +    S+ +    GT
Sbjct: 132 LADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGT 184
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 185 LDYLPP 190

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 67/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L+      ++ 
Sbjct: 66  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI 124
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L +++   + DF +A   +    S 
Sbjct: 125 KLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH 181
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 182 QFEQLSGSILWMAP 195

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 67/134 (50%), Gaps = 4/134 (2%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L+      ++ 
Sbjct: 74  QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI 132
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L +++   + DF +A   +    S 
Sbjct: 133 KLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH 189
Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 190 QFEQLSGSILWMAP 203

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A   F  E  +M S+ H +L++++  C +   + LV + MPHG L +Y++     +   
Sbjct: 82  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQ 140
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +A+LL G+++  
Sbjct: 141 LLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 197
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 198 NADGGKMPIKWMA 210

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK + H N++K+      E+   LV+EY   G +  YL +   + +   R      
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-Q 114
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
           + SA++Y H      ++H DLK  N+LLD +M   ++DF  +   T
Sbjct: 115 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 157

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRL 525
           +F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L
Sbjct: 50  AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 108
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           ++   +A  + ++        IH +L+ +N+L+ D +   ++DF +A+L+  ED   T  
Sbjct: 109 DMAAQIAEGMAFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLI--EDNEYTAR 163
Query: 586 QTLG-TIGYMAP 596
           +     I + AP
Sbjct: 164 EGAKFPIKWTAP 175

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 71/135 (52%), Gaps = 7/135 (5%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + ++F  E  +MK+++H  L+++ +  + EE   ++ EYM  GSL  +L S      +  
Sbjct: 51  SVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP 110
Query: 524 RL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           +L +    +A  + Y+        IH DL+ +NVL+ ++++  ++DF +A+++  ED   
Sbjct: 111 KLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI--EDNEY 165
Query: 583 TQTQTLG-TIGYMAP 596
           T  +     I + AP
Sbjct: 166 TAREGAKFPIKWTAP 180

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYS-SNCIL 519
           R  + F+ EC  ++   H N++ V+ +C +       L+  +MP+GSL   L+  +N ++
Sbjct: 49  RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV 108
Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           D  Q +   +D+A  + +LH     L+    L   +V++D++M A +S
Sbjct: 109 DQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARIS 155

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 7/107 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
           E ++++++ H ++IK    C +    +L  V+EY+P GSL  YL   +  + + Q L   
Sbjct: 83  EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFA 140
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
             +   + YLH   +   IH DL   NVLLD++ +  + DF +AK +
Sbjct: 141 QQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 43/188 (22%)
Query: 443 ATDEFSENNLIGRGGFAL----------------------------FIRAFKSFDVECEM 474
           A +E      IG+GGF L                             I  F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 475 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 534
           M ++ H N++K+     N     +V+E++P G L   L      +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 535 LEYLHFGYSALVIHCDLKPSNVL---LDDN--MVAHLSDFSIAKLLTGEDQSM-TQTQTL 588
           +EY+    +  ++H DL+  N+    LD+N  + A ++DFS+++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLL 187
Query: 589 GTIGYMAP 596
           G   +MAP
Sbjct: 188 GNFQWMAP 195

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 7/107 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
           E ++++++ H ++IK    C ++  K+L  V+EY+P GSL  YL   +  + + Q L   
Sbjct: 66  EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFA 123
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 575
             +   + YLH   +   IH +L   NVLLD++ +  + DF +AK +
Sbjct: 124 QQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 63/121 (52%), Gaps = 3/121 (2%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I +    +  +   ++ EYM +GSL+ +L  ++    + Q +
Sbjct: 54  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV 113
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            ++  + S ++YL        +H DL   N+L++ N+V  +SDF ++++L  + ++   T
Sbjct: 114 GMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT 170
Query: 586 Q 586
           +
Sbjct: 171 R 171

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 65/137 (47%), Gaps = 12/137 (8%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC---ILDIF 522
           +  + E E++KS+ H N+IK+     +     +V+E    G L + + S+      L   
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGED 579
               +M  + +AL Y H   S  V+H DLKP N+L  D   +    + DF +A+L   ++
Sbjct: 125 YVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181
Query: 580 QSMTQTQTLGTIGYMAP 596
            S   T   GT  YMAP
Sbjct: 182 HS---TNAAGTALYMAP 195

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK + H N++K+      E+   LV+EY   G +  YL +   + +   R      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-Q 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
           + SA++Y H      ++H DLK  N+LLD +M   ++DF  +   T
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 8/129 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 529
           E  + K ++H+N+++ + S S   F  + +E +P GSL   L S    + D  Q +    
Sbjct: 55  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 114
Query: 530 -DVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQT 587
             +   L+YLH      ++H D+K  NVL++  + V  +SDF  +K L G +   T+T T
Sbjct: 115 KQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT 170
Query: 588 LGTIGYMAP 596
            GT+ YMAP
Sbjct: 171 -GTLQYMAP 178

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 63/121 (52%), Gaps = 3/121 (2%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I +    +  +   ++ EYM +GSL+ +L  ++    + Q +
Sbjct: 60  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV 119
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            ++  + S ++YL        +H DL   N+L++ N+V  +SDF ++++L  + ++   T
Sbjct: 120 GMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT 176
Query: 586 Q 586
           +
Sbjct: 177 R 177

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK + H N++K+      E+   LV+EY   G +  YL +   + +   R      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-Q 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
           + SA++Y H      ++H DLK  N+LLD +M   ++DF  +   T
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK + H N++K+      E+   LV+EY   G +  YL +   + +   R      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-Q 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
           + SA++Y H      ++H DLK  N+LLD +M   ++DF  +   T
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK + H N++K+      E+   LV+EY   G +  YL +   + +   R      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-Q 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
           + SA++Y H      ++H DLK  N+LLD +M   ++DF  +   T
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK + H N++K+      E+   LV+EY   G +  YL +   + +   R      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-Q 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
           + SA++Y H      ++H DLK  N+LLD +M   ++DF  +   T
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I +    +      ++ E+M +GSL+ +L  ++    + Q +
Sbjct: 53  RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV 112
Query: 526 NIMIDVASALEYL-HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            ++  +A+ ++YL    Y    +H  L   N+L++ N+V  +SDF +++ L  +    T 
Sbjct: 113 GMLRGIAAGMKYLADMNY----VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 168
Query: 585 TQTLG---TIGYMAP 596
           T  LG    I + AP
Sbjct: 169 TSALGGKIPIRWTAP 183

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 22/146 (15%)
Query: 466 KSFDVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI------ 518
           + F  E E++  + H  N+I ++ +C +  +  L +EY PHG+L  +L  S  +      
Sbjct: 67  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 126
Query: 519 ---------LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF 569
                    L   Q L+   DVA  ++YL        IH +L   N+L+ +N VA ++DF
Sbjct: 127 AIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADF 183
Query: 570 SIAKLLTGEDQSMTQTQTLGTIGYMA 595
            +++   G++  + +T     + +MA
Sbjct: 184 GLSR---GQEVYVKKTMGRLPVRWMA 206

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILD 520
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL         +S N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHN 142
Query: 521 IFQRL------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
             ++L      +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 200 IHHIDXXKKTTNGRLPVKWMAP 221

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A   F  E  +M S+ H +L++++  C +   + LV + MPHG L +Y++     +   
Sbjct: 59  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQ 117
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +A+LL G+++  
Sbjct: 118 LLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 174
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 175 NADGGKMPIKWMA 187

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 8/129 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 529
           E  + K ++H+N+++ + S S   F  + +E +P GSL   L S    + D  Q +    
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 530 -DVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQT 587
             +   L+YLH      ++H D+K  NVL++  + V  +SDF  +K L G +   T+T T
Sbjct: 129 KQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT 184
Query: 588 LGTIGYMAP 596
            GT+ YMAP
Sbjct: 185 -GTLQYMAP 192

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 78/187 (41%), Gaps = 41/187 (21%)
Query: 443 ATDEFSENNLIGRGGFAL----------------------------FIRAFKSFDVECEM 474
           A +E      IG+GGF L                             I  F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 475 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 534
           M ++ H N++K+     N     +V+E++P G L   L      +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 535 LEYLHFGYSALVIHCDLKPSNVL---LDDN--MVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           +EY+    +  ++H DL+  N+    LD+N  + A ++DF      T +    + +  LG
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-----TSQQSVHSVSGLLG 188
Query: 590 TIGYMAP 596
              +MAP
Sbjct: 189 NFQWMAP 195

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITE 120
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL  N    ++DF      +    S  +T   GT
Sbjct: 121 LANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGT 173
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 174 LDYLPP 179

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 54/107 (50%), Gaps = 3/107 (2%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 526
            F  E  ++K   H N++++I  C+ ++   +V+E +  G    +L +    L +   L 
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQ 217
Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           ++ D A+ +EYL    S   IH DL   N L+ +  V  +SDF +++
Sbjct: 218 MVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 54/107 (50%), Gaps = 3/107 (2%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 526
            F  E  ++K   H N++++I  C+ ++   +V+E +  G    +L +    L +   L 
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQ 217
Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           ++ D A+ +EYL    S   IH DL   N L+ +  V  +SDF +++
Sbjct: 218 MVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 61/127 (48%), Gaps = 8/127 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY-LYSSNCILDIFQRLNIMI 529
           E +++K +RH NL+ ++  C  ++   LV E++ H  L+   L+ +     + Q+    I
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI 133
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
                +  + F +S  +IH D+KP N+L+  + V  L DF  A+ L    +       + 
Sbjct: 134 -----INGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVA 186
Query: 590 TIGYMAP 596
           T  Y AP
Sbjct: 187 TRWYRAP 193

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILD 520
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL         Y  N   +
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 127
Query: 521 IFQRL------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
             ++L      +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAP 206

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 66/122 (54%), Gaps = 6/122 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           ++F  E  +MK+++H  L+++ +  + EE   ++ E+M  GSL  +L S      +  +L
Sbjct: 52  QAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKL 111
Query: 526 -NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            +    +A  + Y+        IH DL+ +NVL+ ++++  ++DF +A+++  ED   T 
Sbjct: 112 IDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTA 166
Query: 585 TQ 586
            +
Sbjct: 167 RE 168

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILD 520
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL         Y  N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 142
Query: 521 IFQRL------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
             ++L      +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAP 221

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 43/188 (22%)
Query: 443 ATDEFSENNLIGRGGFAL----------------------------FIRAFKSFDVECEM 474
           A +E      IG+GGF L                             I  F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 475 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 534
           M ++ H N++K+     N     +V+E++P G L   L      +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 535 LEYLHFGYSALVIHCDLKPSNVL---LDDN--MVAHLSDFSIAKLLTGEDQSM-TQTQTL 588
           +EY+    +  ++H DL+  N+    LD+N  + A ++DF +++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLL 187
Query: 589 GTIGYMAP 596
           G   +MAP
Sbjct: 188 GNFQWMAP 195

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/165 (22%), Positives = 67/165 (40%), Gaps = 36/165 (21%)
Query: 442 RATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRH--------------------- 480
           R   +F E  ++G+G F   ++A  + D     +K IRH                     
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 481 ------------RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
                       RN +K +++   +    + +EY  + +L   ++S N      +   + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
             +  AL Y+H   S  +IH DLKP N+ +D++    + DF +AK
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++ Y   G+L +YL           Y  N +
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAP 228

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 14/130 (10%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR---LNI 527
           E  M+K ++H NL+ ++     +    LV EY  H  L +        LD +QR    ++
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHL 103
Query: 528 MIDVA-SALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           +  +    L+ ++F +    IH D+KP N+L+  + V  L DF  A+LLTG   S     
Sbjct: 104 VKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDD 161
Query: 587 TLGTIGYMAP 596
            + T  Y +P
Sbjct: 162 EVATRWYRSP 171

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 51/111 (45%), Gaps = 14/111 (12%)
Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------GYSALVIHCDL 551
           LV+EY P+GSL KYL  S    D      +   V   L YLH        Y   + H DL
Sbjct: 89  LVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDL 146
Query: 552 KPSNVLLDDNMVAHLSDFSIAKLLTGE------DQSMTQTQTLGTIGYMAP 596
              NVL+ ++    +SDF ++  LTG       ++       +GTI YMAP
Sbjct: 147 NSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP 197

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G + K L       D  +    + +
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITE 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 122 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 174
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 175 LDYLPP 180

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 19/142 (13%)
Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 518
           E EMMK I +H+N+I ++ +C+ +    +++ Y   G+L +YL           Y  N +
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 519 LD---IFQRL-NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            +    F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +   D     T     + +MAP
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAP 228

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 116
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T+  GT
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGT 169
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 170 LDYLPP 175

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 35/175 (20%)
Query: 447 FSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNL-------------IKVISSCSNE 493
           F++   IG+G F      FK  D   + + +I+  +L             I V+S C + 
Sbjct: 25  FTKLERIGKGSFG---EVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSS 81
Query: 494 EFKA------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 541
                           +++EY+  GS    L +     D FQ   ++ ++   L+YLH  
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH-- 137
Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            S   IH D+K +NVLL +     L+DF +A  LT  D  + +   +GT  +MAP
Sbjct: 138 -SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 189

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 64/126 (50%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E   +K +RH ++IK+    +      +V+EY   G L  Y+     + +   R      
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQ 116
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +  A+EY H      ++H DLKP N+LLDDN+   ++DF ++ ++T  D +  +T + G+
Sbjct: 117 IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGS 170
Query: 591 IGYMAP 596
             Y AP
Sbjct: 171 PNYAAP 176

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK + H N++K+      E+   L++EY   G +  YL +   + +   R      
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-Q 119
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
           + SA++Y H      ++H DLK  N+LLD +M   ++DF  +   T
Sbjct: 120 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 162

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++ +   + +   L+LE+ P G L K L   +   D  +    M +
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEE 123
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A AL Y H      VIH D+KP N+L+       ++DF      +    S+ +    GT
Sbjct: 124 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGT 176
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 177 LDYLPP 182

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 12/129 (9%)
Query: 471 ECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR--LNI 527
           E ++++ +  H N+I++  +     F  LV + M  G L  YL     + +   R  +  
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
           +++V  AL  L+      ++H DLKP N+LLDD+M   L+DF  +  L   D      + 
Sbjct: 120 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREV 170
Query: 588 LGTIGYMAP 596
            GT  Y+AP
Sbjct: 171 CGTPSYLAP 179

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK + H N++K+      E+   L++EY   G +  YL +   + +   R      
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-Q 122
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
           + SA++Y H      ++H DLK  N+LLD +M   ++DF  +   T
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++ +   + +   L+LE+ P G L K L   +   D  +    M +
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEE 122
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A AL Y H      VIH D+KP N+L+       ++DF      +    S+ +    GT
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGT 175
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 176 LDYLPP 181

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 12/129 (9%)
Query: 471 ECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR--LNI 527
           E ++++ +  H N+I++  +     F  LV + M  G L  YL     + +   R  +  
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
           +++V  AL  L+      ++H DLKP N+LLDD+M   L+DF  +  L   D      + 
Sbjct: 133 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREV 183
Query: 588 LGTIGYMAP 596
            GT  Y+AP
Sbjct: 184 CGTPSYLAP 192

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITE 120
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL  N    ++DF      +    S  +    GT
Sbjct: 121 LANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGT 173
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 174 LDYLPP 179

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 116
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGT 169
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 170 LDYLPP 175

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 120
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 121 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 173
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 174 LDYLPP 179

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 116
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGT 169
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 170 LDYLPP 175

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 51/198 (25%)
Query: 435 FSYLELC-RATDEFSENNLIGRGGFALFIRAFKS-----------------------FDV 470
           F  +  C R TD++     +G+G F++  R  K                         + 
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDI 521
           E  + + ++H N++++  S S E F  LV + +  G L      +  YS    S+CI  I
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI 139
Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGE 578
            + +N +             +   ++H DLKP N+LL          L+DF +A  + GE
Sbjct: 140 LESVNHI-------------HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 186
Query: 579 DQSMTQTQTLGTIGYMAP 596
            Q+       GT GY++P
Sbjct: 187 QQAW--FGFAGTPGYLSP 202

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 115
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 116 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 168
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 169 LDYLPP 174

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L   +   D  +    + +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITE 116
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 169
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 170 LDYLPP 175

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 117
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGT 170
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 171 LDYLPP 176

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 122 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 174
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 175 LDYLPP 180

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 122 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGT 174
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 175 LDYLPP 180

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 64/128 (50%), Gaps = 9/128 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCS--NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
           E  ++K + H N++K++      NE+   +V E +  G + +         D  Q     
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--QARFYF 143
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
            D+   +EYLH+     +IH D+KPSN+L+ ++    ++DF ++    G D  +  + T+
Sbjct: 144 QDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTV 198
Query: 589 GTIGYMAP 596
           GT  +MAP
Sbjct: 199 GTPAFMAP 206

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 65/147 (44%), Gaps = 20/147 (13%)
Query: 462 IRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE--------FK----ALVLEYMPHGSLE 509
           I A K   VE ++ + I+    I ++  C +          FK     +V+EY   GS+ 
Sbjct: 56  IVAIKQVPVESDLQEIIKE---ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112
Query: 510 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF 569
             +   N  L   +   I+      LEYLHF      IH D+K  N+LL+    A L+DF
Sbjct: 113 DIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADF 169
Query: 570 SIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            +A  LT  D    +   +GT  +MAP
Sbjct: 170 GVAGQLT--DXMAKRNXVIGTPFWMAP 194

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L   +   D  +    + +
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITE 142
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 143 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 195
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 196 LDYLPP 201

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 113
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 114 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 166
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 167 LDYLPP 172

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G + K L       D  +    + +
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITE 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +    GT
Sbjct: 122 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGT 174
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 175 LDYLPP 180

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L   +   D  +    + +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITE 116
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGT 169
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 170 LDYLPP 175

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 469 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIF 522
           + E E++K + H  +IK+ +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED 579
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DF  +K+L GE 
Sbjct: 261 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 309
Query: 580 QSMTQTQTL-GTIGYMAP 596
             M   +TL GT  Y+AP
Sbjct: 310 SLM---RTLCGTPTYLAP 324

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 117
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGT 170
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 171 LDYLPP 176

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L   +   D  +    + +
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITE 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 122 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 174
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 175 LDYLPP 180

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 469 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIF 522
           + E E++K + H  +IK+ +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED 579
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DF  +K+L GE 
Sbjct: 247 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 295
Query: 580 QSMTQTQTL-GTIGYMAP 596
             M   +TL GT  Y+AP
Sbjct: 296 SLM---RTLCGTPTYLAP 310

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 119
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 172
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 173 LDYLPP 178

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L   +   D  +    + +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITE 119
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 172
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 173 LDYLPP 178

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L   +   D  +    + +
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITE 133
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +T   GT
Sbjct: 134 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 186
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 187 LDYLPP 192

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 35/185 (18%)
Query: 437 YLELCRATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNL------------- 483
           Y +     + F++   IG+G F      FK  D   + + +I+  +L             
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFG---EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE 75
Query: 484 IKVISSCSNEEFKA------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 531
           I V+S C +                 +++EY+  GS    L      LD  Q   I+ ++
Sbjct: 76  ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREI 133
Query: 532 ASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTI 591
              L+YLH   S   IH D+K +NVLL ++    L+DF +A  LT  D  + +   +GT 
Sbjct: 134 LKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTP 188
Query: 592 GYMAP 596
            +MAP
Sbjct: 189 FWMAP 193

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           ++F  E  +MK+++H  L+K+ +  + E    ++ E+M  GSL  +L S        Q L
Sbjct: 55  EAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPL 110
Query: 526 NIMIDVASAL-EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
             +ID ++ + E + F      IH DL+ +N+L+  ++V  ++DF +A+++  ED   T 
Sbjct: 111 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTA 168
Query: 585 TQTLG-TIGYMAP 596
            +     I + AP
Sbjct: 169 REGAKFPIKWTAP 181

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 469 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIF 522
           + E E++K + H  +IK+ +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED 579
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DF  +K+L GE 
Sbjct: 128 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 176
Query: 580 QSMTQTQTL-GTIGYMAP 596
             M   +TL GT  Y+AP
Sbjct: 177 SLM---RTLCGTPTYLAP 191

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/133 (24%), Positives = 64/133 (48%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           ++F++       + S+ H ++++++  C     + LV +Y+P GSL  ++      L   
Sbjct: 75  QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQ 133
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H +L   NVLL       ++DF +A LL  +D+ +
Sbjct: 134 LLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 190
Query: 583 TQTQTLGTIGYMA 595
             ++    I +MA
Sbjct: 191 LYSEAKTPIKWMA 203

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 469 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIF 522
           + E E++K + H  +IK+ +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED 579
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DF  +K+L GE 
Sbjct: 121 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 169
Query: 580 QSMTQTQTL-GTIGYMAP 596
             M   +TL GT  Y+AP
Sbjct: 170 SLM---RTLCGTPTYLAP 184

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 469 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIF 522
           + E E++K + H  +IK+ +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED 579
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DF  +K+L GE 
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 580 QSMTQTQTL-GTIGYMAP 596
             M   +TL GT  Y+AP
Sbjct: 171 SLM---RTLCGTPTYLAP 185

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 469 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIF 522
           + E E++K + H  +IK+ +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED 579
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DF  +K+L GE 
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 580 QSMTQTQTL-GTIGYMAP 596
             M   +TL GT  Y+AP
Sbjct: 171 SLM---RTLCGTPTYLAP 185

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 21/150 (14%)
Query: 463 RAFKSFDVECEMMKSI--RHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSN 516
           R  KS+  E E+  ++  RH N++  I+S       +    L+  Y   GSL  YL  + 
Sbjct: 71  RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT 130
Query: 517 CILDIFQRLNIMIDVASALEYLH---FGYSA--LVIHCDLKPSNVLLDDNMVAHLSDFSI 571
             LD    L I++ +AS L +LH   FG      + H DLK  N+L+  N    ++D  +
Sbjct: 131 --LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 188
Query: 572 AKLLTGEDQSMTQTQT-----LGTIGYMAP 596
           A +     QS  Q        +GT  YMAP
Sbjct: 189 AVM---HSQSTNQLDVGNNPRVGTKRYMAP 215

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/133 (24%), Positives = 64/133 (48%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           ++F++       + S+ H ++++++  C     + LV +Y+P GSL  ++      L   
Sbjct: 57  QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H +L   NVLL       ++DF +A LL  +D+ +
Sbjct: 116 LLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172
Query: 583 TQTQTLGTIGYMA 595
             ++    I +MA
Sbjct: 173 LYSEAKTPIKWMA 185

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 469 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIF 522
           + E E++K + H  +IK+ +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED 579
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DF  +K+L GE 
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 580 QSMTQTQTL-GTIGYMAP 596
             M   +TL GT  Y+AP
Sbjct: 171 SLM---RTLCGTPTYLAP 185

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 471 ECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR--LNI 527
           E ++++ +  H N+I++  +     F  LV + M  G L  YL     + +   R  +  
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
           +++V  AL  L+      ++H DLKP N+LLDD+M   L+DF  +  L   D        
Sbjct: 133 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLRSV 183
Query: 588 LGTIGYMAP 596
            GT  Y+AP
Sbjct: 184 CGTPSYLAP 192

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 71/135 (52%), Gaps = 8/135 (5%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + ++F  E  +MK+++H  L+K+ +  + E    ++ E+M  GSL  +L S        Q
Sbjct: 226 SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---Q 281
Query: 524 RLNIMIDVASAL-EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
            L  +ID ++ + E + F      IH DL+ +N+L+  ++V  ++DF +A+++  ED   
Sbjct: 282 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEY 339
Query: 583 TQTQTLG-TIGYMAP 596
           T  +     I + AP
Sbjct: 340 TAREGAKFPIKWTAP 354

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 14/133 (10%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
           VE +++  +  R ++ +  +   +    LV+  M  G +  ++Y+ +     FQ    + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 530 ---DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
               + S LE+LH      +I+ DLKP NVLLDD+    +SD  +A  L        QT+
Sbjct: 294 YTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA-----GQTK 345
Query: 587 T---LGTIGYMAP 596
           T    GT G+MAP
Sbjct: 346 TKGYAGTPGFMAP 358

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 14/133 (10%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
           VE +++  +  R ++ +  +   +    LV+  M  G +  ++Y+ +     FQ    + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 530 ---DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
               + S LE+LH      +I+ DLKP NVLLDD+    +SD  +A  L        QT+
Sbjct: 294 YTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA-----GQTK 345
Query: 587 T---LGTIGYMAP 596
           T    GT G+MAP
Sbjct: 346 TKGYAGTPGFMAP 358

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 14/133 (10%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
           VE +++  +  R ++ +  +   +    LV+  M  G +  ++Y+ +     FQ    + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 530 ---DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
               + S LE+LH      +I+ DLKP NVLLDD+    +SD  +A  L        QT+
Sbjct: 294 YTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA-----GQTK 345
Query: 587 T---LGTIGYMAP 596
           T    GT G+MAP
Sbjct: 346 TKGYAGTPGFMAP 358

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 498 LVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV 556
           + +E+   G+LE+++       LD    L +   +   ++Y+H   S  +IH DLKPSN+
Sbjct: 111 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNI 167
Query: 557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            L D     + DF +   L  + +   +T++ GT+ YM+P
Sbjct: 168 FLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSP 204

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 35/175 (20%)
Query: 447 FSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNL-------------IKVISSCSNE 493
           F++   IG+G F      FK  D   + + +I+  +L             I V+S C + 
Sbjct: 9   FTKLEKIGKGSFG---EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 494 EFKA------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 541
                           +++EY+  GS    L      LD  Q   I+ ++   L+YLH  
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH-- 121
Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            S   IH D+K +NVLL ++    L+DF +A  LT  D  + +   +GT  +MAP
Sbjct: 122 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 173

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 66/134 (49%), Gaps = 9/134 (6%)
Query: 468 FDVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           F  E +   ++ H  ++ V ++   E        +V+EY+   +L   +++   +     
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---P 115
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           +  I + +A A + L+F +   +IH D+KP+N+++       + DF IA+ +     S+T
Sbjct: 116 KRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 584 QTQT-LGTIGYMAP 596
           QT   +GT  Y++P
Sbjct: 175 QTAAVIGTAQYLSP 188

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 35/175 (20%)
Query: 447 FSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNL-------------IKVISSCSNE 493
           F++   IG+G F      FK  D   + + +I+  +L             I V+S C + 
Sbjct: 9   FTKLEKIGKGSFG---EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 494 EFKA------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 541
                           +++EY+  GS    L      LD  Q   I+ ++   L+YLH  
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH-- 121
Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            S   IH D+K +NVLL ++    L+DF +A  LT  D  + +   +GT  +MAP
Sbjct: 122 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 173

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 35/175 (20%)
Query: 447 FSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNL-------------IKVISSCSNE 493
           F++   IG+G F      FK  D   + + +I+  +L             I V+S C + 
Sbjct: 24  FTKLEKIGKGSFG---EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 494 EFKA------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 541
                           +++EY+  GS    L      LD  Q   I+ ++   L+YLH  
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH-- 136
Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            S   IH D+K +NVLL ++    L+DF +A  LT  D  + +   +GT  +MAP
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 188

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 78/199 (39%), Gaps = 48/199 (24%)
Query: 442 RATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRH--------------------- 480
           R   +F E  ++G+G F   ++A  + D     +K IRH                     
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQ 62
Query: 481 ------------RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
                       RN +K  ++   +    +  EY  + +L   ++S N      +   + 
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK-------LLTGEDQS 581
             +  AL Y+H   S  +IH +LKP N+ +D++    + DF +AK       +L  + Q+
Sbjct: 123 RQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 582 M-----TQTQTLGTIGYMA 595
           +       T  +GT  Y+A
Sbjct: 180 LPGSSDNLTSAIGTAXYVA 198

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 14/133 (10%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
           VE +++  +  R ++ +  +   +    LV+  M  G +  ++Y+ +     FQ    + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 530 ---DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
               + S LE+LH      +I+ DLKP NVLLDD+    +SD  +A  L        QT+
Sbjct: 294 YTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA-----GQTK 345
Query: 587 T---LGTIGYMAP 596
           T    GT G+MAP
Sbjct: 346 TKGYAGTPGFMAP 358

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 21/150 (14%)
Query: 463 RAFKSFDVECEMMKSI--RHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSN 516
           R  KS+  E E+  ++  RH N++  I+S       +    L+  Y   GSL  YL  + 
Sbjct: 42  RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT 101
Query: 517 CILDIFQRLNIMIDVASALEYLH---FGYSA--LVIHCDLKPSNVLLDDNMVAHLSDFSI 571
             LD    L I++ +AS L +LH   FG      + H DLK  N+L+  N    ++D  +
Sbjct: 102 --LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159
Query: 572 AKLLTGEDQSMTQTQT-----LGTIGYMAP 596
           A +     QS  Q        +GT  YMAP
Sbjct: 160 AVM---HSQSTNQLDVGNNPRVGTKRYMAP 186

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 62/134 (46%), Gaps = 6/134 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F  E +++K++    ++K   +S     +   LV+EY+P G L  +L      LD  +
Sbjct: 57  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 116
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSM 582
            L     +   +EYL    S   +H DL   N+L++      ++DF +AKLL   +D  +
Sbjct: 117 LLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 173
Query: 583 TQTQTLGTIGYMAP 596
            +      I + AP
Sbjct: 174 VREPGQSPIFWYAP 187

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 62/134 (46%), Gaps = 6/134 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F  E +++K++    ++K   +S     +   LV+EY+P G L  +L      LD  +
Sbjct: 56  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 115
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSM 582
            L     +   +EYL    S   +H DL   N+L++      ++DF +AKLL   +D  +
Sbjct: 116 LLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 172
Query: 583 TQTQTLGTIGYMAP 596
            +      I + AP
Sbjct: 173 VREPGQSPIFWYAP 186

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 21/150 (14%)
Query: 463 RAFKSFDVECEMMKSI--RHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSN 516
           R  KS+  E E+  ++  RH N++  I+S       +    L+  Y   GSL  YL  + 
Sbjct: 42  RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT 101
Query: 517 CILDIFQRLNIMIDVASALEYLH---FGYSA--LVIHCDLKPSNVLLDDNMVAHLSDFSI 571
             LD    L I++ +AS L +LH   FG      + H DLK  N+L+  N    ++D  +
Sbjct: 102 --LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159
Query: 572 AKLLTGEDQSMTQTQT-----LGTIGYMAP 596
           A +     QS  Q        +GT  YMAP
Sbjct: 160 AVM---HSQSTNQLDVGNNPRVGTKRYMAP 186

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 61/134 (45%), Gaps = 6/134 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F  E +++K++    ++K   +S         LV+EY+P G L  +L      LD  +
Sbjct: 53  RDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASR 112
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSM 582
            L     +   +EYL    S   +H DL   N+L++      ++DF +AKLL   +D  +
Sbjct: 113 LLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXV 169
Query: 583 TQTQTLGTIGYMAP 596
            +      I + AP
Sbjct: 170 VREPGQSPIFWYAP 183

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 58/128 (45%), Gaps = 5/128 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
           E ++++ +RH+N+I+++    NEE + +  V+EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
             +   LEYLH   S  ++H D+KP N+LL       +S   +A+ L       T   + 
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 589 GTIGYMAP 596
           G+  +  P
Sbjct: 173 GSPAFQPP 180

>pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 83  SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLID 142
             L  L L  N  S      F  LR L++L + +N+L    P L          SL  + 
Sbjct: 78  QHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP--------SSLVELR 129
Query: 143 LSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLT-------NLVEIDLGG 195
           + +N +  + PK   S L          NC   GG P E S           L  + +  
Sbjct: 130 IHDNRIRKV-PKGVFSGLRN-------MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181
Query: 196 NKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFG 255
            KL G IP  L +   L  L+L+ N ++    +D+ R ++LYRL LG N++         
Sbjct: 182 AKLTG-IPKDLPE--TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 256 NLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT 294
            L +LR L L +NKL+ +P    +LK +  +   +N +T
Sbjct: 239 FLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT 277

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 468 FDVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           F  E +   ++ H  ++ V  +   E        +V+EY+   +L   +++   +     
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---P 115
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           +  I + +A A + L+F +   +IH D+KP+N+++       + DF IA+ +     S+T
Sbjct: 116 KRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 584 QTQT-LGTIGYMAP 596
           QT   +GT  Y++P
Sbjct: 175 QTAAVIGTAQYLSP 188

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 119
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +    GT
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGT 172
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 173 LDYLPP 178

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 468 FDVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           F  E +   ++ H  ++ V  +   E        +V+EY+   +L   +++   +     
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---P 115
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           +  I + +A A + L+F +   +IH D+KP+N+++       + DF IA+ +     S+T
Sbjct: 116 KRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 584 QTQT-LGTIGYMAP 596
           QT   +GT  Y++P
Sbjct: 175 QTAAVIGTAQYLSP 188

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 62/134 (46%), Gaps = 6/134 (4%)
Query: 466 KSFDVECEMMKSIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F  E +++K++    ++K   +S     +   LV+EY+P G L  +L      LD  +
Sbjct: 69  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 128
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSM 582
            L     +   +EYL    S   +H DL   N+L++      ++DF +AKLL   +D  +
Sbjct: 129 LLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 185
Query: 583 TQTQTLGTIGYMAP 596
            +      I + AP
Sbjct: 186 VREPGQSPIFWYAP 199

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 64/129 (49%), Gaps = 10/129 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++KS+ H N+IK+     ++++  LV E+   G L + + + +   D     NIM  
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQ 154
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGEDQSMTQTQT 587
           + S + YLH      ++H D+KP N+LL++    +   + DF ++   +   +       
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRDR 208
Query: 588 LGTIGYMAP 596
           LGT  Y+AP
Sbjct: 209 LGTAYYIAP 217

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 116
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +    GT
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGT 169
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 170 LDYLPP 175

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 468 FDVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           F  E +   ++ H  ++ V  +   E        +V+EY+   +L   +++   +     
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---P 115
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           +  I + +A A + L+F +   +IH D+KP+N+++       + DF IA+ +     S+T
Sbjct: 116 KRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 584 QTQT-LGTIGYMAP 596
           QT   +GT  Y++P
Sbjct: 175 QTAAVIGTAQYLSP 188

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L   +   D  +    + +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITE 119
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +    GT
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGT 172
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 173 LDYLPP 178

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 116
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +    GT
Sbjct: 117 LANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGT 169
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 170 LDYLPP 175

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 36/183 (19%)
Query: 445 DEFSENNLIGRGGFALFIRAFK--------------SFDV---------ECEMMKSIRHR 481
           DE+     IG G + +   A +              +FDV         E +++K  +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 482 NLIKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 535
           N+I +      +    EFK++  VL+ M    L + ++SS   L +      +  +   L
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP-LTLEHVRYFLYQLLRGL 172
Query: 536 EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL--TGEDQSMTQTQTLGTIGY 593
           +Y+H   SA VIH DLKPSN+L+++N    + DF +A+ L  +  +     T+ + T  Y
Sbjct: 173 KYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 229
Query: 594 MAP 596
            AP
Sbjct: 230 RAP 232

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 115
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 116 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 173
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 174 LWYRAP 179

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 116
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +    GT
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 169
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 170 LDYLPP 175

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 115
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 116 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 173
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 174 LWYRAP 179

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 76  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 135
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  ++YL    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 136 GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHN 192
Query: 586 QT 587
           +T
Sbjct: 193 KT 194

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/137 (23%), Positives = 66/137 (48%), Gaps = 9/137 (6%)
Query: 465 FKSFDVECEMMKSIRHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILD 520
           +  F  E +   ++ H  ++ V  +   E        +V+EY+   +L   +++   +  
Sbjct: 73  YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT- 131
Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
              +  I + +A A + L+F +   +IH D+KP+N+++       + DF IA+ +     
Sbjct: 132 --PKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 188
Query: 581 SMTQTQT-LGTIGYMAP 596
           S+TQT   +GT  Y++P
Sbjct: 189 SVTQTAAVIGTAQYLSP 205

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 36/183 (19%)
Query: 445 DEFSENNLIGRGGFALFIRAFK--------------SFDV---------ECEMMKSIRHR 481
           DE+     IG G + +   A +              +FDV         E +++K  +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 482 NLIKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 535
           N+I +      +    EFK++  VL+ M    L + ++SS   L +      +  +   L
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP-LTLEHVRYFLYQLLRGL 171
Query: 536 EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL--TGEDQSMTQTQTLGTIGY 593
           +Y+H   SA VIH DLKPSN+L+++N    + DF +A+ L  +  +     T+ + T  Y
Sbjct: 172 KYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228
Query: 594 MAP 596
            AP
Sbjct: 229 RAP 231

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 78/185 (42%), Gaps = 40/185 (21%)
Query: 446 EFSENNLIGRGGFALFIRAFKSFDVECEMMKSIRHRNL-----IKVI------------- 487
           +F E  LIG GGF    +A    D +  ++K +++ N      +K +             
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNG 71
Query: 488 ---------------SSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDV 531
                          SS S  +   + +E+   G+LE+++       LD    L +   +
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131
Query: 532 ASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTI 591
              ++Y+H   S  +I+ DLKPSN+ L D     + DF +   L  + +   + ++ GT+
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRSKGTL 185
Query: 592 GYMAP 596
            YM+P
Sbjct: 186 RYMSP 190

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 32/179 (17%)
Query: 444 TDEFSENNLIGRGGFALFIRAFK-----------------------SFDVECEMMKSIRH 480
           TDE+     IG+G F++  R  K                         + E  + + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 481 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 540
            N++++  S S E F  LV + +  G     L+      + +   +    +   LE +  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 541 GYSALVIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            +   V+H DLKP N+LL          L+DF +A  + G+ Q+       GT GY++P
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSP 175

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 119
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       +++F      +    S  +T   GT
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGT 172
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 173 LDYLPP 178

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 108
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 166
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 167 LWYRAP 172

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L   +   D  +    + +
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITE 142
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +    GT
Sbjct: 143 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGT 195
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 196 LDYLPP 201

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 60/128 (46%), Gaps = 10/128 (7%)
Query: 479 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 538
           +H N++ ++ +C++     ++ EY  +G L  +L   + +L+      I    AS  + L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 539 HF------GYSALV----IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
           HF      G + L     IH D+   NVLL +  VA + DF +A+ +  +   + +    
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 589 GTIGYMAP 596
             + +MAP
Sbjct: 228 LPVKWMAP 235

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 109
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 110 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 167
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 168 LWYRAP 173

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 9/123 (7%)
Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           M+  + H  +I++  +  + +   ++++Y+  G L   L  S    +   +     +V  
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCL 117
Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
           ALEYLH   S  +I+ DLKP N+LLD N    ++DF  AK +      +      GT  Y
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDY 169
Query: 594 MAP 596
           +AP
Sbjct: 170 IAP 172

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 107
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 165
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 166 LWYRAP 171

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 108
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 109 LFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 166
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 167 LWYRAP 172

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 112
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 113 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 170
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 171 LWYRAP 176

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 108
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 166
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 167 LWYRAP 172

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 50/188 (26%)
Query: 444 TDEFSENNLIGRGGFALFIRAFK-----------------------SFDVECEMMKSIRH 480
           TDE+     +G+G F++  R  K                         + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 481 RNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 531
            N++++  S S E F  LV + +  G L      +  YS    S+CI  I + +N     
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----- 117
Query: 532 ASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
                + H      ++H DLKP N+LL          L+DF +A  + G+ Q+       
Sbjct: 118 -----HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW--FGFA 167
Query: 589 GTIGYMAP 596
           GT GY++P
Sbjct: 168 GTPGYLSP 175

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 119
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +    GT
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 172
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 173 LDYLPP 178

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 68/126 (53%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E   ++ +RH ++IK+     +++   +V+EY  +  L  Y+   + + +   R      
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQ 120
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SA+EY H      ++H DLKP N+LLD+++   ++DF ++ ++T  D +  +T + G+
Sbjct: 121 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGS 174
Query: 591 IGYMAP 596
             Y AP
Sbjct: 175 PNYAAP 180

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 108
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 166
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 167 LWYRAP 172

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 107
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 165
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 166 LWYRAP 171

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L   +   D  +    + +
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITE 118
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +    GT
Sbjct: 119 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 171
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 172 LDYLPP 177

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 108
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 166
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 167 LWYRAP 172

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 107
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 165
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 166 LWYRAP 171

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 68/126 (53%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E   ++ +RH ++IK+     +++   +V+EY  +  L  Y+   + + +   R      
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQ 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SA+EY H      ++H DLKP N+LLD+++   ++DF ++ ++T  D +  +T + G+
Sbjct: 122 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGS 175
Query: 591 IGYMAP 596
             Y AP
Sbjct: 176 PNYAAP 181

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 68/126 (53%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E   ++ +RH ++IK+     +++   +V+EY  +  L  Y+   + + +   R      
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQ 111
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SA+EY H      ++H DLKP N+LLD+++   ++DF ++ ++T  D +  +T + G+
Sbjct: 112 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGS 165
Query: 591 IGYMAP 596
             Y AP
Sbjct: 166 PNYAAP 171

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 68/126 (53%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E   ++ +RH ++IK+     +++   +V+EY  +  L  Y+   + + +   R      
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQ 115
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           + SA+EY H      ++H DLKP N+LLD+++   ++DF ++ ++T  D +  +T + G+
Sbjct: 116 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGS 169
Query: 591 IGYMAP 596
             Y AP
Sbjct: 170 PNYAAP 175

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 118
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       +++F      +    S  +T   GT
Sbjct: 119 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGT 171
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 172 LDYLPP 177

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E E+   +RH N++++     +     L+LEY P G++ + L       D  +    + +
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE 117
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +A+AL Y H   S  VIH D+KP N+LL       ++DF      +    S  +    GT
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGT 170
Query: 591 IGYMAP 596
           + Y+ P
Sbjct: 171 LDYLPP 176

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 69  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 128
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  ++YL    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 129 GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 185
Query: 586 QT 587
           +T
Sbjct: 186 KT 187

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 476
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            V+  ++YL     +  +H DL   NVLL     A +SDF ++K L   D++  + QT G
Sbjct: 477 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 532
Query: 590 T--IGYMAP 596
              + + AP
Sbjct: 533 KWPVKWYAP 541

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 477
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            V+  ++YL     +  +H DL   NVLL     A +SDF ++K L   D++  + QT G
Sbjct: 478 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 533
Query: 590 T--IGYMAP 596
              + + AP
Sbjct: 534 KWPVKWYAP 542

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 50/188 (26%)
Query: 444 TDEFSENNLIGRGGFALFIRAFK-----------------------SFDVECEMMKSIRH 480
           TDE+     +G+G F++  R  K                         + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 481 RNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 531
            N++++  S S E F  LV + +  G L      +  YS    S+CI  I + +N     
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----- 117
Query: 532 ASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
                + H      ++H DLKP N+LL          L+DF +A  + G+ Q+       
Sbjct: 118 -----HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 589 GTIGYMAP 596
           GT GY++P
Sbjct: 168 GTPGYLSP 175

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 58/127 (45%), Gaps = 13/127 (10%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL-----VLEYMPHGSLEKYLYSSNC 517
           R  + F  E   MK   H N+I+++  C     + +     +L +M +G L  YL  S  
Sbjct: 78  REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL 137
Query: 518 -----ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA 572
                 + +   L  M+D+A  +EYL    +   +H DL   N +L D+M   ++DF ++
Sbjct: 138 ETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
Query: 573 KLLTGED 579
           K +   D
Sbjct: 195 KKIYSGD 201

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 32/177 (18%)
Query: 447 FSENNLIGRGGFALFIRA-------------FKSFDV-----------ECEMMKSIRHRN 482
           F     IGRG F+   RA              + FD+           E +++K + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLH 539
           +IK  +S   +    +VLE    G L    K+      ++         + + SALE++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              S  V+H D+KP+NV +    V  L D  + +  +   ++      +GT  YM+P
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSP 205

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 95  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 154
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  ++YL    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 155 GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 211
Query: 586 QT 587
           +T
Sbjct: 212 KT 213

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 11/127 (8%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G      +T TL G
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCG 201
Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 202 TPEYLAP 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 62/112 (55%), Gaps = 5/112 (4%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + ++F  E  +MK+++H  L+K+ +  + E    ++ E+M  GSL  +L S        Q
Sbjct: 220 SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---Q 275
Query: 524 RLNIMIDVASAL-EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
            L  +ID ++ + E + F      IH DL+ +N+L+  ++V  ++DF +A++
Sbjct: 276 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 327

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 96  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 155
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  ++YL    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 156 GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 212
Query: 586 QT 587
           +T
Sbjct: 213 KT 214

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 75  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 134
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  ++YL    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 135 GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 191
Query: 586 QT 587
           +T
Sbjct: 192 KT 193

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  ++YL    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 137 GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 193
Query: 586 QT 587
           +T
Sbjct: 194 KT 195

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 11/127 (8%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 135
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G      +T TL G
Sbjct: 136 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCG 186
Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 187 TPEYLAP 193

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EYMP G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EYMP G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 74  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 133
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  ++YL    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 134 GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 190
Query: 586 QT 587
           +T
Sbjct: 191 KT 192

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 72  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 131
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  ++YL    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 132 GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 188
Query: 586 QT 587
           +T
Sbjct: 189 KT 190

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 468 FDVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           F  E +   ++ H  ++ V  +   E        +V+EY+   +L   +++   +     
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---P 115
Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           +  I + +A A + L+F +   +IH D+KP+N+L+       + DF IA+ +     S+ 
Sbjct: 116 KRAIEV-IADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX 174
Query: 584 QTQT-LGTIGYMAP 596
           QT   +GT  Y++P
Sbjct: 175 QTAAVIGTAQYLSP 188

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  ++YL    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 137 GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 193
Query: 586 QT 587
           +T
Sbjct: 194 KT 195

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 134/303 (44%), Gaps = 43/303 (14%)
Query: 63  KLYLWGNNFSGTIPRFIFN-ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           K  L   N + T+ +   +  + L    LG+ S  G        L NL Q+    N LT 
Sbjct: 23  KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQINFSNNQLTD 77
Query: 122 STP---------------ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
            TP               +++ ++ L+N  +LT + L NN +  I P  +++NL+R LE 
Sbjct: 78  ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR-LEL 136
Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
                 +IS      +S LT+L +++   N++    P  L  L  L+RL++  N +    
Sbjct: 137 SSNTISDISA-----LSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVS--- 186
Query: 227 PDDICRLAELYRLE--LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDIL 284
             DI  LA+L  LE  + +N     I    G L +L  LSL  N+L  I  T  +L ++ 
Sbjct: 187 --DISVLAKLTNLESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDIG-TLASLTNLT 242
Query: 285 QLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
            L+ ++N ++   L  +  L  L  +    N  S + P      L+ L +L L+ N+L+ 
Sbjct: 243 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPL---AGLTALTNLELNENQLED 297
Query: 345 EIP 347
             P
Sbjct: 298 ISP 300

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 76  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 135
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  ++YL    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 136 GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 192
Query: 586 QT 587
           +T
Sbjct: 193 KT 194

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 9/133 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYS---SNCILDIFQRL 525
           E  +++ ++H N+++      +     L  V+EY   G L   +         LD    L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 526 NIMIDVASALEYLHFGYSA--LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            +M  +  AL+  H        V+H DLKP+NV LD      L DF +A++L   D S  
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFA 173
Query: 584 QTQTLGTIGYMAP 596
           +T  +GT  YM+P
Sbjct: 174 KT-FVGTPYYMSP 185

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 529
           E ++++ +  R ++ +  +   ++   LVL  M  G L+ ++Y          + +    
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++   LE LH      +++ DLKP N+LLDD+    +SD  +A  +    +  T    +G
Sbjct: 294 EICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVG 347
Query: 590 TIGYMAP 596
           T+GYMAP
Sbjct: 348 TVGYMAP 354

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 80/201 (39%), Gaps = 49/201 (24%)
Query: 442 RATDEFSENNLIGRGGFALFIRAFKSFDVECEMMKSIR-------HRNLIKVISSCSNEE 494
           R   +F     +GRGGF +   A    D     +K IR          +++ + + +  E
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 495 FKALV-----------LEYMPHGSLEKYLY---------------SSNCILDIFQR---L 525
              +V            E +   S + YLY               +  C ++  +R   L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT-- 583
           +I + +A A+E+LH   S  ++H DLKPSN+    + V  + DF +   +  +++  T  
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 584 --------QTQTLGTIGYMAP 596
                    T  +GT  YM+P
Sbjct: 179 TPMPAYARHTGQVGTKLYMSP 199

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            V+  ++YL     +  +H DL   NVLL     A +SDF ++K L   D++  + QT G
Sbjct: 119 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENXYKAQTHG 174
Query: 590 T--IGYMAP 596
              + + AP
Sbjct: 175 KWPVKWYAP 183

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 4/106 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  + K + H N++K+      E+   LV EY   G +  YL +     +   R      
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-Q 121
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
           + SA++Y H      ++H DLK  N+LLD +    ++DF  +   T
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFT 164

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            V+  ++YL     +  +H DL   NVLL     A +SDF ++K L   D++  + QT G
Sbjct: 119 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 174
Query: 590 T--IGYMAP 596
              + + AP
Sbjct: 175 KWPVKWYAP 183

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQ 142
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 143 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 194
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 195 PEYLAP 200

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQ 150
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 203 PEYLAP 208

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 55  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 112
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            V+  ++YL     +  +H DL   NVLL     A +SDF ++K L   D++  + QT G
Sbjct: 113 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 168
Query: 590 T--IGYMAP 596
              + + AP
Sbjct: 169 KWPVKWYAP 177

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 529
           E ++++ +  R ++ +  +   ++   LVL  M  G L+ ++Y          + +    
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++   LE LH      +++ DLKP N+LLDD+    +SD  +A  +    +  T    +G
Sbjct: 294 EICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVG 347
Query: 590 TIGYMAP 596
           T+GYMAP
Sbjct: 348 TVGYMAP 354

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 124
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            V+  ++YL     +  +H DL   NVLL     A +SDF ++K L   D++  + QT G
Sbjct: 125 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 180
Query: 590 T--IGYMAP 596
              + + AP
Sbjct: 181 KWPVKWYAP 189

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           LE +H  +   ++H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +GT+ YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 595 AP 596
            P
Sbjct: 177 PP 178

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           LE +H  +   ++H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +GT+ YM
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 595 AP 596
            P
Sbjct: 180 PP 181

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 43/303 (14%)
Query: 63  KLYLWGNNFSGTIPRFIFN-ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           K  L   N + T+ +   +  + L    LG+ S  G        L NL Q+    N LT 
Sbjct: 23  KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQINFSNNQLTD 77
Query: 122 STP---------------ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
            TP               +++ ++ L+N  +LT + L NN +  I P  +++NL+R LE 
Sbjct: 78  ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR-LEL 136
Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
                 +IS      +S LT+L ++    N++    P  L  L  L+RL++  N +    
Sbjct: 137 SSNTISDISA-----LSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVS--- 186
Query: 227 PDDICRLAELYRLE--LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDIL 284
             DI  LA+L  LE  + +N     I    G L +L  LSL  N+L  I  T  +L ++ 
Sbjct: 187 --DISVLAKLTNLESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDIG-TLASLTNLT 242
Query: 285 QLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
            L+ ++N ++   L  +  L  L  +    N  S + P      L+ L +L L+ N+L+ 
Sbjct: 243 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPL---AGLTALTNLELNENQLED 297
Query: 345 EIP 347
             P
Sbjct: 298 ISP 300

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            V+  ++YL     +  +H DL   NVLL     A +SDF ++K L   D++  + QT G
Sbjct: 135 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 190
Query: 590 T--IGYMAP 596
              + + AP
Sbjct: 191 KWPVKWYAP 199

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            V+  ++YL     +  +H DL   NVLL     A +SDF ++K L   D++  + QT G
Sbjct: 135 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 190
Query: 590 T--IGYMAP 596
              + + AP
Sbjct: 191 KWPVKWYAP 199

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           LE +H  +   ++H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +GT+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 595 AP 596
            P
Sbjct: 224 PP 225

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 57  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 114
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            V+  ++YL     +  +H DL   NVLL     A +SDF ++K L   D++  + QT G
Sbjct: 115 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 170
Query: 590 T--IGYMAP 596
              + + AP
Sbjct: 171 KWPVKWYAP 179

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 132
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            V+  ++YL     +  +H DL   NVLL     A +SDF ++K L   D++  + QT G
Sbjct: 133 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHG 188
Query: 590 T--IGYMAP 596
              + + AP
Sbjct: 189 KWPVKWYAP 197

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           LE +H  +   ++H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +GT+ YM
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 595 AP 596
            P
Sbjct: 176 PP 177

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 35/179 (19%)
Query: 445 DEFSENNLIGRGGFALF----------IRAFKSFDVECEMMK-----SIRHRNLIKVISS 489
           ++FS + +IGRGGF             + A K  D +   MK     ++  R ++ ++S+
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 490 -------CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 537
                  C +  F      + +L+ M  G L  +L       +   R     ++   LE+
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 306
Query: 538 LHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +H   +  V++ DLKP+N+LLD++    +SD  +A   + +        ++GT GYMAP
Sbjct: 307 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 358

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 35/179 (19%)
Query: 445 DEFSENNLIGRGGFALF----------IRAFKSFDVECEMMK-----SIRHRNLIKVISS 489
           ++FS + +IGRGGF             + A K  D +   MK     ++  R ++ ++S+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 490 -------CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 537
                  C +  F      + +L+ M  G L  +L       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 538 LHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +H   +  V++ DLKP+N+LLD++    +SD  +A   + +        ++GT GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 359

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/148 (20%), Positives = 66/148 (44%), Gaps = 26/148 (17%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI------------ 518
           E  ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S  +            
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 519 -----------LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
                      L +   ++    ++  ++YL       ++H DL   N+L+ +     +S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKIS 192
Query: 568 DFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
           DF +++ +  ED  + ++Q    + +MA
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMA 220

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 66/145 (45%), Gaps = 20/145 (13%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF-------- 522
           E  ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S  +   +        
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 523 --------QRLNIMIDVASALEYLHFGYSAL----VIHCDLKPSNVLLDDNMVAHLSDFS 570
                   +R   M D+ S    +  G   L    ++H DL   N+L+ +     +SDF 
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFG 195
Query: 571 IAKLLTGEDQSMTQTQTLGTIGYMA 595
           +++ +  ED  + ++Q    + +MA
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMA 220

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 43/303 (14%)
Query: 63  KLYLWGNNFSGTIPRFIFN-ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           K  L   N + T+ +   +  + L    LG+ S  G        L NL Q+    N LT 
Sbjct: 23  KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQINFSNNQLTD 77
Query: 122 STP---------------ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
            TP               +++ ++ L+N  +LT + L NN +  I P  +++NL+R LE 
Sbjct: 78  ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR-LEL 136
Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
                 +IS      +S LT+L ++    N++    P  L  L  L+RL++  N +    
Sbjct: 137 SSNTISDISA-----LSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVS--- 186
Query: 227 PDDICRLAELYRLE--LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDIL 284
             DI  LA+L  LE  + +N     I    G L +L  LSL  N+L  I  T  +L ++ 
Sbjct: 187 --DISVLAKLTNLESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDIG-TLASLTNLT 242
Query: 285 QLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
            L+ ++N ++   L  +  L  L  +    N  S + P      L+ L +L L+ N+L+ 
Sbjct: 243 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPL---AGLTALTNLELNENQLED 297
Query: 345 EIP 347
             P
Sbjct: 298 ISP 300

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 35/179 (19%)
Query: 445 DEFSENNLIGRGGFALF----------IRAFKSFDVECEMMK-----SIRHRNLIKVISS 489
           ++FS + +IGRGGF             + A K  D +   MK     ++  R ++ ++S+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 490 -------CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 537
                  C +  F      + +L+ M  G L  +L       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 538 LHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +H   +  V++ DLKP+N+LLD++    +SD  +A   + +        ++GT GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 359

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 35/179 (19%)
Query: 445 DEFSENNLIGRGGFALF----------IRAFKSFDVECEMMK-----SIRHRNLIKVISS 489
           ++FS + +IGRGGF             + A K  D +   MK     ++  R ++ ++S+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 490 -------CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 537
                  C +  F      + +L+ M  G L  +L       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 538 LHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +H   +  V++ DLKP+N+LLD++    +SD  +A   + +        ++GT GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 359

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 52/108 (48%), Gaps = 4/108 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYS-SNCIL 519
           R  + F+ EC  ++   H N++ V+ +C +       L+  + P+GSL   L+  +N ++
Sbjct: 49  RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVV 108
Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           D  Q +   +D A    +LH     L+    L   +V +D++  A +S
Sbjct: 109 DQSQAVKFALDXARGXAFLH-TLEPLIPRHALNSRSVXIDEDXTARIS 155

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           LE +H  +   ++H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +GT+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 595 AP 596
            P
Sbjct: 224 PP 225

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           LE +H  +   ++H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +GT+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 595 AP 596
            P
Sbjct: 196 PP 197

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 17/149 (11%)
Query: 462 IRAFKSFDVECEM--MKSIRHRNLIKVISS----CSNEEFKALVLEYMPHGSLEKYLYSS 515
           I+  +S+  E E+  +  ++H N+++ I +     S +    L+  +   GSL  +L ++
Sbjct: 57  IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN 116
Query: 516 NCILDIFQRLNIMIDVASALEYLHF-------GYSALVIHCDLKPSNVLLDDNMVAHLSD 568
             ++   +  +I   +A  L YLH        G+   + H D+K  NVLL +N+ A ++D
Sbjct: 117 --VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 569 FSIA-KLLTGEDQSMTQTQTLGTIGYMAP 596
           F +A K   G+    T  Q +GT  YMAP
Sbjct: 175 FGLALKFEAGKSAGDTHGQ-VGTRRYMAP 202

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 203 PEYLAP 208

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 170
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 222
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 223 PEYLAP 228

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/148 (20%), Positives = 66/148 (44%), Gaps = 26/148 (17%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI------------ 518
           E  ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S  +            
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 519 -----------LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
                      L +   ++    ++  ++YL       ++H DL   N+L+ +     +S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKIS 192
Query: 568 DFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
           DF +++ +  ED  + ++Q    + +MA
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMA 220

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 112
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 113 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 170
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 171 LWYRAP 176

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 203 PEYLAP 208

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 203 PEYLAP 208

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 203 PEYLAP 208

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 111
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 112 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 169
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 170 LWYRAP 175

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 142
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 143 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 194
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 195 PEYLAP 200

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 111
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 112 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 169
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 170 LWYRAP 175

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 110
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 111 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 168
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 169 LWYRAP 174

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK++ H +++K+I     EE   +++E  P+G L  YL  +   L +   +
Sbjct: 70  EKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLV 128
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + +  A+ YL    S   +H D+   N+L+       L DF +++ +  ED      
Sbjct: 129 LYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 185
Query: 586 QTLGTIGYMAP 596
             L  I +M+P
Sbjct: 186 TRL-PIKWMSP 195

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 110
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 111 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 168
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 169 LWYRAP 174

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
           +E +++  + H  ++K+  +   E    L+L+++  G L   L S   +         + 
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA 133
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++A AL++LH   S  +I+ DLKP N+LLD+     L+DF ++K     D         G
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 188
Query: 590 TIGYMAP 596
           T+ YMAP
Sbjct: 189 TVEYMAP 195

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 195
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  +++L    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 196 GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 252
Query: 586 QT 587
           +T
Sbjct: 253 KT 254

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
           +E +++  + H  ++K+  +   E    L+L+++  G L   L S   +         + 
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA 133
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++A AL++LH   S  +I+ DLKP N+LLD+     L+DF ++K     D         G
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 188
Query: 590 TIGYMAP 596
           T+ YMAP
Sbjct: 189 TVEYMAP 195

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K ++H N++ +      E+   LV EY+    L++YL     I+++    N+ + 
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMH---NVKLF 105
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           +   L  L + +   V+H DLKP N+L+++     L+DF +A+
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/135 (24%), Positives = 64/135 (47%), Gaps = 9/135 (6%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           K+F  E    +  RH N++  + +C +    A++       +L   +  +  +LD+ +  
Sbjct: 74  KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR 133
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD---FSIAKLL-TGEDQS 581
            I  ++   + YLH   +  ++H DLK  NV  D+  V  ++D   FSI+ +L  G  + 
Sbjct: 134 QIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRRED 189
Query: 582 MTQTQTLGTIGYMAP 596
             + Q  G + ++AP
Sbjct: 190 KLRIQN-GWLCHLAP 203

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
           +E +++  + H  ++K+  +   E    L+L+++  G L   L S   +         + 
Sbjct: 76  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA 134
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++A AL++LH   S  +I+ DLKP N+LLD+     L+DF ++K     D         G
Sbjct: 135 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 189
Query: 590 TIGYMAP 596
           T+ YMAP
Sbjct: 190 TVEYMAP 196

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 107
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 165
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 166 LWYRAP 171

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 109
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 110 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 167
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 168 LWYRAP 173

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 110
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 111 LFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 168
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 169 LWYRAP 174

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  +++L    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 137 GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 193
Query: 586 QT 587
           +T
Sbjct: 194 KT 195

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK++ H +++K+I     EE   +++E  P+G L  YL  +   L +   +
Sbjct: 58  EKFMSEAVIMKNLDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLV 116
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + +  A+ YL    S   +H D+   N+L+       L DF +++ +  ED      
Sbjct: 117 LYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 173
Query: 586 QTLGTIGYMAP 596
             L  I +M+P
Sbjct: 174 TRL-PIKWMSP 183

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 108
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 166
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 167 LWYRAP 172

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 108
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 166
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 167 LWYRAP 172

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 78  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 137
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  +++L    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 138 GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 194
Query: 586 QT 587
           +T
Sbjct: 195 KT 196

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 107
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 165
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 166 LWYRAP 171

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 6/126 (4%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++ +I    +E    LV E+M    L+K L  +   L   Q   I I 
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIY 124
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L  +   +   ++H DLKP N+L++ +    L+DF +A+      +S   T  + T
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVT 182
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 183 LWYRAP 188

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 108
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 166
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 167 LWYRAP 172

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 109
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 110 LFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 167
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 168 LWYRAP 173

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 109
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 110 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 167
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 168 LWYRAP 173

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+K++  ++ +  I   L I   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSY 108
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 166
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 167 LWYRAP 172

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 77/164 (46%), Gaps = 19/164 (11%)
Query: 448 SENNLIGRGGF--------ALFIRAFKSFDVECEMMK-SIRHRNLIKVISSCSNEEFKAL 498
           +E  ++ RG F         +    F   D E ++++ S  H N+I+   +  + +F+ +
Sbjct: 36  AEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95
Query: 499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL 558
            +E     +L++Y+   +      + + ++    S L +LH   S  ++H DLKP N+L+
Sbjct: 96  AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILI 151
Query: 559 -----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIGYMAP 596
                   + A +SDF + K L     S ++   + GT G++AP
Sbjct: 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 18/146 (12%)
Query: 466 KSFDVECEMMKS--IRHRNLIKVISS---CSNEEFK-ALVLEYMPHGSLEKYLYSSNCIL 519
           +S+  E E+  +  ++H NL++ I++    SN E +  L+  +   GSL  YL  +  I+
Sbjct: 52  QSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGN--II 109
Query: 520 DIFQRLNIMIDVASALEYLHF--------GYSALVIHCDLKPSNVLLDDNMVAHLSDFSI 571
              +  ++   ++  L YLH         G+   + H D K  NVLL  ++ A L+DF +
Sbjct: 110 TWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGL 169
Query: 572 A-KLLTGEDQSMTQTQTLGTIGYMAP 596
           A +   G+    T  Q +GT  YMAP
Sbjct: 170 AVRFEPGKPPGDTHGQ-VGTRRYMAP 194

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 82  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 141
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  +++L    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 142 GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 198
Query: 586 QT 587
           +T
Sbjct: 199 KT 200

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 78  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 137
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  +++L    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 138 GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHN 194
Query: 586 QT 587
           +T
Sbjct: 195 KT 196

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 23/143 (16%)
Query: 464 AFK--SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS-----LEKYLYSSN 516
           AF+  S + E  ++K I+H N++ +     +     LV++ +  G      LE+ +Y+  
Sbjct: 47  AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK 106
Query: 517 CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAK 573
               + Q+      V SA++YLH      ++H DLKP N+L    ++N    ++DF ++K
Sbjct: 107 DASLVIQQ------VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157
Query: 574 LLTGEDQSMTQTQTLGTIGYMAP 596
           +    +Q+   +   GT GY+AP
Sbjct: 158 M----EQNGIMSTACGTPGYVAP 176

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  +++L    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 137 GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 193
Query: 586 QT 587
           +T
Sbjct: 194 KT 195

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 63/140 (45%), Gaps = 10/140 (7%)
Query: 460 LFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 519
           L  R F+  + E  + + ++H N++++  S   E F  LV + +  G     L+      
Sbjct: 67  LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAR 122
Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLT 576
           + +   +    +   LE + + +S  ++H +LKP N+LL          L+DF +A  + 
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV- 181
Query: 577 GEDQSMTQTQTLGTIGYMAP 596
             + S       GT GY++P
Sbjct: 182 --NDSEAWHGFAGTPGYLSP 199

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 61/133 (45%), Gaps = 9/133 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYS---SNCILDIFQRL 525
           E  +++ ++H N+++      +     L  V+EY   G L   +         LD    L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 526 NIMIDVASALEYLHFGYSA--LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            +M  +  AL+  H        V+H DLKP+NV LD      L DF +A++L   D+   
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDEDFA 173
Query: 584 QTQTLGTIGYMAP 596
           + + +GT  YM+P
Sbjct: 174 K-EFVGTPYYMSP 185

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 6/126 (4%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++ +I    +E    LV E+M    L+K L  +   L   Q   I I 
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIY 124
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L  +   +   ++H DLKP N+L++ +    L+DF +A+      +S   T  + T
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVT 182
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 183 LWYRAP 188

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           +V+EY+  GSL   + +  C +D  Q   +  +   ALE+LH   S  VIH D+K  N+L
Sbjct: 94  VVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNIL 148
Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           L  +    L+DF     +T E     +++ +GT  +MAP
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAP 185

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +MK++ H +++K+I     EE   +++E  P+G L  YL  +   L +   +
Sbjct: 54  EKFMSEAVIMKNLDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLV 112
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + +  A+ YL    S   +H D+   N+L+       L DF +++ +  ED      
Sbjct: 113 LYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 169
Query: 586 QTLGTIGYMAP 596
             L  I +M+P
Sbjct: 170 TRL-PIKWMSP 179

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 54/100 (54%), Gaps = 4/100 (4%)
Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           ++K ++H+N++++     +++   LV E+     L+KY  S N  LD     + +  +  
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            L + H   S  V+H DLKP N+L++ N    L+DF +A+
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/128 (24%), Positives = 59/128 (46%), Gaps = 10/128 (7%)
Query: 479 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 538
           +H N++ ++ +C++     ++ EY  +G L  +L   + +L+      I     S  + L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 539 HF------GYSALV----IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
           HF      G + L     IH D+   NVLL +  VA + DF +A+ +  +   + +    
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 589 GTIGYMAP 596
             + +MAP
Sbjct: 228 LPVKWMAP 235

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRL 525
            F  E  +MK   H N++ ++  C   E   LV L YM HG L  ++ +      +   +
Sbjct: 75  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 134
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              + VA  +++L    S   +H DL   N +LD+     ++DF +A+ +  ++      
Sbjct: 135 GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 191
Query: 586 QT 587
           +T
Sbjct: 192 KT 193

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 135/303 (44%), Gaps = 44/303 (14%)
Query: 63  KLYLWGNNFSGTIPRFIFN-ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           K  L   N + T+ +   +  + L    LG+ S  G        L NL Q+    N LT 
Sbjct: 23  KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQINFSNNQLTD 77
Query: 122 STP---------------ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
            TP               +++ ++ L+N  +LT + L NN +  I P  +++NL+R LE 
Sbjct: 78  ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR-LEL 136
Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
                 +IS      +S LT+L +++  GN++    P  L  L  L+RL++  N +    
Sbjct: 137 SSNTISDISA-----LSGLTSLQQLNF-GNQVTDLKP--LANLTTLERLDISSNKVS--- 185
Query: 227 PDDICRLAELYRLE--LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDIL 284
             DI  LA+L  LE  + +N     I    G L +L  LSL  N+L  I  T  +L ++ 
Sbjct: 186 --DISVLAKLTNLESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDIG-TLASLTNLT 241
Query: 285 QLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
            L+ ++N ++   L  +  L  L  +    N  S + P      L+ L +L L+ N+L+ 
Sbjct: 242 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPL---AGLTALTNLELNENQLED 296
Query: 345 EIP 347
             P
Sbjct: 297 ISP 299

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K+F + E ++M+ + H N++++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 140
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 141 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K+F + E ++M+ + H N++++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 140
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 141 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K+F + E ++M+ + H N++++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 140
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 141 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 9/133 (6%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYS---SNCILDIFQRL 525
           E  +++ ++H N+++      +     L  V+EY   G L   +         LD    L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 526 NIMIDVASALEYLHFGYSA--LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            +M  +  AL+  H        V+H DLKP+NV LD      L DF +A++L   D S  
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFA 173
Query: 584 QTQTLGTIGYMAP 596
           +   +GT  YM+P
Sbjct: 174 KA-FVGTPYYMSP 185

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 53  IANVRLPNLEKLYLWGN--NFSGTIPRFIFNASKLSKLSLGMNSFSGFIP--STFGNLRN 108
            + V LP+LE L L  N  +F G   +  F  + L  L L   SF+G I   S F  L  
Sbjct: 341 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL---SFNGVITMSSNFLGLEQ 397
Query: 109 LEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNN----PLDGILPKTSISNLSRSL 164
           LE L    ++  S+  ++S  S   + ++L  +D+S+       +GI    S      SL
Sbjct: 398 LEHL----DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS------SL 447
Query: 165 EEFYMY-NCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE 223
           E   M  N      +P+  + L NL  +DL   +L    P     L  LQ LN+  N L+
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
Query: 224 GSIPDDIC-RLAELYRLELGSNKLYGSIP 251
            S+PD I  RL  L ++ L +N    S P
Sbjct: 508 -SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 12/140 (8%)
Query: 461 FIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-EKYLYSSNCIL 519
           F+     F  E E+MKS+ H N+I++  +  +     LV+E    G L E+ ++    + 
Sbjct: 63  FVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VF 120
Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL-LDDNMVAHLS--DFSIAKLLT 576
                  IM DV SA+ Y H      V H DLKP N L L D+  + L   DF +A    
Sbjct: 121 RESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF- 176
Query: 577 GEDQSMTQTQTLGTIGYMAP 596
            +   M +T+ +GT  Y++P
Sbjct: 177 -KPGKMMRTK-VGTPYYVSP 194

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 119
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 178
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 179 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 215

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 12/140 (8%)
Query: 461 FIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-EKYLYSSNCIL 519
           F+     F  E E+MKS+ H N+I++  +  +     LV+E    G L E+ ++    + 
Sbjct: 46  FVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VF 103
Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL-LDDNMVAHLS--DFSIAKLLT 576
                  IM DV SA+ Y H      V H DLKP N L L D+  + L   DF +A    
Sbjct: 104 RESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF- 159
Query: 577 GEDQSMTQTQTLGTIGYMAP 596
            +   M +T+ +GT  Y++P
Sbjct: 160 -KPGKMMRTK-VGTPYYVSP 177

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+++D      ++DF +AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 58/114 (50%), Gaps = 6/114 (5%)
Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           ++++  +  ++ +  +V+EYMP G L   L S+  + + + R     +V  AL+ +H   
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH--- 185
Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           S   IH D+KP N+LLD +    L+DF     +  E      T  +GT  Y++P
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 238

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 135/303 (44%), Gaps = 44/303 (14%)
Query: 63  KLYLWGNNFSGTIPRFIFN-ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           K  L   N + T+ +   +  + L    LG+ S  G        L NL Q+    N LT 
Sbjct: 23  KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQINFSNNQLTD 77
Query: 122 STP---------------ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
            TP               +++ ++ L+N  +LT + L NN +  I P  +++NL+R LE 
Sbjct: 78  ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR-LEL 136
Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
                 +IS      +S LT+L +++  GN++    P  L  L  L+RL++  N +    
Sbjct: 137 SSNTISDISA-----LSGLTSLQQLNF-GNQVTDLKP--LANLTTLERLDISSNKVS--- 185
Query: 227 PDDICRLAELYRLE--LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDIL 284
             DI  LA+L  LE  + +N     I    G L +L  LSL  N+L  I  T  +L ++ 
Sbjct: 186 --DISVLAKLTNLESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDIG-TLASLTNLT 241
Query: 285 QLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
            L+ ++N ++   L  +  L  L  +    N  S + P      L+ L +L L+ N+L+ 
Sbjct: 242 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPL---AGLTALTNLELNENQLED 296
Query: 345 EIP 347
             P
Sbjct: 297 ISP 299

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 58/114 (50%), Gaps = 6/114 (5%)
Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           ++++  +  ++ +  +V+EYMP G L   L S+  + + + R     +V  AL+ +H   
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH--- 190
Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           S   IH D+KP N+LLD +    L+DF     +  E      T  +GT  Y++P
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 243

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+++D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 174
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 175 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 160
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 219
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 220 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 256

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 58/114 (50%), Gaps = 6/114 (5%)
Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           ++++  +  ++ +  +V+EYMP G L   L S+  + + + R     +V  AL+ +H   
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH--- 190
Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           S   IH D+KP N+LLD +    L+DF     +  E      T  +GT  Y++P
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 243

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 56/126 (44%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  + +++    L+K+  S  +     +VLEY P G +  +L       +   R      
Sbjct: 92  EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GT 202
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 203 PEYLAP 208

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 117
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 176
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 177 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 213

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 86
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 145
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 146 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 182

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
           +E +++  + H  ++K+  +   E    L+L+++  G L   L S   +         + 
Sbjct: 79  MERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA 137
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++A  L++LH   S  +I+ DLKP N+LLD+     L+DF ++K     D         G
Sbjct: 138 ELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCG 192
Query: 590 TIGYMAP 596
           T+ YMAP
Sbjct: 193 TVEYMAP 199

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 174
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 175 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           LE +H  +   ++H DLKP+N L+ D M+  L DF IA  +  +   + +   +GT+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 595 AP 596
            P
Sbjct: 196 PP 197

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+++D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 63/140 (45%), Gaps = 10/140 (7%)
Query: 460 LFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 519
           L  R F+  + E  + + ++H N++++  S   E F  LV + +  G     L+      
Sbjct: 44  LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAR 99
Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLT 576
           + +   +    +   LE + + +S  ++H +LKP N+LL          L+DF +A  + 
Sbjct: 100 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV- 158
Query: 577 GEDQSMTQTQTLGTIGYMAP 596
             + S       GT GY++P
Sbjct: 159 --NDSEAWHGFAGTPGYLSP 176

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 109
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 168
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 169 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 205

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
           LE +H  +   ++H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +G + YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 595 AP 596
            P
Sbjct: 224 PP 225

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+ ++  ++ +  I   L I   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPL-IKSY 107
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T T  + T
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 165
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 166 LWYRAP 171

>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 2/91 (2%)
Query: 185 LTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC-RLAELYRLELGS 243
           LT+L ++ LGGNKL         KL  L  LNL  N L+ S+P+ +  +L +L  L L +
Sbjct: 51  LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNT 109
Query: 244 NKLYGSIPACFGNLASLRILSLGSNKLTSIP 274
           N+L       F  L  L+ L L  N+L S+P
Sbjct: 110 NQLQSLPDGVFDKLTQLKDLRLYQNQLKSVP 140

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 89
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 148
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 149 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 185

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 79/181 (43%), Gaps = 41/181 (22%)
Query: 175 SGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNI---LEGSIPDDIC 231
           S   P + S     V+     +K + S+P   G     Q L L DN    LE  + D + 
Sbjct: 10  SAACPSQCSCSGTTVDCR---SKRHASVPA--GIPTNAQILYLHDNQITKLEPGVFDSLI 64
Query: 232 RLAELYRLELGSNKLYGSIP-ACFGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFS 289
            L ELY   LGSN+L G++P   F +L  L +L LG+N+LT +P   F  L  + +L   
Sbjct: 65  NLKELY---LGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC 120
Query: 290 SNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
            N LT                          +PR I E+L++L  L L  N+LK  IP G
Sbjct: 121 CNKLTE-------------------------LPRGI-ERLTHLTHLALDQNQLK-SIPHG 153
Query: 350 G 350
Sbjct: 154 A 154

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 94
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 153
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 154 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 190

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 100
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 159
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 160 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 196

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 134/303 (44%), Gaps = 44/303 (14%)
Query: 63  KLYLWGNNFSGTIPRFIFN-ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           K  L   N + T+ +   +  + L    LG+ S  G        L NL Q+    N LT 
Sbjct: 27  KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQINFSNNQLTD 81
Query: 122 STP---------------ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
            TP               +++ ++ L+N  +LT + L NN +  I P  +++NL+R LE 
Sbjct: 82  ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR-LEL 140
Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
                 +IS      +S LT+L ++   GN++    P  L  L  L+RL++  N +    
Sbjct: 141 SSNTISDISA-----LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVS--- 189
Query: 227 PDDICRLAELYRLE--LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDIL 284
             DI  LA+L  LE  + +N     I    G L +L  LSL  N+L  I  T  +L ++ 
Sbjct: 190 --DISVLAKLTNLESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDIG-TLASLTNLT 245
Query: 285 QLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
            L+ ++N ++   L  +  L  L  +    N  S + P      L+ L +L L+ N+L+ 
Sbjct: 246 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPL---AGLTALTNLELNENQLED 300
Query: 345 EIP 347
             P
Sbjct: 301 ISP 303

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 63/152 (41%), Gaps = 26/152 (17%)
Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----C------ 517
           F  E  +M    + N++K++  C+  +   L+ EYM +G L ++L S +    C      
Sbjct: 97  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 518 -------------ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVA 564
                         L   ++L I   VA+ + YL        +H DL   N L+ +NMV 
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVV 213
Query: 565 HLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            ++DF +++ +   D           I +M P
Sbjct: 214 KIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 152
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 153 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+++D      ++DF +AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 134/303 (44%), Gaps = 44/303 (14%)
Query: 63  KLYLWGNNFSGTIPRFIFN-ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           K  L   N + T+ +   +  + L    LG+ S  G        L NL Q+    N LT 
Sbjct: 28  KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQINFSNNQLTD 82
Query: 122 STP---------------ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
            TP               +++ ++ L+N  +LT + L NN +  I P  +++NL+R LE 
Sbjct: 83  ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR-LEL 141
Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
                 +IS      +S LT+L ++   GN++    P  L  L  L+RL++  N +    
Sbjct: 142 SSNTISDISA-----LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVS--- 190
Query: 227 PDDICRLAELYRLE--LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDIL 284
             DI  LA+L  LE  + +N     I    G L +L  LSL  N+L  I  T  +L ++ 
Sbjct: 191 --DISVLAKLTNLESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDIG-TLASLTNLT 246
Query: 285 QLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
            L+ ++N ++   L  +  L  L  +    N  S + P      L+ L +L L+ N+L+ 
Sbjct: 247 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPL---AGLTALTNLELNENQLED 301
Query: 345 EIP 347
             P
Sbjct: 302 ISP 304

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 152
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 153 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 63/140 (45%), Gaps = 9/140 (6%)
Query: 460 LFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 519
           L  R  +  + E  + + ++H N++++  S S E    L+ + +  G     L+      
Sbjct: 60  LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAR 115
Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM---VAHLSDFSIAKLLT 576
           + +   +    +   LE +   +   V+H DLKP N+LL   +      L+DF +A  + 
Sbjct: 116 EYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE 175
Query: 577 GEDQSMTQTQTLGTIGYMAP 596
           GE Q+       GT GY++P
Sbjct: 176 GEQQAWFGFA--GTPGYLSP 193

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 85
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 144
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 145 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 181

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           +V+EY+  GSL   + +  C +D  Q   +  +   ALE+LH   S  VIH D+K  N+L
Sbjct: 94  VVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNIL 148
Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           L  +    L+DF     +T E     ++  +GT  +MAP
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAP 185

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           +V+EY+  GSL   + +  C +D  Q   +  +   ALE+LH   S  VIH D+K  N+L
Sbjct: 94  VVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNIL 148
Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           L  +    L+DF     +T E QS   T  +GT  +MAP
Sbjct: 149 LGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAP 185

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           +V+EY+  GSL   + +  C +D  Q   +  +   ALE+LH   S  VIH D+K  N+L
Sbjct: 95  VVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNIL 149
Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           L  +    L+DF     +T E     ++  +GT  +MAP
Sbjct: 150 LGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAP 186

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/71 (39%), Positives = 38/71 (53%), Gaps = 5/71 (7%)
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            I + +  ALE+LH   S  VIH D+KPSNVL++      + DF I+  L     S+ +T
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKT 211
Query: 586 QTLGTIGYMAP 596
              G   YMAP
Sbjct: 212 IDAGCKPYMAP 222

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 140
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 141 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 82
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 141
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 142 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 178

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 140
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 141 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY P G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+++D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKVI-- 487
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 488 ----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
                   +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 140
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 141 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY P G +  +L       +   R      
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+++D      ++DF  AK + G    +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GT 202
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 203 PEYLAP 208

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 62/129 (48%), Gaps = 8/129 (6%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFK-ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
            E ++++ IR    +  +      E K  L+L+Y+  G L  +L       +    + I 
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIY 164
Query: 529 I-DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
           + ++  ALE+LH      +I+ D+K  N+LLD N    L+DF ++K     D++      
Sbjct: 165 VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDF 220
Query: 588 LGTIGYMAP 596
            GTI YMAP
Sbjct: 221 CGTIEYMAP 229

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 9/99 (9%)
Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           +V+EY P G +  +L       +   R      +    EYLH   S  +I+ DLKP N++
Sbjct: 119 MVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLM 174
Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +D      ++DF  AK + G    +      GT  Y+AP
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 63/140 (45%), Gaps = 10/140 (7%)
Query: 460 LFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 519
           L  R F+  + E  + + ++H N++++  S   E F  LV + +  G     L+      
Sbjct: 44  LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAR 99
Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLT 576
           + +   +    +   LE + + +S  ++H +LKP N+LL          L+DF +A  + 
Sbjct: 100 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV- 158
Query: 577 GEDQSMTQTQTLGTIGYMAP 596
             + S       GT GY++P
Sbjct: 159 --NDSEAWHGFAGTPGYLSP 176

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 60/133 (45%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +   
Sbjct: 63  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ 121
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 122 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 178
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 179 HAEGGKVPIKWMA 191

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  +++ ++H  ++ +I +        L+LEY+  G L   L      ++       + 
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLA 128
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           +++ AL +LH      +I+ DLKP N++L+      L+DF + K  +  D ++T T   G
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHT-FCG 183
Query: 590 TIGYMAP 596
           TI YMAP
Sbjct: 184 TIEYMAP 190

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 11/135 (8%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           +  + E  +++ IRH N+I +     N+    L+LE +  G L  +L     + +  +  
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EAT 132
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLTGEDQS 581
             +  +   + YLH   S  + H DLKP N++L D  V +    L DF IA  +   ++ 
Sbjct: 133 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 189
Query: 582 MTQTQTLGTIGYMAP 596
                  GT  ++AP
Sbjct: 190 ---KNIFGTPEFVAP 201

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 63/140 (45%), Gaps = 10/140 (7%)
Query: 460 LFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 519
           L  R F+  + E  + + ++H N++++  S   E F  LV + +  G     L+      
Sbjct: 43  LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAR 98
Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLT 576
           + +   +    +   LE + + +S  ++H +LKP N+LL          L+DF +A  + 
Sbjct: 99  EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV- 157
Query: 577 GEDQSMTQTQTLGTIGYMAP 596
             + S       GT GY++P
Sbjct: 158 --NDSEAWHGFAGTPGYLSP 175

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 12/132 (9%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI- 529
           E +++   RH N+I +         +A+   Y+    +E  LY    +L   Q  N  I 
Sbjct: 91  EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK---LLKSQQLSNDHIC 147
Query: 530 ----DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQ 584
                +   L+Y+H   SA V+H DLKPSN+L++      + DF +A++   E D +   
Sbjct: 148 YFLYQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFL 204
Query: 585 TQTLGTIGYMAP 596
           T+ + T  Y AP
Sbjct: 205 TEXVATRWYRAP 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 60/133 (45%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +   
Sbjct: 60  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQ 118
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 119 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 175
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 176 HAEGGKVPIKWMA 188

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 60/133 (45%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +   
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ 119
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 120 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 176
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 177 HAEGGKVPIKWMA 189

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 60/133 (45%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +   
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ 120
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 121 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 178 HAEGGKVPIKWMA 190

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 11/135 (8%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           +  + E  +++ IRH N+I +     N+    L+LE +  G L  +L     + +  +  
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EAT 118
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLTGEDQS 581
             +  +   + YLH   S  + H DLKP N++L D  V +    L DF IA  +   ++ 
Sbjct: 119 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 175
Query: 582 MTQTQTLGTIGYMAP 596
                  GT  ++AP
Sbjct: 176 ---KNIFGTPEFVAP 187

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 11/135 (8%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           +  + E  +++ IRH N+I +     N+    L+LE +  G L  +L     + +  +  
Sbjct: 53  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EAT 111
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLTGEDQS 581
             +  +   + YLH   S  + H DLKP N++L D  V +    L DF IA  +   ++ 
Sbjct: 112 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 582 MTQTQTLGTIGYMAP 596
                  GT  ++AP
Sbjct: 169 ---KNIFGTPEFVAP 180

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+ ++  ++ +  I   L I   
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPL-IKSY 111
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 112 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 169
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 170 LWYRAP 175

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 60/133 (45%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +   
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ 124
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 125 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 182 HAEGGKVPIKWMA 194

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 51/113 (45%), Gaps = 19/113 (16%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC----------ILD 520
           E  +MK ++H N++++      E    LV E+M    L+KY+ S             ++ 
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            FQ           L+ L F +   ++H DLKP N+L++      L DF +A+
Sbjct: 112 YFQ--------WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 60/133 (45%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +   
Sbjct: 60  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ 118
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 119 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 175
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 176 HAEGGKVPIKWMA 188

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 60/133 (45%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +   
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ 117
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 118 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 175 HAEGGKVPIKWMA 187

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 62/115 (53%), Gaps = 8/115 (6%)
Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           ++++  +  ++++  +V+EYMP G L   L S+  + + + +     +V  AL+ +H   
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH--- 191
Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LGTIGYMAP 596
           S  +IH D+KP N+LLD +    L+DF     +  ++  M    T +GT  Y++P
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAVGTPDYISP 244

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 14/143 (9%)
Query: 458 FALFIRAFKSFDVECEMMKSIRHRNLIKVIS----SCSNEEFKALVLEYMPHGSLEKYLY 513
           F   I A +++  E  ++K ++H N+I ++     + S E+F  + L     G+    + 
Sbjct: 65  FQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV 123
Query: 514 SSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            S  + D   +  ++  +   L+Y+H   SA +IH DLKPSNV ++++    + DF +A+
Sbjct: 124 KSQALSDEHVQF-LVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR 179
Query: 574 LLTGEDQSMTQTQTLGTIGYMAP 596
                D+ M  T  + T  Y AP
Sbjct: 180 ---QADEEM--TGYVATRWYRAP 197

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 78/176 (44%), Gaps = 29/176 (16%)
Query: 445 DEFSENNLIGRGGFALFIRA-------------------FKSFDV-----ECEMMKSIRH 480
           ++F   NL+G+G FA   RA                   +K+  V     E ++   ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 481 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 540
            +++++ +   +  +  LVLE   +G + +YL +        +  + M  + + + YLH 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH- 129
Query: 541 GYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             S  ++H DL  SN+LL  NM   ++DF +A  L    +        GT  Y++P
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISP 181

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 5/71 (7%)
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            + + +  AL YL   +   VIH D+KPSN+LLD+     L DF I+  L  +     + 
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKD 182
Query: 586 QTLGTIGYMAP 596
           ++ G   YMAP
Sbjct: 183 RSAGCAAYMAP 193

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/71 (36%), Positives = 39/71 (54%), Gaps = 5/71 (7%)
Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            I+ ++   L+YLH   S   IH D+K +NVLL +     L+DF +A  LT  D  + + 
Sbjct: 120 TILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRN 174
Query: 586 QTLGTIGYMAP 596
             +GT  +MAP
Sbjct: 175 XFVGTPFWMAP 185

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQ 170
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 222
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 223 PEYLAP 228

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQ 144
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 145 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 196
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 197 PEYLAP 202

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 136
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D+     ++DF  AK + G    +      GT
Sbjct: 137 IVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GT 188
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 189 PEYLAP 194

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 22/139 (15%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSS-NCILD 520
           S + E  ++  I+H N++ +     +     L+++ +  G L     EK  Y+  +    
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLTG 577
           IFQ L+       A++YLH      ++H DLKP N+L   LD++    +SDF ++K+   
Sbjct: 122 IFQVLD-------AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--- 168
Query: 578 EDQSMTQTQTLGTIGYMAP 596
           ED     +   GT GY+AP
Sbjct: 169 EDPGSVLSTACGTPGYVAP 187

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 5/126 (3%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++K++     E    LV E++ H  L+ ++  ++ +  I   L I   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPL-IKSY 108
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +   L+ L F +S  V+H DLKP N+L++      L+DF +A+      +  T    + T
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVT 166
Query: 591 IGYMAP 596
           + Y AP
Sbjct: 167 LWYRAP 172

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 54/100 (54%), Gaps = 4/100 (4%)
Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           ++K ++H+N++++     +++   LV E+     L+KY  S N  LD     + +  +  
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            L + H   S  V+H DLKP N+L++ N    L++F +A+
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 11/127 (8%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 170
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G       T TL G
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ATWTLCG 221
Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 222 TPEYLAP 228

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 9/99 (9%)
Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           +V+EY P G +  +L       +   R      +    EYLH   S  +I+ DLKP N++
Sbjct: 119 MVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLM 174
Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +D      ++DF  AK + G    +      GT  Y+AP
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 9/99 (9%)
Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           +V+EY P G +  +L       +   R      +    EYLH   S  +I+ DLKP N++
Sbjct: 119 MVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLM 174
Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +D      ++DF  AK + G    +      GT  Y+AP
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/129 (24%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR---LNI 527
           E  ++ +++H N+++   S        +V++Y   G L K + +   +L  FQ    L+ 
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDW 130
Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            + +  AL+++H      ++H D+K  N+ L  +    L DF IA++L    +       
Sbjct: 131 FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARAC 185
Query: 588 LGTIGYMAP 596
           +GT  Y++P
Sbjct: 186 IGTPYYLSP 194

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  ++++ RH  L  +  +    +    V+EY   G L  +L       +   R     
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA 112
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++ SALEYLH   S  V++ D+K  N++LD +    ++DF + K   G     T     G
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 167
Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 168 TPEYLAP 174

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 7/128 (5%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + +  ++++I  C  E    LV+E    G L K+L      + +     ++  
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           V+  ++YL        +H DL   NVLL +   A +SDF ++K L G D S    ++ G 
Sbjct: 119 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGK 174
Query: 591 --IGYMAP 596
             + + AP
Sbjct: 175 WPLKWYAP 182

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 34/161 (21%)
Query: 447 FSENNLIGRGGFALFIRAF----------------KSF-DVECEMMKSIRHRNLIKV--- 486
           +++  +IG G F +  +A                 K F + E ++M+ + H N++++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 487 -ISSCSNEE--FKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 539
             SS   ++  +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H 
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 140
Query: 540 FGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAK-LLTGE 578
           FG    + H D+KP N+LLD D  V  L DF  AK L+ GE
Sbjct: 141 FG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNCIL 519
           + F  E   MK   H ++ K++        K       ++L +M HG L  +L +S    
Sbjct: 70  EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 520 DIF-----QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
           + F       +  M+D+A  +EYL    S   IH DL   N +L ++M   ++DF +++ 
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 575 LTGED 579
           +   D
Sbjct: 187 IYSGD 191

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  ++++ RH  L  +  +    +    V+EY   G L  +L       +   R     
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA 112
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++ SALEYLH   S  V++ D+K  N++LD +    ++DF + K   G     T     G
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 167
Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 168 TPEYLAP 174

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  ++++ RH  L  +  +    +    V+EY   G L  +L       +   R     
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA 112
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++ SALEYLH   S  V++ D+K  N++LD +    ++DF + K   G     T     G
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCG 167
Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 168 TPEYLAP 174

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  ++++ RH  L  +  +    +    V+EY   G L  +L       +   R     
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA 112
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++ SALEYLH   S  V++ D+K  N++LD +    ++DF + K   G     T     G
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCG 167
Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 168 TPEYLAP 174

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 65/138 (47%), Gaps = 20/138 (14%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDI 521
           S + E  ++  I+H N++ +     +     L+++ +  G L     EK  Y+       
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER----- 116
Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLTGE 578
                ++  V  A++YLH      ++H DLKP N+L   LD++    +SDF ++K+   E
Sbjct: 117 -DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---E 169
Query: 579 DQSMTQTQTLGTIGYMAP 596
           D     +   GT GY+AP
Sbjct: 170 DPGSVLSTACGTPGYVAP 187

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  ++++ RH  L  +  +    +    V+EY   G L  +L       +   R     
Sbjct: 57  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA 115
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++ SALEYLH   S  V++ D+K  N++LD +    ++DF + K   G     T     G
Sbjct: 116 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 170
Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 171 TPEYLAP 177

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  ++++ RH  L  +  +    +    V+EY   G L  +L       +   R     
Sbjct: 59  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA 117
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++ SALEYLH   S  V++ D+K  N++LD +    ++DF + K   G     T     G
Sbjct: 118 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCG 172
Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 173 TPEYLAP 179

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/181 (21%), Positives = 74/181 (40%), Gaps = 32/181 (17%)
Query: 442 RATDEFSENNLIGRGGFALFIRAFK-----------------------SFDVECEMMKSI 478
           R T+E+     +G+G F++  R  K                         + E  + + +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 479 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 538
           +H N++++  S S E    L+ + +  G     L+      + +   +    +   LE +
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAV 123
Query: 539 HFGYSALVIHCDLKPSNVLLDDNM---VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
              +   V+H +LKP N+LL   +      L+DF +A  + GE Q+       GT GY++
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLS 181
Query: 596 P 596
           P
Sbjct: 182 P 182

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 22/139 (15%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSS-NCILD 520
           S + E  ++  I+H N++ +     +     L+++ +  G L     EK  Y+  +    
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLTG 577
           IFQ L+       A++YLH      ++H DLKP N+L   LD++    +SDF ++K+   
Sbjct: 122 IFQVLD-------AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--- 168
Query: 578 EDQSMTQTQTLGTIGYMAP 596
           ED     +   GT GY+AP
Sbjct: 169 EDPGSVLSTACGTPGYVAP 187

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 6/127 (4%)
Query: 470 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
            E  ++++ RH  L  +  +    +    V+EY   G L  +L       +   R     
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA 112
Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
           ++ SALEYLH   S  V++ D+K  N++LD +    ++DF + K   G     T     G
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCG 167
Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 168 TPEYLAP 174

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 150
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 203 PEYLAP 208

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|3G3A|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor In Complex With A Protein Antigen Length = 178

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 31/86 (36%), Positives = 41/86 (47%), Gaps = 5/86 (5%)
Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           LYL+ N  +   P      ++L++L L  N  +      F  L  L QL L++N L  S 
Sbjct: 43  LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL-KSI 101
Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLD 149
           P  +F     N KSLT I L NNP D
Sbjct: 102 PRGAF----DNLKSLTHIWLLNNPWD 123

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 56/136 (41%), Gaps = 9/136 (6%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDI 521
           A   F  E   M S+ HRNLI++         K +V E  P GSL   L  +  + +L  
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQ 580
             R  +   VA  + YL    S   IH DL   N+LL    +  + DF + + L   +D 
Sbjct: 123 LSRYAVQ--VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 581 SMTQTQTLGTIGYMAP 596
            + Q        + AP
Sbjct: 178 XVMQEHRKVPFAWCAP 193

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 510 KYLYSSNCILD--IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS 567
           KY+YS   +LD  I + +   I +A+     H   +  +IH D+KPSN+LLD +    L 
Sbjct: 112 KYVYS---VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC 168
Query: 568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           DF I+  L     S+ +T+  G   YMAP
Sbjct: 169 DFGISGQLV---DSIAKTRDAGCRPYMAP 194

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQ 117
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 118 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 175 HAEGGKVPIKWMA 187

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 119
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 120 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 176
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 177 HAEGGKVPIKWMA 189

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 124
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 125 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 182 HAEGGKVPIKWMA 194

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 17/148 (11%)
Query: 463 RAFKSFDVECEMMKSI--RHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSN 516
           R  +S+  E E+ +++  RH N++  I++ + +        LV +Y  HGSL  YL    
Sbjct: 76  REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 135
Query: 517 CILDIFQRLNIMIDVASALEYLHF------GYSALVIHCDLKPSNVLLDDNMVAHLSDFS 570
             ++    + + +  AS L +LH       G  A+  H DLK  N+L+  N    ++D  
Sbjct: 136 VTVEGM--IKLALSTASGLAHLHMEIVGTQGKPAIA-HRDLKSKNILVKKNGTCCIADLG 192
Query: 571 IA-KLLTGEDQ-SMTQTQTLGTIGYMAP 596
           +A +  +  D   +     +GT  YMAP
Sbjct: 193 LAVRHDSATDTIDIAPNHRVGTKRYMAP 220

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 120
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 121 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 178 HAEGGKVPIKWMA 190

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 65/138 (47%), Gaps = 20/138 (14%)
Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDI 521
           S + E  ++  I+H N++ +     +     L+++ +  G L     EK  Y+       
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER----- 116
Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLTGE 578
                ++  V  A++YLH      ++H DLKP N+L   LD++    +SDF ++K+   E
Sbjct: 117 -DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---E 169
Query: 579 DQSMTQTQTLGTIGYMAP 596
           D     +   GT GY+AP
Sbjct: 170 DPGSVLSTACGTPGYVAP 187

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 84  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 142
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 143 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 199
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 200 HAEGGKVPIKWMA 212

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 120
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 121 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 178 HAEGGKVPIKWMA 190

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 120
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 121 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 178 HAEGGKVPIKWMA 190

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 471 ECEMMKSIRHRNLI---KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLN 526
           E +++   RH N+I    +I + + E+ K + +++ +    L K L + +   D      
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICY 128
Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQT 585
            +  +   L+Y+H   SA V+H DLKPSN+LL+      + DF +A++   + D +   T
Sbjct: 129 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT 185
Query: 586 QTLGTIGYMAP 596
           + + T  Y AP
Sbjct: 186 EYVATRWYRAP 196

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 118 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 175 HAEGGKVPIKWMA 187

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQ 149
Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G    +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 591 IGYMAP 596
             Y+AP
Sbjct: 202 PEYLAP 207

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 88  LSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNP 147
           L+L  NS       TF +LR+LE L L +N +         + + +   SL  ++L +N 
Sbjct: 40  LNLQENSIQVIRTDTFKHLRHLEILQLSKNLVRKIE-----VGAFNGLPSLNTLELFDNR 94
Query: 148 LDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG-NKLNGSIPITL 206
           L  + P  +   LS+ L E ++ N  I        + + +L  +DLG   +L        
Sbjct: 95  LTTV-PTQAFEYLSK-LRELWLRNNPIESIPSYAFNRVPSLRRLDLGELKRLEYISEAAF 152
Query: 207 GKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLG 266
             L  L+ LNL    L+  IP+ +  L  L  LEL  N+L    P  F  L SLR L L 
Sbjct: 153 EGLVNLRYLNLGMCNLK-DIPN-LTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLM 210
Query: 267 SNKLTSIPL-TFWNLKDILQLNFSSNFL 293
             ++ +I    F +LK + +LN S N L
Sbjct: 211 HAQVATIERNAFDDLKSLEELNLSHNNL 238

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 75/162 (46%), Gaps = 9/162 (5%)
Query: 185 LTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPD-DICRLAELYRLELGS 243
           L +L  ++L  N+L          L KL+ L L +N +E SIP     R+  L RL+LG 
Sbjct: 82  LPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLRRLDLGE 140
Query: 244 NKLYGSI-PACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIG 302
            K    I  A F  L +LR L+LG   L  IP     L  + +L  S N L    L+  G
Sbjct: 141 LKRLEYISEAAFEGLVNLRYLNLGMCNLKDIP-NLTALVRLEELELSGNRLD---LIRPG 196
Query: 303 NLKVLIGID--FSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
           + + L  +   + M+     I R   + L  LE+LNLS N L
Sbjct: 197 SFQGLTSLRKLWLMHAQVATIERNAFDDLKSLEELNLSHNNL 238

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 124
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 125 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 182 HAEGGKVPIKWMA 194

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 118 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 175 HAEGGKVPIKWMA 187

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 13/82 (15%)
Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-- 582
           L+I I +A A+E+LH   S  ++H DLKPSN+    + V  + DF +   +  +++    
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 583 --------TQTQTLGTIGYMAP 596
                   T    +GT  YM+P
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSP 245

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 65/131 (49%), Gaps = 10/131 (7%)
Query: 471 ECEMMKSIRHRNLI---KVISSCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDIFQRLN 526
           E +++   RH N+I    +I + + E+ K + L  ++    L K L + +   D      
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND--HICY 148
Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQT 585
            +  +   L+Y+H   SA V+H DLKPSN+LL+      + DF +A++   + D +   T
Sbjct: 149 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 205
Query: 586 QTLGTIGYMAP 596
           + + T  Y AP
Sbjct: 206 EYVATRWYRAP 216

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 56/136 (41%), Gaps = 9/136 (6%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDI 521
           A   F  E   M S+ HRNLI++         K +V E  P GSL   L  +  + +L  
Sbjct: 54  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT 112
Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQ 580
             R    + VA  + YL    S   IH DL   N+LL    +  + DF + + L   +D 
Sbjct: 113 LSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 581 SMTQTQTLGTIGYMAP 596
            + Q        + AP
Sbjct: 168 XVMQEHRKVPFAWCAP 183

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 67/131 (51%), Gaps = 10/131 (7%)
Query: 471 ECEMMKSIRHRNLI---KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLN 526
           E +++ + RH N+I    +I + + E+ K + +++ +    L K L + +   D      
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICY 130
Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQT 585
            +  +   L+Y+H   SA V+H DLKPSN+LL+      + DF +A++   + D +   T
Sbjct: 131 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 586 QTLGTIGYMAP 596
           + + T  Y AP
Sbjct: 188 EYVATRWYRAP 198

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 65  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 123
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 124 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 180
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 181 HAEGGKVPIKWMA 193

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 25/152 (16%)
Query: 463 RAFKSFDVECEMMKSI--RHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSN 516
           R  +S+  E E+ +++  RH N++  I++ + +        LV +Y  HGSL  YL    
Sbjct: 63  REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 122
Query: 517 CILDIFQRLNIMIDVASALEYLHF------GYSALVIHCDLKPSNVLLDDNMVAHLSDFS 570
             ++    + + +  AS L +LH       G  A+  H DLK  N+L+  N    ++D  
Sbjct: 123 VTVEGM--IKLALSTASGLAHLHMEIVGTQGKPAIA-HRDLKSKNILVKKNGTCCIADLG 179
Query: 571 IAKLLTGEDQSMTQT------QTLGTIGYMAP 596
           +A        S T T        +GT  YMAP
Sbjct: 180 LAV----RHDSATDTIDIAPNHRVGTKRYMAP 207

>pdb|3G39|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor Length = 170

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 31/86 (36%), Positives = 41/86 (47%), Gaps = 5/86 (5%)
Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           LYL+ N  +   P      ++L++L L  N  +      F  L  L QL L++N L  S 
Sbjct: 35  LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL-KSI 93
Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLD 149
           P  +F     N KSLT I L NNP D
Sbjct: 94  PRGAF----DNLKSLTHIWLLNNPWD 115

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +   
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ 119
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF  AKLL  E++  
Sbjct: 120 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 176
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 177 HAEGGKVPIKWMA 189

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/146 (21%), Positives = 65/146 (44%), Gaps = 18/146 (12%)
Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR- 524
           + F  E  +   ++H N++ ++   + ++  +++  Y  HG L ++L   +   D+    
Sbjct: 57  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 116
Query: 525 --------------LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS 570
                         ++++  +A+ +EYL    S  V+H DL   NVL+ D +   +SD  
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLG 173
Query: 571 IAKLLTGEDQSMTQTQTLGTIGYMAP 596
           + + +   D       +L  I +MAP
Sbjct: 174 LFREVYAADYYKLLGNSLLPIRWMAP 199

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 118 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 175 HAEGGKVPIKWMA 187

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 67/131 (51%), Gaps = 10/131 (7%)
Query: 471 ECEMMKSIRHRNLI---KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLN 526
           E +++ + RH N+I    +I + + E+ K + +++ +    L K L + +   D      
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICY 130
Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQT 585
            +  +   L+Y+H   SA V+H DLKPSN+LL+      + DF +A++   + D +   T
Sbjct: 131 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT 187
Query: 586 QTLGTIGYMAP 596
           + + T  Y AP
Sbjct: 188 EYVATRWYRAP 198

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 69  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 127
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 128 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 184
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 185 HAEGGKVPIKWMA 197

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +   
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ 119
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF  AKLL  E++  
Sbjct: 120 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 176
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 177 HAEGGKVPIKWMA 189

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 471 ECEMMKSIRHRNLI---KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLN 526
           E +++   RH N+I    +I + + E+ K + +++ +    L K L + +   D      
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICY 128
Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQT 585
            +  +   L+Y+H   SA V+H DLKPSN+LL+      + DF +A++   + D +   T
Sbjct: 129 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 586 QTLGTIGYMAP 596
           + + T  Y AP
Sbjct: 186 EYVATRWYRAP 196

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 25/152 (16%)
Query: 463 RAFKSFDVECEMMKSI--RHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSN 516
           R  +S+  E E+ +++  RH N++  I++ + +        LV +Y  HGSL  YL    
Sbjct: 43  REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 102
Query: 517 CILDIFQRLNIMIDVASALEYLHF------GYSALVIHCDLKPSNVLLDDNMVAHLSDFS 570
             ++    + + +  AS L +LH       G  A+  H DLK  N+L+  N    ++D  
Sbjct: 103 VTVEGM--IKLALSTASGLAHLHMEIVGTQGKPAIA-HRDLKSKNILVKKNGTCCIADLG 159
Query: 571 IAKLLTGEDQSMTQT------QTLGTIGYMAP 596
           +A        S T T        +GT  YMAP
Sbjct: 160 LAV----RHDSATDTIDIAPNHRVGTKRYMAP 187

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 17/148 (11%)
Query: 463 RAFKSFDVECEMMKSI--RHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSN 516
           R  +S+  E E+ +++  RH N++  I++ + +        LV +Y  HGSL  YL    
Sbjct: 40  REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 99
Query: 517 CILDIFQRLNIMIDVASALEYLHF------GYSALVIHCDLKPSNVLLDDNMVAHLSDFS 570
             ++    + + +  AS L +LH       G  A+  H DLK  N+L+  N    ++D  
Sbjct: 100 VTVEGM--IKLALSTASGLAHLHMEIVGTQGKPAIA-HRDLKSKNILVKKNGTCCIADLG 156
Query: 571 IA-KLLTGEDQ-SMTQTQTLGTIGYMAP 596
           +A +  +  D   +     +GT  YMAP
Sbjct: 157 LAVRHDSATDTIDIAPNHRVGTKRYMAP 184

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 471 ECEMMKSIRHRNLI---KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLN 526
           E +++   RH N+I    +I + + E+ K + +++ +    L K L + +   D      
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICY 132
Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQT 585
            +  +   L+Y+H   SA V+H DLKPSN+LL+      + DF +A++   + D +   T
Sbjct: 133 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 586 QTLGTIGYMAP 596
           + + T  Y AP
Sbjct: 190 EYVATRWYRAP 200

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 462 IRAFKSFDVECEMMKSIRHRNLIKVIS-SCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 520
           ++  ++F  E  +M+ + H N++ +I      E    ++L YM HG L +++ S      
Sbjct: 63  MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122
Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK-LLTGED 579
           +   ++  + VA  +EYL        +H DL   N +LD++    ++DF +A+ +L  E 
Sbjct: 123 VKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179
Query: 580 QSMTQ 584
            S+ Q
Sbjct: 180 YSVQQ 184

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 93  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 151
Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             LN  + +A  + YL       ++H DL   NVL+       ++DF +AKLL  E++  
Sbjct: 152 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 208
Query: 583 TQTQTLGTIGYMA 595
                   I +MA
Sbjct: 209 HAEGGKVPIKWMA 221

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 56/136 (41%), Gaps = 9/136 (6%)
Query: 464 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDI 521
           A   F  E   M S+ HRNLI++         K +V E  P GSL   L  +  + +L  
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQ 580
             R  +   VA  + YL    S   IH DL   N+LL    +  + DF + + L   +D 
Sbjct: 123 LSRYAVQ--VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 581 SMTQTQTLGTIGYMAP 596
            + Q        + AP
Sbjct: 178 YVMQEHRKVPFAWCAP 193

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 81/199 (40%), Gaps = 58/199 (29%)
Query: 440 LCRATDEFSENNLIGRGGFALFIRAFKSFDVE---------------------------- 471
           LCRA  ++     IG G +    + FK+ D++                            
Sbjct: 6   LCRADQQYECVAEIGEGAYG---KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 472 --CEMMKSIRHRNLIKVISSCS----NEEFK-ALVLEYMPHGSLEKYL-------YSSNC 517
                +++  H N++++   C+    + E K  LV E++    L  YL         +  
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 518 ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 577
           I D+      M  +   L++LH   S  V+H DLKP N+L+  +    L+DF +A++ + 
Sbjct: 122 IKDM------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 578 EDQSMTQTQTLGTIGYMAP 596
           +   M  T  + T+ Y AP
Sbjct: 173 Q---MALTSVVVTLWYRAP 188

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 84/185 (45%), Gaps = 33/185 (17%)
Query: 438 LELCRATDEFSENNLIGRGGFA-LFIRAFKSF------------------DVECEMMK-- 476
           L++    ++F  + ++G+G F  +F+  FK                    DVEC M++  
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 70
Query: 477 ----SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 532
               +  H  L  +  +   +E    V+EY+  G L  ++ S +   D+ +      ++ 
Sbjct: 71  VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEII 129
Query: 533 SALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LTGEDQSMTQTQTLGTI 591
             L++LH   S  +++ DLK  N+LLD +    ++DF + K  + G+ ++    +  GT 
Sbjct: 130 LGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NEFCGTP 183
Query: 592 GYMAP 596
            Y+AP
Sbjct: 184 DYIAP 188

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	596
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-94
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-93
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-84
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-79
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-76
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-16
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-76
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-63
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-53
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-41
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-64
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-61
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-44
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-30
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-57
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-56
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-54
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-35
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-55
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-52
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-48
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-39
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-48
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-47
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-45
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-43
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-42
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-26
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-46
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-45
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-45
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-43
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-43
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-45
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-45
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-43
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-40
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-39
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-35
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-34
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-38
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-32
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-30
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-26
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-36
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-41
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-39
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-39
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-37
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-27
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-07
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-37
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-36
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-23
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-22
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-34
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-34
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-34
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-20
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-23
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-14
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-34
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-33
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-31
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-24
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-23
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-19
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-13
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-33
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-33
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-22
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-32
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-30
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-32
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-14
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-32
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-32
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-32
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-31
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-12
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-30
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-28
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-21
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-17
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-15
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-30
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-08
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-29
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-18
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-17
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-20
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-21
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-19
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-10
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-15
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-20
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-20
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-15
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-20
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-20
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-20
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-09
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-07
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-19
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-19
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-05
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-18
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-14
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-18
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-17
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-07
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-17
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-17
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-17
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-16
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-16
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-16
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-16
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-15
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-04
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-04
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-15
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-12
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-15
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-15
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-14
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-14
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-14
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-14
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-14
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-14
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-13
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-13
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-13
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-10
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-13
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-13
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-13
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-13
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-13
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-05
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-13
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-13
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-13
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-12
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-12
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-12
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-12
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-05
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-06
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-12
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-12
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-04
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-12
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-12
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-12
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-12
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-11
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-11
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-11
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-11
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-11
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-11
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-11
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-11
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	9e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-11
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-10
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-10
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-10
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-10
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-10
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-10
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-10
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-09
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-09
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-07
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-08
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-08
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-07
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-07
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	7e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	6e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  304 bits (781), Expect = 4e-94
 Identities = 126/419 (30%), Positives = 181/419 (43%), Gaps = 18/419 (4%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
            IP  +G+   L+ L +  NKL G    AI   + LK L + +N   G +  +    L +
Sbjct: 215 GIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKS 270

Query: 61  LEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
           L+ L L  N F+G IP F+      L+ L L  N F G +P  FG+   LE L L  N  
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330

Query: 120 TSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
           +   P      +L   + L ++DLS N   G LP  S++NLS SL    + + N SG I 
Sbjct: 331 SGELPM----DTLLKMRGLKVLDLSFNEFSGELP-ESLTNLSASLLTLDLSSNNFSGPIL 385

Query: 180 EEISN--LTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELY 237
             +       L E+ L  N   G IP TL    +L  L+L  N L G+IP  +  L++L 
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445

Query: 238 RLELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGP 296
            L+L  N L G IP     + +L  L L  N LT  IP    N  ++  ++ S+N LTG 
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505

Query: 297 LLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFS 356
           +   IG L+ L  +  S N+FSG IP E+G     L  L+L+ N   G IP   +    S
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIPAELG-DCRSLIWLDLNTNLFNGTIPA--AMFKQS 562

Query: 357 AESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRQ 415
            +       + G   + +             N L    +       L       +  R 
Sbjct: 563 GK--IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  301 bits (773), Expect = 5e-93
 Identities = 127/460 (27%), Positives = 171/460 (37%), Gaps = 87/460 (18%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPA-AIFNVSTLKFLGLQNNSLSGSL-SSIANVRL 58
            +P   G+   LE L L  N   G +P   +  +  LK L L  N  SG L  S+ N+  
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLS- 367

Query: 59  PNLEKLYLWGNNFSGTIPRFIFNASK--LSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE 116
            +L  L L  NNFSG I   +    K  L +L L  N F+G IP T  N   L  L L  
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427

Query: 117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG 176
           NYL+ + P     SSL +   L  + L  N L+G +P   +  +  +LE   +   +++G
Sbjct: 428 NYLSGTIP-----SSLGSLSKLRDLKLWLNMLEGEIP-QELMYVK-TLETLILDFNDLTG 480

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAEL 236
            IP  +SN TNL  I L  N+L G IP  +G+L  L  L L +N   G+IP ++     L
Sbjct: 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL 540

Query: 237 YRLELGSNKLYGSIPACFGNL--------------------ASLRILSLGSNKLT---SI 273
             L+L +N   G+IPA                            +      N L      
Sbjct: 541 IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600

Query: 274 PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLE 333
                 L      N +S    G       N   ++ +D S N  SG IP+EIG  + YL 
Sbjct: 601 SEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG-SMPYLF 659

Query: 334 DLNLSFNKLKGEIP---------------------------------------------- 347
            LNL  N + G IP                                              
Sbjct: 660 ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 719

Query: 348 --RGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTS 385
               G F  F    F  N  LCG P   +P C  S     
Sbjct: 720 IPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGY 756

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  278 bits (714), Expect = 2e-84
 Identities = 103/364 (28%), Positives = 155/364 (42%), Gaps = 24/364 (6%)

Query: 2   IPLEIG-NLQNLEELQLGQNKLIGTVPAAIF---NVSTLKFLGLQNNSLSGSLSSIANVR 57
             +  G  L +LE L L  N + G              LK L +  N +SG +  ++   
Sbjct: 142 GKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV-DVSR-- 198

Query: 58  LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
             NLE L +  NNFS  IP F+ + S L  L +  N  SG           L+ L +  N
Sbjct: 199 CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257

Query: 118 YLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGG 177
                 P           KSL  + L+ N   G +P         +L    +   +  G 
Sbjct: 258 QFVGPIPP-------LPLKSLQYLSLAENKFTGEIPDFLSGACD-TLTGLDLSGNHFYGA 309

Query: 178 IPEEISNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDICRL-AE 235
           +P    + + L  + L  N  +G +P+ TL K+R L+ L+L  N   G +P+ +  L A 
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369

Query: 236 LYRLELGSNKLYGSIPACFGN--LASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNF 292
           L  L+L SN   G I          +L+ L L +N  T  IP T  N  +++ L+ S N+
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429

Query: 293 LTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSF 352
           L+G +   +G+L  L  +   +N   G IP+E+   +  LE L L FN L GEIP     
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM-YVKTLETLILDFNDLTGEIPS--GL 486

Query: 353 GNFS 356
            N +
Sbjct: 487 SNCT 490

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  263 bits (675), Expect = 7e-79
 Identities = 98/366 (26%), Positives = 164/366 (44%), Gaps = 25/366 (6%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV-RLP 59
            +   + +L  LE L L  + + G+V       ++L  L L  NSLSG ++++ ++    
Sbjct: 68  AVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126

Query: 60  NLEKLYLWGNNFSGTIPR-FIFNASKLSKLSLGMNSFSGFIPSTF---GNLRNLEQLGLD 115
            L+ L +  N              + L  L L  NS SG     +        L+ L + 
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186

Query: 116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS 175
            N ++           +S C +L  +D+S+N     +P   + + S +L+   +    +S
Sbjct: 187 GNKISGDVD-------VSRCVNLEFLDVSSNNFSTGIP--FLGDCS-ALQHLDISGNKLS 236

Query: 176 GGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC-RLA 234
           G     IS  T L  +++  N+  G IP     L+ LQ L+L +N   G IPD +     
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACD 294

Query: 235 ELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPL-TFWNLKDILQLNFSSNF 292
            L  L+L  N  YG++P  FG+ + L  L+L SN  +  +P+ T   ++ +  L+ S N 
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354

Query: 293 LTGPLLLEIGNLKV-LIGIDFSMNNFSGVIPREIGE-KLSYLEDLNLSFNKLKGEIPRGG 350
            +G L   + NL   L+ +D S NNFSG I   + +   + L++L L  N   G+IP   
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP-- 412

Query: 351 SFGNFS 356
           +  N S
Sbjct: 413 TLSNCS 418

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  256 bits (656), Expect = 3e-76
 Identities = 90/361 (24%), Positives = 152/361 (42%), Gaps = 22/361 (6%)

Query: 8   NLQNLEELQLGQNKL---IGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKL 64
               +  + L    L      V +++ +++ L+ L L N+ ++GS+S        +L  L
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKC--SASLTSL 105

Query: 65  YLWGNNFSGTIP--RFIFNASKLSKLSLGMNSFSGFIP-STFGNLRNLEQLGLDENYLTS 121
            L  N+ SG +     + + S L  L++  N+       S    L +LE L L  N ++ 
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
           +            C  L  + +S N + G +    +S    +LE   + + N S GIP  
Sbjct: 166 ANV--VGWVLSDGCGELKHLAISGNKISGDVD---VSRCV-NLEFLDVSSNNFSTGIPF- 218

Query: 182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLEL 241
           + + + L  +D+ GNKL+G     +    +L+ LN+  N   G IP    +   L  L L
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK--SLQYLSL 276

Query: 242 GSNKLYGSIPAC-FGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLL 299
             NK  G IP    G   +L  L L  N    ++P  F +   +  L  SSN  +G L +
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336

Query: 300 E-IGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAE 358
           + +  ++ L  +D S N FSG +P  +    + L  L+LS N   G I    +       
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP--NLCQNPKN 394

Query: 359 S 359
           +
Sbjct: 395 T 395

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 82.6 bits (205), Expect = 1e-16
 Identities = 30/122 (24%), Positives = 51/122 (41%), Gaps = 5/122 (4%)

Query: 231 CRLAELYRLELGSNKLY---GSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLN 287
           CR  ++  ++L S  L     ++ +   +L  L  L L ++ +      F     +  L+
Sbjct: 47  CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLD 106

Query: 288 FSSNFLTG--PLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE 345
            S N L+G    L  +G+   L  ++ S N          G KL+ LE L+LS N + G 
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 346 IP 347
             
Sbjct: 167 NV 168

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  243 bits (623), Expect = 5e-76
 Identities = 83/314 (26%), Positives = 142/314 (45%), Gaps = 42/314 (13%)

Query: 69  NNFSGTIPRFIFNASKLSKLSLGMNSFSG--FIPSTFGNLRNLEQLGL-DENYLTSSTPE 125
             + G +        +++ L L   +      IPS+  NL  L  L +   N L    P 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP- 94

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNL 185
                +++    L  + +++                           N+SG IP+ +S +
Sbjct: 95  ----PAIAKLTQLHYLYITHT--------------------------NVSGAIPDFLSQI 124

Query: 186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYR-LELGSN 244
             LV +D   N L+G++P ++  L  L  +  + N + G+IPD     ++L+  + +  N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184

Query: 245 KLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGN 303
           +L G IP  F NL +L  + L  N L     + F + K+  +++ + N L    L ++G 
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD-LGKVGL 242

Query: 304 LKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGN 363
            K L G+D   N   G +P+ +  +L +L  LN+SFN L GEIP+GG+   F   ++  N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301

Query: 364 ELLCGSPNLQVPPC 377
           + LCGSP   +P C
Sbjct: 302 KCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  210 bits (537), Expect = 2e-63
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 18/280 (6%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGT--VPAAIFNVSTLKFLGLQN-NSLSGSL-SSIANVR 57
           +         +  L L    L     +P+++ N+  L FL +   N+L G +  +IA   
Sbjct: 42  LCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK-- 99

Query: 58  LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
           L  L  LY+   N SG IP F+     L  L    N+ SG +P +  +L NL  +  D N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159

Query: 118 YLTSSTPELSFLSSLSNCKSL-TLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG 176
            ++ + P      S  +   L T + +S N L G +P  + +NL  +L    +    + G
Sbjct: 160 RISGAIP-----DSYGSFSKLFTSMTISRNRLTGKIPP-TFANL--NLAFVDLSRNMLEG 211

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAEL 236
                  +  N  +I L  N L   +   +G  + L  L+L +N + G++P  + +L  L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270

Query: 237 YRLELGSNKLYGSIPACFGNLASLRILSLGSNK-LTSIPL 275
           + L +  N L G IP   GNL    + +  +NK L   PL
Sbjct: 271 HSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPL 309

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  182 bits (465), Expect = 5e-53
 Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 14/222 (6%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSL-SSIANVRLP 59
            IP  I  L  L  L +    + G +P  +  + TL  L    N+LSG+L  SI++  LP
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS--LP 149

Query: 60  NLEKLYLWGNNFSGTIPRFIFNASKLSK-LSLGMNSFSGFIPSTFGNLRNLEQLGLDENY 118
           NL  +   GN  SG IP    + SKL   +++  N  +G IP TF NL NL  + L  N 
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM 208

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
           L              + K+   I L+ N L   L    +    ++L    + N  I G +
Sbjct: 209 LEGDAS-----VLFGSDKNTQKIHLAKNSLAFDLG--KVGLS-KNLNGLDLRNNRIYGTL 260

Query: 179 PEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN 220
           P+ ++ L  L  +++  N L G IP   G L++       +N
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  150 bits (381), Expect = 4e-41
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 9/189 (4%)

Query: 171 NCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPI--TLGKLRKLQRLNLED-NILEGSIP 227
           N    G + +  +    +  +DL G  L    PI  +L  L  L  L +   N L G IP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 228 DDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT-SIPLTFWNLKDILQL 286
             I +L +L+ L +    + G+IP     + +L  L    N L+ ++P +  +L +++ +
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154

Query: 287 NFSSNFLTGPLLLEIGNLKVLI-GIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE 345
            F  N ++G +    G+   L   +  S N  +G IP      L+ L  ++LS N L+G+
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NLN-LAFVDLSRNMLEGD 212

Query: 346 IPRGGSFGN 354
                 FG+
Sbjct: 213 ASV--LFGS 219

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  222 bits (567), Expect = 2e-64
 Identities = 55/376 (14%), Positives = 114/376 (30%), Gaps = 42/376 (11%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIAN------ 55
             L+  NL++L ++++     +  +P  +  +  ++ + +  N          +      
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300

Query: 56  -VRLPNLEKLYLWGNNF-SGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLG 113
                 ++ +Y+  NN  +  +   +    KL  L    N   G +P+ FG+   L  L 
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLN 359

Query: 114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCN 173
           L  N +T               + +  +  ++N L  I       ++S  +         
Sbjct: 360 LAYNQITEIPANF-----CGFTEQVENLSFAHNKLKYIPNIFDAKSVS-VMSAIDFSYNE 413

Query: 174 ISG-------GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEG-- 224
           I          +        N+  I+L  N+++            L  +NL  N+L    
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473

Query: 225 -----SIPDDICRLAELYRLELGSNKLYGSIPA--CFGNLASLRILSLGSNKLTSIPLTF 277
                   ++      L  ++L  NKL   +        L  L  + L  N  +  P   
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSKFPTQP 532

Query: 278 WNLKDI------LQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSY 331
            N   +       Q +   N         I     L  +    N+    +  +I      
Sbjct: 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI---TPN 588

Query: 332 LEDLNLSFNKLKGEIP 347
           +  L++  N       
Sbjct: 589 ISVLDIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  214 bits (546), Expect = 2e-61
 Identities = 70/378 (18%), Positives = 131/378 (34%), Gaps = 38/378 (10%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIG----TVPAAIFNVSTLKFLGLQNNSLSGS-LSSIAN 55
            +P  IG L  LE L LG +          P  I    + +           + +     
Sbjct: 96  RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPR 155

Query: 56  VRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD 115
               +L K  +  +    +I +      K +++    N+ +  +      L  L Q  + 
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMG 214

Query: 116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS 175
            +   +             C++    +                NL   L +  +YNC   
Sbjct: 215 NSPFVAENI----------CEAWENENSEYAQQYKTEDL-KWDNLK-DLTDVEVYNCPNL 262

Query: 176 GGIPEEISNLTNLVEIDLGGNKL--------NGSIPITLGKLRKLQRLNLEDN-ILEGSI 226
             +P  +  L  +  I++  N+         +           K+Q + +  N +    +
Sbjct: 263 TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPV 322

Query: 227 PDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFW-NLKDILQ 285
              + ++ +L  LE   N+L G +PA FG+   L  L+L  N++T IP  F    + +  
Sbjct: 323 ETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVEN 381

Query: 286 LNFSSNFLTG-PLLLEIGNLKVLIGIDFSMNNFSGVIPREIGE------KLSYLEDLNLS 338
           L+F+ N L   P + +  ++ V+  IDFS N    V  +          K   +  +NLS
Sbjct: 382 LSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441

Query: 339 FNKLKGEIPRGGSFGNFS 356
            N++         F   S
Sbjct: 442 NNQISKFPK--ELFSTGS 457

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  194 bits (494), Expect = 3e-54
 Identities = 57/333 (17%), Positives = 98/333 (29%), Gaps = 25/333 (7%)

Query: 2   IPLEIGNLQNLEELQLGQNKLI-GTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
              +    + ++ + +G N L    V  ++  +  L  L    N L G L +  +     
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS--EIK 354

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTF-GNLRNLEQLGLDENYL 119
           L  L L  N  +     F     ++  LS   N            ++  +  +    N +
Sbjct: 355 LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEI 414

Query: 120 TSSTPEL--SFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG- 176
            S   +       +     +++ I+LSNN +    PK   S  S  L    +    ++  
Sbjct: 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF-PKELFSTGS-PLSSINLMGNMLTEI 472

Query: 177 ------GIPEEISNLTNLVEIDLGGNKLNGSIP-ITLGKLRKLQRLNLEDNILEGSIPDD 229
                    E   N   L  IDL  NKL           L  L  ++L  N      P  
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531

Query: 230 ICRLAELYRLELG------SNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDI 283
               + L    +        N+     P       SL  L +GSN +  +        +I
Sbjct: 532 PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNI 589

Query: 284 LQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNN 316
             L+   N      L  +             + 
Sbjct: 590 SVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  165 bits (419), Expect = 5e-44
 Identities = 49/290 (16%), Positives = 87/290 (30%), Gaps = 22/290 (7%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVST-LKFLGLQNNSLSGSLSSIANVRLP 59
                 G+   L  L L  N++   +PA     +  ++ L   +N L    +      + 
Sbjct: 344 GKLPAFGSEIKLASLNLAYNQI-TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS 402

Query: 60  NLEKLYLWGNNFSG-------TIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQL 112
            +  +    N            +    F    +S ++L  N  S F    F     L  +
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462

Query: 113 GLDENYLTSSTPEL--SFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMY 170
            L  N LT            +  N   LT IDL  N L  +      + L   L    + 
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLP-YLVGIDLS 521

Query: 171 NCNISGGIPEEISNLTNLVEIDLG------GNKLNGSIPITLGKLRKLQRLNLEDNILEG 224
             + S   P +  N + L    +       GN+     P  +     L +L +  N +  
Sbjct: 522 YNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR- 579

Query: 225 SIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP 274
            + + I     +  L++  N       +         +  L  +K   I 
Sbjct: 580 KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIR 627

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  123 bits (311), Expect = 8e-30
 Identities = 31/280 (11%), Positives = 84/280 (30%), Gaps = 24/280 (8%)

Query: 89  SLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPL 148
           +  ++ +      +  +   +  L L+    +   P      ++     L ++ L ++  
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP-----DAIGQLTELEVLALGSHGE 117

Query: 149 DGILPKTSISNLS--RSLEEFYMYNCNISGGIPEEIS--NLTNLVEIDLGGNKLNGSIPI 204
                      +S   S E+      +      +     + ++L++  +  +    SI  
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177

Query: 205 TLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILS 264
           +     K  ++    N +   +   + RL +L +  +G++              +     
Sbjct: 178 SSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ 236

Query: 265 LGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNF------- 317
                  +  L + NLKD+  +   +      L   +  L  +  I+ + N         
Sbjct: 237 Q----YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292

Query: 318 -SGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFS 356
                  +       ++ + + +N LK   P   S     
Sbjct: 293 DDWQALADAP-VGEKIQIIYIGYNNLK-TFPVETSLQKMK 330

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  202 bits (515), Expect = 8e-57
 Identities = 85/371 (22%), Positives = 130/371 (35%), Gaps = 21/371 (5%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
                    NL EL L  N +             L  L L +N LS S      V+L NL
Sbjct: 89  SDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS-STKLGTQVQLENL 147

Query: 62  EKLYLWGNNFSGTIPRFI--FNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
           ++L L  N         +  F  S L KL L  N    F P  F  +  L  L L+   L
Sbjct: 148 QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207

Query: 120 TSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
             S  E   L       S+  + LSN+ L      T +     +L    +   N++    
Sbjct: 208 GPSLTEKLCLEL--ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 180 EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI---------PDDI 230
           +  + L  L    L  N +      +L  L  ++ LNL+ +  + SI             
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

Query: 231 CRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL---TFWNL--KDILQ 285
             L  L  L +  N + G     F  L +L+ LSL ++  +   L   TF +L    +  
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385

Query: 286 LNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE 345
           LN + N ++         L  L  +D  +N     +  +    L  + ++ LS+NK    
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445

Query: 346 IPRGGSFGNFS 356
                SF    
Sbjct: 446 TR--NSFALVP 454

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  200 bits (510), Expect = 4e-56
 Identities = 75/374 (20%), Positives = 135/374 (36%), Gaps = 24/374 (6%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           ++P ++    N+  L L  N+L     A     S L  L +  N++S  L      +LP 
Sbjct: 18  QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK-LEPELCQKLPM 74

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L+ L L  N  S    +     + L++L L  NS      + F   +NL  L L  N L+
Sbjct: 75  LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPE 180
           S+        +    ++L  + LSNN +  +  +      + SL++  + +  I    P 
Sbjct: 135 STKL-----GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLG---KLRKLQRLNLEDNILEGSIPDDI--CRLAE 235
               +  L  + L   +L  S+   L        ++ L+L ++ L  +        +   
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249

Query: 236 LYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNFLT 294
           L  L+L  N L       F  L  L    L  N +  +   +   L ++  LN   +F  
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309

Query: 295 GPL---------LLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE 345
             +               LK L  ++   N+  G+        L  L+ L+LS +     
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT-GLINLKYLSLSNSFTSLR 368

Query: 346 IPRGGSFGNFSAES 359
                +F + +   
Sbjct: 369 TLTNETFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  195 bits (497), Expect = 2e-54
 Identities = 83/397 (20%), Positives = 139/397 (35%), Gaps = 34/397 (8%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLS--SIANVR-- 57
                  L  LE   L  N +      ++  +  +++L L+ +    S+S  S+  +   
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323

Query: 58  ----LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMN--SFSGFIPSTFGNLRN--L 109
               L  LE L +  N+  G           L  LSL  +  S       TF +L +  L
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383

Query: 110 EQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM 169
             L L +N ++    +     + S    L ++DL  N +   L       L  ++ E Y+
Sbjct: 384 HILNLTKNKISKIESD-----AFSWLGHLEVLDLGLNEIGQELTGQEWRGLE-NIFEIYL 437

Query: 170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNG--SIPITLGKLRKLQRLNLEDNILEGSIP 227
                        + + +L  + L    L    S P     LR L  L+L +N +     
Sbjct: 438 SYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND 497

Query: 228 DDICRLAELYRLELGSNKL--------YGSIPACFGNLASLRILSLGSNKLTSI-PLTFW 278
           D +  L +L  L+L  N L         G        L+ L IL+L SN    I    F 
Sbjct: 498 DMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK 557

Query: 279 NLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLS 338
           +L ++  ++   N L         N   L  ++   N  + V  +  G     L +L++ 
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMR 617

Query: 339 FNKLKGEIPRGGSFGNFSAES-----FEGNELLCGSP 370
           FN           F N+  E+        +  LC +P
Sbjct: 618 FNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  140 bits (356), Expect = 2e-35
 Identities = 46/220 (20%), Positives = 79/220 (35%), Gaps = 9/220 (4%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN 196
           S  + D S+  L  +       +L  ++    + +  +        +  + L  +D+G N
Sbjct: 5   SHEVADCSHLKLTQV-----PDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59

Query: 197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGN 256
            ++   P    KL  L+ LNL+ N L             L  L L SN +       F  
Sbjct: 60  TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119

Query: 257 LASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTG--PLLLEIGNLKVLIGIDFS 313
             +L  L L  N L+S  L T   L+++ +L  S+N +       L+I     L  ++ S
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 314 MNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFG 353
            N      P      +  L  L L+  +L   +       
Sbjct: 180 SNQIKEFSPGCFH-AIGRLFGLFLNNVQLGPSLTEKLCLE 218

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 87.0 bits (216), Expect = 5e-18
 Identities = 40/179 (22%), Positives = 61/179 (34%), Gaps = 23/179 (12%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
             P     L+NL  L L  N +       +  +  L+ L LQ+N+L+             
Sbjct: 471 SSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA------------- 517

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
                LW +   G    F+   S L  L+L  N F       F +L  L+ + L  N L 
Sbjct: 518 ----RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN 573

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
           +        S  +N  SL  ++L  N +  +  K       R+L E  M          
Sbjct: 574 TLPA-----SVFNNQVSLKSLNLQKNLITSV-EKKVFGPAFRNLTELDMRFNPFDCTCE 626

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  199 bits (507), Expect = 6e-55
 Identities = 59/408 (14%), Positives = 119/408 (29%), Gaps = 47/408 (11%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV---- 56
              L   NL++L +++L     +  +P  ++++  L+ L +  N    +    A+     
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541

Query: 57  ----RLPNLEKLYLWGNNFSG-TIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQ 111
                 P ++  Y+  NN         +    KL  L    N         FG    L  
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTD 599

Query: 112 LGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN 171
           L LD N +     +       +    +  +  S+N L  I    +  ++   +       
Sbjct: 600 LKLDYNQIEEIPEDF-----CAFTDQVEGLGFSHNKLKYIPNIFNAKSV-YVMGSVDFSY 653

Query: 172 CNISG-----GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE--- 223
             I           +     N   + L  N++             +  + L +N++    
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713

Query: 224 ----GSIPDDICRLAELYRLELGSNKLYGSIPA--CFGNLASLRILSLGSNKLTSIPLTF 277
                    +      L  ++L  NKL  S+        L  L  + +  N  +S P   
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCFSSFPTQP 772

Query: 278 WNLKDILQLN------FSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSY 331
            N   +             N +       I     LI +    N+    +  ++      
Sbjct: 773 LNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL---TPQ 828

Query: 332 LEDLNLSFNKLKGEIPRGGSFGNFSAE----SFEGNELLCGSPNLQVP 375
           L  L+++ N     I          A      ++  + + G   L + 
Sbjct: 829 LYILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  190 bits (483), Expect = 9e-52
 Identities = 65/378 (17%), Positives = 120/378 (31%), Gaps = 40/378 (10%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
            +P  IG L  L+ L  G +    +         T      + + +      +       
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397

Query: 61  LEKLYLWGNNFS-----GTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD 115
           L    L  +  +       I +    + K +++    N  +  I      L  L+ +   
Sbjct: 398 LNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFA 456

Query: 116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS 175
            +  T     +               +             S SNL   L +  +YNC   
Sbjct: 457 NSPFTYDNIAV----------DWEDANSDYAKQYENEEL-SWSNLK-DLTDVELYNCPNM 504

Query: 176 GGIPEEISNLTNLVEIDLGGNKLNG---------SIPITLGKLRKLQRLNLEDNILEG-S 225
             +P+ + +L  L  +++  N+             +        K+Q   +  N LE   
Sbjct: 505 TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFP 564

Query: 226 IPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDIL 284
               + ++ +L  L+   NK+   + A FG    L  L L  N++  IP         + 
Sbjct: 565 ASASLQKMVKLGLLDCVHNKV-RHLEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVE 622

Query: 285 QLNFSSNFLTG-PLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSY-----LEDLNLS 338
            L FS N L   P +    ++ V+  +DFS N       R I   +          + LS
Sbjct: 623 GLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLS 681

Query: 339 FNKLKGEIPRGGSFGNFS 356
           +N+++        F   S
Sbjct: 682 YNEIQKFPT--ELFATGS 697

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  178 bits (454), Expect = 6e-48
 Identities = 58/363 (15%), Positives = 119/363 (32%), Gaps = 23/363 (6%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
             +++ N   +  L L      G VP AI  ++ LK L    +S + S     +  L   
Sbjct: 315 PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPD 374

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
                           F+    +L+   L  ++ +         ++   ++ L +  + +
Sbjct: 375 MSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGN 432

Query: 122 STPELSFL-SSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPE 180
            T  ++F+  ++     L +I  +N+P           + +                   
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-------YAKQYENEEL 485

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEG---------SIPDDIC 231
             SNL +L +++L        +P  L  L +LQ LN+  N              + DD  
Sbjct: 486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545

Query: 232 RLAELYRLELGSNKLYG-SIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSS 290
              ++    +G N L      A    +  L +L    NK+  +   F     +  L    
Sbjct: 546 TGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLDY 604

Query: 291 NFLTGPLLLEIG-NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
           N +   +  +       + G+ FS N    +      + +  +  ++ S+NK+  E    
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663

Query: 350 GSF 352
              
Sbjct: 664 SCS 666

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  152 bits (385), Expect = 5e-39
 Identities = 55/345 (15%), Positives = 99/345 (28%), Gaps = 40/345 (11%)

Query: 42  QNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPS 101
           +   + G    +       +  L L G    G +P  I   ++L  LS G +S +     
Sbjct: 306 KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRL 365

Query: 102 TFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS 161
                   +     ++ +     ++ FL          L+  + N    + P    S +S
Sbjct: 366 FGDEELTPDMSEERKHRIRMHYKKM-FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424

Query: 162 RSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNI 221
               +       I+  I + I  LT L  I    +                +  N +   
Sbjct: 425 LKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAK 478

Query: 222 LEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS--------- 272
              +       L +L  +EL +      +P    +L  L+ L++  N+  S         
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538

Query: 273 -IPLTFWNLKDILQLNFSSNFLTG-PLLLEIGNLKVLIGIDFSMNNFSGV---------- 320
            +         I       N L   P    +  +  L  +D   N    +          
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEAFGTNVKLT 598

Query: 321 -----------IPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGN 354
                      IP +       +E L  S NKLK  IP   +  +
Sbjct: 599 DLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 25/163 (15%), Positives = 50/163 (30%), Gaps = 31/163 (19%)

Query: 215 LNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP 274
            N E ++       D+     +  L L      G +P   G L  L++LS G++  T   
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 275 ----------LTFWNLKDILQLNFSSNFLTGPLLL--------------EIGNLKVLIGI 310
                           K  +++++   FL     L              E+  +K    I
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423

Query: 311 DFSMNNFSGV------IPREIGEKLSYLEDLNLSFNKLKGEIP 347
                    +      I + I  +L+ L+ +  + +    +  
Sbjct: 424 SLKDTQIGNLTNRITFISKAIQ-RLTKLQIIYFANSPFTYDNI 465

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  175 bits (446), Expect = 8e-48
 Identities = 68/358 (18%), Positives = 115/358 (32%), Gaps = 13/358 (3%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           EIP  +    + E L+   N L          +  L FL L    +   +          
Sbjct: 26  EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-WIHEDTFQSQHR 82

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L+ L L  N         +     L  L       S        N + LE L L  N+++
Sbjct: 83  LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPE 180
           S              + L ++D  NN +  +  K  +S+L ++       N N   GI  
Sbjct: 143 SIKL-----PKGFPTEKLKVLDFQNNAIHYL-SKEDMSSLQQATNLSLNLNGNDIAGIEP 196

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLG--KLRKLQRLNLEDNILEGSIPDDICRLAELY- 237
              +      ++ GG +    I   L    ++ L     ED   E   P     L E+  
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256

Query: 238 -RLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGP 296
             + L  +  +      F   + L+ L L +  L+ +P     L  + +L  S+N     
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENL 316

Query: 297 LLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGN 354
             +   N   L  +    N     +     E L  L +L+LS + ++          N
Sbjct: 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  172 bits (439), Expect = 7e-47
 Identities = 77/381 (20%), Positives = 113/381 (29%), Gaps = 30/381 (7%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
                 +   L+ L L  N LI     A+     LK L      +S S+  I       L
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTL 131

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD--ENYL 119
           E LYL  N+ S       F   KL  L    N+          +L+    L L+   N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191

Query: 120 TSSTPELSFLSSL--------------------SNCKSLTLIDLSNNPLDGILPKTSISN 159
               P     +                      S  +SL L    +   + I P      
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251

Query: 160 LSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLED 219
              S+E   +                + L E+DL    L+  +P  L  L  L++L L  
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310

Query: 220 NILEGSIPDDICRLAELYRLELGSNKLYGSI-PACFGNLASLRILSLGSNKLTSIPL--- 275
           N  E            L  L +  N     +   C  NL +LR L L  + + +      
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370

Query: 276 TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDL 335
              NL  +  LN S N               L  +D +         +   + L  L+ L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430

Query: 336 NLSFNKLKGEIPRGGSFGNFS 356
           NLS + L         F    
Sbjct: 431 NLSHSLLDISSE--QLFDGLP 449

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  167 bits (425), Expect = 7e-45
 Identities = 72/357 (20%), Positives = 124/357 (34%), Gaps = 21/357 (5%)

Query: 3   PLEIGNLQNLEELQLGQNKL-IGTVPAAIFNVSTLKFLGLQNNSLSG-SLSSIANVRLPN 60
             ++ +LQ    L L  N   I  +    F+ +  + L              + N  + +
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLS--KLSLGMNSFSGFIPSTFGNLRNLEQLGLDENY 118
           L        +     P       ++S   ++L  + F     +TF     L++L L   +
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH 289

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
           L+         S L    +L  + LS N  + +  + S SN   SL    +        +
Sbjct: 290 LSE------LPSGLVGLSTLKKLVLSANKFENL-CQISASNFP-SLTHLSIKGNTKRLEL 341

Query: 179 PEE-ISNLTNLVEIDLGGNKLNGS--IPITLGKLRKLQRLNLEDNILEGSIPDDICRLAE 235
               + NL NL E+DL  + +  S    + L  L  LQ LNL  N       +      +
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ 401

Query: 236 LYRLELGSNKLYGSIP-ACFGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSNFL 293
           L  L+L   +L      + F NL  L++L+L  + L       F  L  +  LN   N  
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461

Query: 294 TGPLLLEIG---NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
               + +      L  L  +  S  + S +        L  +  ++LS N+L     
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT-SLKMMNHVDLSHNRLTSSSI 517

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  162 bits (412), Expect = 3e-43
 Identities = 71/314 (22%), Positives = 112/314 (35%), Gaps = 12/314 (3%)

Query: 11  NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNN 70
           ++E + L ++             S L+ L L    LS   S +    L  L+KL L  N 
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVG--LSTLKKLVLSANK 312

Query: 71  FSGTIPRFIFNASKLSKLSLGMNSFSGFIPS-TFGNLRNLEQLGLDENYLTSSTPELSFL 129
           F         N   L+ LS+  N+    + +    NL NL +L L  + + +S       
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL-- 370

Query: 130 SSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SNLTNL 188
             L N   L  ++LS N    +    +       LE   +    +     +    NL  L
Sbjct: 371 -QLRNLSHLQSLNLSYNEPLSL-KTEAFKECP-QLELLDLAFTRLKVKDAQSPFQNLHLL 427

Query: 189 VEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE---LGSNK 245
             ++L  + L+ S       L  LQ LNL+ N            L  L RLE   L    
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487

Query: 246 LYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLK 305
           L       F +L  +  + L  N+LTS  +   +    + LN +SN ++  L   +  L 
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILS 547

Query: 306 VLIGIDFSMNNFSG 319
               I+   N    
Sbjct: 548 QQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  160 bits (406), Expect = 2e-42
 Identities = 76/380 (20%), Positives = 134/380 (35%), Gaps = 24/380 (6%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFN--VSTLKFLGLQNNSLSG-SLSSIANVR 57
            I     +    + L  G  + +  +   + N  + +L     ++      S +    + 
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 58  LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
             ++E + L  + F           S L +L L     S  +PS    L  L++L L  N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSAN 311

Query: 118 YLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNI--S 175
              +         S SN  SLT + +  N     L    + NL  +L E  + + +I  S
Sbjct: 312 KFENLCQ-----ISASNFPSLTHLSIKGNTKRLELGTGCLENL-ENLRELDLSHDDIETS 365

Query: 176 GGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI-CRLA 234
                ++ NL++L  ++L  N+          +  +L+ L+L    L+          L 
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425

Query: 235 ELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL----TFWNLKDILQLNFSS 290
            L  L L  + L  S    F  L +L+ L+L  N      +    +   L  +  L  S 
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485

Query: 291 NFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGG 350
             L+        +LK++  +D S N  +     E    L  +  LNL+ N +   +P   
Sbjct: 486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI-EALSHLKGIY-LNLASNHISIILP--S 541

Query: 351 SFGNFSAES---FEGNELLC 367
                S +       N L C
Sbjct: 542 LLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  112 bits (283), Expect = 2e-26
 Identities = 41/218 (18%), Positives = 70/218 (32%), Gaps = 8/218 (3%)

Query: 141 IDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNG 200
            +  N  L+ I        L  S E        +        S L NL  +DL   ++  
Sbjct: 17  YNCENLGLNEI-----PGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71

Query: 201 SIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASL 260
               T     +L  L L  N L       +     L  L      +         N  +L
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131

Query: 261 RILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMN-NFS 318
             L LGSN ++SI L   +  + +  L+F +N +      ++ +L+    +  ++N N  
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191

Query: 319 GVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFS 356
             I        +  + LN    +    I +G       
Sbjct: 192 AGIEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  109 bits (274), Expect = 3e-25
 Identities = 53/274 (19%), Positives = 94/274 (34%), Gaps = 41/274 (14%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
             L++ NL +L+ L L  N+ +     A      L+ L L    L    +      L  L
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFI---PSTFGNLRNLEQLGLDENY 118
           + L L  +    +  +       L  L+L  N F        ++   L  LE L L    
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
           L+S         + ++ K +  +DLS+N                           ++   
Sbjct: 488 LSSIDQH-----AFTSLKMMNHVDLSHN--------------------------RLTSSS 516

Query: 179 PEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYR 238
            E +S+L  +  ++L  N ++  +P  L  L + + +NL  N L+ +     C       
Sbjct: 517 IEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT-----CSNIYFLE 570

Query: 239 -LELGSNKLYGSIPACFGNLASLRILSLGSNKLT 271
             +    KL  +      N   LR + L    L+
Sbjct: 571 WYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  170 bits (434), Expect = 4e-46
 Identities = 70/382 (18%), Positives = 126/382 (32%), Gaps = 43/382 (11%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
                  L +L++L   +  L       I ++ TLK L + +N +           L NL
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLS----KLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
           E L L  N         +    ++      L L +N  +   P  F  +  L +L L  N
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNN 210

Query: 118 YLTSSTPELSF--------------------------LSSLSNCKSLTLIDLSNNPLDGI 151
           + + +  +                              S+L    +LT+ +     LD  
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270

Query: 152 LPK-TSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLR 210
           L     + N   ++  F + +  I     ++ S       ++L   K      + L  L+
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328

Query: 211 KLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLY--GSIPACFGNLASLRILSLGSN 268
           +L   + +       +      L  L  L+L  N L   G          SL+ L L  N
Sbjct: 329 RLTFTSNKGGNAFSEVD-----LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 269 KLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEI-GNLKVLIGIDFSMNNFSGVIPREIGE 327
            + ++   F  L+ +  L+F  + L       +  +L+ LI +D S  +           
Sbjct: 384 GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN- 442

Query: 328 KLSYLEDLNLSFNKLKGEIPRG 349
            LS LE L ++ N  +      
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPD 464

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  169 bits (429), Expect = 2e-45
 Identities = 70/358 (19%), Positives = 112/358 (31%), Gaps = 26/358 (7%)

Query: 2   IPLEIGNLQNLEELQL------GQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIAN 55
           +   I  L  LE  +L       +  L     +A+  +  L     +   L   L  I +
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276

Query: 56  V--RLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLG 113
           +   L N+    L        +  F +N      L L    F  F      +L+ L    
Sbjct: 277 LFNCLTNVSSFSLVSVTIER-VKDFSYN-FGWQHLELVNCKFGQFPTLKLKSLKRLTFTS 334

Query: 114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGI-LPKTSISNLSRSLEEFYMYNC 172
                  S            +  SL  +DLS N L        S    + SL+   +   
Sbjct: 335 NKGGNAFS----------EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT-SLKYLDLSFN 383

Query: 173 NISGGIPEEISNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDIC 231
            +   +      L  L  +D   + L           LR L  L++       +      
Sbjct: 384 GVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442

Query: 232 RLAELYRLELGSNKLYGSIPAC-FGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFS 289
            L+ L  L++  N    +     F  L +L  L L   +L  + P  F +L  +  LN S
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502

Query: 290 SNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
            N            L  L  +D+S+N+      +E+    S L  LNL+ N       
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  168 bits (428), Expect = 2e-45
 Identities = 70/371 (18%), Positives = 124/371 (33%), Gaps = 31/371 (8%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKF----LGLQNNSLSGSLSSIANV 56
           ++P    NL NLE L L  NK+       +  +  +      L L  N ++         
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA--F 197

Query: 57  RLPNLEKLYLWGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSG------FIPSTFGNLRNL 109
           +   L KL L  N  S  + +      + L    L +  F        F  S    L NL
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 110 EQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM 169
                   YL     ++      +   +++   L +  ++ +      S      +   +
Sbjct: 258 TIEEFRLAYLDYYLDDII--DLFNCLTNVSSFSLVSVTIERVKD---FSYNF-GWQHLEL 311

Query: 170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNIL--EGSIP 227
            NC        ++ +L  L           G    +   L  L+ L+L  N L  +G   
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCS 366

Query: 228 DDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI--PLTFWNLKDILQ 285
                   L  L+L  N +   + + F  L  L  L    + L  +     F +L++++ 
Sbjct: 367 QSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425

Query: 286 LNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE 345
           L+ S              L  L  +  + N+F      +I  +L  L  L+LS  +L+  
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485

Query: 346 IPRGGSFGNFS 356
            P   +F + S
Sbjct: 486 SP--TAFNSLS 494

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  164 bits (416), Expect = 1e-43
 Identities = 70/396 (17%), Positives = 115/396 (29%), Gaps = 59/396 (14%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSL-SSIANVRLPN 60
                 +L +L  L L  N +      A   +S+L+ L     +L+      I +  L  
Sbjct: 68  EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH--LKT 125

Query: 61  LEKLYLWGNNF-SGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLE----QLGLD 115
           L++L +  N   S  +P +  N + L  L L  N       +    L  +      L L 
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185

Query: 116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS-------------- 161
            N +    P             L  + L NN     + KT I  L+              
Sbjct: 186 LNPMNFIQP------GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

Query: 162 ------------RSLEEFYM------YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIP 203
                         L    +      Y       I +  + LTN+    L    +     
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299

Query: 204 ITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRIL 263
            +       Q L L +          +  L  L           G       +L SL  L
Sbjct: 300 FSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFL 352

Query: 264 SLGSNKLT---SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGV 320
            L  N L+       + +    +  L+ S N +   +      L+ L  +DF  +N   +
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 321 IPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFS 356
               +   L  L  L++S    +      G F   S
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFN--GIFNGLS 445

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  161 bits (409), Expect = 9e-43
 Identities = 80/389 (20%), Positives = 126/389 (32%), Gaps = 45/389 (11%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
                 +   L+ L L + ++      A  ++S L  L L  N +   L+  A   L +L
Sbjct: 44  GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSL 102

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENYLT 120
           +KL     N +      I +   L +L++  N    F +P  F NL NLE L L  N + 
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 121 SSTPE-LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
           S     L  L  +        +DLS NP++ I P  +   +   L +  + N   S  + 
Sbjct: 163 SIYCTDLRVLHQMPL--LNLSLDLSLNPMNFIQP-GAFKEI--RLHKLTLRNNFDSLNVM 217

Query: 180 EE-ISNLTNLVEIDLGGNKLNGSIPI------TLGKLRKLQRLNLEDNILEGS---IPDD 229
           +  I  L  L    L   +      +       L  L  L         L+     I D 
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277

Query: 230 ICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP--------------- 274
              L  +    L S  +       F      + L L + K    P               
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN 335

Query: 275 -----LTFWNLKDILQLNFSSNFLT--GPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGE 327
                 +  +L  +  L+ S N L+  G           L  +D S N    +    +G 
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG- 394

Query: 328 KLSYLEDLNLSFNKLKGEIPRGGSFGNFS 356
            L  LE L+   + LK        F +  
Sbjct: 395 -LEQLEHLDFQHSNLKQMSEF-SVFLSLR 421

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  150 bits (381), Expect = 4e-39
 Identities = 67/362 (18%), Positives = 115/362 (31%), Gaps = 45/362 (12%)

Query: 26  VPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKL 85
           +P  +    + K L L  N L    S  +    P L+ L L              + S L
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSY-SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 86  SKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSN 145
           S L L  N         F  L +L++L   E  L S          + + K+L  +++++
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN-----FPIGHLKTLKELNVAH 133

Query: 146 NPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNL----VEIDLGGNKLNGS 201
           N +         SNL+ +LE   + +  I      ++  L  +    + +DL  N +N  
Sbjct: 134 NLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192

Query: 202 IPITLGKLRKLQRLNLEDNILEGSIPDDIC-RLAELYRLEL------GSNKLYGSIPACF 254
            P    ++R L +L L +N    ++       LA L    L          L     +  
Sbjct: 193 QPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251

Query: 255 GNLASLRILSLGSNKLT----SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGI 310
             L +L I       L      I   F  L ++   +  S  +    + +         +
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHL 309

Query: 311 DFSMNNFSGVIPREIGE------------------KLSYLEDLNLSFNKLKGEIPRGGSF 352
           +     F      ++                     L  LE L+LS N L  +     S 
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369

Query: 353 GN 354
             
Sbjct: 370 FG 371

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  146 bits (371), Expect = 1e-37
 Identities = 69/332 (20%), Positives = 106/332 (31%), Gaps = 34/332 (10%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSG------------ 48
           +I      L N+    L    +      +       + L L N                 
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQFPTLKLKSLKRL 330

Query: 49  ------SLSSIANVRLPNLEKLYLWGN--NFSGTIPRFIFNASKLSKLSLGMNSFSGFIP 100
                   ++ + V LP+LE L L  N  +F G   +  F  + L  L L  N     + 
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MS 389

Query: 101 STFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL 160
           S F  L  LE L    + L   +      S   + ++L  +D+S+            + L
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSE----FSVFLSLRNLIYLDISHTHTRVAFNGI-FNGL 444

Query: 161 SRSLEEFYMYNCNISGGI-PEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLED 219
           S SLE   M   +      P+  + L NL  +DL   +L    P     L  LQ LN+  
Sbjct: 445 S-SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503

Query: 220 NILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLA-SLRILSLGSNKLT-SIPLT- 276
           N            L  L  L+   N +  S      +   SL  L+L  N    +     
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS 563

Query: 277 -FWNLKDILQLNFSSNFLTGPLLLEIGNLKVL 307
               +KD  QL      +      +   + VL
Sbjct: 564 FLQWIKDQRQLLVEVERMECATPSDKQGMPVL 595

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 95.9 bits (239), Expect = 6e-21
 Identities = 32/188 (17%), Positives = 64/188 (34%), Gaps = 5/188 (2%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
             +L+NL  L +               +S+L+ L +  NS   +        L NL  L 
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
           L         P    + S L  L++  N+F       +  L +L+ L    N++ +S   
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK- 535

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNL 185
              L       SL  ++L+ N         S     +   +  +    +    P +   +
Sbjct: 536 -QELQHF--PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 592

Query: 186 TNLVEIDL 193
             ++ +++
Sbjct: 593 P-VLSLNI 599

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  162 bits (413), Expect = 2e-45
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 26/204 (12%)

Query: 416 RGKKPSNDANMPLVATWRTFSYLELCRATDEFSENNLIGRGGFAL----FIR-------- 463
                +  ++  +         ++L  AT+ F    LIG G F       +R        
Sbjct: 10  NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69

Query: 464 --------AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 515
                     + F+ E E +   RH +L+ +I  C       L+ +YM +G+L+++LY S
Sbjct: 70  RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129

Query: 516 N---CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA 572
           +     +   QRL I I  A  L YLH      +IH D+K  N+LLD+N V  ++DF I+
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186

Query: 573 KLLTGEDQSMTQTQTLGTIGYMAP 596
           K  T  DQ+   T   GT+GY+ P
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDP 210

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  160 bits (408), Expect = 9e-45
 Identities = 65/189 (34%), Positives = 91/189 (48%), Gaps = 25/189 (13%)

Query: 432 WRTFSYLELCRATDEFSENNLIGRGGFALFIR---------AFKS------------FDV 470
            + FS  EL  A+D FS  N++GRGGF    +         A K             F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---SSNCILDIFQRLNI 527
           E EM+    HRNL+++   C     + LV  YM +GS+   L     S   LD  +R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            +  A  L YLH      +IH D+K +N+LLD+   A + DF +AKL+  +D  +T T  
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAV 195

Query: 588 LGTIGYMAP 596
            GTIG++AP
Sbjct: 196 RGTIGHIAP 204

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  159 bits (404), Expect = 5e-43
 Identities = 84/354 (23%), Positives = 139/354 (39%), Gaps = 43/354 (12%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
              L    +  LG+  +  TV     ++  +  L      +  S+  +    L NL ++ 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEY--LNNLTQIN 74

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTP- 124
              N  +   P  + N +KL  + +  N  +   P    NL NL  L L  N +T   P 
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPL 130

Query: 125 --------------ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMY 170
                          +S +S+LS   SL  +   N   D       ++NL+ +LE   + 
Sbjct: 131 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK----PLANLT-TLERLDIS 185

Query: 171 NCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI 230
           +  +S      ++ LTNL  +    N+++   P  LG L  L  L+L  N L+      +
Sbjct: 186 SNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTL 239

Query: 231 CRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSS 290
             L  L  L+L +N++    P     L  L  L LG+N++++I      L  +  L  + 
Sbjct: 240 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNE 296

Query: 291 NFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
           N L    +  I NLK L  +    NN S + P      L+ L+ L    NK+  
Sbjct: 297 NQLED--ISPISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFYNNKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  153 bits (388), Expect = 1e-40
 Identities = 84/362 (23%), Positives = 150/362 (41%), Gaps = 51/362 (14%)

Query: 5   EIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKL 64
            +  L NL ++    N+L    P  + N++ L  + + NN ++  ++ +AN  L NL  L
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITPLAN--LTNLTGL 117

Query: 65  YLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIP-------------------STFGN 105
            L+ N  +   P  + N + L++L L  N+ S                           N
Sbjct: 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLAN 175

Query: 106 LRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLE 165
           L  LE+L +  N ++        +S L+   +L  +  +NN +  I P   +  L+ +L+
Sbjct: 176 LTTLERLDISSNKVSD-------ISVLAKLTNLESLIATNNQISDITP---LGILT-NLD 224

Query: 166 EFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGS 225
           E  +    +       +++LTNL ++DL  N+++   P  L  L KL  L L  N +   
Sbjct: 225 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 280

Query: 226 IPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQ 285
            P  +  L  L  LEL  N+L    P    NL +L  L+L  N ++ I     +L  + +
Sbjct: 281 SP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS-PVSSLTKLQR 335

Query: 286 LNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE 345
           L F +N ++   +  + NL  +  +    N  S + P      L+ +  L L+       
Sbjct: 336 LFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPL---ANLTRITQLGLNDQAWTNA 390

Query: 346 IP 347
             
Sbjct: 391 PV 392

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  148 bits (376), Expect = 4e-39
 Identities = 84/338 (24%), Positives = 145/338 (42%), Gaps = 33/338 (9%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
           + NL NL  L+L  N +  +  +A+  +++L+ L   N      L  +AN  L  LE+L 
Sbjct: 130 LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQVTD--LKPLAN--LTTLERLD 183

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
           +  N  S      +   + L  L    N  S   P   G L NL++L L+ N L      
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD---- 235

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNL 185
              + +L++  +LT +DL+NN +  + P   +S L+  L E  +    IS      ++ L
Sbjct: 236 ---IGTLASLTNLTDLDLANNQISNLAP---LSGLT-KLTELKLGANQISN--ISPLAGL 286

Query: 186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNK 245
           T L  ++L  N+L    PI    L+ L  L L  N +    P  +  L +L RL   +NK
Sbjct: 287 TALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342

Query: 246 LYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLK 305
           +  S  +   NL ++  LS G N+++ +     NL  I QL  +    T   +    N+ 
Sbjct: 343 V--SDVSSLANLTNINWLSAGHNQISDLT-PLANLTRITQLGLNDQAWTNAPVNYKANVS 399

Query: 306 VLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
           +   +       + + P  I +      + ++++N   
Sbjct: 400 IPNTV--KNVTGALIAPATISD-GGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  138 bits (351), Expect = 1e-35
 Identities = 71/320 (22%), Positives = 126/320 (39%), Gaps = 28/320 (8%)

Query: 3   PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLE 62
              + NL  LE L +  NK+  +  + +  ++ L+ L   NN +S  ++ +    L NL+
Sbjct: 170 LKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQIS-DITPLGI--LTNLD 224

Query: 63  KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSS 122
           +L L GN         + + + L+ L L  N  S   P     L  L +L L  N +++ 
Sbjct: 225 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN- 279

Query: 123 TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI 182
                 +S L+   +LT ++L+ N L+ I P   ISNL  +L    +Y  NIS      +
Sbjct: 280 ------ISPLAGLTALTNLELNENQLEDISP---ISNLK-NLTYLTLYFNNISD--ISPV 327

Query: 183 SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG 242
           S+LT L  +    NK++     +L  L  +  L+   N +    P  +  L  + +L L 
Sbjct: 328 SSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 383

Query: 243 SNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIG 302
                 +      N+ S+             P T  +     + + + N  +    +   
Sbjct: 384 DQAWTNAPVNYKANV-SIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEV-SY 441

Query: 303 NLKVLIGIDFSMNNFSGVIP 322
                + I      FSG + 
Sbjct: 442 TFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  134 bits (340), Expect = 3e-34
 Identities = 68/307 (22%), Positives = 128/307 (41%), Gaps = 33/307 (10%)

Query: 41  LQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIP 100
            Q+  ++  + +     L    K  L   N + T+     +  +++ L            
Sbjct: 9   TQDTPIN-QIFTDTA--LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SI 61

Query: 101 STFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL 160
                L NL Q+    N LT        ++ L N   L  I ++NN +  I P   ++NL
Sbjct: 62  DGVEYLNNLTQINFSNNQLTD-------ITPLKNLTKLVDILMNNNQIADITP---LANL 111

Query: 161 SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN 220
           + +L    ++N  I+    + + NLTNL  ++L  N ++      L  L  LQ+L+  + 
Sbjct: 112 T-NLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ 166

Query: 221 ILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNL 280
           + +      +  L  L RL++ SNK+  S  +    L +L  L   +N+++ I      L
Sbjct: 167 VTD---LKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDIT-PLGIL 220

Query: 281 KDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFN 340
            ++ +L+ + N L    +  + +L  L  +D + N  S + P      L+ L +L L  N
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPL---SGLTKLTELKLGAN 275

Query: 341 KLKGEIP 347
           ++    P
Sbjct: 276 QISNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 90.8 bits (226), Expect = 2e-19
 Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 33/227 (14%)

Query: 139 TLIDLSNNPLDGILPKTSISNLSR------------------SLEEFYMYNCNISGGIPE 180
           +     + P++ I   T+++   +                   +         I     +
Sbjct: 5   SATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK--SID 62

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE 240
            +  L NL +I+   N+L    P  L  L KL  + + +N +    P  +  L  L  L 
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118

Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLE 300
           L +N++    P    NL +L  L L SN ++ I      L  + QL+F +       L  
Sbjct: 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLSFGNQVTD---LKP 172

Query: 301 IGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
           + NL  L  +D S N  S +       KL+ LE L  + N++    P
Sbjct: 173 LANLTTLERLDISSNKVSDISVL---AKLTNLESLIATNNQISDITP 216

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  155 bits (395), Expect = 1e-42
 Identities = 79/341 (23%), Positives = 152/341 (44%), Gaps = 31/341 (9%)

Query: 3   PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLE 62
            +    L+++ +L +   K+       I  ++ L++L L  N ++  +S ++N  L  L 
Sbjct: 37  VVTQEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGNQIT-DISPLSN--LVKLT 91

Query: 63  KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSS 122
            LY+  N    T    + N + L +L L  ++ S   P    NL  +  L L  N+  S 
Sbjct: 92  NLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD 147

Query: 123 TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI 182
                 LS LSN   L  + ++ + +  + P   I+NL+  L    +    I       +
Sbjct: 148 ------LSPLSNMTGLNYLTVTESKVKDVTP---IANLT-DLYSLSLNYNQIED--ISPL 195

Query: 183 SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG 242
           ++LT+L       N++    P  +  + +L  L + +N +    P  +  L++L  LE+G
Sbjct: 196 ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIG 251

Query: 243 SNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIG 302
           +N++   I A   +L  L++L++GSN+++ I     NL  +  L  ++N L    +  IG
Sbjct: 252 TNQI-SDINA-VKDLTKLKMLNVGSNQISDIS-VLNNLSQLNSLFLNNNQLGNEDMEVIG 308

Query: 303 NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
            L  L  +  S N+ + + P      LS ++  + +   +K
Sbjct: 309 GLTNLTTLFLSQNHITDIRPL---ASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  144 bits (366), Expect = 1e-38
 Identities = 75/343 (21%), Positives = 129/343 (37%), Gaps = 55/343 (16%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
             +L       L +  +   V      + ++  L +    ++ S+  I    L NLE L 
Sbjct: 18  DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQGIEY--LTNLEYLN 72

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
           L GN  +   P  + N  KL+ L +G N  +    S   NL NL +L L+E+ ++     
Sbjct: 73  LNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD---- 124

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNL 185
              +S L+N   +  ++L  N                                   +SN+
Sbjct: 125 ---ISPLANLTKMYSLNLGANHN---------------------------LSDLSPLSNM 154

Query: 186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNK 245
           T L  + +  +K+    PI    L  L  L+L  N +E   P  +  L  L+      N+
Sbjct: 155 TGLNYLTVTESKVKDVTPI--ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210

Query: 246 LYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLK 305
           +    P    N+  L  L +G+NK+T +     NL  +  L   +N ++   +  + +L 
Sbjct: 211 ITDITP--VANMTRLNSLKIGNNKITDLS-PLANLSQLTWLEIGTNQISD--INAVKDLT 265

Query: 306 VLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR 348
            L  ++   N  S +        LS L  L L+ N+L  E   
Sbjct: 266 KLKMLNVGSNQISDISVLN---NLSQLNSLFLNNNQLGNEDME 305

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  126 bits (319), Expect = 3e-32
 Identities = 47/223 (21%), Positives = 96/223 (43%), Gaps = 22/223 (9%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
                + N+  L  L + ++K+       I N++ L  L L  N +   +S +A+  L +
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKV--KDVTPIANLTDLYSLSLNYNQIE-DISPLAS--LTS 200

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L     + N  +   P  + N ++L+ L +G N  +   P    NL  L  L +  N ++
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPE 180
                   ++++ +   L ++++ +N +  I   + ++NLS  L   ++ N  +     E
Sbjct: 257 D-------INAVKDLTKLKMLNVGSNQISDI---SVLNNLS-QLNSLFLNNNQLGNEDME 305

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE 223
            I  LTNL  + L  N +    P  L  L K+   +  + +++
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  120 bits (304), Expect = 3e-30
 Identities = 56/275 (20%), Positives = 101/275 (36%), Gaps = 34/275 (12%)

Query: 85  LSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTP---------------ELSFL 129
            + L+      +   P    +L    +  L +  +T                   +++ +
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASI 59

Query: 130 SSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLV 189
             +    +L  ++L+ N +  I P   +SNL   L   Y+    I+      + NLTNL 
Sbjct: 60  QGIEYLTNLEYLNLNGNQITDISP---LSNLV-KLTNLYIGTNKIT--DISALQNLTNLR 113

Query: 190 EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS 249
           E+ L  + ++   P  L  L K+  LNL  N    S    +  +  L  L +  +K+   
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDV 170

Query: 250 IPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIG 309
            P    NL  L  LSL  N++  I     +L  +       N +T   +  + N+  L  
Sbjct: 171 TP--IANLTDLYSLSLNYNQIEDIS-PLASLTSLHYFTAYVNQITD--ITPVANMTRLNS 225

Query: 310 IDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
           +    N  + + P      LS L  L +  N++  
Sbjct: 226 LKIGNNKITDLSP---LANLSQLTWLEIGTNQISD 257

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  109 bits (274), Expect = 3e-26
 Identities = 43/229 (18%), Positives = 83/229 (36%), Gaps = 17/229 (7%)

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
           L +    ++ +   ++        L    +  ++       L  S+ +  +    ++   
Sbjct: 5   LATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT---QEELE-SITKLVVAGEKVAS-- 58

Query: 179 PEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYR 238
            + I  LTNL  ++L GN++    P  L  L KL  L +  N +  +    +  L  L  
Sbjct: 59  IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRE 114

Query: 239 LELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLL 298
           L L  + +    P    NL  +  L+LG+N   S      N+  +  L  + + +    +
Sbjct: 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD--V 170

Query: 299 LEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
             I NL  L  +  + N    + P      L+ L       N++    P
Sbjct: 171 TPIANLTDLYSLSLNYNQIEDISP---LASLTSLHYFTAYVNQITDITP 216

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  152 bits (385), Expect = 2e-41
 Identities = 51/303 (16%), Positives = 95/303 (31%), Gaps = 24/303 (7%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
                +   Q        +            N +  +       +L  +   + +   P 
Sbjct: 27  PYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALKATADLLEDATQPG 82

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
              L L         P   F  S L  +++        +P T      LE L L  N L 
Sbjct: 83  RVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR 140

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS--------RSLEEFYMYNC 172
           +        +S+++   L  + +   P    LP+  +++           +L+   +   
Sbjct: 141 A------LPASIASLNRLRELSIRACPELTELPE-PLASTDASGEHQGLVNLQSLRLEWT 193

Query: 173 NISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICR 232
            I   +P  I+NL NL  + +  + L+ ++   +  L KL+ L+L       + P     
Sbjct: 194 GIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251

Query: 233 LAELYRLELGSNKLYGSIPACFGNLASLRILSLGSN-KLTSIPLTFWNLKDILQLNFSSN 291
            A L RL L       ++P     L  L  L L     L+ +P     L     +    +
Sbjct: 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

Query: 292 FLT 294
              
Sbjct: 312 LQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  138 bits (349), Expect = 1e-36
 Identities = 49/299 (16%), Positives = 99/299 (33%), Gaps = 24/299 (8%)

Query: 58  LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
               E LY  G+         +    +                    N  N +       
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66

Query: 118 YLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGG 177
            L ++   L   +          ++L + PL    P      LS  L+   +    +   
Sbjct: 67  ALKATADLLEDATQ----PGRVALELRSVPLP-QFPD-QAFRLS-HLQHMTIDAAGLME- 118

Query: 178 IPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICR----- 232
           +P+ +     L  + L  N L  ++P ++  L +L+ L++        +P+ +       
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177

Query: 233 ----LAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNF 288
               L  L  L L    +  S+PA   NL +L+ L + ++ L+++     +L  + +L+ 
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDL 236

Query: 289 SSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
                        G    L  +     +    +P +I  +L+ LE L+L        +P
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLP 294

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  151 bits (383), Expect = 2e-41
 Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 34/195 (17%)

Query: 433 RTFSYLELCRATDEFSE------NNLIGRGGF-------------------ALFIRA--- 464
            +FS+ EL   T+ F E       N +G GGF                   A+       
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72

Query: 465 -FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY--SSNCILDI 521
             + FD E ++M   +H NL++++   S+ +   LV  YMP+GSL   L        L  
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 581
             R  I    A+ + +LH       IH D+K +N+LLD+   A +SDF +A+      Q+
Sbjct: 133 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 582 MTQTQTLGTIGYMAP 596
           +  ++ +GT  YMAP
Sbjct: 190 VMTSRIVGTTAYMAP 204

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  151 bits (383), Expect = 3e-39
 Identities = 66/351 (18%), Positives = 109/351 (31%), Gaps = 24/351 (6%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLG-LQNNSLSGSLSSIANVR--- 57
           +   + NL  L   +L   +        IF  S ++ L  +  +    + ++  +     
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280

Query: 58  ---LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGL 114
              L N+  + L G +    +     +  K   LS+       F      +L  L+ L L
Sbjct: 281 FHCLANVSAMSLAGVSIK-YLEDVPKH-FKWQSLSIIRCQLKQF---PTLDLPFLKSLTL 335

Query: 115 DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNI 174
             N       + S         SL+ +DLS N L      +     + SL    +     
Sbjct: 336 TMN-------KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388

Query: 175 SGGIPEEISNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDICRL 233
              +      L  L  +D   + L           L KL  L++     +         L
Sbjct: 389 II-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447

Query: 234 AELYRLELGSNKLYGSIPAC-FGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSN 291
             L  L++  N    +  +  F N  +L  L L   +L  I    F  L  +  LN S N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507

Query: 292 FLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
            L          L  L  +D S N         +      L   NL+ N +
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKG-ILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  150 bits (380), Expect = 8e-39
 Identities = 73/370 (19%), Positives = 122/370 (32%), Gaps = 28/370 (7%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           ++P +I +  + + + L  N L      +  N S L++L L    +  ++   A   L +
Sbjct: 25  KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHH 81

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L  L L GN      P      + L  L       +       G L  L++L +  N++ 
Sbjct: 82  LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKT--SISNLSRSLEEFYMYNCNISGGI 178
           S        +  SN  +L  +DLS N +  I       +    +      M    I   I
Sbjct: 142 S----CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FI 196

Query: 179 PEEISNLTNLVEIDLGGNKLNGSIP-ITLGKLRKLQRLNLEDNILEGSI------PDDIC 231
            ++      L E+ L GN  + +I    L  L  L    L     +         P  + 
Sbjct: 197 QDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256

Query: 232 RLAELYRLEL--GSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFS 289
            L ++   E        +      F  LA++  +SL    +  +            L+  
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLE-DVPKHFKWQSLSII 315

Query: 290 SNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
              L     L++  LK L     +MN  S          L  L  L+LS N L       
Sbjct: 316 RCQLKQFPTLDLPFLKSL---TLTMNKGSISFK---KVALPSLSYLDLSRNALSFSGC-- 367

Query: 350 GSFGNFSAES 359
            S+ +    S
Sbjct: 368 CSYSDLGTNS 377

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  144 bits (364), Expect = 9e-37
 Identities = 70/371 (18%), Positives = 118/371 (31%), Gaps = 32/371 (8%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKF----LGLQNNSLSGSLSSIANV 56
           ++P    NL NL  + L  N +       +  +         L +  N +          
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA--F 201

Query: 57  RLPNLEKLYLWGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSG------FIPSTFGNLRNL 109
           +   L +L L GN  S  I +      + L    L +  F        F PS    L ++
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261

Query: 110 EQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM 169
                   Y    + ++     L+N   ++ + L+   +  +             +   +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLAN---VSAMSLAGVSIKYLEDVPK----HFKWQSLSI 314

Query: 170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDD 229
             C +    P    +L  L  + L  NK   SI      L  L  L+L  N L  S    
Sbjct: 315 IRCQLKQ-FPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCS 369

Query: 230 ICRLA--ELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP--LTFWNLKDILQ 285
              L    L  L+L  N     + A F  L  L+ L    + L  +     F +L+ +L 
Sbjct: 370 YSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428

Query: 286 LNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE 345
           L+ S              L  L  +  + N+F       +    + L  L+LS  +L+  
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488

Query: 346 IPRGGSFGNFS 356
               G F    
Sbjct: 489 SW--GVFDTLH 497

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  130 bits (328), Expect = 4e-32
 Identities = 57/307 (18%), Positives = 96/307 (31%), Gaps = 32/307 (10%)

Query: 3   PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLE 62
            ++   L N+  + L    +       +      + L +    L         + LP L+
Sbjct: 278 IVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLK----QFPTLDLPFLK 331

Query: 63  KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNL--RNLEQLGLDENYLT 120
            L L  N  S +          LS L L  N+ S     ++ +L   +L  L L  N   
Sbjct: 332 SLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389

Query: 121 SSTPELSFLSSL-------------------SNCKSLTLIDLSNNPLDGILPKTSISNLS 161
             +     L  L                    + + L  +D+S               L+
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID-FDGIFLGLT 448

Query: 162 RSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN 220
            SL    M   +        + +N TNL  +DL   +L          L +LQ LN+  N
Sbjct: 449 -SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507

Query: 221 ILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNL 280
            L         +L  L  L+   N++  S         SL   +L +N +  I      L
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFL 567

Query: 281 KDILQLN 287
           + + +  
Sbjct: 568 QWVKEQK 574

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  117 bits (294), Expect = 1e-27
 Identities = 43/229 (18%), Positives = 83/229 (36%), Gaps = 14/229 (6%)

Query: 127 SFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLT 186
           S    +    ++T     +  L  +       ++  S +   +    +        SN +
Sbjct: 3   SLNPCIEVVPNITY-QCMDQKLSKV-----PDDIPSSTKNIDLSFNPLKILKSYSFSNFS 56

Query: 187 NLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKL 246
            L  +DL   ++          L  L  L L  N ++   P     L  L  L     KL
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 247 YGSIPACFGNLASLRILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLTGPLLLEIGNL 304
                   G L +L+ L++  N + S  L   F NL +++ ++ S N++    + ++  L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 305 K----VLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
           +    V + +D S+N     I  +  + +  L +L L  N     I + 
Sbjct: 177 RENPQVNLSLDMSLNPIDF-IQDQAFQGIK-LHELTLRGNFNSSNIMKT 223

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 20/144 (13%), Positives = 36/144 (25%), Gaps = 26/144 (18%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
           +     N  NL  L L + + +  +   +F+                         L  L
Sbjct: 465 LSNVFANTTNLTFLDLSKCQ-LEQISWGVFD------------------------TLHRL 499

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           + L +  NN              LS L    N             ++L    L  N +  
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA- 558

Query: 122 STPELSFLSSLSNCKSLTLIDLSN 145
              E          +   L+++  
Sbjct: 559 CICEHQKFLQWVKEQKQFLVNVEQ 582

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  140 bits (355), Expect = 2e-37
 Identities = 41/191 (21%), Positives = 73/191 (38%), Gaps = 31/191 (16%)

Query: 435 FSYLELCRATDEFSENNLIGRGGFA----------------LFIRAFKSFDVECEM--MK 476
                L   +       +  RG F                   I+  +S+  E E+  + 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLP 73

Query: 477 SIRHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 532
            ++H N+++ I +            L+  +   GSL  +L ++  ++   +  +I   +A
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMA 131

Query: 533 SALEYLHFGYSAL-------VIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
             L YLH     L       + H D+K  NVLL +N+ A ++DF +A        +    
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191

Query: 586 QTLGTIGYMAP 596
             +GT  YMAP
Sbjct: 192 GQVGTRRYMAP 202

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  139 bits (352), Expect = 2e-36
 Identities = 72/368 (19%), Positives = 134/368 (36%), Gaps = 29/368 (7%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
           I   +       ++ +               ++  K +  +N+++   L +        +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 62  EKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           E L L        I  + F  A  + KL +G N+     P  F N+  L  L L+ N L+
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPE 180
           S    +       N   LT + +SNN L+ I    +      SL+   + +  ++  +  
Sbjct: 131 SLPRGI-----FHNTPKLTTLSMSNNNLERI-EDDTFQAT-TSLQNLQLSSNRLT-HVD- 181

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE 240
            +S + +L   ++  N L+     TL     ++ L+   N +   +   +    EL  L+
Sbjct: 182 -LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 232

Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSNFLTGPLLL 299
           L  N L         N   L  + L  N+L  I    F  ++ + +L  S+N L   L L
Sbjct: 233 LQHNNL-TDTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNL 289

Query: 300 EIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAES 359
               +  L  +D S N+    + R   +    LE+L L  N +   +    +       +
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-HVERNQPQ-FDRLENLYLDHNSIV-TLKL-STHHTLKNLT 345

Query: 360 FEGNELLC 367
              N+  C
Sbjct: 346 LSHNDWDC 353

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  135 bits (343), Expect = 7e-36
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 26/175 (14%)

Query: 445 DEFSENNLIGRGGFALFIRA---------------------FKSFDVECEMMKSIRHRNL 483
            + +    IG G F    RA                        F  E  +MK +RH N+
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 484 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFG 541
           +  + + +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155

Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            +  ++H +LK  N+L+D      + DF +++L      S       GT  +MAP
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAP 208

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  137 bits (347), Expect = 4e-35
 Identities = 68/288 (23%), Positives = 109/288 (37%), Gaps = 15/288 (5%)

Query: 11  NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNN 70
               L LG+N++         +   L+ L L  N +S ++   A   L NL  L L  N 
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNR 91

Query: 71  FSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFL 129
               IP  +F   S L+KL +  N     +   F +L NL+ L + +N L   +      
Sbjct: 92  LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR---- 146

Query: 130 SSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLV 189
            + S   SL  + L    L  I P  ++S+L   L    + + NI+         L  L 
Sbjct: 147 -AFSGLNSLEQLTLEKCNLTSI-PTEALSHL-HGLIVLRLRHLNINAIRDYSFKRLYRLK 203

Query: 190 EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICR-LAELYRLELGSNKLYG 248
            +++       ++         L  L++    L  ++P    R L  L  L L  N +  
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI-S 261

Query: 249 SIPAC-FGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSNFLT 294
           +I       L  L+ + L   +L  +    F  L  +  LN S N LT
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  124 bits (314), Expect = 1e-30
 Identities = 80/329 (24%), Positives = 125/329 (37%), Gaps = 26/329 (7%)

Query: 49  SLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLR 107
              ++          L L  N    T+ +  F +   L +L L  N  S   P  F NL 
Sbjct: 22  RFVAVPEGIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF 80

Query: 108 NLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEF 167
           NL  LGL  N L      +      +   +LT +D+S N +  +L      +L  +L+  
Sbjct: 81  NLRTLGLRSNRLKLIPLGV-----FTGLSNLTKLDISENKIVILLDYM-FQDLY-NLKSL 133

Query: 168 YMYNCNISGGIPEEI-SNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGS 225
            + + ++   I     S L +L ++ L    L  SIP   L  L  L  L L    +  +
Sbjct: 134 EVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-A 190

Query: 226 IPDDICR-LAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP-LTFWNLKDI 283
           I D   + L  L  LE+       ++        +L  LS+    LT++P L   +L  +
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250

Query: 284 LQLNFSSNFLTGPLLLEIG---NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFN 340
             LN S N ++    +E      L  L  I       + V+       L+YL  LN+S N
Sbjct: 251 RFLNLSYNPIS---TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN 306

Query: 341 KLKGEIPRG--GSFGNFSAESFEGNELLC 367
           +L   +      S GN      + N L C
Sbjct: 307 QLT-TLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  114 bits (287), Expect = 3e-27
 Identities = 64/290 (22%), Positives = 117/290 (40%), Gaps = 19/290 (6%)

Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           +      F   +P  I   ++   L LG N         F +  +LE+L L+EN +++  
Sbjct: 16  VLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72

Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI- 182
           P      + +N  +L  + L +N L  ++P    + LS +L +  +    I   + + + 
Sbjct: 73  PG-----AFNNLFNLRTLGLRSNRLK-LIPLGVFTGLS-NLTKLDISENKIVI-LLDYMF 124

Query: 183 SNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDI-CRLAELYRLE 240
            +L NL  +++G N L   I       L  L++L LE   L  SIP +    L  L  L 
Sbjct: 125 QDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLR 182

Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNK-LTSIPLTFWNLKDILQLNFSSNFLTGPLLL 299
           L    +       F  L  L++L +     L ++        ++  L+ +   LT    L
Sbjct: 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL 242

Query: 300 EIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
            + +L  L  ++ S N  S  I   +  +L  L+++ L   +L   +   
Sbjct: 243 AVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPY 290

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  102 bits (257), Expect = 2e-23
 Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 12/215 (5%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
           +L NL+ L++G N L+     A   +++L+ L L+  +L+ S+ + A   L  L  L L 
Sbjct: 126 DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184

Query: 68  GNNFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL 126
             N +  I  + F    +L  L +    +   +        NL  L +    LT + P L
Sbjct: 185 HLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYL 242

Query: 127 SFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLT 186
           +      +   L  ++LS NP+  I   + +  L   L+E  +    ++   P     L 
Sbjct: 243 AV----RHLVYLRFLNLSYNPISTI-EGSMLHEL-LRLQEIQLVGGQLAVVEPYAFRGLN 296

Query: 187 NLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDN 220
            L  +++ GN+L  ++       +  L+ L L+ N
Sbjct: 297 YLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 36/194 (18%), Positives = 75/194 (38%), Gaps = 12/194 (6%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            L +LE+L L +   + ++P     ++  L  L L++ +++ ++   +  RL  L+ L +
Sbjct: 150 GLNSLEQLTLEKCN-LTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEI 207

Query: 67  WGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL 126
               +  T+         L+ LS+   + +        +L  L  L L  N +++     
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEG-- 265

Query: 127 SFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SNL 185
              S L     L  I L    L  +    +   L+  L    +    ++  + E +  ++
Sbjct: 266 ---SMLHELLRLQEIQLVGGQLAVV-EPYAFRGLN-YLRVLNVSGNQLT-TLEESVFHSV 319

Query: 186 TNLVEIDLGGNKLN 199
            NL  + L  N L 
Sbjct: 320 GNLETLILDSNPLA 333

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  132 bits (333), Expect = 1e-34
 Identities = 33/134 (24%), Positives = 68/134 (50%), Gaps = 4/134 (2%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++F  E  +++  RH N++  +   +  +  A+V ++    SL  +L++S    ++ 
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMK 120

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           + ++I    A  ++YLH   +  +IH DLK +N+ L ++    + DF +A   +    S 
Sbjct: 121 KLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177

Query: 583 TQTQTLGTIGYMAP 596
              Q  G+I +MAP
Sbjct: 178 QFEQLSGSILWMAP 191

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  138 bits (350), Expect = 1e-34
 Identities = 73/384 (19%), Positives = 122/384 (31%), Gaps = 36/384 (9%)

Query: 8   NLQNLEELQLGQNKL--IGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
            L +L EL+L    L           N+  L  L L  N +       +  +L +L+ + 
Sbjct: 95  GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154

Query: 66  LWGNNFSGTIPRFIFN---ASKLSKLSLGMNSFSGFIPSTFGNLRN------LEQLGLDE 116
              N     +            LS  SL  NS    +   +G   N      LE L +  
Sbjct: 155 FSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG 213

Query: 117 NYLTSSTPELSF-------LSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM 169
           N  T                 SL     +       + +      T       S+    +
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDL 273

Query: 170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDD 229
            +  +          L +L  ++L  NK+N         L  LQ LNL  N+L      +
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333

Query: 230 ICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP---------LTFWNL 280
              L ++  ++L  N +       F  L  L+ L L  N LT+I          L+   L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKL 393

Query: 281 KDILQLNFSSNFL--------TGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYL 332
             + ++N ++N +           +L  +  +  L  +  + N FS     +   +   L
Sbjct: 394 VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453

Query: 333 EDLNLSFNKLKGEIPRGGSFGNFS 356
           E L L  N L+        +  F 
Sbjct: 454 EQLFLGENMLQLAWETELCWDVFE 477

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  138 bits (348), Expect = 3e-34
 Identities = 81/362 (22%), Positives = 135/362 (37%), Gaps = 34/362 (9%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            L   E L L  N  I TV A+ F  +  L+ L L +     ++   A   LPNL  L L
Sbjct: 22  VLNTTERLLLSFNY-IRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80

Query: 67  WGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFI--PSTFGNLRNLEQLGLDENYLTSST 123
             +     +    F     L +L L     S  +     F NL+ L +L L +N + S  
Sbjct: 81  GSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139

Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS-RSLEEFYMYNCNISGGIPEEI 182
              SF        SL  ID S+N +  +  +  +  L  ++L  F +   ++   +  + 
Sbjct: 140 LHPSF----GKLNSLKSIDFSSNQIFLV-CEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194

Query: 183 SNLTN------LVEIDLGGNK------------LNGSIPITLGKLRKLQRLNLEDNILEG 224
               N      L  +D+ GN             ++ S   +L     +       + ++ 
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254

Query: 225 SIPDDICRLAELY--RLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP-LTFWNLK 281
              +    LA      L+L    ++      F  L  L++L+L  NK+  I    F+ L 
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLD 314

Query: 282 DILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNK 341
           ++  LN S N L          L  +  ID   N+ + +I  +  + L  L+ L+L  N 
Sbjct: 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNA 373

Query: 342 LK 343
           L 
Sbjct: 374 LT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  124 bits (314), Expect = 4e-30
 Identities = 87/436 (19%), Positives = 142/436 (32%), Gaps = 65/436 (14%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNV---STLKFLGLQNNSLS-----GSLSS 52
            +    G L +L+ +    N+ I  V           TL F  L  NSL           
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQ-IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197

Query: 53  IANVRLPNLEKLYLWGNNFSGTIPRFIFNA------------SKLSKLSLGMNSFSGFIP 100
           +   R   LE L + GN ++  I     NA              +     G ++      
Sbjct: 198 MNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQ 257

Query: 101 STFGNLR--NLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSIS 158
           +TF  L   ++  L L   ++ S              K L +++L+ N ++ I    +  
Sbjct: 258 NTFAGLARSSVRHLDLSHGFVFSLNS-----RVFETLKDLKVLNLAYNKINKI-ADEAFY 311

Query: 159 NLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLE 218
            L  +L+   +    +          L  +  IDL  N +      T   L KLQ L+L 
Sbjct: 312 GLD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLR 370

Query: 219 DNILEGSIPDDICRLAELYRLELGSNKLYG---------------------SIPACFGNL 257
           DN L       I  +  +  + L  NKL                        I      +
Sbjct: 371 DNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRV 425

Query: 258 ASLRILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLTGPLLLEI-----GNLKVLIGI 310
             L+IL L  N+ +S     T      + QL    N L      E+       L  L  +
Sbjct: 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVL 485

Query: 311 DFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSP 370
             + N  +  +P  +   L+ L  L+L+ N+L   +       N        N+LL  +P
Sbjct: 486 YLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNP 543

Query: 371 NLQVPPCKTSIHHTSW 386
           ++ V      I H  +
Sbjct: 544 DVFVSLSVLDITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 93.7 bits (233), Expect = 4e-20
 Identities = 53/267 (19%), Positives = 93/267 (34%), Gaps = 33/267 (12%)

Query: 103 FGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSR 162
              L   E+L L  NY+ + T      SS    + L L++L +      + K +  NL  
Sbjct: 20  PQVLNTTERLLLSFNYIRTVTA-----SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLP- 73

Query: 163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSI--PITLGKLRKLQRLNLEDN 220
           +L    + +  I    P+    L +L E+ L    L+ ++        L+ L RL+L  N
Sbjct: 74  NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133

Query: 221 -ILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLA--SLRILSLGSNKLTSIPLTF 277
            I    +     +L  L  ++  SN+++         L   +L   SL +N L S     
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193

Query: 278 W-------------------NLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFS 318
           W                   N   +      SN ++      +     ++G  F  +N  
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253

Query: 319 GVIPREI--GEKLSYLEDLNLSFNKLK 343
               +    G   S +  L+LS   + 
Sbjct: 254 -DPDQNTFAGLARSSVRHLDLSHGFVF 279

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 86.0 bits (213), Expect = 1e-17
 Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 18/223 (8%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN 196
              +       L      T +  +  + E   +    I          L  L  ++LG  
Sbjct: 5   DGRIAFYRFCNL------TQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ 58

Query: 197 KLNGSI-PITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSI--PAC 253
               +I       L  L+ L+L  + +    PD    L  L+ L L    L  ++     
Sbjct: 59  YTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY 118

Query: 254 FGNLASLRILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLTGPLLLEIGNLKV--LIG 309
           F NL +L  L L  N++ S+ L  +F  L  +  ++FSSN +      E+  L+   L  
Sbjct: 119 FRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178

Query: 310 IDFSMNNFSGVIPREIGEKLS-----YLEDLNLSFNKLKGEIP 347
              + N+    +  + G+ ++      LE L++S N    +I 
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT 221

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 83.3 bits (206), Expect = 8e-17
 Identities = 51/188 (27%), Positives = 76/188 (40%), Gaps = 10/188 (5%)

Query: 168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP 227
           +   CN++  +P+ ++    L    L  N +      +   L +LQ L L       +I 
Sbjct: 10  FYRFCNLTQ-VPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65

Query: 228 DDICR-LAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL---TFWNLKDI 283
            +  R L  L  L+LGS+K+Y   P  F  L  L  L L    L+   L    F NLK +
Sbjct: 66  KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125

Query: 284 LQLNFSSNFLTG-PLLLEIGNLKVLIGIDFSMNNFSGVIPREI-GEKLSYLEDLNLSFNK 341
            +L+ S N +    L    G L  L  IDFS N    V   E+   +   L   +L+ N 
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS 185

Query: 342 LKGEIPRG 349
           L   +   
Sbjct: 186 LYSRVSVD 193

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 77.2 bits (190), Expect = 7e-15
 Identities = 57/308 (18%), Positives = 107/308 (34%), Gaps = 31/308 (10%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLS--GSLSSIANVRL------- 58
            L  +  + L +N +          +  L+ L L++N+L+    + SI ++ L       
Sbjct: 336 GLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVT 395

Query: 59  -----PNLEKLYLWGNNFSG-TIPRFIFNASKLSKLSLGMNSFSGFIPS-TFGNLRNLEQ 111
                     ++L  N      I  F+     L  L L  N FS      T     +LEQ
Sbjct: 396 LPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQ 455

Query: 112 LGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN 171
           L L EN L  +               L ++ L++N L+ + P    S+L+ +L    + +
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSL-PPGVFSHLT-ALRGLSLNS 513

Query: 172 CNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC 231
             ++  +        NL  +D+  N+L             L  L++  N          C
Sbjct: 514 NRLT-VLSHN-DLPANLEILDISRNQLLA---PNPDVFVSLSVLDITHNKF-----ICEC 563

Query: 232 RLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSN 291
            L+        +N     I     ++  +   S     L S+     + +++L+    S 
Sbjct: 564 ELSTFINWLNHTNVT---IAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSL 620

Query: 292 FLTGPLLL 299
           F+   + L
Sbjct: 621 FIVCTVTL 628

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  137 bits (346), Expect = 2e-34
 Identities = 67/354 (18%), Positives = 127/354 (35%), Gaps = 35/354 (9%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLE 62
            E   L N + +    +  +  +PAA+  +   ++ L L +  +   + + A      ++
Sbjct: 45  FEDITLNNQKIVTFKNST-MRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102

Query: 63  KLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           KLY+  N     +P  +F N   L+ L L  N  S      F N   L  L +  N L  
Sbjct: 103 KLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 161

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPL----DGILPKTSISNLSR----------SLEEF 167
              +           SL  + LS+N L      ++P    +N+S           ++EE 
Sbjct: 162 IEDDT-----FQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEEL 216

Query: 168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP 227
              + +I+  +   +     L  + L  N L       L     L  ++L  N LE  I 
Sbjct: 217 DASHNSINV-VRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIM 270

Query: 228 DDICR-LAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQL 286
                 +  L RL + +N+L  ++      + +L++L L  N L  +         +  L
Sbjct: 271 YHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENL 329

Query: 287 NFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFN 340
               N +     L++     L  +  S N++     R +   ++     +   +
Sbjct: 330 YLDHNSIVT---LKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  136 bits (344), Expect = 3e-34
 Identities = 72/369 (19%), Positives = 134/369 (36%), Gaps = 29/369 (7%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
            I   +       ++ +               ++  K +  +N+++   L +        
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 61  LEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
           +E L L        I  + F  A  + KL +G N+     P  F N+  L  L L+ N L
Sbjct: 77  VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135

Query: 120 TSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
           +S    +       N   LT + +SNN L+ I    +      SL+   + +  ++  + 
Sbjct: 136 SSLPRGI-----FHNTPKLTTLSMSNNNLERI-EDDTFQAT-TSLQNLQLSSNRLT-HVD 187

Query: 180 EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
             +S + +L   ++  N L+     TL     ++ L+   N +   +   +    EL  L
Sbjct: 188 --LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV--ELTIL 237

Query: 240 ELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSNFLTGPLL 298
           +L  N L         N   L  + L  N+L  I    F  ++ + +L  S+N L   L 
Sbjct: 238 KLQHNNL-TDTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LN 294

Query: 299 LEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAE 358
           L    +  L  +D S N+    + R    +   LE+L L  N +   +    +       
Sbjct: 295 LYGQPIPTLKVLDLSHNHLL-HVERNQP-QFDRLENLYLDHNSIV-TLK-LSTHHTLKNL 350

Query: 359 SFEGNELLC 367
           +   N+  C
Sbjct: 351 TLSHNDWDC 359

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  103 bits (259), Expect = 1e-23
 Identities = 52/340 (15%), Positives = 100/340 (29%), Gaps = 51/340 (15%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
           +G  Q               + + +        + + +           ++ L N + + 
Sbjct: 1   VGGQQRYNVKPR--QPEYKCIDSNLQYDCVFYDVHI-DMQTQDVYFGFEDITLNNQKIVT 57

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
              +     +P                        +   + R +E L L++  +      
Sbjct: 58  FKNSTMR-KLP-----------------------AALLDSFRQVELLNLNDLQIEEIDTY 93

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SN 184
                + +   ++  + +  N +   LP     N+   L    +   ++S  +P  I  N
Sbjct: 94  -----AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVP-LLTVLVLERNDLS-SLPRGIFHN 145

Query: 185 LTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSN 244
              L  + +  N L      T      LQ L L  N L   +   +  +  L+   +  N
Sbjct: 146 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYN 202

Query: 245 KLYGSIPACFGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSNFLTGPLLLEIGN 303
            L     +      ++  L    N +  +       L     L    N LT    L   N
Sbjct: 203 LL-----STLAIPIAVEELDASHNSINVVRGPVNVELT---ILKLQHNNLTDTAWL--LN 252

Query: 304 LKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
              L+ +D S N     I      K+  LE L +S N+L 
Sbjct: 253 YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 73.8 bits (181), Expect = 5e-14
 Identities = 57/364 (15%), Positives = 107/364 (29%), Gaps = 36/364 (9%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEK 63
           +       L  L+L  N L  T  A + N   L  + L  N L   +     V++  LE+
Sbjct: 226 VRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLER 282

Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           LY+  N     +  +      L  L L  N     +         LE L LD N + +  
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL- 339

Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI- 182
                   LS   +L  + LS+N  D    +    N++R   +    +C I   +   + 
Sbjct: 340 -------KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 392

Query: 183 -----SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELY 237
                    + +   +    +   +    G+      +N   ++           L    
Sbjct: 393 CKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNE 452

Query: 238 RLELGSNKLYGSIPACFGN---------------LASLRILSLGSNKLTSIPLTFWNLKD 282
           +LE   N+L   +                       +LR   L  + L         +  
Sbjct: 453 QLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFT 512

Query: 283 ILQ-LNFSSNFLTGPLLLEIGN-LKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFN 340
            L+         T     E     K    ++         +  +  ++    ++ +L   
Sbjct: 513 HLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQ 572

Query: 341 KLKG 344
           K+K 
Sbjct: 573 KVKQ 576

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  128 bits (325), Expect = 9e-34
 Identities = 31/137 (22%), Positives = 61/137 (44%), Gaps = 11/137 (8%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCI-L 519
           R  + F+ EC  ++   H N++ V+ +C +       L+  +MP+GSL   L+      +
Sbjct: 49  RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV 108

Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           D  Q +   +D+A  + +LH     L+    L   +V++D++M A +S   +        
Sbjct: 109 DQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------ 161

Query: 580 QSMTQTQTLGTIGYMAP 596
            S      +    ++AP
Sbjct: 162 -SFQSPGRMYAPAWVAP 177

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  132 bits (334), Expect = 2e-33
 Identities = 78/353 (22%), Positives = 129/353 (36%), Gaps = 57/353 (16%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           E+P+E  N+++  E     ++     P        +    L++                 
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC------------LDRQ 72

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
             +L L     S ++P    +   L  L    NS +  +P    +L++L     +   L+
Sbjct: 73  AHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 127

Query: 121 SSTP----------ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMY 170
              P          +L  L  L N   L +ID+ NN L        + +L  SLE     
Sbjct: 128 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL------KKLPDLPPSLEFIAAG 181

Query: 171 NCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI 230
           N  +   +P E+ NL  L  I    N L   +P        L+ +   +NIL      ++
Sbjct: 182 NNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLP---DLPLSLESIVAGNNIL--EELPEL 233

Query: 231 CRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSS 290
             L  L  +   +N L  ++P    +   L  L++  N LT +P    +L     L+ S 
Sbjct: 234 QNLPFLTTIYADNNLL-KTLPDLPPS---LEALNVRDNYLTDLPELPQSLT---FLDVSE 286

Query: 291 NFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
           N  +G L     NL  L   + S N         + +    LE+LN+S NKL 
Sbjct: 287 NIFSG-LSELPPNLYYL---NASSNEIR-----SLCDLPPSLEELNVSNNKLI 330

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  127 bits (320), Expect = 1e-31
 Identities = 75/369 (20%), Positives = 123/369 (33%), Gaps = 70/369 (18%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           E+P    +L++L         L             L++LG+ NN L   L  + N     
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQLE-KLPELQN--SSF 154

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L+ + +  N+    +P    +   L  ++ G N           NL  L  +  D N L 
Sbjct: 155 LKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK 208

Query: 121 SSTPE-------------LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEF 167
                             L  L  L N   LT I   NN L       ++ +L  SLE  
Sbjct: 209 KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL------KTLPDLPPSLEAL 262

Query: 168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIP-----------IT--LGKLRKLQR 214
            + +  ++  +PE   +LT L   +   + L+   P           I         L+ 
Sbjct: 263 NVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEE 321

Query: 215 LNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP 274
           LN+ +N L   +P    RL  L       N L   +P    NL   + L +  N L   P
Sbjct: 322 LNVSNNKLI-ELPALPPRLERLI---ASFNHL-AEVPELPQNL---KQLHVEYNPLREFP 373

Query: 275 LTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLED 334
               +++D+   +  +      +     NLK L       N      P         +ED
Sbjct: 374 DIPESVEDLRMNSHLAE-----VPELPQNLKQL---HVETNPLR-EFPDIPES----VED 420

Query: 335 LNLSFNKLK 343
           L ++  ++ 
Sbjct: 421 LRMNSERVV 429

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  105 bits (265), Expect = 2e-24
 Identities = 63/321 (19%), Positives = 113/321 (35%), Gaps = 56/321 (17%)

Query: 54  ANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLR------ 107
            NV    L++     +N +  +P    N    ++     + +    P   G  R      
Sbjct: 6   RNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64

Query: 108 -------NLEQLGLDENYLTSSTPELSFLSSL--------------SNCKSLTLIDLSNN 146
                     +L L+   L+S       L SL               + KSL + + +  
Sbjct: 65  LRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLK 124

Query: 147 PLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITL 206
                    ++S+L   LE   + N  +   +P E+ N + L  ID+  N L   +P   
Sbjct: 125 ---------ALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP 172

Query: 207 GKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLG 266
                L+ +   +N LE  +P ++  L  L  +   +N L   +P       SL  +  G
Sbjct: 173 P---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSL-KKLP---DLPLSLESIVAG 223

Query: 267 SNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIG 326
           +N L  +P    NL  +  +   +N L   L     +L+ L   +   N  +  +P    
Sbjct: 224 NNILEELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEAL---NVRDNYLTD-LPELPQ 277

Query: 327 EKLSYLEDLNLSFNKLKGEIP 347
             L++L+     F+ L    P
Sbjct: 278 -SLTFLDVSENIFSGLSELPP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  100 bits (252), Expect = 8e-23
 Identities = 59/291 (20%), Positives = 99/291 (34%), Gaps = 51/291 (17%)

Query: 5   EIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKL 64
           E+ NL  L  +    N L   +P    +   L+ +   NN L   L  + N  LP L  +
Sbjct: 190 ELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE-ELPELQN--LPFLTTI 242

Query: 65  YLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTP 124
           Y   N    T+P        L  L++  N  +  +P    +L  L+      + L+   P
Sbjct: 243 YADNNLLK-TLPDLP---PSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP 297

Query: 125 ELSFLSSLSN--------CKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG 176
            L +L++ SN          SL  +++SNN L        +  L   LE       +++ 
Sbjct: 298 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKL------IELPALPPRLERLIASFNHLAE 351

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLR----------------KLQRLNLEDN 220
            +PE   NL  L    +  N L    P     +                  L++L++E N
Sbjct: 352 -VPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETN 406

Query: 221 ILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT 271
            L    PD    + +L    + S ++             L       +   
Sbjct: 407 PLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 90.8 bits (226), Expect = 1e-19
 Identities = 52/257 (20%), Positives = 88/257 (34%), Gaps = 41/257 (15%)

Query: 98  FIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSI 157
           FI     +   L++     + LT             N KS T    + +  +   P  + 
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLT------EMPVEAENVKSKTEYYNAWSEWERNAPPGNG 55

Query: 158 -----------SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITL 206
                        L R   E  + N  +S  +PE   +L +L       N L   +P   
Sbjct: 56  EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELP 110

Query: 207 GKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLG 266
             L+ L   N     L    P        L  L + +N+L   +P    N + L+I+ + 
Sbjct: 111 QSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQL-EKLPE-LQNSSFLKIIDVD 161

Query: 267 SNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIG 326
           +N L  +P    +L+    +   +N L    L E+ NL  L  I    N+       ++ 
Sbjct: 162 NNSLKKLPDLPPSLE---FIAAGNNQLEE--LPELQNLPFLTAIYADNNSLK-----KLP 211

Query: 327 EKLSYLEDLNLSFNKLK 343
           +    LE +    N L+
Sbjct: 212 DLPLSLESIVAGNNILE 228

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 36/247 (14%), Positives = 72/247 (29%), Gaps = 47/247 (19%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRL-- 58
           E   E+ NL  L  +    N L  T+P    ++  L         L     S+  + +  
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSE 286

Query: 59  ----------PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRN 108
                     PNL  L    N    ++         L +L++  N     +P+    L  
Sbjct: 287 NIFSGLSELPPNLYYLNASSNEIR-SLCDLP---PSLEELNVSNNKLI-ELPALPPRLER 341

Query: 109 LEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPK-------------T 155
           L       N+L                 +L  + +  NPL                    
Sbjct: 342 LI---ASFNHLAEVPELPQ---------NLKQLHVEYNPLREFPDIPESVEDLRMNSHLA 389

Query: 156 SISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRL 215
            +  L ++L++ ++    +    P+   ++ +L    +   ++            KL+  
Sbjct: 390 EVPELPQNLKQLHVETNPLRE-FPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDD 445

Query: 216 NLEDNIL 222
             E +  
Sbjct: 446 VFEHHHH 452

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  128 bits (324), Expect = 3e-33
 Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 27/172 (15%)

Query: 445 DEFSENNLIGRGGFALFIRA-----------------FKSFDVECEMMKSIRHRNLIKVI 487
            E     ++GRG F +  +A                  K+F VE   +  + H N++K+ 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLY 67

Query: 488 SSCSNEEFKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAL 545
            +C N     LV+EY   GSL   L+ +           ++  +  +  + YLH      
Sbjct: 68  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 546 VIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +IH DLKP N+LL     V  + DF  A      D     T   G+  +MAP
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 172

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  129 bits (325), Expect = 3e-33
 Identities = 49/197 (24%), Positives = 69/197 (35%), Gaps = 37/197 (18%)

Query: 435 FSYLELCRATDEFSENNLIGRGGFA----------------LFIRAFKSFDVECEMMK-- 476
            +  E     D      LIGRG +                       ++F  E  + +  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVP 62

Query: 477 SIRHRNLIKVISSC-----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 531
            + H N+ + I               LV+EY P+GSL KYL       D      +   V
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSV 120

Query: 532 ASALEYLH------FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
              L YLH        Y   + H DL   NVL+ ++    +SDF ++  LTG        
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 586 QTL------GTIGYMAP 596
           +        GTI YMAP
Sbjct: 181 EDNAAISEVGTIRYMAP 197

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (332), Expect = 1e-32
 Identities = 72/338 (21%), Positives = 124/338 (36%), Gaps = 52/338 (15%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEK 63
           +          L +G++ L  T+P  +     +  L + +N+L+ SL +      P L  
Sbjct: 34  MRACLNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPA----LPPELRT 85

Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           L + GN  + ++P       +LS  S  +                L +L +  N LTS  
Sbjct: 86  LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLTSLP 137

Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEIS 183
                L  L          +S+N L       S+  L   L + + YN  ++  +P   S
Sbjct: 138 VLPPGLQEL---------SVSDNQL------ASLPALPSELCKLWAYNNQLT-SLPMLPS 181

Query: 184 NLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGS 243
            L  L    +  N+L  S+P    +L KL   N        S+P     L EL    +  
Sbjct: 182 GLQEL---SVSDNQLA-SLPTLPSELYKLWAYNNRLT----SLPALPSGLKELI---VSG 230

Query: 244 NKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGN 303
           N+L  S+P        L+ L +  N+LTS+P+    L     L+   N LT  L   + +
Sbjct: 231 NRL-TSLPVLPSE---LKELMVSGNRLTSLPMLPSGLL---SLSVYRNQLTR-LPESLIH 282

Query: 304 LKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNK 341
           L     ++   N  S     +   +++     +    +
Sbjct: 283 LSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIR 319

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  127 bits (320), Expect = 4e-31
 Identities = 69/310 (22%), Positives = 120/310 (38%), Gaps = 52/310 (16%)

Query: 34  STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMN 93
           +    L +  + L+    ++ +    ++  L +  NN + ++P       +L  L +  N
Sbjct: 40  NGNAVLNVGESGLT----TLPDCLPAHITTLVIPDNNLT-SLPALP---PELRTLEVSGN 91

Query: 94  SFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILP 153
             +  +P     L  L        +L +                L  + +  N L     
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPAL------------PSGLCKLWIFGNQL----- 133

Query: 154 KTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQ 213
            TS+  L   L+E  + +  ++  +P   S L  L       N+L  S+P+       LQ
Sbjct: 134 -TSLPVLPPGLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPS---GLQ 184

Query: 214 RLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI 273
            L++ DN L  S+P     L +L+     +N+L  S+PA     + L+ L +  N+LTS+
Sbjct: 185 ELSVSDNQLA-SLPTLPSELYKLWAY---NNRLT-SLPA---LPSGLKELIVSGNRLTSL 236

Query: 274 PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLE 333
           P+    LK   +L  S N LT  L +    L  L       N  +  +P  +   LS   
Sbjct: 237 PVLPSELK---ELMVSGNRLTS-LPMLPSGLLSL---SVYRNQLT-RLPESLI-HLSSET 287

Query: 334 DLNLSFNKLK 343
            +NL  N L 
Sbjct: 288 TVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 99.6 bits (248), Expect = 4e-22
 Identities = 43/214 (20%), Positives = 78/214 (36%), Gaps = 32/214 (14%)

Query: 135 CKSLTLIDLSNNPLDGILPKTSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL 193
                ++++  + L      T++   L   +    + + N++  +P     L  L   ++
Sbjct: 39  NNGNAVLNVGESGL------TTLPDCLPAHITTLVIPDNNLT-SLPALPPELRTL---EV 88

Query: 194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPAC 253
            GN+L  S+P+    L +L   +     L             L +L +  N+L  S+P  
Sbjct: 89  SGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQL-TSLPVL 139

Query: 254 FGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFS 313
                 L+ LS+  N+L S+P     L    +L   +N LT  L +    L+ L     S
Sbjct: 140 PPG---LQELSVSDNQLASLPALPSELC---KLWAYNNQLTS-LPMLPSGLQEL---SVS 189

Query: 314 MNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
            N  +  +P     +L  L   N     L     
Sbjct: 190 DNQLA-SLPTLPS-ELYKLWAYNNRLTSLPALPS 221

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 22/103 (21%), Positives = 35/103 (33%), Gaps = 10/103 (9%)

Query: 245 KLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNL 304
            +   + AC  N     +L++G + LT++P        I  L    N LT  L      L
Sbjct: 29  AVVQKMRACLNN--GNAVLNVGESGLTTLPDCL--PAHITTLVIPDNNLTS-LPALPPEL 83

Query: 305 KVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
           + L   + S N  +  +P      L  L   +     L     
Sbjct: 84  RTL---EVSGNQLT-SLPVLPP-GLLELSIFSNPLTHLPALPS 121

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  129 bits (327), Expect = 2e-32
 Identities = 51/348 (14%), Positives = 108/348 (31%), Gaps = 29/348 (8%)

Query: 7   GNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            +  N++EL L  N L     A +   + L+ L L +N L      + +  L  L  L L
Sbjct: 31  QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDLES--LSTLRTLDL 87

Query: 67  WGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL 126
             N         +     +  L    N+ S    S     +  + + L  N +T      
Sbjct: 88  NNNYVQE-----LLVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKITMLRDL- 138

Query: 127 SFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLT 186
                      +  +DL  N +D +      ++   +LE   +    I   +  ++    
Sbjct: 139 ----DEGCRSRVQYLDLKLNEIDTVNFAELAASS-DTLEHLNLQYNFIY-DVKGQV-VFA 191

Query: 187 NLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKL 246
            L  +DL  NKL   +         +  ++L +N L   I   +     L   +L  N  
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

Query: 247 -YGSIPACFGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSNFLTGPLLLEIGNL 304
             G++   F      R+ ++    +  +              ++ +             L
Sbjct: 250 HCGTLRDFFSKN--QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307

Query: 305 KVLIGIDFSMNNFSGVIPREIG---EKLSYLEDLNLSFNKLKGEIPRG 349
             L   + ++ +  G     +    E  +   +++    + +  +   
Sbjct: 308 IALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQ 354

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  125 bits (316), Expect = 5e-31
 Identities = 55/343 (16%), Positives = 113/343 (32%), Gaps = 48/343 (13%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
           I     N    +  ++  +  +    A++                             N+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSS-LKQALASLRQ------------------------SAWNV 36

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           ++L L GN  S      +   +KL  L+L  N     +     +L  L  L L+ NY+  
Sbjct: 37  KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ- 93

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
                     L    S+  +  +NN +  +       +  +  +  Y+ N  I+     +
Sbjct: 94  ---------ELLVGPSIETLHAANNNISRVSC-----SRGQGKKNIYLANNKITMLRDLD 139

Query: 182 ISNLTNLVEIDLGGNKLNG-SIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE 240
               + +  +DL  N+++  +          L+ LNL+ N +   +   +   A+L  L+
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLD 197

Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLE 300
           L SNKL   +   F + A +  +SL +NKL  I       +++   +   N       L 
Sbjct: 198 LSSNKL-AFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHC-GTLR 255

Query: 301 IGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
               K       +       +  +  E+ +     +      +
Sbjct: 256 DFFSKNQRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCE 297

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  122 bits (308), Expect = 5e-30
 Identities = 47/275 (17%), Positives = 101/275 (36%), Gaps = 22/275 (8%)

Query: 75  IPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSN 134
           I     N ++     +  +S    + S   +  N+++L L  N L+  +        L+ 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA-----DLAP 56

Query: 135 CKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLG 194
              L L++LS+N L   L    + +LS +L    + N  +      E+    ++  +   
Sbjct: 57  FTKLELLNLSSNVLYETLD---LESLS-TLRTLDLNNNYVQ-----ELLVGPSIETLHAA 107

Query: 195 GNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG-SIPAC 253
            N ++    ++  + +  + + L +N +      D    + +  L+L  N++   +    
Sbjct: 108 NNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 254 FGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFS 313
             +  +L  L+L  N +  +         +  L+ SSN L   +  E  +   +  I   
Sbjct: 165 AASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLR 222

Query: 314 MNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR 348
            N    +I + +      LE  +L  N       R
Sbjct: 223 NNKLV-LIEKALRF-SQNLEHFDLRGNGFHCGTLR 255

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  112 bits (282), Expect = 1e-26
 Identities = 48/343 (13%), Positives = 92/343 (26%), Gaps = 16/343 (4%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEK 63
           +     Q  + + L  NK+           S +++L L+ N +     +        LE 
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173

Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           L L  N     +   +   +KL  L L  N  + F+   F +   +  + L  N L    
Sbjct: 174 LNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIE 230

Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEIS 183
             L F  +L +       DL  N       +   S   R           ++G   +   
Sbjct: 231 KALRFSQNLEH------FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG---QNEE 281

Query: 184 NLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGS----IPDDICRLAELYRL 239
             T       G             +L  L+R        +GS    +  +    A    +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREI 341

Query: 240 ELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLL 299
           +    +    I        +   L      L             L            L  
Sbjct: 342 DALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQH 401

Query: 300 EIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
                  L  +   +  +  +   +   + + + D ++  +K 
Sbjct: 402 ATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 26/148 (17%), Positives = 55/148 (37%), Gaps = 12/148 (8%)

Query: 209 LRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSN 268
             + +   + D+ L+ ++         +  L+L  N L     A       L +L+L SN
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 269 KLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEK 328
            L        +L  +  L+ ++N++      E+     +  +  + NN S V       +
Sbjct: 69  VLYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSC----SR 118

Query: 329 LSYLEDLNLSFNKLKGEIPRGGSFGNFS 356
               +++ L+ NK+   +      G  S
Sbjct: 119 GQGKKNIYLANNKIT-MLRD-LDEGCRS 144

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  129 bits (326), Expect = 2e-32
 Identities = 77/370 (20%), Positives = 138/370 (37%), Gaps = 42/370 (11%)

Query: 11  NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNN 70
           ++  + L  N +      +   +  L+FL ++  +    + +     L +L  L L  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 71  FSGTIPRFIFNA-SKLSKLSLGMNSF-SGFIPS-TFGNLRNLEQLGLDENYLTSSTPELS 127
           F   +    FN  + L  L+L   +     +    F  L +LE L L +N +    P   
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 128 FLSSLSNCKSLTLIDLSNNPLDGI-------LPKTSISNLS-RSLEEFYMYNCNISGGIP 179
           F     N +   ++DL+ N +  I             + L   S+    M    +     
Sbjct: 150 F----LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205

Query: 180 EEISNLTNLVEIDLGGNKLNGSIP---ITLGKLRKLQRLNLEDNILEG---------SIP 227
                 T++  +DL GN    S+           K+Q L L ++   G            
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265

Query: 228 DDICR---LAELYRLELGSNKLYGSIPAC-FGNLASLRILSLGSNKLTSIPL-TFWNLKD 282
           +   +    + +   +L  +K+  ++    F +   L  L+L  N++  I    FW L  
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324

Query: 283 ILQLNFSSNFLTGPLLLEIG---NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSF 339
           +L+LN S NFL     ++     NL  L  +D S N+    +  +    L  L++L L  
Sbjct: 325 LLKLNLSQNFLGS---IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDT 380

Query: 340 NKLKGEIPRG 349
           N+LK  +P G
Sbjct: 381 NQLK-SVPDG 389

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  121 bits (305), Expect = 9e-30
 Identities = 64/311 (20%), Positives = 119/311 (38%), Gaps = 33/311 (10%)

Query: 8   NLQNLEELQLGQNKLIGT-VPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
            L NLE L L Q  L G  +    F  +++L+ L L++N++     +   + +     L 
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160

Query: 66  LWGNNFSGTIPRFIF---NASKLSKLSLGMN--------SFSGFIPSTFGNLRNLEQLGL 114
           L  N    +I             + L L                         ++  L L
Sbjct: 161 LTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDL 219

Query: 115 DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSR---------SLE 165
             N    S  +  F  +++  K  +LI  ++  +      T+  +             ++
Sbjct: 220 SGNGFKESMAK-RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK 278

Query: 166 EFYMYNCNISGGIPEEI-SNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILE 223
              +    I   + + + S+ T+L ++ L  N++N  I       L  L +LNL  N L 
Sbjct: 279 TCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL- 335

Query: 224 GSIPDDICR-LAELYRLELGSNKLYGSIPAC-FGNLASLRILSLGSNKLTSIPL-TFWNL 280
           GSI   +   L +L  L+L  N +  ++    F  L +L+ L+L +N+L S+P   F  L
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394

Query: 281 KDILQLNFSSN 291
             + ++   +N
Sbjct: 395 TSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 95.6 bits (238), Expect = 4e-21
 Identities = 56/319 (17%), Positives = 103/319 (32%), Gaps = 36/319 (11%)

Query: 47  SGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPS-TFGN 105
           +  L  +  +   ++  + L  N+ +            L  L +   +    I + TF  
Sbjct: 19  NRGLHQVPEL-PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG 77

Query: 106 LRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPL-DGILPKTSISNLSRSL 164
           L +L  L LD N               +   +L ++ L+   L   +L       L+ SL
Sbjct: 78  LSSLIILKLDYNQFLQLETGA-----FNGLANLEVLTLTQCNLDGAVLSGNFFKPLT-SL 131

Query: 165 EEFYMYNCNISGGIPEEI-SNLTNLVEIDLGGNKLNGSIPITLGKLRK--LQRLNLEDNI 221
           E   + + NI    P     N+     +DL  NK+       L   +      L L    
Sbjct: 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSIT 191

Query: 222 LEGSIPDDIC--------RLAELYRLELGSNKLYGSIPACFGNLAS---LRILSLGSNKL 270
           L+      +         +   +  L+L  N    S+   F +  +   ++ L L ++  
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251

Query: 271 TSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLS 330
                   N KD     F          LE   +K     D S +     + + +    +
Sbjct: 252 MGSSFGHTNFKDPDNFTFKG--------LEASGVKTC---DLSKSKIF-ALLKSVFSHFT 299

Query: 331 YLEDLNLSFNKLKGEIPRG 349
            LE L L+ N++  +I   
Sbjct: 300 DLEQLTLAQNEIN-KIDDN 317

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 41/141 (29%), Positives = 61/141 (43%), Gaps = 10/141 (7%)

Query: 11  NLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGN 69
            ++   L ++K I  +  ++F + + L+ L L  N ++  +   A   L +L KL L  N
Sbjct: 276 GVKTCDLSKSK-IFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333

Query: 70  NFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSF 128
               +I   +F    KL  L L  N        +F  L NL++L LD N L  S P+  F
Sbjct: 334 FLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIF 391

Query: 129 LSSLSNCKSLTLIDLSNNPLD 149
                   SL  I L  NP D
Sbjct: 392 ----DRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 41/187 (21%), Positives = 67/187 (35%), Gaps = 32/187 (17%)

Query: 186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICR-LAELYRLELGSN 244
            ++  +DL  N +      +  +L+ LQ L +E       I ++  R L+ L  L+L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 245 KLYGSIPA-CFGNLASLRILSLGSNKLTSIPL---TFWNLKDILQLNFSSNFLTGPLLLE 300
           +    +    F  LA+L +L+L    L    L    F  L                    
Sbjct: 90  QF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT------------------- 129

Query: 301 IGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESF 360
             +L++L       NN   + P      +     L+L+FNK+K  I       NF  + F
Sbjct: 130 --SLEML---VLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICE-EDLLNFQGKHF 182

Query: 361 EGNELLC 367
               L  
Sbjct: 183 TLLRLSS 189

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.5 bits (147), Expect = 8e-10
 Identities = 35/126 (27%), Positives = 53/126 (42%), Gaps = 5/126 (3%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
           +  +LE+L L QN+ I  +    F  ++ L  L L  N L  S+ S     L  LE L L
Sbjct: 297 HFTDLEQLTLAQNE-INKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDL 354

Query: 67  WGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
             N+    +    F     L +L+L  N         F  L +L+++ L  N    S P 
Sbjct: 355 SYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413

Query: 126 LSFLSS 131
           + +LS 
Sbjct: 414 IDYLSR 419

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  126 bits (318), Expect = 2e-32
 Identities = 48/292 (16%), Positives = 105/292 (35%), Gaps = 22/292 (7%)

Query: 75  IPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSN 134
           I     N ++     +  +S    + S   +  N+++L L  N L+  +        L+ 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA-----DLAP 56

Query: 135 CKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLG 194
              L L++LS+N L   L    + +LS +L    + N  +      E+    ++  +   
Sbjct: 57  FTKLELLNLSSNVLYETLD---LESLS-TLRTLDLNNNYVQ-----ELLVGPSIETLHAA 107

Query: 195 GNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG-SIPAC 253
            N ++    ++  + +  + + L +N +      D    + +  L+L  N++   +    
Sbjct: 108 NNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 254 FGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFS 313
             +  +L  L+L  N +  +         +  L+ SSN L   +  E  +   +  I   
Sbjct: 165 AASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLR 222

Query: 314 MNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNEL 365
            N    +I + +      LE  +L  N       R     N   ++     +
Sbjct: 223 NNKLV-LIEKALR-FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  125 bits (317), Expect = 3e-32
 Identities = 53/294 (18%), Positives = 102/294 (34%), Gaps = 46/294 (15%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
           I     N    +  ++  + L     A++                             N+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLK-QALASLR------------------------QSAWNV 36

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           ++L L GN  S      +   +KL  L+L  N           +L  L  L L+ NY+  
Sbjct: 37  KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ- 93

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
                     L    S+  +  +NN +  +       +  +  +  Y+ N  I+     +
Sbjct: 94  ---------ELLVGPSIETLHAANNNISRVSC-----SRGQGKKNIYLANNKITMLRDLD 139

Query: 182 ISNLTNLVEIDLGGNKLNG-SIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE 240
               + +  +DL  N+++  +          L+ LNL+ N +   +   +   A+L  L+
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLD 197

Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT 294
           L SNKL   +   F + A +  +SL +NKL  I       +++   +   N   
Sbjct: 198 LSSNKL-AFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  121 bits (306), Expect = 8e-31
 Identities = 49/291 (16%), Positives = 96/291 (32%), Gaps = 24/291 (8%)

Query: 1   EIPLEIG-NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLP 59
           +    +  +  N++EL L  N L     A +   + L+ L L +N L      + +  L 
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDLES--LS 80

Query: 60  NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
            L  L L  N         +     +  L    N+ S    S     +  + + L  N +
Sbjct: 81  TLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKI 132

Query: 120 TSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
           T                 +  +DL  N +D +      ++   +LE   +    I   + 
Sbjct: 133 TMLRDL-----DEGCRSRVQYLDLKLNEIDTVNFAELAASSD-TLEHLNLQYNFIY-DVK 185

Query: 180 EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
            ++     L  +DL  NKL   +         +  ++L +N L   I   +     L   
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 240 ELGSNKLY-GSIPACFGNLASLRILSLGSNK-LTSIPLTFWNLKDILQLNF 288
           +L  N  + G++   F     ++ ++  + K LT        +  +     
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 35/216 (16%), Positives = 63/216 (29%), Gaps = 14/216 (6%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEK 63
           +     Q  + + L  NK+           S +++L L+ N +     +        LE 
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173

Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           L L  N     +   +   +KL  L L  N  + F+   F +   +  + L  N L    
Sbjct: 174 LNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIE 230

Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEIS 183
             L F  +L +       DL  N       +   S   R               +  +  
Sbjct: 231 KALRFSQNLEH------FDLRGNGFHCGTLRDFFSKNQRVQT----VAKQTVKKLTGQNE 280

Query: 184 NLTNLVEIDLGGNKLNGSIPITLG-KLRKLQRLNLE 218
               +  +   G      +P     +L  L   +  
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 27/156 (17%), Positives = 58/156 (37%), Gaps = 12/156 (7%)

Query: 201 SIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASL 260
           +I        + +   + D+ L+ ++         +  L+L  N L     A       L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 261 RILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGV 320
            +L+L SN L        +L  +  L+ ++N++      E+     +  +  + NN S  
Sbjct: 61  ELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113

Query: 321 IPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFS 356
           +    G+     +++ L+ NK+   +      G  S
Sbjct: 114 VSCSRGQG---KKNIYLANNKIT-MLRD-LDEGCRS 144

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  125 bits (315), Expect = 3e-32
 Identities = 40/185 (21%), Positives = 74/185 (40%), Gaps = 41/185 (22%)

Query: 445 DEFSENNLIGRGGFA----------------------------LFIRAFKSFDVECEMMK 476
           +E      IG+GGF                               I  F+ F  E  +M 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 477 SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 536
           ++ H N++K+     N     +V+E++P G L   L      +    +L +M+D+A  +E
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136

Query: 537 YLHFGYSALVIHCDLKPSNVLLD-----DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTI 591
           Y+    +  ++H DL+  N+ L        + A ++DF +++         + +  LG  
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNF 190

Query: 592 GYMAP 596
            +MAP
Sbjct: 191 QWMAP 195

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  129 bits (327), Expect = 4e-32
 Identities = 67/355 (18%), Positives = 119/355 (33%), Gaps = 25/355 (7%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV--RLP 59
           +P    NL NLE L L  NK+       +  +  +  L L  +     ++ I     +  
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200

Query: 60  NLEKLYLWGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSG------FIPSTFGNLRNLEQL 112
            L KL L  N  S  + +      + L    L +  F        F  S    L NL   
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 113 GLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNC 172
                YL     ++      +   +++   L +  ++ +   +      + LE       
Sbjct: 261 EFRLAYLDYYLDDII--DLFNCLTNVSSFSLVSVTIERVKDFSYNFGW-QHLELVNCKFG 317

Query: 173 NISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE--GSIPDDI 230
                       L +L  +    NK   +   +   L  L+ L+L  N L   G      
Sbjct: 318 QFPTL------KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSD 369

Query: 231 CRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP--LTFWNLKDILQLNF 288
                L  L+L  N +  ++ + F  L  L  L    + L  +     F +L++++ L+ 
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428

Query: 289 SSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
           S              L  L  +  + N+F      +I  +L  L  L+LS  +L+
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  129 bits (325), Expect = 9e-32
 Identities = 82/364 (22%), Positives = 132/364 (36%), Gaps = 20/364 (5%)

Query: 3   PLEIGNLQNLEELQLGQNKL-IGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
              IG+L+ L+EL +  N +    +P    N++ L+ L L +N +  S+       L  +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQM 175

Query: 62  EKLYLW---GNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPST-FGNLRNLEQLGLDEN 117
             L L      N    I    F   +L KL+L  N  S  +  T    L  LE   L   
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235

Query: 118 YLTSSTPELSF-LSSLSNCKSLTLIDLSNNPLDGILPK-TSISNLSRSLEEFYMYNCNIS 175
              +      F  S+L    +LT+ +     LD  L     + N   ++  F + +  I 
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295

Query: 176 GGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAE 235
               ++ S       ++L   K          KL+ L+RL    N    +  +    L  
Sbjct: 296 R--VKDFSYNFGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAFSEV--DLPS 348

Query: 236 LYRLELGSNKLY--GSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFL 293
           L  L+L  N L   G          SL+ L L  N + ++   F  L+ +  L+F  + L
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408

Query: 294 TG-PLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSF 352
                     +L+ LI +D S  +   V    I   LS LE L ++ N  +        F
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP-DIF 466

Query: 353 GNFS 356
               
Sbjct: 467 TELR 470

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  127 bits (320), Expect = 4e-31
 Identities = 71/368 (19%), Positives = 122/368 (33%), Gaps = 31/368 (8%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           +IP  +    + + L L  N L      + F+   L+ L L    +  ++   A   L +
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L  L L GN             S L KL     + +       G+L+ L++L +  N + 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKT--SISNLSRSLEEFYMYNCNISGGI 178
           S           SN  +L  +DLS+N +  I       +  +        +    ++  I
Sbjct: 138 S----FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192

Query: 179 PEEISNLTNLVEIDLGGNKLNGSIPIT-LGKLRKLQRLNLE------DNILEGSIPDDIC 231
                    L ++ L  N  + ++  T +  L  L+   L       +  LE      + 
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252

Query: 232 RLAELYRLELGSNKLYGS---IPACFGNLASLRILSLGSNKLTSIP--LTFWNLKDILQL 286
            L  L   E     L      I   F  L ++   SL S  +  +      +  + +  +
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELV 312

Query: 287 NFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEI 346
           N           L++ +LK L    F+ N             L  LE L+LS N L  + 
Sbjct: 313 NCKFGQFPT---LKLKSLKRL---TFTSNKGGNAFS---EVDLPSLEFLDLSRNGLSFKG 363

Query: 347 PRGGSFGN 354
               S   
Sbjct: 364 CCSQSDFG 371

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  121 bits (306), Expect = 2e-29
 Identities = 65/351 (18%), Positives = 110/351 (31%), Gaps = 49/351 (13%)

Query: 3   PLEIGNLQNLEELQL------GQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV 56
              I  L  LE  +L       +  L     +A+  +  L     +   L   L  I ++
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277

Query: 57  --RLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGL 114
              L N+    L        +  F +N      L L    F  F       L++L++L  
Sbjct: 278 FNCLTNVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVNCKFGQF---PTLKLKSLKRLTF 332

Query: 115 DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNI 174
             N   +         S  +  SL  +DLS N L      +     + SL+   +    +
Sbjct: 333 TSNKGGN-------AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385

Query: 175 SGGIPEEISNLTNLVEIDLGGNKLNGSIP-ITLGKLRKLQRLNLEDNILEGSIPDDICRL 233
              +      L  L  +D   + L           LR L  L++       +       L
Sbjct: 386 IT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444

Query: 234 AELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSN 291
           + L  L++  N    +     F  L +L  L L   +L  +    F +L  +  LN +SN
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504

Query: 292 FLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
            L                           +P  I ++L+ L+ + L  N  
Sbjct: 505 QLK-------------------------SVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  107 bits (270), Expect = 8e-25
 Identities = 45/223 (20%), Positives = 87/223 (39%), Gaps = 11/223 (4%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSG-SLSSIANVRLPNLEKLYL 66
            L++L+ L    NK       +  ++ +L+FL L  N LS     S ++    +L+ L L
Sbjct: 323 KLKSLKRLTFTSNKG--GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380

Query: 67  WGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIP-STFGNLRNLEQLGLDENYLTSSTPE 125
             N    T+        +L  L    ++       S F +LRNL  L +   +   +   
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNL 185
           +      +   SL ++ ++ N           + L  +L    +  C +    P   ++L
Sbjct: 440 I-----FNGLSSLEVLKMAGNSFQENFLPDIFTELR-NLTFLDLSQCQLEQLSPTAFNSL 493

Query: 186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPD 228
           ++L  +++  N+L         +L  LQ++ L  N  + S P 
Sbjct: 494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 99.4 bits (248), Expect = 4e-22
 Identities = 38/213 (17%), Positives = 71/213 (33%), Gaps = 11/213 (5%)

Query: 142 DLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGS 201
                    I       NL  S +   +    +         +   L  +DL   ++   
Sbjct: 13  QCMELNFYKI-----PDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67

Query: 202 IPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLR 261
                  L  L  L L  N ++         L+ L +L      L        G+L +L+
Sbjct: 68  EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127

Query: 262 ILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMN---N 316
            L++  N + S  L   F NL ++  L+ SSN +      ++  L  +  ++ S++   N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187

Query: 317 FSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
               I     +++  L  L L  N     + + 
Sbjct: 188 PMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKT 219

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 84.4 bits (209), Expect = 3e-17
 Identities = 41/201 (20%), Positives = 72/201 (35%), Gaps = 31/201 (15%)

Query: 3   PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLE 62
                   +L+ L L  N +I T+ +    +  L+ L  Q+++L         + L NL 
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424

Query: 63  KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSS 122
            L +   +                                F  L +LE L +  N    +
Sbjct: 425 YLDISHTH------------------------TRVAFNGIFNGLSSLEVLKMAGNSFQEN 460

Query: 123 TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI 182
                F    +  ++LT +DLS   L+ +   T+ ++LS SL+   M +  +        
Sbjct: 461 FLPDIF----TELRNLTFLDLSQCQLEQL-SPTAFNSLS-SLQVLNMASNQLKSVPDGIF 514

Query: 183 SNLTNLVEIDLGGNKLNGSIP 203
             LT+L +I L  N  + S P
Sbjct: 515 DRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 83.6 bits (207), Expect = 4e-17
 Identities = 35/151 (23%), Positives = 55/151 (36%), Gaps = 8/151 (5%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLP 59
            +      L+ LE L    + L      ++F ++  L +L + +        +     L 
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 445

Query: 60  NLEKLYLWGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENY 118
           +LE L + GN+F       IF     L+ L L         P+ F +L +L+ L +  N 
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLD 149
           L S               SL  I L  NP D
Sbjct: 506 LKSVPD-----GIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 30/135 (22%), Positives = 47/135 (34%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
           +L+NL  L +               +S+L+ L +  NS   +        L NL  L L 
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 68  GNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELS 127
                   P    + S L  L++  N         F  L +L+++ L  N    S P + 
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538

Query: 128 FLSSLSNCKSLTLID 142
           +LS   N  S     
Sbjct: 539 YLSRWLNKNSQKEQG 553

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  124 bits (314), Expect = 7e-32
 Identities = 33/175 (18%), Positives = 66/175 (37%), Gaps = 27/175 (15%)

Query: 445 DEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLI 484
           ++     LIG+G F                           K+F  E    +  RH N++
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92

Query: 485 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 544
             + +C +    A++       +L   +  +  +LD+ +   I  ++   + YLH   + 
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AK 149

Query: 545 LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT---GEDQSMTQTQTLGTIGYMAP 596
            ++H DLK  NV  D+  V  ++DF +  +        +        G + ++AP
Sbjct: 150 GILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  122 bits (308), Expect = 2e-31
 Identities = 34/142 (23%), Positives = 61/142 (42%), Gaps = 14/142 (9%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +  ++   E ++   ++H N+I +   C  E    LV+E+   G L + L      +   
Sbjct: 48  QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPD 105

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD--------DNMVAHLSDFSIAKL 574
             +N  + +A  + YLH      +IH DLK SN+L+          N +  ++DF +A+ 
Sbjct: 106 ILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165

Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
                  M+     G   +MAP
Sbjct: 166 WH-RTTKMSAA---GAYAWMAP 183

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  126 bits (318), Expect = 5e-31
 Identities = 71/357 (19%), Positives = 132/357 (36%), Gaps = 25/357 (7%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKL 64
            G L +L+ L L  N        ++F N++ L+ L + N      +  I    L +L +L
Sbjct: 94  FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153

Query: 65  YLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS--- 121
            +   +      + + +   +  L+L ++  +  +      L ++  L L +  L     
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213

Query: 122 ---STPELSFLSSLSNCKSLTLIDLSNNPL----DGILPKTSISNLSRSLEEFYMYNCNI 174
                 E+S        +   L D S N L      IL  + +     +L     +N + 
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE 273

Query: 175 SGGIPEEIS-NLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICR- 232
           S  + E        +  + +    L   +      L K++R+ +E++ +   +P    + 
Sbjct: 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQH 332

Query: 233 LAELYRLELGSNKL---YGSIPACFGNLASLRILSLGSNKLTSIPL---TFWNLKDILQL 286
           L  L  L+L  N +   Y    AC G   SL+ L L  N L S+         LK++  L
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392

Query: 287 NFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
           + S N    P+       + +  ++ S      V+   I      LE L++S N L 
Sbjct: 393 DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI---PQTLEVLDVSNNNLD 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  125 bits (316), Expect = 9e-31
 Identities = 66/372 (17%), Positives = 131/372 (35%), Gaps = 29/372 (7%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLP 59
            +     NL NL+ L++G  +    +    F  +++L  L ++  SL  +  S +   + 
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIR 172

Query: 60  NLEKLYLWGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENY 118
           ++  L L   + S  +     +  S +  L L   + + F  S          +      
Sbjct: 173 DIHHLTL-HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231

Query: 119 LTSSTPE--LSFLSSLSNCKSLTLIDLSNNPLDGI--LPKTSISNLSR-------SLEEF 167
            +  T E     L  L     L+ ++  +  L+G+     +    +S        ++   
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291

Query: 168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP 227
           ++    +   +    S L  +  I +  +K+          L+ L+ L+L +N++     
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 228 DD---ICRLAELYRLELGSNKLY--GSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKD 282
            +         L  L L  N L            L +L  L +  N    +P +    + 
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEK 411

Query: 283 ILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
           +  LN SS  +    +++    + L  +D S NN            L  L++L +S NKL
Sbjct: 412 MRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLD-----SFSLFLPRLQELYISRNKL 463

Query: 343 KGEIPRGGSFGN 354
           K  +P    F  
Sbjct: 464 K-TLPDASLFPV 474

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  123 bits (310), Expect = 5e-30
 Identities = 71/362 (19%), Positives = 129/362 (35%), Gaps = 25/362 (6%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
           +L +LE L L  N L     +    +S+LK+L L  N       +     L NL+ L + 
Sbjct: 72  SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131

Query: 68  GNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL 126
                  I R  F   + L++L +   S   +   +  ++R++  L L  +         
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE-- 189

Query: 127 SFLSSLSNCKSLTLIDLS-----NNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
            F   LS+ + L L D +      +PL      + +  L+         + N    +   
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249

Query: 182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRK--------LQRLNLEDNILEGSIPDDICRL 233
           I  L+ +   D   N L    P     + +        ++RL++    L   +      L
Sbjct: 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309

Query: 234 AELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLT----FWNLKDILQLNFS 289
            ++ R+ + ++K++    +   +L SL  L L  N +    L           +  L  S
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369

Query: 290 SNFLT--GPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
            N L         +  LK L  +D S N F   +P    +    +  LNLS   ++  + 
Sbjct: 370 QNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSC-QWPEKMRFLNLSSTGIR-VVK 426

Query: 348 RG 349
             
Sbjct: 427 TC 428

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  117 bits (294), Expect = 6e-28
 Identities = 62/355 (17%), Positives = 127/355 (35%), Gaps = 20/355 (5%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
            IP  +     ++ L L  NK+       +   + L+ L L+++ ++ ++   A   L +
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGS 75

Query: 61  LEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENY 118
           LE L L  N+ S ++    F   S L  L+L  N +    + S F NL NL+ L +    
Sbjct: 76  LEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
             S    + F    +   SL  +++    L       S+ ++ R +    ++    +  +
Sbjct: 135 TFSEIRRIDF----AGLTSLNELEIKALSLRNY-QSQSLKSI-RDIHHLTLHLSESAFLL 188

Query: 179 PEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYR 238
                 L+++  ++L    L       L        +            +    L +L R
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248

Query: 239 LELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSNFLTGPL 297
             L  +++       F +     +     ++   +  L       I +L+    +L   L
Sbjct: 249 YILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302

Query: 298 LLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSF 352
                 L+ +  I    +    ++P    + L  LE L+LS N +  E  +  + 
Sbjct: 303 STVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  113 bits (284), Expect = 1e-26
 Identities = 62/354 (17%), Positives = 134/354 (37%), Gaps = 29/354 (8%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV--RLPNLEK 63
           + +++++  L L  ++    +      +S++++L L++ +L+    S   V      ++K
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227

Query: 64  LYLWGNNFS----GTIPRFIFNASKLSKLSL------GMNSFSGFIPSTFGNLRNLEQLG 113
           L   G+  +      + + +    +LS++        G+  F+         L  +E + 
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287

Query: 114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCN 173
           +   ++          +  S  + +  I + N+ +  + P +   +L  SLE   +    
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV-PCSFSQHLK-SLEFLDLSENL 345

Query: 174 ISGGIPEE---ISNLTNLVEIDLGGNKLN--GSIPITLGKLRKLQRLNLEDNILEGSIPD 228
           +     +         +L  + L  N L         L  L+ L  L++  N     +PD
Sbjct: 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404

Query: 229 DICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNF 288
                 ++  L L S  +   +  C     +L +L + +N L S  L    L+   +L  
Sbjct: 405 SCQWPEKMRFLNLSSTGI-RVVKTC--IPQTLEVLDVSNNNLDSFSLFLPRLQ---ELYI 458

Query: 289 SSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
           S N L    L +     VL+ +  S N     +P  I ++L+ L+ + L  N  
Sbjct: 459 SRNKLKT--LPDASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  111 bits (279), Expect = 4e-26
 Identities = 51/320 (15%), Positives = 107/320 (33%), Gaps = 26/320 (8%)

Query: 49  SLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRN 108
           S +SI +     ++ L L  N  +      +   + L  L L  +  +      F +L +
Sbjct: 16  SFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75

Query: 109 LEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFY 168
           LE L L +N+L+S +             SL  ++L  NP   +   +   NL+ +L+   
Sbjct: 76  LEHLDLSDNHLSSLSSSW-----FGPLSSLKYLNLMGNPYQTLGVTSLFPNLT-NLQTLR 129

Query: 169 MYNCNISGGIPEE-ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP 227
           + N      I     + LT+L E+++    L      +L  +R +  L L  +     + 
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189

Query: 228 DDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNK-----------LTSIPLT 276
                L+ +  LEL    L     +          +   + +           L  +   
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249

Query: 277 FWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSM-------NNFSGVIPREIGEKL 329
              L ++   + + N L      E   +  L  ++            +       +   L
Sbjct: 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309

Query: 330 SYLEDLNLSFNKLKGEIPRG 349
             ++ + +  +K+   +P  
Sbjct: 310 EKVKRITVENSKVF-LVPCS 328

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 95.9 bits (239), Expect = 4e-21
 Identities = 51/272 (18%), Positives = 96/272 (35%), Gaps = 26/272 (9%)

Query: 35  TLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNS 94
           TL  LG  N S S  +S +  V    + +L++        +        K+ ++++  + 
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321

Query: 95  FSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPK 154
                 S   +L++LE L L EN +     + S  +      SL  + LS N L  +   
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS--ACKGAWPSLQTLVLSQNHLRSMQKT 379

Query: 155 TSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQR 214
             I    ++L    +        +P+       +  ++L    +     +     + L+ 
Sbjct: 380 GEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEV 435

Query: 215 LNLEDNILEGSIPDDICRLAELY-------------------RLELGSNKLYGSIPACFG 255
           L++ +N L+ S    + RL ELY                    +++  N+L       F 
Sbjct: 436 LDVSNNNLD-SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFD 494

Query: 256 NLASLRILSLGSNKLTSIPLTFWNLKDILQLN 287
            L SL+ + L +N           L   L  N
Sbjct: 495 RLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 526

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 34/142 (23%), Positives = 53/142 (37%), Gaps = 10/142 (7%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
            +P      + +  L L    +   V   I    TL+ L + NN+L  S S      LP 
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGI-RVVKTCIP--QTLEVLDVSNNNLD-SFSL----FLPR 452

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           L++LY+  N    T+P        L  + +  N         F  L +L+++ L  N   
Sbjct: 453 LQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

Query: 121 SSTPELSFLSSLSNCKSLTLID 142
            S P + +LS   N  S     
Sbjct: 511 CSCPRIDYLSRWLNKNSQKEQG 532

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  120 bits (304), Expect = 2e-30
 Identities = 61/275 (22%), Positives = 110/275 (40%), Gaps = 31/275 (11%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
           NL+NL  L L  NK I  +    F  +  L+ L L  N     L  +       L++L +
Sbjct: 74  NLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLSKN----QLKELPEKMPKTLQELRV 128

Query: 67  WGNNFSGTIPRFIF-NASKLSKLSLGMNSF--SGFIPSTFGNLRNLEQLGLDENYLTSST 123
             N  +  + + +F   +++  + LG N    SG     F  ++ L  + + +  +T+  
Sbjct: 129 HENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 187

Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEIS 183
             L          SLT + L  N +  +    S+  L  +L +  +   +IS      ++
Sbjct: 188 QGL--------PPSLTELHLDGNKITKV-DAASLKGL-NNLAKLGLSFNSISAVDNGSLA 237

Query: 184 NLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDD-------ICRLAEL 236
           N  +L E+ L  NKL   +P  L   + +Q + L +N +  +I  +         + A  
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASY 295

Query: 237 YRLELGSNKL-YGSIPAC-FGNLASLRILSLGSNK 269
             + L SN + Y  I    F  +     + LG+ K
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  117 bits (296), Expect = 2e-29
 Identities = 67/341 (19%), Positives = 106/341 (31%), Gaps = 52/341 (15%)

Query: 11  NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNN 70
           +L  +Q     L   VP  +        L LQNN ++  +       L NL  L L  N 
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87

Query: 71  FSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLS 130
            S  I                        P  F  L  LE+L L +N L     ++    
Sbjct: 88  IS-KIS-----------------------PGAFAPLVKLERLYLSKNQLKELPEKMP--- 120

Query: 131 SLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM-YNCNISGGIPEEI-SNLTNL 188
                K+L  + +  N +  +  K+  + L   +    +  N   S GI       +  L
Sbjct: 121 -----KTLQELRVHENEITKV-RKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKL 173

Query: 189 VEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLY 247
             I +    +  +IP  L     L  L+L+ N +   +       L  L +L L  N + 
Sbjct: 174 SYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS 229

Query: 248 GSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTG------PLLLEI 301
                   N   LR L L +NKL  +P    + K I  +   +N ++             
Sbjct: 230 AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289

Query: 302 GNLKVLIGIDFSMNNFSGV-IPREIGEKLSYLEDLNLSFNK 341
                  G+    N      I       +     + L   K
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 43/217 (19%), Positives = 80/217 (36%), Gaps = 42/217 (19%)

Query: 137 SLTLIDLSNNPLDGILPKTSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG 195
            L ++  S+  L        +  +L        + N  I+     +  NL NL  + L  
Sbjct: 32  HLRVVQCSDLGL------EKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85

Query: 196 NKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFG 255
           NK++   P     L KL+RL L  N L+  +P+ +     L  L +  N++     + F 
Sbjct: 86  NKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFN 142

Query: 256 NLASLRILSLGSNKLTSIPL---TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDF 312
            L  + ++ LG+N L S  +    F  +K +  +  +   +T                  
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT------------------ 184

Query: 313 SMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
                   IP+ +      L +L+L  NK+  ++   
Sbjct: 185 -------TIPQGL---PPSLTELHLDGNKIT-KVDAA 210

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 33/148 (22%), Positives = 56/148 (37%), Gaps = 15/148 (10%)

Query: 7   GNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
           G   +L EL L  NK I  V AA    ++ L  LGL  NS+S ++ + +    P+L +L+
Sbjct: 189 GLPPSLTELHLDGNK-ITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELH 246

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFG------NLRNLEQLGLDENYL 119
           L  N     +P  + +   +  + L  N+ S    + F          +   + L  N +
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305

Query: 120 TSST-PELSFLSSLSNCKSLTLIDLSNN 146
                   +F            + L N 
Sbjct: 306 QYWEIQPSTF----RCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 37/144 (25%), Positives = 60/144 (41%), Gaps = 8/144 (5%)

Query: 212 LQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT 271
           L+ +   D  LE  +P D+    +   L+L +NK+       F NL +L  L L +NK++
Sbjct: 33  LRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 272 SI-PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLS 330
            I P  F  L  + +L  S N L     L     K L  +    N  +  + + +   L+
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK---ELPEKMPKTLQELRVHENEIT-KVRKSVFNGLN 145

Query: 331 YLEDLNLSFNKLKGEIPRGGSFGN 354
            +  + L  N LK      G+F  
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQG 169

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  120 bits (304), Expect = 2e-30
 Identities = 73/303 (24%), Positives = 117/303 (38%), Gaps = 31/303 (10%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLP 59
            +P EI    +   L L  N  I  +    F  +  L  L L NN +S  +   A   L 
Sbjct: 47  AVPKEIS--PDTTLLDLQNND-ISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLR 102

Query: 60  NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
            L+KLY+  N+    IP  +   S L +L +  N         F  LRN+  + +  N L
Sbjct: 103 KLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL 159

Query: 120 TSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
            +S  E      L     L  + +S   L GI       +L  +L E ++ +  I   I 
Sbjct: 160 ENSGFEPGAFDGLK----LNYLRISEAKLTGIPK-----DLPETLNELHLDHNKIQA-IE 209

Query: 180 EEI-SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYR 238
            E     + L  + LG N++      +L  L  L+ L+L++N L   +P  +  L  L  
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQV 268

Query: 239 LELGSNKLYGSIPA-------CFGNLASLRILSLGSNKLTSI---PLTFWNLKDILQLNF 288
           + L +N +   +              A    +SL +N +      P TF  + D L + F
Sbjct: 269 VYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQF 327

Query: 289 SSN 291
            + 
Sbjct: 328 GNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  116 bits (293), Expect = 6e-29
 Identities = 68/294 (23%), Positives = 112/294 (38%), Gaps = 27/294 (9%)

Query: 59  PNLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
           P+   L L  N+ S  + +  F     L  L L  N  S      F  LR L++L + +N
Sbjct: 54  PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112

Query: 118 YLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM-YNCNISG 176
           +L    P L          SL  + + +N +  + PK   S L R++    M  N   + 
Sbjct: 113 HLVEIPPNLP--------SSLVELRIHDNRIRKV-PKGVFSGL-RNMNCIEMGGNPLENS 162

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI-CRLAE 235
           G      +   L  + +   KL   IP  L     L  L+L+ N ++ +I  +   R ++
Sbjct: 163 GFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSK 218

Query: 236 LYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT 294
           LYRL LG N++   I       L +LR L L +NKL+ +P    +LK +  +   +N +T
Sbjct: 219 LYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT 277

Query: 295 G------PLLLEIGNLKVLIGIDFSMNNFSGV-IPREIGEKLSYLEDLNLSFNK 341
                    +          GI    N      +       ++    +     K
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 30/144 (20%), Positives = 57/144 (39%), Gaps = 8/144 (5%)

Query: 212 LQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT 271
           L+ +   D  L+ ++P +I    +   L+L +N +       F  L  L  L L +NK++
Sbjct: 35  LRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 272 SI-PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLS 330
            I    F  L+ + +L  S N L     +       L+ +    N     +P+ +   L 
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV---EIPPNLPSSLVELRIHDNRIR-KVPKGVFSGLR 147

Query: 331 YLEDLNLSFNKLKGEIPRGGSFGN 354
            +  + +  N L+      G+F  
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDG 171

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  119 bits (301), Expect = 3e-30
 Identities = 43/175 (24%), Positives = 68/175 (38%), Gaps = 31/175 (17%)

Query: 451 NLIGRGGFA----------------LFIRAFKSFDVECEM--MKSIRHRNLIKVISSCSN 492
             +G+G +                    R  KS+  E E+     +RH N++  I+S   
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73

Query: 493 EEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGYS 543
               +    L+  Y   GSL  YL      LD    L I++ +AS L +LH         
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131

Query: 544 ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM--TQTQTLGTIGYMAP 596
             + H DLK  N+L+  N    ++D  +A + +     +       +GT  YMAP
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  119 bits (299), Expect = 1e-29
 Identities = 40/181 (22%), Positives = 65/181 (35%), Gaps = 31/181 (17%)

Query: 445 DEFSENNLIGRGGFA----------------LFIRAFKSFDVECEM--MKSIRHRNLIKV 486
            +      IG+G +                  F     S+  E E+     +RH N++  
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGF 96

Query: 487 ISSCSNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH--- 539
           I++            L+ +Y  +GSL  YL S+   LD    L +     S L +LH   
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 540 --FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT--LGTIGYMA 595
                   + H DLK  N+L+  N    ++D  +A     +   +       +GT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 596 P 596
           P
Sbjct: 215 P 215

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  117 bits (294), Expect = 3e-29
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 15/143 (10%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           ++F  E ++M+ + H N++K I     ++    + EY+  G+L   + S +      QR+
Sbjct: 52  RTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRV 111

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
           +   D+AS + YLH   S  +IH DL   N L+ +N    ++DF +A+L+  E       
Sbjct: 112 SFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168

Query: 586 QTL------------GTIGYMAP 596
           ++L            G   +MAP
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAP 191

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  114 bits (288), Expect = 3e-28
 Identities = 41/175 (23%), Positives = 68/175 (38%), Gaps = 31/175 (17%)

Query: 451 NLIGRGGFA----------------LFIRAFKSFDVECEM--MKSIRHRNLIKVISSCSN 492
             IG+G F                    R  +S+  E E+     +RH N++  I++ + 
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107

Query: 493 EEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGYS 543
           +        LV +Y  HGSL  YL      + +   + + +  AS L +LH         
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 165

Query: 544 ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT--LGTIGYMAP 596
             + H DLK  N+L+  N    ++D  +A        ++       +GT  YMAP
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  113 bits (284), Expect = 7e-28
 Identities = 62/272 (22%), Positives = 93/272 (34%), Gaps = 39/272 (14%)

Query: 25  TVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFS-GTIPRFIF-NA 82
           +VP  I   S+   L L++N L  SL      +L  L KL L  N  S            
Sbjct: 21  SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77

Query: 83  SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLID 142
           + L  L L  N     + S F  L  LE L    + L   +    F     + ++L  +D
Sbjct: 78  TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF----LSLRNLIYLD 132

Query: 143 LSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGGNKLNGS 201
           +S+     +      + LS SLE   M   +       +I + L NL  +DL   +L   
Sbjct: 133 ISHTHTR-VAFNGIFNGLS-SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 190

Query: 202 IPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLR 261
            P     L  LQ LN+  N    S+                           +  L SL+
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFF-SLDTFP-----------------------YKCLNSLQ 226

Query: 262 ILSLGSNKLTSIPL-TFWNLKDILQ-LNFSSN 291
           +L    N + +       +    L  LN + N
Sbjct: 227 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  109 bits (275), Expect = 1e-26
 Identities = 48/239 (20%), Positives = 92/239 (38%), Gaps = 14/239 (5%)

Query: 60  NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
           +  ++       + ++P  I   S  ++L L  N         F  L  L +L L  N L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 120 TSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP 179
           +            ++   L  +DLS N +  +   ++   L   LE     + N+     
Sbjct: 65  SFKGCCSQSDFGTTS---LKYLDLSFNGVITM--SSNFLGLE-QLEHLDFQHSNLKQMSE 118

Query: 180 EEI-SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI-CRLAELY 237
             +  +L NL+ +D+       +       L  L+ L +  N  + +   DI   L  L 
Sbjct: 119 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178

Query: 238 RLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSNFLT 294
            L+L   +L   +    F +L+SL++L++  N   S+    +  L  +  L++S N + 
Sbjct: 179 FLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 51/218 (23%), Positives = 80/218 (36%), Gaps = 14/218 (6%)

Query: 8   NLQNLEELQLGQNKL--IGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
            L  L +L L  N L   G    + F  ++LK+L L  N +    S+     L  LE L 
Sbjct: 50  KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG--LEQLEHLD 107

Query: 66  LWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTP 124
              +N        +F +   L  L +            F  L +LE L +  N    +  
Sbjct: 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167

Query: 125 ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISN 184
              F    +  ++LT +DLS   L+ +   T+ ++LS SL+   M + N           
Sbjct: 168 PDIF----TELRNLTFLDLSQCQLEQL-SPTAFNSLS-SLQVLNMSHNNFFSLDTFPYKC 221

Query: 185 LTNLVEIDLGGNKLNGSIPITL--GKLRKLQRLNLEDN 220
           L +L  +D   N +  +            L  LNL  N
Sbjct: 222 LNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 35/173 (20%), Positives = 61/173 (35%), Gaps = 9/173 (5%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLP 59
            +      L+ LE L    + L      ++F ++  L +L + +        +     L 
Sbjct: 92  TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 150

Query: 60  NLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENY 118
           +LE L + GN+F       IF     L+ L L         P+ F +L +L+ L +  N 
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN 171
             S               SL ++D S N +     K  + +   SL    +  
Sbjct: 211 FFSLDT-----FPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQ 257

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 42/224 (18%), Positives = 78/224 (34%), Gaps = 40/224 (17%)

Query: 133 SNCK-SLTLIDLSNNPLDGILPKTSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVE 190
           S C  S T I  ++  L      TS+ + +  S     + +  +          LT L +
Sbjct: 3   SRCSCSGTEIRCNSKGL------TSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTK 56

Query: 191 IDLGGNKLN--GSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG 248
           + L  N L+  G    +      L+ L+L  N +  ++  +   L +L  L+   + L  
Sbjct: 57  LSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-K 114

Query: 249 SIPAC--FGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLK 305
            +     F +L +L  L +            F  L                      +L+
Sbjct: 115 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS---------------------SLE 153

Query: 306 VLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
           VL     + N+F      +I  +L  L  L+LS  +L+ ++   
Sbjct: 154 VL---KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 193

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 33/144 (22%), Positives = 56/144 (38%), Gaps = 8/144 (5%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
           +L+NL  L +            IF  +S+L+ L +  NS   +        L NL  L L
Sbjct: 124 SLRNLIYLDISHTH-TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 67  WGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
                   +    FN+ S L  L++  N+F       +  L +L+ L    N++ +S  +
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLD 149
              L       SL  ++L+ N   
Sbjct: 242 E--LQHFP--SSLAFLNLTQNDFA 261

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  112 bits (282), Expect = 9e-27
 Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 18/240 (7%)

Query: 59  PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENY 118
               K+       S  +P+ I   S    L+L  N+       TF +L +LE L L  N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
           +           + +   SL  ++L +N L  I P  +   L   L E ++ N  I   I
Sbjct: 111 IRQIEVG-----AFNGLASLNTLELFDNWLTVI-PSGAFEYL-SKLRELWLRNNPIE-SI 162

Query: 179 PEEI-SNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDICRLAEL 236
           P    + + +L+ +DLG  K    I       L  L+ LNL    ++  +P ++  L  L
Sbjct: 163 PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGL 220

Query: 237 YRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLT 294
             LE+  N     I    F  L+SL+ L + +++++ I    F  L  +++LN + N L+
Sbjct: 221 EELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  104 bits (262), Expect = 3e-24
 Identities = 60/260 (23%), Positives = 97/260 (37%), Gaps = 37/260 (14%)

Query: 11  NLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGN 69
           N   L L +N  I  + A  F ++  L+ L L  NS+   +   A   L +L  L L+ N
Sbjct: 76  NTRYLNLMENN-IQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN 133

Query: 70  NFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFL 129
                          L+ +              F  L  L +L L  N + S        
Sbjct: 134 W--------------LTVIP----------SGAFEYLSKLRELWLRNNPIESIPS----- 164

Query: 130 SSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLV 189
            + +   SL  +DL        + + +   L  +L+   +  CNI   +P  ++ L  L 
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLF-NLKYLNLGMCNIK-DMP-NLTPLVGLE 221

Query: 190 EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS 249
           E+++ GN      P +   L  L++L + ++ +     +    LA L  L L  N L  S
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL-SS 280

Query: 250 IPA-CFGNLASLRILSLGSN 268
           +P   F  L  L  L L  N
Sbjct: 281 LPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  104 bits (262), Expect = 4e-24
 Identities = 59/241 (24%), Positives = 95/241 (39%), Gaps = 41/241 (17%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
           +L +LE LQLG+N  I  +    F  +++L  L L +N L+  + S A   L  L +L+L
Sbjct: 97  HLHHLEVLQLGRNS-IRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWL 154

Query: 67  WGNNFSGTIPRFIFNA-SKLSKLSLG-MNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTP 124
             N    +IP + FN    L +L LG +          F  L NL+ L L    +     
Sbjct: 155 RNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--- 210

Query: 125 ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISN 184
               + +L+    L  +++S N    I P +                             
Sbjct: 211 ----MPNLTPLVGLEELEMSGNHFPEIRPGS--------------------------FHG 240

Query: 185 LTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICR-LAELYRLELGS 243
           L++L ++ +  ++++         L  L  LNL  N L  S+P D+   L  L  L L  
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHH 299

Query: 244 N 244
           N
Sbjct: 300 N 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 85.2 bits (211), Expect = 9e-18
 Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 36/217 (16%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGG 195
           +   ++L  N +  ++   +  +L   LE   +   +I   I     + L +L  ++L  
Sbjct: 76  NTRYLNLMENNIQ-MIQADTFRHL-HHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFD 132

Query: 196 NKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA- 252
           N L   IP      L KL+ L L +N +E SIP     R+  L RL+LG  K    I   
Sbjct: 133 NWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEG 190

Query: 253 CFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDF 312
            F  L +L+ L+LG   +  +P     L  + +L  S N                     
Sbjct: 191 AFEGLFNLKYLNLGMCNIKDMP-NLTPLVGLEELEMSGNHFP------------------ 231

Query: 313 SMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
                   I       LS L+ L +  +++   I R 
Sbjct: 232 -------EIRPGSFHGLSSLKKLWVMNSQVS-LIERN 260

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 50/217 (23%), Positives = 74/217 (34%), Gaps = 39/217 (17%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN 196
             + +  +   L  + P      +  +     +   NI     +   +L +L  + LG N
Sbjct: 55  QFSKVVCTRRGLSEV-P----QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109

Query: 197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICR-LAELYRLELGSNKLYGSIPA-CF 254
            +          L  L  L L DN L   IP      L++L  L L +N +  SIP+  F
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAF 167

Query: 255 GNLASLRILSLGS-NKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDF 312
             + SL  L LG   KL  I    F  L ++  LN     +                   
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK------------------ 209

Query: 313 SMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
            M N +          L  LE+L +S N    EI  G
Sbjct: 210 DMPNLTP---------LVGLEELEMSGNHFP-EIRPG 236

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  109 bits (273), Expect = 4e-26
 Identities = 57/288 (19%), Positives = 106/288 (36%), Gaps = 44/288 (15%)

Query: 18  GQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPR 77
           G +  + ++P+ +     +K L L NN ++  +S+    R  NL+ L L  N  + TI  
Sbjct: 38  GSSGSLNSIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIE- 92

Query: 78  FIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS 137
                                   +F +L +LE L L  NYL++ +             S
Sbjct: 93  ----------------------EDSFSSLGSLEHLDLSYNYLSNLSSSW-----FKPLSS 125

Query: 138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGGN 196
           LT ++L  NP   +   +  S+L   L+   + N +    I  +  + LT L E+++  +
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHL-TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184

Query: 197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYG----SIP 251
            L    P +L  ++ +  L L        + +      + +  LEL    L       + 
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243

Query: 252 AC----FGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTG 295
                      + R + +    L  +      +  +L+L FS N L  
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS 291

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  104 bits (260), Expect = 2e-24
 Identities = 62/252 (24%), Positives = 103/252 (40%), Gaps = 23/252 (9%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
              NL+ L L  N  I T+    F ++ +L+ L L  N LS +LSS     L +L  L L
Sbjct: 74  RCVNLQALVLTSNG-INTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131

Query: 67  WGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPS-TFGNLRNLEQLGLDENYLTSSTP 124
            GN +       +F+  +KL  L +G       I    F  L  LE+L +D + L S  P
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191

Query: 125 ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN--------CNISG 176
           +     SL + ++++ + L       +L +  +   S S+E   + +          +S 
Sbjct: 192 K-----SLKSIQNVSHLILHMKQHI-LLLEIFVDVTS-SVECLELRDTDLDTFHFSELST 244

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC-RLAE 235
           G    +        + +    L   +   L ++  L  L    N L+ S+PD I  RL  
Sbjct: 245 GETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTS 302

Query: 236 LYRLELGSNKLY 247
           L ++ L +N   
Sbjct: 303 LQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 33/141 (23%), Positives = 56/141 (39%), Gaps = 5/141 (3%)

Query: 212 LQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKL 270
           ++ L+L +N +      D+ R   L  L L SN +  +I    F +L SL  L L  N L
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYL 112

Query: 271 TSIPL-TFWNLKDILQLNFSSNFLTG-PLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEK 328
           +++    F  L  +  LN   N            +L  L  +     +    I R+    
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172

Query: 329 LSYLEDLNLSFNKLKGEIPRG 349
           L++LE+L +  + L+      
Sbjct: 173 LTFLEELEIDASDLQ-SYEPK 192

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 59.7 bits (145), Expect = 8e-10
 Identities = 23/131 (17%), Positives = 49/131 (37%), Gaps = 10/131 (7%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSG----SLSSIAN---VRLP 59
           ++QN+  L L   +    +        S+++ L L++  L       LS+      ++  
Sbjct: 196 SIQNVSHLILHMKQ-HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254

Query: 60  NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
               + +   +    + + +   S L +L    N         F  L +L+++ L  N  
Sbjct: 255 TFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

Query: 120 TSSTPELSFLS 130
             S P + +LS
Sbjct: 314 DCSCPRIDYLS 324

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (274), Expect = 9e-26
 Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 15/216 (6%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
           +L++LE LQL +N  I T+    F  ++ L  L L +N L+ ++ + A V L  L++L+L
Sbjct: 86  HLRHLEILQLSRNH-IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWL 143

Query: 67  WGNNFSGTIPRFIFNA-SKLSKLSLG-MNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTP 124
             N    +IP + FN    L +L LG +   S      F  L NL  L L    L     
Sbjct: 144 RNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--- 199

Query: 125 ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISN 184
               + +L+    L  +DLS N L  I    S   L   L++ +M    I         N
Sbjct: 200 ----IPNLTPLIKLDELDLSGNHLSAI-RPGSFQGLM-HLQKLWMIQSQIQVIERNAFDN 253

Query: 185 LTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN 220
           L +LVEI+L  N L          L  L+R++L  N
Sbjct: 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (261), Expect = 4e-24
 Identities = 60/260 (23%), Positives = 98/260 (37%), Gaps = 37/260 (14%)

Query: 11  NLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGN 69
           N   L L +N+ I  +    F ++  L+ L L  N +  ++   A   L NL  L L+ N
Sbjct: 65  NTRLLNLHENQ-IQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN 122

Query: 70  NFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFL 129
                          L+ +              F  L  L++L L  N + S        
Sbjct: 123 R--------------LTTIP----------NGAFVYLSKLKELWLRNNPIESIPS----- 153

Query: 130 SSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLV 189
            + +   SL  +DL        + + +   LS +L    +  CN+   IP  ++ L  L 
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLS-NLRYLNLAMCNLR-EIP-NLTPLIKLD 210

Query: 190 EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS 249
           E+DL GN L+   P +   L  LQ+L +  + ++    +    L  L  + L  N L   
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL-TL 269

Query: 250 IPA-CFGNLASLRILSLGSN 268
           +P   F  L  L  + L  N
Sbjct: 270 LPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 98.3 bits (245), Expect = 4e-22
 Identities = 63/314 (20%), Positives = 104/314 (33%), Gaps = 68/314 (21%)

Query: 59  PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENY 118
               K+     N    +P  I   +    L+L  N       ++F +LR+LE L L  N+
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
           + +         + +   +L  ++L +N L      T+I                     
Sbjct: 100 IRTIEIG-----AFNGLANLNTLELFDNRL------TTIP-------------------- 128

Query: 179 PEEISNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDI-CRLAEL 236
                 L+ L E+ L  N +  SIP     ++  L+RL+L +      I +     L+ L
Sbjct: 129 NGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL 187

Query: 237 YRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTG 295
             L L    L   IP     L  L  L L  N L++I   +F  L  + +L    + +  
Sbjct: 188 RYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ- 244

Query: 296 PLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG--GSFG 353
                                   VI R   + L  L ++NL+ N L   +P        
Sbjct: 245 ------------------------VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLH 279

Query: 354 NFSAESFEGNELLC 367
           +        N   C
Sbjct: 280 HLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 37/144 (25%), Positives = 63/144 (43%), Gaps = 11/144 (7%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            + +L  L LG+ K +  +    F  +S L++L L   +L   + ++    L  L++L L
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP--LIKLDELDL 214

Query: 67  WGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
            GN+ S  I    F     L KL +  +       + F NL++L ++ L  N LT    +
Sbjct: 215 SGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLD 149
           L      +    L  I L +NP +
Sbjct: 274 L-----FTPLHHLERIHLHHNPWN 292

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  108 bits (271), Expect = 4e-25
 Identities = 59/344 (17%), Positives = 114/344 (33%), Gaps = 52/344 (15%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
           I L I N  +L +     N + GT           +   L   + + ++S +    +   
Sbjct: 3   IMLPINNNFSLSQNSF-YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF 61

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
            +L L   N S ++P  +    +++ L +  N+    +P    +L  L+     +N L++
Sbjct: 62  SELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLST 114

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
                      ++ K L   D+ NN L      T +  L   LE     N  ++  +PE 
Sbjct: 115 ------LPELPASLKHL---DVDNNQL------TMLPELPALLEYINADNNQLTM-LPEL 158

Query: 182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLEL 241
            ++L  L    +  N+L   +P        L+ L++  N+LE S+P    R         
Sbjct: 159 PTSLEVL---SVRNNQLT-FLP---ELPESLEALDVSTNLLE-SLPAVPVRNHHS----- 205

Query: 242 GSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEI 301
                            +        N++T IP    +L     +    N L+  +   +
Sbjct: 206 ---------------EETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESL 250

Query: 302 GNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE 345
                          FS    ++        + +   F + K  
Sbjct: 251 SQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 71.5 bits (175), Expect = 3e-13
 Identities = 44/229 (19%), Positives = 71/229 (31%), Gaps = 49/229 (21%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
            +P    +L+ L+      N+L  T+P    +   LK L + NN L+  L  +       
Sbjct: 94  SLPELPASLEYLD---ACDNRLS-TLPELPAS---LKHLDVDNNQLT-MLPEL----PAL 141

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           LE +    N  +  +P      + L  LS+  N  + F+P       +LE L +  N L 
Sbjct: 142 LEYINADNNQLT-MLPELP---TSLEVLSVRNNQLT-FLPEL---PESLEALDVSTNLLE 193

Query: 121 SSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPE 180
           S              ++        N +      T                      IPE
Sbjct: 194 SLPAVPVRNHHSE--ETEIFFRCRENRI------TH---------------------IPE 224

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDD 229
            I +L     I L  N L+  I  +L +       +        S    
Sbjct: 225 NILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  107 bits (268), Expect = 1e-24
 Identities = 68/367 (18%), Positives = 124/367 (33%), Gaps = 25/367 (6%)

Query: 5   EIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKL 64
           E GNL  L  L L   K    +         L  + L   S         ++++PN   L
Sbjct: 141 EFGNLTKLTFLGLSAAKF-RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL 199

Query: 65  YLWGN-NFSGTIPRFIFNAS----KLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL 119
           +L  + N   ++   +   +    +LS + L   +    +       R    L +   ++
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259

Query: 120 TSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM---YNCNISG 176
            ++      L      + +  +++ N  +   + +   +    +L+   +    N     
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAEL 236
                 S    +    L  +       +          LN   N+   S+      L  L
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379

Query: 237 YRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP------LTFWNLKDILQLNFSS 290
             L L  N L  +         ++  L      L S+          W  + IL LN SS
Sbjct: 380 QTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW-AESILVLNLSS 437

Query: 291 NFLTGPLLLEI-GNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
           N LTG +   +   +KVL   D   N     IP+++   L  L++LN++ N+LK  +P  
Sbjct: 438 NMLTGSVFRCLPPKVKVL---DLHNNRIM-SIPKDV-THLQALQELNVASNQLK-SVPD- 490

Query: 350 GSFGNFS 356
           G F   +
Sbjct: 491 GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 92.6 bits (230), Expect = 6e-20
 Identities = 55/347 (15%), Positives = 107/347 (30%), Gaps = 16/347 (4%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
             Q+LE L +  N+L   +       ++L+ L L  N             L  L  L L 
Sbjct: 98  FNQDLEYLDVSHNRL-QNISCCPM--ASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS 154

Query: 68  GNNF-SGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL 126
              F    +            L L      G    +     N   L L  +  +  + ++
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQV 213

Query: 127 SFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNL- 185
           +   +      L+ I L++     ++   S      +L    + +   +     ++    
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273

Query: 186 --TNLVEIDLGGNKLNGSIP-----ITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYR 238
               +  +++    +   I       +   L+ L   ++++ +   S        AE+  
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333

Query: 239 LELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLT-FWNLKDILQLNFSSNFLT--G 295
             L  +        C  + +S   L+   N  T         LK +  L    N L    
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF 393

Query: 296 PLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
            + L   N+  L  +D S+N+ +             +  LNLS N L
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML 440

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 52/316 (16%), Positives = 97/316 (30%), Gaps = 32/316 (10%)

Query: 47  SGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGN 105
           + +L+ +     P  + L L  N+ S  +        S+L  L L  N         F  
Sbjct: 40  NRNLTHVPKDLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF 98

Query: 106 LRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLE 165
            ++LE L +  N L +    +S         SL  +DLS N  D +       NL+  L 
Sbjct: 99  NQDLEYLDVSHNRLQN----ISC----CPMASLRHLDLSFNDFDVLPVCKEFGNLT-KLT 149

Query: 166 EFYMYNCNISGGIPEEISNL-TNLVEIDLGGNKLNGSIPITLGKL-RKLQRLNLEDNILE 223
              +            +++L  + + +DL    + G    +L      +  L    N L 
Sbjct: 150 FLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF 209

Query: 224 GSIPDDICRLAELYRLELGSNKLYGSIPACFGNLA------------SLRILSLGSNKLT 271
               +    +  L  L+L + KL                        +L+ +        
Sbjct: 210 SVQVNMS--VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267

Query: 272 SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVL----IGIDFSMNNFSGVIPREIGE 327
            +   FW  + +  LN  +  +T  +  E           + I+   N         +  
Sbjct: 268 KLFQFFWP-RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYS 326

Query: 328 KLSYLEDLNLSFNKLK 343
             + +    LS +   
Sbjct: 327 VFAEMNIKMLSISDTP 342

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 38/148 (25%), Positives = 58/148 (39%), Gaps = 14/148 (9%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRL----PNL 61
              L+ L+ L L +N L             +  L   + SL+ SL+S A  R      ++
Sbjct: 373 CSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESI 430

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
             L L  N  +G++ R +    K+  L L  N     IP    +L+ L++L +  N L S
Sbjct: 431 LVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKS 487

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLD 149
                          SL  I L +NP D
Sbjct: 488 VPD-----GVFDRLTSLQYIWLHDNPWD 510

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  105 bits (264), Expect = 2e-24
 Identities = 53/339 (15%), Positives = 113/339 (33%), Gaps = 44/339 (12%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEK 63
           L++    NL  L    NKL   +   +  ++ L +L    N     L+ +   + P L  
Sbjct: 79  LDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTN----KLTKLDVSQNPLLTY 131

Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           L    N  +  I   + + ++L++L   +N     +         L  L    N +T   
Sbjct: 132 LNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE-- 184

Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEIS 183
                   +S  K L  ++   N +  +     ++     L      +  ++     +++
Sbjct: 185 ------LDVSQNKLLNRLNCDTNNITKL----DLNQNI-QLTFLDCSSNKLTE---IDVT 230

Query: 184 NLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGS 243
            LT L   D   N L     + +  L KL  L+     L   I  D+    +L   +   
Sbjct: 231 PLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EI--DLTHNTQLIYFQAEG 284

Query: 244 NKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGN 303
            +    +     +   L +L   +  +T + L+      ++ L  ++  LT    L++ +
Sbjct: 285 CRKIKELD--VTHNTQLYLLDCQAAGITELDLS--QNPKLVYLYLNNTELTE---LDVSH 337

Query: 304 LKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
              L  +     +           K+  L +   +  + 
Sbjct: 338 NTKLKSLSCVNAHIQDFSS---VGKIPALNNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  103 bits (260), Expect = 6e-24
 Identities = 57/341 (16%), Positives = 111/341 (32%), Gaps = 44/341 (12%)

Query: 3   PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLE 62
            +    L  L  L    + +  T    I  ++ L  L   +N    +++++   +  NL 
Sbjct: 35  TISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSN----NITTLDLSQNTNLT 88

Query: 63  KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSS 122
            L    N  +  +   +   +KL+ L+   N  +            L  L    N LT  
Sbjct: 89  YLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLTE- 141

Query: 123 TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI 182
                    +S+   LT +D   N     L    ++  +  L         I+     ++
Sbjct: 142 -------IDVSHNTQLTELDCHLNKKITKLD---VTPQT-QLTTLDCSFNKITE---LDV 187

Query: 183 SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG 242
           S    L  ++   N +     + L +  +L  L+   N L   I  D+  L +L   +  
Sbjct: 188 SQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCS 241

Query: 243 SNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIG 302
            N L   +      L+ L  L      L  I LT  +   ++              L++ 
Sbjct: 242 VNPL-TELD--VSTLSKLTTLHCIQTDLLEIDLT--HNTQLIYFQAEGCRKIKE--LDVT 294

Query: 303 NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
           +   L  +D      + +   ++  +   L  L L+  +L 
Sbjct: 295 HNTQLYLLDCQAAGITEL---DLS-QNPKLVYLYLNNTELT 331

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  103 bits (259), Expect = 8e-24
 Identities = 58/341 (17%), Positives = 111/341 (32%), Gaps = 41/341 (12%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEK 63
           L++  L  L  L    NKL       +     L +L    N+L+     I       L +
Sbjct: 100 LDVTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNCARNTLT----EIDVSHNTQLTE 152

Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           L    N     +   +   ++L+ L    N  +          + L +L  D N +T   
Sbjct: 153 LDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITKL- 206

Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEIS 183
                   L+    LT +D S+N L  I     ++ L+  L  F      ++     ++S
Sbjct: 207 -------DLNQNIQLTFLDCSSNKLTEI----DVTPLT-QLTYFDCSVNPLT---ELDVS 251

Query: 184 NLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGS 243
            L+ L  +      L     I L    +L     E       +  D+    +LY L+  +
Sbjct: 252 TLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQA 306

Query: 244 NKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGN 303
             +   +         L  L L + +LT + ++  +   +  L+  +  +       +G 
Sbjct: 307 AGI-TELD--LSQNPKLVYLYLNNTELTELDVS--HNTKLKSLSCVNAHIQD--FSSVGK 359

Query: 304 LKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
           +  L     +       +P+E     S    ++       G
Sbjct: 360 IPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFG 399

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 95.5 bits (238), Expect = 4e-21
 Identities = 61/353 (17%), Positives = 108/353 (30%), Gaps = 79/353 (22%)

Query: 10  QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGN 69
            N         ++  T   +   ++TL  L   N+S++  ++ I    L  L KL    N
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEK--LTGLTKLICTSN 74

Query: 70  NFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFL 129
           N + T+   +   + L+ L+   N  +         L  L  L  D N LT         
Sbjct: 75  NIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKL------- 121

Query: 130 SSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLV 189
             +S    LT ++ + N L  I     +S+ +  L E   +          +++  T L 
Sbjct: 122 -DVSQNPLLTYLNCARNTLTEI----DVSHNT-QLTELDCHLNKKIT--KLDVTPQTQLT 173

Query: 190 EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS 249
            +D   NK+     + + + + L RLN + N +                           
Sbjct: 174 TLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-------------------------K 205

Query: 250 IPACFGNLASLRILSLGSNKLTSIPLT-------------------FWNLKDILQLNFSS 290
           +         L  L   SNKLT I +T                      L  +  L+   
Sbjct: 206 LD--LNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQ 263

Query: 291 NFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
             L     +++ +   LI            I        + L  L+     + 
Sbjct: 264 TDLLE---IDLTHNTQLIYFQAEGCRK---IKELDVTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 47/265 (17%), Positives = 94/265 (35%), Gaps = 32/265 (12%)

Query: 79  IFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL 138
            F     +               +   L  L  L    + +T        ++ +     L
Sbjct: 14  WFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-------MTGIEKLTGL 66

Query: 139 TLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKL 198
           T +  ++N +  +     +S  + +L      +  ++  +   ++ LT L  ++   NKL
Sbjct: 67  TKLICTSNNITTL----DLSQNT-NLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL 118

Query: 199 NGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLA 258
                + + +   L  LN   N L   I  D+    +L  L+   NK    +        
Sbjct: 119 T---KLDVSQNPLLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKKITKLD--VTPQT 170

Query: 259 SLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFS 318
            L  L    NK+T + ++    K + +LN  +N +T    L++     L  +D S N  +
Sbjct: 171 QLTTLDCSFNKITELDVS--QNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT 225

Query: 319 GVIPREIGEKLSYLEDLNLSFNKLK 343
            +   ++   L+ L   + S N L 
Sbjct: 226 EI---DVT-PLTQLTYFDCSVNPLT 246

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 82.8 bits (205), Expect = 6e-17
 Identities = 43/291 (14%), Positives = 82/291 (28%), Gaps = 58/291 (19%)

Query: 3   PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLE 62
            L++     L  L    NK+   +   +     L  L    N    +++ +   +   L 
Sbjct: 163 KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTN----NITKLDLNQNIQLT 215

Query: 63  KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSS 122
            L    N  +  I                              L  L       N LT  
Sbjct: 216 FLDCSSNKLT-EID--------------------------VTPLTQLTYFDCSVNPLTE- 247

Query: 123 TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI 182
                    +S    LT +      L  I     +++ +  L  F    C        ++
Sbjct: 248 -------LDVSTLSKLTTLHCIQTDLLEI----DLTHNT-QLIYFQAEGCRKI--KELDV 293

Query: 183 SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG 242
           ++ T L  +D     +     + L +  KL  L L +  L   +  D+    +L  L   
Sbjct: 294 THNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCV 347

Query: 243 SNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFL 293
           +  +     +  G + +L        +  ++P         L +  S + L
Sbjct: 348 NAHI-QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNS-LTIAVSPDLL 395

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 28/158 (17%), Positives = 57/158 (36%), Gaps = 11/158 (6%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEK 63
           +++ +   L   Q    + I  +   + + + L  L  Q   ++     +   + P L  
Sbjct: 269 IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT----ELDLSQNPKLVY 322

Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           LYL     +  +   + + +KL  LS        F  S+ G +  L      E    +  
Sbjct: 323 LYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMP 377

Query: 124 PELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS 161
            E    +SL+   S  L+D   NP++       + + +
Sbjct: 378 KETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQA 415

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  105 bits (264), Expect = 3e-24
 Identities = 75/366 (20%), Positives = 136/366 (37%), Gaps = 21/366 (5%)

Query: 5   EIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSL--SGSLSSIANVRLPNLE 62
           E GN+  L+ L L    L  +    I +++  K L +   +         + +    +L 
Sbjct: 110 EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLH 169

Query: 63  KLYLWGNNFSGTIPRFIFNASKLS----KLSLGMNSFSGFIPSTFGNLRNLEQLGLDENY 118
            ++     F   +   +   + L     K  L  N  S F+        N +   L  N 
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNC--NISG 176
           + ++      +  L    ++    +SN  L G L          SL+   ++    ++ G
Sbjct: 230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289

Query: 177 GIPEEI-SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAE 235
                I    +N+   +   +       +   K+     L+  +N+L  ++ ++   L E
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349

Query: 236 LYRLELGSNKL--YGSIPACFGNLASLRILSLGSNKLTSI--PLTFWNLKDILQLNFSSN 291
           L  L L  N+L     I      + SL+ L +  N ++           K +L LN SSN
Sbjct: 350 LETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409

Query: 292 FLT-GPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGG 350
            LT          +KVL   D   N     IP+++  KL  L++LN++ N+LK  +P  G
Sbjct: 410 ILTDTIFRCLPPRIKVL---DLHSNKIK-SIPKQVV-KLEALQELNVASNQLK-SVPD-G 462

Query: 351 SFGNFS 356
            F   +
Sbjct: 463 IFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 98.4 bits (245), Expect = 7e-22
 Identities = 58/356 (16%), Positives = 103/356 (28%), Gaps = 20/356 (5%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
             Q LE L L  NKL   +         LK L L  N+            +  L+ L L 
Sbjct: 67  FNQELEYLDLSHNKL-VKISCHPT--VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123

Query: 68  GNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELS 127
             +   +    I + +    L +   ++          L++     L   + T+      
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFI 181

Query: 128 FLSSLSNCKSLTLIDLSNNP----LDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEIS 183
              S+    +L L ++            L   +    +  L    + N   +      I 
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241

Query: 184 NL---TNLVEIDLGGNKLNG-----SIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAE 235
            L   T +    +   KL G         +   L+ L    +  ++            + 
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301

Query: 236 LYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLT-FWNLKDILQLNFSSNFLT 294
           +       +        C   ++    L   +N LT        +L ++  L    N L 
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

Query: 295 --GPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR 348
               +      +K L  +D S N+ S    +        L  LN+S N L   I R
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 97.6 bits (243), Expect = 1e-21
 Identities = 65/366 (17%), Positives = 125/366 (34%), Gaps = 30/366 (8%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLE 62
           +      NL+ L L  N          F N+S LKFLGL    L       + + + +L 
Sbjct: 84  ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE----KSSVLPIAHLN 139

Query: 63  KLYLWGNNFSGTIPRF------IFNASKLSKLSLGMNSFSGFIPSTFGNLRNLE----QL 112
              +          +        FN   L  +      F   +  +   + NLE    + 
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199

Query: 113 GLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNC 172
            L++N  +     L+ L +     +LTL ++       I     + + +  +  F + N 
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT--VWYFSISNV 257

Query: 173 NISGGIPEEI-----SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP 227
            + G +         ++L  L    +  +               +   N   +       
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317

Query: 228 DDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLT---FWNLKDIL 284
               +++    L+  +N L  ++    G+L  L  L L  N+L  +         +K + 
Sbjct: 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQ 377

Query: 285 QLNFSSNFLTGPLLLEI-GNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
           QL+ S N ++           K L+ ++ S N  +  I R +      ++ L+L  NK+K
Sbjct: 378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL---PPRIKVLDLHSNKIK 434

Query: 344 GEIPRG 349
             IP+ 
Sbjct: 435 -SIPKQ 439

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 93.8 bits (233), Expect = 2e-20
 Identities = 54/243 (22%), Positives = 87/243 (35%), Gaps = 15/243 (6%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVS-----TLKFLGLQNNSLSGSLSSIANVRLPNLE 62
               +    +   KL G +    F+ S      L    + ++      S I      N+ 
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE-IFSNMN 303

Query: 63  KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSS 122
                 +             S    L    N  +  +    G+L  LE L L  N L   
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL 363

Query: 123 TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI 182
           +      + + +   L  +D+S N +     K   S    SL    M +  ++  I   +
Sbjct: 364 SKIAEMTTQMKS---LQQLDISQNSVSYDEKKGDCSWTK-SLLSLNMSSNILTDTIFRCL 419

Query: 183 SNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC-RLAELYRLEL 241
                +  +DL  NK+  SIP  + KL  LQ LN+  N L+ S+PD I  RL  L ++ L
Sbjct: 420 --PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWL 475

Query: 242 GSN 244
            +N
Sbjct: 476 HTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 76.8 bits (189), Expect = 5e-15
 Identities = 54/317 (17%), Positives = 90/317 (28%), Gaps = 32/317 (10%)

Query: 47  SGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNL 106
              L  +          L +  N  S      I + SKL  L +  N       S F   
Sbjct: 9   KNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFN 68

Query: 107 RNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
           + LE L L  N L      +S         +L  +DLS N  D +       N+S  L+ 
Sbjct: 69  QELEYLDLSHNKLVK----ISC----HPTVNLKHLDLSFNAFDALPICKEFGNMS-QLKF 119

Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
             +   ++       I++L     + + G             L+     +L         
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKE 177

Query: 227 PDDICRLAELYRLELGSNKLYG-----------SIPACFGNLASLRILSLGSNKLTSIPL 275
              I  ++      L  + +             SI A       L  L+L + + T    
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237

Query: 276 T----FWNLKDILQLNFSSNFLTGPLLLEIG-----NLKVLIGIDFSMNNFSGVIPREIG 326
                      +   + S+  L G L          +LK L       + F       I 
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIY 296

Query: 327 EKLSYLEDLNLSFNKLK 343
           E  S +   N + +  +
Sbjct: 297 EIFSNMNIKNFTVSGTR 313

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 70.3 bits (172), Expect = 7e-13
 Identities = 36/164 (21%), Positives = 59/164 (35%), Gaps = 24/164 (14%)

Query: 7   GNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV--RLPNLEKL 64
             +     L    N L  TV     +++ L+ L LQ N L   LS IA +  ++ +L++L
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQL 379

Query: 65  YLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
            +  N+ S    +        L  L++  N  +  I         ++ L L  N + S  
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIP 437

Query: 124 PELSFLSSL------------------SNCKSLTLIDLSNNPLD 149
            ++  L +L                      SL  I L  NP D
Sbjct: 438 KQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 41/203 (20%), Positives = 68/203 (33%), Gaps = 8/203 (3%)

Query: 191 IDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSI 250
           +D   N L   +P  L   +K   LN+  N +      DI  L++L  L +  N++    
Sbjct: 5   VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 251 PACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTG-PLLLEIGNLKVLIG 309
            + F     L  L L  NKL  I        ++  L+ S N     P+  E GN+  L  
Sbjct: 62  ISVFKFNQELEYLDLSHNKLVKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119

Query: 310 IDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGS 369
           +  S  +        I         L L     + E P      +F+ ES          
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKE 177

Query: 370 PNLQVPPCKTSIHHTSWKNSLLL 392
            +  +     ++ +    N   +
Sbjct: 178 FHFILDVSVKTVANLELSNIKCV 200

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 27/124 (21%), Positives = 53/124 (42%), Gaps = 5/124 (4%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            +++L++L + QN +             +L  L + +N L+    +I     P ++ L L
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT---DTIFRCLPPRIKVLDL 428

Query: 67  WGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL 126
             N    +IP+ +     L +L++  N         F  L +L+++ L  N    S P +
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 487

Query: 127 SFLS 130
            +LS
Sbjct: 488 DYLS 491

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  101 bits (255), Expect = 3e-24
 Identities = 56/237 (23%), Positives = 84/237 (35%), Gaps = 37/237 (15%)

Query: 59  PNLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
              ++++L GN  S  +P   F     L+ L L  N  +    + F  L  LEQL L +N
Sbjct: 32  AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 118 YLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGG 177
               S    +F         L  + L    L        +                    
Sbjct: 91  AQLRSVDPATF----HGLGRLHTLHLDRCGL------QELG------------------- 121

Query: 178 IPEEISNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDI-CRLAE 235
            P     L  L  + L  N L  ++P  T   L  L  L L  N +  S+P+     L  
Sbjct: 122 -PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHS 178

Query: 236 LYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSN 291
           L RL L  N++    P  F +L  L  L L +N L+++P      L+ +  L  + N
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (250), Expect = 1e-23
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 17/224 (7%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLP 59
            +P+ I      + + L  N+ I  VPAA F     L  L L +N L+  + + A   L 
Sbjct: 25  AVPVGI--PAASQRIFLHGNR-ISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLA 80

Query: 60  NLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENY 118
            LE+L L  N    ++    F    +L  L L         P  F  L  L+ L L +N 
Sbjct: 81  LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
           L +   +        +  +LT + L  N +  + P+ +   L  SL+   ++   ++  +
Sbjct: 141 LQALPDDT-----FRDLGNLTHLFLHGNRISSV-PERAFRGLH-SLDRLLLHQNRVA-HV 192

Query: 179 PEEI-SNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDN 220
                 +L  L+ + L  N L+ ++P   L  LR LQ L L DN
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 44/215 (20%), Positives = 72/215 (33%), Gaps = 13/215 (6%)

Query: 139 TLIDLSNNPLDGILPKTSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNK 197
                    L       ++   +  + +  +++   IS           NL  + L  N 
Sbjct: 14  VTTSCPQQGL------QAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67

Query: 198 LNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA-CFG 255
           L          L  L++L+L DN    S+       L  L+ L L    L   +    F 
Sbjct: 68  LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFR 126

Query: 256 NLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSM 314
            LA+L+ L L  N L ++P  TF +L ++  L    N ++         L  L  +    
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186

Query: 315 NNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
           N  +  +       L  L  L L  N L   +P  
Sbjct: 187 NRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 28/90 (31%), Positives = 39/90 (43%), Gaps = 5/90 (5%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
           +L NL  L L  N+ I +VP   F  + +L  L L  N ++  +   A   L  L  LYL
Sbjct: 151 DLGNLTHLFLHGNR-ISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYL 208

Query: 67  WGNNFSGTIPRFIFNA-SKLSKLSLGMNSF 95
           + NN S  +P         L  L L  N +
Sbjct: 209 FANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  100 bits (250), Expect = 2e-22
 Identities = 49/240 (20%), Positives = 91/240 (37%), Gaps = 24/240 (10%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
                 +  L +  +   V      ++++  +   N+ +  S+  I    LPN+ KL+L 
Sbjct: 19  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQY--LPNVTKLFLN 73

Query: 68  GNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELS 127
           GN  +   P  + N   L  L L  N       S+  +L+ L+ L L+ N ++       
Sbjct: 74  GNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD------ 123

Query: 128 FLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTN 187
            ++ L +   L  + L NN +  I   T +S L+  L+   + +  IS      ++ LT 
Sbjct: 124 -INGLVHLPQLESLYLGNNKITDI---TVLSRLT-KLDTLSLEDNQISD--IVPLAGLTK 176

Query: 188 LVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLY 247
           L  + L  N ++  +   L  L+ L  L L          +    L     ++     L 
Sbjct: 177 LQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 95.6 bits (237), Expect = 7e-21
 Identities = 48/240 (20%), Positives = 94/240 (39%), Gaps = 27/240 (11%)

Query: 105 NLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS--R 162
                 +  L +  +T          + +   S+  I  +N+ +       S+  +    
Sbjct: 19  AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDI------KSVQGIQYLP 65

Query: 163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNIL 222
           ++ + ++    ++  I + ++NL NL  + L  NK+   +  +L  L+KL+ L+LE N +
Sbjct: 66  NVTKLFLNGNKLTD-I-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGI 121

Query: 223 EGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKD 282
              I + +  L +L  L LG+NK+  +       L  L  LSL  N+++ I      L  
Sbjct: 122 S-DI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTK 176

Query: 283 ILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
           +  L  S N ++   L  +  LK L  ++          P      L     +  +   L
Sbjct: 177 LQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLN-KPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 91.3 bits (226), Expect = 2e-19
 Identities = 45/253 (17%), Positives = 91/253 (35%), Gaps = 26/253 (10%)

Query: 83  SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLID 142
           ++  K +L   S +  +      L +++Q+  + + + S       +  +    ++T + 
Sbjct: 21  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLPNVTKLF 71

Query: 143 LSNNPLDGILPKTSISNLSR--SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNG 200
           L+ N L      T I  L+   +L   ++    I       + +L  L  + L  N ++ 
Sbjct: 72  LNGNKL------TDIKPLTNLKNLGWLFLDENKIK--DLSSLKDLKKLKSLSLEHNGIS- 122

Query: 201 SIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASL 260
            I   L  L +L+ L L +N +  +    + RL +L  L L  N++   I      L  L
Sbjct: 123 DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKL 177

Query: 261 RILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGV 320
           + L L  N ++ +      LK++  L   S       +    NL V   +  +  +    
Sbjct: 178 QNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 236

Query: 321 IPREIGEKLSYLE 333
                        
Sbjct: 237 EIISDDGDYEKPN 249

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.0 bits (220), Expect = 8e-19
 Identities = 45/214 (21%), Positives = 85/214 (39%), Gaps = 18/214 (8%)

Query: 129 LSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNL 188
           +            +L    +   + +  +++    +++    N +I     + I  L N+
Sbjct: 14  IFPDDAFAETIKDNLKKKSVTDAVTQNELNS----IDQIIANNSDIK--SVQGIQYLPNV 67

Query: 189 VEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG 248
            ++ L GNKL   I   L  L+ L  L L++N ++  +   +  L +L  L L  N +  
Sbjct: 68  TKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI-S 122

Query: 249 SIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLI 308
            I     +L  L  L LG+NK+T I      L  +  L+   N ++   ++ +  L  L 
Sbjct: 123 DING-LVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQ 178

Query: 309 GIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
            +  S N+ S +        L  L+ L L   + 
Sbjct: 179 NLYLSKNHISDLRA---LAGLKNLDVLELFSQEC 209

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 35/180 (19%), Positives = 64/180 (35%), Gaps = 36/180 (20%)

Query: 164 LEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE 223
           + E    +  I    P         ++ +L    +     +T  +L  + ++   ++ ++
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK 56

Query: 224 GSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDI 283
            S+   I  L  + +L L  NKL   I     NL +L  L L  NK+  +  +  +LK +
Sbjct: 57  -SV-QGIQYLPNVTKLFLNGNKL-TDIKP-LTNLKNLGWLFLDENKIKDLS-SLKDLKKL 111

Query: 284 LQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
             L+   N ++     +I  L                        L  LE L L  NK+ 
Sbjct: 112 KSLSLEHNGIS-----DINGL----------------------VHLPQLESLYLGNNKIT 144

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 55/314 (17%), Positives = 121/314 (38%), Gaps = 28/314 (8%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
            L N  ++  G++ +  TV     ++  +  L      ++ ++  +    L NL  L L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQY--LNNLIGLELK 71

Query: 68  GNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELS 127
            N  +   P  + N +K+++L L  N            L++++ L L    +T       
Sbjct: 72  DNQITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD------ 121

Query: 128 FLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTN 187
            ++ L+   +L ++ L  N +  I   + ++ L+ +L+   + N  +S      ++NL+ 
Sbjct: 122 -VTPLAGLSNLQVLYLDLNQITNI---SPLAGLT-NLQYLSIGNAQVSD--LTPLANLSK 174

Query: 188 LVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLY 247
           L  +    NK++   P  L  L  L  ++L++N +    P  +   + L+ + L +  + 
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230

Query: 248 GSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVL 307
                   NL    ++   S    + P T  +       N + N  +    +        
Sbjct: 231 NQPVFYNNNLVVPNVVKGPSGAPIA-PATISDNGTYASPNLTWNLTSFINNVSY-TFNQS 288

Query: 308 IGIDFSMNNFSGVI 321
           +    +   FSG +
Sbjct: 289 VTFKNTTVPFSGTV 302

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 43/264 (16%), Positives = 97/264 (36%), Gaps = 29/264 (10%)

Query: 81  NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTL 140
             +   K++ G ++ +     T  +L  +  L      +T+       +  +    +L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 141 IDLSNNPLDGILPKTSISNLS--RSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKL 198
           ++L +N +      T ++ L     + E  +    +       I+ L ++  +DL   ++
Sbjct: 68  LELKDNQI------TDLAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI 119

Query: 199 NGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLA 258
               P  L  L  LQ L L+ N +    P  +  L  L  L +G+ ++    P    NL+
Sbjct: 120 TDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLS 173

Query: 259 SLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFS 318
            L  L    NK++ I     +L ++++++  +N ++   +  + N   L  +  +    +
Sbjct: 174 KLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTIT 230

Query: 319 GVIPREIGEKLSYLEDLNLSFNKL 342
              P      L     +       
Sbjct: 231 N-QPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 22/218 (10%)

Query: 5   EIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKL 64
            +  L NL  L+L  N++  T  A + N++ +  L L  N L  ++S+IA   L +++ L
Sbjct: 58  GVQYLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNPLK-NVSAIAG--LQSIKTL 112

Query: 65  YLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTP 124
            L     +   P  +   S L  L L +N  +   P     L NL+ L +    ++    
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD--- 165

Query: 125 ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISN 184
               L+ L+N   LT +   +N +  I P   +++L  +L E ++ N  IS      ++N
Sbjct: 166 ----LTPLANLSKLTTLKADDNKISDISP---LASLP-NLIEVHLKNNQISD--VSPLAN 215

Query: 185 LTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNIL 222
            +NL  + L    +          L     +       
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 41/215 (19%), Positives = 84/215 (39%), Gaps = 18/215 (8%)

Query: 129 LSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNL 188
           +       +   I    + +   + +  +      +     +   ++    E +  L NL
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVTQADLDG----ITTLSAFGTGVTT--IEGVQYLNNL 65

Query: 189 VEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG 248
           + ++L  N++    P  L  L K+  L L  N L       I  L  +  L+L S ++  
Sbjct: 66  IGLELKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD 121

Query: 249 SIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLI 308
             P     L++L++L L  N++T+I      L ++  L+  +  ++   L  + NL  L 
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSD--LTPLANLSKLT 176

Query: 309 GIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
            +    N  S + P      L  L +++L  N++ 
Sbjct: 177 TLKADDNKISDISPL---ASLPNLIEVHLKNNQIS 208

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 56/237 (23%), Positives = 87/237 (36%), Gaps = 43/237 (18%)

Query: 58  LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
           + +  ++     N +  +P  +      + L L  N    F  +T      L QL LD  
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 118 YLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGG 177
            LT        L        L  +DLS+N L       S+                    
Sbjct: 66  ELTK-------LQVDGTLPVLGTLDLSHNQL------QSL-------------------- 92

Query: 178 IPEEISNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDIC-RLAE 235
            P     L  L  +D+  N+L  S+P+  L  L +LQ L L+ N L+ ++P  +     +
Sbjct: 93  -PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149

Query: 236 LYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSN 291
           L +L L +N L   +PA     L +L  L L  N L +IP  F+    +       N
Sbjct: 150 LEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 46/144 (31%), Positives = 61/144 (42%), Gaps = 10/144 (6%)

Query: 7   GNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
           G L  L  L L  N+L  ++P     +  L  L +  N L+ SL   A   L  L++LYL
Sbjct: 74  GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131

Query: 67  WGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
            GN    T+P  +     KL KLSL  N+ +         L NL+ L L EN L  + P+
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLD 149
             F S       L    L  NP  
Sbjct: 190 GFFGS-----HLLPFAFLHGNPWL 208

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 48/229 (20%), Positives = 85/229 (37%), Gaps = 40/229 (17%)

Query: 131 SLSNCKSLTLIDLSNNPLDGILPKTSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLV 189
            +S   S   ++     L      T++  +L +     ++    +       +   T L 
Sbjct: 5   EVSKVASHLEVNCDKRNL------TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLT 58

Query: 190 EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS 249
           +++L   +L   +    G L  L  L+L  N L+ S+P     L  L  L++  N+L  S
Sbjct: 59  QLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TS 114

Query: 250 IPA-CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVL 307
           +P      L  L+ L L  N+L ++P         + +L+ ++N LT             
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT------------- 161

Query: 308 IGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFS 356
                        +P  +   L  L+ L L  N L   IP+ G FG+  
Sbjct: 162 ------------ELPAGLLNGLENLDTLLLQENSLYT-IPK-GFFGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 44/186 (23%), Positives = 68/186 (36%), Gaps = 12/186 (6%)

Query: 11  NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNN 70
           +   L L +N L     A +   + L  L L    L+  L    +  LP L  L L  N 
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ--VDGTLPVLGTLDLSHNQ 88

Query: 71  FSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLS 130
              ++P        L+ L +  N  +         L  L++L L  N L +  P L  L+
Sbjct: 89  LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL--LT 145

Query: 131 SLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVE 190
                  L  + L+NN L   LP   ++ L   L+   +   ++   IP+       L  
Sbjct: 146 PTPK---LEKLSLANNNLTE-LPAGLLNGLEN-LDTLLLQENSLY-TIPKGFFGSHLLPF 199

Query: 191 IDLGGN 196
             L GN
Sbjct: 200 AFLHGN 205

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 95.2 bits (237), Expect = 4e-21
 Identities = 39/175 (22%), Positives = 75/175 (42%), Gaps = 28/175 (16%)

Query: 446 EFSENNLIGRGGFALFIR---------AFKSFDVECE---------MMKSIRHRNLIKVI 487
            F   +++G G     +          A K    EC          + +S  H N+I+  
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84

Query: 488 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVI 547
            +  + +F+ + +E     +L++Y+   +      + + ++    S L +LH   S  ++
Sbjct: 85  CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140

Query: 548 HCDLKPSNVLL-----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIGYMAP 596
           H DLKP N+L+        + A +SDF + K L     S ++   + GT G++AP
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 64/257 (24%), Positives = 97/257 (37%), Gaps = 44/257 (17%)

Query: 19  QNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF 78
                  +P  +    + K L L  N L   L S +    P L+ L L       TI   
Sbjct: 15  MELNFYKIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70

Query: 79  IF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS 137
            + + S LS L L  N         F  L +L++L   E  L S            + K+
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPI----GHLKT 125

Query: 138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNK 197
           L  +++++N +             +S +             PE  SNLTNL  +DL  NK
Sbjct: 126 LKELNVAHNLI-------------QSFKL------------PEYFSNLTNLEHLDLSSNK 160

Query: 198 LNGSIPI-TLGKLRKLQ----RLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPA 252
           +  SI    L  L ++      L+L  N +   I     +   L  L L +N+L  S+P 
Sbjct: 161 IQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL-KSVPD 217

Query: 253 -CFGNLASLRILSLGSN 268
             F  L SL+ + L +N
Sbjct: 218 GIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 47/215 (21%), Positives = 86/215 (40%), Gaps = 14/215 (6%)

Query: 11  NLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGN 69
           + + L L  N  +  + +  F +   L+ L L    +  ++   A   L +L  L L GN
Sbjct: 29  STKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 70  NFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSF 128
               ++    F+  S L KL     + +       G+L+ L++L +  N +  S     +
Sbjct: 87  PIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEY 144

Query: 129 LSSLSNCKSLTLIDLSNNPLDGILPKT--SISNLSRSLEEFYMYNCNISGGIPEEISNLT 186
            S+L+N   L  +DLS+N +  I       +  +        +    ++  I        
Sbjct: 145 FSNLTN---LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200

Query: 187 NLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDN 220
            L E+ L  N+L  S+P     +L  LQ++ L  N
Sbjct: 201 RLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 14/194 (7%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
           +   L+ L L + + I T+    + ++S L  L L  N +  SL+  A   L +L+KL  
Sbjct: 50  SFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107

Query: 67  WGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFI-PSTFGNLRNLEQLGLDENYLTSSTP 124
              N + ++  F   +   L +L++  N    F  P  F NL NLE L L  N + S   
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166

Query: 125 ELSFLSSLSNCKSLTL-IDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI- 182
               L  L     L L +DLS NP++ I    +   +   L+E  +    +   +P+ I 
Sbjct: 167 TD--LRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEI--RLKELALDTNQLK-SVPDGIF 220

Query: 183 SNLTNLVEIDLGGN 196
             LT+L +I L  N
Sbjct: 221 DRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 57/216 (26%), Positives = 86/216 (39%), Gaps = 22/216 (10%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGG 195
           S   +DLS NPL   L   S  +    L+   +  C I   I +    +L++L  + L G
Sbjct: 29  STKNLDLSFNPL-RHLGSYSFFSFP-ELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTG 85

Query: 196 NKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA- 252
           N +  S+ +     L  LQ+L   +  L  S+ +     L  L  L +  N +  S    
Sbjct: 86  NPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI-QSFKLP 142

Query: 253 -CFGNLASLRILSLGSNKLTSIPL-TFWNL----KDILQLNFSSNFLTG--PLLLEIGNL 304
             F NL +L  L L SNK+ SI       L       L L+ S N +    P   +   L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202

Query: 305 KVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFN 340
           K L       N     +P  I ++L+ L+ + L  N
Sbjct: 203 KEL---ALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 16/205 (7%)

Query: 155 TSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPI-TLGKLRKL 212
             I  NL  S +   +    +         +   L  +DL   ++  +I       L  L
Sbjct: 20  YKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 213 QRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKL 270
             L L  N ++ S+       L+ L +L      L  S+     G+L +L+ L++  N +
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLI 136

Query: 271 TSIPL--TFWNLKDILQLNFSSNFLT---GPLLLEIGNLKVLIG-IDFSMNNFSGVIPRE 324
            S  L   F NL ++  L+ SSN +       L  +  + +L   +D S+N  +  I   
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG 195

Query: 325 IGEKLSYLEDLNLSFNKLKGEIPRG 349
             +++  L++L L  N+LK  +P G
Sbjct: 196 AFKEIR-LKELALDTNQLK-SVPDG 218

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 35/148 (23%), Positives = 56/148 (37%), Gaps = 14/148 (9%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            L +L++L   +   + ++      ++ TLK L + +N +           L NLE L L
Sbjct: 98  GLSSLQKLVAVETN-LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

Query: 67  WGNNFSGTIPRFIF-NASKL----SKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
             N    +I         ++      L L +N  +   P  F  +  L++L LD N L S
Sbjct: 157 SSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKS 214

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLD 149
               +          SL  I L  NP D
Sbjct: 215 VPDGI-----FDRLTSLQKIWLHTNPWD 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 32/129 (24%), Positives = 54/129 (41%), Gaps = 7/129 (5%)

Query: 7   GNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLE--- 62
           G+L+ L+EL +  N +        F N++ L+ L L +N +  S+       L  +    
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179

Query: 63  -KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
             L L  N  +  I    F   +L +L+L  N         F  L +L+++ L  N    
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238

Query: 122 STPELSFLS 130
           S P + +LS
Sbjct: 239 SCPRIDYLS 247

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 9/133 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIF---QRL 525
           E  +++ ++H N+++      +     L  V+EY   G L   +               L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114

Query: 526 NIMIDVASALEYLH--FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            +M  +  AL+  H        V+H DLKP+NV LD      L DF +A++L   D S  
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFA 173

Query: 584 QTQTLGTIGYMAP 596
           +T  +GT  YM+P
Sbjct: 174 KTF-VGTPYYMSP 185

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 33/137 (24%), Positives = 58/137 (42%), Gaps = 10/137 (7%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 523 QRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
             LN  + +A  + YL           +H DL   NVL+       ++DF +AKLL  E+
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

Query: 580 QSMTQTQTLGTIGYMAP 596
           +          I +MA 
Sbjct: 172 KEYHAEGGKVPIKWMAL 188

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 94.9 bits (236), Expect = 2e-20
 Identities = 32/174 (18%), Positives = 64/174 (36%), Gaps = 43/174 (24%)

Query: 452 LIGRGGFA---------LFIR--AFKS------------FDVECEMMKSIRHRNLIKVI- 487
            I  GG           +  R    K                E + +  + H +++++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 488 ----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 543
               +    +    +V+EY+   SL++        L + + +  ++++  AL YLH   S
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---S 200

Query: 544 ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LGTIGYMAP 596
             +++ DLKP N++L +  +  L D             +       GT G+ AP
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAP 246

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 32/137 (23%), Positives = 63/137 (45%), Gaps = 10/137 (7%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           ++F++       + S+ H ++++++  C     + LV +Y+P GSL  ++      L   
Sbjct: 57  QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQ 115

Query: 523 QRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
             LN  + +A  + YL           +H +L   NVLL       ++DF +A LL  +D
Sbjct: 116 LLLNWGVQIAKGMYYLEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

Query: 580 QSMTQTQTLGTIGYMAP 596
           + +  ++    I +MA 
Sbjct: 170 KQLLYSEAKTPIKWMAL 186

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 17/140 (12%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIF---Q 523
           E +M +   H N++++++ C  E        L+L +   G+L   +       +     Q
Sbjct: 76  EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ 135

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L +++ +   LE +H   +    H DLKP+N+LL D     L D           +   
Sbjct: 136 ILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192

Query: 584 QTQTL-------GTIGYMAP 596
           Q  TL        TI Y AP
Sbjct: 193 QALTLQDWAAQRCTISYRAP 212

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 38/170 (22%), Positives = 72/170 (42%), Gaps = 30/170 (17%)

Query: 451 NLIGRGGFAL---------FIRAFK-------------SFDVECEMMKSIRHRNL--IKV 486
             IG GG +           I A K             S+  E   +  ++  +   I++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 487 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALV 546
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H      +
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 547 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +GT+ YM P
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 38/137 (27%), Positives = 71/137 (51%), Gaps = 10/137 (7%)

Query: 461 FIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 520
            ++ F+    E      + H+N++ +I     ++   LV+EY+   +L +Y+  S+  L 
Sbjct: 54  TLKRFER---EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLS 109

Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
           +   +N    +   +++ H      ++H D+KP N+L+D N    + DF IAK L+  + 
Sbjct: 110 VDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ET 164

Query: 581 SMTQTQT-LGTIGYMAP 596
           S+TQT   LGT+ Y +P
Sbjct: 165 SLTQTNHVLGTVQYFSP 181

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 54/272 (19%), Positives = 93/272 (34%), Gaps = 42/272 (15%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           EIP ++   +N  EL+    K +  +    F+                           +
Sbjct: 23  EIPSDL--PRNAIELRFVLTK-LRVIQKGAFS------------------------GFGD 55

Query: 61  LEKLYLWGNNFSGTIPRFIF-NASKLSKLSL-GMNSFSGFIPSTFGNLRNLEQLGLDENY 118
           LEK+ +  N+    I   +F N  KL ++ +   N+     P  F NL NL+ L +    
Sbjct: 56  LEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG 115

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
           +    P++  + SL       L+D+ +N     + + S   LS      ++    I   I
Sbjct: 116 IKHL-PDVHKIHSL----QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EI 169

Query: 179 PEEISNLTNLVEIDL-GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICR-LAEL 236
                N T L E++L   N L                L++    +  S+P      L +L
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKL 228

Query: 237 YRLELGSNKLYGSIPACFGNLASLRILSLGSN 268
                 + K    +P     L +L   SL   
Sbjct: 229 RARSTYNLK---KLPT-LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 51/250 (20%), Positives = 85/250 (34%), Gaps = 25/250 (10%)

Query: 99  IPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSIS 158
           IPS     RN  +L      L           + S    L  I++S N +  ++     S
Sbjct: 24  IPSDL--PRNAIELRFVLTKLRVIQK-----GAFSGFGDLEKIEISQNDVLEVIEADVFS 76

Query: 159 NLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGGNKLNGSIP-ITLGKLRKLQRLN 216
           NL   L E  +   N    I  E   NL NL  + +    +   +P +      +   L+
Sbjct: 77  NLP-KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLD 134

Query: 217 LEDNILEGSIPDD-ICRL-AELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP 274
           ++DNI   +I  +    L  E   L L  N +     + F       +    +N L  +P
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP 194

Query: 275 -LTFWNLKDILQLNFSSNFLT---GPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLS 330
              F      + L+ S   +       L  +  L+       S  N   +      EKL 
Sbjct: 195 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR-----STYNLKKLPTL---EKLV 246

Query: 331 YLEDLNLSFN 340
            L + +L++ 
Sbjct: 247 ALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 48/251 (19%), Positives = 89/251 (35%), Gaps = 20/251 (7%)

Query: 49  SLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPS-TFGNL 106
            ++ I +    N  +L          I +  F     L K+ +  N     I +  F NL
Sbjct: 20  KVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 78

Query: 107 RNLEQLGL-DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLE 165
             L ++ +   N L    PE        N  +L  + +SN  +   LP     +  + + 
Sbjct: 79  PKLHEIRIEKANNLLYINPEA-----FQNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVL 132

Query: 166 EFYMYNCNISGGIPEE-ISNLT-NLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE 223
                N NI   I       L+   V + L  N +           +  +    ++N LE
Sbjct: 133 LDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191

Query: 224 GSIPDDICR-LAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPLTFWNLK 281
             +P+D+    +    L++   ++  S+P+    NL  LR  S     L  +P T   L 
Sbjct: 192 -ELPNDVFHGASGPVILDISRTRI-HSLPSYGLENLKKLRARST--YNLKKLP-TLEKLV 246

Query: 282 DILQLNFSSNF 292
            +++ + +   
Sbjct: 247 ALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 45/220 (20%), Positives = 79/220 (35%), Gaps = 33/220 (15%)

Query: 136 KSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDL- 193
           ++   +      L  I  K + S     LE+  +   ++   I  ++ SNL  L EI + 
Sbjct: 30  RNAIELRFVLTKLRVI-QKGAFSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87

Query: 194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA 252
             N L    P     L  LQ L + +  ++  +PD       +   L++  N    +I  
Sbjct: 88  KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146

Query: 253 -CFGNLAS-LRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGI 310
             F  L+    IL L  N +  I  + +N   + +LN S N                   
Sbjct: 147 NSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDN------------------- 187

Query: 311 DFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGG 350
               NN    +P ++    S    L++S  ++   +P  G
Sbjct: 188 ----NNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYG 221

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 41/192 (21%), Positives = 72/192 (37%), Gaps = 46/192 (23%)

Query: 442 RATDEFSENNLIGRGGFALFIRAFKSFDV--------------------ECEMMKSIRHR 481
           R   +F E  LIG GGF    + FK+                       E + +  + H 
Sbjct: 8   RFGMDFKEIELIGSGGFG---QVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHV 64

Query: 482 NLIKVISSCSNEEFKA----------------LVLEYMPHGSLEKYLYSSNCI-LDIFQR 524
           N++         ++                  + +E+   G+LE+++       LD    
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L +   +   ++Y+H   S  +I+ DLKPSN+ L D     + DF +   L  + +    
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181

Query: 585 TQTLGTIGYMAP 596
               GT+ YM+P
Sbjct: 182 K---GTLRYMSP 190

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 7/100 (7%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           + +  +    L   L      L   + + I+  + SAL+  H   +A   H D+KP N+L
Sbjct: 111 VDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENIL 166

Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LGTIGYMAP 596
           +  +  A+L DF IA   T  D+ +TQ    +GT+ YMAP
Sbjct: 167 VSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAP 204

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 29/127 (22%), Positives = 59/127 (46%), Gaps = 6/127 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMI 529
           E  ++ +++H N+++   S        +V++Y   G L K +      +    Q L+  +
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            +  AL+++H      ++H D+K  N+ L  +    L DF IA++L      + +    G
Sbjct: 133 QICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACI-G 187

Query: 590 TIGYMAP 596
           T  Y++P
Sbjct: 188 TPYYLSP 194

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 39/137 (28%), Positives = 66/137 (48%), Gaps = 14/137 (10%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +      +V EYM +GSL+ +L + +    I Q +
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154

Query: 526 NIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
            ++  V + + YL    +      +H DL   NVL+D N+V  +SDF ++++L  ED   
Sbjct: 155 GMLRGVGAGMRYLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDPD 206

Query: 583 TQTQTLGT---IGYMAP 596
               T G    I + AP
Sbjct: 207 AAYTTTGGKIPIRWTAP 223

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 89.6 bits (223), Expect = 4e-20
 Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 10/132 (7%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E E+M  + H  L+++   C  +    LV E+M HG L  YL +   +      L +
Sbjct: 50  FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM 109

Query: 528 MIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            +DV   + YL           IH DL   N L+ +N V  +SDF + + +  +DQ  + 
Sbjct: 110 CLDVCEGMAYLEEACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSS 162

Query: 585 TQTLGTIGYMAP 596
           T T   + + +P
Sbjct: 163 TGTKFPVKWASP 174

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 40/215 (18%), Positives = 78/215 (36%), Gaps = 13/215 (6%)

Query: 34  STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNA-SKLSKLSLGM 92
            + + L L    L  ++ S A   LPN+ ++Y+  +     +    F   SK++ + +  
Sbjct: 31  PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 93  NSFSGFIPS-TFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGI 151
                +I       L  L+ LG+    L    P+L+ + S        ++++++NP    
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLKMF-PDLTKVYSTD---IFFILEITDNPYMTS 145

Query: 152 LPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITL--GKL 209
           +P  +   L        +YN   +  +     N T L  + L  NK    I      G  
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204

Query: 210 RKLQRLNLEDNILEGSIPDDICRLAELYRLELGSN 244
                L++    +  ++P     L  L  L   + 
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 41/251 (16%), Positives = 86/251 (34%), Gaps = 42/251 (16%)

Query: 49  SLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPS-TFGNL 106
            +  I ++  P+ + L L   +   TIP   F N   +S++ + ++     + S +F NL
Sbjct: 22  DIQRIPSL-PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNL 79

Query: 107 RNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
             +  + +      +     +          L  + + N  L          +L++    
Sbjct: 80  SKVTHIEIRNTRNLTYIDPDAL----KELPLLKFLGIFNTGL------KMFPDLTK---- 125

Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITL--GKLRKLQRLNLEDNILEG 224
                          + +      +++  N    SIP+    G   +   L L +N    
Sbjct: 126 ---------------VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT- 169

Query: 225 SIPDDICRLAELYRLELGSNKLYGSIPA-CFGNLAS-LRILSLGSNKLTSIP-LTFWNLK 281
           S+        +L  + L  NK    I    FG + S   +L +    +T++P     +LK
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLK 229

Query: 282 DILQLNFSSNF 292
              +L   + +
Sbjct: 230 ---ELIARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 42/221 (19%), Positives = 75/221 (33%), Gaps = 35/221 (15%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGG 195
           S   + L    L   +P  + SNL  ++   Y+        +      NL+ +  I++  
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLP-NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 196 NKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDD--ICRLAELYRLELGSNKLYGSIPA 252
            +    I    L +L  L+ L + +  L+   PD   +      + LE+  N    SIP 
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 253 -CFGNLAS-LRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGI 310
             F  L +    L L +N  TS+                     G  L           +
Sbjct: 149 NAFQGLCNETLTLKLYNNGFTSVQ---------------GYAFNGTKLDA---------V 184

Query: 311 DFSMNNFSGVIPREIGEKL-SYLEDLNLSFNKLKGEIPRGG 350
             + N +  VI ++    + S    L++S   +   +P  G
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 64.3 bits (157), Expect = 8e-12
 Identities = 31/158 (19%), Positives = 59/158 (37%), Gaps = 8/158 (5%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
           NL  +  +++   + +  +       +  LKFLG+ N  L                 L +
Sbjct: 78  NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEI 137

Query: 67  WGNNFSGTIPRFIFN--ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTP 124
             N +  +IP   F    ++   L L  N F+      F N   L+ + L++N   +   
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF-NGTKLDAVYLNKNKYLTVID 196

Query: 125 ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSR 162
           + +F    S     +L+D+S   +   LP   + +L  
Sbjct: 197 KDAFGGVYSG---PSLLDVSQTSVTA-LPSKGLEHLKE 230

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 26/217 (11%), Positives = 55/217 (25%), Gaps = 54/217 (24%)

Query: 135 CKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLG 194
           C       ++   +        I +L  S +   +   ++        SNL N+  I + 
Sbjct: 10  CHQEEDFRVTCKDI------QRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63

Query: 195 GNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPAC 253
            +     +   +   L K+  + + +      I  D                        
Sbjct: 64  IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA----------------------- 100

Query: 254 FGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFS 313
              L  L+ L + +  L   P                  +    +  I        ++ +
Sbjct: 101 LKELPLLKFLGIFNTGLKMFP--------------DLTKVYSTDIFFI--------LEIT 138

Query: 314 MNNFSGVIPREIGEKL-SYLEDLNLSFNKLKGEIPRG 349
            N +   IP    + L +    L L  N     +   
Sbjct: 139 DNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 91.4 bits (227), Expect = 5e-20
 Identities = 37/170 (21%), Positives = 71/170 (41%), Gaps = 30/170 (17%)

Query: 451 NLIGRGGFAL---------FIRAFK-------------SFDVECEMMKSIRHRNL--IKV 486
             IG GG +           I A K             S+  E   +  ++  +   I++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 487 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALV 546
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H      +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 176

Query: 547 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +G + YM P
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 92.1 bits (229), Expect = 5e-20
 Identities = 36/127 (28%), Positives = 64/127 (50%), Gaps = 5/127 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMI 529
           E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N   +     L +  
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            ++SA+EYL        IH +L   N L+ +N +  ++DF +++L+T  D          
Sbjct: 326 QISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKF 381

Query: 590 TIGYMAP 596
            I + AP
Sbjct: 382 PIKWTAP 388

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 90.8 bits (226), Expect = 6e-20
 Identities = 32/128 (25%), Positives = 60/128 (46%), Gaps = 7/128 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K   H N++++I  C+ ++   +V+E +  G    +L +    L +   L ++ D
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
            A+ +EYL    S   IH DL   N L+ +  V  +SDF +++     D     +  L  
Sbjct: 222 AAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE--ADGVYAASGGLRQ 276

Query: 591 --IGYMAP 596
             + + AP
Sbjct: 277 VPVKWTAP 284

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 90.6 bits (225), Expect = 9e-20
 Identities = 32/140 (22%), Positives = 59/140 (42%), Gaps = 12/140 (8%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDI 521
                F  E  +MK   H N++ ++  C   E   L VL YM HG L  ++ +      +
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 191

Query: 522 FQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 578
              +   + VA  +++L    F      +H DL   N +LD+     ++DF +A+ +  +
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245

Query: 579 DQSMTQTQTLGT--IGYMAP 596
           +      +T     + +MA 
Sbjct: 246 EFDSVHNKTGAKLPVKWMAL 265

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 89.6 bits (222), Expect = 9e-20
 Identities = 58/296 (19%), Positives = 102/296 (34%), Gaps = 30/296 (10%)

Query: 7   GNLQNLEELQLGQNKLIGTVPAA-IFNVSTLKFLGLQNNSLSGSL--SSIANVRLPNLEK 63
           G  ++LE L    +          I    +LK L ++   +   +   ++  + +  L++
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99

Query: 64  LYLWGNNFSGTIPRFIFNAS--KLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           L L     +GT P  +  A+   L+ L+L   S++    +    L+   + GL    +  
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQ 158

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
           +         +    +L+ +DLS+NP  G                       IS   P +
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERG-------------------LISALCPLK 199

Query: 182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICR-LAELYRLE 240
              L  L   + G    +G          +LQ L+L  N L  +     C   ++L  L 
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259

Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGP 296
           L    L   +P      A L +L L  N+L   P     L  +  L+   N     
Sbjct: 260 LSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRNPS-PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 51/295 (17%), Positives = 87/295 (29%), Gaps = 38/295 (12%)

Query: 60  NLEKLYLWGNNFSGTIPRF-IFNASKLSKLSLGMNSFSGFIPST---FGNLRNLEQLGLD 115
           +LE L    +  +       I  +  L +L++        I         +  L++L L+
Sbjct: 44  SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103

Query: 116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS 175
              +T + P     ++  +   L L ++S    D  L +     L   L+   +   +  
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ-QWLKPGLKVLSIAQAHSL 162

Query: 176 GGIPEEISNLTNLVEIDLGGNKLNGSIPIT----LGKLRKLQRLNLEDNILEGSIPDDIC 231
               E++     L  +DL  N   G   +       K   LQ L L +  +         
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM--------- 213

Query: 232 RLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP--LTFWNLKDILQLNFS 289
                           G   A       L+ L L  N L       +      +  LN S
Sbjct: 214 ------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261

Query: 290 SNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
              L          L VL   D S N           ++L  + +L+L  N    
Sbjct: 262 FTGLKQVPKGLPAKLSVL---DLSYNRLDRN---PSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.2 bits (208), Expect = 6e-18
 Identities = 49/231 (21%), Positives = 83/231 (35%), Gaps = 17/231 (7%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIFNVS--TLKFLGLQNNSLSG---SLSSIANVRL 58
           L +  +  L+EL L   ++ GT P  +   +   L  L L+N S +     L+ +     
Sbjct: 89  LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148

Query: 59  PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPST----FGNLRNLEQLGL 114
           P L+ L +   +        +     LS L L  N   G               L+ L L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208

Query: 115 DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNI 174
               + + +   S L   +    L  +DLS+N L       S    S  L    +    +
Sbjct: 209 RNAGMETPSGVCSAL--AAARVQLQGLDLSHNSLRDAAGAPSCDWPS-QLNSLNLSFTGL 265

Query: 175 SGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGS 225
              +P+ +     L  +DL  N+L+   P     L ++  L+L+ N    S
Sbjct: 266 K-QVPKGLP--AKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 53/291 (18%), Positives = 92/291 (31%), Gaps = 46/291 (15%)

Query: 70  NFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFL 129
           NFS   P +          S   N         +G  R+LE L    +           +
Sbjct: 16  NFSDPKPDW----------SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDII 65

Query: 130 SSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRS-LEEFYMYNCNISGGIPEEISNLT-- 186
            SLS    L  + +    +   +   ++  L  S L+E  + N  ++G  P  +   T  
Sbjct: 66  KSLS----LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGP 121

Query: 187 NLVEIDLGGNKLNGSIP----ITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG 242
           +L  ++L              +       L+ L++          + +     L  L+L 
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181

Query: 243 SNKLYGSIP----ACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLL 298
            N   G        C     +L++L+L +  + +       L                  
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL------------------ 223

Query: 299 LEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
                   L G+D S N+          +  S L  LNLSF  LK ++P+G
Sbjct: 224 --AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 29/121 (23%), Positives = 41/121 (33%), Gaps = 5/121 (4%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
            PL+   LQ L     G     G   A       L+ L L +NSL  +  + +      L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
             L L        +P+ +   +KLS L L  N        +   L  +  L L  N    
Sbjct: 256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310

Query: 122 S 122
           S
Sbjct: 311 S 311

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 33/140 (23%), Positives = 59/140 (42%), Gaps = 12/140 (8%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDI 521
                F  E  +MK   H N++ ++  C   E   L VL YM HG L  ++ +      +
Sbjct: 68  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 127

Query: 522 FQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 578
              +   + VA  ++YL    F      +H DL   N +LD+     ++DF +A+ +  +
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181

Query: 579 DQSMTQTQTLGT--IGYMAP 596
           +      +T     + +MA 
Sbjct: 182 EYYSVHNKTGAKLPVKWMAL 201

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 31/135 (22%), Positives = 65/135 (48%), Gaps = 8/135 (5%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQ 523
                E E+++++ H N++K    C+ +      L++E++P GSL++YL  +   +++ Q
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           +L   + +   ++YL    S   +H DL   NVL++      + DF + K +   D+   
Sbjct: 128 QLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYY 183

Query: 584 QTQTLGT--IGYMAP 596
             +      + + AP
Sbjct: 184 TVKDDRDSPVFWYAP 198

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 33/129 (25%), Positives = 59/129 (45%), Gaps = 8/129 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNI 527
           E +++K + H N+IK  +S   +    +VLE    G L + +        +         
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            + + SALE++H   S  V+H D+KP+NV +    V  L D  + +  + +  +   +  
Sbjct: 142 FVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLV 197

Query: 588 LGTIGYMAP 596
            GT  YM+P
Sbjct: 198 -GTPYYMSP 205

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 38/170 (22%), Positives = 72/170 (42%), Gaps = 30/170 (17%)

Query: 451 NLIGRGGFAL---------FIRAFK-------------SFDVECEMMKSIRHRNL--IKV 486
             IG GG +           I A K             S+  E   +  ++  +   I++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 487 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALV 546
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H      +
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 547 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +GT+ YM P
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 31/140 (22%), Positives = 62/140 (44%), Gaps = 12/140 (8%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNCILDI 521
           +  ++F  E  +M+ + H N++ +I      E    ++L YM HG L +++ S      +
Sbjct: 64  QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123

Query: 522 FQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 578
              ++  + VA  +EYL    F      +H DL   N +LD++    ++DF +A+ +   
Sbjct: 124 KDLISFGLQVARGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDR 177

Query: 579 DQSMTQTQTLGT--IGYMAP 596
           +    Q        + + A 
Sbjct: 178 EYYSVQQHRHARLPVKWTAL 197

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 26/100 (26%), Positives = 51/100 (51%), Gaps = 5/100 (5%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
           +V+EY+   +L   +  +   +   + + ++ D   AL + H      +IH D+KP+N++
Sbjct: 93  IVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIM 148

Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LGTIGYMAP 596
           +       + DF IA+ +     S+TQT   +GT  Y++P
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 37/127 (29%), Positives = 64/127 (50%), Gaps = 5/127 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMI 529
           E  +MK I+H NL++++  C+ E    ++ E+M +G+L  YL   N   +     L +  
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLG 589
            ++SA+EYL        IH DL   N L+ +N +  ++DF +++L+T  D          
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKF 174

Query: 590 TIGYMAP 596
            I + AP
Sbjct: 175 PIKWTAP 181

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 10/112 (8%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + +  ++++I  C  E    LV+E    G L K+L      + +     ++  
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 531 VASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           V+  ++YL   +F      +H DL   NVLL +   A +SDF ++K L  +D
Sbjct: 119 VSMGMKYLEEKNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 36/137 (26%), Positives = 69/137 (50%), Gaps = 14/137 (10%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
             F  E  +M    H N+I++    S  +   ++ EYM +G+L+K+L   +    + Q +
Sbjct: 91  VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV 150

Query: 526 NIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
            ++  +A+ ++YL   ++      +H DL   N+L++ N+V  +SDF ++++L  ED   
Sbjct: 151 GMLRGIAAGMKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPE 202

Query: 583 TQTQTLGT---IGYMAP 596
               T G    I + AP
Sbjct: 203 ATYTTSGGKIPIRWTAP 219

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 34/127 (26%), Positives = 47/127 (37%), Gaps = 10/127 (7%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
            A   F  E   M S+ HRNLI++         K +V E  P GSL   L        + 
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG 121

Query: 523 QRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
                 + VA  + YL    F      IH DL   N+LL    +  + DF + + L   D
Sbjct: 122 TLSRYAVQVAEGMGYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

Query: 580 QSMTQTQ 586
                 +
Sbjct: 176 DHYVMQE 182

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 34/115 (29%), Positives = 52/115 (45%), Gaps = 9/115 (7%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E + M  + H  L+K    CS E    +V EY+ +G L  YL S    L+  Q L +
Sbjct: 50  FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109

Query: 528 MIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
             DV   + +L    F      IH DL   N L+D ++   +SDF + + +  + 
Sbjct: 110 CYDVCEGMAFLESHQF------IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 33/137 (24%), Positives = 58/137 (42%), Gaps = 10/137 (7%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +   
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 523 QRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
             LN  + +A  + YL           +H DL   NVL+       ++DF +AKLL  E+
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

Query: 580 QSMTQTQTLGTIGYMAP 596
           +          I +MA 
Sbjct: 172 KEYHAEGGKVPIKWMAL 188

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 90.2 bits (224), Expect = 2e-19
 Identities = 37/130 (28%), Positives = 68/130 (52%), Gaps = 6/130 (4%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 526
           F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L       L + Q ++
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           +   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+   + +  Q  
Sbjct: 285 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341

Query: 587 TLGTIGYMAP 596
               I + AP
Sbjct: 342 KF-PIKWTAP 350

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 32/115 (27%), Positives = 56/115 (48%), Gaps = 9/115 (7%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           F  E ++M ++ H  L+++   C+ +    ++ EYM +G L  YL          Q L +
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125

Query: 528 MIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
             DV  A+EYL    F      +H DL   N L++D  V  +SDF +++ +  ++
Sbjct: 126 CKDVCEAMEYLESKQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 29/130 (22%), Positives = 66/130 (50%), Gaps = 6/130 (4%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLN 526
           F  E  +MK+++H  L+K+ +  + E    ++ E+M  GSL  +L S       + + ++
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
               +A  + ++        IH DL+ +N+L+  ++V  ++DF +A+++  +++   +  
Sbjct: 289 FSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREG 344

Query: 587 TLGTIGYMAP 596
               I + AP
Sbjct: 345 AKFPIKWTAP 354

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 36/137 (26%), Positives = 67/137 (48%), Gaps = 14/137 (10%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           + F  E  +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150

Query: 526 NIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
            ++  +AS ++YL    +      +H DL   N+L++ N+V  +SDF + ++L  ED   
Sbjct: 151 GMLRGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPE 202

Query: 583 TQTQTLGT---IGYMAP 596
               T G    I + +P
Sbjct: 203 AAYTTRGGKIPIRWTSP 219

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 89.9 bits (223), Expect = 4e-19
 Identities = 37/130 (28%), Positives = 68/130 (52%), Gaps = 6/130 (4%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 526
           F  E ++MK +RH  L+++ +  S E    +V EYM  GSL  +L       L + Q ++
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 586
           +   +AS + Y+        +H DL+ +N+L+ +N+V  ++DF +A+L+   + +  Q  
Sbjct: 368 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424

Query: 587 TLGTIGYMAP 596
               I + AP
Sbjct: 425 KF-PIKWTAP 433

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 11/112 (9%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+ + +  ++++I  C  E +  LV+E    G L KYL   N  +     + ++  
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQ 125

Query: 531 VASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           V+  ++YL   +F      +H DL   NVLL     A +SDF ++K L  ++
Sbjct: 126 VSMGMKYLEESNF------VHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 38/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  +
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 115

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+   
Sbjct: 116 LLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFF 171

Query: 584 QTQTLGT--IGYMAP 596
           + +  G   I + AP
Sbjct: 172 KVKEPGESPIFWYAP 186

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 89.2 bits (221), Expect = 7e-19
 Identities = 29/115 (25%), Positives = 54/115 (46%), Gaps = 10/115 (8%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
              E ++M  + +  ++++I  C  E    LV+E    G L K+L      + +     +
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAEL 441

Query: 528 MIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           +  V+  ++YL   +F      +H +L   NVLL +   A +SDF ++K L  +D
Sbjct: 442 LHQVSMGMKYLEEKNF------VHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 88.6 bits (220), Expect = 8e-19
 Identities = 38/110 (34%), Positives = 57/110 (51%), Gaps = 5/110 (4%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSN-CILDIFQ 523
           ++F  E  +M  +RH NL++++     E+    +V EYM  GSL  YL S    +L    
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 290

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            L   +DV  A+EYL        +H DL   NVL+ ++ VA +SDF + K
Sbjct: 291 LLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 86.7 bits (215), Expect = 9e-19
 Identities = 38/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F+ E E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  +
Sbjct: 87  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 146

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L     +   +EYL    +   IH DL   N+L+++     + DF + K+L  +D+   
Sbjct: 147 LLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYY 202

Query: 584 QTQTLGT--IGYMAP 596
           + +  G   I + AP
Sbjct: 203 KVKEPGESPIFWYAP 217

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 40/183 (21%), Positives = 78/183 (42%), Gaps = 38/183 (20%)

Query: 445 DEFSENNLIGRGGFAL----------FIRAFKSFD------------VECEMMKSIRHRN 482
             +  ++++G+G  A            + A K F+             E E++K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 483 LIK---VISSCSNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEY 537
           ++K   +    +      L++E+ P GSL   L    +   L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 538 LHFGYSALVIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
           L       ++H ++KP N++     D   V  L+DF  A+ L  ++Q ++     GT  Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEY 181

Query: 594 MAP 596
           + P
Sbjct: 182 LHP 184

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 30/116 (25%), Positives = 54/116 (46%), Gaps = 5/116 (4%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQ 523
           + F  E +++K++    ++K          ++  LV+EY+P G L  +L      LD  +
Sbjct: 69  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 128

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
            L     +   +EYL    S   +H DL   N+L++      ++DF +AKLL  + 
Sbjct: 129 LLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 82.7 bits (205), Expect = 2e-18
 Identities = 31/193 (16%), Positives = 67/193 (34%), Gaps = 18/193 (9%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
             +      LGQ+     +  A   +++L ++ L N +++  L+ I      N++ L + 
Sbjct: 21  TFKAYLNGLLGQSS-TANITEA--QMNSLTYITLANINVT-DLTGIEY--AHNIKDLTIN 74

Query: 68  GNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELS 127
             + +   P  I   S L +L +     +         L +L  L +  +    S     
Sbjct: 75  NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI---- 128

Query: 128 FLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTN 187
            L+ ++    +  IDLS N     +    +  L   L+   +    +       I +   
Sbjct: 129 -LTKINTLPKVNSIDLSYNGAITDI--MPLKTLP-ELKSLNIQFDGVHDYRG--IEDFPK 182

Query: 188 LVEIDLGGNKLNG 200
           L ++      + G
Sbjct: 183 LNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 79.6 bits (197), Expect = 2e-17
 Identities = 27/174 (15%), Positives = 62/174 (35%), Gaps = 15/174 (8%)

Query: 3   PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLE 62
            +    + +L  + L    +  T    I     +K L + N   + + + I+   L NLE
Sbjct: 37  NITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHAT-NYNPISG--LSNLE 91

Query: 63  KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSS 122
           +L + G + +      +   + L+ L +  ++    I +    L  +  + L  N   + 
Sbjct: 92  RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151

Query: 123 TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG 176
                 +  L     L  +++  + +        I +    L + Y ++  I G
Sbjct: 152 ------IMPLKTLPELKSLNIQFDGVHDY---RGIEDFP-KLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.0 bits (185), Expect = 9e-16
 Identities = 29/188 (15%), Positives = 61/188 (32%), Gaps = 11/188 (5%)

Query: 133 SNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEID 192
           S  K+     L  +    I    + + ++ SL    + N N++      I    N+ ++ 
Sbjct: 20  STFKAYLNGLLGQSSTANI----TEAQMN-SLTYITLANINVTD--LTGIEYAHNIKDLT 72

Query: 193 LGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPA 252
           +         P  +  L  L+RL +    +      ++  L  L  L++  +    SI  
Sbjct: 73  INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 253 CFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDF 312
               L  +  + L  N   +  +    L ++  LN   + +       I +   L  +  
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYA 188

Query: 313 SMNNFSGV 320
                 G 
Sbjct: 189 FSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 69.6 bits (171), Expect = 7e-14
 Identities = 22/147 (14%), Positives = 51/147 (34%), Gaps = 13/147 (8%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGS-LSSIANVRLPNLEKL 64
           I    N+++L +       T    I  +S L+ L +    ++   + +++   L +L  L
Sbjct: 62  IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSG--LTSLTLL 117

Query: 65  YLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTP 124
            +  +    +I   I    K++ + L  N     I      L  L+ L +  + +     
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--- 173

Query: 125 ELSFLSSLSNCKSLTLIDLSNNPLDGI 151
                  + +   L  +   +  + G 
Sbjct: 174 ----YRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 33/172 (19%), Positives = 68/172 (39%), Gaps = 14/172 (8%)

Query: 49  SLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRN 108
           S ++I   ++ +L  + L   N +      I  A  +  L++     + +  +    L N
Sbjct: 34  STANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNY--NPISGLSN 89

Query: 109 LEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFY 168
           LE+L +    +TS       + +LS   SLTL+D+S++  D  +  T I+ L   +    
Sbjct: 90  LERLRIMGKDVTSDK-----IPNLSGLTSLTLLDISHSAHDDSIL-TKINTLP-KVNSID 142

Query: 169 MYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN 220
           +        I   +  L  L  +++  + ++      +    KL +L     
Sbjct: 143 LSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.5 bits (111), Expect = 5e-06
 Identities = 20/140 (14%), Positives = 48/140 (34%), Gaps = 9/140 (6%)

Query: 204 ITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRIL 263
           I     +      L  +            +  L  + L +  +            +++ L
Sbjct: 17  IPDSTFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVTDLTG--IEYAHNIKDL 71

Query: 264 SLGSNKLTSI-PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIP 322
           ++ +   T+  P++   L ++ +L      +T   +  +  L  L  +D S +     I 
Sbjct: 72  TINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

Query: 323 REIGEKLSYLEDLNLSFNKL 342
            +I   L  +  ++LS+N  
Sbjct: 130 TKI-NTLPKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 43.0 bits (102), Expect = 7e-05
 Identities = 21/123 (17%), Positives = 40/123 (32%), Gaps = 9/123 (7%)

Query: 225 SIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDIL 284
           +IPD            LG +       A    + SL  ++L +  +T +        +I 
Sbjct: 16  NIPDS--TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDLT-GIEYAHNIK 69

Query: 285 QLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
            L  ++   T      I  L  L  +     + +      +   L+ L  L++S +    
Sbjct: 70  DLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNL-SGLTSLTLLDISHSAHDD 126

Query: 345 EIP 347
            I 
Sbjct: 127 SIL 129

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 30/125 (24%), Positives = 55/125 (44%), Gaps = 17/125 (13%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           +SF     MM  + H++L+     C   +   LV E++  GSL+ YL  +   ++I  +L
Sbjct: 57  ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL 116

Query: 526 NIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLD--------DNMVAHLSDFSIAKL 574
            +   +A+A+ +L           IH ++   N+LL         +     LSD  I+  
Sbjct: 117 EVAKQLAAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170

Query: 575 LTGED 579
           +  +D
Sbjct: 171 VLPKD 175

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 38/166 (22%), Positives = 61/166 (36%), Gaps = 24/166 (14%)

Query: 451 NLIGRGGF-----AL-----FIRAFKSFDVEC------EMMKSIRHRNLIKVISSCSNEE 494
             +GRG F            F  A K   +E            +    ++ +  +     
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGP 123

Query: 495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPS 554
           +  + +E +  GSL + +    C L   + L  +      LEYLH   +  ++H D+K  
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHGDVKAD 179

Query: 555 NVLLDDN-MVAHLSDFSIAKLLTGEDQSMTQTQTL---GTIGYMAP 596
           NVLL  +   A L DF  A  L  +    +        GT  +MAP
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 29/113 (25%), Positives = 62/113 (54%), Gaps = 5/113 (4%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 526
           F  E  +MK ++H+ L+++ +  + E    ++ EYM +GSL  +L + +   L I + L+
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLD 113

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           +   +A  + ++        IH DL+ +N+L+ D +   ++DF +A+L+   +
Sbjct: 114 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 34/179 (18%), Positives = 57/179 (31%), Gaps = 31/179 (17%)

Query: 442 RATDEFSENNLIGRGGFALFIRAFKSFD-----------------------VECEMMKSI 478
                F   + +G G +    +     D                        E    + +
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113

Query: 479 -RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 537
            +H   +++  +        L  E     SL+++  +    L   Q    + D   AL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 538 LHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           LH   S  ++H D+KP+N+ L       L DF +   L        Q    G   YMAP
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAP 225

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 87.4 bits (216), Expect = 3e-18
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 17/137 (12%)

Query: 471 ECEMMKSIRHRNLIKVI------SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIF 522
           E ++MK + H N++            +  +   L +EY   G L KYL  + + C L   
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGED 579
               ++ D++SAL YLH      +IH DLKP N++L      ++  + D   AK L  + 
Sbjct: 122 PIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQ 176

Query: 580 QSMTQTQTLGTIGYMAP 596
             +     +GT+ Y+AP
Sbjct: 177 GELCTEF-VGTLQYLAP 192

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 35/147 (23%), Positives = 63/147 (42%), Gaps = 19/147 (12%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA-----LVLEYMPHGSLEKYL----- 512
           R  + F  E   MK   H N+I+++  C     +      ++L +M +G L  YL     
Sbjct: 78  REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL 137

Query: 513 YSSNCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDF 569
            +    + +   L  M+D+A  +EYL   +F      +H DL   N +L D+M   ++DF
Sbjct: 138 ETGPKHIPLQTLLKFMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADF 191

Query: 570 SIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            ++K +   D           + ++A 
Sbjct: 192 GLSKKIYSGDYYRQGRIAKMPVKWIAI 218

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 26/112 (23%), Positives = 52/112 (46%), Gaps = 10/112 (8%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +MK++ H +++K+I     E    +++E  P+G L  YL  +   L +   +   + 
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 531 VASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           +  A+ YL   +       +H D+   N+L+       L DF +++ +  ED
Sbjct: 122 ICKAMAYLESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 85.3 bits (211), Expect = 5e-18
 Identities = 40/183 (21%), Positives = 78/183 (42%), Gaps = 38/183 (20%)

Query: 445 DEFSENNLIGRGGFAL----------FIRAFKSFDV------------ECEMMKSIRHRN 482
             +  ++++G+G  A            + A K F+             E E++K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 483 LIK---VISSCSNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEY 537
           ++K   +    +      L++E+ P GSL   L    +   L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 538 LHFGYSALVIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
           L       ++H ++KP N++     D   V  L+DF  A+ L  ++Q ++     GT  Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEY 181

Query: 594 MAP 596
           + P
Sbjct: 182 LHP 184

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 33/145 (22%), Positives = 62/145 (42%), Gaps = 20/145 (13%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSS---- 515
           + F  E   MK   H ++ K++        K       ++L +M HG L  +L +S    
Sbjct: 70  EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129

Query: 516 -NCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI 571
               L +   +  M+D+A  +EYL   +F      IH DL   N +L ++M   ++DF +
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGL 183

Query: 572 AKLLTGEDQSMTQTQTLGTIGYMAP 596
           ++ +   D       +   + ++A 
Sbjct: 184 SRKIYSGDYYRQGCASKLPVKWLAL 208

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 85.2 bits (211), Expect = 7e-18
 Identities = 40/191 (20%), Positives = 72/191 (37%), Gaps = 43/191 (22%)

Query: 445 DEFSENNLIGRGGFALFI---------RAFKSFDVECE---------MMKSIRHRNLIKV 486
           +      ++G G     +          A K   ++           + +S  H N+I+ 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74

Query: 487 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------NIMIDVASALEYLHF 540
             S + + F  + LE     +L+  + S N   +  +        +++  +AS + +LH 
Sbjct: 75  YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132

Query: 541 GYSALVIHCDLKPSNVLLD-------------DNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
             S  +IH DLKP N+L+              +N+   +SDF + K L     S      
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 588 --LGTIGYMAP 596
              GT G+ AP
Sbjct: 191 NPSGTSGWRAP 201

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 38/209 (18%)

Query: 87  KLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNN 146
           KL L  N  S      F  L  L  L L++N L  + P   F   L N   L  + +++N
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIF-KELKN---LETLWVTDN 95

Query: 147 PLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITL 206
            L       ++                   G+      L NL E+ L  N+L  S+P  +
Sbjct: 96  KL------QALPI-----------------GVF---DQLVNLAELRLDRNQLK-SLPPRV 128

Query: 207 -GKLRKLQRLNLEDNILEGSIPDDIC-RLAELYRLELGSNKLYGSIPA-CFGNLASLRIL 263
              L KL  L+L  N L+ S+P  +  +L  L  L L +N+L   +P   F  L  L+ L
Sbjct: 129 FDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTL 186

Query: 264 SLGSNKLTSIPL-TFWNLKDILQLNFSSN 291
            L +N+L  +P   F +L+ +  L    N
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 44/144 (30%), Positives = 62/144 (43%), Gaps = 10/144 (6%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            L+NLE L +  NKL   +P  +F  +  L  L L  N L  SL       L  L  L L
Sbjct: 83  ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSL 140

Query: 67  WGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
             N    ++P+ +F+  + L +L L  N         F  L  L+ L LD N L    PE
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPE 198

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLD 149
            +F     + + L ++ L  NP D
Sbjct: 199 GAF----DSLEKLKMLQLQENPWD 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 12/166 (7%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFN-VSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            L  L  L L  NKL  T+PA IF  +  L+ L + +N L  +L      +L NL +L L
Sbjct: 59  RLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116

Query: 67  WGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
             N    ++P  +F++ +KL+ LSLG N         F  L +L++L L  N L    PE
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPE 174

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN 171
            +F   L+    L  + L NN L  + P+ +  +L   L+   +  
Sbjct: 175 GAF-DKLTE---LKTLKLDNNQLKRV-PEGAFDSLE-KLKMLQLQE 214

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 34/200 (17%)

Query: 155 TSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITL-GKLRKL 212
           T+I SN+    ++  + +  +S    +    LT L  + L  NKL  ++P  +  +L+ L
Sbjct: 29  TAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87

Query: 213 QRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKL 270
           + L + DN L+ ++P  +  +L  L  L L  N+L  S+P   F +L  L  LSLG N+L
Sbjct: 88  ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNEL 145

Query: 271 TSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKL 329
            S+P   F  L  + +L   +N L                           +P    +KL
Sbjct: 146 QSLPKGVFDKLTSLKELRLYNNQLK-------------------------RVPEGAFDKL 180

Query: 330 SYLEDLNLSFNKLKGEIPRG 349
           + L+ L L  N+LK  +P G
Sbjct: 181 TELKTLKLDNNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 12/188 (6%)

Query: 11  NLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGN 69
           + ++L L  NK + ++P+  F  ++ L+ L L +N L  +L +     L NLE L++  N
Sbjct: 38  DTKKLDLQSNK-LSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95

Query: 70  NFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSF 128
                +P  +F+    L++L L  N      P  F +L  L  L L  N L  S P+  F
Sbjct: 96  KLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153

Query: 129 LSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNL 188
              L++   L  + L NN L  + P+ +   L+  L+   + N  +         +L  L
Sbjct: 154 -DKLTS---LKELRLYNNQLKRV-PEGAFDKLTE-LKTLKLDNNQLKRVPEGAFDSLEKL 207

Query: 189 VEIDLGGN 196
             + L  N
Sbjct: 208 KMLQLQEN 215

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 10/120 (8%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
              + F  E   M+   H +++K+I   +      +++E    G L  +L      LD+ 
Sbjct: 58  SVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLA 116

Query: 523 QRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
             +     +++AL YL    F      +H D+   NVL+  N    L DF +++ +    
Sbjct: 117 SLILYAYQLSTALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 36/204 (17%), Positives = 76/204 (37%), Gaps = 55/204 (26%)

Query: 442 RATDEFSENNLIGRGGFALFIRAFKSFDV-------------------------ECEMMK 476
           R   +F     +GRGGF      F++ +                          E + + 
Sbjct: 2   RYLTDFEPIQCLGRGGFG---VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 58

Query: 477 SIRHRNLIKVISSCSNEEFKA------------LVLEYMPHGSLEKYL--YSSNCILDIF 522
            + H  +++  ++   +                + ++     +L+ ++    +    +  
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
             L+I + +A A+E+LH   S  ++H DLKPSN+    + V  + DF +   +  +++  
Sbjct: 119 VCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 583 T----------QTQTLGTIGYMAP 596
           T           T  +GT  YM+P
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSP 199

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 38/110 (34%), Positives = 57/110 (51%), Gaps = 5/110 (4%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSN-CILDIFQ 523
           ++F  E  +M  +RH NL++++     E+    +V EYM  GSL  YL S    +L    
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
            L   +DV  A+EYL        +H DL   NVL+ ++ VA +SDF + K
Sbjct: 119 LLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 31/133 (23%), Positives = 61/133 (45%), Gaps = 13/133 (9%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-------YSSNCILDIFQ 523
           E +++  I++   +      +N +   ++ EYM + S+ K+         +  C + I  
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
              I+  V ++  Y+H   +  + H D+KPSN+L+D N    LSDF  ++ +        
Sbjct: 153 IKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKI 207

Query: 584 QTQTLGTIGYMAP 596
           +  + GT  +M P
Sbjct: 208 KG-SRGTYEFMPP 219

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 63/268 (23%), Positives = 99/268 (36%), Gaps = 52/268 (19%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
                 +  L +  +   V      ++++  +   N+ +  S+  I    LPN+ KL+L 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQY--LPNVTKLFLN 76

Query: 68  GNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELS 127
           GN              KL+ +                NL+NL  L LDEN +        
Sbjct: 77  GN--------------KLTDIK------------PLANLKNLGWLFLDENKVKD------ 104

Query: 128 FLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSR--SLEEFYMYNCNISGGIPEEISNL 185
            LSSL + K L  + L +N +      + I+ L     LE  Y+ N  I+      +S L
Sbjct: 105 -LSSLKDLKKLKSLSLEHNGI------SDINGLVHLPQLESLYLGNNKIT--DITVLSRL 155

Query: 186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNK 245
           T L  + L  N+++  I   L  L KLQ L L  N +   +   +  L  L  LEL S +
Sbjct: 156 TKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQE 211

Query: 246 LYGSIPACFGNLASLRILSLGSNKLTSI 273
                     NL     +      L + 
Sbjct: 212 CLNKPINHQSNLVVPNTVKNTDGSLVTP 239

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 47/240 (19%), Positives = 93/240 (38%), Gaps = 27/240 (11%)

Query: 105 NLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS--R 162
                 +  L +  +T          + +   S+  I  +N+ +       S+  +    
Sbjct: 22  AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDI------KSVQGIQYLP 68

Query: 163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNIL 222
           ++ + ++    ++    + ++NL NL  + L  NK+   +  +L  L+KL+ L+LE N +
Sbjct: 69  NVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI 124

Query: 223 EGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKD 282
              I + +  L +L  L LG+NK+  +       L  L  LSL  N+++ I      L  
Sbjct: 125 S-DI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTK 179

Query: 283 ILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
           +  L  S N ++   L  +  LK L  ++          P      L     +  +   L
Sbjct: 180 LQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLN-KPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 46/214 (21%), Positives = 86/214 (40%), Gaps = 18/214 (8%)

Query: 129 LSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNL 188
           + S          +L    +   + +  +++    +++    N +I     + I  L N+
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVTQNELNS----IDQIIANNSDIK--SVQGIQYLPNV 70

Query: 189 VEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG 248
            ++ L GNKL    P  L  L+ L  L L++N ++  +   +  L +L  L L  N +  
Sbjct: 71  TKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI-S 125

Query: 249 SIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLI 308
            I     +L  L  L LG+NK+T I      L  +  L+   N ++   ++ +  L  L 
Sbjct: 126 DING-LVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQ 181

Query: 309 GIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL 342
            +  S N+ S +        L  L+ L L   + 
Sbjct: 182 NLYLSKNHISDLRAL---AGLKNLDVLELFSQEC 212

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 32/164 (19%), Positives = 59/164 (35%), Gaps = 34/164 (20%)

Query: 180 EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL 239
                    ++ +L    +     +T  +L  + ++   ++ ++ S+   I  L  + +L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73

Query: 240 ELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLL 299
            L  NKL   I     NL +L  L L  NK+  +  +  +LK +  L+   N ++     
Sbjct: 74  FLNGNKL-TDIKP-LANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLEHNGIS----- 125

Query: 300 EIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
           +I  L                        L  LE L L  NK+ 
Sbjct: 126 DINGL----------------------VHLPQLESLYLGNNKIT 147

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 10/135 (7%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQ 523
             +  E ++++++ H ++IK    C +    +  LV+EY+P GSL  YL   +  + + Q
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQ 135

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
            L     +   + YLH   +   IH DL   NVLLD++ +  + DF +AK +  E     
Sbjct: 136 LLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYY 191

Query: 584 QTQTLGT--IGYMAP 596
           + +  G   + + AP
Sbjct: 192 RVREDGDSPVFWYAP 206

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 38/203 (18%), Positives = 75/203 (36%), Gaps = 54/203 (26%)

Query: 442 RATDEFSENNLIGRGGFALFIRAFKSFDV-----------------------ECEMMKSI 478
           R   +F E  ++G+G F    +  K+ +                        E  ++ S+
Sbjct: 3   RYASDFEEIAVLGQGAFG---QVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL 59

Query: 479 RHRNLIKVISSCSNEEFKA-------------LVLEYMPHGSLEKYLYSSNCILDIFQRL 525
            H+ +++  ++                     + +EY  +G+L   ++S N      +  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ- 584
            +   +  AL Y+H   S  +IH DLKP N+ +D++    + DF +AK +      +   
Sbjct: 120 RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 585 -----------TQTLGTIGYMAP 596
                      T  +GT  Y+A 
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVAT 199

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 10/130 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIM 528
           E  + K ++H+N+++ + S S   F  + +E +P GSL   L S    L   ++      
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
             +   L+YLH      ++H D+K  NVL++  + V  +SDF  +K L G       T+T
Sbjct: 129 KQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTET 182

Query: 588 L-GTIGYMAP 596
             GT+ YMAP
Sbjct: 183 FTGTLQYMAP 192

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 83.4 bits (206), Expect = 7e-17
 Identities = 29/129 (22%), Positives = 54/129 (41%), Gaps = 11/129 (8%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E   M+   H +++K+I   +      +++E    G L  +L      LD+   +     
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499

Query: 531 VASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
           +++AL YL    F      +H D+   NVL+  N    L DF +++ +         ++ 
Sbjct: 500 LSTALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKG 552

Query: 588 LGTIGYMAP 596
              I +MAP
Sbjct: 553 KLPIKWMAP 561

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 79.9 bits (198), Expect = 8e-17
 Identities = 34/133 (25%), Positives = 59/133 (44%), Gaps = 22/133 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN---- 526
           E E+   +RH N++++     +     L+LEY P G++ + L           + +    
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRT 111

Query: 527 --IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
              + ++A+AL Y H   S  VIH D+KP N+LL       ++DF  +           +
Sbjct: 112 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----R 163

Query: 585 TQTL-GTIGYMAP 596
              L GT+ Y+ P
Sbjct: 164 RTDLCGTLDYLPP 176

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 26/146 (17%), Positives = 58/146 (39%), Gaps = 18/146 (12%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------Y 513
           R    F  E  +MK     ++++++   S  +   +++E M  G L+ YL          
Sbjct: 70  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 129

Query: 514 SSNCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS 570
                  + + + +  ++A  + YL    F      +H DL   N ++ ++    + DF 
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFG 183

Query: 571 IAKLLTGEDQSMTQTQTLGTIGYMAP 596
           + + +   D      + L  + +M+P
Sbjct: 184 MTRDIYETDYYRKGGKGLLPVRWMSP 209

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 24/141 (17%), Positives = 48/141 (34%), Gaps = 18/141 (12%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL----EKYLYSSNCILDIFQRLN 526
             E +K       +K  S+   +    LV E   +G+L      Y  +   ++     ++
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 527 IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH-----------LSDFSIAKLL 575
             + +   +E +H      +IH D+KP N +L +  +             L D   +  +
Sbjct: 177 FAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 576 TGEDQSMTQTQTLGTIGYMAP 596
               +    T    T G+   
Sbjct: 234 KLFPKGTIFTAKCETSGFQCV 254

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 23/142 (16%), Positives = 48/142 (33%), Gaps = 11/142 (7%)

Query: 462 IRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM-PHGSLEKYL------YS 514
            +    F    +++K  + + +I+V     +    +    Y     +L+ +        S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 515 SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
           ++  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
             G        +        A 
Sbjct: 261 D-GASAVSPIGRGFAPPETTAE 281

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 24/152 (15%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------- 512
            A K F  E E++ +++H +++K    C + +   +V EYM HG L K+L          
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118

Query: 513 -----YSSNCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVA 564
                  +   L + Q L+I   +AS + YL   HF      +H DL   N L+  N++ 
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLV 172

Query: 565 HLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            + DF +++ +   D       T+  I +M P
Sbjct: 173 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 204

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 22/133 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN---- 526
           E E+   +RH N++++ +   + +   L+LE+ P G L K L           R +    
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRS 116

Query: 527 --IMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
              M ++A AL Y H      VIH D+KP N+L+       ++DF  +           +
Sbjct: 117 ATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----R 168

Query: 585 TQTL-GTIGYMAP 596
            +T+ GT+ Y+ P
Sbjct: 169 RRTMCGTLDYLPP 181

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 33/127 (25%), Positives = 63/127 (49%), Gaps = 7/127 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++   ++H +++++ +   +  +  LVLE   +G + +YL +        +  + M  
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           + + + YLH   S  ++H DL  SN+LL  NM   ++DF +A  L    +      TL G
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCG 174

Query: 590 TIGYMAP 596
           T  Y++P
Sbjct: 175 TPNYISP 181

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 31/141 (21%), Positives = 58/141 (41%), Gaps = 18/141 (12%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDI 521
           F +E  ++    H+N+++ I        + +++E M  G L+ +L  +         L +
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139

Query: 522 FQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLD---DNMVAHLSDFSIAKLL 575
              L++  D+A   +YL   HF      IH D+   N LL       VA + DF +A+ +
Sbjct: 140 LDLLHVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193

Query: 576 TGEDQSMTQTQTLGTIGYMAP 596
                       +  + +M P
Sbjct: 194 YRASYYRKGGCAMLPVKWMPP 214

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 30/151 (19%), Positives = 63/151 (41%), Gaps = 23/151 (15%)

Query: 463 RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--------- 512
              ++   E ++M  + +H N++ ++ +C++     ++ EY  +G L  +L         
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150

Query: 513 ----YSSNCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAH 565
                 +N        L+    VA  + +L   +       IH D+   NVLL +  VA 
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAK 204

Query: 566 LSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           + DF +A+ +  +   + +      + +MAP
Sbjct: 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAP 235

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 77.6 bits (192), Expect = 6e-16
 Identities = 30/127 (23%), Positives = 57/127 (44%), Gaps = 8/127 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  + +S+ H++++       + +F  +VLE     SL +       + +   R   +  
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQ 123

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           +    +YLH      VIH DLK  N+ L++++   + DF +A  +  + +       L G
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCG 177

Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 178 TPNYIAP 184

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 32/142 (22%), Positives = 61/142 (42%), Gaps = 15/142 (10%)

Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQR 524
           +  V+   M     +N +  +   S + +  + ++     +L+ ++     +   +    
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL--------- 575
           L+I I +A A+E+LH   S  ++H DLKPSN+    + V  + DF +   +         
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

Query: 576 -TGEDQSMTQTQTLGTIGYMAP 596
            T      T T  +GT  YM+P
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSP 245

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 30/127 (23%), Positives = 58/127 (45%), Gaps = 8/127 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  + +S+ H++++       + +F  +VLE     SL +       + +   R   +  
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQ 149

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           +    +YLH      VIH DLK  N+ L++++   + DF +A  +  + +     + L G
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCG 203

Query: 590 TIGYMAP 596
           T  Y+AP
Sbjct: 204 TPNYIAP 210

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 77.7 bits (192), Expect = 9e-16
 Identities = 31/160 (19%), Positives = 65/160 (40%), Gaps = 32/160 (20%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------- 515
              +    E  ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S       
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127

Query: 516 ----------------NCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNV 556
                              L +   ++    ++  ++YL           +H DL   N+
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNI 181

Query: 557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           L+ +     +SDF +++ +  ED  + ++Q    + +MA 
Sbjct: 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI 221

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 40/175 (22%), Positives = 67/175 (38%), Gaps = 34/175 (19%)

Query: 450 NNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKV 486
           +  IGRG F    +                         + F  E EM+K ++H N+++ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 487 ISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
             S  +         LV E M  G+L+ YL     ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 543 SALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +  +IH DLK  N+ +        + D  +A L      S  +   +GT  +MAP
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKA-VIGTPEFMAP 199

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 23/142 (16%), Positives = 51/142 (35%), Gaps = 16/142 (11%)

Query: 462 IRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM-PHGSLEKYL------YS 514
            +    F    +++K  + + +I+V     +    +    Y     +L+ +        S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 515 SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
           ++  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
                    +  +  + G+  P
Sbjct: 256 DG------ARVVSSVSRGFEPP 271

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 32/141 (22%), Positives = 58/141 (41%), Gaps = 18/141 (12%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDI 521
           F +E  ++    H+N+++ I        + ++LE M  G L+ +L  +         L +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180

Query: 522 FQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLD---DNMVAHLSDFSIAKLL 575
              L++  D+A   +YL   HF      IH D+   N LL       VA + DF +A+ +
Sbjct: 181 LDLLHVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234

Query: 576 TGEDQSMTQTQTLGTIGYMAP 596
                       +  + +M P
Sbjct: 235 YRAGYYRKGGCAMLPVKWMPP 255

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 30/147 (20%), Positives = 63/147 (42%), Gaps = 24/147 (16%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--------------- 512
           F  E  +   ++H N++ ++   + ++  +++  Y  HG L ++L               
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118

Query: 513 YSSNCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAHLSDF 569
            +    L+    ++++  +A+ +EYL   H       +H DL   NVL+ D +   +SD 
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDL 172

Query: 570 SIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            + + +   D       +L  I +MAP
Sbjct: 173 GLFREVYAADYYKLLGNSLLPIRWMAP 199

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 48/219 (21%), Positives = 82/219 (37%), Gaps = 27/219 (12%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
              L N  +  LG+  +  T   +   +S ++     N+++  SL+ +      NL++L+
Sbjct: 15  DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLAGMQF--FTNLKELH 69

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
           L  N  S   P  + + +KL +LS+  N               L +L LD N L      
Sbjct: 70  LSHNQISDLSP--LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD---- 120

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS--RSLEEFYMYNCNISGGIPEEIS 183
                SL + K+L ++ + NN L       SI  L     LE   ++   I+      ++
Sbjct: 121 ---TDSLIHLKNLEILSIRNNKL------KSIVMLGFLSKLEVLDLHGNEITN--TGGLT 169

Query: 184 NLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNIL 222
            L  +  IDL G K          +L     +   D   
Sbjct: 170 RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 44/192 (22%), Positives = 77/192 (40%), Gaps = 16/192 (8%)

Query: 125 ELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISN 184
            ++ +       +    +L    +  +    S   LS  ++ F   N NI       +  
Sbjct: 8   PINQVFPDPGLANAVKQNLGKQSVTDL---VSQKELS-GVQNFNGDNSNIQ--SLAGMQF 61

Query: 185 LTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSN 244
            TNL E+ L  N+++  +   L  L KL+ L++  N L+         L+ L+   L +N
Sbjct: 62  FTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNN 116

Query: 245 KLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNL 304
           +L         +L +L ILS+ +NKL SI      L  +  L+   N +T      +  L
Sbjct: 117 EL--RDTDSLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITN--TGGLTRL 171

Query: 305 KVLIGIDFSMNN 316
           K +  ID +   
Sbjct: 172 KKVNWIDLTGQK 183

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 27/143 (18%), Positives = 46/143 (32%), Gaps = 14/143 (9%)

Query: 4   LEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEK 63
           L       L  L L  N+L      ++ ++  L+ L ++NN L  S+  +    L  LE 
Sbjct: 100 LNGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVMLGF--LSKLEV 154

Query: 64  LYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSST 123
           L L GN  + T    +    K++ + L               L     +   +    S  
Sbjct: 155 LDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS-- 210

Query: 124 PELSFLSSLSNCKSLTLIDLSNN 146
                   +SN  S     +   
Sbjct: 211 -----PYYISNGGSYVDGCVLWE 228

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 37/151 (24%), Positives = 66/151 (43%), Gaps = 23/151 (15%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------- 515
            A + F  E E++  ++H+++++    C+      +V EYM HG L ++L S        
Sbjct: 85  SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144

Query: 516 -------NCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMVAH 565
                     L + Q L +   VA+ + YL   HF      +H DL   N L+   +V  
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVK 198

Query: 566 LSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           + DF +++ +   D      +T+  I +M P
Sbjct: 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 229

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 30/142 (21%), Positives = 55/142 (38%), Gaps = 9/142 (6%)

Query: 10  QNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWG 68
           Q   EL+L  N+        IF  +  L+ +   NN ++  +   A      + ++ L  
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90

Query: 69  NNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELS 127
           N     +   +F     L  L L  N  +     +F  L ++  L L +N +T +    +
Sbjct: 91  NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148

Query: 128 FLSSLSNCKSLTLIDLSNNPLD 149
           F        SL+ ++L  NP +
Sbjct: 149 F----DTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 34/143 (23%), Positives = 59/143 (41%), Gaps = 9/143 (6%)

Query: 155 TSI-SNLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGGNKLNGSIPI-TLGKLRK 211
             I  ++ +   E  + N   +      I   L  L +I+   NK+   I          
Sbjct: 24  NKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 212 LQRLNLEDNILEGSIPDDIC-RLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNK 269
           +  + L  N LE ++   +   L  L  L L SN++   +    F  L+S+R+LSL  N+
Sbjct: 83  VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQ 140

Query: 270 LTSIPL-TFWNLKDILQLNFSSN 291
           +T++    F  L  +  LN  +N
Sbjct: 141 ITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 32/122 (26%), Positives = 56/122 (45%), Gaps = 10/122 (8%)

Query: 178 IPEEISNLTNLVEIDLGGNKLNGSIPIT--LGKLRKLQRLNLEDNILEGSIPDDI-CRLA 234
           IPE I       E+ L  N+    +  T    KL +L+++N  +N +   I +      +
Sbjct: 26  IPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81

Query: 235 ELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNF 292
            +  + L SN+L  ++    F  L SL+ L L SN++T +   +F  L  +  L+   N 
Sbjct: 82  GVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ 140

Query: 293 LT 294
           +T
Sbjct: 141 IT 142

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 26/140 (18%), Positives = 49/140 (35%), Gaps = 30/140 (21%)

Query: 213 QRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKL 270
             L L +N         I  +L +L ++   +NK+   I    F   + +  + L SN+L
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRL 93

Query: 271 TSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKL 329
            ++    F  L+ +  L   SN +T                          +  +    L
Sbjct: 94  ENVQHKMFKGLESLKTLMLRSNRIT-------------------------CVGNDSFIGL 128

Query: 330 SYLEDLNLSFNKLKGEIPRG 349
           S +  L+L  N++   +  G
Sbjct: 129 SSVRLLSLYDNQIT-TVAPG 147

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 25/153 (16%)

Query: 463 RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------ 515
           +       E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL +       
Sbjct: 82  KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141

Query: 516 ---------NCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMV 563
                       +     ++    +A  +EYL           IH DL   NVL+ +N V
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNV 195

Query: 564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             ++DF +A+ +   D     T     + +MAP
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 38/153 (24%), Positives = 66/153 (43%), Gaps = 25/153 (16%)

Query: 463 RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------ 515
           +       E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL +       
Sbjct: 116 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 175

Query: 516 ---------NCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMV 563
                       L     ++    VA  +EYL           IH DL   NVL+ ++ V
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNV 229

Query: 564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             ++DF +A+ +   D     T     + +MAP
Sbjct: 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 10/141 (7%)

Query: 11  NLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGN 69
            + E++L QN  I  +P   F     L+ + L NN +S  L+  A   L +L  L L+GN
Sbjct: 33  TITEIRLEQNT-IKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 70  NFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSF 128
             +  +P+ +F     L  L L  N  +      F +L NL  L L +N L  +  + +F
Sbjct: 91  KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148

Query: 129 LSSLSNCKSLTLIDLSNNPLD 149
               S  +++  + L+ NP  
Sbjct: 149 ----SPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 8/142 (5%)

Query: 155 TSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPI-TLGKLRKL 212
           T I +NL  ++ E  +    I    P   S    L  IDL  N+++  +       LR L
Sbjct: 24  TEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82

Query: 213 QRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKL 270
             L L  N +   +P  +   L  L  L L +NK+   +    F +L +L +LSL  NKL
Sbjct: 83  NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKL 140

Query: 271 TSIPL-TFWNLKDILQLNFSSN 291
            +I   TF  L+ I  ++ + N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 32/139 (23%), Positives = 53/139 (38%), Gaps = 9/139 (6%)

Query: 59  PNLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
             + ++ L  N     IP   F    KL ++ L  N  S   P  F  LR+L  L L  N
Sbjct: 32  ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90

Query: 118 YLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGG 177
            +T     L     L +   L L+ L+ N ++ +    +  +L  +L    +Y+  +   
Sbjct: 91  KITELPKSL--FEGLFS---LQLLLLNANKINCL-RVDAFQDL-HNLNLLSLYDNKLQTI 143

Query: 178 IPEEISNLTNLVEIDLGGN 196
                S L  +  + L  N
Sbjct: 144 AKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 37/174 (21%), Positives = 59/174 (33%), Gaps = 55/174 (31%)

Query: 178 IPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC-RLAEL 236
           IP  +     + EI L  N +    P      +KL+R++L +N +   +  D    L  L
Sbjct: 26  IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82

Query: 237 YRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTG 295
             L L  NK+   +P   F  L SL++L L +NK+  +                      
Sbjct: 83  NSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLR--------------------- 120

Query: 296 PLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
                                       +  + L  L  L+L  NKL+  I +G
Sbjct: 121 ---------------------------VDAFQDLHNLNLLSLYDNKLQ-TIAKG 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 5/89 (5%)

Query: 9   LQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
           L++L  L L  NK+   +P ++F  + +L+ L L  N ++  L   A   L NL  L L+
Sbjct: 79  LRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136

Query: 68  GNNFSGTIPRFIFNA-SKLSKLSLGMNSF 95
            N    TI +  F+    +  + L  N F
Sbjct: 137 DNKLQ-TIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 16/65 (24%), Positives = 30/65 (46%), Gaps = 3/65 (4%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            L +L+ L L  NK+   +    F ++  L  L L +N L  +++      L  ++ ++L
Sbjct: 102 GLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHL 159

Query: 67  WGNNF 71
             N F
Sbjct: 160 AQNPF 164

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 27/138 (19%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDI 521
           E  + + ++H N++++  S S E    L+ + +  G L      +  YS    S+CI  I
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI 119

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGE 578
                       A+ + H      V+H +LKP N+LL          L+DF +A  + GE
Sbjct: 120 L----------EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166

Query: 579 DQSMTQTQTLGTIGYMAP 596
            Q+       GT GY++P
Sbjct: 167 QQAW--FGFAGTPGYLSP 182

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 29/152 (19%), Positives = 60/152 (39%), Gaps = 21/152 (13%)

Query: 463 RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--------- 512
              ++   E +++  +  H N++ ++ +C+      ++ EY  +G L  +L         
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 513 --------YSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVA 564
                         LD+   L+    VA  + +L    S   IH DL   N+LL    + 
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRIT 184

Query: 565 HLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            + DF +A+ +  +   + +      + +MAP
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 39/196 (19%), Positives = 72/196 (36%), Gaps = 56/196 (28%)

Query: 439 ELCRATDEFSEN----NLIGRGGFALFIRAF---------------KSFDVECE---MMK 476
           +L R + +F++       IG G +++  R                    D   E   +++
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR 71

Query: 477 SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL----------- 525
             +H N+I +     + ++  +V E M  G L               ++           
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREA 118

Query: 526 -NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQ 580
             ++  +   +EYLH   +  V+H DLKPSN+L      +     + DF  AK L  E+ 
Sbjct: 119 SAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175

Query: 581 SMTQTQTLGTIGYMAP 596
            +       T  ++AP
Sbjct: 176 LL--MTPCYTANFVAP 189

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 35/136 (25%), Positives = 58/136 (42%), Gaps = 26/136 (19%)

Query: 471 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILD 520
           E ++++ +  H N+I++  +     F  LV + M  G L     EK   S       +  
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132

Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
           +             +  LH      ++H DLKP N+LLDD+M   L+DF  +  L    +
Sbjct: 133 LL----------EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGE 178

Query: 581 SMTQTQTLGTIGYMAP 596
            +   +  GT  Y+AP
Sbjct: 179 KL--REVCGTPSYLAP 192

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 43/147 (29%), Positives = 58/147 (39%), Gaps = 11/147 (7%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            L NL  L L  N  +  + +  F  V  L++L L +N L  +L       L  LE L L
Sbjct: 62  RLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119

Query: 67  WGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGN---LRNLEQLGLDENYLTSS 122
           + N+    + R  F + ++L KL L  N  S F      +   L  L  L L  N L   
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178

Query: 123 TPELSFLSSLSNCKSLTLIDLSNNPLD 149
                 L  L       L  L NNPL+
Sbjct: 179 PLTD--LQKLPAWVKNGL-YLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.7 bits (186), Expect = 5e-15
 Identities = 41/186 (22%), Positives = 68/186 (36%), Gaps = 14/186 (7%)

Query: 19  QNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF 78
             + +  VP ++   S    L L +N+LS   +     RL NL  L L  N+ +  I   
Sbjct: 26  SKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSE 82

Query: 79  IF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS 137
            F     L  L L  N         F +L+ LE L L  N++       +F     +   
Sbjct: 83  AFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAF----EDMAQ 137

Query: 138 LTLIDLSNNPLDGILPKTSISNLSR--SLEEFYMYNCNISGGIPEEISNLTNLVE--IDL 193
           L  + LS N +    P   I + ++   L    + +  +      ++  L   V+  + L
Sbjct: 138 LQKLYLSQNQISRF-PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196

Query: 194 GGNKLN 199
             N L 
Sbjct: 197 HNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 37/186 (19%), Positives = 76/186 (40%), Gaps = 33/186 (17%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGG 195
              L+DLS+N L  +  + + + L+  L    + + +++  I  E    + NL  +DL  
Sbjct: 40  YTALLDLSHNNLSRLRAEWTPTRLTN-LHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSS 97

Query: 196 NKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACF 254
           N L+ ++       L+ L+ L L +N +   +  +                        F
Sbjct: 98  NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNA-----------------------F 132

Query: 255 GNLASLRILSLGSNKLTSIPL-TFWN---LKDILQLNFSSNFLTGPLLLEIGNLKVLIGI 310
            ++A L+ L L  N+++  P+    +   L  ++ L+ SSN L    L ++  L   +  
Sbjct: 133 EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192

Query: 311 DFSMNN 316
              ++N
Sbjct: 193 GLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 41/177 (23%), Positives = 69/177 (38%), Gaps = 33/177 (18%)

Query: 178 IPEEISNLTNLVEIDLGGNKLNGSIP--ITLGKLRKLQRLNLEDNILEGSIPDDI-CRLA 234
           +P+ +   +    +DL  N L   +    T  +L  L  L L  N L   I  +    + 
Sbjct: 33  VPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 235 ELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNF 292
            L  L+L SN L  ++    F +L +L +L L +N +  +    F ++  + +L  S N 
Sbjct: 89  NLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147

Query: 293 LTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
           ++                 F +             KL  L  L+LS NKLK ++P  
Sbjct: 148 IS----------------RFPVELIKDG------NKLPKLMLLDLSSNKLK-KLPLT 181

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 25/153 (16%)

Query: 463 RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------ 515
           +       E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL +       
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187

Query: 516 ---------NCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMV 563
                       +     ++    +A  +EYL           IH DL   NVL+ +N V
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNV 241

Query: 564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             ++DF +A+ +   D     T     + +MAP
Sbjct: 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 6/127 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M  + H   +K+  +  ++E     L Y  +G L KY+       +   R     +
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 138

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           + SALEYLH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +      +  G
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVG 194

Query: 590 TIGYMAP 596
           T  Y++P
Sbjct: 195 TAQYVSP 201

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 35/133 (26%), Positives = 64/133 (48%), Gaps = 19/133 (14%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYL----YSSNCILDIFQ 523
           E  ++K + H N++K   V+   + +    +V E +  G + +       S +     FQ
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQARFYFQ 144

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
                 D+   +EYLH      +IH D+KPSN+L+ ++    ++DF ++    G D ++ 
Sbjct: 145 ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-ALL 194

Query: 584 QTQTLGTIGYMAP 596
              T+GT  +MAP
Sbjct: 195 SN-TVGTPAFMAP 206

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 31/154 (20%), Positives = 61/154 (39%), Gaps = 26/154 (16%)

Query: 463 RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSS----- 515
              ++   E +++  I  H N++ ++ +C+      +V +E+   G+L  YL S      
Sbjct: 72  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131

Query: 516 ----------NCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNM 562
                        L +   +     VA  +E+L           IH DL   N+LL +  
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKN 185

Query: 563 VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           V  + DF +A+ +  +   + +      + +MAP
Sbjct: 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 219

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 36/142 (25%), Positives = 60/142 (42%), Gaps = 34/142 (23%)

Query: 471 ECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---- 525
           E   +K    H N++K+     ++    LV+E +  G L             F+R+    
Sbjct: 55  EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL-------------FERIKKKK 101

Query: 526 --------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKL 574
                    IM  + SA+ ++H      V+H DLKP N+L    +DN+   + DF  A+L
Sbjct: 102 HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158

Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
              ++Q +       T+ Y AP
Sbjct: 159 KPPDNQPL--KTPCFTLHYAAP 178

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 32/142 (22%), Positives = 58/142 (40%), Gaps = 31/142 (21%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL---------EKYLYS----SNC 517
           E  +   ++H ++++++ + S++    +V E+M    L           ++YS    S+ 
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135

Query: 518 ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKL 574
           +  I            AL Y H      +IH D+KP  VLL   +++    L  F +A  
Sbjct: 136 MRQIL----------EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182

Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           L            +GT  +MAP
Sbjct: 183 LGESGLVA--GGRVGTPHFMAP 202

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 49/144 (34%), Positives = 64/144 (44%), Gaps = 10/144 (6%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFN-VSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            L  L  L L  N+L  T+ A +F+ ++ L  LGL NN L+ SL       L  L+KLYL
Sbjct: 57  GLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYL 114

Query: 67  WGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
            GN    ++P  +F   +KL +L L  N         F  L NL+ L L  N L S  P 
Sbjct: 115 GGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS-VPH 172

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLD 149
            +F         L  I L  N  D
Sbjct: 173 GAF----DRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 8/168 (4%)

Query: 155 TSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPI-TLGKLRKL 212
            S+ S +    E+  + +  ++         LT L  ++L  N+L  ++       L +L
Sbjct: 27  DSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTEL 85

Query: 213 QRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKL 270
             L L +N L  S+P  +   L +L +L LG N+L  S+P+  F  L  L+ L L +N+L
Sbjct: 86  GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQL 143

Query: 271 TSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNF 317
            SIP   F  L ++  L+ S+N L          L  L  I    N F
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 45/160 (28%), Positives = 69/160 (43%), Gaps = 10/160 (6%)

Query: 13  EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFS 72
           E+L L    L     A    ++ L +L L  N L  +LS+     L  L  L L  N  +
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 73  GTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSS 131
            ++P  +F+  ++L KL LG N         F  L  L++L L+ N L  S P  +F   
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF-DK 153

Query: 132 LSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN 171
           L+N   L  + LS N L  + P  +   L   L+   ++ 
Sbjct: 154 LTN---LQTLSLSTNQLQSV-PHGAFDRLG-KLQTITLFG 188

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 52/176 (29%), Positives = 75/176 (42%), Gaps = 37/176 (21%)

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDI-CRLAE 235
           GIP +   L      DL    L      T   L KL  LNL+ N L+ ++   +   L E
Sbjct: 32  GIPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 236 LYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFL 293
           L  L L +N+L  S+P   F +L  L  L LG N+L S+P   F  L  + +L  ++N L
Sbjct: 85  LGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143

Query: 294 TGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
                                      IP    +KL+ L+ L+LS N+L+  +P G
Sbjct: 144 Q-------------------------SIPAGAFDKLTNLQTLSLSTNQLQS-VPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 52/186 (27%), Positives = 68/186 (36%), Gaps = 37/186 (19%)

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
           EKL L     +          +KL+ L+L  N         F +L  L  LGL  N L  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
           S P   F   L+    L  + L  N L       S                     +P  
Sbjct: 97  SLPLGVF-DHLTQ---LDKLYLGGNQL------KS---------------------LPSG 125

Query: 182 I-SNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDI-CRLAELYR 238
           +   LT L E+ L  N+L  SIP     KL  LQ L+L  N L+ S+P     RL +L  
Sbjct: 126 VFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQT 183

Query: 239 LELGSN 244
           + L  N
Sbjct: 184 ITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 17/132 (12%)

Query: 225 SIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDI 283
           S+P  I    E  +L+L S  L     A F  L  L  L+L  N+L ++    F +L ++
Sbjct: 28  SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85

Query: 284 LQLNFSSNFLTGPLLLEIG------NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNL 337
             L  ++N L     L +G       L  L       N     +P  + ++L+ L++L L
Sbjct: 86  GTLGLANNQLAS---LPLGVFDHLTQLDKL---YLGGNQLKS-LPSGVFDRLTKLKELRL 138

Query: 338 SFNKLKGEIPRG 349
           + N+L+  IP G
Sbjct: 139 NTNQLQ-SIPAG 149

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 34/146 (23%), Positives = 54/146 (36%), Gaps = 21/146 (14%)

Query: 471 ECEMMKSIR-HRNLIKVISSCS-------NEEFKALVLEYMPHGSLEKYL--YSSNCILD 520
           E   MK +  H N+++  S+ S         + + L+L  +  G L ++L    S   L 
Sbjct: 75  EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS 134

Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
               L I      A++++H      +IH DLK  N+LL +     L DF  A  ++    
Sbjct: 135 CDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193

Query: 581 SMTQTQTL----------GTIGYMAP 596
                Q             T  Y  P
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTP 219

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 25/126 (19%)

Query: 463 RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--------- 512
              + F  E E++  +  H N+I ++ +C +  +  L +EY PHG+L  +L         
Sbjct: 67  DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 126

Query: 513 ------YSSNCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNVLLDDNMV 563
                  S+   L   Q L+   DVA  ++YL    F      IH DL   N+L+ +N V
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF------IHRDLAARNILVGENYV 180

Query: 564 AHLSDF 569
           A ++DF
Sbjct: 181 AKIADF 186

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 36/160 (22%), Positives = 62/160 (38%), Gaps = 32/160 (20%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------- 515
                F  E  +M    + N++K++  C+  +   L+ EYM +G L ++L S        
Sbjct: 92  DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151

Query: 516 ----------------NCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNV 556
                              L   ++L I   VA+ + YL    F      +H DL   N 
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNC 205

Query: 557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           L+ +NMV  ++DF +++ +   D           I +M P
Sbjct: 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 32/160 (20%), Positives = 58/160 (36%), Gaps = 32/160 (20%)

Query: 463 RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--------- 512
              ++   E +MM  +  H N++ ++ +C+      L+ EY  +G L  YL         
Sbjct: 90  SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149

Query: 513 -------------YSSNCILDIFQRLNIMIDVASALEYL---HFGYSALVIHCDLKPSNV 556
                             +L     L     VA  +E+L           +H DL   NV
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC------VHRDLAARNV 203

Query: 557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           L+    V  + DF +A+ +  +   + +      + +MAP
Sbjct: 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 14/129 (10%)

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------I 527
           +M+S     +++   +   E    + +E M   S +K+         +   +       I
Sbjct: 74  VMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKI 130

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            +    AL +L       +IH D+KPSN+LLD +    L DF I+  L     S+ +T+ 
Sbjct: 131 TLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRD 185

Query: 588 LGTIGYMAP 596
            G   YMAP
Sbjct: 186 AGCRPYMAP 194

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 36/176 (20%), Positives = 62/176 (35%), Gaps = 31/176 (17%)

Query: 445 DEFSENNLIGRGGF-----ALFIR-----AFKSFDVECE-------------MMKSIRHR 481
           ++      +G G         F +     A K                    ++KS    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 482 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL-DIFQRLNIMIDVASALEYLHF 540
            +++   +        + +E M   + +        I   I  +  + + +  AL YL  
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKE 142

Query: 541 GYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            +   VIH D+KPSN+LLD+     L DF I+  L        + ++ G   YMAP
Sbjct: 143 KHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAP 193

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 28/138 (20%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDI 521
           E  + + ++H N++++  S   E F  LV + +  G L      +  YS    S+CI  I
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 114

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGE 578
                       ++ Y H   S  ++H +LKP N+LL          L+DF +A  +  +
Sbjct: 115 L----------ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-ND 160

Query: 579 DQSMTQTQTLGTIGYMAP 596
            ++       GT GY++P
Sbjct: 161 SEAW--HGFAGTPGYLSP 176

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 28/138 (20%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDI 521
           E  + + ++H N++++  S   E F  LV + +  G L      +  YS    S+CI  I
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 137

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGE 578
                       ++ Y H   S  ++H +LKP N+LL          L+DF +A  +  +
Sbjct: 138 L----------ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-ND 183

Query: 579 DQSMTQTQTLGTIGYMAP 596
            ++       GT GY++P
Sbjct: 184 SEAW--HGFAGTPGYLSP 199

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 48/218 (22%), Positives = 76/218 (34%), Gaps = 51/218 (23%)

Query: 414 RQRGKKPSNDANMPLVATWRTFSYLELCRATDEFSEN----NLIGRGGFALFIRAF---- 465
                  S  A+           Y       D  S+     + +GRG  ++  R      
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77

Query: 466 ----------KSFDV-----ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-- 508
                     K+ D      E  ++  + H N+IK+          +LVLE +  G L  
Sbjct: 78  QKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD 137

Query: 509 ---EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL--- 558
              EK  YS    ++ +  I            A+ YLH      ++H DLKP N+L    
Sbjct: 138 RIVEKGYYSERDAADAVKQIL----------EAVAYLH---ENGIVHRDLKPENLLYATP 184

Query: 559 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             +    ++DF ++K++      M      GT GY AP
Sbjct: 185 APDAPLKIADFGLSKIV-EHQVLM--KTVCGTPGYCAP 219

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 41/140 (29%), Positives = 62/140 (44%), Gaps = 34/140 (24%)

Query: 471 ECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---- 525
           E  +++ +  H ++I +I S  +  F  LV + M  G L             F  L    
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-------------FDYLTEKV 195

Query: 526 --------NIMIDVASALEYLHF-GYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 576
                   +IM  +  A+ +LH       ++H DLKP N+LLDDNM   LSDF  +  L 
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHL- 250

Query: 577 GEDQSMTQTQTLGTIGYMAP 596
              + +   +  GT GY+AP
Sbjct: 251 EPGEKL--RELCGTPGYLAP 268

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 42/127 (33%), Positives = 71/127 (55%), Gaps = 9/127 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M+ + H  L+ +  S  +EE   +V++ +  G L  +L  +    +   +L I  +
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-E 123

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           +  AL+YL    +  +IH D+KP N+LLD++   H++DF+IA +L  E    TQ  T+ G
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAG 176

Query: 590 TIGYMAP 596
           T  YMAP
Sbjct: 177 TKPYMAP 183

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 37/201 (18%), Positives = 70/201 (34%), Gaps = 55/201 (27%)

Query: 442 RATDEFSENNLIGRGGFALFIRAFKSFD-----------------------VECEMMKSI 478
           R T EF E   IG G F    +  K  D                        E      +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 479 -RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASA 534
            +H ++++  S+ + ++   +  EY   GSL   +  +  I+  F   +  ++++ V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDN-------------------MVAHLSDFSIAKLL 575
           L Y+H   S  ++H D+KPSN+ +                      ++  + D      +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 576 TGEDQSMTQTQTLGTIGYMAP 596
                S  Q +  G   ++A 
Sbjct: 185 -----SSPQVEE-GDSRFLAN 199

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 26/173 (15%)

Query: 444 TDEFSENNLIGRGGFALFIR----------AFKSFDVECE---------MMKSIRHRNLI 484
            + F     +G G +    +          A K   VE +         +M+     +++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVV 87

Query: 485 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 544
           K   S        +V+EY   GS+   +   N  L   +   I+      LEYLH     
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FM 144

Query: 545 LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIGYMAP 596
             IH D+K  N+LL+    A L+DF +A  LT    +M +  T+ GT  +MAP
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT---DTMAKRNTVIGTPFWMAP 194

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 41/216 (18%), Positives = 74/216 (34%), Gaps = 47/216 (21%)

Query: 415 QRGKKPSNDANMPLVATWRTFSYLELCRATDEFSEN----NLIGRGGFAL---------- 460
           +      ND +      W+ +    +        +       +G G F +          
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 461 ------FIRAFKSFDV-----ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL- 508
                 FI      D      E  +M  + H  LI +  +  ++    L+LE++  G L 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 509 -----EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM 562
                E Y  S +  I       N M      L+++H      ++H D+KP N++ +   
Sbjct: 137 DRIAAEDYKMSEAEVI-------NYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKK 186

Query: 563 VAHL--SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            + +   DF +A  L   D+ +    T  T  + AP
Sbjct: 187 ASSVKIIDFGLATKL-NPDEIV--KVTTATAEFAAP 219

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 36/138 (26%), Positives = 66/138 (47%), Gaps = 29/138 (21%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDI 521
           E  ++K I+H N++ +     +     LV++ +  G L     E+ +Y+    S  I  +
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV 115

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGE 578
                      SA++YLH      ++H DLKP N+L    ++N    ++DF ++K+   +
Sbjct: 116 L----------SAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--Q 160

Query: 579 DQSMTQTQTLGTIGYMAP 596
           +  M  +   GT GY+AP
Sbjct: 161 NGIM--STACGTPGYVAP 176

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 40/134 (29%), Positives = 62/134 (46%), Gaps = 21/134 (15%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRL 525
           E E++K + H  +IK+ +    E++  +VLE M  G L                  F   
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-- 121

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSM 582
                +  A++YLH      +IH DLKP NVLL   +++ +  ++DF  +K+L GE   M
Sbjct: 122 ----QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM 173

Query: 583 TQTQTLGTIGYMAP 596
                 GT  Y+AP
Sbjct: 174 --RTLCGTPTYLAP 185

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 35/129 (27%), Positives = 57/129 (44%), Gaps = 15/129 (11%)

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------I 527
            M+++     +    +   E    + +E M   SL+K+      ++D  Q +       I
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQ---VIDKGQTIPEDILGKI 114

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
            + +  ALE+LH   S  VIH D+KPSNVL++      + DF I+  L      + +   
Sbjct: 115 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDID 169

Query: 588 LGTIGYMAP 596
            G   YMAP
Sbjct: 170 AGCKPYMAP 178

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 46/144 (31%), Positives = 66/144 (45%), Gaps = 10/144 (6%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFN-VSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYL 66
            L NL  L L  N+L  ++P  +F+ ++ LK L L  N L  SL      +L NL  L L
Sbjct: 83  ELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140

Query: 67  WGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
             N    ++P+ +F+  + L++L L  N         F  L  L+ L L +N L S  P+
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS-VPD 198

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLD 149
             F        SL  I L +NP D
Sbjct: 199 GVF----DRLTSLQYIWLHDNPWD 218

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 45/219 (20%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN 196
                +L    +   + +  ++++     +  + N +    +   I  L N+  + LGGN
Sbjct: 20  ETIKANLKKKSVTDAVTQNELNSI-----DQIIANNSDIKSVQG-IQYLPNVRYLALGGN 73

Query: 197 KLNGSIPITLG---KLRKLQRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA 252
           KL+      +    +L  L  L L  N L+ S+P+ +  +L  L  L L  N+L  S+P 
Sbjct: 74  KLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQL-QSLPD 126

Query: 253 -CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGI 310
             F  L +L  L+L  N+L S+P   F  L ++ +L+ S N L                 
Sbjct: 127 GVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ---------------- 170

Query: 311 DFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
                     +P  + +KL+ L+DL L  N+LK  +P G
Sbjct: 171 ---------SLPEGVFDKLTQLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 58/234 (24%), Positives = 91/234 (38%), Gaps = 44/234 (18%)

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
            K  L   + +          + + ++    +            L N+  L L  N L  
Sbjct: 22  IKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD 77

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
               +S L  L+N   LT + L+ N L       S+ N                 G+ ++
Sbjct: 78  ----ISALKELTN---LTYLILTGNQL------QSLPN-----------------GVFDK 107

Query: 182 ISNLTNLVEIDLGGNKLNGSIPITL-GKLRKLQRLNLEDNILEGSIPDDIC-RLAELYRL 239
           ++NL  L    L  N+L  S+P  +  KL  L  LNL  N L+ S+P  +  +L  L  L
Sbjct: 108 LTNLKEL---VLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTEL 162

Query: 240 ELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSN 291
           +L  N+L  S+P   F  L  L+ L L  N+L S+P   F  L  +  +    N
Sbjct: 163 DLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 61/259 (23%), Positives = 97/259 (37%), Gaps = 68/259 (26%)

Query: 13  EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFS 72
            +  L +  +          ++++  +   N+ +  S+  I    LPN+  L L GN   
Sbjct: 22  IKANLKKKSV-TDAVTQN-ELNSIDQIIANNSDIK-SVQGIQ--YLPNVRYLALGGNKLH 76

Query: 73  GTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSL 132
             I       + L+ L L  N         F  L NL++L L EN L S           
Sbjct: 77  -DISAL-KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS----------- 123

Query: 133 SNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEID 192
                              LP                       G+ ++++NLT L   +
Sbjct: 124 -------------------LP----------------------DGVFDKLTNLTYL---N 139

Query: 193 LGGNKLNGSIPITL-GKLRKLQRLNLEDNILEGSIPDDIC-RLAELYRLELGSNKLYGSI 250
           L  N+L  S+P  +  KL  L  L+L  N L+ S+P+ +  +L +L  L L  N+L  S+
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSV 196

Query: 251 P-ACFGNLASLRILSLGSN 268
           P   F  L SL+ + L  N
Sbjct: 197 PDGVFDRLTSLQYIWLHDN 215

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 29/126 (23%), Positives = 58/126 (46%), Gaps = 7/126 (5%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E +++       ++    +  ++   ++ +E+M  GSL++ +      +       + I 
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIA 139

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGT 590
           V   L YL   +   ++H D+KPSN+L++      L DF ++  L     SM  +  +GT
Sbjct: 140 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGT 193

Query: 591 IGYMAP 596
             YM+P
Sbjct: 194 RSYMSP 199

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 32/141 (22%), Positives = 56/141 (39%), Gaps = 34/141 (24%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL----- 525
           E E++K + H N++K+     +     +V E    G L             F  +     
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-------------FDEIIKRKR 117

Query: 526 -------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLL 575
                   I+  V S + Y+H      ++H DLKP N+LL   + +    + DF ++   
Sbjct: 118 FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 576 TGEDQSMTQTQTLGTIGYMAP 596
             ++  M     +GT  Y+AP
Sbjct: 175 -QQNTKM--KDRIGTAYYIAP 192

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 31/129 (24%), Positives = 57/129 (44%), Gaps = 7/129 (5%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           E ++++ +RH+N+I+   V+ +   ++   +V+EY   G  E           + Q    
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY 114

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
              +   LEYLH   S  ++H D+KP N+LL       +S   +A+ L       T   +
Sbjct: 115 FCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171

Query: 588 LGTIGYMAP 596
            G+  +  P
Sbjct: 172 QGSPAFQPP 180

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 38/181 (20%), Positives = 68/181 (37%), Gaps = 43/181 (23%)

Query: 446 EFSENNLIGRGGFAL----------------FIRAFKSFDV-----ECEMMKSIRHRNLI 484
             S+  ++G G F                   I+     D      E  +M  + H NLI
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 485 KVISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASALEY 537
           ++  +  ++    LV+EY+  G L      E Y  +  + I         M  +   + +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-------LFMKQICEGIRH 202

Query: 538 LHFGYSALVIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
           +H  Y   ++H DLKP N+L  +     +   DF +A+      + +      GT  ++A
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKL--KVNFGTPEFLA 256

Query: 596 P 596
           P
Sbjct: 257 P 257

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 33/134 (24%), Positives = 60/134 (44%), Gaps = 20/134 (14%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRL 525
           E  ++K + H N++K+     ++    LV+E    G L      +  ++           
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV------DAA 139

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSM 582
            I+  V S + YLH      ++H DLKP N+LL   + + +  + DF ++ +     + M
Sbjct: 140 VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKM 195

Query: 583 TQTQTLGTIGYMAP 596
              + LGT  Y+AP
Sbjct: 196 --KERLGTAYYIAP 207

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 40/217 (18%), Positives = 72/217 (33%), Gaps = 47/217 (21%)

Query: 414 RQRGKKPSNDANMPLVATWRTFSYLELCRATDEFSE----NNLIGRGGFAL--------- 460
            +     S++ +  +   W+ +    +    D   +    +  +G G F +         
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 181

Query: 461 -------FIRAFKSFDV-----ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 508
                  F+      D      E + M  +RH  L+ +  +  ++    ++ E+M  G L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241

Query: 509 ------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN 561
                 E    S    +         M  V   L ++H       +H DLKP N++    
Sbjct: 242 FEKVADEHNKMSEDEAV-------EYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTK 291

Query: 562 MVAHL--SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
               L   DF +   L    QS+    T GT  + AP
Sbjct: 292 RSNELKLIDFGLTAHLD-PKQSV--KVTTGTAEFAAP 325

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 16/136 (11%), Positives = 34/136 (25%), Gaps = 16/136 (11%)

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM-PHGSLE------KYLYSSNCILD 520
             +  + +         ++     +      +L        LE       ++Y       
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192

Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
           I     +   +      L    S  ++H    P N+ +  +    L D S    +     
Sbjct: 193 ILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG---- 245

Query: 581 SMTQTQTLGTIGYMAP 596
             T+          AP
Sbjct: 246 --TRGPASSVPVTYAP 259

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 32/134 (23%), Positives = 59/134 (44%), Gaps = 20/134 (14%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRL 525
           E E++K + H N++K+     +     +V E    G L     ++  +S +         
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH------DAA 124

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSM 582
            I+  V S + Y+H      ++H DLKP N+LL   + +    + DF ++     ++  M
Sbjct: 125 RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKM 180

Query: 583 TQTQTLGTIGYMAP 596
                +GT  Y+AP
Sbjct: 181 --KDRIGTAYYIAP 192

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 40/147 (27%), Positives = 61/147 (41%), Gaps = 37/147 (25%)

Query: 471 ECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---- 525
           E EM+   + HRN++++I     E+   LV E M  GS+                +    
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRR 106

Query: 526 --------NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKL 574
                    ++ DVASAL++LH   +  + H DLKP N+L    +      + DF +   
Sbjct: 107 HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163

Query: 575 LT-GEDQSMTQTQTL----GTIGYMAP 596
           +    D S   T  L    G+  YMAP
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAP 190

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 70.5 bits (173), Expect = 6e-13
 Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 20/134 (14%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRL 525
           E  ++KS+ H N+IK+     ++++  LV E+   G L      ++ +      +I ++ 
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ- 154

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSM 582
                + S + YLH      ++H D+KP N+LL   +  +   + DF ++     +D  +
Sbjct: 155 -----ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKL 205

Query: 583 TQTQTLGTIGYMAP 596
                LGT  Y+AP
Sbjct: 206 --RDRLGTAYYIAP 217

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 70.1 bits (172), Expect = 6e-13
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 21/134 (15%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRL 525
           E E++K + H  +IK+ +    E++  +VLE M  G L                  F   
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-- 246

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSM 582
                +  A++YLH      +IH DLKP NVLL   +++ +  ++DF  +K+L   + S+
Sbjct: 247 ----QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 297

Query: 583 TQTQTLGTIGYMAP 596
            +T   GT  Y+AP
Sbjct: 298 MRT-LCGTPTYLAP 310

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 70.6 bits (172), Expect = 6e-13
 Identities = 40/220 (18%), Positives = 81/220 (36%), Gaps = 19/220 (8%)

Query: 57  RLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE 116
               L +  L     S  +   + +  +L +L            +    +R L+ L  ++
Sbjct: 347 TDEQLFRCEL-SVEKSTVLQSELESCKELQELEPENKWCL---LTIILLMRALDPLLYEK 402

Query: 117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG 176
                    L + S+L     +    L +     +L  + +      +   ++ + +++ 
Sbjct: 403 E-------TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT- 454

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAEL 236
            +   +  L  +  +DL  N+L  ++P  L  LR L+ L   DN LE ++   +  L  L
Sbjct: 455 -VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRL 510

Query: 237 YRLELGSNKLYGSIPA--CFGNLASLRILSLGSNKLTSIP 274
             L L +N+L     A     +   L +L+L  N L    
Sbjct: 511 QELLLCNNRL-QQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 66.7 bits (162), Expect = 8e-12
 Identities = 38/242 (15%), Positives = 69/242 (28%), Gaps = 10/242 (4%)

Query: 101 STFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL 160
                          +  +        +    +  + L   +LS      +  +      
Sbjct: 314 PQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKE 373

Query: 161 SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN 220
            + LE    +       +   +  L    E     + L    P+    L  L+   L +N
Sbjct: 374 LQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN 433

Query: 221 ILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNL 280
            +           A++  L L    L  ++      L  +  L L  N+L ++P     L
Sbjct: 434 SVL------KMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAAL 485

Query: 281 KDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFN 340
           + +  L  S N L    +  + NL  L  +    N        +       L  LNL  N
Sbjct: 486 RCLEVLQASDNALEN--VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543

Query: 341 KL 342
            L
Sbjct: 544 SL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 31/203 (15%), Positives = 60/203 (29%), Gaps = 65/203 (32%)

Query: 1   EIPLEIGNLQNLEELQLG-----QNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIAN 55
           E       L+ ++ ++       ++K +          + ++ L L +  L+  L  +  
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQ 461

Query: 56  VRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD 115
             L  +  L L  N                             +P     LR LE L   
Sbjct: 462 --LLLVTHLDLSHNRLRA-------------------------LPPALAALRCLEVLQAS 494

Query: 116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS 175
           +N L +       +  ++N   L  + L NN L         + +               
Sbjct: 495 DNALEN-------VDGVANLPRLQELLLCNNRL------QQSAAI--------------- 526

Query: 176 GGIPEEISNLTNLVEIDLGGNKL 198
               + + +   LV ++L GN L
Sbjct: 527 ----QPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 51.3 bits (122), Expect = 6e-07
 Identities = 34/171 (19%), Positives = 58/171 (33%), Gaps = 19/171 (11%)

Query: 179 PEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYR 238
             + +    L   +L   K    +   L   ++LQ L  E+     +I   I  +  L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDP 397

Query: 239 LELGSNKLYGSIPACFGNLASLRILSLG------SNKLTSIPLTFWNLKDILQLNFSSNF 292
           L      L       F  L ++  +         S  L    +      D+  L+ +   
Sbjct: 398 LLYEKETL-----QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452

Query: 293 LTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
           LT  +L  +  L ++  +D S N     +P  +   L  LE L  S N L+
Sbjct: 453 LT--VLCHLEQLLLVTHLDLSHNRLR-ALPPAL-AALRCLEVLQASDNALE 499

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 45.9 bits (108), Expect = 3e-05
 Identities = 22/73 (30%), Positives = 32/73 (43%), Gaps = 4/73 (5%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVR-LP 59
            +P  +  L+ LE LQ   N L       + N+  L+ L L NN L    ++I  +   P
Sbjct: 477 ALPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCP 533

Query: 60  NLEKLYLWGNNFS 72
            L  L L GN+  
Sbjct: 534 RLVLLNLQGNSLC 546

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 70.1 bits (172), Expect = 7e-13
 Identities = 32/134 (23%), Positives = 58/134 (43%), Gaps = 20/134 (14%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRL 525
           E +++K + H N++K+     ++ +  LV E    G L      +  +S      I ++ 
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ- 134

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSM 582
                V S + Y+H      ++H DLKP N+LL     +    + DF ++       + M
Sbjct: 135 -----VLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKM 185

Query: 583 TQTQTLGTIGYMAP 596
                +GT  Y+AP
Sbjct: 186 --KDKIGTAYYIAP 197

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 9/127 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+  ++ N++  + S    +   +V+EY+  GSL   +  +   +D  Q   +  +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRE 124

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
              ALE+LH   S  VIH D+K  N+LL  +    L+DF     +T      ++  T+ G
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---PEQSKRSTMVG 178

Query: 590 TIGYMAP 596
           T  +MAP
Sbjct: 179 TPYWMAP 185

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 38/134 (28%), Positives = 57/134 (42%), Gaps = 20/134 (14%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRL 525
           E E+MKS+ H N+I++  +  +     LV+E    G L      K ++  +    I +  
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-- 113

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSM 582
               DV SA+ Y H      V H DLKP N L      +    L DF +A       + M
Sbjct: 114 ----DVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMM 165

Query: 583 TQTQTLGTIGYMAP 596
                +GT  Y++P
Sbjct: 166 --RTKVGTPYYVSP 177

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 35/127 (27%), Positives = 64/127 (50%), Gaps = 9/127 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +M+  +H N++++  S    E   +++E++  G+L   +  S   L+  Q   +   
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEA 149

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           V  AL YLH   +  VIH D+K  ++LL  +    LSDF     ++   + + + ++L G
Sbjct: 150 VLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKSLVG 203

Query: 590 TIGYMAP 596
           T  +MAP
Sbjct: 204 TPYWMAP 210

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 4/113 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  M+K ++H NL+ ++     +    LV EY  H ++   L      +      +I   
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
              A+ + H       IH D+KP N+L+  + V  L DF  A+LLTG      
Sbjct: 111 TLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 12/132 (9%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNI 527
           E E++KS+ H N+IK+     +     +V+E    G L + + S+              +
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           M  + +AL Y H   S  V+H DLKP N+L      +    + DF +A+L    D+    
Sbjct: 130 MKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHS-- 183

Query: 585 TQTLGTIGYMAP 596
           T   GT  YMAP
Sbjct: 184 TNAAGTALYMAP 195

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 28/119 (23%), Positives = 46/119 (38%), Gaps = 10/119 (8%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           E  ++    H N++    +             LV E M    L + ++    ++      
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQ 137

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
             M  +   L  LH    A V+H DL P N+LL DN    + DF++A+     D + T 
Sbjct: 138 YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTH 192

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 33/114 (28%), Positives = 62/114 (54%), Gaps = 4/114 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++++ + H N+I ++ +  ++   +LV ++M    LE  +  ++ +L        M+ 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
               LEYLH      ++H DLKP+N+LLD+N V  L+DF +AK     +++ T 
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 4/114 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K + H N++ +I    +E    LV E+M    L+K L  +   L   Q    +  
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +   + + H      ++H DLKP N+L++ +    L+DF +A+      +S T 
Sbjct: 128 LLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 65.5 bits (160), Expect = 2e-12
 Identities = 39/138 (28%), Positives = 57/138 (41%), Gaps = 8/138 (5%)

Query: 13  EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFS 72
             L L  N L          +++L  L L  N L  SL +    +L +L  L L  N   
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 73  GTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSS 131
            ++P  +F+  ++L +L+L  N         F  L  L+ L L +N L  S P+  F   
Sbjct: 90  -SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVF--- 144

Query: 132 LSNCKSLTLIDLSNNPLD 149
                SL  I L +NP D
Sbjct: 145 -DRLTSLQYIWLHDNPWD 161

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 55.8 bits (135), Expect = 5e-09
 Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 7/138 (5%)

Query: 158 SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITL-GKLRKLQRLN 216
           + +        +   ++          LT+L ++ LGGNKL  S+P  +  KL  L  LN
Sbjct: 24  TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLN 82

Query: 217 LEDNILEGSIPDDIC-RLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIP 274
           L  N L+ S+P+ +  +L +L  L L +N+L  S+P   F  L  L+ L L  N+L S+P
Sbjct: 83  LSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSVP 140

Query: 275 L-TFWNLKDILQLNFSSN 291
              F  L  +  +    N
Sbjct: 141 DGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 46/175 (26%), Positives = 68/175 (38%), Gaps = 59/175 (33%)

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC-RLAE 235
           GIP + + L      DL  N L         +L  L +L L  N L+ S+P+ +  +L  
Sbjct: 25  GIPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77

Query: 236 LYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT 294
           L  L L +N+L  S+P   F  L  L+ L+L +N+L S+P                    
Sbjct: 78  LTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQSLP-------------------- 116

Query: 295 GPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
                                   GV      +KL+ L+DL L  N+LK  +P G
Sbjct: 117 -----------------------DGVF-----DKLTQLKDLRLYQNQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.1 bits (102), Expect = 7e-05
 Identities = 52/204 (25%), Positives = 75/204 (36%), Gaps = 62/204 (30%)

Query: 19  QNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF 78
            ++   +VP  I   +   +L L+ NSL  SL +     L +L +LYL GN         
Sbjct: 15  YSQGRTSVPTGIP--AQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGN--------- 62

Query: 79  IFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL 138
                KL  L  G+          F  L +L  L L  N L  S P   F   L+    L
Sbjct: 63  -----KLQSLPNGV----------FNKLTSLTYLNLSTNQLQ-SLPNGVF-DKLTQ---L 102

Query: 139 TLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGGNK 197
             + L+ N L       S                     +P+ +   LT L ++ L  N+
Sbjct: 103 KELALNTNQL------QS---------------------LPDGVFDKLTQLKDLRLYQNQ 135

Query: 198 LNGSIPI-TLGKLRKLQRLNLEDN 220
           L  S+P     +L  LQ + L DN
Sbjct: 136 LK-SVPDGVFDRLTSLQYIWLHDN 158

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 37/183 (20%), Positives = 75/183 (40%), Gaps = 31/183 (16%)

Query: 439 ELCRATD---EFSENNLIGRGGF-----ALFIR-----AFKSFDVECE-----------M 474
            + R  D    +     +G G F     A         A K  + + E           +
Sbjct: 10  HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69

Query: 475 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 534
           + +  H  ++K++ +  ++    +++E+ P G+++  +   +  L   Q   +   +  A
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129

Query: 535 LEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIGY 593
           L +LH   S  +IH DLK  NVL+       L+DF ++       +++ +  +  GT  +
Sbjct: 130 LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKRDSFIGTPYW 183

Query: 594 MAP 596
           MAP
Sbjct: 184 MAP 186

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 29/114 (25%), Positives = 57/114 (50%), Gaps = 4/114 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K ++H+N++++     +++   LV E+     L+KY  S N  LD     + +  
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +   L + H   S  V+H DLKP N+L++ N    L++F +A+      +  + 
Sbjct: 110 LLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 39/138 (28%), Positives = 57/138 (41%), Gaps = 9/138 (6%)

Query: 13  EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFS 72
           + L L  N++    P    ++  LK L L +N L  +L       L  L  L L  N  +
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 73  GTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSS 131
             +P  +F+    L +L +  N  +  +P     L +L  L LD+N L  S P  +F   
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAF--- 155

Query: 132 LSNCKSLTLIDLSNNPLD 149
                SLT   L  NP D
Sbjct: 156 -DRLSSLTHAYLFGNPWD 172

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 35/119 (29%), Positives = 51/119 (42%), Gaps = 10/119 (8%)

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC-RLAE 235
           GIP     L       L  N++    P     L  L+ L L  N L  ++P  +   L +
Sbjct: 37  GIPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89

Query: 236 LYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFL 293
           L  L+LG+N+L   +P+  F  L  L+ L +  NKLT +P     L  +  L    N L
Sbjct: 90  LTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 40/160 (25%), Positives = 60/160 (37%), Gaps = 34/160 (21%)

Query: 110 EQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM 169
           + L L +N +T   P         +  +L  + L +N L              +L     
Sbjct: 43  QILYLHDNQITKLEP-----GVFDSLINLKELYLGSNQL-------------GALPV--- 81

Query: 170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITL-GKLRKLQRLNLEDNILEGSIPD 228
                  G+ +    LT L  +DLG N+L   +P  +  +L  L+ L +  N L   +P 
Sbjct: 82  -------GVFDS---LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPR 129

Query: 229 DICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSN 268
            I RL  L  L L  N+L       F  L+SL    L  N
Sbjct: 130 GIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 46/202 (22%), Positives = 68/202 (33%), Gaps = 59/202 (29%)

Query: 19  QNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF 78
           ++K   +VPA I   +  + L L +N ++  L       L NL++LYL  N         
Sbjct: 27  RSKRHASVPAGI--PTNAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSN--------- 74

Query: 79  IFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL 138
                +L  L +G+          F +L  L  L L  N LT   P   F   L +   L
Sbjct: 75  -----QLGALPVGV----------FDSLTQLTVLDLGTNQLT-VLPSAVF-DRLVH---L 114

Query: 139 TLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKL 198
             + +  N L      T                      +P  I  LT+L  + L  N+L
Sbjct: 115 KELFMCCNKL------TE---------------------LPRGIERLTHLTHLALDQNQL 147

Query: 199 NGSIPITLGKLRKLQRLNLEDN 220
                    +L  L    L  N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 46.2 bits (110), Expect = 8e-06
 Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 18/132 (13%)

Query: 225 SIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDI 283
           S+P  I        L L  N++    P  F +L +L+ L LGSN+L ++P+  F +L  +
Sbjct: 33  SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90

Query: 284 LQLNFSSNFLTGPLLLEIG------NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNL 337
             L+  +N LT    L         +LK L       N  +  +PR I E+L++L  L L
Sbjct: 91  TVLDLGTNQLTV---LPSAVFDRLVHLKEL---FMCCNKLTE-LPRGI-ERLTHLTHLAL 142

Query: 338 SFNKLKGEIPRG 349
             N+LK  IP G
Sbjct: 143 DQNQLKS-IPHG 153

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 34/134 (25%), Positives = 57/134 (42%), Gaps = 20/134 (14%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIF 522
           E  + K + H N++K         N ++  L LEY   G L   +     +        F
Sbjct: 55  EICINKMLNHENVVKFYGHRRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
            +L       + + YLH      + H D+KP N+LLD+     +SDF +A +    ++  
Sbjct: 112 HQL------MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 583 TQTQTLGTIGYMAP 596
              +  GT+ Y+AP
Sbjct: 163 LLNKMCGTLPYVAP 176

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 22/132 (16%), Positives = 52/132 (39%), Gaps = 9/132 (6%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMI 529
           E  + K   H N++   ++   +    +V  +M +GS +  +       ++      I+ 
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ-----SMTQ 584
            V  AL+Y+H       +H  +K S++L+  +   +LS       +    Q         
Sbjct: 136 GVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 585 TQTLGTIGYMAP 596
             ++  + +++P
Sbjct: 193 KYSVKVLPWLSP 204

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 29/114 (25%), Positives = 54/114 (47%), Gaps = 4/114 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E +++K +RH NL+ ++  C  ++   LV E++ H ++   L      LD       +  
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           + + + + H   S  +IH D+KP N+L+  + V  L DF  A+ L    +    
Sbjct: 133 IINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 68.0 bits (166), Expect = 4e-12
 Identities = 28/125 (22%), Positives = 57/125 (45%), Gaps = 10/125 (8%)

Query: 473 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 532
            ++ +     ++ +  +    +  + +L+ M  G L  +L       +   R     ++ 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EII 302

Query: 533 SALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTI 591
             LE++H   +  V++ DLKP+N+LLD++    +SD  +A   + +     +     GT 
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTH 354

Query: 592 GYMAP 596
           GYMAP
Sbjct: 355 GYMAP 359

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 67.5 bits (165), Expect = 5e-12
 Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 38/182 (20%)

Query: 445 DEFSENNLIGRGGFA------------LFIRAFKSF---------DVECEM-----MKSI 478
           D F +  ++GRGGF             L+  A K             +  M     +  +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLY--ACKKLNKKRLKKRKGYQGAMVEKKILAKV 242

Query: 479 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASAL 535
             R ++ +  +   +    LV+  M  G +  ++Y+ +     F   R       + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302

Query: 536 EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIGYM 594
           E+LH      +I+ DLKP NVLLDD+    +SD  +A  L       T+T+   GT G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFM 356

Query: 595 AP 596
           AP
Sbjct: 357 AP 358

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 20/133 (15%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILD------IFQ 523
           E  ++  + H N+IKV+    N+ F  LV+E    G L+ + +   +  LD      IF+
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFR 137

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           +L       SA+ YL       +IH D+K  N+++ ++    L DF  A  L  E   + 
Sbjct: 138 QL------VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLF 186

Query: 584 QTQTLGTIGYMAP 596
            T   GTI Y AP
Sbjct: 187 YT-FCGTIEYCAP 198

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 60/292 (20%), Positives = 98/292 (33%), Gaps = 54/292 (18%)

Query: 11  NLEELQLGQNKLIGTVPAAIFNV----STLKFLGLQNNSLSGS----LSSIANVRLPNLE 62
            LE+LQL    L       + +V       K L + NN ++ +    L          LE
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202

Query: 63  KLYLWGNNFSGTIPRFIFNA----SKLSKLSLGMNSFSG-----FIPSTFGNLRNLEQLG 113
            L L     +    R +       + L +L+LG N           P        L  L 
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262

Query: 114 LDENYLTSSTPELSFLSS-LSNCKSLTLIDLSNNPL--DGILP-KTSISNLSRSLEEFYM 169
           + E  +T+       L   L   +SL  + L+ N L  +G      ++      LE  ++
Sbjct: 263 IWECGITAKG--CGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320

Query: 170 YNCNISG----GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKL-----RKLQRLNLEDN 220
            +C+ +          ++    L+E+ +  N+L  +    L +        L+ L L D 
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380

Query: 221 ILEGSIPDDICR-LAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT 271
                + D  C  LA      L +N              SLR L L +N L 
Sbjct: 381 ----DVSDSSCSSLAAT----LLANH-------------SLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 65/386 (16%), Positives = 120/386 (31%), Gaps = 53/386 (13%)

Query: 10  QNLEELQLGQNKLIGT-VPAAIFNVSTLKFLGLQNNSLS-GSLSSIANV--RLPNLEKLY 65
            +++ L +   +L        +  +   + + L +  L+      I++     P L +L 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 66  LWGNNFSGTIPRFIFNA-----SKLSKLSLGMNSFS----GFIPSTFGNLRNLEQLGLDE 116
           L  N         +         K+ KLSL     +    G + ST   L  L++L L +
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS--RSLEEFYMYNCNI 174
           N L  +  +L     L     L  + L    L     +   S L      +E  + N +I
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 175 SGGIPEEIS-----NLTNLVEIDLGGNKLN----GSIPITLGKLRKLQRLNLEDNILEGS 225
           +      +      +   L  + L    +       +   +     L+ L L  N L   
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

Query: 226 IPDDICRLAE-----LYRLELGSNKL----YGSIPACFGNLASLRILSLGSNKLT----- 271
              ++C         L  L +    +     G +        SL+ LSL  N+L      
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302

Query: 272 ----SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNL----KVLIGIDFSMNNFSGVIPR 323
               ++      L+    L   S   T        ++    + L+ +  S N       R
Sbjct: 303 LLCETLLEPGCQLES---LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359

Query: 324 EIGEKLSY----LEDLNLSFNKLKGE 345
           E+ + L      L  L L+   +   
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVSDS 385

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 61.1 bits (149), Expect = 5e-10
 Identities = 72/383 (18%), Positives = 129/383 (33%), Gaps = 70/383 (18%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNV-----STLKFLGLQNNSLSG-SLSSIANV--R 57
           +     L EL L  N+L       +          ++ L LQN  L+G     +++    
Sbjct: 52  LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111

Query: 58  LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
           LP L++L+L  N               L +  L                  LE+L L+  
Sbjct: 112 LPTLQELHLSDNLLGDA------GLQLLCEGLLDPQC-------------RLEKLQLEYC 152

Query: 118 YLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDG----ILPKTSISNLSRSLEEFYMYNCN 173
            L++++ E    S L        + +SNN ++     +L +  + +    LE   + +C 
Sbjct: 153 SLSAASCE-PLASVLRAKPDFKELTVSNNDINEAGVRVLCQ-GLKDSPCQLEALKLESCG 210

Query: 174 IS----GGIPEEISNLTNLVEIDLGGNKLNGS-----IPITLGKLRKLQRLNLEDNILEG 224
           ++      +   +++  +L E+ LG NKL         P  L    +L+ L + +  +  
Sbjct: 211 VTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGIT- 269

Query: 225 SIPDDICRLAE-------LYRLELGSNKLYGS-----IPACFGNLASLRILSLGSNKLTS 272
                   L         L  L L  N+L                  L  L + S   T+
Sbjct: 270 --AKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA 327

Query: 273 -----IPLTFWNLKDILQLNFSSNFLTGPLLLEIG-----NLKVLIGIDFSMNNFSGVIP 322
                        + +L+L  S+N L    + E+         VL  +  +  + S    
Sbjct: 328 ACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSC 387

Query: 323 REIGEKLSY---LEDLNLSFNKL 342
             +   L     L +L+LS N L
Sbjct: 388 SSLAATLLANHSLRELDLSNNCL 410

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 38/182 (20%), Positives = 67/182 (36%), Gaps = 33/182 (18%)

Query: 6   IGNLQNLEELQLGQNKL-----IGTVPAAIFNVSTLKFLGLQNNSLS-GSLSSIANV--R 57
           +   ++L+EL L  N+L            +     L+ L +++ S +    S  ++V  +
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339

Query: 58  LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDEN 117
              L +L +  N                     G+      +         L  L L + 
Sbjct: 340 NRFLLELQISNNRLEDA----------------GVRELCQGLGQ---PGSVLRVLWLADC 380

Query: 118 YLTSSTPELSFLSS-LSNCKSLTLIDLSNNPLD--GILP-KTSISNLSRSLEEFYMYNCN 173
            ++ S+   S L++ L    SL  +DLSNN L   GIL    S+      LE+  +Y+  
Sbjct: 381 DVSDSS--CSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIY 438

Query: 174 IS 175
            S
Sbjct: 439 WS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 37/214 (17%), Positives = 65/214 (30%), Gaps = 28/214 (13%)

Query: 160 LSRSLEEFYMYNCNIS-GGIPEEISNLTNLVEIDLGGNKLN----GSIPITLGKLRKLQR 214
           +S  ++   +    +S     E +  L     + L    L       I   L     L  
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60

Query: 215 LNLEDNILEGSIPDDICRL-----AELYRLELGSNKL----YGSIPACFGNLASLRILSL 265
           LNL  N L       + +       ++ +L L +  L     G + +    L +L+ L L
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120

Query: 266 GSNKLTSIPLTF------WNLKDILQLNFSSNFLT----GPLLLEIGNLKVLIGIDFSMN 315
             N L    L             + +L      L+     PL   +        +  S N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180

Query: 316 NFSGVIPREIGEKLSY----LEDLNLSFNKLKGE 345
           + +    R + + L      LE L L    +  +
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSD 214

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 30/136 (22%), Positives = 51/136 (37%), Gaps = 23/136 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQR 524
           E  +++ + H N+I +     N     L+LE +  G L     +K   S           
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT------ 118

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQ 580
            + +  +   + YLH      + H DLKP N++L           L DF +A  +  +  
Sbjct: 119 -SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGV 173

Query: 581 SMTQTQTLGTIGYMAP 596
                   GT  ++AP
Sbjct: 174 EF--KNIFGTPEFVAP 187

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 34/134 (25%), Positives = 57/134 (42%), Gaps = 20/134 (14%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIF 522
           E  + K + H N++K         N ++  L LEY   G L   +     +        F
Sbjct: 55  EICINKMLNHENVVKFYGHRRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
            +L       + + YLH      + H D+KP N+LLD+     +SDF +A +    ++  
Sbjct: 112 HQL------MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 583 TQTQTLGTIGYMAP 596
              +  GT+ Y+AP
Sbjct: 163 LLNKMCGTLPYVAP 176

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 23/136 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQR 524
           E  +++ IRH N+I +     N+    L+LE +  G L     EK   +           
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT------ 111

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLTGEDQ 580
              +  +   + YLH      + H DLKP N++L D  V +    L DF IA  +     
Sbjct: 112 -QFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGN 166

Query: 581 SMTQTQTLGTIGYMAP 596
                   GT  ++AP
Sbjct: 167 EF--KNIFGTPEFVAP 180

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 30/136 (22%), Positives = 52/136 (38%), Gaps = 23/136 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQR 524
           E  +++ + H N+I +     N     L+LE +  G L     +K   S           
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT------ 118

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQ 580
            + +  +   + YLH   +  + H DLKP N++L           L DF +A  +  +  
Sbjct: 119 -SFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGV 173

Query: 581 SMTQTQTLGTIGYMAP 596
                   GT  ++AP
Sbjct: 174 EF--KNIFGTPEFVAP 187

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 41/184 (22%), Positives = 68/184 (36%), Gaps = 35/184 (19%)

Query: 445 DEFSENNLIGRGGF-----ALFIR-----AFKSFDVECE------------MMKSIRHRN 482
           D++    +IG G       A         A K  ++E               M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 483 LIKVISSCSNEEFKALVLEYMPHGSL-------EKYLYSSNCILDIFQRLNIMIDVASAL 535
           ++   +S   ++   LV++ +  GS+              + +LD      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 536 EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ--TL-GTIG 592
           EYLH       IH D+K  N+LL ++    ++DF ++  L             T  GT  
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 593 YMAP 596
           +MAP
Sbjct: 192 WMAP 195

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 65.7 bits (161), Expect = 8e-12
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 4/114 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K ++H N++ +      E+   LV EY+    L++YL     I+++      +  
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           +   L Y H      V+H DLKP N+L+++     L+DF +A+  +   ++   
Sbjct: 109 LLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 64.8 bits (159), Expect = 1e-11
 Identities = 26/114 (22%), Positives = 54/114 (47%), Gaps = 4/114 (3%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K ++H N++K+      ++   LV E++    L+K L      L+     + ++ 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           + + + Y H      V+H DLKP N+L++      ++DF +A+      +  T 
Sbjct: 109 LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 31/136 (22%), Positives = 52/136 (38%), Gaps = 23/136 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQR 524
           E  ++K I+H N+I +     N+    L+LE +  G L     EK   +           
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT------ 117

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQ 580
              +  + + + YLH      + H DLKP N++L           + DF +A  +     
Sbjct: 118 -EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGN 172

Query: 581 SMTQTQTLGTIGYMAP 596
                   GT  ++AP
Sbjct: 173 EF--KNIFGTPEFVAP 186

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 36/133 (27%), Positives = 57/133 (42%), Gaps = 19/133 (14%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRL 525
           E    +S+RH N+++           A+++EY   G L + + ++           FQ+L
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLTGEDQSMT 583
                  S + Y H   S  + H DLK  N LLD +    L   DF  +K       S  
Sbjct: 126 ------LSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQP 174

Query: 584 QTQTLGTIGYMAP 596
           ++ T+GT  Y+AP
Sbjct: 175 KS-TVGTPAYIAP 186

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 35/179 (19%), Positives = 64/179 (35%), Gaps = 51/179 (28%)

Query: 453 IGRGGFALFIRAF--------------KSFDVECE---MMKSIRHRNLIKVI----SSCS 491
           +G G     ++ F                     E     ++ +  ++++++    +  +
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 129

Query: 492 NEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVASALEYLHF 540
             +   +V+E +  G L             I  R +          IM  +  A++YLH 
Sbjct: 130 GRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 178

Query: 541 GYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             S  + H D+KP N+L      N +  L+DF  AK  T  +   T      T  Y+AP
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAP 232

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 37/127 (29%), Positives = 58/127 (45%), Gaps = 9/127 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++       + K   S   +    +++EY+  GS    L      LD  Q   I+ +
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILRE 127

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           +   L+YLH   S   IH D+K +NVLL ++    L+DF +A  LT    +  +  T  G
Sbjct: 128 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTFVG 181

Query: 590 TIGYMAP 596
           T  +MAP
Sbjct: 182 TPFWMAP 188

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 23/135 (17%), Positives = 51/135 (37%), Gaps = 22/135 (16%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQ 523
           E  ++   RHRN++ +  S  + E   ++ E++    +        +  +    +     
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV----- 105

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLTGEDQS 581
             + +  V  AL++LH      + H D++P N++      + +   +F  A+ L     +
Sbjct: 106 --SYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDN 159

Query: 582 MTQTQTLGTIGYMAP 596
                      Y AP
Sbjct: 160 F--RLLFTAPEYYAP 172

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 34/180 (18%), Positives = 65/180 (36%), Gaps = 52/180 (28%)

Query: 452 LIGRGGFALFIRAF--------------KSFDVECE---MMKSIRHRNLIKVI----SSC 490
           ++G G     +  F               S     E     ++    +++ ++    +  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH 95

Query: 491 SNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVASALEYLH 539
             +    +++E M  G L             I +R +          IM D+ +A+++LH
Sbjct: 96  HGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 540 FGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              S  + H D+KP N+L    + + V  L+DF  AK       ++       T  Y+AP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCYTPYYVAP 198

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 28/137 (20%), Positives = 57/137 (41%), Gaps = 23/137 (16%)

Query: 471 ECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRL--- 525
           E  +++  +    +I +     N     L+LEY   G +         C+ ++ + +   
Sbjct: 78  EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL------CLPELAEMVSEN 131

Query: 526 ---NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH---LSDFSIAKLLTGED 579
               ++  +   + YLH      ++H DLKP N+LL          + DF +++ + G  
Sbjct: 132 DVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHA 187

Query: 580 QSMTQTQTLGTIGYMAP 596
             +   + +GT  Y+AP
Sbjct: 188 CEL--REIMGTPEYLAP 202

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 42/134 (31%), Positives = 71/134 (52%), Gaps = 23/134 (17%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIF 522
           E + +K  RH ++IK   VIS+   + F  +V+EY+  G L  Y+     +       +F
Sbjct: 61  EIQNLKLFRHPHIIKLYQVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLF 117

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           Q++       SA++Y H     +V+H DLKP NVLLD +M A ++DF ++ +++  +   
Sbjct: 118 QQI------LSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168

Query: 583 TQTQTLGTIGYMAP 596
           T   + G+  Y AP
Sbjct: 169 T---SCGSPNYAAP 179

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 36/169 (21%), Positives = 56/169 (33%), Gaps = 46/169 (27%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL----- 525
           E  +MK + H N+ ++     +E++  LV+E    G L   L            +     
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137

Query: 526 ----------------------------------NIMIDVASALEYLHFGYSALVIHCDL 551
                                             NIM  + SAL YLH   +  + H D+
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDI 194

Query: 552 KPSNVLLDDNMVAHL--SDFSIAKLLTGEDQSMTQ--TQTLGTIGYMAP 596
           KP N L   N    +   DF ++K     +       T   GT  ++AP
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 61.1 bits (149), Expect = 4e-11
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 10/132 (7%)

Query: 19  QNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF 78
            +K + +VP  I   S+   L L++N L  SL      +L  L KL L  N    ++P  
Sbjct: 15  NSKGLTSVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDG 70

Query: 79  IFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS 137
           +F+  +KL+ L L  N         F  L  L++L LD N L S  P+  F        S
Sbjct: 71  VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS-VPDGIF----DRLTS 125

Query: 138 LTLIDLSNNPLD 149
           L  I L  NP D
Sbjct: 126 LQKIWLHTNPWD 137

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 56.1 bits (136), Expect = 2e-09
 Identities = 38/118 (32%), Positives = 59/118 (50%), Gaps = 11/118 (9%)

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC-RLAE 235
           GIP   + L      +L  NKL         KL +L +L+L  N ++ S+PD +  +L +
Sbjct: 25  GIPSSATRL------ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77

Query: 236 LYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSN 291
           L  L L  NKL  S+P   F  L  L+ L+L +N+L S+P   F  L  + ++   +N
Sbjct: 78  LTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 33/113 (29%), Positives = 45/113 (39%), Gaps = 27/113 (23%)

Query: 238 RLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGP 296
           RLEL SNKL       F  L  L  LSL  N++ S+P   F  L  +  L    N L   
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-- 89

Query: 297 LLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
                                   +P  + +KL+ L++L L  N+LK  +P G
Sbjct: 90  -----------------------SLPNGVFDKLTQLKELALDTNQLKS-VPDG 118

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 61.6 bits (150), Expect = 4e-11
 Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 14/120 (11%)

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPIT--LGKLRKLQRLNLEDNILEGSIPDDIC-RL 233
            IP   + L       L  N+L   I      G+L  L +L L+ N L   I  +     
Sbjct: 26  DIPLHTTEL------LLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGA 77

Query: 234 AELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSN 291
           + +  L+LG NK+   I    F  L  L+ L+L  N+++ +   +F +L  +  LN +SN
Sbjct: 78  SHIQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.8 bits (109), Expect = 9e-06
 Identities = 25/109 (22%), Positives = 42/109 (38%), Gaps = 22/109 (20%)

Query: 62  EKLYLWGNNFSGTIPRFIFNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
            +L L  N         +F     L KL L  N  +G  P+ F    ++++L L EN + 
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91

Query: 121 SSTPELSF-----LSSLS---------------NCKSLTLIDLSNNPLD 149
                  F     L +L+               +  SLT ++L++NP +
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 27/85 (31%), Positives = 37/85 (43%), Gaps = 4/85 (4%)

Query: 213 QRLNLEDNILEGSIPDDI-CRLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKL 270
             L L DN L     D +  RL  L +LEL  N+L   I    F   + ++ L LG NK+
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI 90

Query: 271 TSIPL-TFWNLKDILQLNFSSNFLT 294
             I    F  L  +  LN   N ++
Sbjct: 91  KEISNKMFLGLHQLKTLNLYDNQIS 115

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 32/128 (25%), Positives = 43/128 (33%), Gaps = 32/128 (25%)

Query: 225 SIPDDICRLAELYRLELGSNKLYGSIPAC--FGNLASLRILSLGSNKLTSIPL-TFWNLK 281
            IP DI        L L  N+L G I +   FG L  L  L L  N+LT I    F    
Sbjct: 22  EIPRDI--PLHTTELLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78

Query: 282 DILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNK 341
            I +L    N +                           I  ++   L  L+ LNL  N+
Sbjct: 79  HIQELQLGENKIK-------------------------EISNKMFLGLHQLKTLNLYDNQ 113

Query: 342 LKGEIPRG 349
           +   +  G
Sbjct: 114 ISC-VMPG 120

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 11/127 (8%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  +++++    L+K+  S  +     +V+EY+  G +  +L       +   R      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-Q 149

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
           +    EYLH   S  +I+ DLKP N+L+D      ++DF  AK + G      +T TL G
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCG 200

Query: 590 TIGYMAP 596
           T   +AP
Sbjct: 201 TPEALAP 207

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 24/122 (19%), Positives = 59/122 (48%), Gaps = 10/122 (8%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           E  ++  + H +++K   ++     E+F    +VLE       +K   +   + ++  + 
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT 160

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            ++ ++   ++Y+H   SA ++H DLKP+N L++ +    + DF +A+ +   +   +Q 
Sbjct: 161 -LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216

Query: 586 QT 587
             
Sbjct: 217 PI 218

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 46/204 (22%), Positives = 77/204 (37%), Gaps = 38/204 (18%)

Query: 425 NMPLVATWRTFSYLELCRATD---EFSENNLIGRGGF-----ALFIR-----AFKSFDVE 471
           +M   +  R+   ++L    D    F    L+G G +        ++     A K  DV 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 472 CE-----------MMKSIRHRNLIKVISSCSNEEFKA------LVLEYMPHGSL-EKYLY 513
            +           + K   HRN+     +   +          LV+E+   GS+ +    
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 514 SSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           +    L       I  ++   L +LH      VIH D+K  NVLL +N    L DF ++ 
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177

Query: 574 LLTGEDQSMTQTQTL-GTIGYMAP 596
            L    +++ +  T  GT  +MAP
Sbjct: 178 QLD---RTVGRRNTFIGTPYWMAP 198

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 36/135 (26%), Positives = 59/135 (43%), Gaps = 25/135 (18%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-----IFQRL 525
           E  +MK + H N++K+      E+   L++EY   G +  YL +   + +      F+++
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
                  SA++Y H      ++H DLK  N+LLD +M   ++DF       G     T  
Sbjct: 124 ------VSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADF-------GFSNEFTVG 167

Query: 586 QTL----GTIGYMAP 596
             L    G   Y AP
Sbjct: 168 GKLDAFCGAPPYAAP 182

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 63.2 bits (154), Expect = 8e-11
 Identities = 33/136 (24%), Positives = 58/136 (42%), Gaps = 26/136 (19%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E ++M       ++++  +  ++ +  +V+EYMP G L   +             ++   
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEK 168

Query: 531 VA--------SALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQ 580
            A         AL+ +H   S   IH D+KP N+LLD +   H  L+DF     +  E  
Sbjct: 169 WARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGM 223

Query: 581 SMTQTQTLGTIGYMAP 596
               T  +GT  Y++P
Sbjct: 224 VRCDT-AVGTPDYISP 238

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 34/123 (27%), Positives = 57/123 (46%), Gaps = 20/123 (16%)

Query: 471 ECEMMKSIRHRNLIKV----ISSCSNEEFKA--LVLEYMP---HGSLEKYLYSSNCILDI 521
           E  +MK + H+N+I +        S EEF+   +V+E M       ++  L        +
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL 133

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 581
           +Q L         +++LH   SA +IH DLKPSN+++  +    + DF +A+   G    
Sbjct: 134 YQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFM 182

Query: 582 MTQ 584
           MT 
Sbjct: 183 MTP 185

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 41/134 (30%), Positives = 72/134 (53%), Gaps = 23/134 (17%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIF 522
           E + +K  RH ++IK   VIS+  ++ F  +V+EY+  G L  Y+  +  +       +F
Sbjct: 66  EIQNLKLFRHPHIIKLYQVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLF 122

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           Q++       S ++Y H     +V+H DLKP NVLLD +M A ++DF ++ +++  +   
Sbjct: 123 QQI------LSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173

Query: 583 TQTQTLGTIGYMAP 596
           T   + G+  Y AP
Sbjct: 174 T---SCGSPNYAAP 184

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 28/115 (24%), Positives = 56/115 (48%), Gaps = 5/115 (4%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMI 529
           E  ++K + H N++K++     E    LV E++    L+K++ +S    + +    + + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
            +   L + H   S  V+H DLKP N+L++      L+DF +A+      ++ T 
Sbjct: 111 QLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 36/127 (28%), Positives = 50/127 (39%), Gaps = 12/127 (9%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E   ++ +RH N I+       E    LV+EY   GS    L      L   +   +   
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHG 162

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-G 589
               L YLH   S  +IH D+K  N+LL +  +  L DF  A         M    +  G
Sbjct: 163 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVG 212

Query: 590 TIGYMAP 596
           T  +MAP
Sbjct: 213 TPYWMAP 219

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 32/137 (23%), Positives = 59/137 (43%), Gaps = 18/137 (13%)

Query: 469 DVECEM-----MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
                +     ++ +  R ++ +  +   ++   LVL  M  G L+ ++Y  +     F 
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP 284

Query: 524 RLNIMI---DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
               +    ++   LE LH      +++ DLKP N+LLDD+    +SD  +A  +     
Sbjct: 285 EARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 340

Query: 581 SMTQTQTL-GTIGYMAP 596
                +   GT+GYMAP
Sbjct: 341 ---TIKGRVGTVGYMAP 354

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 30/123 (24%), Positives = 52/123 (42%), Gaps = 22/123 (17%)

Query: 471 ECEMMKSIRHRNLIK----VISSCSNEEFKA--LVLEYMP---HGSLEKYLYSSNCILDI 521
           E  ++K ++H N+I        + S   F    LV+ +M       +            +
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV 132

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 581
           +Q L         L+Y+H   SA V+H DLKP N+ ++++    + DF +A+     D  
Sbjct: 133 YQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAE 179

Query: 582 MTQ 584
           MT 
Sbjct: 180 MTG 182

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 34/123 (27%), Positives = 58/123 (47%), Gaps = 15/123 (12%)

Query: 471 ECEMMKSIRHRNLIKVI------SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDI 521
           E ++M+ + H N++++           +E +  LVL+Y+P   +     Y  +   +  I
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQ 580
           + +L  M  +  +L Y+H   S  + H D+KP N+LLD D  V  L DF  AK L    +
Sbjct: 157 YVKL-YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGE 211

Query: 581 SMT 583
              
Sbjct: 212 PNV 214

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 61.4 bits (150), Expect = 2e-10
 Identities = 41/136 (30%), Positives = 64/136 (47%), Gaps = 20/136 (14%)

Query: 469 DVEC-----EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
            VE       M+  + H  +I++  +  + +   ++++Y+  G L   L  S    +   
Sbjct: 49  QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA 108

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQS 581
           +     +V  ALEYLH   S  +I+ DLKP N+LLD N   H  ++DF  AK +      
Sbjct: 109 KFYAA-EVCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP----- 157

Query: 582 MTQTQTL-GTIGYMAP 596
              T TL GT  Y+AP
Sbjct: 158 -DVTYTLCGTPDYIAP 172

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 21/145 (14%), Positives = 41/145 (28%), Gaps = 30/145 (20%)

Query: 452 LIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVI 487
             G      F +A                         +        +  I    + +V+
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 488 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVI 547
                     +V E++  GSL++   +S         +  M  +A+A +  H    A V 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVA 151

Query: 548 HCDLKPSNVLLDDNMVAHLSDFSIA 572
                PS V +  +    L+  +  
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATM 176

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 26/145 (17%), Positives = 55/145 (37%), Gaps = 33/145 (22%)

Query: 469 DVEC-----EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           +  C     +++ +   + +  +  +  ++    LV++Y   G L   L           
Sbjct: 117 ETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL----------S 166

Query: 524 RLNIMID----------VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH--LSDFSI 571
           +    +           +  A++ +H       +H D+KP N+L+D N   H  L+DF  
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGS 221

Query: 572 AKLLTGEDQSMTQTQTLGTIGYMAP 596
              L  +    +    +GT  Y++P
Sbjct: 222 CLKLMEDGTVQSSV-AVGTPDYISP 245

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 28/119 (23%), Positives = 52/119 (43%), Gaps = 9/119 (7%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRL 525
           E  +MK ++H N++++      E    LV E+M +  L+KY+ S         L++    
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
                +   L + H      ++H DLKP N+L++      L DF +A+       + + 
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 15/120 (12%)

Query: 471 ECEMMKSIRHRNLIKV----ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQR 524
           E  ++K ++H N+I +      + S EEF    LV   M    L   +       D  Q 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ- 135

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
             ++  +   L+Y+H   SA +IH DLKPSN+ ++++    + DF +A+        MT 
Sbjct: 136 -FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTG 188

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 33/137 (24%), Positives = 53/137 (38%), Gaps = 31/137 (22%)

Query: 13  EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFS 72
            EL L  N+    VP  + N   L  + L NN +S +LS+ +   +  L  L L  N   
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN--- 88

Query: 73  GTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSL 132
                      +L  +              F  L++L  L L  N + S  PE +F    
Sbjct: 89  -----------RLRCIPPRT----------FDGLKSLRLLSLHGNDI-SVVPEGAF---- 122

Query: 133 SNCKSLTLIDLSNNPLD 149
           ++  +L+ + +  NPL 
Sbjct: 123 NDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 31/117 (26%), Positives = 54/117 (46%), Gaps = 6/117 (5%)

Query: 155 TSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQ 213
             +   + R + E Y+     +  +P+E+SN  +L  IDL  N+++     +   + +L 
Sbjct: 23  KVLPKGIPRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 214 RLNLEDNILEGSIPDDIC-RLAELYRLELGSNKLYGSIP-ACFGNLASLRILSLGSN 268
            L L  N L   IP      L  L  L L  N +   +P   F +L++L  L++G+N
Sbjct: 82  TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 3/63 (4%)

Query: 213 QRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLT 271
             L L+ N     +P ++     L  ++L +N++  ++    F N+  L  L L  N+L 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR 91

Query: 272 SIP 274
            IP
Sbjct: 92  CIP 94

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 28/110 (25%), Positives = 45/110 (40%), Gaps = 10/110 (9%)

Query: 243 SNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIG 302
           SNK    +P   G    +  L L  N+ T +P    N K +  ++ S+N ++    L   
Sbjct: 18  SNKGLKVLPK--GIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIST---LSNQ 72

Query: 303 ---NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG 349
              N+  L+ +  S N     IP    + L  L  L+L  N +   +P G
Sbjct: 73  SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEG 120

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 24/131 (18%), Positives = 53/131 (40%), Gaps = 10/131 (7%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           E  ++  ++   +I+   +I      +F    +VLE      L+K   +   + +   + 
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT 133

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
            I+ ++     ++H    + +IH DLKP+N LL+ +    + DF +A+ +  E  +    
Sbjct: 134 -ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 586 QTLGTIGYMAP 596
                      
Sbjct: 190 DLEENEEPGPH 200

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 26/121 (21%), Positives = 48/121 (39%), Gaps = 14/121 (11%)

Query: 474 MMKSIRHRNLIK---VISSCSNEEFK----ALVLEYMP---HGSLEKYLYSSNCILDIFQ 523
            +  + H N+++      +    + +     +V+EY+P   H     Y         I  
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSM 582
           ++  +  +  ++  LH   S  V H D+KP NVL++  +    L DF  AK L    +  
Sbjct: 132 KV-FLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPN 188

Query: 583 T 583
            
Sbjct: 189 V 189

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 60.3 bits (147), Expect = 5e-10
 Identities = 25/110 (22%), Positives = 54/110 (49%), Gaps = 12/110 (10%)

Query: 471 ECEMMKSIRHRN---LIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIF 522
           E ++++ ++H N   LI++  + ++   +      LV ++  H  L   L +      + 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA 572
           +   +M  + + L Y+H      ++H D+K +NVL+  + V  L+DF +A
Sbjct: 125 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 59.6 bits (145), Expect = 9e-10
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 12/132 (9%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           E +++   RH N+I    +I + + E+ K   +V + M    L K L +   + +     
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICY 132

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ- 584
             +  +   L+Y+H   SA V+H DLKPSN+LL+      + DF +A++   +       
Sbjct: 133 -FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188

Query: 585 TQTLGTIGYMAP 596
           T+ + T  Y AP
Sbjct: 189 TEYVATRWYRAP 200

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 56/316 (17%), Positives = 114/316 (36%), Gaps = 27/316 (8%)

Query: 34  STLKFLGLQNNSLS-GSLSSIANVRLPNLEKLYLWG-NNFSGT-IPRFIFNASKLSKLSL 90
             LK +  +   +S   L  +A  R  +LE L L   + F+   +   + +  K+  L +
Sbjct: 112 RQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLM 171

Query: 91  GMNSFSGFIPSTFG----NLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNN 146
             +SFS            +  +LE L          +P+    +   NC+SL  + + + 
Sbjct: 172 EESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPK-DLETIARNCRSLVSVKVGDF 230

Query: 147 PLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKL--NGSIPI 204
            +  ++        + +LEEF   + N   G+PE+  NL    ++   G        +PI
Sbjct: 231 EILELV---GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPI 287

Query: 205 TLGKLRKLQRLNLED-NILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRIL 263
                 ++++L+L    +        I +   L  LE  +           G+   L +L
Sbjct: 288 LFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRN---------VIGD-RGLEVL 337

Query: 264 SLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIG-NLKVLIGIDFSMNNFSGVIP 322
           +    +L  + +      D   +      ++   L+ +    + L  +   +++ +    
Sbjct: 338 AQYCKQLKRLRIERG--ADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL 395

Query: 323 REIGEKLSYLEDLNLS 338
             IG  L  L D  L 
Sbjct: 396 ESIGTYLKNLCDFRLV 411

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 31/123 (25%), Positives = 56/123 (45%), Gaps = 15/123 (12%)

Query: 471 ECEMMKSIRHRNLIK----VISSCSNEEFKA--LVLEYMPHGSLEKYLYS---SNCILDI 521
           E ++M+ ++H N++       S+   ++     LVLEY+P  ++ +           + +
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQ 580
                 M  +  +L Y+H   S  + H D+KP N+LLD  + V  L DF  AK+L    +
Sbjct: 141 LLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGE 196

Query: 581 SMT 583
              
Sbjct: 197 PNV 199

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 28/119 (23%), Positives = 56/119 (47%), Gaps = 10/119 (8%)

Query: 471 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 530
           E  ++K ++HRN+I++ S   +     L+ EY  +  L+KY+   N  + +    + +  
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQ 140

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH-----LSDFSIAKLLTGEDQSMTQ 584
           + + + + H   S   +H DLKP N+LL  +  +      + DF +A+      +  T 
Sbjct: 141 LINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.0 bits (142), Expect = 1e-09
 Identities = 24/104 (23%), Positives = 39/104 (37%), Gaps = 8/104 (7%)

Query: 48  GSLSSIANVR-LPNLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGN 105
           G+L S+ ++    NL +LY+        +         +L  L++  +      P  F  
Sbjct: 19  GALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHF 78

Query: 106 LRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLD 149
              L +L L  N L S + +     SL        + LS NPL 
Sbjct: 79  TPRLSRLNLSFNALESLSWKTVQGLSLQE------LVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 1e-08
 Identities = 17/96 (17%), Positives = 34/96 (35%), Gaps = 3/96 (3%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSGSLSSIANVRLP 59
           +    +   +NL EL +   + +  +       +  L+ L +  + L   ++  A    P
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 60  NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSF 95
            L +L L  N    ++         L +L L  N  
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.0 bits (129), Expect = 7e-08
 Identities = 20/102 (19%), Positives = 34/102 (33%), Gaps = 3/102 (2%)

Query: 20  NKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFI 79
                     +     L  L ++N      L       L  L  L +  +     +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 80  FNA-SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLT 120
           F+   +LS+L+L  N+       T   L +L++L L  N L 
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 20/118 (16%), Positives = 34/118 (28%), Gaps = 25/118 (21%)

Query: 178 IPEEISNLTNLVEIDLGGNKLNGSIP-ITLGKLRKLQRLNLEDNILEGSIPDDICRLAEL 236
               +    NL E+ +   +    +    L  L +L+ L +  + L   +  D       
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA------ 75

Query: 237 YRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT 294
                            F     L  L+L  N L S+         + +L  S N L 
Sbjct: 76  -----------------FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 19/96 (19%), Positives = 32/96 (33%), Gaps = 4/96 (4%)

Query: 126 LSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEI-SN 184
           L  L  L   ++LT + + N      L    +  L   L    +    +   +  +    
Sbjct: 21  LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLG-ELRNLTIVKSGLR-FVAPDAFHF 78

Query: 185 LTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN 220
              L  ++L  N L  S+     +   LQ L L  N
Sbjct: 79  TPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.3 bits (122), Expect = 5e-07
 Identities = 22/114 (19%), Positives = 37/114 (32%), Gaps = 7/114 (6%)

Query: 135 CKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE-ISNLTNLVEIDL 193
               + +  + +     L    +      L E Y+ N      +    +  L  L  + +
Sbjct: 7   PHGSSGLRCTRDGALDSLH--HLPGAEN-LTELYIENQQHLQHLELRDLRGLGELRNLTI 63

Query: 194 GGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKL 246
             + L   +         +L RLNL  N LE S+     +   L  L L  N L
Sbjct: 64  VKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 14/72 (19%), Positives = 25/72 (34%), Gaps = 2/72 (2%)

Query: 225 SIPDDICRLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTSI-PLTFWNLKD 282
                +     L  L + + +    +       L  LR L++  + L  + P  F     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 283 ILQLNFSSNFLT 294
           + +LN S N L 
Sbjct: 82  LSRLNLSFNALE 93

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 34/123 (27%), Positives = 58/123 (47%), Gaps = 20/123 (16%)

Query: 471 ECEMMKSIRHRNLIKVI----SSCSNEEFKA--LVLEYMP---HGSLEKYLYSSNCILDI 521
           E  +MK + H+N+I ++       + EEF+   LV+E M       ++  L        +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 170

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 581
           +Q L         +++LH   SA +IH DLKPSN+++  +    + DF +A+   G    
Sbjct: 171 YQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFM 219

Query: 582 MTQ 584
           MT 
Sbjct: 220 MTP 222

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 33/146 (22%), Positives = 57/146 (39%), Gaps = 35/146 (23%)

Query: 469 DVECEM-----MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           +V C       + +   R + ++  +  +E +  LV+EY   G L   L           
Sbjct: 104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL----------S 153

Query: 524 RLNIMID----------VASALEYLH-FGYSALVIHCDLKPSNVLLDDNMVAH--LSDFS 570
           +    I           +  A++ +H  GY    +H D+KP N+LLD     H  L+DF 
Sbjct: 154 KFGERIPAEMARFYLAEIVMAIDSVHRLGY----VHRDIKPDNILLDRC--GHIRLADFG 207

Query: 571 IAKLLTGEDQSMTQTQTLGTIGYMAP 596
               L  +    +    +GT  Y++P
Sbjct: 208 SCLKLRADGTVRSLV-AVGTPDYLSP 232

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 30/120 (25%), Positives = 57/120 (47%), Gaps = 15/120 (12%)

Query: 471 ECEMMKSIRHRNLIKVI----SSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQR 524
           E  ++K +RH N+I ++       + ++F    LV+ +M    L K +      L   + 
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE--KLGEDRI 130

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
             ++  +   L Y+H   +A +IH DLKP N+ ++++    + DF +A+     D  MT 
Sbjct: 131 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTG 184

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 30/121 (24%), Positives = 57/121 (47%), Gaps = 11/121 (9%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 525
           E +++K  +H N+I    +    S E F    ++ E M    L + + S+  + D   + 
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-STQMLSDDHIQY 116

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 585
             +     A++ LH    + VIH DLKPSN+L++ N    + DF +A+++       ++ 
Sbjct: 117 -FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 586 Q 586
            
Sbjct: 173 T 173

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 39/134 (29%), Positives = 66/134 (49%), Gaps = 24/134 (17%)

Query: 471 ECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIF 522
           E   +K +RH ++IK   VI++   +    +V+EY   G L  Y+     +        F
Sbjct: 59  EISYLKLLRHPHIIKLYDVITT-PTDIV--MVIEYA-GGELFDYIVEKKRMTEDEGRRFF 114

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
           Q++        A+EY H      ++H DLKP N+LLDDN+   ++DF ++ ++T  +   
Sbjct: 115 QQI------ICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165

Query: 583 TQTQTLGTIGYMAP 596
           T   + G+  Y AP
Sbjct: 166 T---SCGSPNYAAP 176

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 34/134 (25%), Positives = 60/134 (44%), Gaps = 12/134 (8%)

Query: 469 DVECEM-----MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           +V   +     +++ RH  L  +  S    +    V+EY   G L  +L       +   
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA 250

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           R     ++ SAL+YLH   +  V++ DLK  N++LD +    ++DF + K    +  +  
Sbjct: 251 RFYGA-EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 305

Query: 584 QTQTL-GTIGYMAP 596
             +T  GT  Y+AP
Sbjct: 306 -MKTFCGTPEYLAP 318

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 52/356 (14%), Positives = 102/356 (28%), Gaps = 76/356 (21%)

Query: 35  TLKFLGLQNNSLSGS-LSSIANV--RLPNLEKLYLWGNNFSGT----IPRFIFNASKLSK 87
           +++   L+ ++++     S+  V     +++++ L GN         +   I +   L  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 88  LSLGMNSFS----------GFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS 137
                                +         L  + L +N    +  E   +  LS    
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE-PLIDFLSKHTP 123

Query: 138 LTLIDLSNNPLD-----------GILPKTSISNLSRSLEEFYMYNCNISGG----IPEEI 182
           L  + L NN L              L     +  +  L         +  G      +  
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183

Query: 183 SNLTNLVEIDLGGNKLN-----GSIPITLGKLRKLQRLNLEDNIL--EGSIPDDICRLAE 235
            +   L  + +  N +        +   L   ++L+ L+L+DN     GS       LA 
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS-----ALAI 238

Query: 236 LYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI-------PLTFWNLKDILQLNF 288
                L S               +LR L L    L++          +      +  L  
Sbjct: 239 A----LKSWP-------------NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281

Query: 289 SSNFLTGPLLLEIG-----NLKVLIGIDFSMNNFS--GVIPREIGEKLSYLEDLNL 337
             N +    +  +       +  L+ ++ + N FS    +  EI E  S      L
Sbjct: 282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGEL 337

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 52/273 (19%), Positives = 92/273 (33%), Gaps = 45/273 (16%)

Query: 6   IGNLQNLEELQLGQNKL----------IGTVPAAIFNVSTLKFLGLQNNSLSGS-LSSIA 54
           I + ++LE  +                +  +  A+     L  + L +N+   +    + 
Sbjct: 56  IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115

Query: 55  NV--RLPNLEKLYLWGNNFS-------------GTIPRFIFNASKLSKLSLGMNSFSG-- 97
           +   +   LE LYL  N                  + +   NA  L  +  G N      
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175

Query: 98  --FIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPL--DGILP 153
                 TF + R L  + + +N +     E   L  L+ C+ L ++DL +N     G   
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 235

Query: 154 KTSISNLSRSLEEFYMYNCNISG----GIPEEISNLTN--LVEIDLGGNKLNGSIPITLG 207
                    +L E  + +C +S      + +  S L N  L  + L  N++      TL 
Sbjct: 236 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295

Query: 208 -----KLRKLQRLNLEDNIL--EGSIPDDICRL 233
                K+  L  L L  N    E  + D+I  +
Sbjct: 296 TVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 328

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 49/271 (18%), Positives = 85/271 (31%), Gaps = 47/271 (17%)

Query: 107 RNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPL---------DGILPKTSI 157
            ++E   L  + +T+   + S  + L    S+  I LS N +         + I  K  +
Sbjct: 4   FSIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62

Query: 158 SNLSRSLEEFYMYNCNISGG---IPEEISNLTNLVEIDLGGNKL--NGSIPIT--LGKLR 210
                S          I      + + +     L  + L  N        P+   L K  
Sbjct: 63  EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 122

Query: 211 KLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKL 270
            L+ L L +N L    P    ++A   +    + K   +          LR +  G N+L
Sbjct: 123 PLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNA--------PPLRSIICGRNRL 171

Query: 271 TS-----IPLTFWNLKDILQLNFSSNFLT--------GPLLLEIGNLKVLIGIDFSMNNF 317
            +        TF + + +  +    N +            L     LKVL   D   N F
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVL---DLQDNTF 228

Query: 318 SGVIPREIGEKLSY---LEDLNLSFNKLKGE 345
           + +    +   L     L +L L+   L   
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSAR 259

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 56.4 bits (137), Expect = 7e-09
 Identities = 26/106 (24%), Positives = 48/106 (45%), Gaps = 10/106 (9%)

Query: 474 MMKSIRHRN---LIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCI-LDIFQRLNI 527
            +++  H N   L+ V ++   +      LV E++    L  YL  +    L      ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           M      L++LH   +  ++H DLKP N+L+       L+DF +A+
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 29/130 (22%), Positives = 52/130 (40%), Gaps = 12/130 (9%)

Query: 471 ECEMMKSIRHR--NLIKVISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNI 527
           E  ++K +      +I+++      +   L+LE   P   L  ++     + +   R + 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SF 154

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLTGEDQSMTQTQ 586
              V  A+ + H   +  V+H D+K  N+L+D N     L DF    LL     ++    
Sbjct: 155 FWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTD- 207

Query: 587 TLGTIGYMAP 596
             GT  Y  P
Sbjct: 208 FDGTRVYSPP 217

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 25/68 (36%), Positives = 36/68 (52%), Gaps = 8/68 (11%)

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTL 588
           +  ALE+LH      +I+ D+K  N+LLD N   H  L+DF ++K    ++         
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD-FC 221

Query: 589 GTIGYMAP 596
           GTI YMAP
Sbjct: 222 GTIEYMAP 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 39/196 (19%), Positives = 71/196 (36%), Gaps = 43/196 (21%)

Query: 439 ELCRATDEFS-ENNLIGRGGFALFIRA---------------FKSFDVE----CEM--MK 476
           E  R  D F  E   +GRG +    +A                +   +      E+  ++
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR 73

Query: 477 SIRHRN---LIKVISSCSNEEFKALVLEYMPHGSLEKYL--------YSSNCILDIFQRL 525
            ++H N   L KV  S ++ +   L+ +Y  H  L   +              L      
Sbjct: 74  ELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLTGEDQS 581
           +++  +   + YLH   +  V+H DLKP+N+L+           ++D   A+L     + 
Sbjct: 132 SLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188

Query: 582 MTQ-TQTLGTIGYMAP 596
           +      + T  Y AP
Sbjct: 189 LADLDPVVVTFWYRAP 204

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 27/106 (25%), Positives = 47/106 (44%), Gaps = 10/106 (9%)

Query: 474 MMKSIRHRN---LIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYS-SNCILDIFQRLNI 527
            +++  H N   L  V +    +      LV E++    L  YL       +      ++
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
           M  +   L++LH   S  V+H DLKP N+L+  +    L+DF +A+
Sbjct: 126 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 35/138 (25%), Positives = 56/138 (40%), Gaps = 20/138 (14%)

Query: 469 DVECEMM------KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           DVEC M+         +   L ++ S     +    V+EY+  G L  ++         F
Sbjct: 384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRF 439

Query: 523 --QRLNIMI-DVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
                     ++A  L +L    S  +I+ DLK  NV+LD      ++DF + K    + 
Sbjct: 440 KEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496

Query: 580 QSMTQTQTL-GTIGYMAP 596
                T+T  GT  Y+AP
Sbjct: 497 V---TTKTFCGTPDYIAP 511

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 32/164 (19%), Positives = 59/164 (35%), Gaps = 54/164 (32%)

Query: 453 IGRGGFALFIRAF--------------KSFDVECE---MMKSIRHRNLIKVI----SSCS 491
           +G G     ++ F                     E     ++ +  ++++++    +  +
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 85

Query: 492 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--------------NIMIDVASALEY 537
             +   +V+E +  G L             F R+               IM  +  A++Y
Sbjct: 86  GRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 538 LHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGE 578
           LH   S  + H D+KP N+L      N +  L+DF  AK  TGE
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 54.5 bits (132), Expect = 4e-08
 Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 11/69 (15%)

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTL 588
           ++ AL +LH      +I+ DLKP N++L+     H  L+DF + K    +      T T 
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTF 181

Query: 589 -GTIGYMAP 596
            GTI YMAP
Sbjct: 182 CGTIEYMAP 190

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 54.1 bits (131), Expect = 5e-08
 Identities = 26/69 (37%), Positives = 40/69 (57%), Gaps = 11/69 (15%)

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTL 588
           +A AL++LH   S  +I+ DLKP N+LLD+    H  L+DF ++K     ++      + 
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSF 186

Query: 589 -GTIGYMAP 596
            GT+ YMAP
Sbjct: 187 CGTVEYMAP 195

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 53.8 bits (130), Expect = 6e-08
 Identities = 34/134 (25%), Positives = 59/134 (44%), Gaps = 13/134 (9%)

Query: 469 DVECEMM-----KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 523
           +V   +      ++ RH  L  +  +    +    V+EY   G L  +L       +   
Sbjct: 48  EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA 107

Query: 524 RLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 583
           R     ++ SALEYLH   S  V++ D+K  N++LD +    ++DF + K    +  +  
Sbjct: 108 RFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161

Query: 584 QTQTL-GTIGYMAP 596
             +T  GT  Y+AP
Sbjct: 162 -MKTFCGTPEYLAP 174

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 53.4 bits (129), Expect = 9e-08
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 8/100 (8%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
            V+EY+  G L  ++     + +   R     +++ AL YLH      +I+ DLK  NVL
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNVL 142

Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIGYMAP 596
           LD      L+D+ + K           T T  GT  Y+AP
Sbjct: 143 LDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAP 179

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 38/135 (28%), Positives = 57/135 (42%), Gaps = 14/135 (10%)

Query: 469 DVECEMM------KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           DVEC M        +  H  L ++       +    V+E++  G L  ++  S    +  
Sbjct: 66  DVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR 125

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
            R     ++ SAL +LH      +I+ DLK  NVLLD      L+DF + K       + 
Sbjct: 126 ARF-YAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT- 180

Query: 583 TQTQTL-GTIGYMAP 596
             T T  GT  Y+AP
Sbjct: 181 --TATFCGTPDYIAP 193

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 28/69 (40%), Positives = 38/69 (55%), Gaps = 11/69 (15%)

Query: 531 VASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTL 588
           +ASAL YLH   S  +++ DLKP N+LLD     H  L+DF + K     + +   T T 
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTF 199

Query: 589 -GTIGYMAP 596
            GT  Y+AP
Sbjct: 200 CGTPEYLAP 208

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 23/100 (23%), Positives = 46/100 (46%), Gaps = 9/100 (9%)

Query: 488 SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 544
            + S  ++  +++EY+P   H  L+ ++ S   I      +  +  +  A+ ++H   S 
Sbjct: 105 VNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SL 160

Query: 545 LVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMT 583
            + H D+KP N+L++  +    L DF  AK L    +   
Sbjct: 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI-PSEPSV 199

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 18/137 (13%)

Query: 469 DVECEMM------KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
           DVEC M+       +  H  L  +  +   +E    V+EY+  G L  ++ S +      
Sbjct: 60  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR 119

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQ 580
                  ++   L++LH   S  +++ DLK  N+LLD +   H  ++DF + K     D 
Sbjct: 120 ATFYAA-EIILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDA 173

Query: 581 SMTQTQTL-GTIGYMAP 596
               T T  GT  Y+AP
Sbjct: 174 K---TNTFCGTPDYIAP 187

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 31/196 (15%), Positives = 66/196 (33%), Gaps = 64/196 (32%)

Query: 465 FKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYL---------- 512
            ++   E +++  I  H N++ ++ +C+      +V +E+   G+L  YL          
Sbjct: 69  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128

Query: 513 ------------YSSNCILDIFQRLNIMI------------------------------D 530
                       Y     +D+ +RL+ +                               D
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188

Query: 531 VASALEYLHFGY----------SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
             +    + + +          S   IH DL   N+LL +  V  + DF +A+ +  +  
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248

Query: 581 SMTQTQTLGTIGYMAP 596
            + +      + +MAP
Sbjct: 249 YVRKGDARLPLKWMAP 264

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 34/142 (23%), Positives = 65/142 (45%), Gaps = 22/142 (15%)

Query: 471 ECEMMKSIRHRNLIKVI------------SSCSNEEFKA--LVLEYMPHGSLEKYLYSSN 516
           E ++++ + H N++KV                S  E  +  +V EYM    L   L    
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP 116

Query: 517 CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLL 575
            + +  +    M  +   L+Y+H   SA V+H DLKP+N+ ++ +++V  + DF +A+++
Sbjct: 117 LLEEHAR--LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 576 TGEDQSMTQ-TQTLGTIGYMAP 596
                     ++ L T  Y +P
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSP 193

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 8/100 (8%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL 557
            V+EY+  G L  ++     + +   R     +++ AL YLH      +I+ DLK  NVL
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNVL 185

Query: 558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIGYMAP 596
           LD      L+D+ + K           T T  GT  Y+AP
Sbjct: 186 LDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAP 222

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 33/132 (25%), Positives = 53/132 (40%), Gaps = 14/132 (10%)

Query: 471 ECEMMKSIR----HRNLIKVISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRL 525
           E  ++  +     H  +I+++     +E   LVLE  +P   L  Y+     + +   R 
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR- 142

Query: 526 NIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQ 584
                V +A+++ H   S  V+H D+K  N+L+D     A L DF    LL         
Sbjct: 143 CFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYT 196

Query: 585 TQTLGTIGYMAP 596
               GT  Y  P
Sbjct: 197 D-FDGTRVYSPP 207

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 24/129 (18%), Positives = 56/129 (43%), Gaps = 9/129 (6%)

Query: 471 ECEMMKSIR-HRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           E  ++  +  H N++ +++    +  +   LV +YM    L   + ++  IL+   +  +
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYV 114

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
           +  +   ++YLH   S  ++H D+KPSN+LL+      ++DF +++      +       
Sbjct: 115 VYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 588 LGTIGYMAP 596
                    
Sbjct: 172 SINENTENF 180

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 51.8 bits (125), Expect = 3e-07
 Identities = 28/103 (27%), Positives = 44/103 (42%), Gaps = 14/103 (13%)

Query: 498 LVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALEYLHFGYSALVIHCDLKPS 554
            V+EY+  G L  ++         F          ++A  L +L    S  +I+ DLK  
Sbjct: 98  FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLD 150

Query: 555 NVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIGYMAP 596
           NV+LD      ++DF + K    +      T+T  GT  Y+AP
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAP 190

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 33/218 (15%), Positives = 74/218 (33%), Gaps = 30/218 (13%)

Query: 10  QNLEELQLGQNKLIGTVPAAIF------NVSTLKFLGLQNNSLS----GSLSSIANVRLP 59
            ++  L L  N  +G   +           + +  L L+ N+L+      L+        
Sbjct: 138 ASITSLNLRGND-LGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196

Query: 60  NLEKLYLWGNNFSGTIPRFI-----FNASKLSKLSLGMNSFSG----FIPSTFGNLRNLE 110
           ++  L L  N         +        + +  L+L +N   G     +     +L++L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256

Query: 111 QLGLDENYLTSSTPEL--SFLSSLSNCKSLTLIDLSNNPLD---GILPKTSISNLSRSLE 165
            + LD + + + + E   +  ++  N + + L+D +   +     I     I  LS   +
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKAD 316

Query: 166 EFYMYNCNIS-----GGIPEEISNLTNLVEIDLGGNKL 198
              + N  +          E+++    L E       L
Sbjct: 317 VPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 41/248 (16%), Positives = 77/248 (31%), Gaps = 37/248 (14%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNV-----STLKFLGLQNNSLS-GSLSSIANV-RLPN 60
              ++  L L  N L       +  +     + +  L L  N LS  S   +        
Sbjct: 49  TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108

Query: 61  --LEKLYLWGNNFSGTIPRFIFNA-----SKLSKLSLGMNSFS-----GFIPSTFGNLRN 108
             +  L L  N+FS         A     + ++ L+L  N          I        N
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168

Query: 109 LEQLGLDENYLTSSTPELSFLSSL--SNCKSLTLIDLSNNPL--DGILP-KTSISNLSRS 163
           +  L L  N L S     + L+    S   S+T +DLS N L            S++   
Sbjct: 169 VNSLNLRGNNLASKN--CAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNH 226

Query: 164 LEEFYMYNCNISG----GIPEEISNLTNLVEIDLGGNKLNG-------SIPITLGKLRKL 212
           +    +    + G     +     +L +L  + L  + +         ++      ++K+
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286

Query: 213 QRLNLEDN 220
             ++    
Sbjct: 287 ILVDKNGK 294

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 35/236 (14%), Positives = 70/236 (29%), Gaps = 44/236 (18%)

Query: 11  NLEELQLGQNKLIGTVPAAIFNV-----STLKFLGLQNNSLSG-SLSSIANV-RLPN--L 61
            +  L LG N       +          +++  L L+ N L   S   +  +       +
Sbjct: 110 TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANV 169

Query: 62  EKLYLWGNNFSGTIPRFIFNA-----SKLSKLSLGMNSF-----SGFIPSTFGNLRNLEQ 111
             L L GNN +      +        + ++ L L  N       +           ++  
Sbjct: 170 NSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVS 229

Query: 112 LGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN 171
           L L  N L   + E        + K L  + L  + +  +  +     L  +        
Sbjct: 230 LNLCLNCLHGPSLEN-LKLLKDSLKHLQTVYLDYDIVKNMSKE-QCKALGAAF------- 280

Query: 172 CNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKL-----RKLQRLNLEDNIL 222
                       N+  ++ +D  G +++ S  I +  L      K    +L +  L
Sbjct: 281 -----------PNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCL 325

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 44/250 (17%), Positives = 83/250 (33%), Gaps = 39/250 (15%)

Query: 132 LSNCKSLTLIDLSNNPLDGILPK---TSISNLSRSLEEFYMYNCNISGGIPEEI-----S 183
            S    +T +DLS N L  I       + +N   S+    +   ++     +E+     +
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 184 NLTNLVEIDLGGNKLNGSIPITLGKL-----RKLQRLNLEDNILEGSIPDDICRL----- 233
              N+  ++L GN L+      L K        +  L+L  N        +  +      
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 234 AELYRLELGSNKLYGS-----IPACFGNLASLRILSLGSNKLTSI-------PLTFWNLK 281
           A +  L L  N L        I       A++  L+L  N L S         L      
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 282 DILQLNFSSNFLTGPLLLEIG-----NLKVLIGIDFSMNNFSGVIPREIGEKL---SYLE 333
            +  L+ S+N L      E+          ++ ++  +N   G     +        +L+
Sbjct: 198 -VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256

Query: 334 DLNLSFNKLK 343
            + L ++ +K
Sbjct: 257 TVYLDYDIVK 266

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 6e-07
 Identities = 74/470 (15%), Positives = 138/470 (29%), Gaps = 151/470 (32%)

Query: 180 EEISNLTNLVEIDLGGNKLNGSIPITLGKLRK-LQRLNLEDNI-LEG-------SIPDDI 230
           E+   L N  ++     K N S      KLR+ L  L    N+ ++G        +  D+
Sbjct: 114 EQRDRLYNDNQV---FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170

Query: 231 CRLAEL--------YRLELGSNKLYGSIPACFGNLASLRI---LSLGSNKLTSIPLTFWN 279
           C   ++        + L L +     ++      L   +I    +  S+  ++I L   +
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL-LYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 280 LKDILQLNFSSNFLTGPLLL--EIGNLKVLIGIDFS-----MNNFSGVIPREIGEKLSY- 331
           ++  L+    S      LL+   + N K     + S        F  V         ++ 
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289

Query: 332 -LEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPP--CKTSIHHTSWKN 388
            L+  +++    + +         +         L C   +L  P     T+        
Sbjct: 290 SLDHHSMTLTPDEVK----SLLLKY---------LDCRPQDL--PREVLTTN-------- 326

Query: 389 SLLLGIVLPLSTTLLIVVIWLILRYRQRGKKPSNDANMPLVATWRTFSYLELCRATD--E 446
                   P      + +I   +R            +    ATW  + ++   + T   E
Sbjct: 327 --------PR----RLSIIAESIR------------DGL--ATWDNWKHVNCDKLTTIIE 360

Query: 447 FSENNL---IGRGGF-ALFIRAF------------------KSFDVECEMMKSIRHRNLI 484
            S N L     R  F  L +  F                     DV   ++  +   +L+
Sbjct: 361 SSLNVLEPAEYRKMFDRLSV--FPPSAHIPTILLSLIWFDVIKSDVM-VVVNKLHKYSLV 417

Query: 485 KVISSCSNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRL------NIMIDVASA 534
           +       +E      ++ LE       E  L+ S  I+D +         +++      
Sbjct: 418 E----KQPKESTISIPSIYLELKVKLENEYALHRS--IVDHYNIPKTFDSDDLIPPYLDQ 471

Query: 535 LEYLHFGYSALVIHCDLKP----------SNVLLDDNMVAHLSDFSIAKL 574
             Y H G+     H  LK             V LD         F   K+
Sbjct: 472 YFYSHIGH-----H--LKNIEHPERMTLFRMVFLDFR-------FLEQKI 507

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 8e-05
 Identities = 37/203 (18%), Positives = 72/203 (35%), Gaps = 44/203 (21%)

Query: 408 WLILRYRQRGKKPS--------------NDANMPLVA--TWRTFSYLELCRATDEFSENN 451
           +L+   +   ++PS              ND N         R   YL+L +A  E     
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRLYND-NQVFAKYNVSRLQPYLKLRQALLELRPAK 151

Query: 452 LI---GRGGF---ALFIRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 505
            +   G  G     + +    S+ V+C+M   I   NL     +C++ E    +L+ + +
Sbjct: 152 NVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNL----KNCNSPETVLEMLQKLLY 207

Query: 506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV-- 563
                +   S+   +I  R++ +      L       + L++          L +  V  
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV----------LLN--VQN 255

Query: 564 -AHLSDFSI-AK-LLTGEDQSMT 583
               + F++  K LLT   + +T
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVT 278

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 5e-04
 Identities = 59/438 (13%), Positives = 125/438 (28%), Gaps = 118/438 (26%)

Query: 186 TNLVEIDLGGNKLNGSIPITLGKLRK-LQRLNLED---NILEGSIPDDICRLAELYRLEL 241
               E       +   + +            +++D   +IL     D I        +  
Sbjct: 9   FETGEHQYQYKDI---LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHI--------IMS 57

Query: 242 GSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEI 301
                            +LR+     +K   +   F  ++++L++N+   FL  P+  E 
Sbjct: 58  KDAVS-----------GTLRLFWTLLSKQEEMVQKF--VEEVLRINY--KFLMSPIKTEQ 102

Query: 302 GNLKVLIGIDFS-----MNNFSGV-----IPREIGEKLSYLEDLNLSFNKLKGEIPRG-G 350
                ++   +      + N + V     + R   +    L    L     K  +  G  
Sbjct: 103 -RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL--QPYLKLRQALLELRPAKNVLIDGVL 159

Query: 351 SFGN--FSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIW 408
             G    + +     ++ C             I    W N   L      S   ++ ++ 
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDF--------KIF---WLN---LKNCN--SPETVLEMLQ 203

Query: 409 -LILRYRQRGK-KPSNDANMPLVATWRTFSYLELCRATDEFSENNLIGRGGF--ALFI-- 462
            L+ +       +  + +N+ L                 E     L+    +   L +  
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHS----------IQAELR--RLLKSKPYENCLLVLL 251

Query: 463 -----RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG-----SLE--- 509
                +A+ +F++ C+++ + R +    V    S      + L++               
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQ---VTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308

Query: 510 KYLYSSNC--------ILDIFQRLNIMI-----DVASALE-YLHFGYSAL--VIHCDLKP 553
           KYL   +C        +L    R   +I     D  +  + + H     L  +I   L  
Sbjct: 309 KYL---DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL-- 363

Query: 554 SNVLLDDNMVAHLSDFSI 571
            NVL            S+
Sbjct: 364 -NVLEPAEYRKMFDRLSV 380

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 43/253 (16%), Positives = 93/253 (36%), Gaps = 16/253 (6%)

Query: 21  KLIGTVPAAIFNVSTLKFLGLQNNSLS-GSLSSIANVRLPNLEKLYLWGNNFSGTIPRFI 79
             +    A  F+   ++ + L N+ +   +L  I + +   L+ L L G   S  I   +
Sbjct: 80  SFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILS-QCSKLQNLSLEGLRLSDPIVNTL 138

Query: 80  FNASKLSKLSLGMNSF--SGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS 137
              S L +L+L   S      + +   +   L++L L   +  +       ++     ++
Sbjct: 139 AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA--HVSET 196

Query: 138 LTLIDLSNNPLDGILPKTSISNLSRS---LEEFYMYNC-NISGGIPEEISNLTNLVEIDL 193
           +T ++LS       L K+ +S L R    L    + +   +     +E   L  L  + L
Sbjct: 197 ITQLNLSG--YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSL 254

Query: 194 GG-NKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPA 252
                +     + LG++  L+ L +   + +G++      L     L++  +        
Sbjct: 255 SRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFTTIARP 311

Query: 253 CFGNLASLRILSL 265
             GN  +  I  +
Sbjct: 312 TIGNKKNQEIWGI 324

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 48.8 bits (117), Expect = 7e-07
 Identities = 42/131 (32%), Positives = 57/131 (43%), Gaps = 32/131 (24%)

Query: 19  QNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF 78
           QN  + +VPA I   +  + L L NN ++  L       L NL++LY   N         
Sbjct: 20  QNIRLASVPAGIP--TDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSN--------- 67

Query: 79  IFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL 138
                KL+ +  G+          F  L  L QL L++N+L S  P  +F     N KSL
Sbjct: 68  -----KLTAIPTGV----------FDKLTQLTQLDLNDNHLKS-IPRGAF----DNLKSL 107

Query: 139 TLIDLSNNPLD 149
           T I L NNP D
Sbjct: 108 THIYLYNNPWD 118

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 45.7 bits (109), Expect = 7e-06
 Identities = 34/104 (32%), Positives = 45/104 (43%), Gaps = 6/104 (5%)

Query: 190 EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS 249
            ++    +L  S+P   G     QRL L +N +    P     L  L +L   SNKL  +
Sbjct: 16  LVNCQNIRLA-SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TA 71

Query: 250 IPA-CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSN 291
           IP   F  L  L  L L  N L SIP   F NLK +  +   +N
Sbjct: 72  IPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 9e-07
 Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 7/113 (6%)

Query: 8   NLQNLEELQLGQNKL-IGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV-RLPNLEKLY 65
              +++EL L  ++   G +         L+FL   N  L+    SIAN+ +L  L+KL 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT----SIANLPKLNKLKKLE 70

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDEN 117
           L  N  SG +         L+ L+L  N             L NL+ L L   
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.2 bits (110), Expect = 3e-06
 Identities = 21/91 (23%), Positives = 45/91 (49%), Gaps = 3/91 (3%)

Query: 184 NLTNLVEIDLGGNKLN-GSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG 242
             +++ E+ L  ++ N G +     +  +L+ L+  +  L  SI  ++ +L +L +LEL 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 243 SNKLYGSIPACFGNLASLRILSLGSNKLTSI 273
            N++ G +        +L  L+L  NK+  +
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.4 bits (100), Expect = 7e-05
 Identities = 20/107 (18%), Positives = 40/107 (37%), Gaps = 5/107 (4%)

Query: 134 NCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL 193
               +  + L N+  +    +         LE     N  ++      +  L  L +++L
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEF-EELEFLSTINVGLT--SIANLPKLNKLKKLEL 71

Query: 194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE 240
             N+++G + +   K   L  LNL  N ++      I  L +L  L+
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLK 116

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 48.0 bits (115), Expect = 1e-06
 Identities = 40/131 (30%), Positives = 54/131 (41%), Gaps = 32/131 (24%)

Query: 19  QNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF 78
             K + +VP  I   +T + L L +N ++  L      RL  L +L L  N         
Sbjct: 17  SGKSLASVPTGIP--TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNN--------- 64

Query: 79  IFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL 138
                +L+ L  G+          F  L  L QL L++N L S  P  +F     N KSL
Sbjct: 65  -----QLTVLPAGV----------FDKLTQLTQLSLNDNQLKS-IPRGAF----DNLKSL 104

Query: 139 TLIDLSNNPLD 149
           T I L NNP D
Sbjct: 105 THIWLLNNPWD 115

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 38/104 (36%), Positives = 50/104 (48%), Gaps = 6/104 (5%)

Query: 190 EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS 249
            +D  G  L  S+P   G     Q L L DN +    P    RL +L RL+L +N+L   
Sbjct: 13  TVDCSGKSLA-SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TV 68

Query: 250 IPA-CFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSN 291
           +PA  F  L  L  LSL  N+L SIP   F NLK +  +   +N
Sbjct: 69  LPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 36/201 (17%), Positives = 67/201 (33%), Gaps = 49/201 (24%)

Query: 4   LEIGNLQNLEELQL-GQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV-RLPNL 61
            +       E+++L G    I  + A +  +   K L L  N++      I+++  + NL
Sbjct: 17  RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE----KISSLSGMENL 72

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
             L L  N              K+  L                    LE+L +  N + S
Sbjct: 73  RILSLGRNLIK-----------KIENLD--------------AVADTLEELWISYNQIAS 107

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
                  LS +    +L ++ +SNN +        ++ L   LE+  +    +     E 
Sbjct: 108 -------LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALD-KLEDLLLAGNPLYNDYKEN 159

Query: 182 ----------ISNLTNLVEID 192
                     +  L NL ++D
Sbjct: 160 NATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.7 bits (101), Expect = 9e-05
 Identities = 24/120 (20%), Positives = 47/120 (39%), Gaps = 15/120 (12%)

Query: 178 IPEEISNLTNLVEIDLGGNKLNGSIPIT----LGKLRKLQRLNLEDNILEGSIPDDICRL 233
           +   +S L     + L  N       I     L  +  L+ L+L  N+++  I +     
Sbjct: 40  MDATLSTLKACKHLALSTNN------IEKISSLSGMENLRILSLGRNLIK-KIENLDAVA 92

Query: 234 AELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP--LTFWNLKDILQLNFSSN 291
             L  L +  N++  +  +    L +LR+L + +NK+T+         L  +  L  + N
Sbjct: 93  DTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 33/158 (20%), Positives = 55/158 (34%), Gaps = 9/158 (5%)

Query: 197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGN 256
           +    +        +   L+     +E  +   +  L     L L +N +   I +    
Sbjct: 16  ERKSVVATEA----EKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-SSLSG 68

Query: 257 LASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNN 316
           + +LRILSLG N +  I         + +L  S N +    L  I  L  L  +  S N 
Sbjct: 69  MENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNK 126

Query: 317 FSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGN 354
            +     +    L  LEDL L+ N L  +     +   
Sbjct: 127 ITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.8 bits (115), Expect = 3e-06
 Identities = 29/186 (15%), Positives = 59/186 (31%), Gaps = 23/186 (12%)

Query: 57  RLPNLEKLYLWGNNFS---------GTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLR 107
           +  + E L+    +F            +   +     L+ L +   +          NL+
Sbjct: 137 KFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLK 196

Query: 108 NLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSR----S 163
           +LE   +    L  S  E    S L N + L L     +              S+    +
Sbjct: 197 SLE---IISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPN 253

Query: 164 LEEFYMYNCNISGGIPEEISN---LTNLVEIDLGGNKLNGS----IPITLGKLRKLQRLN 216
           L+   + +      + E       L  L  +D+    L       +   + K++ L+ +N
Sbjct: 254 LKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFIN 313

Query: 217 LEDNIL 222
           ++ N L
Sbjct: 314 MKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 5e-06
 Identities = 31/156 (19%), Positives = 48/156 (30%), Gaps = 17/156 (10%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGS-LSSIANVRLPNLEKL 64
           +  +  L  L++     +            LK L + +  L  S +  I    LPNLEKL
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGK---KPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL 224

Query: 65  YLW-------GNNFSGTIPRFIFNAS--KLSKLSLGMNSFSGFIPSTFGN---LRNLEQL 112
            L+        +                 L  L +        +   F     L  LE +
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284

Query: 113 GLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPL 148
            +    LT     L  L  +   K L  I++  N L
Sbjct: 285 DISAGVLTDEGARL-LLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.3 bits (106), Expect = 3e-05
 Identities = 19/129 (14%), Positives = 50/129 (38%), Gaps = 17/129 (13%)

Query: 9   LQNLEELQLGQNKLIGTVPAAIF--NVSTLK----FLGLQNNSLSGSLSSIANV----RL 58
             NL+ L++    L  +V   I   ++  L+    ++G+++    G ++    +    R 
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 59  PNLEKLYLWGNNFSGTIPRFIFNA---SKLSKLSLGMNSFSGF----IPSTFGNLRNLEQ 111
           PNL+ L +        +      +    +L  + +     +      +      +++L+ 
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 112 LGLDENYLT 120
           + +  NYL+
Sbjct: 312 INMKYNYLS 320

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 3/91 (3%)

Query: 184 NLTNLVEIDLGGNKLN-GSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG 242
               + E+ L   K N G I     +   L+ L+L +  L  S+  ++ +L +L +LEL 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 243 SNKLYGSIPACFGNLASLRILSLGSNKLTSI 273
            N+++G +      L +L  L+L  NKL  I
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 32/143 (22%), Positives = 48/143 (33%), Gaps = 34/143 (23%)

Query: 8   NLQNLEELQLGQNKL-IGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV-RLPNLEKLY 65
               + EL L   K   G +         L+FL L N  L     S++N+ +LP L+KL 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI----SVSNLPKLPKLKKLE 77

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
           L  N   G +         L+ L+L  N                               +
Sbjct: 78  LSENRIFGGLDMLAEKLPNLTHLNLSGNKLK----------------------------D 109

Query: 126 LSFLSSLSNCKSLTLIDLSNNPL 148
           +S L  L   + L  +DL N  +
Sbjct: 110 ISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 21/107 (19%), Positives = 42/107 (39%), Gaps = 5/107 (4%)

Query: 134 NCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL 193
              ++  + L N   +    +   +    +LE   + N  +       +  L  L +++L
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEF-VNLEFLSLINVGLI--SVSNLPKLPKLKKLEL 78

Query: 194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE 240
             N++ G + +   KL  L  LNL  N L+      +  L +L  L+
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLK 123

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 37/250 (14%), Positives = 72/250 (28%), Gaps = 38/250 (15%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNV-STLKFLGLQNNSLS----GSLSSIANVRLPNLE 62
               L+E+ L   +L       +  V    + LGLQ NSL       L  +       + 
Sbjct: 99  GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQIT 158

Query: 63  KLYLWGNNFSGTIPRFIFNA----SKLSKLSLGMNSFS----GFIPSTFGNLRNLEQLGL 114
            L L  N  +      +       + ++ LSL            + +     R L++L +
Sbjct: 159 TLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNV 218

Query: 115 DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLD-----GILPKTSISNLSRSLEEFYM 169
             N    +    +   +     SL L+ L  N L       +      +     +     
Sbjct: 219 AYNGAGDTAAL-ALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLT 277

Query: 170 YNCNISGGIPEEISNL---------------TNLVEIDLGGNKLNGSIPITLGKLRK--- 211
               +S      +S +                 L+  DL  ++     P    +L +   
Sbjct: 278 EGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEG 337

Query: 212 -LQRLNLEDN 220
            ++ L  +  
Sbjct: 338 EVRALLEQLG 347

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.2 bits (110), Expect = 4e-06
 Identities = 26/142 (18%), Positives = 41/142 (28%), Gaps = 34/142 (23%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV-RLPNLEKLYL 66
           N     EL L   K I  +      +     +   +N +      +     L  L+ L +
Sbjct: 17  NAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIR----KLDGFPLLRRLKTLLV 71

Query: 67  WGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL 126
             N               L++L L  NS                              EL
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSLV----------------------------EL 103

Query: 127 SFLSSLSNCKSLTLIDLSNNPL 148
             L  L++ KSLT + +  NP+
Sbjct: 104 GDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 24/148 (16%), Positives = 42/148 (28%), Gaps = 34/148 (22%)

Query: 130 SSLSNCKSLTLIDLSNNPLDGILPKTSISNLS---RSLEEFYMYNCNISGGIPEEISNLT 186
           +  +N      +DL    +        I NL       +     +  I     +    L 
Sbjct: 13  AQYTNAVRDRELDLRGYKI------PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLR 64

Query: 187 NLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKL 246
            L  + +  N++          L  L  L L +N         +  L +L  L       
Sbjct: 65  RLKTLLVNNNRICRIGEGLDQALPDLTELILTNN--------SLVELGDLDPLA------ 110

Query: 247 YGSIPACFGNLASLRILSLGSNKLTSIP 274
                    +L SL  L +  N +T+  
Sbjct: 111 ---------SLKSLTYLCILRNPVTNKK 129

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 21/143 (14%), Positives = 51/143 (35%), Gaps = 14/143 (9%)

Query: 81  NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTL 140
           NA +  +L L        I +    L   + +   +N +         L      + L  
Sbjct: 17  NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-------LDGFPLLRRLKT 68

Query: 141 IDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG-GIPEEISNLTNLVEIDLGGN--- 196
           + ++NN +  I     +      L E  + N ++   G  + +++L +L  + +  N   
Sbjct: 69  LLVNNNRICRIGE--GLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

Query: 197 KLNGSIPITLGKLRKLQRLNLED 219
                    + K+ +++ L+ + 
Sbjct: 127 NKKHYRLYVIYKVPQVRVLDFQK 149

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 21/88 (23%), Positives = 32/88 (36%), Gaps = 3/88 (3%)

Query: 256 NLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMN 315
           N    R L L   K+  I      L     ++FS N +    L     L+ L  +  + N
Sbjct: 17  NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNNN 74

Query: 316 NFSGVIPREIGEKLSYLEDLNLSFNKLK 343
                I   + + L  L +L L+ N L 
Sbjct: 75  RICR-IGEGLDQALPDLTELILTNNSLV 101

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 31/247 (12%), Positives = 71/247 (28%), Gaps = 16/247 (6%)

Query: 32  NVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFS-GTIPRFIFNASKLSKLSL 90
           + +    +               +     LE++ L     +   +     +      L L
Sbjct: 78  HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL 137

Query: 91  -GMNSFSGF-IPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPL 148
                FS   + +     RNL++L L E+ +   +             SL  +++S    
Sbjct: 138 SSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGH-WLSHFPDTYTSLVSLNISCLAS 196

Query: 149 ---DGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNG----- 200
                 L    +     +L+   +        +   +     L E+  GG          
Sbjct: 197 EVSFSAL--ERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVY 254

Query: 201 -SIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG-SIPACFGNLA 258
             + + L   ++L+ L+   + +   +P      + L  L L    +    +        
Sbjct: 255 SGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCP 314

Query: 259 SLRILSL 265
            L+ L +
Sbjct: 315 KLQRLWV 321

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 45/334 (13%), Positives = 102/334 (30%), Gaps = 38/334 (11%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANV-----RLPNLE 62
              NL+ L+L +   +  +   +     L+ LG    +        + +         L 
Sbjct: 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELR 268

Query: 63  KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENYLTS 121
            L  + +     +P      S+L+ L+L   +   + +         L++L +  +Y+  
Sbjct: 269 CLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL-DYIED 327

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS--------RSLEEFYMYNCN 173
           +          S CK L  + +  +    + P  +++             LE    +   
Sbjct: 328 A----GLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQ 383

Query: 174 ISG-GIPEEISNLTNLVEIDLGGNKLNGSIPITLG-----------KLRKLQRLNLEDNI 221
           ++   +     N  N+    L   +      +TL              + L+RL+L   +
Sbjct: 384 MTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLL 443

Query: 222 LEGSIPDDICRLAELYRLELGSNKL-YGSIPACFGNLASLRILSLGSNKLT--SIPLTFW 278
            +           ++  L +         +        SLR L +        ++     
Sbjct: 444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANAS 503

Query: 279 NLKDILQLNFSSNFLTGPLLLEIG----NLKVLI 308
            L+ +  L  SS  ++      +G     L V +
Sbjct: 504 KLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEV 537

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 21/110 (19%), Positives = 41/110 (37%), Gaps = 12/110 (10%)

Query: 471 ECEMMKSIRHRNLI-KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 529
           E    K +     I  V           LV++ +   SLE  L        +        
Sbjct: 55  EYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAK 113

Query: 530 DVASALEYLHFGYSALVIHCDLKPSNVLL------DDNMVAHLSDFSIAK 573
            + + ++ +H      +++ D+KP N L+      + NM+ ++ DF + K
Sbjct: 114 QMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 32/145 (22%), Positives = 57/145 (39%), Gaps = 29/145 (20%)

Query: 453 IGRGGF-----ALFIRAFKSFDVECEMMKSIRHRNLI----------------KVISSCS 491
           IG G F        I A +   ++ E +K+ +H  L                  +    +
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGA 75

Query: 492 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDL 551
             ++  +V+E +   SLE      +    +   L +   + S +EY+H   S   IH D+
Sbjct: 76  EGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDV 131

Query: 552 KPSNVLL---DDNMVAHLSDFSIAK 573
           KP N L+       + ++ DF +AK
Sbjct: 132 KPDNFLMGLGKKGNLVYIIDFGLAK 156

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 27/121 (22%), Positives = 49/121 (40%), Gaps = 13/121 (10%)

Query: 460 LFIRAFKSFDVECEM-MKSIRHRNLIKVISSCSNE-EFKALVLEYMPHG-SLEKYL-YSS 515
            F RA K   V     + S     +   +    ++ +++ LVL  +  G SL+  L  S 
Sbjct: 95  FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSP 152

Query: 516 NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIA 572
             +L     L +   +  ALE+LH       +H ++   N+ +   D + V  L+ +  A
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFA 208

Query: 573 K 573
            
Sbjct: 209 F 209

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 31/111 (27%), Positives = 52/111 (46%), Gaps = 14/111 (12%)

Query: 471 ECEMMKSIRHRNLI-KVISSCSNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIM 528
           E    K +   + I +V       ++ A+VLE +  G SLE      +    +   L I 
Sbjct: 54  EYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIA 111

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLL------DDNMVAHLSDFSIAK 573
           I + S +EY+H   S  +I+ D+KP N L+         ++ H+ DF++AK
Sbjct: 112 IQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 44.9 bits (105), Expect = 4e-05
 Identities = 17/77 (22%), Positives = 28/77 (36%), Gaps = 6/77 (7%)

Query: 498 LVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV 556
           +VLE+   G  LE+       +  +    +I+  + ++L            H DL   NV
Sbjct: 139 IVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193

Query: 557 LLDDNMVAHLSDFSIAK 573
           LL    +  L      K
Sbjct: 194 LLKKTSLKKLHYTLNGK 210

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 19/87 (21%), Positives = 42/87 (48%), Gaps = 10/87 (11%)

Query: 491 SNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHC 549
           + + ++ ++++    G  L+K   ++         L + + +   LEY+H       +H 
Sbjct: 122 NGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHG 176

Query: 550 DLKPSNVLL---DDNMVAHLSDFSIAK 573
           D+K SN+LL   + + V +L D+ +A 
Sbjct: 177 DIKASNLLLNYKNPDQV-YLVDYGLAY 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 31/145 (21%), Positives = 58/145 (40%), Gaps = 29/145 (20%)

Query: 453 IGRGGF-----ALFIRAFKSFDVECEMMKSIRHRNLI----------------KVISSCS 491
           IG G F        I+  +   ++ E +K+ +H  L+                 V     
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGV 73

Query: 492 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDL 551
             ++  LV++ +   SLE      +  L +   L +   + + +E++H   S   +H D+
Sbjct: 74  EGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDI 129

Query: 552 KPSNVLLDDNMVAH---LSDFSIAK 573
           KP N L+     A+   + DF +AK
Sbjct: 130 KPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 21/92 (22%)

Query: 491 SNEEFKALVLEYMPHG-SLEKYL-----YSSNCILDIFQRLNIMIDVASALEYLHFGYSA 544
               ++ +V+E +  G  L+K       +  + +L +  R   M+DV   LEY+H     
Sbjct: 122 KGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIR---MLDV---LEYIH---EN 170

Query: 545 LVIHCDLKPSNVLL---DDNMVAHLSDFSIAK 573
             +H D+K +N+LL   + + V +L+D+ ++ 
Sbjct: 171 EYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 25/112 (22%), Positives = 47/112 (41%), Gaps = 21/112 (18%)

Query: 480 HRNLIK----VISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVA 532
             N+I     V    S     ALV E++ +   ++   +    +    +++ L       
Sbjct: 90  GPNIITLADIVKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK------ 141

Query: 533 SALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMT 583
            AL+Y H   S  ++H D+KP NV++D ++    L D+ +A+      Q   
Sbjct: 142 -ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYN 188

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	596
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.98
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.98
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.98
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.98
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.98
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.97
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.94
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.93
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.93
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.93
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.93
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.92
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.92
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.92
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.92
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.92
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.92
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.92
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.92
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.92
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.92
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.92
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.92
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.92
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.92
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.92
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.92
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.92
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.92
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.92
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.92
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.92
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.92
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.92
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.91
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.91
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.91
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.91
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.91
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.91
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.91
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.91
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.91
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.91
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.91
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.91
3niz_A	311	Rhodanese family protein; structural genomics, str	99.91
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.91
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.91
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.91
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.91
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.91
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.91
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.91
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.91
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.91
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.91
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.91
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.91
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.91
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.91
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.91
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.91
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.91
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.91
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.9
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.9
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.9
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.9
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.9
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.9
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.9
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.9
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.9
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.9
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.9
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.9
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.9
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.9
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.9
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.9
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.9
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.9
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.9
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.9
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.9
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.9
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.9
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.9
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.9
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.9
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.9
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.9
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.9
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.9
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.9
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.9
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.9
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.89
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.89
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.89
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.89
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.89
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.89
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.89
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.89
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.89
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.89
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.89
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.89
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.89
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.89
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.89
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.89
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.89
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.89
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.89
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.89
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.89
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.89
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.89
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.89
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.89
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.89
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.89
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.89
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.89
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.89
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.89
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.89
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.89
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.89
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.89
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.89
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.89
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.89
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.89
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.89
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.89
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.89
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.89
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.89
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.89
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.89
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.89
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.89
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.89
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.89
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.89
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.89
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.88
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.88
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.88
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.88
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.88
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.88
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.88
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.88
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.88
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.88
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.88
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.88
3bhy_A	283	Death-associated protein kinase 3; death associate	99.88
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.88
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.88
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.88
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.88
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.88
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.88
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.88
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.88
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.88
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.88
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.88
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.88
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.88
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.88
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.88
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.88
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.88
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.88
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.88
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.88
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.88
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.87
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.87
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.87
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.87
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.87
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.87
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.87
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.87
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.87
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.87
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.87
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.87
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.87
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.87
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.87
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.87
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.87
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.87
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.87
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.86
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.86
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.86
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.86
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.86
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.86
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.86
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.86
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.86
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.86
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.86
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.86
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.85
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.85
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.85
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.85
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.85
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.85
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.85
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.85
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.85
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.85
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.84
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.84
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.84
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.84
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.84
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.84
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.83
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.83
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.83
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.83
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
3uqc_A	286	Probable conserved transmembrane protein; structur	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.81
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.8
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.79
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.79
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.79
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.77
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.77
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.75
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.75
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.75
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.72
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.71
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.7
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.66
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.64
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.64
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.64
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.63
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.61
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.61
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.61
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.54
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.53
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.51
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.51
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.5
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.48
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.44
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.43
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.42
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.41
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.39
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.33
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.33
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.19
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.15
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.94
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.92
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.86
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.61
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.57
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.56
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.55
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.55
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.55
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.08
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.0
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.83
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.79
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.73
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.43
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.26
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.13
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.01
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.01
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.96
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.8
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.36
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	95.95
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	95.94
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	94.45
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	94.11
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	90.99
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	90.54
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	90.16
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	89.92
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.04
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	85.88
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	83.98
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	81.35
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	80.69

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.9e-49  Score=450.30  Aligned_cols=369  Identities=34%  Similarity=0.529  Sum_probs=303.2

Q ss_pred             CCcccCCC-CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcc--
Q 036342            2 IPLEIGNL-QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF--   78 (596)
Q Consensus         2 ip~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--   78 (596)
                      +|..+..+ ++|++|+|++|++++..|..|..+++|++|+|++|+++|.++...+..+++|++|+|++|++++.+|..  
T Consensus       285 ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~  364 (768)
T 3rgz_A          285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT  364 (768)
T ss_dssp             CCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHH
T ss_pred             cCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHH
Confidence            45555554 666666666666666666666666666666666666655555433333555555555555555444444  


Q ss_pred             -----------------------ccC--CCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCC
Q 036342           79 -----------------------IFN--ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLS  133 (596)
Q Consensus        79 -----------------------~~~--l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~  133 (596)
                                             +..  +++|++|+|++|.+++.+|..|.++++|++|++++|.+++..+.     .+.
T Consensus       365 ~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-----~l~  439 (768)
T 3rgz_A          365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS-----SLG  439 (768)
T ss_dssp             HHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCG-----GGG
T ss_pred             hhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccH-----HHh
Confidence                                   433  55677777777777778888888888888888888888865443     688


Q ss_pred             CCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCC
Q 036342          134 NCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQ  213 (596)
Q Consensus       134 ~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  213 (596)
                      ++++|+.|++++|.+++.+|. .+..+ ++|++|++++|++++..|..|.++++|++|++++|++++.+|.+++.+++|+
T Consensus       440 ~l~~L~~L~L~~n~l~~~~p~-~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  517 (768)
T 3rgz_A          440 SLSKLRDLKLWLNMLEGEIPQ-ELMYV-KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA  517 (768)
T ss_dssp             GCTTCCEEECCSSCCCSCCCG-GGGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred             cCCCCCEEECCCCcccCcCCH-HHcCC-CCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCC
Confidence            899999999999999988887 67777 7899999999999999999999999999999999999999999999999999


Q ss_pred             eEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhh---------------------------------------
Q 036342          214 RLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACF---------------------------------------  254 (596)
Q Consensus       214 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---------------------------------------  254 (596)
                      +|++++|.+++.+|..+..+++|+.|++++|++++.+|..+                                       
T Consensus       518 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  597 (768)
T 3rgz_A          518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ  597 (768)
T ss_dssp             EEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECT
T ss_pred             EEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999987777644                                       


Q ss_pred             -------------------------------ccCCCCcEEEeCCCcccC-CCcccccccccceEEcccCCCCCchhhhhc
Q 036342          255 -------------------------------GNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLLEIG  302 (596)
Q Consensus       255 -------------------------------~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~  302 (596)
                                                     +.+++|+.|||++|++++ +|.++..+++|+.|+|++|+++|.+|..++
T Consensus       598 ~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~  677 (768)
T 3rgz_A          598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG  677 (768)
T ss_dssp             TCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred             cccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHh
Confidence                                           335789999999999996 899999999999999999999999999999


Q ss_pred             cccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCCCCCCCCCCccc
Q 036342          303 NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSI  381 (596)
Q Consensus       303 ~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~~~~~~~~~~~~  381 (596)
                      .++.|+.|||++|+++|.+|. .+..+++|++||+++|+++|.+|..+.+..+....+.||+.+||.|.   ++|....
T Consensus       678 ~L~~L~~LdLs~N~l~g~ip~-~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~~  752 (768)
T 3rgz_A          678 DLRGLNILDLSSNKLDGRIPQ-AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPSN  752 (768)
T ss_dssp             GCTTCCEEECCSSCCEECCCG-GGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSCC
T ss_pred             CCCCCCEEECCCCcccCcCCh-HHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCCc
Confidence            999999999999999999998 56789999999999999999999999999999999999999999874   3676543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.5e-47  Score=434.68  Aligned_cols=360  Identities=33%  Similarity=0.480  Sum_probs=305.8

Q ss_pred             CCCCCCEEECCCCCCccccchhhhCC-CCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcc-ccCCCCC
Q 036342            8 NLQNLEELQLGQNKLIGTVPAAIFNV-STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF-IFNASKL   85 (596)
Q Consensus         8 ~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L   85 (596)
                      .+++|++|+|++|++++.+|..+... ++|++|+|++|++++.++.. +..+++|++|+|++|++++.+|.. +.++++|
T Consensus       267 ~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L  345 (768)
T 3rgz_A          267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF-FGSCSLLESLALSSNNFSGELPMDTLLKMRGL  345 (768)
T ss_dssp             CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG-GGGCTTCCEEECCSSEEEEECCHHHHTTCTTC
T ss_pred             ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchH-HhcCCCccEEECCCCcccCcCCHHHHhcCCCC
Confidence            78999999999999999999988775 99999999999999766652 345999999999999999888876 9999999


Q ss_pred             CEEEccCCcccccCCccccCCC-CCCEEecCCCcCcCCCCCc---------------------cccccCCCCCCCCEEEC
Q 036342           86 SKLSLGMNSFSGFIPSTFGNLR-NLEQLGLDENYLTSSTPEL---------------------SFLSSLSNCKSLTLIDL  143 (596)
Q Consensus        86 ~~L~L~~N~i~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~---------------------~~~~~~~~l~~L~~L~l  143 (596)
                      ++|+|++|++++.+|..+.+++ +|++|++++|.+++..+..                     .++..+.++++|+.|++
T Consensus       346 ~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  425 (768)
T 3rgz_A          346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHL  425 (768)
T ss_dssp             CEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEEC
T ss_pred             CEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEEC
Confidence            9999999999999999888877 7888888888776421110                     13345777888888888


Q ss_pred             cCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCccc
Q 036342          144 SNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE  223 (596)
Q Consensus       144 s~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  223 (596)
                      ++|++++.+|. .+..+ ++|++|++++|.+++..|..|..+++|++|++++|.+++.+|..+..+++|++|++++|+++
T Consensus       426 s~N~l~~~~p~-~l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  503 (768)
T 3rgz_A          426 SFNYLSGTIPS-SLGSL-SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT  503 (768)
T ss_dssp             CSSEEESCCCG-GGGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             cCCcccCcccH-HHhcC-CCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccC
Confidence            88888887776 67777 67888888888888888888888889999999999998888888888999999999999998


Q ss_pred             ccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC-CCccc-------------------------
Q 036342          224 GSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTF-------------------------  277 (596)
Q Consensus       224 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-ip~~~-------------------------  277 (596)
                      +.+|..+..+++|++|+|++|++++.+|..++.+++|+.|+|++|.+++ +|..+                         
T Consensus       504 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (768)
T 3rgz_A          504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGM  583 (768)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSC
T ss_pred             CcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccc
Confidence            8888888889999999999999988889899999999999999998874 66433                         


Q ss_pred             ---------------------------------------------ccccccceEEcccCCCCCchhhhhccccccceEec
Q 036342          278 ---------------------------------------------WNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDF  312 (596)
Q Consensus       278 ---------------------------------------------~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l  312 (596)
                                                                   ..+++|++|+|++|+++|.+|..++.++.|+.|||
T Consensus       584 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~L  663 (768)
T 3rgz_A          584 KKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL  663 (768)
T ss_dssp             CTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEEC
T ss_pred             cccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeC
Confidence                                                         23467888999999999999999999999999999


Q ss_pred             CCCcCcccCChhhhccCCCCCeEECCCCcccccCCCC-CCCCCCCcccccccccccCCCC
Q 036342          313 SMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG-GSFGNFSAESFEGNELLCGSPN  371 (596)
Q Consensus       313 s~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~l~~~~N~~~c~~~~  371 (596)
                      ++|+++|.+|. .+..++.|+.|||++|+++|.+|.. ..++.++.+++++|++....|.
T Consensus       664 s~N~l~g~ip~-~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~  722 (768)
T 3rgz_A          664 GHNDISGSIPD-EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE  722 (768)
T ss_dssp             CSSCCCSCCCG-GGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCS
T ss_pred             cCCccCCCCCh-HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCC
Confidence            99999999998 5568899999999999999998876 5688899999999998655443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.9e-43  Score=391.26  Aligned_cols=364  Identities=20%  Similarity=0.175  Sum_probs=265.0

Q ss_pred             cccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCC
Q 036342            4 LEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNAS   83 (596)
Q Consensus         4 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~   83 (596)
                      ..|.++++|++|+|++|+++++.|.+|.++++|++|+|++|++++..| ..+..+++|++|+|++|.+++..+..+.+++
T Consensus        50 ~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  128 (606)
T 3vq2_A           50 YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP-GSFSGLTSLENLVAVETKLASLESFPIGQLI  128 (606)
T ss_dssp             TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCT-TSSTTCTTCCEEECTTSCCCCSSSSCCTTCT
T ss_pred             hhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccCh-hhcCCcccCCEEEccCCccccccccccCCCC
Confidence            356677777777777777776666677777777777777777764323 3334467777777777777666656677777


Q ss_pred             CCCEEEccCCcccc-cCCccccCCCCCCEEecCCCcCcCCCCCc-c---------------------ccc----------
Q 036342           84 KLSKLSLGMNSFSG-FIPSTFGNLRNLEQLGLDENYLTSSTPEL-S---------------------FLS----------  130 (596)
Q Consensus        84 ~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~---------------------~~~----------  130 (596)
                      +|++|+|++|.+++ .+|..|.++++|++|++++|.+++..+.. .                     ++.          
T Consensus       129 ~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~  208 (606)
T 3vq2_A          129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHE  208 (606)
T ss_dssp             TCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEE
T ss_pred             CCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeee
Confidence            77777777777765 34667777777777777777776643320 0                     000          


Q ss_pred             --------------------------------------------------------------------------------
Q 036342          131 --------------------------------------------------------------------------------  130 (596)
Q Consensus       131 --------------------------------------------------------------------------------  130 (596)
                                                                                                      
T Consensus       209 L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~  288 (606)
T 3vq2_A          209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS  288 (606)
T ss_dssp             EEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCS
T ss_pred             eeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCC
Confidence                                                                                            


Q ss_pred             -------------cCCCCCCCCEEECcCCCCCccCCc-------------------hhhhcccccccEEEccccccccc-
Q 036342          131 -------------SLSNCKSLTLIDLSNNPLDGILPK-------------------TSISNLSRSLEEFYMYNCNISGG-  177 (596)
Q Consensus       131 -------------~~~~l~~L~~L~ls~N~l~~~~~~-------------------~~~~~l~~~L~~L~l~~n~l~~~-  177 (596)
                                   .+..+++|+.|++++|.+ +.+|.                   ..+..+ ++|++|++++|.+++. 
T Consensus       289 ~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l-~~L~~L~ls~n~l~~~~  366 (606)
T 3vq2_A          289 AMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVAL-PSLSYLDLSRNALSFSG  366 (606)
T ss_dssp             EEEEESCCCCCCCCCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCCC-TTCCEEECCSSCEEEEE
T ss_pred             EEEecCccchhhhhccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhccC-CCCCEEECcCCccCCCc
Confidence                         011222333333333333 11110                   011122 4566777777777665 


Q ss_pred             -cChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCc-cchhcCCCCcEEEccCCcCcccchhhhc
Q 036342          178 -IPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP-DDICRLAELYRLELGSNKLYGSIPACFG  255 (596)
Q Consensus       178 -~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  255 (596)
                       .|..+..+++|++|++++|.+.+ .|..|..+++|++|++++|.+.+..| ..+..+++|++|++++|++.+..|..+.
T Consensus       367 ~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  445 (606)
T 3vq2_A          367 CCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL  445 (606)
T ss_dssp             ECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             chhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhc
Confidence             36777788888888888888775 45778889999999999999987777 6788899999999999999988899999


Q ss_pred             cCCCCcEEEeCCCcccC--CCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCC
Q 036342          256 NLASLRILSLGSNKLTS--IPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLE  333 (596)
Q Consensus       256 ~l~~L~~L~Ls~N~l~~--ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~  333 (596)
                      .+++|++|++++|.+++  +|..+..+++|++|++++|++++..|..+..+++|+.|++++|++++.+|. .+..+++|+
T Consensus       446 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~  524 (606)
T 3vq2_A          446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS-HYNQLYSLS  524 (606)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGG-GTTTCTTCC
T ss_pred             CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHH-HccCCCcCC
Confidence            99999999999999987  688889999999999999999999899999999999999999999977666 667899999


Q ss_pred             eEECCCCcccccCCCCCCCC-CCCcccccccccccCCCCC
Q 036342          334 DLNLSFNKLKGEIPRGGSFG-NFSAESFEGNELLCGSPNL  372 (596)
Q Consensus       334 ~L~l~~N~l~~~~p~~~~~~-~l~~l~~~~N~~~c~~~~~  372 (596)
                      +|++++|+++..++....++ +++.+++++|++.|+++..
T Consensus       525 ~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~  564 (606)
T 3vq2_A          525 TLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQ  564 (606)
T ss_dssp             EEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred             EEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence            99999999985444434565 5899999999999987753

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=8.5e-44  Score=395.03  Aligned_cols=332  Identities=20%  Similarity=0.286  Sum_probs=272.6

Q ss_pred             CCccccchhhhCCCCCCEEEccCCcCccc-----------------cCc-cCccCCCCccEEEccCCccccccCccccCC
Q 036342           21 KLIGTVPAAIFNVSTLKFLGLQNNSLSGS-----------------LSS-IANVRLPNLEKLYLWGNNFSGTIPRFIFNA   82 (596)
Q Consensus        21 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----------------~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l   82 (596)
                      ++++ +|.+|..+++|++|+|++|++++.                 +|. +++..+++|++|+|++|++.+.+|..+.++
T Consensus       194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l  272 (636)
T 4eco_A          194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL  272 (636)
T ss_dssp             EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred             CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence            3445 788899999999999999999983                 444 663459999999999999999999999999


Q ss_pred             CCCCEEEccCCc-ccc-cCCccccCC------CCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCc
Q 036342           83 SKLSKLSLGMNS-FSG-FIPSTFGNL------RNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPK  154 (596)
Q Consensus        83 ~~L~~L~L~~N~-i~~-~~~~~~~~l------~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  154 (596)
                      ++|++|+|++|+ +++ .+|..++.+      ++|++|++++|.++.++..    ..+.++++|+.|++++|.++|.+| 
T Consensus       273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~----~~l~~l~~L~~L~L~~N~l~g~ip-  347 (636)
T 4eco_A          273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE----TSLQKMKKLGMLECLYNQLEGKLP-  347 (636)
T ss_dssp             SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCH----HHHTTCTTCCEEECCSCCCEEECC-
T ss_pred             CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCch----hhhccCCCCCEEeCcCCcCccchh-
Confidence            999999999998 998 888888877      9999999999999865430    047899999999999999998888 


Q ss_pred             hhhhcccccccEEEccccccccccChhccCCCC-CCEEEccCCcccCCCCccccCCC--CCCeEEccCCcccccCccchh
Q 036342          155 TSISNLSRSLEEFYMYNCNISGGIPEEISNLTN-LVEIDLGGNKLNGSIPITLGKLR--KLQRLNLEDNILEGSIPDDIC  231 (596)
Q Consensus       155 ~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~~~~  231 (596)
                       .+..+ ++|++|++++|+++ .+|..|..+++ |++|++++|.++ .+|..+..++  +|++|++++|.+++.+|..+.
T Consensus       348 -~~~~l-~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  423 (636)
T 4eco_A          348 -AFGSE-IKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD  423 (636)
T ss_dssp             -CCEEE-EEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSC
T ss_pred             -hhCCC-CCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhc
Confidence             57777 68999999999998 77888999998 999999999998 6777777654  889999999999888888777


Q ss_pred             -------cCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccc--------cccceEEcccCCCCCc
Q 036342          232 -------RLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNL--------KDILQLNFSSNFLTGP  296 (596)
Q Consensus       232 -------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l--------~~L~~L~ls~N~l~~~  296 (596)
                             .+++|++|+|++|+++...+..+..+++|+.|+|++|.++.+|......        ++|+.|++++|+++ .
T Consensus       424 ~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~  502 (636)
T 4eco_A          424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-K  502 (636)
T ss_dssp             TTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-B
T ss_pred             ccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-c
Confidence                   7778888899888888655556667888888888888888888765432        28888888888888 4


Q ss_pred             hhhhhc--cccccceEecCCCcCcccCChhhhccCCCCCeEEC------CCCcccccCCCC-CCCCCCCccccccccc
Q 036342          297 LLLEIG--NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNL------SFNKLKGEIPRG-GSFGNFSAESFEGNEL  365 (596)
Q Consensus       297 ~~~~~~--~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l------~~N~l~~~~p~~-~~~~~l~~l~~~~N~~  365 (596)
                      +|..+.  .+++|+.|++++|++++ +|.. +..+++|+.|++      ++|++.+.+|.. ..+++++.+++++|.+
T Consensus       503 lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~-~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  578 (636)
T 4eco_A          503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQ-PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI  578 (636)
T ss_dssp             CCGGGSTTTCTTCCEEECCSSCCSS-CCCG-GGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred             cChhhhhccCCCcCEEECCCCCCCC-cChh-hhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC
Confidence            566665  88888888888888886 6764 446888888888      456677777765 4577888888888887

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=406.22  Aligned_cols=367  Identities=21%  Similarity=0.219  Sum_probs=210.0

Q ss_pred             CcccCCCCCCCEEECCCCCCcccc-chhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcc--c
Q 036342            3 PLEIGNLQNLEELQLGQNKLIGTV-PAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF--I   79 (596)
Q Consensus         3 p~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~   79 (596)
                      |.+|.++++|++|||++|.+.+.+ |.+|.++++|++|+|++|++++..+ ..+..+++|++|+|++|.+++..|..  |
T Consensus        41 ~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  119 (844)
T 3j0a_A           41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP-DAFQGLFHLFELRLYFCGLSDAVLKDGYF  119 (844)
T ss_dssp             SSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT-TSSCSCSSCCCEECTTCCCSSCCSTTCCC
T ss_pred             hhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH-hHccCCcccCEeeCcCCCCCcccccCccc
Confidence            456666666777777666433333 5666667777777777777664333 23334667777777777766544443  6


Q ss_pred             cCCCCCCEEEccCCcccccCC-ccccCCCCCCEEecCCCcCcCCCCCc-c--------------------ccccCCCCC-
Q 036342           80 FNASKLSKLSLGMNSFSGFIP-STFGNLRNLEQLGLDENYLTSSTPEL-S--------------------FLSSLSNCK-  136 (596)
Q Consensus        80 ~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~-~--------------------~~~~~~~l~-  136 (596)
                      .++++|++|+|++|.+++..+ ..|.++++|++|++++|.+++..+.. .                    .+..+..+. 
T Consensus       120 ~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~  199 (844)
T 3j0a_A          120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN  199 (844)
T ss_dssp             SSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSC
T ss_pred             cccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCC
Confidence            667777777777777766544 45667777777777777665532210 0                    001111111 


Q ss_pred             -----CCCEEECcCCCCCccCCchhh-----------------------------------hcc-cccccEEEccccccc
Q 036342          137 -----SLTLIDLSNNPLDGILPKTSI-----------------------------------SNL-SRSLEEFYMYNCNIS  175 (596)
Q Consensus       137 -----~L~~L~ls~N~l~~~~~~~~~-----------------------------------~~l-~~~L~~L~l~~n~l~  175 (596)
                           +|+.|++++|.+++..+....                                   ..+ .++|+.|++++|.++
T Consensus       200 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~  279 (844)
T 3j0a_A          200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF  279 (844)
T ss_dssp             TTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCC
T ss_pred             ccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCccc
Confidence                 255555555544433222100                                   000 135666666666666


Q ss_pred             cccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhc
Q 036342          176 GGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFG  255 (596)
Q Consensus       176 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  255 (596)
                      +..|..|..+++|+.|+|++|.+++..|..|.++++|++|++++|.+++..|..|..+++|+.|++++|++.+..+..|.
T Consensus       280 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  359 (844)
T 3j0a_A          280 SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK  359 (844)
T ss_dssp             EECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSC
T ss_pred             ccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhc
Confidence            66666666666777777777776666666666666677777777666655566666666666666666666655555666


Q ss_pred             cCCCCcEEEeCCCcccCCCc-----------------------------------------ccccccccceEEcccCCCC
Q 036342          256 NLASLRILSLGSNKLTSIPL-----------------------------------------TFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       256 ~l~~L~~L~Ls~N~l~~ip~-----------------------------------------~~~~l~~L~~L~ls~N~l~  294 (596)
                      .+++|+.|+|++|.++.++.                                         .+..+++|++|++++|+++
T Consensus       360 ~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~  439 (844)
T 3j0a_A          360 FLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS  439 (844)
T ss_dssp             SCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCC
T ss_pred             CCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccc
Confidence            66666666666665554321                                         0112334444444444443


Q ss_pred             C------------------------------chhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccc
Q 036342          295 G------------------------------PLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG  344 (596)
Q Consensus       295 ~------------------------------~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~  344 (596)
                      +                              ..+..|.++++|+.|||++|++++..|. .+..+++|++|+|++|++++
T Consensus       440 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~  518 (844)
T 3j0a_A          440 SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG-VFSHLTALRGLSLNSNRLTV  518 (844)
T ss_dssp             CCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTT-SSSSCCSCSEEEEESCCCSS
T ss_pred             ccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChh-HccchhhhheeECCCCCCCc
Confidence            2                              1122344555566666666666543332 44455555555555555554


Q ss_pred             cCCCC--------------------CCCCCCCcccccccccccCCCC
Q 036342          345 EIPRG--------------------GSFGNFSAESFEGNELLCGSPN  371 (596)
Q Consensus       345 ~~p~~--------------------~~~~~l~~l~~~~N~~~c~~~~  371 (596)
                      .+|..                    ..+.+++.+++++||+.|+++.
T Consensus       519 l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          519 LSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             CCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred             cChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence            33321                    1256788899999999998764

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.8e-43  Score=375.07  Aligned_cols=356  Identities=22%  Similarity=0.263  Sum_probs=303.2

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEE
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLS   89 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (596)
                      ++|++|+|++|+|+++.|..|..+++|++|+|++|.+.+.+++..+..+++|++|+|++|++++..|..|.++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            78999999999999988999999999999999999998778776677799999999999999988899999999999999


Q ss_pred             ccCCcccccCCcc--ccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc-cccccE
Q 036342           90 LGMNSFSGFIPST--FGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL-SRSLEE  166 (596)
Q Consensus        90 L~~N~i~~~~~~~--~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l-~~~L~~  166 (596)
                      |++|++++..+..  |.++++|++|++++|.+++..+.    ..+.++++|++|++++|.+++..+. .+..+ ..+++.
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~-~l~~l~~~~L~~  184 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA----SFFLNMRRFHVLDLTFNKVKSICEE-DLLNFQGKHFTL  184 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC----GGGGGCTTCCEEECTTCCBSCCCTT-TSGGGTTCEEEE
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcc----cccCCCCcccEEeCCCCcccccChh-hhhccccccccc
Confidence            9999999855544  99999999999999999987543    1278899999999999999988665 45444 257999


Q ss_pred             EEccccccccccChhc--------cCCCCCCEEEccCCcccCCCCccccCC---CCCCeEEccCCccccc----------
Q 036342          167 FYMYNCNISGGIPEEI--------SNLTNLVEIDLGGNKLNGSIPITLGKL---RKLQRLNLEDNILEGS----------  225 (596)
Q Consensus       167 L~l~~n~l~~~~~~~~--------~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~----------  225 (596)
                      |++++|.+.+..+..+        ..+++|++|++++|.+.+..|..+...   ++|+.|++++|.+.+.          
T Consensus       185 L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~  264 (455)
T 3v47_A          185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP  264 (455)
T ss_dssp             EECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCC
T ss_pred             cccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccC
Confidence            9999999987665443        356889999999999998888777654   8899999998865432          


Q ss_pred             Cccchhc--CCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCC-CcccccccccceEEcccCCCCCchhhhhc
Q 036342          226 IPDDICR--LAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNFLTGPLLLEIG  302 (596)
Q Consensus       226 ~~~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~ls~N~l~~~~~~~~~  302 (596)
                      .+..+..  .++|+.|++++|++.+..|..|..+++|+.|+|++|.++++ |..+..+++|++|++++|.+++..+..+.
T Consensus       265 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  344 (455)
T 3v47_A          265 DNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFE  344 (455)
T ss_dssp             CTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGT
T ss_pred             cccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhc
Confidence            1122222  36899999999999988899999999999999999999986 55788899999999999999988889999


Q ss_pred             cccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCC-CCCCCCCcccccccccccCCCC
Q 036342          303 NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG-GSFGNFSAESFEGNELLCGSPN  371 (596)
Q Consensus       303 ~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~l~~~~N~~~c~~~~  371 (596)
                      .+++|++||+++|++++..|. .+..+++|++|++++|++++.++.. ..+++++.+++++|++.|++|.
T Consensus       345 ~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          345 NLDKLEVLDLSYNHIRALGDQ-SFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             TCTTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             CcccCCEEECCCCcccccChh-hccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence            999999999999999876665 5678999999999999999766654 5688999999999999998774

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=9.2e-44  Score=394.73  Aligned_cols=352  Identities=17%  Similarity=0.199  Sum_probs=309.6

Q ss_pred             CCcccCCCCCCCEEECCCCCCccc-----------------cchhhh--CCCCCCEEEccCCcCccccCccCccCCCCcc
Q 036342            2 IPLEIGNLQNLEELQLGQNKLIGT-----------------VPAAIF--NVSTLKFLGLQNNSLSGSLSSIANVRLPNLE   62 (596)
Q Consensus         2 ip~~~~~l~~L~~L~Ls~n~l~~~-----------------~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~   62 (596)
                      ||++|+++++|++|+|++|++++.                 +|..+.  .+++|++|+|++|++.+.+|. .+..+++|+
T Consensus       198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~  276 (636)
T 4eco_A          198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT-FLKALPEMQ  276 (636)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCT-TTTTCSSCC
T ss_pred             CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChH-HHhcCCCCC
Confidence            789999999999999999999985                 899988  999999999999999988875 234599999


Q ss_pred             EEEccCCc-ccc-ccCccccCC------CCCCEEEccCCcccccCCc--cccCCCCCCEEecCCCcCcCCCCCccccccC
Q 036342           63 KLYLWGNN-FSG-TIPRFIFNA------SKLSKLSLGMNSFSGFIPS--TFGNLRNLEQLGLDENYLTSSTPELSFLSSL  132 (596)
Q Consensus        63 ~L~L~~N~-l~~-~~~~~~~~l------~~L~~L~L~~N~i~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  132 (596)
                      +|+|++|+ +++ .+|..++.+      ++|++|+|++|+++ .+|.  .|.++++|++|++++|.+++..     + .+
T Consensus       277 ~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~i-----p-~~  349 (636)
T 4eco_A          277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKL-----P-AF  349 (636)
T ss_dssp             EEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEEC-----C-CC
T ss_pred             EEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccch-----h-hh
Confidence            99999998 998 899988887      99999999999999 6777  8999999999999999998422     2 47


Q ss_pred             CCCCCCCEEECcCCCCCccCCchhhhccccc-ccEEEccccccccccChhccCCC--CCCEEEccCCcccCCCCcccc--
Q 036342          133 SNCKSLTLIDLSNNPLDGILPKTSISNLSRS-LEEFYMYNCNISGGIPEEISNLT--NLVEIDLGGNKLNGSIPITLG--  207 (596)
Q Consensus       133 ~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~-L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~--  207 (596)
                      ..+++|+.|++++|+++ .+|. .+..+ ++ |++|++++|.++ .+|..+..+.  +|++|++++|.+.+..|..|.  
T Consensus       350 ~~l~~L~~L~L~~N~l~-~lp~-~l~~l-~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~  425 (636)
T 4eco_A          350 GSEIKLASLNLAYNQIT-EIPA-NFCGF-TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL  425 (636)
T ss_dssp             EEEEEESEEECCSSEEE-ECCT-TSEEE-CTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTT
T ss_pred             CCCCCCCEEECCCCccc-cccH-hhhhh-cccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccc
Confidence            88999999999999998 5565 57777 56 999999999999 6788887765  899999999999999999888  


Q ss_pred             -----CCCCCCeEEccCCcccccCccc-hhcCCCCcEEEccCCcCcccchhhhccCC-------CCcEEEeCCCcccCCC
Q 036342          208 -----KLRKLQRLNLEDNILEGSIPDD-ICRLAELYRLELGSNKLYGSIPACFGNLA-------SLRILSLGSNKLTSIP  274 (596)
Q Consensus       208 -----~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-------~L~~L~Ls~N~l~~ip  274 (596)
                           .+++|++|++++|.++ .+|.. +..+++|+.|+|++|+++...+..+..+.       +|+.|+|++|+++.+|
T Consensus       426 ~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp  504 (636)
T 4eco_A          426 DPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLS  504 (636)
T ss_dssp             CSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCBCC
T ss_pred             ccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCccC
Confidence                 8889999999999999 45554 55699999999999999954444555443       9999999999999999


Q ss_pred             cccc--cccccceEEcccCCCCCchhhhhccccccceEec------CCCcCcccCChhhhccCCCCCeEECCCCcccccC
Q 036342          275 LTFW--NLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDF------SMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEI  346 (596)
Q Consensus       275 ~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l------s~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~  346 (596)
                      ..+.  .+++|+.|++++|++++ +|..+..+++|+.|++      ++|++.+.+|. .+..+++|++|++++|++ +.+
T Consensus       505 ~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l-~~i  581 (636)
T 4eco_A          505 DDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE-GITLCPSLTQLQIGSNDI-RKV  581 (636)
T ss_dssp             GGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCT-TGGGCSSCCEEECCSSCC-CBC
T ss_pred             hhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChH-HHhcCCCCCEEECCCCcC-Ccc
Confidence            9987  99999999999999998 7889999999999999      56888989998 556899999999999999 567


Q ss_pred             CCCCCCCCCCcccccccccccCCC
Q 036342          347 PRGGSFGNFSAESFEGNELLCGSP  370 (596)
Q Consensus       347 p~~~~~~~l~~l~~~~N~~~c~~~  370 (596)
                      |... .++++.+++++|++.|...
T Consensus       582 p~~~-~~~L~~L~Ls~N~l~~~~~  604 (636)
T 4eco_A          582 NEKI-TPNISVLDIKDNPNISIDL  604 (636)
T ss_dssp             CSCC-CTTCCEEECCSCTTCEEEC
T ss_pred             CHhH-hCcCCEEECcCCCCccccH
Confidence            7653 3899999999999988554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=5.8e-42  Score=379.39  Aligned_cols=354  Identities=21%  Similarity=0.213  Sum_probs=225.8

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +||.++..  ++++|+|++|+|+++.|.+|..+++|++|+|++|++++ +.+..+..+++|++|+|++|++++..|.+|.
T Consensus        26 ~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~  102 (606)
T 3t6q_A           26 EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIFMAETALS  102 (606)
T ss_dssp             SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCSEECTTTTS
T ss_pred             cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccce-eChhhccCccccCeeeCCCCcccccChhhhc
Confidence            36666643  68888888888888778888888888888888888874 4444445588888888888888877788888


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      ++++|++|+|++|+|+++.+..|.++++|++|++++|.++++...     .+..+++|++|++++|.+++..+. .+..+
T Consensus       103 ~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l  176 (606)
T 3t6q_A          103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP-----KGFPTEKLKVLDFQNNAIHYLSKE-DMSSL  176 (606)
T ss_dssp             SCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCC-----TTCCCTTCCEEECCSSCCCEECHH-HHHTT
T ss_pred             ccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcc-----cccCCcccCEEEcccCcccccChh-hhhhh
Confidence            888888888888888877777788888888888888888775322     244577777777777777765443 45555


Q ss_pred             ccccc--EEEccccccccccChhccCC---------------------------------------------------CC
Q 036342          161 SRSLE--EFYMYNCNISGGIPEEISNL---------------------------------------------------TN  187 (596)
Q Consensus       161 ~~~L~--~L~l~~n~l~~~~~~~~~~l---------------------------------------------------~~  187 (596)
                       ++|+  .|++++|.+++..|..|...                                                   .+
T Consensus       177 -~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~  255 (606)
T 3t6q_A          177 -QQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS  255 (606)
T ss_dssp             -TTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSE
T ss_pred             -cccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCc
Confidence             4555  66666666666555444321                                                   04


Q ss_pred             CCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCC
Q 036342          188 LVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGS  267 (596)
Q Consensus       188 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  267 (596)
                      |+.|++++|.+++..+..|..+++|++|++++|.++ .+|..+..+++|++|++++|++.+..|..+..+++|++|++++
T Consensus       256 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  334 (606)
T 3t6q_A          256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG  334 (606)
T ss_dssp             EEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCS
T ss_pred             eeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCC
Confidence            455555555665555555666666666666666665 4555555566666666666666555555555666666666666


Q ss_pred             Cccc-CCCcc-cccccccceEEcccCCCCCch--hhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCccc
Q 036342          268 NKLT-SIPLT-FWNLKDILQLNFSSNFLTGPL--LLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK  343 (596)
Q Consensus       268 N~l~-~ip~~-~~~l~~L~~L~ls~N~l~~~~--~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~  343 (596)
                      |.+. .+|.. +..+++|++|++++|.+++..  +..+..+++|+.|++++|.+++..|. .+..+++|+.|++++|++.
T Consensus       335 n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~  413 (606)
T 3t6q_A          335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE-AFKECPQLELLDLAFTRLK  413 (606)
T ss_dssp             CSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTT-TTTTCTTCSEEECTTCCEE
T ss_pred             CCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHH-HhcCCccCCeEECCCCcCC
Confidence            6555 24432 455556666666666555544  44555555566666666655544333 3445555666666666555


Q ss_pred             ccCCCC--CCCCCCCcccccccccc
Q 036342          344 GEIPRG--GSFGNFSAESFEGNELL  366 (596)
Q Consensus       344 ~~~p~~--~~~~~l~~l~~~~N~~~  366 (596)
                      +..|..  ..+++++.+++++|.+.
T Consensus       414 ~~~~~~~~~~l~~L~~L~l~~n~l~  438 (606)
T 3t6q_A          414 VKDAQSPFQNLHLLKVLNLSHSLLD  438 (606)
T ss_dssp             CCTTCCTTTTCTTCCEEECTTCCCB
T ss_pred             CcccchhhhCcccCCEEECCCCccC
Confidence            444332  33555555555555543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.4e-42  Score=382.54  Aligned_cols=302  Identities=23%  Similarity=0.195  Sum_probs=240.8

Q ss_pred             CccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCC
Q 036342           60 NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLT  139 (596)
Q Consensus        60 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~  139 (596)
                      +|+.|++++|.+++..+..|.++++|++|++++|+++ .+|..+.++++|++|++++|.++...+.     .+.++++|+
T Consensus       255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~  328 (606)
T 3t6q_A          255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI-----SASNFPSLT  328 (606)
T ss_dssp             EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGG-----CGGGCTTCS
T ss_pred             ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchh-----hhhccCcCC
Confidence            4555666666666555555677777777777777777 4556677777777777777777765332     467778888


Q ss_pred             EEECcCCCCCccCCchhhhcccccccEEEcccccccccc--ChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          140 LIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI--PEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       140 ~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                      .|++++|.+.+.++...+..+ ++|++|++++|.+++..  +..+..+++|++|++++|.+.+..|..|..+++|++|++
T Consensus       329 ~L~l~~n~~~~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  407 (606)
T 3t6q_A          329 HLSIKGNTKRLELGTGCLENL-ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL  407 (606)
T ss_dssp             EEECCSCSSCCBCCSSTTTTC-TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred             EEECCCCCcccccchhhhhcc-CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence            888888887766666567776 67888888888888776  778888889999999999888888888888899999999


Q ss_pred             cCCcccccCccc-hhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC--CC--cccccccccceEEcccCC
Q 036342          218 EDNILEGSIPDD-ICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS--IP--LTFWNLKDILQLNFSSNF  292 (596)
Q Consensus       218 ~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--ip--~~~~~l~~L~~L~ls~N~  292 (596)
                      ++|.+++..+.. +..+++|+.|++++|.+.+..|..+..+++|+.|+|++|.+++  +|  ..+..+++|++|++++|+
T Consensus       408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~  487 (606)
T 3t6q_A          408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD  487 (606)
T ss_dssp             TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred             CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence            999988766554 7888899999999999988888888889999999999999876  23  457788999999999999


Q ss_pred             CCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCC-CCCCCCCcccccccccccCCC
Q 036342          293 LTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG-GSFGNFSAESFEGNELLCGSP  370 (596)
Q Consensus       293 l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~l~~~~N~~~c~~~  370 (596)
                      +++..|..+..++.|+.||+++|++++..|. .+..++.| .|++++|++++.+|.. ..+++++.+++++|+|.|+++
T Consensus       488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE-ALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCGGGGG-GGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             cCccChhhhccccCCCEEECCCCccCcCChh-HhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            9988888899999999999999999877665 66788888 9999999998777664 457788899999999988665

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.2e-42  Score=390.74  Aligned_cols=327  Identities=19%  Similarity=0.262  Sum_probs=244.0

Q ss_pred             cchhhhCCCCCCEEEccCCcCcc-----------------ccCc-cCccCCCCccEEEccCCccccccCccccCCCCCCE
Q 036342           26 VPAAIFNVSTLKFLGLQNNSLSG-----------------SLSS-IANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSK   87 (596)
Q Consensus        26 ~~~~~~~l~~L~~L~Ls~N~l~~-----------------~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~   87 (596)
                      +|..|..+++|++|+|++|++++                 .+|. ++|..+++|++|+|++|++.+.+|..|.++++|++
T Consensus       440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~  519 (876)
T 4ecn_A          440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS  519 (876)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred             hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence            67788888889999999988887                 1444 55456888899999888888888888888888999


Q ss_pred             EEccCCc-ccc-cCCccccCCC-------CCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhh
Q 036342           88 LSLGMNS-FSG-FIPSTFGNLR-------NLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSIS  158 (596)
Q Consensus        88 L~L~~N~-i~~-~~~~~~~~l~-------~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  158 (596)
                      |+|++|+ +++ .+|..|..++       +|++|+|++|.++.++.    ...+.++++|+.|+|++|.++ .+|  .+.
T Consensus       520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~----~~~l~~L~~L~~L~Ls~N~l~-~lp--~~~  592 (876)
T 4ecn_A          520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA----SASLQKMVKLGLLDCVHNKVR-HLE--AFG  592 (876)
T ss_dssp             EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCC----HHHHTTCTTCCEEECTTSCCC-BCC--CCC
T ss_pred             EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCC----hhhhhcCCCCCEEECCCCCcc-cch--hhc
Confidence            9998887 887 6777666554       88888888888885443    004778888888888888887 555  566


Q ss_pred             cccccccEEEccccccccccChhccCCCC-CCEEEccCCcccCCCCccccCCCC--CCeEEccCCcccccCccch---h-
Q 036342          159 NLSRSLEEFYMYNCNISGGIPEEISNLTN-LVEIDLGGNKLNGSIPITLGKLRK--LQRLNLEDNILEGSIPDDI---C-  231 (596)
Q Consensus       159 ~l~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~-  231 (596)
                      .+ ++|+.|+|++|.++ .+|..+..+++ |+.|++++|.++ .+|..+..++.  |+.|++++|.+++.+|...   . 
T Consensus       593 ~L-~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~  669 (876)
T 4ecn_A          593 TN-VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDD  669 (876)
T ss_dssp             TT-SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTT
T ss_pred             CC-CcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhcc
Confidence            66 67888888888888 67777888888 888888888888 66777766544  8888888888876655322   1 


Q ss_pred             -cCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccc--------cccceEEcccCCCCCchhhhhc
Q 036342          232 -RLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNL--------KDILQLNFSSNFLTGPLLLEIG  302 (596)
Q Consensus       232 -~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l--------~~L~~L~ls~N~l~~~~~~~~~  302 (596)
                       .+++|+.|+|++|+++...+..+..+++|+.|+|++|+++.+|..++..        ++|+.|+|++|+++ .+|..+.
T Consensus       670 ~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~  748 (876)
T 4ecn_A          670 YKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFR  748 (876)
T ss_dssp             CCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGS
T ss_pred             ccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhh
Confidence             3347888888888887544445557788888888888888777755432        27888888888887 4556665


Q ss_pred             --cccccceEecCCCcCcccCChhhhccCCCCCeEECCC------CcccccCCCC-CCCCCCCccccccccc
Q 036342          303 --NLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSF------NKLKGEIPRG-GSFGNFSAESFEGNEL  365 (596)
Q Consensus       303 --~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~------N~l~~~~p~~-~~~~~l~~l~~~~N~~  365 (596)
                        .+++|+.|+|++|++++ +|.. +..+++|+.|+|++      |.+.+.+|.. ..+++++.+++++|++
T Consensus       749 ~~~l~~L~~L~Ls~N~L~~-lp~~-l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L  818 (876)
T 4ecn_A          749 ATTLPYLSNMDVSYNCFSS-FPTQ-PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI  818 (876)
T ss_dssp             TTTCTTCCEEECCSSCCSS-CCCG-GGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred             hccCCCcCEEEeCCCCCCc-cchh-hhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence              77788888888888876 5663 34677888887765      6666666655 4577777888888876

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=373.06  Aligned_cols=349  Identities=23%  Similarity=0.292  Sum_probs=278.8

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +||.++.  ++|++|+|++|+|++..|.+|..+++|++|+|++|++++..+ ..+..+++|++|+|++|+++ .+|..  
T Consensus        14 ~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~-~lp~~--   87 (520)
T 2z7x_B           14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDI-SVFKFNQELEYLDLSHNKLV-KISCH--   87 (520)
T ss_dssp             SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEG-GGGTTCTTCCEEECCSSCCC-EEECC--
T ss_pred             ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcCh-HHhhcccCCCEEecCCCcee-ecCcc--
Confidence            4777776  889999999999988888889999999999999999985433 33445889999999999998 45555  


Q ss_pred             CCCCCCEEEccCCccccc-CCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCC--CEEECcCCCC--CccCCch
Q 036342           81 NASKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL--TLIDLSNNPL--DGILPKT  155 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L--~~L~ls~N~l--~~~~~~~  155 (596)
                      .+++|++|+|++|+|++. .|..|+++++|++|++++|.++..        .+..+++|  +.|++++|.+  .+..|. 
T Consensus        88 ~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~--------~~~~l~~L~L~~L~l~~n~l~~~~~~~~-  158 (520)
T 2z7x_B           88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS--------SVLPIAHLNISKVLLVLGETYGEKEDPE-  158 (520)
T ss_dssp             CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG--------GGGGGTTSCEEEEEEEECTTTTSSCCTT-
T ss_pred             ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchh--------hccccccceeeEEEeecccccccccccc-
Confidence            788999999999999874 678899999999999999988751        24555566  7777777777  433332 


Q ss_pred             hhhcc---------------------------------------------------------------------------
Q 036342          156 SISNL---------------------------------------------------------------------------  160 (596)
Q Consensus       156 ~~~~l---------------------------------------------------------------------------  160 (596)
                      .+..+                                                                           
T Consensus       159 ~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~  238 (520)
T 2z7x_B          159 GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI  238 (520)
T ss_dssp             TTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHH
T ss_pred             cccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHH
Confidence            22211                                                                           


Q ss_pred             -------cccccEEEccccccccccChhc-----cCCCCCCEEEccCCcccCCCC-c-----------------------
Q 036342          161 -------SRSLEEFYMYNCNISGGIPEEI-----SNLTNLVEIDLGGNKLNGSIP-I-----------------------  204 (596)
Q Consensus       161 -------~~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~p-~-----------------------  204 (596)
                             .++|++|++++|++++.+|..+     ..+++|+.+++++|.+  .+| .                       
T Consensus       239 ~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~  316 (520)
T 2z7x_B          239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVH  316 (520)
T ss_dssp             HHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCC
T ss_pred             HHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccc
Confidence                   0268888888888887778777     6666666666655555  122 1                       


Q ss_pred             -c-ccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcc--cchhhhccCCCCcEEEeCCCcccC-CCcc-cc
Q 036342          205 -T-LGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG--SIPACFGNLASLRILSLGSNKLTS-IPLT-FW  278 (596)
Q Consensus       205 -~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~-ip~~-~~  278 (596)
                       . +..+++|++|++++|.+++.+|..+..+++|++|++++|++++  .+|..+..+++|++|+|++|.+++ +|.. +.
T Consensus       317 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~  396 (520)
T 2z7x_B          317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS  396 (520)
T ss_dssp             CCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCC
T ss_pred             ccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhc
Confidence             1 2678999999999999998899999999999999999999986  556889999999999999999998 8876 77


Q ss_pred             cccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCC-CCCCCCCCc
Q 036342          279 NLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR-GGSFGNFSA  357 (596)
Q Consensus       279 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~l~~  357 (596)
                      .+++|++|++++|++++..+..+.  +.|+.||+++|+++ .+|..++ .+++|++|++++|+++..++. ...+++++.
T Consensus       397 ~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~-~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~  472 (520)
T 2z7x_B          397 WTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV-KLEALQELNVASNQLKSVPDGIFDRLTSLQK  472 (520)
T ss_dssp             CCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG-GCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh-cCCCCCEEECCCCcCCccCHHHhccCCcccE
Confidence            899999999999999988777664  78999999999999 7888665 899999999999999964444 356888999


Q ss_pred             ccccccccccCCC
Q 036342          358 ESFEGNELLCGSP  370 (596)
Q Consensus       358 l~~~~N~~~c~~~  370 (596)
                      +++++|++.|+++
T Consensus       473 L~l~~N~~~c~c~  485 (520)
T 2z7x_B          473 IWLHTNPWDCSCP  485 (520)
T ss_dssp             EECCSSCBCCCHH
T ss_pred             EECcCCCCcccCC
Confidence            9999999998654

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.7e-42  Score=379.16  Aligned_cols=355  Identities=20%  Similarity=0.200  Sum_probs=240.6

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +||+++.  ++|++|+|++|++++..|.+|..+++|++|+|++|++++. ++..+..+++|++|+|++|++++..|..|.
T Consensus        19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~   95 (549)
T 2z81_A           19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI-EGDAFYSLGSLEHLDLSDNHLSSLSSSWFG   95 (549)
T ss_dssp             SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEE-CTTTTTTCTTCCEEECTTSCCCSCCHHHHT
T ss_pred             cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCcc-ChhhccccccCCEEECCCCccCccCHHHhc
Confidence            4677664  7899999999999888888899999999999999999854 444445688999999999999977777799


Q ss_pred             CCCCCCEEEccCCccccc-CCccccCCCCCCEEecCCCc-CcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhh
Q 036342           81 NASKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENY-LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSIS  158 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  158 (596)
                      ++++|++|+|++|++++. .|..|.++++|++|++++|. +..+++.     .|.++++|++|++++|.+++..|. .+.
T Consensus        96 ~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~-~l~  169 (549)
T 2z81_A           96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI-----DFAGLTSLNELEIKALSLRNYQSQ-SLK  169 (549)
T ss_dssp             TCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTT-----TTTTCCEEEEEEEEETTCCEECTT-TTT
T ss_pred             cCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHh-----hhhcccccCeeeccCCcccccChh-hhh
Confidence            999999999999999864 56788899999999999997 4443322     578888888888888888876554 333


Q ss_pred             cc-----------------------cccccEEEcccccccccc--C-hhc------------------------------
Q 036342          159 NL-----------------------SRSLEEFYMYNCNISGGI--P-EEI------------------------------  182 (596)
Q Consensus       159 ~l-----------------------~~~L~~L~l~~n~l~~~~--~-~~~------------------------------  182 (596)
                      .+                       .++|++|++++|++++..  | ...                              
T Consensus       170 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~  249 (549)
T 2z81_A          170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY  249 (549)
T ss_dssp             TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGG
T ss_pred             ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhh
Confidence            22                       146777777777776531  0 000                              


Q ss_pred             ---------------------------------------------------------cCCCCCCEEEccCCcccCCCCcc
Q 036342          183 ---------------------------------------------------------SNLTNLVEIDLGGNKLNGSIPIT  205 (596)
Q Consensus       183 ---------------------------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~  205 (596)
                                                                               ....+|+.|++++|.+. .+|..
T Consensus       250 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~  328 (549)
T 2z81_A          250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCS  328 (549)
T ss_dssp             CTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHH
T ss_pred             hccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHH
Confidence                                                                     00123444444444444 23333


Q ss_pred             c-cCCCCCCeEEccCCcccccCcc---chhcCCCCcEEEccCCcCcccch--hhhccCCCCcEEEeCCCcccCCCccccc
Q 036342          206 L-GKLRKLQRLNLEDNILEGSIPD---DICRLAELYRLELGSNKLYGSIP--ACFGNLASLRILSLGSNKLTSIPLTFWN  279 (596)
Q Consensus       206 ~-~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~ip~~~~~  279 (596)
                      + ..+++|++|++++|.+++.+|.   .+..+++|++|++++|++++..+  ..+..+++|++|+|++|+++.+|..+..
T Consensus       329 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~  408 (549)
T 2z81_A          329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQW  408 (549)
T ss_dssp             HHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCC
T ss_pred             HHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcc
Confidence            3 4678888888888888776543   35677888888888888875543  4578888888888888888888888888


Q ss_pred             ccccceEEcccCCCCCchhhhh-----------------ccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcc
Q 036342          280 LKDILQLNFSSNFLTGPLLLEI-----------------GNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL  342 (596)
Q Consensus       280 l~~L~~L~ls~N~l~~~~~~~~-----------------~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l  342 (596)
                      +++|++|++++|+++.......                 ..++.|+.||+++|+++ .+|..  ..+++|+.|++++|++
T Consensus       409 ~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~~--~~l~~L~~L~Ls~N~l  485 (549)
T 2z81_A          409 PEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDA--SLFPVLLVMKISRNQL  485 (549)
T ss_dssp             CTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCG--GGCTTCCEEECCSSCC
T ss_pred             cccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCCc--ccCccCCEEecCCCcc
Confidence            8888888888888764322111                 13444455555555554 34431  2344555555555555


Q ss_pred             cccCCCC-CCCCCCCcccccccccccC
Q 036342          343 KGEIPRG-GSFGNFSAESFEGNELLCG  368 (596)
Q Consensus       343 ~~~~p~~-~~~~~l~~l~~~~N~~~c~  368 (596)
                      ++.+|.. ..+++++.+++++|++.|+
T Consensus       486 ~~~~~~~~~~l~~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          486 KSVPDGIFDRLTSLQKIWLHTNPWDCS  512 (549)
T ss_dssp             CCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred             CCcCHHHHhcCcccCEEEecCCCccCC
Confidence            5444432 3344555555555555443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=373.56  Aligned_cols=143  Identities=24%  Similarity=0.295  Sum_probs=101.3

Q ss_pred             CCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccC
Q 036342            2 IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFN   81 (596)
Q Consensus         2 ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (596)
                      ||..+.  +++++|+|++|+++++.+.+|..+++|++|||++|++++ +++..+..+++|++|+|++|++++..|.+|.+
T Consensus        22 ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (570)
T 2z63_A           22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (570)
T ss_dssp             CCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             cCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCc-cCcccccCchhCCEEeCcCCcCCccCHhhhcC
Confidence            566553  467778888877777777777777778888888777763 44444455777788888777777666677777


Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCcc
Q 036342           82 ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGI  151 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~  151 (596)
                      +++|++|++++|+++++.+..|+++++|++|++++|.++.+.    ++..|.++++|++|++++|.+++.
T Consensus        99 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~----lp~~~~~l~~L~~L~l~~n~l~~~  164 (570)
T 2z63_A           99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK----LPEYFSNLTNLEHLDLSSNKIQSI  164 (570)
T ss_dssp             CTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCC----CCGGGGGCTTCCEEECTTSCCCEE
T ss_pred             ccccccccccccccccCCCccccccccccEEecCCCccceec----ChhhhcccCCCCEEeCcCCcccee
Confidence            777777777777777766666777777777777777776532    223466777777777777776654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.2e-41  Score=379.82  Aligned_cols=353  Identities=24%  Similarity=0.251  Sum_probs=241.1

Q ss_pred             CCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCcccc-----ccCc----cccCC
Q 036342           12 LEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSG-----TIPR----FIFNA   82 (596)
Q Consensus        12 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-----~~~~----~~~~l   82 (596)
                      |++|+|++|++++..|.+|..+++|++|+|++|++++.++ ..+..+++|+.|++++|...+     .+|.    .|..+
T Consensus       250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l  328 (680)
T 1ziw_A          250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS-HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL  328 (680)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECT-TTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTC
T ss_pred             CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccCh-hhhcCCCCccEEeccchhhhcccccccccccChhhcccC
Confidence            4444444444444444444444444445544444443222 122234444455444443221     1111    44455


Q ss_pred             CCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCC--CCCCCEEECcCCCCCccCCchhhhcc
Q 036342           83 SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSN--CKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        83 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~--l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      ++|++|++++|+++++.+..|.++++|++|++++|.++.....   ...|..  .++|+.|++++|+++++.+. .+..+
T Consensus       329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~---~~~f~~~~~~~L~~L~L~~n~l~~~~~~-~~~~l  404 (680)
T 1ziw_A          329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT---NETFVSLAHSPLHILNLTKNKISKIESD-AFSWL  404 (680)
T ss_dssp             TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEEC---TTTTGGGTTSCCCEEECTTSCCCEECTT-TTTTC
T ss_pred             CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcc---hhhhcccccCcCceEECCCCCCCeEChh-hhhCC
Confidence            5555555555555555555555555555555555543221000   001211  24566666666776666554 55555


Q ss_pred             cccccEEEccccccccccC-hhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCccc--ccCccchhcCCCCc
Q 036342          161 SRSLEEFYMYNCNISGGIP-EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE--GSIPDDICRLAELY  237 (596)
Q Consensus       161 ~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~  237 (596)
                       ++|++|++++|.+++.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++  +.+|..+..+++|+
T Consensus       405 -~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~  483 (680)
T 1ziw_A          405 -GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT  483 (680)
T ss_dssp             -TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred             -CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence             567777777777776544 56777777777777777777777777777778888888887775  46788888999999


Q ss_pred             EEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCc---------ccccccccceEEcccCCCCCchhhhhccccccc
Q 036342          238 RLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL---------TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLI  308 (596)
Q Consensus       238 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~---------~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  308 (596)
                      .|++++|++++..+..|.++++|++|+|++|+++.++.         .+..+++|++|++++|+++...+..|.++++|+
T Consensus       484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~  563 (680)
T 1ziw_A          484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK  563 (680)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence            99999999998888889999999999999999987632         267889999999999999977777899999999


Q ss_pred             eEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCC-C-CCCCCCcccccccccccCCCC
Q 036342          309 GIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG-G-SFGNFSAESFEGNELLCGSPN  371 (596)
Q Consensus       309 ~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~-~~~~l~~l~~~~N~~~c~~~~  371 (596)
                      .||+++|+++ .+|...+..+++|+.|++++|++++..|.. . .+++++.+++++|||.|+++.
T Consensus       564 ~L~Ls~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          564 IIDLGLNNLN-TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             EEECCSSCCC-CCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             eeECCCCCCC-cCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            9999999999 566667888999999999999999876654 2 578899999999999998874

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.5e-40  Score=368.02  Aligned_cols=364  Identities=20%  Similarity=0.164  Sum_probs=295.2

Q ss_pred             CcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCcccc-ccCccccC
Q 036342            3 PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSG-TIPRFIFN   81 (596)
Q Consensus         3 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~   81 (596)
                      |..|+++++|++|+|++|++++..|.+|..+++|++|+|++|++++ +++..+..+++|++|+|++|.+++ .+|..|.+
T Consensus        73 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~  151 (606)
T 3vq2_A           73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN  151 (606)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCC-SSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGT
T ss_pred             HHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccc-ccccccCCCCCCCEEeCCCCcccceechHhHhh
Confidence            6779999999999999999999999999999999999999999984 454445679999999999999986 56999999


Q ss_pred             CCCCCEEEccCCcccccCCccccCCC------------------------------------------------------
Q 036342           82 ASKLSKLSLGMNSFSGFIPSTFGNLR------------------------------------------------------  107 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~~~~~~~~l~------------------------------------------------------  107 (596)
                      +++|++|+|++|++++..+..|..+.                                                      
T Consensus       152 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L  231 (606)
T 3vq2_A          152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL  231 (606)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTC
T ss_pred             cCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhcccccc
Confidence            99999999999999887766443332                                                      


Q ss_pred             ----------------------------------------------------------------------------CCCE
Q 036342          108 ----------------------------------------------------------------------------NLEQ  111 (596)
Q Consensus       108 ----------------------------------------------------------------------------~L~~  111 (596)
                                                                                                  +|++
T Consensus       232 ~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~  311 (606)
T 3vq2_A          232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQS  311 (606)
T ss_dssp             EEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSE
T ss_pred             ccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCE
Confidence                                                                                        2233


Q ss_pred             EecCCCcCcCCCCC--------------ccccccCCCCCCCCEEECcCCCCCccC--CchhhhcccccccEEEccccccc
Q 036342          112 LGLDENYLTSSTPE--------------LSFLSSLSNCKSLTLIDLSNNPLDGIL--PKTSISNLSRSLEEFYMYNCNIS  175 (596)
Q Consensus       112 L~l~~N~l~~~~~~--------------~~~~~~~~~l~~L~~L~ls~N~l~~~~--~~~~~~~l~~~L~~L~l~~n~l~  175 (596)
                      |++++|.+..++.-              ......+..+++|++|++++|.+++..  +. .+..+ ++|++|++++|.++
T Consensus       312 L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~-~~~~~-~~L~~L~L~~n~l~  389 (606)
T 3vq2_A          312 LSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSY-SDLGT-NSLRHLDLSFNGAI  389 (606)
T ss_dssp             EEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCH-HHHCC-SCCCEEECCSCSEE
T ss_pred             EEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhh-hhccC-CcccEeECCCCccc
Confidence            33333333222100              001114567888999999999988763  44 56666 78999999999998


Q ss_pred             cccChhccCCCCCCEEEccCCcccCCCC-ccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcc-cchhh
Q 036342          176 GGIPEEISNLTNLVEIDLGGNKLNGSIP-ITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG-SIPAC  253 (596)
Q Consensus       176 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~  253 (596)
                      + +|..|..+++|++|++++|.+.+..| ..|..+++|++|++++|.+++..|..+..+++|++|++++|++++ .+|..
T Consensus       390 ~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  468 (606)
T 3vq2_A          390 I-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV  468 (606)
T ss_dssp             E-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC
T ss_pred             c-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHh
Confidence            6 56889999999999999999998887 789999999999999999999999999999999999999999987 47889


Q ss_pred             hccCCCCcEEEeCCCcccCC-CcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCC-C
Q 036342          254 FGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLS-Y  331 (596)
Q Consensus       254 ~~~l~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~-~  331 (596)
                      |..+++|+.|+|++|.++++ |..+..+++|++|++++|++++..|..+..+++|+.||+++|+++ .+|.. +..++ +
T Consensus       469 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~-~~~l~~~  546 (606)
T 3vq2_A          469 FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGI-LQHFPKS  546 (606)
T ss_dssp             CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESC-GGGSCTT
T ss_pred             hccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHh-Hhhhccc
Confidence            99999999999999999985 567889999999999999999999999999999999999999999 67775 55676 6


Q ss_pred             CCeEECCCCcccccCCCCC---CCCCCCcccccccccccCCCCC
Q 036342          332 LEDLNLSFNKLKGEIPRGG---SFGNFSAESFEGNELLCGSPNL  372 (596)
Q Consensus       332 L~~L~l~~N~l~~~~p~~~---~~~~l~~l~~~~N~~~c~~~~~  372 (596)
                      |+.|++++|++.|.++...   .+..-...........|..|..
T Consensus       547 L~~l~l~~N~~~c~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~  590 (606)
T 3vq2_A          547 LAFFNLTNNSVACICEHQKFLQWVKEQKQFLVNVEQMTCATPVE  590 (606)
T ss_dssp             CCEEECCSCCCCCSSTTHHHHTTTTTSSSSBSSGGGCCCC----
T ss_pred             CcEEEccCCCcccCCccHHHHHHHHcCcccccCCccceeCCChH
Confidence            9999999999998777532   1222122222344556766543

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=5.4e-41  Score=368.04  Aligned_cols=349  Identities=25%  Similarity=0.286  Sum_probs=277.2

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +||.++.  ++|++|+|++|+|+++.|.+|..+++|++|+|++|++++ +++..+..+++|++|||++|+++ .+|..  
T Consensus        45 ~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--  118 (562)
T 3a79_B           45 HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNRLQ-NISCC--  118 (562)
T ss_dssp             SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCE-ECTTTTTTCTTCCEEECTTSCCC-EECSC--
T ss_pred             cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCc-CCHHHhCCCCCCCEEECCCCcCC-ccCcc--
Confidence            3677664  789999999999998888899999999999999999985 44444556899999999999998 56665  


Q ss_pred             CCCCCCEEEccCCccccc-CCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCC--CEEECcCCCC--CccCCch
Q 036342           81 NASKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL--TLIDLSNNPL--DGILPKT  155 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L--~~L~ls~N~l--~~~~~~~  155 (596)
                      .+++|++|+|++|+|+++ .|..|.++++|++|++++|.++..        .+..+++|  +.|++++|.+  ++..|. 
T Consensus       119 ~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--------~~~~l~~L~L~~L~L~~n~l~~~~~~~~-  189 (562)
T 3a79_B          119 PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--------DLLPVAHLHLSCILLDLVSYHIKGGETE-  189 (562)
T ss_dssp             CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT--------TTGGGTTSCEEEEEEEESSCCCCSSSCC-
T ss_pred             ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC--------chhhhhhceeeEEEeecccccccccCcc-
Confidence            889999999999999875 368899999999999999988762        24444555  8888888888  555443 


Q ss_pred             hhhccc--------------------------------------------------------------------------
Q 036342          156 SISNLS--------------------------------------------------------------------------  161 (596)
Q Consensus       156 ~~~~l~--------------------------------------------------------------------------  161 (596)
                      .+..+.                                                                          
T Consensus       190 ~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~  269 (562)
T 3a79_B          190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL  269 (562)
T ss_dssp             EEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHH
T ss_pred             cccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHH
Confidence            222210                                                                          


Q ss_pred             ------ccccEEEccccccccccChhc-----cCC--------------------------CCCCEEEccCCcccCCCCc
Q 036342          162 ------RSLEEFYMYNCNISGGIPEEI-----SNL--------------------------TNLVEIDLGGNKLNGSIPI  204 (596)
Q Consensus       162 ------~~L~~L~l~~n~l~~~~~~~~-----~~l--------------------------~~L~~L~Ls~N~l~~~~p~  204 (596)
                            ++|++|++++|.+++.+|..+     ..+                          .+|+.|++++|.+....  
T Consensus       270 ~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--  347 (562)
T 3a79_B          270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--  347 (562)
T ss_dssp             HHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--
T ss_pred             HHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--
Confidence                  156667777777766666554     222                          23555555555554221  


Q ss_pred             cccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCccc--chhhhccCCCCcEEEeCCCcccC-CCcc-cccc
Q 036342          205 TLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS--IPACFGNLASLRILSLGSNKLTS-IPLT-FWNL  280 (596)
Q Consensus       205 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~-ip~~-~~~l  280 (596)
                      ....+++|++|++++|.+++.+|..+..+++|+.|++++|++++.  .|..|..+++|+.|+|++|.+++ +|.. +..+
T Consensus       348 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l  427 (562)
T 3a79_B          348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA  427 (562)
T ss_dssp             CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCC
T ss_pred             CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCc
Confidence            126789999999999999988999999999999999999999873  45779999999999999999998 8875 7789


Q ss_pred             cccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCC-CCCCCCCCccc
Q 036342          281 KDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR-GGSFGNFSAES  359 (596)
Q Consensus       281 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~l~~l~  359 (596)
                      ++|++|++++|++++..+..+.  +.|+.||+++|+++ .+|..++ .+++|++|++++|+++..++. ...+++++.++
T Consensus       428 ~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~-~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~  503 (562)
T 3a79_B          428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVT-HLQALQELNVASNQLKSVPDGVFDRLTSLQYIW  503 (562)
T ss_dssp             TTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTT-SSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEE
T ss_pred             ccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhc-CCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEE
Confidence            9999999999999987776654  78999999999999 6888666 899999999999999965444 35688999999


Q ss_pred             ccccccccCCC
Q 036342          360 FEGNELLCGSP  370 (596)
Q Consensus       360 ~~~N~~~c~~~  370 (596)
                      +++|+|.|+++
T Consensus       504 l~~N~~~c~c~  514 (562)
T 3a79_B          504 LHDNPWDCTCP  514 (562)
T ss_dssp             CCSCCBCCCHH
T ss_pred             ecCCCcCCCcc
Confidence            99999999665

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.9e-41  Score=360.36  Aligned_cols=348  Identities=21%  Similarity=0.243  Sum_probs=302.9

Q ss_pred             CCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEcc
Q 036342           12 LEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLG   91 (596)
Q Consensus        12 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~   91 (596)
                      -+.++.++++++ .+|..+  .+++++|||++|++++ +++..+..+++|++|+|++|.+++..|.+|.++++|++|+|+
T Consensus        13 ~~~v~c~~~~l~-~ip~~~--~~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~   88 (477)
T 2id5_A           13 DRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR   88 (477)
T ss_dssp             TTEEECCSCCCS-SCCSCC--CTTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-cCCCCC--CCCCcEEECCCCccce-ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence            468999999987 566655  4689999999999985 444445569999999999999998889999999999999999


Q ss_pred             CCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccc
Q 036342           92 MNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN  171 (596)
Q Consensus        92 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~  171 (596)
                      +|+|+.+.+..|.++++|++|+|++|.++.+.+.     .|.++++|+.|++++|.+++..+. .+..+ ++|++|++++
T Consensus        89 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l-~~L~~L~l~~  161 (477)
T 2id5_A           89 SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDY-----MFQDLYNLKSLEVGDNDLVYISHR-AFSGL-NSLEQLTLEK  161 (477)
T ss_dssp             SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEEEECCTTCCEECTT-SSTTC-TTCCEEEEES
T ss_pred             CCcCCccCcccccCCCCCCEEECCCCccccCChh-----HccccccCCEEECCCCccceeChh-hccCC-CCCCEEECCC
Confidence            9999988888899999999999999999886554     589999999999999999887665 67777 7899999999


Q ss_pred             cccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccch
Q 036342          172 CNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIP  251 (596)
Q Consensus       172 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  251 (596)
                      |.+++..+..|..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|+.|++++|+++...+
T Consensus       162 n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  241 (477)
T 2id5_A          162 CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY  241 (477)
T ss_dssp             CCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCH
T ss_pred             CcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCH
Confidence            99998888889999999999999999999888899999999999999998887888887777899999999999997777


Q ss_pred             hhhccCCCCcEEEeCCCcccCCCc-ccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCC
Q 036342          252 ACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLS  330 (596)
Q Consensus       252 ~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~  330 (596)
                      ..|..+++|+.|+|++|.++.++. .+..+++|+.|+|++|++++..+..|..+++|+.||+++|++++ ++...+..++
T Consensus       242 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~  320 (477)
T 2id5_A          242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT-LEESVFHSVG  320 (477)
T ss_dssp             HHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSC-CCGGGBSCGG
T ss_pred             HHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCce-eCHhHcCCCc
Confidence            889999999999999999999765 57889999999999999999999999999999999999999995 5666778899


Q ss_pred             CCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCCC
Q 036342          331 YLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN  371 (596)
Q Consensus       331 ~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~~  371 (596)
                      +|++|++++|++.+.++....+.......+.++...|..|.
T Consensus       321 ~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          321 NLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             GCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             ccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence            99999999999998765433333444566778888887765

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.5e-40  Score=366.69  Aligned_cols=361  Identities=21%  Similarity=0.261  Sum_probs=286.8

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +||+++.  +++++|||++|+|+++.+.+|.++++|++|||++|+|+ .+++.+|..+++|++|+|++|+|++..+.+|.
T Consensus        45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~  121 (635)
T 4g8a_A           45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFS  121 (635)
T ss_dssp             SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECGGGGT
T ss_pred             ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCCCHHHhc
Confidence            4677663  58899999999999888889999999999999999998 56666667799999999999999977778899


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      ++++|++|+|++|+|+++.+..|+++++|++|++++|.++....    +..+..+++|++|++++|+|++..+. .+..+
T Consensus       122 ~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~-~l~~L  196 (635)
T 4g8a_A          122 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL----PEYFSNLTNLEHLDLSSNKIQSIYCT-DLRVL  196 (635)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCC----CGGGGGCTTCCEEECCSSCCCEECGG-GGHHH
T ss_pred             CCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCC----chhhccchhhhhhcccCccccccccc-cccch
Confidence            99999999999999999888899999999999999999987532    23578889999999999988765432 11111


Q ss_pred             c-------------------------------------------------------------------------------
Q 036342          161 S-------------------------------------------------------------------------------  161 (596)
Q Consensus       161 ~-------------------------------------------------------------------------------  161 (596)
                      .                                                                               
T Consensus       197 ~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~  276 (635)
T 4g8a_A          197 HQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE  276 (635)
T ss_dssp             HTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTG
T ss_pred             hhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccc
Confidence            0                                                                               


Q ss_pred             ---------------------------------------------------ccccEEEccccccccccCh----------
Q 036342          162 ---------------------------------------------------RSLEEFYMYNCNISGGIPE----------  180 (596)
Q Consensus       162 ---------------------------------------------------~~L~~L~l~~n~l~~~~~~----------  180 (596)
                                                                         ..++.|++.+|.+.+..+.          
T Consensus       277 ~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l  356 (635)
T 4g8a_A          277 GLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF  356 (635)
T ss_dssp             GGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEE
T ss_pred             cccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhccc
Confidence                                                               0122333333333222111          


Q ss_pred             ---------hccCCCCCCEEEccCCcccCC--C-----------------------CccccCCCCCCeEEccCCcccccC
Q 036342          181 ---------EISNLTNLVEIDLGGNKLNGS--I-----------------------PITLGKLRKLQRLNLEDNILEGSI  226 (596)
Q Consensus       181 ---------~~~~l~~L~~L~Ls~N~l~~~--~-----------------------p~~~~~l~~L~~L~L~~N~l~~~~  226 (596)
                               .+..+++|+.|++++|.+...  .                       +..+..+++|+.++++.|......
T Consensus       357 ~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~  436 (635)
T 4g8a_A          357 TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMS  436 (635)
T ss_dssp             ESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTT
T ss_pred             ccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccc
Confidence                     112356777788887776421  1                       234556667777777777665444


Q ss_pred             c-cchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC--CCcccccccccceEEcccCCCCCchhhhhcc
Q 036342          227 P-DDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS--IPLTFWNLKDILQLNFSSNFLTGPLLLEIGN  303 (596)
Q Consensus       227 ~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  303 (596)
                      + ..+..+.+++.++++.|.+.+..+..+..+++|+.|+|++|.+..  +|..+..+++|++|+|++|++++..|..|.+
T Consensus       437 ~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~  516 (635)
T 4g8a_A          437 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS  516 (635)
T ss_dssp             SSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcC
Confidence            3 456778999999999999999999999999999999999998654  6778999999999999999999999999999


Q ss_pred             ccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCC-CCC-CCCCcccccccccccCCC
Q 036342          304 LKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG-GSF-GNFSAESFEGNELLCGSP  370 (596)
Q Consensus       304 l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~-~~l~~l~~~~N~~~c~~~  370 (596)
                      +++|++|+|++|+|++..|. .+..+++|+.|||++|++++..|.. ..+ ++++.+++++|||.|++.
T Consensus       517 l~~L~~L~Ls~N~l~~l~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          517 LSSLQVLNMSHNNFFSLDTF-PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CTTCCEEECTTSCCCBCCCG-GGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CCCCCEEECCCCcCCCCChh-HHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            99999999999999965554 7788999999999999999988876 334 689999999999999765

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2e-40  Score=354.08  Aligned_cols=340  Identities=23%  Similarity=0.214  Sum_probs=292.5

Q ss_pred             CCcccCCCCCCCEEECCCCCCcccc-chhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcc--
Q 036342            2 IPLEIGNLQNLEELQLGQNKLIGTV-PAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRF--   78 (596)
Q Consensus         2 ip~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--   78 (596)
                      .|..|+++++|++|+|++|++.+.+ +..|..+++|++|+|++|++++..+. .+..+++|++|+|++|++++..+..  
T Consensus        46 ~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~  124 (455)
T 3v47_A           46 NETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETG-AFNGLANLEVLTLTQCNLDGAVLSGNF  124 (455)
T ss_dssp             CTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTT-TTTTCTTCCEEECTTSCCBTHHHHSST
T ss_pred             ChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChh-hccCcccCCEEeCCCCCCCccccCccc
Confidence            3778999999999999999997444 67899999999999999999855443 3456999999999999999755554  


Q ss_pred             ccCCCCCCEEEccCCcccccCCcc-ccCCCCCCEEecCCCcCcCCCCCccccccCCCC--CCCCEEECcCCCCCccCCch
Q 036342           79 IFNASKLSKLSLGMNSFSGFIPST-FGNLRNLEQLGLDENYLTSSTPELSFLSSLSNC--KSLTLIDLSNNPLDGILPKT  155 (596)
Q Consensus        79 ~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l--~~L~~L~ls~N~l~~~~~~~  155 (596)
                      +.++++|++|+|++|++++..|.. |.++++|++|++++|.+++..+.     .+..+  .+|+.|++++|.+.+..+..
T Consensus       125 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~l~~l~~~~L~~L~l~~n~l~~~~~~~  199 (455)
T 3v47_A          125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEE-----DLLNFQGKHFTLLRLSSITLQDMNEYW  199 (455)
T ss_dssp             TTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTT-----TSGGGTTCEEEEEECTTCBCTTCSTTC
T ss_pred             ccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChh-----hhhccccccccccccccCcccccchhh
Confidence            999999999999999999988876 89999999999999999987654     34444  68999999999998764321


Q ss_pred             -------hhhcccccccEEEccccccccccChhccCC---CCCCEEEccCCcccCC----------CCccccC--CCCCC
Q 036342          156 -------SISNLSRSLEEFYMYNCNISGGIPEEISNL---TNLVEIDLGGNKLNGS----------IPITLGK--LRKLQ  213 (596)
Q Consensus       156 -------~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~----------~p~~~~~--l~~L~  213 (596)
                             .+..+ ++|++|++++|.+++..|..+...   ++|+.|++++|.+.+.          .+..+.+  .++|+
T Consensus       200 ~~~~~~~~~~~~-~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~  278 (455)
T 3v47_A          200 LGWEKCGNPFKN-TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK  278 (455)
T ss_dssp             TTHHHHCCTTTT-CEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCC
T ss_pred             cccccccccccc-ceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCce
Confidence                   01123 579999999999999888887665   8999999999865542          2233333  36899


Q ss_pred             eEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCC-CcccccccccceEEcccCC
Q 036342          214 RLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNF  292 (596)
Q Consensus       214 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~ls~N~  292 (596)
                      +|++++|.+++..|..+..+++|+.|+|++|++++..|..|.++++|++|+|++|.++++ |..+..+++|++|++++|+
T Consensus       279 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  358 (455)
T 3v47_A          279 TCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH  358 (455)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSC
T ss_pred             EEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCc
Confidence            999999999999999999999999999999999998899999999999999999999986 5678899999999999999


Q ss_pred             CCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCC
Q 036342          293 LTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG  349 (596)
Q Consensus       293 l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  349 (596)
                      +++..+..+..+++|++|++++|++++ +|...+..+++|++|++++|++++.+|..
T Consensus       359 l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  414 (455)
T 3v47_A          359 IRALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPRI  414 (455)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             ccccChhhccccccccEEECCCCcccc-CCHhHhccCCcccEEEccCCCcccCCCcc
Confidence            999999999999999999999999995 56657788999999999999999988854

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.1e-39  Score=363.80  Aligned_cols=306  Identities=24%  Similarity=0.233  Sum_probs=185.9

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +||.++.  +++++|+|++|+++++.+..|..+++|++|+|++|.+++..+. .+..+++|++|+|++|++++..+.+|.
T Consensus        18 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~l~~~~~~   94 (680)
T 1ziw_A           18 QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE-LCQKLPMLKVLNLQHNELSQLSDKTFA   94 (680)
T ss_dssp             SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTT-HHHHCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHH-HHhcccCcCEEECCCCccCccChhhhc
Confidence            3566554  6777777777777776667777777777777777777643333 333477777777777777755555677


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      ++++|++|+|++|+++++.|..|.++++|++|++++|.+++..+.     .+.++++|++|++++|.+++..+. .+..+
T Consensus        95 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~-~~~~~  168 (680)
T 1ziw_A           95 FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG-----TQVQLENLQELLLSNNKIQALKSE-ELDIF  168 (680)
T ss_dssp             TCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCC-----SSSCCTTCCEEECCSSCCCCBCHH-HHGGG
T ss_pred             cCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCch-----hhcccccCCEEEccCCcccccCHH-Hhhcc
Confidence            777777777777777777777777777777777777777665443     466777777777777777665433 22211


Q ss_pred             -cccccEEEccccccccccChhccCC---------------------------CCCCEEEccCCcccCCCCccccCCCC-
Q 036342          161 -SRSLEEFYMYNCNISGGIPEEISNL---------------------------TNLVEIDLGGNKLNGSIPITLGKLRK-  211 (596)
Q Consensus       161 -~~~L~~L~l~~n~l~~~~~~~~~~l---------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~-  211 (596)
                       .++|++|++++|.+++..|..|..+                           ++|+.|++++|.+.+..|.+|.+++. 
T Consensus       169 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~  248 (680)
T 1ziw_A          169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT  248 (680)
T ss_dssp             TTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGS
T ss_pred             ccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcC
Confidence             1456677777776666665555432                           34555556666666555555555533 


Q ss_pred             -CCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCccc------CCCc----ccccc
Q 036342          212 -LQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT------SIPL----TFWNL  280 (596)
Q Consensus       212 -L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~------~ip~----~~~~l  280 (596)
                       |++|++++|.+++..|..|..+++|++|++++|++.+..|..|.++++|+.|++++|...      .+|.    .+..+
T Consensus       249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l  328 (680)
T 1ziw_A          249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL  328 (680)
T ss_dssp             CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTC
T ss_pred             CCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccC
Confidence             666666666666555555666666666666666666555555555555555555544322      1221    34444


Q ss_pred             cccceEEcccCCCCCchhhhhccccccceEecCCC
Q 036342          281 KDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMN  315 (596)
Q Consensus       281 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N  315 (596)
                      ++|++|++++|.+++..+..|..+++|+.|++++|
T Consensus       329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n  363 (680)
T 1ziw_A          329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS  363 (680)
T ss_dssp             TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTC
T ss_pred             CCCCEEECCCCccCCCChhHhccccCCcEEECCCC
Confidence            55555555555555444444444444444444443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.9e-40  Score=373.36  Aligned_cols=349  Identities=18%  Similarity=0.193  Sum_probs=292.8

Q ss_pred             CCcccC--CCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCc-Ccc-ccCc-c-----CccCCCCccEEEccCCcc
Q 036342            2 IPLEIG--NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNS-LSG-SLSS-I-----ANVRLPNLEKLYLWGNNF   71 (596)
Q Consensus         2 ip~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~-~-----~~~~l~~L~~L~L~~N~l   71 (596)
                      ||++++  ++++|++|+|++|++.+.+|..|..+++|++|+|++|+ ++| .+|. +     .+..+++|+.|+|++|++
T Consensus       481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            899988  99999999999999999999999999999999999998 887 5654 2     233467999999999999


Q ss_pred             ccccCc--cccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCC-CCEEECcCCCC
Q 036342           72 SGTIPR--FIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS-LTLIDLSNNPL  148 (596)
Q Consensus        72 ~~~~~~--~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~-L~~L~ls~N~l  148 (596)
                      + .+|.  .+.++++|++|+|++|+|+ .+| .|..+++|++|+|++|.++.++.      .+.++++ |+.|+|++|.+
T Consensus       561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp~------~l~~l~~~L~~L~Ls~N~L  631 (876)
T 4ecn_A          561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPE------DFCAFTDQVEGLGFSHNKL  631 (876)
T ss_dssp             C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCCT------TSCEECTTCCEEECCSSCC
T ss_pred             C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccchH------HHhhccccCCEEECcCCCC
Confidence            9 8888  9999999999999999999 666 89999999999999999986443      5888999 99999999999


Q ss_pred             CccCCchhhhccc-ccccEEEccccccccccChhc---c--CCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcc
Q 036342          149 DGILPKTSISNLS-RSLEEFYMYNCNISGGIPEEI---S--NLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNIL  222 (596)
Q Consensus       149 ~~~~~~~~~~~l~-~~L~~L~l~~n~l~~~~~~~~---~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  222 (596)
                      + .+|. .+.... ++|+.|++++|.+++.+|...   .  .+++|+.|++++|.++..++..+..+++|+.|+|++|.|
T Consensus       632 ~-~lp~-~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L  709 (876)
T 4ecn_A          632 K-YIPN-IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM  709 (876)
T ss_dssp             C-SCCS-CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCC
T ss_pred             C-cCch-hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcC
Confidence            8 4564 444442 349999999999998766433   2  345899999999999965555566899999999999999


Q ss_pred             cccCccchhcC--------CCCcEEEccCCcCcccchhhhc--cCCCCcEEEeCCCcccCCCcccccccccceEEccc--
Q 036342          223 EGSIPDDICRL--------AELYRLELGSNKLYGSIPACFG--NLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSS--  290 (596)
Q Consensus       223 ~~~~~~~~~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~--  290 (596)
                      + .+|..+...        ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+++++|..+..+++|+.|+|++  
T Consensus       710 ~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~  787 (876)
T 4ecn_A          710 T-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQR  787 (876)
T ss_dssp             S-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCB
T ss_pred             C-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCC
Confidence            9 677655443        38999999999999 6777776  99999999999999999999999999999999977  


Q ss_pred             ----CCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCCC-CCCCCCccccccccc
Q 036342          291 ----NFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGG-SFGNFSAESFEGNEL  365 (596)
Q Consensus       291 ----N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~~~l~~l~~~~N~~  365 (596)
                          |++.+.+|..+..+++|+.|+|++|++ +.+|..+.   ++|+.|||++|++....+... .......+.+.+|++
T Consensus       788 ~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~---~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~  863 (876)
T 4ecn_A          788 DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT---PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT  863 (876)
T ss_dssp             CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC---SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTT
T ss_pred             CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc---CCCCEEECCCCCCCccChHHccccccchheeecCCCc
Confidence                888899999999999999999999999 58888533   689999999999876544321 122334456666665


Q ss_pred             cc
Q 036342          366 LC  367 (596)
Q Consensus       366 ~c  367 (596)
                      .+
T Consensus       864 ~~  865 (876)
T 4ecn_A          864 QD  865 (876)
T ss_dssp             SE
T ss_pred             cc
Confidence            54

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=347.93  Aligned_cols=336  Identities=21%  Similarity=0.157  Sum_probs=294.3

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +||..+.  +++++|+|++|+|+++.+..|..+++|++|+|++|.+++ +.+..+..+++|++|+|++|+++...+..|.
T Consensus        25 ~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  101 (477)
T 2id5_A           25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFT  101 (477)
T ss_dssp             SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCSCCTTSST
T ss_pred             cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCE-eChhhhhCCccCCEEECCCCcCCccCccccc
Confidence            4677664  689999999999999999999999999999999999985 4444455699999999999999977777899


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      ++++|++|+|++|++++..+..|.++++|++|++++|.++.+.+.     .|.++++|+.|++++|.+++.. ...+..+
T Consensus       102 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l  175 (477)
T 2id5_A          102 GLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR-----AFSGLNSLEQLTLEKCNLTSIP-TEALSHL  175 (477)
T ss_dssp             TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT-----SSTTCTTCCEEEEESCCCSSCC-HHHHTTC
T ss_pred             CCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh-----hccCCCCCCEEECCCCcCcccC-hhHhccc
Confidence            999999999999999999999999999999999999999887654     6899999999999999998754 4467777


Q ss_pred             cccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEE
Q 036342          161 SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE  240 (596)
Q Consensus       161 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (596)
                       ++|+.|++++|.+++..+..|..+++|+.|++++|.+.+.+|.......+|+.|++++|.+++..+..+..+++|+.|+
T Consensus       176 -~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  254 (477)
T 2id5_A          176 -HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLN  254 (477)
T ss_dssp             -TTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEE
T ss_pred             -CCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeE
Confidence             7899999999999999999999999999999999998877777777777999999999999965556789999999999


Q ss_pred             ccCCcCcccchhhhccCCCCcEEEeCCCcccCC-CcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcc
Q 036342          241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSG  319 (596)
Q Consensus       241 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~  319 (596)
                      |++|++++..+..|..+++|+.|+|++|+++.+ |..+..+++|+.|++++|++++..+..|..+++|+.|++++|.+..
T Consensus       255 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c  334 (477)
T 2id5_A          255 LSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC  334 (477)
T ss_dssp             CCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred             CCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence            999999988888999999999999999999996 6688899999999999999999988899999999999999999985


Q ss_pred             cCChhhhccCCCCCeEECCCCcccccCCC
Q 036342          320 VIPREIGEKLSYLEDLNLSFNKLKGEIPR  348 (596)
Q Consensus       320 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  348 (596)
                      .-+..++  ...+..+++.++...+..|.
T Consensus       335 ~c~~~~~--~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          335 DCRLLWV--FRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             SGGGHHH--HTTTTSSCCTTCCCBEEESG
T ss_pred             ccchHhH--HhhhhccccCccCceeCCch
Confidence            4333222  23345566677777766554

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=356.37  Aligned_cols=361  Identities=21%  Similarity=0.215  Sum_probs=278.3

Q ss_pred             CcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCC
Q 036342            3 PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNA   82 (596)
Q Consensus         3 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l   82 (596)
                      |.+|..+++|++|+|++|+++++.|.+|..+++|++|+|++|++++ +++..+..+++|++|++++|++++..+..+.++
T Consensus        45 ~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l  123 (570)
T 2z63_A           45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHL  123 (570)
T ss_dssp             TTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTC
T ss_pred             hhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc-cCHhhhcCccccccccccccccccCCCcccccc
Confidence            4468888999999999999888888888888999999999998874 444445568888888888888886666578888


Q ss_pred             CCCCEEEccCCccccc-CCccccCCCCCCEEecCCCcCcCCCCCc-c---------------------------------
Q 036342           83 SKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENYLTSSTPEL-S---------------------------------  127 (596)
Q Consensus        83 ~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~---------------------------------  127 (596)
                      ++|++|+|++|.++++ .|..|.++++|++|++++|.++...+.. .                                 
T Consensus       124 ~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~  203 (570)
T 2z63_A          124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH  203 (570)
T ss_dssp             TTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEE
T ss_pred             ccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcce
Confidence            8888888888888774 5788888888888888888876643220 0                                 


Q ss_pred             ----------------------------------------------------------------------ccccCCCCCC
Q 036342          128 ----------------------------------------------------------------------FLSSLSNCKS  137 (596)
Q Consensus       128 ----------------------------------------------------------------------~~~~~~~l~~  137 (596)
                                                                                            .+..+..+++
T Consensus       204 ~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~  283 (570)
T 2z63_A          204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN  283 (570)
T ss_dssp             EEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTT
T ss_pred             eEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCc
Confidence                                                                                  0011222334


Q ss_pred             CCEEECcCCCCCccCCchhhhcccccccEEEccccccc---------------------cccChhccCCCCCCEEEccCC
Q 036342          138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS---------------------GGIPEEISNLTNLVEIDLGGN  196 (596)
Q Consensus       138 L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~---------------------~~~~~~~~~l~~L~~L~Ls~N  196 (596)
                      |+.|++++|.+++ +|. .+..+  +|++|++++|.++                     +..+.  ..+++|++|++++|
T Consensus       284 L~~L~l~~~~l~~-l~~-~~~~~--~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n  357 (570)
T 2z63_A          284 VSSFSLVSVTIER-VKD-FSYNF--GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRN  357 (570)
T ss_dssp             CSEEEEESCEECS-CCB-CCSCC--CCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSS
T ss_pred             ccEEEecCccchh-hhh-hhccC--CccEEeeccCcccccCcccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCC
Confidence            4444444444332 121 11111  2333333333333                     22221  56789999999999


Q ss_pred             cccCCC--CccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccch-hhhccCCCCcEEEeCCCcccC-
Q 036342          197 KLNGSI--PITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIP-ACFGNLASLRILSLGSNKLTS-  272 (596)
Q Consensus       197 ~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~-  272 (596)
                      .+++..  |..+..+++|++|++++|.+++. +..+..+++|+.|++++|.+.+..| ..+..+++|++|++++|.++. 
T Consensus       358 ~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~  436 (570)
T 2z63_A          358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA  436 (570)
T ss_dssp             CCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEEC
T ss_pred             ccCccccccccccccCccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCccccc
Confidence            998764  77889999999999999999954 4459999999999999999987766 578999999999999999998 


Q ss_pred             CCcccccccccceEEcccCCCC-CchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCC-C
Q 036342          273 IPLTFWNLKDILQLNFSSNFLT-GPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG-G  350 (596)
Q Consensus       273 ip~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~  350 (596)
                      .|..+..+++|++|++++|.++ +..|..+..+++|+.|++++|++++..|. .+..+++|++|++++|++++.+|.. .
T Consensus       437 ~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~  515 (570)
T 2z63_A          437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT-AFNSLSSLQVLNMASNQLKSVPDGIFD  515 (570)
T ss_dssp             CTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred             chhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChh-hhhcccCCCEEeCCCCcCCCCCHHHhh
Confidence            5667889999999999999998 67889999999999999999999977676 6678999999999999999887765 5


Q ss_pred             CCCCCCcccccccccccCCCCC
Q 036342          351 SFGNFSAESFEGNELLCGSPNL  372 (596)
Q Consensus       351 ~~~~l~~l~~~~N~~~c~~~~~  372 (596)
                      .+++++.+++++|++.|++|..
T Consensus       516 ~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          516 RLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             TCTTCCEEECCSSCBCCCTTTT
T ss_pred             cccCCcEEEecCCcccCCCcch
Confidence            6889999999999999987754

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=8.1e-39  Score=334.59  Aligned_cols=337  Identities=20%  Similarity=0.201  Sum_probs=289.7

Q ss_pred             CCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCE
Q 036342            8 NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSK   87 (596)
Q Consensus         8 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~   87 (596)
                      .++++++|++++|.++.+.+..|..+++|++|+|++|.+++ ++...+..+++|++|+|++|.+++..|..|.++++|++
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  121 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  121 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccc-cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence            46899999999999987777778999999999999999984 55545566999999999999999888889999999999


Q ss_pred             EEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEE
Q 036342           88 LSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEF  167 (596)
Q Consensus        88 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L  167 (596)
                      |+|++|+|+.+.+..|.++++|++|++++|.++.+.+.     .+.++++|++|++++|++++.    .+..+ ++|+.|
T Consensus       122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~----~~~~l-~~L~~L  191 (390)
T 3o6n_A          122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD-----TFQATTSLQNLQLSSNRLTHV----DLSLI-PSLFHA  191 (390)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT-----TTSSCTTCCEEECCSSCCSBC----CGGGC-TTCSEE
T ss_pred             EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChh-----hccCCCCCCEEECCCCcCCcc----ccccc-ccccee
Confidence            99999999988888889999999999999999987654     589999999999999999876    34455 689999


Q ss_pred             EccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCc
Q 036342          168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLY  247 (596)
Q Consensus       168 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  247 (596)
                      ++++|.+++.     ...++|++|++++|.+......   ..++|+.|++++|.+++.  ..+..+++|+.|++++|.++
T Consensus       192 ~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~  261 (390)
T 3o6n_A          192 NVSYNLLSTL-----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE  261 (390)
T ss_dssp             ECCSSCCSEE-----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred             eccccccccc-----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCC
Confidence            9999999854     3456899999999999865332   357999999999999853  57889999999999999999


Q ss_pred             ccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhc
Q 036342          248 GSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGE  327 (596)
Q Consensus       248 ~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~  327 (596)
                      +..|..|..+++|+.|+|++|+++++|..+..+++|++|++++|++++ +|..+..+++|+.|++++|.++. ++   ..
T Consensus       262 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~-~~---~~  336 (390)
T 3o6n_A          262 KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT-LK---LS  336 (390)
T ss_dssp             EEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCC-CC---CC
T ss_pred             CcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccce-eC---ch
Confidence            988999999999999999999999999888889999999999999995 46668889999999999999985 44   35


Q ss_pred             cCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCCC
Q 036342          328 KLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN  371 (596)
Q Consensus       328 ~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~~  371 (596)
                      .+++|+.|++++|++++.... ..+..+....+.+++..|..+.
T Consensus       337 ~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~  379 (390)
T 3o6n_A          337 THHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDY  379 (390)
T ss_dssp             TTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTC
T ss_pred             hhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecccc
Confidence            788999999999999875432 2344556666777887887543

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.5e-39  Score=348.28  Aligned_cols=326  Identities=22%  Similarity=0.257  Sum_probs=268.3

Q ss_pred             CcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCcccc-ccCccccC
Q 036342            3 PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSG-TIPRFIFN   81 (596)
Q Consensus         3 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~   81 (596)
                      |..|.++++|++|+|++|+|++..|.+|..+++|++|||++|+++ .+|..   .+++|++|+|++|++++ .+|..|.+
T Consensus        38 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~  113 (520)
T 2z7x_B           38 TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGN  113 (520)
T ss_dssp             HHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGG
T ss_pred             hhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc---ccCCccEEeccCCccccccchhhhcc
Confidence            357999999999999999999999999999999999999999998 45554   48999999999999997 47899999


Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCC--CEEecCCCcC--cCCCCCccccccCCC-----------------------
Q 036342           82 ASKLSKLSLGMNSFSGFIPSTFGNLRNL--EQLGLDENYL--TSSTPELSFLSSLSN-----------------------  134 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~l~~N~l--~~~~~~~~~~~~~~~-----------------------  134 (596)
                      +++|++|+|++|.|++   ..|.++++|  ++|++++|.+  ++..+.     .+..                       
T Consensus       114 l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~-----~l~~l~~~~l~l~l~~n~~~~~~~~~~  185 (520)
T 2z7x_B          114 MSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPE-----GLQDFNTESLHIVFPTNKEFHFILDVS  185 (520)
T ss_dssp             CTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTT-----TTTTCCEEEEEEECCSSSCCCCCCCCC
T ss_pred             CCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccc-----cccccccceEEEEeccCcchhhhhhhh
Confidence            9999999999999986   457777777  9999999988  332221     1111                       


Q ss_pred             ------------------------------------------------------------CCCCCEEECcCCCCCccCCc
Q 036342          135 ------------------------------------------------------------CKSLTLIDLSNNPLDGILPK  154 (596)
Q Consensus       135 ------------------------------------------------------------l~~L~~L~ls~N~l~~~~~~  154 (596)
                                                                                  +++|++|++++|++++.+|.
T Consensus       186 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~  265 (520)
T 2z7x_B          186 VKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF  265 (520)
T ss_dssp             CTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCC
T ss_pred             hhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCcccc
Confidence                                                                        12677777777777766665


Q ss_pred             hhh----hccccc--------------------------ccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCc
Q 036342          155 TSI----SNLSRS--------------------------LEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPI  204 (596)
Q Consensus       155 ~~~----~~l~~~--------------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  204 (596)
                      ..+    ..+ ++                          |+.|++++|.+....  .+..+++|++|++++|.+++..|.
T Consensus       266 ~~~~~~~~~l-~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~  342 (520)
T 2z7x_B          266 RDFDYSGTSL-KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFE  342 (520)
T ss_dssp             CCCCCCSCCC-CEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTT
T ss_pred             chhhcccccC-ceeEeccccccceecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhh
Confidence            221    333 33                          555555555554321  126789999999999999998999


Q ss_pred             cccCCCCCCeEEccCCcccc--cCccchhcCCCCcEEEccCCcCcccchh-hhccCCCCcEEEeCCCcccC-CCcccccc
Q 036342          205 TLGKLRKLQRLNLEDNILEG--SIPDDICRLAELYRLELGSNKLYGSIPA-CFGNLASLRILSLGSNKLTS-IPLTFWNL  280 (596)
Q Consensus       205 ~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l  280 (596)
                      .+..+++|++|++++|.+++  .+|..+..+++|++|++++|++++.+|. .+..+++|+.|+|++|.+++ +|..+.  
T Consensus       343 ~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--  420 (520)
T 2z7x_B          343 NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--  420 (520)
T ss_dssp             TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--
T ss_pred             hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--
Confidence            99999999999999999996  5567899999999999999999984554 58899999999999999976 555543  


Q ss_pred             cccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCC
Q 036342          281 KDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP  347 (596)
Q Consensus       281 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  347 (596)
                      ++|+.|++++|+++ .+|..+..+++|+.|++++|+++ .+|...+..+++|++|++++|+++|.++
T Consensus       421 ~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence            79999999999999 56777779999999999999999 5787667889999999999999998765

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=9.2e-38  Score=334.32  Aligned_cols=327  Identities=27%  Similarity=0.385  Sum_probs=262.8

Q ss_pred             cCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCC
Q 036342            6 IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKL   85 (596)
Q Consensus         6 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L   85 (596)
                      +..+++|++|+|++|++++..+  +..+++|++|+|++|.+++.. +  +..+++|++|+|++|.+++..+  +.++++|
T Consensus        64 ~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L  136 (466)
T 1o6v_A           64 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT-P--LANLTNLTGLTLFNNQITDIDP--LKNLTNL  136 (466)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-G--GTTCTTCCEEECCSSCCCCCGG--GTTCTTC
T ss_pred             hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccCh-h--hcCCCCCCEEECCCCCCCCChH--HcCCCCC
Confidence            5667777777777777765544  677777777777777776433 3  3347777777777777774432  6777777


Q ss_pred             CEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhccccccc
Q 036342           86 SKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLE  165 (596)
Q Consensus        86 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~  165 (596)
                      ++|++++|.+++..  .+.++++|++|+++ |.+...       ..+.++++|+.|++++|.+++..   .+..+ ++|+
T Consensus       137 ~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~-------~~~~~l~~L~~L~l~~n~l~~~~---~l~~l-~~L~  202 (466)
T 1o6v_A          137 NRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDL-------KPLANLTTLERLDISSNKVSDIS---VLAKL-TNLE  202 (466)
T ss_dssp             SEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCC-------GGGTTCTTCCEEECCSSCCCCCG---GGGGC-TTCS
T ss_pred             CEEECCCCccCCCh--hhccCCcccEeecC-CcccCc-------hhhccCCCCCEEECcCCcCCCCh---hhccC-CCCC
Confidence            77777777776532  36777777777775 334332       23788999999999999998752   46666 7899


Q ss_pred             EEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCc
Q 036342          166 EFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNK  245 (596)
Q Consensus       166 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  245 (596)
                      +|++++|.+++..|  +..+++|++|++++|.+++.  ..+..+++|+.|++++|.+++..+  +..+++|+.|++++|+
T Consensus       203 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~  276 (466)
T 1o6v_A          203 SLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ  276 (466)
T ss_dssp             EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred             EEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCc
Confidence            99999999998766  77899999999999999864  468899999999999999996544  8889999999999999


Q ss_pred             CcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhh
Q 036342          246 LYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREI  325 (596)
Q Consensus       246 l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~  325 (596)
                      +++..+  +..+++|+.|+|++|++++++. +..+++|+.|++++|++++..+  +..+++|+.|++++|.+++. +  .
T Consensus       277 l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~--~  348 (466)
T 1o6v_A          277 ISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-S--S  348 (466)
T ss_dssp             CCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-G--G
T ss_pred             cCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-h--h
Confidence            987655  8899999999999999999876 7889999999999999998776  78899999999999999864 3  4


Q ss_pred             hccCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccC
Q 036342          326 GEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCG  368 (596)
Q Consensus       326 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~  368 (596)
                      +..+++|+.|++++|++++..| ...+++++.+++++|++.+.
T Consensus       349 l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          349 LANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             GTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEECC
T ss_pred             hccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccCC
Confidence            6689999999999999998877 66788999999999998763

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2.9e-38  Score=348.50  Aligned_cols=338  Identities=20%  Similarity=0.198  Sum_probs=293.2

Q ss_pred             CCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCE
Q 036342            8 NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSK   87 (596)
Q Consensus         8 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~   87 (596)
                      .+++++.|++++|.+..+.+..|..+++|++|+|++|.+++ +++..+..+++|++|+|++|.+++..|..|.++++|++
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  127 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  127 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCC-CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence            46889999999999988777788999999999999999985 44444556999999999999999988889999999999


Q ss_pred             EEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEE
Q 036342           88 LSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEF  167 (596)
Q Consensus        88 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L  167 (596)
                      |+|++|.|+++++..|.++++|++|+|++|.++++.+.     .|.++++|+.|++++|.+++.    .+..+ ++|+.|
T Consensus       128 L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~-----~~~~l~~L~~L~L~~N~l~~~----~~~~l-~~L~~L  197 (597)
T 3oja_B          128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD-----TFQATTSLQNLQLSSNRLTHV----DLSLI-PSLFHA  197 (597)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT-----TTTTCTTCCEEECTTSCCSBC----CGGGC-TTCSEE
T ss_pred             EEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChh-----hhhcCCcCcEEECcCCCCCCc----Chhhh-hhhhhh
Confidence            99999999988888899999999999999999987654     589999999999999999876    24445 689999


Q ss_pred             EccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCc
Q 036342          168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLY  247 (596)
Q Consensus       168 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  247 (596)
                      ++++|.+++.     ...++|+.|++++|.+....+..   .++|+.|+|++|.+++  +..+..+++|+.|+|++|.++
T Consensus       198 ~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~  267 (597)
T 3oja_B          198 NVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE  267 (597)
T ss_dssp             ECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred             hcccCccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccC
Confidence            9999999863     44578999999999998655433   3689999999999996  467899999999999999999


Q ss_pred             ccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhc
Q 036342          248 GSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGE  327 (596)
Q Consensus       248 ~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~  327 (596)
                      +..|..|..+++|+.|+|++|.++++|..+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.+++. |   +.
T Consensus       268 ~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~-~---~~  342 (597)
T 3oja_B          268 KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K---LS  342 (597)
T ss_dssp             EEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C---CC
T ss_pred             CCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCCCc-C---hh
Confidence            999999999999999999999999999988889999999999999995 567788999999999999999854 4   34


Q ss_pred             cCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCCCC
Q 036342          328 KLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNL  372 (596)
Q Consensus       328 ~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~~~  372 (596)
                      .+++|+.|++++|+++|..... .+..+....+.+++..|+.+..
T Consensus       343 ~~~~L~~L~l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~C~~~~~  386 (597)
T 3oja_B          343 THHTLKNLTLSHNDWDCNSLRA-LFRNVARPAVDDADQHCKIDYQ  386 (597)
T ss_dssp             TTCCCSEEECCSSCEEHHHHHH-HTTTCCTTTBCCCCCCCCTTCE
T ss_pred             hcCCCCEEEeeCCCCCChhHHH-HHHHHhhhccccccccCCcchh
Confidence            6889999999999999864322 3455556667788888887543

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=5.7e-39  Score=351.14  Aligned_cols=340  Identities=22%  Similarity=0.259  Sum_probs=247.3

Q ss_pred             CcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccc-cCccccC
Q 036342            3 PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGT-IPRFIFN   81 (596)
Q Consensus         3 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~   81 (596)
                      |.+|+.+++|++|+|++|++++..|.+|..+++|++|||++|++++.++. .+..+++|++|+|++|.+++. .|..+.+
T Consensus        43 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~  121 (549)
T 2z81_A           43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS-WFGPLSSLKYLNLMGNPYQTLGVTSLFPN  121 (549)
T ss_dssp             SSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHH-HHTTCTTCCEEECTTCCCSSSCSSCSCTT
T ss_pred             hhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHH-HhccCCCCcEEECCCCcccccchhhhhhc
Confidence            67789999999999999999988888999999999999999999854443 334589999999999999863 5678889


Q ss_pred             CCCCCEEEccCCc-ccccCCccccCCCCCCEEecCCCcCcCCCCCc-ccc-----------------c-cCCCCCCCCEE
Q 036342           82 ASKLSKLSLGMNS-FSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL-SFL-----------------S-SLSNCKSLTLI  141 (596)
Q Consensus        82 l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-----------------~-~~~~l~~L~~L  141 (596)
                      +++|++|++++|. +..+.+..|.++++|++|++++|.+++..+.. ...                 . .+..+++|++|
T Consensus       122 l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L  201 (549)
T 2z81_A          122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYL  201 (549)
T ss_dssp             CTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEE
T ss_pred             cCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEE
Confidence            9999999999998 55555578899999999999999888743321 000                 0 01347889999


Q ss_pred             ECcCCCCCccC--Cchh-------------------------------------------------------------h-
Q 036342          142 DLSNNPLDGIL--PKTS-------------------------------------------------------------I-  157 (596)
Q Consensus       142 ~ls~N~l~~~~--~~~~-------------------------------------------------------------~-  157 (596)
                      ++++|++++..  +...                                                             + 
T Consensus       202 ~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~  281 (549)
T 2z81_A          202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG  281 (549)
T ss_dssp             EEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCT
T ss_pred             EccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhc
Confidence            99999988731  0000                                                             0 


Q ss_pred             ------------------------hcccccccEEEccccccccccChhc-cCCCCCCEEEccCCcccCCCC---ccccCC
Q 036342          158 ------------------------SNLSRSLEEFYMYNCNISGGIPEEI-SNLTNLVEIDLGGNKLNGSIP---ITLGKL  209 (596)
Q Consensus       158 ------------------------~~l~~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l  209 (596)
                                              .....+|+.|++++|.++. +|..+ ..+++|++|++++|.+.+..|   ..+..+
T Consensus       282 ~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~-ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l  360 (549)
T 2z81_A          282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW  360 (549)
T ss_dssp             TCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC-CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSS
T ss_pred             ccccccccccccchhhhcccchhhhhhcccceEEEeccCcccc-CCHHHHhcCccccEEEccCCccccccccchhhhhcc
Confidence                                    0001245566666666653 34443 467777777777777776543   235667


Q ss_pred             CCCCeEEccCCcccccCc--cchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCccc----------
Q 036342          210 RKLQRLNLEDNILEGSIP--DDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTF----------  277 (596)
Q Consensus       210 ~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~----------  277 (596)
                      ++|++|++++|.+++..+  ..+..+++|++|++++|+++ .+|..+..+++|++|+|++|.++.+|..+          
T Consensus       361 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls  439 (549)
T 2z81_A          361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVS  439 (549)
T ss_dssp             TTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECC
T ss_pred             ccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECC
Confidence            777777777777764322  34666777777777777776 45666666677777777777766554332          


Q ss_pred             --------ccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCC
Q 036342          278 --------WNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR  348 (596)
Q Consensus       278 --------~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  348 (596)
                              ..+++|++|++++|+++.. |. ...++.|+.||+++|++++..|. .+..+++|+.|++++|++.|.+|.
T Consensus       440 ~N~l~~~~~~l~~L~~L~Ls~N~l~~i-p~-~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          440 NNNLDSFSLFLPRLQELYISRNKLKTL-PD-ASLFPVLLVMKISRNQLKSVPDG-IFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             SSCCSCCCCCCTTCCEEECCSSCCSSC-CC-GGGCTTCCEEECCSSCCCCCCTT-GGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             CCChhhhcccCChhcEEECCCCccCcC-CC-cccCccCCEEecCCCccCCcCHH-HHhcCcccCEEEecCCCccCCCcc
Confidence                    2678999999999999854 43 46789999999999999976555 677899999999999999988773

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=9e-38  Score=342.43  Aligned_cols=333  Identities=18%  Similarity=0.213  Sum_probs=269.7

Q ss_pred             CcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccc-cCccccC
Q 036342            3 PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGT-IPRFIFN   81 (596)
Q Consensus         3 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~   81 (596)
                      |.+|.++++|++|+|++|+|+++.|.+|..+++|++|||++|+++ .+|..   .+++|++|+|++|++++. .|..|.+
T Consensus        69 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~  144 (562)
T 3a79_B           69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGN  144 (562)
T ss_dssp             GGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGG
T ss_pred             hhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc---ccccCCEEECCCCCccccCchHhhcc
Confidence            368999999999999999999999999999999999999999998 55554   489999999999999963 4689999


Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCC--CEEecCCCcC--cCCCCCc-cccc--------------------cCCC--
Q 036342           82 ASKLSKLSLGMNSFSGFIPSTFGNLRNL--EQLGLDENYL--TSSTPEL-SFLS--------------------SLSN--  134 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~l~~N~l--~~~~~~~-~~~~--------------------~~~~--  134 (596)
                      +++|++|+|++|+|++.   .|.++++|  ++|++++|.+  ++..+.. ..+.                    .+..  
T Consensus       145 l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~  221 (562)
T 3a79_B          145 LTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG  221 (562)
T ss_dssp             CTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEE
T ss_pred             cCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccc
Confidence            99999999999999864   45555666  9999999988  5443321 0000                    0001  


Q ss_pred             -----------------------------------------------------CCCCCEEECcCCCCCccCCchhh----
Q 036342          135 -----------------------------------------------------CKSLTLIDLSNNPLDGILPKTSI----  157 (596)
Q Consensus       135 -----------------------------------------------------l~~L~~L~ls~N~l~~~~~~~~~----  157 (596)
                                                                           .++|++|++++|.+++.+|...+    
T Consensus       222 ~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~  301 (562)
T 3a79_B          222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE  301 (562)
T ss_dssp             EEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCS
T ss_pred             eEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhccc
Confidence                                                                 12677788888888876665221    


Q ss_pred             hcc-------------------------cccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCC
Q 036342          158 SNL-------------------------SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKL  212 (596)
Q Consensus       158 ~~l-------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  212 (596)
                      ..+                         ..+|++|++++|.+....  .+..+++|++|++++|.+++..|..+..+++|
T Consensus       302 ~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  379 (562)
T 3a79_B          302 TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL  379 (562)
T ss_dssp             CSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSC
T ss_pred             ccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCC
Confidence            111                         024888888888876432  12688999999999999999999999999999


Q ss_pred             CeEEccCCccccc--CccchhcCCCCcEEEccCCcCcccch-hhhccCCCCcEEEeCCCcccC-CCcccccccccceEEc
Q 036342          213 QRLNLEDNILEGS--IPDDICRLAELYRLELGSNKLYGSIP-ACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNF  288 (596)
Q Consensus       213 ~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~l  288 (596)
                      ++|++++|.+++.  +|..+..+++|+.|++++|++++.+| ..+..+++|+.|+|++|++++ +|..+.  ++|++|++
T Consensus       380 ~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L  457 (562)
T 3a79_B          380 QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDL  457 (562)
T ss_dssp             CEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEEC
T ss_pred             CEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEEC
Confidence            9999999999963  34678899999999999999998444 568899999999999999976 554443  79999999


Q ss_pred             ccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCC
Q 036342          289 SSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR  348 (596)
Q Consensus       289 s~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  348 (596)
                      ++|+++. +|..+..++.|+.||+++|+++ .+|...+..+++|+.|++++|++.|.++.
T Consensus       458 ~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          458 HNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             CSSCCCC-CCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred             CCCcCcc-cChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence            9999995 5556669999999999999999 67876678899999999999999987664

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=5.2e-37  Score=341.10  Aligned_cols=367  Identities=22%  Similarity=0.225  Sum_probs=285.7

Q ss_pred             CcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCC
Q 036342            3 PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNA   82 (596)
Q Consensus         3 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l   82 (596)
                      |.+|.++++|++|||++|+|+++.|.+|.++++|++|+|++|+|+ .++...|..+++|++|+|++|++++..+..|.++
T Consensus        69 ~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L  147 (635)
T 4g8a_A           69 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHL  147 (635)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTC
T ss_pred             HHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcC
Confidence            357999999999999999999988999999999999999999998 4666566679999999999999998878889999


Q ss_pred             CCCCEEEccCCccccc-CCccccCCCCCCEEecCCCcCcCCCCCc-c---------------------c-----------
Q 036342           83 SKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENYLTSSTPEL-S---------------------F-----------  128 (596)
Q Consensus        83 ~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~---------------------~-----------  128 (596)
                      ++|++|+|++|+|++. .|..+.++++|++|++++|+++++.+.. .                     +           
T Consensus       148 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~  227 (635)
T 4g8a_A          148 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH  227 (635)
T ss_dssp             TTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEE
T ss_pred             cccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhh
Confidence            9999999999999875 5788899999999999999886542210 0                     0           


Q ss_pred             --------------------------------------------------------------------------------
Q 036342          129 --------------------------------------------------------------------------------  128 (596)
Q Consensus       129 --------------------------------------------------------------------------------  128 (596)
                                                                                                      
T Consensus       228 ~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~  307 (635)
T 4g8a_A          228 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTN  307 (635)
T ss_dssp             EEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTT
T ss_pred             hhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcc
Confidence                                                                                            


Q ss_pred             -------------cccCCCCCCCCEEECcCCCCCccCCch------------------hhhcccccccEEEccccccccc
Q 036342          129 -------------LSSLSNCKSLTLIDLSNNPLDGILPKT------------------SISNLSRSLEEFYMYNCNISGG  177 (596)
Q Consensus       129 -------------~~~~~~l~~L~~L~ls~N~l~~~~~~~------------------~~~~l~~~L~~L~l~~n~l~~~  177 (596)
                                   ...+....+|+.|++++|.+.+..+..                  ....+ ++|+.|++++|.+...
T Consensus       308 l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l-~~L~~L~ls~n~l~~~  386 (635)
T 4g8a_A          308 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFK  386 (635)
T ss_dssp             CSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBC-TTCCEEECCSSCCBEE
T ss_pred             cccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccc-cccccchhhccccccc
Confidence                         000112234455555555544321110                  01122 4677777777766421


Q ss_pred             -------------------------cChhccCCCCCCEEEccCCcccCCC-CccccCCCCCCeEEccCCcccccCccchh
Q 036342          178 -------------------------IPEEISNLTNLVEIDLGGNKLNGSI-PITLGKLRKLQRLNLEDNILEGSIPDDIC  231 (596)
Q Consensus       178 -------------------------~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  231 (596)
                                               .+..+..+++|+.++++.|...... +..|..+++++.++++.|.+++..+..+.
T Consensus       387 ~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~  466 (635)
T 4g8a_A          387 GCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN  466 (635)
T ss_dssp             EECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             cccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccc
Confidence                                     2345666778888888877766554 45688999999999999999988999999


Q ss_pred             cCCCCcEEEccCCcC-cccchhhhccCCCCcEEEeCCCcccCC-CcccccccccceEEcccCCCCCchhhhhccccccce
Q 036342          232 RLAELYRLELGSNKL-YGSIPACFGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIG  309 (596)
Q Consensus       232 ~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~  309 (596)
                      .+++|+.|++++|++ .+..|..|..+++|+.|+|++|+|+++ |..|..+++|++|+|++|+|++..+..|..+++|++
T Consensus       467 ~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~  546 (635)
T 4g8a_A          467 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV  546 (635)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCE
T ss_pred             cchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCE
Confidence            999999999999985 456788999999999999999999996 567899999999999999999999999999999999


Q ss_pred             EecCCCcCcccCChhhhccC-CCCCeEECCCCcccccCCCCCC---CCCCCcccccccccccCCCCC
Q 036342          310 IDFSMNNFSGVIPREIGEKL-SYLEDLNLSFNKLKGEIPRGGS---FGNFSAESFEGNELLCGSPNL  372 (596)
Q Consensus       310 L~ls~N~~~~~~~~~~~~~l-~~L~~L~l~~N~l~~~~p~~~~---~~~l~~l~~~~N~~~c~~~~~  372 (596)
                      ||+++|++++..|. .+..+ ++|+.|+|++|+++|.+.....   +..-...........|..|+.
T Consensus       547 L~Ls~N~l~~~~~~-~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~~~~~~~~~~~~~~C~~P~~  612 (635)
T 4g8a_A          547 LDYSLNHIMTSKKQ-ELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD  612 (635)
T ss_dssp             EECTTSCCCBCCSS-CTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHHHTTTTBSCGGGCBBCSSTT
T ss_pred             EECCCCcCCCCCHH-HHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHHhCCCccCCCCCceeCCchH
Confidence            99999999987776 55566 6899999999999987653211   111111112334567887764

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-37  Score=352.39  Aligned_cols=350  Identities=22%  Similarity=0.232  Sum_probs=304.9

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +||.   ..++|++|||++|+|+++.|..|..+++|++|||++|...+.+++..+..+++|++|+|++|.+++..|.+|.
T Consensus        18 ~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~   94 (844)
T 3j0a_A           18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ   94 (844)
T ss_dssp             CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred             CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence            4676   4689999999999999999999999999999999999777778776777899999999999999999999999


Q ss_pred             CCCCCCEEEccCCcccccCCcc--ccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhh
Q 036342           81 NASKLSKLSLGMNSFSGFIPST--FGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSIS  158 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~--~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  158 (596)
                      ++++|++|+|++|.+++..+..  |.++++|++|+|++|.+++..+.    ..|+++++|++|+|++|.+++..+. .+.
T Consensus        95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~----~~~~~L~~L~~L~Ls~N~i~~~~~~-~l~  169 (844)
T 3j0a_A           95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH----PSFGKLNSLKSIDFSSNQIFLVCEH-ELE  169 (844)
T ss_dssp             SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCC----GGGGTCSSCCEEEEESSCCCCCCSG-GGH
T ss_pred             CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccc----hhHhhCCCCCEEECCCCcCCeeCHH-Hcc
Confidence            9999999999999999866655  99999999999999999886432    3589999999999999999988766 555


Q ss_pred             ccc-ccccEEEccccccccccChhccCCCC------CCEEEccCCcccCCCCccccC-----------------------
Q 036342          159 NLS-RSLEEFYMYNCNISGGIPEEISNLTN------LVEIDLGGNKLNGSIPITLGK-----------------------  208 (596)
Q Consensus       159 ~l~-~~L~~L~l~~n~l~~~~~~~~~~l~~------L~~L~Ls~N~l~~~~p~~~~~-----------------------  208 (596)
                      .+. ++|+.|++++|.+++..|..+..+++      |+.|++++|.+++..+..+..                       
T Consensus       170 ~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~  249 (844)
T 3j0a_A          170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF  249 (844)
T ss_dssp             HHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSC
T ss_pred             cccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccc
Confidence            442 58999999999999988887777665      999999999887666544432                       


Q ss_pred             ---------------CCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCC
Q 036342          209 ---------------LRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI  273 (596)
Q Consensus       209 ---------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i  273 (596)
                                     .++|+.|++++|.+.+..|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|.++.+
T Consensus       250 ~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~  329 (844)
T 3j0a_A          250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL  329 (844)
T ss_dssp             SSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCC
T ss_pred             cccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCcc
Confidence                           26899999999999988888999999999999999999988899999999999999999999986


Q ss_pred             -CcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCCCCC
Q 036342          274 -PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSF  352 (596)
Q Consensus       274 -p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  352 (596)
                       |..+..+++|++|++++|.+++..+..|..+++|+.|++++|.+++ ++     .+++|+.|++++|+++. +|..  .
T Consensus       330 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~-----~~~~L~~L~l~~N~l~~-l~~~--~  400 (844)
T 3j0a_A          330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH-----FIPSIPDIFLSGNKLVT-LPKI--N  400 (844)
T ss_dssp             CSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS-----SCCSCSEEEEESCCCCC-CCCC--C
T ss_pred             CHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc-----CCCCcchhccCCCCccc-cccc--c
Confidence             6688899999999999999999888899999999999999999984 33     27889999999999984 4443  4


Q ss_pred             CCCCccccccccccc
Q 036342          353 GNFSAESFEGNELLC  367 (596)
Q Consensus       353 ~~l~~l~~~~N~~~c  367 (596)
                      .+++.+++++|.+..
T Consensus       401 ~~l~~L~ls~N~l~~  415 (844)
T 3j0a_A          401 LTANLIHLSENRLEN  415 (844)
T ss_dssp             TTCCEEECCSCCCCS
T ss_pred             cccceeecccCcccc
Confidence            567888999998765

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=3e-36  Score=309.92  Aligned_cols=307  Identities=24%  Similarity=0.384  Sum_probs=242.9

Q ss_pred             cCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCC
Q 036342            6 IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKL   85 (596)
Q Consensus         6 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L   85 (596)
                      +..+++|++|++++|+++.. + .+..+++|++|++++|++++ ++.  +..+++|++|++++|.++. + +.+.++++|
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~-~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L  112 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITD-ISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTNL  112 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC
T ss_pred             chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCcccc-chh--hhcCCcCCEEEccCCcccC-c-hHHcCCCcC
Confidence            34678889999999988754 3 37888899999999998874 444  4458899999999998884 3 468888999


Q ss_pred             CEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhccccccc
Q 036342           86 SKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLE  165 (596)
Q Consensus        86 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~  165 (596)
                      ++|++++|.+++..+  +..+++|++|++++|......      ..+..+++|++|++++|.+.+..+   +..+ ++|+
T Consensus       113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~------~~~~~l~~L~~L~l~~~~~~~~~~---~~~l-~~L~  180 (347)
T 4fmz_A          113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL------SPLSNMTGLNYLTVTESKVKDVTP---IANL-TDLY  180 (347)
T ss_dssp             SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC------GGGTTCTTCCEEECCSSCCCCCGG---GGGC-TTCS
T ss_pred             CEEECcCCcccCchh--hccCCceeEEECCCCCCcccc------cchhhCCCCcEEEecCCCcCCchh---hccC-CCCC
Confidence            999999999886544  888899999999998654422      237888899999999998876532   5555 6789


Q ss_pred             EEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCc
Q 036342          166 EFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNK  245 (596)
Q Consensus       166 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  245 (596)
                      +|++++|.+++..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|.+++. +. +..+++|+.|++++|.
T Consensus       181 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~  254 (347)
T 4fmz_A          181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQ  254 (347)
T ss_dssp             EEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred             EEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCc
Confidence            99999998886544  7888889999999998886554  77888899999999988843 43 7888889999999998


Q ss_pred             CcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhh
Q 036342          246 LYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREI  325 (596)
Q Consensus       246 l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~  325 (596)
                      +++.  ..+..+++|+.|++++|.+++++ .+..+++|+.|++++|++++..+..+..+++|+.|++++|.+++..|   
T Consensus       255 l~~~--~~~~~l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~---  328 (347)
T 4fmz_A          255 ISDI--NAVKDLTKLKMLNVGSNQISDIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP---  328 (347)
T ss_dssp             CCCC--GGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG---
T ss_pred             cCCC--hhHhcCCCcCEEEccCCccCCCh-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC---
Confidence            8754  45788888999999999888874 47778888999999998888888888888888889999888886544   


Q ss_pred             hccCCCCCeEECCCCccc
Q 036342          326 GEKLSYLEDLNLSFNKLK  343 (596)
Q Consensus       326 ~~~l~~L~~L~l~~N~l~  343 (596)
                      +..+++|++|++++|+++
T Consensus       329 ~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          329 LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GGGCTTCSEESSSCC---
T ss_pred             hhhhhccceeehhhhccc
Confidence            456888888888888875

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.3e-36  Score=321.39  Aligned_cols=326  Identities=26%  Similarity=0.363  Sum_probs=283.1

Q ss_pred             CCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEE
Q 036342            9 LQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKL   88 (596)
Q Consensus         9 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L   88 (596)
                      +++++.|++++|.++. +| .+..+++|++|||++|.+++. ++  +..+++|++|++++|.+++..+  +.++++|++|
T Consensus        45 l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~-~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  117 (466)
T 1o6v_A           45 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL  117 (466)
T ss_dssp             HHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             hccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCc-hh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence            5789999999999975 44 478899999999999999854 44  4559999999999999996554  9999999999


Q ss_pred             EccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEE
Q 036342           89 SLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFY  168 (596)
Q Consensus        89 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~  168 (596)
                      ++++|.+++..+  |.++++|++|++++|.++.++       .+..+++|+.|+++ |.+.+..   .+..+ ++|++|+
T Consensus       118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-------~~~~l~~L~~L~l~-~~~~~~~---~~~~l-~~L~~L~  183 (466)
T 1o6v_A          118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS-------ALSGLTSLQQLSFG-NQVTDLK---PLANL-TTLERLD  183 (466)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG-------GGTTCTTCSEEEEE-ESCCCCG---GGTTC-TTCCEEE
T ss_pred             ECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh-------hhccCCcccEeecC-CcccCch---hhccC-CCCCEEE
Confidence            999999998754  899999999999999998743       37899999999997 5555442   36666 7899999


Q ss_pred             ccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcc
Q 036342          169 MYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG  248 (596)
Q Consensus       169 l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  248 (596)
                      +++|.+++.  ..+..+++|++|++++|.+.+..|  +..+++|++|++++|.+++ + +.+..+++|+.|++++|++.+
T Consensus       184 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~  257 (466)
T 1o6v_A          184 ISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISN  257 (466)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCC
T ss_pred             CcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCcccc
Confidence            999999875  458999999999999999998766  7789999999999999985 3 468899999999999999987


Q ss_pred             cchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhcc
Q 036342          249 SIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEK  328 (596)
Q Consensus       249 ~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~  328 (596)
                      ..+  +..+++|+.|++++|.++.++. +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..|   +..
T Consensus       258 ~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~---~~~  329 (466)
T 1o6v_A          258 LAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP---VSS  329 (466)
T ss_dssp             CGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG---GGG
T ss_pred             chh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh---hcc
Confidence            665  8899999999999999999886 8889999999999999998765  7899999999999999997655   468


Q ss_pred             CCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCC
Q 036342          329 LSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSP  370 (596)
Q Consensus       329 l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~  370 (596)
                      +++|+.|++++|++++. +....+++++.+++++|++....|
T Consensus       330 l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~  370 (466)
T 1o6v_A          330 LTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLTP  370 (466)
T ss_dssp             CTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred             CccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccCccch
Confidence            99999999999999875 455678899999999999865444

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.6e-36  Score=317.21  Aligned_cols=294  Identities=22%  Similarity=0.228  Sum_probs=260.2

Q ss_pred             CCcc-cCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            2 IPLE-IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         2 ip~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +|.. +..+++|++|+|++|+++++.+.+|..+++|++|+|++|++++ +++..+..+++|++|+|++|+++...+..|.
T Consensus        60 l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~  138 (390)
T 3o6n_A           60 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFH  138 (390)
T ss_dssp             ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc-CCHHHhcCCCCCCEEECCCCccCcCCHHHhc
Confidence            4555 6889999999999999998888899999999999999999985 4444445699999999999999965555678


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      ++++|++|+|++|.++++.+..|.++++|++|++++|.++...        +..+++|+.|++++|.+++..       .
T Consensus       139 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------~~~l~~L~~L~l~~n~l~~~~-------~  203 (390)
T 3o6n_A          139 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--------LSLIPSLFHANVSYNLLSTLA-------I  203 (390)
T ss_dssp             TCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--------GGGCTTCSEEECCSSCCSEEE-------C
T ss_pred             CCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc--------cccccccceeecccccccccC-------C
Confidence            9999999999999999999999999999999999999998752        566789999999999998642       2


Q ss_pred             cccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEE
Q 036342          161 SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE  240 (596)
Q Consensus       161 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (596)
                      +.+|++|++++|.++.....   ..++|+.|++++|.+++.  ..+..+++|++|++++|.+++..|..+..+++|+.|+
T Consensus       204 ~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  278 (390)
T 3o6n_A          204 PIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY  278 (390)
T ss_dssp             CSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred             CCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEE
Confidence            26799999999999976433   247899999999999864  5789999999999999999988899999999999999


Q ss_pred             ccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCccc
Q 036342          241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGV  320 (596)
Q Consensus       241 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~  320 (596)
                      |++|++++ +|..+..+++|+.|+|++|+++.+|..+..+++|++|++++|+++...   +..++.|+.|++++|.++..
T Consensus       279 L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~  354 (390)
T 3o6n_A          279 ISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN  354 (390)
T ss_dssp             CCSSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred             CCCCcCcc-cCcccCCCCCCCEEECCCCcceecCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCccch
Confidence            99999985 566778899999999999999999999999999999999999998763   67788999999999999864

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=7.2e-36  Score=317.70  Aligned_cols=316  Identities=18%  Similarity=0.146  Sum_probs=257.8

Q ss_pred             CcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCC
Q 036342            3 PLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNA   82 (596)
Q Consensus         3 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l   82 (596)
                      |..++.+++|++|++++|+|++. | .+..+++|++|+|++|++++ ++   +..+++|++|+|++|++++. +  +.++
T Consensus        35 ~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~---~~~l~~L~~L~Ls~N~l~~~-~--~~~l  105 (457)
T 3bz5_A           35 TISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD---LSQNTNLTYLACDSNKLTNL-D--VTPL  105 (457)
T ss_dssp             EEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC---CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred             ccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec---cccCCCCCEEECcCCCCcee-e--cCCC
Confidence            34577899999999999999975 5 78999999999999999985 43   44589999999999999964 4  8899


Q ss_pred             CCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccc
Q 036342           83 SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSR  162 (596)
Q Consensus        83 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~  162 (596)
                      ++|++|++++|+++++ +  +..+++|++|++++|+++++        .++.+++|++|++++|...+.+   .+..+ +
T Consensus       106 ~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l--------~l~~l~~L~~L~l~~n~~~~~~---~~~~l-~  170 (457)
T 3bz5_A          106 TKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI--------DVSHNTQLTELDCHLNKKITKL---DVTPQ-T  170 (457)
T ss_dssp             TTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC--------CCTTCTTCCEEECTTCSCCCCC---CCTTC-T
T ss_pred             CcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee--------ccccCCcCCEEECCCCCccccc---ccccC-C
Confidence            9999999999999985 3  89999999999999999885        2688999999999999665554   35555 7


Q ss_pred             cccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEcc
Q 036342          163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG  242 (596)
Q Consensus       163 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  242 (596)
                      +|++|++++|++++. |  +..+++|+.|++++|.+++.   .+..+++|++|++++|++++ +|  +..+++|+.|+++
T Consensus       171 ~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~  241 (457)
T 3bz5_A          171 QLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCS  241 (457)
T ss_dssp             TCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECC
T ss_pred             cCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEee
Confidence            899999999999984 4  88999999999999999975   48899999999999999996 56  8889999999999


Q ss_pred             CCcCcccchhhhccCCCCcEEEeCCCcccCCCc---------ccccccccceEEcccCCCCCchhh--------hhcccc
Q 036342          243 SNKLYGSIPACFGNLASLRILSLGSNKLTSIPL---------TFWNLKDILQLNFSSNFLTGPLLL--------EIGNLK  305 (596)
Q Consensus       243 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~---------~~~~l~~L~~L~ls~N~l~~~~~~--------~~~~l~  305 (596)
                      +|++++..+.   .+++|+.|++++|+++.+..         .+..+++|+.|++++|...+.+|.        .+..++
T Consensus       242 ~N~l~~~~~~---~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~  318 (457)
T 3bz5_A          242 VNPLTELDVS---TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNP  318 (457)
T ss_dssp             SSCCSCCCCT---TCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCT
T ss_pred             CCcCCCcCHH---HCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCcccceeccCCCcceEechhhcc
Confidence            9999976544   45555555555555544321         145678999999999988776654        345667


Q ss_pred             ccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCccccccccc
Q 036342          306 VLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNEL  365 (596)
Q Consensus       306 ~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~  365 (596)
                      .|+.|++++|++++ ++   +..+++|+.|++++|++++       ++.+..+.+.+|.+
T Consensus       319 ~L~~L~L~~N~l~~-l~---l~~l~~L~~L~l~~N~l~~-------l~~L~~L~l~~n~l  367 (457)
T 3bz5_A          319 KLVYLYLNNTELTE-LD---VSHNTKLKSLSCVNAHIQD-------FSSVGKIPALNNNF  367 (457)
T ss_dssp             TCCEEECTTCCCSC-CC---CTTCTTCSEEECCSSCCCB-------CTTGGGSSGGGTSE
T ss_pred             cCCEEECCCCcccc-cc---cccCCcCcEEECCCCCCCC-------ccccccccccCCcE
Confidence            88999999999997 44   5678999999999999986       23444455555544

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=3.5e-35  Score=301.98  Aligned_cols=307  Identities=25%  Similarity=0.364  Sum_probs=265.8

Q ss_pred             hhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCC
Q 036342           29 AIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRN  108 (596)
Q Consensus        29 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  108 (596)
                      .+..+++|++|++++|.++ .++.+.  .+++|++|++++|+++.. +. +.++++|++|++++|.++.+  +.|.++++
T Consensus        39 ~~~~l~~L~~L~l~~~~i~-~~~~~~--~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~  111 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVA-SIQGIE--YLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNLTN  111 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCC-CCTTGG--GCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred             cchhcccccEEEEeCCccc-cchhhh--hcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCCCc
Confidence            3456889999999999997 566544  489999999999999954 44 99999999999999999874  46999999


Q ss_pred             CCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCC
Q 036342          109 LEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNL  188 (596)
Q Consensus       109 L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L  188 (596)
                      |++|++++|.++..+       .+..+++|+.|++++|......+  .+..+ ++|++|++++|.+++..+  +..+++|
T Consensus       112 L~~L~l~~n~i~~~~-------~~~~l~~L~~L~l~~n~~~~~~~--~~~~l-~~L~~L~l~~~~~~~~~~--~~~l~~L  179 (347)
T 4fmz_A          112 LRELYLNEDNISDIS-------PLANLTKMYSLNLGANHNLSDLS--PLSNM-TGLNYLTVTESKVKDVTP--IANLTDL  179 (347)
T ss_dssp             CSEEECTTSCCCCCG-------GGTTCTTCCEEECTTCTTCCCCG--GGTTC-TTCCEEECCSSCCCCCGG--GGGCTTC
T ss_pred             CCEEECcCCcccCch-------hhccCCceeEEECCCCCCccccc--chhhC-CCCcEEEecCCCcCCchh--hccCCCC
Confidence            999999999998753       27899999999999997655443  36666 789999999999987655  8899999


Q ss_pred             CEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCC
Q 036342          189 VEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSN  268 (596)
Q Consensus       189 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  268 (596)
                      ++|++++|.+.+..+  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|
T Consensus       180 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n  253 (347)
T 4fmz_A          180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN  253 (347)
T ss_dssp             SEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             CEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCC
Confidence            999999999986554  8899999999999999995443  8899999999999999986555  899999999999999


Q ss_pred             cccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCC
Q 036342          269 KLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR  348 (596)
Q Consensus       269 ~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  348 (596)
                      .++.++ .+..+++|++|++++|.+++.  ..+..+++|+.|++++|.+++..+. .+..+++|+.|++++|++++..| 
T Consensus       254 ~l~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~~~-  328 (347)
T 4fmz_A          254 QISDIN-AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME-VIGGLTNLTTLFLSQNHITDIRP-  328 (347)
T ss_dssp             CCCCCG-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH-HHHTCTTCSEEECCSSSCCCCGG-
T ss_pred             ccCCCh-hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh-HhhccccCCEEEccCCccccccC-
Confidence            999985 678899999999999999986  4688999999999999999976555 67789999999999999998777 


Q ss_pred             CCCCCCCCccccccccc
Q 036342          349 GGSFGNFSAESFEGNEL  365 (596)
Q Consensus       349 ~~~~~~l~~l~~~~N~~  365 (596)
                      ...+++++.+++++|++
T Consensus       329 ~~~l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          329 LASLSKMDSADFANQVI  345 (347)
T ss_dssp             GGGCTTCSEESSSCC--
T ss_pred             hhhhhccceeehhhhcc
Confidence            56789999999999986

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=7.3e-36  Score=329.30  Aligned_cols=297  Identities=22%  Similarity=0.225  Sum_probs=263.2

Q ss_pred             CCcc-cCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            2 IPLE-IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         2 ip~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +|+. |+.+++|++|+|++|+|+++.|..|..+++|++|+|++|.+++ +++..+..+++|++|+|++|.+++..+..|.
T Consensus        66 lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~  144 (597)
T 3oja_B           66 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFH  144 (597)
T ss_dssp             ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC-CCHHHHcCCCCCCEEEeeCCCCCCCCHHHhc
Confidence            3444 6789999999999999999989999999999999999999986 4444445699999999999999976666789


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      ++++|++|+|++|.|+++.|..|.++++|++|++++|.+++.+        +..+++|+.|++++|.+++..       .
T Consensus       145 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--------~~~l~~L~~L~l~~n~l~~l~-------~  209 (597)
T 3oja_B          145 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--------LSLIPSLFHANVSYNLLSTLA-------I  209 (597)
T ss_dssp             TCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--------GGGCTTCSEEECCSSCCSEEE-------C
T ss_pred             cCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--------hhhhhhhhhhhcccCcccccc-------C
Confidence            9999999999999999999999999999999999999998753        456789999999999998642       2


Q ss_pred             cccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEE
Q 036342          161 SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE  240 (596)
Q Consensus       161 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (596)
                      +.+|+.|++++|.++...+..+   ++|+.|++++|.+++  +..+..+++|+.|+|++|.+++..|..|..+++|+.|+
T Consensus       210 ~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  284 (597)
T 3oja_B          210 PIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY  284 (597)
T ss_dssp             CTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred             CchhheeeccCCcccccccccC---CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEE
Confidence            2679999999999987655433   689999999999997  46789999999999999999999999999999999999


Q ss_pred             ccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCccc
Q 036342          241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGV  320 (596)
Q Consensus       241 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~  320 (596)
                      |++|.+++ +|..+..+++|+.|+|++|.++.+|..+..+++|++|++++|.+++..   +..++.|+.|++++|.+++.
T Consensus       285 Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~  360 (597)
T 3oja_B          285 ISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN  360 (597)
T ss_dssp             CTTSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred             CCCCCCCC-CCcccccCCCCcEEECCCCCCCccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCCh
Confidence            99999986 577778899999999999999999999999999999999999998763   66788999999999999865


Q ss_pred             CCh
Q 036342          321 IPR  323 (596)
Q Consensus       321 ~~~  323 (596)
                      ...
T Consensus       361 ~~~  363 (597)
T 3oja_B          361 SLR  363 (597)
T ss_dssp             HHH
T ss_pred             hHH
Confidence            433

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=4.8e-35  Score=311.35  Aligned_cols=320  Identities=18%  Similarity=0.200  Sum_probs=261.0

Q ss_pred             CCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccC
Q 036342            2 IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFN   81 (596)
Q Consensus         2 ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (596)
                      +| +++.+++|++|+|++|+|+++ |  +..+++|++|+|++|++++ ++   +..+++|++|++++|++++ +|  +..
T Consensus        57 ~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~---~~~l~~L~~L~L~~N~l~~-l~--~~~  125 (457)
T 3bz5_A           57 MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD---VTPLTKLTYLNCDTNKLTK-LD--VSQ  125 (457)
T ss_dssp             CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC---CTTCTTCCEEECCSSCCSC-CC--CTT
T ss_pred             Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee---cCCCCcCCEEECCCCcCCe-ec--CCC
Confidence            45 689999999999999999975 3  8899999999999999986 33   4459999999999999996 44  899


Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhccc
Q 036342           82 ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS  161 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~  161 (596)
                      +++|++|++++|+|+++ +  +.++++|++|++++|...+..       .+..+++|+.|++++|+++++ |   +..+ 
T Consensus       126 l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~-------~~~~l~~L~~L~ls~n~l~~l-~---l~~l-  190 (457)
T 3bz5_A          126 NPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL-------DVTPQTQLTTLDCSFNKITEL-D---VSQN-  190 (457)
T ss_dssp             CTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC-------CCTTCTTCCEEECCSSCCCCC-C---CTTC-
T ss_pred             CCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc-------ccccCCcCCEEECCCCcccee-c---cccC-
Confidence            99999999999999985 2  889999999999999543321       378899999999999999985 3   5566 


Q ss_pred             ccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCC-------
Q 036342          162 RSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLA-------  234 (596)
Q Consensus       162 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-------  234 (596)
                      ++|+.|++++|++++.   .+..+++|++|++++|++++ +|  +..+++|+.|++++|.+++..+..+..+.       
T Consensus       191 ~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n  264 (457)
T 3bz5_A          191 KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQT  264 (457)
T ss_dssp             TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTC
T ss_pred             CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCC
Confidence            6899999999999986   48899999999999999998 45  88999999999999999976555555444       


Q ss_pred             CCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC-CCc--------ccccccccceEEcccCCCCCchhhhhcccc
Q 036342          235 ELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPL--------TFWNLKDILQLNFSSNFLTGPLLLEIGNLK  305 (596)
Q Consensus       235 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-ip~--------~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  305 (596)
                      +|+.|++++|.+.+.+|  ++.+++|+.|+|++|...+ +|.        .+..+++|++|++++|++++.   .+..++
T Consensus       265 ~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l---~l~~l~  339 (457)
T 3bz5_A          265 DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL---DVSHNT  339 (457)
T ss_dssp             CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC---CCTTCT
T ss_pred             CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc---ccccCC
Confidence            56677777777766666  5778999999999998654 443        355678999999999999985   388999


Q ss_pred             ccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCCC
Q 036342          306 VLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN  371 (596)
Q Consensus       306 ~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~~  371 (596)
                      .|+.||+++|++++ +        +.|..|++++|.++|.    +.+..+..+++++|.+....|+
T Consensus       340 ~L~~L~l~~N~l~~-l--------~~L~~L~l~~n~l~g~----~~~~~l~~l~l~~N~l~g~ip~  392 (457)
T 3bz5_A          340 KLKSLSCVNAHIQD-F--------SSVGKIPALNNNFEAE----GQTITMPKETLTNNSLTIAVSP  392 (457)
T ss_dssp             TCSEEECCSSCCCB-C--------TTGGGSSGGGTSEEEE----EEEEECCCBCCBTTBEEEECCT
T ss_pred             cCcEEECCCCCCCC-c--------cccccccccCCcEEec----ceeeecCccccccCcEEEEcCh
Confidence            99999999999985 2        3466667777777765    1234556667777776554443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.8e-35  Score=312.92  Aligned_cols=318  Identities=28%  Similarity=0.351  Sum_probs=205.5

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCC-------------CEEEccCCcCccccCccCccCCCCccEEEcc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTL-------------KFLGLQNNSLSGSLSSIANVRLPNLEKLYLW   67 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-------------~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~   67 (596)
                      +||++|+++++|++|++++|++++..|..++.+.+|             ++|++++|.+++ +|..    .++|++|+++
T Consensus        25 ~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~----~~~L~~L~l~   99 (454)
T 1jl5_A           25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL----PPHLESLVAS   99 (454)
T ss_dssp             ---------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC----CTTCSEEECC
T ss_pred             hCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC----cCCCCEEEcc
Confidence            477888888888888888888887888877776654             788888888774 3332    4678888888


Q ss_pred             CCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCC
Q 036342           68 GNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNP  147 (596)
Q Consensus        68 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~  147 (596)
                      +|.+++ +|..   +++|++|++++|+++++.. .   .++|++|++++|++++++       .++++++|++|++++|+
T Consensus       100 ~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-~---~~~L~~L~L~~n~l~~lp-------~~~~l~~L~~L~l~~N~  164 (454)
T 1jl5_A          100 CNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-L---PPLLEYLGVSNNQLEKLP-------ELQNSSFLKIIDVDNNS  164 (454)
T ss_dssp             SSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-C---CTTCCEEECCSSCCSSCC-------CCTTCTTCCEEECCSSC
T ss_pred             CCcCCc-cccc---cCCCcEEECCCCccCcccC-C---CCCCCEEECcCCCCCCCc-------ccCCCCCCCEEECCCCc
Confidence            888885 5543   3678888888888775322 1   257888888888877643       27778888888888888


Q ss_pred             CCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCc
Q 036342          148 LDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP  227 (596)
Q Consensus       148 l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  227 (596)
                      ++++ |.     ...+|++|++++|++++ +| .|.++++|++|++++|.+++ +|..   .++|++|++++|.++ .+|
T Consensus       165 l~~l-p~-----~~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp  231 (454)
T 1jl5_A          165 LKKL-PD-----LPPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP  231 (454)
T ss_dssp             CSCC-CC-----CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC
T ss_pred             Cccc-CC-----CcccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc
Confidence            8763 32     12468888888888876 34 57788888888888888875 3332   247788888888777 566


Q ss_pred             cchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCc--hhhhh----
Q 036342          228 DDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGP--LLLEI----  301 (596)
Q Consensus       228 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~--~~~~~----  301 (596)
                       .+..+++|++|++++|++++ +|.   .+++|+.|++++|.++++|..   +++|++|++++|++++.  .|..+    
T Consensus       232 -~~~~l~~L~~L~l~~N~l~~-l~~---~~~~L~~L~l~~N~l~~l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~  303 (454)
T 1jl5_A          232 -ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLPEL---PQSLTFLDVSENIFSGLSELPPNLYYLN  303 (454)
T ss_dssp             -CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSEESCCCTTCCEEE
T ss_pred             -ccCCCCCCCEEECCCCcCCc-ccc---cccccCEEECCCCcccccCcc---cCcCCEEECcCCccCcccCcCCcCCEEE
Confidence             37777778888888887774 333   236777777777777776653   25666666666666652  11111    


Q ss_pred             ---------ccc-cccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCccccccccccc
Q 036342          302 ---------GNL-KVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLC  367 (596)
Q Consensus       302 ---------~~l-~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c  367 (596)
                               ..+ +.|+.|++++|++++ +|.    .+++|++|++++|++++ +|.  .+++++.+++++|++.+
T Consensus       304 l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~----~~~~L~~L~L~~N~l~~-lp~--~l~~L~~L~L~~N~l~~  371 (454)
T 1jl5_A          304 ASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA----LPPRLERLIASFNHLAE-VPE--LPQNLKQLHVEYNPLRE  371 (454)
T ss_dssp             CCSSCCSEECCCCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSS
T ss_pred             CcCCcCCcccCCcCcCCEEECCCCcccc-ccc----cCCcCCEEECCCCcccc-ccc--hhhhccEEECCCCCCCc
Confidence                     111 356666666666664 443    24566666666666663 333  35566666666666654

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=2.8e-34  Score=293.11  Aligned_cols=291  Identities=19%  Similarity=0.181  Sum_probs=237.6

Q ss_pred             CCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEe
Q 036342           34 STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLG  113 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  113 (596)
                      .+++.++++++.++ .+|...   .++|+.|+|++|++++..+..|.++++|++|+|++|+|+++.|+.|.++++|++|+
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSC---CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCCeEEEecCCCcc-ccCccC---CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            47888999999887 454422   36889999999999977777889999999999999999988889999999999999


Q ss_pred             cCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEcccccccc--ccChhccCCCCCCEE
Q 036342          114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG--GIPEEISNLTNLVEI  191 (596)
Q Consensus       114 l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L  191 (596)
                      +++|.++.++..      +.  ++|++|++++|.+++..+. .+..+ ++|++|++++|.++.  ..+..|..+++|++|
T Consensus       107 Ls~n~l~~l~~~------~~--~~L~~L~l~~n~l~~~~~~-~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L  176 (330)
T 1xku_A          107 LSKNQLKELPEK------MP--KTLQELRVHENEITKVRKS-VFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYI  176 (330)
T ss_dssp             CCSSCCSBCCSS------CC--TTCCEEECCSSCCCBBCHH-HHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEE
T ss_pred             CCCCcCCccChh------hc--ccccEEECCCCcccccCHh-HhcCC-ccccEEECCCCcCCccCcChhhccCCCCcCEE
Confidence            999998876543      22  6899999999999876443 66777 689999999999864  778889999999999


Q ss_pred             EccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCccc
Q 036342          192 DLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT  271 (596)
Q Consensus       192 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  271 (596)
                      ++++|.++. +|..+.  ++|++|++++|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.|+|++|.++
T Consensus       177 ~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  253 (330)
T 1xku_A          177 RIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV  253 (330)
T ss_dssp             ECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred             ECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence            999999985 444432  78999999999999888888999999999999999999888888999999999999999999


Q ss_pred             CCCcccccccccceEEcccCCCCCchhhhhccc------cccceEecCCCcCcc-cCChhhhccCCCCCeEECCCCc
Q 036342          272 SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNL------KVLIGIDFSMNNFSG-VIPREIGEKLSYLEDLNLSFNK  341 (596)
Q Consensus       272 ~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l------~~L~~L~ls~N~~~~-~~~~~~~~~l~~L~~L~l~~N~  341 (596)
                      .+|..+..+++|++|++++|++++..+..|...      ..++.|++++|.+.. .++...+..+..++.++|++|+
T Consensus       254 ~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            999999999999999999999998877777543      677888888888752 2444466678888888888874

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.3e-34  Score=295.76  Aligned_cols=290  Identities=23%  Similarity=0.275  Sum_probs=237.7

Q ss_pred             CCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEe
Q 036342           34 STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLG  113 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  113 (596)
                      .+++.+++++|.++ .+|...   .++|+.|+|++|.+++..|..|.++++|++|+|++|+|+++.|.+|.++++|++|+
T Consensus        33 c~l~~l~~~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           33 CHLRVVQCSDLGLK-AVPKEI---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             EETTEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred             ccCCEEECCCCCcc-ccCCCC---CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence            36899999999987 455422   36899999999999987788899999999999999999988899999999999999


Q ss_pred             cCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccc--cccChhccCCCCCCEE
Q 036342          114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS--GGIPEEISNLTNLVEI  191 (596)
Q Consensus       114 l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L  191 (596)
                      +++|.++.++..      +.  ++|++|++++|.+++..+. .+..+ ++|++|++++|.++  +..+..|..+ +|++|
T Consensus       109 L~~n~l~~l~~~------~~--~~L~~L~l~~n~i~~~~~~-~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L  177 (332)
T 2ft3_A          109 ISKNHLVEIPPN------LP--SSLVELRIHDNRIRKVPKG-VFSGL-RNMNCIEMGGNPLENSGFEPGAFDGL-KLNYL  177 (332)
T ss_dssp             CCSSCCCSCCSS------CC--TTCCEEECCSSCCCCCCSG-GGSSC-SSCCEEECCSCCCBGGGSCTTSSCSC-CCSCC
T ss_pred             CCCCcCCccCcc------cc--ccCCEEECCCCccCccCHh-HhCCC-ccCCEEECCCCccccCCCCcccccCC-ccCEE
Confidence            999999876554      22  7899999999999865443 57777 68999999999996  3777888888 89999


Q ss_pred             EccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCccc
Q 036342          192 DLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT  271 (596)
Q Consensus       192 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  271 (596)
                      ++++|.+++ +|..+.  ++|++|++++|.+++..+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|+++
T Consensus       178 ~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  254 (332)
T 2ft3_A          178 RISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS  254 (332)
T ss_dssp             BCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred             ECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence            999999986 444443  78999999999999877788999999999999999999888888999999999999999999


Q ss_pred             CCCcccccccccceEEcccCCCCCchhhhhccc------cccceEecCCCcCcc-cCChhhhccCCCCCeEECCCCc
Q 036342          272 SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNL------KVLIGIDFSMNNFSG-VIPREIGEKLSYLEDLNLSFNK  341 (596)
Q Consensus       272 ~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l------~~L~~L~ls~N~~~~-~~~~~~~~~l~~L~~L~l~~N~  341 (596)
                      .+|..+..+++|+.|++++|++++..+..|.+.      ..|+.|++++|.+.. .++...+..++.|+.+++++|+
T Consensus       255 ~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            999989999999999999999998777777653      568888888888861 2344466778888888888874

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.3e-34  Score=294.04  Aligned_cols=288  Identities=24%  Similarity=0.295  Sum_probs=245.9

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEE
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLS   89 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (596)
                      .+++.+++++|+++ .+|..+  .++|++|+|++|.+++ +++..+..+++|++|+|++|++++..|.+|.++++|++|+
T Consensus        33 c~l~~l~~~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           33 CHLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             EETTEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred             ccCCEEECCCCCcc-ccCCCC--CCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence            37999999999997 566665  3689999999999985 4444455699999999999999988899999999999999


Q ss_pred             ccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCc--cCCchhhhcccccccEE
Q 036342           90 LGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDG--ILPKTSISNLSRSLEEF  167 (596)
Q Consensus        90 L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~--~~~~~~~~~l~~~L~~L  167 (596)
                      |++|+++.+.+..+   ++|++|++++|.++.+++.     .|.++++|+.|++++|.++.  ..+. .+..+  +|++|
T Consensus       109 L~~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~~-~~~~l--~L~~L  177 (332)
T 2ft3_A          109 ISKNHLVEIPPNLP---SSLVELRIHDNRIRKVPKG-----VFSGLRNMNCIEMGGNPLENSGFEPG-AFDGL--KLNYL  177 (332)
T ss_dssp             CCSSCCCSCCSSCC---TTCCEEECCSSCCCCCCSG-----GGSSCSSCCEEECCSCCCBGGGSCTT-SSCSC--CCSCC
T ss_pred             CCCCcCCccCcccc---ccCCEEECCCCccCccCHh-----HhCCCccCCEEECCCCccccCCCCcc-cccCC--ccCEE
Confidence            99999996554443   8999999999999987654     48899999999999999964  3343 55554  79999


Q ss_pred             EccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCc
Q 036342          168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLY  247 (596)
Q Consensus       168 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  247 (596)
                      ++++|++++. |..+.  ++|++|++++|.+++..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|+++
T Consensus       178 ~l~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  254 (332)
T 2ft3_A          178 RISEAKLTGI-PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS  254 (332)
T ss_dssp             BCCSSBCSSC-CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred             ECcCCCCCcc-Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence            9999999974 54443  78999999999999998899999999999999999999887788999999999999999998


Q ss_pred             ccchhhhccCCCCcEEEeCCCcccCCCcc-ccc------ccccceEEcccCCCC--CchhhhhccccccceEecCCCc
Q 036342          248 GSIPACFGNLASLRILSLGSNKLTSIPLT-FWN------LKDILQLNFSSNFLT--GPLLLEIGNLKVLIGIDFSMNN  316 (596)
Q Consensus       248 ~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~-~~~------l~~L~~L~ls~N~l~--~~~~~~~~~l~~L~~L~ls~N~  316 (596)
                       .+|..+..+++|+.|++++|.++.+|.. +..      ..+|+.|++++|++.  ...+..|..++.|+.+++++|.
T Consensus       255 -~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          255 -RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             -BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             -ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence             6788899999999999999999998754 333      367899999999998  6778899999999999999885

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=6e-35  Score=295.54  Aligned_cols=256  Identities=30%  Similarity=0.525  Sum_probs=166.6

Q ss_pred             CCCCEEEccCCcccc--cCCccccCCCCCCEEecCC-CcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhc
Q 036342           83 SKLSKLSLGMNSFSG--FIPSTFGNLRNLEQLGLDE-NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISN  159 (596)
Q Consensus        83 ~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~  159 (596)
                      .+++.|+|++|.+++  .+|..|.++++|++|++++ |.+++..+     ..|.++++|++|++++|.++          
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p-----~~l~~l~~L~~L~Ls~n~l~----------  114 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP-----PAIAKLTQLHYLYITHTNVS----------  114 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCC-----GGGGGCTTCSEEEEEEECCE----------
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCC-----hhHhcCCCCCEEECcCCeeC----------
Confidence            467788888888877  6777777777777777773 66654322     23555555555555555554          


Q ss_pred             ccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCC-CCcE
Q 036342          160 LSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLA-ELYR  238 (596)
Q Consensus       160 l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~  238 (596)
                                      +..|..|..+++|++|++++|.+++..|..|..+++|++|++++|.+++.+|..+..++ +|+.
T Consensus       115 ----------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~  178 (313)
T 1ogq_A          115 ----------------GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS  178 (313)
T ss_dssp             ----------------EECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCE
T ss_pred             ----------------CcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcE
Confidence                            44445555555555555555555555555555555555555555555555555555554 5555


Q ss_pred             EEccCCcCcccchhhhccCCCCcEEEeCCCcccC-CCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcC
Q 036342          239 LELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNF  317 (596)
Q Consensus       239 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~  317 (596)
                      |++++|++++..|..+..++ |+.|+|++|.+++ +|..+..+++|+.|++++|.+++..+. +..+++|++||+++|++
T Consensus       179 L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l  256 (313)
T 1ogq_A          179 MTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRI  256 (313)
T ss_dssp             EECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCC
T ss_pred             EECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcc
Confidence            55555555555555555554 5555555555554 344455556666666666666655444 56677788888888888


Q ss_pred             cccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCCCC
Q 036342          318 SGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNL  372 (596)
Q Consensus       318 ~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~~~  372 (596)
                      ++.+|. .+..+++|+.|++++|++++.+|....+++++.+++++|++.|+.|..
T Consensus       257 ~~~~p~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          257 YGTLPQ-GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             EECCCG-GGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred             cCcCCh-HHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence            877777 456788888888888888888888877888999999999999987653

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.4e-33  Score=287.99  Aligned_cols=289  Identities=21%  Similarity=0.282  Sum_probs=244.9

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEE
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLS   89 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (596)
                      .+++.++++++.++ .+|..+  .++|++|+|++|++++ ++...+..+++|++|+|++|++++..|..|.++++|++|+
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~--~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSC--CTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCCeEEEecCCCcc-ccCccC--CCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            37899999999997 466655  3689999999999985 5444455699999999999999988899999999999999


Q ss_pred             ccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCc--cCCchhhhcccccccEE
Q 036342           90 LGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDG--ILPKTSISNLSRSLEEF  167 (596)
Q Consensus        90 L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~--~~~~~~~~~l~~~L~~L  167 (596)
                      |++|+|+.+....+   ++|++|++++|.++.+.+.     .|.++++|+.|++++|.++.  ..+. .+..+ ++|++|
T Consensus       107 Ls~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~~-~~~~l-~~L~~L  176 (330)
T 1xku_A          107 LSKNQLKELPEKMP---KTLQELRVHENEITKVRKS-----VFNGLNQMIVVELGTNPLKSSGIENG-AFQGM-KKLSYI  176 (330)
T ss_dssp             CCSSCCSBCCSSCC---TTCCEEECCSSCCCBBCHH-----HHTTCTTCCEEECCSSCCCGGGBCTT-GGGGC-TTCCEE
T ss_pred             CCCCcCCccChhhc---ccccEEECCCCcccccCHh-----HhcCCccccEEECCCCcCCccCcChh-hccCC-CCcCEE
Confidence            99999996544333   7899999999999886543     58899999999999999964  4343 67777 789999


Q ss_pred             EccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCc
Q 036342          168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLY  247 (596)
Q Consensus       168 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  247 (596)
                      ++++|.++.. |..+.  ++|++|++++|.+++..|..|..+++|++|++++|.+++..+..+..+++|+.|++++|+++
T Consensus       177 ~l~~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  253 (330)
T 1xku_A          177 RIADTNITTI-PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV  253 (330)
T ss_dssp             ECCSSCCCSC-CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred             ECCCCccccC-Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence            9999999864 44443  79999999999999988999999999999999999999888888999999999999999998


Q ss_pred             ccchhhhccCCCCcEEEeCCCcccCCCcccc-------cccccceEEcccCCCCC--chhhhhccccccceEecCCCc
Q 036342          248 GSIPACFGNLASLRILSLGSNKLTSIPLTFW-------NLKDILQLNFSSNFLTG--PLLLEIGNLKVLIGIDFSMNN  316 (596)
Q Consensus       248 ~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~-------~l~~L~~L~ls~N~l~~--~~~~~~~~l~~L~~L~ls~N~  316 (596)
                       .+|..+..+++|++|+|++|+++++|...+       ....++.|++++|++..  ..|..|..+..++.+++++|+
T Consensus       254 -~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          254 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             -SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             -cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence             778889999999999999999999876432       24678999999999974  567889999999999999985

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.3e-33  Score=298.20  Aligned_cols=264  Identities=28%  Similarity=0.326  Sum_probs=163.1

Q ss_pred             CCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCC
Q 036342           59 PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL  138 (596)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L  138 (596)
                      ++|++|++++|++++ +| +|.++++|++|++++|++++ +|..   ..+|++|++++|.+++++       .+.++++|
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~---~~~L~~L~L~~n~l~~l~-------~~~~l~~L  197 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEELP-------ELQNLPFL  197 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCC-------CCTTCTTC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC---cccccEEECcCCcCCcCc-------cccCCCCC
Confidence            355555555555553 44 35555566666666665554 2222   235556666666555532       35677777


Q ss_pred             CEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEcc
Q 036342          139 TLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLE  218 (596)
Q Consensus       139 ~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  218 (596)
                      +.|++++|.+++. |.     .+++|++|++++|.++ .+| .|..+++|++|++++|++++ +|.   .+++|++|+++
T Consensus       198 ~~L~l~~N~l~~l-~~-----~~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~---~~~~L~~L~l~  265 (454)
T 1jl5_A          198 TAIYADNNSLKKL-PD-----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVR  265 (454)
T ss_dssp             CEEECCSSCCSSC-CC-----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECC
T ss_pred             CEEECCCCcCCcC-CC-----CcCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-ccc---cccccCEEECC
Confidence            7777777777653 22     2246777777777777 345 37777777777777777775 332   23677777777


Q ss_pred             CCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchh
Q 036342          219 DNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLL  298 (596)
Q Consensus       219 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~  298 (596)
                      +|.+++ +|..   .++|+.|++++|++++. |..   .++|++|++++|.+++++..   .++|++|++++|++++ +|
T Consensus       266 ~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~~~---~~~L~~L~Ls~N~l~~-lp  333 (454)
T 1jl5_A          266 DNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSLCDL---PPSLEELNVSNNKLIE-LP  333 (454)
T ss_dssp             SSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEECCC---CTTCCEEECCSSCCSC-CC
T ss_pred             CCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcccCC---cCcCCEEECCCCcccc-cc
Confidence            777774 4433   36777788888777652 211   15777888888887775531   2589999999999997 34


Q ss_pred             hhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccc--cCCCC-CCC-------------CCCCcccccc
Q 036342          299 LEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG--EIPRG-GSF-------------GNFSAESFEG  362 (596)
Q Consensus       299 ~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~-~~~-------------~~l~~l~~~~  362 (596)
                      ..   +++|+.|++++|+++ .+|.    .+++|++|++++|++++  .+|.. ..+             ++++.+++++
T Consensus       334 ~~---~~~L~~L~L~~N~l~-~lp~----~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~  405 (454)
T 1jl5_A          334 AL---PPRLERLIASFNHLA-EVPE----LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVET  405 (454)
T ss_dssp             CC---CTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-------------------
T ss_pred             cc---CCcCCEEECCCCccc-cccc----hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCC
Confidence            33   578999999999998 5676    47889999999999998  55654 233             7789999999


Q ss_pred             ccccc
Q 036342          363 NELLC  367 (596)
Q Consensus       363 N~~~c  367 (596)
                      |++.+
T Consensus       406 N~l~~  410 (454)
T 1jl5_A          406 NPLRE  410 (454)
T ss_dssp             -----
T ss_pred             CcCCc
Confidence            99875

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.6e-34  Score=292.52  Aligned_cols=250  Identities=30%  Similarity=0.428  Sum_probs=193.5

Q ss_pred             CCccEEEccCCcccc--ccCccccCCCCCCEEEccC-CcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCC
Q 036342           59 PNLEKLYLWGNNFSG--TIPRFIFNASKLSKLSLGM-NSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNC  135 (596)
Q Consensus        59 ~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l  135 (596)
                      .+++.|+|++|.+++  .+|..+.++++|++|+|++ |.+.+.+|..|.++++|++|++++|.+++..+.     .|.++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~-----~~~~l  124 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD-----FLSQI  124 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG-----GGGGC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCH-----HHhCC
Confidence            689999999999998  8999999999999999995 999999999999999999999999999864332     46666


Q ss_pred             CCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCC-CCCe
Q 036342          136 KSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLR-KLQR  214 (596)
Q Consensus       136 ~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~  214 (596)
                      ++|++|++++|.+++.                          .|..|..+++|++|++++|.+++.+|..+..++ +|++
T Consensus       125 ~~L~~L~Ls~N~l~~~--------------------------~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~  178 (313)
T 1ogq_A          125 KTLVTLDFSYNALSGT--------------------------LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS  178 (313)
T ss_dssp             TTCCEEECCSSEEESC--------------------------CCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCE
T ss_pred             CCCCEEeCCCCccCCc--------------------------CChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcE
Confidence            6666666666665544                          444555566666666666666666666666665 6666


Q ss_pred             EEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCC
Q 036342          215 LNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       215 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~  294 (596)
                      |++++|.+++.+|..+..+. |+.|++++|++++..|..|..+++|+.|+|++|.++..+..+..+++|++|++++|+++
T Consensus       179 L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~  257 (313)
T 1ogq_A          179 MTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY  257 (313)
T ss_dssp             EECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCE
T ss_pred             EECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCccc
Confidence            66666666666666666665 77777777777766777777777777777777777765555667778888888888888


Q ss_pred             CchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcc
Q 036342          295 GPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL  342 (596)
Q Consensus       295 ~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l  342 (596)
                      +..|..+..++.|+.|++++|++++.+|..  ..+++|+.+++++|+.
T Consensus       258 ~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~--~~l~~L~~l~l~~N~~  303 (313)
T 1ogq_A          258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQG--GNLQRFDVSAYANNKC  303 (313)
T ss_dssp             ECCCGGGGGCTTCCEEECCSSEEEEECCCS--TTGGGSCGGGTCSSSE
T ss_pred             CcCChHHhcCcCCCEEECcCCcccccCCCC--ccccccChHHhcCCCC
Confidence            778888888888888889999988888873  5788899999999984

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=287.42  Aligned_cols=151  Identities=25%  Similarity=0.436  Sum_probs=128.2

Q ss_pred             HhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ...+++...+.||+|+||+||+|.                    +.|.+|+.++++++|||||+++|++.+ +..|+|||
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            345678888999999999999862                    568899999999999999999999865 56899999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ||++|+|.++++.....++|.++..|+.|||+|++|||   +++||||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999887777999999999999999999999   889999999999999999999999999999876433323


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      ......+||+.||||
T Consensus       189 ~~~~~~~GT~~ymAP  203 (307)
T 3omv_A          189 QQVEQPTGSVLWMAP  203 (307)
T ss_dssp             -----CCCCTTSCCH
T ss_pred             eeecccccCCCccCH
Confidence            334557899999998

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4e-34  Score=284.72  Aligned_cols=148  Identities=30%  Similarity=0.493  Sum_probs=133.5

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||+||+|.                        +.+.+|++++++++|||||++++++++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            579999999999999999852                        35788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |||+||+|.+++...+ .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999998764 6899999999999999999999   89999999999999999999999999999998754333


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                      .......+||+.||||
T Consensus       188 ~~~~~~~~GTp~YmAP  203 (311)
T 4aw0_A          188 QARANSFVGTAQYVSP  203 (311)
T ss_dssp             CCCBCCCCSCGGGCCH
T ss_pred             cccccCcccCcccCCH
Confidence            3334567999999998

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=4.7e-35  Score=312.91  Aligned_cols=352  Identities=18%  Similarity=0.164  Sum_probs=151.1

Q ss_pred             CCCEEECCCCCCccccchh-hhCCCCCCEEEccCCcCccc----cCccCccCCCCccEEEccCCccccccCcccc-CCC-
Q 036342           11 NLEELQLGQNKLIGTVPAA-IFNVSTLKFLGLQNNSLSGS----LSSIANVRLPNLEKLYLWGNNFSGTIPRFIF-NAS-   83 (596)
Q Consensus        11 ~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~-   83 (596)
                      +|++|||++|++++..... +..+++|++|+|++|.++..    ++. .+..+++|++|+|++|.++...+..+. .++ 
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISS-ALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHH-HHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHH-HHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            3455555555554333222 44455555555555555421    111 111245555555555555433222222 233 


Q ss_pred             ---CCCEEEccCCcccc----cCCccccCCCCCCEEecCCCcCcCCCCCcccccc-CCCCCCCCEEECcCCCCCccCCc-
Q 036342           84 ---KLSKLSLGMNSFSG----FIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSS-LSNCKSLTLIDLSNNPLDGILPK-  154 (596)
Q Consensus        84 ---~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-~~~l~~L~~L~ls~N~l~~~~~~-  154 (596)
                         +|++|+|++|+|+.    .++..|..+++|++|++++|.++...... +... +...++|++|++++|.+++.... 
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~-l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  161 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL-LCEGLLDPQCRLEKLQLEYCSLSAASCEP  161 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH-HHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHH-HHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence               35555555555542    23444555555555555555544311100 0000 12234455555555555432110 


Q ss_pred             --hhhhcccccccEEEccccccccccChhcc-----CCCCCCEEEccCCcccCC----CCccccCCCCCCeEEccCCccc
Q 036342          155 --TSISNLSRSLEEFYMYNCNISGGIPEEIS-----NLTNLVEIDLGGNKLNGS----IPITLGKLRKLQRLNLEDNILE  223 (596)
Q Consensus       155 --~~~~~l~~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~  223 (596)
                        ..+..+ ++|++|++++|.++...+..+.     ..++|++|++++|.+++.    ++..+..+++|++|++++|.++
T Consensus       162 l~~~l~~~-~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~  240 (461)
T 1z7x_W          162 LASVLRAK-PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG  240 (461)
T ss_dssp             HHHHHHHC-TTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred             HHHHHhhC-CCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence              122222 3455555555555443333332     133555555555555432    2344444555555555555544


Q ss_pred             ccCc-----cchhcCCCCcEEEccCCcCccc----chhhhccCCCCcEEEeCCCcccCCC-cccc-----cccccceEEc
Q 036342          224 GSIP-----DDICRLAELYRLELGSNKLYGS----IPACFGNLASLRILSLGSNKLTSIP-LTFW-----NLKDILQLNF  288 (596)
Q Consensus       224 ~~~~-----~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ip-~~~~-----~l~~L~~L~l  288 (596)
                      +...     ..+..+++|++|++++|.++..    ++..+..+++|++|+|++|.++... ..+.     ..++|++|++
T Consensus       241 ~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L  320 (461)
T 1z7x_W          241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV  320 (461)
T ss_dssp             HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred             hHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEc
Confidence            3211     1111344555555555555432    3444444555555555555554311 1111     1135555555


Q ss_pred             ccCCCCCc----hhhhhccccccceEecCCCcCcccCChhhhc----cCCCCCeEECCCCcccc----cCCCC-CCCCCC
Q 036342          289 SSNFLTGP----LLLEIGNLKVLIGIDFSMNNFSGVIPREIGE----KLSYLEDLNLSFNKLKG----EIPRG-GSFGNF  355 (596)
Q Consensus       289 s~N~l~~~----~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~----~l~~L~~L~l~~N~l~~----~~p~~-~~~~~l  355 (596)
                      ++|.+++.    ++..+..++.|+.||+++|.+++..+..+..    ..+.|++|++++|++++    .+|.. ..++++
T Consensus       321 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L  400 (461)
T 1z7x_W          321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL  400 (461)
T ss_dssp             TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred             CCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCc
Confidence            55555443    2333444455555555555554322221111    13455555555555543    22222 224445


Q ss_pred             Cccccccccc
Q 036342          356 SAESFEGNEL  365 (596)
Q Consensus       356 ~~l~~~~N~~  365 (596)
                      +.+++++|++
T Consensus       401 ~~L~l~~N~i  410 (461)
T 1z7x_W          401 RELDLSNNCL  410 (461)
T ss_dssp             CEEECCSSSC
T ss_pred             cEEECCCCCC
Confidence            5555555544

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.1e-34  Score=282.79  Aligned_cols=149  Identities=28%  Similarity=0.487  Sum_probs=129.7

Q ss_pred             ccccccccccCCCceeehhh--------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRA--------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~--------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ++|...+.||+|+||+||+|                          .+.|.+|+++|++++|||||+++|+|.+++..|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888899999999999985                          1468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEE
Q 036342          499 VLEYMPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHL  566 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl  566 (596)
                      |||||++|+|.++++...            ..++|.++..++.|||+|+.|||   +++|+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997642            46899999999999999999999   889999999999999999999999


Q ss_pred             eccccccccCCCCCccccccccccccccCC
Q 036342          567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       567 ~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|||+|+..............+||++||||
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  199 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  199 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCH
Confidence            999999876433322233345799999998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.98  E-value=2.8e-33  Score=280.49  Aligned_cols=149  Identities=22%  Similarity=0.396  Sum_probs=130.9

Q ss_pred             ccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      +++...+.||+|+||+||+|.                           +.|.+|+.++++++|||||+++|+|.+++..|
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            356667899999999999852                           46889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC
Q 036342          498 LVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM  562 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~  562 (596)
                      +|||||++|+|.+++....               ..++|.++..|+.|||+|++|||   +++||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999996532               35899999999999999999999   88999999999999999999


Q ss_pred             cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          563 VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 ~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+||+|||+|+.+...+........+||++||||
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  216 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP  216 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCH
Confidence            9999999999976543333334456899999998

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.98  E-value=2.1e-33  Score=284.31  Aligned_cols=148  Identities=23%  Similarity=0.401  Sum_probs=125.8

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .++|+..+.||+|+||+||+|.                       +.+.+|++++++++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            4689999999999999999852                       45789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          501 EYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+||+|.+++.... ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+... 
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999997654 45789999999999999999999   899999999999999999999999999999976321 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                       .......+||+.||||
T Consensus       179 -~~~~~~~~GT~~YmAP  194 (350)
T 4b9d_A          179 -VELARACIGTPYYLSP  194 (350)
T ss_dssp             -HHHHHHHHSCCTTCCH
T ss_pred             -cccccccCCCccccCH
Confidence             1123456899999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.98  E-value=5e-33  Score=281.33  Aligned_cols=149  Identities=26%  Similarity=0.463  Sum_probs=123.1

Q ss_pred             ccccccccccCCCceeehhh--------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRA--------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~--------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ++|...+.||+|+||+||+|                          .+.|.+|+++|++++|||||+++|+|.+++..|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46777899999999999985                          1468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcE
Q 036342          499 VLEYMPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVA  564 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~  564 (596)
                      |||||++|+|.++++...              ..++|.+++.|+.|||+|+.|||   .++|+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997642              35899999999999999999999   8899999999999999999999


Q ss_pred             EEeccccccccCCCCCccccccccccccccCC
Q 036342          565 HLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       565 kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||+|||+|+..............+||++||||
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  229 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  229 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCH
T ss_pred             EEcccccceeccCCCcceecCcccccccccCh
Confidence            99999999976543333334456899999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.98  E-value=4.8e-33  Score=281.18  Aligned_cols=145  Identities=25%  Similarity=0.327  Sum_probs=131.1

Q ss_pred             ccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..|+..+.||+|+||+||+|.                     +.+.+|+.+|++++|||||+++++|.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            468999999999999999862                     35789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      +||+|.+++...  .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CC
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cc
Confidence            999999999764  4899999999999999999999   8999999999999999999999999999999764332  22


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      ....+||++||||
T Consensus       227 ~~~~~GTp~YmAP  239 (346)
T 4fih_A          227 RKSLVGTPYWMAP  239 (346)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             ccccccCcCcCCH
Confidence            3457999999998

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.98  E-value=9e-32  Score=277.18  Aligned_cols=281  Identities=20%  Similarity=0.190  Sum_probs=139.8

Q ss_pred             CCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEc
Q 036342           11 NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSL   90 (596)
Q Consensus        11 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L   90 (596)
                      .....++++|+++ .+|..+.  ++|++|+|++|++++ ++...+..+++|++|+|++|++++..|.+|.++++|++|+|
T Consensus        32 ~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (353)
T 2z80_A           32 RNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL  107 (353)
T ss_dssp             TTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence            3344566666655 3344332  356666666666653 33323334566666666666666555555666666666666


Q ss_pred             cCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCC-CCccCCchhhhcccccccEEEc
Q 036342           91 GMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNP-LDGILPKTSISNLSRSLEEFYM  169 (596)
Q Consensus        91 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~-l~~~~~~~~~~~l~~~L~~L~l  169 (596)
                      ++|+|+++.+..|.++++|++|++++|+++.++..    ..+.++++|++|++++|. +.+..+. .+..+ ++|++|++
T Consensus       108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~----~~~~~l~~L~~L~l~~n~~~~~~~~~-~~~~l-~~L~~L~l  181 (353)
T 2z80_A          108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGET----SLFSHLTKLQILRVGNMDTFTKIQRK-DFAGL-TFLEELEI  181 (353)
T ss_dssp             CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSS----CSCTTCTTCCEEEEEESSSCCEECTT-TTTTC-CEEEEEEE
T ss_pred             CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCch----hhhccCCCCcEEECCCCccccccCHH-HccCC-CCCCEEEC
Confidence            66666655555556666666666666666554330    135555566666665553 3332222 34444 44555555


Q ss_pred             cccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchh---cCCCCcEEEccCCcC
Q 036342          170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC---RLAELYRLELGSNKL  246 (596)
Q Consensus       170 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l  246 (596)
                      ++|.+++..|..|..+++|++|++++|.+....+..+..+++|++|++++|.+++..+..+.   ....++.+++++|.+
T Consensus       182 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l  261 (353)
T 2z80_A          182 DASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI  261 (353)
T ss_dssp             EETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBC
T ss_pred             CCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccc
Confidence            55555555555555555555555555555433333333455555555555555543332222   123344444444444


Q ss_pred             cccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCccc
Q 036342          247 YGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGV  320 (596)
Q Consensus       247 ~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~  320 (596)
                      .+.                   .+..+|..+..+++|++|++++|+++......|..+++|+.|++++|.+++.
T Consensus       262 ~~~-------------------~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~  316 (353)
T 2z80_A          262 TDE-------------------SLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  316 (353)
T ss_dssp             CHH-------------------HHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             cCc-------------------chhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence            321                   0011344444455555555555555533333345555555666666655543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.1e-31  Score=276.55  Aligned_cols=279  Identities=20%  Similarity=0.240  Sum_probs=191.0

Q ss_pred             CCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEe
Q 036342           34 STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLG  113 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  113 (596)
                      +.....++++|.++ .+|...   .++|++|+|++|++++..+..|.++++|++|+|++|+|+++.+++|.++++|++|+
T Consensus        31 ~~~~~c~~~~~~l~-~iP~~~---~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (353)
T 2z80_A           31 DRNGICKGSSGSLN-SIPSGL---TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD  106 (353)
T ss_dssp             CTTSEEECCSTTCS-SCCTTC---CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCeEeeCCCCCcc-cccccc---cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence            44455777777776 344422   24677777777777765555677777777777777777776666777777777777


Q ss_pred             cCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccC-hhccCCCCCCEEE
Q 036342          114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP-EEISNLTNLVEID  192 (596)
Q Consensus       114 l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~  192 (596)
                      +++|.++.+++.     .|.++++|++|++++|+++++                          .+ ..|..+++|++|+
T Consensus       107 Ls~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~l--------------------------~~~~~~~~l~~L~~L~  155 (353)
T 2z80_A          107 LSYNYLSNLSSS-----WFKPLSSLTFLNLLGNPYKTL--------------------------GETSLFSHLTKLQILR  155 (353)
T ss_dssp             CCSSCCSSCCHH-----HHTTCTTCSEEECTTCCCSSS--------------------------CSSCSCTTCTTCCEEE
T ss_pred             CCCCcCCcCCHh-----HhCCCccCCEEECCCCCCccc--------------------------CchhhhccCCCCcEEE
Confidence            777776654332     255566666666666665532                          22 3455666666666


Q ss_pred             ccCC-cccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCccc
Q 036342          193 LGGN-KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT  271 (596)
Q Consensus       193 Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  271 (596)
                      +++| .+.+..+..|..+++|++|++++|.+++..|..+..+++|++|++++|++....+..+..+++|+.|+|++|.++
T Consensus       156 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~  235 (353)
T 2z80_A          156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD  235 (353)
T ss_dssp             EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCT
T ss_pred             CCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccc
Confidence            6666 355555566666667777777777766666666667777777777777765444444555677777777777777


Q ss_pred             CCCcc----cccccccceEEcccCCCCC----chhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCccc
Q 036342          272 SIPLT----FWNLKDILQLNFSSNFLTG----PLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK  343 (596)
Q Consensus       272 ~ip~~----~~~l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~  343 (596)
                      +++..    ......++.+++++|.+++    .+|..+..+++|+.||+++|+++ .+|...+..+++|++|++++|++.
T Consensus       236 ~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~  314 (353)
T 2z80_A          236 TFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD  314 (353)
T ss_dssp             TCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             cccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCcc
Confidence            65432    1235667888888888876    36777889999999999999999 678877788999999999999999


Q ss_pred             ccCCC
Q 036342          344 GEIPR  348 (596)
Q Consensus       344 ~~~p~  348 (596)
                      +.+|.
T Consensus       315 ~~~~~  319 (353)
T 2z80_A          315 CSCPR  319 (353)
T ss_dssp             CCHHH
T ss_pred             CcCCC
Confidence            87763

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=2e-31  Score=269.01  Aligned_cols=249  Identities=26%  Similarity=0.287  Sum_probs=176.8

Q ss_pred             CEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccc--cCccccCCCCCCEEEc
Q 036342           13 EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGT--IPRFIFNASKLSKLSL   90 (596)
Q Consensus        13 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L   90 (596)
                      +.+++++++++ .+|..+  .++|++|+|++|+++ .++...+..+++|++|+|++|.++..  .+..+.++++|++|+|
T Consensus        10 ~~l~c~~~~l~-~ip~~~--~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L   85 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL   85 (306)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred             CEEEcCCCCcc-cCCCCC--CCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence            57888888886 455544  367888888888887 55554455688888888888888732  3667777888888888


Q ss_pred             cCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEcc
Q 036342           91 GMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMY  170 (596)
Q Consensus        91 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~  170 (596)
                      ++|.++. +|..|.++++|++|++++|.++...+.    ..+..+++|++|++++|.+++..+. .+..+ ++|++|+++
T Consensus        86 s~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l-~~L~~L~l~  158 (306)
T 2z66_A           86 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF----SVFLSLRNLIYLDISHTHTRVAFNG-IFNGL-SSLEVLKMA  158 (306)
T ss_dssp             CSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTT----TTTTTCTTCCEEECTTSCCEECSTT-TTTTC-TTCCEEECT
T ss_pred             CCCcccc-ChhhcCCCCCCCEEECCCCcccccccc----hhhhhccCCCEEECCCCcCCccchh-hcccC-cCCCEEECC
Confidence            8888875 455688888888888888888776431    2467777888888888877765544 45555 567777777


Q ss_pred             cccccc-ccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCccc
Q 036342          171 NCNISG-GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS  249 (596)
Q Consensus       171 ~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  249 (596)
                      +|.+++ ..|..|..+++|++|++++|.+++..|..|..+++|++|++++|.+++..+..+..+++|+.|++++|++++.
T Consensus       159 ~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  238 (306)
T 2z66_A          159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS  238 (306)
T ss_dssp             TCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBC
T ss_pred             CCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCccc
Confidence            777765 5666677777777777777777766666677777777777777777655555666667777777777777666


Q ss_pred             chhhhccCC-CCcEEEeCCCcccC
Q 036342          250 IPACFGNLA-SLRILSLGSNKLTS  272 (596)
Q Consensus       250 ~p~~~~~l~-~L~~L~Ls~N~l~~  272 (596)
                      .|..+..++ +|++|+|++|.++.
T Consensus       239 ~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          239 KKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             SSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             CHHHHHhhhccCCEEEccCCCeec
Confidence            666666663 66666666666654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=3.7e-34  Score=305.98  Aligned_cols=337  Identities=20%  Similarity=0.185  Sum_probs=268.0

Q ss_pred             cCCCCCCCEEECCCCCCccc----cchhhhCCCCCCEEEccCCcCccccCccCccCCC----CccEEEccCCcccc----
Q 036342            6 IGNLQNLEELQLGQNKLIGT----VPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLP----NLEKLYLWGNNFSG----   73 (596)
Q Consensus         6 ~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~----~L~~L~L~~N~l~~----   73 (596)
                      +..+++|++|+|++|++++.    ++..+..+++|++|+|++|.++..........++    +|++|+|++|.++.    
T Consensus        24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~  103 (461)
T 1z7x_W           24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG  103 (461)
T ss_dssp             HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred             HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH
Confidence            56688999999999999853    4677888899999999999997433321112244    79999999999984    


Q ss_pred             ccCccccCCCCCCEEEccCCcccccCCcccc-----CCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCC
Q 036342           74 TIPRFIFNASKLSKLSLGMNSFSGFIPSTFG-----NLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPL  148 (596)
Q Consensus        74 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l  148 (596)
                      .++..+..+++|++|+|++|.+++..+..+.     ..++|++|++++|.++..... .++..+..+++|++|++++|.+
T Consensus       104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i  182 (461)
T 1z7x_W          104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-PLASVLRAKPDFKELTVSNNDI  182 (461)
T ss_dssp             HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH-HHHHHHHHCTTCCEEECCSSBC
T ss_pred             HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH-HHHHHHhhCCCCCEEECcCCCc
Confidence            5688899999999999999999866555443     356899999999998864321 1334567789999999999998


Q ss_pred             CccCCchhhhc-c---cccccEEEccccccccc----cChhccCCCCCCEEEccCCcccCCC-----CccccCCCCCCeE
Q 036342          149 DGILPKTSISN-L---SRSLEEFYMYNCNISGG----IPEEISNLTNLVEIDLGGNKLNGSI-----PITLGKLRKLQRL  215 (596)
Q Consensus       149 ~~~~~~~~~~~-l---~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L  215 (596)
                      ++..+. .+.. +   .++|++|++++|.+++.    ++..+..+++|++|++++|.+.+..     +..+..+++|++|
T Consensus       183 ~~~~~~-~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L  261 (461)
T 1z7x_W          183 NEAGVR-VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL  261 (461)
T ss_dssp             HHHHHH-HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred             chHHHH-HHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEE
Confidence            754222 2211 1   14899999999999874    5778888999999999999987643     2333468999999


Q ss_pred             EccCCccccc----CccchhcCCCCcEEEccCCcCcccchhhhccC-----CCCcEEEeCCCcccC-----CCccccccc
Q 036342          216 NLEDNILEGS----IPDDICRLAELYRLELGSNKLYGSIPACFGNL-----ASLRILSLGSNKLTS-----IPLTFWNLK  281 (596)
Q Consensus       216 ~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~-----ip~~~~~l~  281 (596)
                      ++++|.++..    ++..+..+++|+.|++++|.+.+..+..+...     ++|+.|+|++|.++.     ++..+..++
T Consensus       262 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~  341 (461)
T 1z7x_W          262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR  341 (461)
T ss_dssp             ECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCS
T ss_pred             ECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCC
Confidence            9999999854    67778889999999999999986666555543     799999999999986     355677789


Q ss_pred             ccceEEcccCCCCCchhhhhcc-----ccccceEecCCCcCcc----cCChhhhccCCCCCeEECCCCccccc
Q 036342          282 DILQLNFSSNFLTGPLLLEIGN-----LKVLIGIDFSMNNFSG----VIPREIGEKLSYLEDLNLSFNKLKGE  345 (596)
Q Consensus       282 ~L~~L~ls~N~l~~~~~~~~~~-----l~~L~~L~ls~N~~~~----~~~~~~~~~l~~L~~L~l~~N~l~~~  345 (596)
                      +|++|++++|.+++..+..+..     .+.|+.|++++|.+++    .+|. .+..+++|++|++++|++++.
T Consensus       342 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~-~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          342 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA-TLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             SCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH-HHHHCCCCCEEECCSSSCCHH
T ss_pred             CccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH-HHHhCCCccEEECCCCCCCHH
Confidence            9999999999998876666553     6799999999999985    5666 456789999999999999764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.97  E-value=8.2e-33  Score=296.69  Aligned_cols=30  Identities=17%  Similarity=0.203  Sum_probs=26.0

Q ss_pred             HHhHHHHHHHHhhcCCCccceeeeeeccCC
Q 036342          465 FKSFDVECEMMKSIRHRNLIKVISSCSNEE  494 (596)
Q Consensus       465 ~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  494 (596)
                      .+.|..|++++.+++|+|+|+++|||....
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            578999999999999999999999997754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.97  E-value=2.2e-32  Score=283.16  Aligned_cols=146  Identities=25%  Similarity=0.325  Sum_probs=131.8

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .+.|+..+.||+|+||+||+|.                     +.+.+|+.+|++++|||||+++++|.+++.+|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            3569999999999999999862                     4588999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      |+||+|.++++..  .+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+....  .
T Consensus       230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~  302 (423)
T 4fie_A          230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P  302 (423)
T ss_dssp             CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred             CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence            9999999999765  4899999999999999999999   8999999999999999999999999999999764332  2


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      .....+||++||||
T Consensus       303 ~~~~~~GTp~YmAP  316 (423)
T 4fie_A          303 RRKSLVGTPYWMAP  316 (423)
T ss_dssp             CBCCCEECTTTCCH
T ss_pred             cccccccCcCcCCH
Confidence            23557999999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.97  E-value=3e-32  Score=269.87  Aligned_cols=141  Identities=28%  Similarity=0.477  Sum_probs=122.7

Q ss_pred             cccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc----CCeeEEEE
Q 036342          448 SENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN----EEFKALVL  500 (596)
Q Consensus       448 ~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lV~  500 (596)
                      ...+.||+|+||+||+|.                       +.+.+|+.++++++|||||+++++|..    ++.+|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            556789999999999852                       458899999999999999999999864    34689999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eEeCCCCCCCeeeCC-CCcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL--VIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~Hrdlk~~NILl~~-~~~~kl~dfGla~~~~~  577 (596)
                      |||++|+|.++++... .+++..+..++.||+.||+|||   +++  |+||||||+|||++. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999998754 6899999999999999999999   766  999999999999984 79999999999986432


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .    .....+||+.||||
T Consensus       185 ~----~~~~~~GTp~YmAP  199 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAP  199 (290)
T ss_dssp             T----SBEESCSSCCCCCG
T ss_pred             C----ccCCcccCccccCH
Confidence            1    23457899999999

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=1.6e-32  Score=276.48  Aligned_cols=149  Identities=24%  Similarity=0.296  Sum_probs=127.6

Q ss_pred             cccccccccccCCCceeehhhH----------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS  507 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g~  507 (596)
                      .+.|...+.||+|+||+||+|.                ....+|+.++++++|||||++++++.+++..|+|||||+||+
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~  136 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS  136 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence            4578888999999999999863                123579999999999999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-cEEEeccccccccCCCCCc---cc
Q 036342          508 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQS---MT  583 (596)
Q Consensus       508 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-~~kl~dfGla~~~~~~~~~---~~  583 (596)
                      |.++++..+ .+++.++..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+.+......   ..
T Consensus       137 L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          137 LGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             HHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence            999998764 6899999999999999999999   99999999999999999987 6999999999976533211   12


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      ....+||+.||||
T Consensus       213 ~~~~~GT~~YmAP  225 (336)
T 4g3f_A          213 GDYIPGTETHMAP  225 (336)
T ss_dssp             -CCCCCCGGGCCH
T ss_pred             CCccccCccccCH
Confidence            2346899999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=6.7e-33  Score=275.94  Aligned_cols=146  Identities=26%  Similarity=0.377  Sum_probs=124.4

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ++|+..+.||+|+||+||+|.                          ..+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            579999999999999999752                          247789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      |||||+||+|.+++.... .+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999998764 6899999999999999999999   899999999999999999999999999999865432


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      .  ......+||+.||||
T Consensus       180 ~--~~~~~~~GT~~YmAP  195 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAP  195 (304)
T ss_dssp             ---CCCCSCCCCGGGCCH
T ss_pred             C--ccccccccCcccCCH
Confidence            2  123457899999998

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.97  E-value=3.7e-32  Score=266.89  Aligned_cols=144  Identities=24%  Similarity=0.468  Sum_probs=117.9

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||+||+|.                        +.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            689999999999999999852                        35789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||| +|+|.+++...+ .+++.++..++.|++.|++|||   +++|+||||||+|||+++++.+||+|||+|+.....  
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence            999 689999998764 6899999999999999999999   899999999999999999999999999999875432  


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                       ......+||+.||||
T Consensus       166 -~~~~~~~GT~~Y~AP  180 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAP  180 (275)
T ss_dssp             ----------CTTSCH
T ss_pred             -CccCCeeECcccCCh
Confidence             123457899999998

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=1.4e-30  Score=260.00  Aligned_cols=254  Identities=21%  Similarity=0.213  Sum_probs=154.8

Q ss_pred             CEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCC
Q 036342           37 KFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE  116 (596)
Q Consensus        37 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~  116 (596)
                      ++++.+++.++ .+|.. .  .++|++|+|++|.+++..+..|..+++|++|+|++|.|+++.+..|.++++|++|++++
T Consensus        14 ~~~~c~~~~l~-~ip~~-~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVG-I--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCS-SCCTT-C--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcc-cCCcC-C--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            45566666555 23321 1  34566666666666655555566666666666666666666666666666666666666


Q ss_pred             Cc-CcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccC
Q 036342          117 NY-LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG  195 (596)
Q Consensus       117 N~-l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~  195 (596)
                      |. ++.+.+.     .+..+++|++|++++|.+++..+. .+..+ ++|++|++++|.+++..+..|..+++|++|++++
T Consensus        90 n~~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  162 (285)
T 1ozn_A           90 NAQLRSVDPA-----TFHGLGRLHTLHLDRCGLQELGPG-LFRGL-AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG  162 (285)
T ss_dssp             CTTCCCCCTT-----TTTTCTTCCEEECTTSCCCCCCTT-TTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCCccccCHH-----HhcCCcCCCEEECCCCcCCEECHh-HhhCC-cCCCEEECCCCcccccCHhHhccCCCccEEECCC
Confidence            65 5554332     355566666666666666554333 34444 4566666666666655556677777777777777


Q ss_pred             CcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCc
Q 036342          196 NKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL  275 (596)
Q Consensus       196 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~  275 (596)
                      |.+++..+..|..+++|++|++++|.+++..|..+..+++|+.|++++|++++..+..+..+++|+.|+|++|.+..-..
T Consensus       163 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~  242 (285)
T 1ozn_A          163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (285)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             CcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence            77776666667777777777777777776667777777777777777777776666667777777777777777764222


Q ss_pred             ccccccccceEEcccCCCCCchhhhh
Q 036342          276 TFWNLKDILQLNFSSNFLTGPLLLEI  301 (596)
Q Consensus       276 ~~~~l~~L~~L~ls~N~l~~~~~~~~  301 (596)
                      ..+-...++.+..+.|.+....|..+
T Consensus       243 ~~~~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          243 ARPLWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             GHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred             cHHHHHHHHhcccccCccccCCchHh
Confidence            11111223333444555554444443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=3.2e-32  Score=277.60  Aligned_cols=160  Identities=24%  Similarity=0.413  Sum_probs=138.3

Q ss_pred             ccCHHHHHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCC-Cccce
Q 036342          434 TFSYLELCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRH-RNLIK  485 (596)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H-~niv~  485 (596)
                      .++..+|+...++|+..+.||+|+||+||+|.                           +.+.+|+.+|++++| ||||+
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            35566788888999999999999999999851                           357889999999976 89999


Q ss_pred             eeeeeccC-CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeC
Q 036342          486 VISSCSNE-EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHC  549 (596)
Q Consensus       486 l~~~~~~~-~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hr  549 (596)
                      ++|+|.++ +..|+|||||++|+|.++++...               ..+++.++..++.|||+|++|||   +++||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecC
Confidence            99999764 56899999999999999997532               34789999999999999999999   8999999


Q ss_pred             CCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          550 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       550 dlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||||+|||+++++.+||+|||+|+.+............+||++||||
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  256 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  256 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence            99999999999999999999999977544433344557899999998

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=9.7e-31  Score=263.92  Aligned_cols=279  Identities=18%  Similarity=0.204  Sum_probs=159.0

Q ss_pred             CCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCccccc--CCccccCCCCCCEEe
Q 036342           36 LKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGF--IPSTFGNLRNLEQLG  113 (596)
Q Consensus        36 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~--~~~~~~~l~~L~~L~  113 (596)
                      -+.++++++.++ .+|...   .++|++|+|++|+++...+..|.++++|++|+|++|.++..  .+..+.++++|++|+
T Consensus         9 ~~~l~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~   84 (306)
T 2z66_A            9 GTEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD   84 (306)
T ss_dssp             TTEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred             CCEEEcCCCCcc-cCCCCC---CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence            357888888887 444422   35788888888888855555678888888888888888743  356677788888888


Q ss_pred             cCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEc
Q 036342          114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL  193 (596)
Q Consensus       114 l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  193 (596)
                      +++|.++.++      ..+..+++|++|++++|++++..+...+..+ ++|++|++++|.+++..+..|..+++|++|++
T Consensus        85 Ls~n~i~~l~------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  157 (306)
T 2z66_A           85 LSFNGVITMS------SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL-RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM  157 (306)
T ss_dssp             CCSCSEEEEE------EEEETCTTCCEEECTTSEEESSTTTTTTTTC-TTCCEEECTTSCCEECSTTTTTTCTTCCEEEC
T ss_pred             CCCCccccCh------hhcCCCCCCCEEECCCCcccccccchhhhhc-cCCCEEECCCCcCCccchhhcccCcCCCEEEC
Confidence            8888777533      2366677777777777777654332233444 34555555555555544555555555555555


Q ss_pred             cCCcccC-CCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC
Q 036342          194 GGNKLNG-SIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS  272 (596)
Q Consensus       194 s~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  272 (596)
                      ++|.+.+ ..|..+..+++|++|++++|.+++..|..+..+++|+.|+|++|++++..+..+..                
T Consensus       158 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----------------  221 (306)
T 2z66_A          158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC----------------  221 (306)
T ss_dssp             TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT----------------
T ss_pred             CCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC----------------
Confidence            5555543 34444444555555555555554444444444444444444444444444434444                


Q ss_pred             CCcccccccccceEEcccCCCCCchhhhhccc-cccceEecCCCcCcccCCh-hhhccCCCCCeEECCCCcccccCCC
Q 036342          273 IPLTFWNLKDILQLNFSSNFLTGPLLLEIGNL-KVLIGIDFSMNNFSGVIPR-EIGEKLSYLEDLNLSFNKLKGEIPR  348 (596)
Q Consensus       273 ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l-~~L~~L~ls~N~~~~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~  348 (596)
                             +++|++|++++|++++..+..+..+ +.|+.|++++|.+++.-+. ++...+...+.+....+.+.+..|.
T Consensus       222 -------l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          222 -------LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             -------CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             -------cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence                   4555555555555555445455544 2555555555555533221 1122223344445555566655554

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=6.1e-32  Score=270.00  Aligned_cols=149  Identities=23%  Similarity=0.448  Sum_probs=117.9

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC--------
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE--------  494 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------  494 (596)
                      ++|+..+.||+|+||+||+|.                      +.+.+|++++++++|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            479999999999999999852                      45789999999999999999999986543        


Q ss_pred             ----eeEEEEecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEec
Q 036342          495 ----FKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD  568 (596)
Q Consensus       495 ----~~~lV~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~d  568 (596)
                          ..|+|||||++|+|.+++....  ...++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                3799999999999999998754  23466778899999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCc----------cccccccccccccCC
Q 036342          569 FSIAKLLTGEDQS----------MTQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~----------~~~~~~~gt~~y~aP  596 (596)
                      ||+|+.+......          ...+..+||+.||||
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP  199 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP  199 (299)
T ss_dssp             CCCC--------------------------CCCTTSCH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCH
Confidence            9999976533211          112346899999998

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=5.4e-30  Score=272.92  Aligned_cols=247  Identities=24%  Similarity=0.263  Sum_probs=203.0

Q ss_pred             CCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEec
Q 036342           35 TLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGL  114 (596)
Q Consensus        35 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l  114 (596)
                      +...++.+++.++ .+|...   .++|++|+|++|+|++..+..|.++++|++|+|++|+|+++.++.|.++++|++|+|
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L  130 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL  130 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCcEEEECCCCcC-ccCCCC---CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence            4567888888887 444422   357888888888888877888888888888888888888888888888888888888


Q ss_pred             CCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccc-cccccccChhccCCCCCCEEEc
Q 036342          115 DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN-CNISGGIPEEISNLTNLVEIDL  193 (596)
Q Consensus       115 ~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L  193 (596)
                      ++|.++.+++.     .|.++++|++|+|++|+++.+.+. .+..+ ++|++|++++ |.+..+.+..|.++++|++|++
T Consensus       131 ~~n~l~~~~~~-----~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l-~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L  203 (452)
T 3zyi_A          131 FDNWLTVIPSG-----AFEYLSKLRELWLRNNPIESIPSY-AFNRV-PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL  203 (452)
T ss_dssp             CSSCCSBCCTT-----TSSSCTTCCEEECCSCCCCEECTT-TTTTC-TTCCEEECCCCTTCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCcCCccChh-----hhcccCCCCEEECCCCCcceeCHh-HHhcC-CcccEEeCCCCCCccccChhhccCCCCCCEEEC
Confidence            88888876654     477888888888888888765433 66666 6788888888 5555555667889999999999


Q ss_pred             cCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCC
Q 036342          194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI  273 (596)
Q Consensus       194 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i  273 (596)
                      ++|.+++. | .+..+++|++|+|++|.+++..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|+++.+
T Consensus       204 ~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  281 (452)
T 3zyi_A          204 GMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSL  281 (452)
T ss_dssp             TTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCcc
Confidence            99999864 3 477889999999999999988888999999999999999999988888999999999999999999997


Q ss_pred             Ccc-cccccccceEEcccCCCC
Q 036342          274 PLT-FWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       274 p~~-~~~l~~L~~L~ls~N~l~  294 (596)
                      |.. +..+++|+.|+|++|++.
T Consensus       282 ~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          282 PHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             CTTSSTTCTTCCEEECCSSCEE
T ss_pred             ChHHhccccCCCEEEccCCCcC
Confidence            764 567899999999999875

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=8e-30  Score=270.65  Aligned_cols=247  Identities=23%  Similarity=0.235  Sum_probs=204.1

Q ss_pred             CCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEec
Q 036342           35 TLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGL  114 (596)
Q Consensus        35 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l  114 (596)
                      +...++.+++.++ .+|...   .++++.|+|++|++++..+..|.++++|++|+|++|+|+++.+++|.++++|++|+|
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L  119 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL  119 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCC---CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred             CCCEEEeCCCCcC-cCCCCC---CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence            4678888888887 455422   367888888888888777788888888888888888888888888888888888888


Q ss_pred             CCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccc-cccccccChhccCCCCCCEEEc
Q 036342          115 DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN-CNISGGIPEEISNLTNLVEIDL  193 (596)
Q Consensus       115 ~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L  193 (596)
                      ++|+++.+++.     .|.++++|++|+|++|.++.+.+. .+..+ ++|++|++++ |.++.+.+..|.++++|++|++
T Consensus       120 ~~n~l~~~~~~-----~~~~l~~L~~L~L~~N~i~~~~~~-~~~~l-~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L  192 (440)
T 3zyj_A          120 FDNRLTTIPNG-----AFVYLSKLKELWLRNNPIESIPSY-AFNRI-PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL  192 (440)
T ss_dssp             CSSCCSSCCTT-----TSCSCSSCCEEECCSCCCCEECTT-TTTTC-TTCCEEECCCCTTCCEECTTTTTTCSSCCEEEC
T ss_pred             CCCcCCeeCHh-----HhhccccCceeeCCCCcccccCHH-HhhhC-cccCEeCCCCCCCcceeCcchhhcccccCeecC
Confidence            88888876654     478888888888888888765443 66676 6788888888 4555555668889999999999


Q ss_pred             cCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCC
Q 036342          194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI  273 (596)
Q Consensus       194 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i  273 (596)
                      ++|.++.. | .+..+++|++|+|++|.+++..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|+++.+
T Consensus       193 ~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  270 (440)
T 3zyj_A          193 AMCNLREI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL  270 (440)
T ss_dssp             TTSCCSSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCC
T ss_pred             CCCcCccc-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCcc
Confidence            99999854 4 478889999999999999988888899999999999999999988888999999999999999999997


Q ss_pred             Ccc-cccccccceEEcccCCCC
Q 036342          274 PLT-FWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       274 p~~-~~~l~~L~~L~ls~N~l~  294 (596)
                      |.. +..+++|+.|+|++|++.
T Consensus       271 ~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          271 PHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CTTTTSSCTTCCEEECCSSCEE
T ss_pred             ChhHhccccCCCEEEcCCCCcc
Confidence            764 567899999999999875

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=5.4e-32  Score=274.45  Aligned_cols=257  Identities=22%  Similarity=0.204  Sum_probs=154.3

Q ss_pred             CCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecC
Q 036342           36 LKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD  115 (596)
Q Consensus        36 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~  115 (596)
                      ++.++++.+.+...+... +..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+  |..+++|++|+++
T Consensus        12 l~i~~ls~~~l~~~~~~~-~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls   88 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASL-RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN   88 (317)
T ss_dssp             EEEESCCTTTHHHHHHHH-HTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred             eeEeeccccchhhhHHHH-hccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence            344455555554322221 2235566677777666665555666666777777777777665543  6666777777777


Q ss_pred             CCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccC
Q 036342          116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG  195 (596)
Q Consensus       116 ~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~  195 (596)
                      +|.+++++          ..++|+.|++++|++++..+.    .+ ++|++|++++|++++..+..|..+++|++|++++
T Consensus        89 ~n~l~~l~----------~~~~L~~L~l~~n~l~~~~~~----~~-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~  153 (317)
T 3o53_A           89 NNYVQELL----------VGPSIETLHAANNNISRVSCS----RG-QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL  153 (317)
T ss_dssp             SSEEEEEE----------ECTTCCEEECCSSCCSEEEEC----CC-SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTT
T ss_pred             CCcccccc----------CCCCcCEEECCCCccCCcCcc----cc-CCCCEEECCCCCCCCccchhhhccCCCCEEECCC
Confidence            77665432          225666677777766654322    12 4566666666666666666666666677777777


Q ss_pred             CcccCCCCcccc-CCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCC
Q 036342          196 NKLNGSIPITLG-KLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP  274 (596)
Q Consensus       196 N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip  274 (596)
                      |.+++..+..+. .+++|++|++++|.+++. + ....+++|+.|+|++|++++.. ..+..+++|+.|+|++|.++.+|
T Consensus       154 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~~l~  230 (317)
T 3o53_A          154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVLIE  230 (317)
T ss_dssp             SCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCEEC
T ss_pred             CCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcch-hhhcccCcccEEECcCCcccchh
Confidence            766665555543 566666777766666643 2 2223566666666666666433 33666666666666666666666


Q ss_pred             cccccccccceEEcccCCCC-CchhhhhccccccceEecC
Q 036342          275 LTFWNLKDILQLNFSSNFLT-GPLLLEIGNLKVLIGIDFS  313 (596)
Q Consensus       275 ~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~ls  313 (596)
                      ..+..+++|+.|++++|+++ +..+..+..++.|+.|+++
T Consensus       231 ~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             TTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             hHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            66666666666666666665 4455555555555555554

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.97  E-value=3.6e-31  Score=265.67  Aligned_cols=150  Identities=27%  Similarity=0.413  Sum_probs=121.5

Q ss_pred             ccccccccccCCCceeehhhH----------------HhH--HHHHHHHhhcCCCccceeeeeeccCC----eeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------KSF--DVECEMMKSIRHRNLIKVISSCSNEE----FKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------~~~--~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lV~e~  502 (596)
                      .+|...+.||+|+||+||+|.                +.+  ..|+..+.+++|||||+++++|.+++    ..|+||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            357778999999999999963                223  34566667899999999999997654    57999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcc-----CCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      |++|+|.++++..  .++|.++.+++.|+++|++|+|..     +.++|+||||||+|||++.++.+||+|||+|+....
T Consensus        83 ~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  160 (303)
T 3hmm_A           83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             CCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence            9999999999875  488999999999999999999932     234999999999999999999999999999987654


Q ss_pred             CCCcc--ccccccccccccCC
Q 036342          578 EDQSM--TQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~--~~~~~~gt~~y~aP  596 (596)
                      .....  .....+||++||||
T Consensus       161 ~~~~~~~~~~~~~GT~~ymAP  181 (303)
T 3hmm_A          161 ATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             TTTEESCC-----CCGGGCCH
T ss_pred             CCCceeeecccccccccccCH
Confidence            33211  22346899999998

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=2.1e-29  Score=268.30  Aligned_cols=247  Identities=24%  Similarity=0.293  Sum_probs=188.7

Q ss_pred             CccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCC
Q 036342           60 NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLT  139 (596)
Q Consensus        60 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~  139 (596)
                      +...++.+++.++ .+|..+.  ++|++|+|++|+|+++.++.|.++++|++|+|++|.++.+.+.     .|.++++|+
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-----~~~~l~~L~  126 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG-----AFNGLASLN  126 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT-----TTTTCTTCC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChh-----hccCcccCC
Confidence            3567778877777 5665543  5788888888888888788888888888888888888776543     577888888


Q ss_pred             EEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccC-CcccCCCCccccCCCCCCeEEcc
Q 036342          140 LIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG-NKLNGSIPITLGKLRKLQRLNLE  218 (596)
Q Consensus       140 ~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~  218 (596)
                      +|+|++|+++++.+. .+..+ ++|++|+|++|.|+.+.+..|..+++|++|++++ |.+....+..|.++++|++|+++
T Consensus       127 ~L~L~~n~l~~~~~~-~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~  204 (452)
T 3zyi_A          127 TLELFDNWLTVIPSG-AFEYL-SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG  204 (452)
T ss_dssp             EEECCSSCCSBCCTT-TSSSC-TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECT
T ss_pred             EEECCCCcCCccChh-hhccc-CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECC
Confidence            888888888765443 56666 6788888888888877777788888888888887 45555555567788888888888


Q ss_pred             CCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCC-CcccccccccceEEcccCCCCCch
Q 036342          219 DNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNFLTGPL  297 (596)
Q Consensus       219 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~ls~N~l~~~~  297 (596)
                      +|.+++ +| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|.++.+ |..+..+++|+.|+|++|++++..
T Consensus       205 ~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  282 (452)
T 3zyi_A          205 MCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLP  282 (452)
T ss_dssp             TSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccC
Confidence            888874 34 477778888888888888877788888888888888888888875 445777888888888888888777


Q ss_pred             hhhhccccccceEecCCCcCc
Q 036342          298 LLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       298 ~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      +..+..+++|+.|++++|.+.
T Consensus       283 ~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          283 HDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             TTSSTTCTTCCEEECCSSCEE
T ss_pred             hHHhccccCCCEEEccCCCcC
Confidence            777778888888888888776

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.97  E-value=3.9e-29  Score=273.77  Aligned_cols=263  Identities=26%  Similarity=0.319  Sum_probs=198.4

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEE
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLS   89 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (596)
                      .++++|++++|+|+ .+|..+.  ++|++|+|++|.|+ .++.    .+++|++|+|++|+|+ .+|.   .+++|++|+
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~  107 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPV---LPPGLLELS  107 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCS-CCCC---CCTTCCEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEE
Confidence            35888999999987 5666554  78999999999987 4554    2688999999999988 4555   678899999


Q ss_pred             ccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEc
Q 036342           90 LGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM  169 (596)
Q Consensus        90 L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l  169 (596)
                      |++|+|+++.+    .+++|+.|++++|+++.++..         +++|++|++++|.++++ |.     .+.+|+.|++
T Consensus       108 Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~lp~~---------l~~L~~L~Ls~N~l~~l-~~-----~~~~L~~L~L  168 (622)
T 3g06_A          108 IFSNPLTHLPA----LPSGLCKLWIFGNQLTSLPVL---------PPGLQELSVSDNQLASL-PA-----LPSELCKLWA  168 (622)
T ss_dssp             ECSCCCCCCCC----CCTTCCEEECCSSCCSCCCCC---------CTTCCEEECCSSCCSCC-CC-----CCTTCCEEEC
T ss_pred             CcCCcCCCCCC----CCCCcCEEECCCCCCCcCCCC---------CCCCCEEECcCCcCCCc-CC-----ccCCCCEEEC
Confidence            99999887544    567888999999988876432         37888899999988764 22     2357888888


Q ss_pred             cccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCccc
Q 036342          170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS  249 (596)
Q Consensus       170 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  249 (596)
                      ++|.|+++ |   ..+++|+.|++++|.+++. |.   .+++|+.|++++|.++ .+|..   +++|+.|+|++|++++ 
T Consensus       169 ~~N~l~~l-~---~~~~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-  235 (622)
T 3g06_A          169 YNNQLTSL-P---MLPSGLQELSVSDNQLASL-PT---LPSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-  235 (622)
T ss_dssp             CSSCCSCC-C---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-
T ss_pred             CCCCCCCC-c---ccCCCCcEEECCCCCCCCC-CC---ccchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-
Confidence            88888864 4   4567888888888888853 33   2478888888888887 45543   4678888888888875 


Q ss_pred             chhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCCh
Q 036342          250 IPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPR  323 (596)
Q Consensus       250 ~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~  323 (596)
                      +|   ..+++|+.|+|++|.|+.+|.   .+++|+.|+|++|+|+ .+|..+..+++|+.|++++|.+++.+|.
T Consensus       236 lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~  302 (622)
T 3g06_A          236 LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  302 (622)
T ss_dssp             CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred             CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence            44   455778888888888888776   5677888888888887 4466777788888888888888766555

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=2.9e-29  Score=266.29  Aligned_cols=247  Identities=25%  Similarity=0.296  Sum_probs=172.1

Q ss_pred             CccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCC
Q 036342           60 NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLT  139 (596)
Q Consensus        60 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~  139 (596)
                      ....++.+++.++ .+|..+.  ++++.|+|++|+|+++.+..|.++++|++|+|++|.++.+.+.     .|.++++|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~-----~~~~l~~L~  115 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG-----AFNGLANLN  115 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGG-----GGTTCSSCC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChh-----hccCCccCC
Confidence            3556777777776 5565543  5677777777777777777777777777777777777665433     467777777


Q ss_pred             EEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccC-CcccCCCCccccCCCCCCeEEcc
Q 036342          140 LIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG-NKLNGSIPITLGKLRKLQRLNLE  218 (596)
Q Consensus       140 ~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~  218 (596)
                      +|+|++|+++++.+. .+..+ ++|++|+|++|.|+...+..|..+++|++|++++ |.+....+..|.++++|++|+++
T Consensus       116 ~L~L~~n~l~~~~~~-~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~  193 (440)
T 3zyj_A          116 TLELFDNRLTTIPNG-AFVYL-SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA  193 (440)
T ss_dssp             EEECCSSCCSSCCTT-TSCSC-SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECT
T ss_pred             EEECCCCcCCeeCHh-Hhhcc-ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCC
Confidence            777777777655333 55555 5677777777777776666777777777777777 34444445567777777777777


Q ss_pred             CCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCC-CcccccccccceEEcccCCCCCch
Q 036342          219 DNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNFLTGPL  297 (596)
Q Consensus       219 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~ls~N~l~~~~  297 (596)
                      +|.++ .+| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+++.+ +..|..+++|+.|+|++|++++..
T Consensus       194 ~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  271 (440)
T 3zyj_A          194 MCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP  271 (440)
T ss_dssp             TSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCC
T ss_pred             CCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccC
Confidence            77777 344 466677777777777777766677777777777777777777775 345666777777777777777776


Q ss_pred             hhhhccccccceEecCCCcCc
Q 036342          298 LLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       298 ~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      +..|..+++|+.|+|++|.+.
T Consensus       272 ~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          272 HDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             TTTTSSCTTCCEEECCSSCEE
T ss_pred             hhHhccccCCCEEEcCCCCcc
Confidence            667777777777777777765

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=1.2e-31  Score=271.90  Aligned_cols=266  Identities=22%  Similarity=0.203  Sum_probs=215.5

Q ss_pred             CccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCC
Q 036342           60 NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLT  139 (596)
Q Consensus        60 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~  139 (596)
                      +++.++++.+.+....+..+..+++|++|+|++|+|++..|+.|.++++|++|++++|.+++..       .+..+++|+
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------~~~~l~~L~   83 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLR   83 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE-------EETTCTTCC
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch-------hhhhcCCCC
Confidence            4667788888888666666777889999999999999998899999999999999999998643       278899999


Q ss_pred             EEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccC
Q 036342          140 LIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLED  219 (596)
Q Consensus       140 ~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  219 (596)
                      +|++++|.+++..+      . ++|++|++++|.+++..+..   +++|++|++++|.+++..+..+..+++|++|++++
T Consensus        84 ~L~Ls~n~l~~l~~------~-~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~  153 (317)
T 3o53_A           84 TLDLNNNYVQELLV------G-PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL  153 (317)
T ss_dssp             EEECCSSEEEEEEE------C-TTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTT
T ss_pred             EEECcCCccccccC------C-CCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCC
Confidence            99999999886532      2 67999999999998876554   57789999999999988888888899999999999


Q ss_pred             CcccccCccchh-cCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchh
Q 036342          220 NILEGSIPDDIC-RLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLL  298 (596)
Q Consensus       220 N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~  298 (596)
                      |.+++..+..+. .+++|++|+|++|.+++. +. ...+++|+.|+|++|+++++|..+..+++|+.|++++|+++. +|
T Consensus       154 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~-l~  230 (317)
T 3o53_A          154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IE  230 (317)
T ss_dssp             SCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-EC
T ss_pred             CCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccc-hh
Confidence            999877777664 688999999999998855 32 334788999999999998888888888888888888888884 56


Q ss_pred             hhhccccccceEecCCCcCc-ccCChhhhccCCCCCeEECCCC-cccccC
Q 036342          299 LEIGNLKVLIGIDFSMNNFS-GVIPREIGEKLSYLEDLNLSFN-KLKGEI  346 (596)
Q Consensus       299 ~~~~~l~~L~~L~ls~N~~~-~~~~~~~~~~l~~L~~L~l~~N-~l~~~~  346 (596)
                      ..+..+++|+.|++++|.++ +.+|. ++..++.|+.|++++| .+++..
T Consensus       231 ~~~~~l~~L~~L~l~~N~~~~~~~~~-~~~~~~~L~~l~l~~~~~l~~~~  279 (317)
T 3o53_A          231 KALRFSQNLEHFDLRGNGFHCGTLRD-FFSKNQRVQTVAKQTVKKLTGQN  279 (317)
T ss_dssp             TTCCCCTTCCEEECTTCCCBHHHHHH-HHHTCHHHHHHHHHHHHHHHSSS
T ss_pred             hHhhcCCCCCEEEccCCCccCcCHHH-HHhccccceEEECCCchhccCCc
Confidence            67788888888888888887 44444 5667777788877743 444433

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=1.6e-29  Score=252.23  Aligned_cols=254  Identities=22%  Similarity=0.224  Sum_probs=154.6

Q ss_pred             ccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCE
Q 036342           61 LEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTL  140 (596)
Q Consensus        61 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~  140 (596)
                      -+.++.+++.++ .+|..+  .++|++|+|++|.|+++.++.|.++++|++|++++|.++.+.+.     .|.++++|++
T Consensus        13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~   84 (285)
T 1ozn_A           13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA-----AFTGLALLEQ   84 (285)
T ss_dssp             SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT-----TTTTCTTCCE
T ss_pred             CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHh-----hcCCccCCCE
Confidence            367888888888 556544  46899999999999988888888899999999999988876443     5778888888


Q ss_pred             EECcCCC-CCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccC
Q 036342          141 IDLSNNP-LDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLED  219 (596)
Q Consensus       141 L~ls~N~-l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  219 (596)
                      |++++|. ++...+. .+..+ ++|++|++++|.+++..|..|.++++|++|++++|.+++..+..|..+++|++|++++
T Consensus        85 L~l~~n~~l~~~~~~-~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  162 (285)
T 1ozn_A           85 LDLSDNAQLRSVDPA-TFHGL-GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG  162 (285)
T ss_dssp             EECCSCTTCCCCCTT-TTTTC-TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             EeCCCCCCccccCHH-HhcCC-cCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCC
Confidence            8888886 5544333 44444 4566666666666655555555566666666666666555555555555555555555


Q ss_pred             CcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhh
Q 036342          220 NILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLL  299 (596)
Q Consensus       220 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~  299 (596)
                      |.+++..+..+..+++|+.|++++|++++..|..|..+++|+.|+|++|.+++                       ..+.
T Consensus       163 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------------~~~~  219 (285)
T 1ozn_A          163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA-----------------------LPTE  219 (285)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC-----------------------CCHH
T ss_pred             CcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCc-----------------------CCHH
Confidence            55554444445555555555555555555445555555555555555555554                       4444


Q ss_pred             hhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCC
Q 036342          300 EIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRG  349 (596)
Q Consensus       300 ~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  349 (596)
                      .+..++.|+.|++++|.+....+...  ...+++.+..+.|.+.+..|..
T Consensus       220 ~~~~l~~L~~L~l~~N~~~c~~~~~~--~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          220 ALAPLRALQYLRLNDNPWVCDCRARP--LWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             HHTTCTTCCEEECCSSCEECSGGGHH--HHHHHHHCCSEECCCBEEESGG
T ss_pred             HcccCcccCEEeccCCCccCCCCcHH--HHHHHHhcccccCccccCCchH
Confidence            44555555555555555543322211  1123444445556666555543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=1.1e-30  Score=264.09  Aligned_cols=246  Identities=20%  Similarity=0.177  Sum_probs=144.1

Q ss_pred             CCCccEEEccCCccccccCccccCCCCCCEEEccCCccc-ccCCcccc-------CCCCCCEEecCCCcCcCCCCCcccc
Q 036342           58 LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFS-GFIPSTFG-------NLRNLEQLGLDENYLTSSTPELSFL  129 (596)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~-------~l~~L~~L~l~~N~l~~~~~~~~~~  129 (596)
                      .++|++|++++|.+  .+|..+...  |++|+|++|.++ ..+|..+.       ++++|++|++++|.+++..+.    
T Consensus        42 ~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----  113 (312)
T 1wwl_A           42 GRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP----  113 (312)
T ss_dssp             EEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC----
T ss_pred             CCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH----
Confidence            45666777777766  455554443  666777777763 33444443       566777777777777653322    


Q ss_pred             ccC--CCCCCCCEEECcCCCCCccCCchhhhccc----ccccEEEccccccccccChhccCCCCCCEEEccCCcccCC--
Q 036342          130 SSL--SNCKSLTLIDLSNNPLDGILPKTSISNLS----RSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGS--  201 (596)
Q Consensus       130 ~~~--~~l~~L~~L~ls~N~l~~~~~~~~~~~l~----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--  201 (596)
                       .+  ..+++|++|++++|++++. |. .+..++    ++|++|++++|+|++..|..|..+++|++|++++|++.+.  
T Consensus       114 -~~~~~~l~~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  190 (312)
T 1wwl_A          114 -PLLEATGPDLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG  190 (312)
T ss_dssp             -CSSSCCSCCCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHH
T ss_pred             -HHHHhcCCCccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchH
Confidence             22  6677777777777777765 43 444442    4566666666666666666666667777777777766543  


Q ss_pred             CCccc--cCCCCCCeEEccCCcccc---cCccchhcCCCCcEEEccCCcCcccch-hhhccCCCCcEEEeCCCcccCCCc
Q 036342          202 IPITL--GKLRKLQRLNLEDNILEG---SIPDDICRLAELYRLELGSNKLYGSIP-ACFGNLASLRILSLGSNKLTSIPL  275 (596)
Q Consensus       202 ~p~~~--~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ip~  275 (596)
                      .|..+  ..+++|++|++++|.+++   .....+..+++|++|+|++|++++..| ..+..+++|++|+|++|.++.+|.
T Consensus       191 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~  270 (312)
T 1wwl_A          191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK  270 (312)
T ss_dssp             HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCS
T ss_pred             HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhh
Confidence            12222  566666666666666652   111223455666666666666665543 344455666666666666666665


Q ss_pred             ccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCc
Q 036342          276 TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       276 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      .+.  ++|++|++++|++++. |. +..+++|+.|++++|+++
T Consensus       271 ~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          271 GLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             SCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             hcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            544  5556666666655554 22 555555555555555554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=4.1e-31  Score=267.39  Aligned_cols=249  Identities=20%  Similarity=0.213  Sum_probs=134.1

Q ss_pred             CCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCc-cccCccC------ccCCCCccEEEccCCccccccCccc--
Q 036342            9 LQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLS-GSLSSIA------NVRLPNLEKLYLWGNNFSGTIPRFI--   79 (596)
Q Consensus         9 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~------~~~l~~L~~L~L~~N~l~~~~~~~~--   79 (596)
                      .++|++|++++|++  .+|..+...  |++|+|++|.++ +.++...      +..+++|++|+|++|++++..|..+  
T Consensus        42 ~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  117 (312)
T 1wwl_A           42 GRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE  117 (312)
T ss_dssp             EEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSS
T ss_pred             CCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHH
Confidence            34455555555555  344433322  555555555552 1122110      0024455555555555555555543  


Q ss_pred             cCCCCCCEEEccCCcccccCCccccCC-----CCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCc
Q 036342           80 FNASKLSKLSLGMNSFSGFIPSTFGNL-----RNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPK  154 (596)
Q Consensus        80 ~~l~~L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  154 (596)
                      ..+++|++|+|++|+|++. |..|.++     ++|++|++++|++++..+.     .|.++++|++|++++|++.+.++ 
T Consensus       118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~-  190 (312)
T 1wwl_A          118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCE-----QVRVFPALSTLDLSDNPELGERG-  190 (312)
T ss_dssp             CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTT-----TCCCCSSCCEEECCSCTTCHHHH-
T ss_pred             hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHH-----HhccCCCCCEEECCCCCcCcchH-
Confidence            4555555555555555544 4444444     4555555555555444322     34455555555555555433210 


Q ss_pred             hhhhcccccccEEEccccccccccChhc--cCCCCCCEEEccCCcccCC---CCccccCCCCCCeEEccCCcccccCc-c
Q 036342          155 TSISNLSRSLEEFYMYNCNISGGIPEEI--SNLTNLVEIDLGGNKLNGS---IPITLGKLRKLQRLNLEDNILEGSIP-D  228 (596)
Q Consensus       155 ~~~~~l~~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~~-~  228 (596)
                                             .+..+  ..+++|++|++++|.+++.   ....+..+++|++|++++|.+++..| .
T Consensus       191 -----------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  247 (312)
T 1wwl_A          191 -----------------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP  247 (312)
T ss_dssp             -----------------------HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCS
T ss_pred             -----------------------HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchh
Confidence                                   12222  5566666666666666621   12333456666666666666665543 3


Q ss_pred             chhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCC
Q 036342          229 DICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTG  295 (596)
Q Consensus       229 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~  295 (596)
                      .+..+++|++|+|++|+++ .+|..+.  ++|++|+|++|+|+++|. +..+++|++|++++|++++
T Consensus       248 ~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          248 SCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSCCC-TTTSCEEEEEECTTCTTTC
T ss_pred             hhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCChh-HhhCCCCCEEeccCCCCCC
Confidence            3445667777777777776 4555444  677777777777777765 6677777777777777765

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=3.2e-29  Score=255.02  Aligned_cols=234  Identities=22%  Similarity=0.287  Sum_probs=139.2

Q ss_pred             CCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCC
Q 036342           58 LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS  137 (596)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~  137 (596)
                      .++++.|+|++|.++ .+|..++.+++|++|+|++|.|+ .+|..|.++++|++|+|++|.++.++      ..+.++++
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp------~~l~~l~~  151 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALP------ASIASLNR  151 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCC------GGGGGCTT
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCc------HHHhcCcC
Confidence            356666666666666 55666666666666666666666 55666666666666666666666432      23566666


Q ss_pred             CCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       138 L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                      |++|++++|++.+.+|. .+..       .         ..+..|.++++|++|++++|.++ .+|..+..+++|++|++
T Consensus       152 L~~L~L~~n~~~~~~p~-~~~~-------~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L  213 (328)
T 4fcg_A          152 LRELSIRACPELTELPE-PLAS-------T---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI  213 (328)
T ss_dssp             CCEEEEEEETTCCCCCS-CSEE-------E---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEE
T ss_pred             CCEEECCCCCCccccCh-hHhh-------c---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEc
Confidence            66666666666555544 1111       0         11223445556666666666665 45555566666666666


Q ss_pred             cCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC-CCcccccccccceEEcccCCCCCc
Q 036342          218 EDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGP  296 (596)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ls~N~l~~~  296 (596)
                      ++|.++ .+|..+..+++|++|+|++|++.+.+|..|..+++|+.|+|++|++.+ +|..+..+++|++|++++|++.+.
T Consensus       214 ~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~  292 (328)
T 4fcg_A          214 RNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR  292 (328)
T ss_dssp             ESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred             cCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence            666665 344455566666666666666655666666666666666666655443 555566666666666666666666


Q ss_pred             hhhhhccccccceEecCCCcCc
Q 036342          297 LLLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       297 ~~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      +|..+..++.|+.+++..|.+.
T Consensus       293 iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          293 LPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CCGGGGGSCTTCEEECCGGGSC
T ss_pred             ccHHHhhccCceEEeCCHHHHH
Confidence            6666666666666666655444

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=7e-29  Score=252.53  Aligned_cols=230  Identities=23%  Similarity=0.299  Sum_probs=135.3

Q ss_pred             CCCCCEEEccCCcCccccCc-cCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCE
Q 036342           33 VSTLKFLGLQNNSLSGSLSS-IANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQ  111 (596)
Q Consensus        33 l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  111 (596)
                      ..+++.|+|++|.++ .+|. +..  +++|++|+|++|.++ .+|..+.++++|++|+|++|+++ .+|..|.++++|++
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~--l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~  154 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFR--LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE  154 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGG--GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCE
T ss_pred             ccceeEEEccCCCch-hcChhhhh--CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCE
Confidence            467788888888877 4444 333  778888888888887 77777788888888888888887 55777888888888


Q ss_pred             EecCCCcCcCCCCCc-c---ccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCC
Q 036342          112 LGLDENYLTSSTPEL-S---FLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTN  187 (596)
Q Consensus       112 L~l~~N~l~~~~~~~-~---~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~  187 (596)
                      |++++|.+.+..+.. .   +...|.++++|++|++++|.++ .+|. .+..+ ++|++|++++|.+++ +|..|..+++
T Consensus       155 L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~-~l~~l-~~L~~L~L~~N~l~~-l~~~l~~l~~  230 (328)
T 4fcg_A          155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA-SIANL-QNLKSLKIRNSPLSA-LGPAIHHLPK  230 (328)
T ss_dssp             EEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCG-GGGGC-TTCCEEEEESSCCCC-CCGGGGGCTT
T ss_pred             EECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchH-hhcCC-CCCCEEEccCCCCCc-CchhhccCCC
Confidence            888886655433220 0   0011233555555555555555 3333 34444 345555555555553 3334555555


Q ss_pred             CCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCC
Q 036342          188 LVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGS  267 (596)
Q Consensus       188 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  267 (596)
                      |++|++++|.+.+.+|..|..+++|++|++++|.+.+.+|..+..+++|+.|+|++|++.+.+|..++.+++|+.+++..
T Consensus       231 L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~  310 (328)
T 4fcg_A          231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP  310 (328)
T ss_dssp             CCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCG
T ss_pred             CCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCH
Confidence            55555555555555555555555555555555555555555555555555555555555555555555555555555554


Q ss_pred             Cccc
Q 036342          268 NKLT  271 (596)
Q Consensus       268 N~l~  271 (596)
                      |.+.
T Consensus       311 ~~~~  314 (328)
T 4fcg_A          311 HLQA  314 (328)
T ss_dssp             GGSC
T ss_pred             HHHH
Confidence            4443

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=5.9e-28  Score=264.43  Aligned_cols=263  Identities=24%  Similarity=0.264  Sum_probs=220.4

Q ss_pred             CCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEe
Q 036342           34 STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLG  113 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  113 (596)
                      .+++.|++++|.++ .+|...   .++|++|+|++|+|+ .+|.   .+++|++|+|++|+|+++.+    .+++|++|+
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~  107 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCL---PAHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELS  107 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCC---CTTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC----CCTTCCEEE
T ss_pred             CCCcEEEecCCCcC-ccChhh---CCCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC----CCCCCCEEE
Confidence            46999999999998 566533   279999999999999 5665   57899999999999996544    789999999


Q ss_pred             cCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEc
Q 036342          114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL  193 (596)
Q Consensus       114 l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  193 (596)
                      +++|.++.++.         .+++|+.|++++|+++++ |. .   + ++|++|++++|+|+++ |.   .+.+|+.|++
T Consensus       108 Ls~N~l~~l~~---------~l~~L~~L~L~~N~l~~l-p~-~---l-~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L  168 (622)
T 3g06_A          108 IFSNPLTHLPA---------LPSGLCKLWIFGNQLTSL-PV-L---P-PGLQELSVSDNQLASL-PA---LPSELCKLWA  168 (622)
T ss_dssp             ECSCCCCCCCC---------CCTTCCEEECCSSCCSCC-CC-C---C-TTCCEEECCSSCCSCC-CC---CCTTCCEEEC
T ss_pred             CcCCcCCCCCC---------CCCCcCEEECCCCCCCcC-CC-C---C-CCCCEEECcCCcCCCc-CC---ccCCCCEEEC
Confidence            99999988643         467899999999999874 33 1   2 7899999999999964 43   3578999999


Q ss_pred             cCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCC
Q 036342          194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI  273 (596)
Q Consensus       194 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i  273 (596)
                      ++|.+++ +|   ..+++|+.|++++|.|++ +|..   +++|+.|++++|.++. +|.   .+++|+.|+|++|.|+.+
T Consensus       169 ~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~l  236 (622)
T 3g06_A          169 YNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTSL  236 (622)
T ss_dssp             CSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSCC
T ss_pred             CCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCcC
Confidence            9999996 44   457899999999999994 5543   4789999999999984 443   358999999999999999


Q ss_pred             CcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCC
Q 036342          274 PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR  348 (596)
Q Consensus       274 p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  348 (596)
                      |   ..+++|+.|++++|.|+....    .+++|+.|++++|+++ .+|. .+..+++|+.|+|++|++++..|.
T Consensus       237 p---~~l~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~-~lp~-~l~~l~~L~~L~L~~N~l~~~~~~  302 (622)
T 3g06_A          237 P---VLPSELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLT-RLPE-SLIHLSSETTVNLEGNPLSERTLQ  302 (622)
T ss_dssp             C---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCC-SCCG-GGGGSCTTCEEECCSCCCCHHHHH
T ss_pred             C---CCCCcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCC-cCCH-HHhhccccCEEEecCCCCCCcCHH
Confidence            9   456899999999999996443    5788999999999999 7787 467899999999999999987655

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=1.6e-29  Score=271.20  Aligned_cols=236  Identities=22%  Similarity=0.203  Sum_probs=163.5

Q ss_pred             CCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCC
Q 036342           58 LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS  137 (596)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~  137 (596)
                      .++|++|+|++|.+++..|..|.++++|++|+|++|.|++..|  |..+++|++|+|++|.+++++          ..++
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~----------~~~~  100 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL----------VGPS  100 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE----------ECTT
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC----------CCCC
Confidence            3467777777777776666777777777777777777776555  777777777777777776532          1267


Q ss_pred             CCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCcccc-CCCCCCeEE
Q 036342          138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLG-KLRKLQRLN  216 (596)
Q Consensus       138 L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~  216 (596)
                      |+.|++++|.+++..+.    .+ ++|++|+|++|.|++..|..|..+++|++|+|++|.+++..|..+. .+++|++|+
T Consensus       101 L~~L~L~~N~l~~~~~~----~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~  175 (487)
T 3oja_A          101 IETLHAANNNISRVSCS----RG-QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN  175 (487)
T ss_dssp             CCEEECCSSCCCCEEEC----CC-SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred             cCEEECcCCcCCCCCcc----cc-CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence            77777777777765332    22 4677777777777777777777777777777777777776666665 677777777


Q ss_pred             ccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCC-C
Q 036342          217 LEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT-G  295 (596)
Q Consensus       217 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~-~  295 (596)
                      |++|.|++. | ....+++|+.|+|++|.+++..| .+..+++|+.|+|++|.++++|..+..+++|+.|++++|++. +
T Consensus       176 Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          176 LQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG  252 (487)
T ss_dssp             CTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred             cCCCccccc-c-ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence            777777754 2 23346777777777777775444 377777777777777777777777777777777777777776 5


Q ss_pred             chhhhhccccccceEecC
Q 036342          296 PLLLEIGNLKVLIGIDFS  313 (596)
Q Consensus       296 ~~~~~~~~l~~L~~L~ls  313 (596)
                      ..|..+..++.|+.++++
T Consensus       253 ~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          253 TLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             HHHHHHTTCHHHHHHHHH
T ss_pred             chHHHHHhCCCCcEEecc
Confidence            555566666666555553

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=1.5e-29  Score=273.76  Aligned_cols=145  Identities=24%  Similarity=0.381  Sum_probs=127.8

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhH---HHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSF---DVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~---~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .++|+..+.||+|+||+||+|.                        ...   ..++.+++.++|||||+++++|.+++.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            4689999999999999999752                        112   2346677888999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+|||||+||+|.+++...+ .+++..+..+++||+.||+|||   .++||||||||+|||++.+|.+||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999998764 6899999999999999999999   9999999999999999999999999999999764


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...    ....+||+.||||
T Consensus       344 ~~~----~~t~~GTp~YmAP  359 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAP  359 (689)
T ss_dssp             SCC----CCSCCSCGGGCCH
T ss_pred             CCC----CCCccCCcCccCH
Confidence            322    3457999999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=261.17  Aligned_cols=147  Identities=30%  Similarity=0.414  Sum_probs=125.9

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc------CCe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN------EEF  495 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~  495 (596)
                      ++|+..+.||+|+||+||+|.                       +.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            579999999999999999852                       356789999999999999999998754      357


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      +|+|||||+ |+|.+++...+ .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999995 68999997654 6899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCC--CccccccccccccccCC
Q 036342          576 TGED--QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~--~~~~~~~~~gt~~y~aP  596 (596)
                      ....  ........+||++||||
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~AP  231 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAP  231 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCH
T ss_pred             ccCccccccccccceeChHhcCH
Confidence            4321  11223457999999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=3.4e-29  Score=256.97  Aligned_cols=131  Identities=22%  Similarity=0.322  Sum_probs=117.8

Q ss_pred             HHHHhcccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCe
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEF  495 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~  495 (596)
                      .+....++|+..+.||+|+||+||+|.                      ..+.+|+++++++ +|||||++++++.+++.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            334456789999999999999999862                      2467899999998 69999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC-CcEEEeccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDFSIAKL  574 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~-~~~kl~dfGla~~  574 (596)
                      .|+|||||++|+|.++++    .+++.++..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+.
T Consensus        95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            999999999999999984    3789999999999999999999   9999999999999999876 8999999999986


Q ss_pred             cC
Q 036342          575 LT  576 (596)
Q Consensus       575 ~~  576 (596)
                      ..
T Consensus       168 ~~  169 (361)
T 4f9c_A          168 TH  169 (361)
T ss_dssp             CT
T ss_pred             cC
Confidence            53

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.95  E-value=1.8e-28  Score=266.73  Aligned_cols=147  Identities=22%  Similarity=0.387  Sum_probs=132.0

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|+..+.||+|+||+||+|.                     +.+.+|+++|++++|||||+++++|.+++..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            4689999999999999999852                     4577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC--CcEEEeccccccccCCCCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN--MVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~--~~~kl~dfGla~~~~~~~~  580 (596)
                      |+||+|.+++......+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+.... 
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            9999999999776667899999999999999999999   8999999999999999854  899999999999875322 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        .....+||+.||||
T Consensus       312 --~~~~~~GT~~y~AP  325 (573)
T 3uto_A          312 --SVKVTTGTAEFAAP  325 (573)
T ss_dssp             --EEEEECSSGGGCCH
T ss_pred             --ceeeeEECccccCH
Confidence              23457899999998

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=1.2e-26  Score=230.16  Aligned_cols=225  Identities=24%  Similarity=0.242  Sum_probs=165.0

Q ss_pred             CEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccC
Q 036342           13 EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGM   92 (596)
Q Consensus        13 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~   92 (596)
                      ..++.++.+++ .+|..+.  ++|++|+|++|++++ ++...+..+++|++|+|++|++++..+..|.++++|++|+|++
T Consensus        10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~   85 (276)
T 2z62_A           10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG   85 (276)
T ss_dssp             TEEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCE-ECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             ceEEecCCCcc-ccCCCCC--CCccEEECCCCcccc-cCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCC
Confidence            35666666665 4555442  568888888888874 3333444577888888888888776667778888888888888


Q ss_pred             CcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCcc-CCchhhhcccccccEEEccc
Q 036342           93 NSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGI-LPKTSISNLSRSLEEFYMYN  171 (596)
Q Consensus        93 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~~l~~~L~~L~l~~  171 (596)
                      |.+++..++.|.++++|++|++++|.++.+.+.     .+.++++|++|++++|.+++. +|. .+..+ ++|++|++++
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~l~~-~~~~l-~~L~~L~Ls~  158 (276)
T 2z62_A           86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENF-----PIGHLKTLKELNVAHNLIQSFKLPE-YFSNL-TNLEHLDLSS  158 (276)
T ss_dssp             CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTC-----CCTTCTTCCEEECCSSCCCCCCCCG-GGGGC-TTCCEEECCS
T ss_pred             CccCccChhhhcCCccccEEECCCCCccccCch-----hcccCCCCCEEECcCCccceecCch-hhccC-CCCCEEECCC
Confidence            888877777788888888888888887776543     377778888888888888764 244 56666 6788888888


Q ss_pred             cccccccChhccCCCCCC----EEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCc
Q 036342          172 CNISGGIPEEISNLTNLV----EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLY  247 (596)
Q Consensus       172 n~l~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  247 (596)
                      |++++..+..|..+++|+    .|++++|.+++..+..+.. .+|+.|++++|.+++..+..+..+++|+.|++++|++.
T Consensus       159 N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  237 (276)
T 2z62_A          159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  237 (276)
T ss_dssp             SCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred             CCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence            888877777777666666    7888888888766665554 47888888888888665556677888888888888887


Q ss_pred             cc
Q 036342          248 GS  249 (596)
Q Consensus       248 ~~  249 (596)
                      +.
T Consensus       238 c~  239 (276)
T 2z62_A          238 CS  239 (276)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=2.6e-26  Score=227.86  Aligned_cols=208  Identities=21%  Similarity=0.296  Sum_probs=118.1

Q ss_pred             CCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhccccc
Q 036342           84 KLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRS  163 (596)
Q Consensus        84 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~  163 (596)
                      +|++|+|++|+|+++.+..|.++++|++|++++|.++.+.+.     .|.++++|++|++++|.++              
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~--------------   89 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-----AYQSLSHLSTLILTGNPIQ--------------   89 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTT-----TTTTCTTCCEEECTTCCCC--------------
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHH-----HccCCcCCCEEECCCCccC--------------
Confidence            455555555555555554555555555555555555443322     2444444444444444443              


Q ss_pred             ccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCccccc-CccchhcCCCCcEEEcc
Q 036342          164 LEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGS-IPDDICRLAELYRLELG  242 (596)
Q Consensus       164 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls  242 (596)
                                  +..+..|.++++|++|++++|.+.+..+..+..+++|++|++++|.+++. +|..+..+++|+.|+++
T Consensus        90 ------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls  157 (276)
T 2z62_A           90 ------------SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS  157 (276)
T ss_dssp             ------------EECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECC
T ss_pred             ------------ccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECC
Confidence                        33344555666667777777766666555666677777777777776642 46666677777777777


Q ss_pred             CCcCcccchhhhccCCCCc----EEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCc
Q 036342          243 SNKLYGSIPACFGNLASLR----ILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       243 ~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      +|++++..+..+..+++|+    .|++++|.++.++.......+|++|+                        +++|+++
T Consensus       158 ~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~------------------------L~~n~l~  213 (276)
T 2z62_A          158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELA------------------------LDTNQLK  213 (276)
T ss_dssp             SSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEE------------------------CCSSCCS
T ss_pred             CCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEE------------------------CCCCcee
Confidence            7777666666666666555    56666666666554444333444444                        4444444


Q ss_pred             ccCChhhhccCCCCCeEECCCCcccccCC
Q 036342          319 GVIPREIGEKLSYLEDLNLSFNKLKGEIP  347 (596)
Q Consensus       319 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  347 (596)
                      + +|...+..+++|+.|++++|++++.+|
T Consensus       214 ~-~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          214 S-VPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             C-CCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             e-cCHhHhcccccccEEEccCCcccccCC
Confidence            2 333344455566666666666665544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.94  E-value=9.4e-28  Score=252.82  Aligned_cols=157  Identities=21%  Similarity=0.306  Sum_probs=138.0

Q ss_pred             CHHHHHHhcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeec
Q 036342          436 SYLELCRATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCS  491 (596)
Q Consensus       436 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~  491 (596)
                      .+.++....++|+..+.||+|+||+||++.                        +.+..|..+++.++|||||+++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            345556678899999999999999999852                        12778999999999999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                      +++..|+|||||++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            999999999999999999999876567899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+...... .......+||++||||
T Consensus       222 a~~~~~~~-~~~~~~~~GT~~Y~AP  245 (437)
T 4aw2_A          222 CLKLMEDG-TVQSSVAVGTPDYISP  245 (437)
T ss_dssp             CEECCTTS-CEECCSCCSCGGGCCH
T ss_pred             hhhcccCC-CcccccccCCcCeeCh
Confidence            98764332 2223446899999998

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.94  E-value=2.5e-28  Score=269.25  Aligned_cols=355  Identities=15%  Similarity=0.109  Sum_probs=240.8

Q ss_pred             CCCCCCEEECCCCCCccccchhhhCC--CCCCEEEccCCcC-cc-ccCccCccCCCCccEEEccCCccccc----cCccc
Q 036342            8 NLQNLEELQLGQNKLIGTVPAAIFNV--STLKFLGLQNNSL-SG-SLSSIANVRLPNLEKLYLWGNNFSGT----IPRFI   79 (596)
Q Consensus         8 ~l~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l-~~-~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~   79 (596)
                      .+++|++|+|++|.+++..+..+...  .+|++|+|++|.- +. .++... ..+++|++|+|++|.+++.    ++..+
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~-~~~~~L~~L~L~~~~~~~~~~~~l~~~~  188 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIV-THCRKIKTLLMEESSFSEKDGKWLHELA  188 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHH-HHCTTCSEEECTTCEEECCCSHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHH-hhCCCCCEEECccccccCcchhHHHHHH
Confidence            67889999999998877666666553  4488888888762 10 111111 1367888888888887654    33345


Q ss_pred             cCCCCCCEEEccCCcccc----cCCccccCCCCCCEEecCCCcCcCCCCC---------------------ccccccCCC
Q 036342           80 FNASKLSKLSLGMNSFSG----FIPSTFGNLRNLEQLGLDENYLTSSTPE---------------------LSFLSSLSN  134 (596)
Q Consensus        80 ~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~---------------------~~~~~~~~~  134 (596)
                      .++++|++|+|++|.+++    ..+..+.++++|++|++++|.+.+++..                     ......+..
T Consensus       189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~  268 (592)
T 3ogk_B          189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF  268 (592)
T ss_dssp             HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred             hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence            567788888888888763    3344456778888888888776542210                     011223455


Q ss_pred             CCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccC-hhccCCCCCCEEEccCCcccCCCCccccCCCCCC
Q 036342          135 CKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIP-EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQ  213 (596)
Q Consensus       135 l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  213 (596)
                      +++|+.|+++++... .+|. .+..+ ++|++|++++|.+++... ..+..+++|++|+++++...+.++..+..+++|+
T Consensus       269 ~~~L~~L~l~~~~~~-~l~~-~~~~~-~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~  345 (592)
T 3ogk_B          269 PRKLCRLGLSYMGPN-EMPI-LFPFA-AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLK  345 (592)
T ss_dssp             CTTCCEEEETTCCTT-TGGG-GGGGG-GGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCC
T ss_pred             cccccccCccccchh-HHHH-HHhhc-CCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCC
Confidence            566666666654322 2222 34444 689999999999875544 4467889999999984333333444456788999


Q ss_pred             eEEcc-----------CCccccc-CccchhcCCCCcEEEccCCcCcccchhhhcc-CCCCcEEEeC----CCcccCCCc-
Q 036342          214 RLNLE-----------DNILEGS-IPDDICRLAELYRLELGSNKLYGSIPACFGN-LASLRILSLG----SNKLTSIPL-  275 (596)
Q Consensus       214 ~L~L~-----------~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~ip~-  275 (596)
                      +|+++           .|.+++. ++..+..+++|++|+++.|++++..+..+.. +++|+.|+|+    .|.+++.|. 
T Consensus       346 ~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~  425 (592)
T 3ogk_B          346 RLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLD  425 (592)
T ss_dssp             EEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCH
T ss_pred             EEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHH
Confidence            99999           3666543 2223456889999999999998777777765 8899999996    778887543 


Q ss_pred             -----ccccccccceEEcccC--CCCCchhhhhcc-ccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCC
Q 036342          276 -----TFWNLKDILQLNFSSN--FLTGPLLLEIGN-LKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP  347 (596)
Q Consensus       276 -----~~~~l~~L~~L~ls~N--~l~~~~~~~~~~-l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  347 (596)
                           .+..+++|+.|+++++  .+++..+..+.. +++|+.|++++|++++.........+++|+.|++++|++++...
T Consensus       426 ~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  505 (592)
T 3ogk_B          426 NGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAI  505 (592)
T ss_dssp             HHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHH
T ss_pred             HHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHH
Confidence                 2566889999999753  477666655554 78899999999998753333355678899999999999865422


Q ss_pred             C-C-CCCCCCCcccccccccc
Q 036342          348 R-G-GSFGNFSAESFEGNELL  366 (596)
Q Consensus       348 ~-~-~~~~~l~~l~~~~N~~~  366 (596)
                      . . ..+++++.+++++|++.
T Consensus       506 ~~~~~~l~~L~~L~ls~n~it  526 (592)
T 3ogk_B          506 AAAVTKLPSLRYLWVQGYRAS  526 (592)
T ss_dssp             HHHHHHCSSCCEEEEESCBCC
T ss_pred             HHHHHhcCccCeeECcCCcCC
Confidence            2 1 34778899999999853

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=2.6e-25  Score=219.88  Aligned_cols=203  Identities=26%  Similarity=0.301  Sum_probs=115.2

Q ss_pred             CCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEe
Q 036342           34 STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLG  113 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  113 (596)
                      .+++.+++++|.++. +|...   .++|++|+|++|+++...+.+|.++++|++|+|++|+|+.+.+..|.++++|++|+
T Consensus        16 ~~~~~l~~~~~~l~~-ip~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~   91 (270)
T 2o6q_A           16 NNKNSVDCSSKKLTA-IPSNI---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW   91 (270)
T ss_dssp             TTTTEEECTTSCCSS-CCSCC---CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEE
T ss_pred             CCCCEEEccCCCCCc-cCCCC---CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEE
Confidence            356677777777763 43311   24566777777766655555666666666666666666665555566666666666


Q ss_pred             cCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEc
Q 036342          114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL  193 (596)
Q Consensus       114 l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  193 (596)
                      +++|.++.+++.     .|.++++|++|++++|.++                          +..+..|..+++|++|++
T Consensus        92 l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~--------------------------~~~~~~~~~l~~L~~L~L  140 (270)
T 2o6q_A           92 VTDNKLQALPIG-----VFDQLVNLAELRLDRNQLK--------------------------SLPPRVFDSLTKLTYLSL  140 (270)
T ss_dssp             CCSSCCCCCCTT-----TTTTCSSCCEEECCSSCCC--------------------------CCCTTTTTTCTTCCEEEC
T ss_pred             CCCCcCCcCCHh-----HcccccCCCEEECCCCccC--------------------------eeCHHHhCcCcCCCEEEC
Confidence            666666554332     2444444444444444443                          333444555566666666


Q ss_pred             cCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCccc
Q 036342          194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT  271 (596)
Q Consensus       194 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  271 (596)
                      ++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            666666555555555666666666666655444444555555555555555555444445555555555555555544

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=3e-25  Score=219.39  Aligned_cols=203  Identities=30%  Similarity=0.369  Sum_probs=151.9

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEE
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLS   89 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (596)
                      .+.+++++++++++ .+|..+.  ++|++|+|++|+++ .++...+..+++|++|+|++|+++...+..|.++++|++|+
T Consensus        16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~   91 (270)
T 2o6q_A           16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW   91 (270)
T ss_dssp             TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEE
T ss_pred             CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEE
Confidence            35789999999998 4666553  68999999999998 45555566799999999999999977777788999999999


Q ss_pred             ccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEc
Q 036342           90 LGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM  169 (596)
Q Consensus        90 L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l  169 (596)
                      |++|+++++.+..|.++++|++|++++|.++.+++.     .|.++++|++|+|++|.+++..+. .+..+ ++|++|++
T Consensus        92 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l-~~L~~L~L  164 (270)
T 2o6q_A           92 VTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPR-----VFDSLTKLTYLSLGYNELQSLPKG-VFDKL-TSLKELRL  164 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTT-TTTTC-TTCCEEEC
T ss_pred             CCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHH-----HhCcCcCCCEEECCCCcCCccCHh-HccCC-cccceeEe
Confidence            999999999999999999999999999999987654     478888888888888888754332 34444 45555555


Q ss_pred             cccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCccc
Q 036342          170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE  223 (596)
Q Consensus       170 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  223 (596)
                      ++|.+++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|++.
T Consensus       165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             cCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            555555555555555555555555555555544444555555555555555544

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.94  E-value=3.6e-26  Score=226.32  Aligned_cols=225  Identities=23%  Similarity=0.271  Sum_probs=150.5

Q ss_pred             CEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccC
Q 036342           13 EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGM   92 (596)
Q Consensus        13 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~   92 (596)
                      ..+++..+.+.+..  ....+++|+.|++++|.++ .++.+..  +++|++|+|++|.+++.  ..+..+++|++|+|++
T Consensus        22 ~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~~~l~~--l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~   94 (272)
T 3rfs_A           22 IKANLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQGIQY--LPNVRYLALGGNKLHDI--SALKELTNLTYLILTG   94 (272)
T ss_dssp             HHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCC-CCTTGGG--CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT
T ss_pred             HHHHhcCccccccc--ccccccceeeeeeCCCCcc-ccccccc--CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC
Confidence            34455555555432  3445677777888777776 4544443  77778888887777742  3677777777788877


Q ss_pred             CcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEcccc
Q 036342           93 NSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNC  172 (596)
Q Consensus        93 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n  172 (596)
                      |.|+++.+..|.++++|++|++++|.++++++.     .|.++++|++|++++|.+++..+. .+..+ ++|++|++++|
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l-~~L~~L~l~~n  167 (272)
T 3rfs_A           95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDG-----VFDKLTNLTYLNLAHNQLQSLPKG-VFDKL-TNLTELDLSYN  167 (272)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTT-TTTTC-TTCCEEECCSS
T ss_pred             CccCccChhHhcCCcCCCEEECCCCcCCccCHH-----HhccCCCCCEEECCCCccCccCHH-HhccC-ccCCEEECCCC
Confidence            777777777777777777777777777765543     366777777777777777655433 44555 56777777777


Q ss_pred             ccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchh
Q 036342          173 NISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPA  252 (596)
Q Consensus       173 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  252 (596)
                      ++++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|.+.+.       +++|+.|+++.|+++|.+|.
T Consensus       168 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~  240 (272)
T 3rfs_A          168 QLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN  240 (272)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred             CcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence            77766666666777777777777777766666666777777777777766533       33566666777777666666


Q ss_pred             hhccCC
Q 036342          253 CFGNLA  258 (596)
Q Consensus       253 ~~~~l~  258 (596)
                      .++.++
T Consensus       241 ~~~~~~  246 (272)
T 3rfs_A          241 SAGSVA  246 (272)
T ss_dssp             TTSCBC
T ss_pred             cccccC
Confidence            665543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=2.6e-25  Score=221.96  Aligned_cols=200  Identities=25%  Similarity=0.230  Sum_probs=127.0

Q ss_pred             CCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCC
Q 036342           58 LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS  137 (596)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~  137 (596)
                      +++|+++++++|.++ .+|..+.  +++++|+|++|.|++..+..|.++++|++|++++|.++.++.       ...+++
T Consensus         9 l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-------~~~l~~   78 (290)
T 1p9a_G            9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-------DGTLPV   78 (290)
T ss_dssp             STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-------CSCCTT
T ss_pred             cCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-------CCCCCc
Confidence            445555555555555 3343332  455666666666665555566666666666666665554321       234455


Q ss_pred             CCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       138 L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                      |++|++++|+++.                           +|..+..+++|++|++++|++++..|..|..+++|++|+|
T Consensus        79 L~~L~Ls~N~l~~---------------------------l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L  131 (290)
T 1p9a_G           79 LGTLDLSHNQLQS---------------------------LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL  131 (290)
T ss_dssp             CCEEECCSSCCSS---------------------------CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred             CCEEECCCCcCCc---------------------------CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence            5555555555431                           2334455666666677777666666666677777777777


Q ss_pred             cCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCC
Q 036342          218 EDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~  294 (596)
                      ++|.|++..+..|..+++|+.|+|++|+++...+..|..+++|+.|+|++|+++.+|..++.+.+|+.+++++|++.
T Consensus       132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCcc
Confidence            77777655555566677777777777777766666677778888888888888888877777777777777777765

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.93  E-value=6.6e-27  Score=257.82  Aligned_cols=329  Identities=13%  Similarity=0.023  Sum_probs=218.2

Q ss_pred             CCCCCCEEECCCCCCccc----cchhhhCCCCCCEEEccCCcCcc----ccCccCccCCCCccEEEccCCccccccCccc
Q 036342            8 NLQNLEELQLGQNKLIGT----VPAAIFNVSTLKFLGLQNNSLSG----SLSSIANVRLPNLEKLYLWGNNFSGTIPRFI   79 (596)
Q Consensus         8 ~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~   79 (596)
                      ++++|++|+|++|.+++.    ++..+..+++|++|+|++|.+++    .++.. +..+++|+.|+|++|.+.+ +|..+
T Consensus       162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~-~~~~~~L~~L~L~~~~~~~-l~~~~  239 (592)
T 3ogk_B          162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETI-ARNCRSLVSVKVGDFEILE-LVGFF  239 (592)
T ss_dssp             HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHH-HHHCTTCCEEECSSCBGGG-GHHHH
T ss_pred             hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHH-HhhCCCCcEEeccCccHHH-HHHHH
Confidence            445555666655555443    22233345555666665555541    11111 1124556666666655553 44555


Q ss_pred             cCCCCCCEEEccCCccc---ccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchh
Q 036342           80 FNASKLSKLSLGMNSFS---GFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTS  156 (596)
Q Consensus        80 ~~l~~L~~L~L~~N~i~---~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  156 (596)
                      .++++|++|+++.....   ...+..+..+++|+.|+++++....      ++..+..+++|++|++++|.+++......
T Consensus       240 ~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~------l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~  313 (592)
T 3ogk_B          240 KAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE------MPILFPFAAQIRKLDLLYALLETEDHCTL  313 (592)
T ss_dssp             HHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTT------GGGGGGGGGGCCEEEETTCCCCHHHHHHH
T ss_pred             hhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhH------HHHHHhhcCCCcEEecCCCcCCHHHHHHH
Confidence            55556666665542221   1223344555566666665543222      33456788999999999999765433223


Q ss_pred             hhcccccccEEEccccccccccChhccCCCCCCEEEcc-----------CCcccCCC-CccccCCCCCCeEEccCCcccc
Q 036342          157 ISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLG-----------GNKLNGSI-PITLGKLRKLQRLNLEDNILEG  224 (596)
Q Consensus       157 ~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls-----------~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~  224 (596)
                      +..+ ++|++|+++++-..+.++..+..+++|++|+++           .|.+++.. +..+..+++|++|+++.|.+++
T Consensus       314 ~~~~-~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~  392 (592)
T 3ogk_B          314 IQKC-PNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITN  392 (592)
T ss_dssp             HTTC-TTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCH
T ss_pred             HHhC-cCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccH
Confidence            4555 789999999443334445555778999999999           46666432 2234568999999999999987


Q ss_pred             cCccchhc-CCCCcEEEcc----CCcCccc-----chhhhccCCCCcEEEeCCCc--ccC-CCcccc-cccccceEEccc
Q 036342          225 SIPDDICR-LAELYRLELG----SNKLYGS-----IPACFGNLASLRILSLGSNK--LTS-IPLTFW-NLKDILQLNFSS  290 (596)
Q Consensus       225 ~~~~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~--l~~-ip~~~~-~l~~L~~L~ls~  290 (596)
                      ..+..+.. +++|+.|+++    .|++++.     ++..+.++++|+.|+|++|.  ++. .+..+. .+++|++|++++
T Consensus       393 ~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~  472 (592)
T 3ogk_B          393 ESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGY  472 (592)
T ss_dssp             HHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECS
T ss_pred             HHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccC
Confidence            77777765 8999999996    7788764     55567889999999998543  554 223333 478999999999


Q ss_pred             CCCCCc-hhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCccccc
Q 036342          291 NFLTGP-LLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE  345 (596)
Q Consensus       291 N~l~~~-~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~  345 (596)
                      |.+++. .+..+..+++|+.|++++|.+++.........+++|+.|++++|++++.
T Consensus       473 n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          473 VGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             CCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             CCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            999874 4555678999999999999987554444556799999999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.93  E-value=2.3e-26  Score=240.51  Aligned_cols=156  Identities=24%  Similarity=0.341  Sum_probs=136.3

Q ss_pred             HHHHHHhcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeecc
Q 036342          437 YLELCRATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSN  492 (596)
Q Consensus       437 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~  492 (596)
                      +.+.....++|+..+.||+|+||.||++.                        +.+..|..++++++|||||++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            34555567899999999999999999752                        236789999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccc
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla  572 (596)
                      ++..|+||||+++|+|.+++...+..+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            99999999999999999999876557899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCC
Q 036342          573 KLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +...... .......+||+.|+||
T Consensus       210 ~~~~~~~-~~~~~~~~Gt~~Y~AP  232 (412)
T 2vd5_A          210 LKLRADG-TVRSLVAVGTPDYLSP  232 (412)
T ss_dssp             EECCTTS-CEECSSCCSCGGGCCH
T ss_pred             eeccCCC-ccccceeccccCcCCH
Confidence            8764322 2223346899999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.93  E-value=2.2e-26  Score=240.57  Aligned_cols=153  Identities=25%  Similarity=0.362  Sum_probs=134.0

Q ss_pred             HHHHHhcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccC
Q 036342          438 LELCRATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE  493 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~  493 (596)
                      .++....++|+..+.||+|+||.||++.                        +.+..|+.+++.++|||||+++++|.++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            3445567899999999999999999752                        2367899999999999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      +..|+|||||++|+|.+++...  .+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+|+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999999765  4789999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...... .......+||+.|+||
T Consensus       217 ~~~~~~-~~~~~~~~gt~~Y~AP  238 (410)
T 3v8s_A          217 KMNKEG-MVRCDTAVGTPDYISP  238 (410)
T ss_dssp             ECCTTS-EEECCSCCSCGGGCCH
T ss_pred             eeccCC-cccccCCcCCccccCH
Confidence            764322 1223457899999998

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.93  E-value=6.5e-27  Score=241.64  Aligned_cols=260  Identities=19%  Similarity=0.186  Sum_probs=151.3

Q ss_pred             EEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCc---cCccCCC-CccEEEccCCccccccCccccCC-----CC
Q 036342           14 ELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSS---IANVRLP-NLEKLYLWGNNFSGTIPRFIFNA-----SK   84 (596)
Q Consensus        14 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~   84 (596)
                      ++++++|++++.+|..+...++|++|||++|.+++....   ..+..++ +|++|+|++|.+++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            467788888877777766666788888888887643221   2233455 67777777777776656666554     67


Q ss_pred             CCEEEccCCcccccCCccccC----C-CCCCEEecCCCcCcCCCCCccccccCCC-CCCCCEEECcCCCCCccCCchhhh
Q 036342           85 LSKLSLGMNSFSGFIPSTFGN----L-RNLEQLGLDENYLTSSTPELSFLSSLSN-CKSLTLIDLSNNPLDGILPKTSIS  158 (596)
Q Consensus        85 L~~L~L~~N~i~~~~~~~~~~----l-~~L~~L~l~~N~l~~~~~~~~~~~~~~~-l~~L~~L~ls~N~l~~~~~~~~~~  158 (596)
                      |++|+|++|.|++..+..+..    + ++|++|++++|.++...... +...+.. .++|++|+|++|.+++....    
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~-l~~~l~~~~~~L~~L~Ls~N~l~~~~~~----  156 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSE-FKQAFSNLPASITSLNLRGNDLGIKSSD----  156 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHH-HHHHHTTSCTTCCEEECTTSCGGGSCHH----
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHH-HHHHHHhCCCceeEEEccCCcCCHHHHH----
Confidence            777777777777655554333    2 56666666666665533210 1111222 23455555555544432111    


Q ss_pred             cccccccEEEccccccccccChhccCCC-CCCEEEccCCcccCCCCcccc----CC-CCCCeEEccCCccccc----Ccc
Q 036342          159 NLSRSLEEFYMYNCNISGGIPEEISNLT-NLVEIDLGGNKLNGSIPITLG----KL-RKLQRLNLEDNILEGS----IPD  228 (596)
Q Consensus       159 ~l~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~----~~~  228 (596)
                                        .++..+..++ +|++|+|++|.+++..+..+.    .+ ++|++|+|++|.|++.    ++.
T Consensus       157 ------------------~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~  218 (362)
T 3goz_A          157 ------------------ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY  218 (362)
T ss_dssp             ------------------HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred             ------------------HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence                              2223334444 677777777777665554333    33 4777777777777642    344


Q ss_pred             chhcC-CCCcEEEccCCcCcccch----hhhccCCCCcEEEeCCCcccCCC--------cccccccccceEEcccCCCCC
Q 036342          229 DICRL-AELYRLELGSNKLYGSIP----ACFGNLASLRILSLGSNKLTSIP--------LTFWNLKDILQLNFSSNFLTG  295 (596)
Q Consensus       229 ~~~~l-~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~ip--------~~~~~l~~L~~L~ls~N~l~~  295 (596)
                      .+... ++|+.|+|++|.+++..+    ..+..+++|+.|+|++|.+..++        ..+..+++|+.|++++|++..
T Consensus       219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~  298 (362)
T 3goz_A          219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP  298 (362)
T ss_dssp             HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred             HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence            44443 477777777777765544    23355677777777777754433        234455566666666666654


Q ss_pred             c
Q 036342          296 P  296 (596)
Q Consensus       296 ~  296 (596)
                      .
T Consensus       299 ~  299 (362)
T 3goz_A          299 S  299 (362)
T ss_dssp             G
T ss_pred             c
Confidence            4

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=8.9e-25  Score=218.11  Aligned_cols=201  Identities=22%  Similarity=0.206  Sum_probs=104.8

Q ss_pred             hCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCC
Q 036342           31 FNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLE  110 (596)
Q Consensus        31 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  110 (596)
                      ..+++++++++++|.++ .+|...   .++|+.|+|++|.+++..+..|.++++|++|+|++|.|+++.+.  ..+++|+
T Consensus         7 ~~l~~l~~l~~~~~~l~-~ip~~~---~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            7 SKVASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             cccCCccEEECCCCCCC-cCCCCC---CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            34555666666666665 233211   24566666666666666666666666777777777776655432  5667777


Q ss_pred             EEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCE
Q 036342          111 QLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVE  190 (596)
Q Consensus       111 ~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  190 (596)
                      +|++++|+++.++.      .+.++++|+.|++++|+|++..+. .+..+ ++|++|+|++|+|++..+..|..+++|+.
T Consensus        81 ~L~Ls~N~l~~l~~------~~~~l~~L~~L~l~~N~l~~l~~~-~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  152 (290)
T 1p9a_G           81 TLDLSHNQLQSLPL------LGQTLPALTVLDVSFNRLTSLPLG-ALRGL-GELQELYLKGNELKTLPPGLLTPTPKLEK  152 (290)
T ss_dssp             EEECCSSCCSSCCC------CTTTCTTCCEEECCSSCCCCCCSS-TTTTC-TTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             EEECCCCcCCcCch------hhccCCCCCEEECCCCcCcccCHH-HHcCC-CCCCEEECCCCCCCccChhhcccccCCCE
Confidence            77777777765432      355666666666666666543222 23333 33444444444444333344444445555


Q ss_pred             EEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcC
Q 036342          191 IDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKL  246 (596)
Q Consensus       191 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  246 (596)
                      |+|++|++++..+..|..+++|++|+|++|+|+ .+|..+..+.+|+.++|++|.+
T Consensus       153 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~  207 (290)
T 1p9a_G          153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (290)
T ss_dssp             EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             EECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence            555555554444444444444444444444444 3344333333444444444433

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=2.3e-25  Score=220.52  Aligned_cols=211  Identities=22%  Similarity=0.284  Sum_probs=186.7

Q ss_pred             cCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCC
Q 036342            6 IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKL   85 (596)
Q Consensus         6 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L   85 (596)
                      ...+++|++|++++|.++..  ..+..+++|++|+|++|++++ ++.+.  .+++|++|+|++|.+++..+..|.++++|
T Consensus        37 ~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  111 (272)
T 3rfs_A           37 QNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-ISALK--ELTNLTYLILTGNQLQSLPNGVFDKLTNL  111 (272)
T ss_dssp             HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-CGGGT--TCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred             cccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-chhhc--CCCCCCEEECCCCccCccChhHhcCCcCC
Confidence            45678999999999998743  458889999999999999985 55443  58999999999999998888889999999


Q ss_pred             CEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhccccccc
Q 036342           86 SKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLE  165 (596)
Q Consensus        86 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~  165 (596)
                      ++|+|++|++++..+..|.++++|++|++++|.++++++.     .+.++++|+.|++++|++++..+. .+..+ ++|+
T Consensus       112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l-~~L~  184 (272)
T 3rfs_A          112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKG-----VFDKLTNLTELDLSYNQLQSLPEG-VFDKL-TQLK  184 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTT-TTTTC-TTCC
T ss_pred             CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHH-----HhccCccCCEEECCCCCcCccCHH-HhcCC-ccCC
Confidence            9999999999999999999999999999999999987664     478999999999999999976554 56777 7899


Q ss_pred             EEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCC
Q 036342          166 EFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAE  235 (596)
Q Consensus       166 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  235 (596)
                      +|++++|++++..+..|..+++|++|++++|.+.+.       +++|+.|+++.|.++|.+|..++.++.
T Consensus       185 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          185 DLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             EEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            999999999999888899999999999999998753       567999999999999999998877654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.93  E-value=1e-25  Score=227.40  Aligned_cols=150  Identities=27%  Similarity=0.482  Sum_probs=130.9

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|...+.||+|+||.||++.                     +.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            4688999999999999999852                     4578999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++|+|.++++.....+++.++..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999986667899999999999999999999   8999999999999999999999999999998764322110


Q ss_pred             ------------ccccccccccccCC
Q 036342          583 ------------TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ------------~~~~~~gt~~y~aP  596 (596)
                                  .....+||+.|+||
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAP  191 (310)
T ss_dssp             --------------CCCCSCGGGCCH
T ss_pred             cccccccccccccccccCCCcceeCH
Confidence                        01145799999998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.92  E-value=5.7e-26  Score=230.93  Aligned_cols=147  Identities=27%  Similarity=0.404  Sum_probs=131.4

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ..++|...+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++..++..|+|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            45689999999999999999752                       3467899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++...+ .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            99999999999997754 5889999999999999999999   8999999999999999999999999999998764322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         .....+||++|+||
T Consensus       169 ---~~~~~~gt~~y~aP  182 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAP  182 (328)
T ss_dssp             ---GGGTTSSSGGGCCH
T ss_pred             ---ccccccCCcceeCc
Confidence               23456899999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.92  E-value=1.4e-25  Score=232.26  Aligned_cols=150  Identities=29%  Similarity=0.478  Sum_probs=130.8

Q ss_pred             cccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhc-CCCccceeeeeeccC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNE  493 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~  493 (596)
                      .++|...+.||+|+||.||+|.                             +.+.+|+.+++++ +|||||+++++|..+
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            4689999999999999999641                             3577899999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL  558 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl  558 (596)
                      +..|+||||+++|+|.+++....               ..+++.+++.++.|+++|+.|||   ..+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999998653               24788999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          559 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       559 ~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +.++.+||+|||+++...............+|+.|+||
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  274 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  274 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence            99999999999999876543322233445688999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.92  E-value=1.2e-25  Score=232.57  Aligned_cols=151  Identities=19%  Similarity=0.240  Sum_probs=131.4

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcC---CCccceeeeeeccCCee
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIR---HRNLIKVISSCSNEEFK  496 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~  496 (596)
                      ..++|...+.||+|+||.||+|.                       ..+..|++++++++   |+||+++++++..++..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            45789999999999999999981                       35678888888887   99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-----------C
Q 036342          497 ALVLEYMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-----------N  561 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-----------~  561 (596)
                      |+|||||++|+|.+++..    ....+++..++.++.|+++||+|||   ..+|+||||||+|||++.           +
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------C
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccccc
Confidence            999999999999999975    2346899999999999999999999   899999999999999998           8


Q ss_pred             CcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          562 MVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       562 ~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +.+||+|||+|+.+............+||++||||
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP  254 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV  254 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCCh
Confidence            99999999999765422223334557899999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.92  E-value=1.5e-25  Score=232.14  Aligned_cols=146  Identities=30%  Similarity=0.437  Sum_probs=130.8

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||.||++.                        +.+.+|+.++++++|||||++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            4689999999999999999741                        3567899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999998653 5889999999999999999999   8999999999999999999999999999998764322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         .....+||+.|+||
T Consensus       170 ---~~~~~~gt~~Y~aP  183 (384)
T 4fr4_A          170 ---QITTMAGTKPYMAP  183 (384)
T ss_dssp             ---CBCCCCSCGGGCCG
T ss_pred             ---ceeccCCCccccCC
Confidence               23457899999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.92  E-value=1.6e-25  Score=228.44  Aligned_cols=147  Identities=27%  Similarity=0.350  Sum_probs=129.9

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||.||++.                        +.+.+|+.++++++||||+++++++...+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            4689999999999999999742                        2467899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence            99999999999997654 5789999999999999999999   889999999999999999999999999999864322 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                       .......+||+.|+||
T Consensus       159 -~~~~~~~~gt~~y~aP  174 (337)
T 1o6l_A          159 -GATMKTFCGTPEYLAP  174 (337)
T ss_dssp             -TCCBCCCEECGGGCCG
T ss_pred             -CCcccccccChhhCCh
Confidence             1223457899999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.92  E-value=1.7e-25  Score=227.46  Aligned_cols=166  Identities=37%  Similarity=0.562  Sum_probs=143.8

Q ss_pred             ccccccCHHHHHHhcccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeee
Q 036342          430 ATWRTFSYLELCRATDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVIS  488 (596)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~  488 (596)
                      .....+++.++....++|+..+.||+|+||.||+|.                     ..+.+|+.++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            345678999999999999999999999999999852                     25789999999999999999999


Q ss_pred             eeccCCeeEEEEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEE
Q 036342          489 SCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAH  565 (596)
Q Consensus       489 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~k  565 (596)
                      ++..++..++||||+++|+|.+++....   ..+++..+..++.|++.|+.|||..+..+|+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999998653   3489999999999999999999933333999999999999999999999


Q ss_pred             EeccccccccCCCCCccccccccccccccCC
Q 036342          566 LSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       566 l~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+|||+++...... ........||+.|+||
T Consensus       175 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aP  204 (326)
T 3uim_A          175 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAP  204 (326)
T ss_dssp             ECCCSSCEECCSSS-SCEECCCCSCGGGCCH
T ss_pred             eccCccccccCccc-ccccccccCCcCccCH
Confidence            99999998764322 2223445699999998

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.92  E-value=8.9e-26  Score=229.12  Aligned_cols=159  Identities=36%  Similarity=0.612  Sum_probs=136.8

Q ss_pred             cCHHHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCC
Q 036342          435 FSYLELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE  494 (596)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~  494 (596)
                      +.+.++...+++|+..+.||+|+||.||+|.                    +.+.+|+.++++++||||+++++++..++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            3444556678899999999999999999852                    46789999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                      ..|+||||+++|+|.+++....   ..+++.++..++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999987653   35889999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++...............||+.|+||
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aP  210 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDP  210 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCH
T ss_pred             ccccccccccccccccCCCccccCH
Confidence            9875433222223445689999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.92  E-value=1.4e-25  Score=230.38  Aligned_cols=148  Identities=26%  Similarity=0.334  Sum_probs=125.0

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  497 (596)
                      ..++|+..+.||+|+||.||+|.                        +.+..|..+++.+ +|||||++++++..++..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            35689999999999999999752                        2356789999988 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|||||++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+|+....
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999998754 5889999999999999999999   88999999999999999999999999999986432


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .  .......+||+.|+||
T Consensus       177 ~--~~~~~~~~gt~~y~aP  193 (353)
T 3txo_A          177 N--GVTTATFCGTPDYIAP  193 (353)
T ss_dssp             -----------CCGGGCCH
T ss_pred             C--CccccccCCCcCeECh
Confidence            2  2234457899999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.6e-25  Score=227.18  Aligned_cols=147  Identities=22%  Similarity=0.365  Sum_probs=131.3

Q ss_pred             cccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      .++|...+.||+|+||.||++.                    ..+.+|+.++++++|||||++++++.+.+..|+|||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            4689999999999999999852                    34678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC--CCcEEEeccccccccCCCCCc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~--~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ++|+|.+++......+++.++..++.|++.|+.|||   ..+|+||||||+||+++.  ++.+||+|||+++......  
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--  158 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--  158 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence            999999999876667899999999999999999999   889999999999999987  7899999999998764322  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......||+.|+||
T Consensus       159 -~~~~~~gt~~y~aP  172 (321)
T 1tki_A          159 -NFRLLFTAPEYYAP  172 (321)
T ss_dssp             -EEEEEESCGGGSCH
T ss_pred             -ccccccCChhhcCc
Confidence             23446799999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.92  E-value=1.3e-25  Score=233.44  Aligned_cols=148  Identities=27%  Similarity=0.323  Sum_probs=130.0

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  497 (596)
                      ..++|+..+.||+|+||.||++.                        +.+..|..+++++ +|||||++++++.+++..|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            35689999999999999999752                        2367899999887 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+|+....
T Consensus       130 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999999998754 5899999999999999999999   89999999999999999999999999999986332


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .  .......+||+.|+||
T Consensus       206 ~--~~~~~~~~gt~~Y~aP  222 (396)
T 4dc2_A          206 P--GDTTSTFCGTPNYIAP  222 (396)
T ss_dssp             T--TCCBCCCCBCGGGCCH
T ss_pred             C--CCccccccCCcccCCc
Confidence            2  2234557899999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.92  E-value=2.3e-25  Score=223.51  Aligned_cols=146  Identities=27%  Similarity=0.393  Sum_probs=130.5

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|+..+.||+|+||.||+|.                     +.+.+|+.++++++|||||++++++..++..|+||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            4679999999999999999862                     3578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++|+|.+++...  .+++.++..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            9999999999875  4789999999999999999999   88999999999999999999999999999987643322  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      .....+||+.|+||
T Consensus       172 ~~~~~~gt~~y~aP  185 (297)
T 3fxz_A          172 KRSTMVGTPYWMAP  185 (297)
T ss_dssp             CBCCCCSCGGGCCH
T ss_pred             ccCCccCCcCccCh
Confidence            23446899999998

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=1.8e-25  Score=225.63  Aligned_cols=205  Identities=22%  Similarity=0.222  Sum_probs=110.3

Q ss_pred             CCccEEEccCCccccccCccc--cCCCCCCEEEccCCcccccCC----ccccCCCCCCEEecCCCcCcCCCCCccccccC
Q 036342           59 PNLEKLYLWGNNFSGTIPRFI--FNASKLSKLSLGMNSFSGFIP----STFGNLRNLEQLGLDENYLTSSTPELSFLSSL  132 (596)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  132 (596)
                      ++|++|+|++|.+++..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|++++|.++...+.     .|
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~-----~~  165 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCE-----QV  165 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTT-----SC
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHH-----Hh
Confidence            345555555555554454444  445555555555555544322    2223444555555555555443322     24


Q ss_pred             CCCCCCCEEECcCCCCCccCCchhhhcccccccEEEcccccccccc-ChhccCCCCCCEEEccCCcccCCCCc---cccC
Q 036342          133 SNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI-PEEISNLTNLVEIDLGGNKLNGSIPI---TLGK  208 (596)
Q Consensus       133 ~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~  208 (596)
                      .++++|++|+|++|++.+..                       +.. +..+..+++|++|++++|.++...+.   .+..
T Consensus       166 ~~l~~L~~L~Ls~N~l~~~~-----------------------~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~  222 (310)
T 4glp_A          166 RAFPALTSLDLSDNPGLGER-----------------------GLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAA  222 (310)
T ss_dssp             CCCTTCCEEECCSCTTCHHH-----------------------HHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred             ccCCCCCEEECCCCCCccch-----------------------hhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhc
Confidence            44444555555554443210                       011 11224556666666666666522111   2355


Q ss_pred             CCCCCeEEccCCcccccCccchhcC---CCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccce
Q 036342          209 LRKLQRLNLEDNILEGSIPDDICRL---AELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQ  285 (596)
Q Consensus       209 l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~  285 (596)
                      +++|++|+|++|.+++..|..+..+   ++|++|+|++|+++ .+|..+.  ++|+.|+|++|+++++|. +..+++|+.
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~-~~~l~~L~~  298 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQ-PDELPEVDN  298 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCC-TTSCCCCSC
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCch-hhhCCCccE
Confidence            6666666666666665555555554   46777777777776 4454443  677777777777777655 566777777


Q ss_pred             EEcccCCCCC
Q 036342          286 LNFSSNFLTG  295 (596)
Q Consensus       286 L~ls~N~l~~  295 (596)
                      |++++|+++.
T Consensus       299 L~L~~N~l~~  308 (310)
T 4glp_A          299 LTLDGNPFLV  308 (310)
T ss_dssp             EECSSTTTSC
T ss_pred             EECcCCCCCC
Confidence            7777777764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.92  E-value=3.6e-25  Score=223.04  Aligned_cols=163  Identities=34%  Similarity=0.584  Sum_probs=142.3

Q ss_pred             cccccCHHHHHHhccccccc------ccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCC
Q 036342          431 TWRTFSYLELCRATDEFSEN------NLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHR  481 (596)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~  481 (596)
                      ....|++.++..++++|...      +.||+|+||.||+|.                       +.+.+|+.++++++||
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            34678999999999999887      899999999999852                       4578999999999999


Q ss_pred             ccceeeeeeccCCeeEEEEecCCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC
Q 036342          482 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD  559 (596)
Q Consensus       482 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~  559 (596)
                      ||+++++++..++..++||||+++|+|.+++...  ...+++..+..++.|++.|+.|||   ..+|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998743  245899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          560 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       560 ~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .++.+||+|||+++...............||+.|+||
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP  204 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP  204 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCCh
Confidence            9999999999999876433222223345799999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.92  E-value=3.4e-25  Score=224.25  Aligned_cols=144  Identities=28%  Similarity=0.375  Sum_probs=128.9

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||.||++.                        +.+.+|..+++.++|||||++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            4689999999999999999742                        3456799999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999998754 5889999999999999999999   999999999999999999999999999999875321 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                          ....+||+.|+||
T Consensus       160 ----~~~~~gt~~y~aP  172 (318)
T 1fot_A          160 ----TYTLCGTPDYIAP  172 (318)
T ss_dssp             ----BCCCCSCTTTCCH
T ss_pred             ----cccccCCccccCH
Confidence                2346899999998

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.92  E-value=1.2e-24  Score=210.95  Aligned_cols=205  Identities=19%  Similarity=0.260  Sum_probs=155.6

Q ss_pred             CccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCc-cccccCccccCCCCCCEEEccC-CcccccC
Q 036342           22 LIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNN-FSGTIPRFIFNASKLSKLSLGM-NSFSGFI   99 (596)
Q Consensus        22 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~   99 (596)
                      ++ .+|. +  ..+|++|+|++|+++ .++...+..+++|++|++++|+ ++...+.+|.++++|++|+|++ |+|+++.
T Consensus        23 l~-~ip~-~--~~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~   97 (239)
T 2xwt_C           23 IQ-RIPS-L--PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID   97 (239)
T ss_dssp             CS-SCCC-C--CTTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC
T ss_pred             cc-ccCC-C--CCcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC
Confidence            54 4555 3  347888888888887 4444445568888888888886 7766666788888888888887 8888887


Q ss_pred             CccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCC---EEECcCC-CCCccCCchhhhccccccc-EEEcccccc
Q 036342          100 PSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLT---LIDLSNN-PLDGILPKTSISNLSRSLE-EFYMYNCNI  174 (596)
Q Consensus       100 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~---~L~ls~N-~l~~~~~~~~~~~l~~~L~-~L~l~~n~l  174 (596)
                      +..|.++++|++|++++|.+++++.       |..+++|+   .|++++| .++++.+. .+..+ ++|+ +|++++|++
T Consensus        98 ~~~f~~l~~L~~L~l~~n~l~~lp~-------~~~l~~L~~L~~L~l~~N~~l~~i~~~-~~~~l-~~L~~~L~l~~n~l  168 (239)
T 2xwt_C           98 PDALKELPLLKFLGIFNTGLKMFPD-------LTKVYSTDIFFILEITDNPYMTSIPVN-AFQGL-CNETLTLKLYNNGF  168 (239)
T ss_dssp             TTSEECCTTCCEEEEEEECCCSCCC-------CTTCCBCCSEEEEEEESCTTCCEECTT-TTTTT-BSSEEEEECCSCCC
T ss_pred             HHHhCCCCCCCEEeCCCCCCccccc-------cccccccccccEEECCCCcchhhcCcc-cccch-hcceeEEEcCCCCC
Confidence            7888888888888888888877432       56666666   8888888 77765443 56666 6788 888888888


Q ss_pred             ccccChhccCCCCCCEEEccCCc-ccCCCCccccCC-CCCCeEEccCCcccccCccchhcCCCCcEEEccCC
Q 036342          175 SGGIPEEISNLTNLVEIDLGGNK-LNGSIPITLGKL-RKLQRLNLEDNILEGSIPDDICRLAELYRLELGSN  244 (596)
Q Consensus       175 ~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  244 (596)
                      +.+.+..|.. ++|+.|++++|+ +++..+..|..+ ++|+.|++++|++++ +|..  .+++|+.|+++++
T Consensus       169 ~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          169 TSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             CEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred             cccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence            8655556665 788899999994 887777888888 889999999998884 4543  5678888888776

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.92  E-value=6.2e-26  Score=234.25  Aligned_cols=259  Identities=18%  Similarity=0.189  Sum_probs=170.5

Q ss_pred             EEEccCCccccccCccccCCCCCCEEEccCCcccccCC----ccccCCC-CCCEEecCCCcCcCCCCCccccccCCCC-C
Q 036342           63 KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIP----STFGNLR-NLEQLGLDENYLTSSTPELSFLSSLSNC-K  136 (596)
Q Consensus        63 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~----~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~~~~~~l-~  136 (596)
                      +++|++|.+++.+|..+...++|++|+|++|.|++..+    ++|.+++ +|++|+|++|.++...+.. +...+... +
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~-l~~~l~~~~~   80 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE-LVQILAAIPA   80 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHH-HHHHHHTSCT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHH-HHHHHhccCC
Confidence            46889999998888877777779999999999988777    7788888 8999999999888754321 11112222 7


Q ss_pred             CCCEEECcCCCCCccCCchh---hhcccccccEEEccccccccccChhcc----C-CCCCCEEEccCCcccCCCC----c
Q 036342          137 SLTLIDLSNNPLDGILPKTS---ISNLSRSLEEFYMYNCNISGGIPEEIS----N-LTNLVEIDLGGNKLNGSIP----I  204 (596)
Q Consensus       137 ~L~~L~ls~N~l~~~~~~~~---~~~l~~~L~~L~l~~n~l~~~~~~~~~----~-l~~L~~L~Ls~N~l~~~~p----~  204 (596)
                      +|++|+|++|.+++..+...   +...+++|++|++++|.|++..+..+.    . .++|++|+|++|.+++..+    .
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  160 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ  160 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred             CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence            88888888888876544311   222225688888888888766555443    3 2578888888887775433    3


Q ss_pred             cccCCC-CCCeEEccCCcccccCccchhc----C-CCCcEEEccCCcCccc----chhhhcc-CCCCcEEEeCCCcccCC
Q 036342          205 TLGKLR-KLQRLNLEDNILEGSIPDDICR----L-AELYRLELGSNKLYGS----IPACFGN-LASLRILSLGSNKLTSI  273 (596)
Q Consensus       205 ~~~~l~-~L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~i  273 (596)
                      .+..++ +|++|+|++|.+++..+..+..    . ++|+.|+|++|.+++.    ++..+.. .++|+.|+|++|.++..
T Consensus       161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~  240 (362)
T 3goz_A          161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP  240 (362)
T ss_dssp             HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCC
T ss_pred             HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcH
Confidence            334444 7778888888777655544433    3 4777777777777652    3444444 34777777777777764


Q ss_pred             Cc-----ccccccccceEEcccCCCCCch-------hhhhccccccceEecCCCcCcccCC
Q 036342          274 PL-----TFWNLKDILQLNFSSNFLTGPL-------LLEIGNLKVLIGIDFSMNNFSGVIP  322 (596)
Q Consensus       274 p~-----~~~~l~~L~~L~ls~N~l~~~~-------~~~~~~l~~L~~L~ls~N~~~~~~~  322 (596)
                      +.     .+..+++|+.|++++|.+.+..       +..+..++.|+.||+++|.+....+
T Consensus       241 ~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             CHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             HHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence            33     2345667777777777644332       2244455666666666666654433

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.92  E-value=2.4e-25  Score=226.28  Aligned_cols=150  Identities=27%  Similarity=0.461  Sum_probs=128.5

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|...+.||+|+||.||+|.                         +.+.+|+.++++++|||||++++++..++..|+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            4578899999999999999742                         357889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.++++.....+++.++..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999999877667899999999999999999999   899999999999999999999999999999876433


Q ss_pred             CC-ccccccccccccccCC
Q 036342          579 DQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~-~~~~~~~~gt~~y~aP  596 (596)
                      .. ........+|+.|+||
T Consensus       205 ~~~~~~~~~~~~t~~y~aP  223 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAP  223 (325)
T ss_dssp             --CCEECC---CCGGGSCH
T ss_pred             ccceeeccCCCCcccccCH
Confidence            21 1122334568889998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.92  E-value=1.3e-25  Score=228.10  Aligned_cols=149  Identities=23%  Similarity=0.373  Sum_probs=131.0

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .++|+..+.||+|+||.||+|.                      +.+.+|+.++++++|||||++++++..++..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            4689999999999999999852                      357799999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999987653 5889999999999999999999   899999999999999999999999999999865433222


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      ......+||+.|+||
T Consensus       162 ~~~~~~~gt~~y~aP  176 (323)
T 3tki_A          162 RLLNKMCGTLPYVAP  176 (323)
T ss_dssp             CCBCSCCSCGGGSCH
T ss_pred             cccCCCccCcCccCc
Confidence            223456899999998

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.92  E-value=2.3e-26  Score=239.74  Aligned_cols=136  Identities=23%  Similarity=0.261  Sum_probs=70.8

Q ss_pred             CCCCEEEccCCccc-CCCC---ccccCCCCCCeEEccCCccc--c---cCccchhcCCCCcEEEccCCcCc----ccchh
Q 036342          186 TNLVEIDLGGNKLN-GSIP---ITLGKLRKLQRLNLEDNILE--G---SIPDDICRLAELYRLELGSNKLY----GSIPA  252 (596)
Q Consensus       186 ~~L~~L~Ls~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~--~---~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~  252 (596)
                      ++|++|++++|.++ +..+   ..+..+++|++|++++|.++  |   ..+..+..+++|+.|+|++|.++    ..+|.
T Consensus       159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~  238 (386)
T 2ca6_A          159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  238 (386)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence            55666666666654 2222   24445556666666666554  1   22324555556666666666553    34455


Q ss_pred             hhccCCCCcEEEeCCCcccCC-----Cccc--ccccccceEEcccCCCCC----chhhhh-ccccccceEecCCCcCccc
Q 036342          253 CFGNLASLRILSLGSNKLTSI-----PLTF--WNLKDILQLNFSSNFLTG----PLLLEI-GNLKVLIGIDFSMNNFSGV  320 (596)
Q Consensus       253 ~~~~l~~L~~L~Ls~N~l~~i-----p~~~--~~l~~L~~L~ls~N~l~~----~~~~~~-~~l~~L~~L~ls~N~~~~~  320 (596)
                      .+..+++|+.|+|++|.++..     |..+  +.+++|+.|+|++|.+++    .++..+ .++++|+.|++++|.+++.
T Consensus       239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~  318 (386)
T 2ca6_A          239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  318 (386)
T ss_dssp             HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence            555555666666666655542     3333  225555555555555554    244443 3455555555555555544


Q ss_pred             C
Q 036342          321 I  321 (596)
Q Consensus       321 ~  321 (596)
                      .
T Consensus       319 ~  319 (386)
T 2ca6_A          319 D  319 (386)
T ss_dssp             S
T ss_pred             h
Confidence            3

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.92  E-value=2.5e-25  Score=225.94  Aligned_cols=149  Identities=25%  Similarity=0.378  Sum_probs=128.6

Q ss_pred             hcccccccccccCCCceeehhhH------------------HhHHHHHHHHhhcCCCccceeeeeeccCC----eeEEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE----FKALVL  500 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lV~  500 (596)
                      ..++|+..+.||+|+||.||+|.                  .....|+.++++++|||||++++++....    ..|+||
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            35689999999999999999862                  23556888999999999999999998744    479999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCC----------ceEeCCCCCCCeeeCCCCcEEEeccc
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA----------LVIHCDLKPSNVLLDDNMVAHLSDFS  570 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~----------~i~Hrdlk~~NILl~~~~~~kl~dfG  570 (596)
                      ||+++|+|.++++..  .+++..+..++.|+++|+.|||   +.          +|+||||||+||+++.++.+||+|||
T Consensus       102 e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            999999999999775  4889999999999999999999   77          99999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCC
Q 036342          571 IAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +++..............+||+.|+||
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aP  202 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAP  202 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCH
T ss_pred             cccccccccCccccccCccCccccCH
Confidence            99876543333233446899999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.92  E-value=3.6e-25  Score=226.72  Aligned_cols=147  Identities=27%  Similarity=0.323  Sum_probs=129.1

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|+..+.||+|+||.||++.                        +.+.+|..+++++ +|||||++++++..++..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            4689999999999999999752                        2367899999987 89999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999997654 5889999999999999999999   889999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      .  ......+||+.|+||
T Consensus       164 ~--~~~~~~~gt~~y~aP  179 (345)
T 3a8x_A          164 G--DTTSTFCGTPNYIAP  179 (345)
T ss_dssp             T--CCBCCCCSCGGGCCH
T ss_pred             C--CcccccCCCccccCc
Confidence            1  123456899999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.92  E-value=3.8e-25  Score=226.21  Aligned_cols=149  Identities=25%  Similarity=0.355  Sum_probs=129.1

Q ss_pred             HhcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCee
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  496 (596)
                      ...++|...+.||+|+||.||+|.                        +.+..|..+++++ +||||+++++++.+++..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            346789999999999999999752                        2356788888876 999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999998754 5889999999999999999999   8899999999999999999999999999998643


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...  ......+||+.|+||
T Consensus       170 ~~~--~~~~~~~gt~~y~aP  187 (345)
T 1xjd_A          170 LGD--AKTNTFCGTPDYIAP  187 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCH
T ss_pred             cCC--CcccCCCCCcccCCh
Confidence            221  123457899999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.92  E-value=5.2e-25  Score=226.66  Aligned_cols=146  Identities=25%  Similarity=0.422  Sum_probs=129.6

Q ss_pred             cccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .+.|+..+.||+|+||.||++.                           +.+.+|+.++++++|||||++++++.+++..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            4679999999999999999852                           3478999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC----cEEEeccccc
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM----VAHLSDFSIA  572 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~----~~kl~dfGla  572 (596)
                      |+||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||++++++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997653 6899999999999999999999   88999999999999998776    7999999999


Q ss_pred             cccCCCCCccccccccccccccCC
Q 036342          573 KLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +......   .....+||+.|+||
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aP  187 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAP  187 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCH
T ss_pred             eEcCCCC---ccccCCCCccEECc
Confidence            8764321   23446799999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.92  E-value=3.2e-25  Score=222.08  Aligned_cols=148  Identities=26%  Similarity=0.484  Sum_probs=125.5

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||.||++.                        +.+.+|+.++++++||||+++++++..++..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            3579999999999999999752                        4578899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++.... .+++..+..++.|++.|+.|+|   ..+|+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999998764 5889999999999999999999   8899999999999999999999999999998764322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                       .......+||+.|+||
T Consensus       166 -~~~~~~~~gt~~y~aP  181 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSP  181 (294)
T ss_dssp             ----------CCSSCCH
T ss_pred             -ccccCccccCccccCH
Confidence             1223345799999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.92  E-value=2.8e-25  Score=229.02  Aligned_cols=161  Identities=24%  Similarity=0.412  Sum_probs=136.9

Q ss_pred             cccCHHHHHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccc
Q 036342          433 RTFSYLELCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLI  484 (596)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv  484 (596)
                      ..+...+++...++|...+.||+|+||.||+|.                           +.+.+|+++++++ +|||||
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            445667777888999999999999999999862                           3478899999999 889999


Q ss_pred             eeeeeeccCC-eeEEEEecCCCCCHHHHHhhCCC----------------------------------------------
Q 036342          485 KVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNC----------------------------------------------  517 (596)
Q Consensus       485 ~l~~~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~----------------------------------------------  517 (596)
                      ++++++...+ ..++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999998755 48999999999999999976532                                              


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          518 -------------------ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       518 -------------------~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                                         .+++..++.++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                               1889999999999999999999   889999999999999999999999999999876443


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      ..........||+.|+||
T Consensus       247 ~~~~~~~~~~~t~~y~aP  264 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAP  264 (359)
T ss_dssp             TTCEEC--CEECGGGCCH
T ss_pred             ccchhccccCCCceeECh
Confidence            333334456789999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.92  E-value=4.2e-25  Score=228.74  Aligned_cols=150  Identities=25%  Similarity=0.467  Sum_probs=120.1

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|+..+.||+|+||.||+|.                         +.+.+|+.++++++|||||++++++..++..|+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            3589999999999999999752                         357789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++......+++.++..++.|+++|++|||   ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999887667899999999999999999999   889999999999999999999999999999876432


Q ss_pred             CCc-cccccccccccccCC
Q 036342          579 DQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~-~~~~~~~gt~~y~aP  596 (596)
                      ... .......+|+.|+||
T Consensus       201 ~~~~~~~~~~~~~~~y~aP  219 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSP  219 (373)
T ss_dssp             -------------CTTSCH
T ss_pred             CccceeccCCCcCCCccCh
Confidence            211 112223467889998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.91  E-value=4.7e-25  Score=233.04  Aligned_cols=148  Identities=25%  Similarity=0.430  Sum_probs=128.7

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ..++|+..+.||+|+||.||+|.                       +.+.+|+.++++++|||||++++++.+++..|+|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            35689999999999999999852                       3577999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC---CCCcEEEeccccccccC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~---~~~~~kl~dfGla~~~~  576 (596)
                      ||||++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+|||++   .++.+||+|||+++...
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999998764 5899999999999999999999   89999999999999998   46889999999998764


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....  .....+||++|+||
T Consensus       165 ~~~~--~~~~~~gt~~Y~AP  182 (444)
T 3soa_A          165 GEQQ--AWFGFAGTPGYLSP  182 (444)
T ss_dssp             TTCC--BCCCSCSCGGGCCH
T ss_pred             CCCc--eeecccCCcccCCH
Confidence            3322  23456899999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.91  E-value=5.6e-25  Score=225.63  Aligned_cols=144  Identities=25%  Similarity=0.331  Sum_probs=129.3

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||.||++.                        +.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            4689999999999999999752                        3466799999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            99999999999998754 5889999999999999999999   899999999999999999999999999999876432 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                          ....+||+.|+||
T Consensus       195 ----~~~~~gt~~y~aP  207 (350)
T 1rdq_E          195 ----TWTLCGTPEALAP  207 (350)
T ss_dssp             ----BCCCEECGGGCCH
T ss_pred             ----cccccCCccccCH
Confidence                2346899999998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.91  E-value=2.3e-25  Score=231.24  Aligned_cols=152  Identities=24%  Similarity=0.400  Sum_probs=130.4

Q ss_pred             HhcccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ...++|...+.||+|+||.||+|.                      +.+.+|+.++++++|||||++++++..++..|+|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            345689999999999999999852                      3567899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++......+++..+..++.|+++|++|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999999999876666899999999999999999999   8999999999999999999999999999998653221


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                      .........+++.|+||
T Consensus       268 ~~~~~~~~~~~~~y~aP  284 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAP  284 (377)
T ss_dssp             EECCSSCCEEEGGGSCH
T ss_pred             eeecCCCCCCCcCcCCH
Confidence            11111223467789998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.91  E-value=6.2e-25  Score=225.37  Aligned_cols=148  Identities=23%  Similarity=0.273  Sum_probs=129.3

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  497 (596)
                      ..++|+..+.||+|+||.||++.                        +.+..|..+++.+ +||+|+++++++..++..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            35689999999999999999752                        2356789999887 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999998654 5889999999999999999999   88999999999999999999999999999986432


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .  .......+||+.|+||
T Consensus       174 ~--~~~~~~~~gt~~y~aP  190 (353)
T 2i0e_A          174 D--GVTTKTFCGTPDYIAP  190 (353)
T ss_dssp             T--TCCBCCCCSCGGGCCH
T ss_pred             C--CcccccccCCccccCh
Confidence            2  1223457899999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.91  E-value=8.3e-25  Score=221.92  Aligned_cols=157  Identities=24%  Similarity=0.286  Sum_probs=135.4

Q ss_pred             cccCHHHHHHhccc----------ccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCC
Q 036342          433 RTFSYLELCRATDE----------FSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHR  481 (596)
Q Consensus       433 ~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~  481 (596)
                      ..++++++..+++.          |+..+.||+|+||.||+|.                     +.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45777777777653          7777899999999999852                     3577999999999999


Q ss_pred             ccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC
Q 036342          482 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN  561 (596)
Q Consensus       482 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~  561 (596)
                      ||+++++++...+..|+||||+++|+|.+++...  .+++..+..++.|+++|+.|||   ..+|+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999998754  5889999999999999999999   8899999999999999999


Q ss_pred             CcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          562 MVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       562 ~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +.+||+|||+++......  .......||+.|+||
T Consensus       178 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aP  210 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAP  210 (321)
T ss_dssp             CCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCH
T ss_pred             CcEEEeeeeeeeecccCc--cccccccCCccccCH
Confidence            999999999998764322  123446799999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.91  E-value=2.9e-25  Score=223.96  Aligned_cols=153  Identities=29%  Similarity=0.491  Sum_probs=123.3

Q ss_pred             HHHHhcccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ++....++|+..+.||+|+||.||+|.                     +.+.+|+.++++++|||||++++++..++..+
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            334456789999999999999999852                     35778999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhccCCCc--eEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          498 LVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAL--VIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      +||||+++|+|.+++.....  .+++..++.++.|++.|++|||   ..+  |+||||||+||+++.++.+||+|||+++
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            99999999999999987542  3889999999999999999999   888  9999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .....  ........||+.|+||
T Consensus       188 ~~~~~--~~~~~~~~gt~~y~aP  208 (309)
T 3p86_A          188 LKAST--FLSSKSAAGTPEWMAP  208 (309)
T ss_dssp             ----------------CCTTSCH
T ss_pred             ccccc--ccccccCCCCccccCh
Confidence            64322  1123446799999998

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.91  E-value=3.3e-25  Score=225.54  Aligned_cols=149  Identities=25%  Similarity=0.423  Sum_probs=127.9

Q ss_pred             cccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      .++|+..+.||+|+||.||+|.                          +.+.+|+.++++++|||||+++++|..++ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            3579999999999999999852                          35778999999999999999999998765 78


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|+||+++|+|.+++......+++..++.++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999999887777899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...........||+.|+||
T Consensus       170 ~~~~~~~~~~~~t~~y~aP  188 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             TCC-------CCCGGGSCH
T ss_pred             CcccccccCCCccccccCh
Confidence            4333333445678899998

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.91  E-value=1.1e-24  Score=219.98  Aligned_cols=232  Identities=19%  Similarity=0.214  Sum_probs=152.8

Q ss_pred             CCCEEECCCCCCccccch---hhhCCCCCCEEEccCCcCccccCccCc-cCCCCccEEEccCCccccccC----ccccCC
Q 036342           11 NLEELQLGQNKLIGTVPA---AIFNVSTLKFLGLQNNSLSGSLSSIAN-VRLPNLEKLYLWGNNFSGTIP----RFIFNA   82 (596)
Q Consensus        11 ~L~~L~Ls~n~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~----~~~~~l   82 (596)
                      .++.|.+.++.+....-.   .+..+++|++|+|++|.+++.++...+ ..+++|++|+|++|.+++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            478889988887532211   122357799999999999977766432 568999999999999997555    345679


Q ss_pred             CCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccc
Q 036342           83 SKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSR  162 (596)
Q Consensus        83 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~  162 (596)
                      ++|++|+|++|+|++..+..|.++++|++|+|++|++.+... +.....+..+++|++|++++|+++.. +. .      
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~-~------  215 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERG-LMAALCPHKFPAIQNLALRNTGMETP-TG-V------  215 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHH-HHTTSCTTSSCCCCSCBCCSSCCCCH-HH-H------
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchh-hhHHHhhhcCCCCCEEECCCCCCCch-HH-H------
Confidence            999999999999999999999999999999999999865100 00011246788888888888888632 11 0      


Q ss_pred             cccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCC---CCCCeEEccCCcccccCccchhcCCCCcEE
Q 036342          163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKL---RKLQRLNLEDNILEGSIPDDICRLAELYRL  239 (596)
Q Consensus       163 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  239 (596)
                                     ....+..+++|++|+|++|.+++..|..+..+   ++|++|+|++|.|+ .+|..+.  ++|+.|
T Consensus       216 ---------------~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L  277 (310)
T 4glp_A          216 ---------------CAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVL  277 (310)
T ss_dssp             ---------------HHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCE
T ss_pred             ---------------HHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEE
Confidence                           00113344555555555555555444444433   45555555555555 4444443  456666


Q ss_pred             EccCCcCcccchhhhccCCCCcEEEeCCCccc
Q 036342          240 ELGSNKLYGSIPACFGNLASLRILSLGSNKLT  271 (596)
Q Consensus       240 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  271 (596)
                      +|++|++++. |. +..+++|+.|+|++|.++
T Consensus       278 ~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          278 DLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             ECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             ECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence            6666666543 22 455566666666666654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.91  E-value=8e-25  Score=227.63  Aligned_cols=151  Identities=29%  Similarity=0.463  Sum_probs=131.9

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhc-CCCccceeeeeecc
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSI-RHRNLIKVISSCSN  492 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~  492 (596)
                      ..++|...+.||+|+||.||+|.                             +.+.+|+++++++ +|||||++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            35689999999999999999652                             3477899999999 99999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCee
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL  557 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NIL  557 (596)
                      ++..|+||||+++|+|.+++....               ..+++.++..++.|++.|+.|||   +.+|+||||||+||+
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence            999999999999999999998753               34899999999999999999999   889999999999999


Q ss_pred             eCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       558 l~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++.++.+||+|||+++...............+|+.|+||
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  262 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  262 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence            999999999999999876543322333445788999998

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.91  E-value=5.1e-24  Score=214.69  Aligned_cols=195  Identities=24%  Similarity=0.424  Sum_probs=106.9

Q ss_pred             CCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCC
Q 036342           58 LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS  137 (596)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~  137 (596)
                      +++|++|++++|.++. ++ .+..+++|++|+|++|.++++.+  |.++++|++|++++|.++.++       .+..+++
T Consensus        40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~~-------~~~~l~~  108 (308)
T 1h6u_A           40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVS-------AIAGLQS  108 (308)
T ss_dssp             HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCG-------GGTTCTT
T ss_pred             cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCch-------hhcCCCC
Confidence            4556666666665552 33 35555666666666666655433  556666666666666655431       2455556


Q ss_pred             CCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       138 L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                      |+.|++++|.+++..   .+..+ ++|++|++++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|+.|++
T Consensus       109 L~~L~l~~n~l~~~~---~l~~l-~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l  180 (308)
T 1h6u_A          109 IKTLDLTSTQITDVT---PLAGL-SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA  180 (308)
T ss_dssp             CCEEECTTSCCCCCG---GGTTC-TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             CCEEECCCCCCCCch---hhcCC-CCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEEC
Confidence            666666666555431   13333 345555555555544322  5555666666666666654333  555666666666


Q ss_pred             cCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCc
Q 036342          218 EDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL  275 (596)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~  275 (596)
                      ++|.+++. +. +..+++|+.|++++|++++..+  +..+++|+.|+|++|.++..|.
T Consensus       181 ~~n~l~~~-~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~~  234 (308)
T 1h6u_A          181 DDNKISDI-SP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV  234 (308)
T ss_dssp             CSSCCCCC-GG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCCE
T ss_pred             CCCccCcC-hh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCCe
Confidence            66666532 22 5556666666666666654432  5556666666666666655544

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.91  E-value=8.3e-25  Score=222.72  Aligned_cols=150  Identities=24%  Similarity=0.435  Sum_probs=124.3

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC-------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE-------  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~-------  494 (596)
                      .++|+..+.||+|+||.||+|.                      +.+.+|+.++++++|||||+++++|.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            4679999999999999999852                      45789999999999999999999985432       


Q ss_pred             --------------------------------------------------eeEEEEecCCCCCHHHHHhhCC--CCCCHH
Q 036342          495 --------------------------------------------------FKALVLEYMPHGSLEKYLYSSN--CILDIF  522 (596)
Q Consensus       495 --------------------------------------------------~~~lV~e~~~~g~L~~~l~~~~--~~l~~~  522 (596)
                                                                        ..++|||||++|+|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3799999999999999998754  235677


Q ss_pred             HHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc----------ccccccccccc
Q 036342          523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS----------MTQTQTLGTIG  592 (596)
Q Consensus       523 ~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~----------~~~~~~~gt~~  592 (596)
                      .++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++........          ......+||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999   899999999999999999999999999999876543211          12234579999


Q ss_pred             ccCC
Q 036342          593 YMAP  596 (596)
Q Consensus       593 y~aP  596 (596)
                      |+||
T Consensus       242 y~aP  245 (332)
T 3qd2_B          242 YMSP  245 (332)
T ss_dssp             GSCH
T ss_pred             ccCh
Confidence            9998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.91  E-value=3.5e-25  Score=225.19  Aligned_cols=149  Identities=23%  Similarity=0.392  Sum_probs=126.5

Q ss_pred             cccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      .++|...+.||+|+||.||+|.                          +.+.+|+.++++++|||||++++++.. +..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence            3578999999999999999852                          245689999999999999999999864 5689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999876567888999999999999999999   88999999999999999999999999999998754


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...........||+.|+||
T Consensus       168 ~~~~~~~~~~~~~~~y~aP  186 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMAL  186 (325)
T ss_dssp             CTTCCC-----CCTTTSCH
T ss_pred             ccccccccCCCCcccccCh
Confidence            4333333456788899998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.91  E-value=9.2e-25  Score=235.74  Aligned_cols=148  Identities=26%  Similarity=0.416  Sum_probs=130.9

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..++|...+.||+|+||.||++.                        ..+.+|+.++++++|||||++++++.+++..|+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            35679999999999999999752                        236789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          499 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      ||||++||+|.+++.... ..+++..+..++.||+.|+.|||   ..+|+||||||+|||++.++.+||+|||+++....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999997654 34899999999999999999999   88999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   .....+||+.|+||
T Consensus       339 ~~---~~~~~~GT~~Y~AP  354 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAP  354 (576)
T ss_dssp             TC---CEECCCSCGGGCCH
T ss_pred             Cc---cccccCCCccccCH
Confidence            22   23346899999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.91  E-value=9.7e-25  Score=220.42  Aligned_cols=148  Identities=24%  Similarity=0.371  Sum_probs=129.5

Q ss_pred             hcccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ..++|+..+.||+|+||.||+|.                      +.+.+|++++++++|||||++++++..++..|+||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            35789999999999999999852                      34678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||++ |++.+++......+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            9997 5899988877667899999999999999999999   89999999999999999999999999999987643221


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......||+.|+||
T Consensus       175 --~~~~~~~t~~y~aP  188 (311)
T 3niz_A          175 --SYTHEVVTLWYRAP  188 (311)
T ss_dssp             -----CCCCCCTTCCH
T ss_pred             --cccCCcccCCcCCH
Confidence              23345789999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.91  E-value=1e-24  Score=226.44  Aligned_cols=147  Identities=22%  Similarity=0.390  Sum_probs=130.1

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|+..+.||+|+||.||+|.                     ..+.+|+.++++++|||||++++++.+++..|+||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            4679999999999999999852                     3577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC--CCcEEEeccccccccCCCCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~--~~~~kl~dfGla~~~~~~~~  580 (596)
                      +++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.  .+.+||+|||+++...... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999876667899999999999999999999   889999999999999974  5789999999998764322 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        .....+||+.|+||
T Consensus       206 --~~~~~~gt~~y~aP  219 (387)
T 1kob_A          206 --IVKVTTATAEFAAP  219 (387)
T ss_dssp             --CEEEECSSGGGCCH
T ss_pred             --ceeeeccCCCccCc
Confidence              22345799999998

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.91  E-value=9.1e-26  Score=235.21  Aligned_cols=264  Identities=17%  Similarity=0.209  Sum_probs=183.1

Q ss_pred             CccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCcc----ccCCCCCCEEecCCCcCcCCCCCc-----cccc
Q 036342           60 NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPST----FGNLRNLEQLGLDENYLTSSTPEL-----SFLS  130 (596)
Q Consensus        60 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~----~~~l~~L~~L~l~~N~l~~~~~~~-----~~~~  130 (596)
                      .|+...++...+. .++..+..+++|++|+|++|.|+...+..    |..+++|++|+|++|.+..+...+     .+..
T Consensus        10 ~L~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~   88 (386)
T 2ca6_A           10 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ   88 (386)
T ss_dssp             CCEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHH
T ss_pred             ccccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHH
Confidence            3444444444444 55666777788888888888887654433    556777777777776554332110     0111


Q ss_pred             cCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCcccc---
Q 036342          131 SLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLG---  207 (596)
Q Consensus       131 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---  207 (596)
                      .+..+++|++|+|++|.+++..    ..                  .+|..+..+++|++|+|++|.+.+..+..+.   
T Consensus        89 ~l~~~~~L~~L~Ls~n~l~~~~----~~------------------~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l  146 (386)
T 2ca6_A           89 ALLKCPKLHTVRLSDNAFGPTA----QE------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL  146 (386)
T ss_dssp             HHTTCTTCCEEECCSCCCCTTT----HH------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHH
T ss_pred             HHhhCCcccEEECCCCcCCHHH----HH------------------HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHH
Confidence            2245555555555555554310    00                  3455667777888888888887644433333   


Q ss_pred             -CC---------CCCCeEEccCCccc-ccCc---cchhcCCCCcEEEccCCcCcc-----cchhhhccCCCCcEEEeCCC
Q 036342          208 -KL---------RKLQRLNLEDNILE-GSIP---DDICRLAELYRLELGSNKLYG-----SIPACFGNLASLRILSLGSN  268 (596)
Q Consensus       208 -~l---------~~L~~L~L~~N~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N  268 (596)
                       .+         ++|++|++++|.++ +.++   ..+..+++|++|+|++|.++.     ..|..+..+++|+.|+|++|
T Consensus       147 ~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n  226 (386)
T 2ca6_A          147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN  226 (386)
T ss_dssp             HHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSS
T ss_pred             HHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCC
Confidence             33         89999999999997 4445   466788999999999999872     34547888999999999999


Q ss_pred             ccc-----CCCcccccccccceEEcccCCCCCc----hhhhhc--cccccceEecCCCcCcc----cCChhhhccCCCCC
Q 036342          269 KLT-----SIPLTFWNLKDILQLNFSSNFLTGP----LLLEIG--NLKVLIGIDFSMNNFSG----VIPREIGEKLSYLE  333 (596)
Q Consensus       269 ~l~-----~ip~~~~~l~~L~~L~ls~N~l~~~----~~~~~~--~l~~L~~L~ls~N~~~~----~~~~~~~~~l~~L~  333 (596)
                      .++     .+|..+..+++|+.|+|++|.+++.    ++..+.  .++.|+.|++++|.+++    .+|..+...+++|+
T Consensus       227 ~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~  306 (386)
T 2ca6_A          227 TFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL  306 (386)
T ss_dssp             CCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCC
T ss_pred             CCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCce
Confidence            994     4788888899999999999999876    455553  38899999999999987    47775556789999


Q ss_pred             eEECCCCcccccC
Q 036342          334 DLNLSFNKLKGEI  346 (596)
Q Consensus       334 ~L~l~~N~l~~~~  346 (596)
                      .|++++|++++..
T Consensus       307 ~L~l~~N~l~~~~  319 (386)
T 2ca6_A          307 FLELNGNRFSEED  319 (386)
T ss_dssp             EEECTTSBSCTTS
T ss_pred             EEEccCCcCCcch
Confidence            9999999887543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.91  E-value=6.1e-25  Score=216.98  Aligned_cols=149  Identities=30%  Similarity=0.508  Sum_probs=131.4

Q ss_pred             cccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .++|+..+.||+|+||.||+|.                   +.+.+|+.++++++||||+++++++.+++..|+||||++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            4689999999999999999852                   457899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +|+|.+++......+++..+..++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++..... .....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~  164 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSS  164 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHST
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc-ccccc
Confidence            99999999877667899999999999999999999   899999999999999999999999999999865422 11123


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....+|+.|+||
T Consensus       165 ~~~~~~~~y~aP  176 (269)
T 4hcu_A          165 TGTKFPVKWASP  176 (269)
T ss_dssp             TSTTCCGGGCCH
T ss_pred             cCcccccccCCH
Confidence            345678889998

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.91  E-value=5.3e-26  Score=250.65  Aligned_cols=202  Identities=12%  Similarity=0.091  Sum_probs=120.2

Q ss_pred             ccccEEEccccccccccC-hhccCCCCCCEEEccCCcccCC-CCccccCCCCCCeEEcc---------CCcccccCccch
Q 036342          162 RSLEEFYMYNCNISGGIP-EEISNLTNLVEIDLGGNKLNGS-IPITLGKLRKLQRLNLE---------DNILEGSIPDDI  230 (596)
Q Consensus       162 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~---------~N~l~~~~~~~~  230 (596)
                      ++|++|++++|.+++... ..+..+++|++|++++| +... .+.....+++|++|+++         .+.+++.....+
T Consensus       289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l  367 (594)
T 2p1m_B          289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV  367 (594)
T ss_dssp             TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred             CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence            567777777777654322 23456677777777766 3321 22222346777777773         344443222223


Q ss_pred             h-cCCCCcEEEccCCcCcccchhhhc-cCCCCcEEEeC--C----CcccCCCc------ccccccccceEEcccCCCCCc
Q 036342          231 C-RLAELYRLELGSNKLYGSIPACFG-NLASLRILSLG--S----NKLTSIPL------TFWNLKDILQLNFSSNFLTGP  296 (596)
Q Consensus       231 ~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~ip~------~~~~l~~L~~L~ls~N~l~~~  296 (596)
                      . .+++|+.|+++.|.+++.....+. .+++|+.|+|+  +    |.++..|.      .+..+++|+.|++++ .++..
T Consensus       368 ~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~  446 (594)
T 2p1m_B          368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDK  446 (594)
T ss_dssp             HHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHH
T ss_pred             HHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHH
Confidence            2 367777777777777655555554 46777777777  4    55654332      244567777777766 66655


Q ss_pred             hhhhhcc-ccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCC-C-CCCCCCCccccccccc
Q 036342          297 LLLEIGN-LKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPR-G-GSFGNFSAESFEGNEL  365 (596)
Q Consensus       297 ~~~~~~~-l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~-~~~~~l~~l~~~~N~~  365 (596)
                      .+..+.. +++|+.|++++|.+++.........+++|++|++++|++++..+. . ..+++++.+++++|+.
T Consensus       447 ~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          447 VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             HHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             HHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence            5555554 677777888877776544433335577788888888777543222 1 2356777777777664

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=4.5e-24  Score=206.94  Aligned_cols=196  Identities=21%  Similarity=0.194  Sum_probs=133.6

Q ss_pred             CCCEEECcCCCCCccCCchhhhcccccccEEEccccc-cccccChhccCCCCCCEEEccC-CcccCCCCccccCCCCCCe
Q 036342          137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCN-ISGGIPEEISNLTNLVEIDLGG-NKLNGSIPITLGKLRKLQR  214 (596)
Q Consensus       137 ~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~  214 (596)
                      +|+.|++++|+++++.+. .+..+ ++|++|++++|. ++.+.+.+|.++++|++|++++ |.+++..+..|.++++|++
T Consensus        32 ~l~~L~l~~n~l~~i~~~-~~~~l-~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~  109 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSH-AFSNL-PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF  109 (239)
T ss_dssp             TCCEEEEESCCCSEECTT-TTTTC-TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred             cccEEEEeCCcceEECHH-HccCC-CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence            445555555555443322 34444 455666666664 5555556677777777777777 7777666677777777777


Q ss_pred             EEccCCcccccCccchhcCCCCc---EEEccCC-cCcccchhhhccCCCCc-EEEeCCCcccCCCcccccccccceEEcc
Q 036342          215 LNLEDNILEGSIPDDICRLAELY---RLELGSN-KLYGSIPACFGNLASLR-ILSLGSNKLTSIPLTFWNLKDILQLNFS  289 (596)
Q Consensus       215 L~L~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~ip~~~~~l~~L~~L~ls  289 (596)
                      |++++|.+++ +|. +..+++|+   +|++++| ++++..+..|.++++|+ .|++++|.++.+|...+..++|+.|+++
T Consensus       110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~  187 (239)
T 2xwt_C          110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLN  187 (239)
T ss_dssp             EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECT
T ss_pred             EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcC
Confidence            7777777774 554 66667776   7888887 77766666777788888 8888888887777665555777788888


Q ss_pred             cCC-CCCchhhhhccc-cccceEecCCCcCcccCChhhhccCCCCCeEECCCC
Q 036342          290 SNF-LTGPLLLEIGNL-KVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFN  340 (596)
Q Consensus       290 ~N~-l~~~~~~~~~~l-~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N  340 (596)
                      +|+ +++..+..|..+ ++|+.||+++|+++ .+|..   .+++|+.|+++++
T Consensus       188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             TCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT---TCTTCSEEECTTC
T ss_pred             CCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh---HhccCceeeccCc
Confidence            884 776666777777 77778888887777 34542   4667777777665

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.91  E-value=8.1e-25  Score=222.93  Aligned_cols=145  Identities=26%  Similarity=0.449  Sum_probs=128.8

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|...+.||+|+||.||+|.                        +.+.+|+.+++.++|||||++++++..++..|+|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4689999999999999999752                        2577899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+ +|+|.+++.... .+++.++..++.|++.|+.|||   ..+|+||||||+||++++++.+||+|||+++..... 
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-  161 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-  161 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence            9999 789999987654 5889999999999999999999   889999999999999999999999999999875432 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                        ......+||+.|+||
T Consensus       162 --~~~~~~~gt~~y~aP  176 (336)
T 3h4j_B          162 --NFLKTSCGSPNYAAP  176 (336)
T ss_dssp             --BTTCCCTTSTTTSCG
T ss_pred             --cccccccCCcCcCCH
Confidence              123456899999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.91  E-value=5.6e-25  Score=227.33  Aligned_cols=147  Identities=30%  Similarity=0.386  Sum_probs=122.8

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHH-HhhcCCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEM-MKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|+..+.||+|+||.||++.                        +.+..|..+ ++.++|||||++++++..++..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4689999999999999999752                        123455555 577899999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999998754 5788999999999999999999   899999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      .  ......+||+.|+||
T Consensus       193 ~--~~~~~~~gt~~y~aP  208 (373)
T 2r5t_A          193 N--STTSTFCGTPEYLAP  208 (373)
T ss_dssp             C--CCCCSBSCCCCCCCH
T ss_pred             C--CccccccCCccccCH
Confidence            2  123457899999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.91  E-value=1.3e-24  Score=224.22  Aligned_cols=146  Identities=23%  Similarity=0.485  Sum_probs=128.5

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .++|+..+.||+|+||.||+|.                       +.+.+|+.++++++|||||++++++.+++..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4689999999999999999852                       35778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC---CcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~---~~~kl~dfGla~~~~~  577 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.+   +.+||+|||+++....
T Consensus       108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999987654 5889999999999999999999   8899999999999999865   4599999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   .....+||+.|+||
T Consensus       184 ~~---~~~~~~gt~~y~aP  199 (362)
T 2bdw_A          184 SE---AWHGFAGTPGYLSP  199 (362)
T ss_dssp             CC---SCCCSCSCTTTCCH
T ss_pred             Cc---ccccCCCCccccCH
Confidence            22   23346899999998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.91  E-value=3.5e-25  Score=228.94  Aligned_cols=150  Identities=22%  Similarity=0.360  Sum_probs=128.0

Q ss_pred             cccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .++|...+.||+|+||.||+|.                           ..+.+|+.++++++|||||++++++..++..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            4678999999999999999753                           2467899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC---cEEEe
Q 036342          497 ALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM---VAHLS  567 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~---~~kl~  567 (596)
                      |+||||+++|+|.+++....      ..+++.+++.++.|+++|+.|||   ..+|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999998643      35889999999999999999999   89999999999999999554   59999


Q ss_pred             ccccccccCCCCCccccccccccccccCC
Q 036342          568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       568 dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||+++...............||+.|+||
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  255 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPP  255 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred             CCccccccccccccccCCCcCCcccEECH
Confidence            99999865322222223345789999998

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.91  E-value=7.8e-24  Score=217.42  Aligned_cols=242  Identities=18%  Similarity=0.147  Sum_probs=178.4

Q ss_pred             CEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccC-ccccCCCCCCE-EEc
Q 036342           13 EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIP-RFIFNASKLSK-LSL   90 (596)
Q Consensus        13 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~-L~L   90 (596)
                      ++++.++++++ .+|..+  .+++++|+|++|+|+ .++...|..+++|++|+|++|++.+.+| .+|.++++|++ +.+
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            67899999997 567665  468999999999998 6777667779999999999999865554 56788888765 677


Q ss_pred             cCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcC-CCCCccCCchhhhcccccccEEEc
Q 036342           91 GMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSN-NPLDGILPKTSISNLSRSLEEFYM  169 (596)
Q Consensus        91 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~-N~l~~~~~~~~~~~l~~~L~~L~l  169 (596)
                      ++|+|+.+.|++|.++++|++|++++|.++..++.     .+....++..|++++ |.+..+ +...+..+...++.|++
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~-----~~~~~~~l~~l~l~~~~~i~~l-~~~~f~~~~~~l~~L~L  161 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV-----HKIHSLQKVLLDIQDNINIHTI-ERNSFVGLSFESVILWL  161 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCC-----TTCCBSSCEEEEEESCTTCCEE-CTTSSTTSBSSCEEEEC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCch-----hhcccchhhhhhhccccccccc-cccchhhcchhhhhhcc
Confidence            78999999999999999999999999999887654     355666778888865 455544 43356666567888888


Q ss_pred             cccccccccChhccCCCCCCEEEccC-CcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcc
Q 036342          170 YNCNISGGIPEEISNLTNLVEIDLGG-NKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG  248 (596)
Q Consensus       170 ~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  248 (596)
                      ++|+|+.+.+.+|. ..+|++|++++ |.++.+.+.+|.++++|++|||++|+|+...+..+   .+|+.|.+.++.-..
T Consensus       162 ~~N~i~~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~---~~L~~L~~l~~~~l~  237 (350)
T 4ay9_X          162 NKNGIQEIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL---ENLKKLRARSTYNLK  237 (350)
T ss_dssp             CSSCCCEECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC---TTCCEEECTTCTTCC
T ss_pred             ccccccCCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh---ccchHhhhccCCCcC
Confidence            88888876665554 46788888874 66776666778888888888888888884333333   445555544443222


Q ss_pred             cchhhhccCCCCcEEEeCCCc
Q 036342          249 SIPACFGNLASLRILSLGSNK  269 (596)
Q Consensus       249 ~~p~~~~~l~~L~~L~Ls~N~  269 (596)
                      .+| .+..+++|+.++++++.
T Consensus       238 ~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          238 KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             CCC-CTTTCCSCCEEECSCHH
T ss_pred             cCC-CchhCcChhhCcCCCCc
Confidence            455 36777788888876543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.91  E-value=8.3e-25  Score=224.79  Aligned_cols=148  Identities=24%  Similarity=0.413  Sum_probs=127.6

Q ss_pred             cccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      .+.|+..+.||+|+||.||+|.                          +.+.+|+.++++++|||||++++++..++..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3579999999999999999852                          34678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc---EEEecccc
Q 036342          498 LVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV---AHLSDFSI  571 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~---~kl~dfGl  571 (596)
                      +|||||++|+|.+++...   ...+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998887643   235789999999999999999999   899999999999999986554   99999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++......  ......+||+.|+||
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aP  202 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAP  202 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCH
T ss_pred             eeEecCCC--eeecCCcCCcCccCH
Confidence            98764322  123446899999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.91  E-value=1.4e-24  Score=217.28  Aligned_cols=146  Identities=25%  Similarity=0.392  Sum_probs=128.1

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++..++..|+|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            579999999999999999852                       456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+++ ++.+.+......+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence            9975 777777766667899999999999999999999   8899999999999999999999999999998764322  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......||+.|+||
T Consensus       156 ~~~~~~~~t~~y~aP  170 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPP  170 (292)
T ss_dssp             SCCCSCCSCGGGCCH
T ss_pred             ccccCCccccCCcCh
Confidence            123446789999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.91  E-value=1.3e-24  Score=214.52  Aligned_cols=150  Identities=27%  Similarity=0.419  Sum_probs=131.9

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..++|+..+.||+|+||.||++.                   +.+.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            35689999999999999999752                   45789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      ++|+|.+++......+++..++.++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence            999999999876666899999999999999999999   8899999999999999999999999999998764332 222


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....+|+.|+||
T Consensus       162 ~~~~~~~~~y~aP  174 (268)
T 3sxs_A          162 SVGTKFPVKWSAP  174 (268)
T ss_dssp             CCSCCCCGGGCCH
T ss_pred             ccCCCcCcccCCH
Confidence            3345677889998

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=7.6e-25  Score=223.65  Aligned_cols=234  Identities=16%  Similarity=0.273  Sum_probs=120.3

Q ss_pred             CCccEEEccCCccccccCccccCCCCCCEEEccCCccccc-CCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCC
Q 036342           59 PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS  137 (596)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~  137 (596)
                      ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. .+..+..+++|++|++++|.++..     .+..++.+++
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~-----~~~~l~~~~~  143 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDP-----IVNTLAKNSN  143 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHH-----HHHHHTTCTT
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHH-----HHHHHhcCCC
Confidence            3444444444444433222 33444444444444444433 344444444455555544444321     1123444455


Q ss_pred             CCEEECcCC-CCCccCCchhhhcccccccEEEcccc-ccccc-cChhccCCC-CCCEEEccCC--ccc-CCCCccccCCC
Q 036342          138 LTLIDLSNN-PLDGILPKTSISNLSRSLEEFYMYNC-NISGG-IPEEISNLT-NLVEIDLGGN--KLN-GSIPITLGKLR  210 (596)
Q Consensus       138 L~~L~ls~N-~l~~~~~~~~~~~l~~~L~~L~l~~n-~l~~~-~~~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~  210 (596)
                      |++|++++| .+++......+..+ ++|++|++++| .+++. ++..+..++ +|++|++++|  .++ +.+|..+..++
T Consensus       144 L~~L~L~~~~~l~~~~l~~~~~~~-~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~  222 (336)
T 2ast_B          144 LVRLNLSGCSGFSEFALQTLLSSC-SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP  222 (336)
T ss_dssp             CSEEECTTCBSCCHHHHHHHHHHC-TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCT
T ss_pred             CCEEECCCCCCCCHHHHHHHHhcC-CCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCC
Confidence            555555555 34321001123333 44555555555 55543 345555566 6666666666  333 23445555666


Q ss_pred             CCCeEEccCCc-ccccCccchhcCCCCcEEEccCCc-CcccchhhhccCCCCcEEEeCCCcccCCCc-ccccc-cccceE
Q 036342          211 KLQRLNLEDNI-LEGSIPDDICRLAELYRLELGSNK-LYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNL-KDILQL  286 (596)
Q Consensus       211 ~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l-~~L~~L  286 (596)
                      +|++|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.|++++|    ++. .+..+ ..+..|
T Consensus       223 ~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~----i~~~~~~~l~~~l~~L  298 (336)
T 2ast_B          223 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI----VPDGTLQLLKEALPHL  298 (336)
T ss_dssp             TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS----SCTTCHHHHHHHSTTS
T ss_pred             CCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc----cCHHHHHHHHhhCcce
Confidence            67777777666 555555566666777777777764 22222224666777777777777    333 22333 236666


Q ss_pred             EcccCCCCCchhhhhcc
Q 036342          287 NFSSNFLTGPLLLEIGN  303 (596)
Q Consensus       287 ~ls~N~l~~~~~~~~~~  303 (596)
                      ++++|.+++..|..++.
T Consensus       299 ~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          299 QINCSHFTTIARPTIGN  315 (336)
T ss_dssp             EESCCCSCCTTCSSCSS
T ss_pred             EEecccCccccCCcccc
Confidence            67777777776665543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.91  E-value=2e-24  Score=232.42  Aligned_cols=148  Identities=28%  Similarity=0.400  Sum_probs=130.5

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|...+.||+|+||.||++.                        +.+..|+.++++++|||||++++++..++..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            4689999999999999999752                        3467899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          500 LEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |||++||+|.+++....   ..+++..+..++.||+.|+.|||   ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999987643   36899999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....  .....+||+.||||
T Consensus       341 ~~~~--~~~~~~GT~~Y~AP  358 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAP  358 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCH
T ss_pred             CCCc--ccccccCCccccCh
Confidence            3221  23346899999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.91  E-value=1.9e-24  Score=219.80  Aligned_cols=146  Identities=26%  Similarity=0.428  Sum_probs=129.0

Q ss_pred             cccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .++|...+.||+|+||.||++.                           +.+.+|+.++++++|||||++++++..++..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3578999999999999999852                           3478999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC----cEEEeccccc
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM----VAHLSDFSIA  572 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~----~~kl~dfGla  572 (596)
                      |+||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            99999999999999997653 6889999999999999999999   89999999999999999877    8999999999


Q ss_pred             cccCCCCCccccccccccccccCC
Q 036342          573 KLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +......   .....+||+.|+||
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aP  186 (326)
T 2y0a_A          166 HKIDFGN---EFKNIFGTPEFVAP  186 (326)
T ss_dssp             EECCTTS---CCCCCCSCTTTCCH
T ss_pred             eECCCCC---ccccccCCcCcCCc
Confidence            8764322   22346799999998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.91  E-value=8.7e-25  Score=222.37  Aligned_cols=147  Identities=25%  Similarity=0.384  Sum_probs=122.3

Q ss_pred             cccccccccccCCCceeehhhH----------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      .++|+..+.||+|+||.||++.                            ..+.+|+.++++++|||||++++++..++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            4689999999999999999631                            235679999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999997654 5788999999999999999999   889999999999999999999999999999864


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....  ......+||+.|+||
T Consensus       172 ~~~~--~~~~~~~gt~~y~aP  190 (327)
T 3a62_A          172 IHDG--TVTHTFCGTIEYMAP  190 (327)
T ss_dssp             ---------CTTSSCCTTSCH
T ss_pred             ccCC--ccccccCCCcCccCH
Confidence            3221  123446799999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.91  E-value=9.6e-25  Score=220.58  Aligned_cols=151  Identities=23%  Similarity=0.421  Sum_probs=131.2

Q ss_pred             hcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      ..++|...+.||+|+||.||+|.                           +.+.+|+.++++++||||+++++++..++.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            45789999999999999999751                           356789999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC
Q 036342          496 KALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLK  552 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk  552 (596)
                      .|+||||+++|+|.+++....                       ..+++.+++.++.|+++|+.|||   ..+|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence            999999999999999998643                       23788999999999999999999   8899999999


Q ss_pred             CCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          553 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       553 ~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+||+++.++.+||+|||+++...............+|+.|+||
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  221 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI  221 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence            99999999999999999999876543332233445678899998

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.91  E-value=6.3e-25  Score=224.88  Aligned_cols=154  Identities=27%  Similarity=0.438  Sum_probs=131.1

Q ss_pred             HHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeecc
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSN  492 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~  492 (596)
                      +....++|...+.||+|+||.||+|.                           +.+.+|+.++++++||||+++++++..
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            33456789999999999999999752                           347789999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeC
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHC  549 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hr  549 (596)
                      ++..|+||||+++|+|.+++....                       ..+++.+++.++.|+++|+.|||   ..+|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            999999999999999999998642                       45889999999999999999999   8899999


Q ss_pred             CCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          550 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       550 dlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||||+||+++.++.+||+|||+++...............||+.|+||
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  245 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  245 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence            99999999999999999999999865432222223345789999998

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=1.5e-24  Score=221.49  Aligned_cols=249  Identities=18%  Similarity=0.242  Sum_probs=142.0

Q ss_pred             CCEEEccCCcccccCCccccCC--CCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCcc-CCchhhhccc
Q 036342           85 LSKLSLGMNSFSGFIPSTFGNL--RNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGI-LPKTSISNLS  161 (596)
Q Consensus        85 L~~L~L~~N~i~~~~~~~~~~l--~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~~l~  161 (596)
                      ++.|++++|.+.   +..+..+  ++++.|++++|.+++..+.      +..+++|++|++++|.+++. ++. .+..+ 
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~------~~~~~~L~~L~L~~~~l~~~~~~~-~~~~~-  117 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE------HFSPFRVQHMDLSNSVIEVSTLHG-ILSQC-  117 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS------CCCCBCCCEEECTTCEECHHHHHH-HHTTB-
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh------hccCCCCCEEEccCCCcCHHHHHH-HHhhC-
Confidence            444444444443   2333333  4455555555554443322      33445555555555554432 221 33344 


Q ss_pred             ccccEEEccccccccccChhccCCCCCCEEEccCC-cccCC-CCccccCCCCCCeEEccCC-ccccc-CccchhcCC-CC
Q 036342          162 RSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN-KLNGS-IPITLGKLRKLQRLNLEDN-ILEGS-IPDDICRLA-EL  236 (596)
Q Consensus       162 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L  236 (596)
                      ++|++|++++|.+++..+..+..+++|++|++++| .+++. .+..+..+++|++|++++| .+++. ++..+..++ +|
T Consensus       118 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L  197 (336)
T 2ast_B          118 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI  197 (336)
T ss_dssp             CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred             CCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCC
Confidence            45666666666666555666666677777777776 45542 4455666677777777777 66643 455566666 77


Q ss_pred             cEEEccCC--cCc-ccchhhhccCCCCcEEEeCCCc-ccC-CCcccccccccceEEcccCC-CCCchhhhhccccccceE
Q 036342          237 YRLELGSN--KLY-GSIPACFGNLASLRILSLGSNK-LTS-IPLTFWNLKDILQLNFSSNF-LTGPLLLEIGNLKVLIGI  310 (596)
Q Consensus       237 ~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~-ip~~~~~l~~L~~L~ls~N~-l~~~~~~~~~~l~~L~~L  310 (596)
                      ++|++++|  .++ +.+|..+..+++|+.|+|++|. ++. .+..+..+++|++|++++|. ++......+..+++|+.|
T Consensus       198 ~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L  277 (336)
T 2ast_B          198 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL  277 (336)
T ss_dssp             CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             CEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEE
Confidence            77777777  344 3455666667777777777777 443 45566667777777777774 333333356667777777


Q ss_pred             ecCCCcCcccCChhhhccC-CCCCeEECCCCcccccCCCC
Q 036342          311 DFSMNNFSGVIPREIGEKL-SYLEDLNLSFNKLKGEIPRG  349 (596)
Q Consensus       311 ~ls~N~~~~~~~~~~~~~l-~~L~~L~l~~N~l~~~~p~~  349 (596)
                      ++++| ++    ...+..+ ..++.|++++|++++..|..
T Consensus       278 ~l~~~-i~----~~~~~~l~~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          278 QVFGI-VP----DGTLQLLKEALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             ECTTS-SC----TTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred             eccCc-cC----HHHHHHHHhhCcceEEecccCccccCCc
Confidence            77777 33    2222222 23666667777777766553

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.91  E-value=1.3e-24  Score=231.61  Aligned_cols=148  Identities=24%  Similarity=0.413  Sum_probs=116.3

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-----Ce
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-----EF  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  495 (596)
                      .++|+..+.||+|+||+||+|.                       +.+.+|+.++++++|||||++++++...     +.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            4689999999999999999852                       4577899999999999999999999443     56


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+||||+ +|+|.+++.... .+++..+..++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 579999987653 6899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCc-------------------------cccccccccccccCC
Q 036342          576 TGEDQS-------------------------MTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~-------------------------~~~~~~~gt~~y~aP  596 (596)
                      ......                         ......+||++|+||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP  252 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP  252 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCH
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccCh
Confidence            422110                         123456889999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.91  E-value=2.2e-24  Score=229.41  Aligned_cols=146  Identities=27%  Similarity=0.464  Sum_probs=130.2

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|...+.||+|+||.||+|.                        +.+.+|+.+++.++||||+++++++..++..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4579999999999999999752                        2467899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999997653 6899999999999999999999   9999999999999999999999999999998764321


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         .....+||+.|+||
T Consensus       171 ---~~~~~~gt~~y~aP  184 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAP  184 (476)
T ss_dssp             ---CBCCCCSCSTTCCH
T ss_pred             ---cccccCCCcCeECh
Confidence               23456899999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.91  E-value=2.2e-24  Score=218.49  Aligned_cols=147  Identities=25%  Similarity=0.418  Sum_probs=114.6

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .++|+..+.||+|+||.||+|.                      +.+.+|+.++++++|||||++++++..++..|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            4689999999999999999852                      357789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          502 YMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |++ |+|.+++....     ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999987542     35889999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....  ......||+.|+||
T Consensus       160 ~~~~--~~~~~~~t~~y~aP  177 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAP  177 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCH
T ss_pred             CCcc--cCCCCcccccccCc
Confidence            3221  22345789999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.2e-24  Score=223.07  Aligned_cols=154  Identities=24%  Similarity=0.413  Sum_probs=132.6

Q ss_pred             HHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeec
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCS  491 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~  491 (596)
                      ++...++|...+.||+|+||.||+|.                           +.+.+|+.+++++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34456789999999999999999742                           3477899999999 9999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhccCCCceEeC
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSSNC----------------------ILDIFQRLNIMIDVASALEYLHFGYSALVIHC  549 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hr  549 (596)
                      .++..|+||||+++|+|.+++.....                      .+++..++.++.|++.|+.|||   ..+|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence            99999999999999999999986542                      2788999999999999999999   8999999


Q ss_pred             CCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          550 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       550 dlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||||+||+++.++.+||+|||+++...............||+.|+||
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  243 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  243 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence            99999999999999999999999876433322233445688899998

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.91  E-value=1.6e-24  Score=217.48  Aligned_cols=147  Identities=26%  Similarity=0.464  Sum_probs=125.1

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------------------------------HhHHHHHHHH
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------------------------------KSFDVECEMM  475 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------------------------------~~~~~e~~~l  475 (596)
                      ..++|...+.||+|+||.||+|.                                               +.+.+|++++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            35689999999999999999852                                               2367899999


Q ss_pred             hhcCCCccceeeeeecc--CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCC
Q 036342          476 KSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKP  553 (596)
Q Consensus       476 ~~l~H~niv~l~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~  553 (596)
                      ++++||||+++++++..  ++..|+||||+++|+|.+++..  ..+++.++..++.|+++|+.|||   ..+|+||||||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  165 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP  165 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence            99999999999999986  5679999999999999887543  35899999999999999999999   88999999999


Q ss_pred             CCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          554 SNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       554 ~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +||+++.++.+||+|||+++.......  ......||+.|+||
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  206 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAP  206 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCG
T ss_pred             HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccCh
Confidence            999999999999999999987643221  23346799999998

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.90  E-value=1.8e-24  Score=224.01  Aligned_cols=144  Identities=24%  Similarity=0.433  Sum_probs=121.4

Q ss_pred             ccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          447 FSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      |...+.||+|+||.||+|.                     +.+.+|+.++++++|||||++++++..++..|+||||+++
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            3446789999999999852                     4578999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee--CCCCcEEEeccccccccCCCCCccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL--DDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl--~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      |+|.+++......+++..+..++.|+++|+.|||   ..+|+||||||+|||+  +.++.+||+|||+++.+....   .
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~  244 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K  244 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence            9999999876667899999999999999999999   8899999999999999  677899999999998764322   2


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      ....+||++|+||
T Consensus       245 ~~~~~gt~~y~aP  257 (373)
T 2x4f_A          245 LKVNFGTPEFLAP  257 (373)
T ss_dssp             CCCCCSSCTTCCH
T ss_pred             cccccCCCcEeCh
Confidence            2345799999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.90  E-value=6.7e-25  Score=233.04  Aligned_cols=148  Identities=28%  Similarity=0.343  Sum_probs=123.1

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..++|+..+.||+|+||.||+|.                        ..+.+|+.++++++||||+++++++...+..|+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            35689999999999999999742                        235678999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   . .+|+||||||+|||++.++.+||+|||+|+....
T Consensus       226 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999997654 6889999999999999999999   7 8899999999999999999999999999986432


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .  .......+||++|+||
T Consensus       302 ~--~~~~~~~~gt~~y~aP  318 (446)
T 4ejn_A          302 D--GATMKTFCGTPEYLAP  318 (446)
T ss_dssp             -------CCSSSCGGGCCH
T ss_pred             C--CcccccccCCccccCH
Confidence            2  2223457899999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.90  E-value=2e-24  Score=220.03  Aligned_cols=149  Identities=26%  Similarity=0.347  Sum_probs=130.0

Q ss_pred             cccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      .++|...+.||+|+||.||+|.                   +.+.+|+.+++++ +||||+++++++..++..|+||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            3579999999999999999863                   3578999999999 9999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc-----EEEeccccccccCCC
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV-----AHLSDFSIAKLLTGE  578 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~-----~kl~dfGla~~~~~~  578 (596)
                       +|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.     +||+|||+++.+...
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence             99999999876667899999999999999999999   889999999999999998887     999999999876433


Q ss_pred             CCcc-----ccccccccccccCC
Q 036342          579 DQSM-----TQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~-----~~~~~~gt~~y~aP  596 (596)
                      ....     .....+||+.|+||
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aP  186 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSI  186 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             CCCccccccccCCcCCCccccCh
Confidence            2211     12356899999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.90  E-value=7e-25  Score=221.49  Aligned_cols=145  Identities=22%  Similarity=0.256  Sum_probs=122.8

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||+||+|.                       .....|+..+.++ +|||||+++++|.+++..|+||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            579999999999999999852                       1234455555544 9999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+ +|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 77999999887767999999999999999999999   8899999999999999999999999999998764321 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......||++|+||
T Consensus       212 --~~~~~~gt~~y~aP  225 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAP  225 (311)
T ss_dssp             -----CCCCCGGGCCG
T ss_pred             --CCcccCCCccccCH
Confidence              23345799999998

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.90  E-value=1.7e-24  Score=215.50  Aligned_cols=151  Identities=24%  Similarity=0.419  Sum_probs=128.7

Q ss_pred             HhcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ...++|+..+.||+|+||.||++.                   +.+.+|++++++++||||+++++++..++..|+||||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            345689999999999999999752                   4678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++|+|.+++......+++.++..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence            9999999999875557899999999999999999999   8999999999999999999999999999998654221 11


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......+|+.|+||
T Consensus       177 ~~~~~~~~~~y~aP  190 (283)
T 3gen_A          177 SSVGSKFPVRWSPP  190 (283)
T ss_dssp             STTSTTSCGGGCCH
T ss_pred             cccCCccCcccCCH
Confidence            22334577889998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.90  E-value=1.7e-24  Score=223.24  Aligned_cols=146  Identities=25%  Similarity=0.343  Sum_probs=120.9

Q ss_pred             cccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      .++|...+.||+|+||+||++.                    +.+.+|+.++++++|||||++++++..++..|+||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            4689999999999999999752                    45789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc--EEEeccccccccCCCCCc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV--AHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~--~kl~dfGla~~~~~~~~~  581 (596)
                      ++|+|.+++.... .+++..+..++.|+++|+.|||   ..+|+||||||+||+++.++.  +||+|||+++.....   
T Consensus        99 ~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---  171 (361)
T 3uc3_A           99 SGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---  171 (361)
T ss_dssp             CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc---
Confidence            9999999997654 5889999999999999999999   899999999999999987665  999999999854221   


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      ......+||++|+||
T Consensus       172 ~~~~~~~gt~~y~aP  186 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAP  186 (361)
T ss_dssp             ---------CTTSCH
T ss_pred             CCCCCCcCCCCcCCh
Confidence            123345799999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.90  E-value=1.2e-24  Score=217.24  Aligned_cols=146  Identities=23%  Similarity=0.398  Sum_probs=125.6

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|+||.||+|.                      +.+.+|++++++++||||+++++++..++..|+||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            578999999999999999852                      3567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++ +|.+++......+++..+..++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence            975 999999876667899999999999999999999   88999999999999999999999999999987543211  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......||+.|+||
T Consensus       156 ~~~~~~~t~~y~aP  169 (288)
T 1ob3_A          156 KYTHEIVTLWYRAP  169 (288)
T ss_dssp             ------CCCTTCCH
T ss_pred             ccccccccccccCc
Confidence            22345789999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.90  E-value=8.9e-25  Score=221.76  Aligned_cols=159  Identities=19%  Similarity=0.373  Sum_probs=134.1

Q ss_pred             cCHHHHHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceee
Q 036342          435 FSYLELCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVI  487 (596)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~  487 (596)
                      +..+++....++|...+.||+|+||.||+|.                           ..+.+|+.++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            3444555667899999999999999999741                           2477899999999999999999


Q ss_pred             eeeccCCeeEEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee
Q 036342          488 SSCSNEEFKALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL  558 (596)
Q Consensus       488 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl  558 (596)
                      +++..++..++||||+++|+|.+++....         ..+++..++.++.|++.|+.|||   ..+|+||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence            99999999999999999999999987532         34688999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          559 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       559 ~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +.++.+||+|||+++...............||+.|+||
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  209 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccCh
Confidence            99999999999999865432222223345678899998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.90  E-value=1.4e-24  Score=215.80  Aligned_cols=149  Identities=23%  Similarity=0.389  Sum_probs=118.4

Q ss_pred             hcccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ..++|+..+.||+|+||.||+|.                         +.+.+|+.++++++||||+++++++. ++..|
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            45689999999999999999742                         35778999999999999999999985 45689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999999877667899999999999999999999   88999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .. ........+|+.|+||
T Consensus       169 ~~-~~~~~~~~~~~~y~aP  186 (281)
T 1mp8_A          169 ST-YYKASKGKLPIKWMAP  186 (281)
T ss_dssp             -----------CCGGGCCH
T ss_pred             cc-ccccccCCCcccccCh
Confidence            22 1122334678899998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.90  E-value=8.6e-25  Score=223.00  Aligned_cols=154  Identities=23%  Similarity=0.401  Sum_probs=131.6

Q ss_pred             HHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeec
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCS  491 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~  491 (596)
                      ++...++|...+.||+|+||.||+|.                           +.+.+|+.+++++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34456789999999999999999752                           3477899999999 8999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSS-------------NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL  558 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl  558 (596)
                      .++..|+||||+++|+|.+++...             ...+++..++.++.|++.|+.|||   ..+|+||||||+||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence            999999999999999999998753             234789999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          559 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       559 ~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +.++.+||+|||+++...............||+.|+||
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  235 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP  235 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCH
Confidence            99999999999999866433222223345678899998

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=4.7e-23  Score=201.34  Aligned_cols=177  Identities=25%  Similarity=0.271  Sum_probs=97.4

Q ss_pred             CCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEec
Q 036342           35 TLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGL  114 (596)
Q Consensus        35 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l  114 (596)
                      +.++++++++.++ .+|...   .++|+.|+|++|.+++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGI---PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCC---CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCeEEecCCCCcc-ccCCCC---CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            4567777777776 344321   246777777777777666667777777777777777777777766777777777777


Q ss_pred             CCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEcc
Q 036342          115 DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLG  194 (596)
Q Consensus       115 ~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls  194 (596)
                      ++|.++.+++.     .|..+++|++|+|++|+|++..+. .+..+ ++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        91 ~~n~l~~~~~~-----~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  163 (251)
T 3m19_A           91 ANNQLASLPLG-----VFDHLTQLDKLYLGGNQLKSLPSG-VFDRL-TKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLS  163 (251)
T ss_dssp             TTSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTT-TTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCcccccChh-----HhcccCCCCEEEcCCCcCCCcChh-HhccC-CcccEEECcCCcCCccCHHHcCcCcCCCEEECC
Confidence            77777665443     355566666666666655543221 22333 334444444444443333333334444444444


Q ss_pred             CCcccCCCCccccCCCCCCeEEccCCcc
Q 036342          195 GNKLNGSIPITLGKLRKLQRLNLEDNIL  222 (596)
Q Consensus       195 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l  222 (596)
                      +|++++..+..|..+++|++|++++|.+
T Consensus       164 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~  191 (251)
T 3m19_A          164 TNQLQSVPHGAFDRLGKLQTITLFGNQF  191 (251)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred             CCcCCccCHHHHhCCCCCCEEEeeCCce
Confidence            4444333333333333333333333333

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.90  E-value=9.5e-24  Score=216.80  Aligned_cols=229  Identities=17%  Similarity=0.181  Sum_probs=188.0

Q ss_pred             CCCcccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccE-EEccCCccccccCccc
Q 036342            1 EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEK-LYLWGNNFSGTIPRFI   79 (596)
Q Consensus         1 ~ip~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~   79 (596)
                      +||.++  .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.++...|..+++|++ ++++.|+++...|..|
T Consensus        23 ~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f  100 (350)
T 4ay9_X           23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF  100 (350)
T ss_dssp             SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSB
T ss_pred             ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhh
Confidence            578877  4789999999999998777899999999999999999987888877778888775 6677899998889999


Q ss_pred             cCCCCCCEEEccCCcccccCCccccCCCCCCEEecCC-CcCcCCCCCccccccCCCCC-CCCEEECcCCCCCccCCchhh
Q 036342           80 FNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE-NYLTSSTPELSFLSSLSNCK-SLTLIDLSNNPLDGILPKTSI  157 (596)
Q Consensus        80 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~~~~~~l~-~L~~L~ls~N~l~~~~~~~~~  157 (596)
                      .++++|++|++++|+|+...+..+....++..|++.+ |.+..++..     .|..+. .++.|++++|+|+.+.+. .+
T Consensus       101 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~-----~f~~~~~~l~~L~L~~N~i~~i~~~-~f  174 (350)
T 4ay9_X          101 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN-----SFVGLSFESVILWLNKNGIQEIHNS-AF  174 (350)
T ss_dssp             CCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTT-----SSTTSBSSCEEEECCSSCCCEECTT-SS
T ss_pred             hhccccccccccccccccCCchhhcccchhhhhhhcccccccccccc-----chhhcchhhhhhccccccccCCChh-hc
Confidence            9999999999999999998888888888899999865 678776654     466664 688999999999876443 44


Q ss_pred             hcccccccEEEccc-cccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCC-cccccCccchhcCCC
Q 036342          158 SNLSRSLEEFYMYN-CNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN-ILEGSIPDDICRLAE  235 (596)
Q Consensus       158 ~~l~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~  235 (596)
                      ..  .+|++|++++ |.++.+.+.+|.++++|++||+++|+|+..++..|.   +|+.|.+.++ .++ .+| .+..+++
T Consensus       175 ~~--~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~-~lP-~l~~l~~  247 (350)
T 4ay9_X          175 NG--TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNLK-KLP-TLEKLVA  247 (350)
T ss_dssp             TT--EEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTCC-CCC-CTTTCCS
T ss_pred             cc--cchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCcC-cCC-CchhCcC
Confidence            33  4799999975 778777678899999999999999999977666555   4555554444 344 666 4888999


Q ss_pred             CcEEEccCC
Q 036342          236 LYRLELGSN  244 (596)
Q Consensus       236 L~~L~Ls~N  244 (596)
                      |+.++++++
T Consensus       248 L~~l~l~~~  256 (350)
T 4ay9_X          248 LMEASLTYP  256 (350)
T ss_dssp             CCEEECSCH
T ss_pred             hhhCcCCCC
Confidence            999999765

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.90  E-value=3.5e-24  Score=217.13  Aligned_cols=147  Identities=26%  Similarity=0.420  Sum_probs=127.5

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC--eeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE--FKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lV  499 (596)
                      .++|...+.||+|+||.||+|.                      +.+.+|++++++++||||+++++++...+  ..|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            3579999999999999999852                      34678999999999999999999987654  78999


Q ss_pred             EecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee----CCCCcEEEecccccc
Q 036342          500 LEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL----DDNMVAHLSDFSIAK  573 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl----~~~~~~kl~dfGla~  573 (596)
                      |||+++|+|.+++....  ..+++.++..++.|++.|+.|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999998754  23899999999999999999999   8899999999999999    788899999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ......   ......||+.|+||
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aP  184 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHP  184 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCH
T ss_pred             ecCCCC---ceeecccCCCccCH
Confidence            764332   22345799999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.90  E-value=1.7e-24  Score=216.30  Aligned_cols=150  Identities=25%  Similarity=0.405  Sum_probs=118.7

Q ss_pred             hcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ..++|...+.||+|+||.||+|.                    +.+.+|+.++++++||||+++++++. .+..++||||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~  100 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQW  100 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEEe
Confidence            45689999999999999999852                    45789999999999999999999764 4568999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +++++|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.........
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred             cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence            9999999999877667899999999999999999999   8899999999999999999999999999998654322222


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......||+.|+||
T Consensus       178 ~~~~~~gt~~y~aP  191 (289)
T 3og7_A          178 QFEQLSGSILWMAP  191 (289)
T ss_dssp             ------CCCTTCCH
T ss_pred             cccccCCCccccCc
Confidence            23446799999998

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.90  E-value=1.9e-24  Score=219.85  Aligned_cols=149  Identities=25%  Similarity=0.423  Sum_probs=122.5

Q ss_pred             cccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      .++|+..+.||+|+||.||+|.                          +.+.+|+.++++++||||+++++++..++ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            3579999999999999999852                          45788999999999999999999998765 78


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|+||+++|+|.+++......+++..++.++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887767899999999999999999999   88999999999999999999999999999987644


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...........+|+.|+||
T Consensus       170 ~~~~~~~~~~~~t~~y~aP  188 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             ----------CCCGGGSCH
T ss_pred             ccccccccCCCccccccCH
Confidence            3322233345678899998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.90  E-value=3e-24  Score=230.70  Aligned_cols=151  Identities=26%  Similarity=0.465  Sum_probs=131.6

Q ss_pred             HhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ...++|...+.||+|+||.||+|.                    +.+.+|+.++++++|||||+++++|..++..|+|||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            345678999999999999999852                    468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||++|+|.+++.... ..+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-  372 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence            999999999998743 45889999999999999999999   8999999999999999999999999999998764322 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                      ........+|+.|+||
T Consensus       373 ~~~~~~~~~~~~y~aP  388 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAP  388 (495)
T ss_dssp             EECCTTCCCCGGGCCH
T ss_pred             eeecCCCcCCcceeCH
Confidence            2222344577899998

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.90  E-value=2.7e-24  Score=217.15  Aligned_cols=151  Identities=23%  Similarity=0.413  Sum_probs=131.4

Q ss_pred             hcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEE  494 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  494 (596)
                      ..++|...+.||+|+||.||+|.                           +.+.+|+.+++++ +||||+++++++..++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            45689999999999999999752                           3577899999999 9999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCee
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNC-----------------ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL  557 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NIL  557 (596)
                      ..++||||+++|+|.+++.....                 .+++..++.++.|+++|+.|||   ..+|+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence            99999999999999999986542                 3889999999999999999999   889999999999999


Q ss_pred             eCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       558 l~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++.++.+||+|||+++...............||+.|+||
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  216 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence            999999999999999876543322223345678899998

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=4.1e-23  Score=208.01  Aligned_cols=208  Identities=22%  Similarity=0.376  Sum_probs=162.3

Q ss_pred             EECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCc
Q 036342           15 LQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNS   94 (596)
Q Consensus        15 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~   94 (596)
                      +.+..+.+++..+  +..+++|++|++++|.++ .++.+.  .+++|++|+|++|.+++..+  +..+++|++|+|++|+
T Consensus        24 ~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~~~~--~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~   96 (308)
T 1h6u_A           24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQ--YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP   96 (308)
T ss_dssp             HHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCTTGG--GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred             HHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cchhhh--ccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence            3455555554332  345678888888888887 455443  48888888888888885443  8888888888888888


Q ss_pred             ccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEcccccc
Q 036342           95 FSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNI  174 (596)
Q Consensus        95 i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l  174 (596)
                      +++.  +.|..+++|++|++++|.++.++       .+..+++|+.|++++|.+++..+   +..+ ++|++|++++|.+
T Consensus        97 l~~~--~~~~~l~~L~~L~l~~n~l~~~~-------~l~~l~~L~~L~l~~n~l~~~~~---l~~l-~~L~~L~l~~n~l  163 (308)
T 1h6u_A           97 LKNV--SAIAGLQSIKTLDLTSTQITDVT-------PLAGLSNLQVLYLDLNQITNISP---LAGL-TNLQYLSIGNAQV  163 (308)
T ss_dssp             CSCC--GGGTTCTTCCEEECTTSCCCCCG-------GGTTCTTCCEEECCSSCCCCCGG---GGGC-TTCCEEECCSSCC
T ss_pred             CCCc--hhhcCCCCCCEEECCCCCCCCch-------hhcCCCCCCEEECCCCccCcCcc---ccCC-CCccEEEccCCcC
Confidence            8864  36888888899999888887742       37788889999999998886532   5566 6799999999998


Q ss_pred             ccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcc
Q 036342          175 SGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG  248 (596)
Q Consensus       175 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  248 (596)
                      ++..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|.+++..  .+..+++|+.|++++|++++
T Consensus       164 ~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          164 SDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred             CCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence            87544  8889999999999999987654  788999999999999998544  37889999999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.90  E-value=1.4e-24  Score=217.46  Aligned_cols=150  Identities=26%  Similarity=0.464  Sum_probs=124.6

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccC--Cee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  496 (596)
                      .++|+..+.||+|+||.||++.                         +.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            4689999999999999998752                         4578999999999999999999998653  458


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ++||||+++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999887666899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCc-cccccccccccccCC
Q 036342          577 GEDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aP  596 (596)
                      ..... .......+|+.|+||
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aP  186 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAP  186 (295)
T ss_dssp             ----------CTTCGGGGCCH
T ss_pred             CCcceeeeccCCCCccceeCc
Confidence            33221 122334578889998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.90  E-value=5.4e-24  Score=211.11  Aligned_cols=146  Identities=30%  Similarity=0.427  Sum_probs=129.7

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|...+.||+|+||.||+|.                     +.+.+|++++++++||||+++++++..++..|+||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            4679999999999999999852                     4678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee---CCCCcEEEeccccccccCCCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl---~~~~~~kl~dfGla~~~~~~~  579 (596)
                      +++++|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||++   +.++.+||+|||+++......
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999987754 5789999999999999999999   8999999999999999   788999999999998764322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         ......||+.|+||
T Consensus       164 ---~~~~~~~t~~y~aP  177 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSP  177 (277)
T ss_dssp             ---CBCCCCSCTTTCCH
T ss_pred             ---chhccCCCCCccCh
Confidence               23345799999998

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.90  E-value=2e-24  Score=215.58  Aligned_cols=144  Identities=24%  Similarity=0.417  Sum_probs=128.1

Q ss_pred             cccccccccccCCCceeehhhH----------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      .++|...+.||+|+||.||+|.                            +.+.+|+.++++++||||+++++++..++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4689999999999999999851                            457789999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc--------EEEe
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV--------AHLS  567 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~--------~kl~  567 (596)
                      .++||||+++|+|.+++......+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999887656899999999999999999999   899999999999999988876        9999


Q ss_pred             ccccccccCCCCCccccccccccccccCC
Q 036342          568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       568 dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||+++....      .....||+.|+||
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aP  186 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPP  186 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCH
T ss_pred             cCcccccccC------ccccCCcCcccCH
Confidence            9999875421      2234688899998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.90  E-value=3.6e-24  Score=214.74  Aligned_cols=150  Identities=25%  Similarity=0.422  Sum_probs=126.7

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeec-cCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCS-NEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~  497 (596)
                      ...|...+.||+|+||.||+|.                         +.+.+|+.++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            4568889999999999999742                         35778999999999999999999864 556789


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999999876667899999999999999999999   88999999999999999999999999999987643


Q ss_pred             CCC--ccccccccccccccCC
Q 036342          578 EDQ--SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~--~~~~~~~~gt~~y~aP  596 (596)
                      ...  ........||+.|+||
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aP  201 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMAL  201 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCH
T ss_pred             cchhccccccCCCCCccccCh
Confidence            221  1123345678899998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.90  E-value=6.7e-24  Score=235.72  Aligned_cols=148  Identities=23%  Similarity=0.272  Sum_probs=129.6

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  497 (596)
                      ..++|+..+.||+|+||.||+|.                        +.+..|..+++.+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            45689999999999999999752                        2356788888887 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++.... .+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998754 5899999999999999999999   89999999999999999999999999999986432


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..  ......+||+.||||
T Consensus       495 ~~--~~~~~~~GT~~Y~AP  511 (674)
T 3pfq_A          495 DG--VTTKTFCGTPDYIAP  511 (674)
T ss_dssp             TT--CCBCCCCSCSSSCCH
T ss_pred             CC--cccccccCCCcccCH
Confidence            22  234557899999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.90  E-value=4.5e-24  Score=216.88  Aligned_cols=141  Identities=25%  Similarity=0.375  Sum_probs=111.3

Q ss_pred             cccccCCCceeehhhH------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEecCCCCCHHH
Q 036342          450 NNLIGRGGFALFIRAF------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEK  510 (596)
Q Consensus       450 ~~~ig~G~~g~v~~~~------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~  510 (596)
                      .+.||+|+||.||+|.                  ..+.+|+.++++++ |||||++++++.+++..|+||||+++|+|.+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE   95 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence            4789999999999852                  45778999999997 9999999999999999999999999999999


Q ss_pred             HHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC---cEEEeccccccccCCCCCccccccc
Q 036342          511 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM---VAHLSDFSIAKLLTGEDQSMTQTQT  587 (596)
Q Consensus       511 ~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~---~~kl~dfGla~~~~~~~~~~~~~~~  587 (596)
                      ++.... .+++.++..++.|++.|+.|||   ..+|+||||||+||+++.++   .+||+|||+++......  ......
T Consensus        96 ~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~  169 (325)
T 3kn6_A           96 RIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTP  169 (325)
T ss_dssp             HHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred             HHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cccccc
Confidence            998764 6899999999999999999999   89999999999999997665   89999999998654322  223456


Q ss_pred             cccccccCC
Q 036342          588 LGTIGYMAP  596 (596)
Q Consensus       588 ~gt~~y~aP  596 (596)
                      +||+.|+||
T Consensus       170 ~~t~~y~aP  178 (325)
T 3kn6_A          170 CFTLHYAAP  178 (325)
T ss_dssp             ---------
T ss_pred             CCCcCccCH
Confidence            789999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.90  E-value=3.7e-24  Score=226.19  Aligned_cols=148  Identities=24%  Similarity=0.404  Sum_probs=124.9

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-----Ce
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-----EF  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  495 (596)
                      .++|...+.||+|+||.||+|.                       +.+.+|+.++++++|||||++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            4689999999999999999852                       4577999999999999999999999766     56


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+||||++ |+|.++++.. ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 5999999765 35899999999999999999999   889999999999999999999999999999976


Q ss_pred             CCCCCc--------------------cccccccccccccCC
Q 036342          576 TGEDQS--------------------MTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~--------------------~~~~~~~gt~~y~aP  596 (596)
                      ......                    ......+||++|+||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  220 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP  220 (432)
T ss_dssp             -------------------------------CCCCCTTCCH
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCH
Confidence            432211                    113557899999998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.90  E-value=7.2e-24  Score=210.30  Aligned_cols=149  Identities=27%  Similarity=0.453  Sum_probs=120.8

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..++|...+.||+|+||.||+|.                        +.+.+|+.++++++||||+++++++..++..|+
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            34689999999999999999852                        357789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++......+++..+..++.|+++|+.|||   ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999999877667899999999999999999999   889999999999999999999999999999875422


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      ..  ......||+.|+||
T Consensus       166 ~~--~~~~~~~~~~y~aP  181 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISP  181 (278)
T ss_dssp             ------------------
T ss_pred             CC--cceeccCCCCcCCc
Confidence            21  12345789999998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.90  E-value=8.8e-24  Score=215.66  Aligned_cols=151  Identities=28%  Similarity=0.481  Sum_probs=130.3

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhc-CCCccceeeeeecc
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSI-RHRNLIKVISSCSN  492 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~  492 (596)
                      ..++|...+.||+|+||.||+|.                             +.+.+|+.+++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            35789999999999999999751                             3467899999999 99999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCee
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVL  557 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NIL  557 (596)
                      ++..|+||||+++|+|.+++....               ..+++..++.++.|++.|+.|||   ..+|+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence            999999999999999999998653               23789999999999999999999   889999999999999


Q ss_pred             eCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          558 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       558 l~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++.++.+||+|||+++...............+|+.|+||
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  228 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  228 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence            999999999999999876543322223345678899998

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=6.8e-23  Score=200.18  Aligned_cols=158  Identities=26%  Similarity=0.285  Sum_probs=89.1

Q ss_pred             ccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEc
Q 036342          162 RSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLEL  241 (596)
Q Consensus       162 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (596)
                      ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|+|
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  114 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL  114 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence            34555555555555555555556666666666666666555555556666666666666665444445555556666666


Q ss_pred             cCCcCcccchhhhccCCCCcEEEeCCCcccCCCc-ccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcc
Q 036342          242 GSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSG  319 (596)
Q Consensus       242 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~  319 (596)
                      ++|++++..+..|..+++|+.|+|++|+++.+|. .+..+++|++|++++|++++..+..+..+++|+.|++++|.+++
T Consensus       115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            6666555555555555566666666665555544 34455555555555555555444455555555555555555543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.90  E-value=4.1e-24  Score=218.51  Aligned_cols=148  Identities=26%  Similarity=0.422  Sum_probs=127.3

Q ss_pred             hcccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      ..++|+..+.||+|+||.||++.                 ....+|++++.++ +|||||++++++.+++..|+|||||+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   99 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK   99 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence            35689999999999999999863                 2356799999888 79999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC----CcEEEeccccccccCCCCC
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN----MVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~----~~~kl~dfGla~~~~~~~~  580 (596)
                      +|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||++.++    +.+||+|||+++.......
T Consensus       100 gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A          100 GGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             SCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            999999997654 5899999999999999999999   8899999999999998543    3599999999987643321


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        .....+||+.|+||
T Consensus       176 --~~~~~~gt~~y~aP  189 (342)
T 2qr7_A          176 --LLMTPCYTANFVAP  189 (342)
T ss_dssp             --CBCCSSCCSSCCCH
T ss_pred             --ceeccCCCccccCH
Confidence              23456899999998

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.90  E-value=6.3e-24  Score=213.36  Aligned_cols=149  Identities=22%  Similarity=0.442  Sum_probs=128.7

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccC--Cee
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFK  496 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  496 (596)
                      +.|+..+.||+|+||.||+|.                          +.+.+|+.++++++||||+++++++..+  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            468899999999999998752                          3577899999999999999999999876  568


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ++||||+++|+|.+++......+++.++..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999776667899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc-cccccccccccccCC
Q 036342          577 GEDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aP  596 (596)
                      ..... .......||..|+||
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aP  198 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAP  198 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCH
T ss_pred             CCCcceeccCCCCCCccccCC
Confidence            43221 123345688889998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.90  E-value=3.3e-24  Score=220.04  Aligned_cols=147  Identities=26%  Similarity=0.410  Sum_probs=116.5

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..++|+..+.||+|+||.||+|.                   +.+.+|+.++++++||||+++++++..++..++||||+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            35679999999999999999852                   34678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEeccccccccCCCCC
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~dfGla~~~~~~~~  580 (596)
                      ++|+|.+++.... .+++.++..++.|++.|+.|||   ..+|+||||||+||+++.   ++.+||+|||+++.....  
T Consensus       131 ~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--  204 (349)
T 2w4o_A          131 TGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--  204 (349)
T ss_dssp             CSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--
Confidence            9999999997654 5889999999999999999999   889999999999999975   889999999999865322  


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                       ......+||+.|+||
T Consensus       205 -~~~~~~~gt~~y~aP  219 (349)
T 2w4o_A          205 -VLMKTVCGTPGYCAP  219 (349)
T ss_dssp             ---------CGGGSCH
T ss_pred             -cccccccCCCCccCH
Confidence             122346799999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.90  E-value=6.8e-24  Score=210.66  Aligned_cols=146  Identities=28%  Similarity=0.457  Sum_probs=126.5

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..++|+..+.||+|+||.||+|.                        +.+.+|+.++++++||||+++++++...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            45789999999999999999852                        346789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            999999999999997654 5789999999999999999999   899999999999999999999999999998754322


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                          ......||+.|+||
T Consensus       163 ----~~~~~~~~~~y~aP  176 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPP  176 (279)
T ss_dssp             ---------CCCCTTCCH
T ss_pred             ----cccccCCCCCccCH
Confidence                12345789999998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.90  E-value=4.7e-24  Score=218.75  Aligned_cols=143  Identities=29%  Similarity=0.388  Sum_probs=127.2

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .+.|+..+.||+|+||.||+|.                        +.+.+|+.++++++|||||++++++..++..|+|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            3568899999999999999752                        3577899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||++ |++.+++......+++..+..++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++....  
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            99997 6898888766667899999999999999999999   88999999999999999999999999999986532  


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                          ....+||+.|+||
T Consensus       207 ----~~~~~gt~~y~aP  219 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAP  219 (348)
T ss_dssp             ----BCCCCSCGGGCCH
T ss_pred             ----CCcccCCcceeCH
Confidence                2235799999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.90  E-value=4.6e-24  Score=217.72  Aligned_cols=147  Identities=28%  Similarity=0.412  Sum_probs=129.3

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhcCCCccceeeeeeccC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE  493 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~  493 (596)
                      ..++|...+.||+|+||.||+|.                             +.+.+|+.++++++||||+++++++..+
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            35689999999999999999862                             1345799999999999999999999999


Q ss_pred             CeeEEEEecCCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccc
Q 036342          494 EFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       494 ~~~~lV~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla  572 (596)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999987654 5899999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCC
Q 036342          573 KLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +......   .....+||+.|+||
T Consensus       178 ~~~~~~~---~~~~~~gt~~y~aP  198 (335)
T 3dls_A          178 AYLERGK---LFYTFCGTIEYCAP  198 (335)
T ss_dssp             EECCTTC---CBCEECSCGGGCCH
T ss_pred             eECCCCC---ceeccCCCccccCh
Confidence            8764332   22346799999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.90  E-value=8.8e-24  Score=212.14  Aligned_cols=151  Identities=28%  Similarity=0.435  Sum_probs=124.7

Q ss_pred             cccccccccccCCCceeehhhH----------------HhHHHHHHHHhh--cCCCccceeeeeecc----CCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------KSFDVECEMMKS--IRHRNLIKVISSCSN----EEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------~~~~~e~~~l~~--l~H~niv~l~~~~~~----~~~~~lV~e  501 (596)
                      .++|+..+.||+|+||.||+|.                +.+..|.+++..  ++||||+++++++..    .+..|+|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e   86 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH   86 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence            4689999999999999999862                345567777766  899999999998654    346899999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcc-----CCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+++|+|.++++..  .+++..+..++.|++.|++|||..     ..++|+||||||+||+++.++.+||+|||+++...
T Consensus        87 ~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  164 (301)
T 3q4u_A           87 YHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS  164 (301)
T ss_dssp             CCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             hccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecc
Confidence            99999999999654  588999999999999999999942     26789999999999999999999999999998764


Q ss_pred             CCCCcc--ccccccccccccCC
Q 036342          577 GEDQSM--TQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~--~~~~~~gt~~y~aP  596 (596)
                      ......  ......||+.|+||
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aP  186 (301)
T 3q4u_A          165 QSTNQLDVGNNPRVGTKRYMAP  186 (301)
T ss_dssp             TTTTEEECCCCCCCCCGGGCCH
T ss_pred             cccccccccccccccccceeCh
Confidence            332211  12334799999998

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.90  E-value=1.7e-24  Score=219.81  Aligned_cols=153  Identities=25%  Similarity=0.428  Sum_probs=117.5

Q ss_pred             HHhcccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCC
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE  494 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~  494 (596)
                      ....++|+..+.||+|+||.||+|.                          +.+.+|+.++++++||||+++++++...+
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3456789999999999999999752                          35778999999999999999999998766


Q ss_pred             ee------EEEEecCCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc
Q 036342          495 FK------ALVLEYMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV  563 (596)
Q Consensus       495 ~~------~lV~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~  563 (596)
                      ..      ++||||+++|+|.+++....     ..+++..+..++.|++.|+.|||   ..+|+||||||+||++++++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence            54      99999999999999986532     25889999999999999999999   889999999999999999999


Q ss_pred             EEEeccccccccCCCCCccccccccccccccCC
Q 036342          564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       564 ~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +||+|||+++...............+|+.|+||
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  208 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL  208 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCH
T ss_pred             EEEeeccccccccccccccccccccCcccccCc
Confidence            999999999876433322223345678889998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.90  E-value=1.5e-24  Score=218.97  Aligned_cols=149  Identities=22%  Similarity=0.436  Sum_probs=120.1

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCC----e
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE----F  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~  495 (596)
                      .++|+..+.||+|+||.||++.                        +.+.+|+.++++++|||||++++++...+    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            4689999999999999999752                        35778999999999999999999987654    3


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+||||+++|+|.+++.... .+++.++..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999998654 5889999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccccccccCC
Q 036342          576 TGEDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~-~~~~~~~gt~~y~aP  596 (596)
                      ...... .......||+.|+||
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aP  188 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSP  188 (311)
T ss_dssp             ---------------CCTTCCH
T ss_pred             cccccccccccccCcCcccCCH
Confidence            433221 122345799999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=3.7e-24  Score=221.53  Aligned_cols=149  Identities=25%  Similarity=0.412  Sum_probs=117.7

Q ss_pred             ccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeecc-CCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSN-EEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~l  498 (596)
                      ..|...+.||+|+||.||+|.                         +.+.+|+.++++++|||||++++++.. ++..|+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            356778899999999999742                         457889999999999999999998754 567899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++......+++.++..++.|+++|+.|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999999877667889999999999999999999   889999999999999999999999999999865432


Q ss_pred             CC--ccccccccccccccCC
Q 036342          579 DQ--SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~--~~~~~~~~gt~~y~aP  596 (596)
                      ..  ........+|+.|+||
T Consensus       246 ~~~~~~~~~~~~~~~~y~aP  265 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMAL  265 (373)
T ss_dssp             ------------CCGGGSCH
T ss_pred             ccccccccCCCCCcccccCh
Confidence            21  1112345678899998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.90  E-value=6.4e-24  Score=211.63  Aligned_cols=146  Identities=30%  Similarity=0.439  Sum_probs=123.8

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|...+.||+|+||.||++.                      +.+.+|++++++++||||+++++++...+..|+||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            578999999999999999742                      4578999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee---CCCCcEEEeccccccccC
Q 036342          503 MPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       503 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl---~~~~~~kl~dfGla~~~~  576 (596)
                      +++|+|.+++...   ...+++..+..++.|+++|+.|||   ..+|+||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988643   246899999999999999999999   8899999999999999   456889999999998654


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...   ......||+.|+||
T Consensus       179 ~~~---~~~~~~~t~~y~aP  195 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAP  195 (285)
T ss_dssp             -----------CTTGGGCCH
T ss_pred             Ccc---cCcCcccccCcCCh
Confidence            321   23346799999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.89  E-value=8.8e-24  Score=224.49  Aligned_cols=147  Identities=31%  Similarity=0.445  Sum_probs=126.7

Q ss_pred             HhcccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeeccCC-eeEEEEecC
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYM  503 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lV~e~~  503 (596)
                      ...++|+..+.||+|+||.||+|.                 +.+.+|+.++++++|||||++++++...+ ..|+|||||
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            345789999999999999999852                 56889999999999999999999987654 799999999


Q ss_pred             CCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++|+|.+++..... .+++..+..++.|+++|++|||   ..+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----  342 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  342 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence            99999999987653 3689999999999999999999   889999999999999999999999999999864321    


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                       .....+|+.|+||
T Consensus       343 -~~~~~~~~~y~aP  355 (450)
T 1k9a_A          343 -QDTGKLPVKWTAP  355 (450)
T ss_dssp             -----CCCTTTSCH
T ss_pred             -ccCCCCCcceeCH
Confidence             1223678899998

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.89  E-value=4.2e-24  Score=216.04  Aligned_cols=160  Identities=24%  Similarity=0.412  Sum_probs=135.3

Q ss_pred             ccCHHHHHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccce
Q 036342          434 TFSYLELCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIK  485 (596)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~  485 (596)
                      .+....+....++|...+.||+|+||.||+|.                           +.+.+|+.+++++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            34555666677899999999999999999752                           3467899999999 7999999


Q ss_pred             eeeeeccCC-eeEEEEecCCCCCHHHHHhhCCCC---------------CCHHHHHHHHHHHHHHHHHHhccCCCceEeC
Q 036342          486 VISSCSNEE-FKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMIDVASALEYLHFGYSALVIHC  549 (596)
Q Consensus       486 l~~~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~~---------------l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hr  549 (596)
                      +++++...+ ..++||||+++|+|.+++......               +++..+..++.|++.|+.|||   ..+|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence            999987654 589999999999999999875422               788999999999999999999   8899999


Q ss_pred             CCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          550 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       550 dlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||||+||+++.++.+||+|||+++...............||+.|+||
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  219 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence            99999999999999999999999876443332333445788999998

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.89  E-value=2.6e-24  Score=214.67  Aligned_cols=154  Identities=26%  Similarity=0.456  Sum_probs=133.5

Q ss_pred             HHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      +++...++|+..+.||+|+||.||+|.                    +.+.+|+.++++++||||+++++++..++..|+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            334456789999999999999999852                    467899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          499 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      ||||+++|+|.+++.... ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++....
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999999998743 45889999999999999999999   88999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .. ........+|+.|+||
T Consensus       164 ~~-~~~~~~~~~~~~y~aP  181 (288)
T 3kfa_A          164 DT-YTAHAGAKFPIKWTAP  181 (288)
T ss_dssp             SS-SEEETTEEECGGGCCH
T ss_pred             Cc-cccccCCccccCcCCh
Confidence            32 2223345678889998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.89  E-value=9.1e-24  Score=220.29  Aligned_cols=150  Identities=17%  Similarity=0.215  Sum_probs=129.3

Q ss_pred             cccccccccccCC--CceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRG--GFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G--~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|+..+.||+|  +||.||+|.                       +.+.+|+.++++++|||||++++++..++..|+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4689999999999  999999852                       356789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          499 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      |||||++|+|.+++.... ..+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999998752 46899999999999999999999   88999999999999999999999999998875432


Q ss_pred             CCC-----ccccccccccccccCC
Q 036342          578 EDQ-----SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~-----~~~~~~~~gt~~y~aP  596 (596)
                      ...     .......+||+.|+||
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aP  204 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSP  204 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCH
T ss_pred             ccccccccccccccccccccccCH
Confidence            111     1112234789999998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.89  E-value=7.9e-24  Score=220.65  Aligned_cols=148  Identities=21%  Similarity=0.419  Sum_probs=116.8

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcC-CCccceeeeeeccCC--ee
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEE--FK  496 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~  496 (596)
                      ..++|+..+.||+|+||.||+|.                       +.+.+|+.+++++. |||||++++++..++  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            45689999999999999999852                       34668999999997 999999999997544  68


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+|||||+ |+|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999997 6999999764  5789999999999999999999   8999999999999999999999999999998653


Q ss_pred             CCC-------------------CccccccccccccccCC
Q 036342          577 GED-------------------QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~-------------------~~~~~~~~~gt~~y~aP  596 (596)
                      ...                   ........+||++|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  199 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP  199 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCH
Confidence            211                   01122346899999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.89  E-value=5.2e-24  Score=220.02  Aligned_cols=150  Identities=20%  Similarity=0.266  Sum_probs=122.7

Q ss_pred             hcccccccccccCCCceeehhhH----------------------HhH---------------HHHHHHHhhcCCCccce
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF----------------------KSF---------------DVECEMMKSIRHRNLIK  485 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~---------------~~e~~~l~~l~H~niv~  485 (596)
                      ..++|...+.||+|+||.||+|.                      ..+               ..|+..++.++|||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999861                      112               23445566778999999


Q ss_pred             eeeeeccC----CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC--
Q 036342          486 VISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD--  559 (596)
Q Consensus       486 l~~~~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~--  559 (596)
                      +++++...    ...|+||||+ +|+|.+++......+++..+..++.|++.||.|||   ..+|+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence            99998764    4589999999 99999999887667999999999999999999999   88999999999999998  


Q ss_pred             CCCcEEEeccccccccCCCCCc-----cccccccccccccCC
Q 036342          560 DNMVAHLSDFSIAKLLTGEDQS-----MTQTQTLGTIGYMAP  596 (596)
Q Consensus       560 ~~~~~kl~dfGla~~~~~~~~~-----~~~~~~~gt~~y~aP  596 (596)
                      .++.+||+|||+++.+......     ......+||+.||||
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  230 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI  230 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCH
Confidence            8899999999999876432111     112335699999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.89  E-value=2.6e-24  Score=228.94  Aligned_cols=153  Identities=22%  Similarity=0.402  Sum_probs=129.6

Q ss_pred             HHHHhcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      +++...++|...+.||+|+||.||+|.                   +.+.+|+.++++++|||||++++++. ++..|+|
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            344556789999999999999999862                   46889999999999999999999987 5578999


Q ss_pred             EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          500 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||++|+|.++++... ..+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            99999999999997543 35788899999999999999999   889999999999999999999999999999876422


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                       .........+|+.|+||
T Consensus       338 -~~~~~~~~~~~~~y~aP  354 (454)
T 1qcf_A          338 -EYTAREGAKFPIKWTAP  354 (454)
T ss_dssp             -HHHTTCSSSSCGGGSCH
T ss_pred             -ceeccCCCcccccccCH
Confidence             11112334567889998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=7.6e-24  Score=215.99  Aligned_cols=150  Identities=25%  Similarity=0.471  Sum_probs=123.1

Q ss_pred             cccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ..+|...+.||+|+||.||+|.                          ..+.+|+.++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3467788999999999999852                          34678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++......+++.+++.++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999877667899999999999999999999   88999999999999999999999999999987643


Q ss_pred             CCC-ccccccccccccccCC
Q 036342          578 EDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~-~~~~~~~~gt~~y~aP  596 (596)
                      ... ........+|+.|+||
T Consensus       200 ~~~~~~~~~~~~~~~~y~aP  219 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAP  219 (333)
T ss_dssp             -----------CCCGGGSCH
T ss_pred             ccccccccCCCCccccccCc
Confidence            221 1112234568889998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.89  E-value=1.1e-23  Score=226.75  Aligned_cols=146  Identities=23%  Similarity=0.416  Sum_probs=124.9

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .+.|...+.||+|+||.||+|.                       ..+.+|+.++++++|||||+++++|..++..|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            3579999999999999999752                       34778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~dfGla~~~~~  577 (596)
                      |||++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.   ++.+||+|||+++....
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999887654 5889999999999999999999   889999999999999976   45699999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   .....+||++|+||
T Consensus       192 ~~---~~~~~~gt~~y~aP  207 (494)
T 3lij_A          192 QK---KMKERLGTAYYIAP  207 (494)
T ss_dssp             TB---CBCCCCSCTTTCCH
T ss_pred             Cc---cccccCCCcCeeCH
Confidence            21   23446799999998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.89  E-value=1.7e-23  Score=209.50  Aligned_cols=147  Identities=23%  Similarity=0.398  Sum_probs=129.3

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|...+.||+|+||.||++.                        +.+.+|+.++++++||||+++++++..++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            4689999999999999999742                        3467899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++++|.+++.... .+++.++..++.|+++|+.|||   ..+++||||||+||+++.++.+||+|||+++......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999987654 5889999999999999999999   8899999999999999999999999999998754222


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                        .......||+.|+||
T Consensus       170 --~~~~~~~~~~~y~aP  184 (294)
T 2rku_A          170 --ERKKVLCGTPNYIAP  184 (294)
T ss_dssp             --CCBCCCCSCCSSCCH
T ss_pred             --cccccccCCCCcCCc
Confidence              123346799999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.89  E-value=1.5e-23  Score=213.98  Aligned_cols=147  Identities=23%  Similarity=0.406  Sum_probs=129.7

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|...+.||+|+||.||++.                        +.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4689999999999999999742                        3567899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++++|.+++.... .+++.++..++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999987653 5889999999999999999999   8899999999999999999999999999998764222


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                      .  ......||+.|+||
T Consensus       196 ~--~~~~~~gt~~y~aP  210 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAP  210 (335)
T ss_dssp             C--CBCCCCSCCSSCCH
T ss_pred             c--cccccCCCccccCH
Confidence            1  23346799999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.89  E-value=3.4e-24  Score=217.70  Aligned_cols=146  Identities=24%  Similarity=0.420  Sum_probs=122.9

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|...+.||+|+||.||+|.                      ..+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            578999999999999999863                      1234699999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++ |+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            97 5999999887767899999999999999999999   8999999999999999999999999999998654221  1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......||++|+||
T Consensus       156 ~~~~~~~t~~y~aP  169 (324)
T 3mtl_A          156 TYDNEVVTLWYRPP  169 (324)
T ss_dssp             -------CGGGCCH
T ss_pred             ccccccCcccccCh
Confidence            23345789999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.89  E-value=9.3e-24  Score=213.09  Aligned_cols=146  Identities=26%  Similarity=0.397  Sum_probs=122.9

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++..++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            579999999999999999852                       346789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+++++|.+++... ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            99999998887654 35889999999999999999999   88999999999999999999999999999987643221 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......||++|+||
T Consensus       158 -~~~~~~~~~~y~aP  171 (311)
T 4agu_A          158 -YYDDEVATRWYRSP  171 (311)
T ss_dssp             ---------GGGCCH
T ss_pred             -ccCCCcCCccccCh
Confidence             22345789999998

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=9.2e-24  Score=211.65  Aligned_cols=148  Identities=22%  Similarity=0.375  Sum_probs=126.2

Q ss_pred             cccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee-EEE
Q 036342          446 EFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK-ALV  499 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lV  499 (596)
                      .|...+.||+|+||.||+|.                         +.+.+|+.++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667899999999999752                         4577899999999999999999999876654 999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+.+|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999886667899999999999999999999   8899999999999999999999999999998653321


Q ss_pred             C--ccccccccccccccCC
Q 036342          580 Q--SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~--~~~~~~~~gt~~y~aP  596 (596)
                      .  ........+|+.|+||
T Consensus       179 ~~~~~~~~~~~~~~~y~aP  197 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTAL  197 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCH
T ss_pred             ccccccCcCCCCCccccCh
Confidence            1  1122345688899987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.89  E-value=2.5e-23  Score=207.39  Aligned_cols=143  Identities=27%  Similarity=0.524  Sum_probs=125.9

Q ss_pred             cccccccccccCCCceeehhhH----------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      .++|+..+.||+|+||.||+|.                            +.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            4689999999999999999741                            45788999999999999999999997765 


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eEeCCCCCCCeeeCCCCc-----EEEec
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL--VIHCDLKPSNVLLDDNMV-----AHLSD  568 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~Hrdlk~~NILl~~~~~-----~kl~d  568 (596)
                       ++||||+++|+|.+++......+++..+..++.|++.|++|||   ..+  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             7999999999999999877777899999999999999999999   888  999999999999988776     99999


Q ss_pred             cccccccCCCCCccccccccccccccCC
Q 036342          569 FSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||+++....     ......||+.|+||
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aP  195 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAP  195 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCG
T ss_pred             CCccccccc-----cccccCCCccccCc
Confidence            999985432     23346799999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.89  E-value=8.6e-24  Score=209.41  Aligned_cols=149  Identities=23%  Similarity=0.376  Sum_probs=129.9

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .++|+..+.||+|+||.||+|.                      +.+.+|+.++++++||||+++++++..++..|+|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            4689999999999999999852                      457789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+++|+|.+++... ..+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++........
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            99999999998754 35889999999999999999999   889999999999999999999999999999865432222


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......||+.|+||
T Consensus       162 ~~~~~~~~~~~y~aP  176 (276)
T 2yex_A          162 RLLNKMCGTLPYVAP  176 (276)
T ss_dssp             CCBCCCCSCGGGCCG
T ss_pred             hcccCCccccCccCh
Confidence            223446789999998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.89  E-value=1.5e-23  Score=212.76  Aligned_cols=146  Identities=25%  Similarity=0.423  Sum_probs=129.1

Q ss_pred             cccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .++|+..+.||+|+||.||+|.                           +.+.+|+.++++++||||+++++++..++..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4679999999999999999852                           3478999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC----cEEEeccccc
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM----VAHLSDFSIA  572 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~----~~kl~dfGla  572 (596)
                      |+||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999997653 5789999999999999999999   88999999999999999887    7999999999


Q ss_pred             cccCCCCCccccccccccccccCC
Q 036342          573 KLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +......   ......||+.|+||
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aP  187 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAP  187 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCH
T ss_pred             eecCccc---cccccCCCCCccCc
Confidence            8764322   22345799999998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.89  E-value=9.2e-24  Score=216.35  Aligned_cols=147  Identities=23%  Similarity=0.431  Sum_probs=122.7

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCC--CccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRH--RNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||.||++.                      +.+.+|+.++++++|  |||+++++++..++..|+|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4579999999999999999751                      457789999999987  9999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      || +.+|+|.+++.... .+++.++..++.|++.|+.|||   ..+|+||||||+|||++ ++.+||+|||+++......
T Consensus        88 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             Ee-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            99 45889999998764 6889999999999999999999   88999999999999997 5789999999998765433


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                      ........+||++|+||
T Consensus       162 ~~~~~~~~~gt~~y~aP  178 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPP  178 (343)
T ss_dssp             --------CCCCSSCCH
T ss_pred             ccccCCCCcCCcCcCCH
Confidence            22233456899999998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.89  E-value=8e-24  Score=208.54  Aligned_cols=149  Identities=30%  Similarity=0.501  Sum_probs=130.6

Q ss_pred             cccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      .++|+..+.||+|+||.||++.                   +.+.+|+.++++++||||+++++++..++..|+||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            4688999999999999999852                   467899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      +|+|.+++......+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++..... .....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~  162 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSS  162 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHST
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-ccccc
Confidence            99999999887667899999999999999999999   889999999999999999999999999999865321 11122


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....+|+.|+||
T Consensus       163 ~~~~~~~~y~aP  174 (267)
T 3t9t_A          163 TGTKFPVKWASP  174 (267)
T ss_dssp             TSTTCCGGGCCH
T ss_pred             ccccccccccCh
Confidence            334678889998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=7.9e-24  Score=217.12  Aligned_cols=149  Identities=28%  Similarity=0.471  Sum_probs=126.4

Q ss_pred             HhcccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      ...++|+..+.||+|+||.||+|.                          +.+.+|+.++++++||||+++++++..++.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            345789999999999999999852                          246689999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .++||||+++ +|.+++......+++..+..++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999976 899999877667888899999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .....  .....+||+.|+||
T Consensus       163 ~~~~~--~~~~~~~t~~y~aP  181 (346)
T 1ua2_A          163 GSPNR--AYTHQVVTRWYRAP  181 (346)
T ss_dssp             TSCCC--CCCCSCCCCTTCCH
T ss_pred             cCCcc--cCCcccccccccCc
Confidence            43221  23346799999998

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.89  E-value=7.4e-24  Score=217.13  Aligned_cols=153  Identities=27%  Similarity=0.398  Sum_probs=124.9

Q ss_pred             HHhcccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCC
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE  494 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~  494 (596)
                      ....++|...+.||+|+||.||+|.                          +.+.+|+.++++++|||||++++++.+++
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            4456789999999999999999751                          35678999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 036342          495 FKALVLEYMPHGSLEKYLYSS---------------------------------------NCILDIFQRLNIMIDVASAL  535 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~l  535 (596)
                      ..++||||+++|+|.+++...                                       ...+++..+..++.|++.|+
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998521                                       11235667888999999999


Q ss_pred             HHHhccCCCceEeCCCCCCCeeeCCCC--cEEEeccccccccCCCCC--ccccccccccccccCC
Q 036342          536 EYLHFGYSALVIHCDLKPSNVLLDDNM--VAHLSDFSIAKLLTGEDQ--SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       536 ~~lh~~~~~~i~Hrdlk~~NILl~~~~--~~kl~dfGla~~~~~~~~--~~~~~~~~gt~~y~aP  596 (596)
                      +|||   ..+|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+||
T Consensus       182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  243 (345)
T 3hko_A          182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP  243 (345)
T ss_dssp             HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred             HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence            9999   88999999999999998766  899999999986533211  1123456799999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.89  E-value=1.4e-23  Score=225.45  Aligned_cols=146  Identities=23%  Similarity=0.418  Sum_probs=127.3

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .++|...+.||+|+||.||+|.                       ..+.+|+.++++++|||||++++++...+..|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            3579999999999999999852                       35778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC---CCCcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~---~~~~~kl~dfGla~~~~~  577 (596)
                      |||++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++   .++.+||+|||+++....
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999999987654 5889999999999999999999   88999999999999995   456899999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   .....+||++|+||
T Consensus       177 ~~---~~~~~~gt~~y~aP  192 (486)
T 3mwu_A          177 NT---KMKDRIGTAYYIAP  192 (486)
T ss_dssp             C-------CCTTGGGGCCG
T ss_pred             CC---ccCCCcCCCCCCCH
Confidence            21   23446799999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.89  E-value=9.6e-24  Score=217.69  Aligned_cols=157  Identities=26%  Similarity=0.353  Sum_probs=135.6

Q ss_pred             cccccCHHHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcC-----CCccce
Q 036342          431 TWRTFSYLELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIR-----HRNLIK  485 (596)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~-----H~niv~  485 (596)
                      +...+++.+.....++|...+.||+|+||.||+|.                    +.+..|+.++++++     |||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            44556666666778899999999999999999852                    34667999999987     999999


Q ss_pred             eeeeeccCCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC----
Q 036342          486 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD----  560 (596)
Q Consensus       486 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~----  560 (596)
                      +++++...+..|+||||+ +++|.+++.... ..+++..+..++.|++.||+|||   ..+|+||||||+|||++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 999999998754 35889999999999999999999   899999999999999975    


Q ss_pred             ---------------------CCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          561 ---------------------NMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       561 ---------------------~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                                           ++.+||+|||+++.....     .....||+.|+||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aP  228 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAP  228 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCc
Confidence                                 789999999999865322     2345799999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=5.1e-24  Score=219.25  Aligned_cols=148  Identities=25%  Similarity=0.350  Sum_probs=128.7

Q ss_pred             cccccccccccCCCceeehhhH----------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEE  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  494 (596)
                      .++|+..+.||+|+||.||++.                            +.+.+|+++++++ +||||+++++++..++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            4689999999999999999642                            2355799999999 6999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999998754 5889999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..... .......+||+.|+||
T Consensus       209 ~~~~~-~~~~~~~~gt~~y~aP  229 (355)
T 1vzo_A          209 FVADE-TERAYDFCGTIEYMAP  229 (355)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCH
T ss_pred             cccCC-CCcccCcccCcCccCh
Confidence            53221 2223346799999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.89  E-value=2.5e-23  Score=208.46  Aligned_cols=149  Identities=17%  Similarity=0.227  Sum_probs=130.5

Q ss_pred             cccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      .++|+..+.||+|+||.||+|.                   +.+.+|+.+++++ +|++++++++++..+...++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            4579999999999999999863                   3578999999999 8999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc-----EEEeccccccccCCC
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV-----AHLSDFSIAKLLTGE  578 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~-----~kl~dfGla~~~~~~  578 (596)
                       +|+|.+++......+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.     +||+|||+++.....
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence             99999999877667899999999999999999999   999999999999999987766     999999999876543


Q ss_pred             CCc-----cccccccccccccCC
Q 036342          579 DQS-----MTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~-----~~~~~~~gt~~y~aP  596 (596)
                      ...     .......||+.|+||
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aP  187 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSI  187 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             cccccccccCccCCCCCcccCCc
Confidence            221     123446799999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.89  E-value=2.4e-23  Score=207.15  Aligned_cols=146  Identities=23%  Similarity=0.481  Sum_probs=128.0

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .++|+..+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4689999999999999999852                       35678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc---EEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV---AHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~---~kl~dfGla~~~~~  577 (596)
                      ||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999999887654 5889999999999999999999   889999999999999986654   99999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   ......||+.|+||
T Consensus       161 ~~---~~~~~~~~~~y~aP  176 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSP  176 (284)
T ss_dssp             SC---BCCCSCSCGGGCCH
T ss_pred             Cc---cccCCCCCcCCcCc
Confidence            22   22346799999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.89  E-value=1.4e-23  Score=218.58  Aligned_cols=146  Identities=23%  Similarity=0.428  Sum_probs=123.3

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcC--CCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIR--HRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||++.                      +.+.+|+.++++++  |||||++++++..++..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            469999999999999999852                      45789999999997  599999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      | +.+|+|.+++.... .+++..+..++.|++.||.|||   ..+|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56889999998764 6788899999999999999999   89999999999999995 58999999999987643322


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                      .......+||+.|+||
T Consensus       210 ~~~~~~~~gt~~y~aP  225 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPP  225 (390)
T ss_dssp             ----CCSCCCGGGCCH
T ss_pred             cccCCCCCcCCCccCh
Confidence            2223456899999998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.89  E-value=8.9e-24  Score=220.78  Aligned_cols=147  Identities=26%  Similarity=0.420  Sum_probs=127.2

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC--eeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE--FKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lV  499 (596)
                      .++|...+.||+|+||.||+|.                      +.+.+|++++++++|||||++++++...+  ..|+|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            3579999999999999999852                      34678999999999999999999987654  68999


Q ss_pred             EecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee----CCCCcEEEecccccc
Q 036342          500 LEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL----DDNMVAHLSDFSIAK  573 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl----~~~~~~kl~dfGla~  573 (596)
                      |||+++|+|.+++....  ..+++..++.++.|++.|+.|||   ..+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999997643  23899999999999999999999   8899999999999999    778889999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ......   ......||+.|+||
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aP  184 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHP  184 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCH
T ss_pred             EccCCC---ccccccCCccccCH
Confidence            764321   22346799999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=2.5e-23  Score=212.35  Aligned_cols=150  Identities=26%  Similarity=0.403  Sum_probs=123.8

Q ss_pred             HhcccccccccccCCCceeehhhH----------------HhHHHHHHHHhhc--CCCccceeeeeeccC----CeeEEE
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF----------------KSFDVECEMMKSI--RHRNLIKVISSCSNE----EFKALV  499 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~----------------~~~~~e~~~l~~l--~H~niv~l~~~~~~~----~~~~lV  499 (596)
                      ...++|+..+.||+|+||.||+|.                ..+..|.+++...  +||||+++++++...    ...|+|
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  113 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI  113 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence            345689999999999999999852                2345566666554  999999999999876    678999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCC--------ceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA--------LVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~--------~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                      |||+++|+|.++++..  .+++..++.++.|++.|++|||   ..        +|+||||||+||+++.++.+||+|||+
T Consensus       114 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~  188 (337)
T 3mdy_A          114 TDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  188 (337)
T ss_dssp             ECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence            9999999999999765  4889999999999999999999   66        999999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccccccccCC
Q 036342          572 AKLLTGEDQS--MTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~--~~~~~~~gt~~y~aP  596 (596)
                      ++........  ......+||+.|+||
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aP  215 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPP  215 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCH
T ss_pred             ceeeccccccccCCCCCCccCcceeCh
Confidence            9876432221  112345799999998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.89  E-value=1e-23  Score=220.31  Aligned_cols=147  Identities=24%  Similarity=0.394  Sum_probs=117.6

Q ss_pred             ccccccc-ccccCCCceeehhhH----------------HhHHHHHHHH-hhcCCCccceeeeeecc----CCeeEEEEe
Q 036342          444 TDEFSEN-NLIGRGGFALFIRAF----------------KSFDVECEMM-KSIRHRNLIKVISSCSN----EEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~-~~ig~G~~g~v~~~~----------------~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~~lV~e  501 (596)
                      .++|... +.||+|+||.||++.                ..+.+|+.++ +..+|||||++++++..    ++..|+|||
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E  139 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME  139 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence            3466665 689999999999863                3567888887 45589999999998865    567899999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEeccccccccCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~dfGla~~~~~  577 (596)
                      ||++|+|.+++.... ..+++..+..++.|++.||.|||   ..+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999998754 35899999999999999999999   889999999999999997   78999999999987542


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   .....+||+.|+||
T Consensus       217 ~~---~~~~~~gt~~y~aP  232 (400)
T 1nxk_A          217 HN---SLTTPCYTPYYVAP  232 (400)
T ss_dssp             -------------CTTCCG
T ss_pred             CC---ccccCCCCCCccCH
Confidence            21   23456899999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.89  E-value=9.3e-24  Score=222.16  Aligned_cols=146  Identities=29%  Similarity=0.404  Sum_probs=119.6

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhcCCCccceeeeeeccC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE  493 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~  493 (596)
                      ..++|...+.||+|+||.||+|.                             ..+.+|+.++++++|||||++++++..+
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  212 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE  212 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            45689999999999999999852                             1367899999999999999999998654


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC---CcEEEeccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFS  570 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~---~~~kl~dfG  570 (596)
                       ..|+||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+|||++.+   +.+||+|||
T Consensus       213 -~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          213 -DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             -EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             -ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence             5799999999999999987654 6889999999999999999999   8899999999999999654   469999999


Q ss_pred             cccccCCCCCccccccccccccccCC
Q 036342          571 IAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +++.....   ......+||+.|+||
T Consensus       288 ~a~~~~~~---~~~~~~~gt~~y~aP  310 (419)
T 3i6u_A          288 HSKILGET---SLMRTLCGTPTYLAP  310 (419)
T ss_dssp             TTTSCC--------------CTTCCT
T ss_pred             cceecCCC---ccccccCCCCCccCc
Confidence            99876432   123456899999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.89  E-value=2.6e-23  Score=207.04  Aligned_cols=145  Identities=28%  Similarity=0.441  Sum_probs=128.8

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||.||+|.                        +.+.+|+.++++++||||+++++++..++..|+|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            4689999999999999999852                        3467899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++|+|.+++.... .+++..+..++.|+++|+.|||   ..+++||||||+||+++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            99999999999998754 5789999999999999999999   899999999999999999999999999998765322 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         ......||+.|+||
T Consensus       168 ---~~~~~~~~~~y~aP  181 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPP  181 (284)
T ss_dssp             ---CBCCCCSCGGGCCH
T ss_pred             ---ccccccCCCCcCCH
Confidence               12345789999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.89  E-value=1.7e-23  Score=212.91  Aligned_cols=150  Identities=24%  Similarity=0.404  Sum_probs=129.1

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeec--cCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCS--NEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~  496 (596)
                      .++|+..+.||+|+||.||++.                         +.+.+|++++++++||||+++++++.  .++..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            4689999999999999998752                         34789999999999999999999886  45568


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+||||+++|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999999875556899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCc-cccccccccccccCC
Q 036342          577 GEDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aP  596 (596)
                      ..... .......||+.|+||
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aP  199 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAP  199 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCH
T ss_pred             cCCccceeeccCCccccccCH
Confidence            33221 122345688889998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.89  E-value=1.6e-23  Score=206.70  Aligned_cols=143  Identities=20%  Similarity=0.381  Sum_probs=126.2

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccC--CeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~  500 (596)
                      .++|...+.||+|+||.||+|.                     +.+.+|+.++++++||||+++++++...  +..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            4689999999999999999852                     4578999999999999999999999876  6789999


Q ss_pred             ecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCc--eEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAL--VIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      ||+++|+|.+++..... .+++.++..++.|++.|+.|||   ..+  ++||||||+||+++.++.++++|||++.... 
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            99999999999987653 5899999999999999999999   777  9999999999999999999999999876432 


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                            .....||+.|+||
T Consensus       165 ------~~~~~~t~~y~aP  177 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAP  177 (271)
T ss_dssp             ------CTTCBSCGGGSCH
T ss_pred             ------ccCccCCccccCh
Confidence                  1234689999998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.89  E-value=2.8e-23  Score=224.04  Aligned_cols=146  Identities=25%  Similarity=0.466  Sum_probs=126.7

Q ss_pred             cccccccccccCCCceeehhhH----------------------------------HhHHHHHHHHhhcCCCccceeeee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------------------KSFDVECEMMKSIRHRNLIKVISS  489 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------------------~~~~~e~~~l~~l~H~niv~l~~~  489 (596)
                      .++|...+.||+|+||.||+|.                                  +.+.+|+.++++++|||||+++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            5689999999999999999742                                  236689999999999999999999


Q ss_pred             eccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC---cEEE
Q 036342          490 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM---VAHL  566 (596)
Q Consensus       490 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~---~~kl  566 (596)
                      +..++..|+|||||++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++   .+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            999999999999999999999987654 5899999999999999999999   88999999999999998775   6999


Q ss_pred             eccccccccCCCCCccccccccccccccCC
Q 036342          567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       567 ~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|||+++......   .....+||+.|+||
T Consensus       191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aP  217 (504)
T 3q5i_A          191 VDFGLSSFFSKDY---KLRDRLGTAYYIAP  217 (504)
T ss_dssp             CCCTTCEECCTTS---CBCCCCSCTTTCCH
T ss_pred             EECCCCEEcCCCC---ccccccCCcCCCCH
Confidence            9999998764321   23446799999998

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.89  E-value=4.3e-25  Score=243.40  Aligned_cols=332  Identities=16%  Similarity=0.133  Sum_probs=230.9

Q ss_pred             CCCCCCEEECCCC-CCccc-cchhhhCCCCCCEEEccCCcCccccCc-c--CccCCCCccEEEccCCc--ccc-ccCccc
Q 036342            8 NLQNLEELQLGQN-KLIGT-VPAAIFNVSTLKFLGLQNNSLSGSLSS-I--ANVRLPNLEKLYLWGNN--FSG-TIPRFI   79 (596)
Q Consensus         8 ~l~~L~~L~Ls~n-~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~--~~~~l~~L~~L~L~~N~--l~~-~~~~~~   79 (596)
                      .+++|++|+|++| .+++. .+..+..+++|++|+|++|.+++.... +  ....+++|+.|+|++|.  +.. .++..+
T Consensus       128 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~  207 (594)
T 2p1m_B          128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLV  207 (594)
T ss_dssp             HCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHH
T ss_pred             hCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHH
Confidence            5789999999998 55443 334445789999999999987643221 1  11246789999999886  221 112223


Q ss_pred             cCCCCCCEEEccCC-cccccCCccccCCCCCCEEecCCCcC--------------------------cCCCCCccccccC
Q 036342           80 FNASKLSKLSLGMN-SFSGFIPSTFGNLRNLEQLGLDENYL--------------------------TSSTPELSFLSSL  132 (596)
Q Consensus        80 ~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~l~~N~l--------------------------~~~~~~~~~~~~~  132 (596)
                      ..+++|++|+|++| .+.+ ++..+..+++|++|+++.+..                          ...... .++..+
T Consensus       208 ~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~  285 (594)
T 2p1m_B          208 TRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPA-YLPAVY  285 (594)
T ss_dssp             HHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGG-GGGGGH
T ss_pred             HhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchh-hHHHHH
Confidence            45688999999988 4444 677777888888888665521                          111100 122223


Q ss_pred             CCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccc-cChhccCCCCCCEEEccC---------CcccCCC
Q 036342          133 SNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGG-IPEEISNLTNLVEIDLGG---------NKLNGSI  202 (596)
Q Consensus       133 ~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~---------N~l~~~~  202 (596)
                      ..+++|+.|++++|.+++......+..+ ++|++|++++| ++.. .+.....+++|++|++++         +.+++..
T Consensus       286 ~~~~~L~~L~L~~~~l~~~~l~~~~~~~-~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~  363 (594)
T 2p1m_B          286 SVCSRLTTLNLSYATVQSYDLVKLLCQC-PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQG  363 (594)
T ss_dssp             HHHTTCCEEECTTCCCCHHHHHHHHTTC-TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHH
T ss_pred             HhhCCCCEEEccCCCCCHHHHHHHHhcC-CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHH
Confidence            3678999999999997654222223455 78999999999 5432 333334589999999943         5555433


Q ss_pred             Ccccc-CCCCCCeEEccCCcccccCccchh-cCCCCcEEEcc--C----CcCcc-----cchhhhccCCCCcEEEeCCCc
Q 036342          203 PITLG-KLRKLQRLNLEDNILEGSIPDDIC-RLAELYRLELG--S----NKLYG-----SIPACFGNLASLRILSLGSNK  269 (596)
Q Consensus       203 p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~l~~-----~~p~~~~~l~~L~~L~Ls~N~  269 (596)
                      ...+. ++++|+.|+++.|.+++.....+. .+++|+.|+++  +    |.+++     .++..+..+++|+.|+|++ .
T Consensus       364 l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~  442 (594)
T 2p1m_B          364 LVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-L  442 (594)
T ss_dssp             HHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-S
T ss_pred             HHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-c
Confidence            33333 589999999999999876666665 58999999999  4    56652     2333477889999999987 5


Q ss_pred             ccC-CCccccc-ccccceEEcccCCCCCchhhhh-ccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCcccc
Q 036342          270 LTS-IPLTFWN-LKDILQLNFSSNFLTGPLLLEI-GNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG  344 (596)
Q Consensus       270 l~~-ip~~~~~-l~~L~~L~ls~N~l~~~~~~~~-~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~  344 (596)
                      ++. .+..+.. +++|+.|++++|.+++..+..+ ..+++|+.|++++|.+++.........+++|+.|++++|+++.
T Consensus       443 l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~  520 (594)
T 2p1m_B          443 LTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF  520 (594)
T ss_dssp             CCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred             ccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence            554 2333444 8899999999999987766665 6789999999999999654444355568999999999998853

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.89  E-value=1.5e-23  Score=210.38  Aligned_cols=150  Identities=25%  Similarity=0.421  Sum_probs=123.2

Q ss_pred             cccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeecc-----------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSN-----------  492 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~-----------  492 (596)
                      .++|+..+.||+|+||.||+|.                    +.+.+|+.++++++||||+++++++.+           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            4679999999999999999852                    457789999999999999999998754           


Q ss_pred             --CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccc
Q 036342          493 --EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS  570 (596)
Q Consensus       493 --~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfG  570 (596)
                        .+..|+||||+++|+|.+++......+++..++.++.|+++|++|||   ..+|+||||||+||+++.++.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence              35689999999999999999877666788999999999999999999   8899999999999999999999999999


Q ss_pred             cccccCCCCC------------ccccccccccccccCC
Q 036342          571 IAKLLTGEDQ------------SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~------------~~~~~~~~gt~~y~aP  596 (596)
                      +++.......            ........||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT  199 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCc
Confidence            9986542210            1112345789999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.89  E-value=2.7e-23  Score=213.55  Aligned_cols=149  Identities=23%  Similarity=0.390  Sum_probs=127.4

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc--------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN--------  492 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~--------  492 (596)
                      .++|+..+.||+|+||.||+|.                       ..+.+|+.++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4689999999999999999862                       256789999999999999999999876        


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccc
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla  572 (596)
                      .+..|+||||+++ ++.+.+......+++.++..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3468999999975 888888776667899999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCC--ccccccccccccccCC
Q 036342          573 KLLTGEDQ--SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~--~~~~~~~~gt~~y~aP  596 (596)
                      +.+.....  ........||++|+||
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPP  197 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCH
T ss_pred             ccccccccccccccCCcccccCccCc
Confidence            87642211  1123446789999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.89  E-value=1.1e-23  Score=229.09  Aligned_cols=123  Identities=20%  Similarity=0.165  Sum_probs=107.6

Q ss_pred             HHhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCC
Q 036342          465 FKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS  543 (596)
Q Consensus       465 ~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~  543 (596)
                      .+.+.+|+++|+++ .|+||+++++++++++..||||||++||+|.+.+...+ .++..   +|+.||+.||+|+|   +
T Consensus       285 ~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~  357 (569)
T 4azs_A          285 KYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---K  357 (569)
T ss_dssp             HHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---H
T ss_pred             HHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---H
Confidence            46789999999999 79999999999999999999999999999999998764 45553   48999999999999   9


Q ss_pred             CceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          544 ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       544 ~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++||||||||+|||++++|.+||+|||+|+......  ......+||++||||
T Consensus       358 ~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAP  408 (569)
T 4azs_A          358 QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVN  408 (569)
T ss_dssp             TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHH
T ss_pred             CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccH
Confidence            999999999999999999999999999999764332  223457899999997

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.89  E-value=2.5e-23  Score=209.71  Aligned_cols=146  Identities=29%  Similarity=0.471  Sum_probs=118.7

Q ss_pred             cccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG  506 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g  506 (596)
                      .++|+..+.||+|+||.||++.                 +.+.+|+.++++++||||+++++++.+.  .|+||||+++|
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~~~   84 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGG   84 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCTTC
T ss_pred             HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCCCC
Confidence            3578999999999999999852                 4678999999999999999999998743  79999999999


Q ss_pred             CHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc-EEEeccccccccCCCCCccc
Q 036342          507 SLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV-AHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       507 ~L~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~-~kl~dfGla~~~~~~~~~~~  583 (596)
                      +|.+++.....  .+++..++.++.|+++|+.|||..+..+|+||||||+||+++.++. +||+|||+++.....     
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----  159 (307)
T 2eva_A           85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----  159 (307)
T ss_dssp             BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred             CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence            99999986542  4678899999999999999999433389999999999999988876 799999999865321     


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....||+.|+||
T Consensus       160 ~~~~~gt~~y~aP  172 (307)
T 2eva_A          160 MTNNKGSAAWMAP  172 (307)
T ss_dssp             -----CCTTSSCH
T ss_pred             cccCCCCCceECh
Confidence            2234689999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.89  E-value=1.3e-23  Score=225.55  Aligned_cols=146  Identities=25%  Similarity=0.451  Sum_probs=129.3

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|...+.||+|+||.||+|.                        +.+.+|+.++++++|||||++++++...+..|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            4579999999999999999742                        3578999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee---CCCCcEEEeccccccccC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl---~~~~~~kl~dfGla~~~~  576 (596)
                      |||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||++   +.++.+||+|||+++...
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999987654 5889999999999999999999   8899999999999999   467899999999998764


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...   .....+||++|+||
T Consensus       181 ~~~---~~~~~~gt~~y~aP  197 (484)
T 3nyv_A          181 ASK---KMKDKIGTAYYIAP  197 (484)
T ss_dssp             CCC---SHHHHTTGGGTCCH
T ss_pred             ccc---ccccCCCCccccCc
Confidence            332   23446799999998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.89  E-value=3.9e-23  Score=208.31  Aligned_cols=147  Identities=26%  Similarity=0.422  Sum_probs=123.8

Q ss_pred             hcccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcC---CCccceeeeeeccC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIR---HRNLIKVISSCSNE  493 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~---H~niv~l~~~~~~~  493 (596)
                      ..++|+..+.||+|+||.||+|.                          ..+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            46789999999999999999852                          24668888887775   99999999999765


Q ss_pred             C-----eeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEe
Q 036342          494 E-----FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLS  567 (596)
Q Consensus       494 ~-----~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~  567 (596)
                      .     ..++||||++ |+|.+++.... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5799999996 59999998765 34899999999999999999999   8899999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccccccCC
Q 036342          568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       568 dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||+++......   .....+||+.|+||
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aP  188 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAP  188 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCH
T ss_pred             eCccccccCCCc---ccCCccccccccCc
Confidence            999998764322   23456899999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.89  E-value=5.2e-24  Score=226.37  Aligned_cols=152  Identities=26%  Similarity=0.438  Sum_probs=124.5

Q ss_pred             HHHhcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++...++|...+.||+|+||.||+|.                   +.+.+|+.++++++|||||++++++.. +..|+||
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            34456789999999999999999852                   468899999999999999999999876 6689999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          501 EYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||+++|+|.+++.... ..+++.++..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+++......
T Consensus       258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            9999999999997532 35889999999999999999999   8999999999999999999999999999998764321


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                       ........+|+.|+||
T Consensus       335 -~~~~~~~~~~~~y~aP  350 (452)
T 1fmk_A          335 -YTARQGAKFPIKWTAP  350 (452)
T ss_dssp             ---------CCGGGSCH
T ss_pred             -eecccCCcccccccCH
Confidence             1222334578899998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=1.9e-23  Score=215.86  Aligned_cols=142  Identities=26%  Similarity=0.384  Sum_probs=119.1

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE------  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~------  494 (596)
                      .++|...+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++..++      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            4689999999999999999852                       35678999999999999999999997653      


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ..|+||||+ +++|.+++...  .+++..+..++.|+++|+.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            469999999 88999999774  5789999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....     ....+||++|+||
T Consensus       178 ~~~~-----~~~~~~t~~y~aP  194 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAP  194 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCT
T ss_pred             cccc-----cCcCcCCCCcCCH
Confidence            5321     2346799999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.89  E-value=2.1e-23  Score=212.10  Aligned_cols=147  Identities=29%  Similarity=0.516  Sum_probs=126.2

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|...+.||+|+||.||+|.                        +.+.+|+.+++++ +||||+++++++..++..|+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            3689999999999999999852                        3477899999999 99999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc
Q 036342          499 VLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV  563 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~  563 (596)
                      ||||+++|+|.+++....               ..+++.+++.++.|++.|+.|||   ..+|+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence            999999999999997653               36889999999999999999999   899999999999999999999


Q ss_pred             EEEeccccccccCCCCCccccccccccccccCC
Q 036342          564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       564 ~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +||+|||+++....   ........+|+.|+||
T Consensus       181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aP  210 (327)
T 1fvr_A          181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAI  210 (327)
T ss_dssp             EEECCTTCEESSCE---ECCC----CCTTTCCH
T ss_pred             EEEcccCcCccccc---cccccCCCCCccccCh
Confidence            99999999875321   1122334678899998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.89  E-value=1.7e-24  Score=221.24  Aligned_cols=142  Identities=18%  Similarity=0.193  Sum_probs=116.9

Q ss_pred             cccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcC---------C-------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIR---------H-------  480 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~---------H-------  480 (596)
                      .++|+..+.||+|+||.||+|.                           +.+.+|+.++++++         |       
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4689999999999999999851                           45788999999886         4       


Q ss_pred             ----------Cccceeeeeecc-------------CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 036342          481 ----------RNLIKVISSCSN-------------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY  537 (596)
Q Consensus       481 ----------~niv~l~~~~~~-------------~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~  537 (596)
                                ||||++++++..             ++..|+|||||++|++.+.+..  ..+++..+..++.|++.||.|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence                      555555555543             6789999999999987776644  357899999999999999999


Q ss_pred             HhccCCCceEeCCCCCCCeeeCCCC--------------------cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          538 LHFGYSALVIHCDLKPSNVLLDDNM--------------------VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       538 lh~~~~~~i~Hrdlk~~NILl~~~~--------------------~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||+  ..+|+||||||+|||++.++                    .+||+|||+|+....       ...+||+.||||
T Consensus       177 lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            992  35799999999999999887                    999999999987642       134799999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.89  E-value=1.5e-23  Score=213.19  Aligned_cols=150  Identities=21%  Similarity=0.365  Sum_probs=124.9

Q ss_pred             cccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .++|...+.||+|+||.||+|.                           ..+.+|+.++++++||||+++++++..++..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            4689999999999999999853                           3467899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEe
Q 036342          497 ALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLS  567 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~  567 (596)
                      |+||||+++|+|.+++....      ..+++.+++.++.|++.|+.|||   ..+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998753      34889999999999999999999   889999999999999984   4569999


Q ss_pred             ccccccccCCCCCccccccccccccccCC
Q 036342          568 DFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       568 dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |||+++...............||+.|+||
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  214 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPP  214 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred             ccccccccccccccccCCCcCCCcceeCH
Confidence            99999865433222223345688999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.89  E-value=1.8e-23  Score=207.89  Aligned_cols=149  Identities=25%  Similarity=0.440  Sum_probs=126.0

Q ss_pred             hcccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ..++|...+.||+|+||.||+|.                         +.+.+|+.++++++||||+++++++.++ ..|
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            45689999999999999999752                         3577899999999999999999998754 468


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999999876667899999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .. ........+|+.|+||
T Consensus       166 ~~-~~~~~~~~~~~~y~aP  183 (281)
T 3cc6_A          166 ED-YYKASVTRLPIKWMSP  183 (281)
T ss_dssp             --------CCCCCGGGCCH
T ss_pred             cc-ccccccCCCCcceeCc
Confidence            22 1122345678899998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.89  E-value=3.6e-23  Score=211.21  Aligned_cols=149  Identities=32%  Similarity=0.490  Sum_probs=119.9

Q ss_pred             hcccccccccccCCCceeehhhH----------------HhHHHHHHH--HhhcCCCccceeeeeec-----cCCeeEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF----------------KSFDVECEM--MKSIRHRNLIKVISSCS-----NEEFKALV  499 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~----------------~~~~~e~~~--l~~l~H~niv~l~~~~~-----~~~~~~lV  499 (596)
                      ..++|+..+.||+|+||.||+|.                ..+..|.++  ++.++||||+++++++.     .....|+|
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            35689999999999999999862                234444444  45689999999998542     23467899


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCC---------ceEeCCCCCCCeeeCCCCcEEEeccc
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA---------LVIHCDLKPSNVLLDDNMVAHLSDFS  570 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~---------~i~Hrdlk~~NILl~~~~~~kl~dfG  570 (596)
                      |||+++|+|.+++....  .++..+..++.|+++|+.|||   ..         +|+||||||+|||++.++.+||+|||
T Consensus        91 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             ECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            99999999999997764  488999999999999999999   77         99999999999999999999999999


Q ss_pred             cccccCCCCC------ccccccccccccccCC
Q 036342          571 IAKLLTGEDQ------SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~------~~~~~~~~gt~~y~aP  596 (596)
                      +++.+.....      .......+||+.|+||
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP  197 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCH
T ss_pred             ceeecccccccCccccccccccCCCccceeCc
Confidence            9987643211      1112345799999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.89  E-value=2.6e-23  Score=207.08  Aligned_cols=144  Identities=21%  Similarity=0.390  Sum_probs=125.5

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||.||+|.                       ..+.+|+..+.++ +||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            4689999999999999999852                       3567899999999 999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC----------------
Q 036342          500 LEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD----------------  560 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~----------------  560 (596)
                      |||+++|+|.+++....   ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999997642   45889999999999999999999   889999999999999984                


Q ss_pred             ---CCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          561 ---NMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       561 ---~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                         ...+|++|||.++.....      ....||+.|+||
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aP  199 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLAN  199 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCH
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccCh
Confidence               447999999999876432      224589999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.89  E-value=2.7e-23  Score=210.00  Aligned_cols=154  Identities=23%  Similarity=0.404  Sum_probs=120.0

Q ss_pred             HHHhcccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccC
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNE  493 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~  493 (596)
                      +....++|...+.||+|+||.||+|.                          +.+.+|+.++++++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            33456789999999999999999641                          3477899999999999999999999775


Q ss_pred             C-----eeEEEEecCCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc
Q 036342          494 E-----FKALVLEYMPHGSLEKYLYS-----SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV  563 (596)
Q Consensus       494 ~-----~~~lV~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~  563 (596)
                      +     ..++||||+++|+|.+++..     ....+++..++.++.|+++|+.|||   ..+|+||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCc
Confidence            4     35999999999999999853     2246899999999999999999999   899999999999999999999


Q ss_pred             EEEeccccccccCCCCCccccccccccccccCC
Q 036342          564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       564 ~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +||+|||+++...............+++.|+||
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  218 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  218 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCH
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCc
Confidence            999999999876433222223345678889987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.88  E-value=1.4e-23  Score=223.51  Aligned_cols=143  Identities=27%  Similarity=0.373  Sum_probs=117.5

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC------C
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE------E  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~------~  494 (596)
                      .++|+..+.||+|+||+||+|.                       +.+.+|+.++++++|||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            5689999999999999999852                       4567899999999999999999999654      3


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            57999999976 57776643   3789999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....   ......+||++|+||
T Consensus       214 ~~~~---~~~~~~~gt~~y~aP  232 (464)
T 3ttj_A          214 AGTS---FMMTPYVVTRYYRAP  232 (464)
T ss_dssp             ---C---CCC----CCCTTCCH
T ss_pred             cCCC---cccCCCcccccccCH
Confidence            6432   123456899999998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.88  E-value=2.1e-23  Score=216.98  Aligned_cols=149  Identities=26%  Similarity=0.432  Sum_probs=122.4

Q ss_pred             HHhcccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeecc-----------
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCSN-----------  492 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~~-----------  492 (596)
                      +...++|...+.||+|+||+||+|.                 +...+|++++++++|||||++++++..           
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence            4456789999999999999999863                 234589999999999999999999843           


Q ss_pred             ---------------------------CCeeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccC
Q 036342          493 ---------------------------EEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGY  542 (596)
Q Consensus       493 ---------------------------~~~~~lV~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~  542 (596)
                                                 +...++||||++ |+|.+.+..   ....+++..+..++.|+++|+.|||   
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---  158 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---  158 (383)
T ss_dssp             ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence                                       334889999998 588777653   3356899999999999999999999   


Q ss_pred             CCceEeCCCCCCCeeeC-CCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          543 SALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       543 ~~~i~Hrdlk~~NILl~-~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +.+|+||||||+||+++ .++.+||+|||+|+.+....   ......||+.|+||
T Consensus       159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aP  210 (383)
T 3eb0_A          159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAP  210 (383)
T ss_dssp             TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCH
T ss_pred             HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCH
Confidence            99999999999999997 68999999999998764322   23346789999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.88  E-value=1.3e-23  Score=208.66  Aligned_cols=152  Identities=23%  Similarity=0.448  Sum_probs=128.8

Q ss_pred             HHHhcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++...++|+..+.||+|+||.||+|.                   +.+.+|++++++++||||+++++++.. +..++||
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            34455789999999999999999852                   457899999999999999999999874 4589999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          501 EYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||+++|+|.+++.... ..+++..+..++.|++.|+.|||   ..+++||||||+||++++++.+||+|||+++......
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999999987542 25789999999999999999999   8999999999999999999999999999998764322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                       ........+|+.|+||
T Consensus       164 -~~~~~~~~~~~~y~aP  179 (279)
T 1qpc_A          164 -YTAREGAKFPIKWTAP  179 (279)
T ss_dssp             -EECCTTCCCCTTTSCH
T ss_pred             -cccccCCCCccCccCh
Confidence             1122334578889998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.88  E-value=4.3e-23  Score=206.09  Aligned_cols=143  Identities=27%  Similarity=0.465  Sum_probs=123.5

Q ss_pred             cccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc----CCeeEE
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN----EEFKAL  498 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~l  498 (596)
                      .|...+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++..    +...++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            47778899999999999852                       357789999999999999999998864    356899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eEeCCCCCCCeeeC-CCCcEEEecccccccc
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL--VIHCDLKPSNVLLD-DNMVAHLSDFSIAKLL  575 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~Hrdlk~~NILl~-~~~~~kl~dfGla~~~  575 (596)
                      ||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+  |+||||||+||+++ +++.+||+|||+++..
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999998753 5789999999999999999999   777  99999999999997 7899999999999764


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...    ......||+.|+||
T Consensus       183 ~~~----~~~~~~~t~~y~aP  199 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAP  199 (290)
T ss_dssp             CTT----SBEESCSSCCCCCG
T ss_pred             ccc----ccccccCCcCcCCH
Confidence            322    22345799999998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=3.1e-23  Score=206.76  Aligned_cols=149  Identities=23%  Similarity=0.408  Sum_probs=126.3

Q ss_pred             cccccccc-cccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENN-LIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~-~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|...+ .||+|+||.||+|.                        +.+.+|++++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            34666666 99999999999752                        3477899999999999999999999 4456899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999999876667899999999999999999999   889999999999999999999999999999876433


Q ss_pred             CCc-cccccccccccccCC
Q 036342          579 DQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~-~~~~~~~gt~~y~aP  596 (596)
                      ... .......||+.|+||
T Consensus       164 ~~~~~~~~~~~~~~~y~aP  182 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAP  182 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCH
T ss_pred             cceeeccccccccccccCH
Confidence            221 112334578899998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.88  E-value=3.5e-23  Score=209.18  Aligned_cols=149  Identities=27%  Similarity=0.358  Sum_probs=126.3

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..++|+..+.||+|+||.||+|.                   +.+.+|+.++++++||||+++++++...+..|+||||+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            45679999999999999999862                   45789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      ++|+|.+++......+++..+..++.|++.|+.|||   ..+++|+||||+||+++.++.+||+|||+++......  ..
T Consensus       107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~  181 (314)
T 3com_A          107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AK  181 (314)
T ss_dssp             TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SC
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cc
Confidence            999999999865567899999999999999999999   8899999999999999999999999999998764321  12


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....||+.|+||
T Consensus       182 ~~~~~~~~~y~aP  194 (314)
T 3com_A          182 RNTVIGTPFWMAP  194 (314)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             cCccCCCCCccCh
Confidence            3345789999998

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.88  E-value=2e-23  Score=207.55  Aligned_cols=147  Identities=27%  Similarity=0.510  Sum_probs=127.6

Q ss_pred             cccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeecc--------------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCSN--------------  492 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~~--------------  492 (596)
                      .++|+..+.||+|+||.||+|.                 +.+.+|++++++++||||+++++++..              
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            4579999999999999999863                 457899999999999999999998854              


Q ss_pred             --CCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          493 --EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       493 --~~~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                        ....|+||||+++|+|.+++.... ..+++..+..++.|++.|+.|||   ..+|+||||||+||++++++.+||+||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcc
Confidence              345899999999999999997642 46889999999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCC
Q 036342          570 SIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       570 Gla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+++......   ......||+.|+||
T Consensus       167 g~~~~~~~~~---~~~~~~~~~~y~aP  190 (284)
T 2a19_B          167 GLVTSLKNDG---KRTRSKGTLRYMSP  190 (284)
T ss_dssp             TTCEESSCCS---CCCCCCSCCTTSCH
T ss_pred             hhheeccccc---cccccCCcccccCh
Confidence            9998764322   12345799999998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.88  E-value=2.1e-23  Score=206.12  Aligned_cols=144  Identities=29%  Similarity=0.518  Sum_probs=117.8

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .++|+..+.||+|+||.||+|.                       +.+.+|++++++++||||+++++++..++..++||
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            4689999999999999999852                       45778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc---eEeCCCCCCCeeeCC--------CCcEEEecc
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL---VIHCDLKPSNVLLDD--------NMVAHLSDF  569 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~---i~Hrdlk~~NILl~~--------~~~~kl~df  569 (596)
                      ||+++|+|.+++...  .+++..+..++.|+++|+.|||   ..+   |+||||||+||+++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999998643  5889999999999999999999   666   999999999999986        678999999


Q ss_pred             ccccccCCCCCccccccccccccccCC
Q 036342          570 SIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       570 Gla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+++......    .....||+.|+||
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aP  183 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAP  183 (271)
T ss_dssp             CC-----------------CCGGGSCH
T ss_pred             Cccccccccc----ccCCCCccceeCH
Confidence            9998654321    2235789999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.88  E-value=4.2e-23  Score=208.81  Aligned_cols=148  Identities=27%  Similarity=0.401  Sum_probs=121.2

Q ss_pred             cccccc-ccccCCCceeehhhH---------------------HhHHHHHHHHhh-cCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSEN-NLIGRGGFALFIRAF---------------------KSFDVECEMMKS-IRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~-~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      +.|... +.||+|+||.||+|.                     +.+.+|++++++ .+||||+++++++..++..|+|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567774 789999999999852                     457889999998 479999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc---EEEeccccccccCCC
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV---AHLSDFSIAKLLTGE  578 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~---~kl~dfGla~~~~~~  578 (596)
                      |+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.   +||+|||+++.....
T Consensus        92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            999999999998754 5789999999999999999999   889999999999999988765   999999998865322


Q ss_pred             CC-----ccccccccccccccCC
Q 036342          579 DQ-----SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~-----~~~~~~~~gt~~y~aP  596 (596)
                      ..     .......+||+.|+||
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aP  190 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAP  190 (316)
T ss_dssp             --------------CCSGGGCCH
T ss_pred             CccccccccccccccCCcCccCh
Confidence            11     1112235699999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.88  E-value=2.8e-23  Score=214.32  Aligned_cols=154  Identities=23%  Similarity=0.314  Sum_probs=125.7

Q ss_pred             CHHHHHHhcccccccccccCCCceeehhhH-------------------------------HhHHHHHHHHhhcCCCccc
Q 036342          436 SYLELCRATDEFSENNLIGRGGFALFIRAF-------------------------------KSFDVECEMMKSIRHRNLI  484 (596)
Q Consensus       436 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~-------------------------------~~~~~e~~~l~~l~H~niv  484 (596)
                      ...++....++|...+.||+|+||.||+|.                               +.+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            356777888999999999999999999851                               4578999999999999999


Q ss_pred             eeeeeecc-----CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC
Q 036342          485 KVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD  559 (596)
Q Consensus       485 ~l~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~  559 (596)
                      ++++++..     ....|+||||++ |+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence            99999843     346899999997 6999998877667899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          560 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       560 ~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .++.+||+|||+++......   ......||+.|+||
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aP  202 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAP  202 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCH
T ss_pred             CCCCEEEEecCccccccccc---ccceecccceecCc
Confidence            99999999999998543221   23345789999998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.88  E-value=5.1e-23  Score=212.56  Aligned_cols=151  Identities=31%  Similarity=0.505  Sum_probs=131.7

Q ss_pred             HHHHhcccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhc-CCCccceeee
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSI-RHRNLIKVIS  488 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l-~H~niv~l~~  488 (596)
                      ......++|...+.||+|+||.||+|.                             +.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            334456789999999999999999852                             2466899999999 8999999999


Q ss_pred             eeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEec
Q 036342          489 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD  568 (596)
Q Consensus       489 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~d  568 (596)
                      ++...+..|+||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+|||+||+||+++.++.+|++|
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999999997653 5889999999999999999999   88999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccCC
Q 036342          569 FSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||++..+....   .....+||+.|+||
T Consensus       244 fG~~~~~~~~~---~~~~~~gt~~y~aP  268 (365)
T 2y7j_A          244 FGFSCHLEPGE---KLRELCGTPGYLAP  268 (365)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCH
T ss_pred             cCcccccCCCc---ccccCCCCCCccCh
Confidence            99998764322   23346899999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.88  E-value=4.4e-23  Score=205.15  Aligned_cols=145  Identities=28%  Similarity=0.469  Sum_probs=125.4

Q ss_pred             ccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ++|...+.||+|+||.||++.                           +.+.+|+.++++++||||+++++++..++..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            578999999999999999852                           34789999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC----cEEEecccccc
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM----VAHLSDFSIAK  573 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~----~~kl~dfGla~  573 (596)
                      +||||+++++|.+++.... .+++..+..++.|++.|+.|||   ..+++||||||+||+++.++    .+||+|||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999997653 5889999999999999999999   88999999999999998877    89999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ......   ......||+.|+||
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aP  180 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAP  180 (283)
T ss_dssp             ECC-----------CCCGGGCCH
T ss_pred             eccCCC---cccccCCCcCccCc
Confidence            764321   12345789999998

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.88  E-value=1.7e-23  Score=215.90  Aligned_cols=145  Identities=22%  Similarity=0.354  Sum_probs=126.7

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .++|+..+.||+|+||.||++.                      +.+.+|+.++++++||||+++++++..++..|+|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            4679999999999999999852                      457899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~-~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |+++|+|.+++.... .+++..+..++.+++.|+.|||   .. +|+||||||+||+++.++.+||+|||+++.....  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999998754 5789999999999999999999   65 8999999999999999999999999998765321  


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......||+.|+||
T Consensus       186 --~~~~~~gt~~y~aP  199 (360)
T 3eqc_A          186 --MANSFVGTRSYMSP  199 (360)
T ss_dssp             --C----CCCCTTCCH
T ss_pred             --cccCCCCCCCeECH
Confidence              12345799999998

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.88  E-value=2.5e-23  Score=228.92  Aligned_cols=147  Identities=22%  Similarity=0.391  Sum_probs=120.3

Q ss_pred             cccccc-cccCCCceeehhh------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          446 EFSENN-LIGRGGFALFIRA------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       446 ~~~~~~-~ig~G~~g~v~~~------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++...+ .||+|+||.||+|                        .+.+.+|++++++++|||||+++++|.. +..|+||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344344 7999999999975                        1457899999999999999999999976 4589999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |||++|+|.+++......+++.++..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            999999999999877667899999999999999999999   88999999999999999999999999999987643221


Q ss_pred             c-cccccccccccccCC
Q 036342          581 S-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~-~~~~~~~gt~~y~aP  596 (596)
                      . .......+|+.|+||
T Consensus       492 ~~~~~~~~~~~~~y~AP  508 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAP  508 (613)
T ss_dssp             ----------CCTTSCH
T ss_pred             eeeeccCCCCccceeCH
Confidence            1 112234567899998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.88  E-value=1.6e-23  Score=213.21  Aligned_cols=149  Identities=23%  Similarity=0.396  Sum_probs=121.0

Q ss_pred             HHhcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ....++|...+.||+|+||.||+|.                       +.+.+|+.++++++|||||++++++..++..|
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            3456789999999999999999862                       23568999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee-----CCCCcEEEeccccc
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL-----DDNMVAHLSDFSIA  572 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl-----~~~~~~kl~dfGla  572 (596)
                      +||||++ |+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||++     +.++.+||+|||++
T Consensus       110 lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999997 59999998764 5889999999999999999999   8899999999999999     45566999999999


Q ss_pred             cccCCCCCccccccccccccccCC
Q 036342          573 KLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +......  .......||+.|+||
T Consensus       185 ~~~~~~~--~~~~~~~~t~~y~aP  206 (329)
T 3gbz_A          185 RAFGIPI--RQFTHEIITLWYRPP  206 (329)
T ss_dssp             HHHC-------------CCTTCCH
T ss_pred             cccCCcc--cccCCCcCCccccCH
Confidence            8764321  123345789999998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.88  E-value=2.7e-23  Score=211.72  Aligned_cols=147  Identities=25%  Similarity=0.463  Sum_probs=123.2

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .++|+..+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++..++..|+||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4689999999999999999852                       34678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||++++++.++.... ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.......
T Consensus       104 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            999998888876544 35889999999999999999999   88999999999999999999999999999986543221


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......||++|+||
T Consensus       180 --~~~~~~~t~~y~aP  193 (331)
T 4aaa_A          180 --VYDDEVATRWYRAP  193 (331)
T ss_dssp             ------CCCCCTTCCH
T ss_pred             --ccCCCcCCccccCc
Confidence              23345789999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.88  E-value=1.5e-23  Score=210.66  Aligned_cols=149  Identities=23%  Similarity=0.351  Sum_probs=126.5

Q ss_pred             hcccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ..++|+..+.||+|+||.||+|.                     +.+.+|+.++++++||||+++++++..++..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            34689999999999999999852                     457789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+++|+|.+++......+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||++......  .
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            99999999998876667899999999999999999999   889999999999999999999999999987643211  1


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......||+.|+||
T Consensus       172 ~~~~~~~~~~~y~aP  186 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAP  186 (302)
T ss_dssp             HC-----CCGGGCCH
T ss_pred             cccccccCChhhcCC
Confidence            112335789999998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.88  E-value=1.8e-23  Score=209.95  Aligned_cols=153  Identities=25%  Similarity=0.401  Sum_probs=117.5

Q ss_pred             HHhcccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ....++|...+.||+|+||.||+|.                      +.+.+|+.++++++||||+++++++..++..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            3446789999999999999999852                      345689999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          499 VLEYMPHGSLEKYLYS-------SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                      ||||+++|+|.+++..       ....+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999874       2345889999999999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCC---ccccccccccccccCC
Q 036342          572 AKLLTGEDQ---SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~---~~~~~~~~gt~~y~aP  596 (596)
                      ++.......   ........||+.|+||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAP  195 (303)
T ss_dssp             HHHCC---------------CCCTTCCH
T ss_pred             hheeccCCCccchhhhcccCCCccccCH
Confidence            886543211   1112345799999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.88  E-value=6.8e-23  Score=206.01  Aligned_cols=146  Identities=28%  Similarity=0.423  Sum_probs=129.2

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .+.|+..+.||+|+||.||+|.                      +.+.+|+.++++++||||+++++++..++..|+|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            3568999999999999999852                      457899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+++++|.+++...  .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++......  
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            99999999998753  5889999999999999999999   8899999999999999999999999999998764321  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......||+.|+||
T Consensus       174 ~~~~~~~~~~~y~aP  188 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAP  188 (303)
T ss_dssp             CCBCCCCSCGGGCCH
T ss_pred             cccCccCCCcCccCH
Confidence            123446799999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.88  E-value=6.3e-23  Score=203.21  Aligned_cols=146  Identities=27%  Similarity=0.464  Sum_probs=121.5

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|...+.||+|+||.||+|.                        +.+.+|+.++++++||||+++++++..++..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            4689999999999999999752                        2567899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++++|.+++.... .+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999997654 5789999999999999999999   8899999999999999999999999999998754321


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         ......||+.|+||
T Consensus       166 ---~~~~~~~~~~y~aP  179 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAP  179 (276)
T ss_dssp             --------------CCT
T ss_pred             ---ceecccCCccccCH
Confidence               12345789999998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.88  E-value=5e-23  Score=207.67  Aligned_cols=148  Identities=25%  Similarity=0.318  Sum_probs=122.4

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|...+.||+|+||.||++.                        +.+.+|+.++++++||||+++++++..++..|+|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            4689999999999999999852                        4577899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||+++++|.+++.... .+++..+..++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999998754 5889999999999999999999   8899999999999999999999999999988654322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                       ........||+.|+||
T Consensus       189 -~~~~~~~~~~~~y~aP  204 (309)
T 2h34_A          189 -LTQLGNTVGTLYYMAP  204 (309)
T ss_dssp             ---------CCGGGCCG
T ss_pred             -cccccccCCCcCccCH
Confidence             1122345789999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.88  E-value=3.6e-23  Score=229.19  Aligned_cols=151  Identities=23%  Similarity=0.366  Sum_probs=126.4

Q ss_pred             HHhcccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF  495 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  495 (596)
                      ....++|+..+.||+|+||.||+|.                         +.+.+|+.++++++|||||++++++.+ +.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence            3345678889999999999999752                         457789999999999999999999854 56


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+||||+++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+||+|||+++..
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            89999999999999999877667899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .... ........+|+.||||
T Consensus       542 ~~~~-~~~~~~~~~t~~y~aP  561 (656)
T 2j0j_A          542 EDST-YYKASKGKLPIKWMAP  561 (656)
T ss_dssp             CC-----------CCGGGCCH
T ss_pred             CCCc-ceeccCCCCCcceeCH
Confidence            4332 1222345678899998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.88  E-value=1.2e-22  Score=205.76  Aligned_cols=145  Identities=26%  Similarity=0.464  Sum_probs=123.6

Q ss_pred             ccccccccCCCceeehhh--------------------------HHhHHHHHHHHhhcCCCccceeeeeeccC--CeeEE
Q 036342          447 FSENNLIGRGGFALFIRA--------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKAL  498 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~--------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l  498 (596)
                      |+..+.||+|+||.||++                          .+.+.+|+.++++++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999542                          13578999999999999999999999864  57899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||+++|+|.+++....  +++..++.++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997754  789999999999999999999   889999999999999999999999999999876543


Q ss_pred             CCc-cccccccccccccCC
Q 036342          579 DQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~-~~~~~~~gt~~y~aP  596 (596)
                      ... .......||+.|+||
T Consensus       188 ~~~~~~~~~~~~~~~y~aP  206 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAP  206 (318)
T ss_dssp             CSEEEC---CCCCGGGCCH
T ss_pred             ccccccccCCCCCceeeCh
Confidence            221 123345688889998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.88  E-value=4.3e-23  Score=206.18  Aligned_cols=149  Identities=24%  Similarity=0.407  Sum_probs=125.2

Q ss_pred             hcccccccc-cccCCCceeehhh-------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          443 ATDEFSENN-LIGRGGFALFIRA-------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       443 ~~~~~~~~~-~ig~G~~g~v~~~-------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      ..++|...+ .||+|+||.||+|                         .+.+.+|+.++++++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            345788777 9999999999986                         13577899999999999999999999 55678


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999999998754 5889999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCCc-cccccccccccccCC
Q 036342          577 GEDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aP  596 (596)
                      ..... .......+|+.|+||
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aP  189 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAP  189 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCH
T ss_pred             cCCCcccccccCCCCceeeCh
Confidence            33221 112234567889998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.88  E-value=6e-23  Score=207.10  Aligned_cols=149  Identities=28%  Similarity=0.442  Sum_probs=118.0

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      ..++|...+.||+|+||.||+|.                        +.+.+|+.++++++||||+++++++..++..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            34689999999999999999752                        346789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          499 VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ||||+++|+|.+++..   ....+++..++.++.|+++|+.|||   ..+++||||||+||+++.++.+||+|||+++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999865   2346889999999999999999999   889999999999999999999999999998865


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....  .......||+.|+||
T Consensus       187 ~~~~--~~~~~~~~~~~y~aP  205 (310)
T 2wqm_A          187 SSKT--TAAHSLVGTPYYMSP  205 (310)
T ss_dssp             --------------CCSSCCH
T ss_pred             cCCC--ccccccCCCeeEeCh
Confidence            4321  122345789999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.88  E-value=9.1e-24  Score=229.06  Aligned_cols=152  Identities=26%  Similarity=0.436  Sum_probs=129.2

Q ss_pred             HHHhcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++...++|...+.||+|+||.||+|.                   +.+.+|+++|++++|||||++++++.+ +..|+||
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            34456789999999999999999852                   468899999999999999999999876 6689999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          501 EYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||++|+|.++++... ..+++.+++.++.|+++||.|||   ..+|+||||||+|||+++++.+||+|||+++..... 
T Consensus       341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  416 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-  416 (535)
T ss_dssp             CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-
T ss_pred             ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-
Confidence            9999999999997532 35889999999999999999999   899999999999999999999999999999875421 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                      .........++..|+||
T Consensus       417 ~~~~~~~~~~~~~y~aP  433 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAP  433 (535)
T ss_dssp             HHHTTCSTTSCGGGSCH
T ss_pred             ceecccCCcCcccccCH
Confidence            11112234577889998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.88  E-value=8e-23  Score=207.79  Aligned_cols=150  Identities=26%  Similarity=0.463  Sum_probs=127.9

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCC--ee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE--FK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~  496 (596)
                      .++|+..+.||+|+||.||++.                         +.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            4578999999999999998752                         35789999999999999999999987654  68


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ++||||+++|+|.+++......+++.+++.++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999887667899999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCCc-cccccccccccccCC
Q 036342          577 GEDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aP  596 (596)
                      ..... .......++..|+||
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aP  217 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAP  217 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCH
T ss_pred             ccccccccccCCCCceeEECc
Confidence            33221 112234577889998

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.88  E-value=2.8e-23  Score=212.97  Aligned_cols=148  Identities=22%  Similarity=0.286  Sum_probs=119.2

Q ss_pred             cccccccccccCCCceeehhhH-----------------------------------HhHHHHHHHHhhcCCCccceeee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------------------KSFDVECEMMKSIRHRNLIKVIS  488 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------------------~~~~~e~~~l~~l~H~niv~l~~  488 (596)
                      .++|...+.||+|+||.||+|.                                   +.+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3589999999999999999852                                   12456777888899999999999


Q ss_pred             eecc----CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC--
Q 036342          489 SCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM--  562 (596)
Q Consensus       489 ~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~--  562 (596)
                      ++..    ++..|+||||+ +|+|.+++.... .+++.+++.++.|++.|+.|||   +.+|+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9977    67899999999 999999997764 6899999999999999999999   88999999999999998877  


Q ss_pred             cEEEeccccccccCCCCC-----ccccccccccccccCC
Q 036342          563 VAHLSDFSIAKLLTGEDQ-----SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 ~~kl~dfGla~~~~~~~~-----~~~~~~~~gt~~y~aP  596 (596)
                      .+||+|||+++.+.....     ........||+.|+||
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  229 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSL  229 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCH
Confidence            999999999987642211     1112446799999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.88  E-value=5.4e-23  Score=205.29  Aligned_cols=149  Identities=26%  Similarity=0.373  Sum_probs=121.8

Q ss_pred             cccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .++|+..+.||+|+||.||+|.                           +.+.+|+.++++++||||+++++++..++ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4579999999999999999752                           34668999999999999999999998765 8


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ++||||+++|+|.+++......+++..+..++.|+++|+.|||   ..+++||||||+||+++.++.+||+|||+++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            8999999999999999876556899999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCCc-cccccccccccccCC
Q 036342          577 GEDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aP  596 (596)
                      ..... .......+|+.|+||
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aP  193 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAP  193 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCH
T ss_pred             ccccchhhhccCCCCceeeCc
Confidence            33221 112335678889998

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.88  E-value=5e-23  Score=211.22  Aligned_cols=146  Identities=25%  Similarity=0.433  Sum_probs=129.8

Q ss_pred             cccccccccccCCCceeehhhH------------------------------------HhHHHHHHHHhhcCCCccceee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------------------KSFDVECEMMKSIRHRNLIKVI  487 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------------------~~~~~e~~~l~~l~H~niv~l~  487 (596)
                      .++|...+.||+|+||.||+|.                                    +.+.+|+.++++++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            4689999999999999999751                                    5678999999999999999999


Q ss_pred             eeeccCCeeEEEEecCCCCCHHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeC
Q 036342          488 SSCSNEEFKALVLEYMPHGSLEKY------LYSS-NCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLD  559 (596)
Q Consensus       488 ~~~~~~~~~~lV~e~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~  559 (596)
                      +++..++..|+||||+++|+|.++      +... ...+++..+..++.|++.|+.|||   . .+|+||||||+||+++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEEC
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEc
Confidence            999999999999999999999998      5542 356899999999999999999999   7 8999999999999999


Q ss_pred             CCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          560 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       560 ~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .++.+||+|||+++.....    ......||+.|+||
T Consensus       187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aP  219 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPP  219 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCG
T ss_pred             CCCcEEEeccccccccccc----cccCCCCCcCccCc
Confidence            9999999999999875432    23446799999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.88  E-value=1e-22  Score=204.77  Aligned_cols=149  Identities=23%  Similarity=0.417  Sum_probs=123.7

Q ss_pred             cccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeec--cCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCS--NEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~  496 (596)
                      .++|...+.||+|+||.||++.                         +.+.+|++++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            4689999999999999999741                         34678999999999999999999984  45578


Q ss_pred             EEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          497 ALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      |+||||+++| +.+++... ...+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 77777653 346889999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .............||+.|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aP  180 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPP  180 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCH
T ss_pred             CccccccccccCCCCCCCcCh
Confidence            432222223445799999998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.88  E-value=2.1e-23  Score=212.02  Aligned_cols=157  Identities=25%  Similarity=0.346  Sum_probs=127.4

Q ss_pred             cCHHHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhc-CCCccceeeeeecc-
Q 036342          435 FSYLELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSI-RHRNLIKVISSCSN-  492 (596)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~-  492 (596)
                      +++.++....++|+..+.||+|+||.||+|.                    +.+.+|+.+++++ +||||+++++++.. 
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3444455567899999999999999999852                    4578999999999 89999999999976 


Q ss_pred             -----CCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEE
Q 036342          493 -----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHL  566 (596)
Q Consensus       493 -----~~~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl  566 (596)
                           .+..|+||||+++|+|.+++.... ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEE
Confidence                 457899999999999999998653 46889999999999999999999   889999999999999999999999


Q ss_pred             eccccccccCCCCCccccccccccccccCC
Q 036342          567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       567 ~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|||+++......  .......||+.|+||
T Consensus       171 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aP  198 (326)
T 2x7f_A          171 VDFGVSAQLDRTV--GRRNTFIGTPYWMAP  198 (326)
T ss_dssp             CCCTTTC---------------CCGGGCCH
T ss_pred             eeCcCceecCcCc--cccccccCCccccCh
Confidence            9999988654221  122345799999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.88  E-value=1.2e-22  Score=206.74  Aligned_cols=143  Identities=22%  Similarity=0.403  Sum_probs=125.0

Q ss_pred             cccccccccccCCCceeehhhH------------------HhHHHHHHHHhhcC-CCccceeeeeecc--CCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------KSFDVECEMMKSIR-HRNLIKVISSCSN--EEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~e~  502 (596)
                      .++|+..+.||+|+||.||+|.                  +.+.+|+.++++++ ||||+++++++..  ....++||||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~  114 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  114 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence            4679999999999999999862                  56889999999997 9999999999987  5678999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-cEEEeccccccccCCCCCc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-~~kl~dfGla~~~~~~~~~  581 (596)
                      +++++|.+++..    +++.++..++.|++.|+.|||   ..+|+||||||+||+++.++ .+||+|||+++......  
T Consensus       115 ~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--  185 (330)
T 3nsz_A          115 VNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--  185 (330)
T ss_dssp             CCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred             cCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence            999999998853    678899999999999999999   89999999999999999776 89999999998764322  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......||+.|+||
T Consensus       186 -~~~~~~~~~~y~aP  199 (330)
T 3nsz_A          186 -EYNVRVASRYFKGP  199 (330)
T ss_dssp             -CCCSCCSCGGGCCH
T ss_pred             -ccccccccccccCh
Confidence             22345789999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.87  E-value=1.5e-22  Score=202.94  Aligned_cols=147  Identities=28%  Similarity=0.469  Sum_probs=129.0

Q ss_pred             hcccccccccccCCCceeehhhH------------------------------HhHHHHHHHHhhcC-CCccceeeeeec
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------------KSFDVECEMMKSIR-HRNLIKVISSCS  491 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------------~~~~~e~~~l~~l~-H~niv~l~~~~~  491 (596)
                      ..++|+..+.||+|+||.||+|.                              +.+.+|+.++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            35689999999999999999742                              23568999999996 999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                      .++..++||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999998653 5889999999999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++......   ......||+.|+||
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aP  192 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAP  192 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCH
T ss_pred             hhhcCCCc---ccccccCCccccCH
Confidence            98764322   22345789999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.87  E-value=8e-23  Score=205.62  Aligned_cols=145  Identities=26%  Similarity=0.438  Sum_probs=127.1

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|...+.||+|+||.||++.                     +.+.+|+.++++++||||+++++++...+..|+||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            4578999999999999999752                     3477899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee---CCCCcEEEeccccccccCCCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl---~~~~~~kl~dfGla~~~~~~~  579 (596)
                      +++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||++   +.++.+||+|||+++..... 
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            99999999987654 5789999999999999999999   8899999999999999   77899999999998754321 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         ......||+.|+||
T Consensus       163 ---~~~~~~~~~~y~aP  176 (304)
T 2jam_A          163 ---IMSTACGTPGYVAP  176 (304)
T ss_dssp             ---TTHHHHSCCCBCCT
T ss_pred             ---ccccccCCCCccCh
Confidence               22345799999998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.87  E-value=1.2e-22  Score=203.11  Aligned_cols=147  Identities=28%  Similarity=0.450  Sum_probs=125.2

Q ss_pred             ccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ++|.....||+|+||.||+|.                     +.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            455666799999999999852                     45778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEeccccccccCCCCC
Q 036342          504 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       504 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfGla~~~~~~~~  580 (596)
                      ++|+|.+++....  ..+++..+..++.|++.|+.|||   ..+++||||||+||+++. ++.+||+|||+++...... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            9999999998753  24568888999999999999999   889999999999999987 8999999999998764321 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                       .......||+.|+||
T Consensus       178 -~~~~~~~~~~~y~aP  192 (295)
T 2clq_A          178 -PCTETFTGTLQYMAP  192 (295)
T ss_dssp             ----CCCCCCGGGCCH
T ss_pred             -CcccccCCCccccCh
Confidence             122345789999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.87  E-value=1.2e-23  Score=213.03  Aligned_cols=155  Identities=22%  Similarity=0.345  Sum_probs=128.4

Q ss_pred             HHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          438 LELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      .++....++|+..+.||+|+||.||+|.                    +.+.+|+.++++++||||+++++++..++..+
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            3444556789999999999999999863                    34668999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +||||+++|+|.+++......+++..+..++.|++.|+.|||   ..+++||||||+||+++ ++.+||+|||+++....
T Consensus       106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            999999999999999877667889999999999999999999   88999999999999998 67999999999876432


Q ss_pred             CC---CccccccccccccccCC
Q 036342          578 ED---QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~---~~~~~~~~~gt~~y~aP  596 (596)
                      ..   .........||+.|+||
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aP  203 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAP  203 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCH
T ss_pred             ccccccccccccCCCcccccCh
Confidence            11   11122335689999998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.87  E-value=2.2e-22  Score=205.82  Aligned_cols=154  Identities=27%  Similarity=0.415  Sum_probs=129.6

Q ss_pred             HHhcccccccccccCCCceeehhhH----------------HhHHHHHHHHhh--cCCCccceeeeeeccCC----eeEE
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF----------------KSFDVECEMMKS--IRHRNLIKVISSCSNEE----FKAL  498 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~----------------~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~l  498 (596)
                      ....++|...+.||+|+||.||+|.                +.+.+|+++++.  ++||||+++++++...+    ..|+
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            3445789999999999999999852                356788888887  79999999999998765    7899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcc-----CCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ||||+++|+|.+++...  .+++.+++.++.|++.|+.|||..     ...+|+||||||+||+++.++.+||+|||+++
T Consensus       118 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  195 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  195 (342)
T ss_dssp             EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence            99999999999999765  478999999999999999999932     15689999999999999999999999999998


Q ss_pred             ccCCCCCcc--ccccccccccccCC
Q 036342          574 LLTGEDQSM--TQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~--~~~~~~gt~~y~aP  596 (596)
                      .........  ......||+.|+||
T Consensus       196 ~~~~~~~~~~~~~~~~~gt~~y~aP  220 (342)
T 1b6c_B          196 RHDSATDTIDIAPNHRVGTKRYMAP  220 (342)
T ss_dssp             EEETTTTEEEECCCSCCCCGGGCCH
T ss_pred             eccccccccccccccCCcCcccCCH
Confidence            764332211  12345799999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.87  E-value=6.7e-23  Score=207.96  Aligned_cols=145  Identities=30%  Similarity=0.424  Sum_probs=124.5

Q ss_pred             cccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhcCCCccceeeeeeccCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~  494 (596)
                      .++|...+.||+|+||.||+|.                             ..+.+|++++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            4679999999999999999852                             13678999999999999999999997765


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC---cEEEecccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM---VAHLSDFSI  571 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~---~~kl~dfGl  571 (596)
                       .|+||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++   .+||+|||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             799999999999999987653 6889999999999999999999   88999999999999998765   499999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++.....   .......||+.|+||
T Consensus       164 ~~~~~~~---~~~~~~~gt~~y~aP  185 (322)
T 2ycf_A          164 SKILGET---SLMRTLCGTPTYLAP  185 (322)
T ss_dssp             CEECCCC---HHHHHHHSCCTTCCH
T ss_pred             ceecccc---cccccccCCcCccCc
Confidence            9876422   122345799999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.87  E-value=9.5e-23  Score=210.56  Aligned_cols=147  Identities=26%  Similarity=0.381  Sum_probs=125.8

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-----Cee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-----EFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~  496 (596)
                      .++|+..+.||+|+||.||+|.                      +.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            4589999999999999999852                      4577899999999999999999998654     368


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+||||++ |+|.+++...  .+++.++..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus       106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999997 5999998765  4889999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCC-ccccccccccccccCC
Q 036342          577 GEDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~-~~~~~~~~gt~~y~aP  596 (596)
                      .... .......+||++|+||
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aP  200 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAP  200 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCH
T ss_pred             CCCCccccccccccccCCCCC
Confidence            2211 1112345899999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.87  E-value=3.5e-23  Score=205.41  Aligned_cols=148  Identities=26%  Similarity=0.422  Sum_probs=124.6

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeec--cCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCS--NEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~l  498 (596)
                      .++|+..+.||+|+||.||++.                       +.+.+|+.++++++||||+++++++.  .++..|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            4689999999999999999852                       35778999999999999999999874  4568999


Q ss_pred             EEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCc-----eEeCCCCCCCeeeCCCCcEEEeccc
Q 036342          499 VLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAL-----VIHCDLKPSNVLLDDNMVAHLSDFS  570 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~~~~-----i~Hrdlk~~NILl~~~~~~kl~dfG  570 (596)
                      ||||+++|+|.+++....   ..+++..++.++.|++.|+.|||   ..+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999987532   34899999999999999999999   666     9999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCC
Q 036342          571 IAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +++......  .......||+.|+||
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aP  185 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSP  185 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCH
T ss_pred             hheeecccc--ccccccCCCccccCh
Confidence            998754321  122345789999998

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.87  E-value=9.1e-23  Score=204.54  Aligned_cols=146  Identities=26%  Similarity=0.427  Sum_probs=127.6

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++..++..|+|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            579999999999999999852                       346789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |++ |+|.+++.... ..+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  158 (299)
T 2r3i_A           83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  158 (299)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCcc
Confidence            997 69999998754 45789999999999999999999   88999999999999999999999999999987643221


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......||+.|+||
T Consensus       159 --~~~~~~~~~~y~aP  172 (299)
T 2r3i_A          159 --TYTHEVVTLWYRAP  172 (299)
T ss_dssp             --CTTSCBCCCTTCCH
T ss_pred             --ccCcccccccccCc
Confidence              22345789999998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.87  E-value=7.1e-23  Score=207.22  Aligned_cols=150  Identities=23%  Similarity=0.325  Sum_probs=124.4

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeec----cCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCS----NEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~----~~~~~~l  498 (596)
                      .++|+..+.||+|+||.||++.                     +.+.+|+.++++++||||+++++++.    .....|+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            4689999999999999999752                     45778999999999999999999986    3447899


Q ss_pred             EEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          499 VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ||||+++|+|.+++..   ....+++.+++.++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999876   3456899999999999999999999   889999999999999999999999999998764


Q ss_pred             CCCCCc-------cccccccccccccCC
Q 036342          576 TGEDQS-------MTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~-------~~~~~~~gt~~y~aP  596 (596)
                      ......       .......||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  212 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAP  212 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred             ccccccccccccccccccccCCcccCCH
Confidence            321110       011234679999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.87  E-value=5e-23  Score=214.81  Aligned_cols=146  Identities=27%  Similarity=0.425  Sum_probs=120.0

Q ss_pred             cccccccccccCCCceeehhhH----------------HhHHHHHHHHhhcCCCccceeeeeeccCC------eeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------KSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e  501 (596)
                      ..+|...+.||+|+||+||+|.                +...+|++++++++|||||++++++...+      ..|+|||
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            4579999999999999999863                12347999999999999999999985432      3789999


Q ss_pred             cCCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC-CCCcEEEeccccccccCC
Q 036342          502 YMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       502 ~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~-~~~~~kl~dfGla~~~~~  577 (596)
                      |++++ +.+.+.   .....+++..+..++.|+++|++|||   ..+|+||||||+|||++ .++.+||+|||+|+....
T Consensus       119 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          119 YVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             CCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            99875 433332   22346889999999999999999999   89999999999999999 799999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   ......||++|+||
T Consensus       195 ~~---~~~~~~~t~~y~aP  210 (394)
T 4e7w_A          195 GE---PNVSYICSRYYRAP  210 (394)
T ss_dssp             TC---CCCSSCSCGGGCCH
T ss_pred             CC---CCcccccCcCccCH
Confidence            22   22346789999998

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.87  E-value=7.3e-23  Score=225.84  Aligned_cols=141  Identities=26%  Similarity=0.427  Sum_probs=117.0

Q ss_pred             ccccCCCceeehhh-------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRA-------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~-------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||.||+|                         .+.+.+|++++++++|||||++++++..+ ..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence            57999999999975                         14578999999999999999999999654 57899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC-cccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ-SMTQ  584 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~-~~~~  584 (596)
                      |+|.+++.... .+++..+..++.||+.|++|||   ..+|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997654 6889999999999999999999   88999999999999999999999999999987643322 1122


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....+|+.|+||
T Consensus       530 ~~~~~t~~y~AP  541 (635)
T 4fl3_A          530 THGKWPVKWYAP  541 (635)
T ss_dssp             -----CGGGSCH
T ss_pred             cCCCCceeeeCh
Confidence            334678899998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.87  E-value=8.6e-23  Score=203.74  Aligned_cols=147  Identities=25%  Similarity=0.309  Sum_probs=115.5

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ..++|+..+.||+|+||.||++.                       +.+..+...++.++||||+++++++..++..|+|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            35689999999999999999852                       1233445568889999999999999999999999


Q ss_pred             EecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          500 LEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSA-LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~-~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      |||++ |+|.+++..   ....+++..+..++.|++.|+.|||   .. +|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 588877754   3456899999999999999999999   76 9999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....   ......||+.|+||
T Consensus       161 ~~~~---~~~~~~~t~~y~aP  178 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAP  178 (290)
T ss_dssp             ------------CCCCCCSCH
T ss_pred             cccc---cccccCCCccccCh
Confidence            4321   22335799999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.87  E-value=3e-23  Score=215.42  Aligned_cols=144  Identities=17%  Similarity=0.272  Sum_probs=117.2

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHH---HHHhhcCCCccceee-------e
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVEC---EMMKSIRHRNLIKVI-------S  488 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~---~~l~~l~H~niv~l~-------~  488 (596)
                      ..++|...+.||+|+||.||+|.                        +.+.+|+   +++++++|||||+++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            35789999999999999999852                        4567899   556666899999998       5


Q ss_pred             eeccCC-----------------eeEEEEecCCCCCHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHhccCCCc
Q 036342          489 SCSNEE-----------------FKALVLEYMPHGSLEKYLYSSNC------ILDIFQRLNIMIDVASALEYLHFGYSAL  545 (596)
Q Consensus       489 ~~~~~~-----------------~~~lV~e~~~~g~L~~~l~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~~~~  545 (596)
                      ++..++                 ..|+||||+ +|+|.+++.....      .+++..++.++.|++.||+|||   +.+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCC
Confidence            544432                 278999999 6899999986431      2235788889999999999999   889


Q ss_pred             eEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          546 VIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       546 i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+||||||+|||++.++.+||+|||+++....     .....+| +.|+||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aP  271 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPP  271 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccCh
Confidence            99999999999999999999999999986421     2334577 999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.87  E-value=1e-22  Score=207.04  Aligned_cols=153  Identities=20%  Similarity=0.334  Sum_probs=126.7

Q ss_pred             HHHHHhccccccc-ccccCCCceeehhhH-----------------------HhHHHHHHHHhhcC-CCccceeeeeecc
Q 036342          438 LELCRATDEFSEN-NLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIR-HRNLIKVISSCSN  492 (596)
Q Consensus       438 ~~~~~~~~~~~~~-~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~  492 (596)
                      ...+.-.+.|... +.||+|+||.||+|.                       ..+.+|+.++++++ ||||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3444455677776 899999999999852                       45788999999995 6999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEec
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSD  568 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~d  568 (596)
                      .+..|+||||+++|+|.+++... ...+++.++..++.|++.|++|||   ..+|+||||||+||+++.   ++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEee
Confidence            99999999999999999998654 246899999999999999999999   889999999999999987   78999999


Q ss_pred             cccccccCCCCCccccccccccccccCC
Q 036342          569 FSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||+++......   ......||+.|+||
T Consensus       178 fg~a~~~~~~~---~~~~~~gt~~y~aP  202 (327)
T 3lm5_A          178 FGMSRKIGHAC---ELREIMGTPEYLAP  202 (327)
T ss_dssp             GGGCEEC------------CCCGGGCCH
T ss_pred             CccccccCCcc---ccccccCCcCccCC
Confidence            99998764321   22345799999998

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=7.1e-22  Score=213.72  Aligned_cols=188  Identities=26%  Similarity=0.332  Sum_probs=118.7

Q ss_pred             CCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEec
Q 036342           35 TLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGL  114 (596)
Q Consensus        35 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l  114 (596)
                      +|+.|+|++|.|++ +|...   .++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. |.+  +|++|+|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l---~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L  127 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL---PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV  127 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC---CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred             CccEEEeCCCCCCc-cCHhH---cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence            67777777777764 44321   256777777777776 455   335677777777777766 344 444  6777777


Q ss_pred             CCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEcc
Q 036342          115 DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLG  194 (596)
Q Consensus       115 ~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls  194 (596)
                      ++|.+++++.         .+++|+.|++++|.|+++ |.     ..++|++|+|++|+|++ +|. |.  ++|+.|+|+
T Consensus       128 s~N~l~~lp~---------~l~~L~~L~Ls~N~l~~l-p~-----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls  188 (571)
T 3cvr_A          128 DNNQLTMLPE---------LPALLEYINADNNQLTML-PE-----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVS  188 (571)
T ss_dssp             CSSCCSCCCC---------CCTTCCEEECCSSCCSCC-CC-----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECC
T ss_pred             CCCcCCCCCC---------cCccccEEeCCCCccCcC-CC-----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECc
Confidence            7777766321         356677777777777652 32     12567777777777766 444 44  677777777


Q ss_pred             CCcccCCCCccccCCCCC-------CeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCC
Q 036342          195 GNKLNGSIPITLGKLRKL-------QRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLA  258 (596)
Q Consensus       195 ~N~l~~~~p~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  258 (596)
                      +|.|+ .+|. |..  +|       +.|+|++|.|+ .+|..+..+++|+.|+|++|++++.+|..+..++
T Consensus       189 ~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          189 TNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             SSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred             CCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence            77777 3443 433  55       77777777777 5666666677777777777777777777666543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.87  E-value=9.2e-23  Score=214.61  Aligned_cols=146  Identities=26%  Similarity=0.434  Sum_probs=119.4

Q ss_pred             cccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeecc----C--CeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCSN----E--EFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~~----~--~~~~lV~  500 (596)
                      ..+|+..+.||+|+||+||+|.                 +...+|++++++++|||||+++++|..    .  ...++||
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  132 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL  132 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence            3478999999999999999863                 224579999999999999999998843    2  2467999


Q ss_pred             ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC-CcEEEeccccccccC
Q 036342          501 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLT  576 (596)
Q Consensus       501 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~-~~~kl~dfGla~~~~  576 (596)
                      ||+++ ++.+.+..   ....+++..+..++.|+++||.|||   ..+|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus       133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            99976 66665542   3456899999999999999999999   8999999999999999955 678999999998764


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...   .....+||++|+||
T Consensus       209 ~~~---~~~~~~~t~~y~aP  225 (420)
T 1j1b_A          209 RGE---PNVSYICSRYYRAP  225 (420)
T ss_dssp             TTC---CCCSCCSCTTSCCH
T ss_pred             cCC---CceeeeeCCCcCCH
Confidence            322   22346789999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.87  E-value=5.8e-23  Score=203.80  Aligned_cols=145  Identities=32%  Similarity=0.452  Sum_probs=119.6

Q ss_pred             cccccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeeccC-CeeEEEEecCCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCSNE-EFKALVLEYMPH  505 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~~~~  505 (596)
                      .++|+..+.||+|+||.||++.                 +.+.+|+.++++++||||+++++++... +..|+||||+++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   99 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   99 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence            5689999999999999999852                 4678999999999999999999997654 478999999999


Q ss_pred             CCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcccc
Q 036342          506 GSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  584 (596)
Q Consensus       506 g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~  584 (596)
                      |+|.+++..... .+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++.....     .
T Consensus       100 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~  171 (278)
T 1byg_A          100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q  171 (278)
T ss_dssp             EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc-----c
Confidence            999999976532 3788899999999999999999   889999999999999999999999999998865322     1


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....+++.|+||
T Consensus       172 ~~~~~~~~y~aP  183 (278)
T 1byg_A          172 DTGKLPVKWTAP  183 (278)
T ss_dssp             ----CCTTTSCH
T ss_pred             cCCCccccccCH
Confidence            234678899998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.87  E-value=1.4e-22  Score=209.84  Aligned_cols=143  Identities=26%  Similarity=0.370  Sum_probs=114.8

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE------  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~------  494 (596)
                      .++|+..+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            4689999999999999999852                       34678999999999999999999997654      


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ..|+||||++ |+|.+.+..   .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            6899999997 478888853   4789999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....   ......+||+.|+||
T Consensus       177 ~~~~---~~~~~~~gt~~y~aP  195 (371)
T 2xrw_A          177 AGTS---FMMTPYVVTRYYRAP  195 (371)
T ss_dssp             ----------------CTTCCH
T ss_pred             cccc---cccCCceecCCccCH
Confidence            5322   123346799999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.87  E-value=6.2e-23  Score=211.90  Aligned_cols=142  Identities=26%  Similarity=0.394  Sum_probs=107.1

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC------C
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE------E  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~------~  494 (596)
                      .++|+..+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4689999999999999999862                       3566899999999999999999998654      4


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ..|+|+||+ +++|.+++...  .+++..+..++.|+++|+.|||   ..+|+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            579999999 78999988763  5889999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....     ....+||++|+||
T Consensus       182 ~~~~-----~~~~~~t~~y~aP  198 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAP  198 (367)
T ss_dssp             --------------CCCTTCCH
T ss_pred             cccc-----CCCcCcCcCccCh
Confidence            5321     2346799999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.87  E-value=2.3e-22  Score=201.20  Aligned_cols=150  Identities=23%  Similarity=0.356  Sum_probs=125.6

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeee-ccCCeeEEEEec
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSC-SNEEFKALVLEY  502 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lV~e~  502 (596)
                      ..++|+..+.||+|+||.||+|.                   +.+.+|+.++++++|++++..++++ ..++..++||||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            35789999999999999999863                   3578999999999999888777766 556778999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee---CCCCcEEEeccccccccCCCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl---~~~~~~kl~dfGla~~~~~~~  579 (596)
                      + +|+|.+++......+++..+..++.|++.|+.|||   +.+|+||||||+||++   ++++.+||+|||+++......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9 99999999876667899999999999999999999   8899999999999999   788999999999998765432


Q ss_pred             Cc-----cccccccccccccCC
Q 036342          580 QS-----MTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~-----~~~~~~~gt~~y~aP  596 (596)
                      ..     .......||+.|+||
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCH
T ss_pred             cCccCCCCcccccCCCccccch
Confidence            21     122346799999998

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=2e-21  Score=184.05  Aligned_cols=180  Identities=22%  Similarity=0.208  Sum_probs=92.6

Q ss_pred             CEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCC
Q 036342           37 KFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE  116 (596)
Q Consensus        37 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~  116 (596)
                      +.++++++.++ .+|...   .++|++|+|++|++++..+..|.++++|++|+|++|+|+++.+..|.++++|++|++++
T Consensus        10 ~~v~c~~~~l~-~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEecCCCcc-CCCCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            34555555554 222211   34566666666666654444555666666666666666655555555666666666666


Q ss_pred             CcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCC
Q 036342          117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN  196 (596)
Q Consensus       117 N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N  196 (596)
                      |.++.+++.     .|.++++|++|++++|++++.                          .+..|..+++|++|++++|
T Consensus        86 n~l~~~~~~-----~~~~l~~L~~L~L~~N~l~~~--------------------------~~~~~~~l~~L~~L~l~~N  134 (208)
T 2o6s_A           86 NQLQSLPNG-----VFDKLTQLKELALNTNQLQSL--------------------------PDGVFDKLTQLKDLRLYQN  134 (208)
T ss_dssp             SCCCCCCTT-----TTTTCTTCCEEECCSSCCCCC--------------------------CTTTTTTCTTCCEEECCSS
T ss_pred             CcCCccCHh-----HhcCccCCCEEEcCCCcCccc--------------------------CHhHhccCCcCCEEECCCC
Confidence            655554332     244555555555555554432                          2333444445555555555


Q ss_pred             cccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCC
Q 036342          197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLA  258 (596)
Q Consensus       197 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  258 (596)
                      .+++..+..|..+++|++|++++|.+.+       .+++|++|+++.|+++|.+|..++.++
T Consensus       135 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          135 QLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             ccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence            5554444444555555555555554432       223455555555555555555554443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.87  E-value=1.4e-22  Score=212.34  Aligned_cols=148  Identities=22%  Similarity=0.332  Sum_probs=110.3

Q ss_pred             ccccc-cccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeec--cCCeeEEEE
Q 036342          445 DEFSE-NNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCS--NEEFKALVL  500 (596)
Q Consensus       445 ~~~~~-~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~lV~  500 (596)
                      +.|+. .+.||+|+||.||+|.                     +.+.+|+.++++++|||||++++++.  .+...|+||
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            44655 4689999999999863                     35779999999999999999999994  467899999


Q ss_pred             ecCCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee----CCCCcEEEec
Q 036342          501 EYMPHGSLEKYLYSSN--------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL----DDNMVAHLSD  568 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl----~~~~~~kl~d  568 (596)
                      ||++ |+|.+++....        ..+++..+..++.|++.||.|||   ..+|+||||||+|||+    +.++.+||+|
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9996 58888875321        24889999999999999999999   8899999999999999    6789999999


Q ss_pred             cccccccCCCCC-ccccccccccccccCC
Q 036342          569 FSIAKLLTGEDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~-~~~~~~~~gt~~y~aP  596 (596)
                      ||+|+....... .......+||++|+||
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aP  204 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAP  204 (405)
T ss_dssp             TTCCC----------------CCCTTCCH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCc
Confidence            999987643211 1223446899999998

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=2.6e-21  Score=209.35  Aligned_cols=149  Identities=24%  Similarity=0.326  Sum_probs=94.8

Q ss_pred             CCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeE
Q 036342          136 KSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRL  215 (596)
Q Consensus       136 ~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  215 (596)
                      ++|+.|++++|.|++ +|.  +.   .+|++|+|++|.|++ +|.   .+++|+.|++++|.+++ +|.   .+++|++|
T Consensus       100 ~~L~~L~Ls~N~l~~-ip~--l~---~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L  165 (571)
T 3cvr_A          100 ASLEYLDACDNRLST-LPE--LP---ASLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVL  165 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC--CC---TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEE
T ss_pred             CCCCEEEccCCCCCC-cch--hh---cCCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEE
Confidence            445555555555544 222  11   245555555555554 333   45666677777776665 333   45667777


Q ss_pred             EccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCC-------cEEEeCCCcccCCCcccccccccceEEc
Q 036342          216 NLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASL-------RILSLGSNKLTSIPLTFWNLKDILQLNF  288 (596)
Q Consensus       216 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~ip~~~~~l~~L~~L~l  288 (596)
                      +|++|.|++ +|. +.  ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++|.|+.+|..+..+++|+.|+|
T Consensus       166 ~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L  237 (571)
T 3cvr_A          166 SVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIIL  237 (571)
T ss_dssp             ECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEEC
T ss_pred             ECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEe
Confidence            777777764 555 44  66777777777776 4444 443  55       8888888888888888888888888888


Q ss_pred             ccCCCCCchhhhhccccc
Q 036342          289 SSNFLTGPLLLEIGNLKV  306 (596)
Q Consensus       289 s~N~l~~~~~~~~~~l~~  306 (596)
                      ++|++++..|..+..++.
T Consensus       238 ~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          238 EDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             CSSSCCHHHHHHHHHHHH
T ss_pred             eCCcCCCcCHHHHHHhhc
Confidence            888888888887776554

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.86  E-value=3.1e-22  Score=205.67  Aligned_cols=147  Identities=24%  Similarity=0.386  Sum_probs=123.8

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-----Cee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-----EFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~  496 (596)
                      .++|...+.||+|+||.||+|.                      ..+.+|+.++++++||||+++++++..+     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            4689999999999999999852                      3466899999999999999999988654     578


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+||||++ |+|.+++...  .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 6999998774  5889999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCCcc--------ccccccccccccCC
Q 036342          577 GEDQSM--------TQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~--------~~~~~~gt~~y~aP  596 (596)
                      ......        .....+||+.|+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAP  191 (353)
T ss_dssp             ----------------CCCCCCGGGCCH
T ss_pred             cccccccCccccccchhhccccccccCC
Confidence            321110        12235789999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.86  E-value=3.4e-22  Score=203.77  Aligned_cols=150  Identities=25%  Similarity=0.330  Sum_probs=114.8

Q ss_pred             hcccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcC-CCccceeeeeec--------c
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIR-HRNLIKVISSCS--------N  492 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~-H~niv~l~~~~~--------~  492 (596)
                      ...+|...+.||+|+||.||++.                     +.+.+|+.+++++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            34589999999999999999852                     45778999999996 999999999983        3


Q ss_pred             CCeeEEEEecCCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eEeCCCCCCCeeeCCCCcEEEec
Q 036342          493 EEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGYSAL--VIHCDLKPSNVLLDDNMVAHLSD  568 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~Hrdlk~~NILl~~~~~~kl~d  568 (596)
                      ....++||||++ |+|.+++..  ....+++..++.++.|++.|+.|||   ..+  |+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence            446899999995 799998865  3346899999999999999999999   877  99999999999999999999999


Q ss_pred             cccccccCCCCCcc----------ccccccccccccCC
Q 036342          569 FSIAKLLTGEDQSM----------TQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~----------~~~~~~gt~~y~aP  596 (596)
                      ||+++.........          ......||+.|+||
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP  219 (337)
T ss_dssp             CTTCBCCSSCC---------------------------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCCh
Confidence            99998764322110          11135689999998

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.86  E-value=2.1e-21  Score=183.88  Aligned_cols=181  Identities=22%  Similarity=0.274  Sum_probs=137.0

Q ss_pred             CEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccC
Q 036342           13 EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGM   92 (596)
Q Consensus        13 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~   92 (596)
                      +.++++++.++. +|..+  .++|++|+|++|+++ .++...+..+++|++|+|++|++++..+..|.++++|++|+|++
T Consensus        10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A           10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            567888888763 44443  457888888888887 44444445578888888888888866666677888888888888


Q ss_pred             CcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEcccc
Q 036342           93 NSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNC  172 (596)
Q Consensus        93 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n  172 (596)
                      |+|+++.+..|.++++|++|++++|.++.+++.     .|.++++|+.|++++|.+++..+. .+..+ ++|++|++++|
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l-~~L~~L~l~~N  158 (208)
T 2o6s_A           86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDG-----VFDKLTQLKDLRLYQNQLKSVPDG-VFDRL-TSLQYIWLHDN  158 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCSCCCTT-TTTTC-TTCCEEECCSC
T ss_pred             CcCCccCHhHhcCccCCCEEEcCCCcCcccCHh-----HhccCCcCCEEECCCCccceeCHH-HhccC-CCccEEEecCC
Confidence            888877777788888888888888888876554     467888888888888888765443 56666 67888888888


Q ss_pred             ccccccChhccCCCCCCEEEccCCcccCCCCccccCCCC
Q 036342          173 NISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRK  211 (596)
Q Consensus       173 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  211 (596)
                      .+.+       .+++|+.|+++.|.++|.+|..++.++.
T Consensus       159 ~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          159 PWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             Ceec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            7754       3557888888888888888888877664

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.86  E-value=8.1e-23  Score=210.09  Aligned_cols=148  Identities=16%  Similarity=0.238  Sum_probs=125.4

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccce---------------
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIK---------------  485 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~---------------  485 (596)
                      ++|...+.||+|+||.||+|.                        +.+.+|+.++++++|||||+               
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~  121 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT  121 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence            689999999999999999862                        24789999999999999998               


Q ss_pred             eeeeecc-CCeeEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-
Q 036342          486 VISSCSN-EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-  562 (596)
Q Consensus       486 l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-  562 (596)
                      +++++.. ++..|+||||+ +|+|.+++... ...+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++ 
T Consensus       122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~  197 (352)
T 2jii_A          122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQ  197 (352)
T ss_dssp             CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEE
T ss_pred             hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCC
Confidence            5666655 67889999999 99999999875 246899999999999999999999   88999999999999999998 


Q ss_pred             -cEEEeccccccccCCCCCc-----cccccccccccccCC
Q 036342          563 -VAHLSDFSIAKLLTGEDQS-----MTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 -~~kl~dfGla~~~~~~~~~-----~~~~~~~gt~~y~aP  596 (596)
                       .+||+|||+++.+......     .......||+.|+||
T Consensus       198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  237 (352)
T 2jii_A          198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM  237 (352)
T ss_dssp             EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH
T ss_pred             ceEEEecCcceeeccCCCccccccccccccccCCccccCH
Confidence             9999999999876432111     112335799999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.86  E-value=4.8e-22  Score=211.84  Aligned_cols=149  Identities=20%  Similarity=0.295  Sum_probs=126.0

Q ss_pred             cccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCC-ccceeeeeeccCCeeEEEEecC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      .++|...+.||+|+||.||+|.                   ..+..|+++++.++|+ +++.+..++...+..++||||+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            4689999999999999999863                   3578999999999885 5555556666778899999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee---CCCCcEEEeccccccccCCCCC
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl---~~~~~~kl~dfGla~~~~~~~~  580 (596)
                       +|+|.+++......+++..++.++.||+.||.|||   ..+|+||||||+|||+   +.++.+||+|||+++.+.....
T Consensus        86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence             99999999876667999999999999999999999   8899999999999999   5889999999999987654322


Q ss_pred             c-----cccccccccccccCC
Q 036342          581 S-----MTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~-----~~~~~~~gt~~y~aP  596 (596)
                      .     ......+||+.|+||
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aP  182 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASV  182 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCH
T ss_pred             ccccccccccccCCCccccCH
Confidence            1     112356899999997

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.86  E-value=1.6e-22  Score=225.89  Aligned_cols=140  Identities=22%  Similarity=0.394  Sum_probs=120.5

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe-----
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF-----  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----  495 (596)
                      .++|...+.||+|+||.||++.                       ..+.+|+.++++++|||||++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3689999999999999999852                       346789999999999999999999987654     


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+||||+++++|.+++..   .+++.+++.++.|+++||.|+|   ..+|+||||||+|||++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999988754   5889999999999999999999   8899999999999999986 8999999999875


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...      ....||++||||
T Consensus       232 ~~~------~~~~gt~~y~aP  246 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAP  246 (681)
T ss_dssp             TCC------SCCCCCTTTSCT
T ss_pred             ccC------CccCCCccccCH
Confidence            422      345799999998

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.86  E-value=3.9e-22  Score=210.38  Aligned_cols=144  Identities=19%  Similarity=0.340  Sum_probs=124.5

Q ss_pred             cccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhc------CCCccceeeeeeccCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSI------RHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l------~H~niv~l~~~~~~~~~~~  497 (596)
                      ..+|+..+.||+|+||.||+|.                    +.+..|+.+++.+      +|+||+++++++..++..+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            4579999999999999999862                    3466788888877      5779999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc--EEEeccccccc
Q 036342          498 LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV--AHLSDFSIAKL  574 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~--~kl~dfGla~~  574 (596)
                      +||||++ |+|.+++.... ..+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.  +||+|||+++.
T Consensus       176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            9999996 69999988754 35899999999999999999999   889999999999999999887  99999999976


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....     ....+||+.|+||
T Consensus       252 ~~~~-----~~~~~gt~~y~aP  268 (429)
T 3kvw_A          252 EHQR-----VYTYIQSRFYRAP  268 (429)
T ss_dssp             TTCC-----CCSSCSCGGGCCH
T ss_pred             cCCc-----ccccCCCCCccCh
Confidence            4321     2346799999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.86  E-value=5e-22  Score=198.78  Aligned_cols=149  Identities=23%  Similarity=0.358  Sum_probs=126.8

Q ss_pred             cccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeee-ccCCeeEEEEecC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSC-SNEEFKALVLEYM  503 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lV~e~~  503 (596)
                      .++|...+.||+|+||.||+|.                   +.+.+|+.++++++|++++..+.++ ..++..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            4689999999999999999863                   3578999999999999877777666 4566789999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee---CCCCcEEEeccccccccCCCCC
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl---~~~~~~kl~dfGla~~~~~~~~  580 (596)
                       +|+|.+++......+++..+..++.|++.|+.|||   +.+|+||||||+||++   ++++.+||+|||+++.......
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence             99999999866667899999999999999999999   8899999999999999   4789999999999987654322


Q ss_pred             c-----cccccccccccccCC
Q 036342          581 S-----MTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~-----~~~~~~~gt~~y~aP  596 (596)
                      .     .......||+.|+||
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCH
T ss_pred             ccccccccccccccccccCCh
Confidence            1     112346799999998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.86  E-value=2.8e-22  Score=207.54  Aligned_cols=141  Identities=25%  Similarity=0.371  Sum_probs=119.5

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee----
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK----  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~----  496 (596)
                      .++|...+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4689999999999999999852                       4567899999999999999999999877654    


Q ss_pred             --EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          497 --ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       497 --~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                        |+||||++ |+|.+++..   .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 688888743   4789999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....     ....+||++|+||
T Consensus       194 ~~~~-----~~~~~~t~~y~aP  210 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAP  210 (371)
T ss_dssp             -----------CTTCCCTTSCH
T ss_pred             cccC-----cCCcccCccccCH
Confidence            5322     2346789999998

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.86  E-value=1.2e-22  Score=210.48  Aligned_cols=144  Identities=9%  Similarity=0.040  Sum_probs=104.7

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc--CCCccceeee-------ee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI--RHRNLIKVIS-------SC  490 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l--~H~niv~l~~-------~~  490 (596)
                      ..+|...+.||+|+||.||+|.                        +.+..|+.+++.+  +|||||+++.       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            4568999999999999999852                        2455675444444  6999888653       33


Q ss_pred             ccC-----------------CeeEEEEecCCCCCHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHhccCCCceE
Q 036342          491 SNE-----------------EFKALVLEYMPHGSLEKYLYSSNCILDIFQR------LNIMIDVASALEYLHFGYSALVI  547 (596)
Q Consensus       491 ~~~-----------------~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~------~~i~~~i~~~l~~lh~~~~~~i~  547 (596)
                      ..+                 ...|+|||||+ |+|.+++......+++..+      ..++.|+++|++|||   ..+|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            221                 33799999998 8999999875434455555      677899999999999   89999


Q ss_pred             eCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          548 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       548 Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||||||+|||++.++.+||+|||+|+.....     .....+|+.|+||
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aP  260 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPR  260 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCH
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcCh
Confidence            9999999999999999999999999875321     1134677999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.86  E-value=4.9e-22  Score=201.04  Aligned_cols=147  Identities=27%  Similarity=0.400  Sum_probs=116.3

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeec-----------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCS-----------  491 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~-----------  491 (596)
                      .++|...+.||+|+||.||+|.                     +.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            3579999999999999999852                     45778999999999999999999874           


Q ss_pred             ---cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC-CCCcEEEe
Q 036342          492 ---NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLS  567 (596)
Q Consensus       492 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~-~~~~~kl~  567 (596)
                         ..+..|+||||++ |+|.+++...  .+++..+..++.|++.|++|||   ..+|+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3457899999997 6999998653  5789999999999999999999   88999999999999997 56799999


Q ss_pred             ccccccccCCCCC-ccccccccccccccCC
Q 036342          568 DFSIAKLLTGEDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       568 dfGla~~~~~~~~-~~~~~~~~gt~~y~aP  596 (596)
                      |||+++....... ........+|+.|+||
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSP  193 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCH
T ss_pred             cCccccccCCCcccccccccccccccccCc
Confidence            9999987642211 1112345679999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.86  E-value=4.4e-22  Score=198.45  Aligned_cols=146  Identities=23%  Similarity=0.415  Sum_probs=126.8

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .++|+..+.||+|+||.||+|.                       +.+.+|++++++++||||+++++++...+..|+||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            4689999999999999999852                       35778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC---CcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~---~~~kl~dfGla~~~~~  577 (596)
                      ||+++++|.+++.... .+++..+..++.|++.|+.|||   ..+++||||||+||+++.+   +.+||+|||+++....
T Consensus       101 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            9999999999887654 5889999999999999999999   8899999999999999754   4799999999987543


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   ......||+.|+||
T Consensus       177 ~~---~~~~~~~~~~y~aP  192 (287)
T 2wei_A          177 NT---KMKDRIGTAYYIAP  192 (287)
T ss_dssp             CS---SCSCHHHHHTTCCH
T ss_pred             CC---ccccccCcccccCh
Confidence            22   12334688999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.86  E-value=1.6e-22  Score=218.69  Aligned_cols=135  Identities=19%  Similarity=0.223  Sum_probs=105.2

Q ss_pred             cccccccCCCceeehhh---------------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          448 SENNLIGRGGFALFIRA---------------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       448 ~~~~~ig~G~~g~v~~~---------------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ...+.||+|+||.||++                           .+.+.+|++++++++||||+++..++..++..|+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            44678999999999953                           134689999999999999996666665667789999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+++|+|.+++..         +..++.|+++|+.|||   +.+|+||||||+|||++.  .+||+|||+++.......
T Consensus       419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred             ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence            99999999999865         4578999999999999   899999999999999999  999999999998643211


Q ss_pred             cc-----ccccccccccccCC
Q 036342          581 SM-----TQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~-----~~~~~~gt~~y~aP  596 (596)
                      ..     .....+||+.||||
T Consensus       485 ~~~~~~~~~~~~~GT~~y~AP  505 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFD  505 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHH
T ss_pred             cccchhhhhhhhcCCCCcCCH
Confidence            10     12356899999998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.85  E-value=6.6e-22  Score=200.87  Aligned_cols=148  Identities=28%  Similarity=0.435  Sum_probs=125.7

Q ss_pred             HhcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc---CCCccceeeeeec---
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI---RHRNLIKVISSCS---  491 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l---~H~niv~l~~~~~---  491 (596)
                      ...++|+..+.||+|+||.||+|.                        ..+.+|+.+++++   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            356789999999999999999852                        1466788888776   8999999999987   


Q ss_pred             --cCCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEec
Q 036342          492 --NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSD  568 (596)
Q Consensus       492 --~~~~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~d  568 (596)
                        .....++||||++ |+|.+++.... ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence              4567899999997 69999998754 35889999999999999999999   88999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccCC
Q 036342          569 FSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||+++....   ........||+.|+||
T Consensus       164 fg~~~~~~~---~~~~~~~~~~~~y~aP  188 (326)
T 1blx_A          164 FGLARIYSF---QMALTSVVVTLWYRAP  188 (326)
T ss_dssp             CCSCCCCCG---GGGGCCCCCCCTTCCH
T ss_pred             CcccccccC---CCCccccccccceeCH
Confidence            999986532   1123446789999998

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.85  E-value=1.7e-22  Score=204.11  Aligned_cols=155  Identities=23%  Similarity=0.419  Sum_probs=124.0

Q ss_pred             CHHHHHHhcccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCC--Cccceeeeeec
Q 036342          436 SYLELCRATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRH--RNLIKVISSCS  491 (596)
Q Consensus       436 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H--~niv~l~~~~~  491 (596)
                      .++.+....++|+..+.||+|+||.||++.                      +.+.+|+.++++++|  |||+++++++.
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            333344456789999999999999999852                      457789999999984  99999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccc
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSI  571 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGl  571 (596)
                      .++..|+||| +.+|+|.+++.... .+++..+..++.|+++|+.|||   ..+|+||||||+||++++ +.+||+|||+
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccc
Confidence            9999999999 56889999998764 6789999999999999999999   889999999999999965 8999999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++...............||+.|+||
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aP  197 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPP  197 (313)
T ss_dssp             SCC--------------CCGGGCCH
T ss_pred             cccccCccccccccCCCCCCCcCCH
Confidence            9876433222223345799999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.85  E-value=9e-22  Score=214.62  Aligned_cols=147  Identities=31%  Similarity=0.523  Sum_probs=123.9

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeecc------CCe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSN------EEF  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~  495 (596)
                      .++|+..+.||+|+||.||+|.                      +.+.+|+.++++++|||||++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            3689999999999999999852                      357789999999999999999999865      567


Q ss_pred             eEEEEecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc---EEEeccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV---AHLSDFS  570 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~---~kl~dfG  570 (596)
                      .|+||||+++|+|.+++....  ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999998743  25788899999999999999999   889999999999999987654   9999999


Q ss_pred             cccccCCCCCccccccccccccccCC
Q 036342          571 IAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       571 la~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +++......   ......||++|+||
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~AP  192 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAP  192 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSS
T ss_pred             ccccccccc---ccccccCCcccCCh
Confidence            998764322   22346799999998

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.85  E-value=5.2e-22  Score=207.34  Aligned_cols=144  Identities=24%  Similarity=0.360  Sum_probs=122.0

Q ss_pred             cccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcC--------CCccceeeeeec----
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIR--------HRNLIKVISSCS----  491 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~--------H~niv~l~~~~~----  491 (596)
                      .++|...+.||+|+||.||+|.                    +.+.+|+.++++++        |+||+++++++.    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            3679999999999999999862                    45678999999986        888999999987    


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCCeeeCCCC-------
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSA-LVIHCDLKPSNVLLDDNM-------  562 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~-~i~Hrdlk~~NILl~~~~-------  562 (596)
                      .....|+||||+ +|++.+++.... ..+++..+..++.|++.||.|||   .+ +|+||||||+|||++.++       
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhh
Confidence            556799999999 667777665543 56899999999999999999999   77 999999999999999775       


Q ss_pred             ------------------------------------------cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          563 ------------------------------------------VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 ------------------------------------------~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                                                                .+||+|||+++.....     ....+||+.|+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP  262 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence                                                      7999999999875322     2345799999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.85  E-value=1.2e-21  Score=201.98  Aligned_cols=154  Identities=21%  Similarity=0.293  Sum_probs=114.6

Q ss_pred             HHHHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCC---
Q 036342          438 LELCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE---  494 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~---  494 (596)
                      .+.....++|...+.||+|+||.||+|.                    ..+..|++.+++++|||||++++++...+   
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            4455677899999999999999999852                    24667888889999999999999986433   


Q ss_pred             ----eeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEE
Q 036342          495 ----FKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHL  566 (596)
Q Consensus       495 ----~~~lV~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl  566 (596)
                          ..++||||+++ ++.+.+..   ....+++..+..++.|++.|+.|+| .+..+|+||||||+||+++. ++.+||
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                37899999976 55544432   3346788999999999999999999 34678999999999999996 899999


Q ss_pred             eccccccccCCCCCccccccccccccccCC
Q 036342          567 SDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       567 ~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|||+++......   ......||+.|+||
T Consensus       174 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aP  200 (360)
T 3e3p_A          174 CDFGSAKKLSPSE---PNVAYICSRYYRAP  200 (360)
T ss_dssp             CCCTTCBCCCTTS---CCCSTTSCGGGCCH
T ss_pred             eeCCCceecCCCC---CcccccCCcceeCH
Confidence            9999998764322   22345789999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.85  E-value=3.4e-22  Score=210.75  Aligned_cols=150  Identities=25%  Similarity=0.464  Sum_probs=119.4

Q ss_pred             hcccccccccccCCCceeeh-hh----------------HHhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCC
Q 036342          443 ATDEFSENNLIGRGGFALFI-RA----------------FKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~-~~----------------~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      ...+|...+.||+|+||.|| ++                ...+.+|+++++++ +|||||++++++.+++..|+|||||+
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            34578999999999999854 32                13467899999999 89999999999999999999999996


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-----CCcEEEeccccccccCCCC
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-----NMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-----~~~~kl~dfGla~~~~~~~  579 (596)
                       |+|.+++........+..+..++.|+++|+.|||   +.+|+||||||+||+++.     ...+||+|||+|+......
T Consensus       102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence             6999999877655555567789999999999999   889999999999999943     3468899999998764322


Q ss_pred             Cc-cccccccccccccCC
Q 036342          580 QS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~-~~~~~~~gt~~y~aP  596 (596)
                      .. ......+||++|+||
T Consensus       178 ~~~~~~~~~~gt~~y~AP  195 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAP  195 (432)
T ss_dssp             --------CCSCTTSCCG
T ss_pred             cceeeccccCCCcCccCh
Confidence            11 123446799999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.85  E-value=9.3e-22  Score=200.64  Aligned_cols=144  Identities=17%  Similarity=0.330  Sum_probs=125.1

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCc------cceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRN------LIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~~  496 (596)
                      .++|+..+.||+|+||.||+|.                     +.+.+|+.+++.++|++      ++++++++..++..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            4689999999999999999752                     34678999999988765      99999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---------------
Q 036342          497 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---------------  560 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---------------  560 (596)
                      |+||||+ +++|.+++.... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.               
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            9999999 889999998764 35789999999999999999999   889999999999999987               


Q ss_pred             ----CCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          561 ----NMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       561 ----~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                          ++.+||+|||+++.....     .....||+.|+||
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aP  203 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAP  203 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCH
T ss_pred             ccccCCCceEeeCcccccCccc-----cccccCCccccCh
Confidence                678999999999864322     2345799999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.85  E-value=3e-22  Score=202.14  Aligned_cols=150  Identities=27%  Similarity=0.363  Sum_probs=120.3

Q ss_pred             HHHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc----CCCccceee
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI----RHRNLIKVI  487 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l----~H~niv~l~  487 (596)
                      +.....++|...+.||+|+||.||+|.                           ..+.+|+.+++++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            334456789999999999999999862                           1234689999998    899999999


Q ss_pred             eeeccCCeeEEEEec-CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC-CCCcEE
Q 036342          488 SSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAH  565 (596)
Q Consensus       488 ~~~~~~~~~~lV~e~-~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~-~~~~~k  565 (596)
                      +++..++..++|||| +++++|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++ .++.+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            999999999999999 78999999998754 5889999999999999999999   88999999999999999 889999


Q ss_pred             EeccccccccCCCCCccccccccccccccCC
Q 036342          566 LSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       566 l~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+|||+++.....    ......||+.|+||
T Consensus       181 l~dfg~~~~~~~~----~~~~~~~~~~y~aP  207 (312)
T 2iwi_A          181 LIDFGSGALLHDE----PYTDFDGTRVYSPP  207 (312)
T ss_dssp             ECCCSSCEECCSS----CBCCCCSCTTTSCH
T ss_pred             EEEcchhhhcccC----cccccCCcccccCc
Confidence            9999999876432    12345789999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.85  E-value=5.9e-22  Score=203.71  Aligned_cols=141  Identities=25%  Similarity=0.368  Sum_probs=119.2

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCe-----
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEF-----  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----  495 (596)
                      .++|...+.||+|+||.||+|.                       +.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            3579999999999999999852                       356789999999999999999999987654     


Q ss_pred             -eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          496 -KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       496 -~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                       .|+||||++ |+|.+++..   .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 688887743   4789999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....     .....||+.|+||
T Consensus       176 ~~~~-----~~~~~~t~~y~aP  192 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAP  192 (353)
T ss_dssp             -------------CCSBCCSCH
T ss_pred             CCCC-----ccccccCcCcCCH
Confidence            5321     2345789999998

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.85  E-value=6.8e-22  Score=200.38  Aligned_cols=148  Identities=22%  Similarity=0.316  Sum_probs=127.7

Q ss_pred             HHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcC--CCccceeeeeec
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIR--HRNLIKVISSCS  491 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~--H~niv~l~~~~~  491 (596)
                      ....++|+..+.||+|+||.||+|.                           +.+.+|+.++++++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            3445789999999999999999862                           13457999999996  599999999999


Q ss_pred             cCCeeEEEEecCCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC-CCCcEEEecc
Q 036342          492 NEEFKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDF  569 (596)
Q Consensus       492 ~~~~~~lV~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~-~~~~~kl~df  569 (596)
                      .++..++||||+.+ ++|.+++.... .+++..+..++.|+++|+.|||   ..+|+||||||+||+++ +++.+||+||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            99999999999976 89999998754 5789999999999999999999   89999999999999999 7899999999


Q ss_pred             ccccccCCCCCccccccccccccccCC
Q 036342          570 SIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       570 Gla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+++.....    ......||+.|+||
T Consensus       195 g~~~~~~~~----~~~~~~gt~~y~aP  217 (320)
T 3a99_A          195 GSGALLKDT----VYTDFDGTRVYSPP  217 (320)
T ss_dssp             TTCEECCSS----CBCCCCSCGGGSCH
T ss_pred             ccccccccc----cccCCCCCccCCCh
Confidence            999876432    12345799999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.84  E-value=1.4e-21  Score=199.35  Aligned_cols=146  Identities=24%  Similarity=0.355  Sum_probs=108.2

Q ss_pred             cccccccc-cccCCCceeehhhH----------------HhHHHH-HHHHhhcCCCccceeeeeecc----CCeeEEEEe
Q 036342          444 TDEFSENN-LIGRGGFALFIRAF----------------KSFDVE-CEMMKSIRHRNLIKVISSCSN----EEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~-~ig~G~~g~v~~~~----------------~~~~~e-~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e  501 (596)
                      .++|...+ .||+|+||.||+|.                ....+| ...++.++||||+++++++..    +...++|||
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  106 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME  106 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence            56888854 69999999999863                122333 344677899999999999875    445899999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEeccccccccCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~dfGla~~~~~  577 (596)
                      |+++|+|.+++.... ..+++.++..++.|++.|+.|||   ..+|+||||||+||+++.   ++.+||+|||+++....
T Consensus       107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            999999999998764 36899999999999999999999   889999999999999976   45699999999986542


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .    .....+||+.|+||
T Consensus       184 ~----~~~~~~~t~~y~aP  198 (336)
T 3fhr_A          184 N----ALQTPCYTPYYVAP  198 (336)
T ss_dssp             -------------------
T ss_pred             c----ccccCCCCcCccCh
Confidence            2    12345789999998

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.84  E-value=8.5e-21  Score=189.40  Aligned_cols=190  Identities=22%  Similarity=0.288  Sum_probs=99.0

Q ss_pred             CccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCC
Q 036342           60 NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLT  139 (596)
Q Consensus        60 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~  139 (596)
                      ++..+.+..+.++...+  +..+++|++|++++|.++.+ + .+..+++|++|++++|+++++.+       +.++++|+
T Consensus        25 ~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~-------l~~l~~L~   93 (291)
T 1h6t_A           25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-------LANLKNLG   93 (291)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-------GTTCTTCC
T ss_pred             HHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc-------cccCCCCC
Confidence            34445555555553322  33456666666666666644 2 35566666666666666655321       45555555


Q ss_pred             EEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccC
Q 036342          140 LIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLED  219 (596)
Q Consensus       140 ~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  219 (596)
                      .|++++|.+++.                            +.+..+++|++|++++|.+++.  ..+..+++|++|++++
T Consensus        94 ~L~l~~n~l~~~----------------------------~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~  143 (291)
T 1h6t_A           94 WLFLDENKVKDL----------------------------SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGN  143 (291)
T ss_dssp             EEECCSSCCCCG----------------------------GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCS
T ss_pred             EEECCCCcCCCC----------------------------hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccC
Confidence            555555555432                            1244445555555555555432  2344555555555555


Q ss_pred             CcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCC
Q 036342          220 NILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTG  295 (596)
Q Consensus       220 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~  295 (596)
                      |.+++.  ..+..+++|+.|++++|++++..+  +..+++|+.|+|++|.++.+|. +..+++|+.|++++|+++.
T Consensus       144 n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~~-l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          144 NKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRA-LAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             SCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGG-GTTCTTCSEEEEEEEEEEC
T ss_pred             CcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCChh-hccCCCCCEEECcCCcccC
Confidence            555532  345555555555555555554333  5555555555555555555542 4445555555555555443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.84  E-value=1.6e-21  Score=198.19  Aligned_cols=146  Identities=25%  Similarity=0.364  Sum_probs=110.0

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHH-HHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECE-MMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      .++|...+.||+|+||.||+|.                      ..+..|+. +++.++||||+++++++..++..|+||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            4689999999999999999852                      23445555 778889999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          501 EYMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSA-LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       501 e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~-~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      ||+++ +|.+++..    ....+++..+..++.|++.|+.|||   .. +|+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88777763    2346889999999999999999999   77 9999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....   ......||+.|+||
T Consensus       177 ~~~~---~~~~~~gt~~y~aP  194 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAP  194 (327)
T ss_dssp             ---------------------
T ss_pred             cccc---ccccCCCCccccCc
Confidence            4321   22334799999998

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.84  E-value=1.1e-20  Score=194.66  Aligned_cols=175  Identities=24%  Similarity=0.245  Sum_probs=126.0

Q ss_pred             CEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhcc-CCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          139 TLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEIS-NLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       139 ~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                      +.+++++|.++.+ |.    .++..++.|+|++|+|+++.+..|. ++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        21 ~~l~c~~~~l~~i-P~----~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L   95 (361)
T 2xot_A           21 NILSCSKQQLPNV-PQ----SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL   95 (361)
T ss_dssp             TEEECCSSCCSSC-CS----SCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CEEEeCCCCcCcc-Cc----cCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence            4566666666543 32    1234577777777777777777776 7788888888888888777777888888888888


Q ss_pred             cCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCccc----ccccccceEEcccCCC
Q 036342          218 EDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTF----WNLKDILQLNFSSNFL  293 (596)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~----~~l~~L~~L~ls~N~l  293 (596)
                      ++|.|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+.+|...    ..+++|+.|+|++|+|
T Consensus        96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l  175 (361)
T 2xot_A           96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL  175 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred             CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence            888887666667777888888888888888777778888888888888888888877654    3466777777777777


Q ss_pred             CCchhhhhccccc--cceEecCCCcCc
Q 036342          294 TGPLLLEIGNLKV--LIGIDFSMNNFS  318 (596)
Q Consensus       294 ~~~~~~~~~~l~~--L~~L~ls~N~~~  318 (596)
                      ++..+..+..++.  ++.|++++|.+.
T Consensus       176 ~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          176 KKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             CccCHHHhhhccHhhcceEEecCCCcc
Confidence            7666566666655  355666666664

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.84  E-value=2.4e-21  Score=198.94  Aligned_cols=144  Identities=19%  Similarity=0.343  Sum_probs=123.8

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCc------cceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRN------LIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~~  496 (596)
                      .++|+..+.||+|+||.||+|.                     +.+.+|+.++++++|++      ++.+++++...+..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            3689999999999999999752                     34678999999998776      99999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeee-----------------
Q 036342          497 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLL-----------------  558 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl-----------------  558 (596)
                      |+||||+ +|++.+++.... ..+++.++..++.|++.||.|||   ..+|+||||||+||++                 
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccc
Confidence            9999999 667877776654 46899999999999999999999   8999999999999999                 


Q ss_pred             --CCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          559 --DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       559 --~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                        +.++.+||+|||+++.....     .....||+.|+||
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aP  208 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPP  208 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCH
T ss_pred             cccCCCcEEEeecCcccccccc-----ccCCcCCCcccCC
Confidence              56789999999999864322     2345799999998

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.84  E-value=9.8e-21  Score=188.96  Aligned_cols=166  Identities=28%  Similarity=0.372  Sum_probs=87.2

Q ss_pred             CCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecC
Q 036342           36 LKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD  115 (596)
Q Consensus        36 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~  115 (596)
                      +..+++..+.+++ +....  .+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+  +.++++|++|+++
T Consensus        26 ~~~~~l~~~~~~~-~~~~~--~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~   98 (291)
T 1h6t_A           26 TIKDNLKKKSVTD-AVTQN--ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD   98 (291)
T ss_dssp             HHHHHTTCSCTTS-EECHH--HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             HHHHHhcCCCccc-ccchh--hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECC
Confidence            3344455555542 22222  256666777777666632 3 36666677777777777765544  6677777777777


Q ss_pred             CCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccC
Q 036342          116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG  195 (596)
Q Consensus       116 ~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~  195 (596)
                      +|.++.++       .+..+++|+.|++++|++++. +  .+..+ ++|++|++++|++++.  ..+..+++|+.|++++
T Consensus        99 ~n~l~~~~-------~l~~l~~L~~L~L~~n~i~~~-~--~l~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~  165 (291)
T 1h6t_A           99 ENKVKDLS-------SLKDLKKLKSLSLEHNGISDI-N--GLVHL-PQLESLYLGNNKITDI--TVLSRLTKLDTLSLED  165 (291)
T ss_dssp             SSCCCCGG-------GGTTCTTCCEEECTTSCCCCC-G--GGGGC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred             CCcCCCCh-------hhccCCCCCEEECCCCcCCCC-h--hhcCC-CCCCEEEccCCcCCcc--hhhccCCCCCEEEccC
Confidence            77666532       256666777777777766543 1  23333 3344444444444433  2344444444444444


Q ss_pred             CcccCCCCccccCCCCCCeEEccCCccc
Q 036342          196 NKLNGSIPITLGKLRKLQRLNLEDNILE  223 (596)
Q Consensus       196 N~l~~~~p~~~~~l~~L~~L~L~~N~l~  223 (596)
                      |.+++..|  +..+++|+.|++++|.++
T Consensus       166 N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          166 NQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             SCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             Cccccchh--hcCCCccCEEECCCCcCC
Confidence            44443322  444444444444444444

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.84  E-value=1.4e-21  Score=206.44  Aligned_cols=147  Identities=25%  Similarity=0.393  Sum_probs=111.7

Q ss_pred             cccccccccCCCceeehhh-----------------HHhHHHHHHHHhhc-CCCccceeeeeeccCCeeEEEEecCCCCC
Q 036342          446 EFSENNLIGRGGFALFIRA-----------------FKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS  507 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~-----------------~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g~  507 (596)
                      .|...+.||+|+||+||.+                 .+.+.+|+.+++++ +|||||++++++..++..|+|||||+ |+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs   94 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN   94 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence            3455688999999999642                 13567899999886 89999999999999999999999995 69


Q ss_pred             HHHHHhhCCCC------CCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCC-------------CcEEEec
Q 036342          508 LEKYLYSSNCI------LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDN-------------MVAHLSD  568 (596)
Q Consensus       508 L~~~l~~~~~~------l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~-------------~~~kl~d  568 (596)
                      |.+++......      ..+..++.++.|++.|++|||   +.+|+||||||+|||++.+             +.+||+|
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             HHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence            99999865421      123345779999999999999   8899999999999999654             4899999


Q ss_pred             cccccccCCCCCcc--ccccccccccccCC
Q 036342          569 FSIAKLLTGEDQSM--TQTQTLGTIGYMAP  596 (596)
Q Consensus       569 fGla~~~~~~~~~~--~~~~~~gt~~y~aP  596 (596)
                      ||+++.+.......  .....+||++|+||
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aP  201 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAP  201 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCH
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCH
Confidence            99999765432211  12345799999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.83  E-value=2.7e-21  Score=195.49  Aligned_cols=147  Identities=22%  Similarity=0.285  Sum_probs=109.4

Q ss_pred             hcccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ..++|+..+.||+|+||.||+|.                       +.+..+..+++.++||||+++++++..++..|+|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            35689999999999999999852                       1233445578888999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~-~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      |||+ ++.+..........+++..+..++.|+++|+.|||   .. +++||||||+||+++.++.+||+|||+++.....
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 55666666554557899999999999999999999   74 8999999999999999999999999999865432


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      .   ......||+.|+||
T Consensus       179 ~---~~~~~~~~~~y~aP  193 (318)
T 2dyl_A          179 K---AKDRSAGCAAYMAP  193 (318)
T ss_dssp             -----------CCTTCCH
T ss_pred             c---cccccCCCccccCh
Confidence            1   22345789999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.83  E-value=5.1e-21  Score=198.91  Aligned_cols=149  Identities=23%  Similarity=0.368  Sum_probs=124.6

Q ss_pred             HHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcC-CC-----ccceeeeeeccCC
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIR-HR-----NLIKVISSCSNEE  494 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~  494 (596)
                      ....++|+..+.||+|+||.||+|.                    +.+..|+.+++.++ |+     +|+++++++..++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3446789999999999999999862                    34567888888875 44     4999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC--CCCcEEEecccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD--DNMVAHLSDFSI  571 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~--~~~~~kl~dfGl  571 (596)
                      ..|+||||++ |+|.+++.... ..+++..+..++.|++.|+.|||. +..+|+||||||+|||++  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            9999999996 59999998764 458999999999999999999992 246899999999999994  578899999999


Q ss_pred             ccccCCCCCccccccccccccccCC
Q 036342          572 AKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       572 a~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ++.....     .....||+.|+||
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aP  227 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSP  227 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCH
T ss_pred             ceecccc-----cccccCCccccCh
Confidence            9876422     2346799999998

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.83  E-value=1.4e-20  Score=205.68  Aligned_cols=169  Identities=30%  Similarity=0.404  Sum_probs=87.2

Q ss_pred             CCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCC
Q 036342           58 LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS  137 (596)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~  137 (596)
                      +++|+.|++++|.+.. ++ .+..+++|+.|+|++|+|+++.+  |..+++|+.|+|++|.++.++       .+..+++
T Consensus        42 L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-------~l~~l~~  110 (605)
T 1m9s_A           42 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLS-------SLKDLKK  110 (605)
T ss_dssp             HTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCT-------TSTTCTT
T ss_pred             CCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCCh-------hhccCCC
Confidence            4555555555555542 22 35555555555555555554443  555555555555555555432       2455555


Q ss_pred             CCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       138 L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                      |+.|+|++|.++++ +  .+..+ ++|+.|+|++|.|++.  ..|..+++|+.|+|++|.+.+..|  +..+++|+.|+|
T Consensus       111 L~~L~Ls~N~l~~l-~--~l~~l-~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L  182 (605)
T 1m9s_A          111 LKSLSLEHNGISDI-N--GLVHL-PQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL  182 (605)
T ss_dssp             CCEEECTTSCCCCC-G--GGGGC-TTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             CCEEEecCCCCCCC-c--cccCC-CccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEEC
Confidence            55555555555542 1  23333 3455555555555443  345555555555555555554443  455555555555


Q ss_pred             cCCcccccCccchhcCCCCcEEEccCCcCc
Q 036342          218 EDNILEGSIPDDICRLAELYRLELGSNKLY  247 (596)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  247 (596)
                      ++|.|++ + +.+..+++|+.|+|++|++.
T Consensus       183 s~N~i~~-l-~~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          183 SKNHISD-L-RALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             CSSCCCB-C-GGGTTCTTCSEEECCSEEEE
T ss_pred             cCCCCCC-C-hHHccCCCCCEEEccCCcCc
Confidence            5555553 2 23455555555555555554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=7.4e-21  Score=181.65  Aligned_cols=154  Identities=19%  Similarity=0.214  Sum_probs=77.9

Q ss_pred             cEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCC
Q 036342          165 EEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSN  244 (596)
Q Consensus       165 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  244 (596)
                      +.+++++++++.+ |..+.  ++|+.|++++|.++++.+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~~i-P~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLTEI-PTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCSSC-CSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcCcC-CCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            4455555555532 32222  34555555555555444445555555555555555555444444555555555555555


Q ss_pred             cCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChh
Q 036342          245 KLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPRE  324 (596)
Q Consensus       245 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~  324 (596)
                      +|+...+..|.++                       ++|++|+|++|++++..+..|..+++|+.|+|++|++++. +..
T Consensus        91 ~l~~l~~~~f~~l-----------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~  146 (220)
T 2v9t_B           91 KITELPKSLFEGL-----------------------FSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTI-AKG  146 (220)
T ss_dssp             CCCCCCTTTTTTC-----------------------TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC-CTT
T ss_pred             cCCccCHhHccCC-----------------------CCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEE-CHH
Confidence            5544444444444                       4555555555555544455555555555555555555533 322


Q ss_pred             hhccCCCCCeEECCCCccccc
Q 036342          325 IGEKLSYLEDLNLSFNKLKGE  345 (596)
Q Consensus       325 ~~~~l~~L~~L~l~~N~l~~~  345 (596)
                      .+..+++|+.|+|++|++.+.
T Consensus       147 ~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B          147 TFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             TTTTCTTCCEEECCSSCEECS
T ss_pred             HHhCCCCCCEEEeCCCCcCCC
Confidence            444555666666666665543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.83  E-value=1.8e-20  Score=204.82  Aligned_cols=191  Identities=25%  Similarity=0.365  Sum_probs=147.1

Q ss_pred             CCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEc
Q 036342           11 NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSL   90 (596)
Q Consensus        11 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L   90 (596)
                      .+..+.++.+.+.+..+  +..+.+|+.|+|++|.++ .++.+.  .+++|+.|+|++|.+++..|  +..+++|+.|+|
T Consensus        22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~~l~--~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L   94 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQ--YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL   94 (605)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCTTGG--GCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred             HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CChHHc--cCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence            34445667777765544  456778888888888886 455544  38888888888888886544  788888888888


Q ss_pred             cCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEcc
Q 036342           91 GMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMY  170 (596)
Q Consensus        91 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~  170 (596)
                      ++|.|+++  +.|..+++|++|+|++|.++.++       .+..+++|+.|+|++|.+++.   ..+..+ ++|+.|+|+
T Consensus        95 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l~-------~l~~l~~L~~L~Ls~N~l~~l---~~l~~l-~~L~~L~Ls  161 (605)
T 1m9s_A           95 DENKIKDL--SSLKDLKKLKSLSLEHNGISDIN-------GLVHLPQLESLYLGNNKITDI---TVLSRL-TKLDTLSLE  161 (605)
T ss_dssp             CSSCCCCC--TTSTTCTTCCEEECTTSCCCCCG-------GGGGCTTCSEEECCSSCCCCC---GGGGSC-TTCSEEECC
T ss_pred             cCCCCCCC--hhhccCCCCCEEEecCCCCCCCc-------cccCCCccCEEECCCCccCCc---hhhccc-CCCCEEECc
Confidence            88888763  36888888888888888887642       367788888888888888875   256666 678888888


Q ss_pred             ccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCccccc
Q 036342          171 NCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGS  225 (596)
Q Consensus       171 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  225 (596)
                      +|.|++..|  +..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|++.+.
T Consensus       162 ~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          162 DNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             SSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred             CCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence            888887766  88888999999999988864  3578888999999999988753

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.83  E-value=2.4e-20  Score=192.20  Aligned_cols=176  Identities=23%  Similarity=0.197  Sum_probs=93.1

Q ss_pred             CEEEccCCcCccccCccCccCCCCccEEEccCCccccccCcccc-CCCCCCEEEccCCcccccCCccccCCCCCCEEecC
Q 036342           37 KFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD  115 (596)
Q Consensus        37 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~  115 (596)
                      +.+++++|.|+ .+|...   ...++.|+|++|+|++..+..|. ++++|++|+|++|+|+++.+++|.++++|++|+|+
T Consensus        21 ~~l~c~~~~l~-~iP~~~---~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSL---PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TEEECCSSCCS-SCCSSC---CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CEEEeCCCCcC-ccCccC---CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            45666666665 333311   23466666666666655555555 66666666666666666666666666666666666


Q ss_pred             CCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccC
Q 036342          116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG  195 (596)
Q Consensus       116 ~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~  195 (596)
                      +|+|+.+++.     .|.++++|+.|+|++|+|++                          +.|..|.++++|+.|+|++
T Consensus        97 ~N~l~~~~~~-----~~~~l~~L~~L~L~~N~i~~--------------------------~~~~~~~~l~~L~~L~L~~  145 (361)
T 2xot_A           97 SNHLHTLDEF-----LFSDLQALEVLLLYNNHIVV--------------------------VDRNAFEDMAQLQKLYLSQ  145 (361)
T ss_dssp             SSCCCEECTT-----TTTTCTTCCEEECCSSCCCE--------------------------ECTTTTTTCTTCCEEECCS
T ss_pred             CCcCCcCCHH-----HhCCCcCCCEEECCCCcccE--------------------------ECHHHhCCcccCCEEECCC
Confidence            6666554332     24455555555555555443                          3334444445555555555


Q ss_pred             CcccCCCCccc---cCCCCCCeEEccCCcccccCccchhcCCC--CcEEEccCCcCc
Q 036342          196 NKLNGSIPITL---GKLRKLQRLNLEDNILEGSIPDDICRLAE--LYRLELGSNKLY  247 (596)
Q Consensus       196 N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~Ls~N~l~  247 (596)
                      |.+++..+..|   ..+++|+.|+|++|.|++..+..+..++.  ++.|+|++|.+.
T Consensus       146 N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          146 NQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             SCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             CcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            55554333333   33555555555555555333344444444  255556555554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=1e-20  Score=180.67  Aligned_cols=153  Identities=23%  Similarity=0.258  Sum_probs=95.3

Q ss_pred             ccEEEccccccccccChhccCCCCCCEEEccCCcccCCCC-ccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEcc
Q 036342          164 LEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIP-ITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG  242 (596)
Q Consensus       164 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  242 (596)
                      -+.+++++|.++. +|..+.  ..+++|++++|.+++..+ ..|..+++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus        13 ~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   89 (220)
T 2v70_A           13 GTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT   89 (220)
T ss_dssp             TTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence            4567777777764 344332  345677777777776543 346667777777777777776555566667777777777


Q ss_pred             CCcCcccchhhhccCCCCcEEEeCCCcccCC-CcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcc
Q 036342          243 SNKLYGSIPACFGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSG  319 (596)
Q Consensus       243 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~  319 (596)
                      +|++++..+..|.++++|++|+|++|+++++ |..+..+++|++|+|++|++++..|..|..+++|+.|++++|.+++
T Consensus        90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            7777666666666666666666666666664 3445555666666666666655555555555555555555555543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.83  E-value=3.2e-21  Score=199.67  Aligned_cols=144  Identities=19%  Similarity=0.322  Sum_probs=122.5

Q ss_pred             cccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcC-----------CCccceeeeeecc
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIR-----------HRNLIKVISSCSN  492 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~-----------H~niv~l~~~~~~  492 (596)
                      .++|...+.||+|+||.||+|.                    +.+.+|+.++++++           ||||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            3579999999999999999863                    34678999999886           8999999999976


Q ss_pred             CC----eeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCCeeeC------C
Q 036342          493 EE----FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSA-LVIHCDLKPSNVLLD------D  560 (596)
Q Consensus       493 ~~----~~~lV~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~-~i~Hrdlk~~NILl~------~  560 (596)
                      .+    ..++||||+ +++|.+++.... ..+++..+..++.|++.|++|||   .. +|+||||||+||+++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcC
Confidence            54    789999999 899999998743 45889999999999999999999   87 999999999999994      4


Q ss_pred             CCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          561 NMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       561 ~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+.+||+|||+++.....     .....||+.|+||
T Consensus       174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aP  204 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSP  204 (373)
T ss_dssp             EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCH
T ss_pred             cceEEEcccccccccCCC-----CCCCCCCccccCc
Confidence            458999999999875422     2335789999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.82  E-value=1.3e-20  Score=188.88  Aligned_cols=131  Identities=24%  Similarity=0.419  Sum_probs=115.1

Q ss_pred             ccccccc-ccccCCCceeehhhH----------------HhHHHHHHHH-hhcCCCccceeeeeecc----CCeeEEEEe
Q 036342          444 TDEFSEN-NLIGRGGFALFIRAF----------------KSFDVECEMM-KSIRHRNLIKVISSCSN----EEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~-~~ig~G~~g~v~~~~----------------~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~~lV~e  501 (596)
                      .++|... +.||+|+||.||++.                ..+.+|+.++ +..+||||+++++++..    +...|+|||
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e   95 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   95 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence            3567776 789999999999863                4577899888 66799999999999876    667899999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEeccccccccCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~dfGla~~~~~  577 (596)
                      |+++|+|.+++.... ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.   ++.+||+|||+++....
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  172 (299)
T 3m2w_A           96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG  172 (299)
T ss_dssp             CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc
Confidence            999999999998754 36899999999999999999999   899999999999999998   78999999999987643

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=1.2e-19  Score=173.34  Aligned_cols=132  Identities=24%  Similarity=0.243  Sum_probs=73.9

Q ss_pred             ccEEEccccccccccC-hhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEcc
Q 036342          164 LEEFYMYNCNISGGIP-EEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG  242 (596)
Q Consensus       164 L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  242 (596)
                      +++|+|++|+|++..+ ..|..+++|++|+|++|.+++..+.+|.++++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  113 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR  113 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred             CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence            4455555555544432 334555555555555555555555555555555555555555554444455555555666666


Q ss_pred             CCcCcccchhhhccCCCCcEEEeCCCcccCC-CcccccccccceEEcccCCCCC
Q 036342          243 SNKLYGSIPACFGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNFLTG  295 (596)
Q Consensus       243 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~ls~N~l~~  295 (596)
                      +|++++..|..|..+++|+.|+|++|+++++ |..+..+++|+.|++++|+++.
T Consensus       114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A          114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            6655555555555566666666666666554 4455556666666666666553

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.82  E-value=1.4e-20  Score=187.28  Aligned_cols=123  Identities=17%  Similarity=0.086  Sum_probs=111.2

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||+|.                        +.+.+|+.++++++||||+++++++..++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            579999999999999999852                        45789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ||+++++|.++++..   ....++..++.|++.|+.|||   ..+|+||||||+||++++++.+||+++|...
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence            999999999999653   355678889999999999999   8999999999999999999999999877543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=1.6e-19  Score=173.54  Aligned_cols=155  Identities=25%  Similarity=0.196  Sum_probs=104.8

Q ss_pred             cccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEcc
Q 036342          163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG  242 (596)
Q Consensus       163 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  242 (596)
                      +.+.++.+++.++.+ |..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus        20 s~~~v~c~~~~l~~i-p~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls   96 (229)
T 3e6j_A           20 SGTTVDCRSKRHASV-PAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG   96 (229)
T ss_dssp             ETTEEECTTSCCSSC-CSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             eCCEeEccCCCcCcc-CCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence            455566666666533 33222  667777777777777667777777777777777777765444556677777777777


Q ss_pred             CCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCccc
Q 036342          243 SNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGV  320 (596)
Q Consensus       243 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~  320 (596)
                      +|++++..+..|..+++|+.|+|++|+|+.+|..+..+++|+.|++++|++++..+..+..+++|+.|++++|.+...
T Consensus        97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A           97 TNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             CCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence            777776666667777777777777777777777777777777777777777665555566666666666666666543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.81  E-value=5.4e-23  Score=223.51  Aligned_cols=138  Identities=20%  Similarity=0.192  Sum_probs=91.3

Q ss_pred             ccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccC
Q 036342          164 LEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGS  243 (596)
Q Consensus       164 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  243 (596)
                      |..+.+++|.|+...+      ..|+.|+|++|.+++ +|. |..+++|+.|+|++|.|+ .+|..+..+++|+.|+|++
T Consensus       425 L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~  495 (567)
T 1dce_A          425 LRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASD  495 (567)
T ss_dssp             HHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCS
T ss_pred             hhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCC
Confidence            4444555555554322      136777777777775 344 777777777777777777 6677777777777777777


Q ss_pred             CcCcccchhhhccCCCCcEEEeCCCcccCC--CcccccccccceEEcccCCCCCchhh---hhccccccceEec
Q 036342          244 NKLYGSIPACFGNLASLRILSLGSNKLTSI--PLTFWNLKDILQLNFSSNFLTGPLLL---EIGNLKVLIGIDF  312 (596)
Q Consensus       244 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i--p~~~~~l~~L~~L~ls~N~l~~~~~~---~~~~l~~L~~L~l  312 (596)
                      |+|++ +| .++.+++|+.|+|++|+|+++  |..+..+++|+.|+|++|++++..+.   .+..+++|+.||+
T Consensus       496 N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          496 NALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             SCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            77775 45 677777777777777777776  66777777777777777777765432   2334667777654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.81  E-value=2.1e-19  Score=171.60  Aligned_cols=152  Identities=24%  Similarity=0.269  Sum_probs=95.5

Q ss_pred             CEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCC
Q 036342           37 KFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE  116 (596)
Q Consensus        37 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~  116 (596)
                      +.+++++|.++ .+|...   .++|+.|+|++|+|++..+..|.++++|++|+|++|+|+++.|++|.++++|++|+|++
T Consensus        14 ~~v~c~~~~l~-~iP~~l---~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~   89 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNL---PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG   89 (220)
T ss_dssp             TEEECTTSCCS-SCCSSC---CTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred             CEEEcCCCCcC-cCCCcc---CcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence            46777777776 344321   24677777777777766666677777777777777777766666676666666666666


Q ss_pred             CcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCC
Q 036342          117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN  196 (596)
Q Consensus       117 N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N  196 (596)
                      |.|+.+++.     .|.++++|+.|+|++|+|                          ++..|..|..+++|++|+|++|
T Consensus        90 N~l~~l~~~-----~f~~l~~L~~L~L~~N~l--------------------------~~~~~~~~~~l~~L~~L~L~~N  138 (220)
T 2v9t_B           90 NKITELPKS-----LFEGLFSLQLLLLNANKI--------------------------NCLRVDAFQDLHNLNLLSLYDN  138 (220)
T ss_dssp             SCCCCCCTT-----TTTTCTTCCEEECCSSCC--------------------------CCCCTTTTTTCTTCCEEECCSS
T ss_pred             CcCCccCHh-----HccCCCCCCEEECCCCCC--------------------------CEeCHHHcCCCCCCCEEECCCC
Confidence            666655433     244444444444444444                          3344455666666777777777


Q ss_pred             cccCCCCccccCCCCCCeEEccCCccc
Q 036342          197 KLNGSIPITLGKLRKLQRLNLEDNILE  223 (596)
Q Consensus       197 ~l~~~~p~~~~~l~~L~~L~L~~N~l~  223 (596)
                      .+++..+..|..+++|++|+|++|.+.
T Consensus       139 ~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B          139 KLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            776666666666666666666666665

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.80  E-value=3e-20  Score=182.51  Aligned_cols=170  Identities=22%  Similarity=0.299  Sum_probs=100.2

Q ss_pred             CCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEE
Q 036342           33 VSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQL  112 (596)
Q Consensus        33 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  112 (596)
                      +.++..+++++|.+++ ++..  ..+++|++|++++|.++ .++ .+..+++|++|+|++|+|+++.+  |.++++|++|
T Consensus        18 l~~l~~l~l~~~~i~~-~~~~--~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTD-LVSQ--KELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHTCSCTTS-EECH--HHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHhcCCCccc-ccch--hhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            3445555555555542 2222  22556666666666655 233 45556666666666666655443  5666666666


Q ss_pred             ecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEE
Q 036342          113 GLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEID  192 (596)
Q Consensus       113 ~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  192 (596)
                      ++++|+++.+++       +.. ++|+.|++++|++++. +  .+..+ ++|++|++++|+|++.  +.+..+++|++|+
T Consensus        91 ~L~~N~l~~l~~-------~~~-~~L~~L~L~~N~l~~~-~--~l~~l-~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~  156 (263)
T 1xeu_A           91 SVNRNRLKNLNG-------IPS-ACLSRLFLDNNELRDT-D--SLIHL-KNLEILSIRNNKLKSI--VMLGFLSKLEVLD  156 (263)
T ss_dssp             ECCSSCCSCCTT-------CCC-SSCCEEECCSSCCSBS-G--GGTTC-TTCCEEECTTSCCCBC--GGGGGCTTCCEEE
T ss_pred             ECCCCccCCcCc-------ccc-CcccEEEccCCccCCC-h--hhcCc-ccccEEECCCCcCCCC--hHHccCCCCCEEE
Confidence            666666655432       122 5666666666666653 1  34444 5566666666666654  2566677777777


Q ss_pred             ccCCcccCCCCccccCCCCCCeEEccCCccccc
Q 036342          193 LGGNKLNGSIPITLGKLRKLQRLNLEDNILEGS  225 (596)
Q Consensus       193 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  225 (596)
                      +++|.+++.  ..+..+++|+.|++++|.+++.
T Consensus       157 L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          157 LHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             CCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            777777765  5566777777777777777643

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.79  E-value=1.2e-18  Score=167.34  Aligned_cols=153  Identities=23%  Similarity=0.256  Sum_probs=82.1

Q ss_pred             CCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecC
Q 036342           36 LKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD  115 (596)
Q Consensus        36 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~  115 (596)
                      .+.++.+++.++ .+|...   .++|++|+|++|+|++..|..|.++++|++|+|++|+|+.+.+..|.++++|++|+|+
T Consensus        21 ~~~v~c~~~~l~-~ip~~~---~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls   96 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGI---PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG   96 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEeEccCCCcC-ccCCCC---CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence            445666666665 333311   2456666666666665555555556666666666666655555555555555555555


Q ss_pred             CCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccC
Q 036342          116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGG  195 (596)
Q Consensus       116 ~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~  195 (596)
                      +|+++.+++.     .|..+++|+.|+|++|+|+                           .+|..+..+++|++|+|++
T Consensus        97 ~N~l~~l~~~-----~~~~l~~L~~L~Ls~N~l~---------------------------~lp~~~~~l~~L~~L~L~~  144 (229)
T 3e6j_A           97 TNQLTVLPSA-----VFDRLVHLKELFMCCNKLT---------------------------ELPRGIERLTHLTHLALDQ  144 (229)
T ss_dssp             SSCCCCCCTT-----TTTTCTTCCEEECCSSCCC---------------------------SCCTTGGGCTTCSEEECCS
T ss_pred             CCcCCccChh-----HhCcchhhCeEeccCCccc---------------------------ccCcccccCCCCCEEECCC
Confidence            5555544332     2344444444444444443                           2234445555666666666


Q ss_pred             CcccCCCCccccCCCCCCeEEccCCcccc
Q 036342          196 NKLNGSIPITLGKLRKLQRLNLEDNILEG  224 (596)
Q Consensus       196 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  224 (596)
                      |++++..+..|..+++|+.|++++|.+..
T Consensus       145 N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A          145 NQLKSIPHGAFDRLSSLTHAYLFGNPWDC  173 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred             CcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence            66665555555566666666666665553

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.79  E-value=6.8e-19  Score=165.00  Aligned_cols=149  Identities=17%  Similarity=0.191  Sum_probs=82.6

Q ss_pred             ccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEc
Q 036342          162 RSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLEL  241 (596)
Q Consensus       162 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (596)
                      ++|++|++++|.|+. +| .+..+++|++|++++|.+..  +..+..+++|++|++++|.+++..+..+..+++|++|++
T Consensus        44 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L  119 (197)
T 4ezg_A           44 NSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI  119 (197)
T ss_dssp             HTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred             CCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence            345555555555552 23 45556666666666665442  234556666666666666666555556666666666666


Q ss_pred             cCCcCcccchhhhccCCCCcEEEeCCCc-ccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcC
Q 036342          242 GSNKLYGSIPACFGNLASLRILSLGSNK-LTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNF  317 (596)
Q Consensus       242 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~  317 (596)
                      ++|++++..|..+..+++|++|+|++|. ++.+| .+..+++|+.|++++|.+++..  .+..+++|+.|++++|++
T Consensus       120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC--
T ss_pred             cCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCccc
Confidence            6666665556666666666666666665 55554 4455555555555555554422  344444444444444444

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.79  E-value=2.7e-19  Score=181.94  Aligned_cols=287  Identities=16%  Similarity=0.100  Sum_probs=158.0

Q ss_pred             CCCCCEEECCCCCCccccchhhhC-CCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccC------
Q 036342            9 LQNLEELQLGQNKLIGTVPAAIFN-VSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFN------   81 (596)
Q Consensus         9 l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------   81 (596)
                      +.++++|+++++ +....-..+.. +++|++|||++|+++......  ..++.++.+.+..|.   +.+.+|.+      
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~--~~~~~~~~~~~~~~~---I~~~aF~~~~~~~~   97 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKA--GTYPNGKFYIYMANF---VPAYAFSNVVNGVT   97 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESS--SSSGGGCCEEECTTE---ECTTTTEEEETTEE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcc--ccccccccccccccc---cCHHHhcccccccc
Confidence            567889999864 22222233444 788999999999987111111  113345666666663   34556666      


Q ss_pred             --CCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCC----CccCCch
Q 036342           82 --ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPL----DGILPKT  155 (596)
Q Consensus        82 --l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l----~~~~~~~  155 (596)
                        +++|++|+|.+ .++.+.+.+|.++++|+.|+++.|.++.+.+.     +|.++.++..+.++.+..    ..+ ...
T Consensus        98 ~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~-----aF~~~~~l~~l~~~~~~~~~~~~~i-~~~  170 (329)
T 3sb4_A           98 KGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPE-----ALADSVTAIFIPLGSSDAYRFKNRW-EHF  170 (329)
T ss_dssp             EECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTT-----SSCTTTCEEEECTTCTHHHHTSTTT-TTS
T ss_pred             cccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchh-----hhcCCCceEEecCcchhhhhccccc-ccc
Confidence              88888888888 88888888888888888888888888776654     577777777666655221    111 111


Q ss_pred             hhhccccccc-EEEcccccc-ccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcC
Q 036342          156 SISNLSRSLE-EFYMYNCNI-SGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRL  233 (596)
Q Consensus       156 ~~~~l~~~L~-~L~l~~n~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  233 (596)
                      .|.+. .+|+ .+.+....- .......-....++..+.+.++-...........+++|+.+++++|.++...+..|.++
T Consensus       171 ~f~~~-~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~  249 (329)
T 3sb4_A          171 AFIEG-EPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQK  249 (329)
T ss_dssp             CEEES-CCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTC
T ss_pred             ccccc-cccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCC
Confidence            22222 2233 222222110 00000000123344445444432211111111124556666666655554444455556


Q ss_pred             CCCcEEEccCCcCcccchhhhccCCCCc-EEEeCCCcccCCC-cccccccccceEEcccCCCCCchhhhhccccccceEe
Q 036342          234 AELYRLELGSNKLYGSIPACFGNLASLR-ILSLGSNKLTSIP-LTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGID  311 (596)
Q Consensus       234 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~ip-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~  311 (596)
                      .+|+.++|++| ++.+.+.+|.++++|+ .+++.+ .++.|+ .+|.++++|+.+++++|.++......|.++++|+.++
T Consensus       250 ~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          250 KYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             TTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             CCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            66666666555 5545555666666666 666655 555554 3455566666666666666666566666666666654

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.78  E-value=3.1e-19  Score=175.26  Aligned_cols=168  Identities=18%  Similarity=0.214  Sum_probs=99.9

Q ss_pred             cccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEcc
Q 036342          163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG  242 (596)
Q Consensus       163 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  242 (596)
                      ++..+++++|.+++..  .+..+++|+.|++++|.++. ++ .+..+++|++|++++|.+++. +. +..+++|+.|+|+
T Consensus        20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~   93 (263)
T 1xeu_A           20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVN   93 (263)
T ss_dssp             HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECC
T ss_pred             HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECC
Confidence            3455556666665443  35556666666666666653 23 455666666666666666633 32 6666666666666


Q ss_pred             CCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCC
Q 036342          243 SNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIP  322 (596)
Q Consensus       243 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~  322 (596)
                      +|++++. |.. .. ++|+.|+|++|++++++ .+..+++|+.|++++|++++..  .+..+++|+.|++++|++++.  
T Consensus        94 ~N~l~~l-~~~-~~-~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i~~~--  165 (263)
T 1xeu_A           94 RNRLKNL-NGI-PS-ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEITNT--  165 (263)
T ss_dssp             SSCCSCC-TTC-CC-SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCCCBC--
T ss_pred             CCccCCc-Ccc-cc-CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcCcch--
Confidence            6666542 221 22 66666666666666654 3556666666666666666542  466666666677777766644  


Q ss_pred             hhhhccCCCCCeEECCCCccccc
Q 036342          323 REIGEKLSYLEDLNLSFNKLKGE  345 (596)
Q Consensus       323 ~~~~~~l~~L~~L~l~~N~l~~~  345 (596)
                       ..+..+++|+.|++++|++.+.
T Consensus       166 -~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          166 -GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             -TTSTTCCCCCEEEEEEEEEECC
T ss_pred             -HHhccCCCCCEEeCCCCcccCC
Confidence             2345666677777777766644

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.77  E-value=9.6e-19  Score=163.22  Aligned_cols=177  Identities=21%  Similarity=0.277  Sum_probs=85.3

Q ss_pred             cEEEccccccccccChhccCCCCCCEEEccCCcccCCCCc-cccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccC
Q 036342          165 EEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPI-TLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGS  243 (596)
Q Consensus       165 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  243 (596)
                      +++++++|+++. +|..+.  .+|++|++++|.+++..+. .|..+++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCc-CccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            455555555542 233222  2455555555555544432 244555555555555555544444444455555555555


Q ss_pred             CcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCCh
Q 036342          244 NKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPR  323 (596)
Q Consensus       244 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~  323 (596)
                      |+|++..+..|.+                       +++|++|+|++|++++..|..+..+++|+.|++++|.+++..+.
T Consensus        88 N~l~~~~~~~~~~-----------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  144 (192)
T 1w8a_A           88 NKIKEISNKMFLG-----------------------LHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             CCCCEECSSSSTT-----------------------CTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CcCCccCHHHhcC-----------------------CCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence            5554444444444                       44455555555555544455555555555555555555544332


Q ss_pred             hhhccCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCCC
Q 036342          324 EIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN  371 (596)
Q Consensus       324 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~~  371 (596)
                      ..+.  ..++...+.++...+..|..  +......++..+.+.|..+.
T Consensus       145 ~~~~--~~l~~~~~~~~~~~C~~P~~--l~~~~l~~l~~~~~~C~~~~  188 (192)
T 1w8a_A          145 AWFA--EWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             HHHH--HHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCCCC-
T ss_pred             hHHH--HHHHHcCCCCCCCCCCCChH--HcCCChhhCcHhhcCcCCCC
Confidence            2211  11222233344444444432  44455556677777776553

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.77  E-value=2.8e-19  Score=181.79  Aligned_cols=286  Identities=13%  Similarity=0.093  Sum_probs=194.5

Q ss_pred             CCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccc--cccCccccCCCCCCEEEccCCcccccCCccccC-----
Q 036342           33 VSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFS--GTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGN-----  105 (596)
Q Consensus        33 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~-----  105 (596)
                      +.+++.|.++++--...+..+.. .+++|+.|||++|+|.  ...+..+   +.++.+.+..|.   +.+.+|.+     
T Consensus        24 ~~~l~~L~l~g~i~~~~~~~l~~-~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGKLNAEDFRHLRD-EFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEEECHHHHHHHHH-SCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTE
T ss_pred             hCceeEEEEeccccHHHHHHHHH-hhccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhccccccc
Confidence            56789999987632212222211 1788999999999987  3333222   225566666664   45677777     


Q ss_pred             ---CCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccc----ccccc
Q 036342          106 ---LRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCN----ISGGI  178 (596)
Q Consensus       106 ---l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~----l~~~~  178 (596)
                         +++|+.|+|.. .++.+...     +|.+|++|+.+++++|.+..+.+. .|... .++..+.+..+.    .....
T Consensus        97 ~~g~~~L~~l~L~~-~i~~I~~~-----aF~~~~~L~~l~l~~n~i~~i~~~-aF~~~-~~l~~l~~~~~~~~~~~~~i~  168 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIKNIEDA-----AFKGCDNLKICQIRKKTAPNLLPE-ALADS-VTAIFIPLGSSDAYRFKNRWE  168 (329)
T ss_dssp             EEECTTCCC-CBCT-TCCEECTT-----TTTTCTTCCEEEBCCSSCCEECTT-SSCTT-TCEEEECTTCTHHHHTSTTTT
T ss_pred             ccccCCCcEEECCc-cccchhHH-----HhhcCcccceEEcCCCCccccchh-hhcCC-CceEEecCcchhhhhcccccc
Confidence               99999999998 88887665     689999999999999988765443 55554 345555554422    22334


Q ss_pred             ChhccCCCCCC-EEEccCCcc-cCCCCccccCCCCCCeEEccCCcccccCccchh-cCCCCcEEEccCCcCcccchhhhc
Q 036342          179 PEEISNLTNLV-EIDLGGNKL-NGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC-RLAELYRLELGSNKLYGSIPACFG  255 (596)
Q Consensus       179 ~~~~~~l~~L~-~L~Ls~N~l-~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~  255 (596)
                      +.+|.++..|+ .++++...- .......-....++..+.+.++-.. .....+. .+++|+.++|++|+++.+.+.+|.
T Consensus       169 ~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~  247 (329)
T 3sb4_A          169 HFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFA  247 (329)
T ss_dssp             TSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTT
T ss_pred             ccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhh
Confidence            45566666666 444443221 1000011113456667777665332 1112222 378999999999999877788899


Q ss_pred             cCCCCcEEEeCCCcccCCCc-ccccccccc-eEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCC
Q 036342          256 NLASLRILSLGSNKLTSIPL-TFWNLKDIL-QLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLE  333 (596)
Q Consensus       256 ~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~-~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~  333 (596)
                      ++++|+.|+|.+| ++.|+. +|.++.+|+ .+++.+ .++.+.+..|.++++|+.++++.|++. .++..+|..+++|+
T Consensus       248 ~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~-~I~~~aF~~~~~L~  324 (329)
T 3sb4_A          248 QKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT-TLGDELFGNGVPSK  324 (329)
T ss_dssp             TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC-EECTTTTCTTCCCC
T ss_pred             CCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC-ccchhhhcCCcchh
Confidence            9999999999988 888765 577889998 999988 788788889999999999999999998 56766888888888


Q ss_pred             eEEC
Q 036342          334 DLNL  337 (596)
Q Consensus       334 ~L~l  337 (596)
                      .++.
T Consensus       325 ~ly~  328 (329)
T 3sb4_A          325 LIYK  328 (329)
T ss_dssp             EEEC
T ss_pred             hhcc
Confidence            8863

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.77  E-value=1.9e-18  Score=161.97  Aligned_cols=151  Identities=21%  Similarity=0.286  Sum_probs=97.6

Q ss_pred             CCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeE
Q 036342          136 KSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRL  215 (596)
Q Consensus       136 ~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  215 (596)
                      ++|+.|++++|.++.. +  .+..+ ++|++|++++|.++.  +..+..+++|++|++++|.+++..+..+..+++|++|
T Consensus        44 ~~L~~L~l~~n~i~~l-~--~l~~l-~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L  117 (197)
T 4ezg_A           44 NSLTYITLANINVTDL-T--GIEYA-HNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL  117 (197)
T ss_dssp             HTCCEEEEESSCCSCC-T--TGGGC-TTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred             CCccEEeccCCCccCh-H--HHhcC-CCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence            3444444444444421 1  23333 345555555554432  2356667777777777777776667777777777777


Q ss_pred             EccCCcccccCccchhcCCCCcEEEccCCc-CcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCC
Q 036342          216 NLEDNILEGSIPDDICRLAELYRLELGSNK-LYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       216 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~  294 (596)
                      ++++|.+++..|..+..+++|+.|++++|+ ++ .+| .+..+++|+.|++++|.++.++ .+..+++|+.|++++|++.
T Consensus       118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC---
T ss_pred             EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcccC
Confidence            777777776667777777778888888777 54 344 5777788888888888887776 6777788888888888775


Q ss_pred             C
Q 036342          295 G  295 (596)
Q Consensus       295 ~  295 (596)
                      +
T Consensus       195 ~  195 (197)
T 4ezg_A          195 G  195 (197)
T ss_dssp             -
T ss_pred             C
Confidence            3

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=1.2e-20  Score=205.10  Aligned_cols=181  Identities=18%  Similarity=0.190  Sum_probs=84.8

Q ss_pred             CCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccc-------------cccccChhccCCCCCCEEE-ccCCcc
Q 036342          133 SNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCN-------------ISGGIPEEISNLTNLVEID-LGGNKL  198 (596)
Q Consensus       133 ~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l  198 (596)
                      ..+++|+.|+|++|+++. +|. .++.+ ++|+.|++++|.             +.+..|..+..+++|+.|+ ++.|.+
T Consensus       346 ~~~~~L~~L~Ls~n~L~~-Lp~-~i~~l-~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~  422 (567)
T 1dce_A          346 ATDEQLFRCELSVEKSTV-LQS-ELESC-KELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL  422 (567)
T ss_dssp             STTTTSSSCCCCHHHHHH-HHH-HHHHH-HHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH
T ss_pred             ccCccceeccCChhhHHh-hHH-HHHHH-HHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc
Confidence            344455555555555542 232 34444 345555554443             3445555666666666665 444432


Q ss_pred             cCCCCc-----ccc--CCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCccc
Q 036342          199 NGSIPI-----TLG--KLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT  271 (596)
Q Consensus       199 ~~~~p~-----~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  271 (596)
                      ......     .+.  ....|+.|+|++|.|++ +|. +..+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|.|+
T Consensus       423 ~~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~  499 (567)
T 1dce_A          423 DDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE  499 (567)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred             chhhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCC
Confidence            210000     000  00134455555555543 333 445555555555555554 34445555555555555555555


Q ss_pred             CCCcccccccccceEEcccCCCCCch-hhhhccccccceEecCCCcCccc
Q 036342          272 SIPLTFWNLKDILQLNFSSNFLTGPL-LLEIGNLKVLIGIDFSMNNFSGV  320 (596)
Q Consensus       272 ~ip~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~ls~N~~~~~  320 (596)
                      ++| .+..+++|+.|+|++|+|++.. |..+..+++|+.|++++|.+++.
T Consensus       500 ~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~  548 (567)
T 1dce_A          500 NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  548 (567)
T ss_dssp             CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             CCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence            554 4444555555555555555443 44455555555555555555433

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.77  E-value=2.4e-19  Score=200.76  Aligned_cols=162  Identities=22%  Similarity=0.227  Sum_probs=124.1

Q ss_pred             EccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCc
Q 036342          168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLY  247 (596)
Q Consensus       168 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  247 (596)
                      +++.|.+. ..+..|..++.|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+
T Consensus       207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~  283 (727)
T 4b8c_D          207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT  283 (727)
T ss_dssp             ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred             ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence            33444444 56788999999999999999998 56666668999999999999999 88999999999999999999999


Q ss_pred             ccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccc-cceEecCCCcCcccCChhhh
Q 036342          248 GSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKV-LIGIDFSMNNFSGVIPREIG  326 (596)
Q Consensus       248 ~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~-L~~L~ls~N~~~~~~~~~~~  326 (596)
                       .+|..|+.+++|++|+|++|.|+.+|..+..+++|+.|+|++|+|++.+|..+..+.. +..+++++|.+++.+|.   
T Consensus       284 -~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~---  359 (727)
T 4b8c_D          284 -SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH---  359 (727)
T ss_dssp             -SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC---
T ss_pred             -ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc---
Confidence             6799999999999999999999999999999999999999999999999988876543 23478999999988775   


Q ss_pred             ccCCCCCeEECCCC
Q 036342          327 EKLSYLEDLNLSFN  340 (596)
Q Consensus       327 ~~l~~L~~L~l~~N  340 (596)
                          .|+.|+++.|
T Consensus       360 ----~l~~l~l~~n  369 (727)
T 4b8c_D          360 ----ERRFIEINTD  369 (727)
T ss_dssp             ----C---------
T ss_pred             ----ccceeEeecc
Confidence                3566777777

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=3.9e-18  Score=159.05  Aligned_cols=133  Identities=29%  Similarity=0.326  Sum_probs=114.4

Q ss_pred             CEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccC
Q 036342           13 EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGM   92 (596)
Q Consensus        13 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~   92 (596)
                      ++|++++|+++ .+|..+.  .+|++|+|++|++++..+...+..+++|++|+|++|+|++..|.+|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            78999999996 5666553  38999999999998655544456699999999999999988899999999999999999


Q ss_pred             CcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCC
Q 036342           93 NSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILP  153 (596)
Q Consensus        93 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~  153 (596)
                      |+|+++.+..|.++++|++|+|++|+++++.+.     .|..+++|++|+|++|.+++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG-----SFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTT-----SSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHH-----HhhcCCCCCEEEeCCCCccCcCc
Confidence            999999999999999999999999999987554     58889999999999999987644

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.75  E-value=1e-16  Score=166.70  Aligned_cols=245  Identities=15%  Similarity=0.186  Sum_probs=151.5

Q ss_pred             CCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEE
Q 036342            9 LQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKL   88 (596)
Q Consensus         9 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L   88 (596)
                      .++++.+.+. |.++.+...+|.+. +|+.+++..| ++ .++..+|.. .+|+.++|.. .++.+.+.+|.++++|+.+
T Consensus       112 ~~~l~~i~ip-~~i~~I~~~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l  185 (401)
T 4fdw_A          112 LKGYNEIILP-NSVKSIPKDAFRNS-QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKA  185 (401)
T ss_dssp             CSSCSEEECC-TTCCEECTTTTTTC-CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred             cCCccEEEEC-CccCEehHhhcccC-CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCee
Confidence            3566677764 45666666777764 6777777666 54 566666655 4677777775 5665666777777777777


Q ss_pred             EccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEE
Q 036342           89 SLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFY  168 (596)
Q Consensus        89 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~  168 (596)
                      +|++|.++.+...+|. ..+|+.+.+..+ ++.+...     +|.++++|+.+++..| ++.+ +...|.+  .+|+.+.
T Consensus       186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~-----aF~~~~~L~~l~l~~~-l~~I-~~~aF~~--~~L~~i~  254 (401)
T 4fdw_A          186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQ-----AFLKTSQLKTIEIPEN-VSTI-GQEAFRE--SGITTVK  254 (401)
T ss_dssp             ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTT-----TTTTCTTCCCEECCTT-CCEE-CTTTTTT--CCCSEEE
T ss_pred             ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhh-----HhhCCCCCCEEecCCC-ccCc-ccccccc--CCccEEE
Confidence            7777777777777776 467777777644 5555444     5777777777777764 3333 3334444  4566666


Q ss_pred             ccccccccccChhccCCCCCCEEEccCCccc-----CCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccC
Q 036342          169 MYNCNISGGIPEEISNLTNLVEIDLGGNKLN-----GSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGS  243 (596)
Q Consensus       169 l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  243 (596)
                      + .+.++.+.+.+|.++++|+.+++.+|.+.     .+.+.+|.++++|+.+++.+ .++..-...|.++.+|+.+++..
T Consensus       255 l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~  332 (401)
T 4fdw_A          255 L-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPA  332 (401)
T ss_dssp             E-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECT
T ss_pred             e-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECc
Confidence            6 44455566666666666666666666554     34455666666666666663 35444444555556666666643


Q ss_pred             CcCcccchhhhccCCCCcEEEeCCCcccCCC
Q 036342          244 NKLYGSIPACFGNLASLRILSLGSNKLTSIP  274 (596)
Q Consensus       244 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip  274 (596)
                      | ++.+.+.+|.++ +|+.+++++|.+..++
T Consensus       333 ~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~  361 (401)
T 4fdw_A          333 N-VTQINFSAFNNT-GIKEVKVEGTTPPQVF  361 (401)
T ss_dssp             T-CCEECTTSSSSS-CCCEEEECCSSCCBCC
T ss_pred             c-ccEEcHHhCCCC-CCCEEEEcCCCCcccc
Confidence            3 444445555555 5666666665555543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.75  E-value=4.3e-19  Score=186.14  Aligned_cols=144  Identities=19%  Similarity=0.273  Sum_probs=108.9

Q ss_pred             hcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCC-Ccccee-----------
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRH-RNLIKV-----------  486 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H-~niv~l-----------  486 (596)
                      .+..|...+.||+|+||+||+|.                        +.+.+|+.+++.++| +|....           
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            45568888999999999999863                        357799999999987 222111           


Q ss_pred             ----------eeeecc-----CCeeEEEEecCCCCCHHHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc
Q 036342          487 ----------ISSCSN-----EEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYLHFGYSAL  545 (596)
Q Consensus       487 ----------~~~~~~-----~~~~~lV~e~~~~g~L~~~l~------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~  545 (596)
                                ..++..     ....+++|+++ +|+|.+++.      .....+++..++.++.|+++||+|||   ..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence                      111111     11356777766 689999884      22345678889999999999999999   899


Q ss_pred             eEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          546 VIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       546 i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+||||||+|||++.++.+||+|||+++....     .....+| +.||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aP  276 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPP  276 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCc
Confidence            99999999999999999999999999886432     1344578 999998

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.75  E-value=6.2e-19  Score=197.51  Aligned_cols=215  Identities=21%  Similarity=0.184  Sum_probs=94.3

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCcc--------ccCccCccCCCCccEEEccCCccccccCccccC
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSG--------SLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFN   81 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (596)
                      +.++.|+|.+|.+.. .+..+     |+.++|++|.|.+        .+++..+..+++|+.|+|++|.+. .+|..+++
T Consensus       173 ~~~~~l~L~~n~~~~-~~~~~-----l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~  245 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQAL-----LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFK  245 (727)
T ss_dssp             -------------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGG
T ss_pred             CccceEEeeCCCCCc-chhhH-----hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcC
Confidence            346667777777654 23322     2333333333321        122333344677777777777776 56666667


Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhccc
Q 036342           82 ASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS  161 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~  161 (596)
                      +++|++|+|++|.|+ .+|..|.+|++|++|+|++|.|+.++.      .|.++++|++|+|++|.|+ .+|. .+..+ 
T Consensus       246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~------~~~~l~~L~~L~L~~N~l~-~lp~-~~~~l-  315 (727)
T 4b8c_D          246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPA------ELGSCFQLKYFYFFDNMVT-TLPW-EFGNL-  315 (727)
T ss_dssp             CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCS------SGGGGTTCSEEECCSSCCC-CCCS-STTSC-
T ss_pred             CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccCh------hhcCCCCCCEEECCCCCCC-ccCh-hhhcC-
Confidence            777777777777777 556667777777777777777775432      3666777777777777775 3454 36666 


Q ss_pred             ccccEEEccccccccccChhccCCCC-CCEEEccCCcccCCCCccccCCCCCCeEEccCC--------cccccCccchhc
Q 036342          162 RSLEEFYMYNCNISGGIPEEISNLTN-LVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN--------ILEGSIPDDICR  232 (596)
Q Consensus       162 ~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N--------~l~~~~~~~~~~  232 (596)
                      ++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..      |+.|+++.|        .+.+..+..+..
T Consensus       316 ~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~  389 (727)
T 4b8c_D          316 CNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATD  389 (727)
T ss_dssp             TTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----------------------------------
T ss_pred             CCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhc
Confidence            56777777777777777766654321 123667777777666643      345555555        333333444455


Q ss_pred             CCCCcEEEccCCcCc
Q 036342          233 LAELYRLELGSNKLY  247 (596)
Q Consensus       233 l~~L~~L~Ls~N~l~  247 (596)
                      +..+....++.|-+.
T Consensus       390 l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          390 LAKRTFTVLSYNTLC  404 (727)
T ss_dssp             ------------CCC
T ss_pred             ccccceeeeeccccc
Confidence            566666777777664

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.72  E-value=1.6e-17  Score=151.27  Aligned_cols=131  Identities=24%  Similarity=0.217  Sum_probs=64.9

Q ss_pred             CCCCEEEccCCccc-CCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEE
Q 036342          186 TNLVEIDLGGNKLN-GSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILS  264 (596)
Q Consensus       186 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  264 (596)
                      ++|++|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            44555555555554 34444455555555555555555533  4445555555555555555544555555555555555


Q ss_pred             eCCCcccCCC--cccccccccceEEcccCCCCCchh---hhhccccccceEecCCCcCc
Q 036342          265 LGSNKLTSIP--LTFWNLKDILQLNFSSNFLTGPLL---LEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       265 Ls~N~l~~ip--~~~~~l~~L~~L~ls~N~l~~~~~---~~~~~l~~L~~L~ls~N~~~  318 (596)
                      |++|.++.+|  ..+..+++|+.|++++|++++..+   ..+..+++|+.||+++|.+.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            5555555543  334444444444444444443332   23444444444444444443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.71  E-value=3.9e-16  Score=162.24  Aligned_cols=249  Identities=14%  Similarity=0.165  Sum_probs=208.0

Q ss_pred             ccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCC
Q 036342            5 EIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASK   84 (596)
Q Consensus         5 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~   84 (596)
                      +|.+. +|+.+++..+ ++.+...+|.+ .+|+.+++.. .++ .++..+|..+++|+.++|++|+++.+...+|. ..+
T Consensus       131 aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~  204 (401)
T 4fdw_A          131 AFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAG  204 (401)
T ss_dssp             TTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCC
T ss_pred             hcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEe-ecc
Confidence            46664 7999999876 88888889988 4799999986 675 67788888899999999999999966666666 589


Q ss_pred             CCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccc
Q 036342           85 LSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSL  164 (596)
Q Consensus        85 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L  164 (596)
                      |+.+.|.. .++.+...+|.++.+|+.+++..| ++.+...     +|.+ .+|+.+++. +.++.+ +...|..+ ++|
T Consensus       205 L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~-----aF~~-~~L~~i~lp-~~i~~I-~~~aF~~c-~~L  273 (401)
T 4fdw_A          205 IEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQE-----AFRE-SGITTVKLP-NGVTNI-ASRAFYYC-PEL  273 (401)
T ss_dssp             CSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTT-----TTTT-CCCSEEEEE-TTCCEE-CTTTTTTC-TTC
T ss_pred             cCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccc-----cccc-CCccEEEeC-CCccEE-ChhHhhCC-CCC
Confidence            99999985 488899999999999999999986 6666554     5777 789999995 456544 44477777 789


Q ss_pred             cEEEccccccc-----cccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEE
Q 036342          165 EEFYMYNCNIS-----GGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRL  239 (596)
Q Consensus       165 ~~L~l~~n~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  239 (596)
                      +.+++.+|.+.     .+.+.+|.++++|+.+++. +.++.+...+|.++++|+.+++..| ++..-+..|.++ +|+.+
T Consensus       274 ~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l  350 (401)
T 4fdw_A          274 AEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEV  350 (401)
T ss_dssp             CEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEE
T ss_pred             CEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEE
Confidence            99999998876     5778999999999999999 4588788899999999999999765 765677789999 99999


Q ss_pred             EccCCcCcccchhhhccCC-CCcEEEeCCCcccCC
Q 036342          240 ELGSNKLYGSIPACFGNLA-SLRILSLGSNKLTSI  273 (596)
Q Consensus       240 ~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~i  273 (596)
                      ++++|.+....+..|.+++ +++.|.+..+.+...
T Consensus       351 ~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~y  385 (401)
T 4fdw_A          351 KVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEKY  385 (401)
T ss_dssp             EECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHHH
T ss_pred             EEcCCCCcccccccccCCCCCccEEEeCHHHHHHh
Confidence            9999999877888888885 788888888776553

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.71  E-value=2.3e-17  Score=150.30  Aligned_cols=130  Identities=25%  Similarity=0.259  Sum_probs=71.8

Q ss_pred             cccEEEccccccc-cccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEc
Q 036342          163 SLEEFYMYNCNIS-GGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLEL  241 (596)
Q Consensus       163 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (596)
                      +|++|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|++++|.+++.+|..+..+++|++|++
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            4555555555554 34444455555555555555555543  44555555555666655555445555555556666666


Q ss_pred             cCCcCcccch-hhhccCCCCcEEEeCCCcccCCCc----ccccccccceEEcccCCCC
Q 036342          242 GSNKLYGSIP-ACFGNLASLRILSLGSNKLTSIPL----TFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       242 s~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ip~----~~~~l~~L~~L~ls~N~l~  294 (596)
                      ++|++++..+ ..+..+++|++|++++|.++.+|.    .+..+++|++|++++|.+.
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            6665554321 455555666666666666665554    4555566666666666554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.71  E-value=6.3e-18  Score=167.45  Aligned_cols=122  Identities=16%  Similarity=0.198  Sum_probs=99.1

Q ss_pred             HHHHhcccccccccccCCCceeehhhH--------------------------------------HhHHHHHHHHhhcCC
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAF--------------------------------------KSFDVECEMMKSIRH  480 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------------------------~~~~~e~~~l~~l~H  480 (596)
                      .+......|+..+.||+|+||.||+|.                                      ..+.+|+.++++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            444445567778999999999999752                                      12678999999999 


Q ss_pred             CccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC
Q 036342          481 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD  560 (596)
Q Consensus       481 ~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~  560 (596)
                       | +++.+++.. +..|+||||+++|+|.+ +..       .....++.|++.|+.|+|   ..+|+||||||+|||++ 
T Consensus       163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred             -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence             4 666665543 45699999999999988 422       123469999999999999   89999999999999999 


Q ss_pred             CCcEEEeccccccccC
Q 036342          561 NMVAHLSDFSIAKLLT  576 (596)
Q Consensus       561 ~~~~kl~dfGla~~~~  576 (596)
                      ++.+||+|||+|+...
T Consensus       228 ~~~vkl~DFG~a~~~~  243 (282)
T 1zar_A          228 EEGIWIIDFPQSVEVG  243 (282)
T ss_dssp             TTEEEECCCTTCEETT
T ss_pred             CCcEEEEECCCCeECC
Confidence            9999999999998653

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.70  E-value=3.8e-17  Score=145.66  Aligned_cols=111  Identities=23%  Similarity=0.266  Sum_probs=56.5

Q ss_pred             ccccEEEccccccc-cccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEE
Q 036342          162 RSLEEFYMYNCNIS-GGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE  240 (596)
Q Consensus       162 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (596)
                      ++++.|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            44555555555555 44555555555555555555555543  4445555555555555555544444444455555555


Q ss_pred             ccCCcCccc-chhhhccCCCCcEEEeCCCcccCCC
Q 036342          241 LGSNKLYGS-IPACFGNLASLRILSLGSNKLTSIP  274 (596)
Q Consensus       241 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~ip  274 (596)
                      +++|++++. .+..+..+++|++|++++|.++++|
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~  129 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN  129 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGST
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchH
Confidence            555555432 1244444444444444444444443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.69  E-value=6.1e-17  Score=144.29  Aligned_cols=128  Identities=20%  Similarity=0.204  Sum_probs=102.7

Q ss_pred             CCCCCEEEccCCccc-CCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEE
Q 036342          185 LTNLVEIDLGGNKLN-GSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRIL  263 (596)
Q Consensus       185 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  263 (596)
                      .++|+.|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|++++|.+++.+|..+..+++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            367888888888887 66777778888888888888888854  677788888888888888887678777778888888


Q ss_pred             EeCCCcccCCC--cccccccccceEEcccCCCCCchh---hhhccccccceEecCC
Q 036342          264 SLGSNKLTSIP--LTFWNLKDILQLNFSSNFLTGPLL---LEIGNLKVLIGIDFSM  314 (596)
Q Consensus       264 ~Ls~N~l~~ip--~~~~~l~~L~~L~ls~N~l~~~~~---~~~~~l~~L~~L~ls~  314 (596)
                      ++++|.++++|  ..+..+++|++|++++|++++..+   ..+..+++|+.||+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            88888888865  677788888888888888887665   5677888888888763

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=4e-16  Score=145.45  Aligned_cols=128  Identities=21%  Similarity=0.271  Sum_probs=95.3

Q ss_pred             CEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccC
Q 036342           13 EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGM   92 (596)
Q Consensus        13 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~   92 (596)
                      +++++++|+|+ .+|..+  .++|++|+|++|+++ .++. .+..+++|++|+|++|+|++..+.+|.++++|++|+|++
T Consensus        13 ~~l~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~-~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~   87 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPK-ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY   87 (193)
T ss_dssp             TEEECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCG-GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHH-HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence            57788888876 455544  357888888888886 4442 344577888888888888877777788888888888888


Q ss_pred             CcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCc
Q 036342           93 NSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDG  150 (596)
Q Consensus        93 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~  150 (596)
                      |+|+++.+.+|.++++|++|+|++|.++.+++.     .|..+++|+.|+|++|++..
T Consensus        88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEG-----AFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTT-----TTTTCTTCCEEECCSSCEEC
T ss_pred             CccCEeCHHHhCCCCCCCEEECCCCCCCeeChh-----hhhcCccccEEEeCCCCeec
Confidence            888887777888888888888888888776554     46777788888888877753

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.66  E-value=6.6e-16  Score=143.94  Aligned_cols=107  Identities=27%  Similarity=0.384  Sum_probs=53.2

Q ss_pred             cccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEcc
Q 036342          163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG  242 (596)
Q Consensus       163 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  242 (596)
                      ++++|++++|.|+ .+|..|.++++|++|+|++|.|++..+.+|.++++|++|+|++|.|++..|..|..+++|++|+|+
T Consensus        32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~  110 (193)
T 2wfh_A           32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH  110 (193)
T ss_dssp             TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence            4445555555544 233455555555555555555555544555555555555555555554444444445555555555


Q ss_pred             CCcCcccchhhhccCCCCcEEEeCCCcc
Q 036342          243 SNKLYGSIPACFGNLASLRILSLGSNKL  270 (596)
Q Consensus       243 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  270 (596)
                      +|+++...+..|..+++|+.|+|++|.+
T Consensus       111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~  138 (193)
T 2wfh_A          111 GNDISVVPEGAFNDLSALSHLAIGANPL  138 (193)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred             CCCCCeeChhhhhcCccccEEEeCCCCe
Confidence            5555444444444444444444444444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.64  E-value=1.3e-15  Score=139.87  Aligned_cols=110  Identities=26%  Similarity=0.325  Sum_probs=59.7

Q ss_pred             CCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEe
Q 036342          186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSL  265 (596)
Q Consensus       186 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  265 (596)
                      ++|++|++++|.+++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|++++..+..|..+++|++|+|
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            45555555555555555555555555555555555555444444455555555555555555555555555555666655


Q ss_pred             CCCcccCCCcc-cccccccceEEcccCCCCC
Q 036342          266 GSNKLTSIPLT-FWNLKDILQLNFSSNFLTG  295 (596)
Q Consensus       266 s~N~l~~ip~~-~~~l~~L~~L~ls~N~l~~  295 (596)
                      ++|.++.+|.. +..+++|++|++++|++++
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  138 (177)
T 2o6r_A          108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  138 (177)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence            55555555443 2334555555555555443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.64  E-value=1.7e-15  Score=139.09  Aligned_cols=132  Identities=23%  Similarity=0.240  Sum_probs=99.1

Q ss_pred             CCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       138 L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                      .+.+++++|.++.+ |.    .++++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|++
T Consensus         9 ~~~l~~~~~~l~~~-p~----~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l   83 (177)
T 2o6r_A            9 GTEIRCNSKGLTSV-PT----GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYL   83 (177)
T ss_dssp             TTEEECCSSCCSSC-CT----TCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCEEEecCCCCccC-CC----CCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEEC
Confidence            34566666666543 21    12256777777777777766677788888888888888888777777788888888888


Q ss_pred             cCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCC
Q 036342          218 EDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP  274 (596)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip  274 (596)
                      ++|.|++..+..+..+++|++|++++|++++..+..|..+++|++|+|++|.+...+
T Consensus        84 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           84 HENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             CCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            888888666666778888888888888888776667788888888888888887643

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.64  E-value=2.7e-16  Score=144.36  Aligned_cols=110  Identities=23%  Similarity=0.192  Sum_probs=58.2

Q ss_pred             ccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCc
Q 036342          182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLR  261 (596)
Q Consensus       182 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  261 (596)
                      +.++.+|+.|++++|.++.. |......++|++|++++|.|++.  ..+..+++|++|++++|.+++..+..|..+++|+
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             cCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            44555666666666666532 33222223566666666666543  3455555666666666665544444445555666


Q ss_pred             EEEeCCCcccCCCc--ccccccccceEEcccCCCC
Q 036342          262 ILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       262 ~L~Ls~N~l~~ip~--~~~~l~~L~~L~ls~N~l~  294 (596)
                      +|+|++|.++.+|.  .+..+++|+.|++++|+++
T Consensus        92 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           92 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             EEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC
Confidence            66666665555554  3444444444444444444

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.63  E-value=5.8e-18  Score=158.77  Aligned_cols=133  Identities=23%  Similarity=0.225  Sum_probs=63.4

Q ss_pred             cccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccc
Q 036342          205 TLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDIL  284 (596)
Q Consensus       205 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~  284 (596)
                      .+..+++|++|++++|.+++ +| .+..+++|++|++++|+++ .+|..+..+++|+.|+|++|.++++| .+..+++|+
T Consensus        43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~  118 (198)
T 1ds9_A           43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLS-GIEKLVNLR  118 (198)
T ss_dssp             HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCHH-HHHHHHHSS
T ss_pred             HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcCC-ccccCCCCC
Confidence            44444444444444444442 33 4444444444444444444 33344444444555555555554444 344445555


Q ss_pred             eEEcccCCCCCchh-hhhccccccceEecCCCcCcccCCh---------hhhccCCCCCeEECCCCccc
Q 036342          285 QLNFSSNFLTGPLL-LEIGNLKVLIGIDFSMNNFSGVIPR---------EIGEKLSYLEDLNLSFNKLK  343 (596)
Q Consensus       285 ~L~ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~~~~~~~~---------~~~~~l~~L~~L~l~~N~l~  343 (596)
                      +|++++|++++... ..+..+++|+.|++++|.+++.+|.         ..+..+++|+.||  +|+++
T Consensus       119 ~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             EEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            55555555544322 3445555555555555555443222         1344566666665  44443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.61  E-value=1.6e-17  Score=155.72  Aligned_cols=150  Identities=21%  Similarity=0.243  Sum_probs=122.0

Q ss_pred             cccEEEccccccccccCh------hccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCC
Q 036342          163 SLEEFYMYNCNISGGIPE------EISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAEL  236 (596)
Q Consensus       163 ~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  236 (596)
                      .++.++++.+.+++..|.      .|..+++|++|++++|.+++ +| .+..+++|++|++++|.++ .+|..+..+++|
T Consensus        19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L   95 (198)
T 1ds9_A           19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL   95 (198)
T ss_dssp             CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred             cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence            455555555555555554      88889999999999999986 55 8888999999999999998 678778888899


Q ss_pred             cEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCc--ccccccccceEEcccCCCCCchhh----------hhccc
Q 036342          237 YRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLTGPLLL----------EIGNL  304 (596)
Q Consensus       237 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~--~~~~l~~L~~L~ls~N~l~~~~~~----------~~~~l  304 (596)
                      ++|++++|++++ +| .+..+++|++|+|++|.++.++.  .+..+++|++|++++|++++..|.          .+..+
T Consensus        96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l  173 (198)
T 1ds9_A           96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL  173 (198)
T ss_dssp             SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred             CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence            999999999985 45 58888999999999999998765  678899999999999999876554          37888


Q ss_pred             cccceEecCCCcCcc
Q 036342          305 KVLIGIDFSMNNFSG  319 (596)
Q Consensus       305 ~~L~~L~ls~N~~~~  319 (596)
                      ++|+.||  +|.++.
T Consensus       174 ~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          174 PNLKKLD--GMPVDV  186 (198)
T ss_dssp             SSCSEEC--CGGGTT
T ss_pred             CCcEEEC--CcccCH
Confidence            9999887  676653

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.61  E-value=1.6e-15  Score=139.17  Aligned_cols=132  Identities=19%  Similarity=0.184  Sum_probs=66.5

Q ss_pred             CCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCC
Q 036342          132 LSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRK  211 (596)
Q Consensus       132 ~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  211 (596)
                      +.++++|+.|++++|.++.+ +  .+..+.++|++|++++|.|++.  ..                        |..+++
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i-~--~~~~~~~~L~~L~Ls~N~l~~~--~~------------------------l~~l~~   65 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVI-E--NLGATLDQFDAIDFSDNEIRKL--DG------------------------FPLLRR   65 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSC-C--CGGGGTTCCSEEECCSSCCCEE--CC------------------------CCCCSS
T ss_pred             cCCcCCceEEEeeCCCCchh-H--HhhhcCCCCCEEECCCCCCCcc--cc------------------------cccCCC
Confidence            45566666667666666643 2  1223322455555555555443  33                        444455


Q ss_pred             CCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchh--hhccCCCCcEEEeCCCcccCCCcc----cccccccce
Q 036342          212 LQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPA--CFGNLASLRILSLGSNKLTSIPLT----FWNLKDILQ  285 (596)
Q Consensus       212 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~ip~~----~~~l~~L~~  285 (596)
                      |++|++++|.|++..+..+..+++|++|++++|+++ .+|.  .+..+++|+.|++++|.++.+|..    +..+++|+.
T Consensus        66 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~  144 (176)
T 1a9n_A           66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRV  144 (176)
T ss_dssp             CCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSE
T ss_pred             CCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccce
Confidence            555555555554332233345555555555555553 2332  455555566666666665555543    444555555


Q ss_pred             EEcccCCC
Q 036342          286 LNFSSNFL  293 (596)
Q Consensus       286 L~ls~N~l  293 (596)
                      |++++|.+
T Consensus       145 Ld~~~n~~  152 (176)
T 1a9n_A          145 LDFQKVKL  152 (176)
T ss_dssp             ETTEECCH
T ss_pred             eCCCcCCH
Confidence            55555544

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.61  E-value=3.3e-14  Score=148.00  Aligned_cols=309  Identities=14%  Similarity=0.092  Sum_probs=173.9

Q ss_pred             cCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCC
Q 036342            6 IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKL   85 (596)
Q Consensus         6 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L   85 (596)
                      |.++++|+.+.+. +.++.+...+|.++++|+.+++..+ ++ .+...+|....+|+.+.+..+ +......+|.+...+
T Consensus        67 F~~c~~L~~i~lp-~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~  142 (394)
T 4fs7_A           67 FQGCRKVTEIKIP-STVREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFK  142 (394)
T ss_dssp             TTTCTTEEEEECC-TTCCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCS
T ss_pred             hhCCCCceEEEeC-CCccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecceeeeccccc
Confidence            5566666666664 3355555666666666666666544 43 455555555666666655543 333444455554433


Q ss_pred             CEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhccccccc
Q 036342           86 SKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLE  165 (596)
Q Consensus        86 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~  165 (596)
                      +.....  .+..+...+|.++.+|+.+.+..+ +..+...     +|.++.+|+.+++..| ++.+ +...+.+. ..|+
T Consensus       143 ~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~-----~F~~c~~L~~i~l~~~-~~~I-~~~~F~~~-~~L~  211 (394)
T 4fs7_A          143 EITIPE--GVTVIGDEAFATCESLEYVSLPDS-METLHNG-----LFSGCGKLKSIKLPRN-LKII-RDYCFAEC-ILLE  211 (394)
T ss_dssp             EEECCT--TCCEECTTTTTTCTTCCEEECCTT-CCEECTT-----TTTTCTTCCBCCCCTT-CCEE-CTTTTTTC-TTCC
T ss_pred             ccccCc--cccccchhhhcccCCCcEEecCCc-cceeccc-----cccCCCCceEEEcCCC-ceEe-Cchhhccc-cccc
Confidence            322222  222344556666666666666544 2223222     4666666666666554 3222 22244444 4555


Q ss_pred             EEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCc
Q 036342          166 EFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNK  245 (596)
Q Consensus       166 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  245 (596)
                      .+.+.++...  +...+....+|+.+.+..+ +..+...+|.++..|+.+.+..+... .....|..+..++.+....+.
T Consensus       212 ~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~  287 (394)
T 4fs7_A          212 NMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI  287 (394)
T ss_dssp             BCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE
T ss_pred             eeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCcee
Confidence            5555544332  1222333456666666543 23344556666777777777666544 455566666677776666543


Q ss_pred             CcccchhhhccCCCCcEEEeCCCcccCCCc-ccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChh
Q 036342          246 LYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPRE  324 (596)
Q Consensus       246 l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~  324 (596)
                      +   ....|..+.+|+.+.+..+ ++.|+. +|.++.+|+.+++..+ ++......|.++++|+.+++..| +. .++..
T Consensus       288 i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~  360 (394)
T 4fs7_A          288 V---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGAN  360 (394)
T ss_dssp             E---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTT
T ss_pred             e---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHH
Confidence            2   2345666777777777544 555544 4566777777777543 66566667777777777777655 44 45555


Q ss_pred             hhccCCCCCeEECCCC
Q 036342          325 IGEKLSYLEDLNLSFN  340 (596)
Q Consensus       325 ~~~~l~~L~~L~l~~N  340 (596)
                      +|..+++|+++++..+
T Consensus       361 aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          361 AFQGCINLKKVELPKR  376 (394)
T ss_dssp             TBTTCTTCCEEEEEGG
T ss_pred             HhhCCCCCCEEEECCC
Confidence            6777777777776543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.54  E-value=1.1e-15  Score=149.40  Aligned_cols=119  Identities=19%  Similarity=0.167  Sum_probs=92.3

Q ss_pred             cccccccccCCCceeehhhH------------H-----------------------------------hHHHHHHHHhhc
Q 036342          446 EFSENNLIGRGGFALFIRAF------------K-----------------------------------SFDVECEMMKSI  478 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~------------~-----------------------------------~~~~e~~~l~~l  478 (596)
                      -|+..+.||+|+||.||+|.            +                                   .+.+|+.+++++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            36778999999999999752            1                                   356799999999


Q ss_pred             CCCcc--ceeeeeeccCCeeEEEEecCCC-C----CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCC
Q 036342          479 RHRNL--IKVISSCSNEEFKALVLEYMPH-G----SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDL  551 (596)
Q Consensus       479 ~H~ni--v~l~~~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdl  551 (596)
                      +|+++  +..+++    +..++||||+.+ |    +|.+....    .++..+..++.|++.|+.|||.  ..+|+|||+
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            88864  444443    346899999942 4    67665432    1234567799999999999993  358999999


Q ss_pred             CCCCeeeCCCCcEEEeccccccccC
Q 036342          552 KPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       552 k~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      ||+|||+++  .++|+|||+|....
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEETT
T ss_pred             CHHHEEEcC--cEEEEECcccccCC
Confidence            999999998  99999999998754

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.53  E-value=3.8e-13  Score=139.98  Aligned_cols=317  Identities=12%  Similarity=0.064  Sum_probs=224.7

Q ss_pred             CccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCc
Q 036342           22 LIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPS  101 (596)
Q Consensus        22 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~  101 (596)
                      ++.+...+|.++.+|+.+.+..+ ++ .+...+|..+.+|+.++|..+ ++.+...+|.+..+|+.+.+..+ +..+...
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-cc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence            45566677888888888888644 65 677777777888888888765 66566777888888888777644 5556777


Q ss_pred             cccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChh
Q 036342          102 TFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE  181 (596)
Q Consensus       102 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~  181 (596)
                      +|.+...++.......  ..+..     .+|.++++|+.+.+.++. .. ++...|.+. .+|+.+.+..+ ++.+...+
T Consensus       135 aF~~~~~~~~~~~~~~--~~i~~-----~aF~~c~~L~~i~l~~~~-~~-I~~~~F~~c-~~L~~i~l~~~-~~~I~~~~  203 (394)
T 4fs7_A          135 AFKGCDFKEITIPEGV--TVIGD-----EAFATCESLEYVSLPDSM-ET-LHNGLFSGC-GKLKSIKLPRN-LKIIRDYC  203 (394)
T ss_dssp             TTTTCCCSEEECCTTC--CEECT-----TTTTTCTTCCEEECCTTC-CE-ECTTTTTTC-TTCCBCCCCTT-CCEECTTT
T ss_pred             eeecccccccccCccc--cccch-----hhhcccCCCcEEecCCcc-ce-eccccccCC-CCceEEEcCCC-ceEeCchh
Confidence            7877765444433332  22222     268899999999997664 22 344466666 67888888776 66677788


Q ss_pred             ccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCc
Q 036342          182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLR  261 (596)
Q Consensus       182 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  261 (596)
                      |.++..|+.+.+..+... + ...+....+|+.+.+..+. +..-...|..+..|+.+.+..+... .....|..+..++
T Consensus       204 F~~~~~L~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~  279 (394)
T 4fs7_A          204 FAECILLENMEFPNSLYY-L-GDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLK  279 (394)
T ss_dssp             TTTCTTCCBCCCCTTCCE-E-CTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCC
T ss_pred             hccccccceeecCCCceE-e-ehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccc
Confidence            888899988888776543 2 2334455788888887543 3345567788889999999887654 6677888899999


Q ss_pred             EEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCc
Q 036342          262 ILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNK  341 (596)
Q Consensus       262 ~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~  341 (596)
                      .+....+.+.  ...|..+.+|+.+.+..+ ++......|.++.+|+.+++.++ ++ .|+..+|..+.+|+.+++..| 
T Consensus       280 ~~~~~~~~i~--~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-  353 (394)
T 4fs7_A          280 KVIYGSVIVP--EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-  353 (394)
T ss_dssp             EEEECSSEEC--TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-
T ss_pred             eeccCceeec--cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-
Confidence            9888776532  235678899999999765 77677788999999999999754 65 577778889999999999876 


Q ss_pred             ccccCCCC-CCCCCCCccccccc
Q 036342          342 LKGEIPRG-GSFGNFSAESFEGN  363 (596)
Q Consensus       342 l~~~~p~~-~~~~~l~~l~~~~N  363 (596)
                      ++...... ..+.+|+.+.+..+
T Consensus       354 l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          354 LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             ccEehHHHhhCCCCCCEEEECCC
Confidence            54322222 23566777766543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.51  E-value=4.7e-14  Score=128.49  Aligned_cols=106  Identities=25%  Similarity=0.257  Sum_probs=55.8

Q ss_pred             ccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccC
Q 036342          164 LEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGS  243 (596)
Q Consensus       164 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  243 (596)
                      .+.+++++|+++. +|..+  .++|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            3444455554443 23222  14555555555555555555555555555555555555544444445555555555555


Q ss_pred             CcCcccchhhhccCCCCcEEEeCCCcccC
Q 036342          244 NKLYGSIPACFGNLASLRILSLGSNKLTS  272 (596)
Q Consensus       244 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  272 (596)
                      |+|++..+..|..+++|++|+|++|.++.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            55555444455555555555555555544

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.51  E-value=7.5e-14  Score=127.12  Aligned_cols=107  Identities=29%  Similarity=0.359  Sum_probs=77.1

Q ss_pred             CCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecC
Q 036342           36 LKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD  115 (596)
Q Consensus        36 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~  115 (596)
                      .++|++++|.++. +|...   .++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.++.|.++++|++|+|+
T Consensus        11 ~~~l~~s~n~l~~-ip~~~---~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGI---PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcCc-cCccC---CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            4567777777763 44321   3577777777777777767777777788888888888877777777777888888888


Q ss_pred             CCcCcCCCCCccccccCCCCCCCCEEECcCCCCCcc
Q 036342          116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGI  151 (596)
Q Consensus       116 ~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~  151 (596)
                      +|+|+++++.     .|.++++|+.|+|++|+++..
T Consensus        87 ~N~l~~~~~~-----~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           87 DNQLKSIPRG-----AFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SSCCCCCCTT-----TTTTCTTCCEEECCSSCBCTT
T ss_pred             CCccCEeCHH-----HhcCCCCCCEEEeCCCCCCCC
Confidence            8877776554     467777788888888877643

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.50  E-value=5.7e-14  Score=128.38  Aligned_cols=90  Identities=26%  Similarity=0.252  Sum_probs=52.4

Q ss_pred             CCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEe
Q 036342          186 TNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSL  265 (596)
Q Consensus       186 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  265 (596)
                      ++|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            45566666666666555555666666666666666665433334455666666666666665544445666666666666


Q ss_pred             CCCcccCCCc
Q 036342          266 GSNKLTSIPL  275 (596)
Q Consensus       266 s~N~l~~ip~  275 (596)
                      ++|.+...+.
T Consensus       113 ~~N~~~c~~~  122 (174)
T 2r9u_A          113 YNNPWDCECR  122 (174)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCcccccc
Confidence            6666655443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.48  E-value=1.8e-13  Score=125.06  Aligned_cols=105  Identities=30%  Similarity=0.370  Sum_probs=76.6

Q ss_pred             CEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCC
Q 036342           37 KFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE  116 (596)
Q Consensus        37 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~  116 (596)
                      +.+++++|+++ .+|...   .++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        15 ~~l~~~~n~l~-~iP~~~---~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGI---PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             cEEEeCCCCCC-ccCCCc---CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            56777777775 444421   25777788888877777777777788888888888888777777777788888888888


Q ss_pred             CcCcCCCCCccccccCCCCCCCCEEECcCCCCCc
Q 036342          117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDG  150 (596)
Q Consensus       117 N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~  150 (596)
                      |+|+.+++.     .|..+++|+.|+|++|++..
T Consensus        91 N~l~~l~~~-----~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           91 NHLKSIPRG-----AFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             SCCCCCCTT-----TTTTCTTCSEEECCSSCBCT
T ss_pred             CccceeCHH-----HhccccCCCEEEeCCCCccc
Confidence            887776543     36777778888888887764

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.44  E-value=8.8e-12  Score=129.59  Aligned_cols=298  Identities=13%  Similarity=0.144  Sum_probs=141.4

Q ss_pred             ccchhhhCCC-CCCEEEccCCcCccccCccCccCCCCccEEEccCCc---cccccCccccCCCCCCEEEccCCcccccCC
Q 036342           25 TVPAAIFNVS-TLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNN---FSGTIPRFIFNASKLSKLSLGMNSFSGFIP  100 (596)
Q Consensus        25 ~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  100 (596)
                      +...+|.+.. .|+.+.+-.+ ++ .+...+|..+.+|+.+.+..|.   ++.+...+|.+..+|+.+.+..+ ++.+..
T Consensus        54 Ig~~aF~~~~~~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~  130 (394)
T 4gt6_A           54 IGDRVFCNYKYVLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDS  130 (394)
T ss_dssp             ECTTTTTTCCSCCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECT
T ss_pred             cCHhhccCCCCcCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehh
Confidence            3344454442 3555555432 33 4444555555555555555442   44344445555555555554433 344445


Q ss_pred             ccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccCh
Q 036342          101 STFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPE  180 (596)
Q Consensus       101 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~  180 (596)
                      .+|.++.+|+.+.+..+ +..+...     +|.++.+|+.+.+..+ ++.+ ....|..  ..|+.+.+..+- +.+...
T Consensus       131 ~aF~~c~~L~~i~lp~~-~~~I~~~-----~F~~c~~L~~i~~~~~-~~~I-~~~aF~~--~~l~~i~ip~~~-~~i~~~  199 (394)
T 4gt6_A          131 EAFHHCEELDTVTIPEG-VTSVADG-----MFSYCYSLHTVTLPDS-VTAI-EERAFTG--TALTQIHIPAKV-TRIGTN  199 (394)
T ss_dssp             TTTTTCTTCCEEECCTT-CCEECTT-----TTTTCTTCCEEECCTT-CCEE-CTTTTTT--CCCSEEEECTTC-CEECTT
T ss_pred             hhhhhhcccccccccce-eeeeccc-----ceecccccccccccce-eeEe-ccccccc--cceeEEEECCcc-cccccc
Confidence            55555555555555432 2222222     3555555555555443 2222 1223322  245555554332 223445


Q ss_pred             hccCCCCCCEEEccCCcccCCCCccc-------------cCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCc
Q 036342          181 EISNLTNLVEIDLGGNKLNGSIPITL-------------GKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLY  247 (596)
Q Consensus       181 ~~~~l~~L~~L~Ls~N~l~~~~p~~~-------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  247 (596)
                      +|.+..+++......+.........+             .....+..+.+.+ .++..-...|.++.+|+.+.+..+...
T Consensus       200 af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~  278 (394)
T 4gt6_A          200 AFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS  278 (394)
T ss_dssp             TTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE
T ss_pred             hhhhccccceecccccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce
Confidence            55555555555544433221111111             1112223333322 222233345555566666666544332


Q ss_pred             ccchhhhccCCCCcEEEeCCCcccCCCc-ccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhh
Q 036342          248 GSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIG  326 (596)
Q Consensus       248 ~~~p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~  326 (596)
                       +...+|.++++|+.+.+. +.++.|+. .|.++.+|+.+.+..+ ++......|.++.+|+.+.+..+ ++ .|...+|
T Consensus       279 -I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF  353 (394)
T 4gt6_A          279 -IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAF  353 (394)
T ss_dssp             -ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGG
T ss_pred             -ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHh
Confidence             444556666666666664 34555544 3445666666666543 44455556666666666666433 43 4555566


Q ss_pred             ccCCCCCeEECCCCcc
Q 036342          327 EKLSYLEDLNLSFNKL  342 (596)
Q Consensus       327 ~~l~~L~~L~l~~N~l  342 (596)
                      ..+++|+.+++.+|..
T Consensus       354 ~~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          354 SNCTALNNIEYSGSRS  369 (394)
T ss_dssp             TTCTTCCEEEESSCHH
T ss_pred             hCCCCCCEEEECCcee
Confidence            6666666666666543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.43  E-value=2.6e-15  Score=154.50  Aligned_cols=116  Identities=20%  Similarity=0.209  Sum_probs=58.3

Q ss_pred             CCCCEEEccCCcCccccCc-cCc---cCCCCccEEEccCCccccccCcccc-CCCCCCEEEccCCcccccCCcccc----
Q 036342           34 STLKFLGLQNNSLSGSLSS-IAN---VRLPNLEKLYLWGNNFSGTIPRFIF-NASKLSKLSLGMNSFSGFIPSTFG----  104 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~~~~-~~~---~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~----  104 (596)
                      ++|+.|+|++|.++..... +..   ...++|++|+|++|.++......+. .+++|++|+|++|.|+......+.    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            4555666666655421110 110   0124566666666665432222222 244566666666666544333332    


Q ss_pred             -CCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCc
Q 036342          105 -NLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDG  150 (596)
Q Consensus       105 -~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~  150 (596)
                       ..++|++|+|++|.++..... .+...+..+++|++|+|++|.|++
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~-~l~~~L~~~~~L~~L~Ls~N~l~~  197 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVA-VLMEGLAGNTSVTHLSLLHTGLGD  197 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHH-HHHHHHHTCSSCCEEECTTSSCHH
T ss_pred             hcCCccceeeCCCCCCChHHHH-HHHHHHhcCCCcCEEeCCCCCCCc
Confidence             345677777777766542111 122234566677777777777653

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.42  E-value=2.7e-11  Score=125.96  Aligned_cols=315  Identities=13%  Similarity=0.143  Sum_probs=220.8

Q ss_pred             ccCCCC-CCCEEECCCCCCccccchhhhCCCCCCEEEccCCc---CccccCccCccCCCCccEEEccCCccccccCcccc
Q 036342            5 EIGNLQ-NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNS---LSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIF   80 (596)
Q Consensus         5 ~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (596)
                      +|.+.+ .|+.+.+.. .++.+...+|.++.+|+.+.++.|.   ++ .+...+|....+|+.+.+..+ ++.+...+|.
T Consensus        58 aF~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~  134 (394)
T 4gt6_A           58 VFCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQAFMFCSELTDIPILDS-VTEIDSEAFH  134 (394)
T ss_dssp             TTTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred             hccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeee-EechhhchhcccceeeccCCc-cceehhhhhh
Confidence            356664 599999964 5888888999999999999998874   54 577777877889999888766 5557778899


Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           81 NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        81 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      +..+|+.+.+..+ +..+...+|.++.+|+.+.+..+ ++.+...     +|.+ ..|+.+.+..+-.. + ....+...
T Consensus       135 ~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~-----aF~~-~~l~~i~ip~~~~~-i-~~~af~~c  204 (394)
T 4gt6_A          135 HCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEER-----AFTG-TALTQIHIPAKVTR-I-GTNAFSEC  204 (394)
T ss_dssp             TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTT-----TTTT-CCCSEEEECTTCCE-E-CTTTTTTC
T ss_pred             hhcccccccccce-eeeecccceecccccccccccce-eeEeccc-----cccc-cceeEEEECCcccc-c-ccchhhhc
Confidence            9999999999754 55678888999999999999765 5554433     4554 57888888765432 2 22244444


Q ss_pred             cccccEEEccccccccccChh-------------ccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCc
Q 036342          161 SRSLEEFYMYNCNISGGIPEE-------------ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP  227 (596)
Q Consensus       161 ~~~L~~L~l~~n~l~~~~~~~-------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  227 (596)
                       .++.......+.........             +.....+..+.+. +.+..+...+|.++.+|+.+.+.++..+ .-.
T Consensus       205 -~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~  281 (394)
T 4gt6_A          205 -FALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGT  281 (394)
T ss_dssp             -TTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECT
T ss_pred             -cccceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecC
Confidence             45666665554443221111             1122344455443 3344456778999999999999877654 666


Q ss_pred             cchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCc-ccccccccceEEcccCCCCCchhhhhccccc
Q 036342          228 DDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKV  306 (596)
Q Consensus       228 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~  306 (596)
                      ..|.++.+|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.|.. +|.++.+|+.+.+..+ ++......|.++++
T Consensus       282 ~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~  358 (394)
T 4gt6_A          282 GAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTA  358 (394)
T ss_dssp             TTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTT
T ss_pred             cccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCC
Confidence            788889999999996 5566677789999999999999764 777755 5778999999999654 77777889999999


Q ss_pred             cceEecCCCcCcccCChhhhccCCCCCeEECCCCcc
Q 036342          307 LIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKL  342 (596)
Q Consensus       307 L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l  342 (596)
                      |+.+++.+|....    ..+.....|+.+.+..|.+
T Consensus       359 L~~i~~~~~~~~~----~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          359 LNNIEYSGSRSQW----NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CCEEEESSCHHHH----HTCBCCCCC----------
T ss_pred             CCEEEECCceeeh----hhhhccCCCCEEEeCCCCE
Confidence            9999999886541    2345667788888776654

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.41  E-value=2.7e-14  Score=146.94  Aligned_cols=15  Identities=20%  Similarity=0.162  Sum_probs=7.3

Q ss_pred             ccccceEecCCCcCc
Q 036342          304 LKVLIGIDFSMNNFS  318 (596)
Q Consensus       304 l~~L~~L~ls~N~~~  318 (596)
                      .+.|++|||++|.|+
T Consensus       238 ~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          238 HPSLELLHLYFNELS  252 (372)
T ss_dssp             CSSCCEEECTTSSCC
T ss_pred             CCCCCEEeccCCCCC
Confidence            344555555555544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.39  E-value=4.4e-14  Score=143.71  Aligned_cols=119  Identities=13%  Similarity=0.103  Sum_probs=85.7

Q ss_pred             ccccccccCCCceeehhhH---------H-------------------------hHHHHHHHHhhcCCCccceeeeeecc
Q 036342          447 FSENNLIGRGGFALFIRAF---------K-------------------------SFDVECEMMKSIRHRNLIKVISSCSN  492 (596)
Q Consensus       447 ~~~~~~ig~G~~g~v~~~~---------~-------------------------~~~~e~~~l~~l~H~niv~l~~~~~~  492 (596)
                      |++.+.||+|+||.||+|.         |                         ....++.+.....|+|+++++.....
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            8899999999999999852         0                         11223333334455666555443322


Q ss_pred             CC------eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC----
Q 036342          493 EE------FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM----  562 (596)
Q Consensus       493 ~~------~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~----  562 (596)
                      -.      ..++||||++|+++.+....       .....+..|++.++.|||   ..+|||||+||.|||+++++    
T Consensus       177 vp~p~~~~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          177 VPEPIAQSRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             CCCEEEEETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCeeeeccCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCccc
Confidence            11      23699999999888665321       123457899999999999   88999999999999998776    


Q ss_pred             ------cEEEecccccccc
Q 036342          563 ------VAHLSDFSIAKLL  575 (596)
Q Consensus       563 ------~~kl~dfGla~~~  575 (596)
                            .+.|+||+.+...
T Consensus       247 ~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TTSEEEEEEECCCTTCEET
T ss_pred             ccccccceEEEEeCCcccC
Confidence                  3899999987754

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.33  E-value=2.5e-12  Score=131.28  Aligned_cols=105  Identities=23%  Similarity=0.195  Sum_probs=81.3

Q ss_pred             CEEEccCC-cccCCCCccccCCCCCCeEEccC-CcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeC
Q 036342          189 VEIDLGGN-KLNGSIPITLGKLRKLQRLNLED-NILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLG  266 (596)
Q Consensus       189 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  266 (596)
                      ..++++++ .++. +|. +..+++|++|+|++ |.|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            34688887 7875 555 88888888888885 88887777778888888888888888888888888888888888888


Q ss_pred             CCcccCCCcccccccccceEEcccCCCCC
Q 036342          267 SNKLTSIPLTFWNLKDILQLNFSSNFLTG  295 (596)
Q Consensus       267 ~N~l~~ip~~~~~l~~L~~L~ls~N~l~~  295 (596)
                      +|+|+.+|...+....|+.|+|++|.+..
T Consensus        89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c  117 (347)
T 2ifg_A           89 FNALESLSWKTVQGLSLQELVLSGNPLHC  117 (347)
T ss_dssp             SSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred             CCccceeCHHHcccCCceEEEeeCCCccC
Confidence            88888877665443347777777777653

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.33  E-value=4.6e-12  Score=129.32  Aligned_cols=102  Identities=24%  Similarity=0.255  Sum_probs=55.2

Q ss_pred             EEccCC-cCccccCccCccCCCCccEEEccC-CccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCC
Q 036342           39 LGLQNN-SLSGSLSSIANVRLPNLEKLYLWG-NNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE  116 (596)
Q Consensus        39 L~Ls~N-~l~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~  116 (596)
                      ++++++ .|++ +|.  +..+++|++|+|++ |+|++..+..|.++++|++|+|++|+|+++.|++|.+|++|++|+|++
T Consensus        13 v~~~~~n~l~~-ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           13 LRCTRDGALDS-LHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             EECCSSCCCTT-TTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEcCCCCCCCc-cCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            455554 5542 333  22355555555553 555555555555566666666666666655555566666666666666


Q ss_pred             CcCcCCCCCccccccCCCCCCCCEEECcCCCCC
Q 036342          117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLD  149 (596)
Q Consensus       117 N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~  149 (596)
                      |+|+++++.     .|..++ |+.|+|.+|.+.
T Consensus        90 N~l~~~~~~-----~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           90 NALESLSWK-----TVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SCCSCCCST-----TTCSCC-CCEEECCSSCCC
T ss_pred             CccceeCHH-----HcccCC-ceEEEeeCCCcc
Confidence            666555443     233333 666666666654

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.19  E-value=1.7e-09  Score=111.71  Aligned_cols=300  Identities=9%  Similarity=0.057  Sum_probs=159.3

Q ss_pred             CCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCC
Q 036342            7 GNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLS   86 (596)
Q Consensus         7 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~   86 (596)
                      ....+|+.+.+. ..++.+...+|.++.+|+.++|..+ ++ .+...+|... +|+.+.+..+ ++.+...+|.+ .+|+
T Consensus        43 ~~~~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~-~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~  116 (379)
T 4h09_A           43 KDRDRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VT-SIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLD  116 (379)
T ss_dssp             GGGGGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCS
T ss_pred             ccccCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ce-EechhhhcCC-CCceEECCce-eeEeccceecc-CCcc
Confidence            344566666664 3456566666777777777777543 44 4556555543 5666666543 44344444444 4677


Q ss_pred             EEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccE
Q 036342           87 KLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE  166 (596)
Q Consensus        87 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~  166 (596)
                      .+.+..+ ++.+...+|.+. +|+.+.+..+ ++.+...     .|.++..++...+..+..........          
T Consensus       117 ~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~-----~f~~~~~l~~~~~~~~~~~~~~~~~~----------  178 (379)
T 4h09_A          117 DFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDG-----IGYKAENLEKIEVSSNNKNYVAENYV----------  178 (379)
T ss_dssp             EEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSC-----TTTTCTTCCEEEECTTCSSEEEETTE----------
T ss_pred             cccCCCc-cccccccccccc-eeeeeeccce-eeccccc-----hhcccccccccccccccceeecccce----------
Confidence            7776644 333445555543 4555544432 2222222     46666677766665544321110000          


Q ss_pred             EEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcC
Q 036342          167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKL  246 (596)
Q Consensus       167 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  246 (596)
                       ....+   ......+.....+..+.+..+.- ......+....+|+.+.+..+ +.......|.++..|+.+.+..+ +
T Consensus       179 -~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v  251 (379)
T 4h09_A          179 -LYNKN---KTILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-V  251 (379)
T ss_dssp             -EEETT---SSEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-C
T ss_pred             -ecccc---cceecccccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-c
Confidence             00000   01112233344445544433322 234445555666666666544 23244445566666666666554 4


Q ss_pred             cccchhhhccCCCCcEEEeCCCcccCCCc-ccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhh
Q 036342          247 YGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREI  325 (596)
Q Consensus       247 ~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~  325 (596)
                      +.+...+|.++.+|+.+.+..+ ++.++. .|..+.+|+.+.+.++.++......|.++.+|+.+++..+ ++ .|...+
T Consensus       252 ~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~a  328 (379)
T 4h09_A          252 TSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYA  328 (379)
T ss_dssp             CEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTT
T ss_pred             cEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHH
Confidence            4445556666666666666433 444443 3556666777776666666666666777777777777544 44 455556


Q ss_pred             hccCCCCCeEECCCC
Q 036342          326 GEKLSYLEDLNLSFN  340 (596)
Q Consensus       326 ~~~l~~L~~L~l~~N  340 (596)
                      |..+.+|+++.+..+
T Consensus       329 F~~C~~L~~i~ip~~  343 (379)
T 4h09_A          329 FKNCKALSTISYPKS  343 (379)
T ss_dssp             TTTCTTCCCCCCCTT
T ss_pred             hhCCCCCCEEEECCc
Confidence            667777777766443

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.15  E-value=4e-09  Score=108.85  Aligned_cols=284  Identities=12%  Similarity=0.104  Sum_probs=163.5

Q ss_pred             ccCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCC
Q 036342            5 EIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASK   84 (596)
Q Consensus         5 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~   84 (596)
                      +|.++.+|+.++|.. .++.+...+|.+. +|+.+.+..+ ++ .+...+|.. .+|+.+++..+ ++.....+|.+ .+
T Consensus        64 aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~-~~L~~i~lp~~-~~~i~~~~F~~-~~  136 (379)
T 4h09_A           64 NFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQG-TDLDDFEFPGA-TTEIGNYIFYN-SS  136 (379)
T ss_dssp             TTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTT-CCCSEEECCTT-CCEECTTTTTT-CC
T ss_pred             HhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-ee-Eeccceecc-CCcccccCCCc-ccccccccccc-ce
Confidence            588999999999964 5887888899886 7888888755 54 577767754 58999999876 44355555655 46


Q ss_pred             CCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCc-------cccccCCCCCCCCEEECcCCCCCccCCchhh
Q 036342           85 LSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL-------SFLSSLSNCKSLTLIDLSNNPLDGILPKTSI  157 (596)
Q Consensus        85 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-------~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~  157 (596)
                      |+.+.+.. .++.+...+|.+..+++.+.+..+.........       .....+.....+..+.+....          
T Consensus       137 l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  205 (379)
T 4h09_A          137 VKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTV----------  205 (379)
T ss_dssp             CCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTC----------
T ss_pred             eeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccce----------
Confidence            77777664 466677888999999999988765443211110       011123333333333332221          


Q ss_pred             hcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCc
Q 036342          158 SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELY  237 (596)
Q Consensus       158 ~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  237 (596)
                                       ......++....+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++..-...|.++.+|+
T Consensus       206 -----------------~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~  266 (379)
T 4h09_A          206 -----------------KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK  266 (379)
T ss_dssp             -----------------CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred             -----------------eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence                             1123344444455555555433 22234445555555555555544 3323344455555555


Q ss_pred             EEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCc-ccccccccceEEcccCCCCCchhhhhccccccceEecCCCc
Q 036342          238 RLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNN  316 (596)
Q Consensus       238 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~  316 (596)
                      .+.+..+ +......+|.++++|+.+.+.++.++.|+. .|.++.+|+.+.|..+ ++......|.++++|+.+.+..+ 
T Consensus       267 ~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-  343 (379)
T 4h09_A          267 TLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-  343 (379)
T ss_dssp             EEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-
T ss_pred             ccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-
Confidence            5555433 333444455566666666666555555543 3555566666666433 54455556666666666666543 


Q ss_pred             CcccCChhhhccC
Q 036342          317 FSGVIPREIGEKL  329 (596)
Q Consensus       317 ~~~~~~~~~~~~l  329 (596)
                      ++ .|...+|...
T Consensus       344 v~-~I~~~aF~~c  355 (379)
T 4h09_A          344 IT-LIESGAFEGS  355 (379)
T ss_dssp             CC-EECTTTTTTS
T ss_pred             cC-EEchhHhhCC
Confidence            43 3444455443

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.94  E-value=1.2e-09  Score=111.36  Aligned_cols=179  Identities=18%  Similarity=0.197  Sum_probs=90.2

Q ss_pred             CCCCEEECcCCCCCc-cCC------chhhhcccccccEEEccccccc---------cccChhccCCCCCCEEEccCCccc
Q 036342          136 KSLTLIDLSNNPLDG-ILP------KTSISNLSRSLEEFYMYNCNIS---------GGIPEEISNLTNLVEIDLGGNKLN  199 (596)
Q Consensus       136 ~~L~~L~ls~N~l~~-~~~------~~~~~~l~~~L~~L~l~~n~l~---------~~~~~~~~~l~~L~~L~Ls~N~l~  199 (596)
                      ..++.|.+..+...+ ...      ......+ ++|+.|.+.++...         +.+...+..+++|+.|+|++|.-.
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l-~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l  185 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKF-AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL  185 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHH-TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhc-chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence            356777777665442 100      0112334 46777777654321         123345566677777777766311


Q ss_pred             CCCCccccCCCCCCeEEccCCcccccCccchh--cCCCCcEEEccC--CcCccc-----chhhh--ccCCCCcEEEeCCC
Q 036342          200 GSIPITLGKLRKLQRLNLEDNILEGSIPDDIC--RLAELYRLELGS--NKLYGS-----IPACF--GNLASLRILSLGSN  268 (596)
Q Consensus       200 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~--~~l~~L~~L~Ls~N  268 (596)
                       ..+. + .+++|+.|++..+.+.......++  .+++|+.|+|+.  |...+.     +...+  ..+++|++|+|++|
T Consensus       186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~  262 (362)
T 2ra8_A          186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA  262 (362)
T ss_dssp             -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESC
T ss_pred             -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCC
Confidence             1122 3 266777777777666533333333  467777777653  221111     00112  13566666666666


Q ss_pred             cccC-CCccc---ccccccceEEcccCCCCCch----hhhhccccccceEecCCCcCc
Q 036342          269 KLTS-IPLTF---WNLKDILQLNFSSNFLTGPL----LLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       269 ~l~~-ip~~~---~~l~~L~~L~ls~N~l~~~~----~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      .+.. .+..+   ..+++|++|+|+.|.++...    +..+..++.|+.|++++|.++
T Consensus       263 ~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             TTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             CCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            6553 11111   13556666666666665432    222234556666666666554

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.92  E-value=7.2e-10  Score=112.98  Aligned_cols=82  Identities=20%  Similarity=0.240  Sum_probs=53.3

Q ss_pred             CCCCcEEEccCCcCcccchhhhc---cCCCCcEEEeCCCcccC-----CCcccccccccceEEcccCCCCCchhhhhcc-
Q 036342          233 LAELYRLELGSNKLYGSIPACFG---NLASLRILSLGSNKLTS-----IPLTFWNLKDILQLNFSSNFLTGPLLLEIGN-  303 (596)
Q Consensus       233 l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~-----ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-  303 (596)
                      +++|++|+|++|.+.+..+..+.   .+++|++|+|+.|.+..     ++..+..+++|+.|++++|.++......+.. 
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a  330 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS  330 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence            56777777777777644433333   46778888888887765     3444456788888888888887554444433 


Q ss_pred             ccccceEecCCCc
Q 036342          304 LKVLIGIDFSMNN  316 (596)
Q Consensus       304 l~~L~~L~ls~N~  316 (596)
                      +  ...+|++.|+
T Consensus       331 l--g~~~~~~~~~  341 (362)
T 2ra8_A          331 L--PMKIDVSDSQ  341 (362)
T ss_dssp             C--CSEEECCSBC
T ss_pred             c--CCEEEecCCc
Confidence            2  3456777766

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.86  E-value=3.3e-09  Score=103.41  Aligned_cols=126  Identities=14%  Similarity=0.073  Sum_probs=97.3

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEec
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ..+.|......+.|+.+.||+..                   ..+.+|+.+++.+. |..++++++++...+..|+||||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             HhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            34567777777777778887631                   24889999999885 67888999999888899999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcc-----------------------------------------
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----------------------------------------  541 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-----------------------------------------  541 (596)
                      ++|.++.+....      ..+...++.++++++..||..                                         
T Consensus        92 i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           92 ADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             cCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            999998776311      122346788999999999951                                         


Q ss_pred             ---------------CCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          542 ---------------YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       542 ---------------~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                                     ....++|+|+++.||+++++..+.|.||+.+..
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                           014589999999999998766677999997753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.61  E-value=2.6e-08  Score=96.74  Aligned_cols=100  Identities=16%  Similarity=0.144  Sum_probs=75.8

Q ss_pred             HhHHHHHHHHhhcCCCc--cceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccC-
Q 036342          466 KSFDVECEMMKSIRHRN--LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY-  542 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-  542 (596)
                      ..+..|+.+++.+.+.+  +++++++...++..++||||++|.++.  ...    .+   ...++.++++.+..+|... 
T Consensus        58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~  128 (264)
T 1nd4_A           58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDP  128 (264)
T ss_dssp             SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCG
T ss_pred             hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCC
Confidence            35678999999987654  566888888877889999999998883  211    12   2246777888888888421 


Q ss_pred             ------------------------------------------------------CCceEeCCCCCCCeeeCCCCcEEEec
Q 036342          543 ------------------------------------------------------SALVIHCDLKPSNVLLDDNMVAHLSD  568 (596)
Q Consensus       543 ------------------------------------------------------~~~i~Hrdlk~~NILl~~~~~~kl~d  568 (596)
                                                                            ...++|+|++|.||++++++.+.|.|
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD  208 (264)
T 1nd4_A          129 ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFID  208 (264)
T ss_dssp             GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECC
T ss_pred             CCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEc
Confidence                                                                  12399999999999998876778999


Q ss_pred             cccccc
Q 036342          569 FSIAKL  574 (596)
Q Consensus       569 fGla~~  574 (596)
                      ||.+..
T Consensus       209 ~~~a~~  214 (264)
T 1nd4_A          209 CGRLGV  214 (264)
T ss_dssp             CTTCEE
T ss_pred             chhccc
Confidence            998764

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.57  E-value=1.4e-08  Score=98.24  Aligned_cols=42  Identities=33%  Similarity=0.561  Sum_probs=21.7

Q ss_pred             cCCCCcEEEccCCcCcc--cchhhhccCCCCcEEEeCCCcccCC
Q 036342          232 RLAELYRLELGSNKLYG--SIPACFGNLASLRILSLGSNKLTSI  273 (596)
Q Consensus       232 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~i  273 (596)
                      ++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|+++
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~  211 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE  211 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence            34555555555555554  2234444555555555555555543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.56  E-value=1.2e-07  Score=96.83  Aligned_cols=106  Identities=14%  Similarity=0.220  Sum_probs=83.4

Q ss_pred             HhHHHHHHHHhhcC--CCccceeeeeeccC---CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 036342          466 KSFDVECEMMKSIR--HRNLIKVISSCSNE---EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  540 (596)
Q Consensus       466 ~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~  540 (596)
                      ..+.+|..+++.+.  +..++++++++.+.   +..|+||||++|..+.+..   ...++..++..++.++++++..||.
T Consensus        81 ~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A           81 HAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             -CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhC
Confidence            46778999999987  45688999998776   4589999999998774321   1235677888899999999999995


Q ss_pred             cC-------------------------------------------------------CCceEeCCCCCCCeeeCCCCc--
Q 036342          541 GY-------------------------------------------------------SALVIHCDLKPSNVLLDDNMV--  563 (596)
Q Consensus       541 ~~-------------------------------------------------------~~~i~Hrdlk~~NILl~~~~~--  563 (596)
                      ..                                                       ...++|+|+++.||+++.++.  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v  237 (359)
T 3dxp_A          158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRV  237 (359)
T ss_dssp             SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCE
T ss_pred             CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcE
Confidence            20                                                       257999999999999997653  


Q ss_pred             EEEeccccccc
Q 036342          564 AHLSDFSIAKL  574 (596)
Q Consensus       564 ~kl~dfGla~~  574 (596)
                      +.|.||+.+..
T Consensus       238 ~~viDwe~a~~  248 (359)
T 3dxp_A          238 LAVLDWELSTL  248 (359)
T ss_dssp             EEECCCTTCEE
T ss_pred             EEEECcccccc
Confidence            68999998774

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.55  E-value=1.5e-08  Score=93.08  Aligned_cols=122  Identities=15%  Similarity=0.125  Sum_probs=75.2

Q ss_pred             chhhhCCCCCCEEEccCC-cCccc-cCc--cCccCCCCccEEEccCCccccc----cCccccCCCCCCEEEccCCccccc
Q 036342           27 PAAIFNVSTLKFLGLQNN-SLSGS-LSS--IANVRLPNLEKLYLWGNNFSGT----IPRFIFNASKLSKLSLGMNSFSGF   98 (596)
Q Consensus        27 ~~~~~~l~~L~~L~Ls~N-~l~~~-~~~--~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~   98 (596)
                      ...+...++|++|+|++| .+... ...  ......++|++|+|++|.|...    +...+...++|++|+|++|.|+..
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            344556677777777777 66421 000  1112246777777777777532    233344556788888888888653


Q ss_pred             ----CCccccCCCCCCEEec--CCCcCcCCCCCccccccCCCCCCCCEEECcCCCCC
Q 036342           99 ----IPSTFGNLRNLEQLGL--DENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLD  149 (596)
Q Consensus        99 ----~~~~~~~l~~L~~L~l--~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~  149 (596)
                          +..++...++|++|+|  ++|.++..... .+...+...++|++|+|++|.+.
T Consensus       109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~-~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          109 GILALVEALQSNTSLIELRIDNQSQPLGNNVEM-EIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH-HHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH-HHHHHHHhCCCcCEEeccCCCCC
Confidence                3445666678888888  77877652111 12234566678899999988874

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.55  E-value=2.3e-08  Score=96.71  Aligned_cols=96  Identities=21%  Similarity=0.246  Sum_probs=66.4

Q ss_pred             EEccCCcCc---ccchhhhccCCCCcEEEeCCCcccCCC---cccccccccceEEcccCCCCCchhhhhcccc--ccceE
Q 036342          239 LELGSNKLY---GSIPACFGNLASLRILSLGSNKLTSIP---LTFWNLKDILQLNFSSNFLTGPLLLEIGNLK--VLIGI  310 (596)
Q Consensus       239 L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~ip---~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~--~L~~L  310 (596)
                      ++++.|...   +..+....++++|+.|+|++|+|++++   ..+..+++|+.|+|++|+|++.  ..+..++  .|+.|
T Consensus       148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L  225 (267)
T 3rw6_A          148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL  225 (267)
T ss_dssp             CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred             ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence            566666432   223333356889999999999998754   4556788888999999888875  2334444  78888


Q ss_pred             ecCCCcCcccCCh------hhhccCCCCCeEE
Q 036342          311 DFSMNNFSGVIPR------EIGEKLSYLEDLN  336 (596)
Q Consensus       311 ~ls~N~~~~~~~~------~~~~~l~~L~~L~  336 (596)
                      +|++|.+.+.+|.      ..+..+++|+.||
T Consensus       226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            8888888776652      2455677777776

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.55  E-value=3.6e-08  Score=90.55  Aligned_cols=45  Identities=11%  Similarity=0.096  Sum_probs=24.2

Q ss_pred             ChhccCCCCCCEEEccCC-cccCC----CCccccCCCCCCeEEccCCccc
Q 036342          179 PEEISNLTNLVEIDLGGN-KLNGS----IPITLGKLRKLQRLNLEDNILE  223 (596)
Q Consensus       179 ~~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~  223 (596)
                      ...+...++|++|+|++| .+...    +...+...++|++|+|++|.|.
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~   78 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   78 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence            345555666777777776 66532    1223334455555555555554

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.00  E-value=1.6e-05  Score=78.93  Aligned_cols=122  Identities=20%  Similarity=0.227  Sum_probs=85.2

Q ss_pred             cccccCCCceeehhh--------------HHhHHHHHHHHhhcC-CC--ccceeeeeeccCC---eeEEEEecCCCCCHH
Q 036342          450 NNLIGRGGFALFIRA--------------FKSFDVECEMMKSIR-HR--NLIKVISSCSNEE---FKALVLEYMPHGSLE  509 (596)
Q Consensus       450 ~~~ig~G~~g~v~~~--------------~~~~~~e~~~l~~l~-H~--niv~l~~~~~~~~---~~~lV~e~~~~g~L~  509 (596)
                      .+.++.|....||+.              ...+.+|..+++.+. +.  .+.+.+......+   ..|+||||++|.++.
T Consensus        25 i~~~~~G~~n~v~~v~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~  104 (304)
T 3sg8_A           25 IEISGEGNDCIAYEINRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLT  104 (304)
T ss_dssp             CCEEEECSSEEEEESTTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECC
T ss_pred             eEecCCCCcceEEEECCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECC
Confidence            345667777777652              356789999998874 32  2455665554433   358999999998876


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcc------------------------------------------------
Q 036342          510 KYLYSSNCILDIFQRLNIMIDVASALEYLHFG------------------------------------------------  541 (596)
Q Consensus       510 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~------------------------------------------------  541 (596)
                      +....   .++..++..++.++++.+..+|..                                                
T Consensus       105 ~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  181 (304)
T 3sg8_A          105 PLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDIL  181 (304)
T ss_dssp             HHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHH
T ss_pred             ccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHH
Confidence            53322   245666677777787777777731                                                


Q ss_pred             -------CCCceEeCCCCCCCeeeCC--CCcEEEeccccccc
Q 036342          542 -------YSALVIHCDLKPSNVLLDD--NMVAHLSDFSIAKL  574 (596)
Q Consensus       542 -------~~~~i~Hrdlk~~NILl~~--~~~~kl~dfGla~~  574 (596)
                             ....++|+|+++.||++++  ...+.+.||+.+..
T Consensus       182 ~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          182 ENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             TCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             hccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                   1245899999999999988  56688999998765

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.83  E-value=9.8e-06  Score=72.64  Aligned_cols=82  Identities=13%  Similarity=0.131  Sum_probs=35.2

Q ss_pred             CCCEEEccCCcccCCCCccccCCCCCCeEEccCCc-ccccCccchhcC----CCCcEEEccCCc-CcccchhhhccCCCC
Q 036342          187 NLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNI-LEGSIPDDICRL----AELYRLELGSNK-LYGSIPACFGNLASL  260 (596)
Q Consensus       187 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L  260 (596)
                      +|+.||++++.++...-..+.++++|+.|+|++|. |+..--..+..+    ++|+.|+|++|. ++...-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            44555555554443333334445555555555542 332111122221    235555555543 443333334444555


Q ss_pred             cEEEeCCC
Q 036342          261 RILSLGSN  268 (596)
Q Consensus       261 ~~L~Ls~N  268 (596)
                      ++|+|+++
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            55555443

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.79  E-value=6.4e-06  Score=73.83  Aligned_cols=83  Identities=11%  Similarity=0.085  Sum_probs=55.8

Q ss_pred             CCCCEEEccCCcCccc-cCccCccCCCCccEEEccCCc-cccccCccccCC----CCCCEEEccCC-cccccCCccccCC
Q 036342           34 STLKFLGLQNNSLSGS-LSSIANVRLPNLEKLYLWGNN-FSGTIPRFIFNA----SKLSKLSLGMN-SFSGFIPSTFGNL  106 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~-~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N-~i~~~~~~~~~~l  106 (596)
                      -+|++|||+++.++.. +..+  ..+++|+.|+|++|. |+..--..+..+    ++|++|+|++| +|+...-..+..+
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L--~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~  138 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHM--EGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHF  138 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGG--TTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGC
T ss_pred             ceEeEEeCcCCCccHHHHHHh--cCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcC
Confidence            4678888888877521 2222  347788888888874 554333345554    36888888887 4776655667788


Q ss_pred             CCCCEEecCCCc
Q 036342          107 RNLEQLGLDENY  118 (596)
Q Consensus       107 ~~L~~L~l~~N~  118 (596)
                      ++|++|+++++.
T Consensus       139 ~~L~~L~L~~c~  150 (176)
T 3e4g_A          139 RNLKYLFLSDLP  150 (176)
T ss_dssp             TTCCEEEEESCT
T ss_pred             CCCCEEECCCCC
Confidence            888888888874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.73  E-value=0.00011  Score=72.79  Aligned_cols=106  Identities=15%  Similarity=0.167  Sum_probs=70.2

Q ss_pred             HhHHHHHHHHhhcCCC---ccceeeeeec-cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-
Q 036342          466 KSFDVECEMMKSIRHR---NLIKVISSCS-NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF-  540 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~-  540 (596)
                      ..+.+|..+++.+.+.   .+.+.+.++. ..+..|+||||++|..+.+....   .++..+...++.++++.+..||. 
T Consensus        54 ~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~  130 (306)
T 3tdw_A           54 DELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAF  130 (306)
T ss_dssp             HHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcC
Confidence            5678999999999753   3667777664 45567899999999877653211   12233333334444444444431 


Q ss_pred             --------------------------------------------------------cCCCceEeCCCCCCCeeeCC---C
Q 036342          541 --------------------------------------------------------GYSALVIHCDLKPSNVLLDD---N  561 (596)
Q Consensus       541 --------------------------------------------------------~~~~~i~Hrdlk~~NILl~~---~  561 (596)
                                                                              .....++|+|+++.||+++.   +
T Consensus       131 ~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~  210 (306)
T 3tdw_A          131 PVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQ  210 (306)
T ss_dssp             CHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSS
T ss_pred             CcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCC
Confidence                                                                    12456799999999999987   3


Q ss_pred             Cc-EEEeccccccc
Q 036342          562 MV-AHLSDFSIAKL  574 (596)
Q Consensus       562 ~~-~kl~dfGla~~  574 (596)
                      +. +.|.||+.+..
T Consensus       211 ~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          211 TPLTGIIDFGDAAI  224 (306)
T ss_dssp             CCEEEECCCTTCEE
T ss_pred             CceEEEEehhhcCC
Confidence            55 58999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.43  E-value=0.00046  Score=66.87  Aligned_cols=104  Identities=16%  Similarity=0.094  Sum_probs=74.7

Q ss_pred             HhHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcc---
Q 036342          466 KSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG---  541 (596)
Q Consensus       466 ~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---  541 (596)
                      ..+.+|..+++.+. +-.+.++++++.+.+..|+|||+++|.++.+......     .....++.++++.+..||..   
T Consensus        64 ~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~  138 (272)
T 4gkh_A           64 NDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVC  138 (272)
T ss_dssp             HHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGG
T ss_pred             hHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcc
Confidence            45778999888774 3347788999888889999999999988766543221     12233455566666666621   


Q ss_pred             ----------------------------------------------------CCCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          542 ----------------------------------------------------YSALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       542 ----------------------------------------------------~~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                                                                          ....++|+|+.+.||++++++.+-|.||
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDw  218 (272)
T 4gkh_A          139 NCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDV  218 (272)
T ss_dssp             GCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred             cCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEEC
Confidence                                                                0113799999999999998877789999


Q ss_pred             ccccc
Q 036342          570 SIAKL  574 (596)
Q Consensus       570 Gla~~  574 (596)
                      +.+..
T Consensus       219 e~a~~  223 (272)
T 4gkh_A          219 GRVGI  223 (272)
T ss_dssp             TTCEE
T ss_pred             ccccc
Confidence            98764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.29  E-value=0.00014  Score=66.47  Aligned_cols=116  Identities=15%  Similarity=0.164  Sum_probs=64.8

Q ss_pred             hCCCCCCEEEccCC-cCccc----c-CccCccCCCCccEEEccCCccccccC----ccccCCCCCCEEEccCCcccccCC
Q 036342           31 FNVSTLKFLGLQNN-SLSGS----L-SSIANVRLPNLEKLYLWGNNFSGTIP----RFIFNASKLSKLSLGMNSFSGFIP  100 (596)
Q Consensus        31 ~~l~~L~~L~Ls~N-~l~~~----~-~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~i~~~~~  100 (596)
                      ..-++|++|+|++| .|...    + ..+.  .-..|+.|+|++|.|...--    .++..-+.|++|+|++|+|....-
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~--~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAAC--NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHT--TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHh--hCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence            34566777777764 55310    0 0111  23467777777777763222    223345678888888888865322


Q ss_pred             ----ccccCCCCCCEEecCCCcCcCCCCC--ccccccCCCCCCCCEEECcCCCC
Q 036342          101 ----STFGNLRNLEQLGLDENYLTSSTPE--LSFLSSLSNCKSLTLIDLSNNPL  148 (596)
Q Consensus       101 ----~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~~~~~~l~~L~~L~ls~N~l  148 (596)
                          .++..-+.|++|+|++|....+...  ..+...+..-++|+.|+++.|.+
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence                2344456688888876533111111  11233456667888888887764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.13  E-value=0.00044  Score=63.05  Aligned_cols=67  Identities=16%  Similarity=0.199  Sum_probs=32.2

Q ss_pred             hccCCCCCCEEEccCC-cccCC----CCccccCCCCCCeEEccCCcccccCc----cchhcCCCCcEEEccCCcCc
Q 036342          181 EISNLTNLVEIDLGGN-KLNGS----IPITLGKLRKLQRLNLEDNILEGSIP----DDICRLAELYRLELGSNKLY  247 (596)
Q Consensus       181 ~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~  247 (596)
                      .+.+-+.|+.|+|++| .|...    +..++..-+.|+.|+|++|.|...--    ..+..-+.|+.|+|++|.|.
T Consensus        36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            3344466777777764 55421    22334444556666666665542211    12223344555555555554

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.01  E-value=0.00097  Score=56.70  Aligned_cols=37  Identities=19%  Similarity=0.269  Sum_probs=17.5

Q ss_pred             cceEecCCCcCcccCChhhhccCCCCCeEECCCCcccc
Q 036342          307 LIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG  344 (596)
Q Consensus       307 L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~  344 (596)
                      |+.|||++|+|+ .+|...+..+++|+.|+|++|++.+
T Consensus        33 l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           33 TTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             CSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             CCEEECCCCcCC-ccChhhhhhccccCEEEecCCCeec
Confidence            334444444444 3344444445555555555555543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.01  E-value=0.00091  Score=67.71  Aligned_cols=44  Identities=9%  Similarity=0.085  Sum_probs=32.6

Q ss_pred             HhHHHHHHHHhhcCC---CccceeeeeeccC---CeeEEEEecCCCCCHH
Q 036342          466 KSFDVECEMMKSIRH---RNLIKVISSCSNE---EFKALVLEYMPHGSLE  509 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H---~niv~l~~~~~~~---~~~~lV~e~~~~g~L~  509 (596)
                      ..+.+|..+++.+..   -.+.++++++.+.   +..|+||||++|..+.
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            356788888888753   3577888887665   3568999999986654

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.96  E-value=0.0012  Score=56.25  Aligned_cols=35  Identities=23%  Similarity=0.279  Sum_probs=16.0

Q ss_pred             CCEEEccCCcccccCCccccCCCCCCEEecCCCcC
Q 036342           85 LSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYL  119 (596)
Q Consensus        85 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l  119 (596)
                      |++|+|++|+|+.+.++.|..+++|+.|+|++|.+
T Consensus        33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            44444444444444444444444444444444444

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.36  E-value=0.0046  Score=61.85  Aligned_cols=32  Identities=25%  Similarity=0.314  Sum_probs=28.6

Q ss_pred             CCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       543 ~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ...++|+|+.+.||+++.++.+.+.||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            57899999999999998888999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=95.95  E-value=0.015  Score=57.42  Aligned_cols=104  Identities=13%  Similarity=0.120  Sum_probs=66.6

Q ss_pred             HhHHHHHHHHhhcC---CCccceeeeeeccCCeeEEEEecCCCCCHH--------H---HHhhCCC--------------
Q 036342          466 KSFDVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYMPHGSLE--------K---YLYSSNC--------------  517 (596)
Q Consensus       466 ~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lV~e~~~~g~L~--------~---~l~~~~~--------------  517 (596)
                      ..+..|...|+.+.   ...+++.++++..++..++||||+++..+.        +   .++....              
T Consensus        73 ~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~  152 (312)
T 3jr1_A           73 SMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGP  152 (312)
T ss_dssp             HHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETT
T ss_pred             HHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCC
Confidence            45788988888874   367889999888788899999999987541        1   1221110              


Q ss_pred             -------CCCHHHHH---HHHHH----------------HHH-HHHHHh-ccCCCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          518 -------ILDIFQRL---NIMID----------------VAS-ALEYLH-FGYSALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       518 -------~l~~~~~~---~i~~~----------------i~~-~l~~lh-~~~~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                             .-+|....   ++..+                +.. ....+. ....+.++|+|+.+.|++++.++ +.|.|+
T Consensus       153 ~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~  231 (312)
T 3jr1_A          153 IYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNP  231 (312)
T ss_dssp             EEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSC
T ss_pred             cCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcC
Confidence                   01354322   11111                111 112332 12357899999999999999887 889998


Q ss_pred             c
Q 036342          570 S  570 (596)
Q Consensus       570 G  570 (596)
                      .
T Consensus       232 ~  232 (312)
T 3jr1_A          232 A  232 (312)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=95.94  E-value=0.019  Score=58.90  Aligned_cols=31  Identities=19%  Similarity=0.314  Sum_probs=26.4

Q ss_pred             CCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       543 ~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ...++|+|+.+.||+++.+ .+++.||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            5689999999999999876 488999987663

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=94.45  E-value=0.088  Score=52.27  Aligned_cols=32  Identities=28%  Similarity=0.368  Sum_probs=27.9

Q ss_pred             CCceEeCCCCCCCeeeCCC----CcEEEeccccccc
Q 036342          543 SALVIHCDLKPSNVLLDDN----MVAHLSDFSIAKL  574 (596)
Q Consensus       543 ~~~i~Hrdlk~~NILl~~~----~~~kl~dfGla~~  574 (596)
                      ...++|+|+.+.||+++.+    +.+.|.||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            5689999999999999874    6889999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=94.11  E-value=0.097  Score=51.16  Aligned_cols=31  Identities=23%  Similarity=0.343  Sum_probs=25.7

Q ss_pred             CCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       543 ~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ...++|+|+.+.||+ .+++.+.+.||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            456899999999999 5566789999987764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=90.99  E-value=0.15  Score=52.74  Aligned_cols=38  Identities=21%  Similarity=0.317  Sum_probs=25.6

Q ss_pred             HhHHHHHHHHhhcCCCcc-ceeeeeeccCCeeEEEEecCCCCC
Q 036342          466 KSFDVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHGS  507 (596)
Q Consensus       466 ~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~~~~g~  507 (596)
                      ..+..|..+++.+...++ +++++.+..    .+|+||++|..
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~  158 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP  158 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence            455578888887754334 677776643    38999998633

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=90.54  E-value=0.41  Score=49.78  Aligned_cols=35  Identities=17%  Similarity=0.207  Sum_probs=25.0

Q ss_pred             HHHHHHHhhcCCCcc-ceeeeeeccCCeeEEEEecCCCCC
Q 036342          469 DVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHGS  507 (596)
Q Consensus       469 ~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~~~~g~  507 (596)
                      .+|..+++.+...++ +++++.+..    .+||||++|..
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            588888888865444 577777732    25999998743

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=90.16  E-value=0.53  Score=47.54  Aligned_cols=106  Identities=15%  Similarity=0.164  Sum_probs=63.6

Q ss_pred             HHhHHHHHHHHhhcCCC-ccceeeeeeccCCeeEEEEecCCCCCHHH--------------H---HhhCC----CCCC--
Q 036342          465 FKSFDVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYMPHGSLEK--------------Y---LYSSN----CILD--  520 (596)
Q Consensus       465 ~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lV~e~~~~g~L~~--------------~---l~~~~----~~l~--  520 (596)
                      .....+|..+++.+.-. -..++++++..    .+||||++|..+..              .   ++...    ....  
T Consensus        97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l  172 (379)
T 3feg_A           97 VDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL  172 (379)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence            35566898888877422 23667777654    29999998754421              0   11111    1112  


Q ss_pred             HHHHHHHHHHHHH-------------------HHHHHh-----ccCCCceEeCCCCCCCeeeCCC----CcEEEeccccc
Q 036342          521 IFQRLNIMIDVAS-------------------ALEYLH-----FGYSALVIHCDLKPSNVLLDDN----MVAHLSDFSIA  572 (596)
Q Consensus       521 ~~~~~~i~~~i~~-------------------~l~~lh-----~~~~~~i~Hrdlk~~NILl~~~----~~~kl~dfGla  572 (596)
                      |.+..++..++..                   .+.++.     ......++|+|+.+.||+++.+    +.+.+.||..|
T Consensus       173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a  252 (379)
T 3feg_A          173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS  252 (379)
T ss_dssp             HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred             HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence            3344444433321                   223332     1234579999999999999876    78999999877


Q ss_pred             cc
Q 036342          573 KL  574 (596)
Q Consensus       573 ~~  574 (596)
                      ..
T Consensus       253 ~~  254 (379)
T 3feg_A          253 SY  254 (379)
T ss_dssp             EE
T ss_pred             Cc
Confidence            63

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=89.92  E-value=0.45  Score=45.94  Aligned_cols=58  Identities=14%  Similarity=0.064  Sum_probs=39.0

Q ss_pred             cccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCC---CccceeeeeeccCCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRH---RNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H---~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .....+.+|.|..+.|||..                    ..+.+|+..|+.+.-   -.+++.+++.    .-++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            34556777888888888731                    247889999988742   2345555542    24799999


Q ss_pred             CCCCC
Q 036342          503 MPHGS  507 (596)
Q Consensus       503 ~~~g~  507 (596)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            98764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=85.88  E-value=0.75  Score=47.18  Aligned_cols=31  Identities=19%  Similarity=0.341  Sum_probs=27.8

Q ss_pred             CCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       543 ~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ...++|+|+++.||+++.++ +++.||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            78899999999999998876 99999988764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=83.98  E-value=0.66  Score=30.37  Aligned_cols=12  Identities=33%  Similarity=0.379  Sum_probs=5.5

Q ss_pred             HHhhhhhhccCC
Q 036342          407 IWLILRYRQRGK  418 (596)
Q Consensus       407 i~~~~~~rr~~k  418 (596)
                      +|+++|+|+.++
T Consensus        31 ~~~~~RRr~~~~   42 (44)
T 2ks1_B           31 IGLFMRRRHIVR   42 (44)
T ss_dssp             HHHHHHTTTCCS
T ss_pred             HHHHhhhhHhhc
Confidence            344455444443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=81.35  E-value=0.6  Score=30.46  Aligned_cols=10  Identities=10%  Similarity=0.248  Sum_probs=5.1

Q ss_pred             ceeeeehhhh
Q 036342          390 LLLGIVLPLS  399 (596)
Q Consensus       390 ~~~~i~~~~~  399 (596)
                      .+.++++++.
T Consensus        13 ~Ia~~vVGvl   22 (44)
T 2jwa_A           13 SIISAVVGIL   22 (44)
T ss_dssp             HHHHHHHHHH
T ss_pred             chHHHHHHHH
Confidence            3555556633

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=80.69  E-value=0.88  Score=29.72  Aligned_cols=13  Identities=23%  Similarity=0.232  Sum_probs=6.0

Q ss_pred             HHhhhhhhccCCC
Q 036342          407 IWLILRYRQRGKK  419 (596)
Q Consensus       407 i~~~~~~rr~~k~  419 (596)
                      +|+++|+|+.+++
T Consensus        30 ~~~~~RRRr~~~k   42 (44)
T 2l2t_A           30 FAVYVRRKSIKKK   42 (44)
T ss_dssp             HHHHHHTTCSSCC
T ss_pred             HHHHhhhhhhhhc
Confidence            3445554444443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	596
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-34
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-32
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-31
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-31
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-31
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-30
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-30
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-29
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-29
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-28
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-28
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-28
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-28
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-28
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-28
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-28
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-27
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-27
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-27
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-26
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-26
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-26
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-26
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-25
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-25
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-25
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-25
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-25
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-25
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-23
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-23
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-23
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-13
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-22
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-22
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-22
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-21
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-21
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-21
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-21
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-20
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-20
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-20
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-20
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-12
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-19
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-18
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-18
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.001
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-18
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-17
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-17
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-17
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-16
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-07
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-16
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-15
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-15
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-13
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-12
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-10
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-10
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	8e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	5e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 1e-35
 Identities = 36/172 (20%), Positives = 72/172 (41%), Gaps = 24/172 (13%)

Query: 445 DEFSENNLIGRGGFALFIRA--------------------FKSFDVECEMMKSIRHRNLI 484
            + +    IG G F    +                      ++F  E  +++  RH N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 485 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 544
             +   +     A+V ++    SL  +L+      ++ + ++I    A  ++YLH     
Sbjct: 68  LFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---K 123

Query: 545 LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            +IH DLK +N+ L +++   + DF +A + +    S    Q  G+I +MAP
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (325), Expect = 4e-34
 Identities = 42/200 (21%), Positives = 80/200 (40%), Gaps = 40/200 (20%)

Query: 434 TFSYLELCRATDEFSEN---------NLIGRGGFALFIRAF------------------- 465
            F++ +   A  EF++           +IG G F                          
Sbjct: 6   PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 466 ------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 519
                 + F  E  +M    H N+I +    +      ++ E+M +GSL+ +L  ++   
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
            + Q + ++  +A+ ++YL        +H DL   N+L++ N+V  +SDF +++ L  + 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 580 QSMTQTQTLG---TIGYMAP 596
              T T  LG    I + AP
Sbjct: 183 SDPTYTSALGGKIPIRWTAP 202

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 9e-32
 Identities = 37/184 (20%), Positives = 67/184 (36%), Gaps = 30/184 (16%)

Query: 439 ELCRATDEFS-ENNLIGRGGFALFIRAF------------------------KSFDVECE 473
           +L    D     +  +G G F    +                          +    E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           +M  + +  ++++I  C  E    LV+E    G L K+L      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-GTIG 592
            ++YL        +H DL   NVLL +   A +SDF ++K L  +D   T        + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 593 YMAP 596
           + AP
Sbjct: 178 WYAP 181

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 4e-31
 Identities = 36/181 (19%), Positives = 71/181 (39%), Gaps = 31/181 (17%)

Query: 438 LELCRATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMM 475
           +EL    D+F + + +G G   +  +                             E +++
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 476 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 535
                  ++    +  ++   ++ +E+M  GSL++ L  +   +       + I V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 536 EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
            YL   +   ++H D+KPSN+L++      L DF ++  L     SM  +   GT  YM+
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFV-GTRSYMS 171

Query: 596 P 596
           P
Sbjct: 172 P 172

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 4e-31
 Identities = 36/172 (20%), Positives = 77/172 (44%), Gaps = 25/172 (14%)

Query: 445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIK 485
           +       +G G F      +                    +F  E  +MK ++H+ L++
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 486 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSA 544
           + +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + ++      
Sbjct: 73  LYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128

Query: 545 LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             IH DL+ +N+L+ D +   ++DF +A+L+  +++   +      I + AP
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 179

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 6e-31
 Identities = 34/174 (19%), Positives = 64/174 (36%), Gaps = 26/174 (14%)

Query: 445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRN 482
           +++     +G G +     A                       ++   E  + K + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           ++K          + L LEY   G L   +   +  +           + + + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              + H D+KP N+LLD+     +SDF +A +    ++     +  GT+ Y+AP
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 2e-30
 Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 26/174 (14%)

Query: 444 TDEFSENNLIGRGGFALFIRA---------------------FKSFDVECEMMKSIRHRN 482
            D +     +G G F    +A                      + + VE +++ S  H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           ++K++ +   E    +++E+   G+++  +      L   Q   +      AL YLH   
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127

Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              +IH DLK  N+L   +    L+DF ++   T   Q        GT  +MAP
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAP 179

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (295), Expect = 7e-30
 Identities = 39/177 (22%), Positives = 60/177 (33%), Gaps = 34/177 (19%)

Query: 444 TDEFSENNLIGRGGFALFIRA------------------------FKSFDVECEMMKSIR 479
              FS+   IG G F     A                        ++    E   ++ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 480 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 539
           H N I+       E    LV+EY    + +         L   +   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132

Query: 540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              S  +IH D+K  N+LL +  +  L DF  A ++            +GT  +MAP
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAP 180

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 1e-29
 Identities = 36/171 (21%), Positives = 68/171 (39%), Gaps = 23/171 (13%)

Query: 445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIK 485
            + +    +G G F +                          F  E ++M ++ H  L++
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 486 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL 545
           +   C+ +    ++ EYM +G L  YL          Q L +  DV  A+EYL       
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120

Query: 546 VIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            +H DL   N L++D  V  +SDF +++ +  +D+  +   +   + +  P
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPP 170

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 9e-29
 Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 23/171 (13%)

Query: 445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIK 485
            E +    IG G F L    +                   + F  E E+M  + H  L++
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 486 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL 545
           +   C  +    LV E+M HG L  YL +   +      L + +DV   + YL     A 
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 121

Query: 546 VIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           VIH DL   N L+ +N V  +SDF + + +  +  + +   T   + + +P
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASP 171

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-28
 Identities = 37/202 (18%), Positives = 67/202 (33%), Gaps = 53/202 (26%)

Query: 445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKS 477
           +      ++G G F   + A                            ++   E +MM  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 478 I-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-------------------- 516
           +  H N++ ++ +C+      L+ EY  +G L  YL S                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 517 --CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL 574
              +L     L     VA  +E+L        +H DL   NVL+    V  + DF +A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 575 LTGEDQSMTQTQTLGTIGYMAP 596
           +  +   + +      + +MAP
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAP 235

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 1e-28
 Identities = 37/174 (21%), Positives = 68/174 (39%), Gaps = 31/174 (17%)

Query: 449 ENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNL 483
           E+  +G G F    + +                              E  +M+ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 484 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 543
           +++I  C  E +  LV+E    G L KYL  +   +     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125

Query: 544 ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLGTIGYMAP 596
           +  +H DL   NVLL     A +SDF ++K L  + +    QT     + + AP
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-28
 Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 28/179 (15%)

Query: 442 RATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKS 477
           +  ++F    ++G G F+  + A                              E ++M  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 478 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 537
           + H   +K+  +  ++E     L Y  +G L KY+       D         ++ SALEY
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123

Query: 538 LHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           LH      +IH DLKP N+LL+++M   ++DF  AK+L+ E +       +GT  Y++P
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (282), Expect = 2e-28
 Identities = 41/173 (23%), Positives = 74/173 (42%), Gaps = 25/173 (14%)

Query: 445 DEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLI 484
            + +  + +G G +                           + F  E  +MK I+H NL+
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 485 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYS 543
           +++  C+ E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL     
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 133

Query: 544 ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              IH DL   N L+ +N +  ++DF +++L+TG D           I + AP
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 185

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 4e-28
 Identities = 37/179 (20%), Positives = 75/179 (41%), Gaps = 30/179 (16%)

Query: 445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSI 478
              +   +IG G F    +                              F  E  +M   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 479 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 538
            H N+I++    S  +   ++ EYM +G+L+K+L   +    + Q + ++  +A+ ++YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 539 HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLGTIGYMAP 596
               +   +H DL   N+L++ N+V  +SDF ++++L    + + T +     I + AP
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 4e-28
 Identities = 38/172 (22%), Positives = 75/172 (43%), Gaps = 25/172 (14%)

Query: 445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIK 485
           +       +G+G F                          ++F  E ++MK +RH  L++
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 486 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF-QRLNIMIDVASALEYLHFGYSA 544
           + +  S E    +V EYM  GSL  +L           Q +++   +AS + Y+      
Sbjct: 77  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 133

Query: 545 LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             +H DL+ +N+L+ +N+V  ++DF +A+L+  +++   +      I + AP
Sbjct: 134 -YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAP 183

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 7e-28
 Identities = 48/171 (28%), Positives = 71/171 (41%), Gaps = 27/171 (15%)

Query: 445 DEFSENNLIGRGGFALFIRA-----------------FKSFDVECEMMKSIRHRNLIKVI 487
            E      IG+G F   +                    ++F  E  +M  +RH NL++++
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 66

Query: 488 SSCSNEEFK-ALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAL 545
                E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL       
Sbjct: 67  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123

Query: 546 VIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            +H DL   NVL+ ++ VA +SDF + K       S TQ      + + AP
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAP 169

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 1e-27
 Identities = 38/182 (20%), Positives = 65/182 (35%), Gaps = 32/182 (17%)

Query: 445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHR 481
           +++     IG G +    +                         +    E  +++ ++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 482 NLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALE 536
           N+++      +     L  V+EY   G L   +         LD    L +M  +  AL+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 537 YLH--FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYM 594
             H        V+H DLKP+NV LD      L DF +A++L  +           T  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYM 181

Query: 595 AP 596
           +P
Sbjct: 182 SP 183

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-27
 Identities = 39/176 (22%), Positives = 69/176 (39%), Gaps = 32/176 (18%)

Query: 445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRH 480
           ++F     +G+G F     A                              E E+   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 481 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 540
            N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123

Query: 541 GYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             S  VIH D+KP N+LL       ++DF  +       ++       GT+ Y+ P
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPP 173

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 3e-27
 Identities = 39/178 (21%), Positives = 68/178 (38%), Gaps = 30/178 (16%)

Query: 445 DEFSENNLIGRGGF--------------------------ALFIRAFKSFDVECEMMKSI 478
            EF +  ++G G F                          A   +A K    E  +M S+
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 479 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 538
            + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +A  + YL
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 539 HFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
                  ++H DL   NVL+       ++DF +AKLL  E++          I +MA 
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 34/197 (17%), Positives = 68/197 (34%), Gaps = 48/197 (24%)

Query: 445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKS 477
           +  S    +G G F   + A                            ++   E +++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 478 I-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-----------------NCIL 519
           +  H N++ ++ +C+      ++ EY  +G L  +L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
           D+   L+    VA  + +L    S   IH DL   N+LL    +  + DF +A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 580 QSMTQTQTLGTIGYMAP 596
             + +      + +MAP
Sbjct: 200 NYVVKGNARLPVKWMAP 216

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  109 bits (272), Expect = 1e-26
 Identities = 33/175 (18%), Positives = 64/175 (36%), Gaps = 29/175 (16%)

Query: 445 DEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNL 483
           D +  +  +G G F +  R                       ++   E + M  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 484 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 543
           + +  +  ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142

Query: 544 ALVIHCDLKPSNVLL--DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              +H DLKP N++     +    L DF +   L  +      T   GT  + AP
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAP 194

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (267), Expect = 1e-26
 Identities = 39/175 (22%), Positives = 66/175 (37%), Gaps = 34/175 (19%)

Query: 450 NNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKV 486
           +  IGRG F    +                         + F  E EM+K ++H N+++ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 487 ISSC----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
             S       ++   LV E M  G+L+ YL     ++ I    +    +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 543 SALVIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +  +IH DLK  N+ +        + D  +A L             +GT  +MAP
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (265), Expect = 5e-26
 Identities = 43/206 (20%), Positives = 73/206 (35%), Gaps = 58/206 (28%)

Query: 446 EFSENNL-----IGRGGFALFIRAF---------------------------KSFDVECE 473
           E+  NN+     IG G F    +A                              F  E  
Sbjct: 9   EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68

Query: 474 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------------- 516
           +M    + N++K++  C+  +   L+ EYM +G L ++L S +                 
Sbjct: 69  LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 517 ------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFS 570
                   L   ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DF 
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFG 185

Query: 571 IAKLLTGEDQSMTQTQTLGTIGYMAP 596
           +++ +   D           I +M P
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPP 211

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 2e-25
 Identities = 41/173 (23%), Positives = 68/173 (39%), Gaps = 31/173 (17%)

Query: 453 IGRGGFA----------------LFIRAFKSFDVECEMM--KSIRHRNLIKVISSCSNEE 494
           IG+G F                    R  +S+  E E+     +RH N++  I++ + + 
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 70

Query: 495 FKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGYSAL 545
                  LV +Y  HGSL  YL      + +   + + +  AS L +LH           
Sbjct: 71  GTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128

Query: 546 VIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT--QTQTLGTIGYMAP 596
           + H DLK  N+L+  N    ++D  +A        ++       +GT  YMAP
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 2e-25
 Identities = 37/135 (27%), Positives = 52/135 (38%), Gaps = 5/135 (3%)

Query: 463 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 522
            A   F  E   M S+ HRNLI++         K +V E  P GSL   L        + 
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG 111

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQS 581
                 + VA  + YL    S   IH DL   N+LL    +  + DF + + L   +D  
Sbjct: 112 TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168

Query: 582 MTQTQTLGTIGYMAP 596
           + Q        + AP
Sbjct: 169 VMQEHRKVPFAWCAP 183

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  105 bits (262), Expect = 3e-25
 Identities = 32/175 (18%), Positives = 65/175 (37%), Gaps = 29/175 (16%)

Query: 445 DEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNL 483
           D +     +G G F +  R                        +   E  +M  + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 484 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 543
           I +  +  ++    L+LE++  G L   + + +  +   + +N M      L+++H    
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---E 145

Query: 544 ALVIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             ++H D+KP N++ +        + DF +A  L  ++     T    T  + AP
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAP 197

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 5e-25
 Identities = 44/192 (22%), Positives = 81/192 (42%), Gaps = 46/192 (23%)

Query: 445 DEFSENNLIGRGGFALFIRA------------------------FKSFDVECEMMKSI-R 479
           ++    ++IG G F   ++A                         + F  E E++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 480 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQR 524
           H N+I ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 525 LNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 584
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DF +++   G++  + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 585 TQTLGTIGYMAP 596
           T     + +MA 
Sbjct: 184 TMGRLPVRWMAI 195

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 7e-25
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 28/174 (16%)

Query: 444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRN 482
             +++    IG+G       A                      +    E  +M+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           ++  + S    +   +V+EY+  GSL   +  +    D  Q   +  +   ALE+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH--- 133

Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           S  VIH D+K  N+LL  +    L+DF     +T E    +     GT  +MAP
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAP 185

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 8e-25
 Identities = 34/176 (19%), Positives = 62/176 (35%), Gaps = 30/176 (17%)

Query: 445 DEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIR 479
           +       IG G F    +                           + F  E   M+   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 480 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 539
           H +++K+I   + E    +++E    G L  +L      LD+   +     +++AL YL 
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
              S   +H D+   NVL+  N    L DF +++ +         ++    I +MA
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMA 177

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.9 bits (248), Expect = 1e-23
 Identities = 36/175 (20%), Positives = 65/175 (37%), Gaps = 31/175 (17%)

Query: 450 NNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLI 484
           N +IGRG F                                  F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 485 KVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 543
            ++  C   E    +VL YM HG L  ++ +      +   +   + VA  +++L     
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK- 150

Query: 544 ALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED--QSMTQTQTLGTIGYMAP 596
              +H DL   N +LD+     ++DF +A+ +  ++      +T     + +MA 
Sbjct: 151 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 4e-23
 Identities = 27/188 (14%), Positives = 68/188 (36%), Gaps = 39/188 (20%)

Query: 445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKS 477
           ++ + +  +G+G F +                                  F  E  +MK 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 478 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------SSNCILDIFQRLNIM 528
               ++++++   S  +   +++E M  G L+ YL                 + + + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 588
            ++A  + YL+   +   +H DL   N ++ ++    + DF + + +   D      + L
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 589 GTIGYMAP 596
             + +M+P
Sbjct: 197 LPVRWMSP 204

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 97.1 bits (241), Expect = 5e-23
 Identities = 36/182 (19%), Positives = 73/182 (40%), Gaps = 33/182 (18%)

Query: 444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIR 479
           +D +    ++G GG +    A                           F  E +   ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 480 HRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 535
           H  ++ V  +   E        +V+EY+   +L   +++    +   + + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 536 EYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LGTIGYM 594
            + H      +IH D+KP+N+++       + DF IA+ +     S+TQT   +GT  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 595 AP 596
           +P
Sbjct: 182 SP 183

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 95.9 bits (238), Expect = 1e-22
 Identities = 42/183 (22%), Positives = 72/183 (39%), Gaps = 38/183 (20%)

Query: 445 DEFSENNLIGRGGFALFIRAF------------------------------KSFDVECEM 474
           + +    ++GRG  ++  R                                ++   E ++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 475 MKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 533
           ++ +  H N+I++  +     F  LV + M  G L  YL +    L   +   IM  +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121

Query: 534 ALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
            +  LH      ++H DLKP N+LLDD+M   L+DF  +  L   D      +  GT  Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 175

Query: 594 MAP 596
           +AP
Sbjct: 176 LAP 178

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 95.5 bits (236), Expect = 3e-22
 Identities = 53/278 (19%), Positives = 83/278 (29%), Gaps = 17/278 (6%)

Query: 47  SGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNL 106
              L  +     P+   L L  N  +        N   L  L L  N  S   P  F  L
Sbjct: 19  DLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL 78

Query: 107 RNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
             LE+L L +N L     ++         K+L  + +  N +  +            + E
Sbjct: 79  VKLERLYLSKNQLKELPEKM--------PKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130

Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
                   SG        +  L  I +    +     I  G    L  L+L+ N +    
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVD 187

Query: 227 PDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQL 286
              +  L  L +L L  N +         N   LR L L +NKL  +P    + K I  +
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 247

Query: 287 NFSSNFLTG------PLLLEIGNLKVLIGIDFSMNNFS 318
              +N ++                    G+    N   
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 74.7 bits (182), Expect = 3e-15
 Identities = 54/272 (19%), Positives = 96/272 (35%), Gaps = 21/272 (7%)

Query: 2   IPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNL 61
              +  NL+NL  L L  NK+    P A   +  L+ L L  N L   L       L  L
Sbjct: 47  KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQEL 105

Query: 62  EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTS 121
                       ++   +     +  L       SG     F  ++ L  + + +  +T+
Sbjct: 106 RVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164

Query: 122 STPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
               L          SLT + L  N +  +   +       +L +  +   +IS      
Sbjct: 165 IPQGL--------PPSLTELHLDGNKITKVDAASLKGL--NNLAKLGLSFNSISAVDNGS 214

Query: 182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC------RLAE 235
           ++N  +L E+ L  NKL   +P  L   + +Q + L +N +     +D C      + A 
Sbjct: 215 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 273

Query: 236 LYRLELGSNKL--YGSIPACFGNLASLRILSL 265
              + L SN +  +   P+ F  +     + L
Sbjct: 274 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 69.7 bits (169), Expect = 1e-13
 Identities = 46/235 (19%), Positives = 79/235 (33%), Gaps = 9/235 (3%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN 196
            L ++  S+  L+ +       +L        + N  I+     +  NL NL  + L  N
Sbjct: 11  HLRVVQCSDLGLEKVP-----KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 65

Query: 197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGN 256
           K++   P     L KL+RL L  N L+         L EL   E    K+  S+      
Sbjct: 66  KISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125

Query: 257 LASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNN 316
           +  + + +            F  +K +  +  +   +T    +  G    L  +    N 
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNK 182

Query: 317 FSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPN 371
            + V    + + L+ L  L LSFN +        +      E    N  L   P 
Sbjct: 183 ITKVDAASL-KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 96.0 bits (238), Expect = 5e-22
 Identities = 34/178 (19%), Positives = 69/178 (38%), Gaps = 35/178 (19%)

Query: 445 DEFSENNLIGRGGFALFIRA---------------------------FKSFDVECEMMKS 477
           ++FS + +IGRGGF                                   +  +   ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 478 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 537
                ++ +  +    +  + +L+ M  G L  +L       +         ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122

Query: 538 LHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
           +H   +  V++ DLKP+N+LLD++    +SD  +A   + +    +     GT GYMA
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.7 bits (235), Expect = 7e-22
 Identities = 32/174 (18%), Positives = 67/174 (38%), Gaps = 28/174 (16%)

Query: 445 DEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLI 484
           +++     +GRG F +  R                           E  ++   RHRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 485 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 544
            +  S  + E   ++ E++    + + + +S   L+  + ++ +  V  AL++LH   S 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SH 121

Query: 545 LVIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            + H D++P N++     +    + +F  A+ L   D             Y AP
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 93.9 bits (233), Expect = 9e-22
 Identities = 33/175 (18%), Positives = 63/175 (36%), Gaps = 26/175 (14%)

Query: 444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHR 481
            D +   +++G G F+  I A                        S + E  ++  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 482 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 541
           N++ +     +     L+++ +  G L   +              ++  V  A++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
                           LD++    +SDF ++K+   ED     +   GT GY+AP
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 178

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 38/176 (21%), Positives = 66/176 (37%), Gaps = 33/176 (18%)

Query: 445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRH 480
            +F     +G G F                               +  + E  M+  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 481 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 540
             +I++  +  + +   ++++Y+  G     L   +             +V  ALEYLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH- 121

Query: 541 GYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             S  +I+ DLKP N+LLD N    ++DF  AK +     ++      GT  Y+AP
Sbjct: 122 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAP 170

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 2e-21
 Identities = 37/196 (18%), Positives = 65/196 (33%), Gaps = 47/196 (23%)

Query: 445 DEFSENNLIGRGGFALFIRA---------------------------FKSFDVECEMMKS 477
           D       +GRG F   I A                            ++   E +++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 478 IRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNC---------------ILD 520
           I H   +  +     +    L  ++E+   G+L  YL S                   L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 521 IFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 580
           +   +     VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 581 SMTQTQTLGTIGYMAP 596
            + +      + +MAP
Sbjct: 190 YVRKGDARLPLKWMAP 205

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 3e-21
 Identities = 44/197 (22%), Positives = 74/197 (37%), Gaps = 48/197 (24%)

Query: 445 DEFSENNLIGRGGFALFIRA-----------------------------FKSFDVECEMM 475
           D       +G G F   + A                                   E EMM
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 476 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCIL 519
           K I +H+N+I ++ +C+ +    +++EY   G+L +YL               ++    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 520 DIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 579
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 580 QSMTQTQTLGTIGYMAP 596
                T     + +MAP
Sbjct: 190 YYKKTTNGRLPVKWMAP 206

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.1 bits (228), Expect = 4e-21
 Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 31/177 (17%)

Query: 445 DEFSENNLIGRGGFA------------------------LFIRAFKSFDVECE-MMKSIR 479
           ++F  + ++G+G F                         L     +   VE   +  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 480 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 539
           H  L  +  +   +E    V+EY+  G L  ++ S +   D+ +      ++   L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120

Query: 540 FGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              S  +++ DLK  N+LLD +    ++DF + K     D         GT  Y+AP
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAP 172

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 33/170 (19%), Positives = 64/170 (37%), Gaps = 31/170 (18%)

Query: 452 LIGRGGFAL----------------FIRAFKSFDVECE-MMKSIRHRNLIKVISSC---- 490
           ++G G                     ++       E E   ++ +  ++++++       
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY 78

Query: 491 SNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSALVIHC 549
           +  +   +V+E +  G L   +    +      +   IM  +  A++YLH   S  + H 
Sbjct: 79  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHR 135

Query: 550 DLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
           D+KP N+L      N +  L+DF  AK  T  +   T      T  Y+AP
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAP 182

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.6 bits (224), Expect = 2e-20
 Identities = 40/176 (22%), Positives = 76/176 (43%), Gaps = 32/176 (18%)

Query: 447 FSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISS 489
           +++  +IG G F +  +A                  +  + E ++M+ + H N++++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81

Query: 490 C------SNEEFKALVLEYMPHGSLE--KYLYSSNCILDIFQRLNIMIDVASALEYLHFG 541
                   +E +  LVL+Y+P       ++   +   L +      M  +  +L Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139

Query: 542 YSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            S  + H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y AP
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 191

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 3e-20
 Identities = 40/172 (23%), Positives = 73/172 (42%), Gaps = 32/172 (18%)

Query: 451 NLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLI 484
           + +G G FA   +A                           ++   E ++++ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 485 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 544
            ++ +  ++   +LV ++M        +  ++ +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 545 LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            ++H DLKP+N+LLD+N V  L+DF +AK       +   T  + T  Y AP
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAP 169

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 5e-20
 Identities = 37/180 (20%), Positives = 71/180 (39%), Gaps = 32/180 (17%)

Query: 444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHR 481
              ++  + IG G + +   A+                      +    E +++   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 482 NLIKVISSCSNEEFKAL----VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 537
           N+I +         + +    ++ ++    L K L + +  L        +  +   L+Y
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124

Query: 538 LHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSMTQTQTLGTIGYMAP 596
           +H   SA V+H DLKPSN+LL+      + DF +A++     D +   T+ + T  Y AP
Sbjct: 125 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.0 bits (217), Expect = 9e-20
 Identities = 39/189 (20%), Positives = 70/189 (37%), Gaps = 38/189 (20%)

Query: 440 LCRATDEFSENNLIGRGGFALFIRA------------------------FKSFDVECEMM 475
           LCRA  ++     IG G +    +A                          S   E  ++
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 476 K---SIRHRNLIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 527
           +   +  H N++++   C+           LV E++               +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 528 MIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 587
           M  +   L++LH   S  V+H DLKP N+L+  +    L+DF +A++       M  T  
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175

Query: 588 LGTIGYMAP 596
           + T+ Y AP
Sbjct: 176 VVTLWYRAP 184

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 86.3 bits (212), Expect = 3e-19
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 29/273 (10%)

Query: 130 SSLSNCKSLTLIDLSNNPLDGILP-KTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNL 188
            + +    +  +DLS   L    P  +S++NL      +     N+ G IP  I+ LT L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 189 VEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG 248
             + +    ++G+IP  L +++ L  L+   N L G++P  I  L  L  +    N++ G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 249 SIPACFGNLASLRI-LSLGSNKLTSIPLTFWNLKDILQLNFSSNFL-------------- 293
           +IP  +G+ + L   +++  N+LT      +   ++  ++ S N L              
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 294 ---------TGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKG 344
                        L ++G  K L G+D   N   G +P+ +  +L +L  LN+SFN L G
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCG 282

Query: 345 EIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC 377
           EIP+GG+   F   ++  N+ LCGSP   +P C
Sbjct: 283 EIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 67.1 bits (162), Expect = 1e-12
 Identities = 53/248 (21%), Positives = 96/248 (38%), Gaps = 19/248 (7%)

Query: 1   EIPLEIGNLQNLEELQLGQN-KLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLP 59
            IP  + NL  L  L +G    L+G +P AI  ++ L +L + + ++SG++    +    
Sbjct: 67  PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI-K 125

Query: 60  NLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLE--------Q 111
            L  L    N  SGT+P  I +   L  ++   N  SG IP ++G+   L         +
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185

Query: 112 LGLDENYLTSSTPELSFLSSLSNCKSLTLID--------LSNNPLDGILPKTSISNLSRS 163
           L        ++        S +  +    +           +   + +        LS++
Sbjct: 186 LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKN 245

Query: 164 LEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILE 223
           L    + N  I G +P+ ++ L  L  +++  N L G IP   G L++       +N   
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCL 304

Query: 224 GSIPDDIC 231
              P   C
Sbjct: 305 CGSPLPAC 312

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.9 bits (209), Expect = 8e-19
 Identities = 35/175 (20%), Positives = 69/175 (39%), Gaps = 28/175 (16%)

Query: 445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHR 481
           + F +   IG G + +  +A                         +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 482 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 541
           N++K++     E    LV E++     +    S+   + +    + +  +   L + H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
            S  V+H DLKP N+L++      L+DF +A+      ++   T  + T+ Y AP
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 171

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.0 bits (207), Expect = 1e-18
 Identities = 27/139 (19%), Positives = 48/139 (34%), Gaps = 10/139 (7%)

Query: 461 FIRAFKSFDVECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI 518
            +       +E  ++K +      +I+++      +   L+LE            +    
Sbjct: 47  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 106

Query: 519 LDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTG 577
           L      +    V  A+ + H   +  V+H D+K  N+L+D +     L DF    LL  
Sbjct: 107 LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163

Query: 578 EDQSMTQTQTLGTIGYMAP 596
                  T   GT  Y  P
Sbjct: 164 TV----YTDFDGTRVYSPP 178

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 83.0 bits (204), Expect = 4e-18
 Identities = 34/182 (18%), Positives = 57/182 (31%), Gaps = 30/182 (16%)

Query: 442 RATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRN 482
           R  + +     IG G F                              +E ++ K ++   
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 63

Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
            I  I  C  E    +++  +   SLE      +    +   L +   + S +EY+H   
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--- 120

Query: 543 SALVIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLTGED-----QSMTQTQTLGTIGYM 594
           S   IH D+KP N L        + ++ DF +AK                    GT  Y 
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 595 AP 596
           + 
Sbjct: 181 SI 182

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.3 bits (205), Expect = 5e-18
 Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 30/176 (17%)

Query: 445 DEFSENNLIGRGGFALFIRA------------------------FKSFDVECEMMKSIRH 480
           ++F    L+G+G F   I                                E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 481 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 540
             L  +  +    +    V+EY   G L  +L S   +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122

Query: 541 GYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             S  V++ D+K  N++LD +    ++DF + K    +  +M      GT  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 174

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 83.9 bits (206), Expect = 5e-18
 Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 30/198 (15%)

Query: 38  FLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSG 97
            L   NN +S          L NL++L L GN         + + + L+ L L  N  S 
Sbjct: 201 SLIATNNQISDI---TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255

Query: 98  FIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSN---------------CKSLTLID 142
             P     L  L +L L  N +++ +P     +  +                 K+LT + 
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 313

Query: 143 LSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSI 202
           L  N +  I P   +S+L+  L+  +  N  +S      ++NLTN+  +  G N+++   
Sbjct: 314 LYFNNISDISP---VSSLT-KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367

Query: 203 PITLGKLRKLQRLNLEDN 220
           P  L  L ++ +L L D 
Sbjct: 368 P--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 81.2 bits (199), Expect = 4e-17
 Identities = 63/367 (17%), Positives = 124/367 (33%), Gaps = 45/367 (12%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
            L    +  LG+  +  TV     ++  +  L      +  S+  +    L NL ++   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEY--LNNLTQINFS 74

Query: 68  GNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELS 127
            N  +   P  + N +KL  + +  N  +   P           L  ++         L+
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 128 FLSSLSNCKSL------TLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEE 181
            L+ L    +            S   L      T +  L+       +   +        
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLEL 241
           ++ LTNL  +    N+++   P+ +     L  L+L  N L+      +  L  L  L+L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248

Query: 242 GSNKLYGSIPACFGNLASLRILSLGSNKLTSIP---------------------LTFWNL 280
            +N++    P     L  L  L LG+N++++I                          NL
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306

Query: 281 KDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFN 340
           K++  L    N ++   +  + +L  L  + F+ N  S      +   L+ +  L+   N
Sbjct: 307 KNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLA-NLTNINWLSAGHN 361

Query: 341 KLKGEIP 347
           ++    P
Sbjct: 362 QISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 78.5 bits (192), Expect = 3e-16
 Identities = 59/235 (25%), Positives = 85/235 (36%), Gaps = 46/235 (19%)

Query: 57  RLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE 116
           +L NLE L    N  S   P  I   + L +LSL  N        T  +L NL  L L  
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250

Query: 117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG 176
           N +++  P       LS    LT + L  N +  I P   ++ L+         N     
Sbjct: 251 NQISNLAP-------LSGLTKLTELKLGANQISNISP---LAGLTALTNLELNENQLE-- 298

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAEL 236
                ISNL NL  + L  N ++   P+    L KLQRL   +N +              
Sbjct: 299 -DISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD------------ 343

Query: 237 YRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSN 291
                          +   NL ++  LS G N+++ +     NL  I QL  +  
Sbjct: 344 --------------VSSLANLTNINWLSAGHNQISDLT-PLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 77.3 bits (189), Expect = 7e-16
 Identities = 64/342 (18%), Positives = 123/342 (35%), Gaps = 27/342 (7%)

Query: 6   IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLY 65
           +  L NL ++    N+L    P  + N++ L  + + NN ++          L  L    
Sbjct: 62  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119

Query: 66  LWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPE 125
               +          N  +LS  ++   S    + S        +   L      ++   
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 126 LSFLSSL-------SNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
           L   S+        +   +L  +  +NN +  I P   ++NL    +E  +    +    
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNL----DELSLNGNQLKD-- 233

Query: 179 PEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYR 238
              +++LTNL ++DL  N+++   P  L  L KL  L L  N +    P           
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291

Query: 239 LELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLL 298
                N+      +   NL +L  L+L  N ++ I     +L  + +L F++N ++    
Sbjct: 292 ----LNENQLEDISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSDVS- 345

Query: 299 LEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFN 340
             + NL  +  +    N  S + P      L+ +  L L+  
Sbjct: 346 -SLANLTNINWLSAGHNQISDLTPL---ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 5e-05
 Identities = 15/65 (23%), Positives = 33/65 (50%), Gaps = 5/65 (7%)

Query: 5   EIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKL 64
            + +L  L+ L    NK+  +  +++ N++ + +L   +N +S  L+ +AN  L  + +L
Sbjct: 324 PVSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISD-LTPLAN--LTRITQL 378

Query: 65  YLWGN 69
            L   
Sbjct: 379 GLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 0.001
 Identities = 14/84 (16%), Positives = 26/84 (30%), Gaps = 8/84 (9%)

Query: 133 SNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEID 192
           +         L    +   + +T +  +             I     + +  L NL +I+
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQV----TTLQADRLGIKS--IDGVEYLNNLTQIN 72

Query: 193 LGGNKLNGSIPITLGKLRKLQRLN 216
              N+L    P  L  L KL  + 
Sbjct: 73  FSNNQLTDITP--LKNLTKLVDIL 94

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.6 bits (203), Expect = 8e-18
 Identities = 34/190 (17%), Positives = 70/190 (36%), Gaps = 37/190 (19%)

Query: 440 LCRATDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMK 476
            C    ++ +   IG+G F    +A                         +   E ++++
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 477 SIRHRNLIKVISSCSNEEFKA--------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 528
            ++H N++ +I  C  +            LV ++  H               + +   +M
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123

Query: 529 IDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT- 587
             + + L Y+H      ++H D+K +NVL+  + V  L+DF +A+  +    S     T 
Sbjct: 124 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 588 -LGTIGYMAP 596
            + T+ Y  P
Sbjct: 181 RVVTLWYRPP 190

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 81.5 bits (200), Expect = 1e-17
 Identities = 34/174 (19%), Positives = 70/174 (40%), Gaps = 28/174 (16%)

Query: 445 DEFSENNLIGRGGFALFIRA----------------------FKSFDVECEMMKSIRHRN 482
           +++     IG G + +  +A                        +   E  ++K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 483 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
           ++K+      ++   LV E++    L+K L      L+     + ++ + + + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              V+H DLKP N+L++      ++DF +A+           T  + T+ Y AP
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAP 169

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.0 bits (199), Expect = 2e-17
 Identities = 39/183 (21%), Positives = 68/183 (37%), Gaps = 38/183 (20%)

Query: 445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKS 477
           D +     +G G FA+  +                             +  + E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 478 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 537
           I+H N+I +     N+    L+LE +  G L  +  +    L   +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128

Query: 538 LHFGYSALVIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLGTIGY 593
           LH   S  + H DLKP N++L D  V      + DF +A  +   D         GT  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182

Query: 594 MAP 596
           +AP
Sbjct: 183 VAP 185

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 79.1 bits (194), Expect = 8e-17
 Identities = 25/174 (14%), Positives = 48/174 (27%), Gaps = 32/174 (18%)

Query: 452 LIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSN 492
            IG G F +                             E    K +     I  +     
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71

Query: 493 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLK 552
           E    +++  +   SLE  L        +         + + ++ +H      +++ D+K
Sbjct: 72  EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIK 128

Query: 553 PSNVLLDDNMVAH-----LSDFSIAKLLTGEDQS-----MTQTQTLGTIGYMAP 596
           P N L+      +     + DF + K               +    GT  YM+ 
Sbjct: 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 79.1 bits (194), Expect = 1e-16
 Identities = 36/176 (20%), Positives = 66/176 (37%), Gaps = 33/176 (18%)

Query: 445 DEFSENNLIGRGGFA------------------------LFIRAFKSFDVECEMMKSIRH 480
           D+F     +G G F                         + ++  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 481 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 540
             L+K+  S  +     +V+EY+  G +  +L                  +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158

Query: 541 GYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             S  +I+ DLKP N+L+D      ++DF  AK + G   ++      GT   +AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAP 207

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 78.0 bits (191), Expect = 3e-16
 Identities = 32/174 (18%), Positives = 70/174 (40%), Gaps = 32/174 (18%)

Query: 445 DEFSENNLIGRGGFALFIRAF------------------KSFDVECEMMKSIR-HRNLIK 485
           D++     +GRG ++    A                   K    E ++++++R   N+I 
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94

Query: 486 VISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 543
           +     +   +  ALV E++ +   ++   +    L  +     M ++  AL+Y H   S
Sbjct: 95  LADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---S 147

Query: 544 ALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
             ++H D+KP NV++D ++    L D+ +A+              + +  +  P
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGP 198

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (186), Expect = 6e-16
 Identities = 53/273 (19%), Positives = 90/273 (32%), Gaps = 9/273 (3%)

Query: 47  SGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNL 106
              L ++        ++++L GN  S            L+ L L  N  +    + F  L
Sbjct: 20  QQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79

Query: 107 RNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEE 166
             LEQL L +N    S    +F         L  + L    L  +     +     +L+ 
Sbjct: 80  ALLEQLDLSDNAQLRSVDPATF----HGLGRLHTLHLDRCGLQEL--GPGLFRGLAALQY 133

Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
            Y+ +  +     +   +L NL  + L GN+++         L  L RL L  N +    
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193

Query: 227 PDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQL 286
           P     L  L  L L +N L          L +L+ L L  N              + + 
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKF 253

Query: 287 NFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSG 319
             SS+ +   L   +    +      + N+  G
Sbjct: 254 RGSSSEVPCSLPQRLAGRDLK---RLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.7 bits (122), Expect = 8e-08
 Identities = 43/242 (17%), Positives = 73/242 (30%), Gaps = 9/242 (3%)

Query: 134 NCKSLTLIDLSNNPLDGILPKTSI-SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEID 192
             +           L       ++   +  + +  +++   IS           NL  + 
Sbjct: 9   YNEPKVTTSCPQQGL------QAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILW 62

Query: 193 LGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI-PDDICRLAELYRLELGSNKLYGSIP 251
           L  N L          L  L++L+L DN    S+ P     L  L+ L L    L    P
Sbjct: 63  LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122

Query: 252 ACFGNLASLRILSLGSNKLTSI-PLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGI 310
             F  LA+L+ L L  N L ++   TF +L ++  L    N ++         L  L  +
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182

Query: 311 DFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSP 370
               N  + V P    +    +     + N                      N  +C   
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242

Query: 371 NL 372
             
Sbjct: 243 AR 244

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.0 bits (115), Expect = 5e-07
 Identities = 33/158 (20%), Positives = 56/158 (35%), Gaps = 11/158 (6%)

Query: 10  QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGN 69
             L+ L L  N L         ++  L  L L  N +S  +   A   L +L++L L  N
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQN 187

Query: 70  NFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFL 129
             +   P    +  +L  L L  N+ S         LR L+ L L++N            
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247

Query: 130 SSLSNCKSLTLIDLSNNPLDGILPK----TSISNLSRS 163
           + L           S++ +   LP+      +  L+ +
Sbjct: 248 AWLQK------FRGSSSEVPCSLPQRLAGRDLKRLAAN 279

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.1 bits (186), Expect = 8e-16
 Identities = 30/175 (17%), Positives = 68/175 (38%), Gaps = 29/175 (16%)

Query: 445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHR 481
            ++ +   IG G +    +A                         S   E  ++K ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 482 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 541
           N++++     +++   LV E+      + +   +  + D     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSR 120

Query: 542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
               V+H DLKP N+L++ N    L++F +A+      +    +  + T+ Y  P
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPP 170

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.9 bits (183), Expect = 4e-15
 Identities = 40/195 (20%), Positives = 71/195 (36%), Gaps = 44/195 (22%)

Query: 435 FSYLELCRATDEFSEN----NLIGRGGFALFIRAF-----------------------KS 467
           F   E+ +   E          +G G +     A                        K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 468 FDVECEMMKSIRHRNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNCILDI 521
              E  ++K +RH N+I ++   + +E         LV+ +M  G+    L      L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGE 120

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 581
            +   ++  +   L Y+H   +A +IH DLKP N+ ++++    + DF +A+    E   
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--- 174

Query: 582 MTQTQTLGTIGYMAP 596
              T  + T  Y AP
Sbjct: 175 --MTGYVVTRWYRAP 187

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (179), Expect = 8e-15
 Identities = 33/134 (24%), Positives = 58/134 (43%), Gaps = 6/134 (4%)

Query: 463 RAFKSFDVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 521
           +  +    E ++++ IR    L+ +  +   E    L+L+Y+  G L  +L         
Sbjct: 70  KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---- 125

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 581
           F    + I V   +  L   +   +I+ D+K  N+LLD N    L+DF ++K    ++  
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185

Query: 582 MTQTQTLGTIGYMA 595
                  GTI YMA
Sbjct: 186 RAYDFC-GTIEYMA 198

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.0 bits (165), Expect = 6e-13
 Identities = 35/174 (20%), Positives = 65/174 (37%), Gaps = 39/174 (22%)

Query: 452 LIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVIS 488
            IG G   +   A+                       K    E  +MK + H+N+I +++
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 489 SCSNEEFK------ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 542
             + ++         LV+E M     +          D  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHSAG 139

Query: 543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP 596
              +IH DLKPSN+++  +    + DF +A+       S   T  + T  Y AP
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAP 187

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.8 bits (162), Expect = 1e-12
 Identities = 42/194 (21%), Positives = 71/194 (36%), Gaps = 40/194 (20%)

Query: 434 TFSYLELCRATDEFSEN----NLIGRGGFALFIRAF-----------------------K 466
           TF   EL +   E  E     + +G G +     AF                       K
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 467 SFDVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIF 522
               E  ++K ++H N+I ++   +      EF  + L     G+    +      L   
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDD 121

Query: 523 QRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 582
               ++  +   L+Y+H   SA +IH DLKPSN+ ++++    + DF +A+    E    
Sbjct: 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178

Query: 583 TQTQTLGTIGYMAP 596
                  T  Y AP
Sbjct: 179 VA-----TRWYRAP 187

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 65.4 bits (158), Expect = 5e-12
 Identities = 32/181 (17%), Positives = 61/181 (33%), Gaps = 38/181 (20%)

Query: 452 LIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCS 491
            +G G F+    A                     ++ + E ++++ +   +  K  S  +
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 492 NEEFK---------------ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 536
           N   K                +V E +    L       +  + +     I   +   L+
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 537 YLHFGYSALVIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMA 595
           Y+H      +IH D+KP NVL++  +   +L    IA L          T ++ T  Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 596 P 596
           P
Sbjct: 198 P 198

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (143), Expect = 2e-10
 Identities = 41/269 (15%), Positives = 90/269 (33%), Gaps = 11/269 (4%)

Query: 3   PLEIGNL--QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPN 60
           P   G L  Q +   +  ++  +    A  F+   ++ + L N+ +  S       +   
Sbjct: 14  PDVTGRLLSQGVIAFRCPRS-FMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSK 72

Query: 61  LEKLYLWGNNFSGTIPRFIFNASKLSKLSLG--MNSFSGFIPSTFGNLRNLEQLGLDENY 118
           L+ L L G   S  I   +   S L +L+L          + +   +   L++L L   +
Sbjct: 73  LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132

Query: 119 LTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGI 178
             +       ++ +S   +   +      L      T +      +      +  +    
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192

Query: 179 PEEISNLTNLVEIDLGG-NKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAE-L 236
            +E   L  L  + L     +     + LG++  L+ L +   + +G++      L E L
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ----LLKEAL 248

Query: 237 YRLELGSNKLYGSIPACFGNLASLRILSL 265
             L++  +          GN  +  I  +
Sbjct: 249 PHLQINCSHFTTIARPTIGNKKNQEIWGI 277

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 56.3 bits (135), Expect = 9e-10
 Identities = 15/112 (13%), Positives = 36/112 (32%), Gaps = 16/112 (14%)

Query: 466 KSFDVECEMMKSIRHRNLIKVISSCSNEEF----KALVLEYMPHGSLEKYLYSSNCILDI 521
             F V          R L K+      + +     A+++E +               + +
Sbjct: 51  LHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE--------LYRVRV 102

Query: 522 FQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK 573
                ++  +   +   +      ++H DL   NVL+ +  +  + DF  + 
Sbjct: 103 ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.2 bits (134), Expect = 2e-09
 Identities = 35/219 (15%), Positives = 72/219 (32%), Gaps = 16/219 (7%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
            L N  ++  G++ +  TV  A  ++  +  L      ++ ++  +    L NL  L L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQY--LNNLIGLELK 71

Query: 68  GNNF-----SGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSS 122
            N          + +        + L             T                L++ 
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 123 TPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLS--RSLEEFYMYNCNISGGIPE 180
                 L+ ++N   L  +        G    + ++ L+    L      +  IS   P 
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLED 219
            +++L NL+E+ L  N+++   P  L     L  + L +
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 5e-06
 Identities = 28/221 (12%), Positives = 72/221 (32%), Gaps = 24/221 (10%)

Query: 81  NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTL 140
             +   K++ G ++ +  +  T  +L  +  L      +T+       +  +    +L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 141 IDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNG 200
           ++L +N +  + P  +++ ++             +    + I  L            L G
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 201 S------------IPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYG 248
                        I              L     + S    +  L++L  L+   NK+  
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 249 SIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFS 289
             P    +L +L  + L +N+++ +     N  ++  +  +
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 26/214 (12%), Positives = 57/214 (26%), Gaps = 18/214 (8%)

Query: 134 NCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL 193
              +   I    + +   + +  +  +         +   ++    E +  L NL+ ++L
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLDGI----TTLSAFGTGVTT--IEGVQYLNNLIGLEL 70

Query: 194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPAC 253
             N++    P+          L+        +I                ++    +  + 
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 254 FGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFS 313
              L            L  I               S        L  + NL  L  +   
Sbjct: 131 LQVL---------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181

Query: 314 MNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIP 347
            N  S + P      L  L +++L  N++    P
Sbjct: 182 DNKISDISPLA---SLPNLIEVHLKNNQISDVSP 212

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 4e-08
 Identities = 39/193 (20%), Positives = 66/193 (34%), Gaps = 12/193 (6%)

Query: 99  IPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSIS 158
           +P      ++   L L EN L + +      ++L     LT ++L    L  +    ++ 
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSL-----ATLMPYTRLTQLNLDRAELTKLQVDGTLP 77

Query: 159 NLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLE 218
            L                G       + ++       N+L       L  L +LQ L L+
Sbjct: 78  VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSF-----NRLTSLPLGALRGLGELQELYLK 132

Query: 219 DNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFW 278
            N L+   P  +    +L +L L +N L          L +L  L L  N L +IP  F+
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFF 192

Query: 279 NLKDILQLNFSSN 291
               +       N
Sbjct: 193 GSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.0 bits (123), Expect = 6e-08
 Identities = 44/214 (20%), Positives = 74/214 (34%), Gaps = 14/214 (6%)

Query: 57  RLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE 116
           ++ +  ++     N +  +P  +      + L L  N    F  +T      L QL LD 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG 176
             LT                +L ++   +   + +     +     +L    +    ++ 
Sbjct: 65  AELTKLQ----------VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS 114

Query: 177 GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAEL 236
                +  L  L E+ L GN+L    P  L    KL++L+L +N L       +  L  L
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174

Query: 237 YRLELGSNKLYGSIPACFGNLASLRILSLGSNKL 270
             L L  N LY +IP  F     L    L  N  
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 2e-07
 Identities = 44/218 (20%), Positives = 73/218 (33%), Gaps = 13/218 (5%)

Query: 153 PKTSISNLSRSLEEFYMYNCNISG--GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLR 210
           P   +S ++  LE     NC+      +P ++    +   + L  N L      TL    
Sbjct: 2   PICEVSKVASHLE----VNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYT 55

Query: 211 KLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKL 270
           +L +LNL+    E +       L  L  L+L  N+L           A   +    +   
Sbjct: 56  RLTQLNLDRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT 113

Query: 271 TSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLS 330
           +        L ++ +L    N L       +     L  +  + NN + +    +   L 
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN-GLE 172

Query: 331 YLEDLNLSFNKLKGEIPRG-GSFGNFSAESFEGNELLC 367
            L+ L L  N L   IP+G             GN  LC
Sbjct: 173 NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (111), Expect = 2e-06
 Identities = 34/188 (18%), Positives = 61/188 (32%), Gaps = 19/188 (10%)

Query: 49  SLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRN 108
           +L+++      +   L+L  N         +   ++L++L+L  +          G L  
Sbjct: 21  NLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPV 78

Query: 109 LEQLGLDENYLTSSTP----------------ELSFLSSLSNCKSLTLIDLSNNPLDGIL 152
           L  L L  N L S                    L+ L   +      L +L     +   
Sbjct: 79  LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 153 PKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKL 212
               +   +  LE+  + N N++      ++ L NL  + L  N L  +IP        L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197

Query: 213 QRLNLEDN 220
               L  N
Sbjct: 198 PFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 1e-05
 Identities = 40/193 (20%), Positives = 56/193 (29%), Gaps = 52/193 (26%)

Query: 1   EIPLEIGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLS------------- 47
            +P ++   ++   L L +N L     A +   + L  L L    L+             
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81

Query: 48  -------------------------------GSLSSIANVRLPNLEKLYLWGNNFSGTIP 76
                                           SL   A   L  L++LYL GN      P
Sbjct: 82  LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 77  RFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCK 136
             +    KL KLSL  N+ +         L NL+ L L EN L       +         
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY------TIPKGFFGSH 195

Query: 137 SLTLIDLSNNPLD 149
            L    L  NP  
Sbjct: 196 LLPFAFLHGNPWL 208

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 3e-07
 Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 9/92 (9%)

Query: 196 NKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFG 255
           N  +  I         L+ LN+ +N L   +P    RL  L       N L   +P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHL-AEVPELPQ 324

Query: 256 NLASLRILSLGSNKLTSIPLTFWNLKDILQLN 287
           N   L+ L +  N L   P    +++D L++N
Sbjct: 325 N---LKQLHVEYNPLREFPDIPESVED-LRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 2e-06
 Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 9/96 (9%)

Query: 167 FYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSI 226
              Y    S  I        +L E+++  NKL   +P       +L+RL    N L   +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EV 319

Query: 227 PDDICRLAELYRLELGSNKLYGSIPACFGNLASLRI 262
           P+    L +L+   +  N L    P    ++  LR+
Sbjct: 320 PELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 7e-06
 Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 16/97 (16%)

Query: 92  MNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGI 151
           +N+ S  I S      +LE+L +  N L         L  L           S N L   
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERL---------IASFNHL--- 316

Query: 152 LPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNL 188
                +  L ++L++ ++    +    P+   ++ +L
Sbjct: 317 ---AEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.0 bits (102), Expect = 3e-05
 Identities = 23/95 (24%), Positives = 35/95 (36%), Gaps = 12/95 (12%)

Query: 244 NKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGN 303
           N     I +      SL  L++ +NKL  +P     L+   +L  S N L   +     N
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAE-VPELPQN 325

Query: 304 LKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLS 338
           LK L       N        E  +    +EDL ++
Sbjct: 326 LKQL---HVEYNPLR-----EFPDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.5 bits (98), Expect = 1e-04
 Identities = 18/94 (19%), Positives = 33/94 (35%), Gaps = 10/94 (10%)

Query: 16  QLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTI 75
               N     + +      +L+ L + NN L    +       P LE+L    N+ +  +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALP-----PRLERLIASFNHLA-EV 319

Query: 76  PRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNL 109
           P    N   L +L +  N      P    ++ +L
Sbjct: 320 PELPQN---LKQLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.001
 Identities = 20/78 (25%), Positives = 32/78 (41%), Gaps = 10/78 (12%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
              +LEEL +  NKLI  +PA       L+ L    N L+  +  +      NL++L++ 
Sbjct: 282 LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPEL----PQNLKQLHVE 332

Query: 68  GNNFSGTIPRFIFNASKL 85
            N      P    +   L
Sbjct: 333 YNPLR-EFPDIPESVEDL 349

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 9e-07
 Identities = 27/118 (22%), Positives = 48/118 (40%), Gaps = 6/118 (5%)

Query: 168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP 227
           ++ + +++  +   +  L  +  +DL  N+L    P  L  LR L+ L   DN       
Sbjct: 4   HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENV 58

Query: 228 DDICRLAELYRLELGSNKL-YGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDIL 284
           D +  L  L  L L +N+L   +      +   L +L+L  N L         L ++L
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.2 bits (96), Expect = 4e-05
 Identities = 24/107 (22%), Positives = 36/107 (33%), Gaps = 4/107 (3%)

Query: 239 LELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLL 298
           L L    L  ++      L  +  L L  N+L ++P     L+ +  L  S N      +
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNA--LENV 58

Query: 299 LEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGE 345
             + NL  L  +    N        +       L  LNL  N L  E
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 9e-05
 Identities = 24/129 (18%), Positives = 42/129 (32%), Gaps = 11/129 (8%)

Query: 88  LSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNP 147
           L L     +  +      L  +  L L  N L +  P L+ L  L   ++    D +   
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQA---SDNALEN 57

Query: 148 LDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLG 207
           +DG+     +  L          N        + + +   LV ++L GN L     I   
Sbjct: 58  VDGVANLPRLQELLLC------NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111

Query: 208 KLRKLQRLN 216
               L  ++
Sbjct: 112 LAEMLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.001
 Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 7/107 (6%)

Query: 191 IDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSI 250
           + L    L  ++   L +L  +  L+L  N L    P  +  L  L  L+   N L    
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59

Query: 251 PACFGNLASLRILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLTG 295
                    L+ L L +N+L          +   ++ LN   N L  
Sbjct: 60  GVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 2e-06
 Identities = 11/99 (11%), Positives = 31/99 (31%), Gaps = 5/99 (5%)

Query: 137 SLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISG----GIPEEISNLTNLVEID 192
            +  +D+    L        +  L +  +   + +C ++      I   +     L E++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLL-QQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 193 LGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC 231
           L  N+L       + +  +     ++   L+        
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 3e-05
 Identities = 16/93 (17%), Positives = 35/93 (37%), Gaps = 5/93 (5%)

Query: 85  LSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDL 143
           +  L +     S          L+  + + LD+  LT +  +    S+L    +L  ++L
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAELNL 62

Query: 144 SNNPLDGILPKT---SISNLSRSLEEFYMYNCN 173
            +N L  +        +   S  +++  + NC 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 3e-05
 Identities = 12/92 (13%), Positives = 29/92 (31%), Gaps = 4/92 (4%)

Query: 11 NLEELQLGQNKLIGTVPAAIF-NVSTLKFLGLQNNSLSG-SLSSIANV--RLPNLEKLYL 66
          +++ L +   +L     A +   +   + + L +  L+      I++     P L +L L
Sbjct: 3  DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 67 WGNNFSGTIPRFIFNASKLSKLSLGMNSFSGF 98
            N         +    +     +   S    
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 5e-05
 Identities = 16/84 (19%), Positives = 33/84 (39%), Gaps = 9/84 (10%)

Query: 163 SLEEFYMYNCNISG----GIPEEISNLTNLVEIDLGGNKLNGSIPITLGK-----LRKLQ 213
            L   ++ +C++S      +   +    +L E+DL  N L  +  + L +        L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 214 RLNLEDNILEGSIPDDICRLAELY 237
           +L L D      + D +  L +  
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 6e-05
 Identities = 12/92 (13%), Positives = 24/92 (26%), Gaps = 5/92 (5%)

Query: 60  NLEKLYLWGNNFSGT-IPRFIFNASKLSKLSLGMNSFSG----FIPSTFGNLRNLEQLGL 114
           +++ L +     S       +    +   + L     +      I S       L +L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 115 DENYLTSSTPELSFLSSLSNCKSLTLIDLSNN 146
             N L             +    +  + L N 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 2e-04
 Identities = 18/89 (20%), Positives = 29/89 (32%), Gaps = 8/89 (8%)

Query: 27  PAAIFNVSTLKFLGLQNNSLSG-SLSSIANV--RLPNLEKLYLWGNNFSGTIPRFIFNA- 82
                  S L+ L L +  +S  S SS+A       +L +L L  N         +  + 
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 83  ----SKLSKLSLGMNSFSGFIPSTFGNLR 107
                 L +L L    +S  +      L 
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 3e-04
 Identities = 14/92 (15%), Positives = 22/92 (23%), Gaps = 4/92 (4%)

Query: 67  WGNNFSGTIPRFIFNASKLSKLSLGMNSFSG----FIPSTFGNLRNLEQLGLDENYLTSS 122
                           S L  L L     S      + +T     +L +L L  N L  +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412

Query: 123 TPELSFLSSLSNCKSLTLIDLSNNPLDGILPK 154
                  S       L  + L +      +  
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.001
 Identities = 16/80 (20%), Positives = 28/80 (35%), Gaps = 8/80 (10%)

Query: 8   NLQNLEELQLGQNKL----IGTVPAAIFNVSTLKFLGLQNNSLSGS----LSSIANVRLP 59
               L  L L    +      ++ A +    +L+ L L NN L  +    L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 60  NLEKLYLWGNNFSGTIPRFI 79
            LE+L L+   +S  +   +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.001
 Identities = 21/98 (21%), Positives = 36/98 (36%), Gaps = 10/98 (10%)

Query: 187 NLVEIDLGGNKLNGS-IPITLGKLRKLQRLNLEDNILEGSIPDDICR----LAELYRLEL 241
           ++  +D+   +L+ +     L  L++ Q + L+D  L  +   DI         L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 242 GSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWN 279
            SN+L      C         L   S K+  + L    
Sbjct: 63  RSNELGDVGVHCVLQG-----LQTPSCKIQKLSLQNCC 95

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.7 bits (104), Expect = 8e-06
 Identities = 34/208 (16%), Positives = 66/208 (31%), Gaps = 24/208 (11%)

Query: 8   NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLW 67
            L    +  LG+  +  TV     ++  +  L      +  S+  +    L NL ++   
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEY--LNNLTQINFS 70

Query: 68  GNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELS 127
            N  +   P             L   +    I      + ++  L    N    +     
Sbjct: 71  NNQLTDITP-------------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 117

Query: 128 FLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTN 187
                       L  L  +     +   S  +   SL++    +  ++   P  ++NLT 
Sbjct: 118 ITDIDPLKNLTNLNRLELSS--NTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTT 173

Query: 188 LVEIDLGGNKLNGSIPITLGKLRKLQRL 215
           L  +D+  NK++      L KL  L+ L
Sbjct: 174 LERLDISSNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 2e-04
 Identities = 40/194 (20%), Positives = 67/194 (34%), Gaps = 21/194 (10%)

Query: 81  NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTL 140
             ++  K  LG  + +  +  +  +L  +  L  D   + S       +  +    +LT 
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLTQ 66

Query: 141 IDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNG 200
           I+ SNN L  I P  +++ L   L                 ++ LT              
Sbjct: 67  INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTL--------FNNQI 118

Query: 201 SIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASL 260
           +    L  L  L RL L  N +             L +L   SN++    P    NL +L
Sbjct: 119 TDIDPLKNLTNLNRLELSSNTISDISALSGLT--SLQQLNFSSNQVTDLKP--LANLTTL 174

Query: 261 RILSLGSNKLTSIP 274
             L + SNK++ I 
Sbjct: 175 ERLDISSNKVSDIS 188

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 1e-05
 Identities = 37/222 (16%), Positives = 70/222 (31%), Gaps = 30/222 (13%)

Query: 2   IPLEIG------NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIAN 55
           +P  I             +  L +  +   V      ++++  +   N+ +  S+  I  
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQY 66

Query: 56  VRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD 115
             LPN+ KL+L GN  +      I   + L  L       +     +        +    
Sbjct: 67  --LPNVTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL 119

Query: 116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS 175
           E+   S    L  L  L +             L  +    +            + +  IS
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDT----------LSLEDNQIS 169

Query: 176 GGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL 217
             +P  ++ LT L  + L  N ++  +   L  L+ L  L L
Sbjct: 170 DIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 9e-05
 Identities = 36/210 (17%), Positives = 77/210 (36%), Gaps = 22/210 (10%)

Query: 81  NASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTL 140
             ++  K +L   S +  +      L +++Q+  + + + S       +  +    ++T 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-------VQGIQYLPNVTK 72

Query: 141 IDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNG 200
           + L+ N L  I     ++NL      F   N        +++  L +        +  + 
Sbjct: 73  LFLNGNKLTDI---KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS-------LSLEHN 122

Query: 201 SIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASL 260
            I    G +   Q  +L     + +    + RL +L  L L  N++   +P     L  L
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKL 180

Query: 261 RILSLGSNKLTSIPLTFWNLKDILQLNFSS 290
           + L L  N ++ +      LK++  L   S
Sbjct: 181 QNLYLSKNHISDLR-ALAGLKNLDVLELFS 209

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 1e-04
 Identities = 29/226 (12%), Positives = 64/226 (28%), Gaps = 5/226 (2%)

Query: 49  SLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRN 108
            ++ I +    N  +L                    L K+ +  N     I +   +   
Sbjct: 19  KVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 78

Query: 109 LEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFY 168
                 +     ++        +  N  +L  + +SN  +  +     I +L + L +  
Sbjct: 79  KLH---EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135

Query: 169 MYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPD 228
                 +      +      V + L  N +           +  +    ++N LE    D
Sbjct: 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPND 195

Query: 229 DICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP 274
                +    L++   +++        NL  LR  S     L  +P
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (83), Expect = 0.004
 Identities = 25/219 (11%), Positives = 60/219 (27%), Gaps = 6/219 (2%)

Query: 74  TIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLS 133
            IP  +       +L   +          F    +LE++ + +N +        F +   
Sbjct: 22  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 134 NCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL 193
             +       +   ++    +   +     +    + +      I      L ++ +   
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI- 138

Query: 194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPAC 253
             N         +G   +   L L  N ++                   +N L       
Sbjct: 139 --NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDV 196

Query: 254 FGNLASLRILSLGSNKLTSIP-LTFWNLKDILQLNFSSN 291
           F   +   IL +   ++ S+P     NLK +   +  + 
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (92), Expect = 2e-04
 Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 3/94 (3%)

Query: 181 EISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE 240
           + +N     E+DL G K+   I      L +   ++  DN +     D    L  L  L 
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69

Query: 241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIP 274
           + +N++          L  L  L L +N L  + 
Sbjct: 70  VNNNRICRIGEGLDQALPDLTELILTNNSLVELG 103

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 9e-04
 Identities = 14/69 (20%), Positives = 23/69 (33%), Gaps = 2/69 (2%)

Query: 254 FGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFS 313
           + N    R L L   K+  I      L     ++FS N +    L     L+ L  +  +
Sbjct: 14  YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVN 71

Query: 314 MNNFSGVIP 322
            N    +  
Sbjct: 72  NNRICRIGE 80

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.6 bits (93), Expect = 2e-04
 Identities = 36/188 (19%), Positives = 69/188 (36%), Gaps = 12/188 (6%)

Query: 133 SNCK-SLTLIDLSNNPLDGILPKTSI-SNLSRSLEEFYM-YNCNISGGIPEEISNLTNLV 189
           + C    T +D +   L        I  ++     E  +  N             L +LV
Sbjct: 4   AMCHCEGTTVDCTGRGL------KEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLV 57

Query: 190 EIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS 249
           +++L  N+L G  P        +Q L L +N ++         L +L  L L  N++   
Sbjct: 58  KLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCV 117

Query: 250 IPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIG 309
           +P  F +L SL  L+L SN         W  + + + + +          ++ ++++   
Sbjct: 118 MPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIK-- 175

Query: 310 IDFSMNNF 317
            D   + F
Sbjct: 176 -DLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.002
 Identities = 34/167 (20%), Positives = 64/167 (38%), Gaps = 7/167 (4%)

Query: 178 IPEEISNLTNLVEIDLGGNKLNGSIPITL-GKLRKLQRLNLEDNILEGSIPDDICRLAEL 236
           IP +I    +  E+ L  N+L       L G+L  L +L L+ N L G  P+     + +
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 237 YRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGP 296
             L+LG NK+       F  L  L+ L+L  N+++ +    +   + L     ++     
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140

Query: 297 LLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLK 343
                   + L     +        P     K+  ++  +L  ++ K
Sbjct: 141 NCHLAWFAEWLRKKSLNGGAARCGAP----SKVRDVQIKDLPHSEFK 183

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 5e-04
 Identities = 26/133 (19%), Positives = 42/133 (31%), Gaps = 12/133 (9%)

Query: 99  IPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSIS 158
           +        +  Q  LD   L S       L + +    L         L  I       
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLRS----DPDLVAQNIDVVLNRRSSMAATLRIIE-----E 62

Query: 159 NLSRSLEEFYMYNCNISG--GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLN 216
           N+   L    + N  +     +   +    NL  ++L GN+L     +   K  KL+ L 
Sbjct: 63  NIP-ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELW 121

Query: 217 LEDNILEGSIPDD 229
           L+ N L  +  D 
Sbjct: 122 LDGNSLSDTFRDQ 134

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.002
 Identities = 23/123 (18%), Positives = 43/123 (34%), Gaps = 7/123 (5%)

Query: 101 STFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL 160
               +  +L    +D      S+   +      N   L  ++LSNN L  +   +SI   
Sbjct: 30  KGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQK 89

Query: 161 SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPIT-------LGKLRKLQ 213
           + +L+   +    +      +      L E+ L GN L+ +             +  KL 
Sbjct: 90  APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLL 149

Query: 214 RLN 216
           RL+
Sbjct: 150 RLD 152

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.3 bits (82), Expect = 0.003
 Identities = 23/138 (16%), Positives = 42/138 (30%), Gaps = 4/138 (2%)

Query: 135 CKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLG 194
               + +  + +     L    +       E +     ++      ++  L  L  + + 
Sbjct: 7   PHGSSGLRCTRDGALDSLH--HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 195 GNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPAC- 253
            + L    P       +L RLNL  N LE S+     +   L  L L  N L+ S     
Sbjct: 65  KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123

Query: 254 FGNLASLRILSLGSNKLT 271
                   +  +   KL 
Sbjct: 124 LQRWEEEGLGGVPEQKLQ 141

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.2 bits (84), Expect = 0.004
 Identities = 35/316 (11%), Positives = 80/316 (25%), Gaps = 25/316 (7%)

Query: 1   EIPLEIGNLQNLEELQLGQNKL----IGTVPAAIFNVSTLKFLGLQNNSLSGSLSSI--- 53
            +   +    +++E+ L  N +       +   I +   L+     +         I   
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 54  ------ANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLR 107
                 A ++ P L  + L  N F  T    + +          +   +  +    G   
Sbjct: 82  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141

Query: 108 NLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEF 167
                 L  N    + P L  +    N                         + ++    
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLE-NGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200

Query: 168 YMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIP 227
                 +  G+          ++ +   +  + ++ I L     L+ L L D +L     
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260

Query: 228 DDI------CRLAELYRLELGSNKLYGSIP-----ACFGNLASLRILSLGSNKLTSIPLT 276
             +           L  L L  N++               +  L  L L  N+ +     
Sbjct: 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 320

Query: 277 FWNLKDILQLNFSSNF 292
              ++++         
Sbjct: 321 VDEIREVFSTRGRGEL 336

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.2 bits (84), Expect = 0.004
 Identities = 37/318 (11%), Positives = 74/318 (23%), Gaps = 18/318 (5%)

Query: 36  LKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSG----TIPRFIFNASKLSKLSLG 91
           LK   +         + +      +++++ L GN         +   I +   L      
Sbjct: 10  LKLDAITTEDEKSVFAVLLE--DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 92  MNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGI 151
                         LR L Q  L    L +     +     +    +  +          
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 152 LPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRK 211
           L    +   + +     +    ++          + +   +   N        T    R 
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187

Query: 212 LQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLT 271
           L  + +  N +     + +      Y  EL    L  +     G+ A           L 
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA-LKSWPNLR 246

Query: 272 SIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGE---- 327
            + L    L                          L  +    N       R +      
Sbjct: 247 ELGLNDCLLSARGAAAVVDA-------FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 299

Query: 328 KLSYLEDLNLSFNKLKGE 345
           K+  L  L L+ N+   E
Sbjct: 300 KMPDLLFLELNGNRFSEE 317

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	596
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.96
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.96
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.96
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.96
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.96
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.96
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.96
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.96
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.96
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.96
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.96
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.96
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.95
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.95
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.95
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.95
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.95
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.95
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.95
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.95
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.95
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.95
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.95
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.94
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.94
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.94
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.94
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.94
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.94
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.94
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.94
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.94
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.94
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.93
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.92
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.92
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.92
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.92
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.92
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.91
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.91
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.91
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.91
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.9
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.89
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.83
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.83
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.82
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.82
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.82
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.79
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.78
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.77
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.75
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.7
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.65
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.63
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.61
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.6
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.6
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.6
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.56
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.56
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.43
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.4
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.39
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.38
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.69
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.63
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.79
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.67
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.4
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.15
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.1
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.4
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	94.33
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	88.5
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	81.47

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=9.9e-32  Score=269.67  Aligned_cols=257  Identities=30%  Similarity=0.546  Sum_probs=154.3

Q ss_pred             CCCEEEccCCcccc--cCCccccCCCCCCEEecCC-CcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcc
Q 036342           84 KLSKLSLGMNSFSG--FIPSTFGNLRNLEQLGLDE-NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNL  160 (596)
Q Consensus        84 ~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l  160 (596)
                      +++.|+|++|.+++  .+|+.+++|++|++|+|++ |.+++.     +|..++++++|++|+|++|++.+          
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~-----iP~~i~~L~~L~~L~Ls~N~l~~----------  115 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP-----IPPAIAKLTQLHYLYITHTNVSG----------  115 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESC-----CCGGGGGCTTCSEEEEEEECCEE----------
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccc-----cccccccccccchhhhccccccc----------
Confidence            57777777777766  3556666666666666654 555542     12235555555555555555554          


Q ss_pred             cccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCC-cEE
Q 036342          161 SRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAEL-YRL  239 (596)
Q Consensus       161 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L  239 (596)
                                      ..+..+..+..|+.+++++|.+.+.+|..+..+++|+++++++|.+++.+|..+..+.++ +.+
T Consensus       116 ----------------~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l  179 (313)
T d1ogqa_         116 ----------------AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM  179 (313)
T ss_dssp             ----------------ECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEE
T ss_pred             ----------------cccccccchhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccccccc
Confidence                            444444444555555555555554455555555555555555555555555544444443 445


Q ss_pred             EccCCcCcccchhhhccCCCCcEEEeCCCcccC-CCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCc
Q 036342          240 ELGSNKLYGSIPACFGNLASLRILSLGSNKLTS-IPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       240 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      +++.|++++..|..+..+..+ .+++++|...+ +|..+..+++++.+++++|.+++.++ .+..++.|+.||+++|+++
T Consensus       180 ~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~  257 (313)
T d1ogqa_         180 TISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIY  257 (313)
T ss_dssp             ECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCE
T ss_pred             ccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeec
Confidence            555555555555444444322 45555555443 34444455555555555665555433 4566677777777777777


Q ss_pred             ccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCcccccccccccCCCCCCCCCC
Q 036342          319 GVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC  377 (596)
Q Consensus       319 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c~~~~~~~~~~  377 (596)
                      |.+|. .+..+++|++|||++|+|+|.+|..+.+++++.+++.+|+..|+.|.   |+|
T Consensus       258 g~iP~-~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl---p~c  312 (313)
T d1ogqa_         258 GTLPQ-GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL---PAC  312 (313)
T ss_dssp             ECCCG-GGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS---SCC
T ss_pred             ccCCh-HHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC---CCC
Confidence            77787 35677888888888888888888777788888899999999999874   456

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.8e-33  Score=271.24  Aligned_cols=149  Identities=23%  Similarity=0.373  Sum_probs=132.8

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .++|+..+.||+|+||+||+|.                      +.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            4689999999999999999852                      357899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ||++|+|.+++.... .+++.++..++.|+++|++|||   +.+|+||||||+|||+++++.+||+|||+|+........
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999997653 6899999999999999999999   899999999999999999999999999999976543333


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      ......+||+.||||
T Consensus       160 ~~~~~~~GT~~Y~AP  174 (271)
T d1nvra_         160 RLLNKMCGTLPYVAP  174 (271)
T ss_dssp             CCBCCCCSCGGGSCT
T ss_pred             ccccceeeCcCccCH
Confidence            334557899999999

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=270.13  Aligned_cols=151  Identities=24%  Similarity=0.424  Sum_probs=127.9

Q ss_pred             HhcccccccccccCCCceeehhh--------------------HHhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          442 RATDEFSENNLIGRGGFALFIRA--------------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~--------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ...++|...+.||+|+||+||+|                    .+.+.+|+.++++++|||||++++++.+ +..++|||
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            34568999999999999999985                    2568899999999999999999998865 45899999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      ||++|+|.+++......+++.++..++.||++|++|||   +++|+||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877667999999999999999999999   889999999999999999999999999999876433333


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      ......+||+.||||
T Consensus       161 ~~~~~~~gt~~y~AP  175 (276)
T d1uwha_         161 HQFEQLSGSILWMAP  175 (276)
T ss_dssp             -----CCCCGGGCCH
T ss_pred             ccccccccCcccCCH
Confidence            334456899999998

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=3.4e-31  Score=265.72  Aligned_cols=253  Identities=31%  Similarity=0.447  Sum_probs=189.3

Q ss_pred             CCccEEEccCCcccc--ccCccccCCCCCCEEEccC-CcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCC
Q 036342           59 PNLEKLYLWGNNFSG--TIPRFIFNASKLSKLSLGM-NSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNC  135 (596)
Q Consensus        59 ~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l  135 (596)
                      .+++.|||++|.+.+  .+|++++++++|++|+|++ |+++|.+|..|++|++|++|+|++|++.+..+.     .+..+
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~-----~~~~~  124 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD-----FLSQI  124 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG-----GGGGC
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccc-----cccch
Confidence            368888888888876  4788899999999999986 788888888999999999999999988876543     24555


Q ss_pred             CCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCC-Ce
Q 036342          136 KSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKL-QR  214 (596)
Q Consensus       136 ~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~  214 (596)
                      ..|+.++++.|.+                          .+.+|..+.+++.++.+++++|.+.+.+|..+..+.++ +.
T Consensus       125 ~~L~~l~l~~N~~--------------------------~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~  178 (313)
T d1ogqa_         125 KTLVTLDFSYNAL--------------------------SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS  178 (313)
T ss_dssp             TTCCEEECCSSEE--------------------------ESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCE
T ss_pred             hhhcccccccccc--------------------------cccCchhhccCcccceeeccccccccccccccccccccccc
Confidence            5555555555544                          44455556666667777777777766666666666554 66


Q ss_pred             EEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCC
Q 036342          215 LNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       215 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~  294 (596)
                      +++++|++++..|..+..+.. ..+++++|...+.+|..+..+++++.+++++|.++..+..+..+++|+.|+|++|+++
T Consensus       179 l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~  257 (313)
T d1ogqa_         179 MTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY  257 (313)
T ss_dssp             EECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCE
T ss_pred             ccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccCccCeec
Confidence            777777777777766666543 4677777777777777777777788888888877776666777788888888888888


Q ss_pred             CchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeEECCCCc-cccc
Q 036342          295 GPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDLNLSFNK-LKGE  345 (596)
Q Consensus       295 ~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~-l~~~  345 (596)
                      |.+|..++.+++|++|||++|+++|.+|.  +..+++|+.+++++|+ +.|.
T Consensus       258 g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~--~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             ECCCGGGGGCTTCCEEECCSSEEEEECCC--STTGGGSCGGGTCSSSEEEST
T ss_pred             ccCChHHhCCCCCCEEECcCCcccccCCC--cccCCCCCHHHhCCCccccCC
Confidence            88888888888888888888888888885  3567888888898887 4443

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.8e-29  Score=260.21  Aligned_cols=328  Identities=25%  Similarity=0.346  Sum_probs=215.9

Q ss_pred             CCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCE
Q 036342            8 NLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSK   87 (596)
Q Consensus         8 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~   87 (596)
                      .+.+|++|++++|+|+.+  +.+..+++|++|||++|+|++ ++++.  .+++|++|++++|++.+..  .+.++++|+.
T Consensus        42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~-l~~l~--~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~  114 (384)
T d2omza2          42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITPLK--NLTKLVDILMNNNQIADIT--PLANLTNLTG  114 (384)
T ss_dssp             HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC-CGGGT--TCTTCCEEECCSSCCCCCG--GGTTCTTCCE
T ss_pred             HhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCC-Ccccc--CCccccccccccccccccc--cccccccccc
Confidence            456788888888888754  356778888888888888874 44443  4888888888888887543  3778888888


Q ss_pred             EEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCc--------------cccccCCCCCCCCEEECcCCCCCccCC
Q 036342           88 LSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPEL--------------SFLSSLSNCKSLTLIDLSNNPLDGILP  153 (596)
Q Consensus        88 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~--------------~~~~~~~~l~~L~~L~ls~N~l~~~~~  153 (596)
                      |++++|.+++..+  ......+..+....|.+.......              .....+...+.........|.....  
T Consensus       115 L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  190 (384)
T d2omza2         115 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--  190 (384)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccc--
Confidence            8888888876543  344556666666666554321110              0111233344444455555544322  


Q ss_pred             chhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcC
Q 036342          154 KTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRL  233 (596)
Q Consensus       154 ~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  233 (596)
                       .....+ ++++.+++++|.+++..|  +...++|+.|++++|.++..  ..+..+++|+.|++++|.+++..  .+..+
T Consensus       191 -~~~~~l-~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~  262 (384)
T d2omza2         191 -SVLAKL-TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGL  262 (384)
T ss_dssp             -GGGGGC-TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTC
T ss_pred             -cccccc-cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--ccccc
Confidence             133344 567777777777776544  34556777777777777642  35667777777777777777433  36667


Q ss_pred             CCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecC
Q 036342          234 AELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFS  313 (596)
Q Consensus       234 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls  313 (596)
                      ++|++|++++|++++..  .+..++.++.++++.|.++.++ .+..+++++.|++++|++++..+  +..+++|++|+++
T Consensus       263 ~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~  337 (384)
T d2omza2         263 TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA  337 (384)
T ss_dssp             TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC
T ss_pred             ccCCEeeccCcccCCCC--cccccccccccccccccccccc-ccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECC
Confidence            77777777777776443  2666777777777777777654 35667777777777777776532  6667777777777


Q ss_pred             CCcCcccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCccccccc
Q 036342          314 MNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGN  363 (596)
Q Consensus       314 ~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N  363 (596)
                      +|++++ ++  .+..+++|++|++++|++++.+| ...+++++.+++++|
T Consensus       338 ~n~l~~-l~--~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         338 NNKVSD-VS--SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             SSCCCC-CG--GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             CCCCCC-Ch--hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            777763 33  24567777777777777776544 445667777777766

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=4.3e-32  Score=269.45  Aligned_cols=149  Identities=23%  Similarity=0.439  Sum_probs=120.1

Q ss_pred             ccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ++|+..+.||+|+||+||+|.                         +.|.+|++++++++|||||+++|+|..++..|+|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            345667899999999999852                         4688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||||++|+|.+++......++|.++..++.||++|+.|||   +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999887667999999999999999999999   8999999999999999999999999999999765332


Q ss_pred             Cc---cccccccccccccCC
Q 036342          580 QS---MTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~---~~~~~~~gt~~y~aP  596 (596)
                      ..   .......||+.||||
T Consensus       183 ~~~~~~~~~~~~~t~~y~aP  202 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAP  202 (299)
T ss_dssp             -------------CGGGSCH
T ss_pred             CcceeeecccccCCccccCH
Confidence            21   112234689999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-31  Score=261.53  Aligned_cols=145  Identities=28%  Similarity=0.391  Sum_probs=130.7

Q ss_pred             ccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ++|+..+.||+|+||+||+|.                     +.+.+|+.++++++|||||++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            479999999999999999862                     45789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      ++|+|.+++...  .+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cc
Confidence            999999988764  4889999999999999999999   8999999999999999999999999999999764332  22


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      ....+||+.||||
T Consensus       173 ~~~~~gt~~Y~aP  185 (293)
T d1yhwa1         173 RSTMVGTPYWMAP  185 (293)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             ccccccCCCccCh
Confidence            3456899999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=7.7e-32  Score=265.98  Aligned_cols=153  Identities=25%  Similarity=0.449  Sum_probs=134.4

Q ss_pred             HHHhcccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ++...++|+..+.||+|+||+||+|.                    +.+.+|++++++++|||||+++++|.+++..|+|
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            34456789999999999999999862                    5688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          500 LEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      ||||++|+|.+++... ...+++..+..++.|+++|++|||   .++|+||||||+|||+++++.+||+|||+|+.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            9999999999999764 356899999999999999999999   889999999999999999999999999999976543


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      . ........||+.||||
T Consensus       169 ~-~~~~~~~~g~~~y~aP  185 (287)
T d1opja_         169 T-YTAHAGAKFPIKWTAP  185 (287)
T ss_dssp             S-SEEETTEEECGGGCCH
T ss_pred             C-ceeeccccccccccCh
Confidence            2 2223445689999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-31  Score=263.26  Aligned_cols=148  Identities=30%  Similarity=0.493  Sum_probs=128.6

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||+||+|.                        +.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            579999999999999999852                        34788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |||++|+|.+++...+ .+++..+..++.|++.|++|||   +++|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999987764 6899999999999999999999   89999999999999999999999999999997753332


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                      .......+||+.||||
T Consensus       164 ~~~~~~~~GT~~Y~AP  179 (288)
T d1uu3a_         164 QARANSFVGTAQYVSP  179 (288)
T ss_dssp             ------CCCCGGGCCH
T ss_pred             ccccccccCCccccCc
Confidence            2233456899999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-31  Score=258.72  Aligned_cols=145  Identities=28%  Similarity=0.453  Sum_probs=130.5

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||+||+|.                        +.+.+|++++++++|||||++++++.+++..|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            3589999999999999999852                        3467899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||||++|+|.+++.... .+++..+..++.|+++|++|||   +++|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        85 mEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             EeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence            99999999999998654 5899999999999999999999   899999999999999999999999999999875432 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         .....+||+.||||
T Consensus       160 ---~~~~~~Gt~~Y~AP  173 (263)
T d2j4za1         160 ---RRTTLCGTLDYLPP  173 (263)
T ss_dssp             ---CCEETTEEGGGCCH
T ss_pred             ---cccccCCCCcccCH
Confidence               12346899999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-31  Score=264.22  Aligned_cols=148  Identities=25%  Similarity=0.361  Sum_probs=131.8

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .+.|+..+.||+|+||+||+|.                     +.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            3568999999999999999862                     5688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      |++|+|.+++......+++.++..++.|++.|+.|||   +++|+||||||+|||++.++.+||+|||+|+.....  ..
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~  165 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ  165 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HH
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--cc
Confidence            9999999998776667899999999999999999999   899999999999999999999999999999865321  11


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      .....+||+.||||
T Consensus       166 ~~~~~~Gt~~y~AP  179 (288)
T d2jfla1         166 RRDSFIGTPYWMAP  179 (288)
T ss_dssp             HHTCCCSCCTTCCH
T ss_pred             cccccccccccCCH
Confidence            23456899999998

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=7.1e-29  Score=255.68  Aligned_cols=320  Identities=26%  Similarity=0.374  Sum_probs=249.6

Q ss_pred             ECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcc
Q 036342           16 QLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSF   95 (596)
Q Consensus        16 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i   95 (596)
                      +++.+.+++.+..  ..+.+|++|++++|.|+ .++.+..  +++|++|+|++|+|++. | .+.++++|++|++++|+|
T Consensus        28 ~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~-~l~gl~~--L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          28 VLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SIDGVEY--LNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HTTCSSTTSEECH--HHHTTCCEEECCSSCCC-CCTTGGG--CTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred             HhCCCCCCCccCH--HHhCCCCEEECCCCCCC-Ccccccc--CCCCCEEeCcCCcCCCC-c-cccCCccccccccccccc
Confidence            4666666665443  45778999999999997 5655544  89999999999999954 3 389999999999999999


Q ss_pred             cccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCch------------------hh
Q 036342           96 SGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKT------------------SI  157 (596)
Q Consensus        96 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~------------------~~  157 (596)
                      +++.+  +.++++|+.|++++|.+++...       ......+..+....|.+.......                  .+
T Consensus       101 ~~i~~--l~~l~~L~~L~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (384)
T d2omza2         101 ADITP--LANLTNLTGLTLFNNQITDIDP-------LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPL  171 (384)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCCCGG-------GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGG
T ss_pred             ccccc--cccccccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccchhhhh
Confidence            87643  8899999999999999887543       344556666666666554331110                  11


Q ss_pred             hcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCc
Q 036342          158 SNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELY  237 (596)
Q Consensus       158 ~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  237 (596)
                      ... ..........|...  ....+..+++++.+++++|.+++..|  +..+++|++|++++|.++. + +.+..+++|+
T Consensus       172 ~~~-~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~  244 (384)
T d2omza2         172 ANL-TTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLT  244 (384)
T ss_dssp             TTC-TTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCS
T ss_pred             ccc-cccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccc
Confidence            111 22333344444432  34667888999999999999997655  4668899999999999984 3 4688899999


Q ss_pred             EEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcC
Q 036342          238 RLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNF  317 (596)
Q Consensus       238 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~  317 (596)
                      .|++++|.+++..+  +..+++|+.|++++|.+++++. +..+..++.+.+++|.+++.  ..+..++.++.|++++|++
T Consensus       245 ~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l  319 (384)
T d2omza2         245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNI  319 (384)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCC
T ss_pred             hhccccCccCCCCc--ccccccCCEeeccCcccCCCCc-cccccccccccccccccccc--cccchhcccCeEECCCCCC
Confidence            99999999986554  7889999999999999998874 67889999999999999874  4578899999999999999


Q ss_pred             cccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCccccccccccc
Q 036342          318 SGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESFEGNELLC  367 (596)
Q Consensus       318 ~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c  367 (596)
                      ++. +.  +..+++|++|++++|++++ ++....+++++.+++++|++..
T Consensus       320 ~~l-~~--l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~  365 (384)
T d2omza2         320 SDI-SP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISD  365 (384)
T ss_dssp             SCC-GG--GGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCB
T ss_pred             CCC-cc--cccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCC
Confidence            964 32  5689999999999999986 4445668899999999999754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.8e-31  Score=257.90  Aligned_cols=148  Identities=29%  Similarity=0.508  Sum_probs=123.1

Q ss_pred             ccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      ++|+..+.||+|+||.||+|.                   +++.+|++++++++|||||+++|+|..++..|+|||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            578899999999999999862                   5688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |+|.+++......+++..+..++.|+|+|+.|+|   .++|+||||||+|||+++++.+||+|||+|+....... ....
T Consensus        85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~  160 (263)
T d1sm2a_          85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSST  160 (263)
T ss_dssp             CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eeec
Confidence            9999999887777899999999999999999999   89999999999999999999999999999987643322 2233


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...||+.||||
T Consensus       161 ~~~gt~~y~aP  171 (263)
T d1sm2a_         161 GTKFPVKWASP  171 (263)
T ss_dssp             ----CTTSCCH
T ss_pred             ceecCcccCCh
Confidence            46799999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.7e-31  Score=268.25  Aligned_cols=146  Identities=22%  Similarity=0.351  Sum_probs=129.3

Q ss_pred             hcccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ..++|+..+.||+|+||+||+|.                      +.+.+|+.++++++|||||+++++|.+++..|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35789999999999999999852                      45789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-LVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~-~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||++|+|.+++.+.. .+++..+..++.|+++|+.|||   ++ +|+||||||+|||+++++.+||+|||+|+.+... 
T Consensus        84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            9999999999998654 5899999999999999999999   64 7999999999999999999999999999976321 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         .....+||++||||
T Consensus       159 ---~~~~~~GT~~Y~AP  172 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSP  172 (322)
T ss_dssp             ---TC---CCSSCCCCH
T ss_pred             ---ccccccCCccccCc
Confidence               22356899999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.2e-31  Score=265.03  Aligned_cols=151  Identities=25%  Similarity=0.439  Sum_probs=131.7

Q ss_pred             hcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEE  494 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  494 (596)
                      ..++|+..+.||+|+||+||+|.                           +.+.+|+.+++++ +|||||+++++|.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            44689999999999999999852                           3577899999998 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC
Q 036342          495 FKALVLEYMPHGSLEKYLYSSN----------------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLK  552 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk  552 (596)
                      ..|+|||||++|+|.++++...                      ..+++..++.++.||++|++|||   +++|+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence            9999999999999999997643                      24788999999999999999999   8999999999


Q ss_pred             CCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          553 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       553 ~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+||+++.++.+||+|||+|+...............||+.||||
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  235 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  235 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence            99999999999999999999876544333333456789999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.9e-31  Score=257.48  Aligned_cols=150  Identities=25%  Similarity=0.407  Sum_probs=116.4

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc--CCeeEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALV  499 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV  499 (596)
                      ++|+..+.||+|+||+||+|.                       +.+.+|++++++++|||||++++++.+  ++..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            689999999999999999852                       357889999999999999999999865  4568999


Q ss_pred             EecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhccC--CCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          500 LEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGY--SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~--~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ||||++|+|.+++...   ...+++..++.++.|++.|+.|||...  ..+|+||||||+|||+++++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998642   356899999999999999999999321  23599999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +....  ......+||+.||||
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~AP  183 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSP  183 (269)
T ss_dssp             C-------------CCCSCCCH
T ss_pred             cccCC--CccccCCCCcccCCH
Confidence            64322  223457899999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.1e-30  Score=260.72  Aligned_cols=147  Identities=27%  Similarity=0.350  Sum_probs=131.9

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||.||+|.                        +.+.+|+.++++++|||||++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            4689999999999999999852                        3467899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||||++|+|.+++.... .+++..+..++.|++.|++|||   +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999988764 5789999999999999999999   9999999999999999999999999999999754322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                        ......+||+.||||
T Consensus       160 --~~~~~~~GT~~Y~aP  174 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAP  174 (337)
T ss_dssp             --CCBCCCEECGGGCCG
T ss_pred             --cccccceeCHHHhhh
Confidence              233457899999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.2e-31  Score=257.59  Aligned_cols=152  Identities=23%  Similarity=0.448  Sum_probs=130.9

Q ss_pred             HHHhcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          440 LCRATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       440 ~~~~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++...++|+..+.||+|+||.||+|.                   +.+.+|++++++++|||||+++|++.+ +..|+||
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            33445789999999999999999862                   568999999999999999999998865 4579999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          501 EYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      |||++|+|.+++.... ..+++.++..++.||++|+.|||   .++|+||||||+|||+++++.+||+|||+|+.+....
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999999999876543 35899999999999999999999   8999999999999999999999999999999875332


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                       ........||+.||||
T Consensus       164 -~~~~~~~~gt~~y~AP  179 (272)
T d1qpca_         164 -YTAREGAKFPIKWTAP  179 (272)
T ss_dssp             -EECCTTCCCCTTTSCH
T ss_pred             -cccccccCCcccccCh
Confidence             2233456799999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.1e-30  Score=255.02  Aligned_cols=148  Identities=24%  Similarity=0.422  Sum_probs=128.2

Q ss_pred             cccccccc-ccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          445 DEFSENNL-IGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       445 ~~~~~~~~-ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ++|...+. ||+|+||+||+|.                        +.+.+|++++++++|||||+++|++..+ ..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            46666674 9999999999861                        4588999999999999999999998754 57999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||||++|+|.+++......+++.++..++.|+++|++|||   +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998776667999999999999999999999   8999999999999999999999999999999875433


Q ss_pred             Cc-cccccccccccccCC
Q 036342          580 QS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~-~~~~~~~gt~~y~aP  596 (596)
                      .. ......+||+.||||
T Consensus       164 ~~~~~~~~~~gt~~y~aP  181 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAP  181 (285)
T ss_dssp             CEECCCCSSCCCGGGCCH
T ss_pred             cccccccccccCccccCh
Confidence            21 223345789999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.2e-30  Score=259.64  Aligned_cols=142  Identities=27%  Similarity=0.356  Sum_probs=127.3

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ..|+..+.||+|+||+||+|.                        +.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            358999999999999999852                        35788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |||++|++..++... ..+++.++..++.||+.|+.|||   .++|+||||||+|||++.++.+||+|||+|+....   
T Consensus        95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            999999997766554 46899999999999999999999   89999999999999999999999999999986532   


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                         ....+||+.||||
T Consensus       168 ---~~~~~GT~~Y~AP  180 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAP  180 (309)
T ss_dssp             ---BCCCCSCGGGCCH
T ss_pred             ---CCccccCccccCH
Confidence               2346899999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-30  Score=256.78  Aligned_cols=150  Identities=25%  Similarity=0.471  Sum_probs=125.3

Q ss_pred             cccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      .+.|+..+.||+|+||.||+|.                          +.+.+|++++++++|||||+++|++.+++..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            4568889999999999999852                          35789999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|||||++|++.+++......+++.++..++.|++.|+.|||   +++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999998887778999999999999999999999   89999999999999999999999999999997643


Q ss_pred             CCC-ccccccccccccccCC
Q 036342          578 EDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~-~~~~~~~~gt~~y~aP  596 (596)
                      ... ........||+.||||
T Consensus       163 ~~~~~~~~~~~~gt~~Y~AP  182 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAP  182 (283)
T ss_dssp             -----------CCCGGGSCH
T ss_pred             CCccceEeccCCCCccccCH
Confidence            322 2223345789999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.96  E-value=3.2e-30  Score=261.05  Aligned_cols=147  Identities=22%  Similarity=0.387  Sum_probs=131.3

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|+..+.||+|+||+||+|.                     +.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3589999999999999999852                     4577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC--CCCcEEEeccccccccCCCCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~--~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |++|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999776667999999999999999999999   89999999999999996  46899999999999764332 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        .....+||+.||||
T Consensus       181 --~~~~~~gT~~Y~aP  194 (350)
T d1koaa2         181 --SVKVTTGTAEFAAP  194 (350)
T ss_dssp             --CEEEECSCTTTCCH
T ss_pred             --ccceecCcccccCH
Confidence              23456899999998

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1.2e-27  Score=238.81  Aligned_cols=246  Identities=21%  Similarity=0.207  Sum_probs=156.7

Q ss_pred             CCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecC
Q 036342           36 LKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD  115 (596)
Q Consensus        36 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~  115 (596)
                      ++.+|-++++++ .+|.. .  .+++++|+|++|+|+...+.+|.++++|++|++++|.+..+.|.+|.++++|++|+++
T Consensus        12 ~~~~~C~~~~L~-~lP~~-l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKD-L--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             TTEEECTTSCCC-SCCCS-C--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCCC-ccCCC-C--CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            344555555554 23321 1  2355556666665554334455555666666666666655555556666666666666


Q ss_pred             CCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccc--cccChhccCCCCCCEEEc
Q 036342          116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNIS--GGIPEEISNLTNLVEIDL  193 (596)
Q Consensus       116 ~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~L  193 (596)
                      +|+++.++..        ....+..|+++.|.+.++.+. .+... ..+..++...|...  ...+..|..+++|+.+++
T Consensus        88 ~n~l~~l~~~--------~~~~l~~L~~~~n~l~~l~~~-~~~~~-~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l  157 (305)
T d1xkua_          88 KNQLKELPEK--------MPKTLQELRVHENEITKVRKS-VFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI  157 (305)
T ss_dssp             SSCCSBCCSS--------CCTTCCEEECCSSCCCBBCHH-HHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred             CCccCcCccc--------hhhhhhhhhccccchhhhhhh-hhhcc-ccccccccccccccccCCCccccccccccCcccc
Confidence            6665554322        123555666666666544222 23222 34555555555332  334556777788888888


Q ss_pred             cCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCC
Q 036342          194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSI  273 (596)
Q Consensus       194 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~i  273 (596)
                      ++|.+.. +|..  .+++|+.|++++|.+++..+..|.+++.++.|++++|++.+..+..|.++++|++|+|++|.|+.+
T Consensus       158 ~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~l  234 (305)
T d1xkua_         158 ADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV  234 (305)
T ss_dssp             CSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC
T ss_pred             ccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccc
Confidence            8888774 3333  256788888888888877777888888888888888888877778888888888888888888888


Q ss_pred             CcccccccccceEEcccCCCCCchh
Q 036342          274 PLTFWNLKDILQLNFSSNFLTGPLL  298 (596)
Q Consensus       274 p~~~~~l~~L~~L~ls~N~l~~~~~  298 (596)
                      |.++..+++|++|++++|+|+....
T Consensus       235 p~~l~~l~~L~~L~Ls~N~i~~i~~  259 (305)
T d1xkua_         235 PGGLADHKYIQVVYLHNNNISAIGS  259 (305)
T ss_dssp             CTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred             ccccccccCCCEEECCCCccCccCh
Confidence            8888888888888888888775433

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.7e-30  Score=250.46  Aligned_cols=141  Identities=28%  Similarity=0.476  Sum_probs=121.7

Q ss_pred             cccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc----CCeeEEEE
Q 036342          448 SENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN----EEFKALVL  500 (596)
Q Consensus       448 ~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lV~  500 (596)
                      ...+.||+|+||+||+|.                       +.+.+|++++++++|||||+++++|..    +...|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            455689999999999852                       457899999999999999999999864    34689999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eEeCCCCCCCeeeC-CCCcEEEeccccccccCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAL--VIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~Hrdlk~~NILl~-~~~~~kl~dfGla~~~~~  577 (596)
                      |||++|+|.+++.... .+++..+..++.|+++|++|||   +++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999997754 6889999999999999999999   766  99999999999996 578999999999986432


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .    .....+||+.||||
T Consensus       168 ~----~~~~~~GT~~Y~aP  182 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAP  182 (270)
T ss_dssp             T----SBEESCSSCCCCCG
T ss_pred             C----ccCCcccCccccCH
Confidence            2    23456899999999

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.96  E-value=5.3e-30  Score=259.56  Aligned_cols=147  Identities=22%  Similarity=0.391  Sum_probs=131.6

Q ss_pred             cccccccccccCCCceeehhhH---------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      .++|+..+.||+|+||+||+|.                     +.+.+|+.++++++|||||+++++|.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3579999999999999999862                     3567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC--CCCcEEEeccccccccCCCCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~--~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |++|+|.+++......+++.++..++.||+.||.|||   +.+|+||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            9999999988776667999999999999999999999   89999999999999998  57899999999999865332 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                        ......||+.||||
T Consensus       184 --~~~~~~gt~~y~aP  197 (352)
T d1koba_         184 --IVKVTTATAEFAAP  197 (352)
T ss_dssp             --CEEEECSSGGGCCH
T ss_pred             --ceeeccCcccccCH
Confidence              23446899999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=8.3e-30  Score=254.57  Aligned_cols=144  Identities=28%  Similarity=0.375  Sum_probs=129.8

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      .++|+..+.||+|+||+||+|.                        +.+.+|+.++++++|||||++++++.+++..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            3689999999999999999852                        3567899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||||+||++.+++.... .+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        83 mE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            99999999999887765 5788888999999999999999   999999999999999999999999999999976432 


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                          ....+||+.||||
T Consensus       158 ----~~~~~Gt~~Y~AP  170 (316)
T d1fota_         158 ----TYTLCGTPDYIAP  170 (316)
T ss_dssp             ----BCCCCSCTTTCCH
T ss_pred             ----cccccCcccccCH
Confidence                2346899999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.7e-30  Score=246.96  Aligned_cols=148  Identities=24%  Similarity=0.433  Sum_probs=133.1

Q ss_pred             ccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      ++|+..+.||+|+||+||+|.                   +++.+|+.++++++|||||+++|+|.+++..++||||+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            589999999999999999862                   5688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  585 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~  585 (596)
                      |++.+++......+++..+.+++.|+++|++|||   ..+|+||||||+||++++++.+||+|||+++...... .....
T Consensus        84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~  159 (258)
T d1k2pa_          84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSV  159 (258)
T ss_dssp             EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCC
T ss_pred             CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceeec
Confidence            9999998877777899999999999999999999   8899999999999999999999999999998764332 22334


Q ss_pred             cccccccccCC
Q 036342          586 QTLGTIGYMAP  596 (596)
Q Consensus       586 ~~~gt~~y~aP  596 (596)
                      ...||+.||||
T Consensus       160 ~~~~t~~y~aP  170 (258)
T d1k2pa_         160 GSKFPVRWSPP  170 (258)
T ss_dssp             CSCCCGGGCCH
T ss_pred             ccCCCCCcCCc
Confidence            46799999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=3.8e-30  Score=255.95  Aligned_cols=146  Identities=25%  Similarity=0.423  Sum_probs=116.6

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      .+.|+..+.||+|+||+||+|.                      +.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4569999999999999999862                      245689999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC---CCCcEEEeccccccccCCC
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~---~~~~~kl~dfGla~~~~~~  578 (596)
                      ||+||+|.+++.... .+++.++..++.|++.|++|||   +++|+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999997654 6899999999999999999999   89999999999999994   5789999999999865422


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      .   .....+||+.||||
T Consensus       164 ~---~~~~~~GT~~y~AP  178 (307)
T d1a06a_         164 S---VLSTACGTPGYVAP  178 (307)
T ss_dssp             ------------CTTSCH
T ss_pred             C---eeeeeeeCccccCc
Confidence            1   23446899999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-29  Score=248.93  Aligned_cols=141  Identities=26%  Similarity=0.447  Sum_probs=121.0

Q ss_pred             ccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecCCC
Q 036342          451 NLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH  505 (596)
Q Consensus       451 ~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~  505 (596)
                      +.||+|+||+||+|.                         +.+.+|+.++++++|||||+++++|..+ ..|+|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            579999999999852                         3578999999999999999999999654 57899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc-ccc
Q 036342          506 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-MTQ  584 (596)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~-~~~  584 (596)
                      |+|.++++... .+++.++..++.||++|++|||   +++|+||||||+|||++.++.+|++|||+|+.+...... ...
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999998754 6899999999999999999999   889999999999999999999999999999976543222 123


Q ss_pred             ccccccccccCC
Q 036342          585 TQTLGTIGYMAP  596 (596)
Q Consensus       585 ~~~~gt~~y~aP  596 (596)
                      ....||++||||
T Consensus       168 ~~~~gt~~y~AP  179 (277)
T d1xbba_         168 THGKWPVKWYAP  179 (277)
T ss_dssp             ---CCCGGGCCH
T ss_pred             cccCCCceecCc
Confidence            345799999998

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=2.7e-27  Score=236.13  Aligned_cols=284  Identities=21%  Similarity=0.279  Sum_probs=215.9

Q ss_pred             CCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEc
Q 036342           11 NLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSL   90 (596)
Q Consensus        11 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L   90 (596)
                      ..+.+|.++++++ .+|..+  .+++++|+|++|+|+ .+++..|..+++|++|++++|.+....|.+|.++++|++|++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l--~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSC--CTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             cCCEEEecCCCCC-ccCCCC--CCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence            4577888888887 556665  367888999999887 566555666888999999998888777888888889999999


Q ss_pred             cCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccC-CchhhhcccccccEEEc
Q 036342           91 GMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGIL-PKTSISNLSRSLEEFYM  169 (596)
Q Consensus        91 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~~l~~~L~~L~l  169 (596)
                      ++|+|+.+....   ...+..|++..|.+..+...     .+.....+..++...|...... ....+..+ ++|+++++
T Consensus        87 ~~n~l~~l~~~~---~~~l~~L~~~~n~l~~l~~~-----~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l-~~L~~l~l  157 (305)
T d1xkua_          87 SKNQLKELPEKM---PKTLQELRVHENEITKVRKS-----VFNGLNQMIVVELGTNPLKSSGIENGAFQGM-KKLSYIRI  157 (305)
T ss_dssp             CSSCCSBCCSSC---CTTCCEEECCSSCCCBBCHH-----HHTTCTTCCEEECCSSCCCGGGBCTTGGGGC-TTCCEEEC
T ss_pred             cCCccCcCccch---hhhhhhhhccccchhhhhhh-----hhhccccccccccccccccccCCCccccccc-cccCcccc
Confidence            999888654432   35678888888888776543     3566777788888887654321 12245555 67888899


Q ss_pred             cccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCccc
Q 036342          170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGS  249 (596)
Q Consensus       170 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  249 (596)
                      ++|.++.. |..+  +++|+.|++++|.+.+..+..|..++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .
T Consensus       158 ~~n~l~~l-~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~  233 (305)
T d1xkua_         158 ADTNITTI-PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K  233 (305)
T ss_dssp             CSSCCCSC-CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-S
T ss_pred             ccCCcccc-Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-c
Confidence            99888754 4332  578889999999988888888888899999999999998777888888899999999999987 4


Q ss_pred             chhhhccCCCCcEEEeCCCcccCCCcc-------cccccccceEEcccCCCC--CchhhhhccccccceEe
Q 036342          250 IPACFGNLASLRILSLGSNKLTSIPLT-------FWNLKDILQLNFSSNFLT--GPLLLEIGNLKVLIGID  311 (596)
Q Consensus       250 ~p~~~~~l~~L~~L~Ls~N~l~~ip~~-------~~~l~~L~~L~ls~N~l~--~~~~~~~~~l~~L~~L~  311 (596)
                      +|..|..+++|++|+|++|+|+.++..       ...+.+|+.|+|++|++.  ...|..|.-+.....++
T Consensus       234 lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~~  304 (305)
T d1xkua_         234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ  304 (305)
T ss_dssp             CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEE
T ss_pred             cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCcccc
Confidence            577888899999999999999888653       234678899999999885  35566666555444443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.7e-29  Score=248.88  Aligned_cols=146  Identities=26%  Similarity=0.428  Sum_probs=129.9

Q ss_pred             cccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .+.|+..+.||+|+||+||+|.                           +.+.+|+.++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3579999999999999999852                           3578999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC----cEEEeccccc
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM----VAHLSDFSIA  572 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~----~~kl~dfGla  572 (596)
                      |+|||||++|+|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999998764 6899999999999999999999   89999999999999998776    5999999999


Q ss_pred             cccCCCCCccccccccccccccCC
Q 036342          573 KLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +......   ......||+.||||
T Consensus       165 ~~~~~~~---~~~~~~~t~~y~AP  185 (293)
T d1jksa_         165 HKIDFGN---EFKNIFGTPEFVAP  185 (293)
T ss_dssp             EECTTSC---BCSCCCCCGGGCCH
T ss_pred             hhcCCCc---cccccCCCCcccCH
Confidence            8764322   23446799999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.6e-30  Score=250.69  Aligned_cols=149  Identities=23%  Similarity=0.383  Sum_probs=120.2

Q ss_pred             hcccccccccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ..++|+..+.||+|+||+||+|.                         +.+.+|++++++++|||||++++++.+ +..|
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~   83 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW   83 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEE
Confidence            45689999999999999999852                         457899999999999999999999964 5689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|||||++|++.+++......+++.++..++.|+++|+.|||   +++|+||||||+||++++++.+||+|||+|+....
T Consensus        84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            999999999999998877777899999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      .. ........||++||||
T Consensus       161 ~~-~~~~~~~~gt~~y~ap  178 (273)
T d1mp8a_         161 ST-YYKASKGKLPIKWMAP  178 (273)
T ss_dssp             -----------CCGGGCCH
T ss_pred             Cc-ceeccceecCcccchh
Confidence            22 2223446789999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.8e-29  Score=252.85  Aligned_cols=148  Identities=25%  Similarity=0.422  Sum_probs=127.3

Q ss_pred             ccccccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  498 (596)
                      .+|+..+.||+|+||+||+|.                          +.+.+|+.++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999852                          4588999999999999999999999875 4678


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCC
Q 036342          499 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  578 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~  578 (596)
                      |+||+.+|+|.+++......+++..+..++.||++|++|||   .++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999999888778999999999999999999999   889999999999999999999999999999987544


Q ss_pred             CCccccccccccccccCC
Q 036342          579 DQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       579 ~~~~~~~~~~gt~~y~aP  596 (596)
                      ..........||+.||||
T Consensus       165 ~~~~~~~~~~gt~~y~AP  182 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMAL  182 (317)
T ss_dssp             CC--------CCTTTSCH
T ss_pred             cccccccccccCccccCh
Confidence            333334455789999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.95  E-value=4.7e-29  Score=244.24  Aligned_cols=145  Identities=28%  Similarity=0.485  Sum_probs=130.6

Q ss_pred             ccccccccccCCCceeehhhH------------------------------HhHHHHHHHHhhcC-CCccceeeeeeccC
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------------KSFDVECEMMKSIR-HRNLIKVISSCSNE  493 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~  493 (596)
                      ++|+..+.||+|+||+||+|.                              +.+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            689999999999999999852                              24678999999997 99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          494 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       494 ~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      +..|+|||||++|+|.++++... .+++.++..++.||++|++|||   .++|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999998754 6899999999999999999999   8999999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ......   .....+||+.|+||
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~P  178 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAP  178 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCH
T ss_pred             EccCCC---ceeeeeccCCCCCH
Confidence            764322   23456899999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.2e-29  Score=250.18  Aligned_cols=147  Identities=22%  Similarity=0.365  Sum_probs=130.4

Q ss_pred             cccccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      .++|+..+.||+|+||+||+|.                    ..+.+|++++++++|||||++++++.+++..|+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            3679999999999999999863                    34779999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC--CCcEEEeccccccccCCCCCc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~--~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +||+|.+++......+++.++..++.|++.|++|||   +.+|+||||||+|||++.  .+.+|++|||+++......  
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--  158 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--  158 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC--
Confidence            999999999877667899999999999999999999   899999999999999985  4589999999998764322  


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......||+.|+||
T Consensus       159 -~~~~~~~t~~y~ap  172 (321)
T d1tkia_         159 -NFRLLFTAPEYYAP  172 (321)
T ss_dssp             -EEEEEESCGGGSCH
T ss_pred             -cccccccccccccc
Confidence             23446799999997

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=3.9e-29  Score=254.56  Aligned_cols=145  Identities=24%  Similarity=0.372  Sum_probs=126.8

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHH---HHHHHHhhcCCCccceeeeeeccCCee
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFD---VECEMMKSIRHRNLIKVISSCSNEEFK  496 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~---~e~~~l~~l~H~niv~l~~~~~~~~~~  496 (596)
                      .++|+..+.||+|+||.||+|.                        ..+.   .|+.+++.++|||||++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            4689999999999999999852                        1122   346777888999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 036342          497 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  576 (596)
Q Consensus       497 ~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~  576 (596)
                      |+|||||++|+|.+++.... .+++..+..++.||+.||.|||   .++|+||||||+|||++.++.+||+|||+|+...
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999998764 5789999999999999999999   9999999999999999999999999999999764


Q ss_pred             CCCCccccccccccccccCC
Q 036342          577 GEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..    .....+||+.||||
T Consensus       159 ~~----~~~~~~GT~~y~AP  174 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAP  174 (364)
T ss_dssp             SS----CCCSCCSCGGGCCH
T ss_pred             CC----cccccccccccchh
Confidence            32    23346899999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.95  E-value=4.5e-29  Score=252.72  Aligned_cols=143  Identities=25%  Similarity=0.337  Sum_probs=130.0

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVL  500 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~  500 (596)
                      ++|+..+.||+|+||.||+|.                        +.+.+|+.++++++|||||++++++...+..|+||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            589999999999999999852                        34678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          501 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      ||+.+|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999997764 5899999999999999999999   899999999999999999999999999999976432  


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                         ....+||+.||||
T Consensus       195 ---~~~~~Gt~~Y~AP  207 (350)
T d1rdqe_         195 ---TWTLCGTPEALAP  207 (350)
T ss_dssp             ---BCCCEECGGGCCH
T ss_pred             ---cccccCccccCCH
Confidence               2346899999998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=1.9e-29  Score=250.97  Aligned_cols=156  Identities=27%  Similarity=0.442  Sum_probs=134.1

Q ss_pred             HHHHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeee
Q 036342          438 LELCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSC  490 (596)
Q Consensus       438 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~  490 (596)
                      .+++...++|+..+.||+|+||+||+|.                           +.+.+|++++++++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            3455567899999999999999999762                           4588999999999999999999999


Q ss_pred             ccCCeeEEEEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceE
Q 036342          491 SNEEFKALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSALVI  547 (596)
Q Consensus       491 ~~~~~~~lV~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~  547 (596)
                      ..++..++||||+++|+|.++++...                       ..+++..+..++.|++.|++|||   .++|+
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeE
Confidence            99999999999999999999997532                       24789999999999999999999   89999


Q ss_pred             eCCCCCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          548 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       548 Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||||||+|||++.++.+||+|||+|+.+............+||+.||||
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP  211 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  211 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence            9999999999999999999999999876443333334456799999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.1e-29  Score=249.59  Aligned_cols=149  Identities=26%  Similarity=0.460  Sum_probs=123.6

Q ss_pred             hcccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEecC
Q 036342          443 ATDEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM  503 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~  503 (596)
                      ..++|+..+.||+|+||.||+|.                   +.|.+|+.++++++|||||+++++|.+ +..|+|||||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            35689999999999999999862                   568999999999999999999999865 4579999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++|++..++.... ..++|.++..++.||+.|+.|||   ..+|+||||||+|||+++++.+||+|||+|+.+.... ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence            9999998887543 45899999999999999999999   8899999999999999999999999999998764332 22


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......||+.|+||
T Consensus       170 ~~~~~~gt~~y~aP  183 (285)
T d1fmka3         170 ARQGAKFPIKWTAP  183 (285)
T ss_dssp             ------CCGGGSCH
T ss_pred             eeccccccccccCh
Confidence            23446799999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.1e-29  Score=248.53  Aligned_cols=158  Identities=24%  Similarity=0.411  Sum_probs=125.7

Q ss_pred             CHHHHHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceee
Q 036342          436 SYLELCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVI  487 (596)
Q Consensus       436 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~  487 (596)
                      +...++...++|+..+.||+|+||.||+|.                           +.+..|..++.++ +|+|||.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            344555566889999999999999999752                           2456677777776 688999999


Q ss_pred             eeeccC-CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCC
Q 036342          488 SSCSNE-EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDL  551 (596)
Q Consensus       488 ~~~~~~-~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdl  551 (596)
                      +++..+ +..++|||||++|+|.++++...               ..+++.++..++.||++|+.|||   +++|+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcC
Confidence            998764 46899999999999999997542               24789999999999999999999   899999999


Q ss_pred             CCCCeeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          552 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       552 k~~NILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ||+|||+++++.+||+|||+|+..............+||+.||||
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  205 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  205 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence            999999999999999999999876544333334456899999998

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.8e-27  Score=233.43  Aligned_cols=254  Identities=21%  Similarity=0.212  Sum_probs=163.0

Q ss_pred             EEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecC-C
Q 036342           38 FLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD-E  116 (596)
Q Consensus        38 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~-~  116 (596)
                      .++.+++.++ .+|..-   .+++++|+|++|+|+...+.+|.++++|++|++++|+|..+.+..+.++..++.+... .
T Consensus        15 ~v~c~~~~L~-~iP~~i---p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             EEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             EEEcCCCCCC-ccCCCC---CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            3455555555 333211   2356666666666665555556666666666666666666666666666666666543 4


Q ss_pred             CcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCC
Q 036342          117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN  196 (596)
Q Consensus       117 N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N  196 (596)
                      |.++.+.+.     .|.++++|++|++++|.+....+. .+... .+|+.+++++|+|+++.+.+|..+++|+.|++++|
T Consensus        91 ~~~~~l~~~-----~~~~l~~L~~L~l~~n~~~~~~~~-~~~~~-~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N  163 (284)
T d1ozna_          91 AQLRSVDPA-----TFHGLGRLHTLHLDRCGLQELGPG-LFRGL-AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN  163 (284)
T ss_dssp             TTCCCCCTT-----TTTTCTTCCEEECTTSCCCCCCTT-TTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cccccccch-----hhcccccCCEEecCCccccccccc-ccchh-cccchhhhccccccccChhHhccccchhhcccccC
Confidence            445554333     466666666666666666544332 33333 56777777777777666677777788888888888


Q ss_pred             cccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcc
Q 036342          197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLT  276 (596)
Q Consensus       197 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~  276 (596)
                      ++++..+.+|.++++|+.+++++|++++..|..|..+++|++|++++|++.+..+..|+.+++|++|+|++|.+..--..
T Consensus       164 ~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~  243 (284)
T d1ozna_         164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA  243 (284)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred             cccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence            88877778888888888888888888877778888888888888888888877778888888888888888887642111


Q ss_pred             cccccccceEEcccCCCCCchhhhhc
Q 036342          277 FWNLKDILQLNFSSNFLTGPLLLEIG  302 (596)
Q Consensus       277 ~~~l~~L~~L~ls~N~l~~~~~~~~~  302 (596)
                      .+-...++.+....+.+....|..+.
T Consensus       244 ~~l~~~l~~~~~~~~~~~C~~p~~l~  269 (284)
T d1ozna_         244 RPLWAWLQKFRGSSSEVPCSLPQRLA  269 (284)
T ss_dssp             HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred             hHHHHHHHhCcCCCCceEeCCchHHc
Confidence            11112234444445555544444443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-28  Score=240.98  Aligned_cols=148  Identities=26%  Similarity=0.368  Sum_probs=122.8

Q ss_pred             ccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeE
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA  497 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  497 (596)
                      ++|+..+.||+|+||.||+|.                           +.|.+|+.++++++|||||+++|+|.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            579999999999999999851                           4678999999999999999999999764 678


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +|||||++|++.+++......+++..+..++.|++.|+.|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999998877667999999999999999999999   89999999999999999999999999999998754


Q ss_pred             CCCc-cccccccccccccCC
Q 036342          578 EDQS-MTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~-~~~~~~~gt~~y~aP  596 (596)
                      .... .......||.+|+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~aP  183 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAP  183 (273)
T ss_dssp             -CCEEEC-----CCGGGCCH
T ss_pred             CCCcceecCccccCcccCCH
Confidence            3322 223345688899998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.4e-28  Score=244.33  Aligned_cols=146  Identities=25%  Similarity=0.375  Sum_probs=127.7

Q ss_pred             ccccccccccCCCceeehhhH------------------------HhHHHHHHHHh-hcCCCccceeeeeeccCCeeEEE
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMK-SIRHRNLIKVISSCSNEEFKALV  499 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lV  499 (596)
                      ++|...+.||+|+||+||+|.                        +.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            689999999999999999852                        23556766665 68999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 036342          500 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~  579 (596)
                      ||||++|+|.+++.... .+++.++..++.||+.|++|||   +++|+||||||+|||+++++.+|++|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999998754 5789999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                        ......+||+.||||
T Consensus       158 --~~~~~~~gt~~y~aP  172 (320)
T d1xjda_         158 --AKTNTFCGTPDYIAP  172 (320)
T ss_dssp             --CCBCCCCSCGGGCCH
T ss_pred             --ccccccCCCCCcCCH
Confidence              233456899999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.8e-29  Score=247.09  Aligned_cols=155  Identities=19%  Similarity=0.389  Sum_probs=134.1

Q ss_pred             HHHHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcCCCccceeeeeec
Q 036342          439 ELCRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIRHRNLIKVISSCS  491 (596)
Q Consensus       439 ~~~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~H~niv~l~~~~~  491 (596)
                      +|+...++|+..+.||+|+||.||+|.                           ..+.+|++++++++|||||+++++|.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            445556899999999999999999741                           34789999999999999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM  562 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~  562 (596)
                      .++..++|||||++|+|.+++....         ..+++..+..++.|+++|+.|||   .++|+||||||+|||+++++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence            9999999999999999999986432         34688999999999999999999   88999999999999999999


Q ss_pred             cEEEeccccccccCCCCCccccccccccccccCC
Q 036342          563 VAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       563 ~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .+||+|||+|+.+.............||+.||||
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP  204 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  204 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCH
Confidence            9999999999976543333334455789999998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.1e-28  Score=243.04  Aligned_cols=146  Identities=26%  Similarity=0.419  Sum_probs=126.7

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||+||+|.                       +.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            689999999999999999862                       357789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 036342          502 YMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  580 (596)
Q Consensus       502 ~~~~g~L~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~  580 (596)
                      |+.++ +.+++ ......+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+|++|||+|+...... 
T Consensus        82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            99764 44444 344456899999999999999999999   8999999999999999999999999999998764332 


Q ss_pred             ccccccccccccccCC
Q 036342          581 SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       581 ~~~~~~~~gt~~y~aP  596 (596)
                       .......||+.|+||
T Consensus       157 -~~~~~~~gt~~y~ap  171 (298)
T d1gz8a_         157 -RTYTHEVVTLWYRAP  171 (298)
T ss_dssp             -BCTTCCBCCCTTCCH
T ss_pred             -ccceeecccceeeeh
Confidence             233456899999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.1e-28  Score=242.92  Aligned_cols=147  Identities=29%  Similarity=0.514  Sum_probs=127.7

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc-CCCccceeeeeeccCCeeEE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKAL  498 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  498 (596)
                      .++|+..+.||+|+||+||+|.                        +.+.+|+.+++++ +|||||+++++|.+++..|+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            3688899999999999999852                        3578999999998 79999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCc
Q 036342          499 VLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMV  563 (596)
Q Consensus       499 V~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~  563 (596)
                      ||||+++|+|.++++..               ...+++.++..++.||++|+.|+|   +++|+|||+||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCc
Confidence            99999999999999754               246899999999999999999999   899999999999999999999


Q ss_pred             EEEeccccccccCCCCCccccccccccccccCC
Q 036342          564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       564 ~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +||+|||+|+....   .......+||..|+||
T Consensus       166 ~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aP  195 (309)
T d1fvra_         166 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAI  195 (309)
T ss_dssp             EEECCTTCEESSCE---ECCC----CCTTTCCH
T ss_pred             eEEccccccccccc---cccccceecCCcccch
Confidence            99999999986432   1222345789999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.3e-28  Score=244.95  Aligned_cols=147  Identities=24%  Similarity=0.379  Sum_probs=125.3

Q ss_pred             cccccccc-cccCCCceeehhhH----------------HhHHHHHHHHhhc-CCCccceeeeeecc----CCeeEEEEe
Q 036342          444 TDEFSENN-LIGRGGFALFIRAF----------------KSFDVECEMMKSI-RHRNLIKVISSCSN----EEFKALVLE  501 (596)
Q Consensus       444 ~~~~~~~~-~ig~G~~g~v~~~~----------------~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~~~lV~e  501 (596)
                      .++|++.. .||+|+||+||+|.                +.+.+|+.++.++ +|||||+++++|.+    +...|+|||
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE   89 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   89 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence            46888764 69999999999973                4678899987654 89999999999865    456899999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC---CCcEEEeccccccccCC
Q 036342          502 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~---~~~~kl~dfGla~~~~~  577 (596)
                      ||+||+|.+++.... ..+++.++..++.|++.|++|||   ..+|+||||||+|||+++   ++.+||+|||+|+....
T Consensus        90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccC
Confidence            999999999998753 46899999999999999999999   999999999999999985   56799999999987643


Q ss_pred             CCCccccccccccccccCC
Q 036342          578 EDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..   .....+||+.||||
T Consensus       167 ~~---~~~~~~gt~~y~aP  182 (335)
T d2ozaa1         167 HN---SLTTPCYTPYYVAP  182 (335)
T ss_dssp             CC---CCCCCSCCCSSCCC
T ss_pred             CC---ccccccCCcccCCc
Confidence            32   23456899999999

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=7.4e-28  Score=239.24  Aligned_cols=150  Identities=27%  Similarity=0.392  Sum_probs=122.1

Q ss_pred             ccccccccccCCCceeehhhH----------------HhHHH--HHHHHhhcCCCccceeeeeeccCC----eeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------KSFDV--ECEMMKSIRHRNLIKVISSCSNEE----FKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------~~~~~--e~~~l~~l~H~niv~l~~~~~~~~----~~~lV~e~  502 (596)
                      .+|...+.||+|+||.||+|.                +.+.+  |+..+++++|||||+++++|..++    ..|+||||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            356677899999999999863                23333  455556789999999999997654    57999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcc-----CCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      |++|+|.++++..  .++|.+++.++.|+|.|+.|+|..     +.++|+||||||+|||+++++.+||+|||+++....
T Consensus        83 ~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~  160 (303)
T d1vjya_          83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             ccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence            9999999999875  488999999999999999999942     247999999999999999999999999999997754


Q ss_pred             CCCc--cccccccccccccCC
Q 036342          578 EDQS--MTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~~--~~~~~~~gt~~y~aP  596 (596)
                      ....  ......+||++||||
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aP  181 (303)
T d1vjya_         161 ATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             TTTEECC----CCSCGGGCCH
T ss_pred             CCcceeccccceecccCcCCh
Confidence            3321  123456899999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.9e-28  Score=242.44  Aligned_cols=153  Identities=22%  Similarity=0.398  Sum_probs=133.9

Q ss_pred             HHhcccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhc-CCCccceeeeeecc
Q 036342          441 CRATDEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSI-RHRNLIKVISSCSN  492 (596)
Q Consensus       441 ~~~~~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~~  492 (596)
                      +...++|+..+.||+|+||.||+|.                           ..+.+|+.+++++ +|||||+++++|.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            3445789999999999999999851                           3577899999999 69999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCC
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSN-----------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSN  555 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~N  555 (596)
                      ++..|+|||||++|+|.++++...                 ..+++..+..++.||++|++|||   .++++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccc
Confidence            999999999999999999997643                 24789999999999999999999   8999999999999


Q ss_pred             eeeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          556 VLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       556 ILl~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+++.++.+|++|||+++..............+||+.|+||
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP  216 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence            99999999999999999977544433444557899999998

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-26  Score=229.23  Aligned_cols=223  Identities=23%  Similarity=0.247  Sum_probs=151.6

Q ss_pred             cEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEE
Q 036342           62 EKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLI  141 (596)
Q Consensus        62 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L  141 (596)
                      ..++.+++.++ .+|..+.  +.+++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.+.     .+.++..+..+
T Consensus        14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~-----~~~~~~~~~~l   85 (284)
T d1ozna_          14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA-----AFTGLALLEQL   85 (284)
T ss_dssp             CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT-----TTTTCTTCCEE
T ss_pred             eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccc-----ccccccccccc
Confidence            35677888888 6676553  5789999999999988888899999999999999998877654     46777777777


Q ss_pred             ECcC-CCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCC
Q 036342          142 DLSN-NPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN  220 (596)
Q Consensus       142 ~ls~-N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  220 (596)
                      +.+. |.++.+ +...+.++ ++|++|++++|.+....+..+...++|+.+++++|.++++.+.+|..+++|+.|++++|
T Consensus        86 ~~~~~~~~~~l-~~~~~~~l-~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N  163 (284)
T d1ozna_          86 DLSDNAQLRSV-DPATFHGL-GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN  163 (284)
T ss_dssp             ECCSCTTCCCC-CTTTTTTC-TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             ccccccccccc-cchhhccc-ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccC
Confidence            7653 344433 33355555 56666777766666666666666666666666666666666666666666666666666


Q ss_pred             cccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCc-ccccccccceEEcccCCCC
Q 036342          221 ILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL-TFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       221 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~  294 (596)
                      .+++..+..|.++++|+.+++++|++++..|..|..+++|++|++++|.+++++. .|..+++|++|++++|++.
T Consensus       164 ~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             cccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence            6665555666666666666666666666666666666666666666666666443 3445555666666655554

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=8.3e-28  Score=238.64  Aligned_cols=152  Identities=29%  Similarity=0.455  Sum_probs=127.4

Q ss_pred             HhcccccccccccCCCceeehhhH-----------------------------HhHHHHHHHHhhc-CCCccceeeeeec
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF-----------------------------KSFDVECEMMKSI-RHRNLIKVISSCS  491 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~-----------------------------~~~~~e~~~l~~l-~H~niv~l~~~~~  491 (596)
                      ...++|+..+.||+|+||.||+|.                             ..+.+|...+.++ +|||||+++++|.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            345789999999999999999852                             3466788888888 8999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCe
Q 036342          492 NEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNV  556 (596)
Q Consensus       492 ~~~~~~lV~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NI  556 (596)
                      +++..++|||||++|+|.+++....               ..+++.+++.++.|++.|++|||   +.+|+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence            9999999999999999999997553               34799999999999999999999   99999999999999


Q ss_pred             eeCCCCcEEEeccccccccCCCCCccccccccccccccCC
Q 036342          557 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       557 Ll~~~~~~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |++.++.+||+|||+++...............||+.|+||
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  206 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  206 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence            9999999999999999976544333334456799999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.6e-28  Score=241.61  Aligned_cols=142  Identities=28%  Similarity=0.430  Sum_probs=122.3

Q ss_pred             ccccccCCCceeehhhH--------------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          449 ENNLIGRGGFALFIRAF--------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       449 ~~~~ig~G~~g~v~~~~--------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ..+.||+|+||+||+|.                          +.+.+|++++++++|||||++++++..++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            35789999999999852                          2467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      |+++++..... ....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.......  
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            98877665554 3446888899999999999999999   89999999999999999999999999999987643322  


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      .....+||+.||||
T Consensus       156 ~~~~~~gt~~y~aP  169 (299)
T d1ua2a_         156 AYTHQVVTRWYRAP  169 (299)
T ss_dssp             CCCCSCCCCTTCCH
T ss_pred             cccceecChhhccH
Confidence            23446899999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.3e-27  Score=238.04  Aligned_cols=144  Identities=26%  Similarity=0.451  Sum_probs=125.5

Q ss_pred             cccccCCCceeehhhH-------------------------HhHHHHHHHHhhcCCCccceeeeeecc-CCeeEEEEecC
Q 036342          450 NNLIGRGGFALFIRAF-------------------------KSFDVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYM  503 (596)
Q Consensus       450 ~~~ig~G~~g~v~~~~-------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~  503 (596)
                      .+.||+|+||+||+|.                         +++.+|++++++++|||||+++|++.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999852                         468899999999999999999999865 56899999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCC--c
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ--S  581 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~--~  581 (596)
                      ++|+|.+++.......++..++.++.|+++|+.|+|   .++|+||||||+|||+++++.+||+|||+++.......  .
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999887777889999999999999999999   89999999999999999999999999999997643322  1


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                      .......||+.|+||
T Consensus       189 ~~~~~~~gt~~y~aP  203 (311)
T d1r0pa_         189 HNKTGAKLPVKWMAL  203 (311)
T ss_dssp             TCTTCSSCCGGGSCH
T ss_pred             eecccccccccccCh
Confidence            223345789999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.94  E-value=5.6e-28  Score=237.41  Aligned_cols=149  Identities=21%  Similarity=0.429  Sum_probs=121.3

Q ss_pred             cccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhcCCCccceeeeeeccCC----e
Q 036342          444 TDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE----F  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~  495 (596)
                      .++|+..+.||+|+||+||+|.                        +.+.+|++++++++|||||++++++..++    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            3679999999999999999852                        35789999999999999999999987643    4


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+|||||+||+|.+++...+ .+++.++..++.|++.|++|||   +.+|+||||||+|||++.++..+++|||.++..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999987764 5899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCC-ccccccccccccccCC
Q 036342          576 TGEDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~-~~~~~~~~gt~~y~aP  596 (596)
                      ..... .......+||+.||||
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aP  183 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSP  183 (277)
T ss_dssp             C----------------TTCCH
T ss_pred             ccccccccccccccCcccccCH
Confidence            33221 2223456899999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.9e-28  Score=237.94  Aligned_cols=146  Identities=31%  Similarity=0.453  Sum_probs=120.8

Q ss_pred             hcccccccccccCCCceeehhh-----------------HHhHHHHHHHHhhcCCCccceeeeeecc-CCeeEEEEecCC
Q 036342          443 ATDEFSENNLIGRGGFALFIRA-----------------FKSFDVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYMP  504 (596)
Q Consensus       443 ~~~~~~~~~~ig~G~~g~v~~~-----------------~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~~  504 (596)
                      ..++|+..+.||+|+||.||+|                 .+.+.+|++++++++|||||+++|+|.+ ++..|+||||++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            4567889999999999999986                 2568899999999999999999999865 456899999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCccc
Q 036342          505 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  583 (596)
Q Consensus       505 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~~  583 (596)
                      +|+|.+++.... ..++|..++.++.||+.|+.|||   +.+|+||||||+||+++.++.+|++|||+++.....     
T Consensus        85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----  156 (262)
T d1byga_          85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----  156 (262)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC-----
Confidence            999999997643 35789999999999999999999   899999999999999999999999999999875322     


Q ss_pred             cccccccccccCC
Q 036342          584 QTQTLGTIGYMAP  596 (596)
Q Consensus       584 ~~~~~gt~~y~aP  596 (596)
                      .....+|+.|+||
T Consensus       157 ~~~~~~~~~y~aP  169 (262)
T d1byga_         157 QDTGKLPVKWTAP  169 (262)
T ss_dssp             -----CCTTTSCH
T ss_pred             CccccccccCCCh
Confidence            2335689999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=234.57  Aligned_cols=144  Identities=23%  Similarity=0.322  Sum_probs=125.3

Q ss_pred             ccccccccccCCCceeehhhH---------------------------HhHHHHHHHHhhcC--CCccceeeeeeccCCe
Q 036342          445 DEFSENNLIGRGGFALFIRAF---------------------------KSFDVECEMMKSIR--HRNLIKVISSCSNEEF  495 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~---------------------------~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~  495 (596)
                      ++|+..+.||+|+||+||+|.                           +.+.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            579999999999999999862                           12568999999997  8999999999999999


Q ss_pred             eEEEEecCCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-CCcEEEecccccc
Q 036342          496 KALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-NMVAHLSDFSIAK  573 (596)
Q Consensus       496 ~~lV~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-~~~~kl~dfGla~  573 (596)
                      .|+||||+.+ +++.+++.... .+++.++..++.|+++|++|||   +++|+||||||+|||++. ++.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999976 67888877654 6899999999999999999999   999999999999999985 5799999999998


Q ss_pred             ccCCCCCccccccccccccccCC
Q 036342          574 LLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      .....    .....+||+.||||
T Consensus       160 ~~~~~----~~~~~~GT~~y~aP  178 (273)
T d1xwsa_         160 LLKDT----VYTDFDGTRVYSPP  178 (273)
T ss_dssp             ECCSS----CBCCCCSCGGGSCH
T ss_pred             ecccc----cccccccCCCcCCH
Confidence            65322    23456899999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.93  E-value=7.7e-27  Score=230.45  Aligned_cols=146  Identities=21%  Similarity=0.347  Sum_probs=123.7

Q ss_pred             ccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEec
Q 036342          445 DEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  502 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~  502 (596)
                      ++|+..+.||+|+||.||+|.                      +.+.+|+.++++++|||||++++++..++..|+||||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            589999999999999999862                      4688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCcc
Q 036342          503 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~~  582 (596)
                      +.++.+..+... ...+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||.|.......  .
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (286)
T ss_dssp             CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence            987666555543 457899999999999999999999   8899999999999999999999999999998764322  1


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      ......|++.|+||
T Consensus       156 ~~~~~~~~~~y~~p  169 (286)
T d1ob3a_         156 KYTHEIVTLWYRAP  169 (286)
T ss_dssp             ------CCCTTCCH
T ss_pred             ccceecccchhhhH
Confidence            23345689999987

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.9e-25  Score=214.39  Aligned_cols=200  Identities=25%  Similarity=0.232  Sum_probs=134.5

Q ss_pred             CCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCC
Q 036342           58 LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS  137 (596)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~  137 (596)
                      ..++.+.|.+++.++ .+|..+.  ++|++|+|++|+|+++.+++|.++++|++|+|++|+|+.++       .++.+++
T Consensus         9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~-------~~~~l~~   78 (266)
T d1p9ag_           9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ-------VDGTLPV   78 (266)
T ss_dssp             STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE-------CCSCCTT
T ss_pred             cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc-------ccccccc
Confidence            344555566666666 3454442  35667777777776666666777777777777777666432       2445566


Q ss_pred             CCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       138 L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                      |++|+|++|++++.                           +..+..+++|+.|++++|.+....+..+..+.++++|++
T Consensus        79 L~~L~Ls~N~l~~~---------------------------~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l  131 (266)
T d1p9ag_          79 LGTLDLSHNQLQSL---------------------------PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL  131 (266)
T ss_dssp             CCEEECCSSCCSSC---------------------------CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred             cccccccccccccc---------------------------ccccccccccccccccccccceeeccccccccccccccc
Confidence            66666666665432                           233455566667777777766666666667777777777


Q ss_pred             cCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCC
Q 036342          218 EDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~  294 (596)
                      ++|.++...+..+..+++|+.+++++|++++..+..|..+++|++|+|++|+|+.+|..+..+++|+.|+|++|++.
T Consensus       132 ~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred             cccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCC
Confidence            77777755555666677777777777777777777777888888888888888888887777778888888887764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.2e-26  Score=229.46  Aligned_cols=149  Identities=26%  Similarity=0.380  Sum_probs=125.5

Q ss_pred             HhcccccccccccCCCceeehhhH------------------------HhHHHHHHHHhhc---CCCccceeeeeecc--
Q 036342          442 RATDEFSENNLIGRGGFALFIRAF------------------------KSFDVECEMMKSI---RHRNLIKVISSCSN--  492 (596)
Q Consensus       442 ~~~~~~~~~~~ig~G~~g~v~~~~------------------------~~~~~e~~~l~~l---~H~niv~l~~~~~~--  492 (596)
                      ...++|+..+.||+|+||+||+|.                        ..+.+|+.+++.+   +|||||+++++|..  
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            346789999999999999999862                        2456788887766   79999999999853  


Q ss_pred             ---CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          493 ---EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       493 ---~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                         ....|+||||+++|++..........+++..+..++.|++.||+|||   .++|+||||||+|||+++++.+||+||
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence               34689999999988776665555567899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCC
Q 036342          570 SIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       570 Gla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      |+++....   .......+||+.||||
T Consensus       161 g~~~~~~~---~~~~~~~~gT~~Y~AP  184 (305)
T d1blxa_         161 GLARIYSF---QMALTSVVVTLWYRAP  184 (305)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCH
T ss_pred             hhhhhhcc---cccCCCcccChhhcCc
Confidence            99886432   2234557899999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.6e-26  Score=232.05  Aligned_cols=145  Identities=27%  Similarity=0.428  Sum_probs=119.0

Q ss_pred             cccccccccCCCceeehhhH-----------------HhHHHHHHHHhhcCCCccceeeeeecc------CCeeEEEEec
Q 036342          446 EFSENNLIGRGGFALFIRAF-----------------KSFDVECEMMKSIRHRNLIKVISSCSN------EEFKALVLEY  502 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~-----------------~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~~lV~e~  502 (596)
                      +|...+.||+|+||+||+|.                 +...+|++++++++|||||+++++|..      +...|+||||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            68889999999999999863                 234689999999999999999999843      2357899999


Q ss_pred             CCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-cEEEeccccccccCCCC
Q 036342          503 MPHGSLEKYLY--SSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGED  579 (596)
Q Consensus       503 ~~~g~L~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-~~kl~dfGla~~~~~~~  579 (596)
                      |++|.+.....  .....+++.++..++.|++.||+|||   +++|+||||||+|||++.++ .+||+|||+++......
T Consensus       101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_         101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            98764333322  23346899999999999999999999   99999999999999999775 89999999998764322


Q ss_pred             CccccccccccccccCC
Q 036342          580 QSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~~~~~~~~gt~~y~aP  596 (596)
                         .....+||+.|+||
T Consensus       178 ---~~~~~~gt~~y~aP  191 (350)
T d1q5ka_         178 ---PNVSYICSRYYRAP  191 (350)
T ss_dssp             ---CCCSCCSCTTSCCH
T ss_pred             ---ccccccccccccCh
Confidence               23446899999997

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=5.1e-26  Score=230.44  Aligned_cols=148  Identities=24%  Similarity=0.368  Sum_probs=121.3

Q ss_pred             cccccccccccCCCceeehhhH----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC----eeE
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE----FKA  497 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~  497 (596)
                      .++|+..+.||+|+||+||+|.                      +.+.+|+++|++++|||||++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            3579999999999999999862                      35778999999999999999999997653    234


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 036342          498 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  577 (596)
Q Consensus       498 lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~  577 (596)
                      +++||+.+|+|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            455667799999999765  4889999999999999999999   89999999999999999999999999999987543


Q ss_pred             CCC-ccccccccccccccCC
Q 036342          578 EDQ-SMTQTQTLGTIGYMAP  596 (596)
Q Consensus       578 ~~~-~~~~~~~~gt~~y~aP  596 (596)
                      ... .......+||+.|+||
T Consensus       162 ~~~~~~~~~~~~gt~~y~aP  181 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAP  181 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCG
T ss_pred             CCccceeeccccccceechH
Confidence            211 1123456799999998

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.92  E-value=1.5e-25  Score=221.46  Aligned_cols=148  Identities=18%  Similarity=0.239  Sum_probs=128.5

Q ss_pred             ccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCC-CccceeeeeeccCCeeEEEEecCC
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRH-RNLIKVISSCSNEEFKALVLEYMP  504 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~~~  504 (596)
                      ++|++.+.||+|+||+||+|.                   ..+.+|++.++.++| +|++.+++++..+...|+||||+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            579999999999999999963                   347889999999976 89999999999999999999999 


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCC-----CCcEEEeccccccccCCCC
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDD-----NMVAHLSDFSIAKLLTGED  579 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~-----~~~~kl~dfGla~~~~~~~  579 (596)
                      +|+|.+++......+++.++..++.|++.|++|||   +.+|+||||||+|||++.     ++.+|++|||+|+.+....
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            78999999887777899999999999999999999   999999999999999974     5789999999999865332


Q ss_pred             Cc-----cccccccccccccCC
Q 036342          580 QS-----MTQTQTLGTIGYMAP  596 (596)
Q Consensus       580 ~~-----~~~~~~~gt~~y~aP  596 (596)
                      ..     ......+||+.||||
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aP  182 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSI  182 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCH
T ss_pred             cccceeecccCceEEchhhcCH
Confidence            11     123346799999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=8e-26  Score=229.36  Aligned_cols=142  Identities=26%  Similarity=0.384  Sum_probs=118.8

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCC------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEE------  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~------  494 (596)
                      .++|+..+.||+|+||+||+|.                       +.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            4689999999999999999862                       35778999999999999999999997654      


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ..|+||||| ++++.+..+..  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            479999999 66888877654  5899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ....     .+..+||+.|+||
T Consensus       171 ~~~~-----~~~~~~t~~y~aP  187 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAP  187 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCT
T ss_pred             cCCc-----cccccccccccCH
Confidence            5422     2446799999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.92  E-value=8.4e-26  Score=227.47  Aligned_cols=142  Identities=23%  Similarity=0.398  Sum_probs=122.7

Q ss_pred             ccccccccccCCCceeehhhH------------------HhHHHHHHHHhhcC-CCccceeeeeeccC--CeeEEEEecC
Q 036342          445 DEFSENNLIGRGGFALFIRAF------------------KSFDVECEMMKSIR-HRNLIKVISSCSNE--EFKALVLEYM  503 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~------------------~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~e~~  503 (596)
                      ++|+..+.||+|+||+||+|.                  +.+.+|+++|++++ ||||+++++++...  ...++|||||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            589999999999999999862                  46789999999995 99999999998743  4689999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCC-cEEEeccccccccCCCCCcc
Q 036342          504 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQSM  582 (596)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~-~~kl~dfGla~~~~~~~~~~  582 (596)
                      ++|+|.++.    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+|++|||+|+......   
T Consensus       115 ~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---  184 (328)
T d3bqca1         115 NNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---  184 (328)
T ss_dssp             CSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---
T ss_pred             CCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC---
Confidence            999997764    35789999999999999999999   99999999999999998654 69999999998764322   


Q ss_pred             ccccccccccccCC
Q 036342          583 TQTQTLGTIGYMAP  596 (596)
Q Consensus       583 ~~~~~~gt~~y~aP  596 (596)
                      .....+||+.|+||
T Consensus       185 ~~~~~~~t~~y~aP  198 (328)
T d3bqca1         185 EYNVRVASRYFKGP  198 (328)
T ss_dssp             CCCSCCSCGGGCCH
T ss_pred             cccccccCccccCc
Confidence            23456799999998

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=5.1e-24  Score=207.62  Aligned_cols=198  Identities=22%  Similarity=0.200  Sum_probs=105.5

Q ss_pred             CCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEe
Q 036342           34 STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLG  113 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  113 (596)
                      .++.+.|.+++.|+. +|+..   .++|++|+|++|+|++..+.+|.++++|++|+|++|+|+.+.  .++.+++|++|+
T Consensus        10 ~~~~~v~C~~~~L~~-iP~~l---p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~   83 (266)
T d1p9ag_          10 ASHLEVNCDKRNLTA-LPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLD   83 (266)
T ss_dssp             TTCCEEECTTSCCSS-CCSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEE
T ss_pred             CCCeEEEccCCCCCe-eCcCc---CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccccc
Confidence            344444555555542 33211   134555555555555444455555666666666666665432  244566666666


Q ss_pred             cCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEc
Q 036342          114 LDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDL  193 (596)
Q Consensus       114 l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  193 (596)
                      |++|+++....      .+.++++|+.|++++|.+.+..+. .+..+ .++++|++++|.++...+..+..+++++.|++
T Consensus        84 Ls~N~l~~~~~------~~~~l~~L~~L~l~~~~~~~~~~~-~~~~l-~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l  155 (266)
T d1p9ag_          84 LSHNQLQSLPL------LGQTLPALTVLDVSFNRLTSLPLG-ALRGL-GELQELYLKGNELKTLPPGLLTPTPKLEKLSL  155 (266)
T ss_dssp             CCSSCCSSCCC------CTTTCTTCCEEECCSSCCCCCCSS-TTTTC-TTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             ccccccccccc------ccccccccccccccccccceeecc-ccccc-cccccccccccccceeccccccccccchhccc
Confidence            66666655332      255556666666666665543222 22222 34455555555555444555555566666666


Q ss_pred             cCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcC
Q 036342          194 GGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKL  246 (596)
Q Consensus       194 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  246 (596)
                      ++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus       156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             ccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence            666666555555556666666666666665 4555555555555555555544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.2e-26  Score=226.99  Aligned_cols=148  Identities=26%  Similarity=0.360  Sum_probs=128.8

Q ss_pred             cccccccccccCCCceeehhhH----------------------------HhHHHHHHHHhhcCC-CccceeeeeeccCC
Q 036342          444 TDEFSENNLIGRGGFALFIRAF----------------------------KSFDVECEMMKSIRH-RNLIKVISSCSNEE  494 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~----------------------------~~~~~e~~~l~~l~H-~niv~l~~~~~~~~  494 (596)
                      .++|+..+.||+|+||+||+|.                            +.+.+|++++++++| |||+++++++.+.+
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            3689999999999999999852                            235689999999977 79999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          495 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       495 ~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ..++||||+.+|+|.+++.... .+.+..+..++.|++.|++|+|   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999999998765 4678888999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCC
Q 036342          575 LTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +.... ........||+.|+||
T Consensus       179 ~~~~~-~~~~~~~~g~~~~~~p  199 (322)
T d1vzoa_         179 FVADE-TERAYDFCGTIEYMAP  199 (322)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCH
T ss_pred             hcccc-cccccccccccccchh
Confidence            64322 2223446799999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.8e-25  Score=223.97  Aligned_cols=149  Identities=22%  Similarity=0.364  Sum_probs=122.8

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeecc--------
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSN--------  492 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~--------  492 (596)
                      .++|+..+.||+|+||+||+|.                       +++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            5789999999999999999862                       347799999999999999999999855        


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccc
Q 036342          493 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIA  572 (596)
Q Consensus       493 ~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla  572 (596)
                      ++..|+||||++++.+.... .....+++..+..++.|++.|+.|||   +.+|+||||||+|||++.++.+|++|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34589999999877665444 33446788999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCc--cccccccccccccCC
Q 036342          573 KLLTGEDQS--MTQTQTLGTIGYMAP  596 (596)
Q Consensus       573 ~~~~~~~~~--~~~~~~~gt~~y~aP  596 (596)
                      +........  ......+||++|+||
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aP  190 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPP  190 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCH
T ss_pred             eecccccccccccccceecCHHHhhH
Confidence            876432211  122345799999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3.3e-25  Score=219.39  Aligned_cols=146  Identities=22%  Similarity=0.338  Sum_probs=127.0

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccCCeeEEEEe
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  501 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~e  501 (596)
                      ++|+..+.||+|+||+||+|.                       +.+.+|+.++++++|||||+++++|...+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            579999999999999999852                       457899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEeccccccccCCCCCc
Q 036342          502 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      |+.++++..++... ..+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+|++|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            99999888877654 46789999999999999999999   89999999999999999999999999999997643322 


Q ss_pred             cccccccccccccCC
Q 036342          582 MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 ~~~~~~~gt~~y~aP  596 (596)
                       ......+++.|+||
T Consensus       157 -~~~~~~~~~~~~~p  170 (292)
T d1unla_         157 -CYSAEVVTLWYRPP  170 (292)
T ss_dssp             -CCCSCCSCGGGCCH
T ss_pred             -cceeeccccchhhh
Confidence             22334567777775

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.91  E-value=1e-24  Score=216.48  Aligned_cols=148  Identities=22%  Similarity=0.340  Sum_probs=122.4

Q ss_pred             ccccccccccCCCceeehhhH-------------------HhHHHHHHHHhhcCCCccceeee-eeccCCeeEEEEecCC
Q 036342          445 DEFSENNLIGRGGFALFIRAF-------------------KSFDVECEMMKSIRHRNLIKVIS-SCSNEEFKALVLEYMP  504 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-------------------~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~~~lV~e~~~  504 (596)
                      ++|+..+.||+|+||+||+|.                   +.+..|++++++++|+++|..++ ++.+++..++||||+ 
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            579999999999999999863                   35788999999998887665554 556677889999999 


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeC---CCCcEEEeccccccccCCCCCc
Q 036342          505 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQS  581 (596)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~---~~~~~kl~dfGla~~~~~~~~~  581 (596)
                      +|++.+.+......+++..+..++.|++.|++|||   +++|+||||||+|||++   .+..+|++|||+|+.+......
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            56787777766667999999999999999999999   89999999999999986   3567999999999987543221


Q ss_pred             -----cccccccccccccCC
Q 036342          582 -----MTQTQTLGTIGYMAP  596 (596)
Q Consensus       582 -----~~~~~~~gt~~y~aP  596 (596)
                           ......+||+.||||
T Consensus       163 ~~~~~~~~~~~~gt~~y~aP  182 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASI  182 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCH
T ss_pred             cceeccccCCcCCCccccCH
Confidence                 123446899999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=8.4e-25  Score=222.06  Aligned_cols=143  Identities=23%  Similarity=0.363  Sum_probs=119.8

Q ss_pred             cccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC-----Ce
Q 036342          444 TDEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE-----EF  495 (596)
Q Consensus       444 ~~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  495 (596)
                      .++|+..+.||+|+||+||+|.                       +.+.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            5689999999999999999862                       3567899999999999999999998643     33


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .++|+||+.+|+|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+|++|||++...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            56777888899999998654  5899999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ..     ......||+.|+||
T Consensus       172 ~~-----~~~~~~g~~~y~ap  187 (348)
T d2gfsa1         172 DD-----EMTGYVATRWYRAP  187 (348)
T ss_dssp             TG-----GGSSSCHHHHTSCH
T ss_pred             Cc-----ccccccccccccCc
Confidence            22     23446789999997

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=5.4e-24  Score=216.26  Aligned_cols=142  Identities=27%  Similarity=0.379  Sum_probs=111.1

Q ss_pred             ccccccccccCCCceeehhhH-----------------------HhHHHHHHHHhhcCCCccceeeeeeccC------Ce
Q 036342          445 DEFSENNLIGRGGFALFIRAF-----------------------KSFDVECEMMKSIRHRNLIKVISSCSNE------EF  495 (596)
Q Consensus       445 ~~~~~~~~ig~G~~g~v~~~~-----------------------~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~  495 (596)
                      ++|+..+.||+|+||+||+|.                       +.+.+|+.++++++|||||+++++|...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            679999999999999999852                       3477899999999999999999999643      57


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecccccccc
Q 036342          496 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  575 (596)
Q Consensus       496 ~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~~  575 (596)
                      .|+|||||.++ +.+.+.   ..+++..+..++.|++.|+.|||   ..+|+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999664 545443   35789999999999999999999   899999999999999999999999999998865


Q ss_pred             CCCCCccccccccccccccCC
Q 036342          576 TGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      ...   ......+||+.|+||
T Consensus       170 ~~~---~~~~~~~~t~~y~aP  187 (355)
T d2b1pa1         170 GTS---FMMTPYVVTRYYRAP  187 (355)
T ss_dssp             --------------CCTTCCH
T ss_pred             ccc---cccccccccccccCh
Confidence            432   223456799999998

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.87  E-value=2.8e-20  Score=188.04  Aligned_cols=295  Identities=25%  Similarity=0.290  Sum_probs=177.9

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEE
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLS   89 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (596)
                      .++++|||++|+|+ .+|+.   +++|++|+|++|+|+ .+|..    +++|+.|++++|.++ .++..   .+.|++|+
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~  104 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLG  104 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSC---CTTCCEEE
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhh---cccccccc
Confidence            46899999999997 56753   578999999999998 56642    568999999999988 44432   24699999


Q ss_pred             ccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEc
Q 036342           90 LGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM  169 (596)
Q Consensus        90 L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l  169 (596)
                      +++|.|..+ |. ++.+++|++|++++|.++.....         ...+..+++..+......   .+..+ +.++.+++
T Consensus       105 L~~n~l~~l-p~-~~~l~~L~~L~l~~~~~~~~~~~---------~~~l~~l~~~~~~~~~~~---~l~~l-~~l~~L~l  169 (353)
T d1jl5a_         105 VSNNQLEKL-PE-LQNSSFLKIIDVDNNSLKKLPDL---------PPSLEFIAAGNNQLEELP---ELQNL-PFLTAIYA  169 (353)
T ss_dssp             CCSSCCSSC-CC-CTTCTTCCEEECCSSCCSCCCCC---------CTTCCEEECCSSCCSSCC---CCTTC-TTCCEEEC
T ss_pred             ccccccccc-cc-hhhhccceeeccccccccccccc---------cccccchhhccccccccc---ccccc-ccceeccc
Confidence            999999865 43 67899999999999988764332         233444444444433221   12222 34455555


Q ss_pred             ccccccccc------------------ChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchh
Q 036342          170 YNCNISGGI------------------PEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDIC  231 (596)
Q Consensus       170 ~~n~l~~~~------------------~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  231 (596)
                      ++|.+....                  ...+..++.|+.+++++|.... .+.   ...++..+.+..|.+.. .+.   
T Consensus       170 ~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~-~~~---  241 (353)
T d1jl5a_         170 DNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-LPE---  241 (353)
T ss_dssp             CSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC-CCC---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc-ccc---ccccccccccccccccc-ccc---
Confidence            555444221                  1123344444555555444432 111   22334444444444431 111   


Q ss_pred             cCCCCcEEEccCCcCcccchhhhccC-CCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceE
Q 036342          232 RLAELYRLELGSNKLYGSIPACFGNL-ASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGI  310 (596)
Q Consensus       232 ~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L  310 (596)
                      ...++...++..|.+.+.     ..+ ......++..|.+..++.   .+++|++|++++|+++.. |.   .+++|+.|
T Consensus       242 ~~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~~~---~~~~L~~L~Ls~N~l~~l-p~---~~~~L~~L  309 (353)
T d1jl5a_         242 LPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRSLCD---LPPSLEELNVSNNKLIEL-PA---LPPRLERL  309 (353)
T ss_dssp             CCTTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEECC---CCTTCCEEECCSSCCSCC-CC---CCTTCCEE
T ss_pred             cccccccccccccccccc-----ccccchhcccccccCccccccc---cCCCCCEEECCCCccCcc-cc---ccCCCCEE
Confidence            122334444444433211     111 233445555555555432   257899999999998853 43   35778889


Q ss_pred             ecCCCcCcccCChhhhccCCCCCeEECCCCcccccCCCCCCCCCCCcccc
Q 036342          311 DFSMNNFSGVIPREIGEKLSYLEDLNLSFNKLKGEIPRGGSFGNFSAESF  360 (596)
Q Consensus       311 ~ls~N~~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~l~~  360 (596)
                      ++++|+|+ .+|.    .+++|++|++++|+++. +|..  ...++.+++
T Consensus       310 ~L~~N~L~-~l~~----~~~~L~~L~L~~N~L~~-lp~~--~~~L~~L~~  351 (353)
T d1jl5a_         310 IASFNHLA-EVPE----LPQNLKQLHVEYNPLRE-FPDI--PESVEDLRM  351 (353)
T ss_dssp             ECCSSCCS-CCCC----CCTTCCEEECCSSCCSS-CCCC--CTTCCEEEC
T ss_pred             ECCCCcCC-cccc----ccCCCCEEECcCCcCCC-CCcc--ccccCeeEC
Confidence            99999998 5675    35689999999999884 4543  223444443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=1.2e-19  Score=183.38  Aligned_cols=283  Identities=29%  Similarity=0.306  Sum_probs=202.4

Q ss_pred             CCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCC-CCCCEE
Q 036342           34 STLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNL-RNLEQL  112 (596)
Q Consensus        34 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L  112 (596)
                      .++++|||++|.|+ .+|+.    +++|++|+|++|+|+ .+|+.   +.+|++|++++|+++.+ +    .+ +.|++|
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~----~lp~~L~~L  103 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-S----DLPPLLEYL  103 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-C----SCCTTCCEE
T ss_pred             cCCCEEEeCCCCCC-CCCCC----CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchh-h----hhccccccc
Confidence            47999999999998 56642    679999999999999 67765   46899999999999854 2    33 469999


Q ss_pred             ecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEE
Q 036342          113 GLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEID  192 (596)
Q Consensus       113 ~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  192 (596)
                      ++++|.++.++.       ++.+++|+.|++++|.+......      ...+..+.+..+....  ...+..++.++.++
T Consensus       104 ~L~~n~l~~lp~-------~~~l~~L~~L~l~~~~~~~~~~~------~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~  168 (353)
T d1jl5a_         104 GVSNNQLEKLPE-------LQNSSFLKIIDVDNNSLKKLPDL------PPSLEFIAAGNNQLEE--LPELQNLPFLTAIY  168 (353)
T ss_dssp             ECCSSCCSSCCC-------CTTCTTCCEEECCSSCCSCCCCC------CTTCCEEECCSSCCSS--CCCCTTCTTCCEEE
T ss_pred             cccccccccccc-------hhhhccceeeccccccccccccc------cccccchhhccccccc--cccccccccceecc
Confidence            999999987642       57889999999999998754322      2567888887776643  45678889999999


Q ss_pred             ccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC
Q 036342          193 LGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS  272 (596)
Q Consensus       193 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  272 (596)
                      +++|.+.....    .....+.+..+++.+. .++ .+..++.|+.+++++|.... .+   ....++..+.+.+|.+..
T Consensus       169 l~~n~~~~~~~----~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~---~~~~~l~~~~~~~~~~~~  238 (353)
T d1jl5a_         169 ADNNSLKKLPD----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLTD  238 (353)
T ss_dssp             CCSSCCSSCCC----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CC---SCCTTCCEEECCSSCCSC
T ss_pred             ccccccccccc----cccccccccccccccc-ccc-cccccccccccccccccccc-cc---cccccccccccccccccc
Confidence            99998874322    1233456666666655 333 35567778888888777653 22   234556677777777665


Q ss_pred             CCcccccc-----------------cccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCChhhhccCCCCCeE
Q 036342          273 IPLTFWNL-----------------KDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPREIGEKLSYLEDL  335 (596)
Q Consensus       273 ip~~~~~l-----------------~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~~~l~~L~~L  335 (596)
                      .+.....+                 ......++..|.+.+.    ...+++|++|++++|+++ .+|.    .+++|+.|
T Consensus       239 ~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~----~~~~L~~L  309 (353)
T d1jl5a_         239 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPA----LPPRLERL  309 (353)
T ss_dssp             CCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCC----CCTTCCEE
T ss_pred             cccccccccccccccccccccccccchhcccccccCccccc----cccCCCCCEEECCCCccC-cccc----ccCCCCEE
Confidence            43321111                 1223344555544432    233578999999999998 5775    46899999


Q ss_pred             ECCCCcccccCCCCCCCCCCCccccccccccc
Q 036342          336 NLSFNKLKGEIPRGGSFGNFSAESFEGNELLC  367 (596)
Q Consensus       336 ~l~~N~l~~~~p~~~~~~~l~~l~~~~N~~~c  367 (596)
                      +|++|+|+. +|..  .++++.+++++|++..
T Consensus       310 ~L~~N~L~~-l~~~--~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         310 IASFNHLAE-VPEL--PQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             ECCSSCCSC-CCCC--CTTCCEEECCSSCCSS
T ss_pred             ECCCCcCCc-cccc--cCCCCEEECcCCcCCC
Confidence            999999984 5543  5689999999999754

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=1.2e-20  Score=180.78  Aligned_cols=105  Identities=20%  Similarity=0.231  Sum_probs=55.8

Q ss_pred             CEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCcccccc-CccccCCCCCCEEEcc
Q 036342           13 EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTI-PRFIFNASKLSKLSLG   91 (596)
Q Consensus        13 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~   91 (596)
                      +.++.++++++ .+|..+  .+++++|||++|+|+ .++...|..+++|++|+|++|.+...+ +.+|.+++++++|++.
T Consensus        11 ~~i~c~~~~l~-~iP~~l--~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCS-SCCSCS--CSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCC-CcCCCC--CCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            45555555555 344333  135566666666664 344444444566666666666554322 3345555555655543


Q ss_pred             -CCcccccCCccccCCCCCCEEecCCCcCcC
Q 036342           92 -MNSFSGFIPSTFGNLRNLEQLGLDENYLTS  121 (596)
Q Consensus        92 -~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~  121 (596)
                       .|++....++.|.++++|++|++++|.++.
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~  117 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKH  117 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred             ccccccccccccccccccccccccchhhhcc
Confidence             345555555555555556665555555544

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=1.5e-20  Score=180.12  Aligned_cols=227  Identities=18%  Similarity=0.131  Sum_probs=170.0

Q ss_pred             CCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccc-cCCccccCCCCCCEEec
Q 036342           36 LKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSG-FIPSTFGNLRNLEQLGL  114 (596)
Q Consensus        36 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~l  114 (596)
                      .+.++.+++.++ .+|...   .+++++|||++|+|+...+.+|.++++|++|+|++|.+.. +.+++|.++++++++.+
T Consensus        10 ~~~i~c~~~~l~-~iP~~l---~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~   85 (242)
T d1xwdc1          10 NRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI   85 (242)
T ss_dssp             SSEEEEESCSCS-SCCSCS---CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred             CCEEEEeCCCCC-CcCCCC---CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence            367888888887 555422   2578999999999986666688899999999999998865 45667889999999987


Q ss_pred             CC-CcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCC-CCCEEE
Q 036342          115 DE-NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLT-NLVEID  192 (596)
Q Consensus       115 ~~-N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~  192 (596)
                      .. |.+....+.     .|.++++|+.+++++|.+....+...+..+ ..+..+..+++.+..+.+..|.+++ .++.|+
T Consensus        86 ~~~n~l~~~~~~-----~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l-~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~  159 (242)
T d1xwdc1          86 EKANNLLYINPE-----AFQNLPNLQYLLISNTGIKHLPDVHKIHSL-QKVLLDIQDNINIHTIERNSFVGLSFESVILW  159 (242)
T ss_dssp             ECCTTCCEECTT-----SEECCTTCCEEEEESCCCCSCCCCTTTCBS-SCEEEEEESCTTCCEECTTSSTTSBSSCEEEE
T ss_pred             cccccccccccc-----cccccccccccccchhhhcccccccccccc-cccccccccccccccccccccccccccceeee
Confidence            54 667665544     578889999999999988765443333444 5677777788888888788887765 788899


Q ss_pred             ccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccC
Q 036342          193 LGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTS  272 (596)
Q Consensus       193 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  272 (596)
                      +++|+++.+.+..|.....++.+++++|.++...+..|.++++|++|+|++|+++...+..|.++++|+++++.  +++.
T Consensus       160 l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~--~l~~  237 (242)
T d1xwdc1         160 LNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NLKK  237 (242)
T ss_dssp             CCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE--SSSC
T ss_pred             cccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC--CCCc
Confidence            99999987666666543333444678888885445568889999999999999987666678888888877664  3445


Q ss_pred             CC
Q 036342          273 IP  274 (596)
Q Consensus       273 ip  274 (596)
                      +|
T Consensus       238 lp  239 (242)
T d1xwdc1         238 LP  239 (242)
T ss_dssp             SC
T ss_pred             CC
Confidence            55

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.82  E-value=6.6e-20  Score=173.71  Aligned_cols=204  Identities=22%  Similarity=0.374  Sum_probs=97.5

Q ss_pred             CEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCC
Q 036342           37 KFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDE  116 (596)
Q Consensus        37 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~  116 (596)
                      ..++++.+++++.+ ..  ..+.+|++|++++|.|+. ++ .+..+++|++|++++|+|++..+  |.++++|+++++++
T Consensus        22 ~~~~l~~~~~~d~~-~~--~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~   94 (227)
T d1h6ua2          22 IKIAAGKSNVTDTV-TQ--ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG   94 (227)
T ss_dssp             HHHHTTCSSTTSEE-CH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred             HHHHhCCCCcCCcC-CH--HHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence            33445555554322 11  124556666666666552 32 35556666666666666654432  55666666666666


Q ss_pred             CcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCC
Q 036342          117 NYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGN  196 (596)
Q Consensus       117 N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N  196 (596)
                      |.++.+.       .+.++++|+.+++++|...+..   .+... +.+..+.++++.+...  ..+...++|+.|++++|
T Consensus        95 n~~~~i~-------~l~~l~~L~~l~l~~~~~~~~~---~~~~~-~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n  161 (227)
T d1h6ua2          95 NPLKNVS-------AIAGLQSIKTLDLTSTQITDVT---PLAGL-SNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNA  161 (227)
T ss_dssp             CCCSCCG-------GGTTCTTCCEEECTTSCCCCCG---GGTTC-TTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSS
T ss_pred             ccccccc-------cccccccccccccccccccccc---hhccc-cchhhhhchhhhhchh--hhhcccccccccccccc
Confidence            6555431       2455566666666665554331   11111 3344444444444322  22344455555555555


Q ss_pred             cccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeC
Q 036342          197 KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLG  266 (596)
Q Consensus       197 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  266 (596)
                      .+....  .++++++|++|++++|++++ ++ .+..+++|++|+|++|++++..|  ++++++|+.|+++
T Consensus       162 ~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         162 QVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             CCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             ccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence            554322  24445555555555555542 22 24444455555555554443221  4444444444443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.82  E-value=1.2e-19  Score=171.93  Aligned_cols=208  Identities=21%  Similarity=0.350  Sum_probs=169.1

Q ss_pred             CCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEE
Q 036342           10 QNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLS   89 (596)
Q Consensus        10 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (596)
                      +++..++++.+++++..  .+..+.+|+.|++++|.|+ .++.+.  .+++|++|++++|++++..|  +.++++|++++
T Consensus        19 ~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~~l~--~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~   91 (227)
T d1h6ua2          19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEGVQ--YLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (227)
T ss_dssp             HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCTTGG--GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cchhHh--cCCCCcEeecCCceeecccc--ccccccccccc
Confidence            34445678888887654  4466789999999999998 565544  49999999999999985443  88999999999


Q ss_pred             ccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEc
Q 036342           90 LGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYM  169 (596)
Q Consensus        90 L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l  169 (596)
                      +++|.++.+  +.|.++++|+.+++++|......       .+...+.+..+.++++.+....   .+... ++|++|++
T Consensus        92 ~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~-------~~~~~~~~~~l~~~~~~~~~~~---~~~~~-~~L~~L~l  158 (227)
T d1h6ua2          92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVT-------PLAGLSNLQVLYLDLNQITNIS---PLAGL-TNLQYLSI  158 (227)
T ss_dssp             CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCG-------GGTTCTTCCEEECCSSCCCCCG---GGGGC-TTCCEEEC
T ss_pred             ccccccccc--ccccccccccccccccccccccc-------hhccccchhhhhchhhhhchhh---hhccc-cccccccc
Confidence            999999854  35889999999999999887643       3677889999999999987543   34444 67999999


Q ss_pred             cccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccC
Q 036342          170 YNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGS  243 (596)
Q Consensus       170 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  243 (596)
                      ++|.++..  ..|.++++|++|++++|++++..  .+.++++|++|++++|++++ ++ .+.++++|+.|++++
T Consensus       159 ~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         159 GNAQVSDL--TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLTN  226 (227)
T ss_dssp             CSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEEE
T ss_pred             cccccccc--hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEeeC
Confidence            99999764  34889999999999999998643  38899999999999999995 44 388999999999974

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.82  E-value=2.6e-20  Score=171.58  Aligned_cols=174  Identities=25%  Similarity=0.278  Sum_probs=142.3

Q ss_pred             CCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEcc
Q 036342           12 LEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLG   91 (596)
Q Consensus        12 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~   91 (596)
                      .+++++++++++ .+|..+  .+++++|+|++|+|++.++...|..+++|++|+|++|++....+..|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            468999999998 567665  36899999999999877777777889999999999999999999999999999999999


Q ss_pred             CCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEECcCCCCCccCCchhhhcccccccEEEccc
Q 036342           92 MNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYN  171 (596)
Q Consensus        92 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~  171 (596)
                      +|+|+.+.+++|.++++|++|+|++|+|+.++++     +|..+++|++|+|++|.+.......++.   ..++.+.+..
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~-----~f~~l~~L~~l~L~~N~~~~~~~~~~~~---~~l~~~~l~~  158 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG-----SFEHLNSLTSLNLASNPFNCNCHLAWFA---EWLRKKSLNG  158 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTT-----SSTTCTTCCEEECTTCCBCCSGGGHHHH---HHHHHHCCSG
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHH-----HhcCCcccccccccccccccccchHHHh---hhhhhhcccC
Confidence            9999999999999999999999999999998776     5899999999999999987543322222   2355566666


Q ss_pred             cccccccChhccCCCCCCEEEccCCccc
Q 036342          172 CNISGGIPEEISNLTNLVEIDLGGNKLN  199 (596)
Q Consensus       172 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  199 (596)
                      +.++...|..+   ..++.++|+.|.+.
T Consensus       159 ~~~~c~~p~~l---~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         159 GAARCGAPSKV---RDVQIKDLPHSEFK  183 (192)
T ss_dssp             GGCBBCSSTTT---TTSBGGGSCTTTCC
T ss_pred             CCeEeCCChhh---cCCEeeecCHhhCc
Confidence            76665555443   34455666666665

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=6.7e-19  Score=164.45  Aligned_cols=164  Identities=29%  Similarity=0.390  Sum_probs=82.2

Q ss_pred             CCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCC
Q 036342           59 PNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSL  138 (596)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L  138 (596)
                      .+|++|++++|.++.. + .+..+++|++|+|++|+|+++.+  ++++++|++|++++|+++.++       .+.++++|
T Consensus        46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~l~-------~l~~l~~L  114 (210)
T d1h6ta2          46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS-------SLKDLKKL  114 (210)
T ss_dssp             HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGG-------GGTTCTTC
T ss_pred             cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccccc-------cccccccc
Confidence            3444444444444421 1 23444444444444444443221  344444555555444444321       23444455


Q ss_pred             CEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEcc
Q 036342          139 TLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLE  218 (596)
Q Consensus       139 ~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  218 (596)
                      +.|++++|.+...   ..+..+ +.++.+++++|.+++.  ..+..+++|+++++++|++++..  .+.++++|++|+++
T Consensus       115 ~~L~l~~~~~~~~---~~l~~l-~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls  186 (210)
T d1h6ta2         115 KSLSLEHNGISDI---NGLVHL-PQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLS  186 (210)
T ss_dssp             CEEECTTSCCCCC---GGGGGC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred             ccccccccccccc---cccccc-cccccccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECC
Confidence            5555555544322   123333 3455555555555432  33455666666777766666432  25666677777777


Q ss_pred             CCcccccCccchhcCCCCcEEEccC
Q 036342          219 DNILEGSIPDDICRLAELYRLELGS  243 (596)
Q Consensus       219 ~N~l~~~~~~~~~~l~~L~~L~Ls~  243 (596)
                      +|.|+ .++ .+.++++|++|+|++
T Consensus       187 ~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         187 KNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             SSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             CCCCC-CCh-hhcCCCCCCEEEccC
Confidence            77666 343 466667777776653

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=3.1e-21  Score=202.21  Aligned_cols=354  Identities=20%  Similarity=0.184  Sum_probs=218.4

Q ss_pred             CCCEEECCCCCCcccc-chhhhCCCCCCEEEccCCcCccc-cCcc--CccCCCCccEEEccCCccccc----cCccccC-
Q 036342           11 NLEELQLGQNKLIGTV-PAAIFNVSTLKFLGLQNNSLSGS-LSSI--ANVRLPNLEKLYLWGNNFSGT----IPRFIFN-   81 (596)
Q Consensus        11 ~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~-~~~~--~~~~l~~L~~L~L~~N~l~~~----~~~~~~~-   81 (596)
                      +|++||+++|++++.. .+.+..++++++|+|++|.++.. ...+  .....++|++|||++|.|+..    +...+.. 
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            5788999999988643 34456688999999999988621 0111  123478899999999988632    2222322 


Q ss_pred             CCCCCEEEccCCccccc----CCccccCCCCCCEEecCCCcCcCCCCCc----------------------------ccc
Q 036342           82 ASKLSKLSLGMNSFSGF----IPSTFGNLRNLEQLGLDENYLTSSTPEL----------------------------SFL  129 (596)
Q Consensus        82 l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~----------------------------~~~  129 (596)
                      ..+|++|+|++|+|+..    ++..+..+++|++|++++|.++......                            ...
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  162 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence            34799999999998754    3456778889999999999875311000                            000


Q ss_pred             ccCCCCCCCCEEECcCCCCCccCCc---hhhhcccccccEEEccccccccc----cChhccCCCCCCEEEccCCcccCC-
Q 036342          130 SSLSNCKSLTLIDLSNNPLDGILPK---TSISNLSRSLEEFYMYNCNISGG----IPEEISNLTNLVEIDLGGNKLNGS-  201 (596)
Q Consensus       130 ~~~~~l~~L~~L~ls~N~l~~~~~~---~~~~~l~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-  201 (596)
                      ..+.....++.++++.+.+....-.   ..+.........+++..+.+...    ....+...+.++.+++++|.+... 
T Consensus       163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~  242 (460)
T d1z7xw1         163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG  242 (460)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence            1123345677777777665421000   01111123456677777766532    122344567788888888876431 


Q ss_pred             ----CCccccCCCCCCeEEccCCccccc----CccchhcCCCCcEEEccCCcCcccchhhh-----ccCCCCcEEEeCCC
Q 036342          202 ----IPITLGKLRKLQRLNLEDNILEGS----IPDDICRLAELYRLELGSNKLYGSIPACF-----GNLASLRILSLGSN  268 (596)
Q Consensus       202 ----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N  268 (596)
                          .+..+.....++.+++++|.+...    ....+...+.++.+++++|.+.......+     .....|+.+++++|
T Consensus       243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~  322 (460)
T d1z7xw1         243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC  322 (460)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence                233344567888888888887632    22234567788888888888864333322     23457888888888


Q ss_pred             cccCCC-----cccccccccceEEcccCCCCCchhhh----hc-cccccceEecCCCcCccc----CChhhhccCCCCCe
Q 036342          269 KLTSIP-----LTFWNLKDILQLNFSSNFLTGPLLLE----IG-NLKVLIGIDFSMNNFSGV----IPREIGEKLSYLED  334 (596)
Q Consensus       269 ~l~~ip-----~~~~~l~~L~~L~ls~N~l~~~~~~~----~~-~l~~L~~L~ls~N~~~~~----~~~~~~~~l~~L~~  334 (596)
                      .++...     ..+....+|++|+|++|+++......    +. ..+.|++|+|++|+|+..    +.. .+...++|++
T Consensus       323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~-~l~~~~~L~~  401 (460)
T d1z7xw1         323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA-TLLANHSLRE  401 (460)
T ss_dssp             CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH-HHHHCCCCCE
T ss_pred             chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH-HHhcCCCCCE
Confidence            887532     22334567888999988886543222    22 356688889998888632    222 3345688889


Q ss_pred             EECCCCcccccCCCC------CCCCCCCccccccccc
Q 036342          335 LNLSFNKLKGEIPRG------GSFGNFSAESFEGNEL  365 (596)
Q Consensus       335 L~l~~N~l~~~~p~~------~~~~~l~~l~~~~N~~  365 (596)
                      |||++|+++......      .....++.+++.+|.+
T Consensus       402 L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~  438 (460)
T d1z7xw1         402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW  438 (460)
T ss_dssp             EECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred             EECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCC
Confidence            999998886421110      0122466677766665

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=2.3e-19  Score=165.18  Aligned_cols=158  Identities=21%  Similarity=0.254  Sum_probs=83.5

Q ss_pred             ccccEEEcccccccc-ccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEE
Q 036342          162 RSLEEFYMYNCNISG-GIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLE  240 (596)
Q Consensus       162 ~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (596)
                      +++++|+|++|+|++ ..+..|.++++|+.|++++|.+.+..+..|..+++|++|+|++|+|+...+..|.++++|++|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence            344555555555543 2234455555555555555555555555555555555555555555544444555555555555


Q ss_pred             ccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCccc
Q 036342          241 LGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGV  320 (596)
Q Consensus       241 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~  320 (596)
                      |++|+|+++.++.|..+++|++|+|++|.+.......+                      +  ...++.+.+..|.+...
T Consensus       109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~----------------------~--~~~l~~~~l~~~~~~c~  164 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW----------------------F--AEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH----------------------H--HHHHHHHCCSGGGCBBC
T ss_pred             cCCccccccCHHHhcCCcccccccccccccccccchHH----------------------H--hhhhhhhcccCCCeEeC
Confidence            55555555555555555555555555555543221111                      1  11233344555555544


Q ss_pred             CChhhhccCCCCCeEECCCCcccccCC
Q 036342          321 IPREIGEKLSYLEDLNLSFNKLKGEIP  347 (596)
Q Consensus       321 ~~~~~~~~l~~L~~L~l~~N~l~~~~p  347 (596)
                      .|.    .+..++.++|+.|.+.+..+
T Consensus       165 ~p~----~l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         165 APS----KVRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             SST----TTTTSBGGGSCTTTCCCCCC
T ss_pred             CCh----hhcCCEeeecCHhhCcCCCC
Confidence            454    34456667777777766443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=1.5e-18  Score=160.51  Aligned_cols=161  Identities=24%  Similarity=0.353  Sum_probs=84.5

Q ss_pred             CCCccEEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCC
Q 036342           58 LPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKS  137 (596)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~  137 (596)
                      ++++++|++++|.++. + +.+..+++|++|++++|+|++..+  |.++++|++|++++|.+..++       .+.+++.
T Consensus        39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~-------~l~~l~~  107 (199)
T d2omxa2          39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT-------PLANLTN  107 (199)
T ss_dssp             HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-------GGTTCTT
T ss_pred             hcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc-------ccccccc
Confidence            3444555555554442 2 124444555555555555544322  445555555555555444321       2445555


Q ss_pred             CCEEECcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEc
Q 036342          138 LTLIDLSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNL  217 (596)
Q Consensus       138 L~~L~ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  217 (596)
                      |+.|++++|.+....   .+..+ ++|+.|++++|++...  +.+..+++|+.|++++|++++..  .+.++++|++|++
T Consensus       108 L~~L~l~~~~~~~~~---~~~~l-~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~l  179 (199)
T d2omxa2         108 LTGLTLFNNQITDID---PLKNL-TNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDI  179 (199)
T ss_dssp             CSEEECCSSCCCCCG---GGTTC-TTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred             ccccccccccccccc---ccchh-hhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEEC
Confidence            555555555544321   23333 4455555555555432  24566667777777777766532  3666777777777


Q ss_pred             cCCcccccCccchhcCCCCcEE
Q 036342          218 EDNILEGSIPDDICRLAELYRL  239 (596)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L  239 (596)
                      ++|++++ ++ .+..+++|+.|
T Consensus       180 s~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         180 SSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             CSSCCCC-CG-GGGGCTTCSEE
T ss_pred             CCCCCCC-Cc-cccCCCCCCcC
Confidence            7777763 33 46666666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=1.8e-18  Score=161.54  Aligned_cols=181  Identities=22%  Similarity=0.285  Sum_probs=91.6

Q ss_pred             EEEccCCccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecCCCcCcCCCCCccccccCCCCCCCCEEE
Q 036342           63 KLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLDENYLTSSTPELSFLSSLSNCKSLTLID  142 (596)
Q Consensus        63 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~~L~~L~  142 (596)
                      ..+++.+.+++.++.  ..+.+|++|++++|.|+...  .+..+++|++|++++|+++++.       .++.+++|+.|+
T Consensus        28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~-------~~~~l~~L~~L~   96 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK-------PLANLKNLGWLF   96 (210)
T ss_dssp             HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG-------GGTTCTTCCEEE
T ss_pred             HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc-------ccccCccccccc
Confidence            334555555443332  23445555666665555432  2445555555555555554432       134444555555


Q ss_pred             CcCCCCCccCCchhhhcccccccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcc
Q 036342          143 LSNNPLDGILPKTSISNLSRSLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNIL  222 (596)
Q Consensus       143 ls~N~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  222 (596)
                      +++|+++++                           | .+.++++|+.|++++|.+..  ...+..+++++.+++++|.+
T Consensus        97 l~~n~i~~l---------------------------~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l  146 (210)
T d1h6ta2          97 LDENKVKDL---------------------------S-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKI  146 (210)
T ss_dssp             CCSSCCCCG---------------------------G-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCC
T ss_pred             ccccccccc---------------------------c-cccccccccccccccccccc--cccccccccccccccccccc
Confidence            555544322                           1 24455555555555555542  12345555556666665555


Q ss_pred             cccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcc
Q 036342          223 EGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFS  289 (596)
Q Consensus       223 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls  289 (596)
                      ++  +..+..+++|+.+++++|++++..  .+.++++|+.|+|++|.++.+| .+..+++|++|+|+
T Consensus       147 ~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         147 TD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             CC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEE
T ss_pred             cc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCCCh-hhcCCCCCCEEEcc
Confidence            42  223445556666666666655332  2555666666666666665554 35555555555554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=5.5e-20  Score=192.56  Aligned_cols=338  Identities=16%  Similarity=0.097  Sum_probs=226.3

Q ss_pred             cCCCCCCCEEECCCCCCccc----cchhhhCCCCCCEEEccCCcCccc----cCccCccCCCCccEEEccCCccccc---
Q 036342            6 IGNLQNLEELQLGQNKLIGT----VPAAIFNVSTLKFLGLQNNSLSGS----LSSIANVRLPNLEKLYLWGNNFSGT---   74 (596)
Q Consensus         6 ~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~~l~~L~~L~L~~N~l~~~---   74 (596)
                      +..+++++.|+|++|+|+..    ++.++...++|++|||++|+|+..    +.........+|++|+|++|+++..   
T Consensus        23 ~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~  102 (460)
T d1z7xw1          23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG  102 (460)
T ss_dssp             HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred             HHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccc
Confidence            45678999999999998743    345567899999999999998521    1111111235799999999999743   


Q ss_pred             -cCccccCCCCCCEEEccCCcccccCCcc---------------------------------ccCCCCCCEEecCCCcCc
Q 036342           75 -IPRFIFNASKLSKLSLGMNSFSGFIPST---------------------------------FGNLRNLEQLGLDENYLT  120 (596)
Q Consensus        75 -~~~~~~~l~~L~~L~L~~N~i~~~~~~~---------------------------------~~~l~~L~~L~l~~N~l~  120 (596)
                       ++.++..+++|++|+|++|.|+......                                 +.....++.++++.+...
T Consensus       103 ~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~  182 (460)
T d1z7xw1         103 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN  182 (460)
T ss_dssp             HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred             cccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccccccccccccccccccccc
Confidence             4566778899999999999986421111                                 112345666666666543


Q ss_pred             CCCCCccccccC-CCCCCCCEEECcCCCCCccCCc---hhhhcccccccEEEcccccccc-----ccChhccCCCCCCEE
Q 036342          121 SSTPELSFLSSL-SNCKSLTLIDLSNNPLDGILPK---TSISNLSRSLEEFYMYNCNISG-----GIPEEISNLTNLVEI  191 (596)
Q Consensus       121 ~~~~~~~~~~~~-~~l~~L~~L~ls~N~l~~~~~~---~~~~~l~~~L~~L~l~~n~l~~-----~~~~~~~~l~~L~~L  191 (596)
                      ...... ....+ ........+++..+.+......   ..+... ..++.+++++|.+..     ..+..+.....++.+
T Consensus       183 ~~~~~~-~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~-~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l  260 (460)
T d1z7xw1         183 EAGVRV-LCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK-ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL  260 (460)
T ss_dssp             HHHHHH-HHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHC-TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred             cccccc-cccccccccccccccccccccccchhhhccccccccc-ccccccchhhccccccccchhhccccccccccccc
Confidence            210000 00001 1223566788888876532111   011222 578999999998753     233445567789999


Q ss_pred             EccCCcccCCC----CccccCCCCCCeEEccCCcccccCccchh-----cCCCCcEEEccCCcCcccchhh----hccCC
Q 036342          192 DLGGNKLNGSI----PITLGKLRKLQRLNLEDNILEGSIPDDIC-----RLAELYRLELGSNKLYGSIPAC----FGNLA  258 (596)
Q Consensus       192 ~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~p~~----~~~l~  258 (596)
                      ++++|.+....    ...+...+.++.+++++|.++......+.     ....|+.+++++|.++......    +...+
T Consensus       261 ~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~  340 (460)
T d1z7xw1         261 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR  340 (460)
T ss_dssp             ECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhccccccccc
Confidence            99999887432    23456688999999999998643222221     2457999999999987554333    34567


Q ss_pred             CCcEEEeCCCcccC-----CCcccc-cccccceEEcccCCCCCc----hhhhhccccccceEecCCCcCcccCChhhh--
Q 036342          259 SLRILSLGSNKLTS-----IPLTFW-NLKDILQLNFSSNFLTGP----LLLEIGNLKVLIGIDFSMNNFSGVIPREIG--  326 (596)
Q Consensus       259 ~L~~L~Ls~N~l~~-----ip~~~~-~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~~~~~~~~~~~--  326 (596)
                      +|+.|+|++|.++.     ++..+. ..+.|++|+|++|.++..    +...+...+.|++||+++|+|+......+.  
T Consensus       341 ~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~  420 (460)
T d1z7xw1         341 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES  420 (460)
T ss_dssp             SCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHH
T ss_pred             chhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHH
Confidence            89999999999864     333443 356799999999999864    344566778999999999999743222121  


Q ss_pred             --ccCCCCCeEECCCCccccc
Q 036342          327 --EKLSYLEDLNLSFNKLKGE  345 (596)
Q Consensus       327 --~~l~~L~~L~l~~N~l~~~  345 (596)
                        .....|+.|++.+|.+...
T Consensus       421 l~~~~~~L~~l~l~~~~~~~~  441 (460)
T d1z7xw1         421 VRQPGCLLEQLVLYDIYWSEE  441 (460)
T ss_dssp             HTSTTCCCCEEECTTCCCCHH
T ss_pred             HHhCCCccCEEECCCCCCCHH
Confidence              2344799999999998753

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=7.4e-18  Score=155.86  Aligned_cols=159  Identities=31%  Similarity=0.412  Sum_probs=83.1

Q ss_pred             cccEEEccccccccccChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEcc
Q 036342          163 SLEEFYMYNCNISGGIPEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELG  242 (596)
Q Consensus       163 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  242 (596)
                      ++++|++++|+|+..  +.+..+++|++|++++|++++..|  +.++++|++|++++|.+. .++ .+.++++|+.|+++
T Consensus        41 ~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~  114 (199)
T d2omxa2          41 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF  114 (199)
T ss_dssp             TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred             CCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccc
Confidence            344444444444432  224445555555555555554332  555555555555555554 222 25555556666665


Q ss_pred             CCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCCCCchhhhhccccccceEecCCCcCcccCC
Q 036342          243 SNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIP  322 (596)
Q Consensus       243 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~  322 (596)
                      +|.+...  ..+..+++|+.|++++|++..++ .+..+++|++|++++|++++..  .+.++++|+.|++++|+++. ++
T Consensus       115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~  188 (199)
T d2omxa2         115 NNQITDI--DPLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS  188 (199)
T ss_dssp             SSCCCCC--GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG
T ss_pred             ccccccc--cccchhhhhHHhhhhhhhhcccc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-Cc
Confidence            5555432  22455556666666666655544 3455556666666666655432  25556666666666666653 33


Q ss_pred             hhhhccCCCCCeE
Q 036342          323 REIGEKLSYLEDL  335 (596)
Q Consensus       323 ~~~~~~l~~L~~L  335 (596)
                        .+..+++|++|
T Consensus       189 --~l~~L~~L~~L  199 (199)
T d2omxa2         189 --VLAKLTNLESL  199 (199)
T ss_dssp             --GGGGCTTCSEE
T ss_pred             --cccCCCCCCcC
Confidence              23455555544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.75  E-value=1.9e-19  Score=183.12  Aligned_cols=143  Identities=18%  Similarity=0.276  Sum_probs=111.4

Q ss_pred             cccccccccCCCceeehhhH--------------------HhHHHHHHHHhhcC-----------CCccceeeeeeccC-
Q 036342          446 EFSENNLIGRGGFALFIRAF--------------------KSFDVECEMMKSIR-----------HRNLIKVISSCSNE-  493 (596)
Q Consensus       446 ~~~~~~~ig~G~~g~v~~~~--------------------~~~~~e~~~l~~l~-----------H~niv~l~~~~~~~-  493 (596)
                      +|+..+.||+|+||+||+|.                    +.+.+|+.++++++           |+|||++++++..+ 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            59999999999999999862                    34567899888875           57899999988654 


Q ss_pred             -CeeEEEEecCCCCCHH-HHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CceEeCCCCCCCeeeCCCC------c
Q 036342          494 -EFKALVLEYMPHGSLE-KYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYS-ALVIHCDLKPSNVLLDDNM------V  563 (596)
Q Consensus       494 -~~~~lV~e~~~~g~L~-~~l-~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-~~i~Hrdlk~~NILl~~~~------~  563 (596)
                       ...++|++++..+... ... ......+++..+..++.|++.|+.|||   . .+|+||||||+|||++.++      .
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCcccccce
Confidence             4566777776554432 222 223356788899999999999999999   5 7899999999999998654      4


Q ss_pred             EEEeccccccccCCCCCccccccccccccccCC
Q 036342          564 AHLSDFSIAKLLTGEDQSMTQTQTLGTIGYMAP  596 (596)
Q Consensus       564 ~kl~dfGla~~~~~~~~~~~~~~~~gt~~y~aP  596 (596)
                      +|++|||.++....     .....+||+.|+||
T Consensus       171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aP  198 (362)
T d1q8ya_         171 IKIADLGNACWYDE-----HYTNSIQTREYRSP  198 (362)
T ss_dssp             EEECCCTTCEETTB-----CCCSCCSCGGGCCH
T ss_pred             eeEeeccccccccc-----ccccccccccccCh
Confidence            99999999886432     22346799999998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.70  E-value=4.7e-18  Score=156.10  Aligned_cols=113  Identities=16%  Similarity=0.229  Sum_probs=91.1

Q ss_pred             cccccccCCCceeehhhH--------------------------------------HhHHHHHHHHhhcCCCccceeeee
Q 036342          448 SENNLIGRGGFALFIRAF--------------------------------------KSFDVECEMMKSIRHRNLIKVISS  489 (596)
Q Consensus       448 ~~~~~ig~G~~g~v~~~~--------------------------------------~~~~~e~~~l~~l~H~niv~l~~~  489 (596)
                      ...+.||+|+||+||+|.                                      .....|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            457899999999999852                                      123457888999999999998876


Q ss_pred             eccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          490 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       490 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                      ..    .++||||++++...+        ++...+..++.|++++++|||   ..+|+||||||+|||++++ .++++||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            42    379999998865532        233445678999999999999   8999999999999999865 4889999


Q ss_pred             ccccccC
Q 036342          570 SIAKLLT  576 (596)
Q Consensus       570 Gla~~~~  576 (596)
                      |+|+...
T Consensus       147 G~a~~~~  153 (191)
T d1zara2         147 PQSVEVG  153 (191)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9998754

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=1.8e-16  Score=154.95  Aligned_cols=225  Identities=18%  Similarity=0.187  Sum_probs=134.8

Q ss_pred             CEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccc-cCccccCCCCCCEEEcc
Q 036342           13 EELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGT-IPRFIFNASKLSKLSLG   91 (596)
Q Consensus        13 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~   91 (596)
                      ++|||+++.+.......+.. ..+..+.+++..+...+....  ...+|++|||+++.++.. ++..+..+++|++|+|+
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~--~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~   79 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE   79 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCC--CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhc--cCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence            57899988764322222211 245677777766542222222  356899999998887643 34456778889999999


Q ss_pred             CCcccccCCccccCCCCCCEEecCCC-cCcCCCCCccccccCCCCCCCCEEECcCCC-CCccCCchhhhcccccccEEEc
Q 036342           92 MNSFSGFIPSTFGNLRNLEQLGLDEN-YLTSSTPELSFLSSLSNCKSLTLIDLSNNP-LDGILPKTSISNLSRSLEEFYM  169 (596)
Q Consensus        92 ~N~i~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~-l~~~~~~~~~~~l~~~L~~L~l  169 (596)
                      ++.+++..+..+..+++|++|++++| .++..  +  +..-+.++++|++|+++++. ++.......+....++|+.|++
T Consensus        80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~--~--l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l  155 (284)
T d2astb2          80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF--A--LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL  155 (284)
T ss_dssp             TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH--H--HHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred             ccCCCcHHHHHHhcCCCCcCcccccccccccc--c--cchhhHHHHhccccccccccccccccchhhhcccccccchhhh
Confidence            99888777788888888999998885 44421  1  11123567888888888863 4321111122333356777777


Q ss_pred             ccc--ccccc-cChhccCCCCCCEEEccCC-cccCCCCccccCCCCCCeEEccCC-cccccCccchhcCCCCcEEEccCC
Q 036342          170 YNC--NISGG-IPEEISNLTNLVEIDLGGN-KLNGSIPITLGKLRKLQRLNLEDN-ILEGSIPDDICRLAELYRLELGSN  244 (596)
Q Consensus       170 ~~n--~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N  244 (596)
                      +++  .++.. +...+..+++|++|++++| .+++.....+..+++|++|+++++ .++......+..+++|+.|+++++
T Consensus       156 ~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         156 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            754  23321 2223345666777777664 355555555666666666666663 455444445555666666666655

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.63  E-value=1.8e-16  Score=140.84  Aligned_cols=113  Identities=19%  Similarity=0.156  Sum_probs=67.1

Q ss_pred             cCCCCCCCEEECCCCCCccccchhhhCCCCCCEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCC
Q 036342            6 IGNLQNLEELQLGQNKLIGTVPAAIFNVSTLKFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKL   85 (596)
Q Consensus         6 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L   85 (596)
                      +.+..++++|||++|+|+.+ +..+..+++|+.|||++|+|+ .++.+  ..+++|++|++++|+++...+..+..+++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~~~--~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLDGF--PLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EECCC--CCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccCCc--ccCcchhhhhcccccccCCCcccccccccc
Confidence            44556666777777776643 445556666666777666665 34333  236666666666666664444444556666


Q ss_pred             CEEEccCCcccccCC-ccccCCCCCCEEecCCCcCcCC
Q 036342           86 SKLSLGMNSFSGFIP-STFGNLRNLEQLGLDENYLTSS  122 (596)
Q Consensus        86 ~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~  122 (596)
                      ++|+|++|+|+.... ..+..+++|++|++++|.++..
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~  127 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK  127 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred             ccceeccccccccccccccccccccchhhcCCCccccc
Confidence            666666666654322 3455666666666666666543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=7.1e-16  Score=136.89  Aligned_cols=110  Identities=22%  Similarity=0.191  Sum_probs=62.7

Q ss_pred             ccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCc
Q 036342          182 ISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLR  261 (596)
Q Consensus       182 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  261 (596)
                      |.+..++++|||++|+|+.+ +..+..+++|+.|++++|.|+. ++ .+..+++|++|++++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence            45555666666666666643 4445556666666666666662 32 355566666666666666654444555566666


Q ss_pred             EEEeCCCcccCCCc--ccccccccceEEcccCCCC
Q 036342          262 ILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       262 ~L~Ls~N~l~~ip~--~~~~l~~L~~L~ls~N~l~  294 (596)
                      .|+|++|+++.++.  .+..+++|++|++++|+++
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cceeccccccccccccccccccccchhhcCCCccc
Confidence            66666666655542  3444455555555555443

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.60  E-value=2e-16  Score=159.35  Aligned_cols=192  Identities=19%  Similarity=0.280  Sum_probs=81.3

Q ss_pred             ccCCCCCCEEEccCCcccccC----CccccCCCCCCEEecCCCcCcCCCCCc-----cccccCCCCCCCCEEECcCCCCC
Q 036342           79 IFNASKLSKLSLGMNSFSGFI----PSTFGNLRNLEQLGLDENYLTSSTPEL-----SFLSSLSNCKSLTLIDLSNNPLD  149 (596)
Q Consensus        79 ~~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~-----~~~~~~~~l~~L~~L~ls~N~l~  149 (596)
                      +.....|++|+|++|.|....    ...+...++|+.|+++++.........     .+...+..+++|+.|+|++|.+.
T Consensus        27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  106 (344)
T d2ca6a1          27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG  106 (344)
T ss_dssp             HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred             HhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccc
Confidence            333444555555555543221    122334455555555554433221110     11223445566666666666654


Q ss_pred             ccCCc---hhhhcccccccEEEccccccccccCh-------------hccCCCCCCEEEccCCcccCCC----CccccCC
Q 036342          150 GILPK---TSISNLSRSLEEFYMYNCNISGGIPE-------------EISNLTNLVEIDLGGNKLNGSI----PITLGKL  209 (596)
Q Consensus       150 ~~~~~---~~~~~l~~~L~~L~l~~n~l~~~~~~-------------~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l  209 (596)
                      .....   ..+... ++|++|++++|.++.....             .....+.|+.+++++|.+....    ...+...
T Consensus       107 ~~~~~~l~~~l~~~-~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~  185 (344)
T d2ca6a1         107 PTAQEPLIDFLSKH-TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH  185 (344)
T ss_dssp             TTTHHHHHHHHHHC-TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred             cccccchhhhhccc-ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhh
Confidence            32111   011111 3455555555554321111             1123455666666666654221    2223344


Q ss_pred             CCCCeEEccCCccccc-----CccchhcCCCCcEEEccCCcCccc----chhhhccCCCCcEEEeCCCccc
Q 036342          210 RKLQRLNLEDNILEGS-----IPDDICRLAELYRLELGSNKLYGS----IPACFGNLASLRILSLGSNKLT  271 (596)
Q Consensus       210 ~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  271 (596)
                      +.|+.|++++|.++..     +...+...++|+.|+|++|.++..    +...+...++|++|+|++|.|+
T Consensus       186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~  256 (344)
T d2ca6a1         186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS  256 (344)
T ss_dssp             TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred             hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence            5555555555555321     122233444555555555554321    1222334444444444444443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=4.2e-16  Score=152.26  Aligned_cols=222  Identities=15%  Similarity=0.237  Sum_probs=117.2

Q ss_pred             CEEEccCCcCccccCccCccCCCCccEEEccCCccccccCccccCCCCCCEEEccCCccccc-CCccccCCCCCCEEecC
Q 036342           37 KFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGNNFSGTIPRFIFNASKLSKLSLGMNSFSGF-IPSTFGNLRNLEQLGLD  115 (596)
Q Consensus        37 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~  115 (596)
                      +.|||+++.+.........  -..+..+.++...+.. .........+|++|||+++.++.. .+..+..+++|++|+++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~--~~~~~~lrl~~~~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~   79 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLL--SQGVIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE   79 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHH--HTTCSEEECTTCEECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred             CEEECCCCCCCchHHHHHH--hccceEeecccccccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence            5789999887533222111  1245677777776653 233344566899999999988654 34557788999999999


Q ss_pred             CCcCcCCCCCccccccCCCCCCCCEEECcCC-CCCccCCchhhhcccccccEEEcccc-ccccc-cChhccC-CCCCCEE
Q 036342          116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNN-PLDGILPKTSISNLSRSLEEFYMYNC-NISGG-IPEEISN-LTNLVEI  191 (596)
Q Consensus       116 ~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~~l~~~L~~L~l~~n-~l~~~-~~~~~~~-l~~L~~L  191 (596)
                      +|.++..     .+..++.+++|++|+++++ .++...-......+ ++|++|++++| .++.. ....+.. .++|+.|
T Consensus        80 ~~~l~~~-----~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~-~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L  153 (284)
T d2astb2          80 GLRLSDP-----IVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC-SRLDELNLSWCFDFTEKHVQVAVAHVSETITQL  153 (284)
T ss_dssp             TCBCCHH-----HHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHC-TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEE
T ss_pred             ccCCCcH-----HHHHHhcCCCCcCccccccccccccccchhhHHH-Hhccccccccccccccccchhhhcccccccchh
Confidence            9987642     2345777888999999885 44421000011223 45666666664 23321 1112222 2455666


Q ss_pred             EccCCc--ccCC-CCccccCCCCCCeEEccCC-cccccCccchhcCCCCcEEEccCC-cCcccchhhhccCCCCcEEEeC
Q 036342          192 DLGGNK--LNGS-IPITLGKLRKLQRLNLEDN-ILEGSIPDDICRLAELYRLELGSN-KLYGSIPACFGNLASLRILSLG  266 (596)
Q Consensus       192 ~Ls~N~--l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls  266 (596)
                      +++++.  ++.. +...+..+++|++|++++| .+++.....+..+++|++|+++++ .+++.....++.+++|+.|+++
T Consensus       154 ~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~  233 (284)
T d2astb2         154 NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF  233 (284)
T ss_dssp             ECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred             hhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeee
Confidence            655432  2211 1112233445555555543 234333344444444555555442 3333333333444444444443


Q ss_pred             C
Q 036342          267 S  267 (596)
Q Consensus       267 ~  267 (596)
                      +
T Consensus       234 ~  234 (284)
T d2astb2         234 G  234 (284)
T ss_dssp             T
T ss_pred             C
Confidence            3

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.60  E-value=3.6e-15  Score=125.85  Aligned_cols=100  Identities=25%  Similarity=0.295  Sum_probs=51.7

Q ss_pred             CEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCC
Q 036342          189 VEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSN  268 (596)
Q Consensus       189 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  268 (596)
                      ++|||++|+++. ++ .+..+++|++|++++|.|+ .+|+.+..+++|+.|++++|+|+.. | .+..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence            345666666653 22 2555566666666666665 3455555555566666666655532 2 2555555555555555


Q ss_pred             cccCCCc--ccccccccceEEcccCCC
Q 036342          269 KLTSIPL--TFWNLKDILQLNFSSNFL  293 (596)
Q Consensus       269 ~l~~ip~--~~~~l~~L~~L~ls~N~l  293 (596)
                      +++.+|.  .+..+++|++|++++|++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i  102 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSL  102 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcC
Confidence            5555442  233344444444444443

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.56  E-value=6.4e-16  Score=155.49  Aligned_cols=218  Identities=17%  Similarity=0.150  Sum_probs=112.3

Q ss_pred             hhhhCCCCCCEEEccCCcCcccc-Ccc--CccCCCCccEEEccCCccccc----------cCccccCCCCCCEEEccCCc
Q 036342           28 AAIFNVSTLKFLGLQNNSLSGSL-SSI--ANVRLPNLEKLYLWGNNFSGT----------IPRFIFNASKLSKLSLGMNS   94 (596)
Q Consensus        28 ~~~~~l~~L~~L~Ls~N~l~~~~-~~~--~~~~l~~L~~L~L~~N~l~~~----------~~~~~~~l~~L~~L~L~~N~   94 (596)
                      ..+....+|++|+|++|.+...- ..+  .....++|+.|+++++.....          +...+...++|++|+|++|.
T Consensus        25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~  104 (344)
T d2ca6a1          25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA  104 (344)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred             HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence            34556778888888888774211 011  122356777777776654311          11123344556666666665


Q ss_pred             ccccC----CccccCCCCCCEEecCCCcCcCCCCCc--------cccccCCCCCCCCEEECcCCCCCccCCchhhhcccc
Q 036342           95 FSGFI----PSTFGNLRNLEQLGLDENYLTSSTPEL--------SFLSSLSNCKSLTLIDLSNNPLDGILPKTSISNLSR  162 (596)
Q Consensus        95 i~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~--------~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~l~~  162 (596)
                      ++...    ...+...++|++|++++|.++......        .........+                          
T Consensus       105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~--------------------------  158 (344)
T d2ca6a1         105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAP--------------------------  158 (344)
T ss_dssp             CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCC--------------------------
T ss_pred             cccccccchhhhhcccccchheecccccccccccccccccccccccccccccCc--------------------------
Confidence            54321    122234455555555555443210000        0000011233                          


Q ss_pred             cccEEEccccccccc----cChhccCCCCCCEEEccCCcccCC-----CCccccCCCCCCeEEccCCccccc----Cccc
Q 036342          163 SLEEFYMYNCNISGG----IPEEISNLTNLVEIDLGGNKLNGS-----IPITLGKLRKLQRLNLEDNILEGS----IPDD  229 (596)
Q Consensus       163 ~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~  229 (596)
                      .|+.+++++|.++..    +...+...+.|+.|++++|.+...     +...+..+++|+.|++++|.++..    +...
T Consensus       159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~  238 (344)
T d2ca6a1         159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA  238 (344)
T ss_dssp             CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred             ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence            445555555554421    223344556677777777776531     233456667777777777776522    3344


Q ss_pred             hhcCCCCcEEEccCCcCcccchhhhc----c--CCCCcEEEeCCCccc
Q 036342          230 ICRLAELYRLELGSNKLYGSIPACFG----N--LASLRILSLGSNKLT  271 (596)
Q Consensus       230 ~~~l~~L~~L~Ls~N~l~~~~p~~~~----~--l~~L~~L~Ls~N~l~  271 (596)
                      +..+++|+.|+|++|.|++.....+.    .  .++|++|++++|.++
T Consensus       239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~  286 (344)
T d2ca6a1         239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE  286 (344)
T ss_dssp             GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred             ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence            56677788888888877654333332    1  234666666666554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.56  E-value=9.9e-15  Score=123.07  Aligned_cols=101  Identities=21%  Similarity=0.302  Sum_probs=45.9

Q ss_pred             eEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCcccccccccceEEcccCCC
Q 036342          214 RLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPLTFWNLKDILQLNFSSNFL  293 (596)
Q Consensus       214 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l  293 (596)
                      +|+|++|.|+ .++ .+..+++|++|++++|+|+ .+|..++.+++|+.|++++|.|+.+| .+..+++|+.|++++|++
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~i   77 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRL   77 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCC
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC-ccccccccCeEECCCCcc
Confidence            4444444444 222 2444444444455444444 23334444444444555444444443 244444444444444444


Q ss_pred             CCch-hhhhccccccceEecCCCcCc
Q 036342          294 TGPL-LLEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       294 ~~~~-~~~~~~l~~L~~L~ls~N~~~  318 (596)
                      +... ...+..+++|+.||+++|.++
T Consensus        78 ~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          78 QQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             CCCCCchhhcCCCCCCEEECCCCcCC
Confidence            4322 233444444444444444443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.43  E-value=2.7e-15  Score=137.83  Aligned_cols=111  Identities=22%  Similarity=0.270  Sum_probs=60.4

Q ss_pred             ChhccCCCCCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCC
Q 036342          179 PEEISNLTNLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLA  258 (596)
Q Consensus       179 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  258 (596)
                      |..+..+++|++|+|++|+|+.+ + .+.++++|++|++++|.|+ .+|..+..+++|+.|++++|+++.. + .+..++
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~-~~~~l~  115 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-S-GIEKLV  115 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-H-HHHHHH
T ss_pred             hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-c-cccccc
Confidence            34555566666666666666533 2 3556666666666666665 3444444444566666666665532 2 355555


Q ss_pred             CCcEEEeCCCcccCCCc--ccccccccceEEcccCCCC
Q 036342          259 SLRILSLGSNKLTSIPL--TFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       259 ~L~~L~Ls~N~l~~ip~--~~~~l~~L~~L~ls~N~l~  294 (596)
                      +|+.|+|++|+++.++.  .+..+++|+.|++++|++.
T Consensus       116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccccchhccccccccccCCCccceeecCCCccc
Confidence            56666666665555442  3445555555555555443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.40  E-value=1.8e-14  Score=132.25  Aligned_cols=127  Identities=22%  Similarity=0.246  Sum_probs=69.3

Q ss_pred             CCCEEEccCC--cccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEE
Q 036342          187 NLVEIDLGGN--KLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILS  264 (596)
Q Consensus       187 ~L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  264 (596)
                      .++.++++++  .+. ..+..+..+++|++|+|++|.|+ .++ .+..+++|++|+|++|.|+ .+|..+..+++|+.|+
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~   99 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW   99 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccc
Confidence            3455555543  122 23445666666666666666666 333 3556666666666666665 3344444445566666


Q ss_pred             eCCCcccCCCcccccccccceEEcccCCCCCchh-hhhccccccceEecCCCcCc
Q 036342          265 LGSNKLTSIPLTFWNLKDILQLNFSSNFLTGPLL-LEIGNLKVLIGIDFSMNNFS  318 (596)
Q Consensus       265 Ls~N~l~~ip~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~~~  318 (596)
                      +++|.++.++ .+..+++|+.|++++|+++.... ..+..+++|+.|++++|.+.
T Consensus       100 l~~N~i~~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         100 ISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             CSEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccccc-cccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            6666666553 24455556666666666554322 34555555555555555554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.39  E-value=9.5e-13  Score=115.53  Aligned_cols=105  Identities=24%  Similarity=0.242  Sum_probs=56.4

Q ss_pred             CEEEccCCcCccccCccCccCCCCccEEEccCC-ccccccCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEecC
Q 036342           37 KFLGLQNNSLSGSLSSIANVRLPNLEKLYLWGN-NFSGTIPRFIFNASKLSKLSLGMNSFSGFIPSTFGNLRNLEQLGLD  115 (596)
Q Consensus        37 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~  115 (596)
                      +.++.+++.++..+..+.  .+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+++|.++++|++|+|+
T Consensus        11 ~~l~c~~~~~~~~p~~l~--~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3          11 SGLRCTRDGALDSLHHLP--GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SCEECCSSCCCTTTTTSC--SCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CeEEecCCCCccCccccc--CccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            344555554442222222  2455555555443 3554444556666666666666666666666666666666666666


Q ss_pred             CCcCcCCCCCccccccCCCCCCCCEEECcCCCCC
Q 036342          116 ENYLTSSTPELSFLSSLSNCKSLTLIDLSNNPLD  149 (596)
Q Consensus       116 ~N~l~~~~~~~~~~~~~~~l~~L~~L~ls~N~l~  149 (596)
                      +|+|+.++++     .|..+ +|+.|+|++|++.
T Consensus        89 ~N~l~~l~~~-----~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          89 FNALESLSWK-----TVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             SSCCSCCCST-----TTCSC-CCCEEECCSSCCC
T ss_pred             CCCCcccChh-----hhccc-cccccccCCCccc
Confidence            6666655443     13322 4666666666663

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=9.8e-13  Score=115.45  Aligned_cols=107  Identities=21%  Similarity=0.139  Sum_probs=73.8

Q ss_pred             CCCEEEccCCcccCCCCccccCCCCCCeEEccCC-cccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEe
Q 036342          187 NLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDN-ILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSL  265 (596)
Q Consensus       187 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  265 (596)
                      ..+.++.+++.+. ..|..+.++++|++|++++| .|+...+..|.++++|+.|+|++|+|+.+.+..|..+++|++|+|
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            3445666666665 34555666777777777655 466555566777777777777777777666777777777777777


Q ss_pred             CCCcccCCCcccccccccceEEcccCCCC
Q 036342          266 GSNKLTSIPLTFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       266 s~N~l~~ip~~~~~l~~L~~L~ls~N~l~  294 (596)
                      ++|+|+.+|.......+|+.|+|++|++.
T Consensus        88 s~N~l~~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          88 SFNALESLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred             cCCCCcccChhhhccccccccccCCCccc
Confidence            77777777776555556777777777664

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.69  E-value=9.2e-10  Score=96.72  Aligned_cols=103  Identities=23%  Similarity=0.227  Sum_probs=53.7

Q ss_pred             CCCEEEccCCcccCCCCccccCCCCCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccc--hhhhccCCCCcEEE
Q 036342          187 NLVEIDLGGNKLNGSIPITLGKLRKLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSI--PACFGNLASLRILS  264 (596)
Q Consensus       187 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~  264 (596)
                      +.+.||++++...   + .+..+..+..++..+|... .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            3455566554422   1 2333444444444444433 34444455667777777777766432  34455666666666


Q ss_pred             eCCCcccCCCc-ccccccccceEEcccCCCC
Q 036342          265 LGSNKLTSIPL-TFWNLKDILQLNFSSNFLT  294 (596)
Q Consensus       265 Ls~N~l~~ip~-~~~~l~~L~~L~ls~N~l~  294 (596)
                      |++|.++.++. .+....+|+.|++++|+++
T Consensus        98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          98 LSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             cccCccccchhhhhhhccccceeecCCCCcC
Confidence            66666666554 2222334555555555554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.63  E-value=2.3e-09  Score=94.10  Aligned_cols=121  Identities=21%  Similarity=0.136  Sum_probs=72.7

Q ss_pred             CCCeEEccCCcccccCccchhcCCCCcEEEccCCcCcccchhhhccCCCCcEEEeCCCcccCCCc---ccccccccceEE
Q 036342          211 KLQRLNLEDNILEGSIPDDICRLAELYRLELGSNKLYGSIPACFGNLASLRILSLGSNKLTSIPL---TFWNLKDILQLN  287 (596)
Q Consensus       211 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ip~---~~~~l~~L~~L~  287 (596)
                      +.+.|+++++...    ..+..+..+..++...|.. ..++..+..+++|++|+|++|+|+.++.   .+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~-~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHH-HHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHh-hhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            4556677665432    2344444444555544433 3455666678888888888888887642   345677777777


Q ss_pred             cccCCCCCchhhhhccccccceEecCCCcCcccCCh------hhhccCCCCCeEE
Q 036342          288 FSSNFLTGPLLLEIGNLKVLIGIDFSMNNFSGVIPR------EIGEKLSYLEDLN  336 (596)
Q Consensus       288 ls~N~l~~~~~~~~~~l~~L~~L~ls~N~~~~~~~~------~~~~~l~~L~~L~  336 (596)
                      |++|.++......+.....|+.|++++|.+......      ..+..+|+|+.||
T Consensus        98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            777777765544444445567777777777644332      1234566666665

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.79  E-value=1.5e-05  Score=69.36  Aligned_cols=39  Identities=10%  Similarity=0.290  Sum_probs=16.9

Q ss_pred             CCCCCEEEccCC-cccCC----CCccccCCCCCCeEEccCCccc
Q 036342          185 LTNLVEIDLGGN-KLNGS----IPITLGKLRKLQRLNLEDNILE  223 (596)
Q Consensus       185 l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~  223 (596)
                      .++|++|+|+++ .+...    +..++...++|+.|++++|.+.
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS   57 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence            355566666542 23321    1122333344555555555443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.67  E-value=2e-05  Score=68.51  Aligned_cols=66  Identities=14%  Similarity=0.171  Sum_probs=34.9

Q ss_pred             hccCCCCCCEEEccCCcccCCC----CccccCCCCCCeEEccCCcccccC----ccchhcCCCCcEEEccCCcC
Q 036342          181 EISNLTNLVEIDLGGNKLNGSI----PITLGKLRKLQRLNLEDNILEGSI----PDDICRLAELYRLELGSNKL  246 (596)
Q Consensus       181 ~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l  246 (596)
                      ++...+.|++|++++|.+....    ...+...+.|++|+|++|.|+..-    -..+...++|+.|++++|.+
T Consensus        39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred             HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence            3445566777777777665322    223334556666666666665321    11233345566666665543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.40  E-value=0.00021  Score=66.64  Aligned_cols=102  Identities=17%  Similarity=0.137  Sum_probs=71.1

Q ss_pred             hHHHHHHHHhhcC-CCccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhccC---
Q 036342          467 SFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY---  542 (596)
Q Consensus       467 ~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---  542 (596)
                      .+.+|..++..+. +--+.+++++...++..++|||+++|..+.+.....      .+...++.++++.+..+|...   
T Consensus        55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~  128 (263)
T d1j7la_          55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISD  128 (263)
T ss_dssp             CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccc
Confidence            4678888877664 444678888888888899999999998876543221      112224455555555555210   


Q ss_pred             -----------------------------------------------------CCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          543 -----------------------------------------------------SALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       543 -----------------------------------------------------~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                                                                           ...++|+|+.|.||++++++.+-+.||
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDw  208 (263)
T d1j7la_         129 CPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL  208 (263)
T ss_dssp             CSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred             cccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeec
Confidence                                                                 112789999999999998777779999


Q ss_pred             ccccc
Q 036342          570 SIAKL  574 (596)
Q Consensus       570 Gla~~  574 (596)
                      +.+..
T Consensus       209 e~a~~  213 (263)
T d1j7la_         209 GRSGR  213 (263)
T ss_dssp             TTCEE
T ss_pred             hhccc
Confidence            87764

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.15  E-value=7.1e-05  Score=64.79  Aligned_cols=90  Identities=13%  Similarity=0.169  Sum_probs=42.7

Q ss_pred             CCCccEEEccCCccccc----cCccccCCCCCCEEEccCCccccc----CCccccCCCCCCEEec--CCCcCcCCCCCcc
Q 036342           58 LPNLEKLYLWGNNFSGT----IPRFIFNASKLSKLSLGMNSFSGF----IPSTFGNLRNLEQLGL--DENYLTSSTPELS  127 (596)
Q Consensus        58 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~l--~~N~l~~~~~~~~  127 (596)
                      .++|++|+|++|.++..    +-..+...+.++.+++++|.+...    +...+...++|+.++|  ++|.+..... ..
T Consensus        45 n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~-~~  123 (166)
T d1io0a_          45 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE-ME  123 (166)
T ss_dssp             CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH-HH
T ss_pred             CCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH-HH
Confidence            34455555555544321    111233345566666666655432    2234455566665444  3444433110 01


Q ss_pred             ccccCCCCCCCCEEECcCCCC
Q 036342          128 FLSSLSNCKSLTLIDLSNNPL  148 (596)
Q Consensus       128 ~~~~~~~l~~L~~L~ls~N~l  148 (596)
                      +...+...++|+.|+++.+..
T Consensus       124 La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_         124 IANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHhCCCcCEEeCcCCCC
Confidence            223355667777887766543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.10  E-value=0.00019  Score=61.98  Aligned_cols=40  Identities=13%  Similarity=0.145  Sum_probs=17.9

Q ss_pred             cCCCCCCEEEccC-CcccCC----CCccccCCCCCCeEEccCCcc
Q 036342          183 SNLTNLVEIDLGG-NKLNGS----IPITLGKLRKLQRLNLEDNIL  222 (596)
Q Consensus       183 ~~l~~L~~L~Ls~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l  222 (596)
                      .+.++|++|++++ +.++..    +..++...++|++|++++|.+
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l   58 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRS   58 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCC
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcc
Confidence            3445566666655 334321    112233444455555555544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.40  E-value=0.0022  Score=58.96  Aligned_cols=99  Identities=17%  Similarity=0.165  Sum_probs=63.1

Q ss_pred             hHHHHHHHHhhcCC--CccceeeeeeccCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh-----
Q 036342          467 SFDVECEMMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----  539 (596)
Q Consensus       467 ~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lh-----  539 (596)
                      .+..|..+++.+..  -.+.+++++..+++..++||||++|.++.+..      ...   ...+.++++.+.-||     
T Consensus        50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~------~~~---~~~~~~l~~~la~LH~~~~~  120 (255)
T d1nd4a_          50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH------LAP---AEKVSIMADAMRRLHTLDPA  120 (255)
T ss_dssp             CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC------CCH---HHHHHHHHHHHHHHTTSCGG
T ss_pred             HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc------ccH---HHHHHHHHHHHHHHccCChh
Confidence            46778887776643  34677888888888899999999886542210      000   011122222222222     


Q ss_pred             ----------------------------------------------c----cCCCceEeCCCCCCCeeeCCCCcEEEecc
Q 036342          540 ----------------------------------------------F----GYSALVIHCDLKPSNVLLDDNMVAHLSDF  569 (596)
Q Consensus       540 ----------------------------------------------~----~~~~~i~Hrdlk~~NILl~~~~~~kl~df  569 (596)
                                                                    .    .....++|+|+.|.||+++++..+-|.||
T Consensus       121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~  200 (255)
T d1nd4a_         121 TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC  200 (255)
T ss_dssp             GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred             hCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEc
Confidence                                                          1    01223799999999999998777789999


Q ss_pred             ccccc
Q 036342          570 SIAKL  574 (596)
Q Consensus       570 Gla~~  574 (596)
                      +.+..
T Consensus       201 ~~~~~  205 (255)
T d1nd4a_         201 GRLGV  205 (255)
T ss_dssp             TTCEE
T ss_pred             hhccc
Confidence            98764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=94.33  E-value=0.038  Score=54.05  Aligned_cols=31  Identities=19%  Similarity=0.313  Sum_probs=26.0

Q ss_pred             CCceEeCCCCCCCeeeCCCCcEEEeccccccc
Q 036342          543 SALVIHCDLKPSNVLLDDNMVAHLSDFSIAKL  574 (596)
Q Consensus       543 ~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~~  574 (596)
                      ...++|+|+.+.|||++++. ++|.||-.|..
T Consensus       222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             CCEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             CcceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            44689999999999998764 89999987763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=88.50  E-value=0.16  Score=49.24  Aligned_cols=37  Identities=19%  Similarity=0.249  Sum_probs=25.2

Q ss_pred             hHHHHHHHHhhcCCCc-cceeeeeeccCCeeEEEEecCCCCC
Q 036342          467 SFDVECEMMKSIRHRN-LIKVISSCSNEEFKALVLEYMPHGS  507 (596)
Q Consensus       467 ~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~e~~~~g~  507 (596)
                      ...+|..+++.+.-.+ .+++++++.+    .+|+||++|..
T Consensus        90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~  127 (395)
T d1nw1a_          90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP  127 (395)
T ss_dssp             HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEecccc
Confidence            3457888888774333 4578888754    58999998743

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=81.47  E-value=0.41  Score=44.50  Aligned_cols=32  Identities=38%  Similarity=0.414  Sum_probs=28.5

Q ss_pred             CCCceEeCCCCCCCeeeCCCCcEEEecccccc
Q 036342          542 YSALVIHCDLKPSNVLLDDNMVAHLSDFSIAK  573 (596)
Q Consensus       542 ~~~~i~Hrdlk~~NILl~~~~~~kl~dfGla~  573 (596)
                      ...+++|+|+.++||+++.+...-|.||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccceeEecccccc
Confidence            46789999999999999998888899999776